	Unnamed: 0	#TRI ID	texts	TF	TG	labels	Type	validated?
1	1	16373364:0:Ets1:IL-5	A role for [TF], synergizing with AP-1 and GATA-3 in the regulation of [TG] transcription in mouse Th2 lymphocytes.	Ets1	IL-5	0	UNDEFINED	False
4	4	16373364:0:GATA-3:IL-5	A role for Ets1, synergizing with AP-1 and [TF] in the regulation of [TG] transcription in mouse Th2 lymphocytes.	GATA-3	IL-5	0	UNDEFINED	False
8	8	16373364:0:AP-1:IL-5	A role for Ets1, synergizing with [TF] and GATA-3 in the regulation of [TG] transcription in mouse Th2 lymphocytes.	AP-1	IL-5	0	UNDEFINED	False
9	9	16624804:2:ILF:interleukin-2	[TF] can bind to purine-rich regulatory motifs such as the human T-cell leukemia virus-long terminal region and the [TG] promoter.	ILF	interleukin-2	0	UNDEFINED	False
50	50	1321810:4:HNF-1:albumin	Competition gel mobility shift assays suggested that this protein is [TF], which regulates the promoter of the [TG] gene and several other liver-specific genes.	HNF-1	albumin	0	UNDEFINED	False
52	52	11274170:0:PEA3:cyclooxygenase-2	[TF] is up-regulated in response to Wnt1 and activates the expression of [TG].	PEA3	cyclooxygenase-2	1	ACTIVATION	False
53	53	11274170:0:PEA3:matrilysin	We have previously observed coordinate regulation of the [TG] promoter by beta-catenin and Ets family transcription factors of the [TF] subfamily.	PEA3	matrilysin	0	UNDEFINED	False
55	55	11274170:0:PEA3:COX-2 promoter	Promoter mapping experiments suggest that the NF-IL6 site in the [TG] is important for mediating [TF] responsiveness.	PEA3	COX-2 promoter	0	UNDEFINED	False
56	56	11274170:0:PEA3:COX-2	Therefore, we speculate that [TF] factors may contribute to the up-regulation of [TG] expression resulting from both APC mutation and Wnt1 expression.	PEA3	COX-2	1	ACTIVATION	False
59	59	11274170:0:NF-IL6:COX-2	The [TF] site is also important for [TG] transcription in some colorectal cancer lines (Shao, J., Sheng, H., Inoue, H., Morrow, J. D., and DuBois, R.	NF-IL6	COX-2	0	UNDEFINED	True
62	62	21308711:8:AR:MUC1	Stable introduction of exogenous AR in PC3 (PC3/AR) cells and then silencing of AR confirmed [TF]-mediated repression of the [TG] promoter.	AR	MUC1	2	REPRESSION	False
64	64	10744634:7:p53:bax	In addition, we show that GR activation increases and MR activation decreases levels of the tumor suppressor protein [TF] (a direct transcriptional regulator of [TG] and bcl-2 genes), thus providing new information on the early genetic events linking corticosteroid receptors with apoptosis in the nervous system.	p53	bax	0	UNDEFINED	False
65	65	10744634:7:p53:bcl-2	In addition, we show that GR activation increases and MR activation decreases levels of the tumor suppressor protein [TF] (a direct transcriptional regulator of bax and [TG] genes), thus providing new information on the early genetic events linking corticosteroid receptors with apoptosis in the nervous system.	p53	bcl-2	0	UNDEFINED	False
72	72	10744634:7:GR:p53	In addition, we show that [TF] activation increases and MR activation decreases levels of the tumor suppressor protein [TG] (a direct transcriptional regulator of bax and bcl-2 genes), thus providing new information on the early genetic events linking corticosteroid receptors with apoptosis in the nervous system.	GR	p53	1	ACTIVATION	True
76	76	10744634:7:MR:p53	In addition, we show that GR activation increases and [TF] activation decreases levels of the tumor suppressor protein [TG] (a direct transcriptional regulator of bax and bcl-2 genes), thus providing new information on the early genetic events linking corticosteroid receptors with apoptosis in the nervous system.	MR	p53	2	REPRESSION	True
80	80	22615834:9:CTCF:RARRES1	Furthermore, knocking-down CTCF expression hampered RARRES1 expression, suggesting [TF] positively regulated [TG] transcription presumably by binding to unmethylated promoter poised at transcription-ready state.	CTCF	RARRES1	1	ACTIVATION	False
83	83	10910082:15:p53:VEGF	These data indicated that wt [TF] can suppress angiogenesis in human soft-tissue sarcomas by transcriptional repression of [TG] expression.	p53	VEGF	2	REPRESSION	False
90	90	19757157:4:STAT1:MUC4	Through promoter screening, overexpressing methods and luciferase reporter studies, we found that transcription factors CREB, Ets-1, Elk-1 and [TF] can positively regulate [TG] expression at the promoter and mRNA level.	STAT1	MUC4	1	ACTIVATION	False
94	94	19757157:4:Elk-1:MUC4	Through promoter screening, overexpressing methods and luciferase reporter studies, we found that transcription factors CREB, Ets-1, [TF] and STAT1 can positively regulate [TG] expression at the promoter and mRNA level.	Elk-1	MUC4	1	ACTIVATION	False
98	98	19757157:4:Ets-1:MUC4	Through promoter screening, overexpressing methods and luciferase reporter studies, we found that transcription factors CREB, [TF], Elk-1 and STAT1 can positively regulate [TG] expression at the promoter and mRNA level.	Ets-1	MUC4	1	ACTIVATION	False
102	102	19757157:4:CREB:MUC4	Through promoter screening, overexpressing methods and luciferase reporter studies, we found that transcription factors [TF], Ets-1, Elk-1 and STAT1 can positively regulate [TG] expression at the promoter and mRNA level.	CREB	MUC4	1	ACTIVATION	False
109	109	1316240:5:RAR:RAR beta 2	We propose a model for transcriptional regulation of the [TG] promoter in EC cells in which [TF], following activation by RA, functionally interacts with hTFIID via an E1A-like activity present in EC cells.	RAR	RAR beta 2	0	UNDEFINED	True
116	116	12700240:10:Ptx1:LHbeta	Our results suggested that MIP-2A expression inhibits SF-1- and [TF]-mediated transactivation of [TG] promoter.	Ptx1	LHbeta	1	ACTIVATION	False
120	120	12700240:10:SF-1:LHbeta	Our results suggested that MIP-2A expression inhibits [TF]- and Ptx1-mediated transactivation of [TG] promoter.	SF-1	LHbeta	1	ACTIVATION	False
126	126	12560487:0:early growth response (EGR) protein:IL-2	Two important transcription factors, i.e., [TF] EGR-1 and nuclear factors of activated T cells (NFAT) protein NFATc, regulate transcription of the human [TG] cytokine and the same combination of EGR and NFAT proteins seems relevant for coordinated cytokine expression.	early growth response (EGR) protein	IL-2	0	UNDEFINED	False
131	131	12560487:0:EGR-1:IL-2	Two important transcription factors, i.e., early growth response (EGR) protein [TF] and nuclear factors of activated T cells (NFAT) protein NFATc, regulate transcription of the human [TG] cytokine and the same combination of EGR and NFAT proteins seems relevant for coordinated cytokine expression.	EGR-1	IL-2	0	UNDEFINED	False
141	141	12560487:0:NFATc:IL-2	Two important transcription factors, i.e., early growth response (EGR) protein EGR-1 and nuclear factors of activated T cells (NFAT) protein [TF], regulate transcription of the human [TG] cytokine and the same combination of EGR and NFAT proteins seems relevant for coordinated cytokine expression.	NFATc	IL-2	0	UNDEFINED	False
146	146	12560487:0:EGR:IL-2	Two important transcription factors, i.e., early growth response ([TF]) protein EGR-1 and nuclear factors of activated T cells (NFAT) protein NFATc, regulate transcription of the human [TG] cytokine and the same combination of EGR and NFAT proteins seems relevant for coordinated cytokine expression.	EGR	IL-2	0	UNDEFINED	False
148	148	12560487:0:EGR-1:TNFalpha	Here we demonstrate that the zinc finger protein [TF] and two members of the NFAT protein family bind simultaneously to adjacent elements position -168 to -150 within the [TG] promoter.	EGR-1	TNFalpha	0	UNDEFINED	False
166	166	9515031:8:c-fos:c-fos	TGF-beta1 is involved in the regulation of [TG] gene expression through the [TF] SRE and is subsequently involved in the regulation of the gene which has the TRE in the promoter/enhancer region.	c-fos	c-fos	0	UNDEFINED	True
168	168	11358817:6:retinoic acid receptor beta:RARbeta	Furthermore, induction with all of the compounds was accompanied by up-regulation of mRNA levels of the nuclear [TF] (RARbeta) and specific activation of a reporter gene construct (SVbetaRE-CAT) that contains the canonical RA response element located in the [TG] promoter.	retinoic acid receptor beta	RARbeta	1	ACTIVATION	True
174	174	11358817:6:RA:RARbeta	Furthermore, induction with all of the compounds was accompanied by up-regulation of mRNA levels of the nuclear retinoic acid receptor beta (RARbeta) and specific activation of a reporter gene construct (SVbetaRE-CAT) that contains the canonical [TF] response element located in the [TG] promoter.	RA	RARbeta	1	ACTIVATION	True
175	175	15304486:4:NFATc1:cathepsin K	The reporter gene analysis with sequential 5'-deletion constructs of the [TG] gene promoter indicates that limited sets of the transcription factors such as [TF], PU.1,	NFATc1	cathepsin K	0	UNDEFINED	True
177	177	15304486:4:PU.1:cathepsin K	The reporter gene analysis with sequential 5'-deletion constructs of the [TG] gene promoter indicates that limited sets of the transcription factors such as NFATc1, [TF],	PU.1	cathepsin K	0	UNDEFINED	True
179	179	16728402:0:R1:monoamine oxidase A	In summary, this study shows that glucocorticoid enhances [TG] gene expression by 1) regulation of R1 translocation; 2) direct interaction of the glucocorticoid receptor with the third glucocorticoid/androgen response element; and 3) indirect interaction of glucocorticoid receptor with the Sp1 or [TF] transcription factor on Sp1-binding sites of the MAO A promoter.	R1	monoamine oxidase A	1	ACTIVATION	True
185	185	16728402:0:R1:MAO A	In summary, this study shows that glucocorticoid enhances monoamine oxidase A gene expression by 1) regulation of R1 translocation; 2) direct interaction of the glucocorticoid receptor with the third glucocorticoid/androgen response element; and 3) indirect interaction of glucocorticoid receptor with the Sp1 or [TF] transcription factor on Sp1-binding sites of the [TG] promoter.	R1	MAO A	0	UNDEFINED	True
188	188	16728402:0:RAM2:MAO A	A novel transcription factor R1 ([TF]/CDCA7L) interacts with Sp1-binding sites and represses [TG] gene expression.	RAM2	MAO A	2	REPRESSION	False
192	192	16728402:0:CDCA7L:MAO A	A novel transcription factor R1 (RAM2/[TF]) interacts with Sp1-binding sites and represses [TG] gene expression.	CDCA7L	MAO A	2	REPRESSION	False
196	196	16728402:0:Sp1:MAO A	In summary, this study shows that glucocorticoid enhances monoamine oxidase A gene expression by 1) regulation of R1 translocation; 2) direct interaction of the glucocorticoid receptor with the third glucocorticoid/androgen response element; and 3) indirect interaction of glucocorticoid receptor with the Sp1 or R1 transcription factor on [TF]-binding sites of the [TG] promoter.	Sp1	MAO A	1	ACTIVATION	True
199	199	16728402:0:glucocorticoid receptor:monoamine oxidase A	In summary, this study shows that glucocorticoid enhances [TG] gene expression by 1) regulation of R1 translocation; 2) direct interaction of the glucocorticoid receptor with the third glucocorticoid/androgen response element; and 3) indirect interaction of [TF] with the Sp1 or R1 transcription factor on Sp1-binding sites of the MAO A promoter.	glucocorticoid receptor	monoamine oxidase A	1	ACTIVATION	True
205	206	16728402:0:androgen receptor:MAO A	Androgen also up-regulates [TG] gene expression by direct interaction of [TF] with the third glucocorticoid/androgen response element.	androgen receptor	MAO A	1	ACTIVATION	False
209	210	22537161:10:E2F1:MUC4	Our studies show that agents that can promote the growth and invasion of pancreatic cancer cells induce the [TG] gene through multiple pathways and this induction requires the transcriptional activity of [TF] and STAT1.	E2F1	MUC4	1	ACTIVATION	False
211	212	22537161:10:STAT1:MUC4	Our studies show that agents that can promote the growth and invasion of pancreatic cancer cells induce the [TG] gene through multiple pathways and this induction requires the transcriptional activity of E2F1 and [TF].	STAT1	MUC4	1	ACTIVATION	False
215	216	15564063:1:RUNX2:MMP-13	To understand the molecular mechanisms that lead to increased MMP-13 expression and cartilage degeneration during the progression of osteoarthritis (OA), we have investigated the expression of the transcription factor RUNX2 in OA cartilage and the regulation of [TG] expression by [TF] and FGF2 in articular chondrocytes.	RUNX2	MMP-13	0	UNDEFINED	False
217	218	11026574:9:ER alpha:keratin 19	The results of transfections with either the K19 gene promoter or the heterologous thymidine kinase promoter and constructs containing mutated or deleted portions of the enhancer region show that the K19 ERE is responsible for the E2-dependent transactivation of the [TG] gene and for the synergism that is observed between E2 and TPA with both [TF] and ER beta.	ER alpha	keratin 19	1	ACTIVATION	True
222	223	11026574:9:ER beta:keratin 19	The results of transfections with either the K19 gene promoter or the heterologous thymidine kinase promoter and constructs containing mutated or deleted portions of the enhancer region show that the K19 ERE is responsible for the E2-dependent transactivation of the [TG] gene and for the synergism that is observed between E2 and TPA with both ER alpha and [TF].	ER beta	keratin 19	1	ACTIVATION	True
227	228	11026574:9:E2:keratin 19	The results of transfections with either the K19 gene promoter or the heterologous thymidine kinase promoter and constructs containing mutated or deleted portions of the enhancer region show that the K19 ERE is responsible for the [TF]-dependent transactivation of the [TG] gene and for the synergism that is observed between E2 and TPA with both ER alpha and ER beta.	E2	keratin 19	1	ACTIVATION	False
235	236	16621513:8:FTZ-F1:CYP19a	Taken together, these results demonstrate that rt[TF] plays an important role in the transcriptional regulation of the rt[TG] gene in the ovary.	FTZ-F1	CYP19a	0	UNDEFINED	False
236	237	16443828:4:activated protein-1:MIP-1beta	Transient transfection of primary human T cells with 5' deletion and site-specific mutants of the human [TG] promoter identified an [TF] (AP-1)/CRE-like motif at position -74 to -65 base pairs, relative to the TATA box as a vital cis-acting element and a binding site for inducible cAMP early repressor (ICER).	activated protein-1	MIP-1beta	0	UNDEFINED	False
240	241	16443828:4:AP-1:MIP-1beta	Transient transfection of primary human T cells with 5' deletion and site-specific mutants of the human [TG] promoter identified an activated protein-1 ([TF])/CRE-like motif at position -74 to -65 base pairs, relative to the TATA box as a vital cis-acting element and a binding site for inducible cAMP early repressor (ICER).	AP-1	MIP-1beta	0	UNDEFINED	False
244	245	16443828:4:inducible cAMP early repressor:MIP-1beta	Transient transfection of primary human T cells with 5' deletion and site-specific mutants of the human [TG] promoter identified an activated protein-1 (AP-1)/CRE-like motif at position -74 to -65 base pairs, relative to the TATA box as a vital cis-acting element and a binding site for [TF] (ICER).	inducible cAMP early repressor	MIP-1beta	0	UNDEFINED	False
248	249	16443828:4:ICER:MIP-1beta	Transient transfection of primary human T cells with 5' deletion and site-specific mutants of the human [TG] promoter identified an activated protein-1 (AP-1)/CRE-like motif at position -74 to -65 base pairs, relative to the TATA box as a vital cis-acting element and a binding site for inducible cAMP early repressor ([TF]).	ICER	MIP-1beta	0	UNDEFINED	False
252	253	16254209:7:GR:ABCA1	Our results showed that GR ligands affected [TG] expression and cholesterol efflux from macrophages, which are regulated by [TF] through a LXR-independent mechanism.	GR	ABCA1	0	UNDEFINED	False
255	256	16254209:7:LXR:ABCA1	Our results showed that GR ligands affected [TG] expression and cholesterol efflux from macrophages, which are regulated by GR through a [TF]-independent mechanism.	LXR	ABCA1	0	UNDEFINED	False
257	258	15761026:4:Rev-erbalpha:Bmal1	Here we show that [TF] dramatically represses the basal activity of the mouse [TG] gene promoter via two monomeric binding sites, both of which are required for repression and are conserved between mouse and human.	Rev-erbalpha	Bmal1	2	REPRESSION	False
261	262	14522900:12:p53:AFP	These findings provide novel evidence that p33(ING1b) represses [TG] transcription by at least two mechanisms, one of which includes [TF].	p53	AFP	2	REPRESSION	False
263	264	17786964:5:VDR:OC	We report that in intact osteoblastic cells [TF], in association with SRC-1, rapidly binds to the [TG] promoter in response to the ligand.	VDR	OC	0	UNDEFINED	False
265	266	17786964:5:SRC-1:OC	We report that in intact osteoblastic cells VDR, in association with [TF], rapidly binds to the [TG] promoter in response to the ligand.	SRC-1	OC	0	UNDEFINED	False
266	267	16061629:6:STAT3:TERT	Thus, [TF] is a key regulator of h[TG] expression in both normal and tumor cells.	STAT3	TERT	0	UNDEFINED	False
270	271	11896585:0:E2F1:Mcl-1	Differences in DNA binding properties between [TF] and E2F4 specify repression of the [TG] promoter.	E2F1	Mcl-1	2	REPRESSION	False
272	273	11896585:0:E2F4:Mcl-1	Differences in DNA binding properties between E2F1 and [TF] specify repression of the [TG] promoter.	E2F4	Mcl-1	2	REPRESSION	False
277	278	17664281:1:SF1:CYP17	In the human adrenal cortex, adrenocorticotropin (ACTH) activates [TG] transcription by promoting the binding of the nuclear receptor steroidogenic factor 1 ([TF]) (Ad4BP, NR5A1) to the promoter.	SF1	CYP17	1	ACTIVATION	False
283	284	17664281:1:Ad4BP:CYP17	In the human adrenal cortex, adrenocorticotropin (ACTH) activates [TG] transcription by promoting the binding of the nuclear receptor steroidogenic factor 1 (SF1) ([TF], NR5A1) to the promoter.	Ad4BP	CYP17	1	ACTIVATION	False
289	290	17664281:1:NR5A1:CYP17	In the human adrenal cortex, adrenocorticotropin (ACTH) activates [TG] transcription by promoting the binding of the nuclear receptor steroidogenic factor 1 (SF1) (Ad4BP, [TF]) to the promoter.	NR5A1	CYP17	1	ACTIVATION	False
295	296	17664281:1:steroidogenic factor 1:CYP17	In the human adrenal cortex, adrenocorticotropin (ACTH) activates [TG] transcription by promoting the binding of the nuclear receptor [TF] (SF1) (Ad4BP, NR5A1) to the promoter.	steroidogenic factor 1	CYP17	1	ACTIVATION	False
303	304	10446902:4:SF-1:DAX-1	With respect to implication of Ad4BP/[TF] in the transcriptional regulation of the [TG] gene, inconsistent findings have been previously reported.	SF-1	DAX-1	0	UNDEFINED	False
305	306	10446902:4:Ad4BP:DAX-1	With respect to implication of [TF]/SF-1 in the transcriptional regulation of the [TG] gene, inconsistent findings have been previously reported.	Ad4BP	DAX-1	0	UNDEFINED	False
317	318	18368381:5:FBI-1:cyclin A	Interestingly, FBI-1 repressed [TG] promoter activity through an indirect mechanisms that did not involve direct binding of FBI-1 to the promoter sequence, but rather [TF] inhibition of transcriptional activator Sp1 binding to a regulatory element at -452 to -443.	FBI-1	cyclin A	2	REPRESSION	True
321	322	18368381:5:Sp1:cyclin A	Interestingly, FBI-1 repressed [TG] promoter activity through an indirect mechanisms that did not involve direct binding of FBI-1 to the promoter sequence, but rather FBI-1 inhibition of transcriptional activator [TF] binding to a regulatory element at -452 to -443.	Sp1	cyclin A	1	ACTIVATION	True
322	323	21831840:0:p53:MET	Wild-type [TF] controls cell motility and invasion by dual regulation of [TG] expression.	p53	MET	0	UNDEFINED	False
333	334	21514437:8:GATA-6:CAV1	[TF]-induced transcriptional repression represents a new regulatory mechanism of [TG] gene expression in pathologic BSM, and may serve as a target for new therapy for BPH-induced bladder dysfunction in aging men.	GATA-6	CAV1	2	REPRESSION	False
337	338	15828872:0:HNF-3:glucagon	Transcription factors of the Foxa [Fox (forkhead box) subclass A; also known as [TF] (hepatocyte nuclear factor-3)] family are required for cell-specific activation of the [TG] gene in pancreatic islet alpha-cells.	HNF-3	glucagon	1	ACTIVATION	True
341	342	11328853:9:SF-1:LH beta	Cotransfection studies revealed that activation of protein kinase A leads to inhibition of SF-1-stimulated transcription of FSHR, while it synergized with [TF] to activate the equine [TG]-promoter (ebeta).	SF-1	LH beta	1	ACTIVATION	False
349	350	15026180:3:SF-1:CYP11A1	Transcription factor [TF], which binds to the [TG] promoter, plays an important role in the tissue-specific and hormonally regulated expression.	SF-1	CYP11A1	0	UNDEFINED	False
350	351	11297539:8:Sp1:CDK6	Taken together, our results suggest that I3C down-regulates CDK6 transcription by targeting [TF] at a composite DNA site in the [TG] promoter.	Sp1	CDK6	0	UNDEFINED	False
351	352	1705013:0:Tst-1:cell surface adhesion molecule P0	[TF], a member of the POU domain gene family, binds the promoter of the gene encoding the [TG].	Tst-1	cell surface adhesion molecule P0	0	UNDEFINED	False
352	353	1705013:0:Tst-1:myelin protein P0	Bacterially expressed [TF] binds specifically to the promoter of the gene encoding [TG], a Schwann cell surface adhesion molecule.	Tst-1	myelin protein P0	0	UNDEFINED	False
353	354	1705013:0:Tst-1:P0	In cotransfection assays, [TF] can specifically repress the [TG] promoter.	Tst-1	P0	2	REPRESSION	False
356	357	20939893:0:STAT3:MMP-7	Catecholamine up-regulates [TG] expression by activating AP-1 and [TF] in gastric cancer.	STAT3	MMP-7	1	ACTIVATION	False
358	359	20939893:0:AP-1:MMP-7	Catecholamine up-regulates [TG] expression by activating [TF] and STAT3 in gastric cancer.	AP-1	MMP-7	1	ACTIVATION	False
363	364	18238829:0:NOR-1:uncoupling protein-1	Orphan nuclear receptor [TF] enhances 3',5'-cyclic adenosine 5'-monophosphate-dependent [TG] gene transcription.	NOR-1	uncoupling protein-1	1	ACTIVATION	False
378	379	11875072:5:PPARalpha:UCP1	As in rodents, PGC-1 is involved in the transcriptional regulation of the [TG] gene in humans and mediates the effects of [TF] and PPARgamma agonists and retinoic acid.	PPARalpha	UCP1	0	UNDEFINED	True
437	439	18541154:0:androgen receptor:Cdc6	In this report, we studied the involvement of androgen, mediated through [TF] (AR) in regulation of [TG] expression.	androgen receptor	Cdc6	0	UNDEFINED	False
439	441	18541154:0:E2F:Cdc6	Androgen regulates [TG] transcription through interactions between androgen receptor and [TF] transcription factor in prostate cancer cells.	E2F	Cdc6	0	UNDEFINED	False
443	445	18541154:0:AR:Cdc6	We conclude that [TF] regulates Cdc6 transcription through interaction with the [TG] promoter, and complex formation with E2F1 and E2F3 in a differential manner.	AR	Cdc6	0	UNDEFINED	False
468	470	10692469:7:SF1:Oct-3/4	SF1, and its isoforms ELP2 and ELP3 bind to both [TF] sites and activate the [TG] promoter.	SF1	Oct-3/4	1	ACTIVATION	True
471	473	10692469:7:ELP2:Oct-3/4	SF1, and its isoforms [TF] and ELP3 bind to both SF1 sites and activate the [TG] promoter.	ELP2	Oct-3/4	1	ACTIVATION	False
474	476	10692469:7:ELP3:Oct-3/4	SF1, and its isoforms ELP2 and [TF] bind to both SF1 sites and activate the [TG] promoter.	ELP3	Oct-3/4	1	ACTIVATION	False
479	481	18068911:6:NF-kappaB:HOXA9	Our 5' deletion analysis of [TG] promoter shows that [TF] response element is localized within first 400 nucleotides, while minimal basal promoter is within 100 nucleotides upstream of its transcriptional start site.	NF-kappaB	HOXA9	0	UNDEFINED	True
480	482	22012259:9:MITF:HIF1A	Mi-E318K enhanced [TF] protein binding to the [TG] promoter and increased its transcriptional activity compared to wild-type MITF.	MITF	HIF1A	1	ACTIVATION	False
484	486	19799567:0:PBX1:SOX3	[TF] and MEIS1 up-regulate [TG] gene expression by direct interaction with a consensus binding site within the basal promoter region.	PBX1	SOX3	1	ACTIVATION	False
486	488	19799567:0:MEIS1:SOX3	PBX1 and [TF] up-regulate [TG] gene expression by direct interaction with a consensus binding site within the basal promoter region.	MEIS1	SOX3	1	ACTIVATION	False
502	504	19799567:0:NF-Y:SOX3	We have previously reported characterization of the SOX3 promoter and demonstrated that the general transcription factors [TF] (nuclear factor-Y), Sp1 (specificity protein 1) and USF (upstream stimulatory factor) are involved in transcriptional regulation of [TG] promoter activity.	NF-Y	SOX3	0	UNDEFINED	False
508	510	19799567:0:nuclear factor-Y:SOX3	We have previously reported characterization of the SOX3 promoter and demonstrated that the general transcription factors NF-Y ([TF]), Sp1 (specificity protein 1) and USF (upstream stimulatory factor) are involved in transcriptional regulation of [TG] promoter activity.	nuclear factor-Y	SOX3	0	UNDEFINED	False
514	516	19799567:0:Sp1:SOX3	We have previously reported characterization of the SOX3 promoter and demonstrated that the general transcription factors NF-Y (nuclear factor-Y), [TF] (specificity protein 1) and USF (upstream stimulatory factor) are involved in transcriptional regulation of [TG] promoter activity.	Sp1	SOX3	0	UNDEFINED	False
520	522	19799567:0:specificity protein 1:SOX3	We have previously reported characterization of the SOX3 promoter and demonstrated that the general transcription factors NF-Y (nuclear factor-Y), Sp1 ([TF]) and USF (upstream stimulatory factor) are involved in transcriptional regulation of [TG] promoter activity.	specificity protein 1	SOX3	0	UNDEFINED	False
526	528	19799567:0:USF:SOX3	We have previously reported characterization of the SOX3 promoter and demonstrated that the general transcription factors NF-Y (nuclear factor-Y), Sp1 (specificity protein 1) and [TF] (upstream stimulatory factor) are involved in transcriptional regulation of [TG] promoter activity.	USF	SOX3	0	UNDEFINED	False
532	534	19799567:0:upstream stimulatory factor:SOX3	We have previously reported characterization of the SOX3 promoter and demonstrated that the general transcription factors NF-Y (nuclear factor-Y), Sp1 (specificity protein 1) and USF ([TF]) are involved in transcriptional regulation of [TG] promoter activity.	upstream stimulatory factor	SOX3	0	UNDEFINED	False
545	547	19799567:0:pre-B-cell leukaemia homeobox 1:SOX3	In the present study we provide the first evidence that the TALE (three-amino-acid loop extension) transcription factors PBX1 ([TF]) and MEIS1 (myeloid ecotropic viral integration site 1 homologue) participate in regulating human [TG] gene expression in NT2/D1 cells by direct interaction with the consensus PBX/MEIS-binding site, which is conserved in all mammalian orthologue promoters analysed.	pre-B-cell leukaemia homeobox 1	SOX3	0	UNDEFINED	False
555	557	19799567:0:myeloid ecotropic viral integration site 1 homologue:SOX3	In the present study we provide the first evidence that the TALE (three-amino-acid loop extension) transcription factors PBX1 (pre-B-cell leukaemia homeobox 1) and MEIS1 ([TF]) participate in regulating human [TG] gene expression in NT2/D1 cells by direct interaction with the consensus PBX/MEIS-binding site, which is conserved in all mammalian orthologue promoters analysed.	myeloid ecotropic viral integration site 1 homologue	SOX3	0	UNDEFINED	False
562	564	19799567:0:PBX:SOX3	In the present study we provide the first evidence that the TALE (three-amino-acid loop extension) transcription factors PBX1 (pre-B-cell leukaemia homeobox 1) and MEIS1 (myeloid ecotropic viral integration site 1 homologue) participate in regulating human [TG] gene expression in NT2/D1 cells by direct interaction with the consensus [TF]/MEIS-binding site, which is conserved in all mammalian orthologue promoters analysed.	PBX	SOX3	0	UNDEFINED	True
568	570	19799567:0:MEIS:SOX3	In the present study we provide the first evidence that the TALE (three-amino-acid loop extension) transcription factors PBX1 (pre-B-cell leukaemia homeobox 1) and MEIS1 (myeloid ecotropic viral integration site 1 homologue) participate in regulating human [TG] gene expression in NT2/D1 cells by direct interaction with the consensus PBX/[TF]-binding site, which is conserved in all mammalian orthologue promoters analysed.	MEIS	SOX3	0	UNDEFINED	True
571	573	19799567:0:PBX1:SOX3 promote	By functional analysis we also showed that mutations of the [TF]/MEIS1-binding sites resulted in profound reduction of [TG]r responsiveness to RA.	PBX1	SOX3 promote	1	ACTIVATION	True
572	574	19799567:0:MEIS1:SOX3 promote	By functional analysis we also showed that mutations of the PBX1/[TF]-binding sites resulted in profound reduction of [TG]r responsiveness to RA.	MEIS1	SOX3 promote	1	ACTIVATION	True
573	575	18165439:3:steroidogenic factor-1:StAR	The transcription factor [TF] (SF-1) activates the promoters of both [TG] and aromatase in endometriotic tissue.	steroidogenic factor-1	StAR	1	ACTIVATION	False
575	577	18165439:3:steroidogenic factor-1:aromatase	The transcription factor [TF] (SF-1) activates the promoters of both StAR and [TG] in endometriotic tissue.	steroidogenic factor-1	aromatase	1	ACTIVATION	False
577	579	18165439:3:SF-1:StAR	The transcription factor steroidogenic factor-1 ([TF]) activates the promoters of both [TG] and aromatase in endometriotic tissue.	SF-1	StAR	1	ACTIVATION	False
578	580	18165439:3:SF-1:aromatase	The transcription factor steroidogenic factor-1 ([TF]) activates the promoters of both StAR and [TG] in endometriotic tissue.	SF-1	aromatase	1	ACTIVATION	False
579	581	12808109:7:p53:cyclin D1	Importantly, [TF]-mediated suppression of the [TG] promoter was reversed by coexpression of Bcl-3 and inhibition of p52 or deacetylase activity.	p53	cyclin D1	2	REPRESSION	False
584	587	22024429:10:RORA:NR1D1	The results of a luciferase assay showed that [TF] significantly activated the human [TG] promoter regardless of CS.	RORA	NR1D1	1	ACTIVATION	False
586	589	10499490:9:steroidogenic factor-1:StAR	Thus, transcriptional activation of the [TG] gene by a [TF]-dependent mechanism may represent a common pathway for ACTH (protein kinase A) and AII action in stimulating steroid production in the adrenal fasciculata and glomerulosa.	steroidogenic factor-1	StAR	1	ACTIVATION	False
590	593	11839811:2:RAR:RAR beta 2	By comparing the transactivating properties of [TF] and RXR in P19 cells using either plasmid or chromosomal reporter genes containing the m[TG] gene promoter, we found contrasting patterns of transcriptional regulation in each setting.	RAR	RAR beta 2	1	ACTIVATION	False
592	595	11839811:2:RXR:RAR beta 2	By comparing the transactivating properties of RAR and [TF] in P19 cells using either plasmid or chromosomal reporter genes containing the m[TG] gene promoter, we found contrasting patterns of transcriptional regulation in each setting.	RXR	RAR beta 2	1	ACTIVATION	False
595	598	20301197:0:estrogen receptor:p21	Estrogen regulated expression of the [TG] Waf1/Cip1 gene in [TF] positive human breast cancer cells.	estrogen receptor	p21	0	UNDEFINED	False
596	599	20301197:0:estrogen receptor:Waf1	Estrogen regulated expression of the p21 [TG]/Cip1 gene in [TF] positive human breast cancer cells.	estrogen receptor	Waf1	0	UNDEFINED	False
597	600	20301197:0:estrogen receptor:Cip1	Estrogen regulated expression of the p21 Waf1/[TG] gene in [TF] positive human breast cancer cells.	estrogen receptor	Cip1	0	UNDEFINED	False
598	601	20301197:0:estrogen receptor alpha:p21	Estradiol induces [TG](Waf1/Cip1) mRNA expression within 30-60 min independent of new protein synthesis in the [TF] (ER alpha) positive human breast cancer cell line MCF-7.	estrogen receptor alpha	p21	1	ACTIVATION	False
599	602	20301197:0:estrogen receptor alpha:Waf1	Estradiol induces p21([TG]/Cip1) mRNA expression within 30-60 min independent of new protein synthesis in the [TF] (ER alpha) positive human breast cancer cell line MCF-7.	estrogen receptor alpha	Waf1	1	ACTIVATION	False
600	603	20301197:0:estrogen receptor alpha:Cip1	Estradiol induces p21(Waf1/[TG]) mRNA expression within 30-60 min independent of new protein synthesis in the [TF] (ER alpha) positive human breast cancer cell line MCF-7.	estrogen receptor alpha	Cip1	1	ACTIVATION	False
606	609	20301197:0:AP-1:Waf1	Similar to other estradiol responsive promoters, the p21([TG]/Cip1) upstream promoter region has several estrogen response element (ERE) half-sites nestled in [TF] binding sites, which are positioned upstream to Sp1 binding sites.	AP-1	Waf1	0	UNDEFINED	True
607	610	20301197:0:AP-1:Cip1	Similar to other estradiol responsive promoters, the p21(Waf1/[TG]) upstream promoter region has several estrogen response element (ERE) half-sites nestled in [TF] binding sites, which are positioned upstream to Sp1 binding sites.	AP-1	Cip1	0	UNDEFINED	True
608	611	20301197:0:AP-1:p21	Similar to other estradiol responsive promoters, the [TG](Waf1/Cip1) upstream promoter region has several estrogen response element (ERE) half-sites nestled in [TF] binding sites, which are positioned upstream to Sp1 binding sites.	AP-1	p21	0	UNDEFINED	True
610	613	20301197:0:Sp1:Waf1	Although Sp1/Sp3 is not involved in the recruitment of ER alpha to the promoter, [TF] is necessary for estrogen-induced p21([TG]/Cip1) promoter activity.	Sp1	Waf1	1	ACTIVATION	False
611	614	20301197:0:Sp1:Cip1	Although Sp1/Sp3 is not involved in the recruitment of ER alpha to the promoter, [TF] is necessary for estrogen-induced p21(Waf1/[TG]) promoter activity.	Sp1	Cip1	1	ACTIVATION	False
612	615	20301197:0:Sp1:p21	Although Sp1/Sp3 is not involved in the recruitment of ER alpha to the promoter, [TF] is necessary for estrogen-induced [TG](Waf1/Cip1) promoter activity.	Sp1	p21	1	ACTIVATION	False
625	628	11238674:0:cAMP-responsive element modulator:IL-2	Here we show that nuclear extracts from unstimulated SLE T cells, unlike extracts from normal T cells, express increased amounts of phosphorylated [TF] (p-CREM) that binds the -180 site of the [TG] promoter.	cAMP-responsive element modulator	IL-2	0	UNDEFINED	False
629	632	11238674:0:cAMP-responsive element binding protein:IL-2	Nuclear extracts from stimulated normal T cells display increased binding of phosphorylated [TF] (p-CREB) to the -180 site of the [TG] promoter, whereas nuclear extracts from stimulated SLE T cells display primarily p-CREM and decreased p-CREB binding.	cAMP-responsive element binding protein	IL-2	0	UNDEFINED	False
632	635	11238674:0:CREB:IL-2	Nuclear extracts from stimulated normal T cells display increased binding of phosphorylated cAMP-responsive element binding protein (p-CREB) to the -180 site of the [TG] promoter, whereas nuclear extracts from stimulated SLE T cells display primarily p-CREM and decreased p-[TF] binding.	CREB	IL-2	0	UNDEFINED	False
640	643	15024065:0:Meox1:Bapx1	The palindromic sequence TAATTA, present in the Bapx1 promoter, binds the Meox1 protein in vitro and is necessary for [TF]-induced transactivation of the [TG] promoter.	Meox1	Bapx1	1	ACTIVATION	False
643	646	15024065:0:Meox2:Bapx1	Our analysis of Meox1; [TF] mutant mice supports this hypothesis, as [TG] expression in the sclerotome is lost in the absence of both Meox proteins.	Meox2	Bapx1	1	ACTIVATION	False
650	653	15024065:0:Meox:Bapx1	Our data demonstrate that the Meox genes are required for Bapx1 expression in the sclerotome and suggest that the mechanism by which the [TF] proteins exert this function is through direct activation of the [TG] gene.	Meox	Bapx1	1	ACTIVATION	True
656	659	15024065:0:Pax1:Bapx1	Using transient-transfection assays, we show that Meox1 activates the [TG] promoter in a dose-dependent manner and that this activity is enhanced in the presence of [TF] and/or Pax9.	Pax1	Bapx1	1	ACTIVATION	False
659	662	15024065:0:Pax9:Bapx1	Using transient-transfection assays, we show that Meox1 activates the [TG] promoter in a dose-dependent manner and that this activity is enhanced in the presence of Pax1 and/or [TF].	Pax9	Bapx1	1	ACTIVATION	False
666	670	16595680:0:KLF5:survivin	These findings identify a novel regulatory pathway for the expression of [TG] under the control of [TF] and p53.	KLF5	survivin	0	UNDEFINED	False
668	672	16595680:0:p53:survivin	These findings identify a novel regulatory pathway for the expression of [TG] under the control of KLF5 and [TF].	p53	survivin	0	UNDEFINED	False
673	677	19668225:7:HSF1:LDH-A	HSF1 bound to LDH-A promoter and the downregulation of [TF] reduced the expression of [TG] and subsequently decreased cancer cell glycolysis and growth.	HSF1	LDH-A	1	ACTIVATION	False
675	679	21964930:9:p53:osteocalcin	Our findings suggest that [TF] may directly target the human osteocalcin gene and positively affect [TG] gene expression.	p53	osteocalcin	1	ACTIVATION	False
676	680	16168958:7:FXR:SR-BI	No [TF]-response element was identified in the bile acid-responsive region of the [TG] promoter (-1200bp/-937bp).	FXR	SR-BI	0	UNDEFINED	True
677	681	16357303:6:FXR:ET-1	Reporter assays showed that activation of [TF] inhibited transcriptional activation of the human [TG] gene promoter and also repressed the activity of a heterologous promoter driven by activator protein (AP)-1 response elements.	FXR	ET-1	2	REPRESSION	False
681	685	16024609:6:GATA6:DOC-2	Thus, we conclude that transcriptional regulation of DOC-2/DAB2 gene in human TCC is determined by histone acetylation and a specific transcription factor (i.e., [TF]), which underlie the reduced [TG]/DAB2 protein expression in TCC cells.	GATA6	DOC-2	2	REPRESSION	True
682	686	16024609:6:GATA6:DAB2	Thus, we conclude that transcriptional regulation of DOC-2/DAB2 gene in human TCC is determined by histone acetylation and a specific transcription factor (i.e., [TF]), which underlie the reduced DOC-2/[TG] protein expression in TCC cells.	GATA6	DAB2	2	REPRESSION	True
685	689	17606295:0:Elf1:Fli1	Ets factors [TF], Tel and Fli1 bind in vitro to this region and increase endogenous [TG] expression when over-expressed in a T cell line.	Elf1	Fli1	1	ACTIVATION	False
688	692	17606295:0:Tel:Fli1	Ets factors Elf1, [TF] and Fli1 bind in vitro to this region and increase endogenous [TG] expression when over-expressed in a T cell line.	Tel	Fli1	1	ACTIVATION	False
696	700	17606295:0:Ets:Fli1	These results suggest that several [TF] factors, including Fli1 itself, are involved in the transcriptional regulation of [TG] in lymphocytes.	Ets	Fli1	0	UNDEFINED	True
698	702	11118612:8:Nrf2:GCS(L)	By transient transfection studies in nrf2(-/-) fibroblasts, we show that transcriptional activation of reporter constructs bearing the human [TG] promoter, as well as the functional ARE of GCS(H) promoter, required the activator protein [TF].	Nrf2	GCS(L)	1	ACTIVATION	False
699	703	11118612:8:Nrf2:GCS(H	By transient transfection studies in nrf2(-/-) fibroblasts, we show that transcriptional activation of reporter constructs bearing the human GCS(L) promoter, as well as the functional ARE of [TG]) promoter, required the activator protein [TF].	Nrf2	GCS(H	1	ACTIVATION	False
701	705	11118612:8:nrf2:GCS(L)	By transient transfection studies in [TF](-/-) fibroblasts, we show that transcriptional activation of reporter constructs bearing the human [TG] promoter, as well as the functional ARE of GCS(H) promoter, required the activator protein Nrf2.	nrf2	GCS(L)	0	UNDEFINED	True
702	706	11118612:8:nrf2:GCS(H	By transient transfection studies in [TF](-/-) fibroblasts, we show that transcriptional activation of reporter constructs bearing the human GCS(L) promoter, as well as the functional ARE of [TG]) promoter, required the activator protein Nrf2.	nrf2	GCS(H	0	UNDEFINED	True
703	707	11459795:3:estradiol:prothymosin alpha	Analysis of the [TG] promoter and 5'-flanking region, and electrophoretic gel mobility shift studies showed the strong inducibility by the [TF]-ER complex to be mediated by two consensus half-palindromic estrogen response elements at -750 and -1051, which directly bind the ER.	estradiol	prothymosin alpha	1	ACTIVATION	True
706	710	11459795:3:ER:prothymosin alpha	Analysis of the [TG] promoter and 5'-flanking region, and electrophoretic gel mobility shift studies showed the strong inducibility by the estradiol-ER complex to be mediated by two consensus half-palindromic estrogen response elements at -750 and -1051, which directly bind the [TF].	ER	prothymosin alpha	1	ACTIVATION	True
710	714	11459795:3:estrogen:prothymosin alpha	Analysis of the [TG] promoter and 5'-flanking region, and electrophoretic gel mobility shift studies showed the strong inducibility by the estradiol-ER complex to be mediated by two consensus half-palindromic [TF] response elements at -750 and -1051, which directly bind the ER.	estrogen	prothymosin alpha	1	ACTIVATION	True
716	720	20427335:6:AP-1:TGFbeta	Deletion of any one or both of the activating protein-1 (AP-1) binding sites in the TGFbeta reporter construct resulted in loss of O(2) sensitivity, demonstrating that [TF] confers O(2) sensitivity to [TG] transcription.	AP-1	TGFbeta	0	UNDEFINED	True
721	725	8670878:4:NF-kappa B:IL-2	In the present study, we demonstrate that neither [TF]/Rel nor CREB/ATF is sufficient for Tax-mediated activation of the [TG] promoter.	NF-kappa B	IL-2	1	ACTIVATION	False
725	729	8670878:4:Rel:IL-2	In the present study, we demonstrate that neither NF-kappa B/[TF] nor CREB/ATF is sufficient for Tax-mediated activation of the [TG] promoter.	Rel	IL-2	1	ACTIVATION	False
729	733	8670878:4:CREB:IL-2	In the present study, we demonstrate that neither NF-kappa B/Rel nor [TF]/ATF is sufficient for Tax-mediated activation of the [TG] promoter.	CREB	IL-2	1	ACTIVATION	False
730	734	12771217:7:Sp1:vimentin	Deletion constructs confirm that the glutamine-rich region of Sp1 is required to enhance [TG] transcription, whereas the N-terminus of ZBP-89 is required to interact with [TF] and repress gene expression.	Sp1	vimentin	2	REPRESSION	False
734	738	12771217:7:ZBP-89:vimentin	Deletion constructs confirm that the glutamine-rich region of Sp1 is required to enhance [TG] transcription, whereas the N-terminus of [TF] is required to interact with Sp1 and repress gene expression.	ZBP-89	vimentin	2	REPRESSION	False
737	741	10499550:6:GLP-1:PDX-1	Overexpression of PDX-1 in these cells confirmed the finding of the wild type cells such that [TF] induced a 2-fold increase in whole cell extracts and a 3-fold increase in nuclear extracts of [TG] protein levels.	GLP-1	PDX-1	1	ACTIVATION	True
738	742	18451137:4:MITF:ML-IAP	In reporter assays, MITF promoted a strong stimulation of transcriptional activity from the ML-IAP promoter, and [TF] bound the endogenous [TG] promoter in melanoma cells by chromatin immunoprecipitation and electrophoretic mobility shift assay.	MITF	ML-IAP	0	UNDEFINED	False
741	745	10567390:9:activator protein-1:cyclin D1	p300 activated the [TG] promoter through an [TF] (AP-1) site at -954 and was identified within a DNA-bound complex with c-Jun at the AP-1 site.	activator protein-1	cyclin D1	1	ACTIVATION	True
750	754	10567390:9:c-Jun:cyclin D1	p300 activated the [TG] promoter through an activator protein-1 (AP-1) site at -954 and was identified within a DNA-bound complex with [TF] at the AP-1 site.	c-Jun	cyclin D1	1	ACTIVATION	False
754	758	13678390:10:SF-1:MIS	Furthermore, the over-expression of the exogenous [TF] inhibited the activation of the [TG] promoter with ER alpha.	SF-1	MIS	2	REPRESSION	False
756	760	13678390:10:ER alpha:MIS	Furthermore, the over-expression of the exogenous SF-1 inhibited the activation of the [TG] promoter with [TF].	ER alpha	MIS	1	ACTIVATION	False
769	773	11571582:3:androgen receptor:PSA	Previous studies have established that [TF] (AR) molecules bind cooperatively to AREs in the [TG] enhancer core (-4326 to -3935) and act synergistically with AR bound to the proximal promoter to regulate transcriptional output.	androgen receptor	PSA	0	UNDEFINED	False
772	776	11571582:3:AR:PSA	Previous studies have established that androgen receptor (AR) molecules bind cooperatively to AREs in the [TG] enhancer core (-4326 to -3935) and act synergistically with [TF] bound to the proximal promoter to regulate transcriptional output.	AR	PSA	0	UNDEFINED	False
773	777	20510677:6:ZNF24:PDGFR-beta	Overexpression of [TF] resulted in a significant decrease in [TG] promoter activity.	ZNF24	PDGFR-beta	2	REPRESSION	False
775	779	9748239:0:peroxisome proliferator-activated receptor alpha:apolipoprotein A-I	The nuclear receptors [TF] and Rev-erbalpha mediate the species-specific regulation of [TG] expression by fibrates.	peroxisome proliferator-activated receptor alpha	apolipoprotein A-I	0	UNDEFINED	False
777	781	9748239:0:Rev-erbalpha:apolipoprotein A-I	The nuclear receptors peroxisome proliferator-activated receptor alpha and [TF] mediate the species-specific regulation of [TG] expression by fibrates.	Rev-erbalpha	apolipoprotein A-I	0	UNDEFINED	False
782	786	9748239:0:PPARalpha:apoA-I	In conclusion, the opposite regulation of rat and human apoA-I gene expression by fibrates is linked to differences in cis-elements in their respective promoters leading to repression by Rev-erbalpha of rat apoA-I and activation by [TF] of human [TG].	PPARalpha	apoA-I	1	ACTIVATION	False
784	788	15879363:0:DAX-1:ACTH receptor	Clinical and molecular evidence for [TF] inhibition of steroidogenic factor-1-dependent [TG] gene expression.	DAX-1	ACTH receptor	2	REPRESSION	False
786	790	15879363:0:steroidogenic factor-1-:ACTH receptor	Clinical and molecular evidence for DAX-1 inhibition of [TF]dependent [TG] gene expression.	steroidogenic factor-1-	ACTH receptor	1	ACTIVATION	False
789	793	18234909:0:Estrogen receptor-related receptor alpha:osteopontin	[TF] (ERRalpha) regulates [TG] expression through a non-canonical ERRalpha response element in a cell context-dependent manner.	Estrogen receptor-related receptor alpha	osteopontin	0	UNDEFINED	False
791	795	18234909:0:ERRalpha:osteopontin	There are conflicting published data on the transcriptional regulation by ERRalpha of the gene for [TG] (OPN), an extracellular matrix protein required in bone remodeling, and a potential direct target mediating [TF] effects in bone.	ERRalpha	osteopontin	0	UNDEFINED	True
798	802	14580722:0:WT1:P450arom	[TF] and DAX-1 regulate SF-1-mediated human [TG] gene expression in gonadal cells.	WT1	P450arom	0	UNDEFINED	False
801	805	14580722:0:DAX-1:P450arom	WT1 and [TF] regulate SF-1-mediated human [TG] gene expression in gonadal cells.	DAX-1	P450arom	0	UNDEFINED	False
804	808	14580722:0:SF-1:P450arom	WT1 and DAX-1 regulate [TF]-mediated human [TG] gene expression in gonadal cells.	SF-1	P450arom	1	ACTIVATION	False
807	811	11284743:9:HNF-4alpha:DD4	These results indicate that [TF], HNF-4gamma and HNF-1alpha regulate co-operatively the transcription of the human [TG] gene in HepG2 cells.	HNF-4alpha	DD4	0	UNDEFINED	False
810	814	11284743:9:HNF-4gamma:DD4	These results indicate that HNF-4alpha, [TF] and HNF-1alpha regulate co-operatively the transcription of the human [TG] gene in HepG2 cells.	HNF-4gamma	DD4	0	UNDEFINED	False
813	817	11284743:9:HNF-1alpha:DD4	These results indicate that HNF-4alpha, HNF-4gamma and [TF] regulate co-operatively the transcription of the human [TG] gene in HepG2 cells.	HNF-1alpha	DD4	0	UNDEFINED	False
815	819	10399797:5:NF kappa-B:Egr-1	Furthermore, we identified a novel regulatory element in the human [TG] promoter similar to a [TF] binding site.	NF kappa-B	Egr-1	0	UNDEFINED	True
818	822	14580722:5:SF-1:P450arom	We also show herein that the stimulation of [TG] promoter activity by [TF] in ovarian granulosa, testicular Sertoli and JEG-3 choriocarcinoma cells is inhibited by two transcription factors, Wilms' tumor suppressor gene (WT1) and dosage sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome gene 1 (DAX-1).	SF-1	P450arom	1	ACTIVATION	False
823	827	14580722:5:WT1:P450arom	We also show herein that the stimulation of [TG] promoter activity by SF-1 in ovarian granulosa, testicular Sertoli and JEG-3 choriocarcinoma cells is inhibited by two transcription factors, Wilms' tumor suppressor gene ([TF]) and dosage sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome gene 1 (DAX-1).	WT1	P450arom	2	REPRESSION	False
828	832	14580722:5:DAX-1:P450arom	We also show herein that the stimulation of [TG] promoter activity by SF-1 in ovarian granulosa, testicular Sertoli and JEG-3 choriocarcinoma cells is inhibited by two transcription factors, Wilms' tumor suppressor gene (WT1) and dosage sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome gene 1 ([TF]).	DAX-1	P450arom	2	REPRESSION	False
834	838	14580722:5:Wilms' tumor suppressor gene:P450arom	We also show herein that the stimulation of [TG] promoter activity by SF-1 in ovarian granulosa, testicular Sertoli and JEG-3 choriocarcinoma cells is inhibited by two transcription factors, [TF] (WT1) and dosage sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome gene 1 (DAX-1).	Wilms' tumor suppressor gene	P450arom	2	REPRESSION	False
839	843	14580722:5:dosage sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome gene 1:P450arom	We also show herein that the stimulation of [TG] promoter activity by SF-1 in ovarian granulosa, testicular Sertoli and JEG-3 choriocarcinoma cells is inhibited by two transcription factors, Wilms' tumor suppressor gene (WT1) and [TF] (DAX-1).	dosage sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome gene 1	P450arom	2	REPRESSION	False
862	866	16652157:0:p53:DRAL	Here we show that full-length E4F1 protein (p120(E4F1)) but not its E1A-activated and truncated form (p50(E4F1)), interacts directly in vitro and in vivo with the LIM-only protein FHL2, the product of the [TF]-responsive gene FHL2/[TG] (downregulated in rhabdomyosarcoma Lim protein).	p53	DRAL	0	UNDEFINED	True
863	867	16652157:0:p53:downregulated in rhabdomyosarcoma Lim protein	Here we show that full-length E4F1 protein (p120(E4F1)) but not its E1A-activated and truncated form (p50(E4F1)), interacts directly in vitro and in vivo with the LIM-only protein FHL2, the product of the [TF]-responsive gene FHL2/DRAL ([TG]).	p53	downregulated in rhabdomyosarcoma Lim protein	0	UNDEFINED	True
876	880	12242286:0:MyoD:myostatin	Since the myostatin gene is implicated in controlling G(1)-to-S progression of myoblasts, [TF] could be triggering myoblast withdrawal from the cell cycle by regulating [TG] gene expression.	MyoD	myostatin	0	UNDEFINED	False
878	882	12242286:0:MyoD:myostatin promoter	However, in the reserve cells, which lack [TF] expression, a significant reduction in the [TG] activity is observed.	MyoD	myostatin promoter	1	ACTIVATION	True
888	892	14708599:0:hypoxia-inducible factor 1alpha:PAI-1	Treatment with antisense oligonucleotides against [TF] (HIF-1alpha) led to the downregulation of steady-state levels of [TG] mRNA under both normoxic and hypoxic conditions.	hypoxia-inducible factor 1alpha	PAI-1	1	ACTIVATION	False
890	894	14708599:0:HIF-1alpha:PAI-1	Treatment with antisense oligonucleotides against hypoxia-inducible factor 1alpha ([TF]) led to the downregulation of steady-state levels of [TG] mRNA under both normoxic and hypoxic conditions.	HIF-1alpha	PAI-1	1	ACTIVATION	False
891	895	12669312:9:p53:Nm23-H1	In contrast, increased levels of [TF] downregulated the expression of [TG] at the protein and mRNA levels in RKO and H1299 cells and, as a consequence, increased the invasive ability of both cell types.	p53	Nm23-H1	2	REPRESSION	False
892	896	12101186:0:TReP-132:P450scc	The transcriptional regulating protein of 132 kDa ([TF]) enhances [TG] gene transcription through interaction with steroidogenic factor-1 in human adrenal cells.	TReP-132	P450scc	1	ACTIVATION	False
896	900	12101186:0:steroidogenic factor-1:P450scc	The transcriptional regulating protein of 132 kDa (TReP-132) enhances [TG] gene transcription through interaction with [TF] in human adrenal cells.	steroidogenic factor-1	P450scc	1	ACTIVATION	True
899	903	12101186:0:transcriptional regulating protein of 132 kDa:P450scc	The [TF] (TReP-132) enhances [TG] gene transcription through interaction with steroidogenic factor-1 in human adrenal cells.	transcriptional regulating protein of 132 kDa	P450scc	1	ACTIVATION	False
919	923	17526932:11:LXR:ABCA1	We conclude that the dual promoter system driven by SREBP-2 and [TF] regulates hepatic ABCA1 expression and may mediate the unique response of hepatic [TG] gene expression to cellular cholesterol status.	LXR	ABCA1	0	UNDEFINED	True
922	926	17696253:8:PXR:FGF19	Overexpression of PXR and its dimerization partner retinoid X receptor (RXR) and stimulation with LCA or the potent [TF] ligand rifampicin leads to a significant induction of [TG] promoter activity in intestinal cells.	PXR	FGF19	1	ACTIVATION	False
928	932	17696253:8:retinoid X receptor:FGF19	Overexpression of PXR and its dimerization partner [TF] (RXR) and stimulation with LCA or the potent PXR ligand rifampicin leads to a significant induction of [TG] promoter activity in intestinal cells.	retinoid X receptor	FGF19	1	ACTIVATION	False
933	937	17696253:8:RXR:FGF19	Overexpression of PXR and its dimerization partner retinoid X receptor ([TF]) and stimulation with LCA or the potent PXR ligand rifampicin leads to a significant induction of [TG] promoter activity in intestinal cells.	RXR	FGF19	1	ACTIVATION	False
939	943	17696253:8:rifampicin:FGF19	Overexpression of PXR and its dimerization partner retinoid X receptor (RXR) and stimulation with LCA or the potent PXR ligand [TF] leads to a significant induction of [TG] promoter activity in intestinal cells.	rifampicin	FGF19	1	ACTIVATION	False
944	948	17696253:8:LCA:FGF19	Overexpression of PXR and its dimerization partner retinoid X receptor (RXR) and stimulation with [TF] or the potent PXR ligand rifampicin leads to a significant induction of [TG] promoter activity in intestinal cells.	LCA	FGF19	1	ACTIVATION	False
947	951	17998413:0:MAD1:PTEN	Inhibition of apoptosis by [TF] is mediated by repression of the [TG] tumor suppressor gene.	MAD1	PTEN	2	REPRESSION	True
948	952	17005185:7:iver X receptors:ABCG1	Although l[TF] (LXR) augment [TG] expression, macrophages treated with AGE-BSA showed no reduction in LXR mRNA levels or in the binding of nuclear proteins to the LXR response element, compared with BSA.	iver X receptors	ABCG1	1	ACTIVATION	False
953	957	16997917:0:NOBOX:Gdf9	These results suggest that [TF] directly regulates the transcription of Pou5f1 and [TG] in oocytes during early folliculogenesis.	NOBOX	Gdf9	0	UNDEFINED	False
954	958	16997917:0:NOBOX:Pou5f1	These results suggest that [TF] directly regulates the transcription of [TG] and Gdf9 in oocytes during early folliculogenesis.	NOBOX	Pou5f1	0	UNDEFINED	False
964	968	21471200:0:Foxo1:osteocalcin	[TF] mediates insulin-like growth factor 1 (IGF1)/insulin regulation of [TG] expression by antagonizing Runx2 in osteoblasts.	Foxo1	osteocalcin	0	UNDEFINED	False
968	972	21471200:0:Runx2:osteocalcin	Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of [TG] expression by antagonizing [TF] in osteoblasts.	Runx2	osteocalcin	0	UNDEFINED	True
972	976	14754893:0:PE-1:Ets	[TF]/METS, an antiproliferative [TG] repressor factor, is induced by CREB-1/CREM-1 during macrophage differentiation.	PE-1	Ets	2	REPRESSION	True
977	981	14754893:0:CREB-1:PE-1	Overexpression of CREB-1 stimulates the activities of the PE-1/METS, and macrosialin promoters, while expression of a dominant negative form of [TF] during macrophage differentiation inhibits expression of the [TG]/METS and macrosialin genes.	CREB-1	PE-1	1	ACTIVATION	False
978	982	14754893:0:CREB-1:METS	Overexpression of CREB-1 stimulates the activities of the PE-1/METS, and macrosialin promoters, while expression of a dominant negative form of [TF] during macrophage differentiation inhibits expression of the PE-1/[TG] and macrosialin genes.	CREB-1	METS	1	ACTIVATION	False
981	985	14754893:0:CREM-1:PE-1	Chromatin immunoprecipitation experiments demonstrate that CREB-1/[TF] are recruited to the [TG]/METS promoter as well as to the promoters of other genes that are up-regulated during terminal macrophage differentiation.	CREM-1	PE-1	0	UNDEFINED	False
982	986	14754893:0:CREM-1:METS	Chromatin immunoprecipitation experiments demonstrate that CREB-1/[TF] are recruited to the PE-1/[TG] promoter as well as to the promoters of other genes that are up-regulated during terminal macrophage differentiation.	CREM-1	METS	0	UNDEFINED	False
993	997	14754893:0:cyclic AMP response element-binding protein-:PE-1	Here, we present evidence that the [TG]/METS gene is a transcriptional target of the [TF]1 (CREB-1).	cyclic AMP response element-binding protein-	PE-1	0	UNDEFINED	False
994	998	14754893:0:cyclic AMP response element-binding protein-:METS	Here, we present evidence that the PE-1/[TG] gene is a transcriptional target of the [TF]1 (CREB-1).	cyclic AMP response element-binding protein-	METS	0	UNDEFINED	False
1001	1005	14754893:0:CREB-1:macrosialin	Overexpression of CREB-1 stimulates the activities of the PE-1/METS, and macrosialin promoters, while expression of a dominant negative form of [TF] during macrophage differentiation inhibits expression of the PE-1/METS and [TG] genes.	CREB-1	macrosialin	1	ACTIVATION	False
1006	1010	14754893:0:CREB:CD54	Inhibition of [TF] function also results in reduced expression of [TG] and impaired cell adhesion.	CREB	CD54	1	ACTIVATION	False
1007	1011	10508276:0:Egr:CD95	Novel [TF]/NF-AT composite sites mediate activation of the [TG] (APO-1/Fas) ligand promoter in response to T cell stimulation.	Egr	CD95	1	ACTIVATION	True
1008	1012	10508276:0:Egr:APO-1	Novel [TF]/NF-AT composite sites mediate activation of the CD95 ([TG]/Fas) ligand promoter in response to T cell stimulation.	Egr	APO-1	1	ACTIVATION	True
1009	1013	10508276:0:Egr:Fas	Novel [TF]/NF-AT composite sites mediate activation of the CD95 (APO-1/[TG]) ligand promoter in response to T cell stimulation.	Egr	Fas	1	ACTIVATION	True
1014	1018	17312465:8:Pdx-1:insulin	Overexpression of Ad-[TF] in alpha-TC-1 cells induced [TG] gene expression.	Pdx-1	insulin	1	ACTIVATION	False
1015	1019	16557472:5:ER:cyclin D1	Also, we evaluated the effects of this CR extract on the transcriptional regulation of genes involved in cell cycle progression in the [TF]-negative cell lines 293T and T-47D and we found that this extract markedly inhibited the luciferase activity driven by the [TG] promoter and increased the transcriptional activity of the p21 gene promoter.	ER	cyclin D1	1	ACTIVATION	False
1016	1020	16557472:5:ER:p21	Also, we evaluated the effects of this CR extract on the transcriptional regulation of genes involved in cell cycle progression in the [TF]-negative cell lines 293T and T-47D and we found that this extract markedly inhibited the luciferase activity driven by the cyclin D1 promoter and increased the transcriptional activity of the [TG] gene promoter.	ER	p21	2	REPRESSION	True
1018	1022	21077278:10:SP1:SIGIRR	Further, inflammatory conditions induced by TLR ligands and TNF-a caused significant down-regulation of SIGIRR expression in IECs, which was dependent upon decreased [TF] binding at the responsive element of the [TG] promoter.	SP1	SIGIRR	0	UNDEFINED	False
1023	1027	17394235:2:Ad4BP:cyp19a1	We previously reported that [TF]/SF-1, a member of the NR5A subfamily, plays an important role in the regulation of [TG] expression in medaka ovarian follicles during vitellogenesis.	Ad4BP	cyp19a1	0	UNDEFINED	False
1025	1029	17394235:2:SF-1:cyp19a1	We previously reported that Ad4BP/[TF], a member of the NR5A subfamily, plays an important role in the regulation of [TG] expression in medaka ovarian follicles during vitellogenesis.	SF-1	cyp19a1	0	UNDEFINED	False
1027	1031	7760790:0:MEF2D:c-jun	We have found that [TF] is the predominant protein in HeLa cells that binds to the [TG] MEF2 site.	MEF2D	c-jun	0	UNDEFINED	False
1032	1036	7760790:0:MEF2D:MEF2	Deletion analysis of [TF] showed that its DNA binding domain, when fused to a heterologous transcriptional activation domain, was sufficient for serum induction of a [TG] reporter gene.	MEF2D	MEF2	1	ACTIVATION	True
1036	1040	7760790:0:MEF2:MEF2	Serum induction of a [TG] reporter gene was not observed in a line of NIH 3T3 cells which contain low [TF] site binding activity.	MEF2	MEF2	1	ACTIVATION	True
1038	1042	7760790:0:serum response factor:c-fos serum response element	This is the domain homologous to that in the [TF] which is required for serum induction of the [TG], suggesting that serum regulation of c-fos and c-jun may share a common mechanism.	serum response factor	c-fos serum response element	1	ACTIVATION	True
1049	1053	19389135:4:antiandrogens:PSA	The effects of the [TF] on the transcription and translation of the [TG] gene in LNCaP cells expressing a mutant (T877A) androgen receptor were assessed by real-time reverse transcription-polymerase chain reaction and radioimmunoassays.	antiandrogens	PSA	0	UNDEFINED	False
1051	1055	11687571:8:YY-1:IL-4	Thus, [TF] positively regulates [TG] gene expression in lymphocytes.	YY-1	IL-4	1	ACTIVATION	False
1053	1057	17054913:3:VDR:CYP7alpha	In co-transfection experiments in HepG2 cells, [TF] repressed the activity of rat [TG] promoter in a ligand-dependent manner through inhibition of LXRalpha signaling.	VDR	CYP7alpha	2	REPRESSION	False
1055	1059	17054913:3:LXRalpha:CYP7alpha	In co-transfection experiments in HepG2 cells, VDR repressed the activity of rat [TG] promoter in a ligand-dependent manner through inhibition of [TF] signaling.	LXRalpha	CYP7alpha	1	ACTIVATION	True
1059	1063	9822643:0:NF1/L:alpha1B adrenergic receptor	Here we report that in Hep3B cells, cotransfection of NF1/L, NF1/Red1, or NF1/X with the [TG] (alpha1BAR) gene middle (P2) promoter increases P2 activity to more or less the same degree, whereas in DDT1 MF-2 cells cotransfection of [TF] or NF1/Red1 causes a small but statistically significant decrease in the P2 promoter activity, and NF1/X causes a greater, 70% inhibition.	NF1/L	alpha1B adrenergic receptor	2	REPRESSION	False
1065	1069	9822643:0:NF1:alpha1B adrenergic receptor	Here we report that in Hep3B cells, cotransfection of NF1/L, NF1/Red1, or NF1/X with the [TG] (alpha1BAR) gene middle (P2) promoter increases P2 activity to more or less the same degree, whereas in DDT1 MF-2 cells cotransfection of NF1/L or [TF]/Red1 causes a small but statistically significant decrease in the P2 promoter activity, and NF1/X causes a greater, 70% inhibition.	NF1	alpha1B adrenergic receptor	2	REPRESSION	False
1066	1070	9822643:0:NF1:alpha1BAR	Here we report that in Hep3B cells, cotransfection of NF1/L, NF1/Red1, or NF1/X with the alpha1B adrenergic receptor ([TG]) gene middle (P2) promoter increases P2 activity to more or less the same degree, whereas in DDT1 MF-2 cells cotransfection of NF1/L or [TF]/Red1 causes a small but statistically significant decrease in the P2 promoter activity, and NF1/X causes a greater, 70% inhibition.	NF1	alpha1BAR	2	REPRESSION	False
1071	1075	9822643:0:Red1:alpha1B adrenergic receptor	Here we report that in Hep3B cells, cotransfection of NF1/L, NF1/Red1, or NF1/X with the [TG] (alpha1BAR) gene middle (P2) promoter increases P2 activity to more or less the same degree, whereas in DDT1 MF-2 cells cotransfection of NF1/L or NF1/[TF] causes a small but statistically significant decrease in the P2 promoter activity, and NF1/X causes a greater, 70% inhibition.	Red1	alpha1B adrenergic receptor	2	REPRESSION	False
1072	1076	9822643:0:Red1:alpha1BAR	Here we report that in Hep3B cells, cotransfection of NF1/L, NF1/Red1, or NF1/X with the alpha1B adrenergic receptor ([TG]) gene middle (P2) promoter increases P2 activity to more or less the same degree, whereas in DDT1 MF-2 cells cotransfection of NF1/L or NF1/[TF] causes a small but statistically significant decrease in the P2 promoter activity, and NF1/X causes a greater, 70% inhibition.	Red1	alpha1BAR	2	REPRESSION	False
1077	1081	9822643:0:NF1/X:alpha1B adrenergic receptor	Here we report that in Hep3B cells, cotransfection of NF1/L, NF1/Red1, or NF1/X with the [TG] (alpha1BAR) gene middle (P2) promoter increases P2 activity to more or less the same degree, whereas in DDT1 MF-2 cells cotransfection of NF1/L or NF1/Red1 causes a small but statistically significant decrease in the P2 promoter activity, and [TF] causes a greater, 70% inhibition.	NF1/X	alpha1B adrenergic receptor	2	REPRESSION	False
1078	1082	9822643:0:NF1/X:alpha1BAR	Here we report that in Hep3B cells, cotransfection of NF1/L, NF1/Red1, or NF1/X with the alpha1B adrenergic receptor ([TG]) gene middle (P2) promoter increases P2 activity to more or less the same degree, whereas in DDT1 MF-2 cells cotransfection of NF1/L or NF1/Red1 causes a small but statistically significant decrease in the P2 promoter activity, and [TF] causes a greater, 70% inhibition.	NF1/X	alpha1BAR	2	REPRESSION	False
1085	1089	22828990:2:runt-related transcription factor 2:vascular endothelial growth factor	The extraordinary cell volume increase during hypertrophy is accompanied by an up-regulation of collagen X, matrix metalloproteinases (MMPs), and [TG] (VEGF), all which are targets of the [TF] (Runx2).	runt-related transcription factor 2	vascular endothelial growth factor	0	UNDEFINED	False
1087	1092	22828990:2:runt-related transcription factor 2:collagen X	The extraordinary cell volume increase during hypertrophy is accompanied by an up-regulation of [TG], matrix metalloproteinases (MMPs), and vascular endothelial growth factor (VEGF), all which are targets of the [TF] (Runx2).	runt-related transcription factor 2	collagen X	0	UNDEFINED	False
1088	1093	22828990:2:Runx2:vascular endothelial growth factor	The extraordinary cell volume increase during hypertrophy is accompanied by an up-regulation of collagen X, matrix metalloproteinases (MMPs), and [TG] (VEGF), all which are targets of the runt-related transcription factor 2 ([TF]).	Runx2	vascular endothelial growth factor	0	UNDEFINED	False
1089	1094	22828990:2:Runx2:VEGF	The extraordinary cell volume increase during hypertrophy is accompanied by an up-regulation of collagen X, matrix metalloproteinases (MMPs), and vascular endothelial growth factor ([TG]), all which are targets of the runt-related transcription factor 2 ([TF]).	Runx2	VEGF	0	UNDEFINED	False
1091	1096	22828990:2:Runx2:collagen X	The extraordinary cell volume increase during hypertrophy is accompanied by an up-regulation of [TG], matrix metalloproteinases (MMPs), and vascular endothelial growth factor (VEGF), all which are targets of the runt-related transcription factor 2 ([TF]).	Runx2	collagen X	0	UNDEFINED	False
1092	1097	17895316:11:steroidogenic factor 1:CYP17	Transfection with [TF] resulted in an increase in [TG] promoter activity, which was significantly inhibited in the presence of c-fos.	steroidogenic factor 1	CYP17	1	ACTIVATION	False
1095	1100	17895316:11:c-fos:CYP17	Transfection with steroidogenic factor 1 resulted in an increase in [TG] promoter activity, which was significantly inhibited in the presence of [TF].	c-fos	CYP17	2	REPRESSION	False
1096	1101	21606339:0:p53:p21	[TF] binding to nucleosomes within the [TG] promoter in vivo leads to nucleosome loss and transcriptional activation.	p53	p21	1	ACTIVATION	False
1097	1102	18594176:0:STAT3:Mac2- binding protein	Role of [TF] as a negative regulator in [TG] expression.	STAT3	Mac2- binding protein	2	REPRESSION	False
1098	1103	11478782:0:onecut-2:microphthalmia-associated transcription factor	The transcription factor [TF] controls the [TG] gene.	onecut-2	microphthalmia-associated transcription factor	0	UNDEFINED	False
1104	1109	11478782:0:Onecut-2:MITF	We show here that the cut-homeodomain transcription factor [TF] (OC-2) is expressed in melanocytes and binds to the [TG] gene promoter.	Onecut-2	MITF	0	UNDEFINED	False
1106	1111	11478782:0:OC-2:MITF	These results show that [TF] stimulates [TG] expression and that OC2 is a candidate gene, but not a common cause, of WS.	OC-2	MITF	1	ACTIVATION	False
1113	1118	15659537:8:p50:HSD11B2	Overexpression of p50 inhibited HSD11B2 promoter activity and overexpression of Egr-1 inhibited transactivation of the [TG] promoter by p65/[TF].	p50	HSD11B2	1	ACTIVATION	False
1118	1123	15659537:8:Egr-1:HSD11B2	Overexpression of p50 inhibited HSD11B2 promoter activity and overexpression of [TF] inhibited transactivation of the [TG] promoter by p65/p50.	Egr-1	HSD11B2	2	REPRESSION	False
1121	1126	15659537:8:p65:HSD11B2	Overexpression of p50 inhibited HSD11B2 promoter activity and overexpression of Egr-1 inhibited transactivation of the [TG] promoter by [TF]/p50.	p65	HSD11B2	1	ACTIVATION	False
1124	1129	7539003:0:myelin gene expression factor-2:MBP	In this report, we describe the molecular cloning and characterization of [TF] (Myef-2), a protein isolated from mouse brain that binds specifically to single-stranded DNA derived from the MB1 element and represses transcription of the [TG] gene in transient transfection assay.	myelin gene expression factor-2	MBP	2	REPRESSION	False
1126	1131	7539003:0:Myef-2:MBP	In this report, we describe the molecular cloning and characterization of myelin gene expression factor-2 ([TF]), a protein isolated from mouse brain that binds specifically to single-stranded DNA derived from the MB1 element and represses transcription of the [TG] gene in transient transfection assay.	Myef-2	MBP	2	REPRESSION	False
1128	1133	7539003:0:Myef-2:myelin basic protein	The developmental pattern of [TF] mRNA expression coincides with that previously described for SCIP, a POU domain transcription factor that also represses [TG] expression.	Myef-2	myelin basic protein	2	REPRESSION	True
1130	1135	7539003:0:SCIP:myelin basic protein	The developmental pattern of Myef-2 mRNA expression coincides with that previously described for [TF], a POU domain transcription factor that also represses [TG] expression.	SCIP	myelin basic protein	2	REPRESSION	False
1132	1137	15509806:0:FoxO3a:cyclin D2	[TF] and BCR-ABL regulate [TG] transcription through a STAT5/BCL6-dependent mechanism.	FoxO3a	cyclin D2	0	UNDEFINED	False
1137	1142	15509806:0:STAT5:cyclin D2	FoxO3a and BCR-ABL regulate [TG] transcription through a [TF]/BCL6-dependent mechanism.	STAT5	cyclin D2	0	UNDEFINED	False
1141	1146	15509806:0:BCL6:cyclin D2	FoxO3a and BCR-ABL regulate [TG] transcription through a STAT5/[TF]-dependent mechanism.	BCL6	cyclin D2	0	UNDEFINED	False
1147	1152	11694526:6:retinoid X receptor:SREBP-1c	Gel shift mobility and ligand binding domain activation assays demonstrated that PUFA suppression of SREBP-1c expression is mediated through its competition with LXR ligand in the activation of the ligand binding domain of LXR, thereby inhibiting binding of LXR/[TF] heterodimer to the LXREs in the [TG] promoter.	retinoid X receptor	SREBP-1c	0	UNDEFINED	False
1153	1158	11694526:6:LXR:SREBP-1c	Gel shift mobility and ligand binding domain activation assays demonstrated that PUFA suppression of SREBP-1c expression is mediated through its competition with LXR ligand in the activation of the ligand binding domain of LXR, thereby inhibiting binding of [TF]/retinoid X receptor heterodimer to the LXREs in the [TG] promoter.	LXR	SREBP-1c	0	UNDEFINED	False
1157	1162	15126558:4:estrogen receptor-alpha:CRH	Our current study found that in placental cells cotransfected with a CRH promoter construct and an [TF] expression vector results in a differential regulation whereby 17beta-estradiol (E2) decreased and the putative pure estrogen antagonist, ICI 182780, increased [TG] promoter activity.	estrogen receptor-alpha	CRH	2	REPRESSION	True
1160	1165	15126558:4:17beta-estradiol (E2):CRH	Our current study found that in placental cells cotransfected with a CRH promoter construct and an estrogen receptor-alpha expression vector results in a differential regulation whereby [TF] decreased and the putative pure estrogen antagonist, ICI 182780, increased [TG] promoter activity.	17beta-estradiol (E2)	CRH	2	REPRESSION	True
1163	1168	15126558:4:ICI 182780:CRH	Our current study found that in placental cells cotransfected with a CRH promoter construct and an estrogen receptor-alpha expression vector results in a differential regulation whereby 17beta-estradiol (E2) decreased and the putative pure estrogen antagonist, [TF], increased [TG] promoter activity.	ICI 182780	CRH	2	REPRESSION	True
1166	1171	19060920:10:c-Jun:beclin 1	Chromatin immunoprecipitation and luciferase reporter analysis revealed that [TF] was involved in the regulation of [TG] transcription in response to ceramide treatment.	c-Jun	beclin 1	0	UNDEFINED	False
1167	1172	22265908:7:CHOP-10:eNOS	In agreement with these results, eNOS mRNA and protein levels were significantly upregulated in CHOP-10 short interfering RNA-transfected human endothelial cells, whereas overexpression of [TF] inhibited basal transcriptional activation of the [TG] promoter.	CHOP-10	eNOS	2	REPRESSION	False
1170	1175	19783677:8:RelA:cyclooxygenase 2	Knockdown of [TF] or c-Jun decreased the formation of gene loop and down-regulated [TG] (COX2) or matrix metalloproteinase 13 (MMP13) transcription levels.	RelA	cyclooxygenase 2	1	ACTIVATION	False
1171	1176	19783677:8:RelA:COX2	Knockdown of [TF] or c-Jun decreased the formation of gene loop and down-regulated cyclooxygenase 2 ([TG]) or matrix metalloproteinase 13 (MMP13) transcription levels.	RelA	COX2	1	ACTIVATION	False
1172	1177	19783677:8:RelA:matrix metalloproteinase 13	Knockdown of [TF] or c-Jun decreased the formation of gene loop and down-regulated cyclooxygenase 2 (COX2) or [TG] (MMP13) transcription levels.	RelA	matrix metalloproteinase 13	1	ACTIVATION	False
1173	1178	19783677:8:RelA:MMP13	Knockdown of [TF] or c-Jun decreased the formation of gene loop and down-regulated cyclooxygenase 2 (COX2) or matrix metalloproteinase 13 ([TG]) transcription levels.	RelA	MMP13	1	ACTIVATION	False
1175	1180	19783677:8:c-Jun:cyclooxygenase 2	Knockdown of RelA or [TF] decreased the formation of gene loop and down-regulated [TG] (COX2) or matrix metalloproteinase 13 (MMP13) transcription levels.	c-Jun	cyclooxygenase 2	1	ACTIVATION	False
1176	1181	19783677:8:c-Jun:COX2	Knockdown of RelA or [TF] decreased the formation of gene loop and down-regulated cyclooxygenase 2 ([TG]) or matrix metalloproteinase 13 (MMP13) transcription levels.	c-Jun	COX2	1	ACTIVATION	False
1177	1182	19783677:8:c-Jun:matrix metalloproteinase 13	Knockdown of RelA or [TF] decreased the formation of gene loop and down-regulated cyclooxygenase 2 (COX2) or [TG] (MMP13) transcription levels.	c-Jun	matrix metalloproteinase 13	1	ACTIVATION	False
1178	1183	19783677:8:c-Jun:MMP13	Knockdown of RelA or [TF] decreased the formation of gene loop and down-regulated cyclooxygenase 2 (COX2) or matrix metalloproteinase 13 ([TG]) transcription levels.	c-Jun	MMP13	1	ACTIVATION	False
1185	1190	19564409:0:Id1:Deltex4	To understand the underlying mechanisms, we observed that mRNA levels of Deltex1, as well as [TG], were dramatically elevated in [TF]-expressing thymocytes, which could result in developmental arrest by attenuating Notch function.	Id1	Deltex4	1	ACTIVATION	True
1195	1200	19564409:0:Id1:Gfi1b	Furthermore, we showed that [TG] levels decreased, whereas GATA3 levels increased in [TF] transgenic thymocytes.	Id1	Gfi1b	2	REPRESSION	False
1196	1201	19564409:0:Id1:GATA3	Furthermore, we showed that Gfi1b levels decreased, whereas [TG] levels increased in [TF] transgenic thymocytes.	Id1	GATA3	1	ACTIVATION	False
1197	1202	19564409:0:GATA3:Deltex1	Thus, T-cell commitment may be controlled by the interplay among E proteins, Gfi1b, and [TF] transcription regulators, which influence Notch function through the expression of [TG].	GATA3	Deltex1	0	UNDEFINED	False
1199	1204	19564409:0:Gfi1b:Deltex1	Thus, T-cell commitment may be controlled by the interplay among E proteins, [TF], and GATA3 transcription regulators, which influence Notch function through the expression of [TG].	Gfi1b	Deltex1	0	UNDEFINED	False
1201	1206	12788937:0:Elk-1:cytosolic chaperonin theta subunit	Transcriptional regulation of the [TG] gene, Cctq, by Ets domain transcription factors [TF], Sap-1a, and Net in the absence of serum response factor.	Elk-1	cytosolic chaperonin theta subunit	0	UNDEFINED	False
1202	1207	12788937:0:Elk-1:Cctq	We show here that transcription of the gene encoding the theta subunit of mouse CCT, [TG], is regulated by the ternary complex factors (TCFs), [TF], Sap-1a, and Net (Sap-2).	Elk-1	Cctq	0	UNDEFINED	False
1207	1212	12788937:0:Sap-1a:cytosolic chaperonin theta subunit	Transcriptional regulation of the [TG] gene, Cctq, by Ets domain transcription factors Elk-1, [TF], and Net in the absence of serum response factor.	Sap-1a	cytosolic chaperonin theta subunit	0	UNDEFINED	False
1208	1213	12788937:0:Sap-1a:Cctq	We show here that transcription of the gene encoding the theta subunit of mouse CCT, [TG], is regulated by the ternary complex factors (TCFs), Elk-1, [TF], and Net (Sap-2).	Sap-1a	Cctq	0	UNDEFINED	False
1213	1218	12788937:0:Net:cytosolic chaperonin theta subunit	Transcriptional regulation of the [TG] gene, Cctq, by Ets domain transcription factors Elk-1, Sap-1a, and [TF] in the absence of serum response factor.	Net	cytosolic chaperonin theta subunit	0	UNDEFINED	False
1214	1219	12788937:0:Net:Cctq	We show here that transcription of the gene encoding the theta subunit of mouse CCT, [TG], is regulated by the ternary complex factors (TCFs), Elk-1, Sap-1a, and [TF] (Sap-2).	Net	Cctq	0	UNDEFINED	False
1219	1224	12788937:0:serum response factor:cytosolic chaperonin theta subunit	Transcriptional regulation of the [TG] gene, Cctq, by Ets domain transcription factors Elk-1, Sap-1a, and Net in the absence of [TF].	serum response factor	cytosolic chaperonin theta subunit	0	UNDEFINED	True
1225	1230	12788937:0:Ets:cytosolic chaperonin theta subunit	Transcriptional regulation of the [TG] gene, Cctq, by [TF] domain transcription factors Elk-1, Sap-1a, and Net in the absence of serum response factor.	Ets	cytosolic chaperonin theta subunit	0	UNDEFINED	True
1226	1231	12788937:0:Ets:Cctq	Transcriptional regulation of the cytosolic chaperonin theta subunit gene, [TG], by [TF] domain transcription factors Elk-1, Sap-1a, and Net in the absence of serum response factor.	Ets	Cctq	0	UNDEFINED	True
1231	1236	12788937:0:Elk-1:theta subunit of mouse CCT,	We show here that transcription of the gene encoding the [TG] Cctq, is regulated by the ternary complex factors (TCFs), [TF], Sap-1a, and Net (Sap-2).	Elk-1	theta subunit of mouse CCT,	0	UNDEFINED	False
1233	1238	12788937:0:Sap-1a:theta subunit of mouse CCT,	We show here that transcription of the gene encoding the [TG] Cctq, is regulated by the ternary complex factors (TCFs), Elk-1, [TF], and Net (Sap-2).	Sap-1a	theta subunit of mouse CCT,	0	UNDEFINED	False
1235	1240	12788937:0:Net:theta subunit of mouse CCT,	We show here that transcription of the gene encoding the [TG] Cctq, is regulated by the ternary complex factors (TCFs), Elk-1, Sap-1a, and [TF] (Sap-2).	Net	theta subunit of mouse CCT,	0	UNDEFINED	False
1237	1242	12788937:0:Sap-2:theta subunit of mouse CCT,	We show here that transcription of the gene encoding the [TG] Cctq, is regulated by the ternary complex factors (TCFs), Elk-1, Sap-1a, and Net ([TF]).	Sap-2	theta subunit of mouse CCT,	0	UNDEFINED	False
1238	1243	12788937:0:Sap-2:Cctq	We show here that transcription of the gene encoding the theta subunit of mouse CCT, [TG], is regulated by the ternary complex factors (TCFs), Elk-1, Sap-1a, and Net ([TF]).	Sap-2	Cctq	0	UNDEFINED	False
1245	1250	19887646:0:Pit-1:GH	[TF] is a POU-homeodomain transcription factor that dictates the ontogeny of pituitary somatotrophs, lactotrophs, and thyrotrophs through regulation of their respective protein hormone genes: [TG], prolactin (PRL), and TSHbeta.	Pit-1	GH	0	UNDEFINED	False
1246	1251	19887646:0:Pit-1:prolactin	[TF] is a POU-homeodomain transcription factor that dictates the ontogeny of pituitary somatotrophs, lactotrophs, and thyrotrophs through regulation of their respective protein hormone genes: GH, [TG] (PRL), and TSHbeta.	Pit-1	prolactin	0	UNDEFINED	False
1247	1252	19887646:0:Pit-1:PRL	Finally, Pit-1 synergistic activation of the 2500-bp r[TG] promoter with estrogen receptor was reduced by T220D compared with T220A and WT [TF].	Pit-1	PRL	1	ACTIVATION	True
1248	1253	19887646:0:Pit-1:TSHbeta	[TF] is a POU-homeodomain transcription factor that dictates the ontogeny of pituitary somatotrophs, lactotrophs, and thyrotrophs through regulation of their respective protein hormone genes: GH, prolactin (PRL), and [TG].	Pit-1	TSHbeta	0	UNDEFINED	False
1250	1255	19887646:0:Ets-1:PRL	In transfections of HeLa cells, each Pit-1 mutant transcriptionally activated the -425r[TG] promoter and cooperated with [TF] to WT levels.	Ets-1	PRL	1	ACTIVATION	False
1251	1256	19887646:0:Ets-1:rPRL	In the rat PRL promoter ([TG]), Ras-stimulated transcription is mediated by binding of [TF] and Pit-1 at a composite site (FPIV).	Ets-1	rPRL	1	ACTIVATION	False
1253	1258	19887646:0:Pit-1:rPRL	In the rat PRL promoter ([TG]), Ras-stimulated transcription is mediated by binding of Ets-1 and [TF] at a composite site (FPIV).	Pit-1	rPRL	1	ACTIVATION	False
1258	1263	19887646:0:estrogen receptor:PRL	Finally, Pit-1 synergistic activation of the 2500-bp r[TG] promoter with [TF] was reduced by T220D compared with T220A and WT Pit-1.	estrogen receptor	PRL	1	ACTIVATION	False
1260	1265	15242522:11:p53:bax	PTTG also up-regulates the activity of the bax promoter and increases the expression of [TG] through modulation of [TF] expression.	p53	bax	0	UNDEFINED	False
1261	1266	9811446:5:c-myc:gadd45	Myc acts in part by reducing the stress-responsiveness of the gadd45 promoter, as a [TF] expression vector strongly suppressed activation of [TG]-reporter constructs.	c-myc	gadd45	2	REPRESSION	False
1266	1271	9705290:0:GCF2:epidermal growth factor receptor	Cotransfection assays show that [TF] acts to repress transcription from the [TG] promoter in constructs containing the major GCF2 binding site and not when the site had been mutated.	GCF2	epidermal growth factor receptor	2	REPRESSION	False
1269	1274	19106115:6:VDR:CYP7A1	Electrophoretic mobility shift assay and mutagenesis analyses have identified the negative VDR response elements that bind [TF]/retinoid X receptor alpha in the human [TG] promoter.	VDR	CYP7A1	2	REPRESSION	True
1271	1276	19106115:6:retinoid X receptor alpha:CYP7A1	Electrophoretic mobility shift assay and mutagenesis analyses have identified the negative VDR response elements that bind VDR/[TF] in the human [TG] promoter.	retinoid X receptor alpha	CYP7A1	0	UNDEFINED	False
1278	1283	11748232:0:HMGB1:Bax	[TF] and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human [TG] gene promoter.	HMGB1	Bax	2	REPRESSION	False
1282	1287	11748232:0:p53:Bax	HMGB1 and HMGB2 cell-specifically down-regulate the [TF]- and p73-dependent sequence-specific transactivation from the human [TG] gene promoter.	p53	Bax	1	ACTIVATION	False
1286	1291	11748232:0:p73:Bax	HMGB1 and HMGB2 cell-specifically down-regulate the p53- and [TF]-dependent sequence-specific transactivation from the human [TG] gene promoter.	p73	Bax	1	ACTIVATION	False
1295	1300	8926278:0:heat shock factor 1:prointerleukin 1beta	Both exposure to elevated temperatures and heat-independent heat shock factor 1 expression repressed the transcription of the prointerleukin 1beta gene, and repression was strictly dependent on an intact consensus heat shock element in the [TG] promoter to which [TF] bound.	heat shock factor 1	prointerleukin 1beta	2	REPRESSION	True
1297	1302	8926278:0:Heat shock factor 1:prointerleukin 1beta	Transcriptional repression of the [TG] gene by heat shock factor 1. [TF] activates the promoters of heat shock genes at elevated temperatures through its interaction with heat shock elements.	Heat shock factor 1	prointerleukin 1beta	2	REPRESSION	True
1313	1318	19276186:0:GATA4:ERBB2	We propose that the negative feedback loop linking ERBB2 and [TF] plays a role in the transcriptional dysregulation of [TG] gene expression in breast cancer.	GATA4	ERBB2	0	UNDEFINED	True
1315	1320	19276186:0:GATA4:ERBB2 promoter	Phylogenetic foot printing revealed multiple putative [TF] binding sites conserved in mammals within the [TG] region.	GATA4	ERBB2 promoter	0	UNDEFINED	True
1316	1321	16895524:3:p53:HNF4alpha	In the present study we demonstrate that [TF] also down-regulates expression of the human [TG] gene via the proximal P1 promoter.	p53	HNF4alpha	2	REPRESSION	False
1318	1323	17065415:3:Steroidogenic factor-1:StAR	[TF]/adrenal-4-binding protein (SF-1/Ad4BP) plays an important role in the expression of human [TG] gene.	Steroidogenic factor-1	StAR	0	UNDEFINED	False
1322	1327	17065415:3:adrenal-4-binding protein:StAR	Steroidogenic factor-1/[TF] (SF-1/Ad4BP) plays an important role in the expression of human [TG] gene.	adrenal-4-binding protein	StAR	0	UNDEFINED	False
1326	1331	17065415:3:SF-1:StAR	Steroidogenic factor-1/adrenal-4-binding protein ([TF]/Ad4BP) plays an important role in the expression of human [TG] gene.	SF-1	StAR	0	UNDEFINED	False
1330	1335	17065415:3:Ad4BP:StAR	Steroidogenic factor-1/adrenal-4-binding protein (SF-1/[TF]) plays an important role in the expression of human [TG] gene.	Ad4BP	StAR	0	UNDEFINED	False
1338	1343	12370809:5:p53:FDXR	In addition, we identified a p53 response element located within the [TG] promoter that is responsive to wild-type [TF], p63alpha, p63gamma, p73alpha, and p73beta.	p53	FDXR	1	ACTIVATION	False
1345	1350	12370809:5:p63alpha:FDXR	In addition, we identified a p53 response element located within the [TG] promoter that is responsive to wild-type p53, [TF], p63gamma, p73alpha, and p73beta.	p63alpha	FDXR	1	ACTIVATION	False
1350	1355	12370809:5:p63gamma:FDXR	In addition, we identified a p53 response element located within the [TG] promoter that is responsive to wild-type p53, p63alpha, [TF], p73alpha, and p73beta.	p63gamma	FDXR	1	ACTIVATION	False
1355	1360	12370809:5:p73alpha:FDXR	In addition, we identified a p53 response element located within the [TG] promoter that is responsive to wild-type p53, p63alpha, p63gamma, [TF], and p73beta.	p73alpha	FDXR	1	ACTIVATION	False
1360	1365	12370809:5:p73beta:FDXR	In addition, we identified a p53 response element located within the [TG] promoter that is responsive to wild-type p53, p63alpha, p63gamma, p73alpha, and [TF].	p73beta	FDXR	1	ACTIVATION	False
1365	1370	23074094:7:BCL6:EREG	Moreover, we found that the FBXL11 histone demethylase function was activated by associating with [TF] corepressor, and this complex could repress [TG] transcription by increasing histone K4/36 methylation in the EREG promoter.	BCL6	EREG	2	REPRESSION	False
1366	1371	11374025:8:PPAR:IL-2	More recently, [TF] activators were shown to inhibit the activation of inflammatory response genes (such as [TG], IL-6, IL-8, TNF alpha and metalloproteases) by negatively interfering with the NF-kappa B, STAT and AP-1 signalling pathways in cells of the vascular wall.	PPAR	IL-2	2	REPRESSION	False
1367	1372	11374025:8:PPAR:IL-6	More recently, [TF] activators were shown to inhibit the activation of inflammatory response genes (such as IL-2, [TG], IL-8, TNF alpha and metalloproteases) by negatively interfering with the NF-kappa B, STAT and AP-1 signalling pathways in cells of the vascular wall.	PPAR	IL-6	2	REPRESSION	False
1368	1373	11374025:8:PPAR:IL-8	More recently, [TF] activators were shown to inhibit the activation of inflammatory response genes (such as IL-2, IL-6, [TG], TNF alpha and metalloproteases) by negatively interfering with the NF-kappa B, STAT and AP-1 signalling pathways in cells of the vascular wall.	PPAR	IL-8	2	REPRESSION	False
1369	1374	11374025:8:PPAR:TNF alpha	More recently, [TF] activators were shown to inhibit the activation of inflammatory response genes (such as IL-2, IL-6, IL-8, [TG] and metalloproteases) by negatively interfering with the NF-kappa B, STAT and AP-1 signalling pathways in cells of the vascular wall.	PPAR	TNF alpha	2	REPRESSION	False
1394	1399	15620698:0:hypoxia-inducible factor-1:94-kDa glucose-regulated protein	Up-regulation of [TG] by [TF] in human endothelial cells in response to hypoxia.	hypoxia-inducible factor-1	94-kDa glucose-regulated protein	1	ACTIVATION	False
1395	1400	15620698:0:HIF-1:GRP94	Competition experiments of HIF-1 DNA binding using specific probes containing each HRE sequence of the [TG] promoter clearly evidenced that [TF] binds these sequences with high affinity.	HIF-1	GRP94	0	UNDEFINED	False
1398	1403	17692454:4:MR:EGFR	While the former seems to be mediated by the tyrosine kinase cSrc, reporter gene assays and chromatin immunoprecipitation data indicate that the latter is caused by an interaction between [TF] and the [TG] promoter.	MR	EGFR	0	UNDEFINED	False
1399	1404	17054913:1:LXRalpha:cholesterol 7alpha-hydroxylase	The expression of [TG] (CYP7alpha), the rate-limiting enzyme in the catabolism of cholesterol to bile acid, is stimulated by oxysterol receptor, liver X receptor alpha ([TF]) and negatively regulated by a bile acid receptor, farnesoid X receptor.	LXRalpha	cholesterol 7alpha-hydroxylase	1	ACTIVATION	False
1400	1405	17054913:1:LXRalpha:CYP7alpha	The expression of cholesterol 7alpha-hydroxylase ([TG]), the rate-limiting enzyme in the catabolism of cholesterol to bile acid, is stimulated by oxysterol receptor, liver X receptor alpha ([TF]) and negatively regulated by a bile acid receptor, farnesoid X receptor.	LXRalpha	CYP7alpha	1	ACTIVATION	False
1405	1410	17054913:1:liver X receptor alpha:cholesterol 7alpha-hydroxylase	The expression of [TG] (CYP7alpha), the rate-limiting enzyme in the catabolism of cholesterol to bile acid, is stimulated by oxysterol receptor, [TF] (LXRalpha) and negatively regulated by a bile acid receptor, farnesoid X receptor.	liver X receptor alpha	cholesterol 7alpha-hydroxylase	1	ACTIVATION	False
1407	1412	17054913:1:liver X receptor alpha:CYP7alpha	The expression of cholesterol 7alpha-hydroxylase ([TG]), the rate-limiting enzyme in the catabolism of cholesterol to bile acid, is stimulated by oxysterol receptor, [TF] (LXRalpha) and negatively regulated by a bile acid receptor, farnesoid X receptor.	liver X receptor alpha	CYP7alpha	1	ACTIVATION	False
1411	1416	17054913:1:farnesoid X receptor:cholesterol 7alpha-hydroxylase	The expression of [TG] (CYP7alpha), the rate-limiting enzyme in the catabolism of cholesterol to bile acid, is stimulated by oxysterol receptor, liver X receptor alpha (LXRalpha) and negatively regulated by a bile acid receptor, [TF].	farnesoid X receptor	cholesterol 7alpha-hydroxylase	2	REPRESSION	False
1413	1418	17054913:1:farnesoid X receptor:CYP7alpha	The expression of cholesterol 7alpha-hydroxylase ([TG]), the rate-limiting enzyme in the catabolism of cholesterol to bile acid, is stimulated by oxysterol receptor, liver X receptor alpha (LXRalpha) and negatively regulated by a bile acid receptor, [TF].	farnesoid X receptor	CYP7alpha	2	REPRESSION	False
1417	1422	17054913:1:oxysterol receptor:cholesterol 7alpha-hydroxylase	The expression of [TG] (CYP7alpha), the rate-limiting enzyme in the catabolism of cholesterol to bile acid, is stimulated by [TF], liver X receptor alpha (LXRalpha) and negatively regulated by a bile acid receptor, farnesoid X receptor.	oxysterol receptor	cholesterol 7alpha-hydroxylase	1	ACTIVATION	True
1419	1424	17054913:1:oxysterol receptor:CYP7alpha	The expression of cholesterol 7alpha-hydroxylase ([TG]), the rate-limiting enzyme in the catabolism of cholesterol to bile acid, is stimulated by [TF], liver X receptor alpha (LXRalpha) and negatively regulated by a bile acid receptor, farnesoid X receptor.	oxysterol receptor	CYP7alpha	1	ACTIVATION	True
1423	1428	17054913:1:bile acid receptor:cholesterol 7alpha-hydroxylase	The expression of [TG] (CYP7alpha), the rate-limiting enzyme in the catabolism of cholesterol to bile acid, is stimulated by oxysterol receptor, liver X receptor alpha (LXRalpha) and negatively regulated by a [TF], farnesoid X receptor.	bile acid receptor	cholesterol 7alpha-hydroxylase	2	REPRESSION	False
1425	1430	17054913:1:bile acid receptor:CYP7alpha	The expression of cholesterol 7alpha-hydroxylase ([TG]), the rate-limiting enzyme in the catabolism of cholesterol to bile acid, is stimulated by oxysterol receptor, liver X receptor alpha (LXRalpha) and negatively regulated by a [TF], farnesoid X receptor.	bile acid receptor	CYP7alpha	2	REPRESSION	False
1431	1436	10102273:0:FKHRL1:Fas ligand	Within the nucleus, [TF] triggers apoptosis most likely by inducing the expression of genes that are critical for cell death, such as the [TG] gene.	FKHRL1	Fas ligand	1	ACTIVATION	False
1466	1471	15905358:9:AP-2:TbetaRI	Chromatin immunoprecipitation analysis demonstrated DNA binding activity of [TF] in the [TG] promoter and of Sp1 in the TbetaRII promoter after treatment with 5-Aza.	AP-2	TbetaRI	0	UNDEFINED	False
1468	1473	15905358:9:Sp1:TbetaRII	Chromatin immunoprecipitation analysis demonstrated DNA binding activity of AP-2 in the TbetaRI promoter and of [TF] in the [TG] promoter after treatment with 5-Aza.	Sp1	TbetaRII	0	UNDEFINED	False
1471	1476	17245125:0:CBF-1:PTEN	[TF] (RBP-J kappa) binds to the PTEN promoter and regulates [TG] gene expression.	CBF-1	PTEN	0	UNDEFINED	False
1473	1478	17245125:0:RBP-J kappa:PTEN	CBF-1 ([TF]) binds to the PTEN promoter and regulates [TG] gene expression.	RBP-J kappa	PTEN	0	UNDEFINED	False
1475	1480	21225257:5:E2F1:IRF-3	Overexpression of E2F1, but not a mutant E2F1, represses the IRF-3 promoter activity in reporter gene assays while knocking down of endogenous [TF] by shRNA strategy results in enhanced [TG] promoter activity.	E2F1	IRF-3	2	REPRESSION	False
1488	1493	11212251:5:Sp1:MUC2	We show that these GC boxes are binding sites for Sp-family transcription factors and are functionally important since mithramycin, an inhibitor of [TF]/Sp3 binding, blocks [TG] gene expression in HT29 cells.	Sp1	MUC2	1	ACTIVATION	False
1490	1495	11212251:5:Sp3:MUC2	We show that these GC boxes are binding sites for Sp-family transcription factors and are functionally important since mithramycin, an inhibitor of Sp1/[TF] binding, blocks [TG] gene expression in HT29 cells.	Sp3	MUC2	1	ACTIVATION	False
1495	1501	21471200:4:Runx2:Bglap2	Electrophoretic mobility shift assay demonstrated that Foxo1 suppressed [TF] binding to its cognate site within the [TG] promoter.	Runx2	Bglap2	0	UNDEFINED	False
1496	1502	23335796:9:STAT3:SOCS3	Knockdown of [TF] by small interfering RNA abolished [TG] expression in response to IGF-1.	STAT3	SOCS3	1	ACTIVATION	False
1499	1505	17803961:0:Ptf1a:Pdx1	Our data suggest a novel transcriptional network, where [TF] and RBP-J cooperatively regulate [TG] gene expression through binding to Area III.	Ptf1a	Pdx1	0	UNDEFINED	False
1501	1507	17803961:0:RBP-J:Pdx1	Our data suggest a novel transcriptional network, where Ptf1a and [TF] cooperatively regulate [TG] gene expression through binding to Area III.	RBP-J	Pdx1	0	UNDEFINED	False
1514	1520	15330762:7:SREBP-1:SREBP-1c	Insulin and the LXR agonist TO901317 increased the association of [TF] with the [TG] promoter.	SREBP-1	SREBP-1c	0	UNDEFINED	False
1523	1529	15330762:7:LXR:SREBP-1c	Insulin and the [TF] agonist TO901317 increased the association of SREBP-1 with the [TG] promoter.	LXR	SREBP-1c	0	UNDEFINED	True
1527	1533	15330762:7:TO901317:SREBP-1c	Insulin and the LXR agonist [TF] increased the association of SREBP-1 with the [TG] promoter.	TO901317	SREBP-1c	0	UNDEFINED	True
1530	1536	15467742:0:p21SNFT:MMP-1	Transcriptional repression of [TG] by [TF] and reduced in vitro invasiveness of hepatocarcinoma cells.	p21SNFT	MMP-1	2	REPRESSION	False
1533	1539	15467742:0:p21SNFT:matrix metalloproteinase-1	[TF] interacted with Jun at the [TG] promoter -88 Ets/AP-1 enhancer element, where Jun is known to activate transcription via interaction with Fos and Ets proteins.	p21SNFT	matrix metalloproteinase-1	0	UNDEFINED	True
1539	1545	15467742:0:Jun:matrix metalloproteinase-1	p21SNFT interacted with Jun at the [TG] promoter -88 Ets/AP-1 enhancer element, where [TF] is known to activate transcription via interaction with Fos and Ets proteins.	Jun	matrix metalloproteinase-1	1	ACTIVATION	False
1546	1552	15467742:0:Fos:matrix metalloproteinase-1	p21SNFT interacted with Jun at the [TG] promoter -88 Ets/AP-1 enhancer element, where Jun is known to activate transcription via interaction with [TF] and Ets proteins.	Fos	matrix metalloproteinase-1	1	ACTIVATION	False
1551	1557	15467742:0:Ets:matrix metalloproteinase-1	p21SNFT interacted with Jun at the [TG] promoter -88 Ets/AP-1 enhancer element, where Jun is known to activate transcription via interaction with Fos and [TF] proteins.	Ets	matrix metalloproteinase-1	1	ACTIVATION	True
1556	1562	15467742:0:AP-1:matrix metalloproteinase-1	p21SNFT interacted with Jun at the [TG] promoter -88 Ets/[TF] enhancer element, where Jun is known to activate transcription via interaction with Fos and Ets proteins.	AP-1	matrix metalloproteinase-1	1	ACTIVATION	True
1559	1565	9488709:5:Egr-1:PDGF-B	The immediate-early transcription factor, [TF], which footprints the [TG] promoter, is also constitutively expressed in these cells.	Egr-1	PDGF-B	0	UNDEFINED	False
1560	1566	15757903:8:HOXA5:pleiotrophin	Promoter deletion, chromatin immunoprecipitation assay, and gel-shift assays were performed to show that [TF] can directly bind to one binding site on the [TG] promoter.	HOXA5	pleiotrophin	0	UNDEFINED	False
1561	1567	15060147:6:C/EBP beta:IGF-I	Overexpression of C/EBP beta stimulated transcription from the IGF-I promoter, indicating that [TG] is a direct transcriptional target of [TF].	C/EBP beta	IGF-I	0	UNDEFINED	False
1563	1569	17391671:3:ZEB1:PKP3	[TF] physically associates with two conserved E-box elements in the [TG] promoter and partially represses the activity of corresponding human and mouse PKP3 promoter fragments in reporter gene assays.	ZEB1	PKP3	2	REPRESSION	False
1565	1571	10390158:7:Pit-1:tiGH	A dose-dependent activation of the tiGH promoter was achieved in nonpituitary fish EPC and monkey COS cells cotransfected with a rat Pit-1 expression vector, demonstrating the crucial role played by [TF] as an activator of the [TG] gene.	Pit-1	tiGH	1	ACTIVATION	False
1567	1573	12530662:8:SF-1:hCYP17	We conclude that a DSP, possibly MKP-1, is essential for enhancing hCYP17 transcription in the adrenal cortex by desphosphorylating of SF-1, thereby increasing the binding affinity of [TF], p54nrb, and PSF for the [TG] promoter.	SF-1	hCYP17	0	UNDEFINED	False
1572	1578	12530662:8:p54nrb:hCYP17	We conclude that a DSP, possibly MKP-1, is essential for enhancing hCYP17 transcription in the adrenal cortex by desphosphorylating of SF-1, thereby increasing the binding affinity of SF-1, [TF], and PSF for the [TG] promoter.	p54nrb	hCYP17	0	UNDEFINED	False
1575	1581	10459866:0:Sp1:CYP11A	Molecular mechanism for cooperation between [TF] and steroidogenic factor-1 (SF-1) to regulate bovine [TG] gene expression.	Sp1	CYP11A	0	UNDEFINED	False
1578	1584	10459866:0:steroidogenic factor-1:CYP11A	Molecular mechanism for cooperation between Sp1 and [TF] (SF-1) to regulate bovine [TG] gene expression.	steroidogenic factor-1	CYP11A	0	UNDEFINED	False
1581	1587	10459866:0:SF-1:CYP11A	Molecular mechanism for cooperation between Sp1 and steroidogenic factor-1 ([TF]) to regulate bovine [TG] gene expression.	SF-1	CYP11A	0	UNDEFINED	False
1604	1610	10929206:2:RA:RAR beta	P19 cells constitutively express the retinoic acid receptor alpha (RAR alpha) and RAR gamma mRNAs while RAR beta expression is induced by [TF] through a consensus RA-response element in the [TG] promoter.	RA	RAR beta	1	ACTIVATION	True
1605	1611	15126343:7:Sp2:CEACAM1	Our studies show that transcriptional repression by [TF] represents one mechanism by which [TG] tumor suppressor gene is down-regulated in prostate cancer.	Sp2	CEACAM1	2	REPRESSION	False
1606	1612	14627819:7:E47:SHP	Finally, we found that [TF] and steroidogenic factor 1 (SF-1), a regulator of the SHP promoter, synergistically activate the human but not the mouse [TG] promoter.	E47	SHP	1	ACTIVATION	False
1614	1620	14627819:7:steroidogenic factor 1:SHP	Finally, we found that E47 and [TF] (SF-1), a regulator of the SHP promoter, synergistically activate the human but not the mouse [TG] promoter.	steroidogenic factor 1	SHP	1	ACTIVATION	False
1617	1623	14627819:7:SF-1:SHP	Finally, we found that E47 and steroidogenic factor 1 ([TF]), a regulator of the SHP promoter, synergistically activate the human but not the mouse [TG] promoter.	SF-1	SHP	1	ACTIVATION	False
1619	1625	10770937:0:B-MYB:apolipoprotein J	Direct transactivation of the anti-apoptotic gene [TG] (clusterin) by [TF].	B-MYB	apolipoprotein J	1	ACTIVATION	False
1620	1626	10770937:0:B-MYB:clusterin	Direct transactivation of the anti-apoptotic gene apolipoprotein J ([TG]) by [TF].	B-MYB	clusterin	1	ACTIVATION	False
1622	1628	10770937:0:B-MYB:ApoJ	Thus, activation of [TG]/Clusterin by [TF] may be an important step in the regulation of apoptosis in normal and diseased cells.	B-MYB	ApoJ	1	ACTIVATION	False
1623	1629	10770937:0:B-MYB:Clusterin	Thus, activation of ApoJ/[TG] by [TF] may be an important step in the regulation of apoptosis in normal and diseased cells.	B-MYB	Clusterin	1	ACTIVATION	False
1624	1630	10770937:0:B-MYB:SGP-2	One of the genes, the mRNA levels of which were enhanced in [TF] expressing cells, was ApoJ/Clusterin([TG]/TRMP-2) (ApoJ/Clusterin), previously implicated in regulation of apoptosis and tumor progression.	B-MYB	SGP-2	1	ACTIVATION	False
1625	1631	10770937:0:B-MYB:TRMP-2	One of the genes, the mRNA levels of which were enhanced in [TF] expressing cells, was ApoJ/Clusterin(SGP-2/[TG]) (ApoJ/Clusterin), previously implicated in regulation of apoptosis and tumor progression.	B-MYB	TRMP-2	1	ACTIVATION	False
1636	1642	12767074:2:retinoid:Retinoic acid receptor beta	[TG] (RARbeta) is itself a [TF] target gene with a retinoic acid response element (betaRARE) in the 5' untranslated region of the RARbeta2 gene.	retinoid	Retinoic acid receptor beta	0	UNDEFINED	False
1637	1643	12767074:2:retinoid:RARbeta	Retinoic acid receptor beta ([TG]) is itself a [TF] target gene with a retinoic acid response element (betaRARE) in the 5' untranslated region of the RARbeta2 gene.	retinoid	RARbeta	0	UNDEFINED	False
1642	1649	15050899:0:HIF-1:iNOS	Activation of the transcription factor [TF] and its target genes, VEGF, HO-1, [TG], during fracture repair.	HIF-1	iNOS	0	UNDEFINED	False
1643	1650	15050899:0:HIF-1:HO-1	Activation of the transcription factor [TF] and its target genes, VEGF, [TG], iNOS, during fracture repair.	HIF-1	HO-1	0	UNDEFINED	False
1645	1652	15217907:7:ERalpha:PAI-1	We concluded that [TF] and ERbeta exert differential effects on the [TG] promoter activity in transfected BAECs.	ERalpha	PAI-1	0	UNDEFINED	False
1647	1654	15217907:7:ERbeta:PAI-1	We concluded that ERalpha and [TF] exert differential effects on the [TG] promoter activity in transfected BAECs.	ERbeta	PAI-1	0	UNDEFINED	False
1648	1655	15897875:0:ESXR1:K-ras	Identification of [TF] as a transcriptional repressor of [TG] has an important implication for the development of cancer therapy that inhibits oncogenic K-Ras expression.	ESXR1	K-ras	2	REPRESSION	False
1652	1659	20127720:12:SP1:ELMO3	Taken together, the present study reports the first characterization of the ELMO3 promoter and suggests a significant role of CDX2 in the basal transcriptional regulation of the intestine-specific expression of [TG], possibly through interaction with [TF].	SP1	ELMO3	0	UNDEFINED	True
1654	1661	15041706:13:PPARgamma:p21	[TF] ligands inhibit human lung carcinoma cell growth and induce apoptosis by stimulating the cyclin-dependent kinase inhibitor [TG] and by reducing cyclin D1 gene expression.	PPARgamma	p21	1	ACTIVATION	True
1655	1662	15041706:13:PPARgamma:cyclin D1	[TF] ligands inhibit human lung carcinoma cell growth and induce apoptosis by stimulating the cyclin-dependent kinase inhibitor p21 and by reducing [TG] gene expression.	PPARgamma	cyclin D1	2	REPRESSION	False
1656	1663	10559267:7:p53:p21	In addition, the interaction of [TF] with its response element from the bax promoter, as compared with its interaction with its element from the [TG] promoter, involves a conformationally distinct form of the protein.	p53	p21	0	UNDEFINED	False
1657	1664	10559267:7:p53:bax	In addition, the interaction of [TF] with its response element from the [TG] promoter, as compared with its interaction with its element from the p21 promoter, involves a conformationally distinct form of the protein.	p53	bax	0	UNDEFINED	False
1658	1665	14960721:7:PPARalpha:CYP7A1	However, a derivative of the human [TG] gene promoter that contains a mutant form of Site I that does not bind LXRalpha:[TF] was not inhibited by WY 14,643 or 25-hydroxycholesterol in both McArdle RH7777 and HepG2 cells.	PPARalpha	CYP7A1	0	UNDEFINED	False
1660	1667	14960721:7:LXRalpha:CYP7A1	However, a derivative of the human [TG] gene promoter that contains a mutant form of Site I that does not bind [TF]:PPARalpha was not inhibited by WY 14,643 or 25-hydroxycholesterol in both McArdle RH7777 and HepG2 cells.	LXRalpha	CYP7A1	0	UNDEFINED	False
1662	1669	17330845:0:ATBF1:MUC5AC	Subcellular localization of [TF] regulates [TG] transcription in gastric cancer.	ATBF1	MUC5AC	0	UNDEFINED	False
1663	1670	14751232:7:LEF-1:claudin-2	[TF], a nuclear effector of the Wnt signaling pathway which is involved in the regulation of cell differentiation and polarization, was found to bind directly to the [TG] promoter as revealed by electrophoretic mobility shift assays.	LEF-1	claudin-2	0	UNDEFINED	False
1664	1671	17452746:0:SREBP-1:heme oxygenase 1	[TF] regulates the expression of [TG] and the phosphatidylinositol-3 kinase regulatory subunit p55 gamma.	SREBP-1	heme oxygenase 1	0	UNDEFINED	False
1665	1672	17452746:0:SREBP-1:phosphatidylinositol-3 kinase regulatory subunit p55 gamma	[TF] regulates the expression of heme oxygenase 1 and the [TG].	SREBP-1	phosphatidylinositol-3 kinase regulatory subunit p55 gamma	0	UNDEFINED	False
1667	1674	18787026:5:DAX-1:StAR	Notably, the suppression of DAX-1 requires de novo transcription and translation, suggesting that the effect of [TF] in regulating [TG] expression is dynamic.	DAX-1	StAR	0	UNDEFINED	False
1679	1686	12370343:3:CREM:IL-2	In this work we show that transcriptional up-regulation is responsible for the increased CREM protein levels and that [TF] binds to the [TG] promoter in live SLE T cells.	CREM	IL-2	0	UNDEFINED	False
1680	1687	15549733:8:GATA-3:IL-5	This region contains two potential [TF]-binding sites and increases expression from the h[TG] promoter by up to ninefold.	GATA-3	IL-5	1	ACTIVATION	True
1681	1688	12559959:5:OTX2:DCT	[TF] binds to the [TG] gene promoter in vivo, as judged by chromatin immunoprecipitation assays.	OTX2	DCT	0	UNDEFINED	False
1687	1694	10606230:3:androgen:prostate-specific antigen	We found that resveratrol represses different classes of [TF] up-regulated genes at the protein or mRNA level including [TG], human glandular kallikrein-2, AR-specific coactivator ARA70, and the cyclin-dependent kinase inhibitor p21.	androgen	prostate-specific antigen	1	ACTIVATION	False
1688	1695	10606230:3:androgen:glandular kallikrein-2	We found that resveratrol represses different classes of [TF] up-regulated genes at the protein or mRNA level including prostate-specific antigen, human [TG], AR-specific coactivator ARA70, and the cyclin-dependent kinase inhibitor p21.	androgen	glandular kallikrein-2	1	ACTIVATION	False
1689	1696	10606230:3:androgen:ARA70	We found that resveratrol represses different classes of [TF] up-regulated genes at the protein or mRNA level including prostate-specific antigen, human glandular kallikrein-2, AR-specific coactivator [TG], and the cyclin-dependent kinase inhibitor p21.	androgen	ARA70	1	ACTIVATION	False
1690	1697	10606230:3:androgen:p21	We found that resveratrol represses different classes of [TF] up-regulated genes at the protein or mRNA level including prostate-specific antigen, human glandular kallikrein-2, AR-specific coactivator ARA70, and the cyclin-dependent kinase inhibitor [TG].	androgen	p21	1	ACTIVATION	False
1691	1698	10606230:3:androgen:AR	We found that resveratrol represses different classes of [TF] up-regulated genes at the protein or mRNA level including prostate-specific antigen, human glandular kallikrein-2, [TG]-specific coactivator ARA70, and the cyclin-dependent kinase inhibitor p21.	androgen	AR	1	ACTIVATION	True
1692	1699	11395510:8:p53:Bax	How the single mutation or the short deletion affect the conformation of p53 and consequently the transactivation of the [TG] promoter will require further investigation of the relevant [TF] protein: DNA-binding domain by NMR and x-ray crystallographic techniques.	p53	Bax	1	ACTIVATION	True
1695	1702	18669923:0:Id3:adiponectin	These data establish Id3 and E47 as novel regulators of SREBP-1c-mediated adiponectin expression in differentiating adipocytes and provide evidence that [TF] regulates [TG] expression in vivo.	Id3	adiponectin	0	UNDEFINED	False
1715	1722	19342446:6:LXR:ABCA1	DN2 reduced LXR ligand-dependent increases in the levels of ABCA1, ABCG1, and apolipoprotein E (apoE) transcripts as well as the activity of luciferase reporters driven by the [TF] response elements (LXREs) of [TG], ABCG1, and apoE genes.	LXR	ABCA1	1	ACTIVATION	False
1716	1723	19342446:6:LXR:ABCG1	DN2 reduced LXR ligand-dependent increases in the levels of ABCA1, ABCG1, and apolipoprotein E (apoE) transcripts as well as the activity of luciferase reporters driven by the [TF] response elements (LXREs) of ABCA1, [TG], and apoE genes.	LXR	ABCG1	1	ACTIVATION	False
1718	1725	19342446:6:LXR:apoE	DN2 reduced LXR ligand-dependent increases in the levels of ABCA1, ABCG1, and apolipoprotein E (apoE) transcripts as well as the activity of luciferase reporters driven by the [TF] response elements (LXREs) of ABCA1, ABCG1, and [TG] genes.	LXR	apoE	1	ACTIVATION	False
1720	1727	11295116:9:NF-kappaB:RANTES	Our data suggest that [TF] may mediate the induction of [TG] gene expression, in human glial cells, through its cognate cis-acting element.	NF-kappaB	RANTES	1	ACTIVATION	False
1723	1730	16497991:0:CREB:eNOS	Competitive binding of [TF] and ATF2 to cAMP/ATF responsive element regulates [TG] gene expression in endothelial cells.	CREB	eNOS	0	UNDEFINED	False
1726	1733	16497991:0:ATF2:eNOS	Competitive binding of CREB and [TF] to cAMP/ATF responsive element regulates [TG] gene expression in endothelial cells.	ATF2	eNOS	0	UNDEFINED	False
1731	1738	10319325:6:Egr1:LH beta	Coexpression of [TF] and SF-1 led to a synergistic activation of the equine (e)[TG] promoter.	Egr1	LH beta	1	ACTIVATION	False
1733	1740	10319325:6:SF-1:LH beta	Coexpression of Egr1 and [TF] led to a synergistic activation of the equine (e)[TG] promoter.	SF-1	LH beta	1	ACTIVATION	False
1735	1742	17690173:0:FXR:CYP7A1	An overlapping binding site in the [TG] promoter allows activation of [TF] to override the stimulation by LXRalpha.	FXR	CYP7A1	1	ACTIVATION	False
1737	1744	17690173:0:LXRalpha:CYP7A1	An overlapping binding site in the [TG] promoter allows activation of FXR to override the stimulation by [TF].	LXRalpha	CYP7A1	1	ACTIVATION	False
1739	1746	17570480:5:Foxp3:HER-2	[TF] bound and repressed the [TG]/ErbB2 promoter.	Foxp3	HER-2	2	REPRESSION	False
1740	1747	17570480:5:Foxp3:ErbB2	[TF] bound and repressed the HER-2/[TG] promoter.	Foxp3	ErbB2	2	REPRESSION	False
1741	1748	18035482:12:Stat1:XAF1	Results suggested that induction of an immediate early response gene-XAF1 by IFNbeta was mediated by the transcription regulator [TF] through the ISRE site within the promoter region of [TG] gene in colon cancer.	Stat1	XAF1	0	UNDEFINED	True
1743	1750	11337499:0:JunD:tissue inhibitor of metalloproteinases-1	Rat HSCs activated in vitro express [TF], Fra2, and FosB as the predominant AP-1 DNA-binding proteins, and all three associate with an AP-1 sequence that is essential for activity of the [TG] (TIMP-1) promoter.	JunD	tissue inhibitor of metalloproteinases-1	1	ACTIVATION	True
1744	1751	11337499:0:JunD:interleukin-6	In this study, we used expression vectors for wild-type, dominant-negative, and forced homodimeric (Jun/eb1 chimeric factors) forms of JunD and other Fos and Jun proteins to determine the requirement for [TF] in the transcriptional regulation of the TIMP-1 and [TG] (IL-6) genes.	JunD	interleukin-6	0	UNDEFINED	False
1748	1755	11337499:0:JunD:TIMP-1	The ability of homodimeric JunD/eb1 to elevate TIMP-1 promoter activity supports a role for [TF] homodimers as the major AP-1-dependent transactivators of the [TG] gene.	JunD	TIMP-1	1	ACTIVATION	False
1752	1759	11337499:0:Fra2:tissue inhibitor of metalloproteinases-1	Rat HSCs activated in vitro express JunD, [TF], and FosB as the predominant AP-1 DNA-binding proteins, and all three associate with an AP-1 sequence that is essential for activity of the [TG] (TIMP-1) promoter.	Fra2	tissue inhibitor of metalloproteinases-1	1	ACTIVATION	True
1753	1760	11337499:0:Fra2:TIMP-1	JunD activity was required for [TG] gene promoter activity, whereas overexpression of [TF] or FosB caused a repression of promoter activity.	Fra2	TIMP-1	2	REPRESSION	False
1758	1765	11337499:0:FosB:TIMP-1	JunD activity was required for [TG] gene promoter activity, whereas overexpression of Fra2 or [TF] caused a repression of promoter activity.	FosB	TIMP-1	2	REPRESSION	False
1762	1769	11337499:0:AP-1:tissue inhibitor of metalloproteinases-1	Rat HSCs activated in vitro express JunD, Fra2, and FosB as the predominant AP-1 DNA-binding proteins, and all three associate with an [TF] sequence that is essential for activity of the [TG] (TIMP-1) promoter.	AP-1	tissue inhibitor of metalloproteinases-1	0	UNDEFINED	True
1763	1770	11337499:0:AP-1:TIMP-1	The ability of homodimeric JunD/eb1 to elevate TIMP-1 promoter activity supports a role for JunD homodimers as the major [TF]-dependent transactivators of the [TG] gene.	AP-1	TIMP-1	1	ACTIVATION	True
1774	1781	11337499:0:JunD:IL-6	We conclude that [TF] activates [TG] gene transcription as a heterodimer and operates at an alternative DNA-binding site in the promoter.	JunD	IL-6	1	ACTIVATION	False
1780	1787	11337499:0:AP-1:IL-6	Mutagenesis of the [TG] promoter showed that an [TF] DNA-binding site previously reported to be an activator of transcription in fibroblasts functions as a suppressor of promoter activity in HSCs.	AP-1	IL-6	0	UNDEFINED	True
1783	1790	19117054:8:ERalpha:BTG2	Taken together, our results reveal a requirement of HDAC activity for basal BTG2 expression and the [TF]-REA interaction for estrogen repression of the [TG] gene.	ERalpha	BTG2	2	REPRESSION	False
1786	1793	19117054:8:estrogen:BTG2	Taken together, our results reveal a requirement of HDAC activity for basal BTG2 expression and the ERalpha-REA interaction for [TF] repression of the [TG] gene.	estrogen	BTG2	2	REPRESSION	False
1789	1796	15112058:5:PR-B:CRH	Overexpression of progesterone receptor A (PR-A) or glucocorticoid receptor resulted in a decrease in [TG] promoter activity following progesterone treatment, whereas an increase in promoter activity was observed with overexpressed [TF].	PR-B	CRH	1	ACTIVATION	False
1794	1801	15112058:5:progesterone receptor A:CRH	Overexpression of [TF] (PR-A) or glucocorticoid receptor resulted in a decrease in [TG] promoter activity following progesterone treatment, whereas an increase in promoter activity was observed with overexpressed PR-B.	progesterone receptor A	CRH	2	REPRESSION	False
1799	1806	15112058:5:PR-A:CRH	Overexpression of progesterone receptor A ([TF]) or glucocorticoid receptor resulted in a decrease in [TG] promoter activity following progesterone treatment, whereas an increase in promoter activity was observed with overexpressed PR-B.	PR-A	CRH	2	REPRESSION	False
1804	1811	15112058:5:glucocorticoid receptor:CRH	Overexpression of progesterone receptor A (PR-A) or [TF] resulted in a decrease in [TG] promoter activity following progesterone treatment, whereas an increase in promoter activity was observed with overexpressed PR-B.	glucocorticoid receptor	CRH	2	REPRESSION	False
1809	1816	15112058:5:progesterone:CRH	Overexpression of progesterone receptor A (PR-A) or glucocorticoid receptor resulted in a decrease in [TG] promoter activity following [TF] treatment, whereas an increase in promoter activity was observed with overexpressed PR-B.	progesterone	CRH	2	REPRESSION	True
1814	1821	18948418:0:Mn1:Tbx22	Overexpression of [TF] in NIH3T3 cells also increased endogenous [TG] mRNA expression in a dose-dependent manner.	Mn1	Tbx22	1	ACTIVATION	False
1817	1824	17027647:0:ESE-3:death receptor (DR)-5	[TF] transcription factor is involved in the expression of [TG] through putative Ets sites.	ESE-3	death receptor (DR)-5	1	ACTIVATION	True
1820	1827	17027647:0:Ets:death receptor (DR)-5	ESE-3 transcription factor is involved in the expression of [TG] through putative [TF] sites.	Ets	death receptor (DR)-5	0	UNDEFINED	True
1821	1828	17027647:0:ESE-3:DR-5	In addition, we show the possible involvement of co-factors CBP and p300 in [TF]-mediated [TG] up-regulation.	ESE-3	DR-5	1	ACTIVATION	False
1822	1829	17027647:0:Ets:DR-5	Using a combination of the electrophoretic mobility shift assay and the luciferase reporter assay, we identified putative [TF] sites responsible for ESE-3 transcriptional activity on the [TG] promoter.	Ets	DR-5	0	UNDEFINED	True
1825	1832	9036972:2:AML1A:IL-3	We performed cotransfection experiments in T cells, and demonstrated that although [TF] lacks a putative transactivation domain, it can transactivate the [TG] promoter nearly as effectively as AML1B, a known activator.	AML1A	IL-3	1	ACTIVATION	False
1827	1834	9036972:2:AML1B:IL-3	We performed cotransfection experiments in T cells, and demonstrated that although AML1A lacks a putative transactivation domain, it can transactivate the [TG] promoter nearly as effectively as [TF], a known activator.	AML1B	IL-3	1	ACTIVATION	False
1829	1836	22455953:6:MSX1:DKK1	Our investigations showed that [TF] binds the DKK1 promoter and inhibits [TG] transcription.	MSX1	DKK1	2	REPRESSION	False
1850	1857	19022561:5:SF1:STAR	By transient transfections, we found that [TF] and LRH1, but not the related nuclear receptor NUR77, can activate the promoters of three human steroidogenic genes: [TG], HSD3B2, and CYP19A1 PII.	SF1	STAR	1	ACTIVATION	False
1851	1858	19022561:5:SF1:HSD3B2	By transient transfections, we found that [TF] and LRH1, but not the related nuclear receptor NUR77, can activate the promoters of three human steroidogenic genes: STAR, [TG], and CYP19A1 PII.	SF1	HSD3B2	1	ACTIVATION	False
1852	1859	19022561:5:SF1:CYP19A1	By transient transfections, we found that [TF] and LRH1, but not the related nuclear receptor NUR77, can activate the promoters of three human steroidogenic genes: STAR, HSD3B2, and [TG] PII.	SF1	CYP19A1	1	ACTIVATION	False
1855	1862	19022561:5:LRH1:STAR	By transient transfections, we found that SF1 and [TF], but not the related nuclear receptor NUR77, can activate the promoters of three human steroidogenic genes: [TG], HSD3B2, and CYP19A1 PII.	LRH1	STAR	1	ACTIVATION	False
1856	1863	19022561:5:LRH1:HSD3B2	By transient transfections, we found that SF1 and [TF], but not the related nuclear receptor NUR77, can activate the promoters of three human steroidogenic genes: STAR, [TG], and CYP19A1 PII.	LRH1	HSD3B2	1	ACTIVATION	False
1857	1864	19022561:5:LRH1:CYP19A1	By transient transfections, we found that SF1 and [TF], but not the related nuclear receptor NUR77, can activate the promoters of three human steroidogenic genes: STAR, HSD3B2, and [TG] PII.	LRH1	CYP19A1	1	ACTIVATION	False
1860	1867	19022561:5:NUR77:STAR	By transient transfections, we found that SF1 and LRH1, but not the related nuclear receptor [TF], can activate the promoters of three human steroidogenic genes: [TG], HSD3B2, and CYP19A1 PII.	NUR77	STAR	1	ACTIVATION	False
1861	1868	19022561:5:NUR77:HSD3B2	By transient transfections, we found that SF1 and LRH1, but not the related nuclear receptor [TF], can activate the promoters of three human steroidogenic genes: STAR, [TG], and CYP19A1 PII.	NUR77	HSD3B2	1	ACTIVATION	False
1862	1869	19022561:5:NUR77:CYP19A1	By transient transfections, we found that SF1 and LRH1, but not the related nuclear receptor [TF], can activate the promoters of three human steroidogenic genes: STAR, HSD3B2, and [TG] PII.	NUR77	CYP19A1	1	ACTIVATION	False
1865	1872	24486572:0:AP-1:connective tissue growth factor	Endothelin-1 induces [TG] expression in human lung fibroblasts by ETAR-dependent JNK/[TF] pathway.	AP-1	connective tissue growth factor	1	ACTIVATION	True
1869	1876	10660629:0:E2F:Brca1	Moreover, ectopic expression of cyclin D1 and Cdk4 can stimulate the [TG] promoter in an [TF]-dependent manner, and this is inhibited by coexpression of the p16(INK4a) cyclin-dependent kinase inhibitor.	E2F	Brca1	1	ACTIVATION	True
1870	1877	10660629:0:E2F:BRCA1	The human [TG] promoter also contains a conserved [TF] site and is similarly regulated by E2F1 and Rb.	E2F	BRCA1	0	UNDEFINED	True
1871	1878	10660629:0:E2F1:Brca1	The [TG] promoter contains E2F DNA-binding sites that mediate transcriptional activation by [TF] and repression by Rb.	E2F1	Brca1	1	ACTIVATION	False
1879	1886	10660629:0:E2F1:BRCA1	The human [TG] promoter also contains a conserved E2F site and is similarly regulated by [TF] and Rb.	E2F1	BRCA1	0	UNDEFINED	False
1880	1887	15564578:5:ERalpha:CRH	To determine whether ERs could regulate CRH promoter activity, we cotransfected cells with a [TG] promoter construct and either [TF] or individual ERbeta isoforms.	ERalpha	CRH	0	UNDEFINED	True
1892	1899	15902259:0:mesoderm posterior 2:lunatic fringe	Genetic and biochemical studies indicate that this interface is generated by suppression of Notch activity by [TF] (Mesp2) through induction of the [TG] gene (Lfng).	mesoderm posterior 2	lunatic fringe	1	ACTIVATION	False
1893	1900	15902259:0:mesoderm posterior 2:Lfng	Genetic and biochemical studies indicate that this interface is generated by suppression of Notch activity by [TF] (Mesp2) through induction of the lunatic fringe gene ([TG]).	mesoderm posterior 2	Lfng	1	ACTIVATION	False
1895	1902	15902259:0:Mesp2:lunatic fringe	Genetic and biochemical studies indicate that this interface is generated by suppression of Notch activity by mesoderm posterior 2 ([TF]) through induction of the [TG] gene (Lfng).	Mesp2	lunatic fringe	1	ACTIVATION	False
1896	1903	15902259:0:Mesp2:Lfng	Genetic and biochemical studies indicate that this interface is generated by suppression of Notch activity by mesoderm posterior 2 ([TF]) through induction of the lunatic fringe gene ([TG]).	Mesp2	Lfng	1	ACTIVATION	False
1898	1905	19013255:4:YY1:HOXB13	We also show that both HDAC4 and [TF] participated in the repression of [TG] expression through an epigenetic mechanism involving histone acetylation modification.	YY1	HOXB13	2	REPRESSION	False
1905	1912	17616660:6:HMGA1:XPA	Mechanistically, we present both chromatin immunoprecipitation and promoter site-specific mutagenesis evidence linking [TF] to repression of XPA transcription via binding to a negative regulatory element in the endogenous [TG] gene promoter.	HMGA1	XPA	2	REPRESSION	False
1911	1918	12426319:0:BETA-2:insulin	Multiple transcription factors, including Pdx-1, [TF], and Pax6, have been implicated in expression of the [TG] gene in pancreatic beta cells.	BETA-2	insulin	0	UNDEFINED	False
1914	1921	12426319:0:Pax6:insulin	Multiple transcription factors, including Pdx-1, BETA-2, and [TF], have been implicated in expression of the [TG] gene in pancreatic beta cells.	Pax6	insulin	1	ACTIVATION	True
1915	1922	12426319:0:Pdx-1:amyloid polypeptide	[TF] was also shown to bind within a region of the endogenous islet [TG], pax-4, and glucokinase genes that were associated with control in vitro.	Pdx-1	amyloid polypeptide	0	UNDEFINED	False
1916	1923	12426319:0:Pdx-1:pax-4	[TF] was also shown to bind within a region of the endogenous islet amyloid polypeptide, [TG], and glucokinase genes that were associated with control in vitro.	Pdx-1	pax-4	0	UNDEFINED	False
1917	1924	12426319:0:Pdx-1:glucokinase	[TF] was also shown to bind within a region of the endogenous islet amyloid polypeptide, pax-4, and [TG] genes that were associated with control in vitro.	Pdx-1	glucokinase	0	UNDEFINED	False
1931	1938	22740693:12:STAT4:S100A4	Collectively, we conclude that HBXIP up-regulates S100A4 through activating [TG] promoter involving [TF] and inducing PTEN/PI3K/AKT signaling to promote growth and migration of breast cancer cells.	STAT4	S100A4	1	ACTIVATION	False
1937	1944	22740693:12:S100A4:S100A4	Collectively, we conclude that HBXIP up-regulates [TG] through activating [TF] promoter involving STAT4 and inducing PTEN/PI3K/AKT signaling to promote growth and migration of breast cancer cells.	S100A4	S100A4	1	ACTIVATION	True
1939	1946	15514031:5:AR:prostate-specific antigen	We demonstrate that IGF-I enhances the expression of endogenous [TG], an [TF] target gene, and elevates the level of cytoplasmic and nuclear beta-catenin in prostate cancer cells.	AR	prostate-specific antigen	0	UNDEFINED	True
1941	1948	10783396:0:EGR-1:fibronectin	The transcription factor [TF] directly transactivates the [TG] gene and enhances attachment of human glioblastoma cell line U251.	EGR-1	fibronectin	1	ACTIVATION	False
1943	1950	16179649:0:E2F8:E2F	Ectopic expression of [TF] in diploid human fibroblasts reduces expression of E2F-target genes and inhibits cell growth consistent with a role for repressing [TG] transcriptional activity.	E2F8	E2F	2	REPRESSION	True
1958	1967	10809237:0:Androgen:p21	[TF] induction of cyclin-dependent kinase inhibitor [TG] gene: role of androgen receptor and transcription factor Sp1 complex.	Androgen	p21	1	ACTIVATION	False
1962	1971	11278455:0:AP2gamma:estrogen receptor-alpha	Genomic structure of the promoters of the human [TG] gene demonstrate changes in chromatin structure induced by [TF].	AP2gamma	estrogen receptor-alpha	0	UNDEFINED	True
1968	1977	11278455:0:AP2gamma:ERalpha	These results demonstrate that [TF] trans-activates the ERalpha gene in hormone-responsive tumors by inducing changes in the chromatin structure of the [TG] promoter.	AP2gamma	ERalpha	0	UNDEFINED	True
1975	1984	17371876:4:MITF:MET	In the present report, we show that alphaMSH regulates [TG] expression in both human melanocytes and mouse melanoma cells through a transcriptional mechanism that requires [TF].	MITF	MET	0	UNDEFINED	False
1977	1986	15637592:7:HOXC6:neutral endopeptidase	Expression profiling of HOXC6 siRNA transfections and HOXC6 overexpression identified [TG] (NEP) and insulin-like growth factor binding protein-3 (IGFBP-3) as potential proapoptotic repression targets of [TF].	HOXC6	neutral endopeptidase	2	REPRESSION	False
1978	1987	15637592:7:HOXC6:NEP	Expression profiling of HOXC6 siRNA transfections and HOXC6 overexpression identified neutral endopeptidase ([TG]) and insulin-like growth factor binding protein-3 (IGFBP-3) as potential proapoptotic repression targets of [TF].	HOXC6	NEP	2	REPRESSION	False
1979	1988	15637592:7:HOXC6:insulin-like growth factor binding protein-3	Expression profiling of HOXC6 siRNA transfections and HOXC6 overexpression identified neutral endopeptidase (NEP) and [TG] (IGFBP-3) as potential proapoptotic repression targets of [TF].	HOXC6	insulin-like growth factor binding protein-3	2	REPRESSION	False
1980	1989	15637592:7:HOXC6:IGFBP-3	Expression profiling of HOXC6 siRNA transfections and HOXC6 overexpression identified neutral endopeptidase (NEP) and insulin-like growth factor binding protein-3 ([TG]) as potential proapoptotic repression targets of [TF].	HOXC6	IGFBP-3	2	REPRESSION	False
1981	1990	14610066:2:Smad3:COL1A2	We previously showed that [TF] promotes [TG] gene activation by TGF-beta1 in human glomerular mesangial cells.	Smad3	COL1A2	1	ACTIVATION	False
1985	1994	10022869:0:Smad3:c-Jun	[TF]-Smad4 and AP-1 complexes synergize in transcriptional activation of the [TG] promoter by transforming growth factor beta.	Smad3	c-Jun	1	ACTIVATION	False
1989	1998	10022869:0:Smad4:c-Jun	Smad3-[TF] and AP-1 complexes synergize in transcriptional activation of the [TG] promoter by transforming growth factor beta.	Smad4	c-Jun	1	ACTIVATION	False
1993	2002	10022869:0:AP-1:c-Jun	Smad3-Smad4 and [TF] complexes synergize in transcriptional activation of the [TG] promoter by transforming growth factor beta.	AP-1	c-Jun	1	ACTIVATION	False
2000	2009	15601870:0:nuclear factor Y:ODF	We find that [TF] (NF-Y) binds to the CCAAT box on the [TG] promoter and regulates its basal transcriptional activity.	nuclear factor Y	ODF	0	UNDEFINED	False
2002	2011	15601870:0:NF-Y:ODF	[TG] gene induction by parathyroid hormone or prostaglandin E is also dependent on [TF].	NF-Y	ODF	1	ACTIVATION	False
2004	2013	15601870:0:VDR:ODF	Stimulation with vitamin D3 facilitates the recruitment of [TF] and p300 onto the [TG] promoter, resulting in acetylation of histone H4 in an NF-Y-independent manner.	VDR	ODF	0	UNDEFINED	False
2012	2021	15601870:0:NF-Y:osteopontin	Furthermore, [TF] is essential for the recruitment of RNAPII onto other CCAAT box-containing promoters, such as those of [TG], CYP24, and E2F1.	NF-Y	osteopontin	0	UNDEFINED	False
2013	2022	15601870:0:NF-Y:CYP24	Furthermore, [TF] is essential for the recruitment of RNAPII onto other CCAAT box-containing promoters, such as those of osteopontin, [TG], and E2F1.	NF-Y	CYP24	0	UNDEFINED	False
2014	2023	15601870:0:NF-Y:E2F1	Furthermore, [TF] is essential for the recruitment of RNAPII onto other CCAAT box-containing promoters, such as those of osteopontin, CYP24, and [TG].	NF-Y	E2F1	0	UNDEFINED	False
2022	2031	15892717:7:ER-alpha:DCT	p300/CBP was also required by [TF] and MITF to induce high, synergistic activation of the [TG] promoter.	ER-alpha	DCT	1	ACTIVATION	False
2026	2035	15892717:7:MITF:DCT	p300/CBP was also required by ER-alpha and [TF] to induce high, synergistic activation of the [TG] promoter.	MITF	DCT	1	ACTIVATION	False
2027	2036	23201825:6:Sox11:TANK	One gene significantly reduced by [TF] knockdown was TRAF (tumor necrosis factor (TNF) receptor-associated factor)-associated NF-kB activator ([TG]).	Sox11	TANK	1	ACTIVATION	False
2028	2037	23201825:6:Sox11:TRAF (tumor necrosis factor (TNF) receptor-associated factor)-associated NF-kB activator	One gene significantly reduced by [TF] knockdown was [TG] (TANK).	Sox11	TRAF (tumor necrosis factor (TNF) receptor-associated factor)-associated NF-kB activator	1	ACTIVATION	False
2029	2038	10403575:15:DAX-1:StAR	This study is the first to demonstrate that the rat StAR promoter is regulated by DAX-1 and that [TF] reduces [TG] promoter responsiveness to cAMP.	DAX-1	StAR	2	REPRESSION	False
2032	2041	9252422:11:IUF1:IUF1	SAPK2 then activates [TG] indirectly by activating a novel [TF]-activating enzyme.	IUF1	IUF1	1	ACTIVATION	True
2035	2044	11306700:4:NFkappaB:c-myc	Using transient transfection analysis, we show that the trans-activation of c-myc by vinblastine was decreased when [TF] binding sites on [TG] promoter were mutated.	NFkappaB	c-myc	0	UNDEFINED	True
2037	2046	12213901:0:WT1:aromatase P450	[TF] and DAX-1 inhibit [TG] expression in human endometrial and endometriotic stromal cells.	WT1	aromatase P450	2	REPRESSION	False
2039	2048	12213901:0:DAX-1:aromatase P450	WT1 and [TF] inhibit [TG] expression in human endometrial and endometriotic stromal cells.	DAX-1	aromatase P450	2	REPRESSION	False
2048	2057	12228234:5:AP2:RFC-A	When [TF] was cotransfected with the h[TG] reporter construct into HT1080 cells, promoter activity increased 3-fold.	AP2	RFC-A	1	ACTIVATION	False
2055	2064	16972788:4:ERalpha:CYP1A1	Moreover, in chromatin immunoprecipitation assays, these compounds induce binding of AhR and [TF] to the [TG] and pS2 gene promoters, which is consistent with their activities as both selective AhR modulators (SAhRMs) and selective ER modulators (SERMs).	ERalpha	CYP1A1	0	UNDEFINED	False
2056	2065	16972788:4:ERalpha:pS2	Moreover, in chromatin immunoprecipitation assays, these compounds induce binding of AhR and [TF] to the CYP1A1 and [TG] gene promoters, which is consistent with their activities as both selective AhR modulators (SAhRMs) and selective ER modulators (SERMs).	ERalpha	pS2	0	UNDEFINED	False
2068	2077	11830484:9:C/EBPalpha:granulocyte colony-stimulating factor receptor	The inframe deletion and insertion mutations abrogated the transcriptional activation function of [TF] on the [TG] promoter.	C/EBPalpha	granulocyte colony-stimulating factor receptor	1	ACTIVATION	False
2069	2078	15173172:0:Nuclear factor of activated T cells:surfactant protein D	[TF] regulates transcription of the [TG] gene (Sftpd) via direct interaction with thyroid transcription factor-1 in lung epithelial cells.	Nuclear factor of activated T cells	surfactant protein D	0	UNDEFINED	False
2070	2079	15173172:0:Nuclear factor of activated T cells:Sftpd	[TF] regulates transcription of the surfactant protein D gene ([TG]) via direct interaction with thyroid transcription factor-1 in lung epithelial cells.	Nuclear factor of activated T cells	Sftpd	0	UNDEFINED	False
2073	2082	15173172:0:thyroid transcription factor-1:surfactant protein D	Nuclear factor of activated T cells regulates transcription of the [TG] gene (Sftpd) via direct interaction with [TF] in lung epithelial cells.	thyroid transcription factor-1	surfactant protein D	0	UNDEFINED	False
2074	2083	15173172:0:thyroid transcription factor-1:Sftpd	Nuclear factor of activated T cells regulates transcription of the surfactant protein D gene ([TG]) via direct interaction with [TF] in lung epithelial cells.	thyroid transcription factor-1	Sftpd	0	UNDEFINED	False
2076	2085	15173172:0:NFAT:Sftpd	Gel supershift and DNase I protection assays identified DNA elements that bind [TF] in the [TG] promoter.	NFAT	Sftpd	0	UNDEFINED	False
2078	2087	15173172:0:NFATc3:Sftpd	[TF] and TTF-1 activated the [TG] promoter, synergized transcription, co-immunoprecipitated from mouse lung epithelial cells, and physically interacted in vitro.	NFATc3	Sftpd	1	ACTIVATION	False
2080	2089	15173172:0:TTF-1:Sftpd	NFATc3 and [TF] activated the [TG] promoter, synergized transcription, co-immunoprecipitated from mouse lung epithelial cells, and physically interacted in vitro.	TTF-1	Sftpd	1	ACTIVATION	False
2085	2094	15569856:9:Activator protein-1:COX-2	[TF] decoy oligonucleotides prevented the ACE inhibitor-induced increase in [TG] promoter activity and protein expression.	Activator protein-1	COX-2	1	ACTIVATION	False
2087	2096	17355223:11:PPARalpha:BRS-3	Our data suggest that AP-2alpha and [TF] may be especially involved in this ozone-inducible up-regulation mechanism of [TG] expression.	PPARalpha	BRS-3	1	ACTIVATION	False
2089	2098	17355223:11:AP-2alpha:BRS-3	Our data suggest that [TF] and PPARalpha may be especially involved in this ozone-inducible up-regulation mechanism of [TG] expression.	AP-2alpha	BRS-3	1	ACTIVATION	False
2094	2103	16474850:4:LEF-1:AR	Chimeric reporter vectors that use the h[TG] gene promoter to drive luciferase expression confirmed that these [TF]/TCF binding elements are able to confer robust upregulation of luciferase expression when stimulated by Wnt-1 or by transfection with beta-catenin and that dominant-negative TCF or mutations within the dominant TCF-binding element abrogated the response.	LEF-1	AR	1	ACTIVATION	True
2098	2107	16474850:4:TCF:AR	Chimeric reporter vectors that use the h[TG] gene promoter to drive luciferase expression confirmed that these LEF-1/[TF] binding elements are able to confer robust upregulation of luciferase expression when stimulated by Wnt-1 or by transfection with beta-catenin and that dominant-negative TCF or mutations within the dominant TCF-binding element abrogated the response.	TCF	AR	1	ACTIVATION	True
2103	2112	8975883:0:NF-kappaB:TNF-alpha	Maleylated-BSA induces hydrolysis of PIP2, fluxes of Ca2+, [TF] binding, and transcription of the [TG] gene in murine macrophages.	NF-kappaB	TNF-alpha	1	ACTIVATION	True
2104	2113	16452400:6:AR:PSA	However, reporter gene and chromatin immunoprecipitation studies indicate that troglitazone and Delta2TG block [TF] recruitment to the androgen response elements within the [TG] promoter.	AR	PSA	0	UNDEFINED	False
2105	2114	15994225:3:ebp1:AR	Using microarray analysis, we identified six endogenous AR target genes, including the [TG] itself, that are down-regulated by [TF] overexpression.	ebp1	AR	2	REPRESSION	False
2109	2118	22259223:13:OTX2:TYR	In the RPE, [TF] activates the human [TG] gene promoter by direct DNA binding and by interaction with MITF.	OTX2	TYR	1	ACTIVATION	False
2111	2120	22259223:13:MITF:TYR	In the RPE, OTX2 activates the human [TG] gene promoter by direct DNA binding and by interaction with [TF].	MITF	TYR	1	ACTIVATION	True
2112	2121	17074759:0:GAX:p21	We conclude that [TF] activates [TG](WAF1/CIP1) through multiple upstream AT-rich sequences.	GAX	p21	1	ACTIVATION	False
2113	2122	17074759:0:GAX:WAF1	We conclude that [TF] activates p21([TG]/CIP1) through multiple upstream AT-rich sequences.	GAX	WAF1	1	ACTIVATION	False
2114	2123	17074759:0:GAX:CIP1	We conclude that [TF] activates p21(WAF1/[TG]) through multiple upstream AT-rich sequences.	GAX	CIP1	1	ACTIVATION	False
2117	2126	7881411:5:HNF-1:PROC	Gel retardation and cotransfection experiments demonstrated that the mutation abolished both the binding and the transactivating ability of [TF] observed with the wild-type [TG] gene promoter.	HNF-1	PROC	1	ACTIVATION	False
2119	2128	21886810:4:E2F1:MgcRacGAP	We previously showed that the transcription factors [TF] and CUX1 regulate expression of [TG] and Ect2 as cells enter S-phase.	E2F1	MgcRacGAP	0	UNDEFINED	True
2120	2129	21886810:4:E2F1:Ect2	We previously showed that the transcription factors [TF] and CUX1 regulate expression of MgcRacGAP and [TG] as cells enter S-phase.	E2F1	Ect2	0	UNDEFINED	False
2122	2131	21886810:4:CUX1:MgcRacGAP	We previously showed that the transcription factors E2F1 and [TF] regulate expression of [TG] and Ect2 as cells enter S-phase.	CUX1	MgcRacGAP	0	UNDEFINED	False
2123	2132	21886810:4:CUX1:Ect2	We previously showed that the transcription factors E2F1 and [TF] regulate expression of MgcRacGAP and [TG] as cells enter S-phase.	CUX1	Ect2	0	UNDEFINED	False
2126	2135	12750288:6:p53:hdm2	Here, we show that the elevated level of hdm2 protein in ERalpha(+ve) breast cancer cell lines such as MCF-7 and T47D is because of transcription from the [TF]-inducible P2 promoter of [TG].	p53	hdm2	1	ACTIVATION	False
2129	2138	9582278:0:MTF-1:heavy-chain subunit of the gamma-glutamylcysteine synthetase	[TF](-/-) embryos fail to transcribe metallothionein I and II genes, and also show diminished transcripts of the gene which encodes the [TG], a key enzyme for glutathione biosynthesis.	MTF-1	heavy-chain subunit of the gamma-glutamylcysteine synthetase	1	ACTIVATION	False
2130	2139	9582278:0:MTF-1:metallothionein I	[TF](-/-) embryos fail to transcribe [TG] and II genes, and also show diminished transcripts of the gene which encodes the heavy-chain subunit of the gamma-glutamylcysteine synthetase, a key enzyme for glutathione biosynthesis.	MTF-1	metallothionein I	1	ACTIVATION	False
2131	2140	9582278:0:MTF-1:metallothionein I and II	[TF](-/-) embryos fail to transcribe [TG] genes, and also show diminished transcripts of the gene which encodes the heavy-chain subunit of the gamma-glutamylcysteine synthetase, a key enzyme for glutathione biosynthesis.	MTF-1	metallothionein I and II	1	ACTIVATION	False
2152	2161	19153051:0:BCL11A:HBG	Together, these data are consistent with [TF] being able to bind to a core motif in the HBG proximal promoter, recruit and interact with partners to form a repression complex, leading to deacetylation of histones and down-regulation of the [TG] transcription.	BCL11A	HBG	2	REPRESSION	False
2154	2163	19497851:6:DLX5:MYC	We also show that DLX5 binds to the MYC promoter both in vitro and in vivo and that transfection of a [TF] expression plasmid promotes the expression of [TG] in a dose-dependent manner in mammalian cells.	DLX5	MYC	1	ACTIVATION	False
2160	2169	15666827:7:COUP-TFI:CYP17	Coexpression of Ubc9 and PIAS1 synergistically enhanced [TF]-mediated trans-repression of [TG] gene as well as transactivation of CYP11B2 gene.	COUP-TFI	CYP17	2	REPRESSION	True
2161	2170	15666827:7:COUP-TFI:CYP11B2	Coexpression of Ubc9 and PIAS1 synergistically enhanced [TF]-mediated trans-repression of CYP17 gene as well as transactivation of [TG] gene.	COUP-TFI	CYP11B2	1	ACTIVATION	True
2162	2171	12773487:7:NF-kappaB:UbcH2	A dominant negative inhibitor of [TF] activation blocks both [TG] up-regulation and the increase in ubiquitin-conjugating activity stimulated by TNF-alpha.	NF-kappaB	UbcH2	1	ACTIVATION	False
2164	2173	12151347:7:estrogen-receptor:p21	Similar increases in expression of p21 protein and mRNA were observed in both MCF-7 and MDA-MB-231 human breast cancer cells, suggesting that DIM induction of [TG] expression is independent of [TF] signaling and p53.	estrogen-receptor	p21	1	ACTIVATION	False
2166	2175	12151347:7:p53:p21	Similar increases in expression of p21 protein and mRNA were observed in both MCF-7 and MDA-MB-231 human breast cancer cells, suggesting that DIM induction of [TG] expression is independent of estrogen-receptor signaling and [TF].	p53	p21	1	ACTIVATION	False
2168	2177	12765518:6:SF-1:Cyp17	The presence of the putative [TF] binding sites in the regulatory regions of mouse [TG] and 3betaHSDI suggests that gene SF-1 could represent one of the putative genes which (as we predicted earlier) determine coordinated inheritable variability of hormonal activity in mouse Leydig cells.	SF-1	Cyp17	0	UNDEFINED	True
2171	2180	15774498:8:hypoxia-inducible factor 1:VEGF	Western analysis showed that both the alpha- and beta-subunits of the transcription factor [TF] (HIF-1), which regulates [TG] expression in response to hypoxia and several hormones and growth factors, were present in the uterus.	hypoxia-inducible factor 1	VEGF	0	UNDEFINED	False
2173	2182	15774498:8:HIF-1:VEGF	Western analysis showed that both the alpha- and beta-subunits of the transcription factor hypoxia-inducible factor 1 ([TF]), which regulates [TG] expression in response to hypoxia and several hormones and growth factors, were present in the uterus.	HIF-1	VEGF	0	UNDEFINED	False
2175	2184	1639815:6:HNF-4:apoB	In contrast, [TF] activated transcription of reporter genes containing the elements BA1, CIIIB, and AIIJ and reversed the ARP-1-mediated repression of the [TG] and apoCIII genes.	HNF-4	apoB	1	ACTIVATION	True
2176	2185	1639815:6:HNF-4:apoCIII	In contrast, [TF] activated transcription of reporter genes containing the elements BA1, CIIIB, and AIIJ and reversed the ARP-1-mediated repression of the apoB and [TG] genes.	HNF-4	apoCIII	1	ACTIVATION	True
2178	2187	1639815:6:ARP-1:apoB	In contrast, HNF-4 activated transcription of reporter genes containing the elements BA1, CIIIB, and AIIJ and reversed the [TF]-mediated repression of the [TG] and apoCIII genes.	ARP-1	apoB	2	REPRESSION	False
2179	2188	1639815:6:ARP-1:apoCIII	In contrast, HNF-4 activated transcription of reporter genes containing the elements BA1, CIIIB, and AIIJ and reversed the [TF]-mediated repression of the apoB and [TG] genes.	ARP-1	apoCIII	2	REPRESSION	False
2184	2193	15489892:5:Sp1:p21Cip1	Using transactivation assays in Sp1-deficient cells, we showed that mithramycin A inhibited the transcriptional activation of the [TG] and PUMA promoters by [TF] and p53.	Sp1	p21Cip1	1	ACTIVATION	False
2185	2194	15489892:5:Sp1:PUMA	Using transactivation assays in Sp1-deficient cells, we showed that mithramycin A inhibited the transcriptional activation of the p21Cip1 and [TG] promoters by [TF] and p53.	Sp1	PUMA	1	ACTIVATION	False
2188	2197	15489892:5:p53:p21Cip1	Using transactivation assays in Sp1-deficient cells, we showed that mithramycin A inhibited the transcriptional activation of the [TG] and PUMA promoters by Sp1 and [TF].	p53	p21Cip1	1	ACTIVATION	False
2189	2198	15489892:5:p53:PUMA	Using transactivation assays in Sp1-deficient cells, we showed that mithramycin A inhibited the transcriptional activation of the p21Cip1 and [TG] promoters by Sp1 and [TF].	p53	PUMA	1	ACTIVATION	False
2196	2205	10446910:7:ER:E2F1	Thus, transcriptional activation of E2F1 gene expression in MCF-7 cells by E2 is regulated by multiprotein [TF]/Sp1-NF-Y interactions at GC-rich and two CCAAT elements in the proximal region of the [TG] gene promoter.	ER	E2F1	0	UNDEFINED	True
2200	2209	10446910:7:Sp1:E2F1	Thus, transcriptional activation of E2F1 gene expression in MCF-7 cells by E2 is regulated by multiprotein ER/[TF]-NF-Y interactions at GC-rich and two CCAAT elements in the proximal region of the [TG] gene promoter.	Sp1	E2F1	1	ACTIVATION	True
2204	2213	10446910:7:NF-Y:E2F1	Thus, transcriptional activation of E2F1 gene expression in MCF-7 cells by E2 is regulated by multiprotein ER/Sp1-[TF] interactions at GC-rich and two CCAAT elements in the proximal region of the [TG] gene promoter.	NF-Y	E2F1	0	UNDEFINED	False
2221	2230	11518799:12:SF-1:LHbeta	Thus, we conclude that AR suppresses activity of the bovine [TG] promoter through protein-protein interactions with [TF] and that the degree of this interaction can be modified by the presence of Egr-1 and Pitx1.	SF-1	LHbeta	2	REPRESSION	False
2225	2234	11518799:12:Egr-1:LHbeta	Thus, we conclude that AR suppresses activity of the bovine [TG] promoter through protein-protein interactions with SF-1 and that the degree of this interaction can be modified by the presence of [TF] and Pitx1.	Egr-1	LHbeta	0	UNDEFINED	False
2229	2238	11518799:12:Pitx1:LHbeta	Thus, we conclude that AR suppresses activity of the bovine [TG] promoter through protein-protein interactions with SF-1 and that the degree of this interaction can be modified by the presence of Egr-1 and [TF].	Pitx1	LHbeta	0	UNDEFINED	False
2233	2242	11518799:12:AR:LHbeta	Thus, we conclude that [TF] suppresses activity of the bovine [TG] promoter through protein-protein interactions with SF-1 and that the degree of this interaction can be modified by the presence of Egr-1 and Pitx1.	AR	LHbeta	2	REPRESSION	False
2237	2246	9858609:1:p53:mdm2	The mdm2 gene is positively regulated by p53 through a [TF]-responsive DNA element in the first intron of the [TG] gene.	p53	mdm2	0	UNDEFINED	True
2240	2249	15582599:5:SP1:VEGF	Additionally, we determined that ErbB2 overexpression-mediated upregulation of [TG] involves at least two distinct promoter elements, one previously identified as the hypoxia responsive element and the other the core promoter region (-161 to -51bp), which is specifically controlled via two adjacent [TF] binding sites (-80 to -60bp).	SP1	VEGF	1	ACTIVATION	True
2241	2250	17026988:5:PPAR-alpha:ABCA1	Through the transactivation assays of in vitro study, it was discovered that CM108 could activate [TF] PPAR-gamma and liver X receptor alpha at 40-150 microg/ml, which subsequently resulted in activating [TG] promoter and enhancing apoA-I and apoA-II production, whereas reducing apoC-III production significantly.	PPAR-alpha	ABCA1	1	ACTIVATION	False
2248	2257	17026988:5:liver X receptor alpha:ABCA1	Through the transactivation assays of in vitro study, it was discovered that CM108 could activate PPAR-alpha PPAR-gamma and [TF] at 40-150 microg/ml, which subsequently resulted in activating [TG] promoter and enhancing apoA-I and apoA-II production, whereas reducing apoC-III production significantly.	liver X receptor alpha	ABCA1	1	ACTIVATION	False
2254	2263	17026988:5:PPAR-gamma:ABCA1	Through the transactivation assays of in vitro study, it was discovered that CM108 could activate PPAR-alpha [TF] and liver X receptor alpha at 40-150 microg/ml, which subsequently resulted in activating [TG] promoter and enhancing apoA-I and apoA-II production, whereas reducing apoC-III production significantly.	PPAR-gamma	ABCA1	1	ACTIVATION	False
2259	2268	23160481:7:FoxO1:p27	[TF] can control [TG](KIP1) expression in differentiated and tumor cells of the thyroid.	FoxO1	p27	0	UNDEFINED	False
2260	2269	23160481:7:FoxO1:KIP1	[TF] can control p27([TG]) expression in differentiated and tumor cells of the thyroid.	FoxO1	KIP1	0	UNDEFINED	False
2263	2272	15994318:0:nuclear factor Y:Rnf35	We have previously shown that [TG] transcription is positively regulated by the [TF].	nuclear factor Y	Rnf35	1	ACTIVATION	False
2268	2277	15994318:0:Cdp:Rnf35	Transcription of the [TF] gene was shown to first occur between the eight-cell and the blastocyst stages, correlating and possibly explaining the onset of [TG] silencing at the blastocyst stage.	Cdp	Rnf35	1	ACTIVATION	True
2269	2278	22382027:0:SP1:BRAK	Calcium-calmodulin signaling induced by epithelial cell differentiation upregulates BRAK/CXCL14 expression via the binding of [TF] to the [TG] promoter region.	SP1	BRAK	0	UNDEFINED	True
2270	2279	22382027:0:SP1:CXCL14	Calcium-calmodulin signaling induced by epithelial cell differentiation upregulates BRAK/[TG] expression via the binding of [TF] to the BRAK promoter region.	SP1	CXCL14	1	ACTIVATION	False
2273	2282	19318561:0:Androgen receptor:EGFR	[TF] controls [TG] and ERBB2 gene expression at different levels in prostate cancer cell lines.	Androgen receptor	EGFR	0	UNDEFINED	False
2274	2283	19318561:0:Androgen receptor:ERBB2	[TF] controls EGFR and [TG] gene expression at different levels in prostate cancer cell lines.	Androgen receptor	ERBB2	0	UNDEFINED	False
2295	2304	10470095:8:WT1:N-myc	This suggests that the repression of the [TG] promoter is mediated through the [TF] binding sites.	WT1	N-myc	2	REPRESSION	True
2298	2307	12626549:0:cAMP response element modulator:IL-2	The [TF] (CREM) is known to form complexes with CREB and bind to the -180 site of the [TG] promoter in anergic and in systemic lupus erythematosus T cells.	cAMP response element modulator	IL-2	0	UNDEFINED	False
2301	2310	12626549:0:CREM:IL-2	CREM, in turn, binds protein 300 and cAMP response element binding protein, but [TF] is unable to activate its histone acetyltransferase activity, which results in condensation of chromatin and down-regulation of [TG] production.	CREM	IL-2	2	REPRESSION	True
2304	2313	12626549:0:CREB:IL-2	The cAMP response element modulator (CREM) is known to form complexes with [TF] and bind to the -180 site of the [TG] promoter in anergic and in systemic lupus erythematosus T cells.	CREB	IL-2	0	UNDEFINED	False
2310	2319	12626549:0:CREM:IL-2 promoter	Our data suggest that upon T cell activation, [TF] gradually replaces phosphorylated CREB at the -180 site of the [TG].	CREM	IL-2 promoter	0	UNDEFINED	False
2311	2320	12626549:0:CREB:IL-2 promoter	Our data suggest that upon T cell activation, CREM gradually replaces phosphorylated [TF] at the -180 site of the [TG].	CREB	IL-2 promoter	0	UNDEFINED	False
2312	2321	11145693:5:YY1:CXCR4	The binding activity of [TF], which is a repressor of CXCR4 transcription, to the [TG] promoter appeared to significantly increase in HHV-6-infected cells compared with the binding activity in mock-infected cells.	YY1	CXCR4	2	REPRESSION	True
2313	2322	10969820:7:p53:MnSOD	Transient transfection of wt p53 in HeLa cells led to a significant reduction in steady-state [TG] mRNA levels and enzymatic activity, confirming that the expression of this antioxidant enzyme is negatively regulated by [TF].	p53	MnSOD	2	REPRESSION	False
2315	2324	14625302:0:Myeloid ELF1-like factor:interleukin-8	[TF] is a potent activator of [TG] expression in hematopoietic cells.	Myeloid ELF1-like factor	interleukin-8	1	ACTIVATION	False
2329	2338	14625302:0:MEF:interleukin-8	Sixteen genes were reproducibly turned on or off more than 2-fold, 8 h after induction of [TF] expression, and we examined one of the genes, [TG] (IL-8), in greater detail.	MEF	interleukin-8	2	REPRESSION	True
2330	2339	14625302:0:MEF:IL-8	These data demonstrates that [TF] is an important regulator of [TG] expression.	MEF	IL-8	0	UNDEFINED	False
2331	2340	14625302:0:ETS:IL-8	The [TG] promoter contains three [TF] binding sites, and we identified the specific site that binds MEF and is required for MEF responsiveness.	ETS	IL-8	0	UNDEFINED	True
2372	2381	16269451:9:PPARgamma:HSL	These results indicate that PPARgamma positively regulates the HSL gene expression, and up-regulation of [TG] by [TF] requires the involvement of Sp1.	PPARgamma	HSL	1	ACTIVATION	False
2376	2385	16269451:9:Sp1:HSL	These results indicate that PPARgamma positively regulates the HSL gene expression, and up-regulation of [TG] by PPARgamma requires the involvement of [TF].	Sp1	HSL	1	ACTIVATION	True
2378	2387	20972463:6:GLI1:MUC5AC	Luciferase reporter assays revealed that [TF] and GLI2 can activate the [TG] promoter through its conserved CACCC-box-like cis-regulatory elements.	GLI1	MUC5AC	1	ACTIVATION	False
2380	2389	20972463:6:GLI2:MUC5AC	Luciferase reporter assays revealed that GLI1 and [TF] can activate the [TG] promoter through its conserved CACCC-box-like cis-regulatory elements.	GLI2	MUC5AC	1	ACTIVATION	False
2383	2392	12556536:8:STAT3:FAAH	Taken together, these results suggest that leptin, by up-regulating the [TG] promoter through [TF], enhances FAAH expression, thus tuning the immunomodulatory effects of anandamide.	STAT3	FAAH	1	ACTIVATION	False
2386	2395	12756174:0:Pax2:Mitf	Furthermore, both, Pax2 and Pax6 bind to and activate a MITF RPE-promoter element in vitro, whereas prolonged expression of Pax6 in the [TF]-positive optic stalk leads to ectopic [TG] expression and RPE differentiation in vivo.	Pax2	Mitf	1	ACTIVATION	True
2388	2397	12756174:0:Pax6:Mitf	Furthermore, both, Pax2 and Pax6 bind to and activate a MITF RPE-promoter element in vitro, whereas prolonged expression of [TF] in the Pax2-positive optic stalk leads to ectopic [TG] expression and RPE differentiation in vivo.	Pax6	Mitf	1	ACTIVATION	False
2396	2405	14586402:0:p53:Gadd45	Thus, HDAC inhibitors can induce [TG] through its promoter without the need for functional [TF], and both the Oct-1 and NF-Y concertedly participate in TSA-induced activation of the gadd45 promoter.	p53	Gadd45	1	ACTIVATION	True
2405	2414	14586402:0:NF-Y:Gadd45	Thus, HDAC inhibitors can induce [TG] through its promoter without the need for functional p53, and both the Oct-1 and [TF] concertedly participate in TSA-induced activation of the gadd45 promoter.	NF-Y	Gadd45	1	ACTIVATION	True
2411	2420	14586402:0:Oct-1:gadd45	Thus, HDAC inhibitors can induce Gadd45 through its promoter without the need for functional p53, and both the [TF] and NF-Y concertedly participate in TSA-induced activation of the [TG] promoter.	Oct-1	gadd45	1	ACTIVATION	False
2413	2422	14586402:0:NF-Y:gadd45	Thus, HDAC inhibitors can induce Gadd45 through its promoter without the need for functional p53, and both the Oct-1 and [TF] concertedly participate in TSA-induced activation of the [TG] promoter.	NF-Y	gadd45	1	ACTIVATION	False
2414	2423	9065434:0:interleukin-2 (IL-2) enhancer binding factor:IL-2	Constitutive binding of the transcription factor [TF] to the [TG] promoter.	interleukin-2 (IL-2) enhancer binding factor	IL-2	0	UNDEFINED	False
2417	2426	9065434:0:ILF:IL-2	These results suggest that important regulatory sequences in the IL-2 promoter are bound by [TF] and that this binding may be involved in the control of [TG] gene expression.	ILF	IL-2	0	UNDEFINED	False
2420	2429	12456803:7:SF-1:nNOS	We find that its major promoter resides at exon 2 in the pituitary gonadotrope alphaT3-1 cell line and that there is a nuclear hormone receptor binding site in this region, to which [TF] can bind and regulate [TG] transcription.	SF-1	nNOS	0	UNDEFINED	False
2429	2438	1650576:7:RAR beta:RAR beta	These results clearly show that RAR alpha and RAR gamma 1 can transactivate the [TG] gene; that [TF] can stimulate its own expression and that resistance to RA in RAC65 cells is probably due to the altered RAR alpha transcript present in these cells.	RAR beta	RAR beta	1	ACTIVATION	False
2439	2448	9614091:2:Sp1:eNOS	To elucidate the mechanism by which lyso-PC increases the [TG] transcription, we identified [TF] sites at -104 to -90 and PEA3 sites at -40 to -24 as being involved in lyso-PC-induced promoter activity.	Sp1	eNOS	0	UNDEFINED	True
2441	2450	9614091:2:PEA3:eNOS	To elucidate the mechanism by which lyso-PC increases the [TG] transcription, we identified Sp1 sites at -104 to -90 and [TF] sites at -40 to -24 as being involved in lyso-PC-induced promoter activity.	PEA3	eNOS	0	UNDEFINED	True
2444	2453	15181096:2:liver receptor homolog-1:StAR	In the present study, we investigated the role of [TF] (LRH-1) and dosage-sensitive sex reversal, adrenal hypoplasia congenital critical region on the X chromosome, gene 1 (DAX-1) in the regulation of [TG] gene expression in human granulosa cell tumor cells.	liver receptor homolog-1	StAR	0	UNDEFINED	False
2448	2457	15181096:2:LRH-1:StAR	In the present study, we investigated the role of liver receptor homolog-1 ([TF]) and dosage-sensitive sex reversal, adrenal hypoplasia congenital critical region on the X chromosome, gene 1 (DAX-1) in the regulation of [TG] gene expression in human granulosa cell tumor cells.	LRH-1	StAR	0	UNDEFINED	False
2452	2461	15181096:2:DAX-1:StAR	In the present study, we investigated the role of liver receptor homolog-1 (LRH-1) and dosage-sensitive sex reversal, adrenal hypoplasia congenital critical region on the X chromosome, gene 1 ([TF]) in the regulation of [TG] gene expression in human granulosa cell tumor cells.	DAX-1	StAR	0	UNDEFINED	False
2457	2466	15181096:2:dosage-sensitive sex reversal, adrenal hypoplasia congenital critical region on the X chromosome, gene 1:StAR	In the present study, we investigated the role of liver receptor homolog-1 (LRH-1) and [TF] (DAX-1) in the regulation of [TG] gene expression in human granulosa cell tumor cells.	dosage-sensitive sex reversal, adrenal hypoplasia congenital critical region on the X chromosome, gene 1	StAR	0	UNDEFINED	False
2467	2477	19520769:8:AR:Cdc6	Significantly, [TF] silencing in prostate cancer cells markedly decreases [TG] expression and androgen-dependent cellular proliferation.	AR	Cdc6	1	ACTIVATION	False
2472	2482	15817812:4:farnesoid X receptor:cholesterol 7alpha-hydroxylase	As positive controls, a dose-dependent repression of [TG] and a dose-dependent induction of small heterodimer partner (SHP) expression were also observed, suggesting that [TF] (FXR) was activated.	farnesoid X receptor	cholesterol 7alpha-hydroxylase	2	REPRESSION	False
2475	2485	15817812:4:farnesoid X receptor:small heterodimer partner	As positive controls, a dose-dependent repression of cholesterol 7alpha-hydroxylase and a dose-dependent induction of [TG] (SHP) expression were also observed, suggesting that [TF] (FXR) was activated.	farnesoid X receptor	small heterodimer partner	1	ACTIVATION	False
2476	2486	15817812:4:FXR:cholesterol 7alpha-hydroxylase	As positive controls, a dose-dependent repression of [TG] and a dose-dependent induction of small heterodimer partner (SHP) expression were also observed, suggesting that farnesoid X receptor ([TF]) was activated.	FXR	cholesterol 7alpha-hydroxylase	2	REPRESSION	True
2477	2487	15817812:4:FXR:SHP	As positive controls, a dose-dependent repression of cholesterol 7alpha-hydroxylase and a dose-dependent induction of small heterodimer partner ([TG]) expression were also observed, suggesting that farnesoid X receptor ([TF]) was activated.	FXR	SHP	1	ACTIVATION	False
2479	2489	15817812:4:FXR:small heterodimer partner	As positive controls, a dose-dependent repression of cholesterol 7alpha-hydroxylase and a dose-dependent induction of [TG] (SHP) expression were also observed, suggesting that farnesoid X receptor ([TF]) was activated.	FXR	small heterodimer partner	1	ACTIVATION	True
2486	2496	12200429:6:CREB:loricrin	We show that [TF] protein can compete with c-Jun for the AP1 site and repress [TG] promoter activity.	CREB	loricrin	2	REPRESSION	False
2489	2499	12200429:6:c-Jun:loricrin	We show that CREB protein can compete with [TF] for the AP1 site and repress [TG] promoter activity.	c-Jun	loricrin	0	UNDEFINED	True
2492	2502	12200429:6:AP1:loricrin	We show that CREB protein can compete with c-Jun for the [TF] site and repress [TG] promoter activity.	AP1	loricrin	1	ACTIVATION	True
2493	2503	12560229:0:AML-1A:MIP-1alpha	[TF] and AML-1B regulation of [TG] expression in multiple myeloma.	AML-1A	MIP-1alpha	0	UNDEFINED	False
2495	2505	12560229:0:AML-1B:MIP-1alpha	AML-1A and [TF] regulation of [TG] expression in multiple myeloma.	AML-1B	MIP-1alpha	0	UNDEFINED	False
2516	2526	11459795:6:Sp1:prothymosin alpha	Although addition of Sp1 did not further enhance estradiol-ER stimulated prothymosin alpha transcriptional activity in breast cancer cells, transfection and response element mutagenesis studies using Drosophila cells, which are deficient in Sp1, revealed that [TF] and the estradiol occupied-ER can each activate the [TG] gene independently of the other and act in an additive manner.	Sp1	prothymosin alpha	1	ACTIVATION	False
2519	2529	11459795:6:estradiol:prothymosin alpha	Although addition of Sp1 did not further enhance estradiol-ER stimulated prothymosin alpha transcriptional activity in breast cancer cells, transfection and response element mutagenesis studies using Drosophila cells, which are deficient in Sp1, revealed that Sp1 and the [TF] occupied-ER can each activate the [TG] gene independently of the other and act in an additive manner.	estradiol	prothymosin alpha	1	ACTIVATION	False
2523	2533	11459795:6:ER:prothymosin alpha	Although addition of Sp1 did not further enhance estradiol-ER stimulated prothymosin alpha transcriptional activity in breast cancer cells, transfection and response element mutagenesis studies using Drosophila cells, which are deficient in Sp1, revealed that Sp1 and the estradiol occupied-[TF] can each activate the [TG] gene independently of the other and act in an additive manner.	ER	prothymosin alpha	1	ACTIVATION	False
2525	2535	8572170:0:C/EBP:human NHE1	Role of [TF] proteins in hepatic and vascular smooth muscle transcription of [TG] gene.	C/EBP	human NHE1	0	UNDEFINED	True
2526	2536	8572170:0:C/EBP:NHE1	These results indicate that members of the [TF] family of transcription factors are involved in the regulation of hepatic and vascular smooth muscle transcription of the human [TG] gene.	C/EBP	NHE1	0	UNDEFINED	True
2530	2540	8572170:0:C/EBP delta:NHE1	These mutations abolished the binding of rat liver nuclear activities as well as transcription factors C/EBP alpha, C/EBP beta, and C/EBP delta expressed in COS-1 cell lysates to element D. Anti-C/EBP antibodies supershifted DNA-protein complexes formed between hepatic nuclear activities or C/EBP proteins expressed in COS-1 cell lysates and regulatory element D. Finally, cotransfection experiments of NHE1 0.25-kb promoter-chloramphenicol acetyltransferase (CAT) construct and C/EBP expression vectors showed that C/EBP alpha and [TF] are transactivators of the [TG] proximal promoter in Hep G2 and VSM A7r5 cells.	C/EBP delta	NHE1	1	ACTIVATION	False
2540	2550	8572170:0:C/EBP alpha:NHE1	These mutations abolished the binding of rat liver nuclear activities as well as transcription factors C/EBP alpha, C/EBP beta, and C/EBP delta expressed in COS-1 cell lysates to element D. Anti-C/EBP antibodies supershifted DNA-protein complexes formed between hepatic nuclear activities or C/EBP proteins expressed in COS-1 cell lysates and regulatory element D. Finally, cotransfection experiments of NHE1 0.25-kb promoter-chloramphenicol acetyltransferase (CAT) construct and C/EBP expression vectors showed that [TF] and C/EBP delta are transactivators of the [TG] proximal promoter in Hep G2 and VSM A7r5 cells.	C/EBP alpha	NHE1	1	ACTIVATION	False
2575	2585	19160541:5:Prox1:IFN-gamma	In this study, we report for the first time the negative regulation of [TG] expression by Prospero-related Homeobox ([TF]).	Prox1	IFN-gamma	2	REPRESSION	False
2577	2587	19160541:5:rospero-related Homeobox:IFN-gamma	In this study, we report for the first time the negative regulation of [TG] expression by P[TF] (Prox1).	rospero-related Homeobox	IFN-gamma	2	REPRESSION	False
2579	2589	14523007:0:cAMP-responsive element-binding protein:heme oxygenase-1	The [TF] (CREB) was phosphorylated via these pathways in response to OxPAPC treatment and expression of a dominant-negative mutant of CREB inhibited OxPAPC-induced activity of a human [TG] promoter-driven luciferase reporter construct.	cAMP-responsive element-binding protein	heme oxygenase-1	1	ACTIVATION	True
2583	2593	14523007:0:CREB:heme oxygenase-1	The cAMP-responsive element-binding protein (CREB) was phosphorylated via these pathways in response to OxPAPC treatment and expression of a dominant-negative mutant of [TF] inhibited OxPAPC-induced activity of a human [TG] promoter-driven luciferase reporter construct.	CREB	heme oxygenase-1	1	ACTIVATION	False
2584	2594	14523007:0:CREB:HO-1	Induction of [TG] expression by lipid oxidation products via [TF] may represent a feedback mechanism to limit inflammation and associated tissue damage.	CREB	HO-1	1	ACTIVATION	False
2585	2595	12504108:2:PPAR gamma:resistin	The aim of this study was to investigate the role of [TF] in the regulation of [TG] expression in human primary macrophages.	PPAR gamma	resistin	0	UNDEFINED	False
2586	2596	11026574:6:antiestrogen ICI 182,780:K19	Suppression of E2-induced [TG] gene expression by the [TF] suggests that ER mediates this regulation.	antiestrogen ICI 182,780	K19	2	REPRESSION	True
2589	2599	11026574:6:ER:K19	Suppression of E2-induced [TG] gene expression by the antiestrogen ICI 182,780 suggests that [TF] mediates this regulation.	ER	K19	0	UNDEFINED	False
2592	2602	11026574:6:E2:K19	Suppression of [TF]-induced [TG] gene expression by the antiestrogen ICI 182,780 suggests that ER mediates this regulation.	E2	K19	1	ACTIVATION	False
2596	2606	10446138:0:ETF:p53	Our studies indicate that E2F binding is not essential for activation of the [TG] promoter but that [TF] is.	ETF	p53	1	ACTIVATION	False
2607	2617	10446138:0:E2F:p53	Our studies indicate that [TF] binding is not essential for activation of the [TG] promoter but that ETF is.	E2F	p53	1	ACTIVATION	False
2609	2619	15788408:0:ATF4:vascular endothelial growth factor	The oxidative stressor arsenite activates [TG] mRNA transcription by an [TF]-dependent mechanism.	ATF4	vascular endothelial growth factor	1	ACTIVATION	False
2610	2620	15788408:0:HIF-1alpha:VEGF	Arsenite, a thiol-reactive oxidative stressor, induces [TG] expression by a [TF]-independent mechanism.	HIF-1alpha	VEGF	1	ACTIVATION	False
2611	2621	15788408:0:ATF4:VEGF	Thus, arsenite-induced up-regulation of [TG] gene transcription occurs by an [TF]-dependent mechanism.	ATF4	VEGF	1	ACTIVATION	False
2614	2624	17350616:3:Runx2:ERalpha	Here, we investigate the role of [TF] on the regulation of ERalpha expression by determining its interaction with the F promoter, one of the multiple promoters of the human [TG] gene and the only one active in bone.	Runx2	ERalpha	0	UNDEFINED	False
2617	2627	11731616:0:Gsh-1:GHRH	Because Gsh-1 is found to be expressed in the hypothalamus of the adult rat, our data provide evidence that the [TF] homeobox protein plays a key role in the expression of the [TG] gene.	Gsh-1	GHRH	1	ACTIVATION	False
2620	2630	16300731:0:ATF5:cyclin D3	[TF] increases cisplatin-induced apoptosis through up-regulation of [TG] transcription in HeLa cells.	ATF5	cyclin D3	1	ACTIVATION	False
2621	2631	16300731:0:ATF5:Cyclin D3	Taken together, these results suggest that [TF] increases cisplatin-induced apoptosis through up-regulation of [TG] transcription, which elicits survival signals in HeLa cells.	ATF5	Cyclin D3	1	ACTIVATION	False
2627	2637	16300731:0:E2F1:Cyclin D3	The ectopic expression of ATF5 in HeLa cells could markedly increase cisplatin-induced apoptosis and the cleavage of Caspase-3, and induce [TG] mRNA expression via cooperation with [TF] transcription factor.	E2F1	Cyclin D3	1	ACTIVATION	False
2628	2638	19264802:0:zinc finger protein Glis3:insulin	The Kruppel-like [TF] directly and indirectly activates [TG] gene transcription.	zinc finger protein Glis3	insulin	1	ACTIVATION	True
2629	2639	19264802:0:Glis3:insulin	This study uncovers a role of [TF] for regulation of [TG] gene expression and expands our understanding of its role in the beta cell.	Glis3	insulin	0	UNDEFINED	False
2632	2642	19264802:0:Glis3:insulin 2	We demonstrate that [TG] (Ins2) mRNA expression in rat insulinoma 832/13 cells is markedly increased by wild-type [TF] overexpression, but not by the NDH1 mutant.	Glis3	insulin 2	1	ACTIVATION	False
2633	2643	19264802:0:Glis3:Ins2	Moreover, [TF] physically and functionally interacts with Pdx1, MafA and NeuroD1 to modulate [TG] promoter activity.	Glis3	Ins2	0	UNDEFINED	False
2634	2644	19264802:0:Glis3:Ins1	Furthermore, expression of both [TG] and Ins2 mRNA is downregulated when [TF] is knocked down by siRNA.	Glis3	Ins1	1	ACTIVATION	False
2641	2652	19264802:0:Pdx1:Ins2	Moreover, Glis3 physically and functionally interacts with [TF], MafA and NeuroD1 to modulate [TG] promoter activity.	Pdx1	Ins2	0	UNDEFINED	False
2645	2656	19264802:0:MafA:Ins2	Moreover, Glis3 physically and functionally interacts with Pdx1, [TF] and NeuroD1 to modulate [TG] promoter activity.	MafA	Ins2	0	UNDEFINED	False
2649	2660	19264802:0:NeuroD1:Ins2	Moreover, Glis3 physically and functionally interacts with Pdx1, MafA and [TF] to modulate [TG] promoter activity.	NeuroD1	Ins2	0	UNDEFINED	False
2650	2661	19264802:0:Glis3:Nkx6-1	[TF] also may indirectly affect insulin promoter activity through upregulation of MafA and downregulation of [TG].	Glis3	Nkx6-1	2	REPRESSION	False
2651	2662	19264802:0:MafA:insulin	Glis3 also may indirectly affect [TG] promoter activity through upregulation of [TF] and downregulation of Nkx6-1.	MafA	insulin	0	UNDEFINED	True
2654	2665	19264802:0:Nkx6-1:insulin	Glis3 also may indirectly affect [TG] promoter activity through upregulation of MafA and downregulation of [TF].	Nkx6-1	insulin	0	UNDEFINED	True
2659	2670	17634427:7:c-Jun:ETV1	Collectively, these results, together with a parallel overexpression of ETV1, c-Jun, and AR in prostate tumors, imply that [TF] plays a pivotal role in the pathway that connects ligand-activated AR to elevated [TG] expression, leading to enhanced expression of matrix metalloproteinases and prostate cancer cell invasion.	c-Jun	ETV1	1	ACTIVATION	True
2662	2673	17634427:7:AR:ETV1	Collectively, these results, together with a parallel overexpression of ETV1, c-Jun, and AR in prostate tumors, imply that c-Jun plays a pivotal role in the pathway that connects ligand-activated [TF] to elevated [TG] expression, leading to enhanced expression of matrix metalloproteinases and prostate cancer cell invasion.	AR	ETV1	1	ACTIVATION	False
2666	2677	18596066:6:NR4A1:Star	This repression requires an element located at -95 bp previously implicated in the activation of the [TG] promoter by the nuclear receptors, [TF] and NR5A1.	NR4A1	Star	1	ACTIVATION	False
2668	2679	18596066:6:NR5A1:Star	This repression requires an element located at -95 bp previously implicated in the activation of the [TG] promoter by the nuclear receptors, NR4A1 and [TF].	NR5A1	Star	1	ACTIVATION	False
2669	2680	10733944:6:c-jun:p21	Furthermore, c-jun could inhibit butyrate-inducing p21 gene expression through Sp1, indicating at least one common pathway whereby [TG] expression is affected by [TF] and butyrate in opposing actions.	c-jun	p21	0	UNDEFINED	False
2674	2685	7488858:6:p53:MCK	We report here identification of a second [TF]-responsive sequence within the [TG] promoter.	p53	MCK	0	UNDEFINED	False
2675	2686	15312644:3:Rora:Bmal1	Results reported by Sato et al. in this issue of Neuron now show that the transactivator [TF] acts coordinately with Rev-erb alpha and that their competing activities on the same promoter element drive the rhythm in [TG] transcription.	Rora	Bmal1	1	ACTIVATION	True
2680	2691	15312644:3:Rev-erb alpha:Bmal1	Results reported by Sato et al. in this issue of Neuron now show that the transactivator Rora acts coordinately with [TF] and that their competing activities on the same promoter element drive the rhythm in [TG] transcription.	Rev-erb alpha	Bmal1	0	UNDEFINED	False
2689	2700	12947120:4:TR3:E2F1	Addition of antisense E2F1 could partially rescue the TR3-mediated cell apoptosis, and transfection of the TR3 dominant-negative plasmid could block the [TF]-induced [TG] expression.	TR3	E2F1	1	ACTIVATION	False
2691	2702	10446912:0:Activator protein-2:CYP11A1	[TF] mediates transcriptional activation of the [TG] gene by interaction with Sp1 rather than binding to DNA.	Activator protein-2	CYP11A1	1	ACTIVATION	False
2694	2705	10446912:0:Sp1:CYP11A1	Activator protein-2 mediates transcriptional activation of the [TG] gene by interaction with [TF] rather than binding to DNA.	Sp1	CYP11A1	1	ACTIVATION	True
2701	2712	15674334:9:p53:RECQ4	These data suggest that [TF]-mediated repression of [TG] transcription during DNA damage results from the modulation of the promoter occupancy of transcription activators and repressors.	p53	RECQ4	2	REPRESSION	False
2707	2718	15735666:4:KLF2:WEE1	Analysis of genes that could be potential targets of KLF2 revealed that [TF] negatively regulated [TG] expression.	KLF2	WEE1	2	REPRESSION	False
2708	2719	7534248:0:MEF-2:Mbp	Results from the band-shift assays indicated that the bacterially produced [TF] recognizes specific nt in the MB1 motif, and its binding to these nt reduces the overall transcriptional activity of [TG] in a cell-free extract.	MEF-2	Mbp	2	REPRESSION	False
2716	2727	11278253:10:p53:caspase-1	These results show that endogenous [TF] can regulate [TG] gene expression.	p53	caspase-1	0	UNDEFINED	False
2717	2728	21603612:9:NFATc1:TRAIL	These studies identify a novel mechanism for TRAIL regulation by which activation of [TF] increases TRAIL expression through negative regulation of Sp1 binding to the [TG] promoter.	NFATc1	TRAIL	0	UNDEFINED	True
2719	2730	21603612:9:Sp1:TRAIL	These studies identify a novel mechanism for TRAIL regulation by which activation of NFATc1 increases TRAIL expression through negative regulation of [TF] binding to the [TG] promoter.	Sp1	TRAIL	0	UNDEFINED	True
2723	2734	15266826:8:Pit-1:hGH	Neither overexpression of Pit-1 nor inhibiting [TF] expression affected IL-1beta induction of [TG] promoter activity.	Pit-1	hGH	1	ACTIVATION	False
2732	2743	7987850:0:A-myb:MIM-1	We report here the sequence of the entire coding region of A-myb complementary DNA and show that the full-length GST-[TF] fusion protein or a truncated derivative corresponding only to the putative DNA-binding domain interacts specifically with Myb-binding sites of the c-myb responsive promoters, [TG] and CD34.	A-myb	MIM-1	0	UNDEFINED	True
2733	2744	7987850:0:A-myb:CD34	We report here the sequence of the entire coding region of A-myb complementary DNA and show that the full-length GST-[TF] fusion protein or a truncated derivative corresponding only to the putative DNA-binding domain interacts specifically with Myb-binding sites of the c-myb responsive promoters, MIM-1 and [TG].	A-myb	CD34	0	UNDEFINED	False
2736	2747	7987850:0:Myb:MIM-1	We report here the sequence of the entire coding region of A-myb complementary DNA and show that the full-length GST-A-myb fusion protein or a truncated derivative corresponding only to the putative DNA-binding domain interacts specifically with [TF]-binding sites of the c-myb responsive promoters, [TG] and CD34.	Myb	MIM-1	0	UNDEFINED	True
2737	2748	7987850:0:Myb:CD34	We report here the sequence of the entire coding region of A-myb complementary DNA and show that the full-length GST-A-myb fusion protein or a truncated derivative corresponding only to the putative DNA-binding domain interacts specifically with [TF]-binding sites of the c-myb responsive promoters, MIM-1 and [TG].	Myb	CD34	0	UNDEFINED	True
2739	2750	7987850:0:c-myb:MIM-1	We report here the sequence of the entire coding region of A-myb complementary DNA and show that the full-length GST-A-myb fusion protein or a truncated derivative corresponding only to the putative DNA-binding domain interacts specifically with Myb-binding sites of the [TF] responsive promoters, [TG] and CD34.	c-myb	MIM-1	0	UNDEFINED	True
2740	2751	7987850:0:c-myb:CD34	We report here the sequence of the entire coding region of A-myb complementary DNA and show that the full-length GST-A-myb fusion protein or a truncated derivative corresponding only to the putative DNA-binding domain interacts specifically with Myb-binding sites of the [TF] responsive promoters, MIM-1 and [TG].	c-myb	CD34	0	UNDEFINED	True
2744	2755	11743638:10:CDX1:PCNA	Taken together, our results suggest that [TF] have a pro-proliferative effect on proliferation through transactivation of [TG] promoter activity.	CDX1	PCNA	1	ACTIVATION	False
2748	2759	15985428:3:E2F1:H19	H19 repression by pRb and E2F6 confirms the [TF]-dependent control of the [TG] promoter.	E2F1	H19	0	UNDEFINED	False
2751	2762	9174598:9:AP-1:IFN-gamma	We propose a model where basal transcription is maintained by binding of various transcription factors to the IFN-gamma promoter, whereas PMA+PHA-inducible [TG] transcription in CD45R0 T cells is associated with binding of [TF] to the C-site.	AP-1	IFN-gamma	1	ACTIVATION	True
2757	2768	8626802:0:FREAC-1:Clara cell 10-kDa protein	We show that the promoters of genes for lung-specific proteins such as pulmonary surfactant proteins A, B, and C (SPA, SPB, and SPC) and the [TG] (CC10) contain potential binding sites for [TF] and FREAC-2.	FREAC-1	Clara cell 10-kDa protein	0	UNDEFINED	True
2760	2771	8626802:0:FREAC-2:SPB	While an [TG] promoter construct could be transactivated by both FREAC-1 and [TF], CC10 was only activated by FREAC-1.	FREAC-2	SPB	1	ACTIVATION	False
2762	2773	8626802:0:FREAC-2:Clara cell 10-kDa protein	We show that the promoters of genes for lung-specific proteins such as pulmonary surfactant proteins A, B, and C (SPA, SPB, and SPC) and the [TG] (CC10) contain potential binding sites for FREAC-1 and [TF].	FREAC-2	Clara cell 10-kDa protein	0	UNDEFINED	True
2767	2778	12244173:4:LEF-1:RAG-2	Cotransfection assays using a human embryonic kidney cell line (293T) showed that [TF], c-Myb, and Pax-5 cooperatively activated the [TG] promoter, via their synergistic DNA binding.	LEF-1	RAG-2	1	ACTIVATION	False
2770	2781	12244173:4:c-Myb:RAG-2	Cotransfection assays using a human embryonic kidney cell line (293T) showed that LEF-1, [TF], and Pax-5 cooperatively activated the [TG] promoter, via their synergistic DNA binding.	c-Myb	RAG-2	1	ACTIVATION	False
2773	2784	12244173:4:Pax-5:RAG-2	Cotransfection assays using a human embryonic kidney cell line (293T) showed that LEF-1, c-Myb, and [TF] cooperatively activated the [TG] promoter, via their synergistic DNA binding.	Pax-5	RAG-2	1	ACTIVATION	False
2798	2809	19603422:0:c-myc:E2F1	Together, we demonstrate that PI3K-GSK3-dependent control of [TF] protein expression is connected to the transcription of the [TG] gene in PDAC cells, leading to S-phase progression of the cell cycle.	c-myc	E2F1	0	UNDEFINED	False
2805	2816	10748162:10:p53:BK2	Interestingly, removal of the P2 site by truncation or site-directed deletion amplifies [TF]-mediated activation of the [TG] promoter.	p53	BK2	1	ACTIVATION	False
2814	2825	10208422:8:E2F-4:E2F-1	IFN-alpha induced upregulation of E2F-4 along with dephosphorylation of pRB and p130, which resulted in the formation of [TF]/pRB and E2F-4/p130 complexes on the [TG] promoter.	E2F-4	E2F-1	0	UNDEFINED	False
2819	2830	8384306:0:myeloid nuclear factor 1:myeloperoxidase	The murine [TG] promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, [TF] (MyNF1).	myeloid nuclear factor 1	myeloperoxidase	0	UNDEFINED	False
2821	2832	8384306:0:MyNF1:myeloperoxidase	The murine [TG] promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 ([TF]).	MyNF1	myeloperoxidase	0	UNDEFINED	False
2823	2834	19192046:0:MYF-5:FOXE1	CONCLUSIONS: In 45% of non-syndromic cleft palate patients, a novel homozygous polymorphism that prevented the binding of [TF] to FOXE1 promoter and affected the [TG] expression was found.	MYF-5	FOXE1	0	UNDEFINED	True
2832	2843	7597041:5:E2F:c-myc	Transfection with [TF] decoy inhibited expression of [TG], cdc2, and the PCNA gene as well as vascular smooth muscle cell proliferation both in vitro and in the in vivo model of rat carotid injury.	E2F	c-myc	1	ACTIVATION	True
2833	2844	7597041:5:E2F:cdc2	Transfection with [TF] decoy inhibited expression of c-myc, [TG], and the PCNA gene as well as vascular smooth muscle cell proliferation both in vitro and in the in vivo model of rat carotid injury.	E2F	cdc2	1	ACTIVATION	True
2834	2845	7597041:5:E2F:PCNA	Transfection with [TF] decoy inhibited expression of c-myc, cdc2, and the [TG] gene as well as vascular smooth muscle cell proliferation both in vitro and in the in vivo model of rat carotid injury.	E2F	PCNA	1	ACTIVATION	True
2836	2847	18671304:13:C/EBPalpha:hepcidin	HCV-induced ROS also caused hypoacetylation of histones and inhibited binding of two positive regulators, C/EBPalpha and STAT3, to the hepcidin promoter, whereas anti-oxidant treatment of cells recovered [TF] and STAT3 binding to the [TG] promoter.	C/EBPalpha	hepcidin	0	UNDEFINED	False
2839	2850	18671304:13:STAT3:hepcidin	HCV-induced ROS also caused hypoacetylation of histones and inhibited binding of two positive regulators, C/EBPalpha and STAT3, to the hepcidin promoter, whereas anti-oxidant treatment of cells recovered C/EBPalpha and [TF] binding to the [TG] promoter.	STAT3	hepcidin	0	UNDEFINED	False
2841	2852	14988426:5:Nurr1:OPN	[TF] efficiently transactivated a luciferase reporter construct driven by the -857/+191 fragment of the mouse [TG] promoter.	Nurr1	OPN	1	ACTIVATION	False
2842	2853	10215617:10:AP-1:clusterin	Binding studies with PC12 nuclear extracts showed that [TF] binds to this sequence in the [TG] promoter.	AP-1	clusterin	0	UNDEFINED	False
2892	2903	16857744:0:glucocorticoid receptor:Dax-1	Reciprocal regulation of a [TF]-steroidogenic factor-1 transcription complex on the [TG] promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex.	glucocorticoid receptor	Dax-1	0	UNDEFINED	False
2896	2907	16857744:0:steroidogenic factor-1:Dax-1	Reciprocal regulation of a glucocorticoid receptor-[TF] transcription complex on the [TG] promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex.	steroidogenic factor-1	Dax-1	0	UNDEFINED	False
2900	2911	16857744:0:glucocorticoids:Dax-1	Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the [TG] promoter by [TF] and adrenocorticotropic hormone in the adrenal cortex.	glucocorticoids	Dax-1	0	UNDEFINED	False
2905	2916	16140555:11:TRPS1:RUNX2	Interestingly, one of these sites bound the [TF] transcription factor and we demonstrated that TRPS1 is able to repress the [TG] promoter.	TRPS1	RUNX2	2	REPRESSION	False
2924	2935	12846424:0:CRE-binding protein:aromatase	Role of [TF] (CREB) in [TG] expression in breast adipose.	CRE-binding protein	aromatase	0	UNDEFINED	False
2926	2937	12846424:0:CREB:aromatase	Role of CRE-binding protein ([TF]) in [TG] expression in breast adipose.	CREB	aromatase	0	UNDEFINED	False
2933	2944	16467535:5:Hes5:5-HT1A	However, in nonserotonergic cells that express 5-HT1A receptors (septal SN48, neuroblastoma SKN-SH, and neuroblastoma/glioma NG108-15 cells), Deaf-1 enhanced [TG] promoter activity at the C(-1019)-allele but not the G-allele, whereas [TF] repressed in all cell types.	Hes5	5-HT1A	2	REPRESSION	False
2936	2947	16467535:5:Deaf-1:5-HT1A	However, in nonserotonergic cells that express 5-HT1A receptors (septal SN48, neuroblastoma SKN-SH, and neuroblastoma/glioma NG108-15 cells), [TF] enhanced [TG] promoter activity at the C(-1019)-allele but not the G-allele, whereas Hes5 repressed in all cell types.	Deaf-1	5-HT1A	1	ACTIVATION	False
2937	2948	17000673:11:HATH1:MUC2	The results further suggest that [TF] is an important factor in the up-regulation of [TG] expression that occurs in mucinous cancers and signet ring carcinomas.	HATH1	MUC2	1	ACTIVATION	False
2938	2949	15383177:3:SOX9:AMH	Basal expression of [TG] is induced by SOX9; GATA4, SF1, and WT1 enhance [TF]-activated expression.	SOX9	AMH	1	ACTIVATION	False
2943	2954	15383177:3:GATA4:AMH	Basal expression of [TG] is induced by SOX9; [TF], SF1, and WT1 enhance SOX9-activated expression.	GATA4	AMH	1	ACTIVATION	False
2947	2958	15383177:3:SF1:AMH	Basal expression of [TG] is induced by SOX9; GATA4, [TF], and WT1 enhance SOX9-activated expression.	SF1	AMH	1	ACTIVATION	False
2951	2962	15383177:3:WT1:AMH	Basal expression of [TG] is induced by SOX9; GATA4, SF1, and [TF] enhance SOX9-activated expression.	WT1	AMH	1	ACTIVATION	False
2955	2966	10328874:5:NFkappaB:IL1B	At least in the case of the IL1B promoter, repression did not seem to involve another factor whose activity is affected by the NSAIDs, NFkappaB as the [TG] promoter fragment used in our studies is not [TF] responsive and binds specifically to HSF1.	NFkappaB	IL1B	0	UNDEFINED	False
2958	2969	10328874:5:HSF1:IL1B	At least in the case of the IL1B promoter, repression did not seem to involve another factor whose activity is affected by the NSAIDs, NFkappaB as the [TG] promoter fragment used in our studies is not NFkappaB responsive and binds specifically to [TF].	HSF1	IL1B	0	UNDEFINED	False
2960	2971	15955096:0:Sp1:ATP2C1	Transcriptional regulation of [TG] gene by [TF] and YY1 and reduced function of its promoter in Hailey-Hailey disease keratinocytes.	Sp1	ATP2C1	0	UNDEFINED	False
2962	2973	15955096:0:YY1:ATP2C1	Transcriptional regulation of [TG] gene by Sp1 and [TF] and reduced function of its promoter in Hailey-Hailey disease keratinocytes.	YY1	ATP2C1	0	UNDEFINED	False
2964	2975	12559959:0:OTX2:DOPAchrome tautomerase	[TF] regulates expression of [TG] in human retinal pigment epithelium.	OTX2	DOPAchrome tautomerase	0	UNDEFINED	False
2967	2978	12559959:0:OTX2:DCT	Therefore, [TF] may regulate RPE-specific target genes, such as [TG], thereby maintaining the homeostasis of RPE.	OTX2	DCT	0	UNDEFINED	False
2968	2979	12559959:0:OTX2:OTX2	Furthermore, repression of endogenous [TG] expression in Y79 cells by an anti-sense [TF] oligonucleotide resulted in the decrease of DCT protein contents.	OTX2	OTX2	1	ACTIVATION	True
2971	2982	12559959:0:OTX-2:DCT	Transient expression assays revealed that OTX2 activated the [TG] gene promoter through the [TF]-binding site in an RPE-specific manner.	OTX-2	DCT	0	UNDEFINED	True
2975	2986	15703179:0:Runx2:Sox9	We postulate that [TF] is a critical link in BMP-2-mediated initiation of mesenchymal chondrogenesis that results in activation of [TG] at least in part through the Nkx3.2-dependent	Runx2	Sox9	1	ACTIVATION	True
2983	2994	15703179:0:Nkx3.2:Sox9	We postulate that Runx2 is a critical link in BMP-2-mediated initiation of mesenchymal chondrogenesis that results in activation of [TG] at least in part through the [TF]-dependent	Nkx3.2	Sox9	1	ACTIVATION	True
2988	2999	18765668:7:ERbeta:BRCA2	Different from [TF], p53 interacted with HDAC1 and CtBP1 and formed an inhibiting transcriptional complex that could compete for binding to Sp1 sites with ERalpha transcriptional complex and inhibit [TG] transcription more significantly.	ERbeta	BRCA2	0	UNDEFINED	True
2994	3005	18765668:7:p53:BRCA2	Different from ERbeta, [TF] interacted with HDAC1 and CtBP1 and formed an inhibiting transcriptional complex that could compete for binding to Sp1 sites with ERalpha transcriptional complex and inhibit [TG] transcription more significantly.	p53	BRCA2	2	REPRESSION	False
3007	3018	18765668:7:ERalpha:BRCA2	Different from ERbeta, p53 interacted with HDAC1 and CtBP1 and formed an inhibiting transcriptional complex that could compete for binding to Sp1 sites with [TF] transcriptional complex and inhibit [TG] transcription more significantly.	ERalpha	BRCA2	0	UNDEFINED	True
3008	3019	15661074:8:p53:IGFBP-3	In vitro methylation of these [TF] consensus sequences also suppressed [TG] expression.	p53	IGFBP-3	0	UNDEFINED	True
3009	3020	10482545:8:NF-kappaB:bcl-x	Furthermore, Tax-induced transactivation of the [TG] promoter was also diminished by the mutant IkappaBalpha, which specifically inhibits [TF] activity.	NF-kappaB	bcl-x	1	ACTIVATION	True
3012	3023	18940792:7:CHOP:ASNS	The CHOP-dependent repression of the ASNS gene required the entire CHOP protein, arguing against the possibility of simple sequestration of ATF4 by the CHOP leucine zipper domain, and chromatin immunoprecipitation analysis showed association of [TF] with the [TG] and TRB3 promoters.	CHOP	ASNS	0	UNDEFINED	False
3015	3026	18940792:7:CHOP:TRB3	The CHOP-dependent repression of the ASNS gene required the entire CHOP protein, arguing against the possibility of simple sequestration of ATF4 by the CHOP leucine zipper domain, and chromatin immunoprecipitation analysis showed association of [TF] with the ASNS and [TG] promoters.	CHOP	TRB3	0	UNDEFINED	False
3020	3031	11714687:0:MEF2:Mef2c	Mutagenesis of the Mef2c control region shows that a binding site for myogenic bHLH proteins is essential for expression at all stages of skeletal muscle development, whereas an adjacent [TF] binding site is required for maintenance but not for initiation of [TG] transcription.	MEF2	Mef2c	0	UNDEFINED	True
3022	3033	11714687:0:MEF2:muscle-specific	Members of the [TF] family of transcription factors are upregulated during skeletal muscle differentiation and cooperate with the MyoD family of myogenic basic helix-loop-helix (bHLH) transcription factors to control the expression of [TG] genes.	MEF2	muscle-specific	0	UNDEFINED	True
3024	3035	11714687:0:MyoD:muscle-specific	Members of the MEF2 family of transcription factors are upregulated during skeletal muscle differentiation and cooperate with the [TF] family of myogenic basic helix-loop-helix (bHLH) transcription factors to control the expression of [TG] genes.	MyoD	muscle-specific	0	UNDEFINED	True
3027	3038	8196628:1:c-myc:prothymosin alpha	In RAT1A fibroblasts, expression of the [TG] gene is under the transcriptional control of the [TF] proto-oncogene.	c-myc	prothymosin alpha	0	UNDEFINED	False
3038	3049	10233885:0:C/EBPepsilon:neutrophil elastase	These results demonstrate a role for [TF] in regulating myeloid promoters, such as [TG], probably through a direct interaction with c-myb.	C/EBPepsilon	neutrophil elastase	0	UNDEFINED	False
3041	3052	10233885:0:C/EBP:neutrophil elastase	The kd for C/EBPepsilon binding to the [TF] site of the [TG] promoter was 4.2 nmol/L.	C/EBP	neutrophil elastase	0	UNDEFINED	True
3042	3053	10233885:0:p32:mim-1	Cotransfection of c-myb with either the [TF] or p30 isoform of C/EBPepsilon in CV-1 cells cooperatively transactivated the [TG] promoter by 20- and 16-fold, respectively, and the neutrophil elastase promoter by 10-and 7-fold, respectively.	p32	mim-1	1	ACTIVATION	False
3043	3054	10233885:0:p32:neutrophil elastase	Cotransfection of c-myb with either the [TF] or p30 isoform of C/EBPepsilon in CV-1 cells cooperatively transactivated the mim-1 promoter by 20- and 16-fold, respectively, and the [TG] promoter by 10-and 7-fold, respectively.	p32	neutrophil elastase	1	ACTIVATION	False
3044	3055	10233885:0:p32:granulocyte colony-stimulating factor (G-CSF) receptor	In transfection assays using the nonhematopoietic cell line, CV-1, the [TF] isoform activated promoters from the myeloid-specific mim-1, neutrophil elastase, and [TG] genes by 2.5-, 1.8-, and 1.6-fold, respectively.	p32	granulocyte colony-stimulating factor (G-CSF) receptor	1	ACTIVATION	False
3045	3056	10233885:0:p32:G-CSF	In transfection assays using the nonhematopoietic cell line, CV-1, the [TF] isoform activated promoters from the myeloid-specific mim-1, neutrophil elastase, and granulocyte colony-stimulating factor ([TG]) receptor genes by 2.5-, 1.8-, and 1.6-fold, respectively.	p32	G-CSF	1	ACTIVATION	False
3046	3057	10233885:0:p30:mim-1	Cotransfection of c-myb with either the p32 or [TF] isoform of C/EBPepsilon in CV-1 cells cooperatively transactivated the [TG] promoter by 20- and 16-fold, respectively, and the neutrophil elastase promoter by 10-and 7-fold, respectively.	p30	mim-1	1	ACTIVATION	False
3049	3060	10233885:0:c-myb:mim-1	Cotransfection of [TF] with either the p32 or p30 isoform of C/EBPepsilon in CV-1 cells cooperatively transactivated the [TG] promoter by 20- and 16-fold, respectively, and the neutrophil elastase promoter by 10-and 7-fold, respectively.	c-myb	mim-1	1	ACTIVATION	False
3050	3061	10233885:0:c-myb:neutrophil elastase	These results demonstrate a role for C/EBPepsilon in regulating myeloid promoters, such as [TG], probably through a direct interaction with [TF].	c-myb	neutrophil elastase	1	ACTIVATION	True
3053	3064	10233885:0:p30:neutrophil elastase	Cotransfection of c-myb with either the p32 or [TF] isoform of C/EBPepsilon in CV-1 cells cooperatively transactivated the mim-1 promoter by 20- and 16-fold, respectively, and the [TG] promoter by 10-and 7-fold, respectively.	p30	neutrophil elastase	1	ACTIVATION	False
3054	3065	10233885:0:C/EBPepsilon:mim-1	Cotransfection of c-myb with either the p32 or p30 isoform of [TF] in CV-1 cells cooperatively transactivated the [TG] promoter by 20- and 16-fold, respectively, and the neutrophil elastase promoter by 10-and 7-fold, respectively.	C/EBPepsilon	mim-1	1	ACTIVATION	False
3067	3078	11328853:0:steroidogenic factor 1:follicle-stimulating hormone receptor	Activation of the rat [TG] promoter by [TF] is blocked by protein kinase a and requires upstream stimulatory factor binding to a proximal E box element.	steroidogenic factor 1	follicle-stimulating hormone receptor	1	ACTIVATION	False
3069	3080	11328853:0:upstream stimulatory factor:follicle-stimulating hormone receptor	Activation of the rat [TG] promoter by steroidogenic factor 1 is blocked by protein kinase a and requires [TF] binding to a proximal E box element.	upstream stimulatory factor	follicle-stimulating hormone receptor	1	ACTIVATION	False
3073	3084	12915995:11:Ptx1:hCYP11B1	In contrast, co-transfection with both [TF]/Pitx1 and SF-1 synergistically increased [TG] promoter activity in HeLa and CV-1 cells (5-fold and 20-fold over basal, respectively).	Ptx1	hCYP11B1	1	ACTIVATION	False
3076	3087	12915995:11:Pitx1:hCYP11B1	In contrast, co-transfection with both Ptx1/[TF] and SF-1 synergistically increased [TG] promoter activity in HeLa and CV-1 cells (5-fold and 20-fold over basal, respectively).	Pitx1	hCYP11B1	1	ACTIVATION	False
3079	3090	12915995:11:SF-1:hCYP11B1	In contrast, co-transfection with both Ptx1/Pitx1 and [TF] synergistically increased [TG] promoter activity in HeLa and CV-1 cells (5-fold and 20-fold over basal, respectively).	SF-1	hCYP11B1	1	ACTIVATION	False
3080	3091	16049025:0:GDNF-inducible zinc finger protein 1:HOXA10	[TF] is a sequence-specific transcriptional repressor that binds to the [TG] gene regulatory region.	GDNF-inducible zinc finger protein 1	HOXA10	2	REPRESSION	True
3084	3095	16049025:0:GZF1:HOXA10	These findings thus suggest that [TF] may regulate the spatial and temporal expression of the [TG] gene which plays a role in morphogenesis.	GZF1	HOXA10	0	UNDEFINED	False
3086	3097	12559945:4:CDX2:MUC2	The [TF] expression construct activated the [TG] promoter and increased the endogenous MUC2 mRNA level, while the CDX1 one did not.	CDX2	MUC2	1	ACTIVATION	False
3089	3100	12559945:4:CDX1:MUC2	The CDX2 expression construct activated the MUC2 promoter and increased the endogenous [TG] mRNA level, while the [TF] one did not.	CDX1	MUC2	1	ACTIVATION	False
3091	3102	11590145:14:Smad3:PTHrP	These data suggest that TGF beta activates PTHrP expression by specifically up-regulating transcription from the [TG] P3 promoter through a novel [TF]/Ets1 synergism.	Smad3	PTHrP	1	ACTIVATION	False
3094	3105	11590145:14:Ets1:PTHrP	These data suggest that TGF beta activates PTHrP expression by specifically up-regulating transcription from the [TG] P3 promoter through a novel Smad3/[TF] synergism.	Ets1	PTHrP	1	ACTIVATION	False
3100	3111	15826950:3:GR:GM-CSF	We have previously suggested that one such repressive activity is by direct binding of [TF] to elements within the [TG] enhancer that are recognized by the nuclear factor of activated T cells.activator	GR	GM-CSF	2	REPRESSION	True
3102	3113	15826950:3:nuclear factor of activated T cells:GM-CSF	We have previously suggested that one such repressive activity is by direct binding of GR to elements within the [TG] enhancer that are recognized by the [TF].activator	nuclear factor of activated T cells	GM-CSF	1	ACTIVATION	True
3108	3119	18506761:4:Egr1:HIF-1alpha	To elucidate the mechanism of the transcriptional upregulation of the HIF-1alpha gene, we have shown that [TF] is able to directly bind to the [TG] promoter using chromatin immunoprecipitation.	Egr1	HIF-1alpha	0	UNDEFINED	False
3111	3122	16357303:7:FXR:ET-1	Electrophoretic mobility-shift and chromatin immunoprecipitation assays indicated that FXR reduced the binding activity of AP-1 transcriptional factors, suggesting that [TF] may suppress [TG] expression via negatively interfering with AP-1 signaling.	FXR	ET-1	2	REPRESSION	False
3113	3124	16357303:7:AP-1:ET-1	Electrophoretic mobility-shift and chromatin immunoprecipitation assays indicated that FXR reduced the binding activity of AP-1 transcriptional factors, suggesting that FXR may suppress [TG] expression via negatively interfering with [TF] signaling.	AP-1	ET-1	1	ACTIVATION	True
3117	3128	18590721:6:c-Jun:12(S)-lipoxygenase	These results suggested that trichostatin A inhibited EGF-induced [TG] expression by multiple mechanisms, including the attenuation of [TF] and Sp1 expression and p300 recruitment to the 12(S)-lipoxygenase gene promoter.	c-Jun	12(S)-lipoxygenase	1	ACTIVATION	True
3120	3131	18590721:6:Sp1:12(S)-lipoxygenase	These results suggested that trichostatin A inhibited EGF-induced [TG] expression by multiple mechanisms, including the attenuation of c-Jun and [TF] expression and p300 recruitment to the 12(S)-lipoxygenase gene promoter.	Sp1	12(S)-lipoxygenase	1	ACTIVATION	True
3124	3135	19038793:0:Mixl1:Flk1	Our analysis also shows that this differentiation occurs at the expense of hematopoietic mesoderm differentiation, with [TF](C) ESCs expressing only low levels of [TG] and failing to develop hemoglobinized cells.	Mixl1	Flk1	2	REPRESSION	True
3139	3150	16806476:0:AP-1:IL-8	Saxatilin inhibits TNF-alpha-induced proliferation by suppressing [TF]-dependent [TG] expression in the ovarian cancer cell line MDAH 2774.	AP-1	IL-8	1	ACTIVATION	False
3140	3151	17054912:7:TR4:OXT	Taken together, these results suggested that [TF] should be one of important regulators of [TG] gene expression.	TR4	OXT	0	UNDEFINED	False
3143	3154	15024058:0:Mist1:cytokeratin 19	Inhibition of [TF] transcriptional activity also leads to activation of duct-specific genes, such as [TG] and cytokeratin 20, suggesting that alterations in the bHLH network produce a direct acinar-to-ductal phenotypic switch in mature cells.	Mist1	cytokeratin 19	2	REPRESSION	False
3144	3155	15024058:0:Mist1:cytokeratin 20	Inhibition of [TF] transcriptional activity also leads to activation of duct-specific genes, such as cytokeratin 19 and [TG], suggesting that alterations in the bHLH network produce a direct acinar-to-ductal phenotypic switch in mature cells.	Mist1	cytokeratin 20	2	REPRESSION	False
3145	3156	12700240:7:SF-1:LHbeta	The [TG] promoter is regulated by the orphan nuclear receptor [TF] and homeodomain protein Ptx1.	SF-1	LHbeta	0	UNDEFINED	False
3147	3158	12700240:7:Ptx1:LHbeta	The [TG] promoter is regulated by the orphan nuclear receptor SF-1 and homeodomain protein [TF].	Ptx1	LHbeta	0	UNDEFINED	False
3159	3170	17226773:6:SF-1:Oct4	Overexpression of [TF] increased up to about threefold hOct4 promoter activity and endogenous h[TG] protein expression.	SF-1	Oct4	1	ACTIVATION	True
3164	3175	17786964:0:1alpha,25-dihydroxy vitamin D3 recepto:osteocalcin	1alpha,25-dihydroxy vitamin D3-enhanced expression of the [TG] gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the [TF]r-SRC-1 coactivator complex.	1alpha,25-dihydroxy vitamin D3 recepto	osteocalcin	1	ACTIVATION	False
3167	3178	17786964:0:SRC-1:osteocalcin	1alpha,25-dihydroxy vitamin D3-enhanced expression of the [TG] gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-[TF] coactivator complex.	SRC-1	osteocalcin	1	ACTIVATION	False
3170	3181	17786964:0:1alpha,25-dihydroxy vitamin D3:osteocalcin	[TF]-enhanced expression of the [TG] gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex.	1alpha,25-dihydroxy vitamin D3	osteocalcin	1	ACTIVATION	False
3174	3185	23630076:4:NFIL3:TRAIL	We discovered that the bZIP transcriptional repressor [TF] (nuclear factor interleukin 3-regulated) hindered FOXO transcription factor access to chromatin at the [TG] promoter by binding to nearby DNA and recruiting histone deacetylase-2 (HDAC2) to reduce histone acetylation.	NFIL3	TRAIL	0	UNDEFINED	False
3184	3196	23630076:4:FOXO:TRAIL	We discovered that the bZIP transcriptional repressor NFIL3 (nuclear factor interleukin 3-regulated) hindered [TF] transcription factor access to chromatin at the [TG] promoter by binding to nearby DNA and recruiting histone deacetylase-2 (HDAC2) to reduce histone acetylation.	FOXO	TRAIL	0	UNDEFINED	False
3187	3199	2247079:0:CCAAT-box-binding factor:hsp70	A cloned human [TF] stimulates transcription from the human [TG] promoter.	CCAAT-box-binding factor	hsp70	1	ACTIVATION	False
3189	3201	2247079:0:CCAAT-binding factor:hsp70	Expression of this [TF] (CBF) cDNA activated transcription from cotransfected [TG] promoter-reporter gene constructs in a CCAAT-dependent manner.	CCAAT-binding factor	hsp70	1	ACTIVATION	False
3191	3203	2247079:0:CBF:hsp70	Expression of this CCAAT-binding factor ([TF]) cDNA activated transcription from cotransfected [TG] promoter-reporter gene constructs in a CCAAT-dependent manner.	CBF	hsp70	1	ACTIVATION	False
3198	3210	23158658:4:STAT3:hTERT	Chromatin immunoprecipitation assay (ChIP) was performed to detect the binding of [TF] to [TG] promoter in MCF7.	STAT3	hTERT	0	UNDEFINED	False
3201	3213	11358962:0:Foxp1:CC10	[TF] and Foxp2 can regulate epithelial lung gene transcription as was demonstrated by their ability to dramatically repress the mouse [TG] promoter and, to a lesser extent, the human surfactant protein C promoter.	Foxp1	CC10	2	REPRESSION	False
3202	3214	11358962:0:Foxp1:surfactant protein C	[TF] and Foxp2 can regulate epithelial lung gene transcription as was demonstrated by their ability to dramatically repress the mouse CC10 promoter and, to a lesser extent, the human [TG] promoter.	Foxp1	surfactant protein C	2	REPRESSION	False
3203	3215	11358962:0:Foxp2:CC10	Foxp1 and [TF] can regulate epithelial lung gene transcription as was demonstrated by their ability to dramatically repress the mouse [TG] promoter and, to a lesser extent, the human surfactant protein C promoter.	Foxp2	CC10	2	REPRESSION	False
3204	3216	11358962:0:Foxp2:surfactant protein C	Foxp1 and [TF] can regulate epithelial lung gene transcription as was demonstrated by their ability to dramatically repress the mouse CC10 promoter and, to a lesser extent, the human [TG] promoter.	Foxp2	surfactant protein C	2	REPRESSION	False
3205	3217	16213525:11:Androgen receptor:PMEPA1	[TF] binding to predicted promoter upstream sequences of the [TG] gene was confirmed by chromatin immunoprecipitation assay.	Androgen receptor	PMEPA1	0	UNDEFINED	False
3206	3218	11504717:3:AR:PSA	[TF] is able to up-regulate [TG] expression by directly binding and activating the promoter of this gene.	AR	PSA	1	ACTIVATION	False
3207	3219	22625849:9:USF1:GATA5	Furthermore, real-time and RT (reverse transcription)-PCR analyses confirmed that overexpression of [TF] activates endogenous [TG] gene expression in human bronchial epithelial cells.	USF1	GATA5	1	ACTIVATION	False
3211	3223	21986102:0:Runx2:connective tissue growth factor	[TF]/Smad3 complex negatively regulates TGF-b-induced [TG] gene expression in vascular smooth muscle cells.	Runx2	connective tissue growth factor	2	REPRESSION	False
3214	3226	21986102:0:Smad3:connective tissue growth factor	Runx2/[TF] complex negatively regulates TGF-b-induced [TG] gene expression in vascular smooth muscle cells.	Smad3	connective tissue growth factor	2	REPRESSION	False
3218	3230	20422012:0:estrogen receptor:FLT1	The coordinated p53 and [TF] cis-regulation at an [TG] promoter SNP is specific to genotoxic stress and estrogenic compound.	estrogen receptor	FLT1	0	UNDEFINED	False
3219	3231	20422012:0:p53:VEGF receptor	BACKGROUND: Recently, we established that a C>T single nucleotide polymorphism (SNP) in the promoter of the [TG] FLT1 gene generates a (1/2) site [TF] response element (RE-T) that results in p53 responsiveness of the promoter.	p53	VEGF receptor	0	UNDEFINED	True
3223	3235	20422012:0:ER:FLT1	Furthermore, ER activity at [TG]-T was differentially affected by [TF] ligands, compared to a control TFF1/pS2 ER target promoter.	ER	FLT1	0	UNDEFINED	True
3227	3239	20422012:0:ERalpha:FLT1	Gene reporter assays and ChIP experiments conducted in the breast cancer-derived MCF7 cells revealed that the ERE2 site was sufficient for p53-mediated [TF] recruitment and transactivation of the [TG]-T promoter/reporter construct.	ERalpha	FLT1	1	ACTIVATION	True
3233	3245	20422012:0:p73:FLT1	The p53-related transcription factors (TFs) [TF] and p63 had no effect on [TG] transactivation.	p73	FLT1	1	ACTIVATION	False
3236	3248	20422012:0:p63:FLT1	The p53-related transcription factors (TFs) p73 and [TF] had no effect on [TG] transactivation.	p63	FLT1	1	ACTIVATION	True
3237	3249	15731171:4:androgen receptor:c-FLIP	The [TF] was recruited to the promoter of the [TG] gene in the presence of androgens.	androgen receptor	c-FLIP	0	UNDEFINED	False
3240	3252	15731171:4:androgens:c-FLIP	The androgen receptor was recruited to the promoter of the [TG] gene in the presence of [TF].	androgens	c-FLIP	0	UNDEFINED	True
3267	3279	8816493:0:neuroD2:GAP-43	Transfection of vectors expressing neuroD and neuroD2 into P19 cells shows that both can activate expression through simple E-box-driven reporter constructs and can activate a reporter driven by the neuroD2 promoter region, but the [TG] promoter is preferentially activated by [TF].	neuroD2	GAP-43	1	ACTIVATION	False
3271	3283	9271374:0:Serum response factor:c-fos	[TF] (SRF) is a transcription factor which binds to the serum response element (SRE) in the [TG] promoter.	Serum response factor	c-fos	0	UNDEFINED	False
3273	3285	9271374:0:SRF:c-fos	More strikingly, an antisense ATF6 construct reduced serum induction of a [TG] reporter gene, suggesting that ATF6 is involved in activation of transcription by [TF].	SRF	c-fos	1	ACTIVATION	False
3284	3296	9271374:0:ATF6:c-fos	More strikingly, an antisense ATF6 construct reduced serum induction of a [TG] reporter gene, suggesting that [TF] is involved in activation of transcription by SRF.	ATF6	c-fos	1	ACTIVATION	False
3297	3309	11171071:1:3,3',5-tri-iodothyronine (T(3)):MUC5AC	We reported previously that the expression of the gene encoding MUC5AC mucin in human airway epithelial cells is controlled by retinoic acid via the retinoic acid receptor (RAR)-alpha and that [TF] inhibits the expression of [TG].	3,3',5-tri-iodothyronine (T(3))	MUC5AC	2	REPRESSION	False
3300	3312	15528212:7:c-Myc:p21Cip1	[TF] antagonized the induction of [TG] mediated by oncogenic H-, K-, and N-Ras and by constitutively activated Raf and ERK2.	c-Myc	p21Cip1	2	REPRESSION	False
3305	3317	10811295:10:SF-1:ACTHR	Transfection of SF-1-expressing plasmid into non-adrenal cells significantly increased the promoter activity, suggesting that [TF] plays a role in the tissue-specific expression of human [TG] gene.	SF-1	ACTHR	1	ACTIVATION	False
3306	3318	15001984:0:Smad3:Tenascin-C	[TG] upregulation by transforming growth factor-beta in human dermal fibroblasts involves [TF], Sp1, and Ets1.	Smad3	Tenascin-C	1	ACTIVATION	False
3310	3322	15001984:0:Sp1:Tenascin-C	[TG] upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, [TF], and Ets1.	Sp1	Tenascin-C	1	ACTIVATION	False
3314	3326	15001984:0:Ets1:Tenascin-C	[TG] upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and [TF].	Ets1	Tenascin-C	1	ACTIVATION	False
3321	3333	15001984:0:Smad3:TN-C	These findings demonstrate the existence of a novel, functional binding element in the proximal region of the [TG] promoter mediating responsiveness to TGF-beta involving [TF]/4, Sp1, Ets1, and CBP/p300.	Smad3	TN-C	0	UNDEFINED	False
3324	3336	15001984:0:Smad4:TN-C	Moreover, simultaneous cotransfection of Smad3 and [TF] activated the [TG] promoter activity in a synergistic manner.	Smad4	TN-C	1	ACTIVATION	False
3328	3340	15001984:0:Sp1:TN-C	These findings demonstrate the existence of a novel, functional binding element in the proximal region of the [TG] promoter mediating responsiveness to TGF-beta involving Smad3/4, [TF], Ets1, and CBP/p300.	Sp1	TN-C	0	UNDEFINED	False
3332	3344	15001984:0:Ets1:TN-C	These findings demonstrate the existence of a novel, functional binding element in the proximal region of the [TG] promoter mediating responsiveness to TGF-beta involving Smad3/4, Sp1, [TF], and CBP/p300.	Ets1	TN-C	0	UNDEFINED	False
3340	3352	16702959:0:KLF6-SV1:E-cadherin	and conversely, [TF] silencing upregulated [TG] approximately fivefold (P<0.0001).	KLF6-SV1	E-cadherin	2	REPRESSION	False
3348	3360	17331471:2:steroidogenic factor 1:aromatase	We recently reported that atrazine induces human [TG] gene expression via promoter II (ArPII) in a [TF] (SF-1)-dependent manner.	steroidogenic factor 1	aromatase	1	ACTIVATION	True
3351	3363	17331471:2:SF-1:aromatase	We recently reported that atrazine induces human [TG] gene expression via promoter II (ArPII) in a steroidogenic factor 1 ([TF])-dependent manner.	SF-1	aromatase	1	ACTIVATION	True
3352	3364	12161509:8:ER alpha:CRH	Transient transfection assays conducted in the choriocarcinoma cell line JEG-3 demonstrated that E2 repressed CRH promoter activity, whereas the antagonist ICI 182780 up-regulated [TG] promoter activity when [TF] was cotransfected.	ER alpha	CRH	2	REPRESSION	False
3358	3370	12161509:8:ICI 182780:CRH	Transient transfection assays conducted in the choriocarcinoma cell line JEG-3 demonstrated that E2 repressed CRH promoter activity, whereas the antagonist [TF] up-regulated [TG] promoter activity when ER alpha was cotransfected.	ICI 182780	CRH	2	REPRESSION	False
3361	3373	8649389:0:CTCF:c-myc	"This flexibility in Zn finger usage reveals [TF] to be a unique ""multivalent"" transcriptional factor and provides the first feasible explanation of how certain homologous genes (i.e., [TG]) of different vertebrate species are regulated by the same factor and maintain similar expression patterns despite significant promoter sequence divergence."	CTCF	c-myc	0	UNDEFINED	True
3364	3376	8649389:0:c-myc:c-myc	Mutating the contact nucleotides confirms that CTCF binding to the human [TG] P2 promoter requires a number of unique contact DNA bases that are absent in the chicken [TF] CTCF binding site.	c-myc	c-myc	0	UNDEFINED	True
3367	3379	18524846:7:Sp1:CRMP-1	Chromatin immunoprecipitation assays confirmed that Sp1 and C/EBPalpha compete for binding at the overlapping C/EBPalpha and [TF] sites and reciprocally regulate [TG] expression.	Sp1	CRMP-1	0	UNDEFINED	True
3370	3382	18524846:7:C/EBPalpha:CRMP-1	Chromatin immunoprecipitation assays confirmed that Sp1 and C/EBPalpha compete for binding at the overlapping [TF] and Sp1 sites and reciprocally regulate [TG] expression.	C/EBPalpha	CRMP-1	0	UNDEFINED	True
3382	3394	17990281:0:Sp1:mu opioid receptor	The role of transcription factors [TF] and YY1 in proximal promoter region in initiation of transcription of the [TG] gene in human lymphocytes.	Sp1	mu opioid receptor	1	ACTIVATION	False
3384	3396	17990281:0:YY1:mu opioid receptor	The role of transcription factors Sp1 and [TF] in proximal promoter region in initiation of transcription of the [TG] gene in human lymphocytes.	YY1	mu opioid receptor	1	ACTIVATION	False
3387	3399	17668009:0:Tbx6:Msgn1	Expression of [TG] in the presomitic mesoderm is controlled by synergism of WNT signalling and [TF].	Tbx6	Msgn1	0	UNDEFINED	False
3391	3403	17668009:0:T-box 6:mesogenin 1	Here, we show that the expression of [TG], a basic helix-loop-helix transcription factor, which is essential for psm maturation, is regulated by synergism between WNT signalling and the [TF] transcription factor, involving a feed-forward control mechanism.	T-box 6	mesogenin 1	0	UNDEFINED	False
3393	3405	18758709:6:AR:PSA	RFA-binding proteins possibly cooperate with [TF]-mediated transactivation for [TG] promoter as coactivator.	AR	PSA	1	ACTIVATION	False
3398	3410	12432566:4:CREB:c-fos	Our results show that IL-2 activates CREB in human NK cells and that [TF] activation hasa prominent regulatory role on the IL-2-induced expression of functional [TG] and AP-1 in NK cells.	CREB	c-fos	1	ACTIVATION	False
3399	3411	12432566:4:CREB:AP-1	Our results show that IL-2 activates CREB in human NK cells and that [TF] activation hasa prominent regulatory role on the IL-2-induced expression of functional c-fos and [TG] in NK cells.	CREB	AP-1	1	ACTIVATION	False
3406	3418	15003528:0:NF-kappaB:MMP-3	These results are consistent with a role for [TF] in limiting the cytokine induced expression of [TG].	NF-kappaB	MMP-3	2	REPRESSION	False
3408	3420	15003528:0:Zinc-binding protein-89:MMP-3	[TF] (ZBP-89) was cloned from a yeast one-hybrid assay via its ability to interact with this site, but when the protein was over-expressed, it resulted in activation of the [TG] promoter rather than repression.	Zinc-binding protein-89	MMP-3	1	ACTIVATION	False
3410	3422	15003528:0:ZBP-89:MMP-3	Zinc-binding protein-89 ([TF]) was cloned from a yeast one-hybrid assay via its ability to interact with this site, but when the protein was over-expressed, it resulted in activation of the [TG] promoter rather than repression.	ZBP-89	MMP-3	1	ACTIVATION	False
3432	3444	11158330:0:STAT5:beta-casein	Cooperative effects of [TF] (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on [TG] gene transcription are mediated by the glucocorticoid receptor.	STAT5	beta-casein	0	UNDEFINED	False
3437	3449	11158330:0:signal transducer and activator of transcription 5:beta-casein	Cooperative effects of STAT5 ([TF]) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on [TG] gene transcription are mediated by the glucocorticoid receptor.	signal transducer and activator of transcription 5	beta-casein	0	UNDEFINED	False
3442	3454	11158330:0:C/EBPbeta:beta-casein	Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and [TF] (CCAAT/enhancer-binding protein-beta) on [TG] gene transcription are mediated by the glucocorticoid receptor.	C/EBPbeta	beta-casein	0	UNDEFINED	False
3447	3459	11158330:0:CCAAT/enhancer-binding protein-beta:beta-casein	Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta ([TF]) on [TG] gene transcription are mediated by the glucocorticoid receptor.	CCAAT/enhancer-binding protein-beta	beta-casein	0	UNDEFINED	False
3452	3464	11158330:0:glucocorticoid receptor:beta-casein	Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on [TG] gene transcription are mediated by the [TF].	glucocorticoid receptor	beta-casein	0	UNDEFINED	False
3453	3465	7969121:10:c-Myc:p53	Taken together, our findings support a direct role for [TF] in elevating expression of the mutant [TG] gene in some tumors.	c-Myc	p53	1	ACTIVATION	False
3455	3467	21546003:4:p53:S100B	ChIP assay revealed that p53 could bind to putative [TF]-binding sites of the [TG] promoter.	p53	S100B	0	UNDEFINED	True
3458	3470	20237505:9:WT1:IRF8	A reporter construct with the [TG] promoter was repressed by WT1, dependent on a putative [TF]-response element.	WT1	IRF8	2	REPRESSION	True
3460	3472	10919277:2:Steroidogenic factor 1:StAR	[TF] (SF-1) controls basal and cAMP-stimulated transcription of the [TG] gene.	Steroidogenic factor 1	StAR	1	ACTIVATION	False
3462	3474	10919277:2:SF-1:StAR	Steroidogenic factor 1 ([TF]) controls basal and cAMP-stimulated transcription of the [TG] gene.	SF-1	StAR	1	ACTIVATION	False
3469	3481	23977008:10:KLF6:PTTG1	Furthermore, [TF] knockdown by shRNA abolished the suppression of [TG] and reduced the activation of the differentiation marker CD11b in PMA-primed cells.	KLF6	PTTG1	2	REPRESSION	False
3470	3482	23977008:10:KLF6:CD11b	Furthermore, [TF] knockdown by shRNA abolished the suppression of PTTG1 and reduced the activation of the differentiation marker [TG] in PMA-primed cells.	KLF6	CD11b	1	ACTIVATION	False
3483	3495	17412698:0:SOX6:cyclin D1	By using a histone deacetylase (HDAC) inhibitor and co-immunoprecipitation analysis, we showed that [TF] suppressed [TG] activities by interacting withbeta-catenin and HDAC1.	SOX6	cyclin D1	2	REPRESSION	True
3489	3501	17412698:0:SOX6:cyclin D1 promoter	Furthermore, chromatin immunoprecipitation assay revealed that increased [TF] expression significantly reduced the levels of acetylated histones H3 and H4 at the [TG].	SOX6	cyclin D1 promoter	2	REPRESSION	True
3494	3506	15282325:6:EWS:IGFBP-3	We show that [TF]/FLI-1 can bind the [TG] promoter in vitro and in vivo and can repress its activity.	EWS	IGFBP-3	2	REPRESSION	False
3496	3508	15282325:6:FLI-1:IGFBP-3	We show that EWS/[TF] can bind the [TG] promoter in vitro and in vivo and can repress its activity.	FLI-1	IGFBP-3	2	REPRESSION	False
3501	3513	16140973:0:androgen receptor:PSA	Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve [TF] occupancy of the [TG] locus.	androgen receptor	PSA	0	UNDEFINED	False
3506	3518	15899857:8:YY1:Grp78	We also discovered enhancement of the ER-stressed induction of the [TG] promoter through the interaction of [TF] with the arginine methyltransferase PRMT1 and evidence of its action through methylation of the arginine 3 residue on histone H4.	YY1	Grp78	1	ACTIVATION	False
3511	3523	23848403:10:RUNX1:PF4	[TF], but not its mutants, in combination with ETS-1 and CBFb, or FLI-1, synergistically activated the [TG] promoter.	RUNX1	PF4	1	ACTIVATION	False
3515	3527	23848403:10:ETS-1:PF4	RUNX1, but not its mutants, in combination with [TF] and CBFb, or FLI-1, synergistically activated the [TG] promoter.	ETS-1	PF4	1	ACTIVATION	False
3519	3531	23848403:10:CBFb:PF4	RUNX1, but not its mutants, in combination with ETS-1 and [TF], or FLI-1, synergistically activated the [TG] promoter.	CBFb	PF4	1	ACTIVATION	False
3523	3535	23848403:10:FLI-1:PF4	RUNX1, but not its mutants, in combination with ETS-1 and CBFb, or [TF], synergistically activated the [TG] promoter.	FLI-1	PF4	1	ACTIVATION	False
3524	3536	10329662:0:AEBP2:aP2	In co-transfection assays, [TF] repressed transcription from the homologous [TG] promoter containing multiple copies of the AE-1 sequence.	AEBP2	aP2	2	REPRESSION	False
3525	3537	10329662:0:AEBP2:adipose fatty acid-binding protein	We have identified a novel transcriptional repressor, [TF], that binds to a regulatory sequence (termed AE-1) located in the proximal promoter region of the aP2 gene that encodes the [TG].	AEBP2	adipose fatty acid-binding protein	2	REPRESSION	True
3527	3539	9188651:2:AP-1:IL-8	The functional analysis of the [TG] gene revealed that both [TF]- and NF-kappaB factor-binding elements were involved in conferring the responsiveness to CMV.	AP-1	IL-8	0	UNDEFINED	True
3529	3541	9188651:2:NF-kappaB:IL-8	The functional analysis of the [TG] gene revealed that both AP-1- and [TF] factor-binding elements were involved in conferring the responsiveness to CMV.	NF-kappaB	IL-8	0	UNDEFINED	True
3531	3543	16330548:14:NRSF:NRP1	It was concluded that [TF] is a transcription factor that silences [TG] expression and thereby diminishes the Sema3A mediated inhibition of HaCaT keratinocyte migration.	NRSF	NRP1	2	REPRESSION	False
3533	3545	17638884:7:E2F-1:DUSP1	We found that [TF] binds to chromatin encompassing the DUSP1 promoter and greatly stimulates the promoter activity of the [TG] gene.	E2F-1	DUSP1	1	ACTIVATION	False
3538	3550	19930158:8:GLI1:SFRP1	ChIP assay showed that [TF] induced the transcriptional regulation of [TG] gene expression.	GLI1	SFRP1	1	ACTIVATION	False
3540	3552	15465029:0:Brn-3c:BDNF	Additionally, [TG] expression is reduced in the inner ear of a [TF] mutant mouse during embryogenesis.	Brn-3c	BDNF	1	ACTIVATION	False
3541	3553	15465029:0:Brn-3c:NT-3	Using transient transfection assays we show that [TF] is capable of activating both BDNF and [TG] promoters in inner ear sensory epithelial cell lines.	Brn-3c	NT-3	1	ACTIVATION	False
3543	3555	15465029:0:POU4F3:BDNF	Brn-3c ([TF]) regulates [TG] and NT-3 promoter activity.	POU4F3	BDNF	0	UNDEFINED	False
3544	3556	15465029:0:POU4F3:NT-3	Brn-3c ([TF]) regulates BDNF and [TG] promoter activity.	POU4F3	NT-3	0	UNDEFINED	False
3546	3558	15465029:0:Brn-3c:neurotrophin	Our data suggest that [TF] may play a role in regulating [TG] gene expression in the inner ear.	Brn-3c	neurotrophin	0	UNDEFINED	False
3557	3569	16511568:5:c-Jun:c-jun	Dimerization with [TF] in the nucleus prevents the export of ATF2 and is essential for the transcriptional activation of the [TG] promoter.	c-Jun	c-jun	1	ACTIVATION	False
3559	3571	16511568:5:ATF2:c-jun	Dimerization with c-Jun in the nucleus prevents the export of [TF] and is essential for the transcriptional activation of the [TG] promoter.	ATF2	c-jun	1	ACTIVATION	False
3566	3586	16728402:8:glucocorticoid:monoamine oxidase A	In summary, this study shows that [TF] enhances [TG] gene expression by 1) regulation of R1 translocation; 2) direct interaction of the glucocorticoid receptor with the third glucocorticoid/androgen response element; and 3) indirect interaction of glucocorticoid receptor with the Sp1 or R1 transcription factor on Sp1-binding sites of the MAO A promoter.	glucocorticoid	monoamine oxidase A	1	ACTIVATION	False
3577	3597	11533040:0:farnesoid X receptor:Dehydroepiandrosterone sulfotransferase	[TG] gene induction by bile acid activated [TF].	farnesoid X receptor	Dehydroepiandrosterone sulfotransferase	1	ACTIVATION	True
3578	3598	11533040:0:farnesoid X receptor:Std	CDCA is a potent inducer of the [TG] gene, and its inducing effect is mediated through the bile acid-activated [TF] (FXR), a recently characterized member of the nuclear receptor superfamily.	farnesoid X receptor	Std	1	ACTIVATION	False
3580	3600	11533040:0:FXR:Std	Unlike all other previously characterized [TF] target genes, which contain an inverted repeat (IR) of the consensus hexanucleotide half-site (A/G)G(G/T)TCA with a single nucleotide spacer (IR-1), the bile acid response element of the [TG] promoter does not contain any spacer between the two hexanucleotide repeats (IR-0).	FXR	Std	0	UNDEFINED	False
3586	3606	11533040:0:9-cis-retinoic acid receptor:Std	The ligand-activated FXR acts as a heterodimer with the [TF] (RXR) and regulates the [TG] gene by binding to an upstream region at base pair positions -169 to -193.	9-cis-retinoic acid receptor	Std	0	UNDEFINED	False
3589	3609	11533040:0:RXR:Std	The ligand-activated FXR acts as a heterodimer with the 9-cis-retinoic acid receptor ([TF]) and regulates the [TG] gene by binding to an upstream region at base pair positions -169 to -193.	RXR	Std	0	UNDEFINED	False
3591	3611	15456761:0:Bright:murine heavy chain locus	[TF], for B cell regulator of immunoglobulin heavy chain transcription, binds A+T-rich sequences in the intronic enhancer regions of the [TG] and 5'-flanking sequences of some variable heavy chain promoters.	Bright	murine heavy chain locus	0	UNDEFINED	False
3592	3612	15456761:0:Bright:variable heavy chain	[TF], for B cell regulator of immunoglobulin heavy chain transcription, binds A+T-rich sequences in the intronic enhancer regions of the murine heavy chain locus and 5'-flanking sequences of some [TG] promoters.	Bright	variable heavy chain	0	UNDEFINED	True
3594	3614	15456761:0:B cell regulator of immunoglobulin heavy chain transcription:murine heavy chain locus	Bright, for [TF], binds A+T-rich sequences in the intronic enhancer regions of the [TG] and 5'-flanking sequences of some variable heavy chain promoters.	B cell regulator of immunoglobulin heavy chain transcription	murine heavy chain locus	0	UNDEFINED	False
3595	3615	15456761:0:B cell regulator of immunoglobulin heavy chain transcription:variable heavy chain	Bright, for [TF], binds A+T-rich sequences in the intronic enhancer regions of the murine heavy chain locus and 5'-flanking sequences of some [TG] promoters.	B cell regulator of immunoglobulin heavy chain transcription	variable heavy chain	0	UNDEFINED	False
3596	3616	15456761:0:Bright:mu	Dominant negative [TF] prevented the up-regulation of [TG] transcription in transfected Chinese hamster ovary cells transfected with wild type Bright.	Bright	mu	1	ACTIVATION	False
3599	3619	19703903:5:PAR1:MUC18	Indeed, PAR1 silencing down-regulates PAFR expression and PAF production, PAFR silencing blocks MUC18 expression, and re-expression of PAFR in [TF]-silenced cells rescues [TG] expression.	PAR1	MUC18	1	ACTIVATION	True
3601	3621	23782265:4:STAT3:SOCS3	This was in contrast with the action of traditional JAK/[TF] inhibitors and the polyphenol resveratrol, which effectively suppress [TG] gene expression.	STAT3	SOCS3	1	ACTIVATION	True
3605	3625	16000305:0:activating transcription factor 4:osteocalcin	Cooperative interactions between [TF] and Runx2/Cbfa1 stimulate osteoblast-specific [TG] gene expression.	activating transcription factor 4	osteocalcin	1	ACTIVATION	False
3608	3628	16000305:0:Runx2:osteocalcin	Cooperative interactions between activating transcription factor 4 and [TF]/Cbfa1 stimulate osteoblast-specific [TG] gene expression.	Runx2	osteocalcin	1	ACTIVATION	False
3611	3631	16000305:0:Cbfa1:osteocalcin	Cooperative interactions between activating transcription factor 4 and Runx2/[TF] stimulate osteoblast-specific [TG] gene expression.	Cbfa1	osteocalcin	1	ACTIVATION	False
3615	3635	16000305:0:ATF4:osteocalcin (Ocn) gene 2	In this study, we determined the molecular mechanisms through which [TF] activates the mouse [TG] (mOG2) expression and mOG2 promoter activity.	ATF4	osteocalcin (Ocn) gene 2	1	ACTIVATION	False
3616	3636	16000305:0:ATF4:Ocn	This study is the first demonstration that cooperative interactions between [TF] and Runx2/Cbfa1 stimulate osteoblast-specific [TG] expression and suggests that this regulation may represent a novel intramolecular mechanism regulating Runx2 activity and, thereby, osteoblast differentiation and bone formation.	ATF4	Ocn	1	ACTIVATION	False
3625	3645	16000305:0:Cbfa1:Ocn	This study is the first demonstration that cooperative interactions between ATF4 and Runx2/[TF] stimulate osteoblast-specific [TG] expression and suggests that this regulation may represent a novel intramolecular mechanism regulating Runx2 activity and, thereby, osteoblast differentiation and bone formation.	Cbfa1	Ocn	1	ACTIVATION	False
3626	3646	14679188:15:Egr-1:ACE	These results show that HGF transiently increases gene transcription of [TG] via activation of Egr-1, whereas PMA regulation involves [TF] and additional factor(s).	Egr-1	ACE	0	UNDEFINED	True
3631	3651	19372587:7:STAT3:p21	Our data suggest that ErbB2 overexpression can activate [TF] through Src leading to transcriptional up-regulation of [TG](Cip1) that confers Taxol resistance of breast cancer cells.	STAT3	p21	1	ACTIVATION	False
3632	3652	19372587:7:STAT3:Cip1	Our data suggest that ErbB2 overexpression can activate [TF] through Src leading to transcriptional up-regulation of p21([TG]) that confers Taxol resistance of breast cancer cells.	STAT3	Cip1	1	ACTIVATION	False
3635	3655	17171640:7:androgen:prosaposin	In addition, we demonstrate [TF]-responsiveness of [TG] promoter and AR occupancy to a hormone-responsive element located in the proximal region of the prosaposin promoter.	androgen	prosaposin	1	ACTIVATION	False
3637	3657	20544543:7:STAT1:UPase	Notably, the activation of NF-kappaB and [TF] in human breast tissues is consistent with UPase activity; signifying their role in the up-regulation of the [TG] gene expression in human tumors.	STAT1	UPase	1	ACTIVATION	False
3640	3660	20544543:7:NF-kappaB:UPase	Notably, the activation of [TF] and STAT1 in human breast tissues is consistent with UPase activity; signifying their role in the up-regulation of the [TG] gene expression in human tumors.	NF-kappaB	UPase	1	ACTIVATION	False
3642	3662	15947108:0:growth factor independent-1:CYP27B1	Identification of [TF] (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase ([TG]) gene expression in human prostate cancer cells.	growth factor independent-1	CYP27B1	2	REPRESSION	False
3643	3663	15947108:0:growth factor independent-1:25-hydroxyvitamin D 1-alpha hydroxylase	Identification of [TF] (GFI1) as a repressor of [TG] (CYP27B1) gene expression in human prostate cancer cells.	growth factor independent-1	25-hydroxyvitamin D 1-alpha hydroxylase	2	REPRESSION	False
3645	3665	15947108:0:GFI1:CYP27B1	Identification of growth factor independent-1 ([TF]) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase ([TG]) gene expression in human prostate cancer cells.	GFI1	CYP27B1	2	REPRESSION	False
3646	3666	15947108:0:GFI1:25-hydroxyvitamin D 1-alpha hydroxylase	Identification of growth factor independent-1 ([TF]) as a repressor of [TG] (CYP27B1) gene expression in human prostate cancer cells.	GFI1	25-hydroxyvitamin D 1-alpha hydroxylase	2	REPRESSION	False
3647	3668	19799567:7:PBX1:SOX3	With the results of the present study, for the first time, we have established a functional link between the TALE proteins, [TF] and MEIS1, and expression of the human [TG] gene.	PBX1	SOX3	0	UNDEFINED	False
3648	3670	19799567:7:MEIS1:SOX3	With the results of the present study, for the first time, we have established a functional link between the TALE proteins, PBX1 and [TF], and expression of the human [TG] gene.	MEIS1	SOX3	0	UNDEFINED	False
3662	3686	14737107:0:STAT3:c-fos	These data indicate that MITF and [TF] cooperatively induce [TG], resulting in cellular transformation.	STAT3	c-fos	1	ACTIVATION	False
3664	3688	14737107:0:MITF:c-fos	These data indicate that [TF] and STAT3 cooperatively induce [TG], resulting in cellular transformation.	MITF	c-fos	1	ACTIVATION	False
3681	3705	15225122:0:cAMP-response element modulator-tau:phospholipid hydroperoxide	[TF] activates a distinct promoter element for the expression of the [TG]/sperm nucleus glutathione peroxidase gene.	cAMP-response element modulator-tau	phospholipid hydroperoxide	1	ACTIVATION	False
3682	3706	15225122:0:cAMP-response element modulator-tau:sperm nucleus glutathione peroxidase	[TF] activates a distinct promoter element for the expression of the phospholipid hydroperoxide/[TG] gene.	cAMP-response element modulator-tau	sperm nucleus glutathione peroxidase	1	ACTIVATION	False
3684	3708	15225122:0:CREM-tau:snPHGPx	On the basis of these results, we demonstrate that [TG] expression is mediated by the transcription factor [TF], which acts as a cis-acting element localized in the first intron of the PHGPx gene.	CREM-tau	snPHGPx	1	ACTIVATION	False
3686	3710	24051379:7:SALL4:HOXA9	We found that [TF] bound a specific region of the [TG] promoter in leukemic cells.	SALL4	HOXA9	0	UNDEFINED	False
3688	3712	21839814:4:YY1:POSTN	[TF], whose regulatory role in biology includes, besides transcriptional control, also chromatin remodeling, DNA damage repair and tumorigenesis, acts as a strong negative modulator of the [TG] expression.	YY1	POSTN	2	REPRESSION	False
3689	3713	15653692:7:AP1:uPA	Furthermore, introducing mutations to knock out the NF-kappaB binding site of the uPA promoter results in over 80% reduction in LPA-induced [TG] promoter activation, whereas this activity is largely intact with the promoter containing mutations in the [TF] binding sites.	AP1	uPA	1	ACTIVATION	True
3691	3715	15653692:7:NF-kappaB:uPA	Furthermore, introducing mutations to knock out the [TF] binding site of the uPA promoter results in over 80% reduction in LPA-induced [TG] promoter activation, whereas this activity is largely intact with the promoter containing mutations in the AP1 binding sites.	NF-kappaB	uPA	1	ACTIVATION	True
3694	3718	22293114:4:TGIF:SOX3	Here we present the evidence that [TF] (TG-interacting factor) is an additional TALE superfamily member involved in the regulation of human [TG] gene expression in NT2/D1 cells by direct interaction with the consensus binding site that is conserved in primate orthologue promoters.	TGIF	SOX3	0	UNDEFINED	False
3696	3720	22293114:4:TG-interacting factor:SOX3	Here we present the evidence that TGIF ([TF]) is an additional TALE superfamily member involved in the regulation of human [TG] gene expression in NT2/D1 cells by direct interaction with the consensus binding site that is conserved in primate orthologue promoters.	TG-interacting factor	SOX3	0	UNDEFINED	False
3699	3723	10753890:2:farnesoid X receptor:CYP7A1	The goal of this study is to elucidate the mechanism of [TG] transcription by bile acid-activated [TF] (FXR) in its native promoter and cellular context and to identify FXR response elements in the gene.	farnesoid X receptor	CYP7A1	0	UNDEFINED	False
3701	3725	10753890:2:FXR:CYP7A1	The goal of this study is to elucidate the mechanism of [TG] transcription by bile acid-activated farnesoid X receptor (FXR) in its native promoter and cellular context and to identify [TF] response elements in the gene.	FXR	CYP7A1	0	UNDEFINED	True
3705	3729	12907682:8:GATA-4:MIS	We have previously reported that [TF] and SF-1 transcriptionally cooperate to synergistically activate the [TG] promoter.	GATA-4	MIS	1	ACTIVATION	False
3707	3731	12907682:8:SF-1:MIS	We have previously reported that GATA-4 and [TF] transcriptionally cooperate to synergistically activate the [TG] promoter.	SF-1	MIS	1	ACTIVATION	False
3715	3739	23229549:5:PITX2:Lhx6	[TF] activates endogenous Lhx6 expression and the [TG] promoter, whereas LHX6 represses its promoter activity.	PITX2	Lhx6	1	ACTIVATION	False
3721	3745	23229549:5:LHX6:Lhx6	PITX2 activates endogenous Lhx6 expression and the [TG] promoter, whereas [TF] represses its promoter activity.	LHX6	Lhx6	2	REPRESSION	False
3722	3746	16006237:3:pregnane X receptor:MDR1	The expression of [TG] is partially controlled by the [TF] (PXR), which mediates induction by many xenobiotics.	pregnane X receptor	MDR1	1	ACTIVATION	False
3724	3748	16006237:3:PXR:MDR1	The expression of [TG] is partially controlled by the pregnane X receptor ([TF]), which mediates induction by many xenobiotics.	PXR	MDR1	1	ACTIVATION	False
3726	3750	19720140:5:YY1:GDAP1	Overexpression of [TF] activated the [TG] promoter in a reporter gene system as well as increased the level of endogenous mRNA.	YY1	GDAP1	1	ACTIVATION	False
3728	3752	10319325:3:Egr1:LH beta	The present study investigated the roles played by [TF] and SF-1 in regulating activity of the equine [TG]-subunit promoter in the gonadotrope cell line, alpha T3-1, and the importance of these factors and cis-acting elements in regulation of the promoter by GnRH.	Egr1	LH beta	0	UNDEFINED	False
3731	3755	10319325:3:SF-1:LH beta	The present study investigated the roles played by Egr1 and [TF] in regulating activity of the equine [TG]-subunit promoter in the gonadotrope cell line, alpha T3-1, and the importance of these factors and cis-acting elements in regulation of the promoter by GnRH.	SF-1	LH beta	0	UNDEFINED	False
3733	3757	19734891:0:Sox2:Shh	[TF]-deleted NSCs did not express [TG] in vitro and were rapidly lost.	Sox2	Shh	1	ACTIVATION	False
3738	3762	12853459:5:LRH-1:CEL	As reported for other LRH-1 target genes, the nuclear receptor short heterodimer partner represses [TF]-induced [TG] promoter activity.	LRH-1	CEL	1	ACTIVATION	False
3741	3765	12853459:5:short heterodimer partner:CEL	As reported for other LRH-1 target genes, the nuclear receptor [TF] represses LRH-1-induced [TG] promoter activity.	short heterodimer partner	CEL	2	REPRESSION	False
3742	3766	11893733:0:Elf-3:type II transforming growth factor-beta receptor	Activation of the murine [TG] gene: up-regulation and function of the transcription factor [TF]/Ert/Esx/Ese-1.	Elf-3	type II transforming growth factor-beta receptor	1	ACTIVATION	False
3746	3770	11893733:0:Ert:type II transforming growth factor-beta receptor	Activation of the murine [TG] gene: up-regulation and function of the transcription factor Elf-3/[TF]/Esx/Ese-1.	Ert	type II transforming growth factor-beta receptor	1	ACTIVATION	False
3750	3774	11893733:0:Esx:type II transforming growth factor-beta receptor	Activation of the murine [TG] gene: up-regulation and function of the transcription factor Elf-3/Ert/[TF]/Ese-1.	Esx	type II transforming growth factor-beta receptor	1	ACTIVATION	False
3754	3778	11893733:0:Ese-1:type II transforming growth factor-beta receptor	Activation of the murine [TG] gene: up-regulation and function of the transcription factor Elf-3/Ert/Esx/[TF].	Ese-1	type II transforming growth factor-beta receptor	1	ACTIVATION	False
3758	3782	11893733:0:Ets:mTbetaR-II promoter	Analysis of mTbetaR-II promoter/reporter gene constructs demonstrates that two conserved [TF]-binding sites play an important role in the activity of the [TG].	Ets	mTbetaR-II promoter	0	UNDEFINED	True
3759	3783	11893733:0:mElf-3:TbetaR-II	Importantly, we present evidence that [TF], a member of the Ets family, plays a key role in the activation of the m[TG] promoter.	mElf-3	TbetaR-II	1	ACTIVATION	False
3761	3785	11893733:0:Elf-3:TbetaR-II	Importantly, we present evidence that m[TF], a member of the Ets family, plays a key role in the activation of the m[TG] promoter.	Elf-3	TbetaR-II	1	ACTIVATION	False
3765	3789	11893733:0:Ets:TbetaR-II	Importantly, we present evidence that mElf-3, a member of the [TF] family, plays a key role in the activation of the m[TG] promoter.	Ets	TbetaR-II	1	ACTIVATION	True
3766	3790	11893733:0:mElf-3:mTbetaR-II	In conclusion, our data argue that [TF] plays a key role in the regulation of the [TG] gene, and Elf-3 itself is regulated at multiple levels.	mElf-3	mTbetaR-II	0	UNDEFINED	False
3772	3796	15175554:9:SP-1:PDGF-B	These results suggest that oxidative stress mediates the TNFalpha-induced expression of [TG] in HUVECs through redox-sensitive transcription factors, predominantly the [TF] and possibly, to some extent of NF-kappaB.	SP-1	PDGF-B	1	ACTIVATION	False
3775	3799	15175554:9:NF-kappaB:PDGF-B	These results suggest that oxidative stress mediates the TNFalpha-induced expression of [TG] in HUVECs through redox-sensitive transcription factors, predominantly the SP-1 and possibly, to some extent of [TF].	NF-kappaB	PDGF-B	1	ACTIVATION	False
3778	3802	12525499:9:C/EBPalpha:UCP-1	Retrovirus-mediated expression of [TF] and peroxisome proliferator-activated receptor gamma in IRS-1(-/-) brown adipocytes up-regulated UCP-1 protein content and transactivated [TG] promoter regardless of insulin stimulation.	C/EBPalpha	UCP-1	1	ACTIVATION	False
3782	3806	12525499:9:peroxisome proliferator-activated receptor gamma:UCP-1	Retrovirus-mediated expression of C/EBPalpha and [TF] in IRS-1(-/-) brown adipocytes up-regulated UCP-1 protein content and transactivated [TG] promoter regardless of insulin stimulation.	peroxisome proliferator-activated receptor gamma	UCP-1	1	ACTIVATION	False
3790	3814	10625666:8:PDEF:PSA	[TF] also directly interacts with the DNA binding domain of androgen receptor and enhances androgen-mediated activation of the [TG] promoter.	PDEF	PSA	1	ACTIVATION	False
3793	3817	10625666:8:androgen receptor:PSA	PDEF also directly interacts with the DNA binding domain of [TF] and enhances androgen-mediated activation of the [TG] promoter.	androgen receptor	PSA	1	ACTIVATION	True
3797	3821	10625666:8:androgen:PSA	PDEF also directly interacts with the DNA binding domain of androgen receptor and enhances [TF]-mediated activation of the [TG] promoter.	androgen	PSA	1	ACTIVATION	False
3801	3825	20731704:3:GATA3:DeltaEF1	In this study, we found that DeltaEF1 was positively regulated by T-lineage-specific transcriptional regulator GATA3, while ectopically expressed LMO2 targeted to DeltaEF1 promoter by interaction with [TF] and inhibited [TG] expression in transcriptional level.	GATA3	DeltaEF1	2	REPRESSION	True
3804	3828	16109714:0:Nuclear factor of activated T cells c1:osteoclast-associated receptor	[TF] induces [TG] gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.	Nuclear factor of activated T cells c1	osteoclast-associated receptor	1	ACTIVATION	False
3813	3837	16109714:0:microphthalmia transcription factor:OSCAR	Furthermore, NFATc1 synergistically activates an [TG] reporter construct together with [TF] and PU.1,	microphthalmia transcription factor	OSCAR	1	ACTIVATION	False
3816	3840	16109714:0:PU.1:OSCAR	Furthermore, NFATc1 synergistically activates an [TG] reporter construct together with microphthalmia transcription factor and [TF],	PU.1	OSCAR	1	ACTIVATION	False
3821	3845	17297462:4:CDX2:IGFBP-3	Specifically, [TF] binds to the IGFBP-3 gene promoter and can repress [TG] transcription, protein expression and secretion.	CDX2	IGFBP-3	2	REPRESSION	False
3822	3846	11268217:0:AKNA:CD40	Here we describe [TF], a human AT-hook protein that directly binds the A/T-rich regulatory elements of the promoters of [TG] and CD40 ligand (CD40L) and coordinately regulates their expression.	AKNA	CD40	0	UNDEFINED	False
3823	3847	11268217:0:AKNA:CD40 ligand	Here we describe [TF], a human AT-hook protein that directly binds the A/T-rich regulatory elements of the promoters of CD40 and [TG] (CD40L) and coordinately regulates their expression.	AKNA	CD40 ligand	0	UNDEFINED	False
3824	3848	11268217:0:AKNA:CD40L	Here we describe [TF], a human AT-hook protein that directly binds the A/T-rich regulatory elements of the promoters of CD40 and CD40 ligand ([TG]) and coordinately regulates their expression.	AKNA	CD40L	0	UNDEFINED	False
3825	3849	16880529:0:Gli2:bone morphogenetic protein 2	The zinc finger transcription factor [TF] mediates [TG] expression in osteoblasts in response to hedgehog signaling.	Gli2	bone morphogenetic protein 2	1	ACTIVATION	True
3827	3851	16880529:0:Gli2:BMP-2	Taken together, these results indicate that [TF] mediates hedgehog signaling in osteoblasts and is a powerful activator of [TG] gene expression, which is required in turn for normal osteoblast differentiation.	Gli2	BMP-2	1	ACTIVATION	False
3831	3855	16880529:0:Gli2.:BMP-2	Finally, Sonic hedgehog (Shh) stimulates [TG] promoter activity and osteoblast differentiation, and the effects of Shh are mediated by [TF]	Gli2.	BMP-2	1	ACTIVATION	False
3832	3856	16081584:0:androgen receptor:PSA	Decoy androgen-responsive element DNA can inhibit [TF] transactivation of the [TG] promoter gene.	androgen receptor	PSA	1	ACTIVATION	False
3835	3859	16081584:0:androgen:PSA	Decoy [TF]-responsive element DNA can inhibit androgen receptor transactivation of the [TG] promoter gene.	androgen	PSA	1	ACTIVATION	True
3836	3860	12244173:0:Lymphoid enhancer-binding factor-1:recombination-activating gene-2	[TF] binds and activates the [TG] promoter together with c-Myb and Pax-5 in immature B cells.	Lymphoid enhancer-binding factor-1	recombination-activating gene-2	1	ACTIVATION	False
3840	3864	12244173:0:c-Myb:recombination-activating gene-2	Lymphoid enhancer-binding factor-1 binds and activates the [TG] promoter together with [TF] and Pax-5 in immature B cells.	c-Myb	recombination-activating gene-2	1	ACTIVATION	False
3843	3867	12244173:0:Pax-5:recombination-activating gene-2	Lymphoid enhancer-binding factor-1 binds and activates the [TG] promoter together with c-Myb and [TF] in immature B cells.	Pax-5	recombination-activating gene-2	1	ACTIVATION	False
3847	3872	12244173:0:LEF-1:RAG-2 promoter	Finally, we demonstrated that a dominant-negative [TF] protein, which lacks the binding site for beta-catenin, suppressed the [TG] activity as well as the endogenous RAG-2 expression in a pre-B cell line (18.81).	LEF-1	RAG-2 promoter	1	ACTIVATION	True
3858	3885	12244173:0:Pax-5:RAG-2 promoter	We studied the regulation of murine RAG-2 promoter and revealed that -41/-17 RAG-2 promoter region, which was indispensable for the [TG] activity in B cell lines, contained binding sites for lymphoid enhancer-binding factor-1 (LEF-1), c-Myb, and [TF].	Pax-5	RAG-2 promoter	1	ACTIVATION	True
3861	3888	12244173:0:LEF-1:RAG-2 promoter,	Cotransfection assays using a human embryonic kidney cell line (293T) showed that [TF], c-Myb, and Pax-5 cooperatively activated the [TG] via their synergistic DNA binding.	LEF-1	RAG-2 promoter,	1	ACTIVATION	False
3862	3889	12244173:0:c-Myb:RAG-2 promoter,	Cotransfection assays using a human embryonic kidney cell line (293T) showed that LEF-1, [TF], and Pax-5 cooperatively activated the [TG] via their synergistic DNA binding.	c-Myb	RAG-2 promoter,	1	ACTIVATION	False
3863	3890	12244173:0:Pax-5:RAG-2 promoter,	Cotransfection assays using a human embryonic kidney cell line (293T) showed that LEF-1, c-Myb, and [TF] cooperatively activated the [TG] via their synergistic DNA binding.	Pax-5	RAG-2 promoter,	1	ACTIVATION	False
3873	3900	12954631:10:Sp1:keratin 16	Taken together, these results suggest that Sp1 and AP1 sites in the essential promoter region are critical for EGF response, and [TF] showed a functional cooperation with c-Jun and coactivators p300/CBP in driving the transcriptional regulation of EGF-induced [TG] gene expression.	Sp1	keratin 16	1	ACTIVATION	True
3883	3910	12954631:10:c-Jun:keratin 16	Taken together, these results suggest that Sp1 and AP1 sites in the essential promoter region are critical for EGF response, and Sp1 showed a functional cooperation with [TF] and coactivators p300/CBP in driving the transcriptional regulation of EGF-induced [TG] gene expression.	c-Jun	keratin 16	1	ACTIVATION	True
3911	3938	19341811:7:CLOCK:Per1	These include (1) coordinated phasing of expression of Rev-erb alpha, Per1, Cry1 and Bmal1 as assessed by real-time luciferase assays, (2) [TF]/BMAL1 transactivation at the [TG] and Rev-erb alpha promoters, (3) repression of CLOCK/BMAL1 by CRY1-2 and CIPC, (4) a role for REV-ERB alpha in inhibiting Bmal1 and Rev-erb alpha transcription.	CLOCK	Per1	1	ACTIVATION	False
3931	3958	19341811:7:REV-ERB alpha:Bmal1	These include (1) coordinated phasing of expression of Rev-erb alpha, Per1, Cry1 and Bmal1 as assessed by real-time luciferase assays, (2) CLOCK/BMAL1 transactivation at the Per1 and Rev-erb alpha promoters, (3) repression of CLOCK/BMAL1 by CRY1-2 and CIPC, (4) a role for [TF] in inhibiting [TG] and Rev-erb alpha transcription.	REV-ERB alpha	Bmal1	2	REPRESSION	False
3936	3963	19341811:7:REV-ERB alpha:Rev-erb alpha	These include (1) coordinated phasing of expression of Rev-erb alpha, Per1, Cry1 and Bmal1 as assessed by real-time luciferase assays, (2) CLOCK/BMAL1 transactivation at the Per1 and Rev-erb alpha promoters, (3) repression of CLOCK/BMAL1 by CRY1-2 and CIPC, (4) a role for [TF] in inhibiting Bmal1 and [TG] transcription.	REV-ERB alpha	Rev-erb alpha	2	REPRESSION	False
3937	3964	22405968:2:p53:osteocalcin	In previous studies we have shown osteosarcomas to lose [TF] function with a corresponding loss of [TG] gene expression.	p53	osteocalcin	1	ACTIVATION	True
3938	3965	10554042:7:Ets-1:Flt-1	In vitro data also point to a role of [TF] as a transcriptional activator of [TG].	Ets-1	Flt-1	1	ACTIVATION	False
3940	3967	16339279:8:NF-kappaB:PR	Chromatin immunoprecipitation analysis revealed IL-1beta induced binding of [TF] to the [TG] promoter.	NF-kappaB	PR	0	UNDEFINED	False
3945	3972	15833715:0:C/EBPdelta:beta-globin	In reporter assays, we show that [TF] can co-operate with EKLF, a CACC-box binding protein, to activate the [TG] promoter, whereas C/EBPgamma inhibits the transcriptional activity of EKLF in this assay.	C/EBPdelta	beta-globin	1	ACTIVATION	False
3948	3975	15833715:0:C/EBPgamma:beta-globin	In reporter assays, we show that C/EBPdelta can co-operate with EKLF, a CACC-box binding protein, to activate the [TG] promoter, whereas [TF] inhibits the transcriptional activity of EKLF in this assay.	C/EBPgamma	beta-globin	2	REPRESSION	False
3955	3982	15833715:0:NF-Y:beta-globin	DNA-binding assays previously identified [TF], GATA-1, C/EBPbeta and C/EBPgamma as candidate regulators of [TG] transcription via the CCAAT-box, a promoter element situated between CACC- and TATA-boxes.	NF-Y	beta-globin	0	UNDEFINED	False
3959	3986	15833715:0:GATA-1:beta-globin	DNA-binding assays previously identified NF-Y, [TF], C/EBPbeta and C/EBPgamma as candidate regulators of [TG] transcription via the CCAAT-box, a promoter element situated between CACC- and TATA-boxes.	GATA-1	beta-globin	0	UNDEFINED	False
3963	3990	15833715:0:C/EBPbeta:beta-globin	DNA-binding assays previously identified NF-Y, GATA-1, [TF] and C/EBPgamma as candidate regulators of [TG] transcription via the CCAAT-box, a promoter element situated between CACC- and TATA-boxes.	C/EBPbeta	beta-globin	0	UNDEFINED	False
3969	3996	15833715:0:EKLF,:beta-globin	In reporter assays, we show that C/EBPdelta can co-operate with [TF] a CACC-box binding protein, to activate the [TG] promoter, whereas C/EBPgamma inhibits the transcriptional activity of EKLF in this assay.	EKLF,	beta-globin	1	ACTIVATION	False
3981	4008	17438126:7:p50:YY1	NF-kappaB regulation of YY1 occurred at the transcriptional level, mediated by direct binding of the [TF]/p65 heterodimer complex to the [TG] promoter.	p50	YY1	0	UNDEFINED	False
3984	4011	17438126:7:p65:YY1	NF-kappaB regulation of YY1 occurred at the transcriptional level, mediated by direct binding of the p50/[TF] heterodimer complex to the [TG] promoter.	p65	YY1	0	UNDEFINED	False
3990	4017	10914736:10:p16:hTERT	These findings suggest that 5-aza-CR inhibits telomerase activity via transcriptional repression of [TG], in which [TF] and c-Myc may play a key role.	p16	hTERT	2	REPRESSION	False
3993	4020	10914736:10:c-Myc:hTERT	These findings suggest that 5-aza-CR inhibits telomerase activity via transcriptional repression of [TG], in which p16 and [TF] may play a key role.	c-Myc	hTERT	2	REPRESSION	False
3997	4024	19095772:10:Egr-1:LHbeta	MG-132 disrupted GnRH-induced [TF] and SF-1 binding and prevented phosphorylated RNA polymerase II association with the [TG] promoter.	Egr-1	LHbeta	0	UNDEFINED	False
4001	4028	19095772:10:SF-1:LHbeta	MG-132 disrupted GnRH-induced Egr-1 and [TF] binding and prevented phosphorylated RNA polymerase II association with the [TG] promoter.	SF-1	LHbeta	0	UNDEFINED	False
4004	4031	12810599:0:Brn3a:TrkA	Thus, [TG], a gene that is crucial for the differentiation and survival of sensory nociceptive neurons, requires [TF] to maintain normal transcriptional activity.	Brn3a	TrkA	1	ACTIVATION	True
4005	4032	12810599:0:Brn3a:NGF receptor	[TF] regulation of TrkA/[TG] expression in developing sensory neurons.	Brn3a	NGF receptor	0	UNDEFINED	False
4006	4033	16181749:13:E2F1:PNRC2	Transient transfections and luciferase assays further revealed that overexpression of NFY enhanced-promoter activity of PNRC2 gene in a dose-dependent manner while overexpression of [TF] strongly repressed the activity of the [TG] promoter.	E2F1	PNRC2	2	REPRESSION	False
4012	4039	12122114:5:ERalpha:TERT	Crucially, addition of the anti-estrogen 4-hydroxytamoxifen caused a differential recruitment in vivo of [TF] and ERbeta onto the h[TG] promoter and inhibited telomerase activity.	ERalpha	TERT	0	UNDEFINED	False
4016	4043	12122114:5:ERbeta:TERT	Crucially, addition of the anti-estrogen 4-hydroxytamoxifen caused a differential recruitment in vivo of ERalpha and [TF] onto the h[TG] promoter and inhibited telomerase activity.	ERbeta	TERT	0	UNDEFINED	False
4020	4047	12122114:5:4-hydroxytamoxifen:TERT	Crucially, addition of the anti-estrogen [TF] caused a differential recruitment in vivo of ERalpha and ERbeta onto the h[TG] promoter and inhibited telomerase activity.	4-hydroxytamoxifen	TERT	0	UNDEFINED	True
4021	4048	12122114:5:4-hydroxytamoxifen:telomerase	Crucially, addition of the anti-estrogen [TF] caused a differential recruitment in vivo of ERalpha and ERbeta onto the hTERT promoter and inhibited [TG] activity.	4-hydroxytamoxifen	telomerase	1	ACTIVATION	True
4022	4049	19505873:8:AP-4:HDM2	Importantly, inclusion of trichostatin A did not alleviate [TF]-mediated repression of [TG] transcription, suggesting a previously unidentified histone deacetylase-independent repression mechanism.	AP-4	HDM2	2	REPRESSION	False
4023	4050	16670091:9:FOXO1:PPARgamma	We suggest a novel paradigm to increase insulin sensitivity in adipocytes in which [TF] repression of [TG], the latter being a repressor of the GLUT4 promoter, consequently leads to GLUT4 derepression/up-regulation, thus enhancing cellular insulin sensitivity.	FOXO1	PPARgamma	2	REPRESSION	False
4024	4051	16670091:9:FOXO1:GLUT4	We suggest a novel paradigm to increase insulin sensitivity in adipocytes in which [TF] repression of PPARgamma, the latter being a repressor of the GLUT4 promoter, consequently leads to [TG] derepression/up-regulation, thus enhancing cellular insulin sensitivity.	FOXO1	GLUT4	1	ACTIVATION	True
4026	4053	16670091:9:PPARgamma:GLUT4	We suggest a novel paradigm to increase insulin sensitivity in adipocytes in which FOXO1 repression of [TF], the latter being a repressor of the GLUT4 promoter, consequently leads to [TG] derepression/up-regulation, thus enhancing cellular insulin sensitivity.	PPARgamma	GLUT4	2	REPRESSION	True
4038	4065	10723141:0:Mad:telomerase	Identification of [TF] as a repressor of the human [TG] (hTERT) gene.	Mad	telomerase	2	REPRESSION	False
4039	4066	10723141:0:Mad:hTERT	Thus, [TF] may be a direct negative regulator of [TG] in mortal cells and this repression mechanism can be inhibited by induction of Myc in immortal cells.	Mad	hTERT	2	REPRESSION	False
4042	4069	10723141:0:Myc:hTERT	Thus, Mad may be a direct negative regulator of [TG] in mortal cells and this repression mechanism can be inhibited by induction of [TF] in immortal cells.	Myc	hTERT	1	ACTIVATION	True
4046	4073	16793932:8:HNF1beta:hOAT3	Moreover, the expression of hOAT3 was activated de novo by forced expression of HNF1alpha alone or both HNF1alpha and HNF1beta together with the concomitant DNA demethylation in human embryonic kidney 293 cells that lack expression of endogenous HNF1alpha and HNF1beta, whereas forced expression of [TF] alone could not activate the expression of [TG].	HNF1beta	hOAT3	1	ACTIVATION	False
4051	4078	10797313:3:Smad3:COL1A2	In the present study, we establish the functional requirement for endogenous [TF] and Smad4 in TGF-beta-stimulated [TG] transcription in human skin fibroblasts in vitro.	Smad3	COL1A2	1	ACTIVATION	False
4054	4081	10797313:3:Smad4:COL1A2	In the present study, we establish the functional requirement for endogenous Smad3 and [TF] in TGF-beta-stimulated [TG] transcription in human skin fibroblasts in vitro.	Smad4	COL1A2	1	ACTIVATION	False
4070	4097	16782888:7:RARalpha:RARbeta	Overexpressed BTG2 increases PRMT1 participation in the [TF] protein complex on the [TG] promoter, a target gene model, and enhances gene-specific histone H4 arginine methylation.	RARalpha	RARbeta	0	UNDEFINED	False
4074	4101	19028685:1:SAF-1:MMP-1	Previously we determined that inflammation responsive transcription factors AP-1 and [TF] synergistically regulate transcriptional induction of the [TG] gene.	SAF-1	MMP-1	1	ACTIVATION	False
4077	4104	19028685:1:AP-1:MMP-1	Previously we determined that inflammation responsive transcription factors [TF] and SAF-1 synergistically regulate transcriptional induction of the [TG] gene.	AP-1	MMP-1	1	ACTIVATION	False
4080	4107	15862945:11:AP-1:hIR	These data provide the first identification of EREs complexed with [TF]-like sites in the [TG] promoter, which account for the transcriptional repression of the hIR gene mediated by ERbeta in U-937 cells.	AP-1	hIR	0	UNDEFINED	True
4082	4109	9261181:5:GATA-3:IL-5	Whereas mutations in the [TF] site abolished antigen- or cAMP-stimulated [TG] promoter activation in Th2 cells, ectopic expression of GATA-3 in Th1 cells or in a non-lymphoid, non-IL-5-producing cell line activated the IL-5 promoter.	GATA-3	IL-5	1	ACTIVATION	True
4085	4112	22988032:8:KLF2:CCR5	Introduction of [TF] under control of a heterologous promoter could restore [TG] expression and R5 susceptibility to CD3/28 costimulated T cells and some transformed cell lines.	KLF2	CCR5	1	ACTIVATION	False
4086	4113	15466360:5:glucocorticoid receptor:p21	We show that amlodipine-dependent activation of [TG](Waf1/Cip1) involves the action of the [TF] (GR) and C/EBP-alpha.	glucocorticoid receptor	p21	1	ACTIVATION	False
4087	4114	15466360:5:glucocorticoid receptor:Waf1	We show that amlodipine-dependent activation of p21([TG]/Cip1) involves the action of the [TF] (GR) and C/EBP-alpha.	glucocorticoid receptor	Waf1	1	ACTIVATION	False
4088	4115	15466360:5:glucocorticoid receptor:Cip1	We show that amlodipine-dependent activation of p21(Waf1/[TG]) involves the action of the [TF] (GR) and C/EBP-alpha.	glucocorticoid receptor	Cip1	1	ACTIVATION	False
4091	4118	15466360:5:GR:p21	We show that amlodipine-dependent activation of [TG](Waf1/Cip1) involves the action of the glucocorticoid receptor ([TF]) and C/EBP-alpha.	GR	p21	1	ACTIVATION	False
4092	4119	15466360:5:GR:Waf1	We show that amlodipine-dependent activation of p21([TG]/Cip1) involves the action of the glucocorticoid receptor ([TF]) and C/EBP-alpha.	GR	Waf1	1	ACTIVATION	False
4093	4120	15466360:5:GR:Cip1	We show that amlodipine-dependent activation of p21(Waf1/[TG]) involves the action of the glucocorticoid receptor ([TF]) and C/EBP-alpha.	GR	Cip1	1	ACTIVATION	False
4096	4123	15466360:5:C/EBP-alpha:p21	We show that amlodipine-dependent activation of [TG](Waf1/Cip1) involves the action of the glucocorticoid receptor (GR) and [TF].	C/EBP-alpha	p21	1	ACTIVATION	False
4097	4124	15466360:5:C/EBP-alpha:Waf1	We show that amlodipine-dependent activation of p21([TG]/Cip1) involves the action of the glucocorticoid receptor (GR) and [TF].	C/EBP-alpha	Waf1	1	ACTIVATION	False
4098	4125	15466360:5:C/EBP-alpha:Cip1	We show that amlodipine-dependent activation of p21(Waf1/[TG]) involves the action of the glucocorticoid receptor (GR) and [TF].	C/EBP-alpha	Cip1	1	ACTIVATION	False
4101	4129	12525489:0:activator protein 1:Timp-1	We report that the promoter-proximal [TF] (AP1) site is essential for the response of both [TG] and MMP-1 to TGF-beta (induction and repression, respectively).	activator protein 1	Timp-1	0	UNDEFINED	True
4102	4130	12525489:0:activator protein 1:MMP-1	We report that the promoter-proximal [TF] (AP1) site is essential for the response of both Timp-1 and [TG] to TGF-beta (induction and repression, respectively).	activator protein 1	MMP-1	2	REPRESSION	True
4103	4135	12525489:0:Smad:Timp-1	Smad-containing complexes do not interact with the Timp-1 AP1 site, and overexpression of Smads does not substitute or potentiate the induction of the gene by TGF-beta1; furthermore, [TG] is still induced by TGF-beta1 in [TF] knockout cell lines, although to varying extents.	Smad	Timp-1	1	ACTIVATION	True
4111	4147	12525489:0:AP1:MMP-1	In contrast, Smads do interact with the MMP-1 [TF] site and mediate repression of induced [TG] gene expression by TGF-beta1.	AP1	MMP-1	2	REPRESSION	True
4144	4180	15557560:9:PXR:UGT1A1	Together, these results demonstrate a rational mechanistic basis for UGT1A1 induction by glucocorticoids and PXR activators, showing that activated GR enhances CAR/PXR-mediated UGT1A1 regulation with the transcriptional cofactor GRIP1 and that GR may be involved synergistically in the xenobiotic-responsive regulation of [TG] by CAR/[TF].	PXR	UGT1A1	0	UNDEFINED	True
4155	4191	15557560:9:GR:UGT1A1	Together, these results demonstrate a rational mechanistic basis for UGT1A1 induction by glucocorticoids and PXR activators, showing that activated GR enhances CAR/PXR-mediated UGT1A1 regulation with the transcriptional cofactor GRIP1 and that [TF] may be involved synergistically in the xenobiotic-responsive regulation of [TG] by CAR/PXR.	GR	UGT1A1	0	UNDEFINED	False
4161	4197	15557560:9:CAR:UGT1A1	Together, these results demonstrate a rational mechanistic basis for UGT1A1 induction by glucocorticoids and PXR activators, showing that activated GR enhances CAR/PXR-mediated UGT1A1 regulation with the transcriptional cofactor GRIP1 and that GR may be involved synergistically in the xenobiotic-responsive regulation of [TG] by [TF]/PXR.	CAR	UGT1A1	0	UNDEFINED	False
4168	4204	24242046:8:STAT1:PPARa	Overexpression of [TF] and STAT3 in HepG2 cells cotransfected with a reporter vector containing this PPARa promoter region revealed that both the expression plasmids inhibited the IL-6-induced repression of [TG] promoter activity.	STAT1	PPARa	1	ACTIVATION	True
4171	4207	24242046:8:STAT3:PPARa	Overexpression of STAT1 and [TF] in HepG2 cells cotransfected with a reporter vector containing this PPARa promoter region revealed that both the expression plasmids inhibited the IL-6-induced repression of [TG] promoter activity.	STAT3	PPARa	1	ACTIVATION	True
4180	4216	16140944:0:BORIS:NY-ESO-1	Cotransfection experiments using promoter-reporter constructs confirmed that [TF] modulates [TG] expression in lung cancer cells.	BORIS	NY-ESO-1	0	UNDEFINED	False
4182	4218	11034547:10:Arix:DBH	The N-terminal segment of [TF] is essential for transcriptional regulatory activity, and this region bears 50% identity with NBPhox, suggesting a similar mechanism of transcriptional activation of the [TG] gene.	Arix	DBH	1	ACTIVATION	False
4184	4220	11034547:10:NBPhox:DBH	The N-terminal segment of Arix is essential for transcriptional regulatory activity, and this region bears 50% identity with [TF], suggesting a similar mechanism of transcriptional activation of the [TG] gene.	NBPhox	DBH	1	ACTIVATION	True
4185	4221	20805247:7:E2F1:MEF	Subsequently, we determined that [TF] specifically binds to MEF promoter and transactivates [TG].	E2F1	MEF	1	ACTIVATION	False
4188	4224	14645533:0:nuclear factor IL-6:COX-2 promoter	By transfection with various [TG] reporter constructs, we found that the bp -327-to-+59 promoter region was essential for COX-2 gene transcription by bradykinin and IL-1beta and that the cyclic AMP response element (CRE) was critical in bradykinin-induced transcription, whereas [TF] and CRE and, to a lesser extent, nuclear factor-kappaB (NF-kappaB) were involved in IL-1beta-induced transcription.	nuclear factor IL-6	COX-2 promoter	0	UNDEFINED	True
4189	4225	14645533:0:nuclear factor IL-6:COX-2	By transfection with various COX-2 promoter reporter constructs, we found that the bp -327-to-+59 promoter region was essential for [TG] gene transcription by bradykinin and IL-1beta and that the cyclic AMP response element (CRE) was critical in bradykinin-induced transcription, whereas [TF] and CRE and, to a lesser extent, nuclear factor-kappaB (NF-kappaB) were involved in IL-1beta-induced transcription.	nuclear factor IL-6	COX-2	1	ACTIVATION	False
4195	4231	14645533:0:nuclear factor-kappaB:COX-2	By transfection with various COX-2 promoter reporter constructs, we found that the bp -327-to-+59 promoter region was essential for [TG] gene transcription by bradykinin and IL-1beta and that the cyclic AMP response element (CRE) was critical in bradykinin-induced transcription, whereas nuclear factor IL-6 and CRE and, to a lesser extent, [TF] (NF-kappaB) were involved in IL-1beta-induced transcription.	nuclear factor-kappaB	COX-2	1	ACTIVATION	False
4201	4237	14645533:0:NF-kappaB:COX-2	An electrophoretic mobility shift assay revealed that both bradykinin and IL-1beta elicited CRE-binding protein-1 (CREB-1) binding, and IL-1beta also elicited CCAAT/enhancer-binding protein beta and [TF] binding to their respective elements in the [TG] promoter.	NF-kappaB	COX-2	0	UNDEFINED	False
4211	4247	14645533:0:CRE-binding protein-1:COX-2	An electrophoretic mobility shift assay revealed that both bradykinin and IL-1beta elicited [TF] (CREB-1) binding, and IL-1beta also elicited CCAAT/enhancer-binding protein beta and NF-kappaB binding to their respective elements in the [TG] promoter.	CRE-binding protein-1	COX-2	0	UNDEFINED	False
4217	4253	14645533:0:CREB-1:COX-2	An electrophoretic mobility shift assay revealed that both bradykinin and IL-1beta elicited CRE-binding protein-1 ([TF]) binding, and IL-1beta also elicited CCAAT/enhancer-binding protein beta and NF-kappaB binding to their respective elements in the [TG] promoter.	CREB-1	COX-2	0	UNDEFINED	False
4223	4259	14645533:0:CCAAT/enhancer-binding protein beta:COX-2	An electrophoretic mobility shift assay revealed that both bradykinin and IL-1beta elicited CRE-binding protein-1 (CREB-1) binding, and IL-1beta also elicited [TF] and NF-kappaB binding to their respective elements in the [TG] promoter.	CCAAT/enhancer-binding protein beta	COX-2	0	UNDEFINED	False
4227	4263	21532621:5:FoxO3a:CCNG2	Several putative Forkhead box class O (FoxO)3a-binding sites are present in the human CCNG2 promoter and overexpression of [TF] enhanced the [TG] promoter activity.	FoxO3a	CCNG2	1	ACTIVATION	False
4235	4271	16785237:4:Smad3:TERT	In human breast cancer cells TGF-beta induces rapid entry of [TF] into the nucleus where it binds to the TERT gene promoter and represses [TG] gene transcription.	Smad3	TERT	2	REPRESSION	False
4237	4273	8413215:9:NFKB1:IL-8	Furthermore, cotransfection of [TF] and RelA, although able to support activation from the human immunodeficiency virus type 1 long terminal repeat, failed to activate expression from the [TG] promoter.	NFKB1	IL-8	1	ACTIVATION	False
4239	4275	8413215:9:RelA:IL-8	Furthermore, cotransfection of NFKB1 and [TF], although able to support activation from the human immunodeficiency virus type 1 long terminal repeat, failed to activate expression from the [TG] promoter.	RelA	IL-8	1	ACTIVATION	False
4240	4276	22136275:6:E2F1:MCPH1	Overexpression of E2F1 led to the upregulation of MCPH1 transcription, and knocking down the endogenous [TF] resulted in the inhibition of the [TG] promoter activity.	E2F1	MCPH1	1	ACTIVATION	False
4245	4281	16940180:0:CREB3:Herp	Luman/[TF] induces transcription of the endoplasmic reticulum (ER) stress response protein [TG] through an ER stress response element.	CREB3	Herp	1	ACTIVATION	False
4258	4294	21625432:8:p65:PDK4	Chromatin immunoprecipitation analyses demonstrated that [TF] translocation into the nucleus prevented the recruitment of E2F1 to the [TG] promoter and its subsequent E2F1-dependent gene transcription.	p65	PDK4	2	REPRESSION	True
4260	4296	21625432:8:E2F1:PDK4	Chromatin immunoprecipitation analyses demonstrated that p65 translocation into the nucleus prevented the recruitment of [TF] to the [TG] promoter and its subsequent E2F1-dependent gene transcription.	E2F1	PDK4	1	ACTIVATION	False
4262	4298	17408383:0:hepatocyte nuclear factor 3beta:pyruvate carboxylase	Transcriptional regulation of the distal promoter of the rat [TG] gene by [TF]/Foxa2 and upstream stimulatory factors in insulinoma cells.	hepatocyte nuclear factor 3beta	pyruvate carboxylase	0	UNDEFINED	False
4264	4300	17408383:0:Foxa2:pyruvate carboxylase	Transcriptional regulation of the distal promoter of the rat [TG] gene by hepatocyte nuclear factor 3beta/[TF] and upstream stimulatory factors in insulinoma cells.	Foxa2	pyruvate carboxylase	0	UNDEFINED	False
4304	4340	17408383:0:PDX1:PC	Although there are weak binding sites located at regions -904 and -572 for [TF] (pancreatic duodenal homeobox-1), a transcription factor that controls expression of beta-cell-specific genes, it did not appear to regulate [TG] expression in INS-1 cells in the context of the 1.2 kb promoter fragment.	PDX1	PC	0	UNDEFINED	False
4307	4343	17408383:0:pancreatic duodenal homeobox-1:PC	Although there are weak binding sites located at regions -904 and -572 for PDX1 ([TF]), a transcription factor that controls expression of beta-cell-specific genes, it did not appear to regulate [TG] expression in INS-1 cells in the context of the 1.2 kb promoter fragment.	pancreatic duodenal homeobox-1	PC	0	UNDEFINED	False
4312	4348	17408383:0:Foxa2:PC	The results presented here show that [TF] and USFs regulate the distal promoter of the rat [TG] gene in a cell-specific manner.	Foxa2	PC	0	UNDEFINED	False
4314	4350	15181096:10:DAX-1:StAR	[TF] inhibited LRH-1-stimulated [TG] promoter activity in a concentration-dependent manner.	DAX-1	StAR	2	REPRESSION	False
4316	4352	15181096:10:LRH-1:StAR	DAX-1 inhibited [TF]-stimulated [TG] promoter activity in a concentration-dependent manner.	LRH-1	StAR	1	ACTIVATION	False
4317	4353	19127412:8:Foxa1:bcl2	Luciferase reporter showed that [TF] also decreased the transcription activity of [TG] promoter under normal conditions and oxidative stress.	Foxa1	bcl2	2	REPRESSION	False
4319	4355	11145590:10:Pax-8:TG	Overexpression of [TF] abolished the TGF-beta1 suppression of [TG] promoter activity.	Pax-8	TG	1	ACTIVATION	False
4321	4357	1374362:3:IRF-1:MHC class I	These data suggest that [TF] is involved in the IFN-gamma mediated induction of [TG] expression.	IRF-1	MHC class I	1	ACTIVATION	False
4323	4359	15716956:0:Mitf:p21	The results indicate that [TF]-mediated activation of [TG]Cip1 expression and consequent hypophosphorylation of Rb1 will contribute to cell cycle exit and activation of the differentiation programme.	Mitf	p21	1	ACTIVATION	False
4324	4360	15716956:0:Mitf:Cip1	The results indicate that [TF]-mediated activation of p21[TG] expression and consequent hypophosphorylation of Rb1 will contribute to cell cycle exit and activation of the differentiation programme.	Mitf	Cip1	1	ACTIVATION	False
4328	4364	15716956:0:Mitf:CDKN1A	Here we show that Mitf can act as a novel anti-proliferative transcription factor able to induce a G1 cell-cycle arrest that is dependent on [TF]-mediated activation of the p21(Cip1) ([TG]) cyclin-dependent kinase inhibitor gene.	Mitf	CDKN1A	1	ACTIVATION	False
4329	4365	15716956:0:Mitf:cyclin-dependent kinase inhibitor	Here we show that Mitf can act as a novel anti-proliferative transcription factor able to induce a G1 cell-cycle arrest that is dependent on [TF]-mediated activation of the p21(Cip1) (CDKN1A) [TG] gene.	Mitf	cyclin-dependent kinase inhibitor	1	ACTIVATION	False
4334	4370	8637719:0:Mxi1:ornithine decarboxylase	Overexpression of [TF] inhibits the induction of the human [TG] gene by the Myc/Max protein complex.	Mxi1	ornithine decarboxylase	2	REPRESSION	False
4338	4374	8637719:0:Myc:ornithine decarboxylase	Overexpression of Mxi1 inhibits the induction of the human [TG] gene by the [TF]/Max protein complex.	Myc	ornithine decarboxylase	1	ACTIVATION	False
4341	4377	8637719:0:Max:ornithine decarboxylase	Overexpression of Mxi1 inhibits the induction of the human [TG] gene by the Myc/[TF] protein complex.	Max	ornithine decarboxylase	1	ACTIVATION	False
4343	4379	18640093:7:FOXP1:PSA	Notably, we demonstrate that FOXP1 directly interacts with AR and negatively regulates AR signaling ligand-dependently, as exemplified by the transcriptional repression of [TG] gene regulated by androgen-dependent [TF] recruitment on its enhancer region.	FOXP1	PSA	2	REPRESSION	False
4348	4384	18640093:7:AR:PSA	Notably, we demonstrate that FOXP1 directly interacts with AR and negatively regulates [TF] signaling ligand-dependently, as exemplified by the transcriptional repression of [TG] gene regulated by androgen-dependent FOXP1 recruitment on its enhancer region.	AR	PSA	0	UNDEFINED	True
4352	4388	18640093:7:androgen:PSA	Notably, we demonstrate that FOXP1 directly interacts with AR and negatively regulates AR signaling ligand-dependently, as exemplified by the transcriptional repression of [TG] gene regulated by [TF]-dependent FOXP1 recruitment on its enhancer region.	androgen	PSA	2	REPRESSION	False
4355	4391	11559575:5:p53:VPF	[TF] significantly inhibited the transcription of [TG]/VEGF involving the transcription factor Sp1.	p53	VPF	2	REPRESSION	False
4356	4392	11559575:5:p53:VEGF	[TF] significantly inhibited the transcription of VPF/[TG] involving the transcription factor Sp1.	p53	VEGF	2	REPRESSION	False
4359	4396	11559575:5:Sp1:VEGF	p53 significantly inhibited the transcription of VPF/[TG] involving the transcription factor [TF].	Sp1	VEGF	2	REPRESSION	True
4360	4397	17692454:3:MR:EGFR	Both enhanced EGFR transactivation by activated MR as well as upregulation of [TG] expression by aldosterone-bound [TF] have been described.	MR	EGFR	1	ACTIVATION	False
4363	4400	17692454:3:aldosterone:EGFR	Both enhanced EGFR transactivation by activated MR as well as upregulation of [TG] expression by [TF]-bound MR have been described.	aldosterone	EGFR	1	ACTIVATION	True
4369	4406	19736394:0:Gli1:insulin-like growth factor binding protein 6	MATERIALS AND METHODS: We studied the relationship of Shh-Gli1 signaling pathway with proliferation and apoptosis of pancreatic cancer cells and the regulation of transcription factor [TF] to [TG] (IGFBP6) and Bcl-2 genes at the level of transcription.	Gli1	insulin-like growth factor binding protein 6	0	UNDEFINED	False
4380	4417	16636146:6:Ovol1:c-myc	We present molecular evidence that c-myc expression is up-regulated in Ovol1-deficient suprabasal cells and that [TF] represses [TG] transcription by directly binding to its promoter.	Ovol1	c-myc	2	REPRESSION	False
4389	4426	23803610:6:FOXO1:TXNIP	Moreover, [TF] blocked glucose-induced [TG] expression and reduced glucose-induced ChREBP binding at the TXNIP promoter without affecting ChREBP expression or nuclear localization, suggesting that FOXO1 may compete with ChREBP for binding to the TXNIP promoter.	FOXO1	TXNIP	2	REPRESSION	True
4393	4430	23803610:6:ChREBP:TXNIP	Moreover, FOXO1 blocked glucose-induced TXNIP expression and reduced glucose-induced ChREBP binding at the TXNIP promoter without affecting ChREBP expression or nuclear localization, suggesting that FOXO1 may compete with [TF] for binding to the [TG] promoter.	ChREBP	TXNIP	0	UNDEFINED	False
4397	4434	20067416:4:c-maf:MMP13	Using transient transfection system with an c-maf construct, and MMP-13 promoter-luciferase constructs with specific mutations in transcription factor binding sites, we found that c-maf can significantly enhance MMP-13 promoter activity via the AP-1 site, By gene suppression with RNAi technology, we could show that [TF] downregulation leads to a reduced expression of [TG].	c-maf	MMP13	1	ACTIVATION	False
4402	4439	19932681:0:PPARgamma:Adiponectin	[TG] is expressed in adipose tissue by adipogenic transcription factors including [TF], C/EBPalpha, and ADD1/SREBP1c.	PPARgamma	Adiponectin	1	ACTIVATION	False
4406	4443	19932681:0:C/EBPalpha:Adiponectin	[TG] is expressed in adipose tissue by adipogenic transcription factors including PPARgamma, [TF], and ADD1/SREBP1c.	C/EBPalpha	Adiponectin	1	ACTIVATION	False
4410	4447	19932681:0:ADD1:Adiponectin	[TG] is expressed in adipose tissue by adipogenic transcription factors including PPARgamma, C/EBPalpha, and [TF]/SREBP1c.	ADD1	Adiponectin	1	ACTIVATION	False
4414	4451	19932681:0:SREBP1c:Adiponectin	[TG] is expressed in adipose tissue by adipogenic transcription factors including PPARgamma, C/EBPalpha, and ADD1/[TF].	SREBP1c	Adiponectin	1	ACTIVATION	False
4421	4458	19932681:0:CREB:adiponectin promoter	Insulin-like growth factor (IGF-1), which activate [TF], increased the [TG] activity.	CREB	adiponectin promoter	1	ACTIVATION	True
4426	4463	19932681:0:ATF3:adiponectin	Importantly, the transactivation of [TG] expression by CREB was inhibited by [TF].	ATF3	adiponectin	2	REPRESSION	False
4431	4468	22849349:7:NF-kB:E-selectin	Importantly, although NF-kB activation by PKCe induced cytoprotective genes, it did not up-regulate pro-inflammatory [TF] targets [[TG], VCAM-1 (vascular cell adhesion molecule 1) and ICAM-1 (intercellular adhesion molecule 1)].	NF-kB	E-selectin	0	UNDEFINED	True
4432	4469	22849349:7:NF-kB:VCAM-1	Importantly, although NF-kB activation by PKCe induced cytoprotective genes, it did not up-regulate pro-inflammatory [TF] targets [E-selectin, [TG] (vascular cell adhesion molecule 1) and ICAM-1 (intercellular adhesion molecule 1)].	NF-kB	VCAM-1	0	UNDEFINED	True
4433	4470	22849349:7:NF-kB:vascular cell adhesion molecule 1	Importantly, although NF-kB activation by PKCe induced cytoprotective genes, it did not up-regulate pro-inflammatory [TF] targets [E-selectin, VCAM-1 ([TG]) and ICAM-1 (intercellular adhesion molecule 1)].	NF-kB	vascular cell adhesion molecule 1	1	ACTIVATION	False
4434	4471	22849349:7:NF-kB:ICAM-1	Importantly, although NF-kB activation by PKCe induced cytoprotective genes, it did not up-regulate pro-inflammatory [TF] targets [E-selectin, VCAM-1 (vascular cell adhesion molecule 1) and [TG] (intercellular adhesion molecule 1)].	NF-kB	ICAM-1	1	ACTIVATION	False
4435	4472	22849349:7:NF-kB:intercellular adhesion molecule 1	Importantly, although NF-kB activation by PKCe induced cytoprotective genes, it did not up-regulate pro-inflammatory [TF] targets [E-selectin, VCAM-1 (vascular cell adhesion molecule 1) and ICAM-1 ([TG])].	NF-kB	intercellular adhesion molecule 1	0	UNDEFINED	True
4439	4476	18440323:4:Sp1:MCAK	Cotransfection of the luciferase reporter with either Sp1- or E2F1-expression plasmid further verified the role of [TF] as a transcriptional activator and E2F1 as a transcriptional repressor in the human [TG] promoter.	Sp1	MCAK	1	ACTIVATION	False
4442	4479	18440323:4:E2F1:MCAK	Cotransfection of the luciferase reporter with either Sp1- or E2F1-expression plasmid further verified the role of Sp1 as a transcriptional activator and [TF] as a transcriptional repressor in the human [TG] promoter.	E2F1	MCAK	2	REPRESSION	False
4444	4481	16547409:9:SF-1:CYP19	When a luciferase promoter assay in HEK 293 cells was carried out to examine the ability of SF-1 as a transcriptional regulator, we found that R. rugosa [TF] stimulated the expression of the [TG] gene of the tilapia Oreochromis niloticus, but not that of the frogs R. rugosa and Xenopus laevis.	SF-1	CYP19	1	ACTIVATION	False
4448	4485	15879363:12:SF-1:hACTH-R	Mutation of the [TF]-binding sites within the [TG] promoter resulted in reduced or abolished DAX-1 inhibition, arguing for a mechanism that involves SF-1 for DAX-1 inhibition.	SF-1	hACTH-R	0	UNDEFINED	True
4456	4493	15611668:3:p53:MKP1	Here, we identify an additional [TF] responsive element located in the third exon of the [TG] gene.	p53	MKP1	0	UNDEFINED	False
4457	4494	15591138:5:PPAR delta:HSD11B2	Taken together, these findings suggest that activation of [TF] down-regulates [TG] gene expression in human trophoblast cells, and that this effect is mediated primarily at the transcriptional level.	PPAR delta	HSD11B2	2	REPRESSION	False
4458	4495	11459781:0:ERalpha:coagulation factor XII	Inhibition of [TF]-mediated trans-activation of human [TG] gene by heteromeric transcription factor NF-Y.	ERalpha	coagulation factor XII	2	REPRESSION	True
4461	4498	11459781:0:NF-Y:coagulation factor XII	Inhibition of ERalpha-mediated trans-activation of human [TG] gene by heteromeric transcription factor [TF].	NF-Y	coagulation factor XII	2	REPRESSION	False
4466	4503	19218241:8:LXR:apoE	Chromatin immunoprecipitation analyses performed using isolated adipocytes, or adipose tissue from mice treated with PPARgamma agonists, showed increased [TF] binding to the [TG] gene after PPARgamma agonist treatment.	LXR	apoE	0	UNDEFINED	False
4467	4504	15087465:5:TIEG1:CD11d	Transient overexpression of TIEG1 activated the CD11d promoter specifically in myeloid cells, whereas, down-regulation of TIEG1 with small interfering [TF] RNA also down-regulated expression of [TG].	TIEG1	CD11d	1	ACTIVATION	True
4473	4510	21799768:11:JUNB:IL-4	Overexpression of JUNB together with SATB1 synergistically upregulated IL-4 promoter activity, while knockdown [TF] significantly reduced [TG] expression.	JUNB	IL-4	1	ACTIVATION	False
4481	4518	15456860:7:Runx2:OC	Together, our results indicate that [TF] plays a key role in the 1alpha,25-dihydroxyvitamin D3-dependent stimulation of the [TG] promoter in osteoblastic cells by further stabilizing the interaction of the VDR with the VDRE.	Runx2	OC	1	ACTIVATION	False
4487	4524	15456860:7:1alpha,25-dihydroxyvitamin D3:OC	Together, our results indicate that Runx2 plays a key role in the [TF]-dependent stimulation of the [TG] promoter in osteoblastic cells by further stabilizing the interaction of the VDR with the VDRE.	1alpha,25-dihydroxyvitamin D3	OC	1	ACTIVATION	False
4489	4526	8441395:4:hepatocyte nuclear factor 3 alpha:apo-B	Furthermore, we have demonstrated that the transcription factor [TF] (HNF-3 alpha) binds to the sequence 5'-TGTTTGCTTTTC-3' from -95 to -106 of the [TG] promoter, to stimulate transcription.	hepatocyte nuclear factor 3 alpha	apo-B	1	ACTIVATION	False
4491	4528	8441395:4:HNF-3 alpha:apo-B	Furthermore, we have demonstrated that the transcription factor hepatocyte nuclear factor 3 alpha ([TF]) binds to the sequence 5'-TGTTTGCTTTTC-3' from -95 to -106 of the [TG] promoter, to stimulate transcription.	HNF-3 alpha	apo-B	1	ACTIVATION	False
4494	4531	12446773:0:Early B-cell factor:mb-1	[TF], E2A, and Pax-5 cooperate to activate the early B cell-specific [TG] promoter.	Early B-cell factor	mb-1	1	ACTIVATION	False
4497	4534	12446773:0:E2A:mb-1	Using DNA microarrays, we found that expression of endogenous mb-1 transcripts correlates most closely with EBF expression and negatively with Id1, an inhibitor of E2A protein function, further linking regulation of the [TG] gene with EBF and [TF].	E2A	mb-1	0	UNDEFINED	False
4501	4538	12446773:0:EBF:mb-1	Using DNA microarrays, we found that expression of endogenous mb-1 transcripts correlates most closely with EBF expression and negatively with Id1, an inhibitor of E2A protein function, further linking regulation of the [TG] gene with [TF] and E2A.	EBF	mb-1	0	UNDEFINED	False
4502	4539	12446773:0:EBF:Igalpha	Previous studies have suggested that the early-B-cell-specific mb-1([TG]) promoter is regulated by [TF] and Pax-5.	EBF	Igalpha	0	UNDEFINED	False
4504	4541	12446773:0:Pax-5:Igalpha	Previous studies have suggested that the early-B-cell-specific mb-1([TG]) promoter is regulated by EBF and [TF].	Pax-5	Igalpha	0	UNDEFINED	False
4515	4552	11459781:1:ERalpha:coagulation factor XII	Human coagulation factor XII promoter contains an estrogen response element that mediates ligand-activated [TF] induction of [TG] gene expression.	ERalpha	coagulation factor XII	1	ACTIVATION	False
4517	4554	11459781:1:estrogen:coagulation factor XII	Human coagulation factor XII promoter contains an [TF] response element that mediates ligand-activated ERalpha induction of [TG] gene expression.	estrogen	coagulation factor XII	1	ACTIVATION	True
4522	4559	10403485:0:MEF2:c-jun	CD28-mediated regulation of the [TG] promoter involves the [TF] transcription factor in Jurkat T cells.	MEF2	c-jun	0	UNDEFINED	False
4523	4560	16210365:0:androgen receptor:FKBP5	Direct, [TF]-mediated regulation of the [TG] gene via a distal enhancer element.	androgen receptor	FKBP5	0	UNDEFINED	False
4524	4561	18521079:0:E2F1:DAPK2	In summary, our findings establish [TG] as a novel Sp1-dependent target gene for [TF] and KLF6 in cell death response.	E2F1	DAPK2	0	UNDEFINED	False
4526	4563	18521079:0:KLF6:DAPK2	In summary, our findings establish [TG] as a novel Sp1-dependent target gene for E2F1 and [TF] in cell death response.	KLF6	DAPK2	0	UNDEFINED	False
4531	4568	18521079:0:Kruppel-like factor 6:DAPK2	We found that E2F1 and [TF] (KLF6) strongly activate the [TG] promoter.	Kruppel-like factor 6	DAPK2	1	ACTIVATION	False
4544	4581	18521079:0:Sp1:DAPK2	In summary, our findings establish [TG] as a novel [TF]-dependent target gene for E2F1 and KLF6 in cell death response.	Sp1	DAPK2	0	UNDEFINED	False
4546	4583	20530714:0:homeodomain finger 10:caspase-3	A novel plant [TF]-mediated antiapoptotic mechanism involving repression of [TG] in gastric cancer cells.	homeodomain finger 10	caspase-3	2	REPRESSION	True
4547	4584	20530714:0:PHF10:caspase-3	Collectively, our findings show that [TF] repressed [TG] expression and impaired the programmed cell death pathway in human gastric cancer at the transcriptional level.	PHF10	caspase-3	2	REPRESSION	False
4548	4585	20926649:6:Sp1:KCNQ2	We show that the transcription factor [TF] activates expression of both [TG] and KCNQ3, whereas the transcriptional repressor REST (repressor element 1-silencing transcription factor) represses expression of both of these genes.	Sp1	KCNQ2	1	ACTIVATION	False
4549	4586	20926649:6:Sp1:KCNQ3	We show that the transcription factor [TF] activates expression of both KCNQ2 and [TG], whereas the transcriptional repressor REST (repressor element 1-silencing transcription factor) represses expression of both of these genes.	Sp1	KCNQ3	1	ACTIVATION	False
4553	4590	20926649:6:REST:KCNQ2	We show that the transcription factor Sp1 activates expression of both [TG] and KCNQ3, whereas the transcriptional repressor [TF] (repressor element 1-silencing transcription factor) represses expression of both of these genes.	REST	KCNQ2	2	REPRESSION	False
4554	4591	20926649:6:REST:KCNQ3	We show that the transcription factor Sp1 activates expression of both KCNQ2 and [TG], whereas the transcriptional repressor [TF] (repressor element 1-silencing transcription factor) represses expression of both of these genes.	REST	KCNQ3	2	REPRESSION	False
4557	4594	20926649:6:repressor element 1-silencing transcription factor:KCNQ2	We show that the transcription factor Sp1 activates expression of both [TG] and KCNQ3, whereas the transcriptional repressor REST ([TF]) represses expression of both of these genes.	repressor element 1-silencing transcription factor	KCNQ2	2	REPRESSION	False
4558	4595	20926649:6:repressor element 1-silencing transcription factor:KCNQ3	We show that the transcription factor Sp1 activates expression of both KCNQ2 and [TG], whereas the transcriptional repressor REST ([TF]) represses expression of both of these genes.	repressor element 1-silencing transcription factor	KCNQ3	2	REPRESSION	False
4560	4597	12468538:0:Heat shock factor 1:c-fos	[TF] contains two functional domains that mediate transcriptional repression of the [TG] and c-fms genes.	Heat shock factor 1	c-fos	2	REPRESSION	False
4561	4598	12468538:0:Heat shock factor 1:c-fms	[TF] contains two functional domains that mediate transcriptional repression of the c-fos and [TG] genes.	Heat shock factor 1	c-fms	2	REPRESSION	False
4569	4606	12468538:0:NF-IL6:c-fms	One region (NF) appears to be involved in quenching transcriptional activation factors on target promoters and binds to the basic zipper transcription factor [TF] required for activation of [TG] and IL-1beta.	NF-IL6	c-fms	1	ACTIVATION	False
4570	4607	12468538:0:NF-IL6:IL-1beta	One region (NF) appears to be involved in quenching transcriptional activation factors on target promoters and binds to the basic zipper transcription factor [TF] required for activation of c-fms and [TG].	NF-IL6	IL-1beta	1	ACTIVATION	False
4581	4618	12351634:7:FKHRL1:TRAIL	These findings suggest that the decreased activity of [TF] and FKHR in prostate cancers resulting from loss of PTEN leads to a decrease in [TG] expression that may contribute to increased survival of the tumor cells.	FKHRL1	TRAIL	1	ACTIVATION	False
4584	4621	12351634:7:FKHR:TRAIL	These findings suggest that the decreased activity of FKHRL1 and [TF] in prostate cancers resulting from loss of PTEN leads to a decrease in [TG] expression that may contribute to increased survival of the tumor cells.	FKHR	TRAIL	1	ACTIVATION	False
4587	4624	12750007:0:Ets:presenilin 1	[TF] transcription factors ER81 and Elk1 regulate the transcription of the human [TG] gene promoter.	Ets	presenilin 1	0	UNDEFINED	True
4590	4627	12750007:0:ER81:presenilin 1	Ets transcription factors [TF] and Elk1 regulate the transcription of the human [TG] gene promoter.	ER81	presenilin 1	0	UNDEFINED	False
4593	4630	12750007:0:Elk1:presenilin 1	Ets transcription factors ER81 and [TF] regulate the transcription of the human [TG] gene promoter.	Elk1	presenilin 1	0	UNDEFINED	False
4594	4631	12750007:0:Ets1/2:PS1	We have shown that [TF] transcription factors bind specifically to the -10 Ets element and activate [TG] transcription.	Ets1/2	PS1	1	ACTIVATION	False
4601	4638	12750007:0:ER81:PS1	We show that in vitro translated ER81 indeed binds specifically to the -10 region of the PS1 promoter and that [TF] activates by two- to threefold the basal transcription of a presenilin-1 promoter-chloramphenicol acetyltransferase reporter synthetic gene (-119, +178)[TG]CAT in transient infection assays in neuroblastoma cells (SK-N-SH).	ER81	PS1	1	ACTIVATION	True
4603	4640	12750007:0:ER81:presenilin-1	We show that in vitro translated ER81 indeed binds specifically to the -10 region of the PS1 promoter and that [TF] activates by two- to threefold the basal transcription of a [TG] promoter-chloramphenicol acetyltransferase reporter synthetic gene (-119, +178)PS1CAT in transient infection assays in neuroblastoma cells (SK-N-SH).	ER81	presenilin-1	1	ACTIVATION	False
4606	4643	12750007:0:GABPalpha:PS1	Cotransfection of GABPbeta together with [TF] did not increase [TG] transcription.	GABPalpha	PS1	1	ACTIVATION	False
4608	4645	12750007:0:Ets:PS1	In contrast, the more distantly related [TF] factor Elk1 repressed [TG] transcription very effectively.	Ets	PS1	2	REPRESSION	True
4612	4649	12750007:0:GABPbeta:PS1	However, [TF] alone activated [TG] transcription by two- to threefold.	GABPbeta	PS1	1	ACTIVATION	False
4614	4651	12750007:0:Elk1:PS1	In contrast, the more distantly related Ets factor [TF] repressed [TG] transcription very effectively.	Elk1	PS1	2	REPRESSION	False
4615	4652	12759356:2:NF-kappaB:BMP-2	Here we have used both in vitro and in vivo approaches to demonstrate that transcription factor, [TF], regulates [TG] gene expression in chondrocytes.	NF-kappaB	BMP-2	0	UNDEFINED	False
4618	4655	18596066:7:NR4A1:Star	Dex was found to inhibit NR4A1-dependent transactivation of the Star promoter in Leydig cells by decreasing [TF], but not NR5A1, recruitment to the proximal [TG] promoter as determined by chromatin immunoprecipitation assay.	NR4A1	Star	0	UNDEFINED	False
4620	4657	18596066:7:NR5A1:Star	Dex was found to inhibit NR4A1-dependent transactivation of the Star promoter in Leydig cells by decreasing NR4A1, but not [TF], recruitment to the proximal [TG] promoter as determined by chromatin immunoprecipitation assay.	NR5A1	Star	0	UNDEFINED	False
4623	4660	19829305:7:Ets1:Fli1	Furthermore, we show similar binding of Ets factors to the endogenous mouse and human Fli1 promoters in T cells and knocking down [TF] results in an upregulation of [TG] expression.	Ets1	Fli1	2	REPRESSION	False
4625	4662	17804753:0:steroidogenic factor 1:aromatase	Insulin-like growth factor-I, regulating [TG] expression through [TF], supports estrogen-dependent tumor Leydig cell proliferation.	steroidogenic factor 1	aromatase	0	UNDEFINED	False
4627	4664	17851584:0:MZF1:peptidylarginine deiminase type I	Crucial roles of [TF] and Sp1 in the transcriptional regulation of the [TG] gene (PADI1) in human keratinocytes.	MZF1	peptidylarginine deiminase type I	0	UNDEFINED	False
4628	4665	17851584:0:MZF1:PADI1	Crucial roles of [TF] and Sp1 in the transcriptional regulation of the peptidylarginine deiminase type I gene ([TG]) in human keratinocytes.	MZF1	PADI1	0	UNDEFINED	False
4630	4667	17851584:0:Sp1:peptidylarginine deiminase type I	Crucial roles of MZF1 and [TF] in the transcriptional regulation of the [TG] gene (PADI1) in human keratinocytes.	Sp1	peptidylarginine deiminase type I	0	UNDEFINED	False
4631	4668	17851584:0:Sp1:PADI1	Crucial roles of MZF1 and [TF] in the transcriptional regulation of the peptidylarginine deiminase type I gene ([TG]) in human keratinocytes.	Sp1	PADI1	0	UNDEFINED	True
4638	4675	10470095:6:WT1:N-myc	However, mutant [TF] (R394W) which has a mutation in the DNA binding domain could not repress the [TG] promoter.	WT1	N-myc	2	REPRESSION	False
4640	4677	22846578:8:MZF-1:MMP-2	This study shows that [TF] represses [TG] transcription and suggests that this repression may be linked to inhibition of human cervical cancer cell migration and metastasis.	MZF-1	MMP-2	2	REPRESSION	False
4642	4679	12087183:0:ER71:matrix metalloproteinase-1	Finally, we show that [TF] is capable of directly activating both an E74 site-driven and the [TG] promoter.	ER71	matrix metalloproteinase-1	1	ACTIVATION	False
4646	4683	19457926:4:Sf1:Sry	We now show through genetic interactions and expression analyses that Cited2 acts in the gonad with Wt1 and [TF] to increase the expression of [TG] levels to attain a critical threshold to efficiently initiate testis development.	Sf1	Sry	1	ACTIVATION	False
4653	4690	19457926:4:Wt1:Sry	We now show through genetic interactions and expression analyses that Cited2 acts in the gonad with [TF] and Sf1 to increase the expression of [TG] levels to attain a critical threshold to efficiently initiate testis development.	Wt1	Sry	1	ACTIVATION	False
4656	4693	11432852:4:Sp1:endoglin	Since [TG] promoter activity is stimulated by TGF-beta and this stimulation is located at the Sp1-containing proximal region, we have investigated the possible involvement of [TF] in the TGF-beta-mediated induction.	Sp1	endoglin	1	ACTIVATION	False
4657	4694	10858438:8:RXR:ABC1	The results show sterol-dependent transactivation of the [TG] promoter by LXR/[TF] and suggest that small molecule agonists of LXR could be useful drugs to reverse foam cell formation and atherogenesis.	RXR	ABC1	1	ACTIVATION	False
4665	4702	11894840:9:AR:PSA	In cells treated with GA after transfection with a [TG] promoter or an androgen response element-driven reporter gene, [TF]-mediated transactivation of reporter gene expression was reversibly inhibited by GA.	AR	PSA	1	ACTIVATION	False
4671	4709	15738655:6:androgen:p21	However, PC3, an [TF]-insensitive prostate cancer cell line with deletion of p53 showed an appreciable post-transcriptional induction of [TG] expression after treatment with pioglitazone.	androgen	p21	0	UNDEFINED	True
4672	4710	22671145:7:CDX2:CFTR	Moreover, siRNA (small interfering RNA)-mediated knockdown of [TF] caused a significant reduction in endogenous [TG] transcription in intestinal cells, suggesting that this factor is critical for the maintenance of high levels of CFTR expression in these cells.	CDX2	CFTR	1	ACTIVATION	False
4673	4711	19466541:5:CTCF:BRCA1	To test the hypothesis that methylation of CpG sites may affect accessibility of the [TG] promoter to transcription factors and consequently cause down-regulation of BRCA1, we analyzed the binding of four transcription factors ([TF], Sp1, E2F1 and E2F6) to the BRCA1 promoter using chromatin immunoprecipitation assay (ChIP) and quantitative PCR.	CTCF	BRCA1	0	UNDEFINED	False
4677	4715	19466541:5:Sp1:BRCA1	To test the hypothesis that methylation of CpG sites may affect accessibility of the BRCA1 promoter to transcription factors and consequently cause down-regulation of BRCA1, we analyzed the binding of four transcription factors (CTCF, [TF], E2F1 and E2F6) to the [TG] promoter using chromatin immunoprecipitation assay (ChIP) and quantitative PCR.	Sp1	BRCA1	0	UNDEFINED	False
4681	4719	19466541:5:E2F1:BRCA1	To test the hypothesis that methylation of CpG sites may affect accessibility of the [TG] promoter to transcription factors and consequently cause down-regulation of BRCA1, we analyzed the binding of four transcription factors (CTCF, Sp1, [TF] and E2F6) to the BRCA1 promoter using chromatin immunoprecipitation assay (ChIP) and quantitative PCR.	E2F1	BRCA1	0	UNDEFINED	False
4685	4723	19466541:5:E2F6:BRCA1	To test the hypothesis that methylation of CpG sites may affect accessibility of the [TG] promoter to transcription factors and consequently cause down-regulation of BRCA1, we analyzed the binding of four transcription factors (CTCF, Sp1, E2F1 and [TF]) to the BRCA1 promoter using chromatin immunoprecipitation assay (ChIP) and quantitative PCR.	E2F6	BRCA1	0	UNDEFINED	False
4694	4732	8774732:0:Sp1:synaptobrevin II	Role of zinc-finger proteins [TF] and zif268/egr-1 in transcriptional regulation of the human [TG] gene.	Sp1	synaptobrevin II	0	UNDEFINED	False
4697	4735	8774732:0:zif268:synaptobrevin II	Role of zinc-finger proteins Sp1 and [TF]/egr-1 in transcriptional regulation of the human [TG] gene.	zif268	synaptobrevin II	0	UNDEFINED	False
4700	4738	8774732:0:egr-1:synaptobrevin II	Role of zinc-finger proteins Sp1 and zif268/[TF] in transcriptional regulation of the human [TG] gene.	egr-1	synaptobrevin II	0	UNDEFINED	False
4707	4745	11145739:6:SF-1:CYP17	The 5'-flanking region of the human [TG] gene contains three functional [TF] elements that collectively mediate a > or =25-fold induction of promoter activity by SF-1.	SF-1	CYP17	1	ACTIVATION	True
4711	4749	15557281:5:estrogen receptor alpha:p21Waf1	In the presence of ICI182,780, [TF] and HDACs are dissociated from Sp1, resulting in increased histone acetylation and de-repression of the p21Waf1 promoter and induction of [TG] expression.	estrogen receptor alpha	p21Waf1	0	UNDEFINED	True
4714	4752	15557281:5:Sp1:p21Waf1	In the presence of ICI182,780, estrogen receptor alpha and HDACs are dissociated from [TF], resulting in increased histone acetylation and de-repression of the p21Waf1 promoter and induction of [TG] expression.	Sp1	p21Waf1	0	UNDEFINED	True
4717	4755	15557281:5:ICI182,780:p21Waf1	In the presence of [TF], estrogen receptor alpha and HDACs are dissociated from Sp1, resulting in increased histone acetylation and de-repression of the p21Waf1 promoter and induction of [TG] expression.	ICI182,780	p21Waf1	1	ACTIVATION	True
4719	4757	12794825:12:AP-4:TGFbeta1	IL-1beta induces an increase of TGFbeta1 in articular chondrocytes through activation of [TF] and AP-1 binding to the [TG] gene promoter.	AP-4	TGFbeta1	0	UNDEFINED	True
4722	4760	12794825:12:AP-1:TGFbeta1	IL-1beta induces an increase of TGFbeta1 in articular chondrocytes through activation of AP-4 and [TF] binding to the [TG] gene promoter.	AP-1	TGFbeta1	0	UNDEFINED	True
4726	4764	22446378:12:T-bet:HEC-GlcNAc6ST	From these results, we concluded that [TF] and GATA-3 as well as Sp1 control the expression of glycan with cell-adhesion activity by regulating [TG] transcription in Th cells.	T-bet	HEC-GlcNAc6ST	0	UNDEFINED	False
4729	4767	22446378:12:GATA-3:HEC-GlcNAc6ST	From these results, we concluded that T-bet and [TF] as well as Sp1 control the expression of glycan with cell-adhesion activity by regulating [TG] transcription in Th cells.	GATA-3	HEC-GlcNAc6ST	0	UNDEFINED	False
4732	4770	22446378:12:Sp1:HEC-GlcNAc6ST	From these results, we concluded that T-bet and GATA-3 as well as [TF] control the expression of glycan with cell-adhesion activity by regulating [TG] transcription in Th cells.	Sp1	HEC-GlcNAc6ST	0	UNDEFINED	False
4734	4772	16846747:2:Fos:IL-8	In this study, we tested the hypothesis that IGF-I stimulates [TG] expression at the transcriptional level through induction of [TF]/Jun activator protein (AP)-1 complex formation.	Fos	IL-8	1	ACTIVATION	False
4739	4777	16846747:2:Jun:IL-8	In this study, we tested the hypothesis that IGF-I stimulates [TG] expression at the transcriptional level through induction of Fos/[TF] activator protein (AP)-1 complex formation.	Jun	IL-8	1	ACTIVATION	False
4744	4782	16846747:2:activator protein:IL-8	In this study, we tested the hypothesis that IGF-I stimulates [TG] expression at the transcriptional level through induction of Fos/Jun [TF] (AP)-1 complex formation.	activator protein	IL-8	1	ACTIVATION	False
4749	4787	16846747:2:(AP)-1:IL-8	In this study, we tested the hypothesis that IGF-I stimulates [TG] expression at the transcriptional level through induction of Fos/Jun activator protein [TF] complex formation.	(AP)-1	IL-8	1	ACTIVATION	False
4754	4792	15857832:0:ERM:intercellular adhesion molecule 1	To investigate how SUMO modification affects the function of ERM, Ets-responsive [TG] (ICAM-1) and E74 reporter plasmids were employed to demonstrate that SUMO modification causes inhibition of [TF]-dependent transcription without affecting the subcellular localization, stability, or DNA-binding capacity of the protein.	ERM	intercellular adhesion molecule 1	1	ACTIVATION	False
4755	4793	15857832:0:ERM:ICAM-1	To investigate how SUMO modification affects the function of ERM, Ets-responsive intercellular adhesion molecule 1 ([TG]) and E74 reporter plasmids were employed to demonstrate that SUMO modification causes inhibition of [TF]-dependent transcription without affecting the subcellular localization, stability, or DNA-binding capacity of the protein.	ERM	ICAM-1	1	ACTIVATION	True
4760	4798	15857832:0:Ets:intercellular adhesion molecule 1	To investigate how SUMO modification affects the function of ERM, [TF]-responsive [TG] (ICAM-1) and E74 reporter plasmids were employed to demonstrate that SUMO modification causes inhibition of ERM-dependent transcription without affecting the subcellular localization, stability, or DNA-binding capacity of the protein.	Ets	intercellular adhesion molecule 1	0	UNDEFINED	True
4761	4799	15857832:0:Ets:ICAM-1	To investigate how SUMO modification affects the function of ERM, [TF]-responsive intercellular adhesion molecule 1 ([TG]) and E74 reporter plasmids were employed to demonstrate that SUMO modification causes inhibition of ERM-dependent transcription without affecting the subcellular localization, stability, or DNA-binding capacity of the protein.	Ets	ICAM-1	0	UNDEFINED	True
4764	4802	19808779:4:sterol regulatory element binding protein-2:LDL receptor	We recently showed that curcumin suppressed gene expression of [TG] in activated HSCs in vitro by repressing gene expression of the transcription factor [TF] (SREBP-2), leading to the reduction in the level of intracellular cholesterol in HSCs and to the attenuation of the stimulatory effects of LDL on HSCs activation.	sterol regulatory element binding protein-2	LDL receptor	1	ACTIVATION	False
4766	4804	19808779:4:SREBP-2:LDL receptor	We recently showed that curcumin suppressed gene expression of [TG] in activated HSCs in vitro by repressing gene expression of the transcription factor sterol regulatory element binding protein-2 ([TF]), leading to the reduction in the level of intracellular cholesterol in HSCs and to the attenuation of the stimulatory effects of LDL on HSCs activation.	SREBP-2	LDL receptor	1	ACTIVATION	False
4787	4825	21572044:6:STAT1:MD-2	Furthermore, EMSA analysis demonstrated that STAT1 binds to the MD-2 promoter, indicating that [TF] is an [TG] transcription factor.	STAT1	MD-2	0	UNDEFINED	False
4790	4828	24058639:8:Fli1:COL1A2	TGF-b induced [TF] and HDAC1 dissociation from the [TG] promoter, while promoting Ets1 and p300 recruitment.	Fli1	COL1A2	0	UNDEFINED	False
4796	4834	24058639:8:Ets1:COL1A2	TGF-b induced Fli1 and HDAC1 dissociation from the [TG] promoter, while promoting [TF] and p300 recruitment.	Ets1	COL1A2	0	UNDEFINED	False
4810	4848	10625658:0:PCE-1:photoreceptor cell-specific arrestin	(1997) Nature 387, 603-607), binds to the photoreceptor conserved element-1 ([TF]/Ret 1) in the [TG] promoter and stimulates gene expression.	PCE-1	photoreceptor cell-specific arrestin	0	UNDEFINED	True
4812	4850	17283078:11:NURR1:MMP-1	Finally, functional studies indicate that transcriptional antagonism exists between [TF] and ETS1 on the [TG] promoter.	NURR1	MMP-1	0	UNDEFINED	False
4814	4852	17283078:11:ETS1:MMP-1	Finally, functional studies indicate that transcriptional antagonism exists between NURR1 and [TF] on the [TG] promoter.	ETS1	MMP-1	0	UNDEFINED	False
4815	4853	14565956:8:NRSF:Cx36	The [TF]-mediated repression of [TG] in HeLa cells was abolished by trichostatin A, confirming the functional importance of histone deacetylase activity.	NRSF	Cx36	2	REPRESSION	False
4816	4854	17526937:6:SXR:CYP3A4	Transient transfection-based reporter gene assays showed 4-hydroxy TAM activated the [TF]-mediated transcription through [TG] and MDR1 promoters in a ligand- and receptor concentration-dependent manner.	SXR	CYP3A4	1	ACTIVATION	False
4817	4855	17526937:6:SXR:MDR1	Transient transfection-based reporter gene assays showed 4-hydroxy TAM activated the [TF]-mediated transcription through CYP3A4 and [TG] promoters in a ligand- and receptor concentration-dependent manner.	SXR	MDR1	1	ACTIVATION	False
4819	4857	17526937:6:4-hydroxy TAM:CYP3A4	Transient transfection-based reporter gene assays showed [TF] activated the SXR-mediated transcription through [TG] and MDR1 promoters in a ligand- and receptor concentration-dependent manner.	4-hydroxy TAM	CYP3A4	1	ACTIVATION	False
4820	4858	17526937:6:4-hydroxy TAM:MDR1	Transient transfection-based reporter gene assays showed [TF] activated the SXR-mediated transcription through CYP3A4 and [TG] promoters in a ligand- and receptor concentration-dependent manner.	4-hydroxy TAM	MDR1	1	ACTIVATION	False
4822	4860	15988004:4:RUNX1:NF1	In reporter assays, [TF] activated the NF1 promoter and cooperated with C/EBPalpha and ETS2 to activate the [TG] promoter over 80-fold.	RUNX1	NF1	1	ACTIVATION	False
4826	4864	15988004:4:C/EBPalpha:NF1	In reporter assays, RUNX1 activated the NF1 promoter and cooperated with [TF] and ETS2 to activate the [TG] promoter over 80-fold.	C/EBPalpha	NF1	1	ACTIVATION	False
4829	4867	15988004:4:ETS2:NF1	In reporter assays, RUNX1 activated the [TG] promoter and cooperated with C/EBPalpha and [TF] to activate the NF1 promoter over 80-fold.	ETS2	NF1	1	ACTIVATION	False
4831	4869	11518812:2:GATA-4:MIS	Proper spatiotemporal expression of the [TG] gene requires a specific combination of transcription factors, including the zinc finger factor [TF] and the nuclear receptor steroidogenic factor-1, which both colocalize with Mullerian inhibiting substance in Sertoli cells.	GATA-4	MIS	1	ACTIVATION	False
4833	4871	11518812:2:steroidogenic factor-1:MIS	Proper spatiotemporal expression of the [TG] gene requires a specific combination of transcription factors, including the zinc finger factor GATA-4 and the nuclear receptor [TF], which both colocalize with Mullerian inhibiting substance in Sertoli cells.	steroidogenic factor-1	MIS	1	ACTIVATION	False
4835	4873	12615074:0:Oct-3/4:UTF1	These analyses led to the identification of nine distinct nucleotide sequences including the one (5'-ACTAGCAT-3') present in [TG] regulatory element which serves rather as specific binding site for the [TF].	Oct-3/4	UTF1	0	UNDEFINED	False
4837	4875	18703514:3:androgen receptor:PMEPA1	In this study we establish that [TG] is a direct transcriptional target of the [TF] (AR).	androgen receptor	PMEPA1	0	UNDEFINED	False
4839	4877	18703514:3:AR:PMEPA1	In this study we establish that [TG] is a direct transcriptional target of the androgen receptor ([TF]).	AR	PMEPA1	0	UNDEFINED	False
4841	4879	15143173:0:CTCF:Igf2	[TF] binding is thought to play a direct role in inhibiting methylation of the ICR in female germ cells and in somatic cells and, therefore, in establishing and maintaining imprinting of the [TG]/H19 region.	CTCF	Igf2	0	UNDEFINED	True
4842	4880	15143173:0:CTCF:H19	[TF] binding is thought to play a direct role in inhibiting methylation of the ICR in female germ cells and in somatic cells and, therefore, in establishing and maintaining imprinting of the Igf2/[TG] region.	CTCF	H19	2	REPRESSION	True
4843	4881	13678390:7:ER alpha:MIS	Under the low concentration of 17beta-estradiol (E2), the over-expression of exogenous [TF] increased the [TG] promoter activity 3.3-fold compared with the control.	ER alpha	MIS	1	ACTIVATION	False
4847	4885	12097386:0:Bcl6:IL-5	Thus, the IL5BS may act as a silencer element for [TF] to repress expression of the [TG] gene.	Bcl6	IL-5	2	REPRESSION	False
4855	4893	12097386:0:Bcl6:IL5BS	The exogenous [TF] repressed expression of the reporter gene with the [TG] in K562 cells and the repressor activity was lost by a point mutation of the IL5BS.	Bcl6	IL5BS	2	REPRESSION	False
4859	4897	11979430:8:TR3:RAR beta	The inhibition of RAR beta promoter activity was due to the interaction of [TF] with orphan receptor COUP-TF, resulting in inhibition of COUP-TF DNA binding and transactivation on the [TG] promoter.	TR3	RAR beta	1	ACTIVATION	True
4861	4899	11979430:8:COUP-TF:RAR beta	The inhibition of RAR beta promoter activity was due to the interaction of TR3 with orphan receptor COUP-TF, resulting in inhibition of [TF] DNA binding and transactivation on the [TG] promoter.	COUP-TF	RAR beta	2	REPRESSION	True
4864	4902	15385560:0:Nrf3:NAD(P)H:quinone oxidoreductase1	[TF] negatively regulates antioxidant-response element-mediated expression and antioxidant induction of [TG] gene.	Nrf3	NAD(P)H:quinone oxidoreductase1	2	REPRESSION	False
4865	4903	15385560:0:nuclear factor Nrf2:NQO1	Antioxidant-response element (ARE) and [TF]-mediated expression and coordinated induction of genes encoding chemopreventive proteins, including [TG], are critical mechanisms in chemoprotection.	nuclear factor Nrf2	NQO1	1	ACTIVATION	False
4866	4904	15385560:0:Nrf2:NQO1	Antioxidant-response element (ARE) and nuclear factor [TF]-mediated expression and coordinated induction of genes encoding chemopreventive proteins, including [TG], are critical mechanisms in chemoprotection.	Nrf2	NQO1	1	ACTIVATION	False
4873	4911	15385560:0:Nrf3:NQO1	RNA interference specific to Nrf3 reduced intracellular [TF] leading to increased expression and induction of transfected and endogenous [TG] gene expression in response to t-BHQ.	Nrf3	NQO1	2	REPRESSION	False
4879	4917	17311890:9:MR:EGFR	EGFR promoter reporter gene assay as well as chromatin immunoprecipitation data indicate that [TF] interacts with the [TG] promoter.	MR	EGFR	0	UNDEFINED	False
4880	4918	20696134:0:ATF3:adiponectin receptor 1	[TF] negatively regulates [TG] expression.	ATF3	adiponectin receptor 1	2	REPRESSION	False
4881	4919	18346918:8:BCL6:CHEK1	Herein we show that [TF] can directly bind to a DNA consensus element in the [TG] promoter and repress its expression in normal and malignant B-cells.	BCL6	CHEK1	2	REPRESSION	False
4883	4921	18462069:6:Sp1:TSP50	Overexpression of [TF] and C/EBPbeta transcriptional factors upregulated the activities of the [TG] promoter.	Sp1	TSP50	1	ACTIVATION	False
4885	4923	18462069:6:C/EBPbeta:TSP50	Overexpression of Sp1 and [TF] transcriptional factors upregulated the activities of the [TG] promoter.	C/EBPbeta	TSP50	1	ACTIVATION	False
4887	4925	19147544:0:progesterone receptor:kallikrein-related peptidase 4	Direct [TF] and indirect androgen receptor interactions with the [TG] gene promoter in breast and prostate cancer.	progesterone receptor	kallikrein-related peptidase 4	0	UNDEFINED	False
4889	4927	19147544:0:androgen recepto:kallikrein-related peptidase 4	Direct progesterone receptor and indirect [TF]r interactions with the [TG] gene promoter in breast and prostate cancer.	androgen recepto	kallikrein-related peptidase 4	0	UNDEFINED	False
4892	4930	22719258:7:HEY1:PROX1	In LECs, however, PROX1 was rather downregulated by KSHV-induced NOTCH signal via [TF], which binds and represses the [TG] promoter.	HEY1	PROX1	2	REPRESSION	False
4894	4932	12177004:5:LXR agonist:PLTP	Nuclear run-on assay indicated that the effect of [TF] on [TG] expression was at the transcriptional level.	LXR agonist	PLTP	0	UNDEFINED	True
4897	4935	22677193:11:KLF4:VDR	[TG] is a direct transcriptional target of [TF]; we identified 2 sites in the VDR promoter that bound specifically to KLF4.	KLF4	VDR	0	UNDEFINED	False
4900	4938	11981036:11:COUP-TFII:PPARalpha	The nuclear receptor [TF] also bound this site and down-regulated basal as well as HNF4-induced h[TG] promoter activity.	COUP-TFII	PPARalpha	2	REPRESSION	False
4902	4940	11981036:11:HNF4:PPARalpha	The nuclear receptor COUP-TFII also bound this site and down-regulated basal as well as [TF]-induced h[TG] promoter activity.	HNF4	PPARalpha	1	ACTIVATION	False
4910	4948	19351848:4:LEF1:AR	We showed that LEF1 overexpression in LNCaP cells resulted in increased AR expression and consequently enhanced growth and invasion ability, whereas [TF] knockdown in LNCaP-AI cells decreased [TG] expression and, subsequently, growth and invasion capacity.	LEF1	AR	1	ACTIVATION	False
4924	4962	14757763:5:USF-1:TGF-beta1	Overexpression of either [TF] or USF-2 increased [TG] promoter activity 2-fold, which was prevented by mutation or deletion of the GlRE.	USF-1	TGF-beta1	1	ACTIVATION	False
4926	4964	14757763:5:USF-2:TGF-beta1	Overexpression of either USF-1 or [TF] increased [TG] promoter activity 2-fold, which was prevented by mutation or deletion of the GlRE.	USF-2	TGF-beta1	1	ACTIVATION	False
4927	4965	16260782:8:TR-beta:CYP7A1	Elevation of CYP7A1 mRNA levels and reduced hepatic cholesterol content in MUT animals are likely because of cross-talk between [TF] and liver X receptor alpha (LXR-alpha), which both bind to a direct repeat + 4 (DR+4) element in the [TG] promoter.	TR-beta	CYP7A1	0	UNDEFINED	False
4930	4968	16260782:8:LXR-alpha:CYP7A1	Elevation of CYP7A1 mRNA levels and reduced hepatic cholesterol content in MUT animals are likely because of cross-talk between TR-beta and liver X receptor alpha ([TF]), which both bind to a direct repeat + 4 (DR+4) element in the [TG] promoter.	LXR-alpha	CYP7A1	0	UNDEFINED	False
4933	4971	16260782:8:liver X receptor alpha:CYP7A1	Elevation of CYP7A1 mRNA levels and reduced hepatic cholesterol content in MUT animals are likely because of cross-talk between TR-beta and [TF] (LXR-alpha), which both bind to a direct repeat + 4 (DR+4) element in the [TG] promoter.	liver X receptor alpha	CYP7A1	0	UNDEFINED	False
4936	4974	19564873:5:glucocorticoid receptor:CALD1	The upregulation of caldesmon expression is mediated by [TF]-dependent transcription of the [TG] gene encoding caldesmon.	glucocorticoid receptor	CALD1	1	ACTIVATION	False
4937	4975	19564873:5:glucocorticoid receptor:caldesmon	The upregulation of caldesmon expression is mediated by [TF]-dependent transcription of the CALD1 gene encoding [TG].	glucocorticoid receptor	caldesmon	1	ACTIVATION	False
4939	4977	15117961:9:N-Myc:nestin	Gel mobility shift assays show that N-Myc binds specifically to E-box sequences in the regulatory second intron of the nestin gene and nuclear run-off studies show that increases in [TF] protein up-regulate [TG] transcription rate.	N-Myc	nestin	1	ACTIVATION	False
4940	4978	16407236:0:MEF2A:Myospryn	[TG] is a direct transcriptional target for [TF] that encodes a striated muscle, alpha-actinin-interacting, costamere-localized protein.	MEF2A	Myospryn	0	UNDEFINED	False
4941	4979	16407236:0:MEF2A:myospryn	Our findings demonstrate that [TG] functions directly downstream of [TF] at the costamere in striated muscle potentially playing a role in myofibrillogenesis.	MEF2A	myospryn	0	UNDEFINED	True
4944	4982	18588995:8:Sp1:EAPP	We found that [TF] and Egr-1 stimulate the [TG] promoter, whereas Sp3 acts as a repressor that could even overcome the positive effect of the activators.	Sp1	EAPP	1	ACTIVATION	False
4947	4985	18588995:8:Egr-1:EAPP	We found that Sp1 and [TF] stimulate the [TG] promoter, whereas Sp3 acts as a repressor that could even overcome the positive effect of the activators.	Egr-1	EAPP	1	ACTIVATION	False
4951	4989	18588995:8:Sp3:EAPP	We found that Sp1 and Egr-1 stimulate the [TG] promoter, whereas [TF] acts as a repressor that could even overcome the positive effect of the activators.	Sp3	EAPP	2	REPRESSION	False
4958	4996	17785366:0:Progesterone receptor:Bcl-2	[TF] regulates [TG] gene expression through direct binding to its promoter region in uterine leiomyoma cells.	Progesterone receptor	Bcl-2	0	UNDEFINED	False
4962	5000	17785366:0:PR:bcl-2	CONCLUSION: Taken together, progesterone via [TF] interacts with the [TG] promoter to induce its expression in leiomyoma tissue.	PR	bcl-2	1	ACTIVATION	False
4982	5020	8756667:0:NERF-2:lyn	Only [TF] and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the [TG] and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of ELF-1 to a variety of Ets binding sites in, among others, the blk, lck, lyn, mb-1, and immunoglobulin H genes and are expressed at similar levels.	NERF-2	lyn	1	ACTIVATION	False
4989	5027	8756667:0:ELF-1:blk	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of [TF] to a variety of Ets binding sites in, among others, the [TG], lck, lyn, mb-1, and immunoglobulin H genes and are expressed at similar levels.	ELF-1	blk	0	UNDEFINED	False
4991	5029	8756667:0:ELF-1:lck	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of [TF] to a variety of Ets binding sites in, among others, the blk, [TG], lyn, mb-1, and immunoglobulin H genes and are expressed at similar levels.	ELF-1	lck	0	UNDEFINED	False
4992	5030	8756667:0:ELF-1:lyn	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the [TG] and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of [TF] to a variety of Ets binding sites in, among others, the blk, lck, lyn, mb-1, and immunoglobulin H genes and are expressed at similar levels.	ELF-1	lyn	0	UNDEFINED	True
4993	5031	8756667:0:ELF-1:mb-1	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of [TF] to a variety of Ets binding sites in, among others, the blk, lck, lyn, [TG], and immunoglobulin H genes and are expressed at similar levels.	ELF-1	mb-1	0	UNDEFINED	False
4995	5033	8756667:0:ELF-1:immunoglobulin H	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of [TF] to a variety of Ets binding sites in, among others, the blk, lck, lyn, mb-1, and [TG] genes and are expressed at similar levels.	ELF-1	immunoglobulin H	0	UNDEFINED	False
4999	5037	8756667:0:NERF-1a:lyn	Only NERF-2 and ELF-1, and not [TF] and NERF-1b, function as transcriptional activators of the [TG] and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of ELF-1 to a variety of Ets binding sites in, among others, the blk, lck, lyn, mb-1, and immunoglobulin H genes and are expressed at similar levels.	NERF-1a	lyn	1	ACTIVATION	True
5006	5044	8756667:0:NERF-1b:lyn	Only NERF-2 and ELF-1, and not NERF-1a and [TF], function as transcriptional activators of the [TG] and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of ELF-1 to a variety of Ets binding sites in, among others, the blk, lck, lyn, mb-1, and immunoglobulin H genes and are expressed at similar levels.	NERF-1b	lyn	1	ACTIVATION	False
5010	5048	8756667:0:NERF:blk	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of [TF] bind with affinities similar to those of ELF-1 to a variety of Ets binding sites in, among others, the [TG], lck, lyn, mb-1, and immunoglobulin H genes and are expressed at similar levels.	NERF	blk	0	UNDEFINED	False
5011	5049	8756667:0:NERF:lck	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of [TF] bind with affinities similar to those of ELF-1 to a variety of Ets binding sites in, among others, the blk, [TG], lyn, mb-1, and immunoglobulin H genes and are expressed at similar levels.	NERF	lck	0	UNDEFINED	False
5013	5051	8756667:0:NERF:mb-1	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of [TF] bind with affinities similar to those of ELF-1 to a variety of Ets binding sites in, among others, the blk, lck, lyn, [TG], and immunoglobulin H genes and are expressed at similar levels.	NERF	mb-1	0	UNDEFINED	False
5015	5053	8756667:0:NERF:immunoglobulin H	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of [TF] bind with affinities similar to those of ELF-1 to a variety of Ets binding sites in, among others, the blk, lck, lyn, mb-1, and [TG] genes and are expressed at similar levels.	NERF	immunoglobulin H	0	UNDEFINED	True
5020	5058	8756667:0:Ets:blk	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of ELF-1 to a variety of [TF] binding sites in, among others, the [TG], lck, lyn, mb-1, and immunoglobulin H genes and are expressed at similar levels.	Ets	blk	0	UNDEFINED	True
5022	5060	8756667:0:Ets:lck	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of ELF-1 to a variety of [TF] binding sites in, among others, the blk, [TG], lyn, mb-1, and immunoglobulin H genes and are expressed at similar levels.	Ets	lck	0	UNDEFINED	True
5024	5062	8756667:0:Ets:mb-1	Only NERF-2 and ELF-1, and not NERF-1a and NERF-1b, function as transcriptional activators of the lyn and blk gene promoters, although all isoforms of NERF bind with affinities similar to those of ELF-1 to a variety of [TF] binding sites in, among others, the blk, lck, lyn, [TG], and immunoglobulin H genes and are expressed at similar levels.	Ets	mb-1	0	UNDEFINED	True
5026	5064	12453415:0:NFATc2:cyclin-dependent kinase 4	[TF]-mediated repression of [TG] expression.	NFATc2	cyclin-dependent kinase 4	2	REPRESSION	False
5030	5068	12453415:0:NFAT:cyclin-dependent kinase 4	Here, we demonstrate that the calcineurin/[TF] pathway negatively regulates the expression of [TG] (CDK4).	NFAT	cyclin-dependent kinase 4	2	REPRESSION	True
5034	5072	12453415:0:NFATc2:CDK4	Additionally, both calcineurin Aalpha(-/-) and [TF](-/-) mice had elevated protein levels of [TG], confirming a negative regulatory role for the calcineurin/NFAT pathway.	NFATc2	CDK4	2	REPRESSION	True
5040	5078	11299318:0:Pitx3:tyrosine hydroxylase	[TF] activates mouse [TG] promoter via a high-affinity binding site.	Pitx3	tyrosine hydroxylase	1	ACTIVATION	False
5043	5081	11299318:0:Nurr1:TH	In contrast, we did not observe an effect of [TF], an orphan nuclear receptor essential for normal development of MesDA neurons, on [TG] promoter activity.	Nurr1	TH	0	UNDEFINED	False
5044	5082	15890551:2:NF-kappaB:Nos2	Transcriptional regulation of [TG], the inducible nitric-oxide synthase (iNOS) gene, is complex and not fully understood, but appears to be regulated in part by [TF].	NF-kappaB	Nos2	0	UNDEFINED	False
5045	5083	15890551:2:NF-kappaB:inducible nitric-oxide synthase	Transcriptional regulation of Nos2, the [TG] (iNOS) gene, is complex and not fully understood, but appears to be regulated in part by [TF].	NF-kappaB	inducible nitric-oxide synthase	0	UNDEFINED	False
5046	5084	15890551:2:NF-kappaB:iNOS	Transcriptional regulation of Nos2, the inducible nitric-oxide synthase ([TG]) gene, is complex and not fully understood, but appears to be regulated in part by [TF].	NF-kappaB	iNOS	0	UNDEFINED	False
5047	5085	20972246:5:FOXI1:CFTR	Results of transiently transfected vas deferens cells with either the -33G wild-type or the -33A variant CFTR directed luciferase reporter gene confirmed that the -33A variant, which alters the [TF] (Forkhead box I1) binding, significantly decreases the [TG] promoter activity.	FOXI1	CFTR	1	ACTIVATION	True
5049	5087	20972246:5:Forkhead box I1:CFTR	Results of transiently transfected vas deferens cells with either the -33G wild-type or the -33A variant CFTR directed luciferase reporter gene confirmed that the -33A variant, which alters the FOXI1 ([TF]) binding, significantly decreases the [TG] promoter activity.	Forkhead box I1	CFTR	0	UNDEFINED	True
5051	5089	10478838:2:steroidogenic factor-1:SR-BI	We showed previously that [TF] (SF-1) binds a sequence in the human SR-BI promoter whose integrity is required for high-level [TG] expression in cultured adrenocortical tumor cells.	steroidogenic factor-1	SR-BI	1	ACTIVATION	True
5054	5092	10478838:2:SF-1:SR-BI	We showed previously that steroidogenic factor-1 ([TF]) binds a sequence in the human SR-BI promoter whose integrity is required for high-level [TG] expression in cultured adrenocortical tumor cells.	SF-1	SR-BI	1	ACTIVATION	True
5055	5093	18198175:0:STAT3:DeltaNp63	Transcriptional activity of the [TG] promoter is regulated by [TF].	STAT3	DeltaNp63	0	UNDEFINED	False
5058	5096	15752744:0:ICER:cyclin A	Induced [TF] Igamma down-regulates [TG] expression and cell proliferation in insulin-producing beta cells.	ICER	cyclin A	2	REPRESSION	False
5063	5102	21271216:6:FOXL2:aromatase	Using in silico analysis, we further searched for [TF] binding-elements in the [TG] gene promoters.	FOXL2	aromatase	0	UNDEFINED	True
5066	5105	9819228:9:Msx2:OC	[TF] inhibits the DNA binding activity of a third complex, the OC fibroblast growth factor response element binding protein (OCFREB), that supports activity of the basal [TG] promoter.	Msx2	OC	0	UNDEFINED	True
5067	5106	24478438:4:FoxO1:SREBP-1c	Knockdown of [TF] by small interfering RNA in HCV-infected cells significantly decreased [TG] and FASN expression.	FoxO1	SREBP-1c	1	ACTIVATION	False
5068	5107	24478438:4:FoxO1:FASN	Knockdown of [TF] by small interfering RNA in HCV-infected cells significantly decreased SREBP-1c and [TG] expression.	FoxO1	FASN	1	ACTIVATION	False
5071	5110	1396593:0:GATA-1:glycophorin B	Erythroid-specific activity of the [TG] promoter requires [TF] mediated displacement of a repressor.	GATA-1	glycophorin B	1	ACTIVATION	False
5079	5118	20463357:7:HOXA10:KLF9	Reporter constructs driven by the [TG] promoter were repressed by cotransfection with [TF].	HOXA10	KLF9	2	REPRESSION	False
5080	5119	15044620:9:C/EBPbeta:MDR1	The mechanisms of MDR1 activation by C/EBPbeta include C/EBPbeta binding of the chromatin of the [TG] gene and interactions of [TF] with the Y box and Y box-associated proteins.	C/EBPbeta	MDR1	0	UNDEFINED	True
5083	5122	11299720:9:WT1:AR	Additionally, a zinc-finger mutant WT1 (-/-) expression construct, R394W, failed to decrease luciferase activity, suggesting that [TF] downregulates the ARE-reporter gene construct activity by directly repressing the endogenous [TG] gene promoter.	WT1	AR	2	REPRESSION	False
5088	5127	20621834:7:hepatocyte nuclear factor-4alpha:CTRP5	Taken together, these results show that [TF] is involved in transcriptional regulation of [TG] in the liver.	hepatocyte nuclear factor-4alpha	CTRP5	0	UNDEFINED	False
5090	5138	16164412:0:ATF5:asparagine synthetase	Regulation of [TG] gene transcription by the basic region leucine zipper transcription factors [TF] and CHOP.	ATF5	asparagine synthetase	0	UNDEFINED	False
5092	5140	16164412:0:CHOP:asparagine synthetase	Regulation of [TG] gene transcription by the basic region leucine zipper transcription factors ATF5 and [TF].	CHOP	asparagine synthetase	0	UNDEFINED	False
5094	5142	8675014:0:Ptx1:pro-opiomelanocortin	[TF], a bicoid-related homeo box transcription factor involved in transcription of the [TG] gene.	Ptx1	pro-opiomelanocortin	0	UNDEFINED	True
5120	5168	8675014:0:Ptx1:POMC	In the adult pituitary gland, [TF] appears to be recruited for cell-specific transcription of the [TG] gene.	Ptx1	POMC	1	ACTIVATION	True
5122	5170	12640143:4:Stat3:c-fos	The Stat3 decoy was composed of a 15-mer double-stranded oligonucleotide, which corresponded closely to the [TF] response element within the [TG] promoter.	Stat3	c-fos	0	UNDEFINED	True
5135	5183	16010691:12:ERalpha:CYP1B1	These results suggest that [TF] regulates the [TG] expression at a transcriptional level, and CYP1A1 expression at a translational level.	ERalpha	CYP1B1	0	UNDEFINED	False
5138	5186	18854425:2:LXR:SREBP-1	[TF] increases expression of [TG], which in turn regulates at least 32 genes involved in lipid synthesis and transport.	LXR	SREBP-1	1	ACTIVATION	False
5144	5192	23023303:10:PLAG1:IGF2	We suggest that the PLAG1 binding to the IGF2 P3 promoter and [TG] expression is cell type-specific, and that the [TF] transcription factor acts as a transcriptional facilitator that partially overrides the insulation by the H19 ICR.	PLAG1	IGF2	0	UNDEFINED	True
5146	5194	9430690:0:MEF2B:smooth muscle myosin heavy chain	[TF] is a component of a smooth muscle-specific complex that binds an A/T-rich element important for [TG] gene expression.	MEF2B	smooth muscle myosin heavy chain	1	ACTIVATION	True
5160	5208	9430690:0:MEF2B:SMHC	Furthermore, MEF2B overexpression in smooth muscle cells up-regulated the SMHC promoter, suggesting that [TF] is important for [TG] gene regulation.	MEF2B	SMHC	0	UNDEFINED	False
5161	5209	15580302:5:p53:Ipaf	Expression analysis for Ipaf mRNA in doxorubicin-treated human tumor cell lines suggests that p53-dependent as well as [TF]-independent mechanisms are involved in the regulation of [TG] gene expression in a cell-type-specific manner.	p53	Ipaf	0	UNDEFINED	True
5172	5220	11114890:0:SXR:CYP2B	Unexpectedly, we found that [TF] can regulate [TG], both in cultured cells and in transgenic mice via adaptive recognition of the phenobarbital response element (PBRE).	SXR	CYP2B	0	UNDEFINED	False
5185	5233	11114890:0:steroid and xenobiotic receptor:CYP3A	Nuclear receptor SXR/PXR ([TF]/pregnenolone X receptor) has been shown both biochemically and genetically to activate [TG] genes, while similar studies have established constitutive androstane receptor (CAR) as a CYP2B regulator.	steroid and xenobiotic receptor	CYP3A	1	ACTIVATION	True
5198	5246	11114890:0:androstane receptor:CYP2B	Nuclear receptor SXR/PXR (steroid and xenobiotic receptor/pregnenolone X receptor) has been shown both biochemically and genetically to activate CYP3A genes, while similar studies have established constitutive [TF] (CAR) as a [TG] regulator.	androstane receptor	CYP2B	0	UNDEFINED	True
5203	5251	11114890:0:CAR:CYP2B	Nuclear receptor SXR/PXR (steroid and xenobiotic receptor/pregnenolone X receptor) has been shown both biochemically and genetically to activate CYP3A genes, while similar studies have established constitutive androstane receptor ([TF]) as a [TG] regulator.	CAR	CYP2B	0	UNDEFINED	True
5204	5252	11114890:0:CAR:CYP3A	In a type of functional symmetry, orphan receptor [TF] was also found to activate [TG] through previously defined SXR/PXR response elements.	CAR	CYP3A	1	ACTIVATION	False
5206	5254	15564578:0:Estrogen receptor (ER)beta:corticotropin-releasing hormone	[TF] isoforms rather than ERalpha regulate [TG] promoter activity through an alternate pathway.	Estrogen receptor (ER)beta	corticotropin-releasing hormone	0	UNDEFINED	False
5208	5256	15564578:0:ERalpha:corticotropin-releasing hormone	Estrogen receptor (ER)beta isoforms rather than [TF] regulate [TG] promoter activity through an alternate pathway.	ERalpha	corticotropin-releasing hormone	0	UNDEFINED	False
5209	5257	17947829:6:HIF-1 alpha:VEGF	We found that both the mRNA and protein levels of [TF] in the RPE cells increased in response to hypoxia, followed by increasing expression of [TG].	HIF-1 alpha	VEGF	1	ACTIVATION	False
5211	5259	15356291:3:PPARalpha:CPT1beta	We investigated the roles of the PPRE and the MEF2 binding sites and the potential interaction between [TF] and MEF2C regulating the [TG] gene promoter.	PPARalpha	CPT1beta	0	UNDEFINED	False
5214	5262	15356291:3:MEF2C:CPT1beta	We investigated the roles of the PPRE and the MEF2 binding sites and the potential interaction between PPARalpha and [TF] regulating the [TG] gene promoter.	MEF2C	CPT1beta	0	UNDEFINED	False
5218	5266	15356291:3:MEF2:CPT1beta	We investigated the roles of the PPRE and the [TF] binding sites and the potential interaction between PPARalpha and MEF2C regulating the [TG] gene promoter.	MEF2	CPT1beta	0	UNDEFINED	True
5224	5272	16112614:3:LXRalpha:SREBP-1c	In in vitro studies, polyunsaturated fatty acids (PUFAs, n-6, n-3) inhibited binding of [TF]/RXRalpha heterodimer to LXR responsive elements (LXREs) in the [TG] promoter.	LXRalpha	SREBP-1c	0	UNDEFINED	False
5227	5275	16112614:3:RXRalpha:SREBP-1c	In in vitro studies, polyunsaturated fatty acids (PUFAs, n-6, n-3) inhibited binding of LXRalpha/[TF] heterodimer to LXR responsive elements (LXREs) in the [TG] promoter.	RXRalpha	SREBP-1c	0	UNDEFINED	False
5234	5282	16112614:3:LXR:SREBP-1c	In in vitro studies, polyunsaturated fatty acids (PUFAs, n-6, n-3) inhibited binding of LXRalpha/RXRalpha heterodimer to [TF] responsive elements (LXREs) in the [TG] promoter.	LXR	SREBP-1c	0	UNDEFINED	True
5236	5284	11287605:2:LXRalpha:SREBP-1c	We cloned and identified the oxysterol receptors liver X receptor ([TF]) and LXRbeta as strong activators of the mouse [TG] promoter.	LXRalpha	SREBP-1c	1	ACTIVATION	False
5239	5287	11287605:2:LXRbeta:SREBP-1c	We cloned and identified the oxysterol receptors liver X receptor (LXRalpha) and [TF] as strong activators of the mouse [TG] promoter.	LXRbeta	SREBP-1c	1	ACTIVATION	False
5246	5294	11287605:2:oxysterol receptors liver X receptor:SREBP-1c	We cloned and identified the [TF] (LXRalpha) and LXRbeta as strong activators of the mouse [TG] promoter.	oxysterol receptors liver X receptor	SREBP-1c	1	ACTIVATION	False
5248	5296	15371411:9:ICSBP:NF1	Consistent with this, we find that ICSBP activates the [TG] promoter in myeloid cell line transfectants and identify an [TF]-binding NF1 cis element.	ICSBP	NF1	1	ACTIVATION	True
5249	5297	14744869:12:SREBP-1c:PEPCK-C	We propose that insulin represses transcription of the gene for PEPCK-C by inducing [TF] production in the liver, which interferes with the stimulatory effect of Sp1 at -590 of the [TG] gene promoter.	SREBP-1c	PEPCK-C	0	UNDEFINED	True
5252	5300	14744869:12:Sp1:PEPCK-C	We propose that insulin represses transcription of the gene for PEPCK-C by inducing SREBP-1c production in the liver, which interferes with the stimulatory effect of [TF] at -590 of the [TG] gene promoter.	Sp1	PEPCK-C	1	ACTIVATION	False
5256	5304	11427482:0:c-Myb:methionine adenosyltransferase 2A	C. The role of [TF] and Sp1 in the up-regulation of [TG] gene expression in human hepatocellular carcinoma.	c-Myb	methionine adenosyltransferase 2A	1	ACTIVATION	False
5258	5306	11427482:0:Sp1:methionine adenosyltransferase 2A	C. The role of c-Myb and [TF] in the up-regulation of [TG] gene expression in human hepatocellular carcinoma.	Sp1	methionine adenosyltransferase 2A	1	ACTIVATION	False
5261	5309	11427482:0:c-Myb:MAT2A	Increased expression of [TF] and Sp1 and binding to the MAT2A promoter contribute to transcriptional up-regulation of [TG] in HCC.-Yang,	c-Myb	MAT2A	1	ACTIVATION	False
5262	5310	11427482:0:Sp1:MAT2A	Increased expression of c-Myb and [TF] and binding to the MAT2A promoter contribute to transcriptional up-regulation of [TG] in HCC.-Yang,	Sp1	MAT2A	1	ACTIVATION	False
5264	5312	15722551:9:Sp1:eNOS	We further showed that [TF] bound to the endogenous [TG] promoter and associated with HDAC1 in non-endothelial HeLa cells.	Sp1	eNOS	0	UNDEFINED	False
5265	5313	14644503:12:Sp1:PTTG	Our studies indicate an important role of [TF] in transcription regulation of [TG] expression in tumors.	Sp1	PTTG	0	UNDEFINED	False
5266	5314	17980704:3:YY1:p73	Here we reported that YY1-silencing resulted in significant reductions in the activities of the p73 promoters and the endogenous [TG] expression level, conversely, overexpression of [TF] could induce the activities of them.	YY1	p73	1	ACTIVATION	False
5271	5319	17142810:7:AR:Fkbp51	Interestingly, Fkbp51 expression was down-regulated in Fkbp52-deficient males but only in affected tissues, providing further evidence of tissue-specific loss of AR activity and suggesting that [TG] is an [TF] target gene essential to penile and prostate development.	AR	Fkbp51	0	UNDEFINED	False
5274	5322	12782640:2:androgen receptor:PSA	The expression of [TG] is controlled by [TF] (AR) through its binding to androgen-response elements (AREs).	androgen receptor	PSA	0	UNDEFINED	True
5277	5325	12782640:2:AR:PSA	The expression of [TG] is controlled by androgen receptor ([TF]) through its binding to androgen-response elements (AREs).	AR	PSA	0	UNDEFINED	True
5281	5329	12782640:2:androgen:PSA	The expression of [TG] is controlled by androgen receptor (AR) through its binding to [TF]-response elements (AREs).	androgen	PSA	0	UNDEFINED	True
5286	5334	19541765:0:Hes1:p27	Furthermore, pituitaries lacking [TF] have increased cell cycle exit, shown by significant increases in the cyclin-dependent kinase inhibitors, [TG] and p57, from e10.5	Hes1	p27	2	REPRESSION	False
5287	5335	19541765:0:Hes1:p57	Furthermore, pituitaries lacking [TF] have increased cell cycle exit, shown by significant increases in the cyclin-dependent kinase inhibitors, p27 and [TG], from e10.5	Hes1	p57	2	REPRESSION	False
5288	5337	9334210:12:upstream stimulatory factor:insulin	These results demonstrate that [TF] binding to the E-box at -65 is required for [TG] regulation of the fatty acid synthase promoter.	upstream stimulatory factor	insulin	0	UNDEFINED	True
5289	5338	9334210:12:upstream stimulatory factor:fatty acid synthase	These results demonstrate that [TF] binding to the E-box at -65 is required for insulin regulation of the [TG] promoter.	upstream stimulatory factor	fatty acid synthase	0	UNDEFINED	False
5291	5340	15111490:8:Sp1:KDR	Conversely, PPARgamma1 ligand 15-deoxy Delta (12,14)-prostaglandin J2 dose-dependently suppressed the binding of [TG] promoter region with both [TF] and Sp3, resulting an inhibition of KDR gene expression.	Sp1	KDR	1	ACTIVATION	True
5295	5344	15111490:8:Sp3:KDR	Conversely, PPARgamma1 ligand 15-deoxy Delta (12,14)-prostaglandin J2 dose-dependently suppressed the binding of [TG] promoter region with both Sp1 and [TF], resulting an inhibition of KDR gene expression.	Sp3	KDR	0	UNDEFINED	True
5300	5349	15111490:8:KDR:KDR	Conversely, PPARgamma1 ligand 15-deoxy Delta (12,14)-prostaglandin J2 dose-dependently suppressed the binding of [TF] promoter region with both Sp1 and Sp3, resulting an inhibition of [TG] gene expression.	KDR	KDR	1	ACTIVATION	True
5305	5354	15111490:8:PPARgamma1:KDR	Conversely, [TF] ligand 15-deoxy Delta (12,14)-prostaglandin J2 dose-dependently suppressed the binding of [TG] promoter region with both Sp1 and Sp3, resulting an inhibition of KDR gene expression.	PPARgamma1	KDR	0	UNDEFINED	True
5309	5358	15111490:8:15-deoxy Delta (12,14)-prostaglandin J2:KDR	Conversely, PPARgamma1 ligand [TF] dose-dependently suppressed the binding of [TG] promoter region with both Sp1 and Sp3, resulting an inhibition of KDR gene expression.	15-deoxy Delta (12,14)-prostaglandin J2	KDR	0	UNDEFINED	True
5311	5360	8552602:0:Nrl:rhodopsin	Cotransfection studies using an Nrl-expression plasmid and a luciferase reporter gene demonstrate that interaction of the [TF] protein with the -61 to -84 region of the [TG] promoter (which includes the NRE) stimulates expression of the reporter gene in CV-1 monkey kidney cells.	Nrl	rhodopsin	1	ACTIVATION	False
5316	5365	10319992:7:c-Myc:p21	Overexpression of c-Myc reduced the levels of endogenous p21 mRNA, and transfection of [TF] repressed [TG]-promoter luciferase-reporter gene expression.	c-Myc	p21	2	REPRESSION	False
5318	5367	12637547:0:Ets-2:BRCA1	[TF] and components of mammalian SWI/SNF form a repressor complex that negatively regulates the [TG] promoter.	Ets-2	BRCA1	2	REPRESSION	False
5319	5368	12637547:0:ets-2:BRCA1	The combination of Brg-1 and [TF] could repress the [TG] promoter reporter in transfection assays.	ets-2	BRCA1	2	REPRESSION	False
5332	5381	20679491:4:ICSBP:GAS2	We find that [TF], Tel, and histone deacetylase 3 (HDAC3) bind to a cis element in the [TG] promoter and repress transcription in myeloid progenitor cells.	ICSBP	GAS2	2	REPRESSION	False
5336	5385	20679491:4:Tel:GAS2	We find that ICSBP, [TF], and histone deacetylase 3 (HDAC3) bind to a cis element in the [TG] promoter and repress transcription in myeloid progenitor cells.	Tel	GAS2	2	REPRESSION	False
5338	5387	17826772:0:ATOH1:Hes6	Gene expression profiling identifies [TG] as a transcriptional target of [TF] in cochlear hair cells.	ATOH1	Hes6	0	UNDEFINED	False
5340	5389	17826772:0:ATOH1:HES6	Moreover, electrophoretic mobility shift assays and luciferase assays show that [TF] activates [TG] transcription through binding to three clustered E boxes of its promoter.	ATOH1	HES6	1	ACTIVATION	False
5345	5394	11777930:0:p53:GADD45	Previous studies demonstrate that BRCA1 induces [TG], a [TF]-regulated and stress-inducible gene that plays an important role in cellular response to DNA damage.	p53	GADD45	0	UNDEFINED	True
5350	5399	11777930:0:Oct-1:GADD45	Such protein interactions are required for interaction of BRCA1 with the [TG] promoter because either immunodepletion of [TF] and NF-YA proteins or mutations in the OCT-1 and CAAT motifs disrupt BRCA1 binding to the GADD45 promoter.	Oct-1	GADD45	0	UNDEFINED	True
5351	5400	11777930:0:Oct-1:GADD45 promoter	Such protein interactions are required for interaction of BRCA1 with the GADD45 promoter because either immunodepletion of [TF] and NF-YA proteins or mutations in the OCT-1 and CAAT motifs disrupt BRCA1 binding to the [TG].	Oct-1	GADD45 promoter	0	UNDEFINED	False
5354	5403	11777930:0:NF-YA:GADD45 promoter	Such protein interactions are required for interaction of BRCA1 with the GADD45 promoter because either immunodepletion of Oct-1 and [TF] proteins or mutations in the OCT-1 and CAAT motifs disrupt BRCA1 binding to the [TG].	NF-YA	GADD45 promoter	0	UNDEFINED	True
5357	5406	11777930:0:OCT-1:GADD45	Such protein interactions are required for interaction of BRCA1 with the [TG] promoter because either immunodepletion of Oct-1 and NF-YA proteins or mutations in the [TF] and CAAT motifs disrupt BRCA1 binding to the GADD45 promoter.	OCT-1	GADD45	0	UNDEFINED	True
5362	5411	21251764:5:FoxO1:insulin promoter factor-1	Milk signalling down-regulates the key transcription factor [TF] leading to up-regulation of [TG] which stimulates b-cell proliferation, insulin secretion as well as coexpression of islet amyloid polypeptide (IAPP).	FoxO1	insulin promoter factor-1	2	REPRESSION	False
5366	5415	21251764:5:insulin promoter factor-1:IAPP	Milk signalling down-regulates the key transcription factor FoxO1 leading to up-regulation of [TF] which stimulates b-cell proliferation, insulin secretion as well as coexpression of islet amyloid polypeptide ([TG]).	insulin promoter factor-1	IAPP	1	ACTIVATION	False
5368	5417	21251764:5:insulin promoter factor-1:islet amyloid polypeptide	Milk signalling down-regulates the key transcription factor FoxO1 leading to up-regulation of [TF] which stimulates b-cell proliferation, insulin secretion as well as coexpression of [TG] (IAPP).	insulin promoter factor-1	islet amyloid polypeptide	1	ACTIVATION	False
5378	5427	15286705:0:STAT3:p21waf1	In this study, we explore the role of BRG1, a component of the SWI/SNF chromatin-remodeling complex, and the role of cdk9, a component of the elongation factor P-TEFb, in the [TF]-mediated expression of [TG].	STAT3	p21waf1	1	ACTIVATION	False
5385	5436	14988426:6:Nurr1:OPN	The activation of the OPN promoter was mediated by the monomeric form of Nurr1, required direct binding of [TF] to the [TG] promoter, and was dependent on the amino-terminal transactivation function-1.	Nurr1	OPN	0	UNDEFINED	True
5389	5440	17163418:5:estrogen receptor:p27	In the [TF] (ER)-positive MCF-7 cells, FOXA1 increased [TG] promoter activity and inhibited the ER pathway activity.	estrogen receptor	p27	0	UNDEFINED	True
5396	5447	17163418:5:FOXA1:p27	In the estrogen receptor (ER)-positive MCF-7 cells, [TF] increased [TG] promoter activity and inhibited the ER pathway activity.	FOXA1	p27	1	ACTIVATION	False
5397	5449	23598529:0:ISGF3:STAT1	REST negatively and [TF] positively regulate the human [TG] gene in melanoma.	ISGF3	STAT1	1	ACTIVATION	False
5402	5454	23598529:0:REST:STAT1	[TF] negatively and ISGF3 positively regulate the human [TG] gene in melanoma.	REST	STAT1	2	REPRESSION	False
5404	5456	24058639:2:Fli1:COL1A2	Although our previous studies have delineated that TGF-b induces displacement of Fli1 from the COL1A2 promoter through sequential post-translational modifications, the detailed mechanism by which [TF] functions as a potent transcriptional repressor of the [TG] gene has not been fully investigated.	Fli1	COL1A2	2	REPRESSION	False
5406	5458	16730733:0:RXR:ATP-binding cassette transporter G1	Unsaturated fatty acids suppress the expression of the [TG] (ABCG1) and ABCA1 genes via an LXR/[TF] responsive element.	RXR	ATP-binding cassette transporter G1	2	REPRESSION	False
5407	5459	16730733:0:RXR:ABCG1	Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 ([TG]) and ABCA1 genes via an LXR/[TF] responsive element.	RXR	ABCG1	2	REPRESSION	False
5408	5460	16730733:0:RXR:ABCA1	Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and [TG] genes via an LXR/[TF] responsive element.	RXR	ABCA1	2	REPRESSION	False
5410	5462	16730733:0:LXR:ATP-binding cassette transporter G1	Unsaturated fatty acids suppress the expression of the [TG] (ABCG1) and ABCA1 genes via an [TF]/RXR responsive element.	LXR	ATP-binding cassette transporter G1	2	REPRESSION	False
5411	5463	16730733:0:LXR:ABCG1	Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 ([TG]) and ABCA1 genes via an [TF]/RXR responsive element.	LXR	ABCG1	2	REPRESSION	False
5412	5464	16730733:0:LXR:ABCA1	Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and [TG] genes via an [TF]/RXR responsive element.	LXR	ABCA1	2	REPRESSION	False
5414	5466	19017637:9:Sp1:CDK4	Taken together, our results demonstrate that a key event in the artemisinin anti-proliferative effects in prostate cancer cells is the transcriptional down-regulation of CDK4 expression by disruption of [TF] interactions with the [TG] promoter.	Sp1	CDK4	0	UNDEFINED	False
5415	5467	20473547:5:CREB3:CXCR4	Furthermore, [TF] was shown to bind to the CRE element in the CXCR4 promoter and to activate the transcription of the [TG] gene by causing dissociation of HDAC3 and subsequently increasing histone acetylation.	CREB3	CXCR4	1	ACTIVATION	False
5417	5469	15330762:8:LXRalpha:SREBP-1c	Ectopic expression of [TF] or SREBP-1c increased activity of the [TG] promoter, and this effect is further enhanced by insulin.	LXRalpha	SREBP-1c	1	ACTIVATION	False
5422	5474	17139261:2:TR3:MDM2	The expression level of [TG] is negatively regulated by orphan receptor [TF] that mainly acts as a transcriptional factor to regulate gene expression.	TR3	MDM2	2	REPRESSION	False
5424	5476	17404577:0:Id3:p27kip1	[TF] is a novel regulator of [TG] mRNA in early G1 phase and is required for cell-cycle progression.	Id3	p27kip1	0	UNDEFINED	False
5431	5483	17404577:0:Id3:cyclin A	By inhibiting early p27 downregulation, [TF] depletion blocked (i) the G1-phase progression as assessed by the inhibition of pRb phosphorylation and p130 degradation and (ii) the G1/S transition as observed by the inhibition of [TG] induction, demonstrating that p27 mRNA decrease is required for cell proliferation.	Id3	cyclin A	1	ACTIVATION	True
5432	5484	17121920:8:Sp1:XIAP	Luciferase reporter assay and the chromatin immunoprecipitation assay using the XIAP promoter constructs show that mithramycin A down-regulates the transcription of [TG] gene through inhibition of [TF] binding to its promoter.	Sp1	XIAP	1	ACTIVATION	False
5440	5492	16914734:4:androgen:prostate-specific antigen (PSA)	In this study, we uncover important new functional role(s) for hPIRH2 in AR signaling: (i) hPIRH2 interacts with AR and enhances AR-mediated transcription with a dynamic pattern of recruitment to [TF] response elements in the [TG] gene; (ii) hPIRH2 interacts with the AR corepressor HDAC1, leading to reduced HDAC1 protein levels and inhibition of transcriptional repression; (iii) hPIRH2 is required for optimal PSA expression; and (iv) hPIRH2 is involved in prostate cancer cell proliferation.	androgen	prostate-specific antigen (PSA)	0	UNDEFINED	True
5446	5498	17637757:0:Brn-3b:CD1	Thus, [TF] may act to alter growth properties of breast cancer and NB cells by enhancing [TG] expression in these cells.	Brn-3b	CD1	1	ACTIVATION	False
5451	5503	12213901:9:WT1:P450arom	In vitro transcriptional regulation studies showed that both [TF] and DAX-1 inhibited cAMP and/or SF-1-induced [TG] promoter activity in a dose-dependent fashion in cultured human endometriotic and endometrial stromal cells.	WT1	P450arom	2	REPRESSION	False
5454	5506	12213901:9:DAX-1:P450arom	In vitro transcriptional regulation studies showed that both WT1 and [TF] inhibited cAMP and/or SF-1-induced [TG] promoter activity in a dose-dependent fashion in cultured human endometriotic and endometrial stromal cells.	DAX-1	P450arom	2	REPRESSION	False
5457	5509	12213901:9:SF-1:P450arom	In vitro transcriptional regulation studies showed that both WT1 and DAX-1 inhibited cAMP and/or [TF]-induced [TG] promoter activity in a dose-dependent fashion in cultured human endometriotic and endometrial stromal cells.	SF-1	P450arom	1	ACTIVATION	False
5463	5515	11232768:4:SP-1:VEGF	Enhancement of [TG] gene expression by LPS was shown by gel shift analysis and use of transcription factor inhibitors to be mediated via the activation of [TF].	SP-1	VEGF	1	ACTIVATION	False
5464	5516	16199533:8:AP-1:HARP	These results support the notion that HARP is important for human prostate cancer cell proliferation and migration, establish the role of AP-1 in the up-regulation of [TG] expression by low concentrations of HP, and characterize the [TF] dimers involved.	AP-1	HARP	1	ACTIVATION	True
5467	5519	12047722:2:ERbeta:OT	Transfection and DNA-protein binding experiments using high levels of either oestrogen receptor (ER)alpha or [TF] imply a direct interaction of these transcription factors with the multiple hormone response element (HRE) at approximately -160 from the transcription start site of the [TG] gene in most species.	ERbeta	OT	0	UNDEFINED	False
5469	5521	12047722:2:oestrogen receptor (ER)alpha:OT	Transfection and DNA-protein binding experiments using high levels of either [TF] or ERbeta imply a direct interaction of these transcription factors with the multiple hormone response element (HRE) at approximately -160 from the transcription start site of the [TG] gene in most species.	oestrogen receptor (ER)alpha	OT	0	UNDEFINED	False
5470	5522	21856782:11:MYCN:BMI1	Our results indicate that MYCN and MYC regulate BMI1 gene expression at the transcriptional level and that dysregulation of the [TG] gene mediated by [TF] or MYC overexpression, confers increased cell proliferation during neuroblastoma genesis and tumor progression.	MYCN	BMI1	0	UNDEFINED	False
5474	5526	21856782:11:MYC:BMI1	Our results indicate that MYCN and MYC regulate BMI1 gene expression at the transcriptional level and that dysregulation of the [TG] gene mediated by MYCN or [TF] overexpression, confers increased cell proliferation during neuroblastoma genesis and tumor progression.	MYC	BMI1	0	UNDEFINED	False
5479	5531	17272513:8:RARalpha:MRP3	The functional role of RXRalpha:RARalpha as a repressor of MRP3 expression was further confirmed by [TF] small-interfering RNA knockdown in HepG2 cells, which upregulated endogenous [TG] expression.	RARalpha	MRP3	2	REPRESSION	False
5481	5533	15181096:13:LRH-1:StAR	We hypothesize that [TF] could be the major transcription factor responsible for the rapid and significant increase in ovarian [TG] gene expression after ovulation.	LRH-1	StAR	1	ACTIVATION	False
5482	5534	12456679:0:Liver receptor homologue-1:apical sodium-dependent bile acid transporter	[TF] mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the [TG].	Liver receptor homologue-1	apical sodium-dependent bile acid transporter	2	REPRESSION	True
5486	5538	12456679:0:LRH-1:ASBT	In summary cell line- and species-specific negative feedback regulation of ASBT by bile acids is mediated by farnesoid X receptor via small heterodimer partner-dependent repression of [TF] activation of the [TG] promoter.	LRH-1	ASBT	1	ACTIVATION	False
5488	5540	12456679:0:farnesoid X receptor:ASBT	In summary cell line- and species-specific negative feedback regulation of ASBT by bile acids is mediated by [TF] via small heterodimer partner-dependent repression of LRH-1 activation of the [TG] promoter.	farnesoid X receptor	ASBT	2	REPRESSION	True
5490	5542	12456679:0:farnesoid X-receptor:ASBT	Bile acid response was mediated by the farnesoid X receptor, as shown by the fact that overexpression of a dominant-negative [TF] eliminated the bile acid mediated down-regulation of [TG].	farnesoid X-receptor	ASBT	2	REPRESSION	True
5491	5543	12456679:0:farnesoid X receptor:LRH-1	In summary cell line- and species-specific negative feedback regulation of ASBT by bile acids is mediated by [TF] via small heterodimer partner-dependent repression of [TG] activation of the ASBT promoter.	farnesoid X receptor	LRH-1	2	REPRESSION	True
5494	5546	23574718:8:FOXO1:p21	Inhibition of FOXO1 (with AS1842856) or stable [TF] knockdown inhibited progestin-induced [TG] expression and blocked progestin-induced senescence.	FOXO1	p21	1	ACTIVATION	False
5500	5552	12865342:10:LRH-1:alpha-fetoprotein	An abundant granulosa cell protein binding to the SF-1-binding motif (CCAAGGTCA) present in the aromatase promoter and an FTF/[TF] motif (TGTCCTTGAACA) in the [TG] promoter was supershifted by two SF-1-specific antibodies but not by an FTF antibody.	LRH-1	alpha-fetoprotein	0	UNDEFINED	True
5504	5556	12865342:10:SF-1:alpha-fetoprotein	An abundant granulosa cell protein binding to the SF-1-binding motif (CCAAGGTCA) present in the aromatase promoter and an FTF/LRH-1 motif (TGTCCTTGAACA) in the [TG] promoter was supershifted by two [TF]-specific antibodies but not by an FTF antibody.	SF-1	alpha-fetoprotein	0	UNDEFINED	True
5509	5561	10861849:7:NF-kappaB:MNEI	Further upstream at -821, an additional regulatory element was identified controlled by [TF], which supports the highest levels of [TG] transcriptional activity.	NF-kappaB	MNEI	1	ACTIVATION	True
5511	5563	12907682:6:SF-1:MIS	Surprisingly, the initial biochemical characterization of the [TF] G35E mutant revealed that it could bind and activate the [TG] promoter as efficiently as wild-type SF-1.	SF-1	MIS	1	ACTIVATION	False
5513	5565	11891855:7:Cbfa:OC	Inhibition of OC transcription does not occur by a direct mechanism because in vitro methylated [TG] promoter DNA is still recognized by the key regulators Runx/[TF] and the vitamin D receptor complex.	Cbfa	OC	0	UNDEFINED	False
5517	5569	11891855:7:Runx:OC	Inhibition of OC transcription does not occur by a direct mechanism because in vitro methylated [TG] promoter DNA is still recognized by the key regulators [TF]/Cbfa and the vitamin D receptor complex.	Runx	OC	0	UNDEFINED	False
5520	5572	11891855:7:vitamin D receptor:OC	Inhibition of OC transcription does not occur by a direct mechanism because in vitro methylated [TG] promoter DNA is still recognized by the key regulators Runx/Cbfa and the [TF] complex.	vitamin D receptor	OC	0	UNDEFINED	False
5522	5574	11126357:0:p53:p21WAF1/CIP1	Activation of the [TG] promoter independent of [TF] by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.	p53	p21WAF1/CIP1	1	ACTIVATION	False
5524	5576	11126357:0:Sp1:p21WAF1/CIP1	Activation of the [TG] promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the [TF] sites.	Sp1	p21WAF1/CIP1	1	ACTIVATION	True
5526	5578	12676954:10:Elf-1:CD68	We propose that expression of [TG] in myeloid cells requires the Ets transcription factors [TF] and PU.1	Elf-1	CD68	1	ACTIVATION	False
5528	5580	12676954:10:PU.1:CD68	and [TG] expression is down-regulated in lymphoid cells by combinatorial interactions between [TF]	PU.1	CD68	2	REPRESSION	False
5530	5582	12032171:8:LXR:ABCA1	Together, these studies show that LPS regulates [TG] expression through an [TF]-independent mechanism.	LXR	ABCA1	0	UNDEFINED	True
5531	5583	12454263:7:FXR:PLTP	Taken together, the current data suggest that a small number of genes that currently include [TG], apoE, and apoC-II, are induced in macrophages by activated LXR and in liver by activated [TF].	FXR	PLTP	1	ACTIVATION	False
5532	5584	12454263:7:FXR:apoE	Taken together, the current data suggest that a small number of genes that currently include PLTP, [TG], and apoC-II, are induced in macrophages by activated LXR and in liver by activated [TF].	FXR	apoE	1	ACTIVATION	False
5533	5585	12454263:7:FXR:apoC-II	Taken together, the current data suggest that a small number of genes that currently include PLTP, apoE, and [TG], are induced in macrophages by activated LXR and in liver by activated [TF].	FXR	apoC-II	1	ACTIVATION	False
5535	5587	12454263:7:LXR:PLTP	Taken together, the current data suggest that a small number of genes that currently include [TG], apoE, and apoC-II, are induced in macrophages by activated [TF] and in liver by activated FXR.	LXR	PLTP	1	ACTIVATION	False
5536	5588	12454263:7:LXR:apoE	Taken together, the current data suggest that a small number of genes that currently include PLTP, [TG], and apoC-II, are induced in macrophages by activated [TF] and in liver by activated FXR.	LXR	apoE	1	ACTIVATION	False
5537	5589	12454263:7:LXR:apoC-II	Taken together, the current data suggest that a small number of genes that currently include PLTP, apoE, and [TG], are induced in macrophages by activated [TF] and in liver by activated FXR.	LXR	apoC-II	1	ACTIVATION	False
5539	5591	1608930:3:p53:retinoblastoma (Rb)	This study shows that wild-type [TF] suppresses transcription of the [TG] gene.	p53	retinoblastoma (Rb)	2	REPRESSION	False
5541	5593	22537161:5:E2F1:MUC4	Chromatin immunoprecipitation assays and real-time PCR showed that transcription factors [TF] and STAT1 can positively regulate [TG] expression at the transcriptional level.	E2F1	MUC4	1	ACTIVATION	False
5543	5595	22537161:5:STAT1:MUC4	Chromatin immunoprecipitation assays and real-time PCR showed that transcription factors E2F1 and [TF] can positively regulate [TG] expression at the transcriptional level.	STAT1	MUC4	1	ACTIVATION	False
5544	5596	15208672:0:p53:EZH2	Activated [TF] suppresses the histone methyltransferase [TG] gene.	p53	EZH2	2	REPRESSION	False
5546	5598	20102700:10:FOXO1:FABP4	Overexpression of wild-type FOXO1 and constitutively active FOXO1 significantly increased FABP4 expression, whereas dominant negative [TF] dramatically decreased [TG] expression.	FOXO1	FABP4	1	ACTIVATION	False
5549	5601	17311813:0:c-Myb:Ovol1	Collectively, our data suggest that Ovol1 restricts its own expression by counteracting [TF] activation and histone acetylation of the [TG] promoter.	c-Myb	Ovol1	1	ACTIVATION	False
5559	5611	12782599:0:L-Myc:CCL6	Chromatin immunoprecipitation showed that [TF], c-MycDeltaMBII, and full-length c-Myc all bound the [TG] promoter, although the latter was inactive in transcriptional up-regulation.	L-Myc	CCL6	0	UNDEFINED	True
5564	5616	12782599:0:c-MycDeltaMBII:CCL6	Chromatin immunoprecipitation showed that L-Myc, [TF], and full-length c-Myc all bound the [TG] promoter, although the latter was inactive in transcriptional up-regulation.	c-MycDeltaMBII	CCL6	0	UNDEFINED	True
5568	5620	12782599:0:Myc:CCL6	Our results show that [TG] can be either a positive or negative target for [TF] oncoproteins.	Myc	CCL6	1	ACTIVATION	True
5569	5621	15611276:10:NF-kappaB:TNF-alpha	Thus, via their direct inhibitory effects on IKK, AalphaBA and AKbetaBA convey inhibition of [TF] and subsequent down-regulation of [TG] expression in activated human monocytes.	NF-kappaB	TNF-alpha	1	ACTIVATION	True
5573	5625	21207956:5:HIF1a:ALAS2	Enforced HIF1a expression increased the level of ALAS2 expression, while [TF] knockdown by RNA interference decreased the level of [TG] expression.	HIF1a	ALAS2	1	ACTIVATION	False
5575	5627	18297060:0:MesP1:Dkk-1	Independent evidence from ChIP and in vitro DNA-binding studies, expression analysis in wild-type and MesP knockout mice, and reporter assays confirm that [TG] is a direct target of [TF].	MesP1	Dkk-1	0	UNDEFINED	False
5578	5630	18297060:0:MesP:Dkk-1	Independent evidence from ChIP and in vitro DNA-binding studies, expression analysis in wild-type and [TF] knockout mice, and reporter assays confirm that [TG] is a direct target of MesP1.	MesP	Dkk-1	0	UNDEFINED	True
5581	5633	15181096:5:LRH-1:StAR	[TF] significantly induced [TG] promoter activity in a concentration-dependent manner.	LRH-1	StAR	1	ACTIVATION	False
5582	5634	10334992:3:FXR:cholesterol 7alpha-hydroxylase	When bound to bile acids, [TF] repressed transcription of the gene encoding [TG], which is the rate-limiting enzyme in bile acid synthesis, and activated the gene encoding intestinal bile acid-binding protein, which is a candidate bile acid transporter.	FXR	cholesterol 7alpha-hydroxylase	2	REPRESSION	False
5583	5635	10334992:3:FXR:intestinal bile acid-binding protein	When bound to bile acids, [TF] repressed transcription of the gene encoding cholesterol 7alpha-hydroxylase, which is the rate-limiting enzyme in bile acid synthesis, and activated the gene encoding [TG], which is a candidate bile acid transporter.	FXR	intestinal bile acid-binding protein	1	ACTIVATION	False
5585	5637	21046459:7:Egr-1:PNMT	While functional [TF] and Sp1 binding sites exist within the proximal [TG] promoter, a putative hypoxia response element is a weak HIF binding site.	Egr-1	PNMT	0	UNDEFINED	False
5588	5640	21046459:7:Sp1:PNMT	While functional Egr-1 and [TF] binding sites exist within the proximal [TG] promoter, a putative hypoxia response element is a weak HIF binding site.	Sp1	PNMT	0	UNDEFINED	False
5592	5644	21046459:7:HIF:PNMT	While functional Egr-1 and Sp1 binding sites exist within the proximal [TG] promoter, a putative hypoxia response element is a weak [TF] binding site.	HIF	PNMT	0	UNDEFINED	True
5593	5645	12697832:0:Runx2:osteocalcin	Regulation of the bone-specific [TG] gene by p300 requires [TF]/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity.	Runx2	osteocalcin	0	UNDEFINED	False
5597	5649	12697832:0:Cbfa1:osteocalcin	Regulation of the bone-specific [TG] gene by p300 requires Runx2/[TF] and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity.	Cbfa1	osteocalcin	0	UNDEFINED	False
5601	5653	12697832:0:vitamin D3 receptor:osteocalcin	Regulation of the bone-specific [TG] gene by p300 requires Runx2/Cbfa1 and the [TF] but not p300 intrinsic histone acetyltransferase activity.	vitamin D3 receptor	osteocalcin	0	UNDEFINED	False
5609	5661	12169442:6:Ets:FGFR4	We have previously shown that the hematopoietic zinc finger-containing transcription factor Ikaros (Ik) regulates FGFR4 as part of an overlapping site with that for an [TF]-type factor in the [TG] promoter.	Ets	FGFR4	0	UNDEFINED	True
5611	5663	12690040:0:Ear2:renin	These data suggest that [TF] is a negative modulator of [TG] gene transcription in As4.1	Ear2	renin	2	REPRESSION	False
5613	5665	12690040:0:RAR:renin promoter	We previously reported that [TF]/RXR bind to this sequence and mediate the induction of [TG] activity by retinoids.	RAR	renin promoter	1	ACTIVATION	True
5615	5667	12690040:0:RXR:renin promoter	We previously reported that RAR/[TF] bind to this sequence and mediate the induction of [TG] activity by retinoids.	RXR	renin promoter	1	ACTIVATION	True
5616	5668	19336738:9:E2F1:codanin-1	Direct binding of [TF] to [TG] promoter was assessed by chromatin immunoprecipitation.	E2F1	codanin-1	0	UNDEFINED	False
5619	5671	10764806:0:Meis2:D(1A)	Thus, the delicate ratio between [TF] and TGIF expression in a given cell type determines the cell-specific expression of the [TG] gene.	Meis2	D(1A)	0	UNDEFINED	True
5620	5672	10764806:0:TGIF:D(1A)	Thus, the delicate ratio between Meis2 and [TF] expression in a given cell type determines the cell-specific expression of the [TG] gene.	TGIF	D(1A)	0	UNDEFINED	True
5622	5674	10764806:0:Meis2e:D(1A)	We also found that splice variant [TF], which has a truncated homeodomain, cannot bind to the [TG] ACT sequence or activate transcription.	Meis2e	D(1A)	1	ACTIVATION	False
5625	5677	12220737:6:NRSF:PPTA	Expression of [TF] dramatically represses [TG] promoter activity in reporter gene constructs in primary cultures of DRG neurons.(2).	NRSF	PPTA	2	REPRESSION	False
5628	5680	11832226:0:calcium-responsive transcription factor:BDNF	A [TF], CaRF, that regulates neuronal activity-dependent expression of [TG].	calcium-responsive transcription factor	BDNF	0	UNDEFINED	False
5630	5682	11832226:0:CaRF:BDNF	The transcriptional activity of CaRF is regulated in a calcium- and neuron-selective manner, suggesting that [TF] may confer selectivity upon the activity-dependent induction of [TG] exon III expression.	CaRF	BDNF	1	ACTIVATION	False
5632	5684	11438543:0:Stat3:alpha 2-macroglobulin	Functional importance of [TF] tetramerization in activation of the [TG] gene.	Stat3	alpha 2-macroglobulin	1	ACTIVATION	False
5634	5686	11438543:0:Stat3:alpha2-macroglobulin	A tetrameric [TF] complex was found to be essential in transfection experiments for maximal interleukin-6-inducible activation of [TG] gene promoter.	Stat3	alpha2-macroglobulin	1	ACTIVATION	False
5649	5701	14736734:0:liver receptor homolog-1:aromatase	We hypothesized that [TF] (LRH-1) (nuclear receptor 5A2), a receptor closely related to SF-1, could also play a role in regulating [TG] expression in the testis.	liver receptor homolog-1	aromatase	0	UNDEFINED	False
5655	5707	14736734:0:LRH-1:aromatase	We therefore provide evidence that [TF] plays an important role in the regulation of [TG] expression in Leydig cells.	LRH-1	aromatase	0	UNDEFINED	False
5656	5708	14736734:0:steroidogenic factor-1:Aromatase	[TG] expression in testis occurs via transcription from promoter II, and requires the presence of a nuclear receptor half-site that binds the orphan receptor [TF] [SF-1 (nuclear receptor 5A1)] to mediate basal and (in part) cAMP-induced transcription.	steroidogenic factor-1	Aromatase	1	ACTIVATION	False
5659	5711	14736734:0:SF-1:Aromatase	[TG] expression in testis occurs via transcription from promoter II, and requires the presence of a nuclear receptor half-site that binds the orphan receptor steroidogenic factor-1 [[TF] (nuclear receptor 5A1)] to mediate basal and (in part) cAMP-induced transcription.	SF-1	Aromatase	1	ACTIVATION	False
5662	5714	14736734:0:nuclear receptor 5A1:Aromatase	[TG] expression in testis occurs via transcription from promoter II, and requires the presence of a nuclear receptor half-site that binds the orphan receptor steroidogenic factor-1 [SF-1 ([TF])] to mediate basal and (in part) cAMP-induced transcription.	nuclear receptor 5A1	Aromatase	1	ACTIVATION	False
5672	5724	14736734:0:nuclear receptor 5A2:aromatase	We hypothesized that liver receptor homolog-1 (LRH-1) ([TF]), a receptor closely related to SF-1, could also play a role in regulating [TG] expression in the testis.	nuclear receptor 5A2	aromatase	0	UNDEFINED	False
5685	5737	19419955:7:KLF5:p15	Failure in KLF5 acetylation not only prevented p300-assembled Smad4-[TF] complex formation on p15 promoter but also affected the binding of Smad4 and FOXO3 on the [TG] promoter in vivo.	KLF5	p15	0	UNDEFINED	True
5689	5741	19419955:7:Smad4:p15	Failure in KLF5 acetylation not only prevented p300-assembled Smad4-KLF5 complex formation on p15 promoter but also affected the binding of [TF] and FOXO3 on the [TG] promoter in vivo.	Smad4	p15	0	UNDEFINED	False
5695	5747	19419955:7:FOXO3:p15	Failure in KLF5 acetylation not only prevented p300-assembled Smad4-KLF5 complex formation on p15 promoter but also affected the binding of Smad4 and [TF] on the [TG] promoter in vivo.	FOXO3	p15	0	UNDEFINED	False
5697	5749	18754863:2:c-Myc:hTERT	Transcriptional regulation of the human telomerase reverse transcriptase (hTERT) gene is the major mechanism for cancer-specific activation of telomerase, and a number of factors have been identified to directly or indirectly regulate the [TG] promoter, including cellular transcriptional activators ([TF], Sp1, HIF-1, AP2, ER, Ets, etc.) as well as the repressors, most of which comprise tumor suppressor gene products, such as p53, WT1, and Menin.	c-Myc	hTERT	1	ACTIVATION	False
5708	5760	18754863:2:Sp1:hTERT	Transcriptional regulation of the human telomerase reverse transcriptase (hTERT) gene is the major mechanism for cancer-specific activation of telomerase, and a number of factors have been identified to directly or indirectly regulate the [TG] promoter, including cellular transcriptional activators (c-Myc, [TF], HIF-1, AP2, ER, Ets, etc.) as well as the repressors, most of which comprise tumor suppressor gene products, such as p53, WT1, and Menin.	Sp1	hTERT	1	ACTIVATION	False
5719	5771	18754863:2:HIF-1:hTERT	Transcriptional regulation of the human telomerase reverse transcriptase (hTERT) gene is the major mechanism for cancer-specific activation of telomerase, and a number of factors have been identified to directly or indirectly regulate the [TG] promoter, including cellular transcriptional activators (c-Myc, Sp1, [TF], AP2, ER, Ets, etc.) as well as the repressors, most of which comprise tumor suppressor gene products, such as p53, WT1, and Menin.	HIF-1	hTERT	1	ACTIVATION	False
5730	5782	18754863:2:AP2:hTERT	Transcriptional regulation of the human telomerase reverse transcriptase (hTERT) gene is the major mechanism for cancer-specific activation of telomerase, and a number of factors have been identified to directly or indirectly regulate the [TG] promoter, including cellular transcriptional activators (c-Myc, Sp1, HIF-1, [TF], ER, Ets, etc.) as well as the repressors, most of which comprise tumor suppressor gene products, such as p53, WT1, and Menin.	AP2	hTERT	1	ACTIVATION	False
5741	5793	18754863:2:p53:hTERT	Transcriptional regulation of the human telomerase reverse transcriptase (hTERT) gene is the major mechanism for cancer-specific activation of telomerase, and a number of factors have been identified to directly or indirectly regulate the [TG] promoter, including cellular transcriptional activators (c-Myc, Sp1, HIF-1, AP2, ER, Ets, etc.) as well as the repressors, most of which comprise tumor suppressor gene products, such as [TF], WT1, and Menin.	p53	hTERT	2	REPRESSION	False
5752	5804	18754863:2:WT1:hTERT	Transcriptional regulation of the human telomerase reverse transcriptase (hTERT) gene is the major mechanism for cancer-specific activation of telomerase, and a number of factors have been identified to directly or indirectly regulate the [TG] promoter, including cellular transcriptional activators (c-Myc, Sp1, HIF-1, AP2, ER, Ets, etc.) as well as the repressors, most of which comprise tumor suppressor gene products, such as p53, [TF], and Menin.	WT1	hTERT	2	REPRESSION	False
5763	5815	18754863:2:ER:hTERT	Transcriptional regulation of the human telomerase reverse transcriptase (hTERT) gene is the major mechanism for cancer-specific activation of telomerase, and a number of factors have been identified to directly or indirectly regulate the [TG] promoter, including cellular transcriptional activators (c-Myc, Sp1, HIF-1, AP2, [TF], Ets, etc.) as well as the repressors, most of which comprise tumor suppressor gene products, such as p53, WT1, and Menin.	ER	hTERT	1	ACTIVATION	False
5774	5826	18754863:2:Ets:hTERT	Transcriptional regulation of the human telomerase reverse transcriptase (hTERT) gene is the major mechanism for cancer-specific activation of telomerase, and a number of factors have been identified to directly or indirectly regulate the [TG] promoter, including cellular transcriptional activators (c-Myc, Sp1, HIF-1, AP2, ER, [TF], etc.) as well as the repressors, most of which comprise tumor suppressor gene products, such as p53, WT1, and Menin.	Ets	hTERT	1	ACTIVATION	False
5784	5836	10692448:0:20-kDa 5'-(CGG)(n)-3'-binding protein:FMR1	The human [TF] is targeted to the nucleus and affects the activity of the [TG] promoter.	20-kDa 5'-(CGG)(n)-3'-binding protein	FMR1	0	UNDEFINED	False
5787	5839	10692448:0:DNA CGG repeat-binding protein:fragile X mental retardation 1	Previous reports have described the human [TF] (CGGBP1 or p20), which binds specifically to nonmethylated, but not to methylated, 5'-(CGG)(n)-3' repeats in the promoter of the [TG] (FMR1) gene.	DNA CGG repeat-binding protein	fragile X mental retardation 1	0	UNDEFINED	False
5788	5840	10692448:0:DNA CGG repeat-binding protein:FMR1	Previous reports have described the human [TF] (CGGBP1 or p20), which binds specifically to nonmethylated, but not to methylated, 5'-(CGG)(n)-3' repeats in the promoter of the fragile X mental retardation 1 ([TG]) gene.	DNA CGG repeat-binding protein	FMR1	0	UNDEFINED	False
5791	5843	10692448:0:CGGBP1:fragile X mental retardation 1	Previous reports have described the human DNA CGG repeat-binding protein ([TF] or p20), which binds specifically to nonmethylated, but not to methylated, 5'-(CGG)(n)-3' repeats in the promoter of the [TG] (FMR1) gene.	CGGBP1	fragile X mental retardation 1	0	UNDEFINED	False
5792	5844	10692448:0:CGGBP1:FMR1	Previous reports have described the human DNA CGG repeat-binding protein ([TF] or p20), which binds specifically to nonmethylated, but not to methylated, 5'-(CGG)(n)-3' repeats in the promoter of the fragile X mental retardation 1 ([TG]) gene.	CGGBP1	FMR1	0	UNDEFINED	False
5795	5847	10692448:0:p20:fragile X mental retardation 1	Previous reports have described the human DNA CGG repeat-binding protein (CGGBP1 or [TF]), which binds specifically to nonmethylated, but not to methylated, 5'-(CGG)(n)-3' repeats in the promoter of the [TG] (FMR1) gene.	p20	fragile X mental retardation 1	0	UNDEFINED	False
5796	5848	10692448:0:p20:FMR1	Upon transfection of the [TF] cDNA construct into HeLa cells, transcription of the endogenous [TG] gene is decreased.	p20	FMR1	2	REPRESSION	False
5799	5852	9545321:5:HNF3alpha:uteroglobin	Gene transfer experiments into Drosophila Schneider cells that lack many mammalian transcription factor homologs revealed that [TF] and HNF3beta on their own cannot activate the [TG]/CC10 promoter.	HNF3alpha	uteroglobin	1	ACTIVATION	False
5801	5855	9545321:5:HNF3beta:uteroglobin	Gene transfer experiments into Drosophila Schneider cells that lack many mammalian transcription factor homologs revealed that HNF3alpha and [TF] on their own cannot activate the [TG]/CC10 promoter.	HNF3beta	uteroglobin	1	ACTIVATION	False
5802	5856	9545321:5:HNF3beta:CC10	Gene transfer experiments into Drosophila Schneider cells that lack many mammalian transcription factor homologs revealed that HNF3alpha and [TF] on their own cannot activate the uteroglobin/[TG] promoter.	HNF3beta	CC10	1	ACTIVATION	False
5803	5857	7565732:0:NFATp:interleukin-2	Transcriptional repression of the [TG] gene by vitamin D3: direct inhibition of [TF]/AP-1 complex formation by a nuclear hormone receptor.	NFATp	interleukin-2	1	ACTIVATION	True
5806	5860	7565732:0:AP-1:interleukin-2	Transcriptional repression of the [TG] gene by vitamin D3: direct inhibition of NFATp/[TF] complex formation by a nuclear hormone receptor.	AP-1	interleukin-2	1	ACTIVATION	True
5809	5863	7565732:0:vitamin D3:interleukin-2	Transcriptional repression of the [TG] gene by [TF]: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor.	vitamin D3	interleukin-2	2	REPRESSION	False
5814	5868	14630715:10:PAX8:NIS	These data demonstrate a role for APE/Ref-1 protein in the transcriptional regulation of [TG] gene expression by itself and in cooperation with [TF].	PAX8	NIS	0	UNDEFINED	False
5824	5878	13678594:0:FoxD1:placental growth factor	Transcriptional activation of [TG] by the forkhead/winged helix transcription factor [TF].	FoxD1	placental growth factor	1	ACTIVATION	False
5830	5884	13678594:0:BF-2:Placental Growth Factor	Here, we used cells with inducible expression of BF-2, combined with microarray analysis, to identify [TG] (PlGF), a Vascular Endothelial Growth Factor (VEGF) family member previously implicated in angiogenesis, as a downstream target of [TF].	BF-2	Placental Growth Factor	0	UNDEFINED	False
5831	5885	13678594:0:BF-2:PlGF	Our observations indicate that [TG] is a direct and physiologically relevant transcriptional target of [TF].	BF-2	PlGF	0	UNDEFINED	False
5836	5890	13678594:0:HNF3beta:PlGF	BF-2 binds to a conserved [TF] site in the [TG] promoter and activates transcription.	HNF3beta	PlGF	0	UNDEFINED	True
5839	5893	19111069:0:Sp1:BRD7	Transcriptional regulation of [TG] expression by [TF] and c-Myc.	Sp1	BRD7	0	UNDEFINED	False
5841	5895	19111069:0:c-Myc:BRD7	Transcriptional regulation of [TG] expression by Sp1 and [TF].	c-Myc	BRD7	0	UNDEFINED	False
5843	5897	16518840:0:VDR:p27Kip1	Functional role of VDR in the activation of [TG] by the [TF]/Sp1 complex.	VDR	p27Kip1	1	ACTIVATION	False
5847	5901	16518840:0:Sp1:p27Kip1	Functional role of VDR in the activation of [TG] by the VDR/[TF] complex.	Sp1	p27Kip1	1	ACTIVATION	False
5853	5907	12624109:0:Oct-1:SPRR2A	Among the three major POU proteins expressed in human skin, [TF], Tst-1/Oct-6, and Skn-1/Oct-11, only the latter induced [TG], a marker of keratinocyte terminal differentiation.	Oct-1	SPRR2A	1	ACTIVATION	True
5858	5912	12624109:0:Tst-1:SPRR2A	Among the three major POU proteins expressed in human skin, Oct-1, [TF]/Oct-6, and Skn-1/Oct-11, only the latter induced [TG], a marker of keratinocyte terminal differentiation.	Tst-1	SPRR2A	1	ACTIVATION	True
5868	5922	12624109:0:Skn-1:SPRR2A	Among the three major POU proteins expressed in human skin, Oct-1, Tst-1/Oct-6, and [TF]/Oct-11, only the latter induced [TG], a marker of keratinocyte terminal differentiation.	Skn-1	SPRR2A	1	ACTIVATION	False
5873	5927	12624109:0:Oct-11:SPRR2A	Among the three major POU proteins expressed in human skin, Oct-1, Tst-1/Oct-6, and Skn-1/[TF], only the latter induced [TG], a marker of keratinocyte terminal differentiation.	Oct-11	SPRR2A	1	ACTIVATION	True
5875	5929	12624109:0:Skn-1a:SPRR2A	[TF], the largest protein, functionally cooperated with Ese-1/Elf-3, an epithelial-specific transcription factor, previously implicated in [TG] induction.	Skn-1a	SPRR2A	1	ACTIVATION	True
5877	5931	12624109:0:Skn-1d1:SPRR2A	Skn-1a and [TF] bound the [TG] octamer site with comparable affinity and functioned as transcriptional activators.	Skn-1d1	SPRR2A	1	ACTIVATION	False
5878	5932	12624109:0:Skn-1d2:SPRR2A	[TF] did not affect [TG] expression.	Skn-1d2	SPRR2A	0	UNDEFINED	False
5883	5937	12624109:0:Ese-1:SPRR2A	Skn-1a, the largest protein, functionally cooperated with [TF]/Elf-3, an epithelial-specific transcription factor, previously implicated in [TG] induction.	Ese-1	SPRR2A	1	ACTIVATION	False
5886	5940	12624109:0:Elf-3:SPRR2A	Skn-1a, the largest protein, functionally cooperated with Ese-1/[TF], an epithelial-specific transcription factor, previously implicated in [TG] induction.	Elf-3	SPRR2A	1	ACTIVATION	False
5891	5945	15105423:0:A-Myb:DHRS2	Deletion and domain swap experiments identified small, discreet positive and negative elements in [TF] and c-Myb that were required for the regulation of specific genes, such as [TG], DSIPI, and mim-1.	A-Myb	DHRS2	0	UNDEFINED	False
5892	5946	15105423:0:A-Myb:DSIPI	Deletion and domain swap experiments identified small, discreet positive and negative elements in [TF] and c-Myb that were required for the regulation of specific genes, such as DHRS2, [TG], and mim-1.	A-Myb	DSIPI	0	UNDEFINED	False
5893	5947	15105423:0:A-Myb:mim-1	Deletion and domain swap experiments identified small, discreet positive and negative elements in [TF] and c-Myb that were required for the regulation of specific genes, such as DHRS2, DSIPI, and [TG].	A-Myb	mim-1	0	UNDEFINED	False
5894	5948	15105423:0:c-Myb:DHRS2	Deletion and domain swap experiments identified small, discreet positive and negative elements in A-Myb and [TF] that were required for the regulation of specific genes, such as [TG], DSIPI, and mim-1.	c-Myb	DHRS2	0	UNDEFINED	False
5895	5949	15105423:0:c-Myb:DSIPI	Deletion and domain swap experiments identified small, discreet positive and negative elements in A-Myb and [TF] that were required for the regulation of specific genes, such as DHRS2, [TG], and mim-1.	c-Myb	DSIPI	0	UNDEFINED	False
5896	5950	15105423:0:c-Myb:mim-1	Deletion and domain swap experiments identified small, discreet positive and negative elements in A-Myb and [TF] that were required for the regulation of specific genes, such as DHRS2, DSIPI, and [TG].	c-Myb	mim-1	0	UNDEFINED	False
5923	5980	9858508:0:Egr-1:aminopeptidase BP-1/6C3	Analysis of changes in the expression pattern of potential Egr-1 target genes revealed that [TF] enhances the expression of the [TG] in pre-B and immature B cells and upregulates expression of the orphan nuclear receptor nur77 in IgM+ B cells.	Egr-1	aminopeptidase BP-1/6C3	1	ACTIVATION	False
5924	5981	9858508:0:Egr-1:nur77	Analysis of changes in the expression pattern of potential Egr-1 target genes revealed that [TF] enhances the expression of the aminopeptidase BP-1/6C3 in pre-B and immature B cells and upregulates expression of the orphan nuclear receptor [TG] in IgM+ B cells.	Egr-1	nur77	1	ACTIVATION	False
5928	5985	12147685:9:STAT3:cyclin D1	Furthermore, STAT3-C, a constitutively active form of [TF], suppressed transcription of the [TG] promoter in fetal hepatocytes, whereas it activated the transcription in hepatic tumor cells, huH7 and HepG2.	STAT3	cyclin D1	2	REPRESSION	True
5929	5986	16890608:7:c-fos:ASBT	Meanwhile, [TF] antisense treatment activated the human ASBT promoter 5-fold and not only abrogated interleukin-1beta-mediated repression but led to a paradoxical increase in [TG] promoter activity.	c-fos	ASBT	2	REPRESSION	False
5931	5988	21586797:3:KLF4:PFKP	[TF] activated the transcription of the [TG] gene by directly binding to the PFKP promoter.	KLF4	PFKP	1	ACTIVATION	False
5933	5990	16858008:8:GKLF:alpha-SMA	These data taken together suggest that in addition to inhibition via the TCE, [TF] represses [TG] gene expression by interacting with Smad3 to prevent Smad3 binding to the SBE.	GKLF	alpha-SMA	2	REPRESSION	False
5937	5994	12463425:2:androgen receptor:PSA	The [TG] gene is partially regulated by androgen hormone via [TF] (AR).	androgen receptor	PSA	0	UNDEFINED	False
5940	5997	12463425:2:AR:PSA	The [TG] gene is partially regulated by androgen hormone via androgen receptor ([TF]).	AR	PSA	0	UNDEFINED	False
5943	6000	12463425:2:androgen hormone:PSA	The [TG] gene is partially regulated by [TF] via androgen receptor (AR).	androgen hormone	PSA	0	UNDEFINED	False
5953	6013	12047722:0:ERbeta:OT	Second, the human and bovine [TG] promoter can be made artificially responsive towards oestrogen in a cotransfection system over-expressing ERalpha or [TF], but not in cells expressing natural levels of these steroid receptors.	ERbeta	OT	0	UNDEFINED	True
5956	6016	12047722:0:(ER)alpha:OT	Transfection and DNA-protein binding experiments using high levels of either oestrogen receptor [TF] or ERbeta imply a direct interaction of these transcription factors with the multiple hormone response element (HRE) at approximately -160 from the transcription start site of the [TG] gene in most species.	(ER)alpha	OT	0	UNDEFINED	True
5959	6019	12047722:0:ERalpha:OT	Second, the human and bovine [TG] promoter can be made artificially responsive towards oestrogen in a cotransfection system over-expressing [TF] or ERbeta, but not in cells expressing natural levels of these steroid receptors.	ERalpha	OT	1	ACTIVATION	False
5967	6027	12670590:0:androgen:PSA	Analysis of G/A polymorphism in the [TF] response element I of the [TG] gene and its interactions with the androgen receptor polymorphisms.	androgen	PSA	0	UNDEFINED	True
5969	6029	12130557:3:CREB1:PDGFRA	Expression of dominant negative [TF] protein, A-CREB, increases [TG] protein content and the PDGFRalpha-promoter activity in SMCs.	CREB	PDGFRalpha	2	REPRESSION	False
5970	6030	18802055:0:ATF2:IL23A	Promoter analysis reveals critical roles for SMAD-3 and [TF] in expression of [TG] in macrophages.	ATF-2	IL-23 p19	1	ACTIVATION	False
5971	6031	20643408:5:PREB:ABCA1	In the present study, we have examined the role of [TF] in regulating [TG] expression mediated by 3',5'-cyclic adenosine-5'-monophosphate (cAMP).	PREB	ABCA1	0	UNDEFINED	False
5972	6032	11960372:6:STAT3:VEGFA	Furthermore, interrupting [TF] signaling with dominant-negative Stat3 protein or Stat3 antisense oligonucleotide in tumor cells down-regulates [TG] expression.	Stat3	VEGF	1	ACTIVATION	False
5973	6033	21868379:5:NR4A3:SKP2	Conversely, adenovirus-mediated overexpression of [TF] induces [TG] expression in VSMC and decreases protein abundance of its target p27.	NOR1	Skp2	1	ACTIVATION	False
5974	6034	11953011:8:KLF9:CDKN1A	However, while [TF] and its ubiquitous family member Sp1 increased basal p21([TG]) and IGFBP-2 transcription when added as expression constructs in the parental Hec-1-A cell line, only Sp1 activated Axl transcription, despite the presence in all three gene promoters of GC-enriched regions that presumably can bind BTEB1 and Sp1 with similar affinities.	BTEB1	WAF1	1	ACTIVATION	False
5975	6035	8145764:7:TTF1:TSHR	The promoters of the main thyroid differentiation markers thyroglobulin, thyroperoxidase, and now [TG]r, are regulated by [TF].	TTF1	TSH	0	UNDEFINED	False
5976	6036	21982894:5:NFE2L2:HMOX1	However, the regulation of [TG] by the antioxidant-response element is firmly established, with the transcription factor BACH1 serving as a repressor and [TF] as an enhancer.	Nrf2	HMOX1	1	ACTIVATION	False
5977	6037	20097716:11:CREB1:CYP11B2	The constitutively active ATF/[TF] vectors increased the promoter activity of [TG] and had a synergistic effect with NURR1.	CREB	CYP11B2	1	ACTIVATION	False
5978	6038	15461591:8:JUN:MUC4	We also demonstrate that PEA3 acts in synergy with [TF] specificity protein 1 to transactivate the proximal region of the [TG] promoter and increase MUC4 mRNA levels in WD cells.	c-Jun and	MUC4	1	ACTIVATION	False
5979	6039	15708369:9:AP1:MMP9	Collectively, these results suggest that EGCG inhibits G(1) to S-phase cell cycle progress and [TG] expression through the transcription factors NF-kappaB and [TF] in TNF-alpha-induced VSMC.	AP-1	MMP-9	2	REPRESSION	True
5980	6040	19003324:11:MAX:TERT	Furthermore, promoter analysis, using the 5'-region of the [TG] gene, which possess two E-box elements bound to c-Myc/[TF], demonstrated that mTERT promoter activity greatly decreased in TGF-beta-treated SFME cells as compared to non-treated SFME cells.	Max	mTERT	0	UNDEFINED	True
5981	6041	15743889:6:AP1:CCR5	Analysis of some transcription factors associated with [TG] promoter revealed that Abeta increased DNA binding activity of Egr-1 and [TF].	AP-1	CCR5	0	UNDEFINED	False
5982	6042	24183724:8:TP53:TRIM22	This notion is supported by cell line studies, which showed that [TG] was no longer inducible by [TF]-activating genotoxic drugs in breast cancer cell lines and in a p53 null cell line H1299 transfected with wild type p53.	p53	TRIM22	1	ACTIVATION	False
5983	6043	15669179:7:NFKB:TNF	Proportional suppression of [TG] promoter activity was observed when myocytes was transiently transfected with whole length of TNFalpha promoter (-721/+17) after being stimulated with LPS and fenofibrate or pioglitazone, whereas no change of promoter activity was observed with transfection of TNFalpha reporter construct in deletion of [TF] binding site (-182/+17).	NF-kappaB	TNFalpha	1	ACTIVATION	True
5984	6044	8290595:4:NFKB:IL6	We report that, in intact cells, activation of the [TG] promoter by a combination of the factor NF-IL6 and the p65 subunit of [TF] is inhibited by dexamethasone (ligand)-activated glucocorticoid receptor.	NF-kappa B	interleukin 6	1	ACTIVATION	False
5985	6045	17292554:10:NFKB:TNF	Instead, TQ significantly increased the amount of the repressive [TF] p50 homodimer, and simultaneously decreased the amount of transactivating NF-kappaB p65:p50 heterodimer, bound to the [TG] promoter as revealed by electrophoretic mobility shift and chromatin immunoprecipitation assays.	NF-kappaB	TNFalpha	0	UNDEFINED	False
5986	6046	11036073:7:RELA:NOS2	ESE-1 can bind to the p50 subunit of NF-kappaB, and cotransfection of ESE-1 with the p50 and [TF] subunits of NF-kappaB synergistically enhances transactivation of the [TG] promoter by ESE-1.	p65	NOS2	1	ACTIVATION	False
5987	6047	21357443:5:AHR:ABCG2	Activated [TF] was found to be associated with the [TG] promoter only in cell line models that respond to romidepsin with ABCG2 upregulation.	AhR	ABCG2	1	ACTIVATION	False
5988	6048	21252297:7:FUBP3:FGF9	Further examination using ribosome complex pull-down assay showed overexpression of [TF] promotes [TG] expression.	FUBP3	FGF9	1	ACTIVATION	False
5990	6050	20506119:4:EGR2:NAB2	In T lymphocytes [TF] and EGR3 have been shown to inhibit [TG] expression.	EGR2	NAB2	2	REPRESSION	False
5991	6051	15256533:2:PGR:ADAMTS1	Herein we show that induction of [TG] message in vivo and transcription of the ADAMTS-1 promoter in cultured granulosa cells are dependent on separable but coordinate actions of LH and the [TF] (PR).	progesterone receptor	ADAMTS-1	1	ACTIVATION	False
5992	6052	11869689:6:SPI1:IL7R	These results demonstrate that [TF] functions to regulate early B cell development in part by controlling the expression of the [TG] gene.	PU.1	IL-7Ralpha	0	UNDEFINED	False
5993	6053	17997161:9:NFKB:IL8	Taken together, these results suggest that PGN induces [TG] expression in a CD14-enhanced manner in human alveolar type II epithelial cells, through the formation of lipid rafts and the activation of MAP kinases, which ultimately leads to activation of AP-1, [TF], and NF-IL6.	NF-kappaB	IL-8	1	ACTIVATION	True
5994	6054	19095772:12:EGR1:LHB	[TF] and SF-1 were ubiquitinated in gonadotropes and ubiquitinated forms of these factors associated with the [TG] promoter, suggesting their degradation may be key for LHbeta proteasome-dependent transcription.	Egr-1	LHbeta	1	ACTIVATION	False
5995	6055	15040011:6:AP1:PLAUR	The primary components present in the TGF-beta-stimulated AP-1 complex bound to the [TG] promoter were Jun D and [TF].	Fra-2	uPAR	0	UNDEFINED	False
5996	6056	10745175:4:TP53:ABCB1	Unlike in previous reports the [TG] promoter was no more active in two cancer cell lines with mutations in the [TF] gene than in two other lines with wild-type p53, and its expression level could not be increased by either doxorubicin or taxol.	p53	mdr1	0	UNDEFINED	True
5997	6057	18617575:5:PAX5:CD19	Following stable transfection of the ribozymes into a model B cell line (REH), we showed that [TF]B suppression led to an increase of [TG] mRNA and cell surface protein expression.	Pax-5	CD19	2	REPRESSION	False
5998	6058	21628418:10:PGR:CYP19A1	Taken together, progesterone enhances recruitment of [TF] to specific regions of the promoter I.f of [TG] and regulates aromatase expression in hypothalamic neurons.	Pgr	Cyp19a1	0	UNDEFINED	False
5999	6059	22593050:0:EGR1:PPP1R1B	[TF] induces [TG] expression in striatal medium spiny neurons via a conserved intragenic element.	Egr-1	DARPP-32	1	ACTIVATION	False
6000	6060	8557686:7:ETS1:TIMP1	These results suggest that AP-1 tethers c-[TF] to the [TG] promoter via protein-protein interaction to achieve Ets-dependent transcriptional regulation.	Ets-1	TIMP-1	0	UNDEFINED	False
6001	6061	10212281:9:GATA3:IL5	The synergism of [TF] with either Ets1 or Ets2 may play an important role in calcium- or Tax1-dependent regulation of [TG] expression in Th2 cells or in HTLV-I transformed adult T-cell leukemia cells, respectively.	GATA3	IL-5	0	UNDEFINED	False
6002	6062	14573768:9:MAZ:PNMT	Thus, expression of the [TG] gene seems to be modulated through competitive binding of phosphorylated Sp1 and [TF] to their consensus elements in the promoter.	MAZ	PNMT	0	UNDEFINED	False
6003	6063	24835310:5:MYC:NOP16	Additionally, CtBP2 inhibition could decrease the level of [TF] and its direct transcriptional target, [TG].	c-Myc	HSPC111	0	UNDEFINED	True
6004	6064	21257755:5:SP1:ABCA1	In addition, LDL significantly increased the level of phosphorylated specificity protein 1 ([TF]) and the amount of Sp1 bound to the [TG] promoter without alteration in total Sp1 protein level.	Sp1	ABCA1	0	UNDEFINED	False
6005	6065	18625704:8:ETS1:FLT1	Knockdown of [TF] and HIF-2alpha by RNA interference inhibits EGF/FGF2-induced [TG] expression, and loss of expression is associated with impaired RNA-polymerase II recruitment and histone modifications at the VEGFR1 promoter region.	ETS1	VEGFR1	1	ACTIVATION	False
6006	6066	11773447:4:FOXM1:GCG	[TF] has been previously demonstrated to interact with the G2 element and to be crucial for [TG] gene expression; we thus define a second binding site for this transcription on the glucagon gene promoter.	HNF-3	glucagon	1	ACTIVATION	False
6007	6067	10652022:10:STAT1:CIITA	Overexpression of [TF]-mutant lacking 35 C-terminal amino acids strongly suppressed the IFN-gamma-induced signal transduction and inhibited the expression of MHC class II and [TG] genes in mesangial cells.	Stat1	CIITA	1	ACTIVATION	False
6008	6068	18815185:6:IRX5:KCND2	[TF], but not Irx3 or Irx4, increased [TG] promoter activity in 10T1/2 fibroblasts, whereas the transcription factor decreased promoter activity in neonatal ventricular myocytes.	Irx5	Kv4.2	1	ACTIVATION	False
6009	6069	20053791:8:CREB1:DOT1L	Overexpression of [TF] enhanced forskolin-stimulated [TG] promoter activity.	CREB	Dot1	1	ACTIVATION	False
6010	6070	10573531:8:CEBPB:ABCC2	This study suggests that [TF] (-356 to -343) may regulate the liver expression of the [TG] gene.	C/EBPbeta	MRP2	0	UNDEFINED	False
6011	6071	1324403:9:MEF2A:MYOG	Here we show that the [TG] promoter contains a binding site for the myocyte-specific enhancer-binding factor, [TF], which can function as an intermediary of myogenin autoactivation.	MEF-2	myogenin	1	ACTIVATION	False
6012	6072	15226411:1:MYC:PDGFRB	The [TF] transcription factor represses the mRNA expression of the [TG] gene (PDGFRB).	c-Myc	platelet-derived growth factor receptor beta	2	REPRESSION	False
6013	6073	17419679:11:AP1:TCIRG1	We provide data that identify junD proto-oncogene (JunD) and Fos-related antigen 2 ([TF]) as the activator protein-1 (AP-1) factors responsible for the RANKL-induced upregulation of the mouse [TG] gene expression.	Fra-2	Tcirg1	1	ACTIVATION	False
6014	6074	12514743:3:NR1I3:CYP3A4	Currently available studies indicate that the ligand-activated nuclear receptors pregnane X receptor (PXR; NR1I2) and constitutive androstane receptor (CAR; [TF]) regulate [TG]4 expression.	NR1I3	CYP3A	0	UNDEFINED	False
6015	6075	24330518:11:SMAD3:SERPINE1	Furthermore, WWOX expression dramatically decreases [TF] occupancy at the ANGPTL4 and [TG] promoters and significantly quenches activation of a TGF responsive reporter.	SMAD3	SERPINE1	1	ACTIVATION	True
6016	6076	18424770:6:WT1:EPOR	[TF](-KTS) significantly increased endogenous [TG] transcripts in transfected cells.	Wt1	EpoR	1	ACTIVATION	True
6018	6079	9442384:0:CEBPB:LBP	The transcriptional activation pattern of [TG] (LBP) involving transcription factors AP-1 and [TF].	C/EBP beta	lipopolysaccharide binding protein	1	ACTIVATION	True
6019	6080	18213392:5:E2F6:DTL	By measuring the luciferase activity in A549 cells, the intergenic human sequence was shown to be able to drive the reporter gene expression in either direction and notably, among transcription factors E2F, E2F1 approximately E2F4, but not E2F5 and [TF], this sequence clearly up-regulated the reporter gene expression exclusively in the direction of the [TG] gene.	E2F6	CDT2	1	ACTIVATION	False
6020	6081	8108428:6:NR5A1:OXT	The relative expression of these two factors during luteal development correlates with the level of luteal [TG] gene expression, with [TF] being the factor binding to the promoter of the oxytocin gene when this promoter is activated.	SF-1	oxytocin	1	ACTIVATION	False
6021	6082	11795310:8:EGR1:KLF5	Mitogenic stimulation activates [TG]/IKLF gene expression through MEK1 and [TF].	Egr-1	BTEB2	1	ACTIVATION	False
6022	6083	10075021:6:IRF2:NOS2	Our findings could indicate that IL-4 suppresses IFN-gamma-stimulated [TG] transcription by elevating the level of [TF] which, through competition, prevents IRF-1 from binding to ISRE in the iNOS promoter.	IRF-2	iNOS	2	REPRESSION	False
6023	6084	15688401:5:STAT3:VEGFA	We further show that IL-6-induced [TG] transcription and VEGF secretion by human glioblastoma cells is dependent on [TF] (STAT3).	signal transducer and activator of transcription 3	VEGF	1	ACTIVATION	False
6024	6085	18498249:4:NFKB:HIF1A	One important mechanism underlying these responses is the transcriptional regulation of [TG] by the redox-sensitive transcription factor [TF] (nuclear factor kappaB), which binds at a distinct element in the proximal promoter of the HIF-1alpha gene.	NF-kappaB	HIF-1alpha	0	UNDEFINED	False
6025	6086	12824466:8:KLF6:MSRA	In a mutant yeast strain lacking the [TF]-encoding gene, the ability to overexpress [TG] mRNA and MsrA protein was impaired and MsrA catalytic activity was greatly reduced, suggesting that CPBP may enhance msrA gene expression.	CPBP	msrA	1	ACTIVATION	False
6026	6087	7556187:3:MYC:CEBPA	We show that the endogenous [TG] protein level is repressed in stable cell lines overexpressing [TF].	Myc	C/EBP alpha	2	REPRESSION	False
6027	6088	15988009:1:NFE2L2:GCLC	[TG] (GCLC) is regulated transcriptionally by Nrf1 and [TF].	Nrf2	Glutamate-cysteine ligase catalytic subunit	0	UNDEFINED	False
6028	6089	8114693:5:ETS2:PRL	Additionally, using a molecular genetic approach, we determined that inhibitory forms of p42 mitogen-activated protein kinase and an [TF] transcription factor interfere with both the Ras and the Raf activation of the rat [TG] promoter.	Ets-2	prolactin	0	UNDEFINED	True
6029	6090	23584477:5:TP53:DDX3X	Conversely, [TG] expression was markedly elevated by wild-type (WT) [TF] ectopic expression in p53-null H1299 cells, E6-knockdown TL-1 lung cancer and SiHa cervical cancer cells.	p53	DDX3	1	ACTIVATION	False
6030	6091	12039983:8:NFKB:IL6	Binding activity of the activator protein-1 (AP-1), which has been implicated to regulate induction of the [TG] gene together with [TF], was also stimulated by MCP-1.	NF-kappaB	IL-6	1	ACTIVATION	False
6031	6092	24755985:7:DNMT1:KLF4	In vitro, DF increased DNA methylation of CpG islands within the [TG] promoter that significantly contributed to suppression of KLF4 transcription; the effects were mitigated by DNA methyltransferase ([TF]) inhibitors and knockdown of DNMT3A.	DNMT	KLF4	2	REPRESSION	False
6032	6093	23608488:3:JUNB:MMP3	Here we show that IL-1 induced binding of transcription factor [TF] to the [TG] promoter consists primarily of c-Jun, JunB, and c-Fos and that binding of c-Jun and c-Fos is inhibited by the combination of cytokines while binding of Jun B is not.	AP-1	MMP-3	0	UNDEFINED	False
6033	6094	12204775:4:MITF:TYR	We investigated whether [TF] regulates human MC1R gene expression through the same transcriptional mechanism as [TG] and TRP-1 genes in melanocytes.	MITF	tyrosinase	0	UNDEFINED	True
6034	6095	19588995:7:NR1H3:ABCC2	In contrast, [TG] induction by T0901317 was attenuated by transient transfection of a dominant negative [TF] variant, suggesting that LXRalpha is involved in ABCC2 induction.	LXRalpha	ABCC2	1	ACTIVATION	False
6035	6096	17592024:7:PPARG:FST	Activation of PPARalpha and [TF] increased mRNA levels of [TG], but did not affect the expression of follistatin-related gene.	PPARgamma	follistatin	1	ACTIVATION	False
6036	6097	23326414:5:TBX6:HES7	Our results demonstrate that Wnt pathway molecules activate the [TG] promoter cooperatively with [TF] in cell culture and are necessary for its proper expression in the mouse PSM.	Tbx6	Hes7	1	ACTIVATION	False
6037	6098	20133611:0:STAT5A:SLC30A2	[TF]-glucocorticoid receptor interaction and MTF-1 regulate the expression of ZnT2 ([TG]) in pancreatic acinar cells.	STAT5	Slc30a2	0	UNDEFINED	False
6038	6099	15522290:6:MAFB:CRYAB	Regulation of [TG] was studied in the presence of lens epithelial-factors Pax6, [TF], and RARbeta/RXRbeta, and lens fiber-factors Pax6, MafA, c-Maf, and NRL.	MafB	alphaB-crystallin	0	UNDEFINED	False
6039	6100	23649632:8:SMAD2:POU5F1	Additionally, induction of Cdx2 expression, as a result of decreased [TF] expression, leads to repression of [TG] expression, which, together with the decreased Nanog expression, accelerates the loss of pluripotency.	Smad2	Oct4	1	ACTIVATION	True
6040	6101	21212793:0:TCF3:CD38	[TF] is a transcriptional regulator of [TG] expression in chronic lymphocytic leukemia.	E2A	CD38	0	UNDEFINED	False
6041	6102	3945313:5:SP1:DHFR	We report here that [TF] binds to these regions in the [TG] promoter, and that Sp1-containing preparations stimulate transcription from the dhfr promoter in an in vitro reaction.	Sp1	dhfr	1	ACTIVATION	False
6042	6103	9254668:7:EGR1:PNMT	To identify possible transcriptional regulatory elements of the alpha7 subunit gene involved in the restricted expression of nicotinic receptors, we isolated and characterized its 5' flanking region, revealing putative binding sites for the immediate early gene transcription factor [TF], which is known to activate [TG] expression.	Egr-1	PNMT	1	ACTIVATION	False
6043	6104	20659467:3:TFAP2B:CD36	The quantitative real-time RT-PCR and Western blot indicated that [TF] upregulated the expression of [TG].	AP-2beta	CD36	1	ACTIVATION	False
6044	6105	10467400:4:RELA:PLAU	The [TG] promoter contains an NF-kappaB binding site that directly mediates the induction of uPA expression by [TF].	RelA	uPA	1	ACTIVATION	False
6045	6106	18487368:11:TP53:CAT	The results suggest a novel regulating influence of [TF] on [TG] in the retina--more specifically in the RGC--and an influence of p53 on the susceptibility of the cell to oxidative-signaling-induced apoptosis, which could implicate p53 as a potential neuroprotectant for the RGC.	p53	catalase	0	UNDEFINED	False
6046	6107	11278771:10:JUN:PTPN6	Moreover, overexpression of [TF](wt) resulted in increased [TG] promoter activity.	c-Jun	SHP-1	1	ACTIVATION	False
6047	6109	20596645:4:NFKB:BAD	The [TF] consensus binding sequence is detected on [TG] promoter.	NF-kappaB	BAD	0	UNDEFINED	False
6048	6110	9933606:0:CDX2:GCG	Pax-6 and [TF] interact to activate [TG] gene expression on the G1 control element.	Cdx-2/3	glucagon	1	ACTIVATION	False
6049	6111	10866666:2:ATF6:HSPA5	To understand the mechanism of [TG] induction by [TF] in cells subjected to ER calcium depletion stress mediated by thapsigargin (Tg) treatment, we discovered that ATF6 itself undergoes Tg stress-induced changes.	ATF6	grp78	1	ACTIVATION	False
6052	6114	19633298:0:PPARG:HCAR1	[TF] regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/[TG]).	Peroxisome proliferator-activated receptor gamma	Gpr81	0	UNDEFINED	False
6053	6115	11427482:10:MYB:MAT2A	Increased expression of [TF] and Sp1 and binding to the MAT2A promoter contribute to transcriptional up-regulation of MAT2A in HCC.-Yang, H., Huang, Z.-Z., Wang, J., Lu, S. C. The role of c-Myb and Sp1 in the up-regulation of [TG] gene expression in human hepatocellular carcinoma.	c-Myb	methionine adenosyltransferase 2A	1	ACTIVATION	False
6054	6116	14660629:6:ARNT:SIM1	A gel shift assay indicated that AHR-[TF]/2 can bind its putative site in the [TG] promoter.	ARNT	Sim1	0	UNDEFINED	False
6055	6117	12527911:0:NFKB:ABCB1	[TF] transcription factor induces drug resistance through [TG] expression in cancer cells.	NF-kappaB	MDR1	1	ACTIVATION	True
6056	6118	9420275:10:CEBPZ:PDLIM7	In addition, the affinities of [TF] for binding to the [TG], LMP-2, and CD23 promoters were also measured.	CBF2	LMP-1	0	UNDEFINED	False
6057	6119	11754361:0:CREM:FASLG	Differential inducibility of the transcriptional repressor [TF] and its role in modulation of [TG] expression in T and NK lymphocytes.	ICER	Fas ligand	0	UNDEFINED	False
6058	6120	19010343:12:HNF4A:ABCC2	C/EBP, HNF3, and HNF6 inhibited HNF1alpha while [TF] induced [TG] luciferase expression and glucocorticoids stimulated MRP2 expression.	HNF4alpha	MRP2	1	ACTIVATION	False
6059	6121	2284094:9:CTCF:MYC	Removal of 110 bp sequence binding both [TF] and Sp1-like proteins leads to a 4 to 8-fold increase in transcription of stably transfected [TG] fusion constructs in chicken embryonic fibroblasts, suggesting that the CTCF is likely to be one of multiple nuclear factors involved in the transcriptional regulation of the chicken c-myc gene.	CTCF	c-myc	2	REPRESSION	True
6060	6122	11960378:5:STAT3:VEGFA	We also show that activated [TF]alpha can increase transcription from the vascular endothelial growth factor ([TG]) gene.	Stat3	VEGF	1	ACTIVATION	False
6061	6123	16000878:0:JUN:MMP2	Tetraspanin CD9 induces [TG] expression by activating p38 MAPK, JNK and [TF] pathways in human melanoma cells.	c-Jun	MMP-2	1	ACTIVATION	False
6062	6124	8824277:4:NFKB:IL6	In a series of co-transfection assays, we found that 5alpha-dihydrotestosterone, through the androgen receptor, repressed activation of the [TG] promoter, in part, by inhibiting [TF] activity.	NFkappaB	interleukin-6	1	ACTIVATION	False
6063	6125	20543567:7:TP53:DHRS3	A tumor-derived [TF] mutant is unable to activate [TG] transcription.	p53	retSDR1	1	ACTIVATION	False
6064	6126	7538957:4:POU1F1:PRL	Electrophoretic mobility shift assays further demonstrated that [TF] was present in nuclear extracts and displayed equal affinities to bind the 1P responsive element encompassing the -65 to -38 region of the r[TG] promoter, whatever the GH3 cell line tested.	Pit-1	PRL	0	UNDEFINED	False
6065	6127	24367622:8:POU2F2:HMGA1	Overall, our results provide insight into the transcriptional regulation of the [TG] gene, revealing a differential control exerted by both Oct-1 and [TF].	Oct-2	HMGA1	0	UNDEFINED	False
6066	6128	20005806:4:FOXL2:SRY	Inducible deletion of [TF] in adult ovarian follicles leads to immediate upregulation of testis-specific genes including the critical [TG] target gene Sox9.	Foxl2	SRY	2	REPRESSION	True
6067	6129	21357535:0:STAT6:IL24	[TF] and c-Jun mediate Th2 cell-specific [TG] gene expression.	Stat6	IL-24	1	ACTIVATION	False
6068	6130	21317932:6:TP53:CDKN1A	Under the regulation of LKB1, NUAK1 interacts with [TF] in the nucleus and binds to the p53-responsive element of p21/[TG] promoter.	p53	WAF1	0	UNDEFINED	False
6069	6131	20180881:5:MYCN:GCLC	Furthermore, we found that [TF] directly binds to an E-box containing [TG](cat) promoter and that over-expression of MYCN in MYCN-non-amplified cells stimulated GCL(cat) expression and provided resistance to oxidative damage; whereas knock down of MYCN in MYCN-amplified cells decreased GCL(cat) expression and sensitized them to oxidative damage.	MYCN	GCL	1	ACTIVATION	False
6070	6132	20346398:6:ZEB1:REST	NeuroD2 inhibits [TG] indirectly by involving the inhibitor of myogenic genes, [TF], which binds response elements in REST 5'-UTR.	Zfhx1a	REST	2	REPRESSION	False
6071	6133	10085109:8:SP1:PNMT	These findings suggest that [TF] may potentially contribute to the tissue-specific expression of the [TG] gene, with the competition between Sp1 and MAZ conferring additional tissue-specific control.	Sp1	PNMT	1	ACTIVATION	True
6072	6134	23320737:9:FLI1:FLT3LG	[TF] protein binds directly to the promoter region of the [TG] gene.	Fli-1	Flt3L	0	UNDEFINED	False
6073	6135	8102976:1:HNF1A:ALB	[TF] and C/EBP-related proteins are transcription factors important for the activation of [TG] gene expression.	HNF1	albumin	1	ACTIVATION	False
6074	6136	16325549:3:NFKB1:CCL2	The [TF]-binding site in the IL-8 promoter preferentially binds Rel p65/p65 homodimers and p50/p65 heterodimers while the NF-kappaB-binding motifs of the [TG] promoter preferably bind p50/p65 heterodimers and p50/p50 homodimers.	NF-kappaB	MCP-1	0	UNDEFINED	False
6075	6137	11678207:0:AP1:VEGFA	Role of [TF] and HIF-1 transcription factors in TGF-beta activation of [TG] expression.	AP-1	VEGF	1	ACTIVATION	False
6076	6138	18647882:10:MEF2A:SLC2A4	These data support the hypothesis that CaMK II activation by exercise increases [TG] expression via increased accessibility of [TF] to its cis-element on the gene.	MEF2A	GLUT4	1	ACTIVATION	False
6077	6139	10843994:0:AP1:SMAD7	Efficient TGF-beta induction of the [TG] gene requires cooperation between [TF], Sp1, and Smad proteins on the mouse Smad7 promoter.	AP-1	Smad7	1	ACTIVATION	False
6078	6140	23161884:6:SMAD3:SIRT1	Thus, upon TGF- activation, phosphorylated [TF] can be translocated into the nucleus with Smad4, whereat Smad3 in turn collaborates with c-Jun to activate [TG] transcription.	Smad3	SIRT1	1	ACTIVATION	False
6080	6142	12379744:4:GATA1:HBB	We tested whether the hematopoietic-specific activators NF-E2 and [TF], which mediate transactivation of the [TG] genes, induce both histone acetylation and H3-meK4.	GATA-1	beta-globin	1	ACTIVATION	False
6082	6144	12136890:10:NFKB:IL15	The EMSA of the [TF] site in the [TG] promoter showed that PGE2 inhibited binding of NF-kappaB in a dose dependent manner.	NF-kappaB	IL-15	0	UNDEFINED	False
6083	6145	24213577:8:EZH2:FBXO32	This phenomenon was associated with reduced [TF] occupancy and H3K27me3 levels at the [TG] promoter.	EZH2	FBXO32	0	UNDEFINED	False
6084	6146	21765477:6:RELA:BRMS1	The ability of [TF]/p65 to function as an active transcriptional repressor is promoter specific, as the NF-B-regulated gene cIAP2 (cellular inhibitor of apoptosis 2) is transcriptionally activated whereas [TG] is repressed under identical conditions.	RelA	BRMS1	2	REPRESSION	False
6085	6147	20106950:0:ARNTL:PER1	Disruption of CLOCK-[TF] transcriptional activity is responsible for aryl hydrocarbon receptor-mediated regulation of [TG] gene.	BMAL1	Period1	0	UNDEFINED	False
6086	6148	23536577:5:UTF1:CDKN1B	Chromatin immunoprecipitation analysis confirmed the physical interaction between [TF] and the [TG] promoter.	UTF1	p27 (Kip1)	0	UNDEFINED	False
6087	6150	7891708:6:HNF4A:EPO	Transfection of a plasmid expressing [TF] into HeLa cells enabled an eightfold increase in the hypoxic induction of a luciferase reporter construct which contains the minimal [TG] enhancer and Epo promoter, provided that the nuclear hormone receptor consensus DNA elements in both the promoter and the enhancer were intact.	HNF-4	Epo	1	ACTIVATION	False
6088	6151	21689417:0:CEBPB:COPS5	Stat3 and [TF] (C/EBP-beta) regulate [TG]/CSN5 expression in mammary carcinoma cells.	CCAAT/enhancer binding protein beta	Jab1	0	UNDEFINED	False
6089	6152	16500891:10:NFE2L2:FMR1	These data add [TG] to the collection of genes controlled by both NRF-1 and [TF] and disfavor its membership in the immediate early response group of genes.	NRF-2	FMR1	0	UNDEFINED	False
6090	6153	16169710:7:SMARCA5:BMP4	Genes involved in neural patterning and development, such as [TG] and Sonic hedgehog (Shh), are misregulated in the absence of functional [TF], and ISWI binds to the BMP4 gene in vivo.	ISWI	BMP4	0	UNDEFINED	True
6091	6154	17384280:3:HIF1A:SERPINE1	Here, we show that insulin upregulates human [TG] gene expression and promoter activity in HepG2 cells and that mutation of the hypoxia-responsive element (HRE)-binding hypoxia-inducible factor-1 ([TF]) abolished the insulin effects.	HIF-1	PAI-1	1	ACTIVATION	False
6092	6155	10698164:7:TTF1:TPO	As both Tg and [TG] promoters depend upon the thyroid-specific transcription factors, thyroid-specific transcription factor-1 ([TF]) and Pax-8 for full transcriptional activity, we tested whether reduction of GSH concentration impairs the activity of these transcription factors.	TTF-1	TPO	1	ACTIVATION	False
6093	6156	20564216:0:PARP1:BCL2	[TF] binds to [TG] major breakpoint region and regulates BCL2 expression.	Poly (ADP-ribose) polymerase-1	BCL2	0	UNDEFINED	False
6094	6157	15670593:7:CTCF:IRAK2	In contrast, we found that [TF] plays a major role in [TG] transcription.	CTCF	IRAK2	1	ACTIVATION	False
6095	6158	17050676:3:MTA3:WNT4	[TF] represses [TG] transcription and Wnt4 secretion, inhibiting Wnt-target genes in mammary epithelial cells.	MTA3	Wnt4	2	REPRESSION	False
6096	6159	9328347:10:POU5F1:CGB	[TF] is therefore capable of silencing both hCGalpha and [TG] gene expression.	Oct-3/4	hCGbeta	2	REPRESSION	True
6097	6160	14729949:5:NFKB:PTEN	Importantly, TNF, a potent inducer of [TF] activity, suppressed [TG] gene expression in IKK beta(+/+) cells but not in IKK beta(-/-) cells, which are deficient in the NF-kappa B activation pathway.	NF-kappa B	PTEN	2	REPRESSION	False
6098	6161	10411657:9:YBX1:ABCB1	The binding of [TF] and Sp1, transcription factors implicated in [TG] expression, in the MDR1 promoter was not affected by the methylation status of a neighboring CpG sites.	YB-1	MDR1	1	ACTIVATION	True
6099	6162	18682532:7:CEBPB:DUSP1	Instead, we identified binding of [TF] (C/EBPbeta) to a region between -1311 and -1304 bp of the [TG] promoter by EMSA and ChIP.	CCAAT/enhancer-binding protein beta	DUSP1	0	UNDEFINED	False
6100	6163	19939245:8:TP53:MMP2	Inhibition of Ets-2 and [TF] reduced [TG] expression, secretion and invasiveness of Forskolin treated cells.	p53	MMP-2	1	ACTIVATION	False
6101	6164	23751912:5:GATA4:LRRC10	We identify [TG] as a transcriptional target of Nkx2-5 and [TF].	GATA4	Lrrc10	0	UNDEFINED	False
6102	6165	12101186:6:NR5A1:CYP11A1	Considering the colocalization of TReP-132 and [TF] in steroidogenic tissues such as the adrenal and testis, and the presence of two putative LXXLL motifs in TReP-132 that can potentially interact with SF-1, the relationship between these two factors on the [TG] gene promoter was determined.	SF-1	P450scc	0	UNDEFINED	False
6103	6166	14563845:8:NFKB:REN	Our results strongly suggest that [TF] mediates the effect of TNFalpha on [TG] transcription targeting a CRE in the mouse renin promoter.	NFkappaB	renin	0	UNDEFINED	False
6104	6167	18326838:10:TP63:DLX6	ChIP analysis shows that [TF] is directly associated with the Dlx5 and [TG] promoters.	p63	Dlx6	0	UNDEFINED	False
6105	6168	9613591:3:AP1:GCLC	Transcription of deletion constructs of the [TG]-HS promoter cloned in a reporter vector was associated with activator protein-1 ([TF]), consistent with the DNA binding of AP-1 in nuclear extracts of irradiated HepG2.	AP-1	gamma-GCS	0	UNDEFINED	False
6106	6169	15282325:0:EWSR1:IGFBP3	[TF]/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of [TG].	EWS	insulin-like growth factor binding protein 3	2	REPRESSION	False
6107	6170	20510677:5:ZNF24:PDGFRB	Here, overexpression of [TF] resulted in a significant down-regulation of [TG], whereas silencing of ZNF24 with small interfering RNA led to increased PDGFR-beta expression.	ZNF24	PDGFR-beta	2	REPRESSION	False
6108	6171	18593918:8:RELA:MST1R	Treatment of MDA-MB-231 cells with pyrrolidine dithiocarbamate, an inhibitor of [TF], or small interfering RNA knockdown of p65, blocked [TG] gene expression and MSP-mediated invasion of MDA-MB-231 cells.	p65	RON	1	ACTIVATION	False
6109	6172	15684083:0:TBX21:IFNG	[TF] antagonizes mSin3a recruitment and transactivates a fully methylated [TG] promoter via a conserved T-box half-site.	T-bet	IFN-gamma	1	ACTIVATION	False
6110	6173	12947090:1:NFE2L2:NQO1	The antioxidant response element (ARE) and transcription factor [TF] regulate basal expression and antioxidant induction of NAD(P)H:quinone oxidoreductase-1 ([TG]) and other detoxifying genes.	Nrf2	NQO1	0	UNDEFINED	True
6111	6174	18042711:7:MYC:PMAIP1	Conserved [TF]-binding sites identified at the [TG] promoter were validated by ChIP and reporter assays.	MYC	NOXA	0	UNDEFINED	False
6112	6175	9230347:7:PDX1:INS	Forced expression of recombinant [TF] in the glucagonoma resulted in efficient transcriptional activation of the endogenous [TG] and IAPP genes, but did not affect glucagon gene activity.	PDX1	insulin	1	ACTIVATION	False
6113	6176	11024036:0:CEBPA:ADRB3	[TF] is required for transcription of the [TG] gene during adipogenesis.	CCAAT/enhancer-binding protein alpha	beta 3-adrenergic receptor	1	ACTIVATION	False
6114	6177	19608642:4:POU1F1:SYT1	In the present studies we have identified [TG] (Syt1) as a target gene for [TF]1 in GH(3) pituitary cells.	POU1F	synaptotagmin I	0	UNDEFINED	False
6115	6178	17686483:0:SP1:GCK	Role of [TF] and SREBP-1a in the insulin-mediated regulation of [TG] transcription in the liver of gilthead sea bream (Sparus aurata).	Sp1	glucokinase	0	UNDEFINED	False
6117	6180	18053794:7:SP1:LHX4	We conclude [TF] directly regulates [TG] gene expression.	Sp1	Lhx4	0	UNDEFINED	False
6118	6181	18544626:6:DNMT3B:DNMT3L	Genetic studies showed that Dnmt3a, [TF] and [TG] are all involved in the methylation of the Dnmt3L promoter.	Dnmt3b	Dnmt3L	0	UNDEFINED	True
6119	6182	18586672:0:NFKB:SGK1	[TF] inhibits sodium transport via down-regulation of [TG] in renal collecting duct principal cells.	NF-kappaB	SGK1	2	REPRESSION	False
6120	6183	20636440:7:YBX3:HBG2	Functional studies performed by Chromatin Immunoprecipitation and reporter gene assays in K562 cells demonstrated that [TF] is able to bind the [TG] promoter and suppress its expression.	CSDA	HBG2	2	REPRESSION	False
6121	6184	21411665:4:EGR2:PMP22	Using chromatin immunoprecipitation analysis of the rat [TG] locus, we found a major peak of [TF] binding within the large intron of the Pmp22 gene.	Egr2	Pmp22	0	UNDEFINED	False
6122	6185	18945591:0:STAT5A:CSF2	GM-CSF induces [TF] binding at epigenetic regulatory sites within the [TG] promoter of non-obese diabetic (NOD) mouse myeloid cells.	STAT5	Csf2	0	UNDEFINED	False
6123	6186	22507839:8:ATF4:TNC	Our findings thus demonstrate the role of [TF] in both injury- and PDGF-BB-inducible [TG] expression and cell migration.	ATF-4	TN-C	1	ACTIVATION	False
6124	6187	20505756:7:POU5F1:NANOG	A comparison of positively regulated [TF] targets common to EC and ES cells identified genes such as [TG], PHC1, USP44, SOX2, PHF17 and OCT4, thus further confirming their universal role in maintaining self-renewal in both cell types.	OCT4	NANOG	1	ACTIVATION	False
6125	6188	20505756:7:POU5F1:PHC1	A comparison of positively regulated [TF] targets common to EC and ES cells identified genes such as NANOG, [TG], USP44, SOX2, PHF17 and OCT4, thus further confirming their universal role in maintaining self-renewal in both cell types.	OCT4	PHC1	1	ACTIVATION	False
6126	6189	20505756:7:POU5F1:SOX2	A comparison of positively regulated [TF] targets common to EC and ES cells identified genes such as NANOG, PHC1, USP44, [TG], PHF17 and OCT4, thus further confirming their universal role in maintaining self-renewal in both cell types.	OCT4	SOX2	1	ACTIVATION	False
6127	6190	20505756:7:POU5F1:JADE1	A comparison of positively regulated [TF] targets common to EC and ES cells identified genes such as NANOG, PHC1, USP44, SOX2, [TG] and OCT4, thus further confirming their universal role in maintaining self-renewal in both cell types.	OCT4	PHF17	1	ACTIVATION	False
6128	6191	19259985:4:RUNX2:SDC1	[TF] enhances expression of genes related to proteoglycan-mediated signaling, including FGF receptors (e.g., FGFR2 and FGFR3) and proteoglycans (e.g., syndecans [[TG], Sdc2, Sdc3], glypicans [Gpc1], versican [Vcan]).	Runx2	Sdc1	1	ACTIVATION	False
6129	6192	19259985:4:RUNX2:SDC2	[TF] enhances expression of genes related to proteoglycan-mediated signaling, including FGF receptors (e.g., FGFR2 and FGFR3) and proteoglycans (e.g., syndecans [Sdc1, [TG], Sdc3], glypicans [Gpc1], versican [Vcan]).	Runx2	Sdc2	1	ACTIVATION	False
6130	6193	19259985:4:RUNX2:GPC1	[TF] enhances expression of genes related to proteoglycan-mediated signaling, including FGF receptors (e.g., FGFR2 and FGFR3) and proteoglycans (e.g., syndecans [Sdc1, Sdc2, Sdc3], glypicans [[TG]], versican [Vcan]).	Runx2	Gpc1	1	ACTIVATION	False
6131	6194	19259985:4:RUNX2:VCAN	[TF] enhances expression of genes related to proteoglycan-mediated signaling, including FGF receptors (e.g., FGFR2 and FGFR3) and proteoglycans (e.g., syndecans [Sdc1, Sdc2, Sdc3], glypicans [Gpc1], versican [[TG]]).	Runx2	Vcan	1	ACTIVATION	False
6132	6195	19259985:4:RUNX2:FGFR2	[TF] enhances expression of genes related to proteoglycan-mediated signaling, including FGF receptors (e.g., [TG] and FGFR3) and proteoglycans (e.g., syndecans [Sdc1, Sdc2, Sdc3], glypicans [Gpc1], versican [Vcan]).	Runx2	FGFR2	1	ACTIVATION	False
6133	6196	19259985:4:RUNX2:FGFR3	[TF] enhances expression of genes related to proteoglycan-mediated signaling, including FGF receptors (e.g., FGFR2 and [TG]) and proteoglycans (e.g., syndecans [Sdc1, Sdc2, Sdc3], glypicans [Gpc1], versican [Vcan]).	Runx2	FGFR3	1	ACTIVATION	False
6134	6197	24407731:7:SOX17:MACC1	Using quantitative chromatin immunoprecipitation-PCR and promoter activity assays, we confirmed that [TG], MALAT1, NBN, NFAT5, CSNK1A1, FN1 and SERBP1 genes were suppressed by [TF] via the SRY binding-mediated transcriptional regulation.	SOX17	MACC1	2	REPRESSION	False
6135	6198	24407731:7:SOX17:NBN	Using quantitative chromatin immunoprecipitation-PCR and promoter activity assays, we confirmed that MACC1, MALAT1, [TG], NFAT5, CSNK1A1, FN1 and SERBP1 genes were suppressed by [TF] via the SRY binding-mediated transcriptional regulation.	SOX17	NBN	2	REPRESSION	False
6136	6199	24407731:7:SOX17:NFAT5	Using quantitative chromatin immunoprecipitation-PCR and promoter activity assays, we confirmed that MACC1, MALAT1, NBN, [TG], CSNK1A1, FN1 and SERBP1 genes were suppressed by [TF] via the SRY binding-mediated transcriptional regulation.	SOX17	NFAT5	2	REPRESSION	False
6137	6200	24407731:7:SOX17:CSNK1A1	Using quantitative chromatin immunoprecipitation-PCR and promoter activity assays, we confirmed that MACC1, MALAT1, NBN, NFAT5, [TG], FN1 and SERBP1 genes were suppressed by [TF] via the SRY binding-mediated transcriptional regulation.	SOX17	CSNK1A1	2	REPRESSION	False
6138	6201	24407731:7:SOX17:FN1	Using quantitative chromatin immunoprecipitation-PCR and promoter activity assays, we confirmed that MACC1, MALAT1, NBN, NFAT5, CSNK1A1, [TG] and SERBP1 genes were suppressed by [TF] via the SRY binding-mediated transcriptional regulation.	SOX17	FN1	2	REPRESSION	False
6139	6202	24407731:7:SOX17:SERBP1	Using quantitative chromatin immunoprecipitation-PCR and promoter activity assays, we confirmed that MACC1, MALAT1, NBN, NFAT5, CSNK1A1, FN1 and [TG] genes were suppressed by [TF] via the SRY binding-mediated transcriptional regulation.	SOX17	SERBP1	2	REPRESSION	False
6140	6203	22370639:13:ZNF331:DSTN	The tumor-suppressive effect of [TF] is mediated at least by downregulation of genes involved in cell growth promotion ([TG], EIF5A, GARS, DDX5, STAM, UQCRFS1 and SET) and migration/invasion (DSTN and ACTR3), and upregulation of genome-stability gene (SSBP1) and cellular senescence gene (PNPT1).	ZNF331	DSTN	2	REPRESSION	False
6141	6204	22370639:13:ZNF331:DDX5	The tumor-suppressive effect of [TF] is mediated at least by downregulation of genes involved in cell growth promotion (DSTN, EIF5A, GARS, [TG], STAM, UQCRFS1 and SET) and migration/invasion (DSTN and ACTR3), and upregulation of genome-stability gene (SSBP1) and cellular senescence gene (PNPT1).	ZNF331	DDX5	2	REPRESSION	False
6142	6205	22370639:13:ZNF331:STAM	The tumor-suppressive effect of [TF] is mediated at least by downregulation of genes involved in cell growth promotion (DSTN, EIF5A, GARS, DDX5, [TG], UQCRFS1 and SET) and migration/invasion (DSTN and ACTR3), and upregulation of genome-stability gene (SSBP1) and cellular senescence gene (PNPT1).	ZNF331	STAM	2	REPRESSION	False
6143	6206	22370639:13:ZNF331:UQCRFS1	The tumor-suppressive effect of [TF] is mediated at least by downregulation of genes involved in cell growth promotion (DSTN, EIF5A, GARS, DDX5, STAM, [TG] and SET) and migration/invasion (DSTN and ACTR3), and upregulation of genome-stability gene (SSBP1) and cellular senescence gene (PNPT1).	ZNF331	UQCRFS1	2	REPRESSION	False
6144	6207	22370639:13:ZNF331:SET	The tumor-suppressive effect of [TF] is mediated at least by downregulation of genes involved in cell growth promotion (DSTN, EIF5A, GARS, DDX5, STAM, UQCRFS1 and [TG]) and migration/invasion (DSTN and ACTR3), and upregulation of genome-stability gene (SSBP1) and cellular senescence gene (PNPT1).	ZNF331	SET	2	REPRESSION	False
6145	6208	22370639:13:ZNF331:ACTR3	The tumor-suppressive effect of [TF] is mediated at least by downregulation of genes involved in cell growth promotion (DSTN, EIF5A, GARS, DDX5, STAM, UQCRFS1 and SET) and migration/invasion (DSTN and [TG]), and upregulation of genome-stability gene (SSBP1) and cellular senescence gene (PNPT1).	ZNF331	ACTR3	2	REPRESSION	False
6146	6209	22370639:13:ZNF331:SSBP1	The tumor-suppressive effect of [TF] is mediated at least by downregulation of genes involved in cell growth promotion (DSTN, EIF5A, GARS, DDX5, STAM, UQCRFS1 and SET) and migration/invasion (DSTN and ACTR3), and upregulation of genome-stability gene ([TG]) and cellular senescence gene (PNPT1).	ZNF331	SSBP1	1	ACTIVATION	True
6147	6210	24062982:4:POU3F2:MITF	However, recently the paired box transcription factor PAX3 was shown to transcriptionally activate [TF]/BRN2, leading to direct repression of [TG] expression.	POU3F2	MITF	2	REPRESSION	False
6148	6211	23180003:8:NFAT5:AQP4	The amount of [TF] bound to the promoter of [TG] was increased in response to ammonia.	NFAT5	AQP4	0	UNDEFINED	False
6149	6212	18850004:5:SP1:CDKN1A	HDAC4 interacts with [TF], binds and reduces histone H3 acetylation at the Sp1/Sp3 binding site-rich p21([TG]/Cip1) proximal promoter, suggesting a key role for Sp1 in HDAC4-mediated repression of p21(WAF1/Cip1).	Sp1	WAF1	2	REPRESSION	False
6150	6213	18848838:8:RXRA:TXNIP	The interference of PPARalpha/[TF] with the AP-1 transcription factor elements c-Jun/c-Fos resulted in the inhibition of AP-1 binding and down-regulation of the [TG] gene expression.	retinoid X receptor alpha	VDUP-1	2	REPRESSION	True
6151	6214	20452971:9:NFE2L2:RBX1	Experiments using Hepa-1 and HepG2 cells indicate that [TF] controls its own degradation by regulating expression and induction of Cul3-[TG] genes.	Nrf2	Rbx1	0	UNDEFINED	True
6152	6215	19717984:3:KLF4:NOTCH1	Activation of a conditional allele of [TF] in RK3E epithelial cells rapidly induces expression of [TG] mRNA and the active, intracellular form of Notch1.	KLF4	Notch1	1	ACTIVATION	False
6153	6216	9030601:9:CEBPA:LEP	However, TZ treatment did inhibit [TF]-mediated transactivation of the [TG] promoter.	C/EBPalpha	leptin	1	ACTIVATION	False
6154	6217	17997161:8:NFKB:IL8	Electrophoretic mobility shift assay demonstrates that PGN increased the DNA binding of the transcription factors, AP-1 and [TF] while minimally, NF-IL6, all of which are involved in the transcription of [TG].	NF-kappaB	IL-8	1	ACTIVATION	True
6155	6218	9887105:2:PRDM1:IFNB1	Here, we show that [TF] represses transcription of the [TG] promoter and of an artificial promoter through an active repression mechanism.	PRDI-BF1	IFN-beta	2	REPRESSION	False
6156	6219	23851505:3:GATA3:CCND1	We report here that [TF] promotes cell proliferation and tumorigenesis by facilitating the G1/S transition through its transcription regulation of the [TG] gene in breast cancer cells.	GATA3	CCND1	0	UNDEFINED	False
6157	6220	15181011:0:KCNIP3:TG	Transcriptional repressor [TF] interacts with thyroid transcription factor-1 and regulates [TG] gene expression.	DREAM	thyroglobulin	0	UNDEFINED	False
6158	6221	19567879:6:STAT6:KDM6B	After IL-4 stimulation, activated [TF] is increased and binds to consensus sites at the [TG] promoter.	STAT6	Jmjd3	0	UNDEFINED	False
6159	6222	23740952:4:RELA:CXCL10	Small interfering RNA-mediated suppression of NF-B [TF] markedly inhibited the ability of cytokines to induce the expression of the [TG] gene, whereas targeting STAT1 only diminished the synergy provided by IFN-.	p65	CXCL10	1	ACTIVATION	False
6160	6223	17955499:9:CREB1:USF2	Taken together, these data indicate that high glucose levels up-regulate [TG] gene transcription in mesangial cells through [TF]-dependent transactivation of the USF2 promoter.	CREB	USF2	1	ACTIVATION	False
6162	6225	20543135:7:TP53:TRIM3	Our results indicate that [TG] is a unique [TF]-regulated gene and suggest a role for p53 within the central nervous system.	p53	BERP	0	UNDEFINED	False
6163	6226	15569157:5:YBX1:ABCB1	IL-2 induced translocation of [TF], a specific transcriptional factor for [TG], from the cytoplasm into nucleus of lymphocytes in a dose-dependent manner and resulted in the sequential events; transcription of MDR-1, expression of P-glycoprotein on the cell surface, and excretion of the intracellular dexamethasone added in vitro.	YB-1	MDR-1	1	ACTIVATION	False
6164	6227	15963460:5:AP1:PLAUR	Electrophoretic mobility shift assay and transient transfection study using an [TF] decoy oligonucleotide confirmed that the activation of AP-1 is involved in the H. pylori-induced [TG] upregulation.	AP-1	uPAR	1	ACTIVATION	False
6165	6228	19549898:6:HIF1A:MUC1	Chromatin immunoprecipitation assay showed a direct binding of [TF] at the [TG] promoter.	HIF-1alpha	MUC1	0	UNDEFINED	False
6166	6229	10725705:7:IRF1:FASLG	Forced expression of either [TF] or IRF-2 leads to [TG] promoter activation in T cells and FasL expression in heterologous cells.	IRF-1	FasL	1	ACTIVATION	False
6167	6230	21266854:4:ETV4:IL8	Overexpression of ER or [TF] could up-regulate [TG] promoter activity, mRNA and secretion; silencing of ER or PEA3 decreased IL-8 mRNA and secretion.	PEA3	IL-8	1	ACTIVATION	True
6168	6231	11572983:4:TP53:BBC3	[TF] transactivated [TG] through consensus p53 binding sites within the bbc3 promoter region, indicating that bbc3 is a direct target of p53.	p53	bbc3	1	ACTIVATION	False
6169	6232	15240101:5:SMAD4:BAMBI	Our findings suggest that [TG] transcription is regulated by TGF-beta signaling through direct binding of SMAD3 and [TF] to the BAMBI promoter.	SMAD4	BAMBI	0	UNDEFINED	False
6170	6233	9154819:8:RELA:TNC	Furthermore, as demonstrated by gel shift experiments and cotransfections of the reporter plasmid and expression vectors encoding the [TF] subunit of NF-kappaB and c-Jun, the two transcription factors bind and synergistically transactivate the [TG] promoter.	p65	tenascin-C	1	ACTIVATION	False
6171	6234	21357535:11:STAT6:IL24	Knockdown of either [TF] or c-Jun suppressed endogenous [TG] gene expression in Th2 cells.	Stat6	IL-24	1	ACTIVATION	False
6172	6235	21252292:6:NFYB:TOP2A	This further suggests that increased [TF] may be a negative regulator of [TG] in CEM/VM-1-5 cells.	NF-YB	Top2	2	REPRESSION	False
6173	6236	23056300:6:STAT3:GREB1	We tested whether there was interaction between [TF] and ER, which could repress [TG] expression by immunoprecipitation assay.	STAT3	GREB1	2	REPRESSION	True
6174	6237	12130547:0:PITX2:PRL	Regulation of [TG], GH, and Pit-1 gene expression in anterior pituitary by [TF]: An approach using Pitx2 mutants.	Pitx2	prolactin	0	UNDEFINED	False
6175	6238	24634209:5:LHX2:RPE65	ChIP reveals that SOX9 and OTX2 bind to the promoter regions of [TG], RLBP1, and RGR and that [TF] binds to those of RPE65 and RGR in bovine RPE.	LHX2	RPE65	0	UNDEFINED	False
6176	6239	22784578:9:MAFB:C1QA	GATA-1 was found to inhibit the activity of the [TG] promoter with the GATA-1 motifs and [TF] motifs.	MafB	C1qa	0	UNDEFINED	True
6177	6240	10834938:0:RELA:CSN2	Activation of NF-kappaB p50/[TF] is regulated in the developing mammary gland and inhibits STAT5-mediated [TG] gene expression.	p65	beta-casein	2	REPRESSION	False
6178	6241	19366697:0:PPARG:GCK	Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, [TF], and small heterodimer partner in the transcriptional regulation of [TG] gene expression in liver.	peroxisome proliferator-activated receptor gamma	glucokinase	0	UNDEFINED	False
6179	6242	22587838:8:HSF4:RAD51	[TF] up-regulates [TG] expression while mutations in HSF4 fail, and DNA does not get repaired.	HSF4	Rad51	1	ACTIVATION	False
6181	6244	19074998:9:NR1I2:CYP3A4	These results suggest the obligatory role of the newly identified direct repeat separated by four nucleotides-type [TF] binding element of the [TG] gene for xenobiotic induction of CYP3A4.	PXR	CYP3A4	1	ACTIVATION	False
6182	6245	20022930:6:ATF6:G6PC	In a transient transfection study, [TF] inhibited the PEPCK and [TG] promoters.	ATF6	G6Pase	2	REPRESSION	False
6183	6246	19706766:5:RELA:BCL2L1	We show that NF-kappaB [TF] and MUC1-C constitutively occupy the promoter of the [TG] gene in carcinoma cells and that MUC1-C contributes to NF-kappaB-mediated transcriptional activation.	p65	Bcl-xL	1	ACTIVATION	False
6184	6247	22363646:7:ATF4:SIRT1	We demonstrated that [TF] facilitated MDR in gastric cancer cells through direct binding to the [TG] promoter, resulting in SIRT1 up-regulation.	ATF4	SIRT1	1	ACTIVATION	False
6185	6248	21241755:0:HNF4A:MIR122	Positive regulation of hepatic [TG] expression by [TF].	HNF4	miR-122	1	ACTIVATION	False
6186	6249	16287851:7:NFE2:HBB	Finally, we demonstrated by stable transfection assay that only the wild-type [TF], but not its mutant form p45 (K368R), could efficiently rescue [TG] gene expression in the p45-null, erythroid cell line CB3.	p45	beta-globin	1	ACTIVATION	False
6187	6250	22509890:6:SP1:POLI	We observed that the binding affinity of [TF] to the [TG] promoter was significantly increased in cancerous tissues and that Sp1 activated POLI gene transcription in cultured cell lines.	Sp1	POLI	1	ACTIVATION	False
6188	6251	22039367:6:SMAD3:TNFSF13B	Furthermore, overexpression of DN-[TF] abolished activin-induced [TG] expression at the transcriptional and protein levels.	Smad3	BAFF	1	ACTIVATION	False
6189	6252	19797115:0:SMAD3:GLI2	Cloning of the human [TG] Promoter: transcriptional activation by transforming growth factor-beta via [TF]/beta-catenin cooperation.	SMAD3	GLI2	1	ACTIVATION	False
6191	6254	9013901:4:CEBPA:SOD1	Cotransfection assays with the plasmid expressing transcription factor [TF] showed that C/EBP alpha transactivated [TG] gene by 27 fold.	C/EBP alpha	SOD1	1	ACTIVATION	False
6193	6256	22249179:6:KAT5:IL8	In chromatin immunoprecipitation assay, [TF] was primarily recruited to the IL-6, [TG], C-IAP1, and XIAP promoters in TNF- stimulation followed by acetylation of histones H3 and H4.	TIP60	IL-8	0	UNDEFINED	False
6194	6257	20966071:7:NFKB:VCAM1	Additionally, DNA-PK activity appeared to increase the association between p50/p50 and p50/[TF] NF-B dimers upon binding to DNA and after binding of p50 NF-B to the [TG] promoter.	p65	VCAM-1	0	UNDEFINED	False
6195	6258	20127720:6:CDX2:ELMO3	The aim of this study was to investigate the potential role of [TF] in the regulation of the [TG] promoter activity.	CDX2	ELMO3	0	UNDEFINED	False
6196	6259	11549713:0:PHOX2B:PHOX2A	Sp proteins and [TF] regulate the expression of the human [TG] gene.	Phox2b	Phox2a	0	UNDEFINED	False
6197	6260	19720140:6:YY1:GDAP1	RNAi-mediated knockdown of [TF] in HEK293 cells led to decreased [TG] expression.	YY1	GDAP1	1	ACTIVATION	False
6198	6261	19226370:5:PPARG:SESN1	Transcription of both genes appears to be mediated by [TF] as their up-regulation is reversed by the PPARgamma antagonist GW9662 and proliferator hormone response elements were found in the putative promoter regions of mouse SOD-2 and [TG].	PPARgamma	sestrin-1	1	ACTIVATION	False
6199	6262	11901151:3:JUN:PTGS2	The inductive effects of HER-2/neu were mediated, in part, by enhanced binding of [TF] (c-Jun, c-Fos, and ATF-2) to the cyclic AMP-response element (-59/-53) of the [TG] promoter.	AP-1	COX-2	1	ACTIVATION	True
6200	6263	15345676:0:PPARG:CDKN1A	[TF]-dependent activation of [TG] in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.	Peroxisome proliferator-activated receptor gamma	p21	1	ACTIVATION	False
6201	6265	10364563:6:LRRFIP1:PDGFA	5' Deletion and transient cotransfection analysis in vascular endothelial cells revealed that [TF] repression is mediated by a nucleotide region located in the proximal region of the [TG] promoter.	GCF2	PDGF-A	2	REPRESSION	True
6202	6266	15560761:6:IRF1:DST	Transient transfection studies with [TG] promoter-luciferase reporter gene plasmids and [TF] and IRF2 expression plasmids revealed that IRF1 and IRF2 directly down-regulated BPAG1 gene transcription in cultured normal human epidermal keratinocytes.	IRF1	BPAG1	2	REPRESSION	False
6203	6267	21126317:8:GATA5:MUC5B	By RT-PCR, co-transfection studies and gel-shift assays, we show that [TG] promoter activity is completely inhibited by TTF-1, whereas factors of the GATA family (GATA-4/[TF]/GATA-6) are activators.	GATA-5	Muc5b	1	ACTIVATION	False
6204	6268	9325164:2:STAT3:MYC	In the M1 myeloleukemic cell line, [TF] is a critical transcription factor causing repression of [TG] and c-myb genes, expression of junB and IRF1, growth arrest at G1, and subsequent macrophage differentiation.	Stat3	c-myc	2	REPRESSION	False
6205	6269	21124928:3:SOX11:TUBB3	Two genes under direct control of [TF] are the class- III -tubulin gene ([TG]) in neural cells and the transcription factor TEA domain family member 2 (TEAD2) in neural and mesenchymal progenitor cells.	SOX11	TUBB3	0	UNDEFINED	False
6206	6270	22797943:5:HSF1:DNAJB1	A sharp decrease in the transcript level of [TF] target genes such as HSPA1A (Hsp70), DNAJB1 ([TG]), and HSP90AA1 is also seen.	HSF1	Hsp40	0	UNDEFINED	False
6207	6271	12729460:7:EGR1:COL1A2	A target gene for [TF] that is fundamental in osteoblast physiology, [TG], is up-regulated by ATP stimulation of HOBIT cells in a timescale that is compatible with that of Egr-1 activation.	Egr-1	COL1A2	0	UNDEFINED	True
6208	6272	21454713:6:JUN:APOM	Overexpression of c-[TF] or JunB repressed both the basal and the HNF-1-mediated transactivation of the human [TG] promoter.	Jun	apoM	2	REPRESSION	False
6209	6273	15870067:7:TFAP2A:ERBB2	Notably, we showed that YY1 enhances [TF] transcriptional activation of the [TG] promoter through an AP-2 site both in HepG2 and in HCT116 cells, whereas a carboxyl-terminal-truncated form of YY1 cannot.	AP-2alpha	ERBB2	1	ACTIVATION	False
6210	6274	12835724:6:BCL3:BCL2	As p50 and p52 homodimers are devoid of any transactivating domains, we showed that they can transactivate the [TG] promoter through association with [TF].	Bcl-3	bcl-2	1	ACTIVATION	False
6211	6275	22547704:2:IRF1:RSAD2	"In this study, we show that CD40 receptor occupancy results in IFN- upregulation through an unconventional ""feed-forward"" mechanism, which is orchestrated by canonical NF-B and involves the sequential de novo synthesis of IFN regulatory factor (IRF)1 and Viperin ([TG]), an [TF] target."	IRF1	RSAD2	0	UNDEFINED	True
6212	6276	10504464:12:E2F1:CCND1	Because we previously reported that the regulation of G1 cyclins is a key factor in the G1/S transition phase in mesangial cells, we showed that overexpression of [TF] induced protein expression of [TG] and cyclin E and increased promoter activity.	E2F1	cyclin D1	1	ACTIVATION	False
6213	6277	22075993:4:ETV4:EGLN1	Among others, the E-twenty six transcription factor ETS translocation variant 4 ([TF]) was found to contribute to [TG] gene expression particularly under hypoxic conditions.	ETV4	PHD2	1	ACTIVATION	False
6214	6278	9079818:0:PAX5:VPREB1	[TF] is identical to EBB-1/KLP and binds to the [TG] and lambda5 promoters as well as the KI and KII sites upstream of the Jkappa genes.	Pax-5	VpreB	0	UNDEFINED	False
6215	6279	7640286:0:HNF4A:APOC3	Complex interactions between SP1 bound to multiple distal regulatory sites and [TF] bound to the proximal promoter lead to transcriptional activation of liver-specific [TG] gene.	HNF-4	human APOCIII	1	ACTIVATION	False
6216	6280	12730330:9:SREBF1:RETN	Together, these data suggest that ADD1/[TF] and C/EBP alpha may play discrete roles in the regulation of the [TG] gene expression.	SREBP1c	resistin	0	UNDEFINED	False
6217	6281	12493643:6:IRF2:CIITA	To further understand the mechanism of IRF-1 and [TF] cooperativity in the activation of [TG] type IV promoter, we characterized the binding of IRF-1 and IRF-2 to the CIITA IRF-E and mapped the domains of IRF-2 required for the cooperative transactivation.	IRF-2	CIITA	1	ACTIVATION	False
6219	6283	23927931:7:PDX1:INS	We therefore propose that recruitment of CBP/p300 by Glis3 provides a scaffold for the formation of a larger transcriptional regulatory complex that stabilizes the binding of [TF], NeuroD1, and MafA complexes to their respective binding sites within the [TG] promoter.	Pdx1	insulin	0	UNDEFINED	False
6220	6284	11814679:9:SP1:BSG	Transient expression of [TF] and/or Sp3 transcription factors in insect cells lacking the Sp family of transcription factors, stimulated [TG] promoter activity in a synergistic manner.	Sp1	EMMPRIN	1	ACTIVATION	False
6221	6285	11687571:5:YY1:IL4	Cotransfection of Jurkat T cells with different [TG] promoter/reporter constructs together with expression vectors encoding antisense, wild-type, or zinc finger-deleted mutant [TF] suggested that YY-1 enhanced IL-4 promoter activity in a DNA-binding domain-dependent manner.	YY-1	IL-4	1	ACTIVATION	False
6222	6286	18022758:0:SMAD3:FSHB	[TF] and Pitx2 cooperate in stimulation of [TG] gene transcription.	Smad3	FSHbeta	1	ACTIVATION	False
6223	6287	8702826:6:JUN:GSTP1	However, the addition of MCF7 nuclear extract did not disrupt binding of the VCREMS [TF]-Fos C1 complex to the [TG] promoter.	Jun	GSTP1	0	UNDEFINED	False
6224	6288	18552123:10:HNF4A:CYP2C9	Silencing of NCOA6 abrogated the synergistic activation of the [TG] promoter and the synergistic induction of the CYP2C9 gene by CAR-[TF].	HNF4alpha	CYP2C9	1	ACTIVATION	False
6225	6289	10948181:0:NFKB:TNF	Direct evidence for involvement of [TF] in transcriptional activation of [TG] by a spirochetal lipoprotein.	NF-kappaB	tumor necrosis factor	1	ACTIVATION	False
6226	6290	19850937:6:EGR1:CCND1	Additionally, ZnPP inhibited [TG] promoter activity through an Sp1 and [TF] overlapping binding site (S/E).	Egr1	CCND1	0	UNDEFINED	False
6227	6291	22037216:5:ZEB2:ESRP2	EF1 and [TF] each remarkably repressed [TG] transcription through binding to the ESRP2 promoter in NMuMG cells.	SIP1	ESRP2	2	REPRESSION	False
6229	6293	7996184:0:SP1:MAOA	Bidirectional promoter of human monoamine oxidase A ([TG]) controlled by transcription factor [TF].	Sp1	MAO A	0	UNDEFINED	False
6230	6294	16871431:0:SP1:IL10	Direct interaction of C/EBPdelta and [TF] at the GC-enriched promoter region synergizes the [TG] gene transcription in mouse macrophage.	Sp1	IL-10	1	ACTIVATION	False
6231	6295	20826544:6:ETS1:MMP1	Competitive binding and transcription assays demonstrate that CITED2 suppresses [TG] expression by competing with MMP transactivator, [TF] for its coactivator p300.	Ets-1	MMP-1	1	ACTIVATION	False
6232	6296	11444530:7:NFIC:MT1A	Further, an [TF]-C deletion mutant lacking the DNA binding domain continued to repress [TG] promoter.	NFI	MT-I	1	ACTIVATION	True
6233	6297	21969564:4:JUN:MAP3K1	A TGF-/EGFR-RhoA module initiates one of these networks by inducing [TF] expression which, in a phosphorylation-independent manner, binds to the [TG] promoter and causes an increase in MAP3K1 expression.	c-Jun	Map3k1	1	ACTIVATION	False
6234	6298	15666090:6:SP1:CXCL2	Several lines of experimental evidence imply that the [TF]-binding element is an important determinant of [TG] promoter activity, and that NF-kappaB, c-Jun and Sp1 can functionally cooperate to elicit maximal activation of the promoter.	Sp1	MIP-2	1	ACTIVATION	False
6235	6299	10212268:9:GATA4:SLC8A1	Therefore, this work demonstrates that SRF and [TF] are critical for [TG] expression in neonatal cardiomyocytes and that the -172 E-box in addition to a novel enhancer element(s) are required for phenylephrine up-regulation of NCX1 and may mediate its hypertrophic up-regulation.	GATA-4	NCX1	1	ACTIVATION	False
6236	6300	17090534:7:SP1:CDKN1A	Finally, our data strongly suggest that Sp5 has the same DNA binding specificity as [TF] and represses Sp1 target genes such as [TG].	Sp1	p21	0	UNDEFINED	True
6237	6301	11773447:8:CDX2:GCG	However, HNF-3 via its transactivating domains specifically impaired Pax6-mediated transactivation of the [TG] promoter but had no effect on transactivation by [TF].	Cdx2/3	glucagon	1	ACTIVATION	False
6238	6302	16690749:7:FOXO3:IGFBP3	This approach revealed several previously unrecognized transcriptional target genes of [TF], including IGF binding protein-3 ([TG]).	FOXO3a	IGFBP-3	0	UNDEFINED	False
6239	6303	22384243:0:ZNF804A:DRD2	[TF] regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and [TG].	ZNF804a	DRD2	0	UNDEFINED	False
6240	6304	16481345:7:NFKB1:IFNG	The latter findings suggest a role for [TF] as a negative regulator of NK cell production of [TG] and chromatin immunoprecipitation assays demonstrated the association of p50 with the IFN-gamma promoter of resting NK cells.	p50	IFN-gamma	2	REPRESSION	True
6241	6305	18047787:0:MYOD1:UCP3	Differential regulation of the promoter activity of the mouse UCP2 and [TG] genes by [TF] and myogenin.	MyoD	UCP3	0	UNDEFINED	False
6242	6306	20006635:6:FOS:IVL	Chromatin immunoprecipitation assays demonstrated substantial reduction of c-Fos and acetylated histone H3 at the proximal and distal [TF] response elements in the [TG] promoter and of coactivator p300 at the proximal element.	AP1	involucrin	0	UNDEFINED	False
6243	6307	23483971:10:EGR1:BMI1	In addition, [TF] ablation results in abnormal Ezh2 and [TG] expression.	EGR1	Bmi1	0	UNDEFINED	False
6244	6308	22847492:3:FOXL2:CYP11A1	We previously showed that human [TF] functions as a transcriptional repressor of several key genes involved in granulosa cell proliferation and differentiation, including steroidogenic acute regulatory protein (STAR), P450aromatase (CYP19A1 (CYP19)), P450scc ([TG] (CYP11A)), and cyclin D2 (CCND2).	FOXL2	CYP11A1	2	REPRESSION	False
6245	6309	21241755:9:HNF4A:MIR122	We dissected this promoter region and identified putative binding sites for liver-enriched transcriptional factors that contribute to the regulation of [TG] expression, including a putative binding site for hepatocyte nuclear factor 4 ([TF]).	HNF4	miR-122	0	UNDEFINED	False
6246	6310	16442859:6:RUNX2:GNAS	Gel shift experiments performed in this study indicate that [TF] is able to bind to the promoter of [TG], suggesting a direct regulation at the transcriptional level.	Runx2	GNAS	0	UNDEFINED	False
6247	6311	21120446:6:MYC:CDKN1A	The ectopic expression of [TF] in turn antagonized the cell cycle arrest and repressed the elevation of [TG] and p27 in HDAC7 silencing setting.	c-Myc	p21	2	REPRESSION	False
6248	6312	12574125:0:STAT5A:ID1	[TF]-induced [TG] transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta.	STAT5	Id-1	1	ACTIVATION	False
6249	6313	23386620:5:HSF1:ATG7	Mechanistic studies revealed that [TF] regulates autophagy by directly binding to [TG] promoter and transcriptionally up-regulating its expression.	HSF1	ATG7	1	ACTIVATION	False
6250	6314	9363748:2:SP1:DHFR	Given the ability of [TF] to activate the [TG] promoter, we have evaluated the contribution of Sp1 to the cell-growth regulation of the dhfr gene.	Sp1	dhfr	1	ACTIVATION	False
6251	6315	11162441:8:RARA:CYP4F2	These results indicate that retinoic acid can regulate [TG] gene activity with RXRalpha heterodimers stimulating while [TF] functioning to repress CYP4F2 gene expression.	RARalpha	CYP4F2	2	REPRESSION	False
6252	6316	17572495:11:AP1:MMP9	The functional cooperation of the Stat3 and [TF] transcription factors is required for the transcription of [TG] gene.	AP-1	MMP-9	1	ACTIVATION	False
6253	6317	19458195:4:PAX7:ID3	Ectopic [TF] activates expression of a luciferase reporter driven by the [TG] promoter, and maximal induction of this reporter requires a conserved Pax7 binding site located upstream of the Id3 gene.	Pax7	Id3	1	ACTIVATION	False
6254	6318	12902482:7:NFKB:IFNG	The role of [TF] in [TG] gene expression includes a modest decrease in Stat4 activation, T box expressed in T cell levels, and differentiation efficiency along with a more prominent postdifferentiation step.	NF-kappaB	IFN-gamma	0	UNDEFINED	True
6255	6319	17043642:6:TP53:MDM2	Spalax and human-mutated [TF] lost induction of apaf1 transcription, and increased induction of [TG] transcription.	p53	mdm2	2	REPRESSION	True
6256	6320	21145879:6:JUN:SLC29A1	[TF] but not the mutant c-Jun Ser63/73Ala, decreased m[TG] promoter activity.	c-Jun	ENT1	2	REPRESSION	False
6257	6321	18370868:6:IRF9:IL8	We conclude, through use of cell lines deficient for ISGF3 components, that all three members of this complex, Stat1, Stat2, and IFN regulatory factor-9 ([TF]), are required for IFN-beta-mediated inhibition of [TG] expression.	IRF-9	IL-8	2	REPRESSION	True
6258	6322	21325284:3:CTCF:RBL2	We revealed for the first time that in lung fibroblasts the expression of [TG]/p130 gene is directly controlled by the chromatin insulator [TF], CTCF, which by binding to the Rb2/p130 gene promoter induces, and/or maintains, a specific local chromatin organization that in turn governs the transcriptional activity of Rb2/p130 gene.	CCCTC-binding factor	Rb2	0	UNDEFINED	True
6260	6324	9645965:0:AP1:TH	[TF], CREB and CBP transcription factors differentially regulate the [TG] gene.	AP-1	tyrosine hydroxylase	0	UNDEFINED	False
6261	6325	24814047:8:TP53:BCL2	These findings demonstrate that [TF] negatively regulates [TG] expression by targeting miR-1915 processing from primary into precursor miRNA.	p53	Bcl-2	2	REPRESSION	False
6262	6326	10229837:6:MYC:CXCR4	Mutation of the E box abolished USF/[TF]-mediated up-regulation of [TG] promoter activity, and mutation of the YY1 binding site was associated with unresponsiveness to YY1-mediated inhibition.	c-Myc	CXCR4	1	ACTIVATION	True
6263	6327	18506085:6:NEUROG3:INS	Coexpression of Nkx6.1 and [TF] induced endogenous expression of the [TG] 2 gene, while coexpression of Maf A and Ngn3 induced both insulin 1 and 2 genes in AR42J-B13 cells.	Ngn3	insulin	1	ACTIVATION	False
6264	6328	25135222:0:HTATIP2:CCND1	[TF] nuclear translocation negatively regulates EGF-dependent [TG] transcription in human lung adenocarcinoma.	TIP30	cyclin D1	2	REPRESSION	False
6265	6329	10998425:6:NR1H4:PLTP	In CV-1 cells, cotransfection of [TF] and the retinoid X receptor resulted in bile acid-dependent transactivation of a luciferase reporter construct containing the human [TG] promoter.	FXR	PLTP	1	ACTIVATION	False
6266	6330	24760274:6:STAT3:BECN1	At the molecular level, we further revealed that [TF] could directly bind to the promoter region of [TG] and repressed its transcription through recruiting histone deacetylase 3 (HDAC3).	Stat3	Beclin 1	2	REPRESSION	False
6267	6331	11859127:3:TXK:IFNG	In this study, we found that [TF] bound to [TG] promoter region.	Txk	IFN-gamma	0	UNDEFINED	False
6268	6332	23133314:9:FOXO1:SELL	Significantly, [TF] binds to a FOXO1 motif, CCCTTTGG, at -87/-80, and transactivates the [TG] promoter in a dose-dependent manner.	FOXO1	L-selectin	1	ACTIVATION	False
6269	6333	12697721:4:STAT3:POMC	Here we show evidence that leptin stimulates [TG] gene transcription via activation of intracellular [TF] (STAT3) proteins.	signal transducer and activator of transcription 3	pomc	1	ACTIVATION	False
6270	6334	17060321:7:DLX5:RUNX2	Our studies further show regulation of the [TG] gene by several homeodomain proteins: MSX2 and CDP/cut repress whereas DLX3 and [TF] activate endogenous Runx2 expression and promoter activity in non-osseous cells and osteoblasts.	DLX5	Runx2	1	ACTIVATION	False
6271	6335	12456801:0:EGR1:CHGA	Interaction of [TF] (Egr-1), specificity protein 1 (Sp1), and cyclic adenosine 3'5'-monophosphate response element binding protein (CREB) at a proximal response element is critical for gastrin-dependent activation of the [TG] promoter.	early growth response protein 1	chromogranin A	1	ACTIVATION	False
6272	6336	19619559:3:ISL1:INS	Whether [TF] plays a role in the [TG] gene expression has not been fully elucidated.	ISL1	insulin	0	UNDEFINED	True
6273	6337	21608077:9:DNMT3A:POU5F1	Thus, recruitment of MBD3, MBD2, and [TF] by GCNF links two events: gene-specific repression and DNA methylation, which occur differentially at the [TG] promoter.	Dnmt3A	Oct4	2	REPRESSION	False
6274	6338	9875228:9:KLF9:CYP7A1	Transient transfection assays have confirmed that [TF] was able to transactivate the [TG] promoter/luciferase chimergic gene.	BTEB	CYP7A	1	ACTIVATION	False
6275	6339	15855339:8:NFKB:OLR1	LA also led to a significant increase in [TG] gene expression and enhanced the binding of nuclear proteins extracted from HAECs to the [TF] regulatory element of the LOX-1 gene promoter.	NF-kappaB	LOX-1	0	UNDEFINED	False
6276	6340	12917425:3:YBX1:COL1A2	Here we report that [TF] counter-represses TGF-beta-stimulated [TG] transcription by interfering with Smad3 bound to the upstream sequence around -265 and subsequently by interrupting the Smad3-p300 interaction.	YB-1	COL1A2	2	REPRESSION	False
6277	6341	20357224:6:RUNX2:FSHB	Mutation of this -153 activin-response element or, indeed, any of the five activin-responsive regions prevents activin induction and, in fact, [TF] suppression, instead converting RUNX2 to an activator of the [TG] gene.	RUNX2	FSHbeta	2	REPRESSION	False
6278	6342	20371871:6:CEBPB:RCAN1	Overexpression of [TF] increased activity of both the endogenous mouse Rcan1-4 gene and a human [TG]-4 luciferase reporter.	C/EBPbeta	RCAN1	1	ACTIVATION	False
6279	6343	16352814:4:CEBPB:SPI1	ATRA-induced activation was mediated by a region in the [TG] promoter to which [TF] and OCT-1 binding were induced.	CEBPB	PU.1	1	ACTIVATION	False
6280	6344	20238301:2:FOXC2:DLL4	For arterial specification, vascular endothelial growth factor (VEGF) induces expression of Notch signaling genes, including Notch1 and its ligand, Delta-like 4 ([TG]), and Foxc1 and [TF] transcription factors directly regulate Dll4 expression.	Foxc2	Dll4	0	UNDEFINED	False
6282	6346	19426980:10:PREB:CCL2	In summary, our findings show that [TF] can function as a transcriptional regulator of the [TG] promoter in response to cytokines.	PREB	MCP-1	0	UNDEFINED	False
6283	6347	17565687:4:NFKB:IL8	Expression of PAdV-3 E1Blarge inhibited the [TF] dependent transcription of luciferase from [TG] promoter.	NF-kappaB	IL-8	1	ACTIVATION	True
6284	6348	10582586:7:CTCF:APP	These results suggest that [TF] is pivotal for the up-regulation of [TG] expression during synaptogenesis in primary neurons.	CTCF	APP	1	ACTIVATION	False
6285	6349	23569208:10:SP1:FGFR1	KLF10 expression also significantly reduced [TG] promoter activity in myoblasts and [TF]-mediated FGFR1 promoter activity in Drosophila SL2 cells.	Sp1	FGFR1	1	ACTIVATION	False
6286	6350	22865884:6:FOXO1:LHB	Although we did not detect [TF] binding to the proximal [TG] promoter, the FOXO1 DNA binding domain was necessary for the suppression, suggesting that FOXO1 exerts its effect through protein-protein interactions with transcription factors/cofactors required for Lhb gene expression.	FOXO1	Lhb	2	REPRESSION	False
6287	6351	16033859:9:NFKB:HMOX1	By electrophoretic mobility shift assay, it was confirmed that CD40 signaling induced the transcriptional activation of [TG] through the binding of [TF] to its promoter.	NF-kappaB	HO-1	1	ACTIVATION	False
6288	6352	11970950:3:SP1:FASLG	We recently described a novel mechanism mediating inducible [TG] gene expression in smooth muscle cells involving the zinc finger transcription factor [TF] (Kavurma, M. M., Santiago, F. S., Bofocco, E., and Khachigian, L. M. (2001) J. Biol. Chem. 276, 4964-4971).	Sp1	FasL	1	ACTIVATION	True
6289	6353	12713737:5:SOX9:COL2A1	In contrast, when overexpressed at high levels, [TF] induced an inhibition of [TG] gene expression, mediated by the -266 bp promoter region, whatever the differentiation state of chondrocytes.	SOX9	COL2A1	2	REPRESSION	False
6290	6354	21338575:5:HIF1A:GAPDH	Knockdown and overexpression of hypoxia-inducible factor (HIF)-1 indicated that [TF] contributed to the up-regulation of [TG] gene expression by hypoxia.	HIF-1	GAPDH	1	ACTIVATION	False
6291	6355	1737937:8:FOSL1:IL2	Northern analysis indicates that mRNAs for at least six members of the Fos/Jun family (c-fos, fosB, [TF], c-jun, junB, and junD) are expressed in activated Ar-5 cells; thus the AP-1 sites of the [TG] promoter may bind different dimeric Fos/Jun complexes at different times after T cell activation, perhaps mediating both positive and negative regulation of the IL-2 promoter.	fra-1	IL-2	0	UNDEFINED	False
6292	6356	21182526:9:FEV:HTR1A	These data indicate that, in addition to transcriptional regulation by [TF] in raphe neurons, [TG] receptor expression is regulated indirectly by alterations in 5-HT neurotransmission in a region-specific manner that together may contribute to the aggressive/anxiety phenotype observed in Pet-1 null mice.	Pet-1	5-HT1A	0	UNDEFINED	True
6293	6357	20086032:3:HNF4A:CYP2C9	In the present study, we used primary cultures of human hepatocytes to investigate the role of [TF] in the pregnane X receptor (PXR)/rifampicin-mediated up-regulation of [TG]8, CYP2C9, and CYP2C19 gene expression.	HNF4alpha	CYP2C	1	ACTIVATION	False
6294	6358	16857742:0:MYC:NPM1	Ras-dependent recruitment of [TF] for transcriptional activation of nucleophosmin/[TG] in highly malignant U1 bladder cancer cells.	c-Myc	B23	1	ACTIVATION	False
6295	6359	15231498:6:GATA6:PLAU	Laminar shear stress downregulated [TG] gene expression transcriptionally and posttranscriptionally; laminar shear stress activated transcription factor [TF], which binds to a GATA consensus element located between -692 and -687 bp in the uPA promoter, thereby inhibiting uPA gene transcription.	GATA6	uPA	2	REPRESSION	False
6296	6360	19147558:4:RBPJ:TNC	We show that the [TG] gene is transactivated by Notch2 in an [TF]-dependent manner mediated by an RBPJk binding element in the TNC promoter.	RBPJk	TNC	1	ACTIVATION	False
6297	6361	18663001:5:PLAGL1:CDKN1A	Furthermore, [TF] regulates the affinities of PCAF substrates as well as the catalytic activities of PCAF to induce a selective switch in favor of histone H4 acetylation and thereby the efficient transcription of p21([TG]).	Zac1	Cip1	1	ACTIVATION	False
6298	6362	20198350:8:TP53:XAF1	A half-site (-95 to -86 nt) and a quarter-site (-4 to +1 nt) of [TF] responsive element were found within [TG] promoter.	p53	XAF1	0	UNDEFINED	False
6299	6363	22032922:2:TP53:LIF	Interestingly, the cell cycle regulator and tumor suppressor [TF] has been reported to support reproduction in mice by regulating the expression of the [TG] gene in the maternal endometrium.	p53	leukemia inhibitory factor	0	UNDEFINED	False
6300	6364	11589626:1:POU1F1:GH1	The transcription factor [TF]/GHF-1 plays an important role in regulating the prolactin (Prl) and [TG] (GH) genes in mammals.	Pit-1	growth hormone	0	UNDEFINED	True
6302	6366	8857671:8:TP53:TYR	[TF] specifically repressed CAT gene expression from the [TG] promoter and not from the Rous sarcoma virus promoter.	p53	tyrosinase	2	REPRESSION	False
6303	6367	12806965:5:TP53:GADD45A	It is known that [TF] stimulates the promoter activities of p21/WAF1, [TG] and bax genes to enhance their expression as a transcriptional factor, resulting in cell cycle arrest, DNA repair and apoptosis, respectively.	p53	gadd45	1	ACTIVATION	False
6304	6368	15867358:10:MYB:PTGS2	Taken together, these results suggest activation of a transcriptional cascade by which E2F1 regulates [TG] expression through the [TF] oncogene.	c-myb	COX-2	0	UNDEFINED	False
6305	6369	21996739:5:NFKB:IL6	As NFB inhibitor and knockdown [TF] expression greatly reduced constitutive AhR-induced [TG] expression, we hypothesized that AhR expression, in the absence of exogenous ligand, is able to modulate NFB activity and subsequently upregulate IL-6 expression, thus promoting the development of lung AD.	RelA	IL-6	1	ACTIVATION	False
6306	6370	20332243:3:HIF1A:BNIP3	Although [TG] transcription is controlled by [TF] (also elevated in prostate cancer), we postulated the posttranscriptional regulation of BNIP3 by miR145 through bioinformatics analysis, and herein we experimentally showed that miR145 negatively regulated BNIP3 by targeting its 3'-untranslated region.	hypoxia-inducible factor 1alpha	BNIP3	0	UNDEFINED	False
6307	6371	18664364:4:MYC:DDR2	Gel shifting assays showed that hypoxia increased the [TF]-Max-DNA binding activity in the promoter region of [TG]; inhibition of p38 MAPK activation by SB203580 and p38-specific siRNA blocked hypoxia-induced DDR2 promoter activity.	Myc	DDR2	0	UNDEFINED	True
6308	6372	11779634:0:SP1:AGTR1	The transcription factors [TF] and Sp3 are required for [TG] gene expression in H295-R cells.	Sp1	human angiotensin II type 1 receptor	1	ACTIVATION	False
6309	6373	15220343:5:SOX17:LAMA1	In the present study, we further showed that SOX7 and [TF] are involved in the regulation of parietal endoderm-specific enhancer activity of the mouse [TG] gene.	SOX17	Lama1	0	UNDEFINED	False
6310	6374	21205742:5:EGR1:ATF3	Analysis of the [TG] promoter revealed the importance of [TF] (Egr-1; located at -245 to -236) and Krppel-like factor 4 (KLF4; located at -178 to -174) putative binding sites in resveratrol-mediated ATF3 transactivation.	early growth response-1	ATF3	1	ACTIVATION	False
6311	6375	19064995:6:NFKB:IL8	P. aeruginosa increased [TG] expression at the transcriptional level by phosphorylating CCAAT/enhancer-binding protein beta (C/EBPbeta) via p38MAPK and activating [TF].	NF-kappaB	IL-8	1	ACTIVATION	True
6312	6376	19398579:5:CEBPB:GSK3B	The treatment of old mice with GH increases expression of [TG] via removal of the [TF]-HDAC1 complexes from the GSK3beta promoter.	C/EBPbeta	GSK3beta	2	REPRESSION	False
6313	6377	20728021:2:SREBF2:PON1	In an attempt to elucidate the mechanism of action of quercetin, we have now determined the effects of quercetin on [TG] gene expression, activity, protein level, nuclear mature sterol regulatory element binding protein 2 ([TF]) level, and its translocation from the endoplasmic reticulum to nucleus and its interaction with PON1 promoter in human HuH7 liver cells using real-time reverse transcriptase polymerase chain reaction, spectrophotometry, immunoblot, confocal microscopy, and electrophoretic mobility shift assay techniques, respectively.	SREBP2	PON1	0	UNDEFINED	False
6314	6378	15537493:9:GATA4:GJA5	In this work, we cloned the promoter region of the [TG] and demonstrated that the core promoter was modulated by cardiac transcriptional factors Nkx2-5, Tbx5 and [TF] acting together with ubiquitous Sp1.	GATA4	Cx40	0	UNDEFINED	False
6315	6379	16331412:7:CTCF:MEG3	We speculate that this [TF]-binding region may provide a mechanism for the transcriptional regulation of [TG] and DLK1.	CTCF	MEG3	0	UNDEFINED	True
6316	6380	11457839:2:PAX6:GCG	Among these proteins, the paired domain transcription factor [TF] has been shown to bind to G1 and to transactivate [TG] gene expression.	Pax-6	glucagon	1	ACTIVATION	False
6317	6381	20686606:0:STAT3:ROR1	[TF] activates the [TG] gene in chronic lymphocytic leukemia cells.	Stat3	receptor tyrosine kinase like orphan receptor-1	1	ACTIVATION	False
6318	6382	17390372:10:CEBPB:CCL2	Both [TF] and NF-kappaB binding elements are required for PTHrP-induced [TG] transcription.	C/EBPbeta	MCP-1	1	ACTIVATION	False
6319	6383	12527885:6:E2F1:ATM	We show here that [TF] elevates [TG] promoter activity and induces an increase in ATM mRNA and protein levels.	E2F-1	ATM	1	ACTIVATION	False
6320	6384	17330857:11:EGR1:PTEN	TSA promoted doxorubicin-induced apoptosis through a mechanism that involved the stimulation of [TF] expression, acetylation of core histones at the [TG] promoter, and consequently induction of PTEN transcription.	Egr-1	PTEN	1	ACTIVATION	False
6321	6385	10947072:5:NFKB:TNF	These results thus suggest that desensitization of [TG] gene expression in this LPS-tolerant state is closely associated with down-regulation of transactivating [TF] and may involve a defect in the LPS-induced IkappaBalpha kinase pathway.	NF-kappaB	TNF-alpha	1	ACTIVATION	True
6322	6386	18555530:5:KLF2:DPP7	Since lung Kruppel-like factor ([TF]), a transcription factor, and TOB1, a transcriptional co-activator, have been shown to be important in maintaining T-lymphocyte quiescence and are both downregulated upon cellular activation, we also looked at the contributions of these factors to [TG] transcription.	KLF2	Dpp2	0	UNDEFINED	False
6323	6387	16116232:13:RELA:CRP	Combined data from luciferase transactivation assays and EMSA lead us to conclude that the binding of OCT-1 to the promoter, facilitated by p50-p50 in a novel way, represses, whereas replacement of OCT-1 by p50-[TF] induces [TG] transcription in cooperation with C/EBPbeta.	p65	CRP	1	ACTIVATION	False
6324	6388	12355451:4:NFATC2:IL4	Using constitutively-active NFAT proteins with alanine substitutions instead of phosphorylated serine residues in the regulatory domain, we find that [TF] and NFAT2 are both positive regulators of [TG] gene transcription, intrinsically very similar in their ability to induce and sustain transcription of the IL-4 gene.	NFAT1	IL-4	1	ACTIVATION	False
6325	6389	14530270:7:NFKB:CCND1	Results from deletion and mutant analysis indicate that Pak1 regulates [TG] transcription by means of an [TF]-dependent pathway.	NF-kappaB	cyclin D1	0	UNDEFINED	False
6327	6391	12441652:0:FOXM1:VTN	Foxa ([TF]) up-regulates [TG] expression during retinoic acid-induced differentiation in mouse neuroblastoma Neuro2a cells.	HNF3	vitronectin	1	ACTIVATION	False
6328	6392	16319082:5:NFKB:SDC4	The H. pylori- and TLR-induced increase in [TG] mRNA was blocked by the proteosome inhibitor MG-132 suggesting a role for nuclear factor kappaB ([TF]) in the regulation of syndecan-4 gene expression.	NF-kappaB	syndecan-4	0	UNDEFINED	False
6330	6394	10318839:8:GATA4:ADORA1	These observations suggest that embryonic [TG] expression involves activation of the A1AR promoter by [TF] and Nkx2.5.	GATA-4	A1AR	1	ACTIVATION	False
6332	6396	14743396:8:RFX2:HIST1H1T	These observations lead us to conclude that the TE1 and TE2 subelements of the testis-specific histone [TG] promoter are targets of the transcription factor [TF] and that this factor plays a key role in activating transcription of the H1t gene in primary spermatocytes.	RFX2	H1t	1	ACTIVATION	False
6333	6397	11429784:6:AP1:MMP9	The [TF] DNA binding and transcriptional activity on the [TG] promoter were increased in the malignant cell lines, indicating the requirement of this binding site for its activation.	AP-1	MMP-9	1	ACTIVATION	False
6334	6398	10809237:10:SP1:CDKN1A	The current studies suggest a model in which AR and transcription factor [TF] not only bind to their respective consensus sites within the [TG] promoter, but also complex with one another, thereby recruiting coactivators and general transcription factors and inducing p21 transcription.	Sp1	p21	1	ACTIVATION	False
6335	6399	10652365:2:KLF1:HBB	Results have suggested that [TF] functions through the proximal CACC motif of the [TG] promoter.	EKLF	beta-globin	0	UNDEFINED	False
6337	6401	16980581:6:NFIC:CCND1	Interestingly, even in BCC, [TG] levels and proliferation are tightly controlled by E2 through the establishment of a negative feedforward loop involving the induction of [TF], a putative tumor suppressor capable of directly repressing CCND1 transcription.	NFIC	CCND1	2	REPRESSION	False
6338	6402	22143792:10:RBPJ:ABCC1	ChIP and gel-shift assays revealed an interaction between a specific promoter region of [TG] and the N1(IC)-activated transcription factor [TF], suggesting that the regulation of ABCC1 expression by Notch1 is mediated by CBF1.	CBF1	ABCC1	0	UNDEFINED	False
6339	6403	20971808:10:CEBPD:PPARG	Furthermore, increased level of [TF] attenuates E2F1-induced cancer cell proliferation and partially rescues RB/E2F1-mediated repression of [TG] and GADD153 transcription.	CEBPD	PPARG2	2	REPRESSION	True
6340	6404	20043076:0:FOXH1:CXCR4	Integrative genomic analyses of [TG]: transcriptional regulation of CXCR4 based on TGFbeta, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, [TF], SOX17, and GFI1 transcription factors.	FOXH1	CXCR4	0	UNDEFINED	False
6341	6405	18343609:6:SP3:LAT	Collectively, these results provide compelling data that implicates Sp1 and [TF] in the transcriptional regulation of the human [TG] gene.	Sp3	LAT	0	UNDEFINED	False
6343	6407	16731528:4:SFPQ:TH	Here we show that DJ-1 and [TF] bind and regulate the [TG] (TH) promoter.	PSF	human tyrosine hydroxylase	0	UNDEFINED	False
6344	6408	17141225:5:SP1:TERT	Analysis of the h[TG] promoter occupancy in vivo using chromatin immunoprecipitation assays, however, did not detect an increased binding of NFkappaB to the hTERT promoter in the activated T cells, although an increased binding of cMyc and [TF] was detected.	Sp1	TERT	0	UNDEFINED	False
6345	6409	15843409:8:TBX20:NKX2-5	[TF] synergized with Isl1 and Gata4 to activate both the Mef2c and [TG] enhancers, thus providing a unifying mechanism for gene activation by Tbx20 in the AHF.	Tbx20	Nkx2-5	1	ACTIVATION	False
6346	6410	21383775:0:RARA:CDKN1A	HDAC2 phosphorylation-dependent Klf5 deacetylation and [TF] acetylation induced by RAR agonist switch the transcription regulatory programs of [TG] in VSMCs.	RAR	p21	0	UNDEFINED	False
6347	6411	11970950:10:SP1:FASLG	The mutation of the (-365)GGAA(-362) element in the [TG] promoter abolished Ets-1 activation and attenuated [TF]-inducible gene expression.	Sp1	FasL	1	ACTIVATION	False
6348	6412	11504723:0:VEZF1:EDN1	Vezf1/[TF] is an endothelial cell-specific transcription factor that regulates expression of the [TG] promoter.	DB1	endothelin-1	0	UNDEFINED	False
6349	6413	20107107:11:PPARD:CALR	Finally, specific binding of [TF] to a PPAR response element in the promoter region of the [TG] gene was identified by utilizing a specific chromatin immunoprecipitation assay.	PPARdelta	calreticulin	0	UNDEFINED	False
6350	6414	10321740:7:TP53:GADD45A	Furthermore, we found that deletion of the proline-rich region has no or very mild effects on activation of several transiently transfected [TF] target gene promoters, i.e., the p21, MDM2, BAX, and [TG] promoters.	p53	GADD45	1	ACTIVATION	False
6351	6415	15192123:4:TP53:MDM2	Transient transfection of this mutant into a [TF] null cell line resulted in activation not only of the pig3 but also of the [TG] gene compatible with the presence of constitutively expressed MDM2 transcripts initiated from the P2 promoter in the p53-C277Y hemizygous Ewing's sarcoma cell line.	p53	MDM2	1	ACTIVATION	False
6352	6416	15870300:0:TAF1:CCND1	[TF] histone acetyltransferase activity in Sp1 activation of the [TG] promoter.	TAF1	cyclin D1	1	ACTIVATION	False
6353	6417	19131575:7:NR2C1:POU5F1	Mechanism dissection suggests that [TF] and TR4 may affect the [TG] gene by binding to a direct repeat-1 element located in its promoter region, which is influenced by retinoic acid.	TR2	Oct-3/4	0	UNDEFINED	False
6354	6418	15338456:11:SP1:RETN	Therefore, the specific recognition of -420G by [TF]/3 increases [TG] promoter activity, leading to enhanced serum resistin levels, thereby inducing human T2DM.	Sp1	RETN	1	ACTIVATION	False
6355	6419	20048076:6:FOXA1:AGR2	In contrast, EBP1 ablation upregulates [TG] via [TF]- and Foxa2-stimulated AGR2 promoter activity and increases metastatic behavior.	Foxa1	AGR2	1	ACTIVATION	False
6356	6420	20581861:8:ATF2:ATF3	Overexpression of [TF] resulted in significant increase in [TG] promoter activity, and electrophoretic mobility shift assay identified this region as a core sequence to which ATF2 binds.	ATF2	ATF3	1	ACTIVATION	False
6357	6421	23284001:0:ELF1:PYGO2	Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces [TG] expression via [TF] in cervical cancer.	Elf-1	hPygopus2	1	ACTIVATION	False
6358	6422	19164764:7:GFI1:CDKN2B	Consistent with its role in repressing [TG] transcription, knockdown of [TF] in human leukemic cells or deficiency of Gfi-1 in mouse bone marrow cells results in augmented expression of p15(INK4B).	Gfi-1	CDKN2B	2	REPRESSION	False
6360	6424	23967302:10:TP53:LGALS7	The [TF]-induced [TG] expression in breast cancer cells correlated with increased NF-B activity and was inhibited by NF-B inhibitors, indicating that the ability of mutant p53 to induce galectin-7 was dependent on NF-B activity.	p53	galectin-7	1	ACTIVATION	False
6361	6425	16926281:4:EGR1:PNMT	Deletion [TG] promoter-luciferase reporter gene constructs showed that the NGF-responsive sequences lay within the proximal -392 base pairs (bp) of PNMT promoter, wherein binding elements for [TF] (-165 bp) and Sp1 (-48 bp) reside.	Egr-1	PNMT	0	UNDEFINED	False
6362	6426	19609931:5:STAT3:GFAP	Histone H3 acetylation around the STAT-binding site in the [TG] promoter was increased in NPCs treated with RA, allowing [TF] to gain access to the promoter more efficiently.	STAT3	gfap	0	UNDEFINED	False
6363	6427	15466464:0:ESRRA:APOA4	[TF] (ERRalpha) is a transcriptional regulator of [TG] and controls lipid handling in the intestine.	Estrogen-related receptor alpha	apolipoprotein A-IV	0	UNDEFINED	False
6364	6428	1904416:2:MYC:HBB	Of the three DNase I hypersensitive sites around the [TG] gene which were detected in MEL cells after DMSO treatment, the appearance of a specific DNase I hypersensitive site near the promoter was greatly reduced by the overexpression of [TF].	c-Myc	beta-globin	0	UNDEFINED	True
6365	6429	18000219:10:POU2F1:ESR1	The transcription factor [TF] recruited BRCA1 to the [TG] promoter, and both BRCA1 and Oct-1 were required for ER alpha expression.	Oct-1	ESR1	1	ACTIVATION	False
6366	6430	11359907:0:HIF1A:VEGFA	HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha ([TF]) synthesis: novel mechanism for HIF-1-mediated [TG] expression.	HIF-1alpha	vascular endothelial growth factor	1	ACTIVATION	False
6367	6431	21076612:6:GATA6:PLAU	Small interfering RNA (siRNA) knockdown of [TF] resulted in reduced [TG] gene expression and cell invasion.	GATA6	uPA	1	ACTIVATION	False
6368	6432	18391014:12:KLF3:CEBPA	Chromatin immunoprecipitations confirm that [TF] binds the [TG] promoter in vivo.	Klf3	C/ebpalpha	0	UNDEFINED	False
6369	6433	10963848:1:NFKB:IL1B	The transcription factor [TF] is the central regulator for the expression of various genes involved in inflammation, infection and immune response including the genes for [TG], TNF-alpha, IL-6 and leukocyte adhesion molecules.	NF-kappaB	IL-1beta	0	UNDEFINED	False
6370	6434	12107181:7:CREB1:CPT1A	Indeed, (i) cotransfection of [TF] or HNF4 alpha dominant negative mutants completely abolishes the effect of cAMP on the [TG] promoter, and (ii) the cAMP-responsive unit binds HNF4 alpha and CREB through the DR1 and the cAMP-response element sequences, respectively.	CREB	L-CPT I	0	UNDEFINED	True
6371	6435	12794082:4:AP1:CCND1	Transient transfection studies with a series of 5'-deleted [TG] promoter constructs showed that the proximal 964-base region, which contains [TF], SP1, and CRE enhancer elements, is required for activation of the cyclin D1 promoter by PKC-alpha.	AP-1	cyclin D1	1	ACTIVATION	False
6372	6436	17682059:6:CUX1:HIF1AN	With chromatin immunoprecipitation assays, we show that [TF] binds to the [TG] promoter in vivo and that this binding is PKC zeta dependent.	CDP	FIH-1	0	UNDEFINED	False
6373	6437	22282354:8:KLF4:AGTR1	On activation of TGF- signaling, [TF] mediates Sp1 dissociation from, and PPAR- association with, the [TG] promoter, leading to downregulation of AT1R expression in VSMCs.	KLF4	AT1R	2	REPRESSION	False
6374	6438	15297147:6:SP1:GPC4	Transactivation experiments in insect cells showed that both [TF] and Sp3 are major activators of the [TG] promoter.	Sp1	Gpc4	1	ACTIVATION	False
6375	6439	19628706:8:DNMT1:KIR3DL1	Our data suggest that CD8 T cells endure increasing displacement of [TF] from the [TG] promoter with age, possibly because of an active histone signature.	DNMT1	KIR	0	UNDEFINED	False
6376	6440	16260603:7:ELK1:MYOCD	Although overexpression of the SRF-binding B-box domain of [TF] is sufficient to repress the [TG] activation of the telokin promoter, this repression is not as complete as that seen with an Elk-1 fragment that includes the DNA binding domain.	Elk-1	myocardin	2	REPRESSION	True
6377	6441	17516925:8:MITF:TYR	The results suggest that Sox10 directly, and [TF], most likely indirectly, activate the [TG] enhancer, underlining the contribution of Sox10 to tyrosinase gene regulation in melanocytes.	Mitf	tyrosinase	1	ACTIVATION	False
6378	6442	23727894:6:STAT5A:IL9	[TF] and STAT6 regulated [TG] expression by directly binding to the Il9 promoter.	STAT5	IL-9	0	UNDEFINED	False
6379	6443	11491651:10:TFAP2A:SOD2	These results suggest that [TF] may participate in the mechanism(s) underlying decreased expression of [TG] in transformed cells.	AP-2	SOD2	2	REPRESSION	False
6380	6444	18505831:9:NR0B2:G6PC	The knockdown of [TF] expression by oligonucleotide siRNA SHP or adenoviral siRNA SHP released the sodium arsenite-mediated repression of forskolin/dexamethasone-stimulated PEPCK and [TG] gene expression in a variety of hepatic cell lines.	SHP	G6Pase	2	REPRESSION	True
6381	6445	15247301:3:STAT1:MMP9	Previous work from our laboratory has shown that interferon-gamma inhibits [TG] expression in a manner dependent upon [TF].	STAT-1alpha	MMP-9	2	REPRESSION	False
6383	6447	17106239:6:E2F4:BRCA1	In contrast to previous studies, we have also detected promoter occupancy by the pocket proteins p130 and p107, but not Rb, our data indicate that [TF] and p130/p107 complexes basally repress the [TG] promoter.	E2F4	BRCA1	2	REPRESSION	False
6384	6448	17166845:6:CREB1:IL13	Cotransfection of an [TG] reporter construct with expression vectors for wild type or mutant [TF] and ATF-2 showed that CREB, but not ATF-2, regulates CNS-1 enhancer activity.	CREB	IL13	0	UNDEFINED	False
6385	6449	19281374:10:IRF1:NOS2	TK inhibition by genistein had no effect on the expression or nuclear translocation of the transcription factors [TF] and nuclear factor-KB, respectively, both of which have been implicated in transcriptional regulation of the human [TG] gene.	interferon regulatory factor-1	iNOS	0	UNDEFINED	False
6386	6450	15664995:3:STAT1:IRF7	The [TG] gene includes two IFN responsive elements, an IRF-binding element (IRFE) in the promoter region and an ISRE in the first intron, and is induced by the IFN-triggered Jak-STAT pathway by binding of the IFN-stimulated gene factor 3 ([TF]) complex to the ISRE.	ISGF3	IRF7	1	ACTIVATION	False
6387	6451	7991556:7:TBP:CYC1	These results indicate that upstream regulatory factors are not required for the in vivo binding of [TF] to the [TG] promoter and that binding of TFIID to DNA is not necessarily a rate-limiting step in the activation of transcription in cells.	TFIID	CYC1	1	ACTIVATION	False
6388	6452	16728402:8:SP1:MAOA	In summary, this study shows that glucocorticoid enhances [TG] gene expression by 1) regulation of R1 translocation; 2) direct interaction of the glucocorticoid receptor with the third glucocorticoid/androgen response element; and 3) indirect interaction of glucocorticoid receptor with the [TF] or R1 transcription factor on Sp1-binding sites of the MAO A promoter.	Sp1	monoamine oxidase A	1	ACTIVATION	True
6389	6453	17875929:7:SP1:SCT	The stabilization of binding of the widely expressed transcription factor [TF] to the [TG] promoter by NeuroD represents a distinct mechanism from other NeuroD target genes for increasing NeuroD-dependent transcription.	Sp1	secretin	1	ACTIVATION	False
6390	6454	22595886:5:ISL1:SLC2A10	Using real-time PCR we have confirmed upregulation of Caps2, Sec14l4, [TG], P2rx7, Afamin, and Neurogenin 3 that may in part mediate the observed improved insulin secretion in [TF] overexpressing mice.	Isl-1	Slc2a10	1	ACTIVATION	False
6391	6455	21862621:5:FOXL2:CYP19A1	Therefore, we examined the effects of a [TF] mutant protein on the transcriptional repression of the [TG] promoter by the full-length protein.	FOXL2	CYP19	2	REPRESSION	True
6392	6456	14735146:0:STAT1:PSMB9	Regulation of murine Tap1 and [TG] genes in macrophages by interferon gamma is mediated by [TF] and IRF-1.	STAT1	Lmp2	0	UNDEFINED	False
6393	6457	9660935:4:NFKB:IFNB1	However, in virus-infected cells, both proteins are recruited to the endogenous [TG] promoter as part of a protein complex that includes ATF-2/c-Jun and [TF].	NF-kappa B	IFN-beta	0	UNDEFINED	False
6394	6458	18269916:0:TP53:CDKN1A	Induction of [TG] by p65 in [TF] null cells treated with Doxorubicin.	p53	p21	0	UNDEFINED	True
6395	6459	20953676:7:SREBF2:NPC1L1	Furthermore, cotransfection of PGC1 stimulated the [TF]/HNF4- and PPAR/RXR-mediated activation of the human [TG] promoter.	SREBP2	NPC1L1	1	ACTIVATION	False
6396	6460	19716432:7:NR1H3:SREBF1	The [TG] promoter contains an insulin response unit consisting of tandem [TF] response elements (LXREs) as well as sites for NF-Y, Sp1, and SREBP-1c itself.	LXRalpha	SREBP-1c	0	UNDEFINED	False
6397	6461	19564342:0:FOXP3:NFATC1	[TF] inhibits activation-induced [TG] expression in T cells thereby limiting effector cytokine expression.	FOXP3	NFAT2	2	REPRESSION	False
6398	6462	11505017:8:PPARA:ALDH2	Treatment of rats with the [TF] ligand clofibrate repressed expression of [TG] in rats fed either stock rodent chow or a low-protein diet.	PPAR	ALDH2	2	REPRESSION	True
6399	6463	17827213:10:KLF4:HDC	Two-hour gastrin treatment, known to activate [TG] gene expression, significantly decreased the association of [TF], Tip60 and HDAC7 with HDC promoter, suggesting that gastrin activates HDC gene expression at least partly by decreasing the formation of KLF4/Tip60/HDAC7 repressive complexes at the HDC promoter.	KLF4	HDC	2	REPRESSION	False
6400	6464	21536859:5:FLI1:ERG	We further demonstrate that [TG] expression in primary human T-ALL cells is mediated by the binding of other T-cell oncogenes SCL/TAL1, LMO2, and LYL1 in concert with ERG, [TF], and GATA3 to the ERG +85 enhancer.	FLI1	ERG	1	ACTIVATION	False
6401	6465	14654367:3:SRF:TAGLN	We found that TGF-beta1 transiently induces [TF] and [TG] transcription, and that this process is accompanied by transient increases of SRF and Smad3 binding to the SM22 promoter.	SRF	SM22	1	ACTIVATION	True
6402	6466	11829738:8:SP3:FBLN1	The results demonstrate the functional importance of Sp1 and [TF] in regulating the expression of the [TG] gene.	Sp3	fibulin-1	0	UNDEFINED	False
6403	6467	7519016:4:RARB:AFP	Acyclic retinoid and all-trans-RA both induced upregulation of retinoic acid receptor-beta ([TF]), and both suppressed cell proliferation-related phenotypic expressions by the [TG] gene and the c-myc oncogene.	RAR beta	alpha-fetoprotein	2	REPRESSION	True
6404	6468	23145961:2:REST:BDNF	Repressor Element-1 Silencing Transcription Factor ([TF]) is a repressor whose association with Htt in the cytoplasm is disrupted in HD, leading to increased nuclear REST and concomitant repression of several neuronal-specific genes, including [TG] (Bdnf).	REST	brain-derived neurotrophic factor	2	REPRESSION	False
6405	6469	21839069:6:PTF1A:ATOH7	We describe [TF] as a strong, negative regulator of [TG] expression.	Ptf1a	Atoh7	2	REPRESSION	False
6406	6470	8701093:0:PGR:MYC	A nuclear matrix acceptor site for the [TF] in the avian [TG] gene promoter.	progesterone receptor	c-myc	0	UNDEFINED	False
6408	6472	20966071:0:NFKB1:VCAM1	Phosphorylation of p50 [TF] at a single serine residue by DNA-dependent protein kinase is critical for [TG] expression upon TNF treatment.	NF-kappaB	VCAM-1	1	ACTIVATION	True
6409	6473	11094072:5:MYB:RAG2	We show that [TF] can transactivate a [TG] promoter-reporter construct in cotransfection assays and that this transactivation depends on the proximal promoter Myb consensus site.	c-Myb	RAG-2	1	ACTIVATION	False
6410	6474	12488456:11:SOX2:FGF4	Importantly, we also show that [TF] and p300 are physically associated with the endogenous [TG] enhancer but weakly associated with the endogenous FGF-4 promoter.	Sox-2	FGF-4	0	UNDEFINED	False
6411	6475	22146591:4:MYC:BAG2	The association of the [TF]/SP1 complex with the [TG] promoter verified the role of c-Myc/SP1 in regulating BAG2 transcription.	c-Myc	BAG2	0	UNDEFINED	False
6412	6476	12759356:5:NFKB:BMP2	Mutations in [TF] response elements in the [TG] gene lead to decreases in BMP-2 promoter activity.	NF-kappaB	BMP-2	1	ACTIVATION	False
6413	6477	24007921:7:NR1H4:FMO3	[TF] also positively controls [TG] and Gsta2 expression through direct interaction with the response elements in these genes.	FXR	Fmo3	1	ACTIVATION	False
6414	6478	14678994:4:FLI1:TERT	Both telomerase activity and the expression level of [TG] (TERT) mRNA were up-regulated in NIH3T3 cells transformed by EWS/E1AF and EWS/[TF] as well as in two Ewing's sarcoma cell lines.	FLI1	telomerase reverse transcriptase	1	ACTIVATION	True
6415	6479	9510530:5:HNF4A:EPO	The up-regulation of [TG] gene transcription by hypoxia is mediated by at least two known DNA-binding transcription factors, hypoxia-inducible factor 1 (HIF-1) and hepatic nuclear factor 4 ([TF]), which bind to cognate response elements in a critical 3' enhancer approximately 50 bp in length.	HNF-4	Epo	1	ACTIVATION	False
6416	6480	18834855:4:TP53:MIR34A	[TG] expression was markedly reduced in [TF]-null PC3 cells and p53-mutated DU145 cells compared with LNCaP cells expressing wild-type p53.	p53	MiR-34a	1	ACTIVATION	False
6417	6481	17922032:8:MTA1:BRCA1	Together, these findings strongly implicate [TF] in the transcriptional repression of [TG] leading to abnormal centrosome number and chromosomal instability.	MTA1	BRCA1	2	REPRESSION	False
6418	6483	16061629:0:STAT3:TERT	[TF] (STAT3) regulates [TG] (hTERT) expression in human cancer and primary cells.	Signal transducer and activator of transcription 3	human telomerase reverse transcriptase	0	UNDEFINED	False
6419	6484	24821728:3:ZBTB16:CDKN1A	We found that [TF]-RAR can repress transcription of the p21WAF/[TG] gene, which encodes the negative cell cycle regulator p21 by binding to its proximal promoter Sp1-binding GC-boxes 3, 4, 5/6, a retinoic acid response element (RARE), and distal p53-responsive elements (p53REs).	PLZF	CDKN1A	2	REPRESSION	False
6420	6485	17666527:2:MTA1:SIX3	We discovered that [TF] physically interacts with the [TG] chromatin in a histone deacetylase-dependent manner, leading to transcriptional suppression of the Six3 gene.	MTA1	Six3	2	REPRESSION	False
6421	6486	11389717:13:SP1:DHFR	We conclude that one mechanism by which TPA enhances MTX resistance, mainly by gene amplification, is through an increase in [TF] expression which leads to [TG] activation.	Sp1	DHFR	1	ACTIVATION	False
6423	6488	20179320:7:SP1:SREBF1	Promoter analysis indicated that PKCbeta activates [TG] promoter through replacement of Sp3 by [TF] for binding to the GC box in the sterol regulatory element (SRE) complex, a key cis-element of SREBP-1c promoter.	Sp1	SREBP-1c	1	ACTIVATION	True
6424	6490	20513428:5:NFKB2:SKP2	When Akt is active, GSK3beta is repressed, allowing [TF] and p53 to cooperatively induce [TG] expression.	p52	Skp2	1	ACTIVATION	False
6425	6491	18086126:2:POU4F1:NTRK1	While the regulation of the expression of [TG] is a complex process, the transcription factor [TF] is known to play an important role as an enhancer of trkA transcription during development in the mouse.	Brn3a	trkA	1	ACTIVATION	False
6426	6492	20978076:4:MYF5:MYOD1	Whereas [TF] and Mrf4 are dispensable for limb muscle progenitor fate, inactivation of Myf5 and Mrf4 in Pitx2 mutants results in a drastic decrease of limb [TG] expression.	Myf5	MyoD	1	ACTIVATION	False
6427	6493	21172391:6:NRF1:KIF17	By means of in silico analysis, electrophoretic mobility shift and supershift assays, in vivo chromatin immunoprecipitation assays, promoter mutations, and real-time quantitative PCR, we found that [TF] (but not NRF-2) functionally regulates [TG], but not Kif1a, gene.	NRF-1	Kif17	0	UNDEFINED	False
6428	6494	17283078:7:NR4A2:MMP1	Furthermore, [TG] promoter activity is potently suppressed by [TF], resulting in a significant reduction in endogenous MMP-1 mRNA and secreted pro-MMP-1 protein.	NURR1	MMP-1	2	REPRESSION	False
6429	6495	24100303:10:HNF1A:ACE2	We conclude that HNF1 can induce the expression of [TG] in pancreatic islet cells via evolutionarily conserved [TF] in the ACE2 promoter.	HNF1 binding sites	ACE2	1	ACTIVATION	False
6430	6496	16443760:0:MAFB:GCG	[TF]: an activator of the [TG] gene expressed in developing islet alpha- and beta-cells.	MafB	glucagon	1	ACTIVATION	False
6431	6497	11722647:9:AP1:GNLY	These results indicate that [TF] dominantly participates in the regulation of inducible [TG] gene expression in THP-1 cells.	AP-1	granulysin	0	UNDEFINED	True
6432	6498	15590659:9:PAX6:GCG	Both insulin and PKB responsiveness of the [TG] promoter were abolished when the binding sites for the transcription factor [TF] within the G1 and G3 promoter elements were mutated.	Pax6	glucagon	1	ACTIVATION	False
6433	6499	24885573:0:NR4A1:FGF21	Orphan nuclear receptor [TF] mediates fasting-induced hepatic [TG] expression.	Nur77	fibroblast growth factor 21	1	ACTIVATION	False
6434	6500	10594030:7:E2F1:CDKN2A	The [TF] target gene critical for the senescence response appeared to be the [TG] tumor suppressor.	E2F1	p14(ARF)	0	UNDEFINED	False
6435	6501	23874968:4:HSF1:HSPA1A	Bortezomib stimulated the binding of heat shock factor-1 ([TF]) to the [TG] promoter in 253JB-V but not in UM-UC13 cells.	HSF1	HSPA1A	0	UNDEFINED	False
6436	6502	9742082:0:NR1I3:CYP2B6	The nuclear orphan receptor [TF]-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the [TG] gene.	CAR	CYP2B	1	ACTIVATION	False
6437	6503	20571031:8:SOX9:CTGF	Luciferase, electrophoretic mobility shift assay (EMSA), and ChIP analysis revealed that [TF] represses [TG] expression by binding to the consensus TCF x LEF x Sox9 site.	Sox9	Ccn2	2	REPRESSION	False
6438	6504	24576410:8:SP4:GRIA2	By means of multiple approaches, including electrophoretic mobility shift and supershift assays, chromatin immunoprecipitation, promoter mutations, real-time quantitative PCR, and western blot analysis, we found that [TF], but not Sp1 or Sp3, regulates the [TG], but not Gria1, 3, or 4, subunit gene of the AMPA receptor in a concurrent and parallel manner with NRF-1.	Sp4	Gria2	0	UNDEFINED	False
6439	6505	10753864:5:SOX9:ACAN	[TF] overexpression in TC6 cells enhanced by approximately 3-fold the transcriptional activity of the AgCAT-8 construct containing 8-kilobase (kb) promoter/first exon/first intron fragments of the [TG] gene.	SOX9	aggrecan	1	ACTIVATION	False
6440	6506	20540995:15:SP1:TESC	Taken together, the data demonstrated that [TF] and Sp3 transcription factors cooperate positively in the regulation of [TG] promoter, and that the putative ZF5 motif is critical for its activation.	Sp1	Tesc	1	ACTIVATION	False
6441	6507	12610112:9:NFKB:TNF	Thus, rSV5deltaSH induced cell death by activating [TG] expression, possibly through activation of the [TF] subunit p65 and then targeting p65 for degradation, leading to apoptosis.	NF-kappaB	TNF-alpha	1	ACTIVATION	False
6442	6508	18715881:5:STAT1:POMC	Unexpectedly, an activated janus kinases-signal transducer and activator of transcription (JAK-[TF]) cascade is required for IFNG inhibitory action on [TG] promoter activity.	STAT1	POMC	2	REPRESSION	True
6443	6509	23203924:7:EGR2:IL17A	[TF] interacts with Batf in CD4 T cells and suppresses its interaction with DNA sequences derived from the [TG] promoter, whereas the activation of STAT3 and expression of retinoic acid-related orphan receptor t are unchanged in Th17 cells in the absence of Egr-2.	Egr-2	IL-17	0	UNDEFINED	True
6444	6510	15970595:7:SP1:VEGFA	Electrophoretic mobility shift assay and chromatin immunoprecipitation assay confirmed binding of [TF] to the [TG] promoter.	Sp-1	VEGF	0	UNDEFINED	False
6445	6511	15294861:5:MTF2:SHH	Repression of [TF] expression in the early embryo results in randomized heart looping direction, which is accompanied by the ectopic expression of [TG] in the right side of the node and Shh downstream genes in the right lateral plate mesoderm (LPM), while overexpression of chick Pcl2 represses Shh expression in the node.	chick Pcl2	Shh	2	REPRESSION	False
6446	6512	21668646:7:CREB1:PTGS2	Furthermore, promoter-luciferase and chromatin immunoprecipitation assays demonstrated that PGF(2) -derived [TG] expression was activated through binding of [TF] to the promoter region of the COX-2 gene in 3T3-L1 cells.	CREB	COX-2	1	ACTIVATION	False
6447	6513	20803090:9:TCF7L2:SMAD1	Overexpression of [TF] increased the expressions of ALK1 and [TG].	TCF7L2	Smad1	1	ACTIVATION	False
6448	6514	17928076:8:CEBPB:TAS1R3	The 226-bp region upstream of the ATG had promoter activity, and [TF] activated the [TG] promoter activity in HuCCT1 cells.	C/EBPbeta	Tas1r3	1	ACTIVATION	False
6449	6515	12198703:10:JUND:CDKN1A	Treatment with [TF] antisense oligomers inhibited the [TG] promoter and prevented the increase in p21 expression in the presence of DFMO.	JunD	p21	1	ACTIVATION	False
6450	6516	10505791:7:YY1:TP53	In vitro transcription assay also confirmed that the NF1-like protein regulated the [TG] transcription in rat spleen, although the human p53 transcription was regulated by [TF] in that organ.	YY1	p53	0	UNDEFINED	False
6451	6517	11971180:8:TP63:VEGFA	These results suggest that [TF] is involved in the regulation of the [TG] gene expression and that modulation of VEGF expression by TAp63gamma and dNp63alpha is closely correlated with their distinct roles on the regulation of HIF1alpha stability.	p63	VEGF	0	UNDEFINED	False
6452	6518	22820679:11:SOX9:ACAN	Several enhancers contain potential binding sites for [TF], consistent with its described role as an upstream regulator of [TG] expression.	Sox9	ACAN	0	UNDEFINED	False
6453	6519	9252399:2:TTF1:SFTPB	We investigated the role of thyroid transcription factor-1 ([TF]) and hepatocyte nuclear factor 3 (HNF3) in the down-regulation of [TG] gene expression by phorbol ester in pulmonary adenocarcinoma H441 cells.	TTF-1	SP-B	2	REPRESSION	False
6454	6520	21531766:7:ID4:ABCC6	Consequently, [TF]-mediated SOX2 induction enhanced ABCC3 and [TG] expression through direct transcriptional regulation, indicating that ID4 regulates the chemoresistance of iGSCs by promoting SOX2-mediated induction of ABC transporters.	ID4	ABCC6	1	ACTIVATION	False
6455	6521	20036849:5:TP53:PSEN1	Furthermore, overexpression of the repressors [TF], ZNF237 and CHD3 of the [TG] gene also suppressed the processing of APP through repression of PS1 transcription by deacetylation of histone at the PS1 promoter.	p53	PS1	2	REPRESSION	True
6458	6524	11369448:10:SP1:GDA	These results showed that two of the three [TF] cis-elements mediate the basal promoter activity of the [TG] gene.	Sp1	GdA	1	ACTIVATION	False
6459	6525	11481326:8:TP53:SLC19A2	Our findings indicate that [TF] may be involved in maintaining thiamine homeostasis through transactivation of [TG].	p53	THTR-1	1	ACTIVATION	False
6460	6526	11641404:6:TP63:JAG2	We found that the Jagged1 (JAG1) and Jagged2 ([TG]) genes, encoding ligands for the Notch receptors, are up-regulated by [TF] and p73.	p63	JAG2	1	ACTIVATION	False
6461	6527	11641404:6:TP73:JAG2	We found that the Jagged1 (JAG1) and Jagged2 ([TG]) genes, encoding ligands for the Notch receptors, are up-regulated by p63 and [TF].	p73	JAG2	1	ACTIVATION	False
6462	6528	12560508:6:SP1:ABCA2	Transfection of [TF], Sp3 or Sp4 expression constructs into Drosophila S2 induced a dose-dependent increase in transcriptional activation of the [TG] promoter, but transfection of EGR-1 alone failed to activate transcription.	Sp1	ABCA2	1	ACTIVATION	False
6463	6529	12560508:6:SP3:ABCA2	Transfection of Sp1, [TF] or Sp4 expression constructs into Drosophila S2 induced a dose-dependent increase in transcriptional activation of the [TG] promoter, but transfection of EGR-1 alone failed to activate transcription.	Sp3	ABCA2	1	ACTIVATION	False
6464	6530	12560508:6:SP4:ABCA2	Transfection of Sp1, Sp3 or [TF] expression constructs into Drosophila S2 induced a dose-dependent increase in transcriptional activation of the [TG] promoter, but transfection of EGR-1 alone failed to activate transcription.	Sp4	ABCA2	1	ACTIVATION	False
6465	6531	12581877:0:CREB1:SCG2	Gonadotropin-releasing hormone-induced stimulation of the rat [TG] promoter involves activation of [TF].	CREB	secretogranin II	1	ACTIVATION	False
6466	6532	12581877:4:CREB1:SCG2	[TF] was shown to bind to the [TG] CRE and transfection studies with a dominant-negative CREB mutant provided evidence that CREB is required for GnRH responsiveness of the SgII promoter.	CREB	SgII	1	ACTIVATION	True
6467	6533	12853459:4:NR5A2:CEL	[TF] interacts with a consensus LRH-1 response element in the human [TG] promoter, which is perfectly conserved in the rat gene, and induces CEL promoter activity in cotransfection assays.	LRH-1	CEL	1	ACTIVATION	False
6469	6535	1386897:3:ZNF143:TPP1	SWI4 and SWI6 are components of a factor ([TF]) that binds the CACGAAAA (SCB) promoter elements responsible for activation in late G1 of the HO endonuclease, CLN1 and [TG] genes.	SBF	CLN2	1	ACTIVATION	False
6470	6536	1406677:7:MEF2A:MB	These data suggest that cooperative interactions between CBF40 and other factors including [TF] are required for expression of the [TG] gene in skeletal muscle.	MEF-2	human myoglobin	1	ACTIVATION	False
6471	6537	14986171:9:TP53:ALDH4A1	These results suggest that [TF] might play a protective role against cell damage induced by generation of intracellular ROS, through transcriptional activation of [TG].	p53	ALDH4	1	ACTIVATION	False
6472	6538	15001570:10:CRX:PDE6A	Consistent with a requirement for [TF] and Nrl in [TG] promoter activity, Pde6a mRNA is reduced by 87% in the retina of Crx(-/-) mice and is undetectable in Nrl(-/-) mice at postnatal day 10.	Crx	Pde6a	1	ACTIVATION	False
6473	6539	15001570:11:CRX:PDE6A	These results establish that both Nrl and [TF] are required for full transcriptional activity of the [TG] gene.	Crx	PDE6A	1	ACTIVATION	False
6474	6540	15001570:11:NRL:PDE6A	These results establish that both [TF] and Crx are required for full transcriptional activity of the [TG] gene.	Nrl	PDE6A	1	ACTIVATION	False
6475	6541	15001570:5:CRX:PDE6A	Both [TF] and Nrl transactivated the [TG] promoter in HEK293 cells and showed a >100-fold increase when coexpressed.	Crx	PDE6A	1	ACTIVATION	False
6476	6542	15001570:5:NRL:PDE6A	Both Crx and [TF] transactivated the [TG] promoter in HEK293 cells and showed a >100-fold increase when coexpressed.	Nrl	PDE6A	1	ACTIVATION	False
6477	6543	15019837:9:RUNX1:ERAP1	AML1/Runx1/[TF] increased [TG] mRNA in mouse ECs, whereas dominant interfering chimerical PEBP2beta-MYH11 decreased it.	PEBP2alphaB	PILSAP	1	ACTIVATION	False
6478	6544	15252010:6:NR1I2:CYP3A5	Elucidation of the mechanism involved in [TG] induction revealed that constitutively activated receptor (CAR) and pregnane X receptor ([TF]) transactivated the CYP3A5 promoter (-688 to +49) and that the transactivation was dependent on an everted repeat separated by 6 bp (ER6-dependent).	PXR	CYP3A5	1	ACTIVATION	False
6479	6545	15252010:6:NR1I3:CYP3A5	Elucidation of the mechanism involved in [TG] induction revealed that constitutively activated receptor ([TF]) and pregnane X receptor (PXR) transactivated the CYP3A5 promoter (-688 to +49) and that the transactivation was dependent on an everted repeat separated by 6 bp (ER6-dependent).	CAR	CYP3A5	1	ACTIVATION	False
6480	6546	15252010:7:NR1I2:CYP3A5	Treatment with the prototypical [TF] ligand rifampin led to a 2-fold induction of the [TG] promoter activity.	PXR	CYP3A5	1	ACTIVATION	False
6481	6547	15589828:9:SP1:CLDN19	Site-directed mutagenesis using specific oligo probes confirmed that [TF] was crucial for [TG] transactivation in the three cell lines studied.	Sp1	Cldn19	1	ACTIVATION	False
6482	6548	15777731:3:TFAP2A:CKB	Dominant-negative forms of [TF] not only prevented the AP2alpha-mediated activation of [TG] but also blocked the cAMP-mediated increase in CKB transcription caused by forskolin treatment.	AP2alpha	CKB	1	ACTIVATION	False
6483	6549	16260592:6:SP1:IL21R	Moreover, mutation of the [TF] motif markedly reduced [TG] promoter activity, and Sp1 small interfering RNAs effectively diminished IL-21R expression in activated T cells.	Sp1	IL-21R	1	ACTIVATION	False
6484	6550	16529657:0:SP1:P2RX1	[TF] and NF-1 mediate basal transcription of the human [TG] gene in megakaryoblastic MEG-01 cells.	Sp1/3	P2X1	1	ACTIVATION	False
6485	6551	16648583:7:ZNF143:TPP1	Indeed, the levels of the G(1) cyclin [TG] transcripts, which are positively regulated by [TF], were dramatically reduced in bmh mutants.	SBF	CLN2	1	ACTIVATION	False
6486	6552	16886906:6:SP1:ACO1	Transient expression assays following transfection of HuH7 cells with these plasmids revealed that while both the [TF] and GAS sequences are involved in basal transcriptional activity of the [TG] promoter, the role of the latter is predominant.	Sp1	IRP1	1	ACTIVATION	False
6487	6553	16897187:9:TP53:DFNA5	Finally, the expression of [TG] mRNA was remarkably induced by gamma-ray irradiation in the colon of [TF](+/+) mice but not in that of p53(-/-) mice.	p53	DFNA5	1	ACTIVATION	False
6488	6554	16964281:7:EWSR1:PLD2	Results showed that [TF]/Fli-1 and Fli-1 increase [TG] gene expression by binding to an erythroblast transformation-specific domain (-126 to -120 bp from the transcription initiation site) of PLD2 promoter, which is the minimal and most powerful region.	EWS	PLD2	1	ACTIVATION	False
6489	6555	16964281:7:FLI1:PLD2	Results showed that EWS/[TF] and Fli-1 increase [TG] gene expression by binding to an erythroblast transformation-specific domain (-126 to -120 bp from the transcription initiation site) of PLD2 promoter, which is the minimal and most powerful region.	Fli-1	PLD2	1	ACTIVATION	False
6490	6556	17075044:6:TBX21:FUT7	[TF] promotes and GATA-3 represses [TG] transcription.	T-bet	FUT7	1	ACTIVATION	False
6491	6557	17226765:6:CREB1:CLDN11	Binding of Smad proteins at the GATA/NF-Y motif could repress the GATA and [TF] transactivation of [TG] gene.	CREB	claudin-11	1	ACTIVATION	False
6492	6558	17611579:9:PPARA:ABCA12	Together, our data demonstrate that [TF] and LXR activators increase [TG] expression, providing an additional mechanism by which PPAR and LXR activators promote epidermal permeability barrier homeostasis.	PPAR	ABCA12	1	ACTIVATION	False
6493	6559	18097042:8:JUN:HCST	Overexpression of [TF] or c-Fos in NK and T cells led to enhanced [TG] promoter activity and DAP10 protein expression.	c-Jun	DAP10	1	ACTIVATION	False
6495	6561	18384814:0:AP1:MIR21	[TG] Gene expression triggered by [TF] is sustained through a double-negative feedback mechanism.	AP-1	miR-21	1	ACTIVATION	True
6496	6562	18384814:3:AP1:MIR21	We show that activation protein 1 ([TF]) activates the [TG] transcription in conjugation with the SWI/SNF complex, after PMA stimulation, through the conserved AP-1 and PU.1 binding sites in the promoter identified here.	AP-1	miR-21	1	ACTIVATION	False
6498	6564	18394600:9:HIF1A:STC2	To elucidate this possibility, RNA interference studies confirmed that endogenous [TF] was a key factor for [TG] gene activation as well as in the synergistic induction of STC2 expression in 5-aza-CdR pretreated cells.	HIF-1 alpha	STC2	1	ACTIVATION	False
6499	6565	18523561:5:WT1:SLC29A4	[TG] is transcriptionally activated by both isoforms of EWS/[TF] as evidenced by promoter-reporter and chromatin immunoprecipitation (ChIP) analyses.	WT1	ENT4	1	ACTIVATION	False
6500	6566	18588874:5:SP1:TNXB	Transfection experiments in SL2 cells, an [TF]-deficient model system, with an Sp1 expression vector demonstrated that the region from -1380 to -1371, an HRE, is sufficient for efficient activation of the [TG] promoter upon hypoxia.	Sp1	XB-S	1	ACTIVATION	True
6501	6567	19015155:4:E2F1:DUT	In this study we performed the first functional characterization of the [TG] promoter and demonstrate a role for [TF] and Sp1 in driving dUTPase expression.	E2F-1	dUTPase	1	ACTIVATION	False
6502	6568	19015155:4:SP1:DUT	In this study we performed the first functional characterization of the [TG] promoter and demonstrate a role for E2F-1 and [TF] in driving dUTPase expression.	Sp1	dUTPase	1	ACTIVATION	False
6503	6569	19232384:9:GATA3:KLK1	Moreover, introduction of [TF] into fibroblastic NIH3T3 cells enhanced the activity of [TG] promoter containing -954/+40, while that of GATA3 dominant negative mutant to NHEK cells impaired the same promoter's activity.	GATA3	KLK1	1	ACTIVATION	False
6504	6570	19240036:10:ATF4:SLC38A2	Since ATF4 ([TF]) and CCAAT/enhancer-binding protein are known to bind to an amino acid response element within the [TG] promoter and mediate induction of SNAT2 in peripheral cell lines, we tested whether either factor was similarly induced by amino acid deprivation in neurons.	activating transcription factor 4	SNAT2	1	ACTIVATION	False
6505	6571	19259985:4:RUNX2:SDC3	[TF] enhances expression of genes related to proteoglycan-mediated signaling, including FGF receptors (e.g., FGFR2 and FGFR3) and proteoglycans (e.g., syndecans [Sdc1, Sdc2, [TG]], glypicans [Gpc1], versican [Vcan]).	Runx2	Sdc3	1	ACTIVATION	False
6506	6572	19308091:0:AP1:MIR21	BMP-6 inhibits [TG] expression in breast cancer through repressing deltaEF1 and [TF].	AP-1	microRNA-21	1	ACTIVATION	True
6507	6573	19633298:4:PPARG:HCAR1	GPR81/[TG] is a direct [TF] target gene, because mRNA expression of GPR81/Gpr81 (and GPR109A/Gpr109A) increased in mature human and murine adipocytes as well as in vivo in epididymal fat pads of mice upon rosiglitazone stimulation, whereas small interfering RNA-mediated knockdown of PPARgamma in differentiated 3T3-L1 adipocytes showed a significant decrease in Gpr81 protein expression.	PPARgamma	Gpr81	1	ACTIVATION	False
6508	6574	19741195:10:HNF1A:SLC23A1	Additionally, small interfering RNA knockdown of both members of the HNF-1 family, [TF] and HNF-1beta, resulted in a significant decline in [TG] transcription.	HNF-1alpha	SVCT1	1	ACTIVATION	False
6509	6575	19741195:10:HNF1B:SLC23A1	Additionally, small interfering RNA knockdown of both members of the HNF-1 family, HNF-1alpha and [TF], resulted in a significant decline in [TG] transcription.	HNF-1beta	SVCT1	1	ACTIVATION	False
6510	6576	19741195:11:HNF1A:SLC23A1	Together, these data suggest that [TF] and/or HNF-1beta binding is required for [TG] expression and may be involved in the coordinate regulation of whole body vitamin C status.	HNF-1alpha	SVCT1	1	ACTIVATION	False
6511	6577	20038531:4:BHLHA15:RAB3D	We next show that RAB26 and [TG] expression is significantly downregulated in Mist1(-)(/)(-) ZCs, suggesting that [TF] establishes large secretory granules by inducing RAB transcription.	MIST1	RAB3D	1	ACTIVATION	False
6512	6578	20091743:10:SP1:APBB1	Conversely, suppression of the [TG] promoter was observed in cells either treated with an [TF] inhibitor or in which Sp1 was knocked down.	Sp1	FE65	1	ACTIVATION	False
6513	6579	20091743:9:SP1:APBB1	Overexpression of the transcription factor [TF] potentiates the [TG] promoter activity.	Sp1	FE65	1	ACTIVATION	False
6514	6580	20139079:7:GABPA:LIG4	Among these GABP-associated genes, knockdown of [TF] expression by RNA interference diminished expression of [TG], Artemis, and Ku80 components in DNA-dependent protein kinase complex.	GABPalpha	DNA ligase IV	1	ACTIVATION	False
6515	6581	20185824:7:HSF1:ZFAND2A	The [TF] binding HSE sequence in the [TG] promoter critical for heat-induced transcription was identified.	HSF1	AIRAP	1	ACTIVATION	False
6516	6582	20206127:4:SP7:COL5A3	The overexpression of [TF]/Osterix significantly increased the promoter activity and the endogenous mRNA level of the [TG] gene in osteoblastic cells.	Sp7	Col5a3	1	ACTIVATION	False
6517	6583	20206127:5:SP7:COL5A3	Conversely, a reduction of [TF]/Osterix by siRNA treatment decreased the promoter activity and the endogenous mRNA level of the [TG] gene.	Sp7	Col5a3	1	ACTIVATION	False
6518	6584	20442290:4:HIF1A:NEDD9	Moreover, our data show that [TF] mediates the effects of hypoxia on induction of [TG] expression via binding to a hypoxia-responsive element of the HEF1 promoter.	HIF-1alpha	HEF1	1	ACTIVATION	False
6519	6585	20667911:7:SMAD1:NOG	In response to BMP pathway activation, JMJD3 histone demethylase interacts with the [TF]/Smad4 complex to demethylate and activate the [TG] promoter.	Smad1	Noggin	1	ACTIVATION	True
6520	6586	20667911:7:SMAD4:NOG	In response to BMP pathway activation, JMJD3 histone demethylase interacts with the Smad1/[TF] complex to demethylate and activate the [TG] promoter.	Smad4	Noggin	1	ACTIVATION	False
6521	6587	20806931:10:NFE2L2:CBR3	While siRNA-mediated knockdown of [TF] led to a decrease in the level of [TG] mRNA in A549 cells (30% of control), Keap1 knockdown increased the level of CBR3 mRNA expression in HepG2 (9.3-fold) and HT-29 (2.7-fold) cells.	Nrf2	CBR3	1	ACTIVATION	False
6522	6588	20806931:8:NFE2L2:CBR3	Inhibition of [TF]-activating upstream kinase MEK/ERK by PD98059 weakened DEM-mediated induction of [TG] mRNA.	Nrf2	CBR3	1	ACTIVATION	False
6523	6589	20815812:5:AP1:MIR21	PMA stimulation induced [TG] expression via motifs bound with [TF] (activator protein 1) transcription factors.	AP-1	miR-21	1	ACTIVATION	False
6524	6590	20876458:10:RUNX1:MYL9	[TG] expression was inhibited by [TF] short interfering RNA (siRNA) and enhanced by RUNX1 overexpression.	RUNX1	MYL9	1	ACTIVATION	False
6525	6591	21167294:5:NFKB:SPTLC2	Pharmacological inhibition of nuclear factor kappa B (NFB) prevented LPS-induced upregulation of [TG] while transfection of [TF] subunit of NFB upregulated Sptlc2 and increased cellular ceramide levels.	p65	Sptlc2	1	ACTIVATION	False
6526	6592	21224358:3:AR:INPP4B	We discovered that the [TF] induces the expression of the tumor suppressor [TG] (INPP4B) but not PTEN in prostate cancer cells.	androgen receptor	inositol polyphosphate 4-phosphatase type II	1	ACTIVATION	False
6527	6593	21232033:13:HSF1:DLG1	[TF] induced transcription of [TG] through SIRT1-dependent interaction with HSEs; the increase in SAP97 resulted in stabilization of K(v)1.5 channels.	HSF-1	SAP97	1	ACTIVATION	False
6528	6594	21281489:13:HNF1B:LHX1	Significantly, [TF] activates the [TG] promoter directly, thus extending the known activin A regulation of the lhx1 gene via an activin A responsive element.	HNF1B	lhx1	1	ACTIVATION	False
6529	6595	21359952:11:STAT5A:ACO1	These results strongly implicate glucocorticoid receptor and [TF] in stress-induced up-regulation of [TG], which subsequently enhances transferrin receptor-1 expression and down-regulates ferritin, causing iron accumulation in the liver.	STAT5	IRP-1	1	ACTIVATION	False
6530	6596	21420399:5:PAX9:OSR2	We found that endogenous [TG] mRNA expression was significantly downregulated in the developing tooth mesenchyme in [TF](del/del) mice.	Pax9	Osr2	1	ACTIVATION	False
6531	6597	21552207:4:PAX5:NEDD9	One of the newly identified enhancers was shown by transgenic analysis to confer [TF]-dependent B-cell-specific activity to the [TG] gene controlling B-cell trafficking.	Pax5	Nedd9	1	ACTIVATION	True
6532	6598	21617703:4:EHF:RUVBL1	We found that [TF] directly activates the transcription of [TG], an ATPase associated with chromatin-remodelling complexes.	EHF	RUVBL1	1	ACTIVATION	False
6533	6599	21645329:10:SP1:TRPV1	Finally, electroporation of [TF] or Sp4 cDNA into cultures of DRG neurons directed an increase in Sp1/Sp4 mRNA and importantly an increase in [TG] mRNA.	Sp1	TRPV1	1	ACTIVATION	False
6534	6600	21645329:10:SP4:TRPV1	Finally, electroporation of Sp1 or [TF] cDNA into cultures of DRG neurons directed an increase in Sp1/Sp4 mRNA and importantly an increase in [TG] mRNA.	Sp4	TRPV1	1	ACTIVATION	False
6535	6601	21645329:11:SP1:TRPV1	Conversely, combined si-RNA directed knockdown of [TF]/Sp4 resulted in a decrease in [TG] mRNA.	Sp1	TRPV1	1	ACTIVATION	False
6536	6602	21645329:11:SP4:TRPV1	Conversely, combined si-RNA directed knockdown of Sp1/[TF] resulted in a decrease in [TG] mRNA.	Sp4	TRPV1	1	ACTIVATION	False
6537	6603	21645329:12:SP4:TRPV1	Based on these studies, we now propose a model of [TG] expression that is dependent on Sp1-like transcription factors with [TF] playing a predominant role in activating TRPV1 RNA transcription in DRG neurons.	Sp4	TRPV1	1	ACTIVATION	False
6538	6604	21685938:0:NANOG:MIR21	Stem cell marker ([TF]) and Stat-3 signaling promote [TG] expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.	Nanog	MicroRNA-21	1	ACTIVATION	False
6540	6606	22001310:0:NFE2L2:CBR3	A conserved antioxidant response element (ARE) in the promoter of human carbonyl reductase 3 ([TG]) mediates induction by the master redox switch [TF].	Nrf2	CBR3	1	ACTIVATION	False
6541	6607	22001310:5:NFE2L2:CBR3	In this study, experiments with reporter constructs showed that the prototypical [TF] activator tert-butyl hydroquinone (t-BHQ) induces [TG] promoter activity in cultures of HepG2 (2.7-fold; p<0.05) and MCF-7 cells (22-fold; p<0.01).	Nrf2	CBR3	1	ACTIVATION	False
6542	6608	22032922:0:TP53:CGB7	The tumor suppressor [TF] induces expression of the pregnancy-supporting human chorionic gonadotropin (hCG) [TG] gene.	p53	CGB7	1	ACTIVATION	False
6543	6609	22073279:0:MEF2C:PTP4A3	VEGF promotes the transcription of the human [TG] gene in HUVEC through transcription factor [TF].	MEF2C	PRL-3	1	ACTIVATION	False
6544	6610	22210182:7:STAT3:MIR21	There is a growing body of evidence demonstrating that [TF] directly activates [TG], one of miRs that promote cancer cell survival and proliferation.	STAT3	miR-21	1	ACTIVATION	False
6545	6611	22223638:0:CTCFL:FER	Intronic promoter drives the [TF]-regulated expression of [TG]T in colon carcinoma cells.	BORIS	Fer	0	UNDEFINED	True
6546	6612	22223638:5:CTCFL:FER	Transcription of the [TG]T gene in CC cells was found to be driven by an intronic promoter residing in intron 10 of the fer gene and to be regulated by another CTA, the Brother of the Regulator of Imprinted Sites ([TF]) transcription factor.	BORIS	fer	0	UNDEFINED	True
6547	6613	22223638:6:CTCFL:FER	[TF] binds to the [TG]T promoter and down-regulation of BORIS significantly decreases the expression of ferT in CC cells.	BORIS	fer	1	ACTIVATION	False
6548	6614	22370639:13:ZNF331:PNPT1	The tumor-suppressive effect of [TF] is mediated at least by downregulation of genes involved in cell growth promotion (DSTN, EIF5A, GARS, DDX5, STAM, UQCRFS1 and SET) and migration/invasion (DSTN and ACTR3), and upregulation of genome-stability gene (SSBP1) and cellular senescence gene ([TG]).	ZNF331	PNPT1	1	ACTIVATION	False
6549	6615	22422726:6:MEF2A:MYH7B	Using luciferase reporter analysis in rat cardiomyocytes, it can be shown that [TF], GATA, and E-box regulatory elements are essential for efficient expression of the [TG] gene.	MEF2	Myh7b	1	ACTIVATION	False
6550	6616	22427437:11:HSF1:TRPV1	In the PO/AH, electrophoretic mobility shift assay and chromatin immunoprecipitation assay analyses demonstrated that [TF] is recruited to the HSE of the [TG] gene in PO/AH cells during LPS-induced fever, resulting in enhanced TRPV1 expression.	HSF1	TRPV1	1	ACTIVATION	False
6552	6618	22586091:5:ETV1:GRIN2C	BDNF up-regulated both the [TG] and Tiam1 genes via the TrkB-Erk cascade and this up-regulation was blocked not only by inhibition of the activity-dependent signaling mechanisms but also by suppression of [TF] expression with Etv1 siRNA.	Etv1	NR2C	1	ACTIVATION	False
6553	6619	22607194:6:FOXA2:WNT6	More specifically, overexpression of Gata6 or [TF] alone induced molecular and morphological markers of primitive endoderm, which occurred concomitantly with the upregulation of the [TG] gene.	Foxa2	Wnt6	1	ACTIVATION	False
6554	6620	22607194:6:GATA6:WNT6	More specifically, overexpression of [TF] or Foxa2 alone induced molecular and morphological markers of primitive endoderm, which occurred concomitantly with the upregulation of the [TG] gene.	Gata6	Wnt6	1	ACTIVATION	False
6555	6621	22607194:8:FOXA2:WNT6	Chromatin immunoprecipitation analysis revealed that GATA6 and [TF] were bound to the [TG] promoter, and overexpression studies showed that these transcription factors were sufficient to switch on the gene expression of a Wnt6 reporter construct.	FOXA2	Wnt6	1	ACTIVATION	False
6556	6622	22607194:8:GATA6:WNT6	Chromatin immunoprecipitation analysis revealed that [TF] and FOXA2 were bound to the [TG] promoter, and overexpression studies showed that these transcription factors were sufficient to switch on the gene expression of a Wnt6 reporter construct.	GATA6	Wnt6	1	ACTIVATION	False
6557	6623	22931925:7:IRF6:GRHL3	We show that one of these elements has enhancer activity in human keratinocytes and zebrafish periderm, suggesting that [TF] directly stimulates [TG] expression in these tissues.	Irf6	Grhl3	1	ACTIVATION	False
6558	6624	22981541:4:AP1:SPATA12	[TF] is founded to be a potential transcriptional activator of [TG].	AP-1	SPATA12	1	ACTIVATION	False
6559	6625	22981541:7:AP1:SPATA12	The expression of [TG] could be induced by TGF-1 in a dose-dependent manner, suggesting that [TF] as an activator plays a role in the regulation of SPATA12 promoter.	AP-1	SPATA12	1	ACTIVATION	False
6560	6626	23018770:4:RUNX1:TRPV1	Importantly, C/EBP a well-established heterodimer partner of [TF] also binds to the [TG] promoter and cooperates with Runx1 to further stimulate TRPV1 transcription.	Runx1	TRPV1	1	ACTIVATION	False
6561	6627	23055556:8:AP1:MIR21	We mapped the gga-[TG] promoter to the 10th intron of the TMEM49 gene and found it to be driven by [TF] Ets-responsive elements.	AP-1- and	miR-21	1	ACTIVATION	False
6562	6628	23235459:7:TP53:PRAP1	[TG] appears to protect cells from apoptosis by inducing cell-cycle arrest, suggesting that the induction of PRAP1 expression by [TF] in response to DNA-damaging agents contributes to cancer cell survival.	p53	PRAP1	1	ACTIVATION	False
6563	6629	23416424:3:STAT3:MIR21	Bcl6 represses and [TF] activates [TG] transcription through a Stat3 binding element in the promoter, indicating opposing regulation of miR-21 by the two transcription factors via the same DNA site.	Stat3	miR-21	1	ACTIVATION	False
6564	6630	23417899:4:POU5F1:MESP1	This Tcf/Lef-[TF] composite site mediated synergistic activation of the [TG] promoter by Oct4 and canonical Wnt signaling.	Oct4	Mesp1	1	ACTIVATION	False
6565	6631	23517917:4:ATF6:IFRD1	[TG] promoter activity was selectively enhanced by [TF] (ATF6) among different transcription factors tested, while induction of TIS7 by hypoxic stress was markedly prevented by knockdown of ATF6 by shRNA in 3T3-L1 cells.	activating transcription factor-6	TIS7	1	ACTIVATION	False
6566	6632	23773363:10:PPARA:CUBN	Not only was the expression of [TF] and  inducible by 5Aza and TSA, but the positive effects of TSA and 5Aza on [TG] expression were also dependent on both increased PPAR transcription and activation.	PPAR	cubilin	1	ACTIVATION	False
6567	6633	23810250:7:FOS:MIR21	Reduction of [TF] inhibited [TG] expression by binding to the miR-21 promoter using luciferase reporter assays.	FOS	miR-21	1	ACTIVATION	False
6568	6634	23864333:5:XBP1:MANF	Of the six transcription factors, ATF6 most strongly increased the [TG] promoter activity via ERSE-II, while the effects of ATF6 and [TF] were moderate.	sXBP1	MANF	1	ACTIVATION	True
6569	6635	23894477:10:ELK1:KATNB1	We found that [TF] activated [TG] promoter, and increased both mRNA and protein levels of katanin-p80 in SH-SY5Y cells.	Elk1	KATNB1	1	ACTIVATION	False
6570	6636	23939472:4:NRF1:ENOX1	We found that [TF] positively regulates FAM134C and [TG], but negatively regulates C3orf10 in human neuroblastoma IMR-32 cells and primary rat cortical neurons.	NRF-1	ENOX1	1	ACTIVATION	False
6571	6637	23965983:4:TP53:ERAP1	Using a combination of chromatin immunoprecipitation sequencing and gene expression analysis, we demonstrate that [TF] upregulates expression of [TG] by binding to its cognate response element in the ERAP1 gene.	p53	endoplasmic reticulum aminopeptidase 1	1	ACTIVATION	False
6572	6638	23965983:6:TP53:ERAP1	We further show that this mechanism operates in A549 cells infected with H1N1 influenza virus, in which H1N1 activates [TF], leading to [TG] upregulation and a corresponding increase in major histocompatibility complex I expression.	p53	endoplasmic reticulum aminopeptidase 1	1	ACTIVATION	False
6573	6639	24121511:5:HNF1A:SLC6A19	Transcription factors [TF] and HNF4a activate transcription of the [TG] gene in villus enterocytes, whereas high levels of SOX9 repress expression in the crypts.	HNF1a	Slc6a19	1	ACTIVATION	False
6574	6640	24121511:5:HNF4A:SLC6A19	Transcription factors HNF1a and [TF] activate transcription of the [TG] gene in villus enterocytes, whereas high levels of SOX9 repress expression in the crypts.	HNF4a	Slc6a19	1	ACTIVATION	False
6575	6641	24173808:5:PAX9:OSR2	We found that expression of the Bmp4, Fgf10, Msx1 and [TG] genes is significantly downregulated in the developing palatal mesenchyme in [TF] mutant embryos.	Pax9	Osr2	1	ACTIVATION	False
6576	6642	24394418:8:TBX3:JDP2	Suppressing [TF] in osteoclast precursors reduced [TG] expression and significantly impaired RANKL/CSF1-induced osteoclastogenesis.	Tbx3	JDP2	1	ACTIVATION	False
6577	6643	24619424:8:HSF1:ZFAND2A	Interestingly, whereas [TF] has been confirmed to be critical for [TG] gene transcription, HSF2 was found to negatively regulate AIRAP expression after bortezomib treatment, further emphasizing an important modulatory role of this transcription factor under stress conditions.	HSF1	AIRAP	1	ACTIVATION	False
6578	6644	24711583:8:IRF4:ZBTB20	Strikingly, [TG] induction does not require Blimp1 but depends directly on [TF], acting at a newly identified Zbtb20 promoter in ASCs.	Irf4	Zbtb20	1	ACTIVATION	False
6579	6645	24853417:7:JUNB:ERN1	In addition, GEP induces [TG] expressions and this induction of IRE1a by GEP depends on [TF].	JunB	IRE1a	1	ACTIVATION	False
6580	6646	25101494:5:SOX5:CATSPER1	Interestingly, transcription factors [TF] and Sox9 caused a significant increase in transactivation of the [TG] promoter in heterologous systems, and chromatin immunoprecipitation assays showed that both transcription factors interact with the Catsper1 promoter in vivo.	Sox5	Catsper1	1	ACTIVATION	False
6581	6647	25101494:5:SOX9:CATSPER1	Interestingly, transcription factors Sox5 and [TF] caused a significant increase in transactivation of the [TG] promoter in heterologous systems, and chromatin immunoprecipitation assays showed that both transcription factors interact with the Catsper1 promoter in vivo.	Sox9	Catsper1	1	ACTIVATION	False
6582	6648	9089392:6:MEF2A:TNNT1	We showed that a DNA segment between -264 and -44 bp from the most 5' transcriptional initiation site, which has an [TF], and M-CAT-like element, a CArG box and two E boxes, was essential for the expression of the fast [TG] gene.	MEF2	TnT	1	ACTIVATION	False
6583	6649	9359867:0:PURA:APBB1	DNA-binding protein [TF] and transcription factor YY1 function as transcription activators of the neuron-specific [TG] gene promoter.	Pur alpha	FE65	1	ACTIVATION	False
6584	6650	9359867:0:YY1:APBB1	DNA-binding protein Pur alpha and transcription factor [TF] function as transcription activators of the neuron-specific [TG] gene promoter.	YY1	FE65	1	ACTIVATION	False
6585	6651	9418879:4:CEBPA:LNP1	Here we demonstrate that AML-1-ETO also inhibits [TF]-dependent activation of the myeloid cell-specific, rat defensin [TG] promoter.	C/EBP-alpha	NP-3	1	ACTIVATION	False
6586	6652	9780226:6:SP1:TPMT	DNaseI footprinting analysis and cotransfection in Drosophila Schneider SL2 cells documented that [TF] binds to the [TG] promoter and is important for constitutive activity.	Sp1	TPMT	1	ACTIVATION	False
6587	6653	9799798:10:TFAP2A:LIPA	Our data suggest that differentiation dependent increase of lysosomal acid lipase ([TG]) expression in THP-1 cells is mediated by a concerted action of Sp1 and [TF].	AP-2	LAL	1	ACTIVATION	False
6588	6654	10887174:9:CEBPB:KRT6B	Both transcription factors are necessary for the induction of [TG] by TNFalpha and act as a complex, although only [TF] binds the K6b promoter DNA.	C/EBPbeta	K6b	1	ACTIVATION	False
6589	6655	12754203:4:NKX2-5:MOV10L1	One gene that we found to be markedly down-regulated in the hearts from [TF] null embryos is an isoform of Mov10 like-1 ([TG]), a putative RNA helicase expressed in testis.	Nkx2.5	Mov10l1	1	ACTIVATION	False
6590	6656	19741195:11:HNF1B:SLC23A1	Together, these data suggest that HNF-1alpha and/or [TF] binding is required for [TG] expression and may be involved in the coordinate regulation of whole body vitamin C status.	HNF-1beta	SVCT1	1	ACTIVATION	False
6591	6657	20813833:8:STAT3:MIR21	Thus, IFN-induced [TG] expression is coregulated by [TF] and NF-B at the level of the miR-21 promoter.	STAT3	miR-21	0	UNDEFINED	True
6592	6658	20876458:12:RUNX1:MYL9	Our results constitute the first evidence that the [TG] gene is a direct target of [TF] and provide a mechanism for decreased platelet MYL9 expression, MLC phosphorylation, thrombocytopenia, and platelet dysfunction associated with RUNX1 mutations.	RUNX1	MYL9	0	UNDEFINED	True
6593	6659	21233218:4:SP1:NAPEPLD	The transcription factor [TF] is involved in regulating baseline [TG] expression but not in the transcriptional suppression induced by LPS.	Sp1	NAPE-PLD	0	UNDEFINED	False
6594	6660	21281489:10:HNF1B:LHX1	In an additional approach we could show that [TF] induces several genes important in nephrogenesis and regulates [TG] expression by an HNF1 binding site in the lhx1 promoter.	HNF1B	lhx1	0	UNDEFINED	True
6596	6662	21596795:5:NFE2L2:TXNRD1	Simultaneously, CA increased [TF] nuclear accumulation and activated expression of prototypical Nrf2 target genes such as haem oxygenase 1 (HO-1) and thioredoxin reductase 1 ([TG]).	Nrf2	TXNRD1	1	ACTIVATION	False
6597	6663	21685938:0:STAT3:MIR21	Stem cell marker (Nanog) and [TF] signaling promote [TG] expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.	Stat-3	MicroRNA-21	1	ACTIVATION	False
6598	6664	21733184:8:NR1I2:CYP3A5	RNA interference experiments confirmed [TF] involvement in CYP3A4 overexpression and permitted us to identify [TG] and MRP2 transporter as SXR target genes.	SXR	CYP3A5	1	ACTIVATION	True
6600	6666	23066027:4:STAT3:CCDC88A	We identified a single [TF]-binding site on the [TG] promoter that was necessary and sufficient for transcriptional activation of GIV during wound healing and cancer invasion.	STAT3	GIV	1	ACTIVATION	False
6601	6667	23807508:8:ZBTB7A:MAPK11	Both dual luciferase report assay and ChIP assay suggested that [TG] is a novel regulatory target of the transcription factor [TF] and positively regulated by Pokemon in hepatic cells.	Pokemon	p38	1	ACTIVATION	False
6602	6668	9799798:10:SP1:LIPA	Our data suggest that differentiation dependent increase of lysosomal acid lipase ([TG]) expression in THP-1 cells is mediated by a concerted action of [TF] and AP-2.	Sp1	LAL	1	ACTIVATION	False
6603	6669	12560508:7:EGR1:ABCA2	When increasing amounts of [TF] were transfected into the BE(2)-M17 neuroblastoma cells we observed a dose-dependent decrease in expression of the [TG] promoter, although expression of the endogenous ABCA2 gene increased following transfection of EGR-1.	EGR-1	ABCA2	2	REPRESSION	True
6605	6671	10936858:7:GATA1:SPTB	Together, the results suggest that [TF] bound at 5a is a strong, proximal repressor of [TG] enhancer activity.	GATA-1	HS2	2	REPRESSION	True
6606	6672	15525603:1:AR:C1orf116	We characterized the specifically androgen-regulated gene ([TG]), which is expressed in the [TF] (AR) and glucocorticoid receptor (GR) positive cell line lymph node carcinoma of the prostate-1F5 (LNCaP-1F5).	androgen receptor	SARG	0	UNDEFINED	False
6607	6673	24038093:0:HNF1A:NCR1	[TF] controls ILC2 and [TG]+RORt+ innate lymphocyte differentiation and protection in intestinal inflammation.	TCF-1	NKp46	0	UNDEFINED	False
6610	6676	23663782:5:ATF4:SIRT4	Mechanistically, mTORC1 represses [TG] by promoting the proteasome-mediated destabilization of cAMP-responsive element binding 2 ([TF]).	CREB2	SIRT4	1	ACTIVATION	False
6611	6677	11340165:0:XBP1:CLYBL	[TF]-mediated repression of [TG] gene expression contributes to the modifications of yeast cell morphology and cell cycle seen during nitrogen-limited growth.	Xbp1	CLB	2	REPRESSION	False
6612	6678	11340165:9:XBP1:CLYBL	Transcriptional activation of the [TF] gene and the subsequent repression of [TG] gene expression are thus key responses of yeast cells to nitrogen limitation.	XBP1	CLB	2	REPRESSION	False
6613	6679	11585908:10:REST:MAPK8IP1	The introduction of a mutated NRSE in the 5' regulating region of the [TG] gene abolished the repression activity driven by [TF] in insulin-secreting beta cells and relieved the low transcriptional activity of IB1 observed in unrelated cells.	REST	IB1	2	REPRESSION	False
6614	6680	11585908:11:REST:MAPK8IP1	Moreover, transfection in non-beta and nonneuronal cell lines of an expression vector encoding [TF] lacking its transcriptional repression domain relieved [TG] promoter activity.	REST	IB1	0	UNDEFINED	True
6615	6681	11585908:12:REST:MAPK8IP1	Last, the [TF]-mediated repression of [TG] could be abolished by trichostatin A, indicating that deacetylase activity is required to allow REST repression.	REST	IB1	2	REPRESSION	False
6616	6682	16501612:0:TP53:UBD	[TF] negatively regulates the expression of [TG], a gene upregulated in various cancers.	p53	FAT10	2	REPRESSION	False
6618	6684	16501612:8:TP53:UBD	Conversely, inhibiting [TF] expression through siRNA against p53 significantly enhanced [TG] expression and promoter activity.	p53	FAT10	2	REPRESSION	False
6619	6685	16886906:10:STAT5A:ACO1	These findings provide evidence that [TF] proteins play a role in NO-mediated down-regulation of [TG] gene expression.	STAT5	IRP1	2	REPRESSION	False
6620	6686	17075044:6:GATA3:FUT7	T-bet promotes and [TF] represses [TG] transcription.	GATA-3	FUT7	2	REPRESSION	False
6622	6688	17237810:5:EZH2:MSMB	The RNAi-mediated knockdown of [TF] resulted in a loss of H3K27 trimethylation and an increased expression of the [TG] gene.	EZH2	MSMB	2	REPRESSION	False
6623	6689	17237810:6:EZH2:MSMB	Conversely, the overexpression of [TF] was associated with a decreased expression of the [TG] gene.	EZH2	MSMB	2	REPRESSION	False
6624	6690	17670796:7:FOXK1:CTSA	[TF] acts as a transcriptional repressor and it represses SM alpha-actin and [TG] expression.	FOXK1	PPGB	2	REPRESSION	False
6625	6691	19015155:6:TP53:DUT	Treatment of HCT116 [TF](+/+) cells with the DNA-damaging agent oxaliplatin induced a p53-dependent transcriptional downregulation of [TG] not observed in the isogenic null cell line.	p53	dUTPase	2	REPRESSION	False
6627	6693	19361492:6:ISL1:LHX1	Overexpression of [TF] in post-migratory horizontal cells represses endogenous [TG] expression and increases the number of neurons with a dendritic morphology characteristic of type II horizontal cells, which normally express Isl1.	Isl1	Lim1	2	REPRESSION	False
6628	6694	20133480:5:YBX3:CUBN	In confluent OK cells, [TF] overexpression increased proliferation and PCNA while repressing megalin/[TG] expression and impairing differentiation of the brush border and primary cilium.	ZONAB	cubilin	2	REPRESSION	False
6629	6695	20371612:3:FOXO3:MIR21	Here we report that the transcriptional factor [TF] initiates apoptosis by transcriptionally repressing [TG] expression.	Foxo3a	miR-21	2	REPRESSION	False
6630	6696	20371612:7:FOXO3:MIR21	These results indicate that [TF] can transcriptionally repress [TG] expression.	Foxo3a	miR-21	2	REPRESSION	False
6631	6697	20837480:12:PARP1:CKB	Consistently, knockdown of [TF] by lentivirus-delivered shRNA enhanced [TG] mRNA expression.	PARP-1	ckb	2	REPRESSION	False
6633	6699	20926379:5:SMAD1:DPYSL2	Our ChIP assay demonstrates that both [TF] and -4 bind to [TG] promoter in the neocortex, and overexpression of SMAD1 and 4 in vivo suppresses CRMP2 expression.	SMAD1	CRMP2	2	REPRESSION	False
6634	6700	21183735:7:STAT3:NOSTRIN	Furthermore, we demonstrate that activation of blunted signal transducers and activators of transcription 3 ([TF]) in the absence of PECAM-1 results in decreased [TG] expression via direct binding of the signal transducers and activators of transcription 3 to the NOSTRIN promoter.	STAT3	NOSTRIN	2	REPRESSION	False
6635	6701	22370639:13:ZNF331:EIF5A	The tumor-suppressive effect of [TF] is mediated at least by downregulation of genes involved in cell growth promotion (DSTN, [TG], GARS, DDX5, STAM, UQCRFS1 and SET) and migration/invasion (DSTN and ACTR3), and upregulation of genome-stability gene (SSBP1) and cellular senescence gene (PNPT1).	ZNF331	EIF5A	2	REPRESSION	False
6637	6703	22553926:9:ETV4:MIR21	The Ets factor [TF] emerges from our studies as a consistent repressor of [TG] transcription.	Pea3	miR-21	2	REPRESSION	False
6638	6704	22614019:4:GRHL3:MIR21	The [TG] promoter is bound and repressed by [TF] indicating that these two factors are involved in a regulatory loop maintaining homeostasis in the epidermis.	Grhl3	miR-21	2	REPRESSION	False
6639	6705	22634616:8:PRDM1:MIR21	We explored the molecular basis for this repression and identify primary [TG] transcription as a direct target of [TF]-dependent repression, despite continued STAT3 activation and phospho-STAT3 binding to the primary miR-21 promoter.	BLIMP-1	miR-21	2	REPRESSION	False
6640	6706	23416424:3:BCL6:MIR21	[TF] represses and Stat3 activates [TG] transcription through a Stat3 binding element in the promoter, indicating opposing regulation of miR-21 by the two transcription factors via the same DNA site.	Bcl6	miR-21	2	REPRESSION	False
6641	6707	23633521:7:KLF3:FAM132A	We confirmed that [TF] binds the [TG] promoter in vitro and in vivo and that this leads to repression of promoter activity.	KLF3	Fam132a	2	REPRESSION	False
6642	6708	24121511:5:SOX9:SLC6A19	Transcription factors HNF1a and HNF4a activate transcription of the [TG] gene in villus enterocytes, whereas high levels of [TF] repress expression in the crypts.	SOX9	Slc6a19	2	REPRESSION	False
6643	6709	24380054:0:ZNF205:MPV17L	Three Nonsynonymous Single Nucleotide Polymorphisms in the [TF] Gene Cause Reduction of the Repression Activity That Leads to Upregulation of [TG], a Participant in Mitochondrial Function.	RhitH	M-LPH	2	REPRESSION	False
6644	6710	24407731:7:SOX17:MALAT1	Using quantitative chromatin immunoprecipitation-PCR and promoter activity assays, we confirmed that MACC1, [TG], NBN, NFAT5, CSNK1A1, FN1 and SERBP1 genes were suppressed by [TF] via the SRY binding-mediated transcriptional regulation.	SOX17	MALAT1	2	REPRESSION	False
6645	6711	24407731:7:SRY:MALAT1	Using quantitative chromatin immunoprecipitation-PCR and promoter activity assays, we confirmed that MACC1, [TG], NBN, NFAT5, CSNK1A1, FN1 and SERBP1 genes were suppressed by SOX17 via the [TF] binding-mediated transcriptional regulation.	SRY	MALAT1	2	REPRESSION	False
6646	6712	24619424:8:HSF2:ZFAND2A	Interestingly, whereas HSF1 has been confirmed to be critical for [TG] gene transcription, [TF] was found to negatively regulate AIRAP expression after bortezomib treatment, further emphasizing an important modulatory role of this transcription factor under stress conditions.	HSF2	AIRAP	2	REPRESSION	False
6647	6713	24648347:4:HOXC11:PAWR	Combined SRC-1 and [TF] ChIPseq analysis identified the differentiation marker, CD24, and the apoptotic protein, [TG], as direct SRC-1/HOXC11 suppression targets.	HOXC11	PAWR	0	UNDEFINED	True
6648	6714	24732797:4:REST:MIR21	The mechanism of the former is through restraint of SCF(TrCP)-dependent destruction of the repressor element 1 silencing transcription factor ([TF]) tumor suppressor and consequent inhibition of [TG] promoter activation.	REST	miR-21	2	REPRESSION	True
6649	6715	25026555:0:TP53:JDP2	Cloning and characterization of the mouse [TG] gene promoter reveal negative regulation by [TF].	p53	JDP2	2	REPRESSION	False
6650	6716	25026555:5:TP53:JDP2	Interestingly, the tumor suppressor [TF] significantly repressed the transcriptional activity of the [TG] promoter.	p53	JDP2	2	REPRESSION	False
6651	6717	25113559:3:CTCF:CELSR3	Specifically, [TF]/cohesin and NRSF inhibit the expression of [TG] through specific binding to its promoter.	CTCF	Celsr3	2	REPRESSION	False
6652	6718	25113559:3:REST:CELSR3	Specifically, CTCF/cohesin and [TF] inhibit the expression of [TG] through specific binding to its promoter.	NRSF	Celsr3	2	REPRESSION	False
6653	6719	7969181:5:TP53:CKB	Transient transfection experiments showed that wild-type mouse [TF] severely repressed the rat [TG] promoter in HeLa but not CV-1 monkey kidney cells, suggesting that, in HeLa but not CV-1 cells, p53 either associates with a required corepressor or undergoes a posttranslational modification necessary for CKB repression.	p53	CKB	2	REPRESSION	False
6654	6720	8617262:11:ATF4:SCG2	Basal as well as cAMP-stimulated transcription, directed from the [TG] promoter was, however, impaired in insulinoma cells by overexpression of [TF], a negative-acting CRE-binding protein.	CREB-2	secretogranin II	2	REPRESSION	True
6655	6721	15474002:11:HIF1A:PFKFB4	Thus, our results indicate that testis-specific form of PFKFB or PFK-2/FBPase-2 is also expressed in several cancer cell lines and that hypoxia induces transcription of [TG] gene in these cell lines by [TF] dependent mechanism.	HIF-1alpha	PFKFB4	1	ACTIVATION	False
6656	6722	17942419:6:NFE2L2:TXNRD1	In contrast, thioredoxin reductase 1 ([TG]) is regulated by [TF] but not by BACH1.	NRF2	TXNRD1	0	UNDEFINED	False
6657	6723	19633298:4:PPARG:HCAR2	GPR81/Gpr81 is a direct [TF] target gene, because mRNA expression of GPR81/Gpr81 (and GPR109A/[TG]) increased in mature human and murine adipocytes as well as in vivo in epididymal fat pads of mice upon rosiglitazone stimulation, whereas small interfering RNA-mediated knockdown of PPARgamma in differentiated 3T3-L1 adipocytes showed a significant decrease in Gpr81 protein expression.	PPARgamma	Gpr109A	1	ACTIVATION	False
6658	6724	20220144:8:NFKB:NFKBIZ	As IL-17 stimulation stabilizes the IkappaB-zeta transcript, we propose a model where TNF-alpha induces activation and binding of [TF] to the promoters of both [TG] and LCN2 genes but induce only transcription of IkappaB-zeta.	NF-kappaB	NFKBIZ	1	ACTIVATION	False
6659	6725	20505756:7:POU5F1:USP44	A comparison of positively regulated [TF] targets common to EC and ES cells identified genes such as NANOG, PHC1, [TG], SOX2, PHF17 and OCT4, thus further confirming their universal role in maintaining self-renewal in both cell types.	OCT4	USP44	1	ACTIVATION	False
6660	6726	21078663:5:IRF4:APOBEC3G	We found that [TG] expression is critically dependent on NFATc1/NFATc2 and [TF].	IRF-4	A3G	1	ACTIVATION	False
6661	6727	22362749:4:RARG:TGM4	We provide evidence that the retinoic acid receptor gamma ([TF]) plays a major role in the regulation of the [TG] gene and that presence of the AR, but not its transcriptional transactivation activity, is critical for hTGP transcription.	RAR-G	hTGP	1	ACTIVATION	False
6663	6729	24394418:11:TBX3:JDP2	In summary, CSF1 up-regulates [TG] expression by inducing [TF] binding to the JDP2 promoter.	Tbx3	JDP2	1	ACTIVATION	True
6664	6730	8566747:8:ZNF143:TPP1	In contrast, [TF] dissociates from the [TG] promoter when transcription is repressed during G2 and M phases, suggesting that Clb1-Clb4 repress SBF activity by inhibiting its DNA-binding activity.	SBF	CLN2	1	ACTIVATION	True
6665	6731	9566870:11:ZNF143:TPP1	We suggest that differential regulation of CLN1 and [TG] by glucose results from differences in the capacity of [TF] to activate transcription driven by SCB and MCB core elements.	SBF	CLN2	1	ACTIVATION	False
6666	6732	9712915:7:SP3:KCNJ2	The interplay between Sp1, [TF], and NF-Y within the architecture of the [TG] promoter, the ubiquitous nature of these trans-acting factors, and the action of tissue-selective repressor element(s) may combine to enable a wide variety of cell types to differentially regulate Kcnj2 expression through transcriptional control.	Sp3	Kcnj2	0	UNDEFINED	False
6667	6733	11585908:13:REST:MAPK8IP1	Taken together, these data establish a critical role for [TF] in the control of the tissue-specific expression of the human [TG] gene.	REST	IB1	0	UNDEFINED	False
6668	6734	10395674:1:POU2F1:LY6E	The complexity of IFN-mediated regulation of the murine [TG] gene in T cell lines is highlighted by the following observations: 1) multiple regulatory regions are present within different parts of the Ly-6E promoter and are necessary for IFN inducibility of the Ly-6E gene, 2) multiple transcription factors including [TF] and Oct-2 and the high mobility group (HMG) protein HMGI(Y) bind to regulatory elements present within the G region required for both IFN-alphabeta and IFN-gamma responses, 3) mutational analysis of the G region reveals that a complex interaction exists between the factors binding to this region as shown by their mutual interdependence for detection in DMSA, and 4) inhibition of expression of HMG proteins by antisense HMGI-C RNA in EL4 cells causes the loss of IFN-alphabeta and IFN-gamma inducibility of the endogenous Ly-6 gene.	Oct-1	Ly-6E	0	UNDEFINED	False
6669	6735	10395674:1:POU2F2:LY6E	The complexity of IFN-mediated regulation of the murine [TG] gene in T cell lines is highlighted by the following observations: 1) multiple regulatory regions are present within different parts of the Ly-6E promoter and are necessary for IFN inducibility of the Ly-6E gene, 2) multiple transcription factors including Oct-1 and [TF] and the high mobility group (HMG) protein HMGI(Y) bind to regulatory elements present within the G region required for both IFN-alphabeta and IFN-gamma responses, 3) mutational analysis of the G region reveals that a complex interaction exists between the factors binding to this region as shown by their mutual interdependence for detection in DMSA, and 4) inhibition of expression of HMG proteins by antisense HMGI-C RNA in EL4 cells causes the loss of IFN-alphabeta and IFN-gamma inducibility of the endogenous Ly-6 gene.	Oct-2	Ly-6E	0	UNDEFINED	True
6670	6736	10648883:7:CREB1:SCG2	To establish that the activity of the human [TG] promoter in these neuroblastoma cell lines is dependent on the level of [TF], rat CREB was overexpressed in SH-SY5Y cells.	CREB	SgII	0	UNDEFINED	True
6671	6737	10783262:5:CRX:FSCN2	Promoter analysis reveals a consensus retinoic acid response element and several potential binding sites for transcription factors [TF] and Nrl, which correlates with the retina-specific expression of [TG] mRNA.	Crx	FSCN2	0	UNDEFINED	True
6672	6738	10783262:5:NRL:FSCN2	Promoter analysis reveals a consensus retinoic acid response element and several potential binding sites for transcription factors Crx and [TF], which correlates with the retina-specific expression of [TG] mRNA.	Nrl	FSCN2	1	ACTIVATION	True
6673	6739	11290385:2:ATF4:SCG2	Using recombinant proteins we show that [TF] binds in vitro to the palindromic cAMP response element derived from the [TG] gene.	CREB2	secretogranin II	0	UNDEFINED	False
6674	6740	11369448:12:SP1:GDA	[TF] antibody reduced the specific binding complex by 70% suggesting that Sp1 transcription factor regulates [TG] gene expression.	Sp1	GdA	0	UNDEFINED	False
6675	6741	11485307:3:SP3:CYP3A5	A gel shift assay using nuclear extracts prepared from HepG2 cells showed that nuclear factor-Y (NF-Y) and specificity protein (Sp) 1 and [TF] bound to CCAAT box (-78/-68) and a basic transcription element (BTE) (-67/-46) in the [TG] gene.	Sp3	CYP3A5	0	UNDEFINED	False
6676	6742	11485307:5:SP3:CYP3A5	Thus, we conclude that the transcription of the [TG] gene is cooperatively regulated by NF-Y, Sp1, and [TF] in HepG2 cells.	Sp3	CYP3A5	0	UNDEFINED	False
6677	6743	11585908:8:REST:MAPK8IP1	By mobility shift assay, we confirmed that [TF] binds to the NRSE present in the [TG] promoter.	REST	IB1	0	UNDEFINED	False
6678	6744	11722583:5:IRF2:IFI27	We have sequenced the promoter region of the [TG] gene and found ISRE, IRF1/[TF], and STAT elements correlating to the interferon alpha inducibility of the gene.	IRF2	ISG12	1	ACTIVATION	True
6679	6745	12023274:4:GATA1:NFIL3	Gel shift assays demonstrated that both [TF] and GATA-2 proteins bind to the [TG] GATA site in vitro, and the chromatin immunoprecipitation assay further confirmed the in vivo binding of GATA-1 to the E4bp4 promoter.	GATA-1	E4bp4	0	UNDEFINED	False
6680	6746	12032776:6:SPI1:ZFPM1	[TF]:GATA-1 interaction and C/EBP suppression of [TG] transcription inhibits erythroid and megakaryocyte gene expression.	PU.1	FOG	2	REPRESSION	True
6681	6747	12706838:7:AP1:TNFRSF9	Thus, NF-kappaB and [TF] are involved in the TCR stimulation-dependent transcriptional regulation of the [TG] promoter.	AP-1	4-1BB	0	UNDEFINED	False
6682	6748	12706838:7:NFKB:TNFRSF9	Thus, [TF] and AP-1 are involved in the TCR stimulation-dependent transcriptional regulation of the [TG] promoter.	NF-kappaB	4-1BB	0	UNDEFINED	False
6683	6749	12754203:0:NKX2-5:MOV10L1	Csm, a cardiac-specific isoform of the RNA helicase [TG], is regulated by [TF] in embryonic heart.	Nkx2.5	Mov10l1	0	UNDEFINED	True
6684	6750	12853459:6:NR5A2:CEL	Chromatin immunoprecipitation demonstrates that binding of [TF] to the [TG] promoter increases histone H4 acetylation corresponding with the activation of endogenous CEL gene transcription.	LRH-1	CEL	0	UNDEFINED	True
6686	6752	12900388:11:KLF4:SLC19A2	The results demonstrate the importance of [TF], NF-1, and SP-1 in regulating the activity of the [TG] promoter and provide direct in vivo confirmation of promoter activity.	GKLF	SLC19A2	0	UNDEFINED	False
6687	6753	12900388:11:SP1:SLC19A2	The results demonstrate the importance of GKLF, NF-1, and [TF] in regulating the activity of the [TG] promoter and provide direct in vivo confirmation of promoter activity.	SP-1	SLC19A2	0	UNDEFINED	False
6688	6754	12900388:8:SP1:SLC19A2	Cotransfection studies of the [TG] promoter with an [TF] containing vector in Drosophila SL2 cells further confirmed a role for SP-1 in regulating SLC19A2 promoter activity.	SP-1	SLC19A2	0	UNDEFINED	False
6689	6755	14747477:0:NRF1:CD47	Alpha-Pal/[TF] regulates the promoter of the human integrin-associated protein/[TG] gene.	NRF-1	CD47	0	UNDEFINED	False
6690	6756	14986171:1:TP53:ALDH4A1	To identify additional targets of [TF], we used a cDNA microarray system to examine gene-expression patterns in response to enforced expression of exogenous p53 in p53-deficient cancer cells, and identified the aldehyde dehydrogenase 4 ( [TG]) gene as a direct target of p53.	p53	ALDH4	0	UNDEFINED	False
6691	6757	15105423:5:MYB:DHRS2	Deletion and domain swap experiments identified small, discreet positive and negative elements in A-[TF] and c-Myb that were required for the regulation of specific genes, such as [TG], DSIPI, and mim-1.	Myb	DHRS2	0	UNDEFINED	False
6692	6758	15157741:0:PPARG:C1QTNF3	Role of specificity protein-1, [TF], and pituitary protein transcription factor-1 in transcriptional regulation of the murine [TG] promoter.	PPARgamma	CORS-26	0	UNDEFINED	False
6693	6759	15157741:0:SP1:C1QTNF3	Role of specificity protein-1, PPARgamma, and [TF] in transcriptional regulation of the murine [TG] promoter.	pituitary protein transcription factor-1	CORS-26	0	UNDEFINED	False
6694	6760	15157741:7:POU1F1:C1QTNF3	Additionally, specific binding activity of PPARgamma and [TF] to the [TG] promoter was demonstrated.	Pit-1	CORS-26	0	UNDEFINED	False
6695	6761	15157741:7:PPARG:C1QTNF3	Additionally, specific binding activity of [TF] and Pit-1 to the [TG] promoter was demonstrated.	PPARgamma	CORS-26	0	UNDEFINED	False
6696	6762	15207709:7:SP1:DPYSL2	The [TF], E2F, and GATA1/2 binding sites appeared to play some roles in regulation of [TG] expression.	SP1	CRMP-2	0	UNDEFINED	False
6697	6763	15316020:0:CEBPZ:COL5A3	The transcription factor CCAAT-binding factor [TF]/NF-Y and two repressors regulate the core promoter of the human pro-alpha3(V) collagen gene ([TG]).	CBF	COL5A3	0	UNDEFINED	False
6698	6764	15389287:4:TP53:IKBIP	Similar to APAF1, expression of [TG] is enhanced by X-irradiation, and both genes are dependent on [TF].	p53	IKIP	1	ACTIVATION	True
6699	6765	15527973:6:NFKB:NFKBIZ	[TG] expression was strongly regulated by [TF] and partly regulated by CREB.	NF-kappaB	MAIL	0	UNDEFINED	False
6700	6766	15589828:10:SP1:CLDN19	Electromobility shift assay confirmed that the nuclear extracts of these cells bound to the [TF] oligo derived from [TG] promoter, but not to the mutated Sp1 oligo probe.	Sp1	Cldn19	0	UNDEFINED	False
6701	6767	15590640:0:NR1H4:C3	Regulation of [TG] expression by the bile acid receptor [TF].	FXR	complement C3	0	UNDEFINED	False
6702	6768	15722553:11:NFKB:NAF1	Chromatin immunoprecipitation assays show the endogenous IkappaBalpha/epsilon, Gro-beta/gamma, and [TG] promoters directly bound NF-kappaB/[TF] in TNF-stimulated cells.	Rel A	Naf-1	0	UNDEFINED	False
6703	6770	15777731:6:TFAP2A:CKB	Interestingly, the [TG] (-50) [TF] element contains GCCAATGGG which also bound NF-Y, the CCAAT-binding protein, suggesting that interplay between AP2 and NF-Y may modulate CKB transcription.	AP2	CKB	0	UNDEFINED	False
6704	6771	15777731:7:TFAP2A:CKB	This is the first report of a role for [TF] in the regulation of [TG] transcription and of an AP2 element within which an NF-Y site is located.	AP2	CKB	0	UNDEFINED	False
6705	6772	15831526:0:GATA6:CYB5A	Regulation of [TG] gene transcription by Sp3, [TF], and steroidogenic factor 1 in human adrenal NCI-H295A cells.	GATA-6	cytochrome b5	0	UNDEFINED	False
6706	6773	15992771:1:NRF1:CD47	Alpha-Pal/[TF] is a critical regulator of the promoter of human IAP/[TG] gene, a gene related to memory formation in rodents.	NRF-1	CD47	0	UNDEFINED	False
6707	6774	16025159:4:HIF1A:PFKFB4	To better understand the mechanism of hypoxic regulation of [TG] gene expression, we used dimethyloxalylglycine, a specific inhibitor of [TF] hydroxylase enzymes, which strongly increases HIF-1alpha levels and mimics the effect of hypoxia.	HIF-1alpha	PFKFB4	0	UNDEFINED	False
6708	6775	16260592:8:SP1:IL21R	Moreover, phosphatase inhibitors that increased phosphorylation of [TF] diminished [TG] transcription.	Sp1	IL-21R	2	REPRESSION	True
6709	6776	16262660:3:REST:SCG2	Here, we show that treatment with the histone deacetylase inhibitor trichostatin A (TSA) or expression of a mutant of [TF] (DP-REST:ER) that contains a transcriptional activation domain enhanced expression of the REST target genes encoding synaptophysin and [TG] in neuronal as well as in neuroendocrine cells.	REST	secretogranin II	0	UNDEFINED	False
6710	6777	16501612:10:TP53:UBD	Hence, we propose that [TG] is a downstream target of [TF] and dysregulation of FAT10 expression in p53-defective cells could contribute to carcinogenesis.	p53	FAT10	0	UNDEFINED	False
6711	6778	16501612:9:TP53:UBD	[TF] was found to bind in vivo to the 5' half consensus sequence of p53-binding site located at the [TG] promoter.	p53	FAT10	0	UNDEFINED	False
6712	6779	1677811:0:USF1:HOXB7	Characterization of the murine [TG] promoter: involvement of the transcription factor USF ([TF]).	MLTF	Hox-2.3	0	UNDEFINED	False
6713	6780	16788211:9:SREBF2:ABCA7	We conclude that the [TG] gene is regulated by sterol in the opposite direction to ABCA1 through SRE/[TF] and that expression of ABCA7 by this regulation is associated with phagocytic activity.	SREBP2	ABCA7	0	UNDEFINED	False
6714	6781	16964281:2:EWSR1:PLD2	Here, we further investigated the regulation of [TG] gene expression by [TF]/Fli-1 and Fli-1 in another EWS cell line, and also in EWS/Fli-1- or Fli-1-transfected cell line.	EWS	PLD2	0	UNDEFINED	False
6715	6782	16964281:2:FLI1:PLD2	Here, we further investigated the regulation of [TG] gene expression by EWS/[TF] and Fli-1 in another EWS cell line, and also in EWS/Fli-1- or Fli-1-transfected cell line.	Fli-1	PLD2	0	UNDEFINED	False
6716	6783	16987558:3:STAT1:BCL2L14	Promoter analysis of [TG] revealed that IRF-1 and [TF] were both required in this process.	STAT1	BclG	0	UNDEFINED	True
6717	6784	17075044:7:GATA3:FUT7	Our results indicated that T-bet interferes with the binding of [TF] to its target DNA, and also that GATA-3 significantly interferes with the binding of T-bet to the [TG] promoter.	GATA-3	FUT7	0	UNDEFINED	False
6718	6785	17075044:7:TBX21:FUT7	Our results indicated that [TF] interferes with the binding of GATA-3 to its target DNA, and also that GATA-3 significantly interferes with the binding of T-bet to the [TG] promoter.	T-bet	FUT7	0	UNDEFINED	False
6720	6787	17075044:8:TBX21:FUT7	[TF] has a binding ability to GATA-3, CBP/P300, and Sp1 to form a transcription factor complex, and GATA-3 regulates [TG] transcription by phosphorylation-dependently recruiting histone deacetylase (HDAC)-3/HDAC-5 and by competing with CBP/P300 in binding to the N terminus of T-bet.	T-bet	FUT7	0	UNDEFINED	True
6721	6788	17237810:4:EZH2:MSMB	Chromatin immunoprecipitation experiments confirmed an association of [TF] with the [TG] gene.	EZH2	MSMB	0	UNDEFINED	False
6722	6789	17517765:0:SP1:APOBEC3G	[TF] and Sp3 regulate basal transcription of the human [TG] gene.	Sp1	APOBEC3G	0	UNDEFINED	False
6723	6790	17517765:0:SP3:APOBEC3G	Sp1 and [TF] regulate basal transcription of the human [TG] gene.	Sp3	APOBEC3G	0	UNDEFINED	False
6724	6791	17533371:4:TP53:APLP1	[TG] was confirmed to be a novel transcriptional target of [TF] by in vivo and in vitro characterization of a p53 responsive element found in the first intron of the APLP1 gene locus.	p53	APLP1	0	UNDEFINED	False
6725	6792	17611579:0:PPARA:ABCA12	[TF] and LXR activators regulate [TG] expression in human keratinocytes.	PPAR	ABCA12	0	UNDEFINED	False
6726	6793	17670796:6:FOXK1:CTSA	The binding of [TF] to the SM alpha-actin and [TG] promoters requires the presence of SRF on the promoter.	FOXK1	PPGB	0	UNDEFINED	False
6727	6794	17670796:6:SRF:CTSA	The binding of FOXK1 to the SM alpha-actin and [TG] promoters requires the presence of [TF] on the promoter.	SRF	PPGB	0	UNDEFINED	False
6728	6795	17925399:9:YY1:LSS	Extensive promoter analyses coupled with chromatin immunoprecipitation assays reveal that the transcription factor [TF] binds to and recruits HDAC3 to the [TG] promoter.	YY1	lanosterol synthase	0	UNDEFINED	False
6729	6796	18272588:3:CEBPE:LRG1	In this paper, we show that the transcription factors PU.1 and [TF] that regulate the expression of multiple myeloid-specific genes also bind to the [TG] promoter.	C/EBPepsilon	LRG	0	UNDEFINED	False
6730	6797	18272588:3:SPI1:LRG1	In this paper, we show that the transcription factors [TF] and C/EBPepsilon that regulate the expression of multiple myeloid-specific genes also bind to the [TG] promoter.	PU.1	LRG	0	UNDEFINED	False
6731	6798	18272588:8:CEBPE:LRG1	Hence, similar to other genes involved in neutrophil differentiation, the expression of [TG] also appears to be regulated by PU.1 and [TF].	C/EBPepsilon	LRG	0	UNDEFINED	False
6732	6799	18371048:6:AP1:SLC1A3	Cadmium reduced human [TG] promoter activity; however, it increased the binding of Ca(2+)-sensitive activator protein-1 ([TF]) and cAMP response element binding protein (CREB) to their specific elements derived from the human GLAST promoter.	AP-1	GLAST	0	UNDEFINED	False
6733	6800	18371048:6:CREB1:SLC1A3	Cadmium reduced human [TG] promoter activity; however, it increased the binding of Ca(2+)-sensitive activator protein-1 (AP-1) and cAMP response element binding protein ([TF]) to their specific elements derived from the human GLAST promoter.	CREB	GLAST	0	UNDEFINED	False
6734	6801	18394600:0:HIF1A:STC2	Epigenetic and [TF] regulation of [TG] expression in human cancer cells.	HIF-1	stanniocalcin-2	0	UNDEFINED	False
6735	6802	18523561:0:EWSR1:SLC29A4	Adenosine transporter [TG] is a direct target of [TF]/WT1 translocation product and is highly expressed in desmoplastic small round cell tumor.	EWS	ENT4	0	UNDEFINED	False
6736	6803	18523561:0:WT1:SLC29A4	Adenosine transporter [TG] is a direct target of EWS/[TF] translocation product and is highly expressed in desmoplastic small round cell tumor.	WT1	ENT4	0	UNDEFINED	False
6737	6804	18588874:6:SP1:TNXB	The EMSA and a chromatin immunoprecipitation (ChIP) assay showed that [TF] together with the transcriptional repressor histone deacetylase 1 (HDAC1) binds to the HRE of the [TG] promoter under normoxia and that hypoxia causes dissociation of HDAC1 from the Sp1/HDAC1 complex.	Sp1	XB-S	0	UNDEFINED	False
6738	6805	18655181:10:IRF1:SLC26A6	These studies provided novel evidence for the involvement of [TF] in the regulation of [TG] gene expression by IFNgamma in the human intestine.	IRF-1	SLC26A6	0	UNDEFINED	False
6739	6806	18929641:5:AP1:NOXO1	We cloned the 5' flank of the human [TG] gene (-3888 to +263 bp), and found that the region between -585 and -452 bp, which contains consensus elements of YY-1, [TF], and Ets, and the GC-rich region encoding three putative binding sites for SP-1, was crucial for TNF-alpha-dependent promoter activity.	AP-1	NOXO1	1	ACTIVATION	True
6740	6807	18955051:3:PPARA:PDZK1	Previously, we established a tetracycline-regulated human cell line that can be induced to express [TF] and identified candidate target genes, one of which was [TG].	PPARalpha	PDZK1	0	UNDEFINED	False
6741	6808	18955051:5:PPARA:PDZK1	Finally, we demonstrate that endogenous [TF] regulates [TG] expression.	PPARalpha	PDZK1	0	UNDEFINED	False
6742	6809	19015155:5:TP53:DUT	We establish a direct role for both mutant and wild-type forms of [TF] in modulating [TG] promoter activity.	p53	dUTPase	0	UNDEFINED	False
6744	6811	19015155:7:TP53:DUT	Oxaliplatin treatment induced enrichment of [TF] at the [TG] promoter with a concomitant reduction in Sp1.	p53	dUTPase	0	UNDEFINED	False
6745	6812	19100681:6:TP53:PDF	DNA damage and hypoxia resulted in increased [TF] protein accumulation indicating that [TG] expression may be controlled by cellular levels of p53.	p53	PDF	0	UNDEFINED	False
6746	6813	19148275:10:SP1:AMACR	Chromatin immunoprecipitation, siRNA knockdown, gel shift assay, ectopic expression, and promoter analyses supported the regulation by [TF] and ZNF202 of [TG] gene expression in an opposite manner.	Sp1	AMACR	0	UNDEFINED	False
6747	6814	19148275:10:ZNF202:AMACR	Chromatin immunoprecipitation, siRNA knockdown, gel shift assay, ectopic expression, and promoter analyses supported the regulation by Sp1 and [TF] of [TG] gene expression in an opposite manner.	ZNF202	AMACR	0	UNDEFINED	False
6748	6815	19303953:5:RELA:TLR5	In epithelial cells, both stimulation required the same promoter regions, especially the NF-kappaB binding site but involved different NF-kappaB isoforms: [TF]/p50 and p52/RelB, for [TG] and LTbetaR-dependent activation, respectively.	p65	TLR5	0	UNDEFINED	True
6749	6816	19437621:0:SP1:CDK5R2	[TF] and Sp3 regulate transcription of the cyclin-dependent kinase 5 regulatory  subunit 2 ([TG]) promoter in neuronal cells.	Sp1	p39	0	UNDEFINED	False
6750	6817	19437621:0:SP3:CDK5R2	Sp1 and [TF] regulate transcription of the cyclin-dependent kinase 5 regulatory  subunit 2 ([TG]) promoter in neuronal cells.	Sp3	p39	0	UNDEFINED	False
6751	6818	19602589:4:TP53:GPR87	We also found that [TF] directly regulated [TG] potentially via a p53-responsive element in the GPR87 gene.	p53	GPR87	0	UNDEFINED	False
6752	6819	19617351:6:AP1:IL21R	Chromatin immunoprecipitation assay and gel mobility shift assay exhibited that the IL-21 promoter elements bound transcription factors [TF] and NF-kappaB, and the [TG] promoter elements were associated with AP-1 and interferon regulatory factor.	AP-1	IL-21R	0	UNDEFINED	False
6753	6820	19633298:7:PPARG:HCAR1	The coordinated [TF]-mediated regulation of the GPR81/[TG] and GPR109A/Gpr109A genes (and GPR109B in humans) presents a novel mechanism by which TZDs may reduce circulating free fatty acid levels and perhaps ameliorate insulin resistance in obese patients.	PPARgamma	Gpr81	0	UNDEFINED	False
6754	6821	19633298:7:PPARG:HCAR2	The coordinated [TF]-mediated regulation of the GPR81/Gpr81 and GPR109A/[TG] genes (and GPR109B in humans) presents a novel mechanism by which TZDs may reduce circulating free fatty acid levels and perhaps ameliorate insulin resistance in obese patients.	PPARgamma	Gpr109A	0	UNDEFINED	False
6755	6822	19657058:0:SP1:DAG1	Identification of [TF] and GC-boxes as transcriptional regulators of mouse [TG] gene promoter.	Sp1	Dag1	0	UNDEFINED	False
6756	6823	19679660:5:NFKB:HAX1	Quantitative PCR analysis confirmed that the TPCK-induced down-regulation of [TG] occurred at the transcriptional level, and experiments using the specific pharmacological inhibitor, Bay 11-7082, suggested that HAX-1 expression is subject to regulation by the transcription factor, [TF].	NF-kappaB	HAX-1	0	UNDEFINED	True
6757	6824	19924793:9:GATA3:MBNL2	Two of these (LMO4 and [TG]) were shown to be direct targets of [TF] by ChIP.	GATA3	MBNL2	0	UNDEFINED	False
6758	6825	20030931:0:RUNX1:NUCB2	[Influence of [TF] and AML1-ETO on transcriptional regulation of [TG] gene].	AML1	nucb2	0	UNDEFINED	False
6759	6826	20030931:4:RUNX1:NUCB2	The promoter of [TG] could be bound by both [TF] and AML1-ETO.	AML1	nucb2	0	UNDEFINED	False
6760	6827	20038531:0:BHLHA15:RAB3D	RAB26 and [TG] are direct transcriptional targets of [TF] that regulate exocrine granule maturation.	MIST1	RAB3D	0	UNDEFINED	False
6761	6828	20060878:9:SP1:DUOXA1	Gel shift experiments using extracts obtained from PCCl3 cells demonstrated the existence of at least one functional [TF] binding site within the THOX1-[TG] promoter.	Sp1	DUOXA1	0	UNDEFINED	False
6762	6829	20091743:12:SP1:APBB1	These findings reveal that [TF] plays a crucial role in transcriptional control of the human [TG] gene.	Sp1	FE65	0	UNDEFINED	False
6763	6830	20149803:10:CREB1:MALAT1	We identified a shorter transcriptional initiation site and found that [TF] binds to the defined proximal promoter of the [TG] gene.	CREB	MALAT1	0	UNDEFINED	False
6764	6831	20149803:7:CREB1:MALAT1	We investigated binding of the cyclic AMP-responsive element binding ([TF]) transcription factor to the [TG] promoter by using chromatin immunoprecipitation (ChIP) followed by tiling array analysis, and the results were confirmed using ChIP-qPCR.	CREB	MALAT1	0	UNDEFINED	False
6765	6832	20185824:5:HSF1:ZFAND2A	As shown by ChIP analysis, [TF] is recruited to the [TG] promoter rapidly after heat treatment, with a kinetics that parallels HSP70 promoter HSF1-recruitment.	HSF1	AIRAP	0	UNDEFINED	False
6766	6833	20388804:5:TP53:YPEL3	[TG] expression induced by DNA damage leads to [TF] recruitment to a cis-acting DNA response element located near the human YPEL3 promoter.	p53	YPEL3	0	UNDEFINED	False
6767	6834	20471816:7:HNF1A:SLC23A1	The results of these studies further characterize the h[TG] promoters establish that ascorbic acid uptake by human liver epithelial cells is adaptively regulated and show that transcriptional mechanisms via [TF] in the hSVCT1 promoter may, in part, be involved in this regulation.	HNF-1	SVCT1 and 2	0	UNDEFINED	False
6768	6835	20511593:0:AP1:TREX1	Three prime exonuclease I ([TG]) is Fos/[TF] regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damage.	AP-1	TREX1	0	UNDEFINED	False
6769	6836	20518744:0:SP1:NEU3	Regulation of plasma-membrane-associated sialidase [TG] gene by [TF]/Sp3 transcription factors.	Sp1	NEU3	0	UNDEFINED	False
6770	6837	20518744:0:SP3:NEU3	Regulation of plasma-membrane-associated sialidase [TG] gene by Sp1/[TF] transcription factors.	Sp3	NEU3	0	UNDEFINED	False
6771	6838	20547751:0:MYB:DHRS2	Mitochondrial [TG] is a [TF] target gene that inhibits Mdm2 and stabilizes p53.	c-Myb	Hep27	0	UNDEFINED	False
6772	6839	20547751:6:MYB:DHRS2	In addition, [TG] is regulated at the transcriptional level by the proto-oncogene [TF] and is required for c-Myb-induced p53 stabilization.	c-Myb	Hep27	0	UNDEFINED	False
6773	6840	20551518:6:JUNB:MYL9	Concomitantly, we identified myosin regulatory light chain 9 ([TG]), which is critically involved in actomyosin contractility and stress fiber assembly, as a [TF] target.	Junb	Myl9	0	UNDEFINED	False
6774	6841	20551518:8:AP1:MYL9	Our data establish a molecular link between the activator protein-1 transcription factor subunit [TF] and actomyosin-based cellular motility as well as cellular and vascular contractility by governing [TG] transcription.	Junb	Myl9	0	UNDEFINED	False
6775	6843	20813833:3:STAT3:MIR21	[TF] (STAT3) was implicated in this pathway based on the lack of IFN effect on [TG] expression in prostate cancer cells with a deletion in the STAT3 gene.	Signal transducer and activator of transcription 3	miR-21	0	UNDEFINED	False
6776	6844	20813833:5:STAT3:MIR21	Chromatin immunoprecipitation analysis showed that [TF] directly bound the [TG] promoter in response to IFN.	STAT3	miR-21	0	UNDEFINED	False
6777	6845	20813833:7:RELA:MIR21	STAT3 silencing blocked both IFN-induced [TF] binding to the [TG] promoter and p65 nuclear translocation.	p65	miR-21	0	UNDEFINED	False
6778	6846	20813833:7:STAT3:MIR21	[TF] silencing blocked both IFN-induced p65 binding to the [TG] promoter and p65 nuclear translocation.	STAT3	miR-21	0	UNDEFINED	False
6779	6847	20858596:11:FOXP2:SRPX2	p.M406T partially impaired the [TF] regulation of [TG] promoter activity, whereas that of the uPAR promoter remained unchanged.	FOXP2	SRPX2	0	UNDEFINED	False
6780	6848	21303526:9:SRF:MIR21	The [TG] gene is regulated by [TF] and its cofactors, including myocardin and p49/Strap.	SRF	mir-21	0	UNDEFINED	False
6781	6849	21359952:9:STAT5A:ACO1	The electrophoretic mobility shift assays revealed that the binding of glucocorticoid receptor and phospho-[TF] to the promoter region of [TG] gene was enhanced in rats of stress group.	STAT5	IRP-1	0	UNDEFINED	False
6782	6850	21362455:9:TP53:DUOXA1	In conclusion, [TG] is a novel [TF]-regulated neurogenic factor involved in p53 dependent neuronal differentiation.	p53	DUOXA1	0	UNDEFINED	False
6783	6851	21610753:5:HNF1A:SPINK1	Further, binding sites for two transcription factors, [TF] and PTF1, were newly identified within the [TG] promoter by virtue of their being affected by specific variants.	HNF1	SPINK1	0	UNDEFINED	False
6784	6852	21621504:6:CREB1:TIMM50	The p53 mutants R175H and R273H, but not WT p53, upregulated the expression of a [TG] promoter construct and chromatin immunoprecipitation (ChIP) analysis indicated increased histone acetylation and increased interaction of the transcription factors Ets-1, [TF] and CREB-binding protein (CBP) with the Tim50 promoter in the presence of mutant p53.	CREB	Tim50	0	UNDEFINED	False
6785	6853	21621504:6:ETS1:TIMM50	The p53 mutants R175H and R273H, but not WT p53, upregulated the expression of a [TG] promoter construct and chromatin immunoprecipitation (ChIP) analysis indicated increased histone acetylation and increased interaction of the transcription factors [TF], CREB and CREB-binding protein (CBP) with the Tim50 promoter in the presence of mutant p53.	Ets-1	Tim50	0	UNDEFINED	False
6786	6854	21621504:6:TP53:TIMM50	The [TF] mutants R175H and R273H, but not WT p53, upregulated the expression of a [TG] promoter construct and chromatin immunoprecipitation (ChIP) analysis indicated increased histone acetylation and increased interaction of the transcription factors Ets-1, CREB and CREB-binding protein (CBP) with the Tim50 promoter in the presence of mutant p53.	p53	Tim50	1	ACTIVATION	True
6787	6855	21621504:8:TP53:TIMM50	Taken together, these findings identify the [TG] gene as a transcriptional target of mutant [TF] and suggest a novel mechanism by which p53 mutants enhance cell growth and chemoresistance.	p53	Tim50	0	UNDEFINED	False
6788	6856	21636851:9:SP1:PREX1	Altogether, our studies demonstrate that HDACs could regulate [TG] gene transcription by interaction with [TF] and by region-specific changes in histone acetylation within the P-Rex1 promoter.	Sp1	P-Rex1	0	UNDEFINED	False
6789	6857	21645329:0:SP1:TRPV1	Transcription factors [TF] and Sp4 regulate [TG] gene expression in rat sensory neurons.	Sp1	TRPV1	0	UNDEFINED	False
6790	6858	21645329:0:SP4:TRPV1	Transcription factors Sp1 and [TF] regulate [TG] gene expression in rat sensory neurons.	Sp4	TRPV1	0	UNDEFINED	False
6791	6859	21645329:6:SP1:TRPV1	Using ChIP analysis of DRG tissue, we demonstrated that [TF] and Sp4 are bound to the candidate GC-box site region within the endogenous [TG] P2-promoter.	Sp1	TRPV1	0	UNDEFINED	False
6792	6860	21645329:6:SP4:TRPV1	Using ChIP analysis of DRG tissue, we demonstrated that Sp1 and [TF] are bound to the candidate GC-box site region within the endogenous [TG] P2-promoter.	Sp4	TRPV1	0	UNDEFINED	False
6793	6861	21693594:11:CREB1:FILIP1L	A transcription activator, cAMP-responsive element binding protein ([TF]) was shown to bind to the CREB/ATF site in the CpG island of the [TG] promoter.	CREB	FILIP1L	0	UNDEFINED	True
6794	6862	21749909:7:STAT3:SECTM1	Bioinformatic analysis of the [TG] promoter region identified STAT1/GAS, [TF], ISRE, NFB and putative p63 binding sites suggesting a complex transcriptional control.	STAT3	SECTM1	0	UNDEFINED	False
6795	6863	21803035:7:KLF5:GRHL3	[TF] regulated expression of the m[TG] promoter in transient transfection assays.	KLF5	Grhl3	0	UNDEFINED	False
6796	6864	21941086:7:TP53:ULBP2	Using several approaches, we identified [TF] as a direct transcriptional regulator of [TG] and found a p53 response element within ULBP2 gene, which confers the p53 regulation.	p53	ULBP2	0	UNDEFINED	False
6797	6865	22032922:9:TP53:CGB7	Furthermore, we describe [TG] as a direct transcriptional target gene of [TF] by identifying a p53-responsive element in the CGB7 promoter using reporter assays, electrophoretic mobility shift assays and chromatin immunoprecipitations.	p53	CGB7	0	UNDEFINED	False
6799	6867	22216140:9:RUNX1:TRPV1	This switch was correlated with down-regulation of [TF] (Runx1), a transcription factor that controls expression of GFR2 and [TG] during development.	Runt-related transcription factor 1	TRPV1	0	UNDEFINED	False
6800	6868	22243239:6:JUN:SLC4A4	A presumed pH-responsive transcriptional factor-binding domain(s) thus resides in the 285-bp [TG]-B promoter region where candidate domains include the nuclear factor of kappa light polypeptide gene enhancer in B-cells1(NFKB1), [TF] (JUN), and tumor protein p53(TP53)-binding sites.	jun proto-oncogene	NBCe1	0	UNDEFINED	False
6801	6869	22243239:6:NFKB1:SLC4A4	A presumed pH-responsive transcriptional factor-binding domain(s) thus resides in the 285-bp [TG]-B promoter region where candidate domains include the nuclear factor of kappa light polypeptide gene enhancer in B-cells1([TF]), jun proto-oncogene (JUN), and tumor protein p53(TP53)-binding sites.	NFKB1	NBCe1	0	UNDEFINED	False
6802	6870	22243239:6:TP53:SLC4A4	A presumed pH-responsive transcriptional factor-binding domain(s) thus resides in the 285-bp [TG]-B promoter region where candidate domains include the nuclear factor of kappa light polypeptide gene enhancer in B-cells1(NFKB1), jun proto-oncogene (JUN), and tumor protein p53([TF])-binding sites.	TP53	NBCe1	0	UNDEFINED	False
6803	6871	22253448:0:RUNX3:NCR1	Role of [TF] (RUNX3) in transcription regulation of natural cytotoxicity receptor 1 ([TG]/NKp46), an activating natural killer (NK) cell receptor.	runt-related transcription factor 3	NCR1	0	UNDEFINED	False
6804	6872	22306510:3:ZNF205:MPV17L	In this study, we identified zinc-finger protein 205 as a candidate human Rhit ([TF]) and subsequently confirmed its participation in transcriptional regulation of human M-LP ([TG]).	RhitH	M-LPH	0	UNDEFINED	False
6805	6873	22307044:7:ELF3:PRR9	Here we provide evidence that LUX also recruits [TF] to the [TG] promoter.	ELF3	PRR9	0	UNDEFINED	False
6806	6874	22327739:7:ELF3:PRR9	This revealed direct effects on the morning clock gene [TG], and we determined association of [TF] to a conserved region of the PRR9 promoter.	ELF3	PRR9	0	UNDEFINED	False
6807	6875	22387281:8:NFKB:MIR21	As determined by a ChIP-qPCR assay, NF-B [TF] regulated [TG] expression by binding directly to the promoter of miR-21.	p65	miR-21	0	UNDEFINED	False
6808	6876	22391204:6:E2F3:RAD18	We characterized the regulation of one of these ligases, [TG], and we demonstrated that [TF] associates with the Rad18 promoter and directly controls its activity.	E2F3	Rad18	0	UNDEFINED	False
6809	6877	22427437:0:HSF1:TRPV1	[TF] regulates the expression of the [TG] gene in the rat preoptic-anterior hypothalamus area during lipopolysaccharide-induced fever.	Heat shock factor 1	TRPV1	0	UNDEFINED	False
6810	6878	22427437:12:HSF1:TRPV1	Based on these findings, we conclude that [TF] regulates [TG] gene expression in PO/AH of rats with LPS-induced fever.	HSF1	TRPV1	0	UNDEFINED	False
6811	6879	22427437:5:HSF1:TRPV1	We therefore investigated whether [TF] regulates [TG] transcription in response to lipopolysaccharide (LPS)-induced fever in rats.	HSF1	TRPV1	0	UNDEFINED	False
6812	6880	22460667:7:PGR:FAM110C	In rat granulosa cell cultures, hCG induced expression of [TG] mRNA was inhibited by RU486, whereas NS398 and AG1478 had no effect, suggesting that Fam110c expression is regulated in part by the [TF] pathway.	progesterone receptor	Fam110c	0	UNDEFINED	False
6813	6881	22542937:2:RUNX2:OSR2	We previously found that [TG] gene expression is regulated by intracellular transcription factors such as [TF], and C/EBP, whereas it remains unclear if extracellular factors would functionally regulate the Osr2 expression.	Runx2	Osr2	0	UNDEFINED	False
6814	6882	22542937:5:ATF2:OSR2	The [TG] promoter was shown to possess Smad3/4 binding element and [TF] binding element between -647 and -64 of promoter.	ATF2	Osr2	0	UNDEFINED	False
6815	6883	22542937:5:SMAD3:OSR2	The [TG] promoter was shown to possess [TF]/4 binding element and ATF2 binding element between -647 and -64 of promoter.	Smad3	Osr2	0	UNDEFINED	False
6816	6884	22607194:0:FOXA2:WNT6	GATA6 and [TF] regulate [TG] expression during extraembryonic endoderm formation.	FOXA2	Wnt6	0	UNDEFINED	False
6817	6885	22607194:0:GATA6:WNT6	[TF] and FOXA2 regulate [TG] expression during extraembryonic endoderm formation.	GATA6	Wnt6	0	UNDEFINED	False
6818	6886	22638570:0:MYRF:MYH7B	[TG]/miR-499 gene expression is transcriptionally regulated by [TF] and Eos.	MRFs	Myh7b	0	UNDEFINED	False
6819	6887	22638570:5:MYOD1:MYH7B	Further, we show that through physical interaction, [TF] and Eos form an active transcriptional complex on the chromatin to regulate the expression of the endogenous [TG]/miR-499 gene in muscle cells.	MyoD	Myh7b	0	UNDEFINED	False
6820	6888	22644487:6:AP1:C1QTNF3	A promoter enzyme immunoassay and a chromatin immunoprecipitation assay showed that [TF] binds directly to the AP-1 binding site at the region -184/-177 of the mouse [TG] promoter.	c-Jun	CTRP3	0	UNDEFINED	False
6821	6890	22912338:8:E2F1:GPR19	(iv) The putative control of [TG] expression by E2F transcription factors was verified by chromatin immunoprecipitation: antibodies directed against [TF] allowed for the recovery of the Gpr19 promoter.	E2F-1 to -4	Gpr19	0	UNDEFINED	False
6822	6891	22968456:7:NFE2:ANK1	We show that a chromatin loop brings the 3' enhancer and [TF] into proximity with the 5' barrier region including the [TG]E core promoter.	NF-E2	ANK1	0	UNDEFINED	False
6823	6892	22981541:9:AP1:SPATA12	These results suggested that [TF] and HSF may play an important role in regulating [TG] promoter activity.	AP-1	SPATA12	0	UNDEFINED	False
6824	6893	23018034:10:SP1:NPM3	We observed binding of [TF] to the promoters of RAB20, FGF21, IHPK2, ARHGAP18, [TG], SRSF7, CALM3, PGD and Sp1 itself.	Sp1	NPM3	0	UNDEFINED	False
6825	6894	23018034:10:SP1:SRSF7	We observed binding of [TF] to the promoters of RAB20, FGF21, IHPK2, ARHGAP18, NPM3, [TG], CALM3, PGD and Sp1 itself.	Sp1	SRSF7	0	UNDEFINED	False
6826	6895	23018770:2:RUNX1:TRPV1	The transcription factor [TF] is known to play a relevant role in sensory neuron differentiation as it controls the expression of several sensory nociceptive receptors, including [TG].	Runx1	TRPV1	0	UNDEFINED	False
6827	6896	23018770:5:RUNX1:TRPV1	Our results support a mechanism where [TF]-C/EBP-containing transcription regulatory complexes are recruited to the [TG] gene promoter to modulate TRPV1 expression in dorsal root ganglia neurons.	Runx1	TRPV1	0	UNDEFINED	False
6828	6897	23269473:7:AHR:STC2	Of interest, [TG] gene expression is refractory to classic exogenous [TF] agonists, but responds to cellular stress in an AhR-dependent mechanism consistent with a process promoting cell survival.	AhR	Stc2	0	UNDEFINED	True
6829	6898	23318224:0:YY1:SLAMF7	[TF] and a unique DNA repeat element regulates the transcription of mouse [TG] (CD319, SLAMF7) gene.	YY1	CS1	0	UNDEFINED	False
6830	6899	23342162:13:PAX6:NAV1	Moreover, we examined differentially expressed transcripts between E9.5 wild type and [TF]/ lens placodes that suggested Efnb2, Fat4, Has2, [TG], and Trpm3 as novel Pax6-direct targets.	Pax6	Nav1	0	UNDEFINED	False
6831	6900	23610368:6:NFKB:TACSTD2	Our study identified [TG] (TROP2) as a target gene for human breast cancer and discovered its regulation by transcription factors CREB, as well as [TF].	NFkB	TACSTD2	0	UNDEFINED	False
6833	6902	23741501:6:SMAD3:LTBP4	Detailed investigations of the methylation patterns of the promoter regions of LTBP4L and [TG] identified GATA1, SP1, E2F4 and [TF] as potential transcription factors involved in LTBP4 expression.	SMAD3	LTBP4S	0	UNDEFINED	True
6835	6904	23741501:7:E2F4:LTBP4	In in vitro transcription factor activity studies we discovered [TF] as novel powerful regulator for [TG] expression.	E2F4	LTBP4S	0	UNDEFINED	False
6836	6905	23752226:4:TFAP4:LGR5	Besides many genes involved in the control of proliferation, the [TF] target genes included markers of stemness ([TG] and CD44) and epithelial-mesenchymal transition (EMT) such as SNAIL, E-cadherin/CDH1, OCLN, VIM, FN1, and the Claudins 1, 4, and 7.	AP4	LGR5	0	UNDEFINED	False
6837	6906	23788032:7:EED:CPEB1	The epigenetic regulation of H3K27me3 on [TG] promoter is mediated by EZH2 and [TF].	EED	CPEB1	0	UNDEFINED	False
6838	6907	23788032:7:EZH2:CPEB1	The epigenetic regulation of H3K27me3 on [TG] promoter is mediated by [TF] and EED.	EZH2	CPEB1	0	UNDEFINED	False
6839	6908	23870664:4:ZNF143:TPP1	Specifically, the [TG] promoter is constitutively available for [TF] binding, whereas HO has a complex two-step promoter in which chromatin changes in one region allow SBF to bind at a downstream location.	SBF	CLN2	0	UNDEFINED	False
6840	6909	23874697:0:SOX2:PQBP1	[TF] transcriptionally regulates [TG], an intellectual disability-microcephaly causative gene, in neural stem progenitor cells.	Sox2	PQBP1	0	UNDEFINED	False
6841	6910	23874697:8:SOX2:PQBP1	Collectively, these results indicated that [TF] regulated the transcription of [TG] in NSPCs.	Sox2	PQBP1	0	UNDEFINED	False
6842	6911	23894477:9:ELK1:KATNB1	In addition, we showed [TF] binding on the [TG] promoter by EMSA.	Elk1	KATNB1	0	UNDEFINED	False
6843	6912	23900284:8:WHSC1:SLAMF7	Quantitative RT-PCR and ChIP analysis indicated [TF] might regulate the transcription level of [TG] and be an important functional element for SLAMF7 promoter activity.	MMSET	SLAMF7	0	UNDEFINED	False
6845	6914	24250222:6:NRF1:CD47	The set of ChIP-Seq-based [TF] target genes included known NRF1 targets such as EIF2S1, EIF2S2, CYCS, FMR1, FXR2, E2F6, [TG], and TOMM34.	NRF1	CD47	0	UNDEFINED	False
6846	6915	24250222:6:NRF1:EIF2S1	The set of ChIP-Seq-based [TF] target genes included known NRF1 targets such as [TG], EIF2S2, CYCS, FMR1, FXR2, E2F6, CD47, and TOMM34.	NRF1	EIF2S1	0	UNDEFINED	False
6847	6916	24250222:6:NRF1:EIF2S2	The set of ChIP-Seq-based [TF] target genes included known NRF1 targets such as EIF2S1, [TG], CYCS, FMR1, FXR2, E2F6, CD47, and TOMM34.	NRF1	EIF2S2	0	UNDEFINED	False
6848	6917	24348910:6:AP1:IFNE	Bovine ear-derived fibroblast (EF) cells, a model system commonly used for bovine IFNT gene transcription study in this laboratory, were cotransfected with luciferase reporter constructs carrying upstream (positions -637 to +51) regions of [TG] or IFNTc1 gene and various transcription factor expression plasmids including CDX2, [TF] (Jun) and ETS2.	AP-1	IFNT1	0	UNDEFINED	False
6849	6918	24348910:6:CDX2:IFNE	Bovine ear-derived fibroblast (EF) cells, a model system commonly used for bovine IFNT gene transcription study in this laboratory, were cotransfected with luciferase reporter constructs carrying upstream (positions -637 to +51) regions of [TG] or IFNTc1 gene and various transcription factor expression plasmids including [TF], AP-1 (Jun) and ETS2.	CDX2	IFNT1	0	UNDEFINED	False
6850	6919	24348910:6:ETS2:IFNE	Bovine ear-derived fibroblast (EF) cells, a model system commonly used for bovine IFNT gene transcription study in this laboratory, were cotransfected with luciferase reporter constructs carrying upstream (positions -637 to +51) regions of [TG] or IFNTc1 gene and various transcription factor expression plasmids including CDX2, AP-1 (Jun) and [TF].	ETS2	IFNT1	0	UNDEFINED	False
6851	6921	24380054:2:ZNF205:MPV17L	In this study, we identified a [TF] (human regulator of heat-induced transcription) binding site in intron 1 of the [TG] gene.	RhitH	M-LPH	0	UNDEFINED	False
6852	6922	24415751:8:NFATC1:ITPR2	[TF]1 regulates [TG] gene expression by directly binding to the Itpr2 promoter.	NFATc	Itpr2	0	UNDEFINED	False
6853	6923	24586148:6:CREB1:GEM	Using a series of ChIP assays, we show that Tax recruits [TF] and CREB Binding Protein (CBP) onto a c-AMP Responsive Element (CRE) present in the [TG] promoter.	CREB	gem	0	UNDEFINED	False
6854	6924	24619424:7:HSF1:ZFAND2A	Different from heat-mediated induction, in bortezomib-treated cells, [TF] and HSF2 interact directly, forming HSF1-HSF2 heterotrimeric complexes recruited to a specific heat shock element in the [TG] promoter.	HSF1	AIRAP	0	UNDEFINED	False
6855	6925	24619424:7:HSF2:ZFAND2A	Different from heat-mediated induction, in bortezomib-treated cells, HSF1 and [TF] interact directly, forming HSF1-HSF2 heterotrimeric complexes recruited to a specific heat shock element in the [TG] promoter.	HSF2	AIRAP	0	UNDEFINED	False
6856	6926	24843127:4:PDX1:CPE	Here, we show that disruption of insulin receptor (IR) expression in  cells has a direct impact on the expression of the convertase enzyme [TG] (CPE) by inhibition of the eukaryotic translation initiation factor 4 gamma 1 translation initiation complex scaffolding protein that is mediated by the key transcription factors [TF] and sterol regulatory element-binding protein 1, together leading to poor proinsulin processing.	pancreatic and duodenal homeobox 1	carboxypeptidase E	0	UNDEFINED	False
6857	6927	25101494:0:SOX5:CATSPER1	The transcription factors [TF] and Sox9 regulate [TG] gene expression.	Sox5	Catsper1	0	UNDEFINED	False
6858	6928	25101494:0:SOX9:CATSPER1	The transcription factors Sox5 and [TF] regulate [TG] gene expression.	Sox9	Catsper1	0	UNDEFINED	False
6859	6929	7622044:10:SP1:PRPH	Together, these results indicate that interactions between [TF] and the proteins binding PER1 are involved in the control of the [TG] gene.	Sp1	Prph	0	UNDEFINED	False
6860	6930	7969181:7:TP53:CKB	The DNA sequences required for [TF]-mediated modulations were found to be within bp -195 to +5 of the [TG] promoter and within bp -168 to -97 of the CKM promoter.	p53	CKB	0	UNDEFINED	False
6861	6931	8385011:5:SP1:HMBS	Thus, human GATA-1 acts on the [TG] promoter in association with [TF] or CCACC binding proteins.	Sp1	PBGD	0	UNDEFINED	False
6862	6932	8385337:0:CEBPD:C3	Participation of the transcription factor [TF] in the acute-phase regulation of the human gene [TG].	C/EBP delta	for complement component C3	0	UNDEFINED	False
6863	6933	8566747:2:ZNF143:TPP1	Cell cycle-regulated expression of CLN1, [TG] genes is attributable to the heteromeric transcription factor complex [TF].	SBF	CLN2	0	UNDEFINED	False
6864	6934	8972856:0:YY1:ST5	Differential expression of the human [TG] gene in HeLa-fibroblast hybrid cell lines mediated by [TF]: evidence that YY1 plays a part in tumor suppression.	YY1	ST5	0	UNDEFINED	False
6865	6935	9115259:7:TFAP2A:GGT1	Purified [TF] bound and footprinted the AP2 consensus region, making it likely that transcription from the [TG] type II promoter is regulated in part by AP2.	AP2	GGT	0	UNDEFINED	False
6866	6936	9224660:7:RARA:PCP2	That the [TG] gene is a target of ROR alpha, and is suggested that its transcription is also regulated by [TF].	RAR	Pcp-2	0	UNDEFINED	False
6867	6937	9359867:9:PURA:APBB1	The absence of any co-operative effect when CHO cells were co-transfected with both YY1 and [TF] cDNA species suggests that two different transcription regulatory mechanisms could have a role in the regulation of the [TG] gene.	Pur alpha	FE65	0	UNDEFINED	False
6868	6938	9359867:9:YY1:APBB1	The absence of any co-operative effect when CHO cells were co-transfected with both [TF] and Pur alpha cDNA species suggests that two different transcription regulatory mechanisms could have a role in the regulation of the [TG] gene.	YY1	FE65	0	UNDEFINED	False
6869	6939	9712915:7:SP1:KCNJ2	The interplay between [TF], Sp3, and NF-Y within the architecture of the [TG] promoter, the ubiquitous nature of these trans-acting factors, and the action of tissue-selective repressor element(s) may combine to enable a wide variety of cell types to differentially regulate Kcnj2 expression through transcriptional control.	Sp1	Kcnj2	0	UNDEFINED	False
6870	6940	9799798:0:TFAP2A:LIPA	Transcriptional regulation of [TG] in differentiating monocytes is mediated by transcription factors Sp1 and [TF].	AP-2	lysosomal acid lipase	0	UNDEFINED	False
6871	6941	9799798:8:SP1:LIPA	Gel mobility shift assays demonstrated that binding of [TF] and AP-2 to the [TG] promoter is increased by PMA in THP-1 cells.	Sp1	LAL	0	UNDEFINED	False
6872	6942	9799798:8:TFAP2A:LIPA	Gel mobility shift assays demonstrated that binding of Sp1 and [TF] to the [TG] promoter is increased by PMA in THP-1 cells.	AP-2	LAL	0	UNDEFINED	False
6873	6943	10022897:0:RELA:FAS	Activation-dependent transcriptional regulation of the human [TG] promoter requires NF-kappaB p50-[TF] recruitment.	p65	Fas	1	ACTIVATION	True
6874	6944	10029406:7:TP53:CDKN1A	Because [TG] is regulated by [TF] positively and by Rb negatively, p21 may be a link between p53 and Rb in determining cell fate after oxidative damage.	p53	p21	1	ACTIVATION	False
6875	6945	10030670:2:E2F1:CDKN1A	We have found that [TF] and E2F3, transcription factors that activate genes required for cell cycle progression, are strong activators of the [TG] promoter.	E2F1	p21	1	ACTIVATION	False
6876	6946	10030670:2:E2F3:CDKN1A	We have found that E2F1 and [TF], transcription factors that activate genes required for cell cycle progression, are strong activators of the [TG] promoter.	E2F3	p21	1	ACTIVATION	False
6878	6948	10048449:7:NR2C2:CCND1	Moreover, overexpression of [TF]dN inhibited [TG] promoter activity.	TAK1	cyclin D1	1	ACTIVATION	False
6880	6950	10072388:4:TP53:CDKN1A	Furthermore, the absence of c-Jun results in elevated expression of the tumor suppressor gene [TF] and its target gene, the CDK inhibitor [TG], whereas overexpression of c-Jun represses p53 and p21 expression and accelerates cell proliferation.	p53	p21	0	UNDEFINED	False
6881	6951	10073576:6:HLF:F8	We have also demonstrated that an E2A-[TF] chimera, derived from a t(17;19) translocation in pre-B acute lymphoblastic leukemia (ALL) cells, is capable of mediating expression from the [TG] and Factor IX promoters in both hepatoma cells and pre-B ALL cells.	HLF	Factor VIII	1	ACTIVATION	False
6882	6952	10074148:7:USF2:PDLIM7	Moreover, the activity of the [TG] promoter in reporter constructs was upregulated by overexpression of USF1 and [TF], and the transactivation was inhibited by the concurrent expression of Max and Mad1.	USF2a	LMP1	1	ACTIVATION	False
6883	6953	10075717:0:GLI3:GLI1	Sonic Hedgehog-induced activation of the [TG] promoter is mediated by [TF].	GLI3	Gli1	1	ACTIVATION	False
6884	6954	10075717:9:GLI3:GLI1	[TF] directly binds to the [TG] promoter and induces Gli1 transcription in response to Shh.	GLI3	Gli1	1	ACTIVATION	False
6885	6955	10079054:7:REL:NOS2	These data suggest that AAF inhibits [TG] gene expression by a mechanism involving a blockade of LPS-induced nuclear translocation of NF-kappa B/[TF].	Rel	iNOS	1	ACTIVATION	False
6886	6956	10082528:2:ETS2:BCL2L1	The [TG] promoter contains potential Ets binding sites, and we show that the transcription factor, [TF], first identified by its sequence identity to v-ets of the E26 retrovirus, can transactivate the bcl-x promoter.	Ets2	bcl-x	1	ACTIVATION	False
6887	6957	10082528:9:ETS2:BCL2L1	These results strongly suggest a novel role of [TF] in affecting apoptosis through its regulation of [TG] transcription.	Ets2	Bcl-xL	0	UNDEFINED	False
6888	6958	10082535:0:NFKB:CCND1	[TF] function in growth control: regulation of [TG] expression and G0/G1-to-S-phase transition.	NF-kappaB	cyclin D1	0	UNDEFINED	False
6889	6959	10082535:3:NFKB:CCND1	[TF] was found to stimulate transcription of [TG], a key regulator of G1 checkpoint control.	NF-kappaB	cyclin D1	1	ACTIVATION	False
6890	6960	10082535:4:NFKB:CCND1	Two [TF] binding sites in the human [TG] promoter conferred activation by NF-kappaB as well as by growth factors.	NF-kappaB	cyclin D1	1	ACTIVATION	False
6891	6961	10090829:1:ATF2:SELE	[TG] transcription requires binding of transcription factors, NF-kappaB, [TF], and HMG-I(Y).	ATF-2	E-selectin	1	ACTIVATION	False
6892	6962	10092624:6:SMAD3:SERPINE1	Both elements were required for TGFbeta-induced, [TF]- and Smad4-dependent activation of [TG] transcription.	Smad3	PAI-1	1	ACTIVATION	False
6893	6963	10092656:6:STAT1:IRF8	We further show that the [TG] promoter is constitutively bound by lens nuclear factors and that its activation requires binding of additional factors including [TF].	STAT1	ICSBP	1	ACTIVATION	False
6894	6964	10094469:2:TP53:S100A2	A potential [TF] binding site was identified in the promoter of the [TG] gene, which binds to purified p53 as well as p53 in nuclear extract activated by etoposide.	p53	S100A2	0	UNDEFINED	False
6895	6965	10094469:3:TP53:S100A2	Transactivation assays using the promoter driven luciferase reporters revealed that the [TG] promoter was transcriptionally activated by wild-type [TF], but not by p53 mutants, in a dose-dependent as well as a p53 binding site-dependent manner.	p53	S100A2	1	ACTIVATION	False
6896	6966	10094469:4:TP53:S100A2	The [TF]-induced transactivation of the [TG] promoter was enhanced by etoposide and blocked by a dominant negative p53 mutant.	p53	S100A2	1	ACTIVATION	False
6897	6967	10094469:5:TP53:S100A2	Furthermore, endogenous [TG] mRNA expression is induced by etoposide in [TF] positive, but not in p53 negative cells.	p53	S100A2	1	ACTIVATION	False
6898	6968	10094469:6:TP53:S100A2	Thus, [TF] appears to positively regulate [TG] expression.	p53	S100A2	1	ACTIVATION	False
6899	6969	10094833:1:TP53:CDKN1A	[TF] target genes p21(Cip1/[TG]) cyclin-kinase inhibitor (p21 CKI), GADD45, bax, and cyclin G and genes affecting the redox state of the cells are implicated in p53 damage control responses.	p53	Waf1	0	UNDEFINED	False
6900	6970	10095097:4:AP1:TFF3	Electrophoretic gel mobility shift and pAP1-Luc luciferase assays showed that expression of [TG] is associated with increases in [TF] binding and in AP-1 transcriptional activity.	AP-1	ITFs	0	UNDEFINED	True
6901	6971	10098492:5:PPARG:LPL	Cotransfection of COUP-TF expression constructs in the renal epithelial 293T cell line significantly increased transcription from the [TG] promoter in synergy with [TF]2/RXRalpha heterodimers.	PPARgamma	LPL	1	ACTIVATION	False
6902	6972	10194443:4:FLI1:GP9	In this study, transient cotransfection of several [TG] promoter/reporter constructs into 293T kidney fibroblasts with a [TF] expression vector shows that the oncogenic protein Fli-1 can transactivate the GPIX promoter when an intact GPIX Ets site is present.	Fli-1	GPIX	1	ACTIVATION	False
6903	6973	10194767:11:ELK1:EGR1	Coexpression of Sap-1a and [TF] resulted in a marked increase in GH induction of [TG] promoter activity, although transfection with expression vectors for either Ets factor alone did not significantly enhance the GH response.	Elk-1	egr-1	1	ACTIVATION	False
6904	6974	10194767:11:ELK4:EGR1	Coexpression of [TF] and Elk-1 resulted in a marked increase in GH induction of [TG] promoter activity, although transfection with expression vectors for either Ets factor alone did not significantly enhance the GH response.	Sap-1a	egr-1	1	ACTIVATION	False
6905	6975	10196143:5:STAT3:POMC	Attenuation of [TF] activity in the dominant negative AtT20 clones prevented LIF from promoting transcriptional activation of the [TG] promoter (2.1-fold), whereas this LIF action was enhanced (7.7-fold; p < 0.05) in wild-type STAT3-overexpressing clones in comparison to mock-transfected cells (4.5-fold).	STAT3	POMC	1	ACTIVATION	False
6906	6976	10196169:7:TP53:PTGS2	The activity of the [TG] promoter was reduced by 85% in cells expressing wt [TF] but was reduced only by 30% in cells expressing mutant p53 compared with cells null for p53.	p53	Cox-2	2	REPRESSION	False
6907	6977	10196169:8:TP53:PTGS2	The effect of [TF] on the suppression of [TG] promoter activity was localized to the first 40 base pairs 5' from the transcription start site.	p53	Cox-2	2	REPRESSION	False
6908	6978	10196169:9:TP53:PTGS2	Electrophoretic mobility shift assay revealed that [TF] competed with TATA-binding protein for binding to mouse [TG] or human Cox-2 promoter extending from -50 to +52 base pairs.	p53	Cox-2	0	UNDEFINED	False
6909	6979	10199558:10:NFKB:CSF1	Deletion of the seven nucleotides containing the [TF] homology response sequence from the [TG] promoter increased basal gene transcription by twofold.	NFkappaB	MCSF	2	REPRESSION	False
6910	6980	10200294:11:LITAF:TNF	Together, these findings suggest that [TF] plays an important role in the activation of the human [TG] gene and proposes a new mechanism to control TNF-alpha gene expression.	LITAF	TNF-alpha	1	ACTIVATION	False
6911	6981	10201372:6:CREB1:CCND1	The oncoprotein p21ras further activates transcription of the [TG] gene, through sites within the promoter that bind the transcriptional regulators Ets or [TF].	CREB	cyclin D1	1	ACTIVATION	False
6912	6982	10202034:6:NFKB:IL6	Interestingly, it was shown that [TF]-mediated gene transcription, both in the context of the [TG] promoter as well as on its own, was dependent on both serine kinase activity and interaction with c-Jun protein.	NF-kappa B	IL-6	1	ACTIVATION	False
6913	6983	10210266:2:NFKB:PTGS2	Several reports have documented that the activation of [TF] triggers the expression of [TG] gene.	NF-kappaB	COX-2	1	ACTIVATION	False
6914	6984	10210266:7:NFKB:PTGS2	These results suggest that the transcriptional regulation of [TG] expression by [TF] depends upon the types of cells studied and that activation of this transcription factor alone does not play an important role in the expression of COX-2 in rat smooth muscle cells.	NF-kappaB	COX-2	0	UNDEFINED	True
6915	6985	10212208:13:SP1:CDKN1A	Taken together, these results suggest that [TF] or Sp1-related proteins mediate FB1-induced activation of the [TG] promoter.	Sp1	p21	1	ACTIVATION	False
6916	6986	10212268:9:SRF:SLC8A1	Therefore, this work demonstrates that [TF] and GATA-4 are critical for [TG] expression in neonatal cardiomyocytes and that the -172 E-box in addition to a novel enhancer element(s) are required for phenylephrine up-regulation of NCX1 and may mediate its hypertrophic up-regulation.	SRF	NCX1	1	ACTIVATION	False
6917	6988	10218647:7:AP1:GCLC	Collectively, OxLDL induces [TG] expression mediated by [TF] resulting in an increase of GSH levels.	AP-1	gamma-GCS	1	ACTIVATION	False
6918	6989	10218980:0:JUN:OXTR	Identification of a GABP alpha/beta binding site involved in the induction of [TG] gene expression in human breast cells, potentiation by c-Fos/[TF].	c-Jun	oxytocin receptor	1	ACTIVATION	False
6919	6990	10218980:10:AP1:OXTR	We showed the requirement for GABP alpha/beta and c-Fos/c-Jun in endogenous [TG] gene expression, using oligonucleotide GABP and [TF] binding decoys to inhibit serum-induced increases in 125I-labeled OT antagonist binding to Hs578T cells.	AP-1	OTR	1	ACTIVATION	False
6920	6993	10224085:5:WT1:CDKN1A	We found that three N-terminal tumor-associated missense mutations of [TF] were defective for activation of both a synthetic reporter containing WT1-binding sites as well as the promoter of a WT1 responsive gene, [TG].	WT1	p21	1	ACTIVATION	False
6921	6994	10226077:8:AP1:IL1B	In combination with competitive cotransfection studies using consensus oligonucleotides mimicking these motifs, we conclude that transactivation of an NF-kappaB-like sequence is necessary for induction of the [TG] gene, that activation of CRE may repress induction of the gene, and that [TF] potentially modulates induction and repression of the gene induced by fibrinogen.	AP-1	IL-1beta	0	UNDEFINED	False
6922	6995	10228559:10:AP1:ERCC1	The increase in [TF] DNA-binding activity and the increase in [TG] mRNA expression were prevented by pretreatment with cycloheximide.	AP-1	ERCC-1	1	ACTIVATION	False
6923	6996	10228559:11:AP1:ERCC1	These data suggest that [TF] may contribute to the upregulation of [TG] in response to TPA in human ovarian cancer cells.	AP-1	ERCC-1	1	ACTIVATION	False
6924	6997	10228559:9:AP1:ERCC1	The increase in [TF] activity occurs immediately before the increase in [TG] transcription.	AP-1	ERCC-1	1	ACTIVATION	False
6925	6998	10229863:3:NFKB:NOS2	Treatment with wortmannin promoted a prolonged activation of [TF] in LPS-treated cells as well as an increase in the promoter activity of the [TG] gene as deduced from transfection experiments using a 1.7-kb fragment of the 5' flanking region of the iNOS gene.	NF-kappaB	iNOS	1	ACTIVATION	False
6926	6999	10231433:3:CREB1:ANG	We hypothesized that the molecular mechanism(s) of action of isoproterenol on the expression of the [TG] gene is mediated via the interaction of the phosphorylated cAMP-responsive element binding protein ([TF]) and the cAMP-responsive element (CRE; that is, ANG N-806/-779) in the 5'-flanking region of the rat ANG gene.	CREB	ANG	0	UNDEFINED	True
6927	7000	10318916:3:LEF1:CCND1	Here, we show that the [TG] gene is a direct target for transactivation by the beta-catenin/[TF] pathway through a LEF-1 binding site in the cyclin D1 promoter.	LEF-1	cyclin D1	1	ACTIVATION	False
6928	7001	10319992:0:MYC:CDKN1A	Overexpression of [TF] inhibits p21[TG]/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.	c-Myc	WAF1	2	REPRESSION	False
6929	7002	10319992:3:MYC:CDKN1A	We show here that exogenous [TF] inhibits [TG] expression in SkBr3 and LNCaP cells induced to enter into S-phase.	c-Myc	p21	2	REPRESSION	False
6930	7003	10319992:7:MYC:CDKN1A	Overexpression of [TF] reduced the levels of endogenous [TG] mRNA, and transfection of c-Myc repressed p21-promoter luciferase-reporter gene expression.	c-Myc	p21	2	REPRESSION	False
6931	7004	10321737:0:IRF2:CDKN1A	Activation and repression of the 2-5A synthetase and [TG] gene promoters by IRF-1 and [TF].	IRF-2	p21	1	ACTIVATION	True
6932	7005	10321737:7:IRF1:IRF2	[TF] also induced expression of its homologous repressor [TG] as indicated by EMSA analysis using an IRF-E probe from the IRF-2 promoter; and by cotransfection of IRF-1 together with an IRF-2 promoter CAT construct.	IRF-1	IRF-2	1	ACTIVATION	False
6933	7006	10321740:8:TP53:BTG2	However, such deletion differentially affects [TF] induction of endogenous target genes, i.e., induction of p21, MDM2, [TG], p85, PIG3, PIG6 and PIG11 was reduced or abrogated but induction of BAX, KILLER/DR5, PIG2, PIG7 and PIG8 was not substantially affected.	p53	BTG2	1	ACTIVATION	False
6934	7007	10329676:7:NFKB:SDC4	In vitro studies demonstrated that TNF-alpha induced endothelial cell [TG] expression by both increasing syndecan-4 gene expression in an [TF]-dependent manner and by prolonging syndecan-4 mRNA half-life.	NF-kappaB	syndecan-4	1	ACTIVATION	False
6935	7008	10329706:6:ELK1:EGR1	These data suggested that an activated ets factor, such as [TF], in complex with serum response factor, was the likely proximal trigger of [TG] transcription.	Elk-1	Egr-1	1	ACTIVATION	False
6936	7009	10329706:6:SRF:EGR1	These data suggested that an activated ets factor, such as Elk-1, in complex with [TF], was the likely proximal trigger of [TG] transcription.	serum response factor	Egr-1	1	ACTIVATION	False
6937	7010	10329706:7:ELK1:EGR1	Indeed, hypoxia induced activation of [TF], and suppression of Elk-1 blocked up-regulation of [TG] transcription.	Elk-1	Egr-1	1	ACTIVATION	False
6938	7011	10348346:6:TP53:CDKN1A	Induction of p19ARF activated [TF] by increasing its stability, and allowed the expression of [TG], which bound to all of the cyclin D1-cdk complexes (cyclin D1-cdk2, -cdk4, and -cdk6) thereby inhibiting their kinase activities.	p53	p21Cip1	1	ACTIVATION	True
6939	7012	10348347:5:FOS:TP53	The [TF] motif in the human [TG] promoter binds c-Fos and c-Jun and the NF-kappaB motif binds p50(NF-kappaB) and p65RelA.	AP-1	p53	0	UNDEFINED	False
6940	7013	10361124:5:RARA:PLAU	Deletion analysis of the [TG] promoter suggested that [TF]/RXR acts on GC box region within the uPA promoter.	RAR	uPA	0	UNDEFINED	False
6941	7014	10361124:9:SP1:PLAU	Finally, [TF] and RAR/RXR synergistically enhanced the transactivation activity of the [TG] promoter.	Sp1	uPA	1	ACTIVATION	False
6942	7015	10362258:7:SP1:CDKN1A	Furthermore, p300 was able to act as a co-activator for [TF]-mediated transcriptional activation in PC12 cells, suggesting that p300 and Sp1 may cooperate in activating [TG] transcription during the withdrawal of neuronal precursors from the cell cycle.	Sp1	p21	1	ACTIVATION	False
6943	7016	10364563:8:EGR1:PDGFA	Interestingly, the site bound by GCF2 overlaps those for specificity protein-1 (Sp1) and early growth response factor-1 ([TF]), zinc finger transcription factors that direct basal and inducible expression of the [TG] gene.	Egr-1	PDGF-A	1	ACTIVATION	False
6944	7019	10381566:0:MYCN:NDRG1	[TF]-dependent repression of [TG], a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant.	N-myc	ndr1	2	REPRESSION	False
6945	7020	10381566:10:MYCN:NDRG1	c-myc also repressed [TG] promoter activity similarly to [TF].	N-myc	Ndr1	2	REPRESSION	False
6946	7021	10381566:11:MYCN:NDRG1	The effect of [TF]:Max was sensitive to Trichostatin A, indicating involvement of histone deacetylase activity in repression of the [TG] promoter.	N-myc	Ndr1	2	REPRESSION	False
6947	7022	10381566:8:MYCN:NDRG1	The [TG] promoter activity was down-regulated by [TF], and more strongly by the combination of N-myc and Max in the cotransfection assay.	N-myc	Ndr1	2	REPRESSION	False
6948	7023	10383467:0:MAZ:MYC	Transcriptional repression from the [TG] P2 promoter by the zinc finger protein [TF]/MAZ.	ZF87	c-myc	2	REPRESSION	False
6949	7024	10383467:6:MAZ:MYC	[TF]/MAZ functions as a true transcriptional repressor since it can repress transcription independently of the [TG] promoter, as part of a fusion with the GAL4 protein.	ZF87	c-myc	2	REPRESSION	False
6950	7025	10391889:11:ATF1:EGR1	Phosphorylated CREB and [TF] then bind to the CRE of the [TG] promoter and cause a stress-dependent transcriptional activation of this gene.	ATF1	egr-1	1	ACTIVATION	False
6951	7026	10391889:11:CREB1:EGR1	Phosphorylated [TF] and ATF1 then bind to the CRE of the [TG] promoter and cause a stress-dependent transcriptional activation of this gene.	CREB	egr-1	1	ACTIVATION	False
6952	7027	10395693:6:NFKB:PTGS2	LPS increased [TG] gene transcription and activation of the transcription factor [TF] in a transient manner.	NF-kappa B	COX-2	1	ACTIVATION	False
6953	7028	10406964:2:AP1:CLU	Here, we demonstrate, by supershift analysis, that JunB, JunD, Fra1, [TF], and c-Fos bound to AP-1 but that prior treatment of the cells with TGFbeta reduced dramatically c-Fos binding, suggesting that c-Fos might be playing a negative regulatory role in [TG] gene expression.	Fra2	clusterin	0	UNDEFINED	True
6954	7029	10406964:2:FOSL1:CLU	Here, we demonstrate, by supershift analysis, that JunB, JunD, [TF], Fra2, and c-Fos bound to AP-1 but that prior treatment of the cells with TGFbeta reduced dramatically c-Fos binding, suggesting that c-Fos might be playing a negative regulatory role in [TG] gene expression.	Fra1	clusterin	0	UNDEFINED	False
6955	7031	10409739:7:SREBF2:PPARG	Both promoters contain a consensus E-box motif that mediates the regulation of the [TG] gene by ADD-1/SREBP-1 and [TF].	SREBP-2	PPARgamma	0	UNDEFINED	False
6956	7032	10409765:0:NFKB:CCND1	[TF] controls cell growth and differentiation through transcriptional regulation of [TG].	NF-kappaB	cyclin D1	0	UNDEFINED	True
6957	7033	10409765:5:NFKB:CCND1	An analysis of cell cycle markers revealed that [TF] activates [TG] expression, and the results showed that this regulatory pathway is one mechanism by which NF-kappaB inhibits myogenesis.	NF-kappaB	cyclin D1	1	ACTIVATION	False
6958	7034	10409765:6:NFKB:CCND1	[TF] regulation of [TG] occurs at the transcriptional level and is mediated by direct binding of NF-kappaB to multiple sites in the cyclin D1 promoter.	NF-kappaB	cyclin D1	0	UNDEFINED	True
6959	7035	10409765:9:NFKB:CCND1	These data therefore identify [TG] as an important transcriptional target of [TF] and reveal a mechanism to explain how NF-kappaB is involved in the early phases of the cell cycle to regulate cell growth and differentiation.	NF-kappaB	cyclin D1	0	UNDEFINED	True
6960	7036	10411637:8:SP1:HPN	The basal promoter region contains potential binding sites for several transcription factors including [TF], AP2, C/EBP, LF-A1, and E box, which may be responsible for ubiquitous, but liver- and kidney-preferred tissue expression of the [TG] gene.	SP1	hepsin	1	ACTIVATION	True
6961	7037	10411637:8:TFAP2A:HPN	The basal promoter region contains potential binding sites for several transcription factors including SP1, [TF], C/EBP, LF-A1, and E box, which may be responsible for ubiquitous, but liver- and kidney-preferred tissue expression of the [TG] gene.	AP2	hepsin	1	ACTIVATION	True
6962	7038	10415537:5:HIF1A:VEGFA	[TF] target genes include those encoding vascular endothelial growth factor ([TG]), erythropoietin, glucose transporters, and glycolytic enzymes.	HIF-1	VEGF	0	UNDEFINED	False
6963	7039	10433370:3:STAT5A:PTGS2	IL-10-activated STAT1 could bind to the GAS-motif sequence in the promoter region of the Fcgamma receptor, but not to that in the promoter region of the [TG] gene, whereas IFN-gamma-activated STAT1 and [TF] could bind to both sequences.	STAT5	COX-2	0	UNDEFINED	False
6964	7040	10435630:5:TP53:CDKN1A	For example, p73 activates the GADD45 gene more efficiently than [TF], whereas the reverse situation was apparent for the [TG] gene.	p53	p21	1	ACTIVATION	False
6965	7041	10440232:1:STAT3:HSP90AA1	We have previously demonstrated that interleukin-6 (IL-6) increases the levels of the heat shock protein 90 ([TG]) and activates the Hsp90beta promoter via the IL-6-activated transcription factors NF-IL6 and [TF].	STAT-3	Hsp90	1	ACTIVATION	False
6966	7042	10440232:2:STAT1:HSPA4	In addition, interferon-gamma (IFN-gamma) treatment increases the levels of [TG] and Hsp90 and also enhances the activity of the Hsp70 and Hsp90beta promoters with these effects being dependent on activation of the [TF] transcription factor by IFN-gamma.	STAT-1	Hsp70	1	ACTIVATION	False
6967	7043	10440232:3:STAT1:HSPA4	The effect of IL-6/STAT-3 and IFN-gamma/[TF] was mediated via a short region of the [TG]/Hsp90 promoters, which also mediates the effects of NF-IL6.	STAT-1	Hsp70	0	UNDEFINED	False
6968	7044	10440232:6:STAT3:HSP90AA1	In contrast, [TF] and HSF-1 antagonize one another and reduce the activation of both the Hsp70 and [TG] promoters.	STAT-3	Hsp90	2	REPRESSION	True
6969	7045	10446131:6:EGR1:PDGFA	Gel shift and supershift studies show that [TF] protein accumulates in the nuclei of SMCs exposed to ATII and binds to the proximal region of the [TG] promoter in a specific, time-dependent manner.	Egr-1	PDGF-A	0	UNDEFINED	False
6970	7046	10455192:6:FOXA1:AFP	Transient transfection studies illustrate that [TF] can activate [TG] expression in a non-liver cellular environment, confirming a pivotal role for HNF3alpha in establishing hepatic-specific gene expression.	HNF3alpha	AFP	1	ACTIVATION	False
6971	7047	10455192:7:FOXA1:AFP	Restriction enzyme accessibility assays reveal that [TF] promotes the assembly of an open chromatin structure at the [TG] promoter.	HNF3alpha	AFP	1	ACTIVATION	True
6972	7048	10464245:10:NFKB:CCND1	Activation of Rac1 in NIH 3T3 cells induces both [TF] binding and activity and enhances expression of [TG] through an NF-kappaB and ATF-2 site in the proximal promoter, suggesting a critical role for NF-kappaB in cell cycle regulation through cyclin D1 and Rac1.	NF-kappaB	cyclin D1	1	ACTIVATION	False
6973	7049	10464245:6:NFKB:CCND1	Inhibiting [TF] by overexpression of an NF-kappaB trans-dominant inhibitor (nonphosphorylatable IkappaBalpha) reduced [TG] promoter activation by the Rac1 mutants, placing NF-kappaB in a pathway of Rac1 activation of cyclin D1.	NF-kappaB	cyclin D1	1	ACTIVATION	False
6974	7050	10464245:8:NFKB:CCND1	The NF-kappaB factors Rel A (p65) and [TF] (p50) induced the [TG] promoter, requiring both the NF-kappaB binding site and the ATF-2 site.	NF-kappaB(1)	cyclin D1	1	ACTIVATION	False
6975	7052	10464245:8:RELA:CCND1	The NF-kappaB factors [TF] (p65) and NF-kappaB(1) (p50) induced the [TG] promoter, requiring both the NF-kappaB binding site and the ATF-2 site.	Rel A	cyclin D1	1	ACTIVATION	False
6976	7053	10477681:2:HIF1A:VEGFA	[TF] is considered the primary trans-acting factor for the erythropoietin (EPO) and vascular endothelial growth factor ([TG]) genes.	HIF-1	VEGF	1	ACTIVATION	False
6977	7054	10485470:0:SP3:CDKN1A	[TF], but not Sp1, mediates the transcriptional activation of the p21/[TG]/Cip1 gene promoter by histone deacetylase inhibitor.	Sp3	WAF1	1	ACTIVATION	False
6979	7056	10485470:5:SP3:CDKN1A	Taken together, these results suggest that histone deacetylase inhibitor up-regulates p21/[TG]/Cip1 transcription by [TF] but not by Sp1.	Sp3	WAF1	1	ACTIVATION	False
6980	7057	10497251:2:SP1:CCND1	We cloned and characterized the rat [TG] gene 5'-flanking region and, by species- and subspecies-matched transient transfection studies, found that a basic promoter structure with a cAMP response element and two continuous [TF] was crucial for the steady-state expression of the cyclin D1 gene.	Sp1-binding sites	cyclin D1	1	ACTIVATION	True
6981	7058	10498892:2:TP53:CDKN1A	The [TG] gene is a direct transcriptional target for the [TF] protein, and its activation is likely to be important in effecting the p53 response.	p53	p21	1	ACTIVATION	False
6982	7059	10498899:3:IRF1:SLPI	Secretory leukocyte protease inhibitor ([TG]) - a regulator of inflammation and an inhibitor of the LPS response - was identified as a gene repressed after doxycycline induced [TF] expression.	IRF-1	SLPI	2	REPRESSION	False
6983	7060	10499541:0:PGR:PRL	[TF] regulates decidual [TG] expression in differentiating human endometrial stromal cells.	Progesterone receptor	prolactin	0	UNDEFINED	False
6984	7061	10500157:10:JUN:CCND1	To interpret these results, we propose a mechanism in which ATF-2/[TF] heterodimers bind to the CRE-D1 element and mediate the activation of [TG] promoter by the ER.	c-Jun	cyclin D1	1	ACTIVATION	False
6985	7062	10500157:7:JUN:CCND1	Both [TF] and ATF-2 transactivated the [TG] promoter in transient transfection experiments, and a clear additional increase was detected when ER was cotransfected with either c-Jun or with c-Jun and ATF-2 but not with ATF-2 alone.	c-Jun	cyclin D1	1	ACTIVATION	False
6986	7063	10500157:8:JUN:CCND1	Furthermore, the expression of a dominant negative variant of [TF], TAM67, completely abolished the induction of the [TG] promoter both in the absence and presence of ER.	c-Jun	cyclin D1	1	ACTIVATION	False
6987	7064	10500157:9:JUN:CCND1	We show that ATF-2 homodimers and ATF-2/[TF] heterodimers, but not c-Jun homodimers, were able to bind the CRE of the [TG] promoter.	c-Jun	cyclin D1	0	UNDEFINED	False
6988	7065	10506225:0:SP1:CDKN1A	c-Jun transactivates the promoter of the human p21([TG]/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor [TF].	Sp1	WAF1	1	ACTIVATION	True
6989	7066	10506225:3:ATF2:CDKN1A	In the present study we show that the Sp1-occupied promoter region mediates transactivation of the [TG] promoter by c-Jun and the related proteins JunB, JunD, and [TF].	ATF-2	p21	1	ACTIVATION	False
6990	7067	10506225:3:JUNB:CDKN1A	In the present study we show that the Sp1-occupied promoter region mediates transactivation of the [TG] promoter by c-Jun and the related proteins [TF], JunD, and ATF-2.	JunB	p21	1	ACTIVATION	False
6991	7068	10506225:3:JUND:CDKN1A	In the present study we show that the Sp1-occupied promoter region mediates transactivation of the [TG] promoter by c-Jun and the related proteins JunB, [TF], and ATF-2.	JunD	p21	1	ACTIVATION	False
6992	7069	10506225:3:SP1:CDKN1A	In the present study we show that the [TF]-occupied promoter region mediates transactivation of the [TG] promoter by c-Jun and the related proteins JunB, JunD, and ATF-2.	Sp1	p21	1	ACTIVATION	False
6993	7070	10508188:5:TCF12:CD4	We show that ZEB binds to the 5'E-box in the [TG]-3 element of the proximal CD4 enhancer in competition with the transcriptional activators E12 and [TF], thereby reducing CD4 expression on CD4 single-positive but not CD4/CD8 double-positive T cells.	HEB	CD4	1	ACTIVATION	False
6994	7071	10508276:2:EGR3:FASLG	The transcription factors NF-AT and [TF] (a member of the immediate-early transcription factors involved in cellular growth and differentiation) have been implicated in activation of the [TG] promoter upon T cell activation.	Egr-3	CD95L	1	ACTIVATION	False
6995	7072	10510472:0:ETS1:DDIT3	Regulation of the human stress response gene [TG] expression: role of [TF] and FLI-1 gene products.	ETS1	GADD153	0	UNDEFINED	False
6996	7073	10510472:0:FLI1:DDIT3	Regulation of the human stress response gene [TG] expression: role of ETS1 and [TF] gene products.	FLI-1	GADD153	0	UNDEFINED	False
6997	7074	10510472:1:ETS1:TP53	We have previously shown that ETS transcription factors, regulate cell growth and differentiation, and [TF] and ETS2 are able to transcriptionally regulate wt [TG] gene expression.	ETS1	p53	0	UNDEFINED	False
6998	7075	10510472:1:ETS2:TP53	We have previously shown that ETS transcription factors, regulate cell growth and differentiation, and ETS1 and [TF] are able to transcriptionally regulate wt [TG] gene expression.	ETS2	p53	0	UNDEFINED	False
6999	7076	10510472:6:ETS1:DDIT3	Our results also demonstrate how [TF] and FLI-1 specifically regulate [TG] expression.	ETS1	GADD153	0	UNDEFINED	False
7000	7077	10510472:6:FLI1:DDIT3	Our results also demonstrate how ETS1 and [TF] specifically regulate [TG] expression.	FLI-1	GADD153	0	UNDEFINED	False
7001	7078	10512200:0:SP1:POU5F1	Binding of [TF] and Sp3 transcription factors to the [TG] gene promoter.	Sp1	Oct-4	0	UNDEFINED	False
7002	7079	10523830:11:SPI1:ETS2	One of the factors binding to the GATA/EBS region was identified to be [TF] by supershift analysis and was also shown to bind to the EBS element of the [TG] gene.	Spi-1	human Ets-2	0	UNDEFINED	False
7003	7080	10528163:5:STAT1:IRF1	The [TF]-dependent IFN-gamma activation sequence element of the [TG] promoter is a target for Stat6-mediated inhibition despite apparently normal Stat1 DNA binding.	Stat1	IRF-1	1	ACTIVATION	True
7004	7081	10528998:13:HNF1A:CYP27A1	The data suggest that bile acids repress [TG] transcriptional activity by decreasing [TF] binding to the CYP27 promoter.	HNF1alpha	CYP27	1	ACTIVATION	True
7005	7082	10531067:2:MEF2A:NR4A1	[TG] expression is controlled by the transcription factor myocyte enhancer factor 2 ([TF]), but how MEF2 is activated by calcium signaling is still obscure.	MEF2	Nur77	0	UNDEFINED	False
7006	7083	10542237:6:JUN:IL6	Furthermore, activation of PPARalpha represses both [TF]- and p65-induced transcription of the human [TG] promoter.	c-Jun	IL-6	1	ACTIVATION	False
7007	7084	10542237:6:PPARA:IL6	Furthermore, activation of [TF] represses both c-Jun- and p65-induced transcription of the human [TG] promoter.	PPARalpha	IL-6	2	REPRESSION	False
7008	7085	10542237:6:RELA:IL6	Furthermore, activation of PPARalpha represses both c-Jun- and [TF]-induced transcription of the human [TG] promoter.	p65	IL-6	1	ACTIVATION	False
7009	7086	10545530:1:PDX1:INS	The transcription factor [TG] promoter factor-1 ([TF]) plays a central role in both the development of the pancreas and the regulation of insulin gene expression in the mature pancreatic beta cell.	IPF-1	insulin	0	UNDEFINED	False
7010	7087	10551787:7:SREBF1:CYP51A1	[TF] from somatic cell nuclear extracts binds to a conserved [TG]-SRE1 element in the CYP51 proximal promoter.	SREBP-1a	CYP51	0	UNDEFINED	True
7011	7088	10551799:8:AP1:TNF	Additional mutagenesis and transfection studies demonstrated that NF-kappaB and CREB/[TF] are important regulators of inducible [TG] promoter activity in primary human T lymphocytes.	AP-1	TNF	1	ACTIVATION	True
7012	7089	10551830:0:SREBF1:RPS14	Sterol response element-binding protein 1c ([TF]c) is involved in the polyunsaturated fatty acid suppression of hepatic [TG] gene transcription.	SREBP1	S14	2	REPRESSION	False
7013	7090	10552928:5:TFAP2A:RECQL4	In the 5' upstream region, one Sp1 site and several [TF] sites exist near the capping site, suggesting that the expression of [TG] is regulated by a housekeeping-type promoter similar to WRN.	AP 2	RECQL4	0	UNDEFINED	False
7014	7091	10557089:15:ELF1:BRCA2	We propose that interactions between USF-1, USF-2 and [TF] play an important role in the transcriptional regulation of the [TG] gene.	Elf-1	BRCA2	0	UNDEFINED	False
7015	7092	10557089:15:USF1:BRCA2	We propose that interactions between [TF], USF-2 and Elf-1 play an important role in the transcriptional regulation of the [TG] gene.	USF-1	BRCA2	0	UNDEFINED	False
7016	7093	10557089:15:USF2:BRCA2	We propose that interactions between USF-1, [TF] and Elf-1 play an important role in the transcriptional regulation of the [TG] gene.	USF-2	BRCA2	0	UNDEFINED	False
7017	7094	10559225:5:FOSL1:ELN	Western blot analysis shows that bFGF induces a sustained increase in the steady-state levels of [TF], and co-transfection of a Fra 1 expression vector with an [TG] promoter reporter construct results in an inhibition of elastin promoter activity.	Fra 1	elastin	2	REPRESSION	False
7018	7095	10559225:6:FOSL1:ELN	Overall the results suggest that bFGF represses [TG] gene transcription by increasing the amount of the [TF] that subsequently binds to the -564- to -558-bp as a heterodimer with c-Jun to form an inhibitory complex.	Fra 1	elastin	2	REPRESSION	False
7019	7096	10559225:6:JUN:ELN	Overall the results suggest that bFGF represses [TG] gene transcription by increasing the amount of the Fra 1 that subsequently binds to the -564- to -558-bp as a heterodimer with [TF] to form an inhibitory complex.	c-Jun	elastin	2	REPRESSION	False
7020	7097	10559267:2:TP53:CDKN1A	In contrast to Saos-2 cells in which [TF] activated both the [TG] and bax promoters, in MDA-MB-453 cells p53 activated the p21 promoter, but failed to activate the bax promoter.	p53	p21	1	ACTIVATION	False
7021	7099	10559267:8:TP53:CDKN1A	Together, these data suggest a potential mechanism for the differential regulation of [TF]-dependent transactivation of the bax and [TG] genes.	p53	p21	1	ACTIVATION	True
7022	7100	10559391:7:HIF1A:CDKN1A	We show that mRNA, protein, and/or activity levels for genes whose expression is known to be regulated by [TF], including glycolytic enzymes, p21([TG]/cip1), and erythropoietin, are increased in cortical neuronal cultures in response to iron chelator treatment.	HIF-1	waf1	0	UNDEFINED	False
7023	7101	10567390:9:AP1:CCND1	p300 activated the [TG] promoter through an activator protein-1 ([TF]) site at -954 and was identified within a DNA-bound complex with c-Jun at the AP-1 site.	AP-1	cyclin D1	1	ACTIVATION	False
7024	7103	10567637:0:AP1:NR4A1	Transcriptional activation of human [TG]/nur77 gene expression by human T-lymphotropic virus type I Tax protein through two [TF]-like elements.	AP-1	TR3	1	ACTIVATION	False
7025	7104	10567637:11:JUND:NR4A1	This work suggests that [TF] is involved in Tax-regulated [TG]/nur77 expression.	JunD	TR3	0	UNDEFINED	False
7026	7105	10574924:5:HNF4A:ANG	In vitro assays indicated that [TF] bound to the promoter elements and strongly activated the [TG] transcription, but that chicken ovalbumin upstream promoter transcription factor (COUP-TF), a transcriptional repressor, dramatically repressed human ANG transcription through the promoter elements and the downstream enhancer core elements.	HNF4	ANG	1	ACTIVATION	False
7027	7106	10579331:12:SREBF1:SCARB1	The cysteine protease inhibitor N-acetyl-leucyl-leucyl-norleucinal, which inhibits SREBP degradation, enhanced the effect of [TF] on the regulation of the rat HDL receptor [TG] gene.	SREBP-1a	SR-BI	0	UNDEFINED	False
7028	7107	10579331:16:SREBF1:SCARB1	The results confirm that indeed both SF-1 and [TF] synergize to induce HDL receptor [TG] gene expression.	SREBP-1a	SR-BI	1	ACTIVATION	False
7029	7108	10579331:6:SREBF1:SCARB1	Consistent with the possibility that [TF] may be involved in the regulation of the HDL receptor [TG] gene, we found that mature SREBP-1a levels increased up to 11-fold in the ovary after treatment with 50 U hCG.	SREBP-1a	SR-BI	0	UNDEFINED	False
7030	7109	10579331:9:SREBF1:SCARB1	To determine whether [TF] could directly regulate the expression of the rat HDL receptor [TG] gene, approximately 2.2 kb of the receptor SR-BI promoter were cloned and sequenced, and deletion analysis and mobility shift assays were performed.	SREBP-1a	SR-BI	0	UNDEFINED	False
7031	7110	10585438:4:NFKB:CREB1	Overexpression of [TF] proteins in primary Sertoli and NIH 3T3 fibroblast cells induced the [TG] promoter in transient transfection assays.	NF-kappaB	CREB	1	ACTIVATION	False
7032	7111	10585438:8:NFKB:CREB1	Furthermore, the [TG] promoter is also inducible by [TF] in NIH 3T3 cells suggesting that NF-kappaB may be a general regulator of CREB in non-testis tissues.	NF-kappaB	CREB	1	ACTIVATION	False
7033	7112	10585862:13:YY1:PTPRA	Thus [TF] apparently mediates basal transcription of the human [TG] gene through two binding sites within its proximal promoter.	YY1	PTPA	1	ACTIVATION	False
7034	7113	10585876:4:ID2:FAS	Using the [TG] gene as a model of an ADD1-regulated promoter in transiently transfected isolated rat adipocytes or mature 3T3-L1 adipocytes, a potent inhibition of the activity of the FAS-chloramphenicol acetyltransferase reporter gene was observed by overexpression of [TF] or Id3.	Id2	FAS	2	REPRESSION	False
7035	7114	10585876:4:ID3:FAS	Using the [TG] gene as a model of an ADD1-regulated promoter in transiently transfected isolated rat adipocytes or mature 3T3-L1 adipocytes, a potent inhibition of the activity of the FAS-chloramphenicol acetyltransferase reporter gene was observed by overexpression of Id2 or [TF].	Id3	FAS	2	REPRESSION	False
7036	7115	10597227:4:USF1:MT1A	The electrophoretic mobility shift assay using specific oligonucleotide probes showed that the key transcription factors regulating [TG] gene (e.g., MTF-1, Sp 1 and [TF]/USF) are active in P1798 cells.	MLTF	MT-I	0	UNDEFINED	False
7037	7116	10611347:8:PEG3:VEGFA	Furthermore, transient ectopic expression of [TF] transcriptionally activates [TG] in transformed rodent and human cancer cells.	PEG-3	VEGF	1	ACTIVATION	False
7038	7117	10611972:3:HIF1A:VEGFA	Several dozen target genes that are transactivated by [TF] have been identified, including those encoding erythropoietin, glucose transporters, glycolytic enzymes, and [TG].	HIF-1	vascular endothelial growth factor	1	ACTIVATION	False
7039	7118	10618488:0:SP3:FASN	Transcriptional regulation of [TG] gene and ATP citrate-lyase gene by Sp1 and [TF] in rat hepatocytes(1).	Sp3	fatty acid synthase	0	UNDEFINED	False
7040	7119	10618716:5:FLI1:TNC	These three EBSs bind in vitro expressed [TF] protein and mediate transactivation of the [TG] gene by Fli1.	Fli1	TN-C	1	ACTIVATION	False
7041	7120	10618716:9:FLI1:TNC	The studies performed in Drosophila cells demonstrate that either [TF] or GABPalpha+beta1 functionally interact with Sp1 resulting in a synergistic stimulation of the [TG] promoter activity.	Fli1	TN-C	1	ACTIVATION	False
7042	7121	10625678:6:CTCF:MYC	Binding of [TF] and TR to their cognate sites in the region of transcriptional attenuation, as well as direct interactions between both factors, could facilitate the formation of a repressor complex and the inhibition of [TG] gene expression.	CCCTC binding factor	c-myc	2	REPRESSION	False
7043	7122	10625687:0:SP1:CDKN1A	p300 collaborates with [TF] and Sp3 in p21([TG]/cip1) promoter activation induced by histone deacetylase inhibitor.	Sp1	waf1	1	ACTIVATION	False
7044	7123	10625687:0:SP3:CDKN1A	p300 collaborates with Sp1 and [TF] in p21([TG]/cip1) promoter activation induced by histone deacetylase inhibitor.	Sp3	waf1	1	ACTIVATION	False
7045	7124	10625687:1:SP1:CDKN1A	We have reported that histone acetylation induced by trichostatin A (TSA) promotes p21([TG]/cip1) (p21) expression, the GC-box located just upstream of TATA box was responsible for TSA-induced promoter activation, and both [TF] and Sp3 were the working activator of this GC-box.	Sp1	waf1	1	ACTIVATION	False
7046	7125	10625687:1:SP3:CDKN1A	We have reported that histone acetylation induced by trichostatin A (TSA) promotes p21([TG]/cip1) (p21) expression, the GC-box located just upstream of TATA box was responsible for TSA-induced promoter activation, and both Sp1 and [TF] were the working activator of this GC-box.	Sp3	waf1	1	ACTIVATION	False
7047	7126	10625687:4:TP53:CDKN1A	Our data also suggested that p300 collaborates with Sp1 in a way which is different from that when p300 collaborates with [TF] in [TG] transcription.	p53	p21	0	UNDEFINED	True
7048	7127	10640274:4:HIF1A:VEGFA	Loss of p53 in tumor cells enhances [TF] levels and augments HIF-1-dependent transcriptional activation of the vascular endothelial growth factor ([TG]) gene in response to hypoxia.	HIF-1alpha	VEGF	1	ACTIVATION	False
7049	7128	10640274:5:HIF1A:VEGFA	Forced expression of [TF] in p53-expressing tumor cells increases hypoxia-induced [TG] expression and augments neovascularization and growth of tumor xenografts.	HIF-1alpha	VEGF	1	ACTIVATION	False
7050	7129	10644990:7:ELF3:TGFB1	This data strongly suggests that [TF] plays an important role as a transcriptional activator of [TG] RII expression, and that deregulated ERT expression may play a critical role in rendering Hs578t human breast cancer cells insensitive to TGF-beta's growth inhibitory effects.	ERT	TGF-beta	1	ACTIVATION	False
7051	7130	10652293:6:CEBPB:PTGS2	Although mutating the two [TF] sites individually did not affect [TG] promoter activity, mutating both NF-IL6 sites substantially inhibits COX-2 promoter activity.	NF-IL6	COX-2	1	ACTIVATION	False
7052	7131	10652293:7:CEBPB:PTGS2	Moreover, overexpression of wild type [TF] (C/EBPbeta) augments [TG] promoter activity in activated mast cells and cotransfection of a dominant negative C/EBPbeta construct completely blocks COX-2 promoter/luciferase expression.	CCAAT/enhancer-binding protein-beta	COX-2	1	ACTIVATION	False
7053	7132	10657993:6:FOS:CD44	In addition, cotransfection of the architectural transcription factor high mobility group (HMG)-I(Y) protein with c-[TF] and c-Jun markedly increased trans-activation of the [TG] promoter.	Fos	CD44	1	ACTIVATION	False
7054	7133	10666204:11:KLF6:PLAU	These findings suggest a role of [TF] in the injury response by enhancing [TG] synthesis and subsequent activation of latent TGF-beta.	Zf9	uPA	1	ACTIVATION	False
7055	7134	10666204:5:KLF6:PLAU	[TF] transcriptionally activates [TG] (uPA).	Zf9	urokinase plasminogen activator	1	ACTIVATION	False
7056	7135	10666204:7:KLF6:PLAU	Transient transfection of [TF] drives transactivation of a full-length [TG] promoter- and GC box-construct, but not a uPA promoter-construct devoid of GC boxes.	Zf9	uPA	1	ACTIVATION	False
7057	7136	10669633:0:EGR1:FLT1	Zinc finger transcription factor [TF] activates [TG] gene expression in THP-1 cells on induction for macrophage differentiation.	Egr-1	Flt-1	1	ACTIVATION	False
7058	7137	10669633:10:EGR1:FLT1	Taken together, our data demonstrate that PMA induces [TG] gene transcription through an induction of [TF] in THP-1 cells, thus providing new evidence that the flt-1 gene is a direct target of Egr-1, the transcription factor primarily induced on macrophage differentiation.	Egr-1	flt-1	1	ACTIVATION	False
7059	7138	10669633:9:EGR1:FLT1	Consistent with these findings, the [TF] expression plasmid strongly induced [TG] promoter activity in a sequence-specific manner.	Egr-1	flt-1	1	ACTIVATION	False
7060	7139	10671224:0:NFKB:FAS	T cell activation-induced and HIV tat-enhanced [TG](APO-1/Fas) ligand transcription involves [TF].	NF-kappaB	CD95	1	ACTIVATION	False
7061	7140	10671533:12:NFKB:PTGS2	Pharmacological inhibitors of [TF] blocked the induction of [TG] protein and the stimulation of COX-2 promoter activity by B[a]P.	NF-kappaB	COX-2	1	ACTIVATION	False
7062	7141	10671569:3:CEBPG:LDLR	We now identify [TG] promoter region -17 to -1 as a sterol-independent regulatory element (SIRE) that is critically involved in OM-, transcription factor [TF] (C/EBP)-, and second messenger cAMP-mediated activation of LDLR transcription.	CCAAT/enhancer-binding protein	LDLR	1	ACTIVATION	False
7063	7142	10688648:5:E2F1:PLAU	Interestingly, an [TF] mutant lacking the pRB-binding region strongly repressed the [TG] and PAI-1 promoters.	E2F1	uPA	1	ACTIVATION	False
7064	7143	10692396:7:SMAD1:SMAD6	These results indicate that the expression of [TG] is regulated by the effects of BMP-activated [TF]/5 on the Smad6 promoter.	Smad1	Smad6	0	UNDEFINED	False
7065	7144	10692422:3:CEBPG:PTGS2	Luciferase reporter constructs with alterations in presumptive cis-acting transcriptional regulatory elements demonstrate that the cyclic AMP-response element and two nuclear factor interleukin-6 ([TF] (C/EBP)) sites of the [TG] promoter are required for optimal endotoxin-dependent induction.	CCAAT/enhancer-binding protein	COX-2	1	ACTIVATION	False
7066	7145	10701683:8:NFKB:PTGS2	[TF] is known to mediate the transcriptional activation of the [TG] gene.	NF-kappaB	COX-2	1	ACTIVATION	False
7067	7146	10701774:10:ETS1:CTSB	Taken together, these results suggest that Sp1, Sp3, and [TF] are important factors in [TG] transcription.	Ets1	cathepsin B	0	UNDEFINED	False
7068	7147	10702805:0:E2F1:CDKN1A	A role for [TF] in Ras activation of p21([TG]/CIP1) transcription.	E2F1	WAF1	1	ACTIVATION	False
7069	7148	10702805:1:E2F1:CDKN1A	We recently reported that [TF] could transactivate the [TG] promoter via cis-acting elements between -119 to +16 bp of the p21 gene.	E2F1	p21	1	ACTIVATION	False
7070	7149	10702805:3:E2F1:CDKN1A	In contrast, activated Ras was not able to induce the [TG] promoter in [TF]-/- fibroblasts, suggesting that E2F1 is required for induction of the p21 promoter by activated Ras.	E2F1	p21	1	ACTIVATION	False
7071	7150	10702805:4:E2F1:CDKN1A	Cotransfection of increasing concentrations of dominant negative [TF] alone, or with dominant negative DP1 into NIH3T3 cells suppressed induction of the [TG] promoter by activated Ras.	E2F1	p21	1	ACTIVATION	False
7072	7151	10702805:4:TFDP1:CDKN1A	Cotransfection of increasing concentrations of dominant negative E2F1 alone, or with dominant negative [TF] into NIH3T3 cells suppressed induction of the [TG] promoter by activated Ras.	DP1	p21	1	ACTIVATION	False
7073	7152	10702805:5:E2F1:CDKN1A	These data suggest that p53-independent induction of the [TG] promoter by activated Ras is mediated at least in part by [TF].	E2F1	p21	1	ACTIVATION	False
7074	7153	10706725:9:REL:ICAM1	These findings indicate that [TF]-associated I kappa B-epsilon is involved in the induction of [TG] expression.	c-Rel	ICAM-1	1	ACTIVATION	False
7075	7154	10713711:7:NFKB:PTGS2	These results indicate that LPS may stimulate DNA synthesis in certain colon carcinoma cells as a result of PGE2 production involving increased [TG] expression that might result in turn from activation of [TF] by LPS.	NF-kappa B	COX-2	1	ACTIVATION	True
7076	7155	10727511:0:NFKB:SLC1A2	Epidermal growth factor receptor agonists increase expression of glutamate transporter [TG] in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor [TF].	NF-kappaB	GLT-1	1	ACTIVATION	False
7077	7156	10764778:3:STAT1:PSMB9	[TF] and IRF1 associate in untreated cells and bind as a complex to the overlapping ICS-2/GAS element of the [TG] promoter.	Stat1	LMP2	0	UNDEFINED	False
7078	7157	10794524:0:REL:BCL2	[TF]/NF-kappaB represses [TG] transcription in pro-B lymphocytes.	Rel	bcl-2	2	REPRESSION	False
7079	7158	10856262:0:STAT3:AGT	Cardiotrophin-1 increases [TG] mRNA in rat cardiac myocytes through [TF] : an autocrine loop for hypertrophy.	STAT3	angiotensinogen	1	ACTIVATION	False
7080	7159	10856262:4:STAT3:AGT	Tyrosine phosphorylation of [TF] by cardiotrophin-1 treatment resulted in STAT3 homodimer binding to the St-domain in the [TG] gene promoter, which lead to promoter activation in a transient transfection assay.	STAT3	angiotensinogen	1	ACTIVATION	False
7081	7160	10864920:5:NFKB:KDR	Histone acetyltransferases (HATs) P/CAF and CBP/p300 together with p65/[TF], the catalytic subunit of NF-kappaB, increase [TG]/KDR promoter activity 10- to 20-fold.	RelA	Flk-1	1	ACTIVATION	False
7082	7161	10871852:6:NFKB:FAS	ASK1/p38 silences the [TG] promoter by inhibition of IkappaBalpha phosphorylation - thereby limiting [TF] activity.	NF-kappaB	Fas	1	ACTIVATION	True
7083	7162	10915780:5:CREB1:CCND1	ILK activation of the [TG] promoter was abolished by point mutation of a cAMP-responsive element-binding protein ([TF])/ATF-2 binding site at nucleotide -54 in the cyclin D1 promoter, and by overexpression of either glycogen synthase kinase-3beta (GSK-3beta) or dominant negative mutants of CREB or ATF-2.	CREB	cyclin D1	1	ACTIVATION	False
7085	7164	10918585:9:STAT3:CDKN1B	These findings indicate that [TF] controls myeloid differentiation, at least partly, via upregulation of [TG].	STAT3	p27(Kip1)	1	ACTIVATION	False
7086	7165	10921891:0:STAT1:PSMB9	How [TF] mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the [TG] gene.	Stat1	LMP2	1	ACTIVATION	False
7087	7166	10921891:3:STAT1:PSMB9	The overlapping interferon consensus sequence 2/gamma-interferon-activated sequence (ICS-2/GAS) elements in the [TG] promoter bind to interferon regulatory factor 1 (IRF1) and [TF] and are occupied constitutively in vivo.	Stat1	LMP2	0	UNDEFINED	False
7088	7167	10926553:6:REL:ICAM1	Gel supershift assay revealed the presence of p65 (Rel A), p50, and [TF] in both H(2)O(2)- and TNF-alpha-induced NF-kappaB complexes bound to the [TG] promoter, with the binding of the p65 subunit being the most prominent.	c-Rel	ICAM-1	0	UNDEFINED	False
7089	7168	10942208:10:NFKB:PTGS2	These results suggest that [TF] is an important transcription factor for IL-1beta-induced [TG] gene expression, and is involved in inducing COX-2 gene transcription through tyrosine phosphorylation in HGF.	NFkappaB	COX-2	1	ACTIVATION	False
7090	7169	10969841:8:NFKB:EDN1	Binding was functionally significant because overexpression of the cytoplasmic inhibitor of [TF] or deletion of the NF-kappaB binding site reduced [TG] induction, whereas overexpression of NF-kappaB p65 induced ET-1 even in the absence of AGEs.	NF-kappaB	ET-1	1	ACTIVATION	False
7091	7170	10969841:8:RELA:EDN1	Binding was functionally significant because overexpression of the cytoplasmic inhibitor of NF-kappaB or deletion of the NF-kappaB binding site reduced [TG] induction, whereas overexpression of NF-kappaB [TF] induced ET-1 even in the absence of AGEs.	p65	ET-1	1	ACTIVATION	False
7092	7171	10970902:5:NFKB:TERT	The [TF] binding site from the mouse [TG] promoter activated transcription when fused to a basal SV40 promoter and enhanced the activity of the native TERT promoter in mouse hepatoma cells stimulated with phorbol 12-myristate 13-acetate.	NF-kappaB	TERT	1	ACTIVATION	False
7093	7172	10970902:7:NFKB:TERT	[TF] may therefore contribute to the activation of [TG] expression observed in mouse tissue.	NF-kappaB	TERT	1	ACTIVATION	False
7094	7173	10975834:5:STAT1:TAP1	These data show that [TF] is necessary for the activation of [TG] gene expression in APCs and initiation of cellular immune responses.	STAT1	Tap-1	1	ACTIVATION	False
7095	7174	11014230:17:ATF1:CGA	We conclude that differentiation-dependent transcription of the [TG] gene in villous trophoblasts is mainly governed by increasing expression of AP-2alpha and PKA-dependent phosphorylation of CREB-1 and [TF].	ATF-1	CGalpha	1	ACTIVATION	False
7096	7175	11027278:4:NFKB:CCND1	The regulation of [TG] transcription by Ral is dependent on [TF] activation and is mediated through an NF-kappaB binding site in the cyclin D1 promoter.	NF-kappaB	cyclin D1	0	UNDEFINED	True
7097	7176	11059688:8:NFKB:FAS	To elucidate the different role of [TF] in chemotherapy-induced apoptosis, we investigated the expression of Fas ([TG]) and Fas ligand (CD95 ligand), which have been described as important mediators of chemotherapy-induced cell death and as target genes of NFkappaB.	NFkappaB	CD95	0	UNDEFINED	False
7098	7177	11104795:3:STAT3:POMC	Whereas pathways shown thus far to regulate [TG] expression exclusively involve cAMP or calcium, we here describe a direct and indirect [TF]-dependent regulation of POMC transcription by LIF.	STAT3	POMC	0	UNDEFINED	False
7099	7178	11104795:7:STAT3:POMC	We therefore conclude that both a direct and indirect route mediate LIF-induced [TF] activation of [TG] transcription.	STAT3	POMC	1	ACTIVATION	False
7101	7180	11114727:0:NFKB:MYC	The [TF] NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the [TG] promoter in mammary cells.	RelA	c-myc	1	ACTIVATION	False
7102	7182	11114727:6:NFKB:MYC	In transient co-transfection, [TF] and AhR gene products demonstrated cooperation in transactivation of the c-myc promoter, which was dependent on the NF-kappaB elements, and in induction of endogenous [TG] protein levels.	RelA	c-Myc	1	ACTIVATION	False
7103	7185	11274184:9:ATF4:HMOX1	These results indicate that [TF] regulates basal and CdCl(2)-induced expression of the [TG] gene in a cell-specific manner and possibly in a complex with Nrf2.	ATF4	ho-1	1	ACTIVATION	False
7104	7186	11290773:0:RELA:FAS	NF-kappa B [TF] (p65) is essential for TNF-alpha-induced [TG] expression but dispensable for both TCR-induced expression and activation-induced cell death.	RelA	fas	1	ACTIVATION	False
7105	7187	11306700:4:NFKB:MYC	Using transient transfection analysis, we show that the trans-activation of [TG] by vinblastine was decreased when [TF] binding sites on c-myc promoter were mutated.	NFkappaB	c-myc	1	ACTIVATION	False
7106	7188	11310828:1:NFKB:PTGS2	Nuclear factor-kappaB ([TF]) is a transcriptional regulator of inducible expression of genes including cyclooxygenase-2 ([TG]), regulating cell proliferation.	NF-kappaB	COX-2	1	ACTIVATION	False
7107	7189	11310828:17:NFKB:PTGS2	In conclusion, [TF] mediates [TG] expression, which may be related to cell proliferation, in human gastric cancer cells.	NF-kappaB	COX-2	1	ACTIVATION	False
7108	7190	11310828:4:NFKB:PTGS2	We investigated the role of [TF] in [TG] expression and cell proliferation in human gastric cancer AGS cells.	NF-kappaB	COX-2	0	UNDEFINED	False
7109	7191	11360202:7:RELA:DDIT3	Transient transfection assay revealed that the [TF] subunit but not the p50 subunit of NF-kappaB represses [TG] promoter activity.	p65	GADD153	2	REPRESSION	False
7111	7193	11385114:7:NFKB:PTGS2	Using transient transfections and assays for transcriptional activation and promoter binding, we have shown that there is constitutive activity of [TF] in amnion cells at the time of labour, and that [TG] expression depends upon NF-kappaB.	NF-kappaB	COX-2	1	ACTIVATION	False
7112	7194	11473033:10:NFKB:FAS	These results suggest a critical role for [TF] and C/EBP factors in cytokine-regulation of [TG] expression in insulin-producing cells.	NF-kappaB	Fas	0	UNDEFINED	False
7113	7195	11473033:8:NFKB:FAS	In cotransfection experiments, [TF] p65 transactivated the [TG] promoter.	NF-kappaB	Fas	1	ACTIVATION	False
7114	7196	11473033:8:RELA:FAS	In cotransfection experiments, NF-kappaB [TF] transactivated the [TG] promoter.	p65	Fas	1	ACTIVATION	False
7115	7197	11473033:9:NFKB1:FAS	[TF] p50 and C/EBPbeta overexpression had no effect by themselves on the [TG] promoter activity, but when cotransfected with p65, each factor inhibited transactivation by p65.	NF-kappaB	Fas	0	UNDEFINED	True
7116	7198	11473033:9:RELA:FAS	NF-kappaB p50 and C/EBPbeta overexpression had no effect by themselves on the [TG] promoter activity, but when cotransfected with [TF], each factor inhibited transactivation by p65.	p65	Fas	1	ACTIVATION	False
7118	7200	11544302:3:NFKB:TNFSF10	In this T cell model, as well as in primary T lymphocytes, expression of TNF-related apoptosis-inducing ligand ([TG]) apoptotic signaling protein was dramatically down-regulated by inhibition of [TF] binding activity.	NF-kappaB	TRAIL	1	ACTIVATION	False
7119	7201	11544302:9:NFKB:TNFSF10	The regulation of [TG] expression by [TF] may represent a general mechanism that contributes to the control of TRAIL-mediated apoptosis in T lymphocytes.	NF-kappaB	TRAIL	0	UNDEFINED	True
7120	7202	11554754:0:STAT1:PPARG	The identification and characterization of a [TF] binding site in the [TG]2 promoter.	STAT 1	PPARgamma	0	UNDEFINED	False
7121	7203	11554754:4:STAT1:PPARG	Supershift analysis revealed that [TF], and no other STATs present in the adipocyte nucleus, was capable of binding to this site within the [TG]2 promoter.	STAT 1	PPARgamma	0	UNDEFINED	False
7122	7204	11554754:8:STAT1:PPARG	LIF, a potent activator of STAT3 and a weak activator of [TF] in these cells, resulted in some binding to the IFNgamma responsive element in the [TG]2 promoter that was mediated by STAT 1.	STAT 1	PPARgamma	0	UNDEFINED	False
7123	7205	11568974:8:NFKB:FAS	In vitro methylation of the [TG] promoter at the rel/[TF] sites completely abolished its activity.	NFkappaB	TNFRSF6	1	ACTIVATION	False
7124	7206	11668179:8:NFKB:PTGS2	Taken together, these data identify CREB, [TF], and both C/EBP beta and -delta as key factors in coordinately orchestrating transcription from the [TG] promoter in activated macrophages.	NF-kappa B	COX-2	1	ACTIVATION	False
7125	7207	11696979:6:NFKB:PTPN13	Sequence analysis of the region upstream from the [TG] gene strongly suggests that the transcript of the FAP-1 gene may be controlled by a variety of transcriptional regulatory elements, including [TF], NF-IL6, and p53 in its 2 promoters.	NF-kappa B	FAP-1	0	UNDEFINED	False
7126	7208	11704836:6:CREB1:BRCA1	It appears that [TF] acts as a constitutive positive element for [TG] expression and that any mechanism inactivating CREB function would have a dramatic effect on BRCA1 expression.	CREB	BRCA1	1	ACTIVATION	False
7128	7210	11723253:6:NFKB:PTGS2	These results suggest that the inhibitory effect of GF-015 and GF-90 on TNF-alpha-induced [TG] protein expression was caused by suppression of IKK activity and [TF] activation in the COX-2 promoter, resulting in attenuation of COX-2 gene expression and PGE2 production.	NF-kappaB	COX-2	1	ACTIVATION	False
7129	7211	11753650:8:RELB:CDKN1A	Lastly, it is observed that [TG], a protein involved in cell cycle control and oncogenesis known to be regulated by NF-kappaB, is upregulated at the transcriptional level by [TF].	RelB	p21	1	ACTIVATION	False
7130	7212	11781356:6:STAT5B:CDKN1A	Expression of the dominant-negative form of [TF], but not of STAT5A, significantly decreased both [TG](waf) expression and the fraction of cells in G1.	STAT5B	p21	1	ACTIVATION	False
7131	7213	11853875:7:NFKB:PTGS2	Furthermore, [TG] promoter activity was significantly inhibited by the oligonucleotides (ODNs) containing the [TF] element (NF-kappaB decoy ODNs) but not by the scrambled control ODNs, as examined by the luciferase assay.	NF-kappaB	COX-2	1	ACTIVATION	False
7132	7214	11884470:8:NFKB1:NR4A2	Moreover, analyses confirm the presence of CREB-1 and [TF] p50 and p65 subunit binding to the [TG] promoter under basal conditions in freshly explanted RA synovial tissue.	NF-kappaB	NURR1	0	UNDEFINED	False
7133	7215	11884470:8:RELA:NR4A2	Moreover, analyses confirm the presence of CREB-1 and NF-kappaB p50 and [TF] subunit binding to the [TG] promoter under basal conditions in freshly explanted RA synovial tissue.	p65	NURR1	0	UNDEFINED	False
7134	7216	11884470:9:NFKB:NR4A2	In summary, enhanced [TF]- and CREB-1-binding activity on the [TG] promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription.	NF-kappaB	NURR1	0	UNDEFINED	True
7135	7217	11884528:5:RELA:HES1	We have now demonstrated that the increase in [TF]-NFkappaB protein levels enhances Notch-mediated activation of the [TG] promoter up to three-fold.	p65	Hes1	1	ACTIVATION	False
7136	7218	11884528:7:RELA:HES1	Furthermore, we show that [TF]-NFkappaB can modulate subcellular localization of the transcriptional corepressor N-CoR, abrogating N-CoR mediated repression of the [TG] promoter.	p65	Hes1	1	ACTIVATION	True
7137	7219	11901151:3:ATF2:PTGS2	The inductive effects of HER-2/neu were mediated, in part, by enhanced binding of AP-1 (c-Jun, c-Fos, and [TF]) to the cyclic AMP-response element (-59/-53) of the [TG] promoter.	ATF-2	COX-2	0	UNDEFINED	False
7138	7220	11923478:10:STAT3:AGT	Taken together, our results indicate that IL-6-inducible expression of the h[TG] promoter is mediated by physical association of the COOH terminus of [TF] with p300/CBP, the recruitment of which targets histone acetylation and results in chromatin remodeling.	STAT3	AGT	1	ACTIVATION	False
7139	7221	11928721:9:NFKB:EDN1	The reduction of [TF] activation may be involved in the mechanisms for suppressive effects of proteasome inhibitors on [TG] gene transcription and the consequent decrease in ET-1 mRNA expression and ET-1 release.	NF-kappaB	ET-1	1	ACTIVATION	False
7140	7222	11960987:0:ATF4:ASNS	[TF] is a mediator of the nutrient-sensing response pathway that activates the human [TG] gene.	ATF4	asparagine synthetase	1	ACTIVATION	False
7141	7223	12055073:0:NFKB:ELN	[TF] induced by IL-1beta inhibits [TG] transcription and myofibroblast phenotype.	NF-kappaB	elastin	2	REPRESSION	False
7142	7224	12055073:6:RELA:ELN	Overexpression of [TF] decreased [TG] promoter activity and markedly reduced elastin mRNA.	p65	elastin	2	REPRESSION	False
7143	7225	12086396:9:NFKB:PTGS2	A [TF] decoy approach (oligonucleotides directed against NF-kappaB) or transfection of a dominant-negative c-Jun mutant (TAM67) abrogated not only the [TG] expression but also the inducible protection.	NF-kappaB	COX-2	1	ACTIVATION	False
7144	7226	12086398:2:NFKB:PTGS2	We studied the role of [TF] on expression of [TG] in H. pylori-stimulated gastric cancer cell lines by using antioxidants, glutathione (GSH), and N-acetylcysteine (NAC) as well as an NF-kappaB inhibitor, pyrrolidine dithiocarbamate (PDTC).	NF-kappaB	COX-2	0	UNDEFINED	False
7145	7227	12086398:8:NFKB:PTGS2	In conclusion, oxidant-sensitive transcription factor [TF] may play a novel role in expression of [TG] by H. pylori stimulation in gastric cancer cells.	NF-kappaB	COX-2	0	UNDEFINED	True
7146	7228	12147685:9:STAT3:CCND1	Furthermore, [TF]-C, a constitutively active form of STAT3, suppressed transcription of the [TG] promoter in fetal hepatocytes, whereas it activated the transcription in hepatic tumor cells, huH7 and HepG2.	STAT3	cyclin D1	2	REPRESSION	False
7147	7229	12162804:3:NFKB:GADD45B	Recently, we have shown that the suppression of the c-Jun-N-terminal kinase (JNK) cascade is a pivotal protective mechanism by [TF], and that this suppression involves the upregulation of gadd45beta/[TG].	NF-kappaB	myd118	1	ACTIVATION	False
7148	7230	12162804:6:RELA:GADD45B	Activation of [TG] by [TF] depends on three kappaB elements at positions -447/-438 (kappaB-1), -426/-417 (kappaB-2), and -377/-368 (kappaB-3) of the gadd45beta promoter.	RelA	gadd45beta	1	ACTIVATION	False
7149	7231	12208876:7:NFKB:STAT5A	Intriguingly, [TF] positively regulates [TG] expression and signaling pathways in HRS cells, and promotes its persistent activation.	NF-kappaB	STAT5a	1	ACTIVATION	False
7150	7232	12210742:7:NFKB:MUC1	Specific mutation of the kappaB site prevented binding of [TF] p65 and blocked TNF-alpha stimulation of [TG] promoter activity.	NFkappaB	MUC1	1	ACTIVATION	False
7151	7233	12210742:7:RELA:MUC1	Specific mutation of the kappaB site prevented binding of NFkappaB [TF] and blocked TNF-alpha stimulation of [TG] promoter activity.	p65	MUC1	1	ACTIVATION	False
7152	7234	12215258:6:ATF2:CEBPB	Cotransfection experiments showed that [TF] and c-Jun activate the [TG] gene expression cooperatively through URE2 and URE4, and this activation was greatly increased under the treatment of low concentration of anisomycin.	ATF2	C/EBPbeta	1	ACTIVATION	False
7153	7235	12223449:10:NFKB:EPO	Thus, both GATA-2 and [TF] seem to be involved in the suppression of [TG] gene expression by IL-1beta and TNF-alpha in vitro and may be responsible for impaired Epo synthesis in inflammatory diseases in vivo.	NF-kappaB	Epo	2	REPRESSION	False
7154	7236	12223449:5:NFKB:EPO	Herein, we investigated the roles of the transcription factors GATA-2 and [TF] in the modulation of [TG] gene expression by IL-1beta and TNF-alpha in the human hepatoma cell line HepG2.	NF-kappaB	Epo	0	UNDEFINED	False
7155	7237	12235180:7:CREB1:LDLR	We show that overexpression of Egr1 significantly increases [TG] promoter activity when cotransfected with CCAAT/enhancer binding protein beta (c/EBPbeta) or with cAMP-responsive element binding protein ([TF]) expression vectors.	CREB	LDLR	1	ACTIVATION	False
7156	7238	12239103:1:STAT1:POMC	To better understand how leukemia inhibitory factor (LIF) activates [TG] (POMC) gene transcription in pituitary corticotrophs, time-course studies of the induction of POMC promoter activity and specific tyrosine phosphorylation of [TF] (STAT1) and STAT3 were performed.	signal transducer and activator of transcription 1	proopiomelanocortin	1	ACTIVATION	True
7157	7239	12239103:1:STAT3:POMC	To better understand how leukemia inhibitory factor (LIF) activates [TG] (POMC) gene transcription in pituitary corticotrophs, time-course studies of the induction of POMC promoter activity and specific tyrosine phosphorylation of signal transducer and activator of transcription 1 (STAT1) and [TF] were performed.	STAT3	proopiomelanocortin	0	UNDEFINED	False
7158	7240	12239103:5:STAT1:POMC	Degenerated [TF]/3-binding sites from the [TG] promoter were tested for their ability to bind activated STAT1 and 3; only the -390/-379 site, partially overlapping the Nur response element, binds with low affinity activated STAT1 and -3.	STAT1	POMC	0	UNDEFINED	False
7159	7241	12360408:3:REL:IER3	Utilizing an electrophoretic mobility shift assay (EMSA) and a promoter/reporter assay, we show that the NF-kappaB/[TF] consensus sequence in the [TG] promoter is specifically bound and activated by multiple NF-kappaB/rel complexes in descending order p65-c-rel-->p65-50-->p50-50.	rel	IEX-1	1	ACTIVATION	False
7160	7242	12360408:4:REL:IER3	Interestingly, NF-kappaB/[TF]-mediated activation of [TG] expression was synergized by p53, but strongly inhibited by c-Myc in a dose-dependent fashion.	rel	IEX-1	1	ACTIVATION	False
7161	7243	12360408:6:REL:IER3	In support of coordinated regulation of [TG] expression by these three transcription factors in vivo, binding of endogenous p53, c-Myc and NF-kappaB/[TF] proteins, including p50, p65 and c-rel, to the IEX-1 promoter was demonstrated in living cells by chromatin immunoprecipitation using specific antibodies.	rel	IEX-1	0	UNDEFINED	False
7163	7245	12360479:12:RELA:CDX2	[TF] inhibits the activity of the [TG] promoter, whereas p50 prevents p65 action.	p65	Cdx-2	2	REPRESSION	False
7165	7247	12391146:5:CREB1:CCND1	Gel retardation and chromatin immunoprecipitation assays confirm that POU forms a complex with [TF] bound to the [TG] CRE.	CREB	cyclin D1	0	UNDEFINED	False
7166	7248	12466023:11:NFKB:PTGS2	[TF] regulates neuronal [TG] gene expression, and acts as an upstream target of Aspirin.	NF-kappaB	COX-2	0	UNDEFINED	True
7167	7249	12466023:7:NFKB1:PTGS2	Transient transfections showed a significant increase of [TG] promoter activity upon stimulation with PMA, an effect which could be obtained also by cotransfection of the [TF] subunits p65 and p50.	NF-kappaB	COX-2	1	ACTIVATION	False
7168	7250	12466023:7:RELA:PTGS2	Transient transfections showed a significant increase of [TG] promoter activity upon stimulation with PMA, an effect which could be obtained also by cotransfection of the NF-kappaB subunits [TF] and p50.	p65	COX-2	1	ACTIVATION	False
7169	7251	12504100:4:CREB1:CCND1	One was mapped to a cAMP-responsive element (CRE) at position -41bp and was occupied by a CRE-binding protein ([TF]), resulting in [TG] expression.	CREB	cyclin D1	1	ACTIVATION	False
7170	7252	12504100:7:CREB1:CCND1	These results indicate that [TF] binds to the CRE and mediates activation of the [TG] promoter, and suggest that CD1E0.7 may be possibly occupied by a protein induced by growth factors in hepatocytes.	CREB	cyclin D1	1	ACTIVATION	False
7171	7253	12527906:8:ATF1:SH3RF1	Correspondingly, EWS/[TF] expression decreased endogenous [TG] expression, suggesting that six isolated genes may be involved in direct regulation by EWS/ATF-1.	ATF-1	POSH	2	REPRESSION	False
7172	7254	12590942:0:STAT3:NPY	Leptin-induced transactivation of [TG] gene promoter mediated by JAK1, JAK2 and [TF] in the neural cell lines.	STAT3	NPY	1	ACTIVATION	False
7173	7255	12590942:6:STAT3:NPY	The leptin-response element which confers [TG] gene transactivation by leptin was determined in the 221-bp region of rat NPY gene promoter (-553/-335), where two [TF]-binding site-like elements (TCCAGTA) exist.	STAT3	NPY	1	ACTIVATION	True
7174	7256	12590942:7:STAT3:NPY	These results indicated that activation of JAK1, JAK2 and [TF] is necessary for leptin-induced transactivation of [TG] gene through the leptin-response element in these neural cells.	STAT3	NPY	1	ACTIVATION	False
7175	7257	12594338:2:NFKB:TACR1	Because IL-1 beta function involves nuclear factor kappa B ([TF]) activation, these data suggest that this increase in the expression of the [TG] gene is mediated by the NF-kappa B transcription factor.	NF-kappa B	NK-1R	1	ACTIVATION	False
7177	7259	12594338:5:NFKB:TACR1	To further substantiate that the observed [TF]-dependent IL-1 beta induction of the human [TG] gene is regulated via a transcriptional event through this NF-kappa B site on the NK-1R gene promoter, we transfected THP-1 cells with a luciferase promoter-reporter construct containing the 5' promoter region of the human NK-1R gene.	NF-kappa B	NK-1R	1	ACTIVATION	False
7178	7260	12594338:7:NFKB:TACR1	These results directly implicate [TF] in the regulation of the [TG] gene and provide a molecular mechanism for the increase in expression of the NK-1R gene in responsive cells.	NF-kappa B	NK-1R	1	ACTIVATION	False
7179	7261	12658356:12:CREB1:PCNA	Because the [TG] gene has a cAMP-responsive element in its promoter, it can be suggested that [TF] may activate the PCNA gene and lead to the induction of hepatocyte DNA synthesis.	CREB	PCNA	1	ACTIVATION	False
7180	7262	12675842:14:NFKB:SERPINE1	Both antioxidant and [TF] inhibitors dose dependently inhibited the activation of [TG] promoter by indoxyl sulfate.	NF-kappaB	PAI-1	1	ACTIVATION	False
7181	7263	12675842:15:NFKB:SERPINE1	Uremic toxins induce free radical production by renal tubular cells and activate [TF] which, in turn, up-regulates [TG] expression.	NF-kappaB	PAI-1	1	ACTIVATION	False
7182	7264	12695520:7:NFKB:PTGS2	Conclusively, these results demonstrate that endosomal DNA processing and TLR9/MyD88-dependent activation of [TF] and p38 are required for transcriptional regulation of [TG] expression induced by CpG DNA, and suggest that interleukin-1 receptor-associated kinase and/or TRAF6 may be a diverging point for NF-kappaB activation in response to CpG DNA in RAW264.7 cells.	NF-kappaB	Cox-2	0	UNDEFINED	False
7183	7265	12697721:0:STAT3:POMC	Role of [TF] in regulation of hypothalamic [TG] gene expression by leptin.	signal transducer and activator of transcription 3	proopiomelanocortin	0	UNDEFINED	False
7184	7266	12700414:7:NFKB:GZMB	Taken together, these results suggest that [TF] and AP-1 are important regulators of NK cell cytolytic function through regulation of perforin, granzyme A, and [TG] gene expression.	NFkappaB	granzyme B	0	UNDEFINED	False
7185	7267	12734344:7:NFKB:TACR1	Inhibition of T cell [TF] activation or NF-kappa B nuclear translocation also blocked [TG] transcription.	NF-kappa B	NK-1R	1	ACTIVATION	False
7186	7268	12759391:4:NFKB:CCND1	Cyclin D1 promoter activity was measured in LPA-treated OVCAR-3 cells cotransfected with [TG] promoter-driven luciferase constructs and cDNA expression plasmids for IkappaBalphaM (a nuclear factor kappaB [[TF]] super-repressor).	NFkappaB	cyclin D1	2	REPRESSION	True
7187	7269	12759391:8:NFKB:CCND1	Mutation of the [TF]-binding site in the [TG] promoter to block NFkappaB binding and expression of IkappaBalphaM, which binds NFkappaB and inhibits its binding to the promoter, markedly diminished LPA stimulation of cyclin D1 promoter activity (activity stimulated only 1.4-fold, 95% CI = 1.1-fold to 1.7-fold, and 0.7-fold, 95% CI = 0.6-fold to 0.8-fold, respectively).	NFkappaB	cyclin D1	1	ACTIVATION	False
7188	7270	12771929:9:NFKB:PTGS2	Our results are compatible with the hypothesis that IKK alpha and [TF] are involved in [TG] induction in these tumours and the lack of association between COX-2 expression and severity of disease as measured by Dukes' stage is consistent with the proposal that COX-2 expression is an early postinitiation event.	NF-kappa B	COX-2	1	ACTIVATION	False
7189	7271	12783888:0:NFKB:MYC	Regulation of [TG] gene by nitric oxide via inactivating [TF] complex in P19 mouse embryonal carcinoma cells.	NF-kappa B	c-myc	0	UNDEFINED	False
7190	7272	12783888:3:NFKB:MYC	SNP treatment reduces the DNA binding ability of the constitutively active [TF] heterodimer, p65/p50, and its consequent transactivation of the [TG] promoter.	NF-kappa B	c-myc	1	ACTIVATION	False
7191	7274	12783888:3:RELA:MYC	SNP treatment reduces the DNA binding ability of the constitutively active NF-kappa B heterodimer, [TF]/p50, and its consequent transactivation of the [TG] promoter.	p65	c-myc	1	ACTIVATION	False
7192	7275	12783888:7:NFKB1:MYC	Chromatin immunoprecipitation analysis of SNP-treated P19 cells reveals reduced association of p65, but not of [TF], with the promoter region of the endogenous [TG] gene.	p50	c-myc	0	UNDEFINED	False
7193	7276	12783888:7:RELA:MYC	Chromatin immunoprecipitation analysis of SNP-treated P19 cells reveals reduced association of [TF], but not of p50, with the promoter region of the endogenous [TG] gene.	p65	c-myc	0	UNDEFINED	False
7194	7277	12783888:8:RELA:MYC	SNP-induced [TF] dissociation was associated with the recruitment of histone deacetylase 1 and 2 to the endogenous [TG] gene promoter and the subsequent deacetylation of its chromatin histone.	p65	c-myc	0	UNDEFINED	False
7195	7278	12808109:0:NFKB:CCND1	p53 represses [TG] transcription through down regulation of Bcl-3 and inducing increased association of the p52 [TF] subunit with histone deacetylase 1.	NF-kappaB	cyclin D1	2	REPRESSION	True
7196	7279	12808109:0:NFKB2:CCND1	p53 represses [TG] transcription through down regulation of Bcl-3 and inducing increased association of the [TF] NF-kappaB subunit with histone deacetylase 1.	p52	cyclin D1	2	REPRESSION	True
7197	7281	12808109:8:NFKB2:CCND1	p53 therefore induces a transcriptional switch in which [TF]/Bcl-3 activator complexes are replaced by p52/HDAC1 repressor complexes, resulting in active repression of [TG] transcription.	p52	cyclin D1	2	REPRESSION	True
7198	7282	12809676:10:NFKB:PRKCD	This TNF-alpha-mediated upregulation of [TG] is repressed in keratinocytes that are preinfected with IkappaB superrepressor adenovirus, suggesting that [TF] is involved directly in PKC-delta expression.	NFkappaB	PKC-delta	1	ACTIVATION	False
7199	7283	12813034:7:NFKB:FAS	In addition, [TF] downstream of TNFR was required for up-regulation of [TG] expression by endogenous TNF secreted in response to TCR stimulation.	NF kappa B	Fas	1	ACTIVATION	False
7200	7284	12832543:6:ATF3:HSPB1	Immunoprecipitation analysis and promoter assay for [TG] expression suggest that both [TF] and c-Jun are necessary for transcriptional activation of Hsp27.	ATF3	Hsp27	1	ACTIVATION	False
7201	7285	12832543:9:ATF3:HSPB1	Our results suggest that [TF]- and c-Jun-induced [TG] expression is a novel survival response in neurons under death stress such as nerve injury.	ATF3	Hsp27	1	ACTIVATION	False
7202	7286	12835724:0:NFKB2:BCL2	[TF]/p100 induces [TG] expression.	NF- kappa B2	Bcl-2	1	ACTIVATION	False
7203	7287	12835724:6:NFKB2:BCL2	As p50 and [TF] homodimers are devoid of any transactivating domains, we showed that they can transactivate the [TG] promoter through association with Bcl-3.	p52	bcl-2	1	ACTIVATION	False
7204	7288	12835724:7:NFKB2:BCL2	We also observed that stable overexpression of p100 and its processed product [TF] can induce endogenous [TG] expression in MCF7AZ breast cancer cells.	p52	Bcl-2	1	ACTIVATION	False
7205	7289	12855710:6:NFKB:TRPC1	To address the contribution of [TF] in the mechanism of [TG] expression, we determined the effects of TNF-alpha on expression of the reporter luciferase after transfection of hTRPC1 promoter-luciferase (hTRPC1-Pro-Luc) construct in the human dermal microvascular endothelial cell line.	NF-kappaB	TRPC1	0	UNDEFINED	False
7206	7290	12859951:3:RELA:S100A6	Transient expression of NF-kappaB ([TF]) increased [TG] promoter activity and expression of inhibitor of NF-kappaB (IkappaBalpha) decreased TNFalpha-induced S100A6 promoter activity.	p65	S100A6	1	ACTIVATION	False
7207	7291	12859963:0:STAT1:LPL	[TF] binds to the [TG] promoter in vitro.	STAT 1	LPL	0	UNDEFINED	False
7209	7293	12871860:0:NFKB:PTGS2	p38 MAPK and [TF] mediate [TG] expression in human airway myocytes.	NF-kappaB	COX-2	1	ACTIVATION	False
7210	7294	12871860:7:NFKB:PTGS2	These findings suggest that although p38 MAPK and [TF] signaling regulate steady-state levels of [TG] expression, p38 MAPK additionally affects stability of COX-2 mRNA in cytokine-stimulated human airway myocytes.	NF-kappaB	COX-2	0	UNDEFINED	False
7211	7295	12871976:8:ATF1:HSPA5	ER stress induces CREB1 phosphorylation and [TF]/CREB1 binding to the [TG] promoter.	ATF1	Grp78	0	UNDEFINED	False
7212	7296	12881527:8:ATF3:ASNS	Collectively, the results provide evidence for a potential role of multiple predicted [TF] isoforms in the transcriptional regulation of the [TG] gene in response to nutrient deprivation.	ATF3	ASNS	0	UNDEFINED	False
7213	7297	12960330:9:NFKB:PTGS2	Transient transfection of [TF] promoter construct and dominant negative plasmid of IkappaBbeta kinase showed that [TG] transcription is mediated through p38(MAPK) and NF-kappaB pathways.	NF-kappaB	COX-2	1	ACTIVATION	False
7214	7298	10426567:2:PDX1:INS	In this study, we tried to elucidate the role of [TF] in the glucose-induced transcriptional activation of the human [TG] gene promoter in MIN6 cells.	PDX-1	insulin	1	ACTIVATION	False
7215	7299	10506141:8:PAX6:GCG	Further, we found that the presence of cdx-2 enhanced the interaction of [TF] with p300, thus establishing a molecular complex of transcription factors implicated in tissue-specific [TG] gene expression with the basal transcriptional machinery.	pax-6	glucagon	1	ACTIVATION	False
7216	7300	10671224:5:NFKB:FASLG	We show that both elements bind to [TF] and SP-1 transcription factors and NF-kappaB is involved in transactivation of the [TG] promoter upon T cell activation.	NF-kappaB	CD95L	1	ACTIVATION	False
7217	7301	10708950:5:SMAD3:TGFB1	In contrast, [TG] autoinduction is [TF]-dependent, as DN Smad3 inhibits the ability of TGFbeta to stimulate TGFbeta(1) promoter activity.	Smad3	TGFbeta	1	ACTIVATION	False
7218	7302	10713700:0:AP1:HGF	Transcriptional activation of the [TG] receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through [TF].	AP-1	hepatocyte growth factor	1	ACTIVATION	False
7219	7303	10733528:4:CLOCK:DBP	Genetic and biochemical experiments suggest that [TF] regulates [TG] expression by binding to E-box motifs within putative enhancer regions located in the first and second introns.	CLOCK	Dbp	0	UNDEFINED	True
7220	7304	10733944:3:SP1:CDKN1A	After analysis of a series of deletion and point mutants of [TG] promoter, we found that [TF]-3 site (-77 and -83) relative to the transcription start site played an important role for c-jun-repressing-responsive element in the p21 promoter.	Sp1	p21	0	UNDEFINED	False
7221	7305	10733944:5:SP1:CDKN1A	However, the data from electrophoretic mobility shift assay indicated that c-jun did not change the [TF] DNA-binding affinity, suggesting that additional factors may be involved in the repression of [TG] by c-jun.	Sp1	p21	2	REPRESSION	True
7222	7306	10733944:6:SP1:CDKN1A	Furthermore, c-jun could inhibit butyrate-inducing [TG] gene expression through [TF], indicating at least one common pathway whereby p21 expression is affected by c-jun and butyrate in opposing actions.	Sp1	p21	2	REPRESSION	False
7223	7307	10733944:7:SP1:CDKN1A	Moreover, the hyperphosphorylated retinoblastoma protein (Rb) increased in c-jun expressing cells, indicating that phosphorylated Rb may play a role in regulating [TF] to repress [TG] expression.	Sp1	p21	2	REPRESSION	False
7224	7308	10744679:0:AP1:FASLG	Regulation of [TG] by NF-kappaB and [TF] in Fas-dependent thymineless death of human colon carcinoma cells.	AP-1	FasL	0	UNDEFINED	True
7225	7309	10744679:5:AP1:FASLG	These results demonstrate the crucial roles for NF-kappaB and [TF] in the regulation of [TG] in Fas-mediated thymineless death of colon carcinoma cells.	AP-1	FasL	0	UNDEFINED	False
7226	7310	10748140:7:FOXM1:SLC2A2	We identified that both HNF1 and [TF] function as transcriptional activators in [TG] gene expression.	HNF3	GLUT2	1	ACTIVATION	False
7227	7311	10749849:1:TP53:CDKN1A	An important mechanism by which the tumor suppressor [TF] maintains genomic stability is to induce cell cycle arrest through activation of the cyclin-dependent kinase inhibitor p21([TG]/Cip1) gene.	p53	WAF1	1	ACTIVATION	False
7228	7312	10749849:3:TP53:CDKN1A	The increases in expression of both Gklf and p21([TG]/Cip1) due to DNA damage are dependent on [TF].	p53	WAF1	1	ACTIVATION	False
7229	7313	10749849:5:KLF4:CDKN1A	Indeed, [TF] activates p21([TG]/Cip1) through a specific Sp1-like cis-element in the p21(WAF1/Cip1) proximal promoter.	GKLF	WAF1	1	ACTIVATION	False
7230	7314	10749849:6:TP53:CDKN1A	The same element is also required by [TF] to activate the p21([TG]/Cip1) promoter, although p53 does not bind to it.	p53	WAF1	1	ACTIVATION	False
7231	7315	10749849:7:KLF4:CDKN1A	Potential mechanisms by which p53 activates the p21([TG]/Cip1) promoter include a physical interaction between p53 and GKLF and the transcriptional induction of [TF] by p53.	Gklf	WAF1	1	ACTIVATION	False
7232	7316	10749849:7:TP53:CDKN1A	Potential mechanisms by which [TF] activates the p21([TG]/Cip1) promoter include a physical interaction between p53 and GKLF and the transcriptional induction of Gklf by p53.	p53	WAF1	1	ACTIVATION	False
7233	7317	10753197:12:TP53:CDKN1A	To determine whether [TF] was transcriptionally active, we also performed gel mobility shift assays and transient transfection studies using a luciferase plasmid under the control of the p21/[TG] promoter.	p53	waf1	1	ACTIVATION	False
7234	7318	10753873:5:AP1:FGFBP1	This induction was mediated transcriptionally through the [TF] (c-Fos/JunD) and CCAAT/enhancer-binding protein elements as well as through an E-box repressor site in the proximal regulatory region of the [TG] promoter.	AP-1	FGF-BP	1	ACTIVATION	False
7235	7321	10753945:3:TP53:MMP13	Here, we report that cotransfection of fibroblast-like synoviocytes with [TF] expression and h[TG]CAT reporter plasmids revealed that (i) hMMP13, another member of the human MMP family, was down-regulated by wild type p53, whereas all six of the p53 mutants tested lost the wild type p53 repressor activity in fibroblast-like synoviocytes; (ii) this repression of hMMP-13 gene expression by wild type p53 could be reversed by overexpression of p53 mutants p53-143A, p53-248W, p53-273H, and p53-281G; (iii) the dominant effect of p53 mutants over wild type p53 appears to be a promoter- and mutant-specific effect.	p53	MMP13	2	REPRESSION	False
7236	7322	10753945:4:TP53:MMP13	An intriguing finding was that [TF] mutant p53-281G could conversely stimulate the promoter activity of h[TG] up to 2-4-fold and that it was dominant over wild type p53.	p53	MMP13	2	REPRESSION	False
7238	7324	10762614:0:SP1:SLC5A1	Regulation of the human Na(+)-glucose cotransporter gene, [TG], by HNF-1 and [TF].	Sp1	SGLT1	0	UNDEFINED	False
7239	7325	10770922:8:MITF:TBX2	First, isolation and sequencing of the entire murine [TG] gene revealed that the Tbx2 promoter contains a full consensus [TF] recognition element; second, Mitf could bind the promoter in vitro and activate Tbx2 expression in vivo in an E box-dependent fashion; and third, Tbx2 is expressed in melanoma cell lines expressing Mitf, but not in a line in which Mitf expression was not detectable.	Mitf	Tbx2	1	ACTIVATION	False
7240	7326	10770922:9:MITF:TBX2	Taken together, with the fact that [TG] is expressed in [TF]-positive melanoblasts and melanocytes, but not in Mitf-negative melanoblast precursor cells, the evidence suggests that the Tbx2 gene may represent one of the first known targets for Mitf that is not a gene involved directly in the manufacture of pigment.	Mitf	Tbx2	1	ACTIVATION	False
7241	7327	10772826:5:AP1:NR4A1	Among the two potential trans-acting factors that activate [TG] gene promoter, i.e., [TF] and related serum response factor (RSRF), all-trans-RA repressed DNA binding and reporter gene activity of AP-1 but not that of RSRF, suggesting that the inhibition may be mediated through AP-1.	AP-1	Nur77	1	ACTIVATION	False
7242	7328	10772826:5:SRF:NR4A1	Among the two potential trans-acting factors that activate [TG] gene promoter, i.e., AP-1 and related [TF] (RSRF), all-trans-RA repressed DNA binding and reporter gene activity of AP-1 but not that of RSRF, suggesting that the inhibition may be mediated through AP-1.	serum response factor	Nur77	1	ACTIVATION	False
7243	7329	10783396:10:EGR1:SERPINE1	These results suggest that [TF] may regulate cell interaction with the extracellular matrix by coordinated induction of TGF-beta1, FN, and [TG] in human glioblastoma cells.	EGR-1	PAI-1	1	ACTIVATION	False
7244	7330	10787423:10:YY1:PTPRA	Thus, [TG] expression is negatively regulated by p53 in normal conditions and in conditions where p53 is up-regulated, via an as yet unknown mechanism involving the negative control of [TF].	YY1	PTPA	2	REPRESSION	False
7245	7331	10790372:0:JUN:CCND1	Cell cycle-dependent variations in c-[TF] and JunB phosphorylation: a role in the control of [TG] expression.	Jun	cyclin D1	0	UNDEFINED	False
7246	7332	10790372:0:JUNB:CCND1	Cell cycle-dependent variations in c-Jun and [TF] phosphorylation: a role in the control of [TG] expression.	JunB	cyclin D1	0	UNDEFINED	False
7247	7336	10792001:4:TP53:CDKN1A	In the transfected cell line (LVCaP), the wild-type [TF] produced growth arrest at the G1/S interface of the cell cycle, inhibited colony formation, and induced p21([TG]/cip1).	p53	waf1	1	ACTIVATION	False
7248	7337	10799578:7:TP53:CDKN1A	We find that loss of the G(1)/S checkpoint in HIV-1-infected cells may in part be due to Tat's ability to bind [TF] (a known activator of the p21/[TG] promoter) and sequester its transactivation activity, as seen in both in vivo and in vitro transcription assays.	p53	Waf1	1	ACTIVATION	False
7249	7338	10807873:7:AP1:MMP12	Phorbol 12-myristate 13-acetate (PMA) and insulin, 2 known activators of [TF], increased the binding of AP-1 to the [TG] promoter, with higher affinity for the A allele.	AP-1	MMP-12	0	UNDEFINED	False
7250	7341	10811113:2:AP1:FASLG	The induction of the CD95/[TG] pathway can be activated by the activator protein-1 ([TF])-mediated up-regulation of the CD95L promoter, which is responsible for the induction of apoptosis elicited by stimuli such as etoposide.	AP-1	CD95L	1	ACTIVATION	False
7251	7342	10811113:5:AP1:FASLG	Cell death was accompanied by an increase in DNA-binding activity of the transcription factor [TF], transactivation of the AP-1 site-containing [TG] promoter, and caspase 3-like protease activation.	AP-1	CD95L	1	ACTIVATION	False
7252	7343	10811113:8:AP1:FASLG	In conclusion, our data demonstrate that NO can modulate cell death at an upstream level, by interfering with the ability of [TF] to induce [TG] expression.	AP-1	CD95L	1	ACTIVATION	False
7253	7344	10816575:4:SP1:VEGFA	Protein-DNA binding studies using electrophoretic mobility shift and DNA footprinting assays showed that both [TF] and Sp3 proteins bound this region of the [TG] promoter.	Sp1	VEGF	0	UNDEFINED	False
7254	7345	10816575:4:SP3:VEGFA	Protein-DNA binding studies using electrophoretic mobility shift and DNA footprinting assays showed that both Sp1 and [TF] proteins bound this region of the [TG] promoter.	Sp3	VEGF	0	UNDEFINED	False
7255	7346	10825178:6:SP1:PTGS2	Electrophoretic mobility shift assays with hypoxic HUVEC nuclear protein showed that both [TF] and the related protein Sp3 specifically bound to the [TG] promoter.	Sp1	cox-2	0	UNDEFINED	False
7256	7347	10825178:6:SP3:PTGS2	Electrophoretic mobility shift assays with hypoxic HUVEC nuclear protein showed that both Sp1 and the related protein [TF] specifically bound to the [TG] promoter.	Sp3	cox-2	0	UNDEFINED	False
7257	7348	10825178:8:SP1:PTGS2	Overexpression of [TF] through transfection of HUVEC enhanced [TG] promoter activity as measured by reporter gene expression and by the production of COX-2.	Sp1	cox-2	1	ACTIVATION	False
7258	7349	10825208:6:ONECUT1:NEUROG3	Consistent with this, we demonstrated that [TF] binds to and stimulates the [TG] gene promoter.	HNF-6	ngn3	1	ACTIVATION	False
7259	7350	10837481:1:HIF1A:VEGFA	Hypoxia-inducible factor-1 ([TF]) controls the expression of a number of genes such as vascular endothelial growth factor ([TG]) and Erythropoietin in low oxygen conditions (hypoxia).	HIF-1	VEGF	0	UNDEFINED	False
7260	7351	10837481:9:HIF1A:VEGFA	These results implicate [TF] and HIF-1-dependent transcriptional activity in the induction of [TG] expression after agonist stimulation and define novel hypoxia-independent mechanisms that should play a major role in vascular remodeling.	HIF-1alpha	VEGF	1	ACTIVATION	False
7261	7352	10841183:10:CEBPB:PTGS2	Overexpression of p20[TF], a dominant negative inhibitor of C/EBP function, blocked the stimulation of [TG] promoter activity by IL-1 and blocked the ability of overexpressed C/EBPbeta and C/EBPdelta to increase basal and IL-1-stimulated promoter activity.	C/EBPbeta	PGHS-2	1	ACTIVATION	False
7262	7353	10841183:12:CEBPB:PTGS2	These results suggest an essential role for [TF] and C/EBPdelta in the induction of [TG] gene expression by IL-1 in osteoblastic cells.	C/EBPbeta	PGHS-2	1	ACTIVATION	False
7264	7355	10848603:4:ARNTL:DBP	On the other hand, [TG] transcription is activated by CLOCK-[TF] through E-boxes and inhibited by the mPER and mCRY proteins, as is the case for mPer1.	BMAL1	dbp	1	ACTIVATION	False
7265	7356	10848603:4:CLOCK:DBP	On the other hand, [TG] transcription is activated by [TF]-BMAL1 through E-boxes and inhibited by the mPER and mCRY proteins, as is the case for mPer1.	CLOCK	dbp	1	ACTIVATION	False
7266	7357	10849427:8:ETS2:FGF1	Further, the transcription factor [TF] synergistically activated [TG] gene, but not FGF2, in a Ras- and Rac1-dependent signaling pathway.	Ets2	FGF1	1	ACTIVATION	False
7267	7358	10851080:7:USF1:HGF	[TF], but not USF2, of the USF family stimulated [TG] gene promoter activity.	USF1	HGF	1	ACTIVATION	False
7268	7359	10856300:3:ATF6:HSPA5	[TF] has been implicated in the endoplasmic reticulum (ER) stress response pathway since it can activate expression of [TG] and other genes induced by the ER stress response.	ATF6	GRP78	1	ACTIVATION	False
7269	7360	10865841:6:EGR1:KLF5	Functional studies using 5'-deletion and site-directed mutation constructs demonstrated that phorbol ester induces [TF], which can activate the [TG] promoter through binding to -32 from the transcription start site.	Egr-1	BTEB2	1	ACTIVATION	False
7270	7361	10871606:2:AP1:FGFBP1	12-O-Tetradecanoylphorbol-13-acetate (TPA) induction of the [TG] gene occurs through transcriptional mechanisms involving Sp1, [TF], and CCAATT/enhancer-binding protein sites in the proximal FGF-BP gene promoter.	AP-1	FGF-BP	1	ACTIVATION	False
7271	7362	10878024:0:SP1:CDKN1A	Role of Smad proteins and transcription factor [TF] in p21([TG]/Cip1) regulation by transforming growth factor-beta.	Sp1	Waf1	0	UNDEFINED	False
7272	7363	10878024:2:SP1:CDKN1A	Previously we have reported that the intracellular effectors of TGF-beta, Smad3 and Smad4, functionally cooperate with [TF] to activate the human [TG] promoter in hepatoma HepG2 cells.	Sp1	p21	1	ACTIVATION	False
7273	7364	10882074:1:FUBP1:MYC	FUSE-binding protein ([TF]) binds the single-stranded far upstream element of active [TG] genes, possesses potent transcription activation and repression domains, and is necessary for c-myc expression.	FBP	c-myc	1	ACTIVATION	False
7274	7365	10882714:5:HIF1A:VEGFA	However, transient transfection with a luciferase reporter gene that was transcriptionally regulated by the [TG] promoter revealed a significant defect in VEGF up-regulation following hypoxia in old versus young cells (a 43 versus 117% increase in luciferase activity, p < 0.05); this difference was not seen when a deletion construct lacking the hypoxia-inducible 1 ([TF]) binding site was used.	HIF-1	VEGF	1	ACTIVATION	True
7275	7366	10885623:9:AP1:VEGFA	These results suggest that ERK1/2 pathway is involved in the up-regulation of [TG] expression ionizing radiation mediated by [TF], which may lead to further neovascularization and proliferation of glioblastoma cells resistant to radiation therapy.	AP-1	VEGF	1	ACTIVATION	False
7276	7367	10890879:10:NR1H3:MYC	In parallel experiments, we demonstrated that [TF] can also bind to the homologous CNRE in the [TG] promoter.	LXRalpha	c-myc	0	UNDEFINED	False
7277	7368	10899165:13:ZNF148:CDKN1A	Cotransfection of p300 with [TF] stimulated the p21([TG] promoter in the absence of butyrate.	ZBP-89	waf1)	1	ACTIVATION	False
7278	7369	10899165:6:ZNF148:CDKN1A	Adenoviral-mediated expression of [TF] in HT-29 cells revealed that ZBP-89 potentiates butyrate induction of endogenous p21([TG] gene expression.	ZBP-89	waf1)	1	ACTIVATION	False
7279	7370	10899165:8:ZNF148:CDKN1A	DNase I footprinting analysis of the human p21([TG] promoter with recombinant [TF] identified a binding site at -245 to -215.	ZBP-89	waf1)	0	UNDEFINED	False
7280	7371	10910082:0:TP53:VEGFA	Wild-type [TF] suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of [TG] expression.	p53	vascular endothelial growth factor	2	REPRESSION	False
7281	7372	10910082:10:TP53:VEGFA	The introduction of wt [TF] into sarcoma cells containing mutant p53 significantly reduced the expression of vascular endothelial growth factor ([TG]), which is a key mediator of tumor angiogenesis.	p53	VEGF	2	REPRESSION	False
7282	7373	10910082:12:TP53:VEGFA	Using luciferase as the reporter of [TG] promoter activity, we found that wt [TF] inhibited VEGF promoter activity in SKLMS-1 cells.	p53	VEGF	2	REPRESSION	False
7283	7374	10910082:13:TP53:VEGFA	Deletion analysis defined an 87-bp region (bp -135 to -48) in the [TG] promoter that is necessary for inhibiting VEGF promoter activity by wt [TF].	p53	VEGF	2	REPRESSION	False
7284	7375	10910082:14:SP1:VEGFA	The transcription factor [TF] may be involved in the repression of [TG] promoter activity by wt p53 in SKLMS-1 cells.	Sp1	VEGF	2	REPRESSION	False
7285	7376	10910082:14:TP53:VEGFA	The transcription factor Sp1 may be involved in the repression of [TG] promoter activity by wt [TF] in SKLMS-1 cells.	p53	VEGF	2	REPRESSION	False
7287	7379	10913304:3:FOSL1:MMP1	Under basal conditions, the [TG] promoter is repressed in part via protein-DNA interactions at the Ets cognate, and minimally two mechanisms convey MMP1 promoter upregulation by FGF2: (a) transcriptional activation via [TF]/c-Jun containing DNA-protein interactions at the AP1 cognate and (b) derepression of promoter activity regulated by the Ets cognate.	Fra1	MMP1	1	ACTIVATION	False
7288	7380	10915220:8:ETV4:MMP13	Treatment with KN93, a Ca(2+)/calmodulin-dependent protein kinase II specific inhibitor, greatly reduced the amount of protein binding to the [TF] region in response to PTH which correlated to a notable decrease in the amount of [TG] mRNA produced in response to PTH.	PEA3	MMP-13	1	ACTIVATION	False
7289	7381	10918605:6:TP73:VEGFA	To evaluate a possible relationship between [TF] status and [TG] expression, we have studied the effect of ectopically expressed p73 on the regulation of the VEGF gene.	p73	VEGF	0	UNDEFINED	False
7290	7382	10918605:7:TP73:VEGFA	Our results demonstrate that [TF] can down-regulate endogenous [TG] gene expression on mRNA and protein level.	p73	VEGF	2	REPRESSION	False
7291	7383	10920185:3:MYC:CDKN1A	Transforming growth factor beta (TGFbeta) treatment of immortalized human keratinocyte cells inhibits cell-cycle progression and is characterized by down-regulation of [TF] followed by up-regulation of p21([TG].	c-Myc	CIP1)	2	REPRESSION	True
7292	7384	10920185:6:MYC:CDKN1A	Furthermore, overexpression of [TF] in NIH 3T3 cells repressed the basal levels of p21([TG] mRNA.	c-Myc	CIP1)	2	REPRESSION	False
7293	7385	10920185:9:MYC:CDKN1A	Thus, repression of the cell-cycle inhibitory gene p21([TG] plays a role in [TF]-dependent cell-cycle progression.	c-Myc	CIP1)	2	REPRESSION	False
7294	7386	10930400:1:PPARG:TBXAS1	We have studied the transcription regulation of the rat thromboxane synthase ([TG]) gene by peroxisome proliferator-activated receptor gamma ([TF]) in macrophages.	PPARgamma	TXS	0	UNDEFINED	False
7295	7387	10933397:0:MEF2A:NR4A1	Cabin1 represses [TF]-dependent [TG] expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2.	MEF2	Nur77	1	ACTIVATION	False
7296	7388	10935506:7:TP53:CDKN1A	In conclusion, driving the [TF] response (after taxol treatment) by activating the bax gene rather than the [TG] gene results in induction of massive apoptosis, in vitro and in vivo, and greatly enhances sensitivity to the drug.	p53	p21	1	ACTIVATION	True
7297	7389	10942771:4:AP1:MGMT	Deletion and point mutation analysis showed that two [TF] in the [TG] promoter are involved in activation by TSA.	AP-1 binding sites	MGMT	1	ACTIVATION	False
7298	7390	10944115:2:MEF2A:NR4A1	The major calcium- and calcineurin-responsive elements in the [TG] promoter are binding sites for myocyte enhancer factor-2 ([TF]).	MEF2	Nur77	0	UNDEFINED	False
7299	7391	10954723:8:KLF5:TAGLN	In contrast, overexpression of a related factor ([TF]) transactivated [TG] promoter activity.	BTEB2	SM22alpha	1	ACTIVATION	False
7300	7392	10956548:0:CEBPB:PTGS2	[TF] and CRE elements principally account for both basal and interleukin-1 beta-induced transcriptional activity of the proximal 528bp of the [TG] promoter in amnion-derived AV3 cells: evidence for involvement of C/EBP beta.	NF-IL6	PGHS-2	1	ACTIVATION	False
7301	7393	10956548:11:CEBPB:PTGS2	In conclusion, [TF] and CRE elements principally account in AV3 amnion cells for basal and IL-1 beta-inducible transcriptional activity of the proximal 528 bp of the [TG] promoter, while NF-kappa B elements play no substantial role.	NF-IL6	PGHS-2	1	ACTIVATION	False
7302	7394	10956548:12:CEBPB:PTGS2	C/EBPs, particularly C/EBPbeta, are implicated in control of [TG] transcription through the [TF] and CRE sites.	NF-IL6	PGHS-2	0	UNDEFINED	False
7303	7395	10964750:3:CDX1:PSMB9	Expression of the [TG] proteasomal protein was also strongly induced by [TF] and Cdx2 at the transcriptional level, whereas TAP1 expression which is under the control of the same bidirectional promoter as LMP2 remained unchanged.	Cdx1	LMP2	1	ACTIVATION	False
7304	7396	10964750:3:CDX2:PSMB9	Expression of the [TG] proteasomal protein was also strongly induced by Cdx1 and [TF] at the transcriptional level, whereas TAP1 expression which is under the control of the same bidirectional promoter as LMP2 remained unchanged.	Cdx2	LMP2	1	ACTIVATION	False
7307	7399	10970859:0:TFCP2:TYMS	Inhibition of the mammalian transcription factor [TF] induces S-phase-dependent apoptosis by downregulating [TG] expression.	LSF	thymidylate synthase	1	ACTIVATION	False
7308	7400	10973960:6:WT1:CTGF	The promoter of one of these genes, connective tissue growth factor ([TG]), is suppressed by [TF] both in its endogenous location and in reporter constructs.	WT1	CTGF	2	REPRESSION	False
7309	7401	10973960:7:WT1:CTGF	[TF] regulation of [TG] expression is not mediated by previously identified WT1 recognition elements and may therefore involve a novel mechanism.	WT1	CTGF	0	UNDEFINED	False
7310	7402	10982390:5:ETS2:CDKN1A	MAPK signaling increased the phosphorylation of the transcription factors [TF], C/EBPalpha, and C/EBPbeta, and rapidly increased transcription from the [TG] promoter via multiple Ets- and C/EBP-elements within the enhancer region.	Ets2	p21	1	ACTIVATION	True
7311	7403	10982796:5:EGR1:PDGFA	Transfection of [TF] cDNA represses TbetaR-2/CAT constructs but induces [TG]/CAT.	Egr-1	PDGF-A	1	ACTIVATION	False
7312	7404	10987301:0:HIF1A:VEGFA	The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates [TG] expression and secretion through mitogen-activated protein kinase and p38 pathways acting on [TF].	hypoxia-inducible factor 1alpha	vascular endothelial growth factor	1	ACTIVATION	False
7313	7405	11001829:6:HIF1A:VEGFA	[TF] induces the expression of the hypoxia responsive genes [TG] and erythropoietin.	HIF-1	vascular endothelial growth factor	1	ACTIVATION	False
7314	7406	11003676:0:AP1:FASLG	A novel [TF] in the [TG] ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs.	AP-1 element	CD95	0	UNDEFINED	False
7315	7407	11003676:4:AP1:FASLG	The MEKK1/JNKK pathway and a novel [TF] in the [TG] promoter downstream of the TATA box are required for CD95L upregulation.	AP-1 element	CD95L	1	ACTIVATION	False
7316	7408	11007955:3:HIF1A:VEGFA	We demonstrate that p42/p44 MAP kinases play a pivotal role in angiogenesis by exerting a determinant action at three levels: i) persistent activation of p42/p44 MAP kinases abrogates apoptosis; ii) p42/p44 MAP kinase activity is critical for controlling proliferation and growth arrest of confluent endothelial cells; and iii) p42/p44 MAP kinases promote [TG] (vascular endothelial growth factor) expression by activating its transcription via recruitment of the AP-2/Sp1 (activator protein-2) complex on the proximal region (-88/-66) of the VEGF promoter and by direct phosphorylation of hypoxia-inducible factor 1 alpha ([TF]).	HIF-1 alpha	VEGF	1	ACTIVATION	False
7317	7409	11007955:3:SP1:VEGFA	We demonstrate that p42/p44 MAP kinases play a pivotal role in angiogenesis by exerting a determinant action at three levels: i) persistent activation of p42/p44 MAP kinases abrogates apoptosis; ii) p42/p44 MAP kinase activity is critical for controlling proliferation and growth arrest of confluent endothelial cells; and iii) p42/p44 MAP kinases promote [TG] (vascular endothelial growth factor) expression by activating its transcription via recruitment of the AP-2/[TF] (activator protein-2) complex on the proximal region (-88/-66) of the VEGF promoter and by direct phosphorylation of hypoxia-inducible factor 1 alpha (HIF-1 alpha).	Sp1	VEGF	1	ACTIVATION	False
7318	7410	11021966:6:TP53:CDKN1A	This induction of p21([TG]) expression was mediated through [TF].	p53	WAF1	1	ACTIVATION	False
7322	7414	11032828:5:TP53:CDKN1A	These observations suggest that [TF] represses the cdc2 promoter by inducing p21/[TG], which inhibits cyclin-dependent kinase activity, enhancing the binding of p130 and E2F4, which together bind to and repress the cdc2 promoter.	p53	waf1	1	ACTIVATION	True
7323	7415	11035254:12:JUNB:NQO1	In addition to Nrf2 and c-Jun, other nuclear transcription factors including Nrf1, [TF], and Jun-D also bind to the ARE and regulate expression and induction of [TG] gene.	Jun-B	NQO1	1	ACTIVATION	False
7324	7416	11035254:12:JUND:NQO1	In addition to Nrf2 and c-Jun, other nuclear transcription factors including Nrf1, Jun-B, and [TF] also bind to the ARE and regulate expression and induction of [TG] gene.	Jun-D	NQO1	1	ACTIVATION	False
7325	7418	11040101:10:SP1:VEGFA	Together, these results indicate that IL-1 beta induces [TG] gene expression at both transcriptional and post-transcriptional levels, and IL-1 beta evokes p38 MAPK and JNK signalings, which in turn stimulate the transcription of the VEGF gene through [TF]-binding sites.	Sp1	VEGF	1	ACTIVATION	False
7328	7421	11046135:9:MEF2A:NR4A1	The transcriptional activation domain of ERK5 is required for maximal [TF] activity in response to calcium flux in T cells, and it can activate the endogenous [TG] gene when constitutively recruited to the Nur77 promoter via MEF2 sites.	MEF2	Nur77	1	ACTIVATION	False
7329	7422	11053446:4:SP1:FASLG	[TF] activates the [TG] promoter via a distinct nucleotide recognition element whose integrity is crucial for inducible expression.	Sp1	FasL	1	ACTIVATION	False
7330	7423	11054669:6:HES1:ASCL1	In gel mobility shift assays, using extracts from neuroblastoma cells, [TF] bound to an oligonucleotide corresponding to a sequence in the [TG] promoter including the so-called N-box, suggesting that the transiently increased HES-1 activity in differentiating neuroblastoma cells is involved in down-regulation of HASH-1.	HES-1	HASH-1	2	REPRESSION	False
7331	7424	11056102:1:HIF1A:VEGFA	Hypoxia-inducible factor-1 ([TF]) is a heterodimeric transcription factor that regulates expression of genes involved in O(2) homeostasis, including vascular endothelial growth factor ([TG]), a potent stimulator of angiogenesis.	HIF-1	VEGF	0	UNDEFINED	True
7332	7425	11060301:9:SP1:VEGFA	Taken together, these data elucidate the signaling mechanism of Ras-mediated [TG]/VEGF transcriptional activation through PKCzeta and also provide insight into PKCzeta and [TF]-dependent transcriptional regulation of VPF/VEGF.	Sp1	VPF	0	UNDEFINED	False
7333	7426	11064455:0:SP1:CDKN1A	[TF] and Sp3 activate p21 ([TG]/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line.	Sp1	WAF1	1	ACTIVATION	False
7334	7427	11064455:0:SP3:CDKN1A	Sp1 and [TF] activate p21 ([TG]/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line.	Sp3	WAF1	1	ACTIVATION	False
7335	7428	11064455:5:SP1:CDKN1A	[TF] and Sp3 binding to the [TG] promoter increased during Caco-2 cell differentiation, while the absolute level of Sp1 did not change and the absolute level of Sp3 increased approximately twofold.	Sp1	p21	0	UNDEFINED	False
7336	7429	11064455:5:SP3:CDKN1A	Sp1 and [TF] binding to the [TG] promoter increased during Caco-2 cell differentiation, while the absolute level of Sp1 did not change and the absolute level of Sp3 increased approximately twofold.	Sp3	p21	0	UNDEFINED	False
7337	7430	11064455:6:SP1:CDKN1A	Transfection experiments in the SL2 Drosophila cell line that lacks endogenous Sp3 activity demonstrated that Sp1 transactivates the [TG] promoter primarily through the Sp1-2 site, while Sp3 acts through the [TF] site.	Sp1-1	p21	1	ACTIVATION	False
7338	7431	11064455:6:SP3:CDKN1A	Transfection experiments in the SL2 Drosophila cell line that lacks endogenous [TF] activity demonstrated that Sp1 transactivates the [TG] promoter primarily through the Sp1-2 site, while Sp3 acts through the Sp1-1 site.	Sp3	p21	1	ACTIVATION	False
7339	7432	11064455:7:SP1:CDKN1A	In these cells Sp3 is a stronger transactivator of the [TG] promoter than [TF].	Sp1	p21	1	ACTIVATION	False
7340	7433	11064455:7:SP3:CDKN1A	In these cells [TF] is a stronger transactivator of the [TG] promoter than Sp1.	Sp3	p21	1	ACTIVATION	False
7341	7434	11064455:8:SP1:CDKN1A	Our data suggest that induction of [TG] transcription during Caco-2 differentiation is modulated by [TF]/Sp3 interactions with the p21 promoter.	Sp1	p21	1	ACTIVATION	False
7342	7435	11064455:8:SP3:CDKN1A	Our data suggest that induction of [TG] transcription during Caco-2 differentiation is modulated by Sp1/[TF] interactions with the p21 promoter.	Sp3	p21	1	ACTIVATION	False
7343	7436	11075816:2:USF1:FSHR	Previous studies showed that an E box in the proximal promoter of the [TG] gene is required for transcription and that the predominant E box binding proteins are the ubiquitous transcription factors, upstream stimulatory factor 1 ([TF]) and USF2.	USF1	FSHR	1	ACTIVATION	True
7344	7437	11075816:2:USF2:FSHR	Previous studies showed that an E box in the proximal promoter of the [TG] gene is required for transcription and that the predominant E box binding proteins are the ubiquitous transcription factors, upstream stimulatory factor 1 (USF1) and [TF].	USF2	FSHR	1	ACTIVATION	False
7345	7438	11090277:1:SREBF1:LPL	Overexpression of the adipocyte differentiation and determination factor-1 (ADD-1) or sterol regulatory element binding protein-1 ([TF]) induces the expression of numerous genes involved in lipid metabolism, including lipoprotein lipase ([TG]).	SREBP-1	LPL	1	ACTIVATION	False
7346	7439	11095928:13:CEBPB:PTGS2	A permissive role for [TF]/CRE binding proteins in regulating [TG] expression in these cells is indicated, but requires further clarification.	NF-IL6	PGHS-2	0	UNDEFINED	False
7347	7440	11095974:0:TFAP2C:CSTA	Transcriptional factor [TF] increases human [TG] gene transcription of keratinocytes.	AP-2gamma	cystatin A	1	ACTIVATION	False
7348	7441	11095974:16:TFAP2C:CSTA	These results indicate that [TF] regulates the [TG] gene expression of epidermal keratinocytes at the transcriptional level.	AP-2gamma	cystatin A	0	UNDEFINED	False
7349	7442	11095974:6:TFAP2C:CSTA	Among the three isoforms [TF] was most potent in inducing [TG] expression.	AP-2gamma	cystatin A	1	ACTIVATION	False
7350	7443	11103822:8:ETS1:MMP7	Cotransfection of cells with a [TG] promoter-reporter gene plasmid and an [TF] expression vector yielded an increase in MMP-7 promoter activity in an Ets-1-responsive element-dependent manner.	Ets-1	MMP-7	1	ACTIVATION	False
7351	7444	11114727:0:AHR:MYC	The RelA NF-kappaB subunit and the aryl hydrocarbon receptor ([TF]) cooperate to transactivate the [TG] promoter in mammary cells.	AhR	c-myc	1	ACTIVATION	False
7352	7445	11114727:6:AHR:MYC	In transient co-transfection, RelA and [TF] gene products demonstrated cooperation in transactivation of the c-myc promoter, which was dependent on the NF-kappaB elements, and in induction of endogenous [TG] protein levels.	AhR	c-Myc	1	ACTIVATION	False
7353	7446	11115541:8:JUN:PLAU	We further studied the activation and inhibition of [TG] promoter by co-expression of a transactivation domain lacking [TF]: a dominant negative ERK1 and ERK2 mutant and a dominant negative c-raf in glioblastoma cell line showed repressed uPA promoter activity compared with the effect of the empty expression vector.	c-jun	uPA	0	UNDEFINED	True
7354	7447	11145693:8:MAX:CXCR4	These data indicate that the decreased association of YY1 with c-Myc that is caused by impaired interaction in the c-Myc/[TF]/Mad network results in increased binding activity of YY1 to the [TG] promoter, mediating down-regulation of CXCR4 production in HHV-6-infected cells.	Max	CXCR4	1	ACTIVATION	True
7355	7448	11145742:0:NR5A1:AKR1B10	[TF] (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene ([TG]) expression in adrenocortical cells.	SF-1	AKR1B7	0	UNDEFINED	False
7356	7449	11145742:0:SP1:AKR1B10	SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and [TF] (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene ([TG]) expression in adrenocortical cells.	Sp1	AKR1B7	0	UNDEFINED	False
7357	7450	11152513:0:TP53:CDKN1A	Hepatitis C virus NS5A physically associates with [TF] and regulates p21/[TG] gene expression in a p53-dependent manner.	p53	waf1	0	UNDEFINED	False
7358	7451	11152513:3:TP53:CDKN1A	We observed that transcriptional repression of the p21/[TG] gene by NS5A is [TF] dependent by using p53 wild-type (+/+) and null (-/-) cells.	p53	waf1	2	REPRESSION	False
7359	7452	11157480:11:JUN:TPSD1	The binding of +-MITF to [TF] enhanced the transactivation of [TG] gene, and that of mi-MITF suppressed the transactivation.	c-Jun	MMCP-7	1	ACTIVATION	False
7360	7453	11157480:13:JUN:TPSD1	The negative effect of mi-MITF on the transcription of [TG] gene appeared to be executed through the interaction with [TF].	c-Jun	MMCP-7	2	REPRESSION	True
7361	7454	11157480:9:JUN:TPSD1	Instead, there was an AP-1 binding motif, and binding of c-Jun to the [TF] significantly enhanced the transcription of [TG] gene.	AP-1 motif	MMCP-7	1	ACTIVATION	False
7362	7455	11158299:11:E2F4:DHFR	Upon withdrawal of cells into G(0), recruitment of p130 to [TF]-DP-1 complexes at the transcription start site results in a TSA-insensitive complex that cooperates with Sp1-HDAC-pRb complexes to stably repress [TG] promoter activity in quiescent cells.	E2F-4	dhfr	2	REPRESSION	False
7363	7456	11158299:11:SP1:DHFR	Upon withdrawal of cells into G(0), recruitment of p130 to E2F-4-DP-1 complexes at the transcription start site results in a TSA-insensitive complex that cooperates with [TF]-HDAC-pRb complexes to stably repress [TG] promoter activity in quiescent cells.	Sp1	dhfr	2	REPRESSION	False
7364	7457	11158299:11:TFDP1:DHFR	Upon withdrawal of cells into G(0), recruitment of p130 to E2F-4-[TF] complexes at the transcription start site results in a TSA-insensitive complex that cooperates with Sp1-HDAC-pRb complexes to stably repress [TG] promoter activity in quiescent cells.	DP-1	dhfr	2	REPRESSION	False
7366	7459	11161397:1:TP53:PTGS2	Wild-type [TF] competitively binds to the promoter region of [TG] in vitro and inhibits its transcription.	p53	COX-2	2	REPRESSION	False
7367	7460	11161397:2:TP53:PTGS2	We examined the association between [TF] mutation and [TG] expression in gastric cancer.	p53	COX-2	0	UNDEFINED	False
7368	7461	11162600:8:TP53:CDKN1A	In dominant negative [TF] expressing cells, DFMO significantly induced [TG] expression, arrested cells at G(1) phase, and suppressed cell growth effectively.	p53	p21	2	REPRESSION	True
7369	7462	11171071:1:RARA:MUC5AC	We reported previously that the expression of the gene encoding [TG] mucin in human airway epithelial cells is controlled by retinoic acid via the retinoic acid receptor ([TF])-alpha and that 3,3',5-tri-iodothyronine (T(3)) inhibits the expression of MUC5AC.	RAR	MUC5AC	2	REPRESSION	False
7370	7463	11191053:5:SP1:VEGFA	In normoxic conditions, p42/p44 MAPKs activate the [TG] promoter at the proximal (-88/-66) region where [TF]/AP-2 transcriptional factor complexes are recruited.	Sp 1	VEGF	1	ACTIVATION	True
7371	7464	11191064:2:HIF1A:VEGFA	[TF] stimulates angiogenesis by activating transcription of the gene encoding vascular endothelial growth factor ([TG]).	HIF-1	VEGF	1	ACTIVATION	False
7372	7465	11204570:6:AP1:VEGFA	These results suggest that the LPS-induced [TG] expression depends on the p38-mediated expression of c-Jun, which constitutes the [TF] complex and binds to the AP-1 site in the VEGF promoter.	AP-1	VEGF	1	ACTIVATION	False
7373	7468	11213471:8:AP1:SLC7A11	Analysis of the 5'-flanking region of the human [TG] gene revealed several sites for potentially binding of transcriptional factors, including NF-E2 and [TF].	AP-1	xCT	0	UNDEFINED	False
7374	7469	11222374:9:EGR1:HMOX1	Because no [TF] binding site was previously identified on the [TG] promoter, HA-1 cells were transfected with HO-1 CAT constructs containing segments of a 12.5-kb enhancer region of HO-1.	Egr-1	HO-1	0	UNDEFINED	False
7375	7472	11226757:0:AP1:MBP	A role for an [TF]like site in the expression of the [TG] gene during differentiation.	AP-1-	myelin basic protein	1	ACTIVATION	False
7376	7473	11226757:9:AP1:MBP	These results demonstrate a role for the [TF]like site in repression of [TG] gene expression in oligodendrocyte progenitor cells.	AP-1-	MBP	2	REPRESSION	False
7377	7474	11229886:11:FOXM1:APOB	2. Important factors for [TG] gene transcription appear to be C/EBP, [TF], HNF-4 and other nuclear receptors which bind both on the proximal promoter and the intestinal enhancer.	HNF-3	apoB	1	ACTIVATION	False
7378	7475	11230134:5:USF1:MT1A	We report here that MTF-1 is absolutely essential for upregulation of [TG] gene expression in visceral endoderm cells and that optimal expression also involves interactions of the basic helix-loop-helix upstream stimulatory factor-1 ([TF]) with an E-box1-containing sequence at -223 bp in the MT-I promoter.	USF1	MT-I	1	ACTIVATION	False
7379	7476	11231003:5:TP73:AQP3	We found that [TG] (AQP3), a glycerol and water transporter, is regulated by [TF].	p73	aquaporin 3	0	UNDEFINED	False
7380	7477	11231003:6:TP53:AQP3	In addition, we identified a potential [TF] response element in the promoter of the [TG] gene, which is responsive to p73.	p53	AQP3	0	UNDEFINED	False
7381	7478	11231003:6:TP73:AQP3	In addition, we identified a potential p53 response element in the promoter of the [TG] gene, which is responsive to [TF].	p73	AQP3	0	UNDEFINED	False
7382	7480	11234019:5:ETS1:CDKN2A	In senescent cells, where the Ets2 levels and MEK signalling decline, the marked increase in [TG] expression is consistent with the reciprocal reduction of Id1 and accumulation of [TF].	Ets1	p16INK4a	1	ACTIVATION	True
7383	7481	11234019:5:ETS2:CDKN2A	In senescent cells, where the [TF] levels and MEK signalling decline, the marked increase in [TG] expression is consistent with the reciprocal reduction of Id1 and accumulation of Ets1.	Ets2	p16INK4a	1	ACTIVATION	False
7384	7482	11234878:7:FOSL1:PLAUR	Specific antibodies used in an electrophoretic mobility shift assay identified [TF], fra-2, Jun D, and c-Jun proteins in the nuclear protein complex that bind a 51-mer containing the AP-1 consensus sequence at -184 and its flanking sequences in the [TG] promoter.	fra-1	uPAR	0	UNDEFINED	False
7385	7483	11237058:6:PBX1:NDRG1	We identify a portion of the [TG] promoter capable of mediating transcriptional induction by E2a-[TF] and show that NDRG1 is also induced on simple IL-3 deprivation of BaF3 cells.	Pbx1	NDRG1	1	ACTIVATION	False
7386	7484	11237058:7:PBX1:NDRG1	Although we show that E2a-[TF] induction of [TG] is not impaired as a result of targeting p53 using HPV E6, and therefore does not appear to be p53-dependent, our results overall are consistent with the notion that induction of NDRG1 by E2a-Pbx1 may represent part of an apoptotic or cytostatic cellular response to oncogene activation.	Pbx1	NDRG1	1	ACTIVATION	False
7387	7485	11237058:7:TCF3:NDRG1	Although we show that [TF]-Pbx1 induction of [TG] is not impaired as a result of targeting p53 using HPV E6, and therefore does not appear to be p53-dependent, our results overall are consistent with the notion that induction of NDRG1 by E2a-Pbx1 may represent part of an apoptotic or cytostatic cellular response to oncogene activation.	E2a	NDRG1	1	ACTIVATION	False
7388	7486	11238946:0:ETV4:PLAUR	beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor ([TG]) through a [TF]/ets transcriptional silencing element in the u-PAR promoter.	PEA3	u-PAR	2	REPRESSION	False
7389	7487	11238946:7:ETV4:PLAUR	Deletion of the [TF]/ets motif at -248 bp substantially impaired the ability of beta(3)-integrin to downregulate the [TG] promoter, suggesting that the PEA3/ets site acts as a silencing element.	PEA3	u-PAR	2	REPRESSION	False
7390	7488	11238946:8:ETV4:PLAUR	An expression vector encoding the transcription factor [TF] caused inhibition of the wild-type but not the PEA3/ets-deleted [TG] promoter.	PEA3	u-PAR	2	REPRESSION	False
7391	7489	11252722:3:RORA:PTGS2	We demonstrated that ROR alpha is expressed in human primary smooth-muscle cells and that ectopic expression of [TF] inhibits TNFalpha-induced IL-6, IL-8 and [TG] expression in these cells.	ROR alpha1	COX-2	2	REPRESSION	True
7392	7490	11254751:0:JUND:IVL	Cholesterol sulfate stimulates [TG] transcription in keratinocytes by increasing Fra-1, Fra-2, and [TF].	Jun D	involucrin	1	ACTIVATION	False
7393	7492	11259631:9:CEBPB:PTGS2	Because [TF], a basic leucine zipper transcription factor, can be activated via a PKC alpha/mitogen-activated protein kinase pathway and can influence [TG] expression, we examined whether C/EBP beta is involved in TPA-induced epidermal COX-2 expression.	C/EBP beta	COX-2	0	UNDEFINED	True
7394	7493	11274148:3:TTF1:SFTPB	Clustered retinoic acid-responsive element and [TF] binding sites were identified in the enhancer region of the [TG] gene and were required for retinoic acid stimulation of the human SP-B (hSP-B) promoter.	TTF-1	SP-B	1	ACTIVATION	False
7395	7495	11274184:9:NFE2L2:HMOX1	These results indicate that ATF4 regulates basal and CdCl(2)-induced expression of the [TG] gene in a cell-specific manner and possibly in a complex with [TF].	Nrf2	ho-1	1	ACTIVATION	True
7396	7496	11274368:0:MYC:CDKN1A	[TF] represses the p21([TG]/CIP1) promoter and interacts with Sp1/Sp3.	Myc	WAF1	2	REPRESSION	False
7397	7497	11274368:11:MYC:CDKN1A	Because Sp1 is required for [TG] transcription, it is possible that [TF] may down-regulate p21 transcription, at least in part, by sequestering Sp1.	Myc	p21	2	REPRESSION	False
7398	7498	11274368:11:SP1:CDKN1A	Because [TF] is required for [TG] transcription, it is possible that Myc may down-regulate p21 transcription, at least in part, by sequestering Sp1.	Sp1	p21	1	ACTIVATION	False
7399	7499	11274368:3:MYC:CDKN1A	Recent studies showed that [TF] can repress [TG] transcription, thereby overriding a p21-mediated cell cycle checkpoint.	Myc	p21	2	REPRESSION	False
7400	7500	11274368:4:MYC:CDKN1A	We found that activation of a [TF]-estrogen receptor fusion protein by 4-hydroxytamoxifen in mouse cells resulted in suppression of endogenous [TG] transcription.	Myc	p21	2	REPRESSION	False
7401	7501	11278336:4:PPARG:PTGS2	PMA-mediated induction of [TG] promoter activity was inhibited by [TF] ligands; this suppressive effect was prevented by overexpressing a dominant negative form of PPARgamma or a PPAR response element decoy oligonucleotide.	PPARgamma	COX-2	2	REPRESSION	False
7402	7502	11278399:6:JUN:BCL2L1	Although other transcription factors like Fos, [TF], Myc, STAT3, and STAT5a are implicated in the activation of macrophage competence or in CSF-1 signaling, no synergy was observed between Ets2 and these transcription factors on the [TG] promoter.	c-Jun	bcl-x	0	UNDEFINED	False
7403	7503	11278400:10:POU2F1:CDX2	Co-transfecting [TF] cDNA but not five other POU gene cDNAs activates the [TG] promoter in the pancreatic InR1-G9 and the intestinal Caco-2 cell lines.	OCT1	Cdx-2	1	ACTIVATION	False
7405	7505	11278771:11:JUN:PTPN6	Mutation of a putative AP-1 ([TF]) element suppressed c-Jun-mediated activation of the [TG] promoter construct.	c-Jun	SHP-1	1	ACTIVATION	False
7406	7507	11278953:2:TP53:CDKN1A	Unlike the [TG] gene, in which [TF]-dependent transcriptional activation is mediated by a response element containing two consensus p53 half-sites, it previously was reported that activation of the BAX element by p53 requires additional sequences.	p53	p21	1	ACTIVATION	False
7407	7508	11279028:5:YY1:NPPB	We show that [TF] cooperates with GATA-4 to synergistically activate [TG] transcription.	YY1	BNP	1	ACTIVATION	False
7408	7509	11279044:10:SP1:CYCS	These data suggest that variations in the rate of mitochondrial ATP synthesis are important in determining [TG] gene expression in muscle cells and that this is mediated, in part, by [TF]-induced increases in cytochrome c transcription.	Sp1	cytochrome c	1	ACTIVATION	False
7409	7510	11279192:0:TP53:APC	[TF]-dependent transcriptional regulation of the [TG] promoter in colon cancer cells treated with DNA alkylating agents.	p53	APC	0	UNDEFINED	False
7410	7511	11279192:3:TP53:APC	In previous studies, we have shown that the [TG] gene is inducible and that the DNA damage-induced level of APC mRNA requires [TF].	p53	APC	1	ACTIVATION	False
7411	7512	11279192:4:TP53:APC	In the present study, we examined the role of [TF] in the transcriptional regulation of [TG] promoter and characterized two p53-binding sites on the cloned APC promoter (pAPCP).	p53	APC	0	UNDEFINED	False
7412	7513	11281649:3:AP1:FGF2	Among these transcription factors, [TF] is rapidly activated by hypoxia and triggers [TG], VEGF, and tyrosine hydroxylase gene expression.	AP-1	bFGF	1	ACTIVATION	False
7413	7514	11281649:3:AP1:VEGFA	Among these transcription factors, [TF] is rapidly activated by hypoxia and triggers bFGF, [TG], and tyrosine hydroxylase gene expression.	AP-1	VEGF	1	ACTIVATION	False
7414	7515	11310795:10:TFAP2A:F2R	As [TF] also regulates other genes that are involved in the progression of human melanoma such as E-cadherin, p21/WAF-1, HER2/neu, Bcl-2, FAS/APO-1, IGF-R-1, VEGF and the thrombin receptor ([TG]), we therefore propose that loss of AP-2 is a crucial event in the development of malignant melanoma.	AP-2	PAR-1	0	UNDEFINED	False
7415	7516	11310795:10:TFAP2A:FAS	As [TF] also regulates other genes that are involved in the progression of human melanoma such as E-cadherin, p21/WAF-1, HER2/neu, Bcl-2, FAS/[TG], IGF-R-1, VEGF and the thrombin receptor (PAR-1), we therefore propose that loss of AP-2 is a crucial event in the development of malignant melanoma.	AP-2	APO-1	0	UNDEFINED	False
7416	7517	11313255:10:USF2:SERPINE1	These results indicated that the balance between 2 transcriptional factors, HIF-1 and [TF], which can bind adjacent HRE sites, appears to be involved in the regulation of [TG] expression in many clinical conditions.	USF-2a	PAI-1	0	UNDEFINED	False
7417	7518	11313255:5:USF2:SERPINE1	Luciferase (Luc) gene constructs driven by 766 and 276 base pairs of the 5'-flanking region of the [TG] gene were transfected into primary hepatocytes together with expression vectors encoding wild-type [TF] and a USF-2a mutant lacking DNA binding and dimerization activity (DeltaHU2a).	USF-2a	PAI-1	0	UNDEFINED	False
7418	7519	11313463:6:TP53:CDKN1A	Gel shift analyses indicated that [TF] had lower affinity for the consensus binding site in the PIG3 promoters compared to its consensus sites in the [TG] and MDM2 genes, which suggests that additional factors may be required to stabilize the interaction of p53 with the PIG3 promoter.	p53	p21	0	UNDEFINED	False
7419	7520	11313881:0:E2F1:RPA2	Expression analysis using DNA microarrays demonstrates that [TF] up-regulates expression of DNA replication genes including [TG].	E2F-1	replication protein A2	1	ACTIVATION	False
7420	7521	11313928:5:TP53:CDKN1A	Cdc2 is inhibited simultaneously by three transcriptional targets of [TF], Gadd45, [TG], and 14-3-3 sigma.	p53	p21	0	UNDEFINED	True
7421	7522	11313996:9:FOSL1:SPRR1B	Overexpression of [TF] in malignant cells significantly enhanced [TG] promoter activity.	fra1	SPRR1B	1	ACTIVATION	False
7422	7523	11316810:0:EGR1:PTPN1	The reciprocal role of [TF] and Sp family proteins in regulation of the [TG] promoter in response to the p210 Bcr-Abl oncoprotein-tyrosine kinase.	Egr-1	PTP1B	0	UNDEFINED	False
7424	7525	11316810:8:EGR1:PTPN1	Our data indicate that [TF] and Sp family proteins play a reciprocal role in the control of expression from the [TG] promoter.	Egr-1	PTP1B	0	UNDEFINED	False
7425	7526	11331422:4:YY1:PLP1	When overexpressed in an oligodendrocyte cell line, [TF] enhances transcription of the [TG] promoter.	YY1	PLP	1	ACTIVATION	False
7426	7527	11331422:6:YY1:PLP1	The binding site for [TF] in the [TG] promoter (site 3) fits the YY1 consensus site and DNA-protein complexes containing site 3 can be supershifted with an antibody directed against YY1 protein.	YY1	PLP	0	UNDEFINED	False
7427	7528	11331591:0:SMAD3:RUNX2	TGF-beta-induced repression of CBFA1 by [TF] decreases [TG] and osteocalcin expression and inhibits osteoblast differentiation.	Smad3	cbfa1	2	REPRESSION	False
7428	7529	11331591:5:SMAD3:RUNX2	The repression of [TG] function by [TF] contrasts with previous observations that Smads function as transcription activators.	Smad3	CBFA1	2	REPRESSION	False
7430	7531	11331755:8:TFE3:CTSK	This study identifies [TG] as a transcriptional target of Mitf and [TF] via three consensus elements in the cathepsin K promoter.	TFE3	cathepsin K	0	UNDEFINED	False
7431	7532	11332715:0:AP1:BCL2L1	Transcriptional regulation of the [TG] gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NFkappaB, STAT and [TF] transcription factor families.	AP1	bcl-x	0	UNDEFINED	True
7432	7533	11334435:8:HES1:NEUROG3	Together with previous genetic data, these results suggest a model in which the [TG] gene is activated by the coordinated activities of several pancreatic transcription factors and inhibited by Notch signaling through [TF].	HES1	ngn3	2	REPRESSION	False
7433	7534	11337499:2:JUND:TIMP1	Rat HSCs activated in vitro express JunD, Fra2, and FosB as the predominant [TF] DNA-binding proteins, and all three associate with an AP-1 sequence that is essential for activity of the tissue inhibitor of metalloproteinases-1 ([TG]) promoter.	AP-1	TIMP-1	1	ACTIVATION	False
7434	7535	11337499:3:JUND:TIMP1	In this study, we used expression vectors for wild-type, dominant-negative, and forced homodimeric (Jun/eb1 chimeric factors) forms of [TF] and other Fos and Jun proteins to determine the requirement for JunD in the transcriptional regulation of the [TG] and interleukin-6 (IL-6) genes.	JunD	TIMP-1	0	UNDEFINED	False
7435	7536	11337499:4:JUND:TIMP1	[TF] activity was required for [TG] gene promoter activity, whereas overexpression of Fra2 or FosB caused a repression of promoter activity.	JunD	TIMP-1	1	ACTIVATION	False
7436	7537	11337499:5:JUND:TIMP1	The ability of homodimeric JunD/eb1 to elevate [TG] promoter activity supports a role for JunD homodimers as the major [TF]-dependent transactivators of the TIMP-1 gene.	AP-1	TIMP-1	1	ACTIVATION	False
7437	7538	11337511:10:SP1:CES1	Transcriptional activation assays in Schneider SL-2 insect cells demonstrated that [TF] is a potent activator of the [TG] promoter.	Sp1	TGH	1	ACTIVATION	False
7438	7539	11350893:8:HIF1A:VEGFA	These results suggest that components of the hypoxia response pathway, including [TF] and HIF-2 alpha, are important cofactors in the regulation of [TG] in bladder cancer and are therapeutic targets in this disease.	HIF-1 alpha	VEGF	0	UNDEFINED	False
7439	7540	11353786:9:JUN:VEGFA	Forced overexpression of [TF] and c-Fos in OVCAR-3 cells stimulated [TG] promoter activity fourfold.	c-Jun	VEGF	1	ACTIVATION	False
7440	7541	11368006:0:SP1:FASN	Role of [TF] and Sp3 in the transcriptional regulation of the [TG] gene.	Sp1	fatty acid synthase	0	UNDEFINED	False
7441	7542	11368006:0:SP3:FASN	Role of Sp1 and [TF] in the transcriptional regulation of the [TG] gene.	Sp3	fatty acid synthase	0	UNDEFINED	False
7442	7543	11371564:0:CUX1:CXCL1	The role of [TF] in the negative regulation of [TG] gene expression.	CDP	CXCL1	2	REPRESSION	False
7443	7544	11371564:6:CUX1:CXCL1	Furthermore, overexpression of the [TF] protein blocks [TG] promoter activity in reporter gene assays, whereas overexpression of an antisense CDP construct leads to a significant increase in CXCL1 promoter activity.	CDP	CXCL1	2	REPRESSION	False
7444	7545	11371564:7:CUX1:CXCL1	Mutations in the IUR element, which map in the putative [TF]-binding site, inhibit the binding of CDP to the IUR element and favor increased transcription from the [TG] promoter.	CDP	CXCL1	2	REPRESSION	False
7445	7546	11375890:3:TP53:CDKN1A	Using a panel of well-characterized Arg175 [TF] mutants we found that only mutants (Tyr175, Trp175, Asp175 and Phe175) which have completely lost their ability to transactivate repress wild-type p53-stimulated Bax, [TG] PG13 promoter constructs.	p53	p21 and	1	ACTIVATION	False
7446	7547	11384995:0:SP1:CDKN1A	[TF] plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21([TG]/Cip1) gene by the p53 tumor suppressor protein.	Sp1	WAF1	1	ACTIVATION	False
7447	7548	11384995:0:TP53:CDKN1A	Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21([TG]/Cip1) gene by the [TF] tumor suppressor protein.	p53	WAF1	1	ACTIVATION	False
7448	7549	11384995:1:SP1:CDKN1A	In the present study we present evidence for the critical role of [TF] in the mechanism of transactivation of the human cell cycle inhibitor p21([TG]/Cip1) (p21) gene promoter by the tumor suppressor p53 protein.	Sp1	WAF1	1	ACTIVATION	False
7449	7550	11384995:1:TP53:CDKN1A	In the present study we present evidence for the critical role of Sp1 in the mechanism of transactivation of the human cell cycle inhibitor p21([TG]/Cip1) (p21) gene promoter by the tumor suppressor [TF] protein.	p53	WAF1	1	ACTIVATION	False
7450	7551	11384995:3:SP1:CDKN1A	In transfection experiments, p53 transactivated the [TG] promoter in HaCaT cells that express [TF] but have a mutated p53 form.	Sp1	p21	2	REPRESSION	True
7451	7552	11384995:3:TP53:CDKN1A	In transfection experiments, [TF] transactivated the [TG] promoter in HaCaT cells that express Sp1 but have a mutated p53 form.	p53	p21	1	ACTIVATION	False
7452	7553	11384995:4:TP53:CDKN1A	In contrast, [TF] could not transactivate the [TG] promoter in the Drosophila embryo-derived Schneider's SL2 cells that lack endogenous Sp1 or related factors.	p53	p21	1	ACTIVATION	False
7453	7554	11384995:5:SP1:CDKN1A	Cotransfection of SL2 cells with p53 and [TF] resulted in a synergistic transactivation of the [TG] promoter.	Sp1	p21	1	ACTIVATION	False
7454	7555	11384995:5:TP53:CDKN1A	Cotransfection of SL2 cells with [TF] and Sp1 resulted in a synergistic transactivation of the [TG] promoter.	p53	p21	1	ACTIVATION	False
7455	7556	11385614:0:SMAD3:CD79A	[TF] and Smad4 mediate transforming growth factor-beta1-induced [TG] expression in murine B lymphocytes.	Smad3	IgA	1	ACTIVATION	False
7456	7557	11385614:0:SMAD4:CD79A	Smad3 and [TF] mediate transforming growth factor-beta1-induced [TG] expression in murine B lymphocytes.	Smad4	IgA	1	ACTIVATION	False
7457	7558	11385614:10:SMAD3:CD79A	The results from the present study indicate that [TF], Smad4, and Smad7, at least in part, serve as mediators linking TGF-beta1 to transcriptional regulation of [TG] switching related gene and regulation of IgA class switching.	Smad3	IgA	0	UNDEFINED	False
7458	7559	11385614:10:SMAD4:CD79A	The results from the present study indicate that Smad3, [TF], and Smad7, at least in part, serve as mediators linking TGF-beta1 to transcriptional regulation of [TG] switching related gene and regulation of IgA class switching.	Smad4	IgA	0	UNDEFINED	False
7459	7560	11385620:5:MEF2A:NR4A1	The TG-induced [TG] expression is also inhibited by overexpression of Cabin1, an endogenous inhibitor of calcineurin and a corepressor of the transcription factor [TF], suggesting that MEF2 activation is required for Nur77 expression.	MEF2	Nur77	2	REPRESSION	True
7461	7562	11389717:5:SP1:DHFR	Because [TF] controls the [TG] promoter, we determined the effect of TPA on the expression of Sp1 and its binding to DNA.	Sp1	dhfr	0	UNDEFINED	False
7462	7563	11389726:8:ETS1:CSNK2A2	The data strongly support the hypothesis that [TF] acts as a common regulatory element of the [TG] and CK2beta genes involved in directing coordinate transcription and contributing to the balanced availability of transcripts.	Ets1	CK2alpha	0	UNDEFINED	True
7463	7564	11395510:4:TP53:CDKN1A	However, the mechanisms by which [TF] hinge domain mutants differentially activate its target genes, e.g. p21([TG]/CIP1) and Bax, remain unknown.	p53	WAF1	0	UNDEFINED	True
7464	7565	11396965:4:TP53:CDC25C	In contrast to [TF], its homologue p73 is not able to down-modulate [TG] expression.	p53	cdc25C	2	REPRESSION	False
7466	7567	11402335:6:JUN:CCND1	Amongst the [TF] proteins, c-Jun is unique in its ability to positively regulate cell proliferation through the repression of tumor suppressor gene expression and function, and induction of [TG] transcription.	Jun	cyclin D1	1	ACTIVATION	False
7467	7568	11402335:7:JUNB:CCND1	These actions are antagonized by [TF], which upregulates tumor suppressor genes and represses [TG].	JunB	cyclin D1	2	REPRESSION	False
7468	7569	11410592:4:JUN:CCND1	These results contrasted to a recent report showing that induction of [TG] by E2 in ER-positive MCF-7 and HeLa cells was due to up-regulation of c-jun and subsequent interaction of [TF]-ATF-2 with the CRE.	c-Jun	cyclin D1	1	ACTIVATION	False
7469	7570	11420667:5:TFAP2A:CDKN1A	[TF]-transfected PC12 cells displayed enhanced transcription and translation of Rb2/p130 and of the cdk inhibitor p21([TG]/CIP1), a gene known to be under the control of AP-2, but unable by itself to elicit PC12 differentiation.	AP-2	WAF1	1	ACTIVATION	False
7470	7571	11423565:8:NFATC1:PTGS2	[TF] bound directly to the GGAAA sequence, which is the minimal consensus sequence for NFAT binding, in a promoter region of rat [TG] gene, and it enhanced the reporter activity of rat COX-2 promoter in mesangial cells.	NFAT2	COX-2	1	ACTIVATION	False
7471	7572	11423565:9:NFATC1:PTGS2	These findings provide the first evidence that [TF] is expressed and regulates [TG] gene expression in mesangial cells.	NFAT2	COX-2	0	UNDEFINED	False
7472	7573	11423975:5:EWSR1:CDKN1C	The inducible expression of [TF] led to a strong upregulation of c-Myc and a considerable downregulation of [TG].	EWS-FLI-1	p57KIP2	2	REPRESSION	False
7473	7574	11423975:5:FLI1:CDKN1C	The inducible expression of EWS-[TF] led to a strong upregulation of c-Myc and a considerable downregulation of [TG].	FLI-1	p57KIP2	2	REPRESSION	False
7474	7575	11423975:8:FLI1:CDKN1C	Analysis of the [TG] promoter indicated that EWS-[TF] downregulates, possibly through an indirect mechanism, the transcription of this gene.	FLI-1	p57KIP2	2	REPRESSION	False
7476	7577	11432833:0:JUN:CCND1	Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of [TF] towards [TG].	c-Jun	cyclin D1	1	ACTIVATION	True
7477	7578	11432833:8:JUN:CCND1	Moreover, Pin1 cooperates with either activated Ras or JNK to increase transcriptional activity of [TF] towards the [TG] promoter.	c-Jun	cyclin D1	1	ACTIVATION	False
7478	7579	11435416:10:NFATC1:EDN1	Consistent with this interaction, overexpression of GATA4 and [TF] synergistically activated the [TG] promoter.	NFATc	ET-1	1	ACTIVATION	False
7479	7580	11440364:0:AP1:SERPINE1	Transcription factor decoy for activator protein-1 ([TF]) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor ([TG]) gene expression in cultured human vascular smooth muscle cells.	AP-1	PAI-1	1	ACTIVATION	True
7480	7581	11440364:10:AP1:SERPINE1	These data indicate an important role for [TF] in [TG] expression.	AP-1	PAI-1	0	UNDEFINED	False
7481	7582	11440364:2:AP1:SERPINE1	This study tested the hypothesis that hyperglycaemia and Ang II stimulate [TG] gene expression through activator protein-1 ([TF]) binding sites.	AP-1	PAI-1	1	ACTIVATION	False
7482	7583	11440364:3:AP1:SERPINE1	We evaluated the role of [TF] in [TG] gene expression in human vascular smooth muscle cells under high D-glucose and Ang II stimulation using a double-stranded cis-element AP-1 oligodeoxynucleotide (decoy ODN).	AP-1	PAI-1	0	UNDEFINED	False
7483	7584	11440364:8:AP1:SERPINE1	This study shows that high glucose and Ang II stimulate [TG] expression through [TF] binding sites.	AP-1	PAI-1	1	ACTIVATION	False
7484	7585	11445565:6:SP1:GDF15	Gel shift, co-transfection, and chromatin immunoprecipitation assays showed that the Sp transcription factors bind to the [TF]-binding sites and transactivate [TG] expression.	Sp1	NAG-1	1	ACTIVATION	False
7485	7586	11445565:7:SP1:GDF15	In addition, chicken ovalbumin upstream promoter-transcription factor 1 can interact with the C-terminal region of [TF] and Sp3 proteins and induce [TG] promoter activity through Sp1 and Sp3 transcription factors.	Sp1	NAG-1	1	ACTIVATION	False
7486	7587	11445565:7:SP3:GDF15	In addition, chicken ovalbumin upstream promoter-transcription factor 1 can interact with the C-terminal region of Sp1 and [TF] proteins and induce [TG] promoter activity through Sp1 and Sp3 transcription factors.	Sp3	NAG-1	1	ACTIVATION	False
7487	7588	11448969:2:SREBF1:RPS14	In an effort to understand the role [TF] plays in lipogenic gene transcription, we have examined the functional interaction between SREBP-1c, nuclear factor Y, 3,5,3'-triiodothyronine (T(3)) receptors, and co-activators using the [TG] gene promoter as a model.	SREBP-1c	S14	0	UNDEFINED	False
7488	7589	11448969:4:SREBF1:RPS14	Linker scanning analyses of the [TG] promoter showed that an SRE at -139/-131 base pairs (bp) binding [TF] and a Y-box at -104/-99 bp binding NF-Y are indispensable for both T(3)- and SREBP-1c-mediated induction of S14 promoter activity in rat primary hepatocytes.	SREBP-1c	S14	1	ACTIVATION	False
7489	7590	11448969:7:SREBF1:RPS14	Elevating hepatocellular levels of specific co-activators (CBP, p/CAF, or GCN5) induced [TG] promoter activity 2-3-fold, while [TF] induced promoter activity 10-fold.	SREBP-1c	S14	1	ACTIVATION	False
7490	7591	11463719:0:PRRX1:TNC	[TF] controls vascular smooth muscle cell proliferation and [TG] expression and is upregulated with Prx2 in pulmonary vascular disease.	Prx1	tenascin-C	0	UNDEFINED	False
7491	7592	11463719:7:PRRX1:TNC	Because [TG] also promotes SMC growth and its expression is also upregulated by denatured collagen, we tested and thereafter showed that [TF] expression significantly enhances TN-C gene promoter activity 20-fold.	Prx1	TN-C	1	ACTIVATION	False
7492	7593	11463719:8:PRRX1:TNC	Similar experiments conducted with truncated [TF] proteins showed that the N-terminal portion and the homeodomain of Prx1 were necessary to induce the bulk of [TG] promoter activity.	Prx1	TN-C	1	ACTIVATION	False
7493	7594	11470783:6:TP53:SERPINE1	Finally, we showed that [TG] transcriptional induction by MNNG required a [TF]-responsive element located at -136 base pairs in the PAI-1 promoter, because specific mutation of this site abrogated the induction.	p53	PAI-1	1	ACTIVATION	False
7494	7595	11470783:7:TP53:SERPINE1	Because [TG] is a prognostic factor in many metastatic cancers, being involved in the control of tumor invasiveness, our finding that a genotoxic agent induces the PAI-1 gene via [TF] adds a new feature to the role of the tumor-suppressor p53 protein.	p53	PAI-1	1	ACTIVATION	False
7495	7596	11473033:9:CEBPB:FAS	NF-kappaB p50 and [TF] overexpression had no effect by themselves on the [TG] promoter activity, but when cotransfected with p65, each factor inhibited transactivation by p65.	C/EBPbeta	Fas	2	REPRESSION	False
7496	7597	11474579:6:NFKB:NOS2	Cotransfection experiments with [TF] isoforms, IkappaB isoforms, and IKK mutants suggested that the NF-kappaB site at -115/-106 bp is important, but not sufficient, for induction of [TG] promoter and that the role of NF-kappaB is partially independent of its binding site.	NF-kappaB	iNOS	1	ACTIVATION	False
7497	7598	11477405:6:KLF2:MYC	Forced expression of [TF] was associated with markedly decreased [TG] expression.	LKLF	c-Myc	2	REPRESSION	False
7498	7599	11495920:0:SP3:CYP3A7	Novel transcriptional regulation of the human [TG] gene by Sp1 and [TF] through nuclear factor kappa B-like element.	Sp3	CYP3A7	0	UNDEFINED	False
7499	7600	11495920:5:SP3:CYP3A7	A gel shift assay using nuclear extracts from HepG2 cells showed that Sp1 and [TF] bound to the NF-kappaB-like element of the [TG] but not CYP3A4 gene.	Sp3	CYP3A7	0	UNDEFINED	False
7500	7601	11495920:6:SP1:CYP3A7	Specific activation of the [TG] promoter by [TF] and Sp3 was confirmed by a co-transfection of the p3A7NF-kappaB or p3A4NF-kappaB reporter gene with Sp1 or Sp3 expression plasmid into Drosophila cells, which lacked endogenous Sp family.	Sp1	CYP3A7	1	ACTIVATION	False
7501	7602	11495920:6:SP3:CYP3A7	Specific activation of the [TG] promoter by Sp1 and [TF] was confirmed by a co-transfection of the p3A7NF-kappaB or p3A4NF-kappaB reporter gene with Sp1 or Sp3 expression plasmid into Drosophila cells, which lacked endogenous Sp family.	Sp3	CYP3A7	1	ACTIVATION	False
7502	7603	11495920:8:SP3:CYP3A7	Thus, we conclude that the expression of the [TG] gene in HepG2 cells is cooperatively regulated by Sp1, [TF], hepatocyte nuclear factor 3beta, and upstream stimulatory factor 1.	Sp3	CYP3A7	0	UNDEFINED	False
7503	7607	11502752:4:SMAD4:MMP1	The results showed that Smad3 and [TF], but not Smad1 or Smad2, mimicked the inhibitory effect of TGF-beta and abrogated interleukin-1beta (IL-1beta)-induced stimulation of [TG] promoter activity and NFkappaB-specific gene transcription in dermal fibroblasts.	Smad4	MMP-1	2	REPRESSION	False
7504	7608	11502752:6:SMAD4:MMP1	Dominant negative mutants of Smad3 or [TF] and antagonistic Smad7, which disrupts ligand-induced Smad3 phosphorylation, abrogated the repression of [TG] transcription by TGF-beta.	Smad4	MMP-1	2	REPRESSION	True
7505	7609	11509675:7:TCF3:CCND2	Consistent with these findings, [TF] null mice expressed decreased levels of [TG] and cyclin D3 transcripts.	E2A	cyclin D2	1	ACTIVATION	False
7506	7610	11511524:4:EGR1:SOD2	Here we show that PDGF induced the expression of the [TG] gene in NIH3T3 cells, and its induction was associated with [TF] (Egr-1), a transcription factor.	early growth response-1	Mn-SOD	1	ACTIVATION	False
7507	7611	11511524:5:EGR1:SOD2	An electrophoretic mobility shift assay demonstrated that [TF] bound to the proximal promoter of the [TG] gene in response to PDGF.	Egr-1	Mn-SOD	0	UNDEFINED	False
7508	7612	11511524:7:EGR1:SOD2	Forced expression of [TF] in the cells activated [TG] transcription in a dose-dependent manner.	Egr-1	Mn-SOD	1	ACTIVATION	False
7509	7613	11514554:11:SOX9:CDKN1A	These studies demonstrate that [TF] alters the rate of cell cycle progression of chondrocytes and their differentiation by enhancing or inhibiting the expression of selected genes, including p21([TG]) and ERK1, and that N-cadherin is an additional direct target of this transcriptional regulator.	SOX9	cip1	0	UNDEFINED	True
7510	7614	11514554:5:SOX9:CDKN1A	[TF] enhanced p21([TG]) promoter activity in a luciferase reporter assay.	SOX9	cip1	1	ACTIVATION	False
7511	7615	11514734:0:TP53:CDKN1A	[TF]-dependent transcriptional repression of p21([TG]) by hepatitis C virus NS3.	p53	waf1	2	REPRESSION	False
7512	7616	11514734:4:TP53:CDKN1A	Repression of the [TG] promoter by NS3 was almost completely lost when [TF] binding sites present on the p21 promoter were removed.	p53	p21	2	REPRESSION	False
7514	7618	11518759:8:NR5A2:NR0B2	FXR only moderately stimulated [TG] transcription, whereas [TF] strongly inhibited SHP transcription in HepG2 cells.	FTF	SHP	2	REPRESSION	False
7515	7619	11522796:0:CEBPB:PTGS2	The transcription factor [TF] is essential for inducible expression of the [TG] gene in macrophages but not in fibroblasts.	C/EBPbeta	cox-2	1	ACTIVATION	False
7516	7620	11522796:5:CEBPB:PTGS2	The obligatory role of [TF] in [TG] expression appeared to be mediated exclusively by the C/EBP element located at positions -138/-130 of the murine cox-2 promoter, and did not involve altered activity at the level of the other promoter elements described previously (the -402/-392 NF-kappaB site, the -59/-48 CRE/E box element, and a potential second C/EBP site located at positions -93/-85).	C/EBPbeta	COX-2	1	ACTIVATION	False
7517	7621	11526506:7:AP1:SNCG	(2) The activator protein-1 ([TF]) is functionally involved in [TG] transcription in breast cancer cells through its binding to an AP-1 motif located in the intron 1.	AP-1	BCSG1	1	ACTIVATION	False
7518	7622	11530940:0:CEBPZ:FAS	The FIRE3-mediated sterol response of the [TG] promoter requires NF-Y/[TF] as a coactivator.	CBF	FAS	1	ACTIVATION	False
7519	7623	11532965:3:USF1:TYR	By examining the ability of pigment cells to respond to UV irradiation as part of the UV-induced tanning response, we show that while the microphthalmia-associated transcription factor Mitf regulates basal [TG] expression, it is the ubiquitous basic helix-loop-helix-leucine zipper transcription factor [TF] that is required for the UV activation of the Tyrosinase promoter.	Usf-1	Tyrosinase	1	ACTIVATION	False
7520	7624	11545736:3:ZBTB17:LDLR	The myc-interacting zinc finger protein ([TF]) associates with microtubules, can bind directly to the [TG] promoter, and can activate LDLR transcription.	MIZ-1	LDLR	1	ACTIVATION	False
7521	7625	11549290:1:HIF1A:VEGFA	Oncogenic ras upregulates the expression of [TG] through the activation of the transcriptional enhancer hypoxia inducible factor-1alpha ([TF]) by a still poorly understood mechanism.	HIF-1alpha	VEGF	1	ACTIVATION	False
7522	7626	11550088:4:TP53:BNIP3	Overexpression of HIF1alpha, but not [TF], induces the expression of [TG].	p53	BNIP3	1	ACTIVATION	False
7523	7627	11557753:6:TP53:CDKN1A	We report that sanglifehrin A is capable of activating the tumor suppressor gene [TF] at the transcription level, leading to up-regulation of [TG] that then binds and inhibits the cylcinE-Cdk2 complex.	p53	p21	1	ACTIVATION	False
7524	7628	11559575:0:TP53:VEGFA	Central role of [TF] on regulation of vascular permeability factor/vascular endothelial growth factor ([TG]/VEGF) expression in mammary carcinoma.	p53	VPF	0	UNDEFINED	False
7525	7629	11559575:10:SP1:VEGFA	Taken together, our data suggest a central role of p53, through which it can inhibit [TG]/VEGF expression by regulating the transcriptional activity of [TF] and also by down-regulating the Src kinase activity, under both normoxic and hypoxic conditions.	Sp1	VPF	0	UNDEFINED	False
7526	7630	11559575:10:TP53:VEGFA	Taken together, our data suggest a central role of [TF], through which it can inhibit [TG]/VEGF expression by regulating the transcriptional activity of Sp1 and also by down-regulating the Src kinase activity, under both normoxic and hypoxic conditions.	p53	VPF	2	REPRESSION	False
7527	7631	11559575:4:TP53:VEGFA	Here, we have studied the roles of the tumor suppressor gene [TF] and the proto-oncogene c-Src in regulating the transcription of [TG]/VEGF in breast cancer cell lines MCF-7 and MDA-MB 435 under both normoxic and hypoxic conditions.	p53	VPF	0	UNDEFINED	False
7528	7634	11559575:6:SP1:VEGFA	Increased binding of [TF] to the [TG]/VEGF promoter has been observed when the cells were exposed to hypoxia.	Sp1	VPF	0	UNDEFINED	False
7529	7635	11559575:7:SP1:VEGFA	It has been shown that p53 makes a complex with [TF] and inhibits its binding to the [TG]/VEGF promoter to prevent the transcriptional activation.	Sp1	VPF	1	ACTIVATION	False
7530	7636	11559575:7:TP53:VEGFA	It has been shown that [TF] makes a complex with Sp1 and inhibits its binding to the [TG]/VEGF promoter to prevent the transcriptional activation.	p53	VPF	2	REPRESSION	True
7531	7637	11560779:0:EGR1:SOD2	TPA-activated transcription of the human [TG] gene: role of transcription factors Sp-1 and [TF].	Egr-1	MnSOD	1	ACTIVATION	False
7532	7638	11560779:8:EGR1:SOD2	The results showed that Sp1 plays a positive role for both basal and TPA-activated h[TG] transcription, whereas overexpression of [TF] has a negative role in the basal promoter activity without any effect on TPA-mediated activation of hMnSOD transcription.	Egr-1	MnSOD	2	REPRESSION	False
7533	7639	11574165:3:SP1:CDKN1A	As the [TF] binding sites of the p21([TG] promoter were sufficient to confer HBx responsiveness to a previously non-responsive promoter, we suggested that HBx represses the transcription of p21(waf1) by downregulating the activity of Sp1.	Sp1	waf1)	0	UNDEFINED	True
7534	7640	11590167:8:SMAD3:CTGF	We found that PPAR gamma activation inhibits TGF-beta-induced [TG] promoter activity in a dose-dependent manner, and suppression of CTGF promoter activity by PPAR gamma activation is completely rescued by overexpression of [TF], but not by Smad4.	Smad3	CTGF	1	ACTIVATION	False
7535	7641	11591707:14:EGR1:DUSP4	Together, these data suggest that [TF] may be a key factor in mediating GnRH-dependent transcriptional activation of the [TG] gene.	Egr-1	MKP-2	1	ACTIVATION	False
7536	7642	11593387:5:TP63:CDK1	In transient transfection assay, [TF] and p73 repress the [TG] promoter regardless of the presence of a dominant negative mutant form of p53.	p63	cdk1	2	REPRESSION	False
7537	7643	11602259:5:NFYA:JUNB	The CCAAT-binding transcription factor, nuclear factor Y (NF-Y), activated the [TG] promoter and a dominant negative [TF] construct inhibited TAK1 activation of JunB.	NF-YA	JunB	1	ACTIVATION	False
7538	7644	11606591:9:USF1:SPEG	Co-transfection experiments demonstrated that dominant negative USF repressed [TG] promoter activity, and [TF], but not USF2, transactivated the APEG-1 promoter.	USF1	APEG-1	1	ACTIVATION	False
7539	7645	11641404:6:TP63:JAG1	We found that the Jagged1 ([TG]) and Jagged2 (JAG2) genes, encoding ligands for the Notch receptors, are up-regulated by [TF] and p73.	p63	JAG1	1	ACTIVATION	False
7540	7646	11641404:6:TP73:JAG1	We found that the Jagged1 ([TG]) and Jagged2 (JAG2) genes, encoding ligands for the Notch receptors, are up-regulated by p63 and [TF].	p73	JAG1	1	ACTIVATION	False
7541	7647	11641774:5:TP63:EPHA2	Furthermore, we identified a p53 response element located within the [TG] promoter that is responsive to wild-type p53, p73, and [TF], but not mutant p53.	p63	EphA2	0	UNDEFINED	True
7542	7648	11641774:5:TP73:EPHA2	Furthermore, we identified a p53 response element located within the [TG] promoter that is responsive to wild-type p53, [TF], and p63, but not mutant p53.	p73	EphA2	1	ACTIVATION	True
7543	7649	11668179:8:CEBPB:PTGS2	Taken together, these data identify CREB, NF-kappa B, and both [TF] and -delta as key factors in coordinately orchestrating transcription from the [TG] promoter in activated macrophages.	C/EBP beta	COX-2	1	ACTIVATION	False
7544	7650	11668476:7:TP53:CDKN1A	We found that the [TF] protein in these cells acted as an inactive mutant at 37 degrees C and as a functional wild-type p53 below 34 degrees C as demonstrated by several lines of evidence, including (i) restoration of transactivating ability in yeast, (ii) induction of p53-modulated genes such as [TG](p21) and transforming growth factor-alpha, (iii) disappearance of accumulated p53 protein in the nucleus and (iv) decrease in steady state p53 protein levels.	p53	CDKN1	1	ACTIVATION	False
7545	7651	11678207:0:HIF1A:VEGFA	Role of AP-1 and [TF] transcription factors in TGF-beta activation of [TG] expression.	HIF-1	VEGF	1	ACTIVATION	False
7546	7652	11678207:3:AP1:VEGFA	The tyrosine kinase inhibitor genistein and [TF] inhibitor curcumin significantly blocked TGF-beta induction of [TG] expression while SP-1 and MKK1 inhibitors did not.	AP-1	VEGF	1	ACTIVATION	False
7547	7654	11689553:5:E2F4:MYC	Smad3 and [TF] directly bound to the element (TIE/E2F), and substitution of two nucleotides in TIE/E2F impaired binding of both Smad3 and E2F-4 as well as serum-induced activation and TGF-beta-induced suppression of the [TG] promoter activity.	E2F-4	c-myc	2	REPRESSION	False
7548	7655	11689553:8:E2F4:MYC	Therefore, TGF-beta signaling may suppress [TG] promoter activity by dissociating p300 from [TF].	E2F-4	c-myc	0	UNDEFINED	True
7549	7656	11691923:8:AP1:MMP13	In summary, our data suggest that the transcriptional [TG] response to IL-1 is controlled by the p38 pathway interacting at the MMP-13 promoter through the tissue-specific transcription factor Runx-2 and the ubiquitous [TF] transcription factor.	AP-1	MMP-13	0	UNDEFINED	False
7550	7657	11702949:2:NR6A1:POU5F1	In this study, we show that the germ cell nuclear factor ([TF]), an orphan nuclear receptor, represses [TG] gene activity by specifically binding within the proximal promoter.	GCNF	Oct4	2	REPRESSION	False
7551	7658	11702949:4:NR6A1:POU5F1	[TF] overexpression in embryonal cells represses [TG] gene and transgene activities, and we establish a link to transcriptional corepressors mediating repression by GCNF.	GCNF	Oct4	2	REPRESSION	False
7552	7659	11702949:6:NR6A1:POU5F1	Our studies suggest that [TF] is critical in repressing [TG] gene activity as pluripotent stem cells differentiate and in confining Oct4 expression to the germline.	GCNF	Oct4	2	REPRESSION	False
7553	7660	11705994:2:NR1H4:NR0B2	[TG] expression is regulated by several other members of the nuclear receptor superfamily, including the orphan receptors SF-1 and LRH-1, and the bile acid receptor [TF].	FXR	SHP	0	UNDEFINED	False
7554	7661	11707426:1:HIF1A:VEGFA	Hypoxia-inducible factor-1 ([TF]) is a master transcription factor that controls transcriptional activation of a number of genes responsive to the low cellular oxygen tension, including vascular endothelial growth factor ([TG]), erythropoietin, and glycolytic enzymes.	HIF-1	VEGF	1	ACTIVATION	False
7555	7662	11707426:5:HIF1A:VEGFA	Moreover, Jab1-enhanced transcriptional activity of [TF] under hypoxia led to increase the expression of [TG], a major HIF-1 target gene.	HIF-1	VEGF	1	ACTIVATION	False
7556	7663	11719525:7:JUND:NR4A1	PGF(2alpha) induces phosphorylation of [TF] bound to the [TG] promoter.	JunD	nur77	0	UNDEFINED	False
7557	7664	11730831:5:RARA:EDN1	Synthetic retinoids, Ch55 and Am580 (retinoic acid receptor ([TF]) agonists) markedly enhanced this effect, and an RAR antagonist, LE540, blocked this inhibitory effect on [TG] gene expression.	RAR	ET-1	2	REPRESSION	False
7558	7665	11731455:8:PAX2:GDNF	[TF] can activate expression of [TG] in cell lines derived from embryonic metanephroi.	Pax2	GDNF	1	ACTIVATION	False
7559	7666	11733864:1:FOXO1:IGFBP1	Insulin inhibits [TG] (IGFBP-1) transcription by preventing [TF] protein family members from binding a specific insulin response element in the IGFBP-1 promoter.	FKHR	insulin-like growth factor binding protein-1	1	ACTIVATION	False
7560	7667	11735247:0:FOXO1:IGF1R	Transcriptional regulation of [TG] gene expression by the PAX3-[TF] oncoprotein.	FKHR	IGF-I receptor	0	UNDEFINED	False
7561	7668	11735247:4:FOXO1:IGF1R	In the present study the potential regulation of the IGF-I receptor ([TG]) gene by PAX3-[TF] at the transcriptional level was investigated.	FKHR	IGF-I-R	0	UNDEFINED	False
7562	7669	11736649:7:FOS:JUN	A-[TF] and A-ATF2 also reduced MEKK1Delta-induced stimulation of the c-[TG] promoter.	Fos	Jun	0	UNDEFINED	True
7563	7670	11739517:9:ELK1:EGR1	[TF] and serum response factor proteins bound the serum response element-1 domain on the [TG] promoter, and PGN-induced expression of the egr-1 was inhibited by dominant-negative Elk-1.	Elk-1	egr-1	1	ACTIVATION	False
7564	7671	11739517:9:SRF:EGR1	Elk-1 and [TF] proteins bound the serum response element-1 domain on the [TG] promoter, and PGN-induced expression of the egr-1 was inhibited by dominant-negative Elk-1.	serum response factor	egr-1	0	UNDEFINED	True
7565	7672	11739748:8:TP53:CDKN1A	All measures of [TF] function, including the level of apoptosis induced by pRb inactivation, the expression of [TG] (a p53-responsive gene), and the rate of tumor growth, were comparable in mice with and without a functional p19(ARF) gene.	p53	p21	1	ACTIVATION	False
7566	7673	11745411:8:AP1:CCND1	These findings suggest that reduction of EGF-like growth factors and [TG] through the suppression of [TF] and Ets may be 1 mechanism whereby PPARgamma inhibits their growth.	AP-1	cyclin D1	1	ACTIVATION	False
7567	7674	11768239:6:ETS1:NOS2	[TF] may be involved in the [TG] gene transcription in CEVM, presumably through interacting with the NF-kappaB.	Ets-1	iNOS	1	ACTIVATION	False
7568	7675	11773447:0:FOXM1:GCG	Hepatic nuclear factor-3 ([TF] or Foxa2) regulates [TG] gene transcription by binding to the G1 and G2 promoter elements.	HNF-3	glucagon	0	UNDEFINED	True
7569	7676	11773447:8:FOXM1:GCG	However, [TF] via its transactivating domains specifically impaired Pax6-mediated transactivation of the [TG] promoter but had no effect on transactivation by Cdx2/3.	HNF-3	glucagon	2	REPRESSION	False
7570	7677	11773447:9:FOXM1:GCG	We suggest that [TF] may play a dual role on [TG] gene transcription by 1) inhibiting the transactivation potential of Pax6 on the G1 and G3 elements and 2) direct activation through G1 and G2.	HNF-3	glucagon	0	UNDEFINED	True
7571	7678	11784326:4:ETS1:NR2F1	We also show that [TF] binds to these response elements and that other ETS factors also transactivate the [TG] promoter.	Ets-1	COUP-TFI	1	ACTIVATION	False
7572	7679	11801598:10:SMAD3:LAMC1	The cooperative induction of the [TG] promoter and the endogenous LAMC1 gene by TFE3 and [TF] is augmented by the TGF-beta signaling pathway.	Smad3	LAMC1	1	ACTIVATION	False
7573	7680	11809764:4:HES1:CDKN1A	Here we show that the HLH transcription factor [TF] regulates the proliferation of human neural stem cells and that blocking its expression stimulates the expression of cyclin-dependent kinase inhibitor p21(CIP1/[TG]).	HES1	WAF1	2	REPRESSION	False
7574	7681	11821953:4:RARB:PTGS2	Induction of [TF] decreased [TG] expression in RAR-beta transfected TE-8 cells, whereas antisense RAR-beta transfected TE-3 cells increased COX-2 expression.	RAR-beta	COX-2	2	REPRESSION	False
7575	7682	11842244:0:SP1:CDKN1A	The hinge region of the human papillomavirus type 8 E2 protein activates the human p21([TG]/CIP1) promoter via interaction with [TF].	Sp1	WAF1	1	ACTIVATION	False
7576	7683	11842244:4:SP1:CDKN1A	HPV8 E2 lacking the activation domain, which is rather conserved among E2 proteins, cooperated with co-expressed [TF] in stimulation of the p21([TG]/CIP1) promoter, in contrast to HPV18 E2 lacking the activation domain.	Sp1	WAF1	1	ACTIVATION	False
7578	7685	11844788:4:TFAP4:IER3	In addition, p300, Sox, nuclear factor-kappaB, and [TF] appear to be modulators of [TG] gene expression to a lesser degree.	AP4	IEX-1	0	UNDEFINED	False
7579	7686	11844788:6:TP53:IER3	We demonstrate the presence of a [TF] response element that represses [TG] promoter activity in HaCaT keratinocytes, indicating that Sp1 and p53 have opposite effects on IEX-1 gene expression.	p53	IEX-1	2	REPRESSION	False
7580	7687	11850421:0:SP3:HSD11B2	In vivo footprinting of the human [TG] promoter: evidence for cell-specific regulation by Sp1 and [TF].	Sp3	11beta-hydroxysteroid dehydrogenase type 2	0	UNDEFINED	False
7581	7688	11854279:8:IRF2:USP18	IRF-3 plays a primary role in the LPS-inducible activation of the [TG] gene and [TF] confers a basal transcriptional activity to the UBP43 promoter.	IRF-2	UBP43	1	ACTIVATION	False
7582	7689	11854279:8:IRF3:USP18	[TF] plays a primary role in the LPS-inducible activation of the [TG] gene and IRF-2 confers a basal transcriptional activity to the UBP43 promoter.	IRF-3	UBP43	1	ACTIVATION	False
7583	7690	11855828:0:HES1:GAA	[TF], a known transcriptional repressor, acts as a transcriptional activator for the [TG] gene in human fibroblast cells.	Hes-1	human acid alpha-glucosidase	1	ACTIVATION	False
7584	7691	11855828:2:HES1:GAA	[TF] is a transcriptional repressor for a number of known genes including the human acid alpha-glucosidase ([TG]) gene as we have previously shown in Hep G2 cells.	Hes-1	GAA	2	REPRESSION	False
7586	7693	11867623:0:SP1:ASNS	Role of [TF] and Sp3 in the nutrient-regulated expression of the [TG] gene.	Sp1	human asparagine synthetase	0	UNDEFINED	False
7587	7694	11875576:2:FUBP1:MYC	The KH domains of the FUSE-binding protein ([TF]), a regulator of [TG] expression, bind in vivo and in vitro to the single-stranded far-upstream element (FUSE), 1,500 base pairs upstream from the c-myc promoter.	FBP	c-myc	0	UNDEFINED	False
7588	7695	11883315:10:E2F1:FSHR	In order to determine the influence of [TF], E2F4 and E2F5, on [TG] promoter activity, cells were transfected either with promoter construct alone or with its mixture with selected expression vector.	E2F1	FSH-R	0	UNDEFINED	False
7589	7696	11883315:10:E2F4:FSHR	In order to determine the influence of E2F1, [TF] and E2F5, on [TG] promoter activity, cells were transfected either with promoter construct alone or with its mixture with selected expression vector.	E2F4	FSH-R	0	UNDEFINED	False
7590	7697	11883315:16:E2F1:FSHR	Results suggest, that the [TF] and E2F5 factors might play an opposite role in the regulation of [TG] promoter activity.	E2F1	FSH-R	0	UNDEFINED	False
7591	7698	11883315:18:E2F1:FSHR	Since there is no E2F sensitive element in the human [TG] promoter sequence, [TF] and E2F5 can also indirectly influence FSH-R promoter activity.	E2F1	FSH-R	0	UNDEFINED	False
7592	7699	11890673:6:SP1:GJA5	Trans-activation assays in Drosophila Schneider line 2 cells demonstrated that [TF] and Sp3 activate the r[TG] proximal promoter in a dose-dependent and additive manner.	Sp1	Cx40	1	ACTIVATION	False
7593	7700	11890673:6:SP3:GJA5	Trans-activation assays in Drosophila Schneider line 2 cells demonstrated that Sp1 and [TF] activate the r[TG] proximal promoter in a dose-dependent and additive manner.	Sp3	Cx40	1	ACTIVATION	False
7594	7701	11890931:7:TP53:CDKN1A	After MMS treatment, the activation of the cloned [TG] promoter in a transient transfection assay and endogenous p21 mRNA levels in HCT-116([TF]+/+) versus HCT-116(p53-/-) cells increased, which correlates with an increased levels of phospho-p53(Ser15) and phospho-p53(Ser392).	p53	p21	1	ACTIVATION	False
7595	7702	11895854:0:TP53:CDKN1A	Human cells deficient in [TF] regulated p21([TG]/cip1) expression exhibit normal nucleotide excision repair of UV-induced DNA damage.	p53	waf1	0	UNDEFINED	False
7596	7703	11904305:6:SP1:VEGFA	These results highlight [TF] as a key molecular link between elevated activation of the Ras >> p42/p44MAPK signaling pathway and increased [TG] expression, two major steps deregulated in tumor cells.	Sp1	VEGF	1	ACTIVATION	False
7597	7704	11916942:7:AP1:LPL	Hcys also increases the levels of c-fos mRNA in Mo and enhanced nuclear protein binding to the [TF] sequence of the [TG] gene promoter.	AP-1	LPL	0	UNDEFINED	False
7598	7705	11916966:6:MYC:TERT	Because [TF] can activate transcription of the [TG] gene (hTERT), we addressed the role of BRCA1 and Nmi in modulating c-Myc-induced hTERT promoter activity.	c-Myc	human telomerase reverse transcriptase	1	ACTIVATION	False
7599	7706	11922774:4:TP53:CDKN1A	Electrophoretic mobility gel shift assays showed that the nuclear extracts of the MIC-treated COLO 205 cells exerted a significant binding between wild-type [TF] and its consensus-binding site present in the p21/[TG] promoter.	p53	Cip1	0	UNDEFINED	False
7600	7707	11940672:8:TFAP2C:ADA	Analysis of embryo cultures suggests that [TF] is also implicated in the regulation of the [TG] (ADA) gene, a gene involved in purine metabolism found expressed at the maternal-fetal interface.	AP-2 gamma	adenosine deaminase	0	UNDEFINED	False
7601	7708	11953011:8:SP1:CDKN1A	However, while BTEB1 and its ubiquitous family member [TF] increased basal p21([TG]) and IGFBP-2 transcription when added as expression constructs in the parental Hec-1-A cell line, only Sp1 activated Axl transcription, despite the presence in all three gene promoters of GC-enriched regions that presumably can bind BTEB1 and Sp1 with similar affinities.	Sp1	WAF1	1	ACTIVATION	False
7602	7709	11956185:10:NFE2:TBXAS1	Band shifting and chromatin immunoprecipitation assays indicated that p45 [TF] was bound to the [TG] promoter in vitro and in vivo.	NF-E2	TXAS	0	UNDEFINED	False
7603	7710	11956185:12:NFE2:TBXAS1	Collectively, these results indicate that binding of [TF] is critical both for alteration of the nucleosomal structure and for activation of the [TG] promoter, whereas the TATA and initiator elements are essential for transcription.	NF-E2	TXAS	1	ACTIVATION	False
7604	7711	11956185:9:NFE2:TBXAS1	Mutagenesis and forced expression studies demonstrated a critical role of p45 [TF] in controlling [TG] expression under native chromatin conditions.	NF-E2	TXAS	0	UNDEFINED	True
7605	7712	11967217:13:USF2:PTGS2	Upstream stimulatory factor (USF)-1 and [TF] bound to the E-box of the [TG] gene, and binding was similar for nuclear extracts from fresh, cultured, or luteinized granulosa cells.	USF-2	Cox-2	0	UNDEFINED	False
7606	7713	11967999:5:AP1:ELN	Transient transfections of SMC with wild-type and mutated [TG] gene promoter/chloramphenicol acetyl transferase (CAT) constructs show that a previously identified activator protein-1-cAMP response element ([TF]/CRE) (-564 to -558-bp) within the elastin promoter mediates the bFGF-dependent downregulation of elastin gene transcription in SMC.	AP1	elastin	2	REPRESSION	False
7607	7714	11970950:0:ETS1:FASLG	[TF] positively regulates [TG] transcription via cooperative interactions with Sp1.	Ets-1	Fas ligand	1	ACTIVATION	False
7608	7715	11970950:7:ETS1:FASLG	The overexpression of [TF] together with Sp1 produced cooperative activation of the [TG] promoter.	Ets-1	FasL	1	ACTIVATION	False
7609	7716	11970950:8:ETS1:FASLG	Sp1 induction of the [TG] promoter was abrogated by an [TF] mutant lacking the activation domain.	Ets-1	FasL	1	ACTIVATION	False
7610	7717	11970993:8:IRF1:CTSS	Overexpression of [TF], but not IRF-2, markedly augments [TG] promoter activity in A549 cells.	IRF-1	cathepsin S	1	ACTIVATION	False
7611	7718	11970993:9:IRF1:CTSS	Furthermore, overexpression of [TF] increases endogenous [TG] mRNA levels in 293T epithelial cells.	IRF-1	cathepsin S	1	ACTIVATION	False
7612	7719	11971180:1:TP53:VEGFA	Tumor suppressor [TF] has been shown to repress expression of vascular endothelial growth factor ([TG]), an endothelial cell-specific mitogen and a key mediator of tumor angiogenesis.	p53	VEGF	2	REPRESSION	False
7613	7720	11972334:2:TP53:CDC25C	The [TF] down-regulates expression of [TG] as part of G2/M checkpoint control.	tumor suppressor p53	cdc25C	2	REPRESSION	False
7614	7721	11973611:2:TP53:CDKN1A	NF-kappa B and [TF] are two transcriptional factors known to activate p21/[TG] gene expression.	p53	Waf1	1	ACTIVATION	False
7615	7722	11980848:11:SP1:VEGFA	These data suggest that atRA increases [TF] protein levels by posttranscriptional mechanisms, and elevated levels of Sp1 protein induce the expression of [TG] at the transcriptional level.	Sp1	VEGF	1	ACTIVATION	False
7616	7723	11980848:12:SP1:VEGFA	atRA induced transcription of the [TG] gene through [TF]-binding sites in Y79 cells.	Sp1	VEGF	1	ACTIVATION	False
7617	7724	11980898:5:PPARA:VEGFA	Its expression is increased by [TF]alpha, beta, and gamma in RT4 cells and only by PPARbeta in T24 cells via a transcriptional activation of the [TG] promoter through an indirect mechanism.	PPAR	VEGF	1	ACTIVATION	False
7618	7725	11991857:10:SMAD2:CTGF	Lefty inhibits [TF] phosphorylation initiated by TGF-beta or its receptor and prevents [TG] promoter activity driven by TGF-beta.	Smad2	CTGF	1	ACTIVATION	True
7619	7727	11991951:3:ETS1:FLI1	Analysis of the promoter of the mouse [TG] gene reveals that the 1-kb region that comprises the transcription starts and part of exon 1 is responsible for the response of the promoter to [TF].	Ets-1	fli-1	0	UNDEFINED	True
7620	7728	11991951:8:ETS1:FLI1	These results suggest that [TF] activates an auto-regulatory loop of expression of [TG] in endothelial cells, a mechanism that could have significant implications for the endothelial cell fate.	Ets-1	fli-1	1	ACTIVATION	False
7621	7729	11994285:8:HNF1A:INS	Thus, in addition to the previously described indirect action of HNF4 alpha on [TG] gene expression mediated through elevated [TF] levels, HNF4 alpha also activates the insulin gene directly, through a previously unrecognized cis element.	HNF1 alpha	insulin	1	ACTIVATION	False
7622	7730	12000849:9:USF1:HBB	Using this method we show here that antibodies specific for [TF] and NF-E2 precipitate the murine [TG] promoter in MEL cells.	USF1	beta-globin	0	UNDEFINED	False
7623	7731	12006585:5:POU2F1:CDC6	Concentration of the E2F and [TF] transcription factors that have putative binding sites in the [TG] promoter was substantially low in PC3 cells compared with BPH cells.	Oct1	Cdc6	0	UNDEFINED	False
7624	7732	12023898:7:YY1:TAGLN	Expression of [TF] in P19 cells inhibited [TG] promoter activity and conferred responsiveness to LIM kinase.	YY1	SM22alpha	2	REPRESSION	False
7625	7733	12023962:0:HIF1A:VEGFA	Endothelin-1 induces [TG] by increasing [TF] in ovarian carcinoma cells.	hypoxia-inducible factor-1alpha	vascular endothelial growth factor	1	ACTIVATION	False
7626	7734	12023962:4:HIF1A:VEGFA	ET-1 also increases hypoxia-inducible factor-1alpha ([TF]) accumulation and activates the HIF-1 transcription complex under both normoxic and hypoxic conditions, suggesting a role for HIF-1 in the induction of [TG] expression.	HIF-1alpha	VEGF	1	ACTIVATION	False
7627	7735	12023962:7:HIF1A:VEGFA	These results implicate [TF] in the induction of [TG] expression in ET-1-stimulated ovarian carcinoma cells, and provide a mechanism whereby ET-1 acting selectively through ET(A)R can interact with the HIF-1alpha-dependent machinery of angiogenesis.	HIF-1alpha	VEGF	1	ACTIVATION	False
7628	7736	12027802:9:FOXO3:HMGCS2	These results suggest that [TF] contributes to the regulation of [TG] gene expression by insulin.	FKHRL1	HMGCS2	0	UNDEFINED	False
7629	7737	12032158:5:HIF1A:VEGFA	In this study, we show that insulin activates [TF], leading to [TG] expression in retinal epithelial cells.	HIF-1	VEGF	1	ACTIVATION	False
7630	7738	12039047:5:LEF1:EDA	In electrophoretic mobility shift assays, [TF] specifically bound to its site in the [TG] promoter.	Lef-1	EDA	0	UNDEFINED	False
7631	7739	12039047:6:LEF1:EDA	Over-expression of both [TF] and beta-catenin significantly increased [TG] transcription in co-transfection studies.	Lef-1	EDA	1	ACTIVATION	False
7632	7740	12045203:10:TP53:CDKN1A	These results suggest that growth suppression by LKB1 is mediated through signaling of cytoplasmic LKB1 to induce [TG] through a [TF]-dependent mechanism.	p53	p21	1	ACTIVATION	False
7634	7742	12048211:12:ETS1:CYP24A1	Mutagenesis of [TF] (T38A) reduced [TG] promoter activity to levels observed with the dominant-negative MEK5(A) and inhibited ERK5-directed phosphorylation.	Ets-1	CYP24	1	ACTIVATION	False
7635	7743	12052835:7:HIF1A:VEGFA	Hsp90 antagonists also inhibited [TF] transcriptional activity and dramatically reduced both hypoxia-induced accumulation of [TG] mRNA and hypoxia-dependent angiogenic activity.	HIF-1 alpha	VEGF	1	ACTIVATION	False
7637	7745	12055601:2:NR1H4:SLCO1B3	We investigated whether [TG] gene expression is regulated by the nuclear receptors farnesoid X receptor/bile acid receptor (FXR/BAR; [TF]), pregnane X receptor (PXR), or liver X receptor (LXR).	NR1H4	OATP8	0	UNDEFINED	False
7638	7746	12055601:9:NR1H4:SLCO1B3	[TG] gene expression is regulated by bile acids via [TF]/BAR.	FXR	OATP8	0	UNDEFINED	False
7639	7747	12065766:7:PBX2:UGT2B17	This interaction of [TF]-Prep1 and HNF1alpha results in down-regulation of HNF1alpha-mediated activation of the [TG] promoter.	Pbx2	UGT2B17	2	REPRESSION	True
7640	7748	12071960:10:SP1:DNMT1	Our results indicate that expression of the [TG] gene is controled by [TF] and Sp3 and that p300 is involved in the activation by Sp3.	Sp1	Dnmt1	0	UNDEFINED	True
7641	7749	12071960:10:SP3:DNMT1	Our results indicate that expression of the [TG] gene is controled by Sp1 and [TF] and that p300 is involved in the activation by Sp3.	Sp3	Dnmt1	1	ACTIVATION	False
7642	7750	12071960:6:SP3:DNMT1	In Drosophila SL2 cells, which lack the Sp family of transcription factors, forced expression of Sp1 or [TF] enhanced transcription from the [TG] promoter.	Sp3	Dnmt1	1	ACTIVATION	False
7643	7753	12072430:14:AP1:SNCG	Taken together, we provide strong evidence that [TF] plays an overriding role in the transcription of the [TG] gene and that blockade of AP1 transactivation down-regulates BCSG1 expression and suppresses tumor phenotype.	AP1	BCSG1	1	ACTIVATION	False
7644	7754	12072430:5:AP1:SNCG	In this study, we extensively investigated the role of [TF] in [TG] expression in breast cancer cells.	AP1	BCSG1	0	UNDEFINED	True
7645	7755	12080043:10:MYC:YBX1	Our data suggest that p73 stimulates the transcription of the [TG] promoter by enhancing recruitment of the [TF]-Max complex to the E-box.	c-Myc	YB-1	1	ACTIVATION	False
7646	7756	12080043:4:MYC:YBX1	We present evidence from cotransfection experiments for a critical role of [TF] and p73 in the transactivation of the [TG] promoter.	c-Myc	YB-1	1	ACTIVATION	False
7647	7757	12080043:4:TP73:YBX1	We present evidence from cotransfection experiments for a critical role of c-Myc and [TF] in the transactivation of the [TG] promoter.	p73	YB-1	1	ACTIVATION	False
7648	7758	12080043:6:MYC:YBX1	In turn, [TF] transactivated an intact [TG] promoter but not a YB-1 promoter with a mutant E-box, indicating that the E-box is necessary for the response of the promoter to cisplatin.	c-Myc	YB-1	1	ACTIVATION	False
7649	7759	12080472:0:TP53:CDKN1A	Mdm2 inhibition of [TF] induces E2F1 transactivation via [TG].	p53	p21	2	REPRESSION	True
7650	7760	12080472:11:TP53:CDKN1A	Taken together, these results suggest that Mdm2 activation of E2F1 occurs through the repression of [TF]-dependent transcription of [TG], a p53-target gene and cyclin dependent kinase inhibitor.	p53	p21	1	ACTIVATION	False
7651	7761	12083788:4:EGR1:SOD2	We have detected a localized acetylation of histones H3 and H4, in vivo occupation by Sp1, early growth responsive-1 ([TF]), and histone deacetylase-1 (HDAC1) in the proximal promoter region of [TG] gene using chromatin immunoprecipitation assays.	Egr-1	Mn-SOD	0	UNDEFINED	False
7652	7762	12084724:11:SMAD5:BMP2	[TF] stimulated [TG] transcription independent of addition of the ligand.	Smad5	BMP-2	1	ACTIVATION	False
7653	7763	12086398:3:NFKB:PTGS2	Gastric adenocarcinoma cell lines derived from Caucasian (AGS) cells and Korean (SNU-484) cells were used to study the role of [TF] on [TG] expression by H. pylori.	NF-kappaB	COX-2	0	UNDEFINED	False
7654	7764	12086405:6:CEBPB:PTGS2	Two regions of the [TG] promoter, an E box and a nuclear factor-IL6 ([TF]) site, were identified as positive regulatory elements through transient transfection with luciferase reporter vectors containing various 5'-flanking regions of the promoter.	NF-IL6	COX-2	1	ACTIVATION	False
7655	7765	12089154:5:TFCP2:TYMS	The overexpression of Fe65 completely abolishes the activation of a key S phase gene, the [TG] (TS) gene, driven by the transcription factor [TF]/CP2/LBP1 (LSF).	LSF	thymidylate synthase	1	ACTIVATION	False
7656	7766	12101231:4:JUN:NCAM1	Dominant-negative [TF] abolished expression of a 140-kDa neural cell adhesion molecule ([TG]140) and dramatically enhanced the expression of NCAM180 in TAM-67 cells.	c-Jun	NCAM	1	ACTIVATION	True
7657	7767	12101231:5:JUN:NCAM1	Inhibition of [TF] in TAM-67 cells also resulted in a corresponding decrease in the amount of [TG]140 mRNA and an increase in the amount of NCAM180 mRNA.	c-Jun	NCAM	1	ACTIVATION	False
7658	7768	12111005:10:ARNT:SERPINE1	In summary, TCDD induced the [TG] gene directly via an AhR- and [TF]-dependent mechanism, which was distinctly different from TGF-beta-driven PAI-1 transcription.	Arnt	PAI-1	1	ACTIVATION	False
7659	7769	12111005:7:AHR:SERPINE1	Transfection with [TG] promoter led to increased PAI-1 promoter activity in H1(wt) cells treated with TCDD, but no such effect occurred in H1([TF](-)) or H1(Arnt(-)) cells, implying involvement of the AhR and Arnt.	AhR	PAI-1	1	ACTIVATION	False
7660	7770	12111005:7:ARNT:SERPINE1	Transfection with [TG] promoter led to increased PAI-1 promoter activity in H1(wt) cells treated with TCDD, but no such effect occurred in H1(AhR(-)) or H1([TF](-)) cells, implying involvement of the AhR and Arnt.	Arnt	PAI-1	1	ACTIVATION	False
7661	7771	12122099:6:ETS1:MMP2	We analyzed [TG] promoter activity in transfectants with a luciferase reporter assay and with p53 and [TF] gel mobility shift assays.	Ets-1	MMP-2	0	UNDEFINED	False
7662	7772	12135926:6:YY1:HOXB4	The NFY/[TF] motif is reiterated in the [TG] promoter and is known to be required for its activity.	YY1	Hoxb4	1	ACTIVATION	False
7663	7773	12135926:7:YY1:HOXB4	As these two factors are able to mediate opposing transcriptional effects by reorganizing the local chromatin environment, the relative levels of NFY and [TF] binding could represent a mechanism for balancing activation and repression of [TG] through the same site.	YY1	Hoxb4	0	UNDEFINED	False
7664	7774	12137939:4:SP1:DKC1	One of these is a point mutation in a putative [TF] binding site in the 5'-upstream region of the [TG] gene which presumably represents the promoter region of the gene.	Sp1	DKC1	0	UNDEFINED	False
7665	7775	12145208:0:ETS1:TP53	[TF] is required for [TG] transcriptional activity in UV-induced apoptosis in embryonic stem cells.	Ets1	p53	1	ACTIVATION	False
7666	7776	12145339:8:SREBF1:CYP51A1	Interestingly, protein kinase A shows a marked stimulation of the [TG] promoter activity when overexpressed together with [TF] but not when overexpressed with CREB, suggesting phosphorylation of SREBP-1a.	SREBP-1a	CYP51	1	ACTIVATION	False
7667	7777	12145339:9:SREBF1:CYP51A1	Using a DNA probe containing all three regulatory elements, it is found that [TF], a CREB-like factor, and specificity protein (Sp1) all probably bind the [TG] promoter.	SREBP-1a	CYP51	0	UNDEFINED	False
7668	7778	12147235:4:SREBF1:FADS2	A 90-bp region of the [TG] promoter was required for the activation by [TF] as well as for the suppression of the promoter activity by HUFA.	SREBP-1c	D6D	1	ACTIVATION	False
7669	7779	12151092:0:POU2F1:CSN2	Involvement of [TF] in transcriptional regulation of [TG] gene expression in mouse mammary gland.	Oct-1	beta-casein	0	UNDEFINED	False
7670	7780	12151347:0:SP1:CDKN1A	3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by [TF]-mediated activation of p21([TG]/CIP1) expression.	Sp1	WAF1	1	ACTIVATION	False
7671	7781	12151347:11:SP1:CDKN1A	Thus, our observations have uncovered an antiproliferative pathway for DIM that implicates [TF]/Sp3-induced expression of [TG] as a target for cell cycle control in human breast cancer cells.	Sp1	p21	1	ACTIVATION	False
7672	7782	12151347:11:SP3:CDKN1A	Thus, our observations have uncovered an antiproliferative pathway for DIM that implicates Sp1/[TF]-induced expression of [TG] as a target for cell cycle control in human breast cancer cells.	Sp3	p21	1	ACTIVATION	False
7673	7783	12151347:8:SP1:CDKN1A	Transient transfection of 5'-deletion constructs of the [TG] promoter demonstrated that the first 291 bp segment of the proximal promoter, which contains six promoter specific transcription factor 1 ([TF]) elements, maintained DIM responsiveness.	Sp1	p21	0	UNDEFINED	False
7674	7784	12154035:2:HIF1A:VEGFA	[TF] has been implicated in the regulation of genes involved in angiogenesis [e.g., vascular endothelial growth factor ([TG]) and inducible nitric oxide synthase] and anaerobic metabolism (e.g., glycolytic enzymes).	HIF-1	VEGF	0	UNDEFINED	False
7675	7785	12161428:10:SMAD3:SFTPB	Electrophoretic mobility shift analysis showed no evidence for direct binding of [TF] to the [TG] promoter, and a DNA binding mutant of SMAD3 also repressed Sp-B, suggesting that direct DNA binding of SMAD3 may not be required.	SMAD3	Sp-B	0	UNDEFINED	True
7676	7786	12163680:9:JUN:VEGFA	We also showed that GTE decreased c-fos and [TF] RNA transcripts, suggesting that activator protein (AP)-1-responsive regions present in the human [TG] promoter may be involved in the inhibitory effect of GTE.	c-jun	VEGF	2	REPRESSION	False
7677	7787	12168779:5:TP53:CDKN1A	Among the [TF] target genes, the expression of [TG], bax, cyclinG1 and fas mRNAs increased and peaked at 6HAT.	p53	p21	1	ACTIVATION	True
7678	7788	12198703:12:JUND:CDKN1A	Polyamines negatively regulate junD gene expression posttranscriptionally, and increased JunD/[TF] inhibits intestinal epithelial cell proliferation at least partially through the activation of [TG] promoter.	AP-1	p21	1	ACTIVATION	False
7679	7789	12203124:0:TP53:CDKN1A	The Brn-3a transcription factor inhibits the pro-apoptotic effect of [TF] and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/[TG]).	p53	Waf1	0	UNDEFINED	False
7680	7790	12203124:3:TP53:CDKN1A	In contrast, Brn-3a and [TF] co-operative to induce maximal activation of another p53 target gene encoding the cyclin dependent kinase inhibitor, p21(CIP1/[TG]).	p53	Waf1	1	ACTIVATION	False
7681	7791	12205045:4:HIF1A:VEGFA	In addition, bcl-2 overexpression increased [TG] promoter activity through the hypoxia-inducible factor-1 ([TF]) transcription factor.	HIF-1	VEGF	1	ACTIVATION	False
7682	7792	12205102:8:SREBF1:UCP2	The SRE and sterol regulatory element binding protein-1 ([TF]) appear to be crucial for the response of the [TG] gene to FFAs, since overexpression of the nuclear forms of the SREBPs increased UCP2 promoter activity by 7-10-fold and restored the ability of E-Box mutants to respond to oleic acid.	SREBP1	UCP2	1	ACTIVATION	False
7683	7793	12215258:6:JUN:CEBPB	Cotransfection experiments showed that ATF2 and [TF] activate the [TG] gene expression cooperatively through URE2 and URE4, and this activation was greatly increased under the treatment of low concentration of anisomycin.	c-Jun	C/EBPbeta	1	ACTIVATION	False
7685	7795	12225970:0:USF1:NOS2	[TF] and USF-2 trans-repress IL-1beta-induced [TG] transcription in mesangial cells.	USF-1	iNOS	2	REPRESSION	False
7687	7797	12225970:0:USF2:NOS2	USF-1 and [TF] trans-repress IL-1beta-induced [TG] transcription in mesangial cells.	USF-2	iNOS	2	REPRESSION	False
7689	7799	12225970:7:USF1:NOS2	Cotransfection of [TF] and USF-2 expression vectors with [TG] promoter-luciferase reporter constructs suppressed IL-1beta-simulated iNOS promoter activity.	USF-1	iNOS	2	REPRESSION	False
7691	7801	12225970:7:USF2:NOS2	Cotransfection of USF-1 and [TF] expression vectors with [TG] promoter-luciferase reporter constructs suppressed IL-1beta-simulated iNOS promoter activity.	USF-2	iNOS	2	REPRESSION	False
7692	7802	12225970:8:USF2:NOS2	Cotransfection of dominant-negative [TF] mutants lacking the DNA binding domain or cis-element decoys containing concatamers of the -904/-883 region augmented IL-1beta stimulation of [TG] promoter activity.	USF-2	iNOS	2	REPRESSION	False
7693	7803	12226108:7:TFAP2A:CDKN1A	The interaction between [TF] and p53 augments p53-mediated transcriptional activation, which results in up-regulation of the cyclin-dependent kinase inhibitor p21([TG]/CIP1).	AP2alpha	WAF1	1	ACTIVATION	False
7694	7804	12226108:7:TP53:CDKN1A	The interaction between AP2alpha and [TF] augments p53-mediated transcriptional activation, which results in up-regulation of the cyclin-dependent kinase inhibitor p21([TG]/CIP1).	p53	WAF1	1	ACTIVATION	False
7695	7805	12235164:10:NFE2L2:SLC7A11	Furthermore, the experiments using the mouse embryonic fibroblasts derived from the [TF]-deficient mice revealed that the induction of [TG] gene by electrophilic agents is mediated by Nrf2.	Nrf2	xCT	1	ACTIVATION	False
7696	7806	12235180:7:CEBPB:LDLR	We show that overexpression of Egr1 significantly increases [TG] promoter activity when cotransfected with [TF] (c/EBPbeta) or with cAMP-responsive element binding protein (CREB) expression vectors.	CCAAT/enhancer binding protein beta	LDLR	1	ACTIVATION	False
7697	7807	12324467:5:SP1:FLNA	Force promoted the redistribution of p38 to the integrin/bead locus and the nucleus as well as enhanced binding of the transcription factor [TF] to proximal, regulatory domains of the [TG] promoter.	Sp1	filamin-A	0	UNDEFINED	False
7698	7808	12324467:7:SP1:FLNA	Transcriptional activation of [TG] in force-treated fibroblasts was subsequently mediated by [TF]-binding sites on the filamin-A promoter.	Sp1	filamin-A	1	ACTIVATION	False
7699	7809	12351634:6:FOXO3:TNFSF10	Analysis of the effects of FOXO proteins on the [TG] promoter localized the [TF] responsive element of the TRAIL promoter to nucleotides -138 to -121 and demonstrated that TRAIL is a direct target of FKHRL1.	FKHRL1	TRAIL	0	UNDEFINED	False
7700	7810	12351634:7:FOXO1:TNFSF10	These findings suggest that the decreased activity of [TF]L1 and FKHR in prostate cancers resulting from loss of PTEN leads to a decrease in [TG] expression that may contribute to increased survival of the tumor cells.	FKHR	TRAIL	1	ACTIVATION	False
7701	7812	12356737:0:BACH1:HMOX1	Hemoprotein [TF] regulates enhancer availability of [TG] gene.	Bach1	heme oxygenase-1	0	UNDEFINED	False
7702	7813	12356737:3:BACH1:HMOX1	Here we show that a heme-binding factor, [TF], is a critical physiological repressor of [TG].	Bach1	ho-1	2	REPRESSION	False
7703	7814	12356737:4:BACH1:HMOX1	[TF] bound to the multiple Maf recognition elements (MAREs) of [TG] enhancers with MafK in vitro and repressed their activity in vivo, while heme abrogated this repressor function of Bach1 by inhibiting its binding to the ho-1 enhancers.	Bach1	ho-1	2	REPRESSION	False
7704	7815	12356737:4:MAFK:HMOX1	Bach1 bound to the multiple Maf recognition elements (MAREs) of [TG] enhancers with [TF] in vitro and repressed their activity in vivo, while heme abrogated this repressor function of Bach1 by inhibiting its binding to the ho-1 enhancers.	MafK	ho-1	2	REPRESSION	False
7705	7816	12360402:6:IRF4:CCNB1	All HTLV-1 infected cell lines and ATL patient lymphocytes demonstrated a dramatic decrease in [TG] levels; subsequent analysis of the cyclin B1 promoter identified two sites important in [TF] binding and repression of cyclin B1 expression.	IRF-4	cyclin B1	2	REPRESSION	False
7706	7817	12360402:7:IRF4:CCNB1	Furthermore, [TF]-mediated repression of [TG] led to a significant decrease in CDC2 kinase activity in HTLV-1 infected T cells.	IRF-4	cyclin B1	2	REPRESSION	True
7707	7818	12360408:4:MYC:IER3	Interestingly, NF-kappaB/rel-mediated activation of [TG] expression was synergized by p53, but strongly inhibited by [TF] in a dose-dependent fashion.	c-Myc	IEX-1	2	REPRESSION	False
7708	7819	12360408:4:TP53:IER3	Interestingly, NF-kappaB/rel-mediated activation of [TG] expression was synergized by [TF], but strongly inhibited by c-Myc in a dose-dependent fashion.	p53	IEX-1	1	ACTIVATION	False
7709	7820	12370310:5:ZNF8:TGFB1	Overexpression of [TF] represses activity of BMP and transforming growth factor beta ([TG]) reporters.	mZnf8	TGF-beta	2	REPRESSION	False
7710	7821	12374773:8:ELK1:EGR1	Our results demonstrated that overexpression of PLCgamma1 functions as a negative modulator of the tumor suppressor [TG] gene expression, possibly through inhibition of [TF]-dependent transcriptional activity.	Elk-1	Egr-1	1	ACTIVATION	False
7711	7822	12379120:1:SP1:CDKN1A	In the present study we establish that specific members of the [TF] family of transcription factors (Sp1 and Sp3) bind to all six GC-rich motifs (elements 1-6) present in the proximal promoter of the human cell cycle inhibitor p21([TG]/Cip1) gene.	Sp1	WAF-1	0	UNDEFINED	False
7712	7823	12379120:1:SP3:CDKN1A	In the present study we establish that specific members of the Sp1 family of transcription factors (Sp1 and [TF]) bind to all six GC-rich motifs (elements 1-6) present in the proximal promoter of the human cell cycle inhibitor p21([TG]/Cip1) gene.	Sp3	WAF-1	0	UNDEFINED	False
7713	7824	12384302:0:ZBED1:MYB	The DNA replication-related element-binding factor ([TF]) is a transcriptional regulator of the [TG] gene.	DREF	Drosophila myb	0	UNDEFINED	False
7714	7825	12384701:0:MYC:CDKN1A	[TF] suppression of the [TG] Cdk inhibitor influences the outcome of the p53 response to DNA damage.	Myc	p21(Cip1)	2	REPRESSION	True
7715	7826	12384701:2:TP53:CDKN1A	The cytostatic effect of [TF] is mediated by transcriptional activation of the cyclin-dependent kinase (CDK) inhibitor [TG], whereas the apoptotic effect is mediated by transcriptional activation of mediators including PUMA and PIG3 (ref. 2).	p53	p21(Cip1)	1	ACTIVATION	False
7716	7827	12384701:5:MYC:CDKN1A	[TF] is directly recruited to the [TG] promoter by the DNA-binding protein Miz-1.	Myc	p21(Cip1)	0	UNDEFINED	False
7717	7828	12384701:6:TP53:CDKN1A	This interaction blocks [TG] induction by [TF] and other activators.	p53	p21(Cip1)	1	ACTIVATION	False
7718	7829	12387741:0:PAX5:BLNK	Control of pre-BCR signaling by [TF]-dependent activation of the [TG] gene.	Pax5	BLNK	1	ACTIVATION	False
7719	7830	12387741:2:PAX5:BLNK	Here we identified [TG] as a direct target of the transcription factor [TF] (BSAP).	Pax5	BLNK	0	UNDEFINED	False
7720	7831	12390531:7:JUN:SERPINE1	We conclude that OSM and IL-1 regulate the [TG] gene expression via up-regulating c-fos levels and subsequent binding of c-fos/[TF] heterodimers to the proximal element of the PAI-1 gene.	c-jun	PAI-1	0	UNDEFINED	False
7721	7832	12392301:5:TP53:CDKN1A	Here we show that treatment of human cervical carcinoma cell line, ME-180S, with TNF-alpha results in time-dependent accumulation of [TF] and its transcriptional target, [TG].	p53	p21	0	UNDEFINED	False
7723	7834	12393646:6:HIF1A:VEGFA	Moreover, BCR/ABL was found to promote the expression of functionally active hypoxia-inducible factor-1 ([TF]), a major transcriptional regulator of [TG] gene expression.	HIF-1	VEGF	0	UNDEFINED	False
7724	7835	12406571:8:EGR1:RET	Our data suggest that regulation of [TG] expression during development and in medullary thyroid carcinoma may be determined, at least in part, by this complex of Sp and [TF] proteins.	Egr-1	RET	0	UNDEFINED	False
7725	7836	12408820:4:MYC:CDKN1A	Using both [TF](-/-) cells and a point mutant of Myc that is deficient in Miz-1 dependent repression, we show that Myc negatively regulates transcription of [TG] upon UV irradiation and facilitates recovery from UV-induced cell cycle arrest through binding to Miz-1.	c-myc	p21Cip1	2	REPRESSION	False
7726	7837	12408868:4:MYC:CDKN1A	The TCF-4 target gene [TF] plays a central role in this switch by direct repression of the p21(CIP1/[TG]) promoter.	c-MYC	WAF1	2	REPRESSION	False
7727	7838	12411395:4:SMAD2:NOS3	Overexpression of [TF] increases basal levels of [TG], and further increases TGF-beta stimulation of eNOS expression.	Smad2	eNOS	1	ACTIVATION	False
7728	7839	12411395:6:SMAD2:NOS3	Because [TF] can interact with a variety of transcription factors, coactivators, and corepressors, Smad2 may thus act as an integrator of multiple signals in the regulation of [TG] expression.	Smad2	eNOS	0	UNDEFINED	False
7729	7840	12414801:0:ELF3:CCL20	[TF], an enterocyte-specific Ets transcription factor, regulates [TG] gene expression in Caco-2 human colonic epithelial cells.	ESE-1	MIP-3alpha	0	UNDEFINED	False
7730	7841	12414801:10:ELF3:CCL20	Taken together, our findings demonstrate that co-ordinate activation and binding of [TF], Sp1, and NF-kappaB to the [TG] promoter is required for maximal gene expression by cytokine-stimulated Caco-2 human intestinal epithelial cells.	ESE-1	MIP-3alpha	1	ACTIVATION	False
7731	7842	12414801:10:SP1:CCL20	Taken together, our findings demonstrate that co-ordinate activation and binding of ESE-1, [TF], and NF-kappaB to the [TG] promoter is required for maximal gene expression by cytokine-stimulated Caco-2 human intestinal epithelial cells.	Sp1	MIP-3alpha	1	ACTIVATION	False
7732	7843	12414908:12:FOXO1:SLC2A4	Thus, the functional interaction of PAX3/[TF] with [TG]-P appears to require all of the functional domains of PAX3/FKHR, as well as a -4/+36-bp region within the GLUT4 promoter.	FKHR	GLUT4	0	UNDEFINED	False
7733	7844	12414908:13:FOXO1:SLC2A4	Taken together, the data suggest that the [TG] gene is a downstream target of PAX3/[TF] and that GLUT4 is aberrantly transactivated by this oncoprotein both in vivo and in vitro.	FKHR	GLUT4	1	ACTIVATION	False
7734	7845	12414908:5:FOXO1:SLC2A4	Therefore, we evaluated the role of PAX3/[TF] in the regulation of [TG] gene expression in muscle tumorigenesis.	FKHR	GLUT4	0	UNDEFINED	False
7735	7846	12420214:7:TP53:CDKN1A	The data highlight a role for the ATM kinase in orchestrating the coordinated induction and transcriptional cooperation of IRF-1 and [TF] to regulate [TG] expression.	p53	p21	0	UNDEFINED	False
7736	7847	12421350:10:EGR1:DRD2	These results suggest that ERK and CaMKII positively regulate the [TG] promoter and that [TF] is a potential transcription factor for the CaMKII-dependent pathway.	Zif268	D2R	0	UNDEFINED	True
7737	7848	12429655:2:SMAD4:CDKN2B	We seek to determine the role of Smad4/[TF] in the suppression of tumor cell growth and in the regulation of TGF-beta-mediated expression of cell-cycle regulatory genes [TG] and p21(waf1).	DPC4	p15(ink4b)	0	UNDEFINED	False
7738	7849	12429655:7:SMAD4:CDKN2B	Interestingly, Smad4/[TF] induced expression of [TG], p21(waf1), and TGF-beta-responsive reporter gene in Capan-1 but not in CFPac-1 cells.	DPC4	p15(ink4b)	1	ACTIVATION	False
7739	7850	12431761:5:POU4F1:TP53	Similarly, reduction of [TF] expression using anti-sense constructs reduces endogenous [TG] expression in human neuroblastoma or cervical carcinoma cell lines growing in vitro and as tumours in nude mice whilst increasing Brn-3a levels enhances p53 expression.	Brn-3a	p53	1	ACTIVATION	False
7740	7851	12433697:0:KLF6:ENG	Transcriptional activation of [TG] and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and [TF]: their potential role in the response to vascular injury.	KLF6	endoglin	1	ACTIVATION	False
7741	7852	12433697:11:KLF6:ENG	These data provide evidence that injury-induced [TF] and preexisting Sp1 may cooperate in regulating the expression of [TG] and related members of the TGF-beta signaling complex in vascular repair.	KLF6	endoglin	0	UNDEFINED	False
7742	7853	12433697:7:KLF6:ENG	Transient overexpression of [TF], but not Egr-1, stimulated endogenous [TG] mRNA and transactivated the endoglin promoter.	KLF6	endoglin	1	ACTIVATION	False
7744	7855	12433987:3:HIF1A:VEGFA	A hypoxia-responsive (HR) region of the [TG] promoter which binds the [TF] transcription factor is a target for many signals that up-regulate VEGF transcription.	HIF-1	VEGF	1	ACTIVATION	False
7745	7856	12433990:0:TP53:CDKN1A	Distinct promoter elements mediate the co-operative effect of Brn-3a and [TF] on the [TG] promoter and their antagonism on the Bax promoter.	p53	p21	0	UNDEFINED	False
7746	7857	12433990:1:TP53:CDKN1A	Although the promoters of both the Bax and [TG] genes are activated by [TF], they differ in the effect on this activation of the POU family transcription factor Brn-3a.	p53	p21	1	ACTIVATION	False
7748	7859	12434298:7:SP1:CDKN1A	These results suggest that vesnarinone directly activates p21([TG]) promoter via the activation of [TF] and Sp3 transcription factors and the histone hyperacetylation in TYS cells.	Sp1	waf1	1	ACTIVATION	False
7749	7860	12434298:7:SP3:CDKN1A	These results suggest that vesnarinone directly activates p21([TG]) promoter via the activation of Sp1 and [TF] transcription factors and the histone hyperacetylation in TYS cells.	Sp3	waf1	1	ACTIVATION	False
7750	7861	12438259:5:CUX1:CDKN1A	[TF]/Cux p75 was able to repress a reporter carrying the promoter for the cyclin-dependent kinase inhibitor [TG] gene and to activate a DNA polymerase alpha gene reporter.	CDP	p21	2	REPRESSION	False
7751	7862	12439744:0:ETS1:TFRC	Role of [TF] in transcriptional regulation of [TG] and erythroid differentiation.	Ets-1	transferrin receptor	0	UNDEFINED	False
7753	7864	12439744:7:ETS1:TFRC	Consistent with this, FLC constitutively expressing [TF] show a decrease in [TG] gene expression, globin mRNA and hemoglobin synthesis.	Ets-1	TfR	2	REPRESSION	False
7754	7865	12446597:0:POU2F1:GNRHR	[TF] is involved in the transcriptional repression of the [TG] gene.	Oct-1	gonadotropin-releasing hormone receptor	2	REPRESSION	False
7755	7866	12446600:8:SP1:EREG	We also demonstrated by EMSAs that [TF]/Sp3 proteins were involved in the [TG] gene expression via the upstream sequence.	Sp1	epiregulin	1	ACTIVATION	False
7756	7867	12446600:8:SP3:EREG	We also demonstrated by EMSAs that Sp1/[TF] proteins were involved in the [TG] gene expression via the upstream sequence.	Sp3	epiregulin	1	ACTIVATION	False
7757	7868	12447688:9:HNF1A:FGFR4	We conclude that [TF] is a major determinant of [TG] expression in PC.	HNF1alpha	FGFR4	1	ACTIVATION	False
7758	7869	12447693:4:MYC:ID2	An [TG] promoter-luciferase reporter assay showed that transactivation by EWS-ETS involves the minimal Id2 promoter and may function in cooperation with [TF] within the full-length regulatory region.	c-Myc	Id2	1	ACTIVATION	False
7759	7870	12453873:8:MAFG:HMOX1	[TF] dimers that bind to StREs to activate the [TG] gene.	MafG	ho-1	1	ACTIVATION	False
7760	7871	12460732:4:AP1:MMP13	Palytoxin stimulated an increase in c-Fos binding to the activator protein-1 ([TF]) site present in the promoter of the mouse [TG] gene.	AP-1	MMP-13	0	UNDEFINED	False
7761	7873	12470667:5:SREBF1:SCARB1	Here we show that LXRalpha/RXR and LXRbeta/RXR induce [TG] transcription in human and murine hepatoma cell lines, and in 3T3-L1 preadipocytes independently of [TF].	SREBP-1	SR-BI	1	ACTIVATION	True
7762	7874	12471108:2:TP53:IL2	This repression is independent of the intrinsic transcriptional activity of [TF] and is mediated by the Tax-responsive CD28RE-3'-12-O-tetradecanoylphorbol-13-acetate response element (AP1) element of the [TG] promoter.	p53	IL-2	0	UNDEFINED	True
7763	7875	12477864:5:CEBPA:LRPAP1	Although [TG] had no effect on its own promoter by itself, the addition of RAP and [TF] together resulted in a threefold increase in activity over that obtained with C/EBPalpha alone.	C/EBPalpha	RAP	1	ACTIVATION	False
7764	7876	12482909:0:SP1:VEGFA	Increased [TF] phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/[TG]) transcription.	Sp1	VPF	1	ACTIVATION	False
7765	7877	12483538:6:YY1:DEK	In addition, we identify the transcriptional activator NF-Y as a member of the CCAAT-binding complex, and verify binding of the transcription factor [TF] at its consensus site in the [TG] promoter.	YY1	dek	0	UNDEFINED	False
7766	7878	12483538:7:YY1:DEK	The discovery of NF-Y and [TF] as regulatory determinants of [TG] expression is consistent with the well-documented roles of these two factors in cellular proliferation and transformation.	YY1	DEK	0	UNDEFINED	False
7767	7879	12488434:6:FOXO1:PDX1	We show that [TF] acts as a repressor of Foxa2-dependent (Hnf-3beta-dependent) expression from the [TG] promoter.	Foxo1	Pdx1	2	REPRESSION	False
7768	7880	12489182:0:FOS:DMP1	Transcriptional regulation of [TG] (DMP1) by [TF] (c-fos/c-jun) factors.	AP-1	dentin matrix protein 1	0	UNDEFINED	False
7769	7881	12506026:0:NR4A1:SERPINE1	Direct binding of [TF]/NAK-1 to the plasminogen activator inhibitor 1 ([TG]) promoter regulates TNF alpha -induced PAI-1 expression.	Nur77	PAI-1	0	UNDEFINED	False
7770	7882	12506026:4:NR4A1:SERPINE1	Using this region as bait in a genetic screen, we could identify Nur77 (NAK-1, TR3, [TF]) as an inducible DNA-binding protein that binds specifically to the [TG] promoter.	NR4A1	PAI-1	0	UNDEFINED	False
7771	7883	12509426:0:SP1:VEGFA	Oxidative stress regulates [TG] gene transcription through [TF]- and Sp3-dependent activation of two proximal GC-rich promoter elements.	Sp1	vascular endothelial growth factor-A	1	ACTIVATION	False
7772	7884	12509426:0:SP3:VEGFA	Oxidative stress regulates [TG] gene transcription through Sp1- and [TF]-dependent activation of two proximal GC-rich promoter elements.	Sp3	vascular endothelial growth factor-A	1	ACTIVATION	False
7773	7885	12509426:8:SP1:VEGFA	Additionally, in Gal4-[TF]/-Sp3-Gal4-luciferase assays, oxidative stress increased Sp1 but not Sp3 transactivating capacity, indicating additional mechanism(s) of [TG] gene regulation.	Sp1	VEGF-A	1	ACTIVATION	True
7774	7886	12509426:8:SP3:VEGFA	Additionally, in Gal4-Sp1/-[TF]-Gal4-luciferase assays, oxidative stress increased Sp1 but not Sp3 transactivating capacity, indicating additional mechanism(s) of [TG] gene regulation.	Sp3	VEGF-A	1	ACTIVATION	True
7775	7887	12511571:0:BACH1:HMOX1	[TF] functions as a hypoxia-inducible repressor for the [TG] gene in human cells.	Bach1	heme oxygenase-1	2	REPRESSION	False
7776	7888	12511571:10:BACH1:HMOX1	Therefore, [TF] functions as a hypoxia-inducible repressor for the [TG] gene, thereby contributing to fine-tuning of oxygen homeostasis in human cells.	Bach1	HO-1	2	REPRESSION	False
7777	7889	12511571:9:BACH1:HMOX1	We have identified a Maf recognition element in the human [TG] gene that is required for repression of a reporter gene by hypoxia and targeted by [TF].	Bach1	HO-1	2	REPRESSION	False
7778	7890	12525489:7:FOS:TIMP1	c-Fos, JunD, and c-Jun are essential for the induction of [TG] gene expression by TGF-beta1, but these [TF] factors transactivate equally well from both Timp-1 and MMP-1 AP1 sites.	AP1	Timp-1	1	ACTIVATION	False
7779	7892	12533512:3:NRF1:CYCS	[TG] and other nuclear-encoded mitochondrial genes are regulated by the transcription factor nuclear respiratory factor-1 ([TF]).	NRF-1	Cytochrome c	0	UNDEFINED	False
7780	7893	12545156:0:MYC:CDKN1A	[TF] represses differentiation-induced [TG] expression via Miz-1-dependent interaction with the p21 core promoter.	Myc	p21CIP1	2	REPRESSION	False
7781	7894	12545156:5:MYC:CDKN1A	Association of [TF] with the promoter in vivo correlates inversely with [TG] expression.	Myc	p21	2	REPRESSION	False
7782	7895	12545156:6:MYC:CDKN1A	Using mutants of [TF] with impaired binding to Miz-1, our results further show that repression of [TG] promoter/reporters as well as the endogenous p21 gene by Myc depends on interaction with Miz-1.	c-Myc	p21	2	REPRESSION	False
7783	7896	12545156:8:MYC:CDKN1A	In conclusion, repression of differentiation-induced [TG] expression through Miz-1 may be an important mechanism by which [TF] blocks differentiation.	Myc	p21	2	REPRESSION	False
7784	7897	12547252:5:ETS1:TFRC	Moreover, FLC constitutively expressing [TF] show a decrease in [TG] gene expression, globin mRNA and hemoglobin synthesis.	Ets-1	TfR	2	REPRESSION	False
7785	7898	12551904:1:NR1H3:MYC	We have reported previously that liver X receptor-alpha ([TF]) can mediate a novel cAMP-dependent increase in renin and [TG] gene transcription by binding as a monomer to a unique regulatory element termed the cAMP-negative response element (CNRE).	LXRalpha	c-myc	1	ACTIVATION	False
7786	7899	12551904:1:NR1H3:REN	We have reported previously that liver X receptor-alpha ([TF]) can mediate a novel cAMP-dependent increase in [TG] and c-myc gene transcription by binding as a monomer to a unique regulatory element termed the cAMP-negative response element (CNRE).	LXRalpha	renin	1	ACTIVATION	False
7787	7900	12551947:10:MAX:SERPINE1	[TF] inhibited transcription activation by Smad3 and TGF-beta at the [TG] promoter, whereas TFE3 and TFEB stimulated transcription activation.	Max	PAI-1	2	REPRESSION	False
7788	7901	12551947:10:TFE3:SERPINE1	Max inhibited transcription activation by Smad3 and TGF-beta at the [TG] promoter, whereas [TF] and TFEB stimulated transcription activation.	TFE3	PAI-1	1	ACTIVATION	False
7789	7902	12551947:10:TFEB:SERPINE1	Max inhibited transcription activation by Smad3 and TGF-beta at the [TG] promoter, whereas TFE3 and [TF] stimulated transcription activation.	TFEB	PAI-1	1	ACTIVATION	False
7790	7903	12551947:4:MAX:SERPINE1	TFE3, TFEB, and [TF] associated with Smad3 and Smad4 in the absence of DNA and at the PE2.1 element of the [TG] promoter.	Max	PAI-1	0	UNDEFINED	False
7791	7904	12551947:4:TFE3:SERPINE1	[TF], TFEB, and Max associated with Smad3 and Smad4 in the absence of DNA and at the PE2.1 element of the [TG] promoter.	TFE3	PAI-1	0	UNDEFINED	False
7792	7905	12551947:4:TFEB:SERPINE1	TFE3, [TF], and Max associated with Smad3 and Smad4 in the absence of DNA and at the PE2.1 element of the [TG] promoter.	TFEB	PAI-1	0	UNDEFINED	False
7793	7906	12553001:10:MYC:CDKN1A	[TG] promoter activity was repressed by [TF] in proliferating K562 cells, and detoposide-induced down-regulation of c-Myc released this suppression, resulting in the induction of p21.	c-Myc	p21	2	REPRESSION	False
7794	7907	12557222:7:EWSR1:TNC	In addition, a luciferase reporter assay revealed that [TF]-ETSs upregulated the [TG] gene through four ETS binding sites in the TNC promoter.	EWS	TNC	1	ACTIVATION	False
7795	7908	12557222:9:EWSR1:TNC	Together with previous studies showing that [TG] expression is involved in the invasive and malignant phenotype of several tumor types, our data suggest that the oncogenic effect of [TF]-ETS may be mediated in part by upregulating of TNC expression.	EWS	TNC	1	ACTIVATION	False
7796	7909	12560328:9:EWSR1:CDKN1A	These results demonstrated that p21([TG]/CIP1) might be one of the direct targets of [TF]-Fli1, and that p21(WAF1/CIP1) could serve as a target for a molecularly based therapy for Ewing's family tumors.	EWS	WAF1	0	UNDEFINED	False
7797	7910	12560328:9:FLI1:CDKN1A	These results demonstrated that p21([TG]/CIP1) might be one of the direct targets of EWS-[TF], and that p21(WAF1/CIP1) could serve as a target for a molecularly based therapy for Ewing's family tumors.	Fli1	WAF1	0	UNDEFINED	False
7798	7911	12560513:2:TP53:CDKN1A	Active [TF] is able to stimulate the transcription of a variety of genes including the pro-apoptotic gene bax, as well as [TG], a cell cycle regulator.	p53	p21	1	ACTIVATION	False
7800	7913	12565816:4:MYC:CDKN1A	[TF] suppresses expression of cell cycle/growth arrest genes gas1, p15, [TG], p27, and gadd34, -45, and -153.	Myc	p21	2	REPRESSION	False
7801	7914	12570801:3:HIF1A:VEGFA	We will discuss the observation that growth factors and oncogenic transformation via the mitogen-activated protein kinases p42/p44 MAPKs not only activate the [TG] promoter through the Sp1/AP-2 transcriptional factor complex but also phosphorylate [TF] leading in turn to enhance HIF-1 dependent transcriptional activation of VEGF.	HIF-1alpha	VEGF	1	ACTIVATION	False
7802	7915	12570801:3:SP1:VEGFA	We will discuss the observation that growth factors and oncogenic transformation via the mitogen-activated protein kinases p42/p44 MAPKs not only activate the [TG] promoter through the [TF]/AP-2 transcriptional factor complex but also phosphorylate HIF-1alpha leading in turn to enhance HIF-1 dependent transcriptional activation of VEGF.	Sp1	VEGF	1	ACTIVATION	False
7803	7916	12571228:6:NR0B2:CCND1	Overexpression of [TF] in intestinal epithelial crypt cells significantly inhibited dhfr, c-myc, and [TG] gene expression but did not interfere with c-fos gene expression.	SHP-1	cyclin D1	2	REPRESSION	False
7804	7917	12571248:0:YY1:CCR5	[TF] transcription factor down-regulates expression of [TG], a major coreceptor for HIV-1.	YY1	CCR5	2	REPRESSION	False
7805	7918	12571248:2:YY1:CCR5	Here we report that the [TF] transcription factor down-regulates [TG] promoter activity and that overexpression of YY1 reduces cell surface CCR5 expression and infectibility by R5-HIV-1.	YY1	CCR5	2	REPRESSION	False
7806	7919	12571843:3:EGR1:TIMP1	[TF]-regulated TIMP expression was studied in immortalized fibroblast lines using gel retardation assays, RNase protection analysis, reporter gene studies using the human [TG] promoter, and by enzyme-linked immunosorbent assay.	Egr-1	TIMP-1	0	UNDEFINED	False
7808	7921	12571843:5:EGR1:TIMP1	[TF] binding to a recognition sequence in the [TG] promoter was demonstrated in gel retardation and reporter gene assays.	Egr-1	TIMP-1	0	UNDEFINED	False
7809	7922	12571843:8:EGR1:TIMP1	The enhanced expression of [TF] may regulate the activity of matrix metalloproteinases in synovial fibroblasts by enhancing the expression of the [TG], -2, and -3 genes.	Egr-1	TIMP-1	1	ACTIVATION	False
7810	7923	12573582:6:TP53:CDKN1A	Of note, Vpr activated [TG] transcription in endogenous [TF] positive cells, but not in p53-deleted or p53 nonfunctional cells.	p53	p21	1	ACTIVATION	False
7811	7924	12573582:7:TP53:CDKN1A	Vpr and [TF] had an additive effect on [TG] transcription.	p53	p21	0	UNDEFINED	True
7812	7925	12578979:6:MEF2A:PPARGC1A	Examination of the [TG] promoter revealed two [TF]-binding sites that mediate transcriptional activation by MEF2 and repression by HDAC5.	MEF2	PGC-1 alpha	1	ACTIVATION	False
7813	7926	12591615:10:NFIX:REN	Direct study of involvement of [TF]-X in regulation of [TG] genes is underway.	NFI	renin	0	UNDEFINED	False
7815	7928	12609999:4:TP53:CDKN1A	We found that the induction of endogenous [TG] is compromised by AD1-deficient [TF] (p53(AD1(-))), AD2-deficient p53 (p53(AD2(-))), both AD1- and AD2-deficient p53 (p53(AD1(-)AD2(-))), p53(deltaPRD), which lacks PRD, and p53(deltaBD), which lacks BD.	p53	p21	1	ACTIVATION	False
7816	7929	12609999:5:TP53:CDKN1A	However, [TF](AD2(-)), p53(deltaPRD), and p53(deltaBD) are still capable of activating exogenous [TG] promoter to an extent comparable with that by wild-type p53.	p53	p21	1	ACTIVATION	False
7817	7930	12609999:7:TP53:CDKN1A	We found that like wild-type [TF], these p53 mutants are capable of binding to the p53 response elements in the [TG] promoter.	p53	p21	0	UNDEFINED	False
7818	7931	12609999:8:TP53:CDKN1A	In contrast, we found that the extent of acetylated histones on the [TG] promoter, especially the proximal promoter, and the amount of interaction with p300/CREB-binding protein, which contain histone acetyltransferase activity, directly correlate with the activity of [TF] to induce endogenous p21.	p53	p21	1	ACTIVATION	False
7819	7932	12613541:6:ETS1:NRP1	[TG] expression is regulated in EC by tumor necrosis factor-alpha, the transcription factors dHAND and [TF], and vascular injury.	Ets-1	NRP1	0	UNDEFINED	False
7820	7933	12615726:7:SP1:VEGFA	Additional molecular studies using 5' deletion and mutational analysis of the human [TG] promoter revealed that TGF-beta 1 stimulates VEGF through [TF]-dependent transcriptional activation.	Sp1	VEGF	1	ACTIVATION	False
7821	7934	12618758:5:JUN:FASLG	Ectopic expression of transdominant negative [TF] mutants strongly reduced [TG] promoter activity and activation-induced cell death (AICD), confirming the functional significance of FosB/c-Jun binding.	Jun	CD95L	1	ACTIVATION	False
7822	7935	12620991:7:TBX6:DLL1	[TG] expression, which is absent in the [TF]-null mutant, is restored at reduced levels in the partially rescued mutants, suggesting that Dll1 is a target of Tbx6.	Tbx6	Dll1	1	ACTIVATION	False
7823	7936	12631065:12:NR1I3:EDN1	First, activation of [TF] increases [TG] transcription in a dose-dependent manner.	CaR	ET-1	1	ACTIVATION	False
7824	7937	12637527:0:MYC:NBN	[TF] directly regulates the transcription of the [TG] gene involved in DNA double-strand break repair.	c-Myc	NBS1	0	UNDEFINED	False
7825	7938	12637527:6:MYC:NBN	Here we show that [TF] directly activates [TG].	c-Myc	NBS1	1	ACTIVATION	False
7826	7939	12640112:8:TP53:CDKN1A	Further, we show that Delta Np63 alpha and [TF] can bind the [TG] and 14-3-3 sigma promoters in vitro and in vivo, with decreased binding of p63 to these promoters during HEK differentiation.	p53	p21	0	UNDEFINED	False
7827	7940	12642588:10:ETS1:PCYT1A	These results suggest that [TF] is an important transcriptional activator of the [TG] gene and that Ets-1 activity is enhanced by TEF-4.	Ets-1	CTalpha	1	ACTIVATION	False
7828	7941	12642588:9:ETS1:PCYT1A	Co-transfection experiments with [TF] and TEF-4 showed enhanced expression of reporter constructs as well as [TG] mRNA.	Ets-1	CTalpha	1	ACTIVATION	False
7829	7942	12644537:11:SP1:VEGFA	IFN-alpha confers its antitumor activity, at least in part, by its antiangiogenic activity, which results from [TF]- and/or Sp3-mediated inhibition of [TG] gene transcription.	Sp1	VEGF	2	REPRESSION	False
7830	7943	12644537:8:SP1:VEGFA	In vitro, IFN-alpha decreased transcription of [TG] gene expression through an [TF]- and/or Sp3-dependent inhibition of VEGF promoter activity.	Sp1	VEGF	2	REPRESSION	False
7831	7944	12644537:8:SP3:VEGFA	In vitro, IFN-alpha decreased transcription of [TG] gene expression through an Sp1- and/or [TF]-dependent inhibition of VEGF promoter activity.	Sp3	VEGF	2	REPRESSION	False
7832	7945	12649745:6:NFKB:CD80	Although AP-1 and [TF] are considered redox-sensitive transcription factors, L-PAM led only to activation of NF-kappa B that bound specifically to a probe containing the corresponding binding site in the [TG] gene.	NF-kappa B	B7-1	0	UNDEFINED	False
7833	7946	12665570:0:TP53:CDKN1A	The tumor suppressor [TF] and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/[TG]/CIP1 gene.	p53	WAF1	0	UNDEFINED	False
7834	7947	12665570:2:TP53:CDKN1A	Genotoxic stress leads to activation of the tumor suppressor [TF] and subsequently to induction of [TG] expression.	p53	p21	1	ACTIVATION	False
7835	7948	12665570:3:SP1:CDKN1A	Here we show that the tumor suppressor p53 cooperates with the transcription factor [TF] in the activation of the [TG] promoter, whereas histone deacetylase 1 (HDAC1) counteracts p53-induced transcription from the p21 gene.	Sp1	p21	1	ACTIVATION	False
7836	7949	12665570:3:TP53:CDKN1A	Here we show that the tumor suppressor [TF] cooperates with the transcription factor Sp1 in the activation of the [TG] promoter, whereas histone deacetylase 1 (HDAC1) counteracts p53-induced transcription from the p21 gene.	p53	p21	1	ACTIVATION	False
7837	7950	12665570:7:TP53:CDKN1A	Genotoxic stress led to recruitment of [TF], reduced binding of HDAC1, and hyperacetylation of core histones at the [TG] promoter.	p53	p21	0	UNDEFINED	False
7838	7951	12665570:8:TP53:CDKN1A	Our findings show that the deacetylase HDAC1 acts as an antagonist of the tumor suppressor [TF] in the regulation of the cyclin-dependent kinase inhibitor [TG] and provide a basis for understanding the function of histone deacetylase inhibitors as antitumor drugs.	p53	p21	0	UNDEFINED	False
7839	7952	12672795:7:SMAD7:IL6	Adenoviral delivery of [TF] and dominant negative Smad3 (SmadDelta3) reversed the TGF-beta1-mediated inhibition of NF-kappaB transcriptional activity and NF-kappaB recruitment to the [TG] promoter.	Smad7	IL-6	0	UNDEFINED	False
7841	7954	12673251:3:TP53:KLF6	Here we show that during apoptosis, [TF] activates transcription of [TG] by binding to a palindromic site in the PAC1 promoter.	p53	PAC1	1	ACTIVATION	False
7842	7955	12682075:2:FOSL1:SPRR1B	Previously, we have shown that the transcriptional stimulation of [TG] expression by phorbol 12-myristate 13-acetate (PMA) is mainly mediated by a -150/-94 bp enhancer harboring two critical 12-O-tetradecanoylphorbol-13-acetate-responsive elements (TREs) and by Jun.[TF] dimers.	Fra-1	SPRR1B	1	ACTIVATION	False
7843	7956	12695546:2:FOXM1:CYP3A4	Several putative binding sites for CCAAT/enhancer-binding protein (C/EBP) and hepatic nuclear factor 3 ([TF]) were found by computer analysis in [TG] promoter.	HNF-3	CYP3A4	0	UNDEFINED	False
7844	7957	12697836:4:HIF1A:VEGFA	This process is mediated by stabilization of the transcriptional factor hypoxia inducible factor 1 ([TF]), which increases vascular endothelial growth factor ([TG]) production.	HIF-1	VEGF	1	ACTIVATION	False
7845	7958	12700414:5:AP1:GZMB	Pyrrolidine dithiocarbamate (PDTC) and N-tosyl-L-phenylalanine chloromethyl ketone (TPCK) blocked NFkappaB and [TF] binding activity in nuclear extracts of IL-2-stimulated NK cells in an EMSA and also inhibited the IL-2-induced expression of perforin, granzyme A, and [TG] gene expression in enriched NK cells.	AP-1	granzyme B	1	ACTIVATION	True
7846	7959	12700414:7:AP1:GZMB	Taken together, these results suggest that NFkappaB and [TF] are important regulators of NK cell cytolytic function through regulation of perforin, granzyme A, and [TG] gene expression.	AP-1	granzyme B	0	UNDEFINED	False
7847	7960	12702545:3:SMAD3:ACTA1	In this study, the role of [TF], a key component of the Smad pathway that mediates TGF-beta signaling in regulation of [TG] gene expression, is investigated.	Smad3	ASMA	0	UNDEFINED	False
7848	7961	12702545:9:SMAD3:ACTA1	Taken together, these findings suggest a role for [TF] in TGF-beta regulation of [TG] gene expression in myofibroblast differentiation.	Smad3	ASMA	0	UNDEFINED	False
7850	7963	12713736:8:AP1:SAT1	Mutation of the activator protein-1 ([TF]) site at position -52 in the [TG] promoter led to loss of transcriptional activity, suggesting its requirement for SAT1 basal expression.	AP-1	SAT1	1	ACTIVATION	False
7851	7964	12717415:5:TP53:CDKN1A	We also investigated the mechanism through which v-Jun disturbs [TG] expression and the possible involvement of a known p21 CIP1 regulator, [TF], as an intermediate in this process.	p53	p21 CIP1	0	UNDEFINED	False
7852	7965	12717415:6:TP53:CDKN1A	This analysis revealed that repression is mediated primarily at the level of [TG] gene transcription, however the mechanism is complex; both [TF]-dependent and -independent mechanisms contribute as judged by analysis of p21 CIP1 promoter mutants and other assays of p53 transcriptional activity.	p53	p21 CIP1	2	REPRESSION	False
7853	7966	12727210:4:SP1:CDKN1A	Using the Jurkat human T-cells we found that TPA activated p21([TG]) expression by a PKC-dependent mechanism and that out of six [TF] residing in its promoter the second most upstream one was critically essential for this activation.	Sp1 binding sites	WAF-1	1	ACTIVATION	False
7854	7967	12730191:0:TTF1:AGT	[TF], a homeodomain-containing transcription factor, participates in the control of body fluid homeostasis by regulating [TG] gene transcription in the rat subfornical organ.	TTF-1	angiotensinogen	0	UNDEFINED	False
7855	7968	12730191:8:TTF1:AGT	In the C6 glioma cell line, [TF] transactivates the [TG] promoter in a dose-dependent manner.	TTF-1	angiotensinogen	1	ACTIVATION	False
7856	7969	12730330:5:SREBF1:RETN	EMSA and chromatin immunoprecipitation assays demonstrated that ADD1/[TF] binds to the human [TG] promoter in vitro and in vivo.	SREBP1c	resistin	0	UNDEFINED	False
7858	7971	12733991:9:SP3:TFAP2C	We propose that differences in the level and activity of [TF] between breast tumour lines can determine the expression level of their [TG] gene.	Sp3	AP-2gamma	0	UNDEFINED	False
7859	7972	12740370:5:ETS1:CDKN1A	Using transient transfection and Western blot analysis, we determined that [TF] activates p21WAF1/[TG] transcription and protein expression.	Ets-1	Cip1	1	ACTIVATION	False
7860	7973	12740370:9:ETS1:CDKN1A	Co-immunoprecipitation and co-transfection analysis showed that [TF] binds p300 and cooperatively activates p21WAF1/[TG] transcription.	Ets-1	Cip1	1	ACTIVATION	False
7861	7974	12741393:5:PRRX1:TNC	Therefore, we hypothesized that FAK regulates [TG] by controlling the DNA-binding activity of [TF] and/or by inducing Prx1 expression.	Prx1	TN-C	0	UNDEFINED	False
7862	7975	12741393:6:PRRX1:TNC	[TF]-homeodomain binding site complex formation observed with FAK-wild-type fibroblasts failed to occur in FAK-null fibroblasts, yet expression of Prx1 in these cells induced [TG] promoter activity.	Prx1	TN-C	1	ACTIVATION	False
7863	7976	12741956:11:NFYA:CDC25C	Lastly, using an immunoprecipitation assay, we showed that ZHX2 intrinsically interacts with [TF] in HEK-293 cells and that ZHX2 represses the promoter activity of the [TG] gene stimulated by NF-Y in Drosophila Schneider line 2 cells.	NF-YA	cdc25C	1	ACTIVATION	False
7864	7977	12745069:3:NFE2L2:HMOX1	Treatment of cultured MC3T3-E1 osteoblasts with arsenite or arsenate induced increase of [TF], followed by transcriptional activation of target genes encoding [TG], Prx I, and A170.	Nrf2	HO-1	1	ACTIVATION	False
7865	7978	12748179:7:TP53:CASP8	We show that delivery of exogenous [TF] alone is sufficient to induce the [TG] promoter even in p53-deficient Hep3B hepatoma cells.	p53	caspase-8	1	ACTIVATION	False
7866	7979	12748190:10:TP53:CDKN1A	Strikingly, when the [TF]-inducible p21/[TG] gene was deleted, p53 no longer repressed any one among 11 genes that it down-regulates otherwise.	p53	CDKN1A	1	ACTIVATION	False
7867	7980	12748190:12:MYC:CDKN1A	Overexpressed [TF] reduced the transcription of p21/[TG] and impaired p53-mediated repression but did not abolish repression by ectopic p21.	c-Myc	CDKN1A	2	REPRESSION	False
7868	7981	12757710:6:E2F4:MYC	The C/EBPalpha-Rb-[TF] complex occupies the [TG] promoter and blocks induction of c-myc in livers of old animals after partial hepatectomy.	E2F4	c-myc	2	REPRESSION	True
7869	7982	12759432:10:YY1:SPTA1	After stimulation with class-switching activators, such as LPS, Rb becomes hyperphosphorylated and [TF] is released and can then bind to the [TG] enhancer and E mu.	YY1	hs3	0	UNDEFINED	False
7870	7983	12759432:4:YY1:SPTA1	Transient transfection experiments in B cell lines indicate that [TF] is an activator of [TG].	YY1	hs3	1	ACTIVATION	False
7871	7984	12764144:6:SP1:ACACB	The [TF] (-71 to -66) and neighboring two conserved SREs (-62 to -44) play a critical role in the stimulation of [TG] gene expression by SREBP-1.	Sp1-binding site	ACCbeta	1	ACTIVATION	False
7872	7985	12764144:6:SREBF1:ACACB	The Sp1-binding site (-71 to -66) and neighboring two conserved SREs (-62 to -44) play a critical role in the stimulation of [TG] gene expression by [TF].	SREBP-1	ACCbeta	1	ACTIVATION	False
7873	7986	12771133:6:E2F4:CCNB2	[TF] and E2F6, together with HDACs, are bound to repressed promoters, including the [TG].	E2F4	G2/M Cyclin B2	2	REPRESSION	False
7874	7987	12771133:6:E2F6:CCNB2	E2F4 and [TF], together with HDACs, are bound to repressed promoters, including the [TG].	E2F6	G2/M Cyclin B2	2	REPRESSION	False
7877	7990	12782287:4:TP53:CDKN1A	PLD1 repressed the [TG] promoter by decreasing the level of [TF], whereas PLD2 via a p53-independent pathway through modulating Sp1 activity.	p53	p21	1	ACTIVATION	False
7878	7991	12788094:0:SP1:DHFR	Modulation of [TF]-dependent transcription by a cis-acting E2F element in [TG] promoter.	Sp1	dhfr	0	UNDEFINED	False
7879	7992	12788094:5:SP1:DHFR	Cotransfection assays showed that activation of [TG] transcription by expression of E2F1/DP1 requires the reiterated [TF] elements, whereas activation by Sp1 was enhanced by the deletion of the E2F element.	Sp1	dhfr	1	ACTIVATION	False
7880	7993	12788094:5:TFDP1:DHFR	Cotransfection assays showed that activation of [TG] transcription by expression of E2F1/[TF] requires the reiterated Sp1 elements, whereas activation by Sp1 was enhanced by the deletion of the E2F element.	DP1	dhfr	1	ACTIVATION	False
7881	7994	12788094:7:SP1:DHFR	These results suggest that HDAC1 acts through [TF] to repress [TG] promoter activity, and that the E2F element modulates the activity of Sp1 at the dhfr promoter through a cis-acting mechanism.	Sp1	dhfr	2	REPRESSION	False
7882	7995	12788225:8:JUN:LGALS3	Co-transfection of [TF] and pPG3.5 5'-upstream deletion mutants resulted in a reduction of the [TG] promoter activity by 50% to 80%.	c-Jun	galectin-3	1	ACTIVATION	False
7883	7996	12788915:0:TP53:FAS	Characterization of [TF]-mediated up-regulation of [TG] gene expression upon genotoxic treatment in human breast tumor cells.	p53	CD95	1	ACTIVATION	False
7884	7997	12789289:8:TFAP2A:F2R	Our analysis of [TF]/Sp1 complexes within the regulatory region of the thrombin receptor demonstrates that AP-2 binds the proximal 3' region of the promoter and diminishes [TG] expression.	AP-2	PAR-1	2	REPRESSION	False
7885	7998	12791666:9:SP1:CXCR4	Moreover, augmentation of [TG] expression by VEGF, bFGF, and PGE2 involves stimulation of transcription factors binding to the [TF] within the promoter region of the CXCR4 gene.	Sp1-binding sites	CXCR4	1	ACTIVATION	False
7886	7999	12794070:9:SP1:PCYT1A	We conclude that [TF] binding to the [TG] proximal promoter is necessary to enhance transcription during the S phase.	Sp1	CT alpha	1	ACTIVATION	False
7887	8000	12794082:5:AP1:CCND1	Deletion of the [TF] enhancer element located at position -954 upstream from the initiation site abolished PKC-alpha-dependent activation of [TG] expression.	AP-1	cyclin D1	1	ACTIVATION	False
7888	8001	12794082:7:AP1:CCND1	A dominant negative mutant of c-Jun inhibited activation of the [TG] promoter in a concentration-dependent manner, providing further evidence that [TF] activity is required for activation of the cyclin D1 promoter by PKC-alpha and PKC-epsilon.	AP-1	cyclin D1	1	ACTIVATION	False
7889	8003	12799440:7:SP3:HMGA2	Together, these results suggest TSA treatment leads to a decrease in [TG] gene transcription, and a significant decrease in promoter bound Sp1, [TF] and acetylated histones H3 and H4.	Sp3	Hmga2	0	UNDEFINED	True
7890	8004	12801640:16:SP1:S100A10	Therefore, the 5' flanking sequence of the [TG] gene exhibits promoter activity which may be localized to a variety of controlling regions, of which the proximal [TF]/AP-2 site appears to be important for basal activity via its Sp-1 binding ability.	Sp-1	p11	1	ACTIVATION	False
7891	8005	12801994:0:SP1:TFAP2C	[TF] and Sp3 Are important regulators of [TG] gene transcription.	Sp1	AP-2gamma	0	UNDEFINED	False
7892	8006	12801994:0:SP3:TFAP2C	Sp1 and [TF] Are important regulators of [TG] gene transcription.	Sp3	AP-2gamma	0	UNDEFINED	False
7893	8007	12801994:8:SP1:TFAP2C	Electrophoretic mobility shift assays demonstrated that [TF] and Sp3 bind to three sites in the promoter region of the mouse [TG] gene.	Sp1	AP-2gamma	0	UNDEFINED	False
7894	8008	12801994:8:SP3:TFAP2C	Electrophoretic mobility shift assays demonstrated that Sp1 and [TF] bind to three sites in the promoter region of the mouse [TG] gene.	Sp3	AP-2gamma	0	UNDEFINED	False
7895	8009	12806965:5:TP53:CDKN1A	It is known that [TF] stimulates the promoter activities of p21/[TG], gadd45 and bax genes to enhance their expression as a transcriptional factor, resulting in cell cycle arrest, DNA repair and apoptosis, respectively.	p53	WAF1	1	ACTIVATION	False
7896	8010	12808092:3:YY1:SERPINE1	[TF] represses the induction of immediate-early genes to TGF-beta and BMP, such as the plasminogen activator inhibitor 1 gene ([TG]) and the inhibitor of differentiation/inhibitor of DNA binding 1 gene (Id-1).	YY1	PAI-1	2	REPRESSION	False
7897	8011	12808092:4:YY1:SERPINE1	[TF] inhibits binding of Smads to their cognate DNA elements in vitro and blocks Smad recruitment to the Smad-binding element-rich region of the [TG] promoter in vivo.	YY1	PAI-1	0	UNDEFINED	False
7898	8013	1281483:10:AP1:ELN	These observations suggest that the inhibitory effects of TNF-alpha on [TG] gene expression involve the transcription factor [TF].	AP-1	elastin	2	REPRESSION	False
7899	8014	1281483:7:AP1:ELN	Elucidation of the cis-regulatory elements in the [TG] promoter by 5' deletion construct analysis implicated a region -290 to -198 containing one [TF] binding site.	AP-1	elastin	0	UNDEFINED	False
7900	8015	12817472:6:TFAP2A:PLAUR	Transcriptional activation of the [TG] promoter region can be induced by binding of transcription factors (Sp1, AP-1, [TF], NF-kappa B).	AP-2	u-PAR	1	ACTIVATION	False
7901	8016	12820964:0:KLF8:CCND1	Identification of transcription factor [TF] as a downstream target of focal adhesion kinase in its regulation of [TG] and cell cycle progression.	KLF8	cyclin D1	0	UNDEFINED	False
7904	8019	12829700:9:REST:PAX4	Together with earlier reports, these new findings suggest an important functional role for [TF] in the expression of the [TG] gene and infer a role for NRSF in pancreatic islet development.	NRSF	pax4	0	UNDEFINED	False
7905	8020	12832487:8:GATA1:MYC	[TF] inhibited [TG] expression within 3 h, and chromatin immunoprecipitation studies indicated that GATA-1 occupies the Myc promoter in vivo, suggesting a direct mechanism for gene repression.	GATA-1	Myc	2	REPRESSION	False
7906	8021	12835324:3:YBX1:TP53	Using reporter assays we show that [TF] represses transcription of the [TG] promoter in a sequence-specific manner.	YB1	p53	2	REPRESSION	False
7907	8022	12840224:6:ZNF148:CDKN1A	This review summarizes the evidence that supports a crucial role for [TF] in butyrate regulation of p21([TG]).	ZBP-89	Waf1	0	UNDEFINED	False
7908	8023	12840224:7:ZNF148:CDKN1A	Adenovirus-mediated expression of [TF] in HT-29 cells reveals that ZBP-89 potentiates butyrate induction of endogenous p21([TG]) gene expression.	ZBP-89	Waf1	1	ACTIVATION	False
7909	8024	12842887:6:FOXM1:NR0B2	Mutation of the human [TG] promoter defined [TF], HNF-4, GATA, and AP-1 sites as important for basal activity, whereas EE induction required two distinct elements located between -309 and -267.	HNF-3	SHP	1	ACTIVATION	False
7910	8025	12842887:6:HNF4A:NR0B2	Mutation of the human [TG] promoter defined HNF-3, [TF], GATA, and AP-1 sites as important for basal activity, whereas EE induction required two distinct elements located between -309 and -267.	HNF-4	SHP	1	ACTIVATION	False
7911	8026	12852854:5:JARID2:CCND1	In contrast, jmj overexpression represses [TG] expression in cardiac cells, and [TF] protein binds to cyclin D1 promoter in vivo and represses its transcriptional activity.	Jmj	cyclin D1	2	REPRESSION	False
7912	8027	12852854:7:JARID2:CCND1	Therefore, [TF] might control cardiac myocyte proliferation and consequently cardiac morphogenesis by repressing [TG] expression.	Jmj	cyclin D1	2	REPRESSION	False
7913	8028	12853969:0:SMAD2:IL6	Transforming growth factor-beta1 activates [TG] expression in prostate cancer cells through the synergistic collaboration of the [TF], p38-NF-kappaB, JNK, and Ras signaling pathways.	Smad2	interleukin-6	1	ACTIVATION	False
7914	8029	12853969:5:SMAD2:IL6	TGF-beta1-induced [TG] gene expression was strongly inhibited by DN-[TF] but not by DN-Smad3 while it was further activated by wild-type Smad2 transfection.	Smad2	IL-6	1	ACTIVATION	False
7915	8030	12855685:4:SP3:MAOB	Overexpression of [TF] inhibited the induction of [TG] gene by Sp1, and the expression of Sp3 was decreased during Caco-2 cell differentiation.	Sp3	MAO B	2	REPRESSION	False
7916	8031	12855703:8:CDX1:B3GALT5	Four factors, [TF], Cdx2, HNF1alpha, and HNF1beta, could bind to GCE and transcriptionally activate the [TG] gene.	Cdx1	beta3Gal-T5	1	ACTIVATION	False
7917	8032	12857727:6:USF1:IGF2R	[TF] and USF2 bound the [TG] promoter in vitro, and both USF1 and USF2, but not c-Myc, were present within the IGF2R promoter-associated chromatin in vivo.	USF1	IGF2R	0	UNDEFINED	False
7918	8033	12865428:7:CLOCK:FKBP5	We found that [TF] was absolutely concerned with the circadian transcription of one type of liver genes (such as DBP, TEF, and Usp2) and partially with another (such as mPer1, mPer2, mDec1, Nocturnin, P450 oxidoreductase, and [TG]) because the latter were damped but remained rhythmic in the mutant mice.	CLOCK	FKBP51	0	UNDEFINED	False
7919	8034	12869419:7:TP53:CDKN1A	To determine the role of [TF] in [TG] transcription, a reporter construct was used consisting of a WAF1 promoter containing the p53-binding site.	p53	WAF1	0	UNDEFINED	False
7920	8035	12871225:5:AP1:MMP1	Moreover, although above deletion analysis showed that LDL-IC did not stimulate [TG] promoter activity in cells transfected with constructs that contained the proximal [TF] (-72) and Ets (-88) in the promoter fragments that are 2685-bp or less, the mutations of the -72 AP-1 or the -88 Ets motif in the construct 1 abolished the stimulation of MMP-1 expression by LDL-IC, suggesting that a long promoter sequence is required for the -72 AP-1 and -88 Ets motifs to be involved in the stimulation.	AP-1	MMP-1	1	ACTIVATION	False
7921	8036	12875982:11:JUNB:TNFRSF8	Transduction of [TF] small interfering RNAs suppressed [TG] promoter activity in L428 cells but not in control cells.	JunB	CD30	1	ACTIVATION	False
7922	8037	12875982:12:JUNB:TNFRSF8	Taken together, overexpression and binding of JunB to the [TF] site appear to relieve the repression of the core promoter by the [TG] MS in H-RS cells, which provide one basis for the constitutive overexpression of CD30 in Hodgkin's lymphoma.	AP-1	CD30	0	UNDEFINED	True
7923	8038	12875982:9:AP1:TNFRSF8	The [TF] complex contained JunB, whose overexpression activated reporter constructs driven by the [TG] promoter including the MSs, and was dependent on the AP-1 site.	AP-1	CD30	1	ACTIVATION	False
7924	8040	12882931:7:AP1:LPL	In leptin-treated J774 cells, enhanced [TG] synthetic rate and increased binding of nuclear proteins to the activated protein-1 ([TF]) consensus sequence of the LPL gene promoter were also observed.	AP-1	LPL	0	UNDEFINED	False
7925	8041	12884855:4:AP1:IL2	The [TF] and NF-AT binding activities in the [TG] promoter were comparable between wild-type and mutant T cells.	AP-1	IL-2	0	UNDEFINED	False
7927	8043	12896968:4:ETS1:NOS2	Transient transfection assays in macrophages showed that Ets-2 produced an increase in [TG] promoter activity, whereas the induction by [TF] was modest and NERF2 had no effect.	Ets-1	NOS2	1	ACTIVATION	False
7928	8044	12897849:1:CTCF:MYC	The nuclear factor [TF] was first identified as one of the factors binding to the regulatory regions of the [TG] gene.	CTCF	c-myc	0	UNDEFINED	False
7929	8045	12905745:3:AP1:SERPINE1	Through the transient transfection analysis, the roles of [TF] element (from -823 bp to -553 bp) in [TG] promoter have been determined.	AP-1	PAI-1	0	UNDEFINED	False
7930	8046	12905745:6:AP1:SERPINE1	These results indicate that the [TF] element in [TG] promoter may have important role in PAI-1 gene transcriptions in endothelial cells induced by TNF-alpha or mmLDL.	AP-1	PAI-1	0	UNDEFINED	True
7931	8048	12914528:5:CEBPB:PTGS2	Moreover, overexpression of C/EBPalpha and [TF] significantly induced [TG] promoter activity in ESC.	C/EBPbeta	COX-2	1	ACTIVATION	False
7932	8049	12914528:6:CEBPB:PTGS2	Collectively, these results suggest that the basal and MECM-induced transcription of the [TG] gene in ESC is regulated through a combination of the CRE and the [TF] site by functional interactions of C/EBPalpha and C/EBPbeta.	NF-IL6	COX-2	1	ACTIVATION	True
7933	8050	12914794:5:JUN:CXCL2	We also provided evidence that NF-kappaB and [TF] contributes to the expression of [TG] gene in response to CpG-ODN, since ectopical expression of NF-kappaB and c-Jun in RAW 246.7 cells leads to dramatically increase the ability of CpG-ODN 1826(S) in MIP-2 promoter activity.	c-Jun	MIP-2	1	ACTIVATION	False
7934	8051	12925527:0:IFI16:CDKN1A	[TF] as a negative regulator in the regulation of p53 and p21([TG].	IFI16	Waf1)	2	REPRESSION	False
7935	8052	12925527:4:IFI16:CDKN1A	Here we report that the inhibition of endogenous [TF] expression by small interfering RNA (siRNA) induces [TG]Waf1 mRNA and protein expression through p53 but does not induce pro-apoptotic p53 target genes.	IFI16	p21	2	REPRESSION	False
7936	8053	12925527:4:TP53:CDKN1A	Here we report that the inhibition of endogenous IFI16 expression by small interfering RNA (siRNA) induces [TG]Waf1 mRNA and protein expression through [TF] but does not induce pro-apoptotic p53 target genes.	p53	p21	1	ACTIVATION	False
7937	8054	12925527:6:IFI16:CDKN1A	We also showed that the repression of [TF] affects p53 transcriptional activity at the [TG] promoter as well as the protein stability of p53 and p21.	IFI16	p21	0	UNDEFINED	False
7938	8055	12925527:6:TP53:CDKN1A	We also showed that the repression of IFI16 affects [TF] transcriptional activity at the [TG] promoter as well as the protein stability of p53 and p21.	p53	p21	0	UNDEFINED	False
7939	8056	12934104:9:PPARG:BRCA1	Our data suggest that [TF] is a crucial gene regulating [TG] gene expression and might therefore be important for the BRCA1 regulatory pathway involved in the pathogenesis of sporadic breast and ovarian cancer.	PPARgamma	BRCA1	0	UNDEFINED	False
7940	8057	12934105:6:TP53:CDKN1A	This was confirmed by showing that p73alphaR292H no longer stimulated [TG]/p21 expression in MCF7/R-A1 cells that expressed a transcriptional inactive mutant of [TF].	p53	Waf1	1	ACTIVATION	False
7941	8058	12937171:10:MYC:CDK2	Consistent with the notion that [TF] could down-regulate p27 and activate [TG], p27 level is decreased while both cyclin A and cyclin E-associated kinase activities are up-regulated in BPV-1 E7-expressing cells.	c-Myc	Cdk2	1	ACTIVATION	False
7942	8059	12939282:7:AP1:CYR61	Further analyses of transcriptional mechanisms underlying [TG] gene expression under hypoxia demonstrated that an [TF] binding motif within the Cyr61 promoter plays a central role in the hypoxic regulation of Cyr61.	AP-1	Cyr61	0	UNDEFINED	False
7943	8060	12943987:6:AP1:DIO3	In addition, we identified a conserved enhancer located 3' of the gene containing putative [TF] and serum response elements, and that further increases the serum responsiveness of the [TG] promoter in a cell-specific manner.	AP-1	Dio3	1	ACTIVATION	True
7944	8061	12947119:0:CEBPB:LDLR	Specific interaction of Egr1 and [TF] leads to the transcriptional activation of the [TG] gene.	c/EBPbeta	human low density lipoprotein receptor	1	ACTIVATION	False
7945	8062	12947119:10:CEBPB:LDLR	Taken together, we provide strong evidence that Egr1 regulates [TG] transcription via a novel mechanism of protein-protein interaction with [TF].	c/EBPbeta	LDLR	0	UNDEFINED	False
7946	8063	12947119:4:CEBPB:LDLR	Here, we show that treating HepG2 cells with OM specifically leads to prominent increases of the levels of [TF] and Egr1 bound to the [TG] promoter in vivo.	c/EBPbeta	LDLR	0	UNDEFINED	False
7947	8064	12960165:3:AP1:PRDX1	TPA-dependent induction of [TG] gene expression was mediated by two proximal activator protein-1 sites of the rat Prx I promoter region that were nuclear targets of [TF] as determined by transfection studies with luciferase reporter gene constructs and electrophoretic mobility shift assays.	c-Jun	Prx I	1	ACTIVATION	False
7948	8066	12963476:6:HIF1A:VEGFA	FK228 induced the highest acetylation of histone H3 and H4 in the P2 region of the [TG] promoter, which includes the [TF] binding site that plays an important role in regulating the expression of VEGF gene.	hypoxia-inducible factor-1 alpha	VEGF	0	UNDEFINED	False
7949	8067	12975317:6:SP1:VEGFA	Ras-activated phosphorylated Net (P-Net) stimulates the mouse [TG] promoter through the -80 to -53 region that principally binds [TF].	Sp1	VEGF	1	ACTIVATION	True
7950	8068	12975361:6:SP1:F2R	Chromatin immunoprecipitation analysis of the [TG] promoter regions bp -365 to -329 (complex 1) and bp -206 to -180 (complex 2) demonstrated that [TF] was predominantly bound to the PAR-1 promoter in metastatic cells, whereas AP-2 was bound to the PAR-1 promoter in nonmetastatic cells.	Sp1	PAR-1	0	UNDEFINED	False
7951	8069	12975361:6:TFAP2A:F2R	Chromatin immunoprecipitation analysis of the [TG] promoter regions bp -365 to -329 (complex 1) and bp -206 to -180 (complex 2) demonstrated that Sp1 was predominantly bound to the PAR-1 promoter in metastatic cells, whereas [TF] was bound to the PAR-1 promoter in nonmetastatic cells.	AP-2	PAR-1	0	UNDEFINED	False
7952	8070	1370462:10:GATA2:EDN1	We propose that [TF] is the GATA-binding protein required for [TG] gene expression in endothelial cells.	GATA-2	PPET-1	1	ACTIVATION	False
7953	8071	1383560:0:FOS:TH	[TF] complex and c-fos transcription are involved in TPA provoked and trans-synaptic inductions of the [TG] gene: insights into long-term regulatory mechanisms.	AP-1	tyrosine hydroxylase	1	ACTIVATION	False
7954	8072	1409581:0:ETS1:CD79A	An inhibitory carboxyl-terminal domain in [TF] and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the [TG] gene.	Ets-1	mb-1	0	UNDEFINED	False
7955	8073	1416992:7:POU2F1:LPL	The observation of high affinity [TF] and NF-Y binding sites in a region of the proximal [TG] promoter which is necessary for high levels of LPL transcription suggests that these sites with their associated proteins play important functional roles in the transcriptional activation of the LPL promoter during adipocyte differentiation.	OTF-1	LPL	1	ACTIVATION	False
7956	8074	14500810:3:ETS1:CD79A	Pax-5 recruits three members of the Ets family of transcription factors: [TF], Fli-1 and GABPalpha (with GABPbeta1), to assemble ternary complexes on the [TG] promoter in vitro.	Ets-1	mb-1	0	UNDEFINED	False
7957	8075	14500810:4:ETS1:CD79A	Using the Pax-5:[TF]:DNA crystal structure as a guide, we defined amino acid requirements for transcriptional activation of endogenous [TG] genes using a novel cell-based assay.	Ets-1	mb-1	1	ACTIVATION	True
7958	8076	14507857:12:HIF1A:PTGS2	Maximum [TF] and NF-kappaB DNA binding immediately before [TG] expression suggests that these TFs are important regulators of COX-2 induction in hypoxic RF/6A cells.	HIF-1	COX-2	1	ACTIVATION	False
7959	8077	14507857:12:NFKB:PTGS2	Maximum HIF-1 and [TF] DNA binding immediately before [TG] expression suggests that these TFs are important regulators of COX-2 induction in hypoxic RF/6A cells.	NF-kappaB	COX-2	1	ACTIVATION	False
7960	8078	14512876:6:SMAD3:COL1A2	Transient transfection assays indicated that IFN-alpha decreased the steady-state levels of [TG] messenger RNA (mRNA) and inhibited basal and TGF-beta/[TF]-stimulated COL1A2 transcription in activated hepatic stellate cells (HSC).	Smad3	COL1A2	1	ACTIVATION	False
7962	8080	14517211:6:TP53:CDKN1A	The DDATHF-stabilized [TF] bound to the [TG] promoter in vitro and in vivo but did not activate histone acetylation over the p53 binding sites in the p21 promoter that is an integral part of the transcriptional response mediated by the DNA damage pathway.	p53	p21	0	UNDEFINED	False
7963	8081	14519134:0:FOSL1:MMP1	[TF] targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the [TG] promoter.	Fra-1	MMP-1	0	UNDEFINED	True
7964	8082	14520699:6:CREB1:CDKN1A	[TF]/ATF defective Tax mutant (M47) activated the [TG] promoter significantly less efficiently.	CREB	p21	1	ACTIVATION	False
7965	8085	14525978:4:CDX1:MUC2	To evaluate the role of [TF] and Cdx-2 in [TG] transcription we performed co-transfection experiments with expression vectors encoding Cdx-1 and Cdx-2.	Cdx-1	MUC2	0	UNDEFINED	False
7966	8086	14550764:4:POU3F1:CXCR4	We also provide evidence that the POU box transcription factor [TF]/SCIP is involved in the control of [TG] transcription.	Oct-6	CXCR4	0	UNDEFINED	False
7967	8087	14551209:4:SMAD1:MSX2	Lef1 can synergize with Smad4 and [TF] to activate [TG] promoter, and this transcriptional complex is assembled on the endogenous promoter in response to BMP2.	Smad1	Msx2	1	ACTIVATION	False
7968	8088	14555539:11:PPARG:PTGS2	Transient transfection results indicated that EGF stimulated whereas [TF] ligands inhibited [TG] promoter (-327/+59) activity.	PPARgamma	COX-2	2	REPRESSION	False
7969	8089	14555539:15:PPARG:PTGS2	The ability of [TF] ligands to inhibit [TG] appears to be mediated predominantly through inhibition of AP-1 protein binding to the CRE site in the COX-2 promoter.	PPARgamma	COX-2	2	REPRESSION	False
7971	8091	14562055:9:POU2F1:PDRG1	Indeed, UV as well as exogenous [TF] independently increased [TG] promoter activity, suggesting that UV could mediate PDRG upregulation via Oct-1.	Oct-1	PDRG	1	ACTIVATION	False
7972	8092	14565864:3:NFE2:TBXAS1	We previously showed that p45 [TF] activated the [TG] promoter in hematopoietic cells via binding to the nucleotides -86/-77 from the transcriptional start site [Yaekashiwa and Wang (2002) J. Biol. Chem. 277, 22497-22508].	NF-E2	TXAS	1	ACTIVATION	False
7973	8093	14570593:11:SMAD4:MUC5AC	By gel-retardation and co-transfection assays, we identified Sp1 and Sp3 as important regulators of [TG] expression and showed that [TF] and Sp1 act in a co-operative manner to transactivate Muc5ac promoter activity.	Smad4	Muc5ac	1	ACTIVATION	False
7974	8094	14570593:11:SP3:MUC5AC	By gel-retardation and co-transfection assays, we identified Sp1 and [TF] as important regulators of [TG] expression and showed that Smad4 and Sp1 act in a co-operative manner to transactivate Muc5ac promoter activity.	Sp3	Muc5ac	1	ACTIVATION	False
7975	8095	14575638:10:AP1:MMP13	Previous studies showed that palytoxin simulates an ERK-dependent selective increase in the c-Fos content of [TF] complexes that bind to the promoter of the [TG] gene.	AP-1	MMP-13	0	UNDEFINED	False
7976	8097	14580148:12:BACH1:HMOX1	We discuss the potential regulatory role of [TF] and HO-2 in heme catabolism and update the understanding of the regulation of [TG] expression.	Bach1	HO-1	0	UNDEFINED	False
7977	8098	14580148:8:BACH1:HMOX1	The recent discovery of [TF] as a heme-regulated and hypoxia-inducible repressor for transcription of the [TG] gene has provided a missing link in the feedback control of heme catabolism.	Bach1	HO-1	2	REPRESSION	False
7978	8099	14583449:4:TP53:DNMT1	A [TF] consensus binding site in exon 1 of the human [TG] bound recombinant p53 in vitro and endogenous p53 in vivo in the absence of stimuli that activate p53, implying that p53 controls Dnmt1transcription through direct DNA binding.	p53	Dnmt1gene	0	UNDEFINED	False
7979	8100	14583614:6:HNF4A:BAAT	[TF] was found to bind directly to the mouse VLACSR and [TG] gene promoters, and the promoter activities were dependent on HNF4alpha-binding sites and HNF4alpha expression.	HNF4alpha	BAT	1	ACTIVATION	False
7980	8101	14585504:6:EGR1:PSEN2	[TF] represses [TG]-P1 activity by 50% in neuronal cells, suggesting it partially shifts promoter usage from PSEN2-P1 to PSEN2-P2.	Egr-1	PSEN2	2	REPRESSION	False
7981	8102	14585961:0:SP1:MSH6	Regulation of the human [TG] gene by the [TF] transcription factor and alteration of promoter activity and expression by polymorphisms.	Sp1	MSH6	0	UNDEFINED	False
7982	8103	14592829:8:AP1:SERPINE1	Taken together, these data indicate that, in response to T beta 4 stimulation, [TF] activity increases to enhance [TG] transcription through its unique AP-1-like element at -59 to -52 in the PAI-1 promoter.	AP-1	PAI-1	1	ACTIVATION	False
7983	8104	14593102:0:CREB1:CEBPB	Role of [TF] in transcriptional regulation of [TG] gene during adipogenesis.	CREB	CCAAT/enhancer-binding protein beta	0	UNDEFINED	False
7984	8105	14593102:6:ATF1:CEBPB	Consistent with the interaction of CREB and [TF] at the TGA regulatory elements, expression of constitutively active CREB strongly activated [TG] promoter-reporter genes, induced expression of endogenous C/EBPbeta, and caused adipogenesis in the absence of the hormonal inducers normally required.	ATF1	C/EBPbeta	1	ACTIVATION	False
7985	8106	14593102:6:CREB1:CEBPB	Consistent with the interaction of [TF] and ATF1 at the TGA regulatory elements, expression of constitutively active CREB strongly activated [TG] promoter-reporter genes, induced expression of endogenous C/EBPbeta, and caused adipogenesis in the absence of the hormonal inducers normally required.	CREB	C/EBPbeta	1	ACTIVATION	False
7986	8107	14597566:0:SP1:VEGFA	Helicobacter pylori stimulates host [TG] (vegf-A) gene expression via MEK/ERK-dependent activation of [TF] and Sp3.	Sp1	vascular endothelial growth factor-A	1	ACTIVATION	False
7987	8108	14597566:0:SP3:VEGFA	Helicobacter pylori stimulates host [TG] (vegf-A) gene expression via MEK/ERK-dependent activation of Sp1 and [TF].	Sp3	vascular endothelial growth factor-A	1	ACTIVATION	False
7988	8109	14602779:2:AP1:VEGFA	Hypoxia activates the [TG] promoter via response elements that bind the transcription factors hypoxia-inducible factor-1 alpha (HIF-1 alpha) and activator protein-1 ([TF]).	AP-1	VEGF	1	ACTIVATION	False
7989	8110	14602779:2:HIF1A:VEGFA	Hypoxia activates the [TG] promoter via response elements that bind the transcription factors hypoxia-inducible factor-1 alpha ([TF]) and activator protein-1 (AP-1).	HIF-1 alpha	VEGF	1	ACTIVATION	False
7990	8111	14614448:3:TP53:CDKN1A	The expression of DeltaNp73alpha in the [TF]-/- cell line H1299 reduced the mRNA levels of p21/[TG], but did not affect other p53-responsive genes.	p53	CDKN1A	0	UNDEFINED	True
7991	8112	14614455:9:TP53:CDKN1A	Stimulation of p73-mediated transactivation by PCAF requires the HAT domain of PCAF and the [TF]-binding site within the [TG] promoter.	p53	p21	0	UNDEFINED	True
7992	8113	14623878:0:TP53:TNFSF10	Tumor necrosis factor-related apoptosis-inducing ligand ([TG]) decoy receptor TRAIL-R3 is up-regulated by [TF] in breast tumor cells through a mechanism involving an intronic p53-binding site.	p53	TRAIL	1	ACTIVATION	True
7993	8114	14623928:1:JUN:BCL2	We describe the application of the biomolecular interaction (BIA) technique to detection of the interaction between protein (e.g., c-Jun) and DNA (e.g., two [TF] from [TG] promoter), compared with immunohistochemistry (IHC) of c-Jun.	AP-1 motifs	bcl-2	0	UNDEFINED	False
7994	8115	14627819:0:TCF3:NR0B2	Synergistic activation of the human orphan nuclear receptor [TG] gene promoter by basic helix-loop-helix protein [TF] and orphan nuclear receptor SF-1.	E2A	SHP	1	ACTIVATION	False
7995	8116	14627819:3:TCF3:NR0B2	In this study, we have found that basic helix-loop-helix (bHLH) transcription factors, the E2A proteins ([TF], E12 and E2/5), activated the human but not the mouse [TG] promoter.	E47	SHP	1	ACTIVATION	False
7997	8118	14627819:5:TCF3:NR0B2	Using serial deletions and E-box mutant constructs of the h[TG] promoter, we identified two E-boxes (E6 and E7) as [TF]-responsive E-boxes, which are not conserved in the mouse SHP promoter.	E47	SHP	0	UNDEFINED	False
7998	8119	14627819:6:TCF3:NR0B2	Moreover, gel shift, chromatin immunoprecipitation (ChIP) and northern blot assays demonstrated that [TF] directly binds to the h[TG] promoter in vivo and in vitro and that Id proteins inhibited E47 binding to the hSHP promoter.	E47	SHP	0	UNDEFINED	False
7999	8120	14627819:7:TCF3:NR0B2	Finally, we found that [TF] and steroidogenic factor 1 (SF-1), a regulator of the [TG] promoter, synergistically activate the human but not the mouse SHP promoter.	E47	SHP	1	ACTIVATION	False
8000	8121	14627819:8:TCF3:NR0B2	Our findings suggest that the [TF] proteins differentially regulate the human and mouse [TG] promoters and cooperate with orphan nuclear receptor SF-1 for transcriptional activation of the hSHP promoter.	E2A	SHP	1	ACTIVATION	False
8001	8122	14635196:10:TP53:CDKN1A	The p21/[TG] promoter activity was greatly enhanced by the transfection of [TF].	p53	WAF1	1	ACTIVATION	False
8002	8123	14644095:5:MYC:PIGR	Transient transfection of [TG] promoter reporter plasmids in intestinal epithelial cell (IEC) lines suggested that the transcription factors upstream stimulatory factor (USF) and [TF] may exert opposing effects on PIGR promoter activity.	c-Myc	PIGR	0	UNDEFINED	False
8003	8126	14645547:0:ZBTB16:MYC	Growth suppression by acute promyelocytic leukemia-associated protein [TF] is mediated by repression of [TG] expression.	PLZF	c-myc	2	REPRESSION	False
8004	8127	14645547:7:ZBTB16:MYC	An interaction between [TF] and the [TG] promoter could be detected both in vitro and in vivo.	PLZF	c-myc	0	UNDEFINED	False
8005	8128	14645547:9:ZBTB16:MYC	[TF] binding in vivo was coincident with a decrease in RNA polymerase occupation of the [TG] promoter, indicating that repression occurred via a reduction in the initiation of transcription.	PLZF	c-myc	2	REPRESSION	False
8006	8129	14646597:0:NFKB:PPARG	[TF] is involved in the TNF-alpha induced inhibition of the differentiation of 3T3-L1 cells by reducing [TG] expression.	NF-kappaB	PPARgamma	2	REPRESSION	False
8007	8130	14647449:7:SP1:VEGFA	Moreover, E2-dependent activation of constructs containing proximal and distal GC/GT-rich regions of the [TG] promoter was inhibited in ZR-75 cells transfected with small inhibitory RNAs for [TF] and Sp3.	Sp1	VEGF	1	ACTIVATION	False
8008	8131	14647449:7:SP3:VEGFA	Moreover, E2-dependent activation of constructs containing proximal and distal GC/GT-rich regions of the [TG] promoter was inhibited in ZR-75 cells transfected with small inhibitory RNAs for Sp1 and [TF].	Sp3	VEGF	1	ACTIVATION	False
8009	8132	14652633:0:FOXM1:PROS1	Characterization of the human [TG] gene promoter: a possible role of transcription factors Sp1 and [TF] in liver.	HNF3	protein S	0	UNDEFINED	False
8010	8133	14652633:5:FOXM1:PROS1	Isolation and analysis of tissue-specific gene expression in HepG2 and HeLa cells of the 5'-flanking region from -6183 to +294 of the [TG] gene indicated that the consensus binding motifs to [TF] and Sp1 or MAZ transcription factors in the flanking region are essential for protein S gene expression.	HNF3	protein S	1	ACTIVATION	True
8011	8134	14652633:7:FOXM1:PROS1	Taken together, we would conclude that transcription factors of [TF], MAZ, and Sp1 are required for high-level expression of the [TG] gene in hepatic cells, but in non-hepatic cells such as HeLa cells, an unknown factor(s) binds to the Sp1 region and disturbs the action of Sp1 and MAZ.	HNF3	protein S	1	ACTIVATION	False
8012	8135	14654367:0:SRF:TAGLN	Interaction of Smad3 and [TF]-associated complex mediates TGF-beta1 signals to regulate [TG] transcription during myofibroblast differentiation.	SRF	SM22	0	UNDEFINED	False
8013	8136	14654367:4:SMAD6:TAGLN	Interestingly, Smad3, not Smad2, is the primary mediator for TGF-beta1-induced transactivation of the [TG] promoter, while [TF] and Smad7 repress such a transactivation.	Smad6	SM22	2	REPRESSION	False
8014	8137	14654367:4:SMAD7:TAGLN	Interestingly, Smad3, not Smad2, is the primary mediator for TGF-beta1-induced transactivation of the [TG] promoter, while Smad6 and [TF] repress such a transactivation.	Smad7	SM22	2	REPRESSION	False
8015	8138	14654702:7:ZNF148:STAT1	Taken together, we conclude that [TF] is required for constitutive [TG] expression and in this way contributes to the ability of cells to be activated by IFNgamma.	ZBP-89	STAT1	1	ACTIVATION	False
8016	8139	14660559:2:USF2:PTGS2	To directly study the ability of upstream stimulatory factor 1 (USF1) and [TF] to trans-activate the bovine [TG] promoter in granulosa cells, USF1 or USF2 expression vectors were cotransfected with the PGHS-2/luciferase (LUC) chimeric construct, -149/-2PGHS-2.LUC.	USF2	PGHS-2	1	ACTIVATION	True
8019	8142	14662796:9:SP3:VEGFA	[TG] expression in Leydig cells is regulated by gonadotropin via a cAMP-dependent mechanism, and the transcription factors Sp1 and [TF] appear to be involved in the activation of the promoter.	Sp3	VEGF	1	ACTIVATION	False
8020	8143	14669984:6:USF1:CTSB	Chromatin immunoprecipitation assays revealed that both [TF] and USF-2 were associated with the [TG] promoter.	USF-1	cathepsin B	0	UNDEFINED	False
8021	8144	14669984:6:USF2:CTSB	Chromatin immunoprecipitation assays revealed that both USF-1 and [TF] were associated with the [TG] promoter.	USF-2	cathepsin B	0	UNDEFINED	False
8022	8145	14669984:7:USF1:CTSB	The roles of [TF] and USF-2 in the regulation of [TG] expression were demonstrated by (i) co-transfection experiments showing that USF-1 or USF-2 increased promoter activity by 2.5-fold individually and by 3.4-fold together; (ii) co-transfection of pSCB6 with pUSF-2deltaN (a dominant negative USF-2 expression plasmid) resulting in an 80% decrease in promoter activity; and (iii) mutation of the E-box element (from 5'-CACGTG to 5'-CGCGTT in the pSCB6 basal promoter construct) abolishing transactivation of cathepsin B by USF-1 and USF-2.	USF-1	cathepsin B	1	ACTIVATION	False
8023	8146	14669984:7:USF2:CTSB	The roles of USF-1 and [TF] in the regulation of [TG] expression were demonstrated by (i) co-transfection experiments showing that USF-1 or USF-2 increased promoter activity by 2.5-fold individually and by 3.4-fold together; (ii) co-transfection of pSCB6 with pUSF-2deltaN (a dominant negative USF-2 expression plasmid) resulting in an 80% decrease in promoter activity; and (iii) mutation of the E-box element (from 5'-CACGTG to 5'-CGCGTT in the pSCB6 basal promoter construct) abolishing transactivation of cathepsin B by USF-1 and USF-2.	USF-2	cathepsin B	1	ACTIVATION	False
8025	8148	14669984:8:USF2:CTSB	These results collectively indicate that an E-box at nucleotides -7 to -2 of the [TG] promoter is critical to the expression of cathepsin B and that binding of USF-1 and [TF] to this E-box can regulate cathepsin B promoter activity.	USF-2	cathepsin B	0	UNDEFINED	False
8026	8149	14672953:7:HNF4A:ANG	SHP repressed human [TG] promoter activity only when the [TF] expression vector was cotransfected in HeLa cells.	HNF-4	ANG	2	REPRESSION	True
8027	8150	14672953:7:NR0B2:ANG	[TF] repressed human [TG] promoter activity only when the HNF-4 expression vector was cotransfected in HeLa cells.	SHP	ANG	2	REPRESSION	False
8028	8151	14672953:8:HNF4A:ANG	Furthermore, we found that SHP bound to the [TF] N-terminal region including the DNA-binding domain and activation function-1 and that SHP prevented HNF-4 from binding to the human [TG] promoter.	HNF-4	ANG	0	UNDEFINED	False
8029	8152	14672953:8:NR0B2:ANG	Furthermore, we found that [TF] bound to the HNF-4 N-terminal region including the DNA-binding domain and activation function-1 and that SHP prevented HNF-4 from binding to the human [TG] promoter.	SHP	ANG	0	UNDEFINED	False
8030	8153	14672953:9:HNF4A:ANG	These results suggest that bile acids negatively regulate the human [TG] gene through the inhibitory effect of SHP on [TF].	HNF-4	ANG	1	ACTIVATION	True
8031	8154	14673954:17:STAT3:MMP14	From these data, we conclude that FGF-1 induces [TG] expression in prostate carcinoma cells through a transcriptional mechanism mediated through the FGFR and the transcription factor, [TF].	STAT3	MT1-MMP	1	ACTIVATION	False
8032	8155	14684847:0:FOS:PGR	[TF] and Jun inhibit estrogen-induced transcription of the human [TG] gene through an activator protein-1 site.	Fos	progesterone receptor	2	REPRESSION	False
8033	8156	14689584:5:NFKB:CCND1	[TF] may promote cell growth and proliferation in prostate cancer cells by regulating expression of genes such as c-myc, [TG], and IL-6.	NF-kappaB	cyclin D1	0	UNDEFINED	False
8034	8157	14693245:9:NFKB:FAS	Our results suggest that [TF] activated at early stages in the okadaic acid-treated SCC-25 cells stimulated the promoter activity of [TG] in the cells leading to the apoptotic death of these cells.	NF-kappaB	Fas receptor	1	ACTIVATION	False
8035	8158	14698140:6:STAT3:IL3RA	These results suggest that [TF] may play a role in the differentiation of myeloid cells by regulating [TG] expression.	Stat3	IL-3R	0	UNDEFINED	False
8036	8159	14699103:6:HIF1A:VEGFA	The effects of LXR ligands on [TG] expression were independent of hypoxia-inducible factor [TF] activation and did not require the previously characterized hypoxia response element in the VEGF promoter.	HIF-1alpha	VEGF	0	UNDEFINED	True
8037	8160	14699103:8:NR1H2:VEGFA	Both LXRalpha and [TF] transactivated the [TG] promoter in transient transfection assays.	LXRbeta	VEGF	1	ACTIVATION	False
8038	8161	14699103:8:NR1H3:VEGFA	Both [TF] and LXRbeta transactivated the [TG] promoter in transient transfection assays.	LXRalpha	VEGF	1	ACTIVATION	False
8039	8162	14704274:2:ZBTB17:LDLR	As expected, depletion of [TF] resulted in the inhibition of T113242-dependent activation of the [TG] (LDLR) gene in hepatocytes.	MIZ-1	low-density lipoprotein receptor	1	ACTIVATION	False
8040	8163	14704274:7:ZBTB17:LDLR	Taken together, our studies suggest that [TF] regulates a specific set of genes that includes [TG] and that the ERK pathway plays a role in the activation of target promoters by MIZ-1.	MIZ-1	LDLR	1	ACTIVATION	True
8041	8164	14706452:5:E2F1:CTNNB1	Subsequently, protein/DNA array analyses identified numerous other transcription factors through their high-affinity binding to the [TG] promoter, including [TF], NFkappaB, MEF1, Pax5, ISRE2, Smad3/4, GATA, and ZIC.	E2F1	Ctnnb1	0	UNDEFINED	False
8042	8165	14706452:5:NFKB:CTNNB1	Subsequently, protein/DNA array analyses identified numerous other transcription factors through their high-affinity binding to the [TG] promoter, including E2F1, [TF], MEF1, Pax5, ISRE2, Smad3/4, GATA, and ZIC.	NFkappaB	Ctnnb1	0	UNDEFINED	False
8043	8166	14706456:4:TFAP2A:GPRC5A	A functional analysis of the [TG] gene promoter revealed that the proximal region harbors most of the elements necessary for its regulation, including GC boxes and Sp1-, AP1-, and [TF].	AP2-binding sites	Rai3	0	UNDEFINED	False
8044	8167	14722112:4:TP53:CDKN1A	The [TF]-dependent p21([TG]/Cip1) expression induced by 5-aza-CdR was not seen in A549 cells transfected with the wild-type human papilloma virus type-16 E6 gene that induces p53 degradation.	p53	Waf1	1	ACTIVATION	False
8046	8169	14729276:7:POU2F1:CSN2	However, this truncated isoform could still effectively bind to a consensus Oct-1 motif oligonucleotide and, like [TF], activated the basal promoter activity of the [TG] gene.	Oct-1B	mouse beta-casein	1	ACTIVATION	False
8047	8170	14735145:8:ETS2:IL2	Electrophoretic mobility shift assays confirmed cross-reactivity between the unknown repressor and anti-ets-2 antibodies, and cotransfection experiments demonstrated the direct involvement of [TF] in silencing the [TG] promoter.	Ets-2	IL-2	2	REPRESSION	False
8048	8171	14735146:10:STAT1:PSMB9	These results indicate that both [TF] and IRF-1 are required for the IFN-gamma induction of Tap-1 and [TG] genes.	STAT1	Lmp-2	1	ACTIVATION	False
8049	8172	14735146:10:STAT1:TAP1	These results indicate that both [TF] and IRF-1 are required for the IFN-gamma induction of [TG] and Lmp-2 genes.	STAT1	Tap-1	1	ACTIVATION	False
8050	8173	14739090:11:FOXA2:SLCO1B3	[TF] represses transcription of the [TG] but not the OATP-C gene, providing a mechanism for reduced expression of OATP8 in HCC.	HNF3beta	OATP8	2	REPRESSION	False
8052	8175	14743206:8:TP53:CDKN1A	We have found that [TF] missense mutants markedly reduce the binding of wild-type p53 to the p53 responsive element in the target genes of [TG], MDM2, and PIG3.	p53	p21	0	UNDEFINED	False
8053	8176	14744778:7:SP3:VEGFA	Our evidence suggests that AP-2 repressed transcriptionally the [TG] promoter by competing with the transcriptional activator [TF].	Sp3	VEGF	1	ACTIVATION	False
8054	8177	14747657:5:BACH1:HMOX1	Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of [TG], promotes displacement of [TF] from the MafK-occupied ho-1 enhancers, which is followed by Nrf2 binding to these elements.	Bach1	ho-1	0	UNDEFINED	False
8055	8178	14747657:5:NFE2L2:HMOX1	Using chromatin immunoprecipitation assays in NIH 3T3 cells, we show that heme, an inducer of [TG], promotes displacement of Bach1 from the MafK-occupied ho-1 enhancers, which is followed by [TF] binding to these elements.	Nrf2	ho-1	0	UNDEFINED	False
8056	8179	14747657:8:MAF:HMOX1	Heme induces switching of [TF] dimers, resulting in [TG] expression.	Maf	ho-1	0	UNDEFINED	True
8057	8180	14749357:11:NFKB:SAA3P	Overexpression of the inhibitor of [TF] (called IkappaB) blocked [TG] promoter activity induced by TNF and by p65 in OV3121-1 cells.	NF-kappaB	SAA3	1	ACTIVATION	False
8058	8181	14749357:11:RELA:SAA3P	Overexpression of the inhibitor of NF-kappaB (called IkappaB) blocked [TG] promoter activity induced by TNF and by [TF] in OV3121-1 cells.	p65	SAA3	1	ACTIVATION	False
8059	8182	14749357:9:NFKB:SAA3P	In granulosa cells from TNFR1 knockout mice, the [TG] promoter (-198/+73) was responsive to transfection with the p65 component of [TF], but neither TNF treatment nor overexpression of the p50 component of NF-kappaB increased promoter activity.	NF-kappaB	SAA3	1	ACTIVATION	False
8060	8183	14749357:9:RELA:SAA3P	In granulosa cells from TNFR1 knockout mice, the [TG] promoter (-198/+73) was responsive to transfection with the [TF] component of NF-kappaB, but neither TNF treatment nor overexpression of the p50 component of NF-kappaB increased promoter activity.	p65	SAA3	1	ACTIVATION	False
8061	8184	14749395:5:MYOD1:CDKN1A	Inducible expression of a nonphosphorylable [TF] A5/A200 enhances the MyoD interaction with the coactivator P/CAF, thereby stimulating the transcriptional activation of a luciferase reporter gene placed under the control of the [TG] promoter.	MyoD	p21	1	ACTIVATION	False
8062	8185	14749395:8:MYOD1:CDKN1A	These results show that in cycling cells [TF] functions as a transcriptional activator of [TG] and that MyoD phosphorylation is required for G(2)/M transition.	MyoD	p21	1	ACTIVATION	False
8063	8186	14764597:7:CREB1:CCND1	Interestingly overexpression of either wild-type or S37A mutant beta-catenin was unable to rescue PPARgamma2-mediated suppression of [TG] transcription, whereas overexpression of cAMP-response element-binding protein ([TF]) was capable of antagonizing this inhibitory effect of PPARgamma2.	CREB	cyclin D1	1	ACTIVATION	False
8064	8187	14764630:6:STAT3:TRH	Furthermore, using a [TF] antibody, we could immunoprecipitate the STAT-binding site containing regions of both the [TG] promoter and the promoter of the suppressor of cytokine signaling-3 gene, another well-defined target of leptin action.	STAT3	TRH	0	UNDEFINED	False
8065	8188	14767471:0:AP1:IGFBP4	Identification of a novel SP3 binding site in the promoter of human [TG] gene: role of SP3 and [TF] in regulating promoter activity in CaCo2 cells.	AP-1	IGFBP4	0	UNDEFINED	False
8066	8189	14767471:2:AP1:IGFBP4	We recently cloned and identified multiple cis elements (including putative binding sites for activator protein 1 ([TF]) and specificity proteins (Sps) ) in the promoter of human [TG] gene, and measured a significant upregulation of the promoter activity in response to c-Jun.	AP-1	BP4	1	ACTIVATION	False
8067	8191	14767471:3:AP1:IGFBP4	We therefore examined the role of the single [TF] site (-869/-863) and other cis elements, in regulating the expression of h[TG] gene, in the current studies.	AP-1	BP4	0	UNDEFINED	False
8068	8192	14966110:6:CEBPB:PTGS2	Coimmunoprecipitation experiments suggest a role for p300 in [TF] acetylation and [TG] expression.	C/EBP-beta	COX-2	0	UNDEFINED	False
8069	8193	14966110:7:CEBPB:PTGS2	In contrast, E1A inhibits acetylation of [TF] and is correlated with decreased [TG] expression.	C/EBP-beta	COX-2	1	ACTIVATION	False
8070	8194	14966110:9:CEBPB:PTGS2	Concomitantly, [TF] becomes acetylated, and expression of the [TG] gene increases.	C/EBP-beta	COX-2	1	ACTIVATION	True
8071	8195	14976041:5:STAT3:JAK3	Additionally, ectopic overexpression of [TF] enhanced [TG] promoter activity in M1 cells.	Stat3	Jak3	1	ACTIVATION	False
8072	8196	14982724:10:STAT1:LAT	These results indicate that [TF], probably as part of a complex, is capable of binding to the [TG] promoter on or near the TATA box.	STAT1	LAT	0	UNDEFINED	False
8073	8197	14982724:11:STAT1:LAT	Further studies are required to determine if [TF] is required for [TG] expression in vivo.	STAT1	LAT	1	ACTIVATION	False
8074	8198	14986113:8:GATA5:MUC5B	mRNA levels of MUC2, MUC3, and MUC4 were increased, whereas those of MUC1, MUC5AC, [TG], and MUC6 remained unchanged upon the overexpression of [TF] in both COS-7 and 293T cells.	GATA-5	MUC5B	1	ACTIVATION	False
8075	8199	14990565:4:LEF1:SPP1	Here we report that beta-catenin, [TF], Ets transcription factors, and the AP-1 protein c-Jun each weakly enhanced luciferase expression from a [TG] promoter-luciferase reporter construct, transiently transfected into a rat mammary cell line.	Lef-1	OPN	1	ACTIVATION	False
8076	8200	14993931:4:JUN:CTSK	Factors that directly modulate osteoclastic bone resorption, including cytokines (RANK ligand, tumor necrosis factor-alpha and interferon gamma), hormones (retinoic acid and estrogen) and nuclear transcriptional factors ([TF] and Mitf) also regulate [TG] gene expression.	c-jun	cathepsin K	0	UNDEFINED	False
8077	8201	14996741:6:AP1:CP	Furthermore, deletion studies revealed an activator protein-1 ([TF]) site in the [TG] promoter to be critical for optimal ceruloplasmin promoter activity.	AP-1	ceruloplasmin	1	ACTIVATION	False
8078	8202	14998783:3:SP3:LDLR	The pig [TG] gene promoter includes three putative Sp1/[TF]-binding sites and one sterol response element (SRE) site 5' upstream to the transcriptional start site.	Sp3	LDLR	0	UNDEFINED	False
8079	8203	14998994:11:SPI1:OPRM1	This increase is probably mediated through modification of the chromatin structure, as suggested by the reversal of the [TF]-mediated repression of [TG] promoter activity after trichostatin A treatment in neuroblastoma NMB cells.	PU.1	MOR	2	REPRESSION	False
8080	8204	15003510:9:ETS1:ANG	These results indicate that [TF] and the corresponding EBS are critical for the induction of [TG].	Ets-1	Ang-2	1	ACTIVATION	False
8081	8205	15004182:8:STAT6:TFF3	Although only one consensus [TF] binding site is contained in the [TG] gene, located in the intron 1, it did not operate as an enhancer in the context of an SV40 promoter/luciferase construct.	STAT6	TFF3	0	UNDEFINED	False
8082	8206	15009091:2:TP53:CDKN1A	DNA damage activates the [TF]-dependent checkpoint pathway that induces expression of [TG]/WAF1, resulting in cell cycle arrest at G1/S transition by inhibition of cdk activity and DNA replication.	p53	p21Cip1	1	ACTIVATION	False
8083	8207	15013430:5:NFKB:PTGS2	Here we show that CDX2 down-regulates [TG] promoter activity by interacting with [TF].	NF-kappaB	COX-2	2	REPRESSION	False
8084	8208	15013430:9:NFKB:PTGS2	These results suggest that reduced CDX2 expression may be involved in colorectal carcinogenesis by enhancing [TF]-mediated inflammatory genes such as [TG].	NF-kappaB	COX-2	1	ACTIVATION	False
8085	8209	15016316:6:NFKB:PTGS2	It is known that Akt may act through [TF] pathway and that [TG] gene has been shown to be regulated at the promoter level by NF-kappaB.	NF-kappaB	COX-2	0	UNDEFINED	False
8086	8210	15016801:5:TP53:PTTG1	Reporter and chromatin immunoprecipitation assays demonstrated that [TF] can suppress the promoter activities of three further studied candidate genes PLK, [TG], and CHEK1 but would only bind directly to PTTG1 and CHEK1 promoters, revealing that p53 can repress gene expression through both direct and indirect mechanisms.	p53	PTTG1	2	REPRESSION	False
8087	8211	15021909:0:MYC:DDIT3	[TF] represses the proximal promoters of GADD45a and [TG] by a post-RNA polymerase II recruitment mechanism.	c-Myc	GADD153	2	REPRESSION	False
8088	8212	15021909:4:MYC:DDIT3	We show that [TF] represses the expression of GADD45a and [TG] in response to thapsigargin, a nongenotoxic stress, as well as other endoplasmic reticulum (ER) stress agents.	c-Myc	GADD153	2	REPRESSION	False
8089	8213	15023995:11:PPARG:EGR1	These data define mPGES-1 and [TG] as novel targets of [TF] and suggest that inhibition of mPGES-1 gene transcription may be one of the mechanisms by which PPARgamma regulates inflammatory responses.	PPARgamma	Egr-1	0	UNDEFINED	False
8090	8214	15024021:7:TP53:CDKN1A	Expression of exogenous Plk1 and [TF] in p53-deficient lung carcinoma H1299 cells greatly decreased the p53-mediated transcription from the p53-responsive p21([TG]), MDM2, and BAX promoters, whereas the kinase-deficient mutant form of Plk1 failed to reduce the transcriptional activity of p53.	p53	WAF1	2	REPRESSION	True
8091	8215	15025563:3:AP1:IVL	Binding sites for [TF] (activator protein 1) and Sp1 transcription factors were shown to be important for [TG] promoter activity and tissue-specific expression.	AP-1	involucrin	1	ACTIVATION	False
8092	8216	15026340:7:SP1:VEGFA	[TG] promoter deletion and point mutation analyses indicated that a region between nucleotide -109 and -61 and its intact [TF]-binding sites were required for the inhibition of VEGF promoter activity by celecoxib.	Sp1	VEGF	2	REPRESSION	False
8093	8217	15031282:8:KLF4:PLAUR	Mobility-shifting experiments demonstrated binding of [TF] to multiple regions of the [TG] promoter (-154/-128, -105/-71, and -51/-24), and chromatin immunoprecipitation assays confirmed the binding of KLF4 to the endogenous promoter.	KLF4	u-PAR	0	UNDEFINED	False
8094	8218	15031282:9:KLF4:PLAUR	Deletion of the -144/-123 promoter region diminished but did not eliminate the ability of [TF] to transactivate the [TG] promoter, suggesting cooperativity of these binding sites with respect to activation of gene expression.	KLF4	u-PAR	1	ACTIVATION	False
8095	8219	15039660:5:AP1:VEGFA	Some of them (e.g. HIF-1, [TF], and Sp-1) are transcription factors, proteins that bind to the [TG] promoter to initiate and activate the transcription of a gene directly.	AP-1	VEGF	1	ACTIVATION	False
8096	8220	15039660:5:HIF1A:VEGFA	Some of them (e.g. [TF], AP-1, and Sp-1) are transcription factors, proteins that bind to the [TG] promoter to initiate and activate the transcription of a gene directly.	HIF-1	VEGF	1	ACTIVATION	False
8097	8221	15039660:5:SP1:VEGFA	Some of them (e.g. HIF-1, AP-1, and [TF]) are transcription factors, proteins that bind to the [TG] promoter to initiate and activate the transcription of a gene directly.	Sp-1	VEGF	1	ACTIVATION	False
8098	8223	15047604:6:FOXO3:PDK4	A glucocorticoid response element for glucocorticoid receptor (GR) binding and three insulin response sequences (IRSs) that bind FOXO1a and [TF] are identified in the h[TG] promoter.	FOXO3a	PDK4	0	UNDEFINED	False
8099	8224	15048076:5:E2F1:CDKN1A	We confirmed direct interaction of [TF] with the proximal region of the [TG] promoter.	E2F-1	p21	0	UNDEFINED	False
8100	8225	15048876:11:AP1:CYP4B1	The nuclear binding activity of [TF] and NFkappaB probes from the [TG] promoter was also enhanced in response to hypoxia suggesting that these transcription factors contribute to the hypoxic induction of CYP4B1 expression.	AP-1	CYP4B1	1	ACTIVATION	False
8101	8226	15048876:11:NFKB:CYP4B1	The nuclear binding activity of AP-1 and [TF] probes from the [TG] promoter was also enhanced in response to hypoxia suggesting that these transcription factors contribute to the hypoxic induction of CYP4B1 expression.	NFkappaB	CYP4B1	1	ACTIVATION	False
8102	8227	15048879:10:SP1:TIMP1	Therefore, this study suggests that [TF] is involved in the regulation of the [TG] promoter in the presence of cobalt ion as well as in the basal level transcription.	Sp1	TIMP-1	0	UNDEFINED	False
8104	8230	15057274:0:SRF:BCL2	[TF] regulates [TG] expression and promotes cell survival during murine embryonic development.	SRF	Bcl-2	0	UNDEFINED	False
8105	8231	15057274:5:SRF:BCL2	[TF] binds the [TG] promoter in vivo and activates Bcl-2 transcription.	SRF	Bcl-2	1	ACTIVATION	False
8106	8232	15057274:7:SRF:BCL2	At the multicellular level, [TF] deficiency leads to impaired cavitation and reduced [TG] expression in embryoid bodies (EBs) and inappropriate apoptosis in both EBs and pregastrulation mouse embryos.	SRF	Bcl-2	1	ACTIVATION	False
8107	8233	15060276:9:ASCL1:BUB1	Our data indicate that [TF] negatively regulates the cell cycle (e.g., via enhanced Cdkn2d, [TG] expression), promotes differentiation (e.g., through effects on cAMP), and enhances survival by inhibiting apoptosis.	mAsh1	Bub1	1	ACTIVATION	False
8108	8234	15063796:7:AP1:MMP13	[TG] promoter studies indicated that TPA requires [TF], but not Runx, to induce MMP-13 gene expression.	AP-1	MMP-13	1	ACTIVATION	False
8109	8235	15067082:9:MAZ:CDKN1A	In this study we provide evidence that, similar to p53, [TF] is able to activate [TG] gene expression by promoting transcription directly via its interaction with the p21 promoter.	SAF-1	p21	1	ACTIVATION	False
8110	8236	15067082:9:TP53:CDKN1A	In this study we provide evidence that, similar to [TF], SAF-1 is able to activate [TG] gene expression by promoting transcription directly via its interaction with the p21 promoter.	p53	p21	1	ACTIVATION	False
8111	8237	15067314:5:HNF1A:PKHD1	HNF-1beta and the structurally related [TF] bind specifically to the [TG] promoter and stimulate gene transcription.	HNF-1alpha	Pkhd1	1	ACTIVATION	False
8112	8238	15067314:5:HNF1B:PKHD1	[TF] and the structurally related HNF-1alpha bind specifically to the [TG] promoter and stimulate gene transcription.	HNF-1beta	Pkhd1	1	ACTIVATION	False
8113	8239	15067378:11:HNF4A:ANG	These results suggest that PPARalpha and [TF] competitively affect the human [TG] promoter through the C region.	HNF-4	ANG	0	UNDEFINED	False
8114	8240	15067378:11:PPARA:ANG	These results suggest that [TF] and HNF-4 competitively affect the human [TG] promoter through the C region.	PPARalpha	ANG	0	UNDEFINED	False
8115	8241	15067378:3:HNF4A:ANG	We had previously found that hepatocyte nuclear factor 4 ([TF]) dramatically activates the human [TG] promoter.	HNF-4	ANG	1	ACTIVATION	False
8116	8242	15067378:5:PPARA:ANG	To examine whether or not [TF] activates the human [TG] promoter, we used the reporter gene containing the sequence from -1222 to +44 of the human ANG gene promoter.	PPARalpha	ANG	1	ACTIVATION	False
8117	8243	15067378:8:HNF4A:ANG	We suspected that the high level expression of [TF] in HepG2 cells might interfere with the effect of bezafibrate on the human [TG] promoter.	HNF-4	ANG	0	UNDEFINED	False
8118	8244	15069077:0:AP1:SERPINE1	Oxidative stress activates the plasminogen activator inhibitor type 1 ([TG]) promoter through an [TF] response element and cooperates with insulin for additive effects on PAI-1 transcription.	AP-1	PAI-1	1	ACTIVATION	False
8119	8245	15069077:12:AP1:SERPINE1	Thus, oxidative stress stimulated [TF] and activated the [TG] promoter.	AP-1	PAI-1	1	ACTIVATION	False
8120	8246	15071503:3:HIF1A:CDKN1A	Although genetic studies have indicated the requirement of [TF] for hypoxia-induced growth arrest and activation of p21([TG]), a key cyclin-dependent kinase inhibitor controlling cell cycle checkpoint, the mechanism underlying p21(cip1) activation has been elusive.	HIF-1alpha	cip1	1	ACTIVATION	False
8121	8247	15071503:4:MYC:CDKN1A	Here we demonstrate that HIF-1alpha, even in the absence of hypoxic signal, induces cell cycle arrest by functionally counteracting [TF], thereby derepressing p21([TG]).	Myc	cip1	2	REPRESSION	False
8122	8248	15071503:5:MYC:CDKN1A	The HIF-1alpha antagonism is mediated by displacing [TF] binding from p21([TG]) promoter.	Myc	cip1	0	UNDEFINED	False
8123	8249	15072545:10:NFKB:HSD17B1	In a second functional study, overexpression of [TF]/p65 in luteal cells resulted in inhibition of 20alpha-hydroxysteroid dehydrogenase ([TG]) promoter activity as well as endogenous 20alphaHSD mRNA expression.	NFkappaB	20alphaHSD	2	REPRESSION	False
8124	8250	15072545:10:RELA:HSD17B1	In a second functional study, overexpression of NFkappaB/[TF] in luteal cells resulted in inhibition of 20alpha-hydroxysteroid dehydrogenase ([TG]) promoter activity as well as endogenous 20alphaHSD mRNA expression.	p65	20alphaHSD	2	REPRESSION	False
8125	8251	15072545:11:NFKB:HSD17B1	In summary, we have shown that: (i) [TF] is expressed within the CL, primary luteinized granulosa cells, and a rat luteal cell line; (ii) NFkappaB activation within the CL is developmentally regulated in pregnancy, depends on the age of the gland, and can be upregulated by prolactin; (iii) inhibition of NFkappaB/p65 binding to an NFkappaB DNA consensus sequence correlates with induction of cell death in ovarian luteinized granulosa cells; and (iv) overexpression of NFkappaB in luteal cells inhibits [TG] gene expression.	NFkappaB	20alphaHSD	2	REPRESSION	False
8126	8252	15072545:11:RELA:HSD17B1	In summary, we have shown that: (i) NFkappaB is expressed within the CL, primary luteinized granulosa cells, and a rat luteal cell line; (ii) NFkappaB activation within the CL is developmentally regulated in pregnancy, depends on the age of the gland, and can be upregulated by prolactin; (iii) inhibition of NFkappaB/[TF] binding to an NFkappaB DNA consensus sequence correlates with induction of cell death in ovarian luteinized granulosa cells; and (iv) overexpression of NFkappaB in luteal cells inhibits [TG] gene expression.	p65	20alphaHSD	2	REPRESSION	False
8127	8253	15073165:9:PPARG:INSIG1	Furthermore, a [TF] antagonist repressed the transactivation of the [TG] promoter-reporter construct.	PPARgamma	INSIG-1	1	ACTIVATION	False
8128	8254	15073183:5:FOS:NFATC1	Chromatin immunoprecipitation assay showed that c-[TF] bound to the [TG] and Acp5 promoters in osteoclasts.	Fos	Nfatc1	0	UNDEFINED	False
8129	8255	15082782:7:SALL2:CDKN1A	[TF] bound to the [TG] promoter adjacent to the known p53 binding sites and stimulated transcription in the absence of p53.	p150(Sal2)	p21	1	ACTIVATION	False
8130	8256	15082782:7:TP53:CDKN1A	p150(Sal2) bound to the [TG] promoter adjacent to the known [TF] binding sites and stimulated transcription in the absence of p53.	p53	p21	0	UNDEFINED	True
8131	8257	15098654:4:EGR1:KLF5	Mitogenic stimulation activates [TG]/BTEB2 gene expression through MEK1 and [TF].	Egr-1	KLF5	1	ACTIVATION	False
8132	8258	15100175:0:FOXM1:CYP3A4	Role of Sp1, C/EBP alpha, [TF], and PXR in the basal- and xenobiotic-mediated regulation of the [TG] gene.	HNF3	CYP3A4	0	UNDEFINED	False
8133	8259	15107406:9:RUNX2:IHH	Moreover, [TF] directly bound to the promoter region of the [TG] gene and strongly induced expression of the reporter gene driven by the Ihh promoter.	Runx2	Ihh	1	ACTIVATION	False
8134	8260	15111179:4:HIF1A:VEGFA	We studied the mRNA and protein expression of [TF] and its protein-binding capacity to the HBS of the [TG] gene in biopsies of preserved donor and control lungs, using real-time reverse transcription-polymerase chain reaction, Western blotting, and electrophoretic mobility shift assay.	HIF-1	VEGF	0	UNDEFINED	False
8135	8261	15111179:8:HIF1A:VEGFA	[TF] binding to the HBS of the [TG] promoter as well as tissue fluid content were increased in donor lung biopsies versus controls (p < 0.05).	HIF-1	VEGF	0	UNDEFINED	False
8136	8262	15116100:0:CREB1:CCND1	Gastrin-mediated activation of [TG] transcription involves beta-catenin and [TF] pathways in gastric cancer cells.	CREB	cyclin D1	1	ACTIVATION	False
8137	8263	15122755:4:NFE2L2:HMOX1	Furthermore, [TF] was shown to be functionally active, as assessed by the induction of epoxide hydrolase, [TG], and glutamate cysteine ligase gene expression.	Nrf2	heme oxygenase-1	1	ACTIVATION	False
8139	8265	15123650:7:SREBF1:CYP7A1	Moreover, adenovirus-mediated overexpression of [TF]c/ADD-1 induced SHP mRNA expression and repressed [TG] expression in HepG2 cells.	SREBP-1	CYP7A1	2	REPRESSION	False
8140	8266	15131058:11:NFKB:CCND1	The inhibition of [TF] activation correlated with a decreased expression of NF-kappaB-dependent reporter gene and suppressed expression of NF-kappaB-regulated genes [specifically, Bcl2, [TG], cyclooxygenase-2, matrix metalloproteinase 9, nitric oxide synthase-2 (NOS-2), and vascular endothelial growth factor].	NF-kappaB	cyclin D1	1	ACTIVATION	False
8141	8267	15131058:11:NFKB:VEGFA	The inhibition of [TF] activation correlated with a decreased expression of NF-kappaB-dependent reporter gene and suppressed expression of NF-kappaB-regulated genes [specifically, Bcl2, cyclin D1, cyclooxygenase-2, matrix metalloproteinase 9, nitric oxide synthase-2 (NOS-2), and [TG]].	NF-kappaB	vascular endothelial growth factor	1	ACTIVATION	False
8142	8268	15140752:2:HIF1A:VEGFA	Increased expression of hypoxia-inducible factor 1alpha ([TF]) and subsequent formation of HIF-1 dimers active at the vascular endothelial growth factor ([TG]) promoter lead to expression of this potent angiogenic factor in the retina, including retinal pigment epithelial (RPE) cells.	HIF-1alpha	VEGF	1	ACTIVATION	False
8143	8269	15155664:7:EGR1:FASLG	Reporter-promoter transfection studies indicated that [TF] binding is required for the H. pylori-induced transcriptional promoter activity of the CD44, ICAM-1, and [TG] (APO-1/Fas) constructs.	Egr-1	CD95L	1	ACTIVATION	False
8144	8270	15155664:7:EGR1:ICAM1	Reporter-promoter transfection studies indicated that [TF] binding is required for the H. pylori-induced transcriptional promoter activity of the CD44, [TG], and CD95L (APO-1/Fas) constructs.	Egr-1	ICAM-1	1	ACTIVATION	False
8145	8271	15156182:12:RUNX1:FOS	Lastly, AML1/[TF] enhances [TG] activity by activating the c-Fos promoter depending on the second zinc-finger domain of EVI-1, and promotes cell proliferation.	EVI-1	AP-1	1	ACTIVATION	False
8146	8272	15157737:8:NFKB:PTK2	Inhibition of [TF] with NF-kappa B super-repressor decreased [TG] luciferase activity.	NF-kappa B	FAK	1	ACTIVATION	False
8147	8273	15158147:14:SP1:FGF2	This may, however, reflect redundancy in the control of [TG] promoter activity as our data support a stimulatory role for Egr-1 and [TF].	Sp1	FGF-2	1	ACTIVATION	False
8148	8274	15160330:3:AP1:FASLG	The increased expression of FasL in tumor cells is associated with decreased expression of Fas; and the promoter region of the [TG] gene is regulated by transcription factors, such as neuronal factor kappaB (NF-kappaB) and [TF], in the tumor microenvironment.	AP-1	FASL	0	UNDEFINED	False
8149	8275	15169887:2:HIF1A:VEGFA	The specific binding of [TF] to the hypoxia-responsive element (HRE) induces the transcription of genes that respond to hypoxic conditions, including vascular endothelial growth factor ([TG]).	HIF-1	VEGF	1	ACTIVATION	False
8150	8276	15171250:7:MEF2D:NR4A1	The inhibitory effect of HDAC7 on the [TG] promoter is mediated via the transcription factor [TF].	MEF2D	Nur77	2	REPRESSION	False
8151	8277	15180995:6:ETS1:NOS3	We addressed the functional consequences of methylation on [TG] transcription using transient transfection of in vitro methylated promoter/reporter constructs and found that methylated constructs exhibited a marked decrease in the synergistic action of Sp1, Sp3, and [TF] on eNOS promoter activity.	Ets1	eNOS	1	ACTIVATION	False
8152	8278	15184388:8:USF1:THBS1	[TF] and USF2 bound to the endogenous [TG] promoter using a chromatin immunoprecipitation assay.	USF1	TSP1	0	UNDEFINED	False
8153	8279	15184659:3:TP53:CDKN1A	[TF] mediates checkpoint control at G(1) by transcriptional regulation of [TG].	p53	p21	0	UNDEFINED	False
8154	8280	15184659:6:TP53:CDKN1A	The promoter region of [TG] fused to a luciferase reporter can be transactivated by either hRAD9 or [TF], indicating that hRAD9 regulates the p21 promoter for transcriptional control of expression.	p53	p21	1	ACTIVATION	False
8155	8281	15184659:7:TP53:CDKN1A	Using an electrophoretic mobility-shift assay, we show that hRAD9 specifically binds to a [TF]-consensus DNA-binding sequence in the [TG] promoter.	p53	p21	0	UNDEFINED	False
8156	8282	15184872:4:SMAD4:MUC4	Our aim was to study whether the regulation of [TG] expression by TGF-beta in pancreatic cancer cells was strictly dependent on [TF] activity.	Smad4	MUC4	0	UNDEFINED	False
8157	8283	15184872:6:SMAD4:MUC4	By RT-PCR, transfection assays and immunohistochemistry, we show that (i) both [TG] mRNA and apomucin expression are upregulated by TGF-beta, (ii) Smad2 positively cooperates with [TF] to activate the promoter, (iii) activation of Smad4 by exogenous TGF-beta induces Smad4 binding to the promoter, (iv) Smad7 and c-ski both inhibit activation by Smad4.	Smad4	MUC4	1	ACTIVATION	False
8160	8286	15188178:11:SP1:VEGFA	This study identifies activin A as a novel stimulus of [TG] gene expression in hepatocellular carcinoma and delineates physical and functional cooperation of [TF] and Smad2 as the underlying mechanism.	Sp1	vascular endothelial growth factor	1	ACTIVATION	False
8161	8287	15188178:7:SP1:VEGFA	Activin A stimulated [TG] gene transcription through [TF]-dependent induction of vascular endothelial growth factor promoter activity.	Sp1	vascular endothelial growth factor	1	ACTIVATION	False
8162	8288	15190211:2:HIF1A:CDKN1A	We recently demonstrated that the G(1) checkpoint gene p21([TG])is activated by [TF] with a novel mechanism that involves the HIF-1alpha PAS domains to displace Myc binding from p21(cip1) promoter.	HIF-1alpha	cip1	1	ACTIVATION	False
8163	8289	15190211:2:MYC:CDKN1A	We recently demonstrated that the G(1) checkpoint gene p21([TG])is activated by HIF-1alpha with a novel mechanism that involves the HIF-1alpha PAS domains to displace [TF] binding from p21(cip1) promoter.	Myc	cip1	0	UNDEFINED	True
8164	8290	15191799:3:HIF1A:VEGFA	We studied in vivo, in a rat model of intraspinal axotomy of motoneurons, the cell- and time-dependent regulation of the hypoxia-inducible transcription factors (HIFs), [TF] and HIF2alpha, as well as one of their target genes, vascular endothelial growth factor ([TG]).	HIF1alpha	VEGF	0	UNDEFINED	False
8165	8291	15195136:10:MYB:CEBPB	Previous work has shown that v-[TF] acts on the [TG] promoter; it now appears that Myb stimulates C/EBPbeta expression by acting on the promoter as well as on an enhancer of the C/EBPbeta gene.	Myb	C/EBPbeta	1	ACTIVATION	False
8166	8292	15199062:0:ETS1:SOCS1	STAT6 and [TF] form a stable complex that modulates [TG] expression by interleukin-4 in keratinocytes.	Ets-1	Socs-1	0	UNDEFINED	False
8167	8293	15199062:6:ETS1:SOCS1	Exogenous expression of [TF] in conjunction with STAT6 activation strongly inhibited expression of a [TG] promoter-luciferase reporter.	Ets-1	Socs-1	2	REPRESSION	False
8168	8294	15207747:3:HIF1A:VEGFA	Here, we found that US elevation of [TG] expression in human osteoblasts to be mediated by nitric oxide (NO) and hypoxia-inducible factor-1alpha ([TF]).	HIF-1alpha	VEGF-A	1	ACTIVATION	False
8169	8295	15221958:10:CEBPB:PTGS2	Activation of PKC and Erk and DNA-protein interactions at CRE and [TF] (C/EBP) sites in the [TG] gene promoter appear to play key roles in this process.	NF-IL6	COX-2	0	UNDEFINED	False
8170	8296	15221958:7:CEBPG:PTGS2	Electrophoretic mobility shift assays revealed that FN increased the nuclear binding activity of cyclic AMP response element binding protein (CREB) and [TF] (C/EBP), 2 proteins known to play important roles in the regulation of [TG] promoter activity.	CCAAT/enhancer-binding protein	COX-2	0	UNDEFINED	True
8171	8297	15221958:8:CEBPB:PTGS2	Transient transfection assays with wild-type and mutated constructs of the human [TG] gene promoter revealed that the stimulatory effect of FN was prevented when either the CRE or the [TF] (C/EBP) sites were mutated.	NF-IL6	COX-2	1	ACTIVATION	False
8172	8298	15225550:4:EGR1:CREBBP	Induction of p300/[TG] by [TF] results in acetylation and stabilization of Egr1 and transactivation of survival genes but repression of Egr1 and p300/CBP in negative feedback loops.	Egr1	CBP	1	ACTIVATION	True
8173	8299	15225550:5:EGR1:CREBBP	In contrast, induction of [TF] by UV-C irradiation leads to repression of p300/[TG] transcription: Egr1 is preferentially phosphorylated, leading to regulation of target genes that cause cell death.	Egr1	CBP	2	REPRESSION	False
8175	8301	15231818:0:ATF3:PLN	Adenylyl cyclase type VI gene transfer reduces [TG] expression in cardiac myocytes via [TF].	activating transcription factor 3	phospholamban	2	REPRESSION	False
8176	8302	15231818:10:ATF3:PLN	We then showed that AC(VI)-induced [TF] protein binds to the cAMP-responsive-like element on the [TG] promoter and that overexpression of ATF3 in cardiac myocytes inhibits PLB promoter activity.	ATF3	PLB	2	REPRESSION	False
8177	8303	15233805:6:BACH1:HMOX1	Expression levels of [TG] mRNA were reduced by interferon-gamma in two human RPE cell lines, D407 and ARPE-19, which was consistently associated with the induction of mRNA for [TF], a transcriptional repressor for the HO-1 gene.	Bach1	HO-1	2	REPRESSION	False
8179	8305	15234907:9:NFKB:PTGS2	The mechanisms by which cigarette-derived toxicants lead to increased [TG] levels and PGE2 synthesis include increases in steady-state COX-2 mRNA levels (approximately four- to fivefold), phosphorylation of ERK1/2, and nuclear translocation of the p50 and p65 subunits of the transcription factor [TF], which are important elements in COX-2 expression.	NF-kappaB	COX-2	1	ACTIVATION	False
8180	8307	15234907:9:RELA:PTGS2	The mechanisms by which cigarette-derived toxicants lead to increased [TG] levels and PGE2 synthesis include increases in steady-state COX-2 mRNA levels (approximately four- to fivefold), phosphorylation of ERK1/2, and nuclear translocation of the p50 and [TF] subunits of the transcription factor NF-kappaB, which are important elements in COX-2 expression.	p65	COX-2	1	ACTIVATION	False
8181	8308	15240568:0:SOX9:MUC2	[TF] is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and [TG] genes.	SOX9	MUC2	2	REPRESSION	False
8182	8309	15240699:6:STAT1:TAP1	The shared promoter contains several areas that can be controlled by [TF], such as the proximal and distal IFN-gamma activation site (GAS) boxes in the direction of the [TG] gene.	STAT-1	Tap1	1	ACTIVATION	True
8183	8310	15248906:9:TP53:CDKN1A	HBx may not only increase the expression of p21([TG]) by introducing the accumulation of [TF] in cytoplasm but also inhibit the transcriptional activity of p21(WAF1) promoter in a p53-independent manner.	p53	WAF1	1	ACTIVATION	False
8184	8311	15252835:8:SP1:BRCA1	In vivo binding of [TF] has been confirmed at 2 of these sites in the [TG] promoter and at 2 CTCF sites that flank the unmethylated region.	Sp1	BRCA1	0	UNDEFINED	False
8185	8312	15252835:9:CTCF:BRCA1	Our data suggest that these DNA binding sites for Sp1 and [TF] may act as boundary elements that are important in maintaining genomic integrity by delineating the normal methylation free [TG] promoter.	CTCF	BRCA1	0	UNDEFINED	False
8186	8313	15252835:9:SP1:BRCA1	Our data suggest that these DNA binding sites for [TF] and CTCF may act as boundary elements that are important in maintaining genomic integrity by delineating the normal methylation free [TG] promoter.	Sp1	BRCA1	0	UNDEFINED	False
8187	8314	15269344:7:CUX1:CDKN1A	The endogenous level of p21([TG]/cdi1) expression is repressed through [TF]/cut and mediated by HKMT activity of G9a.	CDP	waf1	2	REPRESSION	False
8188	8315	1527086:5:JUND:MYB	Exposure of phytohemagglutinin-stimulated peripheral blood mononuclear cells to c-jun and [TF] antisense oligodeoxynucleotides resulted in a 46 and 43% inhibition of T-lymphocyte proliferation that was accompanied by a decrease in [TG] mRNA levels as compared with sense-treated cultures.	junD	c-myb	1	ACTIVATION	False
8189	8316	15276216:0:USF2:CTSB	Isolation of a novel [TF] isoform: repressor of [TG] expression.	USF2	cathepsin B	2	REPRESSION	False
8190	8317	15276216:1:USF1:CTSB	We previously demonstrated that upstream stimulatory factor 1 ([TF]) and USF2 regulate transcription of [TG].	USF1	cathepsin B	0	UNDEFINED	False
8191	8318	15276216:1:USF2:CTSB	We previously demonstrated that upstream stimulatory factor 1 (USF1) and [TF] regulate transcription of [TG].	USF2	cathepsin B	0	UNDEFINED	False
8192	8319	15276216:5:USF2:CTSB	[TF]c can be transcribed and translated to a protein of approximately 29 kDa in vitro, and the resulting USF2c protein can bind as a homodimer to the E-box of the [TG] promoter.	USF2	cathepsin B	0	UNDEFINED	False
8193	8320	15276216:8:USF2:CTSB	These results suggest that [TF]c regulates expression of [TG] by binding to the E box element in the cathepsin B promoter as a repressor.	USF2	cathepsin B	2	REPRESSION	False
8194	8321	15277220:6:AP1:VEGFA	IGF-I stimulated [TG] promoter activity in vitro, mainly via HIF-1alpha, and secondarily via NF-kappaB and [TF].	AP-1	VEGF	1	ACTIVATION	False
8195	8322	15277220:6:HIF1A:VEGFA	IGF-I stimulated [TG] promoter activity in vitro, mainly via [TF], and secondarily via NF-kappaB and AP-1.	HIF-1alpha	VEGF	1	ACTIVATION	False
8196	8323	15277220:6:NFKB:VEGFA	IGF-I stimulated [TG] promoter activity in vitro, mainly via HIF-1alpha, and secondarily via [TF] and AP-1.	NF-kappaB	VEGF	1	ACTIVATION	False
8197	8324	15277220:7:HIF1A:VEGFA	In conclusion, IGF-I participates in the pathophysiology of diabetic retinopathy by inducing retinal [TG] expression via PI-3K/Akt, [TF], NF-kappaB, and secondarily, JNK/AP-1 activation.	HIF-1alpha	VEGF	1	ACTIVATION	False
8198	8325	15277220:7:NFKB:VEGFA	In conclusion, IGF-I participates in the pathophysiology of diabetic retinopathy by inducing retinal [TG] expression via PI-3K/Akt, HIF-1alpha, [TF], and secondarily, JNK/AP-1 activation.	NF-kappaB	VEGF	1	ACTIVATION	False
8199	8326	15279563:7:SP4:MAOB	Transcription factors Sp1 and [TF] can activate [TG] promoter activity through the proximal cluster of Sp1 sites and its activation can be repressed by the over-expression of Sp3 and a related family member, BTEB2.	Sp4	MAO B	1	ACTIVATION	False
8201	8328	15282324:0:PGR:CCND1	Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor ([TF]) complex assembly to a distal regulatory element and recruitment of [TG] to its own gene promoter.	progesterone receptor	cyclin D1	1	ACTIVATION	True
8202	8329	15289351:6:EGR1:IL12A	"We show also that 1,25D(3) treatment of HL60 cells markedly increases the binding of [TF] to an element in the [TG] gene promoter, whereas transfection of an excess of this Egr1-binding oligonucleotide (""promoter decoy"") reduces p35 gene transcription and cell differentiation."	Egr1	p35	1	ACTIVATION	False
8203	8330	15294971:5:ETS2:TLR9	It appeared that suppression was mediated via c-Jun and NF-kappaB p65 and that cooperation among CREB1, [TF], Elf1, Elk1, and C/EBPalpha culminated in maximal transcription of the [TG] gene.	Ets2	TLR9	1	ACTIVATION	False
8204	8331	15294971:5:JUN:TLR9	It appeared that suppression was mediated via [TF] and NF-kappaB p65 and that cooperation among CREB1, Ets2, Elf1, Elk1, and C/EBPalpha culminated in maximal transcription of the [TG] gene.	c-Jun	TLR9	2	REPRESSION	False
8205	8332	15294971:5:NFKB:TLR9	It appeared that suppression was mediated via c-Jun and [TF] p65 and that cooperation among CREB1, Ets2, Elf1, Elk1, and C/EBPalpha culminated in maximal transcription of the [TG] gene.	NF-kappaB	TLR9	2	REPRESSION	False
8206	8333	15294971:5:RELA:TLR9	It appeared that suppression was mediated via c-Jun and NF-kappaB [TF] and that cooperation among CREB1, Ets2, Elf1, Elk1, and C/EBPalpha culminated in maximal transcription of the [TG] gene.	p65	TLR9	2	REPRESSION	True
8207	8334	15297375:13:ETS1:PDGFA	These findings identify a functional cis-acting element for [TF] in the [TG] promoter and demonstrate that Sp1 and Ets-1 cooperatively activate PDGF-A transcription in vascular SMCs.	Ets-1	PDGF-A	1	ACTIVATION	False
8208	8335	15297375:3:EGR1:PDGFA	We demonstrated previously that [TG] expression is under the positive regulatory influence of Sp1, Sp3, and [TF] and is negatively controlled by GCF2, NF-1(X), and WT-1.	Egr-1	PDGF-A	1	ACTIVATION	False
8209	8336	15297375:6:ETS1:PDGFA	Chromatin immunoprecipitation analysis showed the interaction of endogenous and exogenous [TF] or glutathione S-transferase-tagged Ets-1, bearing only the DNA-binding domain with the authentic [TG] promoter.	Ets-1	PDGF-A	0	UNDEFINED	False
8210	8337	15297375:8:ETS1:PDGFA	Overexpression of [TF] but not the mutant form of Ets-1 activates the [TG] promoter cooperatively with Sp1.	Ets-1	PDGF-A	1	ACTIVATION	False
8211	8338	15302882:10:TP53:CDKN1A	Altogether, the outcome of our functional and binding studies suggested that the physical interaction of Vpr with Sp1 and [TF] could modulate transcriptional activity of [TG].	p53	p21	0	UNDEFINED	False
8212	8339	1530876:11:JUN:NPPA	These data imply that the [TG] gene may be a physiological target for c-fos- and [TF]-dependent activity in the heart and suggest a potential mechanism linking environmental stimuli to its expression.	c-jun	ANP	0	UNDEFINED	False
8213	8340	15310743:2:SRF:PPARGC1A	The transcription factors Egr-1, Sp1, and serum response factor ([TF]) are potentially important mediators of mitochondrial biogenesis based on the prevalence of binding sites for them in the promoter regions of genes encoding mitochondrial proteins, including [TG], the important regulator of mitochondrial biogenesis.	SRF	PGC-1 alpha	0	UNDEFINED	False
8214	8341	15313936:11:AP1:CLU	These data point to HSF-1 as an important factor regulating [TG] expression in response to MX781, although [TF] activity may also participate in a cell type-specific manner.	AP-1	clusterin	0	UNDEFINED	True
8215	8342	15315937:3:HIF1A:VEGFA	One of the key mediators of the cell's response to lowered oxygen environments is hypoxia-inducible-factor-1 ([TF]), a basic helix-loop-helix transcription factor, which enables cells to adapt to hypoxia by regulating the expression of genes involved in increasing oxygen availability ([TG], erythropoietin) and enhancing glucose uptake and metabolism (Glut-1, PGK).	HIF-1	VEGF	0	UNDEFINED	False
8216	8343	15317858:10:NFKB:SOD1	These results illustrate a new mechanism by which the PI3K/Akt pathway protects cells against oxidative stress, involving the upregulation of Cu/Zn-[TG] gene expression, and the results identify [TF] as a key mediator in the regulation of this gene.	NF-kappaB	SOD	0	UNDEFINED	False
8217	8344	15319449:11:STAT1:POMC	We conclude that both CREB phosphorylation at Ser-133 and level of CREB expression are crucial in LIF-CRH synergism where CREB, without direct DNA binding, could improve the stability of Nur77 and [TF] binding to [TG] promoter and facilitate the recruitment of coactivators.	STAT1-3	POMC	1	ACTIVATION	False
8218	8345	15320849:4:NFKB:EDN1	In addition, there is evidence showing that the reduction of nuclear factor-kappaB ([TF]) activation is involved in the mechanisms for suppressive effects of proteasome inhibitors on [TG] gene transcription and the consequent decrease in ET-1 mRNA expression in the cultured vascular endothelial cells.	NF-kappaB	ET-1	1	ACTIVATION	False
8219	8346	15331348:12:NR1I2:PPARGC1A	These results suggest that activation of [TF] by rifampicin promotes PXR interaction with HNF4 alpha and blocks [TG] activation with HNF4 alpha and results in inhibition of CYP7A1 gene transcription.	PXR	PGC-1 alpha	2	REPRESSION	True
8220	8347	15339920:7:STAT1:PPARG	However, acute CT-1 treatment caused an increase in SOCS-3 mRNA in adipocytes and a transient decrease in peroxisome proliferator-activated receptor gamma ([TG]) mRNA that was regulated by the binding of [TF] to the PPARgamma2 promoter.	STAT1	PPARgamma	2	REPRESSION	True
8221	8348	15339933:6:TP53:CDKN1A	Although hDaxx represses [TF]-dependent transcription of the [TG] gene, it does not affect the activation of proapoptotic genes, and therefore acts by influencing the balance between cell cycle arrest and proapoptotic p53 targets.	p53	p21	1	ACTIVATION	False
8222	8349	1534100:0:POU2F1:CR2	Identification of sites for distinct DNA binding proteins including [TF] and Oct-2 in the [TG] gene.	Oct-1	Cr2	0	UNDEFINED	False
8223	8350	15342781:8:HIF1A:VEGFA	Others have proposed that the PI3K/Akt pathway can increase [TG] expression via the hypoxia-inducible factor 1 ([TF]); however, our results suggest an alternative mechanism can also operate.	HIF-1	VEGF	1	ACTIVATION	False
8224	8351	15345217:0:REL:MYC	The mitogen-induced increase in T cell size involves PKC and NFAT activation of [TF]/NF-kappaB-dependent [TG] expression.	Rel	c-myc	1	ACTIVATION	False
8225	8352	15345676:6:SP4:CDKN1A	The results of RNA interference and protein expression/DNA binding assays suggest that DIM-C-pPhCF3 induced [TG] expression through a novel mechanism that involves PPARgamma interactions with both Sp1 and [TF] proteins bound to the proximal GC-rich region of the p21 promoter.	Sp4	p21	1	ACTIVATION	False
8226	8353	15358113:7:VDR:CYP3A7	In addition, we found that the binding of [TF] to the proximal ER6 in [TG] gene was markedly less than that to the proximal ER6 in CYP3A4 gene using gel shift assay.	VDR	CYP3A7	0	UNDEFINED	False
8228	8355	15372625:0:SP1:BGN	Transforming growth factor beta stimulation of [TG] gene expression is potentially mediated by [TF].	sp1 binding factors	biglycan	1	ACTIVATION	False
8229	8356	15372625:9:SP1:BGN	Addition of Sp3 augmented the effect of [TF] on [TG] gene expression.	Sp1	biglycan	0	UNDEFINED	True
8230	8357	15372625:9:SP3:BGN	Addition of [TF] augmented the effect of Sp1 on [TG] gene expression.	Sp3	biglycan	0	UNDEFINED	False
8231	8358	15382039:2:HIF1A:VEGFA	Hypoxia-inducible factor 1 ([TF]) is a critical transcription factor that regulates the expression of genes encoding factors that influence tumor growth including [TG].	HIF-1	vascular endothelial growth factor	0	UNDEFINED	False
8232	8359	15385533:2:ATF4:ASNS	Previous overexpression and electrophoresis mobility shift analysis showed the involvement of the transcription factors [TF], C/EBPbeta, and ATF3-FL through the nutrient-sensing response element-1 (NSRE-1) within the [TG] promoter.	ATF4	ASNS	0	UNDEFINED	False
8233	8360	15385533:2:CEBPB:ASNS	Previous overexpression and electrophoresis mobility shift analysis showed the involvement of the transcription factors ATF4, [TF], and ATF3-FL through the nutrient-sensing response element-1 (NSRE-1) within the [TG] promoter.	C/EBPbeta	ASNS	0	UNDEFINED	False
8234	8361	15385533:5:ATF4:ASNS	Overexpression studies established that [TF], ATF3-FL, and C/EBPbeta-LAP could coordinately modulate the transcription from the human [TG] promoter.	ATF4	ASNS	0	UNDEFINED	False
8235	8362	15385533:5:CEBPB:ASNS	Overexpression studies established that ATF4, ATF3-FL, and [TF]-LAP could coordinately modulate the transcription from the human [TG] promoter.	C/EBPbeta	ASNS	0	UNDEFINED	False
8236	8363	15385533:6:CEBPB:ASNS	Chromatin immunoprecipitation demonstrated that amino acid deprivation increased ATF3-FL, ATF4, and [TF] binding to the [TG] promoter and enhanced promoter association of RNA polymerase II, TATA-binding protein, and TFIIB of the general transcription machinery.	C/EBPbeta	ASNS	0	UNDEFINED	False
8237	8364	15385533:9:ATF4:ASNS	The data suggest that ATF3-FL and C/EBPbeta act as transcriptional suppressors for the [TG] gene to counterbalance the transcription rate activated by [TF] following amino acid deprivation.	ATF4	ASNS	1	ACTIVATION	False
8238	8365	15385533:9:CEBPB:ASNS	The data suggest that ATF3-FL and [TF] act as transcriptional suppressors for the [TG] gene to counterbalance the transcription rate activated by ATF4 following amino acid deprivation.	C/EBPbeta	ASNS	2	REPRESSION	False
8239	8366	15449318:3:ELK1:EGR1	Deletion analysis of the [TG] promoter identified a minimal E2-responsive region of the promoter that contained serum response element (SRE)3 (-376 to -350) which bound [TF] and serum response factor (SRF) in gel mobility shift assays.	Elk-1	Egr-1	0	UNDEFINED	False
8240	8367	15449318:3:SRF:EGR1	Deletion analysis of the [TG] promoter identified a minimal E2-responsive region of the promoter that contained serum response element (SRE)3 (-376 to -350) which bound Elk-1 and serum response factor ([TF]) in gel mobility shift assays.	SRF	Egr-1	0	UNDEFINED	False
8241	8368	15458977:6:AHR:PON1	The resveratrol effect was not ERalpha-dependent and was surprisingly mediated by the aryl hydrocarbon receptor ([TF]) and an unconventional AhR responsive element in the [TG] gene promoter.	AhR	PON-1	0	UNDEFINED	False
8242	8369	15459902:5:ETS1:SH2D1A	The involvement of [TF] and Ets-2 in expression of [TG] was functionally confirmed by overexpression studies of their dominant-negative forms.	Ets-1	SH2D1A	1	ACTIVATION	False
8243	8370	15459902:5:ETS2:SH2D1A	The involvement of Ets-1 and [TF] in expression of [TG] was functionally confirmed by overexpression studies of their dominant-negative forms.	Ets-2	SH2D1A	1	ACTIVATION	False
8244	8371	15466594:1:NR4A1:IL2	The effect of orphan nuclear receptor [TF] overexpression on activation of an interleukin-2 ([TG]) promoter-luciferase construct was analyzed in the human leukemic cell line Jurkat.	Nur77	IL-2	1	ACTIVATION	False
8245	8372	15466854:7:USF1:BAX	We further demonstrate the ability of Pea3 and [TF] to cooperate for the transactivation of the [TG] promoter, mutation of the E boxes dramatically reducing the Pea3 transactivation potential.	USF-1	bax	1	ACTIVATION	False
8246	8373	15466854:8:USF1:BAX	Although Pea3 did not directly bind to the minimal [TG] promoter, we provide evidence that [TF] could form a ternary complex with Pea3 and DNA.	USF-1	bax	0	UNDEFINED	False
8247	8374	15466854:9:USF1:BAX	Taken together, our results suggest that Pea3 may regulate [TG] transcription via the interaction with [TF] but without binding to DNA.	USF-1	bax	0	UNDEFINED	False
8248	8375	15467760:4:AP1:CCND1	A luciferase assay using deletion constructs of the [TG] promoter indicated that E2-induced increase in transcriptional activity was observed in reporters containing [TF]-binding site sequence, and that in the absence of E2, cotransfection of c-Jun also showed increase of transcriptional activity in the same reporters with AP-1 sequence.	AP-1	cyclin D1	1	ACTIVATION	False
8249	8377	15467760:7:JUN:CCND1	These findings suggest that E2-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of [TG] via binding of c-Jun to the [TF] sequences.	AP-1	cyclin D1	1	ACTIVATION	True
8250	8378	15474507:0:MYC:CDKN1A	Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/[TG] expression through downregulation of [TF] and release of the repression of c-myc from the promoter in human cervical cancer cells.	c-myc	CIP1	2	REPRESSION	False
8251	8379	15474507:5:MYC:CDKN1A	These data suggest that [TF] may play a critical role in repression of p21WAF1/[TG] expression in HeLa cells.	c-myc	CIP1	2	REPRESSION	False
8252	8380	15474507:6:MYC:CDKN1A	More importantly, using chromatin immunoprecipitation assay, we observed for the first time that [TF] bound to the endogenous p21WAF1/[TG] promoter in untreated HeLa cells, but not in TSA-treated cells.	c-myc	CIP1	0	UNDEFINED	False
8253	8381	15474507:7:MYC:CDKN1A	Taken together, TSA induced [TF] downregulation and release from the endogenous p21WAF1/[TG] promoter contributes, at least partially, to transcriptional activation of the p21WAF1/CIP1 in HeLa cells.	c-myc	CIP1	2	REPRESSION	False
8255	8383	15477724:5:SP3:VEGFA	In parallel to growth inhibition, we observed a profound inhibition of [TG] gene transcription by IFN-alpha in human neuroendocrine tumor cells due to an Sp1/[TF]-dependent inhibition of VEGF promoter activity.	Sp3	VEGF	2	REPRESSION	False
8256	8384	15486044:13:HNF1B:NNMT	Cotransfection of a [TF] expression plasmid increased [TG] promoter activity significantly in both HNF-1beta-positive and -negative thyroid cancer cell lines and Hep G2 liver cancer cells.	HNF-1beta	NNMT	1	ACTIVATION	False
8257	8385	15486044:14:HNF1B:NNMT	Furthermore, transient expression of [TF] in BHP 14-9 cells increased endogenous [TG] protein levels.	HNF-1beta	NNMT	1	ACTIVATION	False
8258	8386	15486044:15:HNF1B:NNMT	In summary, [TF] functions as a transcription activator for [TG] gene expression in some papillary thyroid cancer cells.	HNF-1beta	NNMT	1	ACTIVATION	False
8259	8387	15486308:4:SREBF1:SCARB1	Transient transfections demonstrated that SREBP factors induce [TG] promoter activity and that SREBP-2 is a more potent inducer than the [TF] isoform.	SREBP-1a	Cla-1	1	ACTIVATION	False
8260	8388	15489892:4:TP53:CDKN1A	However, in contrast to 5-FU, mithramycin A failed to activate [TF] target genes including the cell cycle inhibitor [TG] gene as well as the proapoptotic genes PUMA (p53-upregulated mediator of apotosis) and BAK (bcl2-homologous antagonist/killer) and blocked the induction of the above genes by 5-FU.	p53	p21Cip1	1	ACTIVATION	True
8261	8389	15489892:5:SP1:BBC3	Using transactivation assays in [TF]-deficient cells, we showed that mithramycin A inhibited the transcriptional activation of the p21Cip1 and [TG] promoters by Sp1 and p53.	Sp1	PUMA	1	ACTIVATION	False
8262	8391	15489892:8:TP53:CDKN1A	Our findings suggest that inhibition of Sp1 binding to the promoters of several [TF] target genes, such as the [TG] gene as well as certain proapoptotic genes, by mithramycin A, prevents the transcriptional induction of these genes by p53 and propose a mechanism that could account for some of the tumor suppressing and antiapoptotic effects of mithramycin A.	p53	p21Cip1	0	UNDEFINED	True
8263	8392	15492009:5:EGR1:CCNA2	Transfection experiments of VSMC with deletion constructs of the [TG] promoter revealed the regulatory region responsible for the stretch-induced CCN1 expression in the approximately 200-bp promoter region upstream of the TATA-box containing potential binding sites for [TF] (Egr-1), nuclear factor of activated T-cells and cAMP response element binding protein.	early growth response-1	CCN1	1	ACTIVATION	True
8264	8393	15492238:9:TP53:CDKN1A	Overexpression of COP1 correlated with a striking decrease in steady state [TF] protein levels and attenuation of the downstream target gene, [TG], in cancers that retain a wild-type p53 gene status.	p53	p21	1	ACTIVATION	True
8265	8394	15509808:2:TP53:CDKN1A	Here we investigate the mechanism by which IRF-1 and [TF] synergize at the [TG] promoter and show that stimulation of p21 transcription by IRF-1 does not require its DNA-binding activity but relies on the ability of IRF-1 to bind the coactivator p300 and to stimulate p53-dependent transcription by an allosteric mechanism.	p53	p21	1	ACTIVATION	False
8266	8395	15509808:4:TP53:CDKN1A	Complementing this, small peptides derived from the IRF-1-p300 interface can bind to p300, stabilize the binding of p300 to DNA-bound [TF], stimulate p53 acetylation in trans, and up-regulate p53-dependent activity from the [TG] promoter.	p53	p21	1	ACTIVATION	False
8267	8396	15509808:6:TP53:CDKN1A	These data expand the core p300-[TF] protein LXXLL and PXXP interface by including an IRF-1-p300 interface as an allosteric modifier of DNA-dependent acetylation of p53 at the [TG] promoter.	p53	p21	0	UNDEFINED	False
8268	8397	15510213:5:E2F2:CDK1	We find that E2F1, [TF], and E2F3 bind to the positive-acting E2F site in the [TG] promoter, whereas E2F4 binds to the negative-acting site.	E2F2	cdc2	1	ACTIVATION	False
8269	8398	15510213:5:E2F3:CDK1	We find that E2F1, E2F2, and [TF] bind to the positive-acting E2F site in the [TG] promoter, whereas E2F4 binds to the negative-acting site.	E2F3	cdc2	1	ACTIVATION	True
8270	8399	15520169:4:AR:ABCA1	The antiandrogen Casodex blocked the effect of androgen, implicating the [TF] in regulation of [TG] expression by androgens.	androgen receptor	ABCA1	0	UNDEFINED	True
8271	8400	15528212:10:MYC:CDKN1A	[TF]-mediated impairment of Ras activity on [TG] expression required a transactivation domain, a DNA binding region, and a Max binding region.	c-Myc	p21	0	UNDEFINED	False
8272	8402	15531578:3:ELK1:SRF	The binding of the TCF [TF] to the [TG] promoter and subsequent regulation of SRF expression occurs in a ternary complex-dependent manner.	Elk-1	SRF	0	UNDEFINED	False
8273	8403	15537493:9:SP1:GJA5	In this work, we cloned the promoter region of the [TG] and demonstrated that the core promoter was modulated by cardiac transcriptional factors Nkx2-5, Tbx5 and GATA4 acting together with ubiquitous [TF].	Sp1	Cx40	0	UNDEFINED	False
8274	8404	15539944:0:TP53:CDKN1A	BCCIP functions through [TF] to regulate the expression of p21[TG]/Cip1.	p53	Waf1	0	UNDEFINED	False
8275	8405	15539944:4:TP53:CDKN1A	We further show that the regulation of [TG] expression by BCCIP is dependent on [TF], and BCCIP regulates p53 transcription activity.	p53	p21	0	UNDEFINED	False
8276	8406	15541382:5:GATA4:MUC2	The role of [TF] on [TG] gene regulation was investigated by RT-PCR and co-transfections in the presence of expression vectors encoding either wild-type or mutated GATA-4 or by mutating the GATA-4 site identified within Muc2 promoter.	GATA-4	Muc2	0	UNDEFINED	False
8277	8407	15541382:7:GATA4:MUC2	Altogether, these results identify [TG], a goblet cell marker, as a new target gene of [TF] and point out an important role for this factor in Muc2 expression in the intestine.	GATA-4	Muc2	0	UNDEFINED	True
8278	8408	15541729:2:SP3:TFF1	In chromatin immunoprecipitation (ChIP) assays, we investigated the binding of estrogen receptor alpha (ER), Sp1, and [TF] to the episomal and native estrogen-responsive [TG] (TFF1; formerly pS2) promoter in MCF-7 breast cancer cells.	Sp3	trefoil factor 1	0	UNDEFINED	False
8279	8409	15545275:3:EGR1:SOCS1	Functional analysis of the [TG] promoter demonstrates that [TF] (Egr-1) is an important transcriptional regulator of SOCS-1.	early growth response-1	SOCS-1	0	UNDEFINED	False
8280	8410	15545275:4:EGR1:SOCS1	Two [TF] binding sites are present within the [TG] promoter as shown by EMSA and supershift analysis.	Egr-1	SOCS-1	0	UNDEFINED	False
8281	8411	15545275:6:EGR1:SOCS1	Chromatin immunoprecipitation experiments confirm LPS-induced binding of [TF] to the [TG] promoter in vivo.	Egr-1	SOCS-1	0	UNDEFINED	False
8282	8412	15545275:7:EGR1:SOCS1	Additionally, [TF](-/-) macrophages show reduced levels of LPS-induced [TG] expression in comparison with macrophages derived from Egr-1(+/+) littermate controls.	Egr-1	SOCS-1	1	ACTIVATION	False
8283	8413	15545275:8:EGR1:SOCS1	These results demonstrate an important role for [TF] in regulating both the basal and LPS-induced activity of the [TG] promoter.	Egr-1	SOCS-1	1	ACTIVATION	False
8284	8414	15545628:3:TBX6:DLL1	LEF/TCF factors cooperate with [TF] to activate transcription from the [TG] promoter in vitro.	TBX6	Dll1	1	ACTIVATION	False
8285	8415	15545628:5:TBX6:DLL1	Our results indicate that WNT activity, in synergy with [TF], regulates [TG] transcription and thereby controls Notch activity, somite formation, and patterning.	TBX6	Dll1	0	UNDEFINED	False
8286	8416	15548700:5:TP53:EGR1	Moreover, chromatin immunoprecipitation analysis indicates that mutant [TF] is physically associated with the [TG] promoter.	p53	EGR1	0	UNDEFINED	False
8287	8417	15558021:6:JUNB:PLAU	Upregulation of JunB expression in MEKK1-/- cells forms an inhibitory [TF] complex that binds to the [TG] promoter and inhibits uPA transcription.	AP-1	uPA	2	REPRESSION	False
8288	8418	15566940:1:TP53:CDKN1A	Active [TF] stimulates the transcription of a number of key genes, including the pro-apoptotic gene bax, as well as [TG], a cell cycle regulator.	p53	p21	1	ACTIVATION	False
8289	8419	15566941:5:FOXA2:IAPP	Finally, utilising a series of deletion reporter gene constructs of the human [TG] gene promoter, we used overexpression studies to establish that [TF] (FoxA2) negatively regulates the IAPP promoter, whilst the MODY3 transcription factor HNF-1alpha positively regulates promoter activity.	HNF-3beta	IAPP	2	REPRESSION	False
8290	8420	15569263:9:EGR1:CCR5	This involved abrogation of [TF] DNA binding in the promoter of [TG] by curcumin as determined by: (i) electrophoretic mobility shift assay, (ii) transfection studies with truncated CCR5 gene promoter constructs, and (iii) chromatin immunoprecipitation analysis.	Egr-1	CCR5	0	UNDEFINED	False
8291	8421	15570219:13:KLF4:ENG	[TF] transient overexpression in HCE cells down regulated both [TG] and ODC mRNA levels.	KLF4	endoglin	2	REPRESSION	False
8292	8422	15574328:0:TP53:CDC25C	DNA damage-induced downregulation of Cdc25C is mediated by [TF] via two independent mechanisms: one involves direct binding to the [TG] promoter.	p53	cdc25C	2	REPRESSION	False
8293	8423	15574328:2:TP53:CDC25C	The [TG] gene is a target for transcriptional downregulation by the tumor suppressor protein [TF], and this repression can be shown to contribute to p53-dependent cell cycle arrest.	p53	cdc25C	2	REPRESSION	False
8294	8424	15574328:4:TP53:CDC25C	One involves the direct binding of [TF] to a site in the [TG] promoter, and the second involves a CDE/CHR element.	p53	cdc25C	0	UNDEFINED	False
8295	8425	15574328:7:TP53:CDC25C	Repression of [TG] by [TF] represents an additional mechanism for p53-dependent cell cycle arrest in response to DNA damage.	p53	Cdc25C	2	REPRESSION	False
8296	8426	15574421:7:USF1:SHBG	We have also found that the upstream stimulatory factors ([TF] and USF-2) bind FP4 in vitro by electromobility shift assay of Sertoli cell nuclear extracts and in vivo by chromatin immunoprecipitation assay and conclude that USF transcription factors repress human [TG] transcription in Sertoli cells through an interaction with FP4 within its proximal promoter.	USF-1	SHBG	2	REPRESSION	False
8297	8427	15574421:7:USF2:SHBG	We have also found that the upstream stimulatory factors (USF-1 and [TF]) bind FP4 in vitro by electromobility shift assay of Sertoli cell nuclear extracts and in vivo by chromatin immunoprecipitation assay and conclude that USF transcription factors repress human [TG] transcription in Sertoli cells through an interaction with FP4 within its proximal promoter.	USF-2	SHBG	2	REPRESSION	False
8298	8428	15574422:4:AP1:CCND1	[TF] is required for activation of the [TG] promoter.	AP-1	cyclin D1	1	ACTIVATION	False
8299	8429	15574764:10:AP1:CCND1	We attributed this behavior to the significant down-regulation of [TG], cyclin A, and ATF-3, known [TF] targets implicated in cell cycle control and promotion.	AP-1	cyclin D1	0	UNDEFINED	True
8300	8430	15579507:9:WT1:NPHS1	Finally, it is shown that [TG] expression is lowest in kidneys of mice that lack specifically the [TF](-KTS) splice variant, but in comparison with wild-type littermates, it is also reduced in animals with disruption of the Wt1(+KTS) splice variant.	Wt1	nephrin	1	ACTIVATION	False
8301	8431	15580623:4:E2F4:FGFR1	We have identified the transcription factor [TF] as a negative regulator of [TG] gene expression.	E2F4	FGFR1	2	REPRESSION	False
8302	8432	15580623:6:E2F4:FGFR1	Upon overexpression, [TF] repressed [TG] promoter activity in a dose-dependent manner in myoblasts and Drosophila SL2 cells, and mutation of the E2F4 binding site increased FGFR1 promoter activity and reduced E2F4-mediated repression.	E2F4	FGFR1	2	REPRESSION	False
8303	8433	15580623:7:E2F4:FGFR1	Gel shift assays detected [TF] binding to a synthetic [TG] E2F4 binding site and chromatin immunoprecipitation assays detected E2F4 binding to the endogenous FGFR1 promoter in proliferating myoblasts and myotubes.	E2F4	FGFR1	0	UNDEFINED	False
8304	8434	15585666:0:TCFL5:CLGN	Basic helix-loop-helix transcription factor [TF] interacts with the [TG] gene promoter in mouse spermatogenesis.	Tcfl5	Calmegin	0	UNDEFINED	False
8305	8435	15585666:6:TCFL5:CLGN	Gel-shift and yeast one-hybrid experiments showed that [TF] interacts with a non-canonical CACGCG site that is present in the [TG] promoter.	Tcfl5	Clgn	0	UNDEFINED	False
8306	8436	15586248:0:JUN:IVL	YY-1 and [TF] transcription factors participate in the repression of the human [TG] promoter.	c-Jun	involucrin	2	REPRESSION	False
8307	8437	15586248:4:JUN:IVL	Transient overexpression and site-directed mutagenesis experiments of the [TG] 5'-non-coding region (5'-NCR) confirmed that YY1 and [TF] repress involucrin transcription.	c-Jun	involucrin	2	REPRESSION	False
8308	8438	15586248:6:JUN:IVL	The results with protein pull-down experiments are consistent with the hypothesis that interaction of YY1 with [TF] is an important mechanism for [TG] repression.	c-Jun	involucrin	2	REPRESSION	False
8309	8439	15586362:12:TP53:CDKN1A	Expression of a dominant-negative mutant of [TF] reduced expression of p21([TG]/CIP1) protein.	p53	WAF1	1	ACTIVATION	False
8310	8440	15586362:13:TP53:CDKN1A	Histone H4 acetylation in both the promoter and coding regions of the p21([TG]/CIP1) gene in cells expressing dominant-negative [TF] was less than half of that in cells expressing wild-type p53, whereas histone H3 acetylation in both the promoter and coding regions was slightly reduced (by approximately 20%) in cells expressing the dominant-negative p53.	p53	WAF1	0	UNDEFINED	False
8311	8441	15590635:4:SRF:AKAP12	Using a combination of reporter assays and RNA interference, we demonstrate that [TF] is required for [TG]alpha expression.	SRF	AKAP12	1	ACTIVATION	False
8312	8442	15590635:5:SRF:AKAP12	[TF] regulates the activity of the [TG]alpha promoter through two conserved CArG boxes that bind SRF with different affinities.	SRF	AKAP12	0	UNDEFINED	False
8313	8443	15590657:0:ETS2:HMOX1	Role of [TF] in the regulation of [TG] by endotoxin.	Ets-2	heme oxygenase-1	0	UNDEFINED	False
8314	8444	15590657:10:ETS2:HMOX1	Finally, overexpression of a dominant negative form of [TF] blunted [TG] promoter induction by LPS, and kinase inhibitors (PI3K more than JNK) that reduced Ets-2 expression markedly decreased endogenous HO-1 expression.	Ets-2	HO-1	1	ACTIVATION	False
8315	8445	15590657:3:ETS1:HMOX1	[TF] and Ets-2 both induce [TG] promoter activity; however, Ets-2 was a more potent transactivator of HO-1 in macrophages.	Ets-1	HO-1	1	ACTIVATION	False
8316	8446	15590657:3:ETS2:HMOX1	Ets-1 and [TF] both induce [TG] promoter activity; however, Ets-2 was a more potent transactivator of HO-1 in macrophages.	Ets-2	HO-1	1	ACTIVATION	False
8317	8447	15590657:5:ETS2:HMOX1	To further delineate the role of [TF] in regulating [TG] transcription, we performed HO-1 promoter analysis studies in macrophages.	Ets-2	HO-1	0	UNDEFINED	False
8318	8448	1559244:0:FOS:MYL2	[TF]-mediated repression of [TG] gene transcription.	fos	cardiac myosin light chain-2	2	REPRESSION	False
8319	8449	1559244:3:FOS:MYL2	To identify the DNA element(s) in [TG] gene that responds to [TF]-mediated inhibition, 5'-sequential deletion mutants of MLC-2 promoter were tested in a transient transfection assay.	fos	MLC-2	2	REPRESSION	False
8320	8450	1559244:6:FOS:MYL2	Since over-expression of [TF] is implicated in repression of myogenic process, the selective inhibition of [TG] promoter activity by fos and identification of FRE sequence potentially important in understanding the relationship between myogenesis and the oncoprotein-mediated signal pathway(s).	fos	MLC-2	2	REPRESSION	False
8321	8451	15601669:4:NFKB:FAS	We studied the role of the transcription factor [TF] and of MAPKs in regulating [TG] expression.	NF-kappaB	Fas	0	UNDEFINED	False
8322	8452	15601669:6:NFKB:FAS	Moreover, the use of the proteasome inhibitor lactacystin led us to demonstrate that [TF] is required for TNF-alpha mediated [TG] expression.	NF-kappaB	Fas	1	ACTIVATION	False
8323	8453	15610731:3:SRF:FHL2	Using large-scale expression profiling combined with bioinformatic and biochemical approaches, we identified several [TF] target genes, including [TG], encoding a transcriptional cofactor that is highly expressed in the heart.	SRF	Fhl2	0	UNDEFINED	False
8324	8454	15610731:4:SRF:FHL2	[TF] binds the [TG] promoter in vivo and regulates Fhl2 expression in response to RhoA activation.	SRF	Fhl2	0	UNDEFINED	False
8325	8455	15611130:10:NFKB:BCL2L2	Our results suggest that [TF]-mediated up-regulation of BCL-XL and [TG] expression in glioma cells increases cellular resistance to cytotoxic therapy-induced apoptosis.	NFkappaB	BCL-W	1	ACTIVATION	False
8326	8456	15611130:11:NFKB:BCL2L2	We propose that the Fn14 protein functions, in part, through the [TF] signaling pathway to up-regulate BCL-XL and [TG] expression to foster malignant glioblastoma cell survival.	NFkappaB	BCL-W	1	ACTIVATION	False
8327	8457	15616584:6:MYC:CDKN1A	In addition, we find that [TF] can target Dnmt3a selectively to the promoter of [TG].	Myc	p21Cip1	0	UNDEFINED	False
8328	8458	15616584:7:MYC:CDKN1A	[TF] is known to be recruited to the [TG] promoter by the DNA-binding factor Miz-1.	Myc	p21Cip1	0	UNDEFINED	False
8329	8459	15616584:8:MYC:CDKN1A	Consistent with this, we observe that [TF] and Dnmt3a form a ternary complex with Miz-1 and that this complex can corepress the [TG] promoter.	Myc	p21Cip1	2	REPRESSION	False
8330	8460	15616584:9:MYC:CDKN1A	Finally, we show that DNA methylation is required for [TF]-mediated repression of [TG].	Myc	p21Cip1	2	REPRESSION	False
8331	8461	15616591:5:EGR1:GADD45A	We show that [TF] contributes to the regulation of the [TG] and Gadd45b genes, which are involved in the control of cell cycle, DNA repair and apoptosis, by direct binding to their promoter.	Egr-1	Gadd45a	0	UNDEFINED	True
8332	8462	15616591:5:EGR1:GADD45B	We show that [TF] contributes to the regulation of the Gadd45a and [TG] genes, which are involved in the control of cell cycle, DNA repair and apoptosis, by direct binding to their promoter.	Egr-1	Gadd45b	0	UNDEFINED	True
8333	8463	15619676:15:NFKB:FAS	This event correlates with regulation of the binding activity of [TF] to the [TG] promoter by RANKL, as detected by EMSA.	NF-kappaB	Fas	0	UNDEFINED	False
8334	8464	15619676:16:NFKB:FAS	In osteoclast precursors, the induction of [TG] promoter activity by RANKL was dramatically reduced when [TF] binding sites on the Fas promoter were mutated.	NF-kappaB	Fas	1	ACTIVATION	False
8335	8465	15619676:17:NFKB:FAS	RANKL upregulates [TG] expression in osteoclast progenitors through [TF], making osteoclasts targets of Fas-stimulated apoptosis.	NF-kappaB	Fas	1	ACTIVATION	False
8336	8466	15619676:8:NFKB:FAS	The involvement of [TF] in the regulation of [TG] by RANKL was analyzed by luciferase assay and EMSA.	NF-kappaB	Fas	0	UNDEFINED	False
8337	8467	15621046:13:EGR1:SLC8A1	Thus, the in vitro results indicate that [TF]/NAB interactions are critical for [TG] repression at the NCX1 promoter.	Egr-1	NCX1	2	REPRESSION	False
8338	8468	15621046:15:EGR1:SLC8A1	We propose that one way [TF] action is cardiac sparing is by promoting a reduction in [TG] expression.	Egr-1	NCX1	2	REPRESSION	False
8339	8469	15624698:5:STAT1:CSF1	The promoter assay and the electrophoretic mobility gel shift assay revealed that IFN-gamma stimulates transcription of the [TG] gene through this sequence, which binds [TF].	STAT1	CSF-1	1	ACTIVATION	False
8340	8470	15625237:10:NR0B2:NR4A1	Together, our results suggest that [TF] plays a key role in the regulation of [TG] activation and thereby in Nur77-mediated apoptosis in the liver.	SHP	Nur77	1	ACTIVATION	True
8341	8471	15625767:5:USF1:FSHR	Overexpression of upstream stimulating factor-1 ([TF]) suppresses the activity of the human [TG] promoter/enhancer via Inr and E-box elements.	USF1	FSH-R	2	REPRESSION	False
8342	8472	15625767:9:USF1:FSHR	[TF] and USF2 suppress human [TG] promoter/enhancer activity by acting on E-box 3.	USF1	FSH-R	2	REPRESSION	False
8343	8473	15625767:9:USF2:FSHR	USF1 and [TF] suppress human [TG] promoter/enhancer activity by acting on E-box 3.	USF2	FSH-R	2	REPRESSION	False
8344	8474	15627654:0:SREBF1:HK2	Regulation of [TF] expression and transcriptional action on [TG] and FAS genes during fasting and refeeding in rat tissues.	SREBP-1	HKII	0	UNDEFINED	False
8345	8475	15630458:10:NR1I2:CYP24A1	We demonstrated that [TF] binds to and transactivates the 2 proximal vitamin D-responsive elements of the human [TG] promoter.	PXR	CYP24	1	ACTIVATION	False
8346	8476	15631825:10:NFKB:SERPINE1	Furthermore, in the condition of transfection with [TF]-response element-deletion-pCAT construct, both linoleic acid and fenofibrate increased the [TG] transcriptional activity, whereas in those cells transfected with VLDL/fatty acid response element-deletion-pCAT construct, fenofibrate significantly reduced PAI-1 transcriptional activity, but no change in PAI-1 transcription activity was found with linoleic acid stimulation.	NF-kappaB	PAI-1	0	UNDEFINED	True
8347	8477	15631825:13:NFKB:SERPINE1	The inhibition of [TF] signaling pathway may be involved in the downregulation of [TG] gene expression by fenofibrate.	NF-kappaB	PAI-1	1	ACTIVATION	False
8348	8478	15640148:3:ATF2:EGR1	Initial studies confirmed that PGE2 induces [TG] mRNA expression and protein synthesis by restricted SAPK2/p38 MAPK-dependent [TF] (ATF-2) dimer transactivation of the egr-1 promoter as judged by studies using wild-type (WT) and deletion mutant egr-1 promoter constructs, Northern and Western blotting, and standard and supershift electrophoretic mobility shift analyses.	activating transcription factor-2	egr-1	1	ACTIVATION	False
8350	8480	15647252:2:HNF1B:PKHD1	Mutations of [TF] produce congenital cystic abnormalities of the kidney, and previous studies showed that HNF-1beta regulates the expression of the autosomal recessive polycystic kidney disease (ARPKD) gene, [TG].	HNF-1beta	Pkhd1	0	UNDEFINED	False
8351	8481	15647252:4:HNF1B:PKHD1	An [TF] deletion mutant lacking the C-terminal domain interacts with wild-type HNF-1beta, binds DNA, and functions as a dominant-negative inhibitor of a chromosomally integrated [TG] promoter.	HNF-1beta	Pkhd1	1	ACTIVATION	False
8352	8482	15647252:9:HNF1B:PKHD1	We conclude that the C-terminal domain of [TF] is required for the activation of the [TG] promoter.	HNF-1beta	Pkhd1	1	ACTIVATION	False
8353	8483	15647271:7:SMAD4:TGFB1	Overexpression of MAN1 results in inhibition of R-Smad phosphorylation, heterodimerization with [TF] and nuclear translocation, and repression of transcriptional activation of the [TG], BMP2, and activin-responsive promoters.	Smad4	TGFbeta	0	UNDEFINED	True
8354	8484	15647825:3:VDR:CYP24A1	Our studies show that 1,25(OH)2D3-induced transactivation is a dynamic process that involves promoter-specific localization of [TF] and RXR, recruitment of histone acetyltransferase complexes, and in the case of the [TG] gene, modification of histone 4.	VDR	Cyp24	1	ACTIVATION	True
8355	8485	15655349:4:NFKB:PTGS2	The results suggested the role of nuclear factor-kappa B ([TF]) in transcriptional regulation of [TG].	NF-kappaB	COX-2	0	UNDEFINED	False
8356	8486	15659406:6:TP53:GPRC5A	Follow-up studies on one gene, [TG], suggested that [TF] interacts with the promoter of RAI3 and repressed its expression at the onset of apoptosis.	p53	RAI3	2	REPRESSION	False
8357	8487	15659537:9:NFKB1:HSD11B2	In conclusion, TNF-alpha and PMA down-regulate expression and activity of [TG] most likely by a coordinate binding of [TF]/p50 and Egr-1 to the HSD11B2 promoter.	p50	11beta-HSD2	2	REPRESSION	False
8358	8488	15660126:4:NFKB:SLC1A2	Herein, we demonstrate that both TNFalpha-mediated repression and EGF-mediated activation of [TG] expression require [TF].	NF-kappaB	EAAT2	0	UNDEFINED	True
8359	8489	15660126:6:RELA:SLC1A2	Furthermore, TNFalpha can abrogate IKKbeta- and [TF]-mediated activation of [TG].	p65	EAAT2	1	ACTIVATION	False
8360	8490	15660126:7:NFKB:SLC1A2	Our results suggest that [TF] can intrinsically activate [TG] and that TNFalpha mediates repression through a distinct pathway also requiring NF-kappaB.	NF-kappaB	EAAT2	1	ACTIVATION	True
8361	8491	15670751:8:ATF3:GDF15	The results suggest that I3C represses cell proliferation through up-regulation of [TG] and that [TF] may play a pivotal role in DIM-induced NAG-1 expression in human colorectal cancer cells.	ATF3	NAG-1	1	ACTIVATION	False
8362	8492	15674334:0:TP53:RECQL4	Tumor suppressor [TF] represses transcription of [TG] helicase.	p53	RECQ4	2	REPRESSION	False
8363	8493	15674334:3:TP53:RECQL4	In this study, we demonstrate that [TF] can regulate the transcription of [TG].	p53	RECQ4	0	UNDEFINED	False
8364	8494	15674334:5:TP53:RECQL4	Wild-type [TF] (but not the tumor-derived mutant forms) repressed [TG] promoter activity.	p53	RECQ4	2	REPRESSION	False
8365	8495	15674334:7:TP53:RECQL4	Repression of the [TG] promoter was accompanied with an increased accumulation of HDAC1, and the loss of SP1 and [TF] binding to the promoter.	p53	RECQ4	0	UNDEFINED	False
8366	8497	15677471:0:STAT3:CDC25A	The [TF] transcription factor is a target for the Myc and riboblastoma proteins on the [TG] promoter.	STAT3	Cdc25A	0	UNDEFINED	False
8367	8498	15677471:11:STAT3:CDC25A	Thus, we propose that Myc and [TF] cooperate to induce the expression of [TG] and that their transcriptional activity is normally regulated by the Rb tumor suppressor gene.	STAT3	Cdc25A	1	ACTIVATION	False
8368	8499	15677471:4:STAT3:CDC25A	In this study, we show that [TF] and its transcriptional cofactors are recruited to the promoter of the [TG] gene to activate its expression.	STAT3	Cdc25A	1	ACTIVATION	False
8369	8500	15677471:6:STAT3:CDC25A	Moreover, small interfering RNA-mediated knockdown of Myc specifically inhibits the [TF]-mediated activation of [TG].	STAT3	Cdc25A	1	ACTIVATION	False
8370	8501	15677471:8:STAT3:CDC25A	Surprisingly, the association of [TF] with the [TG] promoter does not necessarily lead to transcriptional induction because this protein also functions as a transcriptional repressor of the Cdc25A gene.	STAT3	Cdc25A	1	ACTIVATION	False
8371	8502	15677471:9:STAT3:CDC25A	Following hydrogen peroxide stimulation, [TF] forms a repressor complex with the retinoblastoma (Rb) tumor suppressor to occupy the [TG] promoter and block its induction.	STAT3	Cdc25A	2	REPRESSION	False
8372	8503	15677507:5:SREBF1:UCP2	beta-Cell-specific expression of [TF]c caused reduction in islet mass and impaired glucose-stimulated insulin secretion and was associated with accumulation of triglycerides, suppression of pancreas duodenal homeobox-1, and upregulation of [TG] gene expression.	SREBP-1	uncoupling protein 2	1	ACTIVATION	False
8373	8504	15684718:4:ELK3:CCND1	Transient transfections revealed that, in addition to its regulation of the c-fos promoter, [TF] from CHO cells seems to inhibit other promoters controlling expression of proteins involved in G1/S phase progression; [TG] and DHFR.	Elk3	Cyclin D1	2	REPRESSION	False
8374	8505	15684718:4:ELK3:DHFR	Transient transfections revealed that, in addition to its regulation of the c-fos promoter, [TF] from CHO cells seems to inhibit other promoters controlling expression of proteins involved in G1/S phase progression; Cyclin D1 and [TG].	Elk3	DHFR	2	REPRESSION	False
8375	8506	15688032:4:NCOA1:SERPINE1	Using transient cell transfection experiments performed in human dermal fibroblasts with the Smad3/4-specific (SBE)4-lux reporter construct, as well as the human [TG] promoter, we determined that [TF] enhances TGF-beta-induced, Smad-mediated, transcription.	SRC-1	PAI-1	1	ACTIVATION	False
8376	8507	15688035:7:FOXO1:EPHA2	Chromatin immunoprecipitations confirmed the direct binding of Pax3/[TF] to the promoter region of several factors including cannabinoid receptor-1, [TG] and EPHA4.	FKHR	EPHA2	0	UNDEFINED	False
8377	8508	15688035:7:FOXO1:EPHA4	Chromatin immunoprecipitations confirmed the direct binding of Pax3/[TF] to the promoter region of several factors including cannabinoid receptor-1, EPHA2 and [TG].	FKHR	EPHA4	0	UNDEFINED	False
8378	8509	15688035:7:PAX3:EPHA2	Chromatin immunoprecipitations confirmed the direct binding of [TF]/FKHR to the promoter region of several factors including cannabinoid receptor-1, [TG] and EPHA4.	Pax3	EPHA2	0	UNDEFINED	False
8379	8510	15688035:7:PAX3:EPHA4	Chromatin immunoprecipitations confirmed the direct binding of [TF]/FKHR to the promoter region of several factors including cannabinoid receptor-1, EPHA2 and [TG].	Pax3	EPHA4	0	UNDEFINED	False
8380	8511	15691871:7:USF1:SLC16A1	With the use of site-directed mutagenesis and promoter activity in Caco-2 cells, the USF proteins appeared to have a repressor role on the [TG] promoter, which was further confirmed by cotransfecting expression vectors encoding [TF] and 2 in Caco-2 cells and determining endogenous MCT1 expression in USF2 overexpressed cells.	USF1	MCT1	2	REPRESSION	False
8381	8512	15691871:7:USF2:SLC16A1	With the use of site-directed mutagenesis and promoter activity in Caco-2 cells, the USF proteins appeared to have a repressor role on the [TG] promoter, which was further confirmed by cotransfecting expression vectors encoding USF1 and 2 in Caco-2 cells and determining endogenous MCT1 expression in [TF] overexpressed cells.	USF2	MCT1	2	REPRESSION	False
8382	8513	15699146:0:GATA3:KLRC1	[TF] is an important transcription factor for regulating human [TG] gene expression.	GATA-3	NKG2A	0	UNDEFINED	False
8383	8514	15699146:10:GATA3:KLRC1	Taken together, our data indicate that [TF] is an important transcription factor for regulating [TG] gene expression.	GATA-3	NKG2A	0	UNDEFINED	False
8384	8515	15699146:8:GATA3:KLRC1	Using chromatin immunoprecipitation assays, we showed that [TF] specifically binds to the [TG] promoter in situ in NKL and primary NK cells, but not in Jurkat T cells.	GATA-3	NKG2A	0	UNDEFINED	False
8385	8516	15706412:6:JUNB:CCND1	We further analyzed the relationship between [TF], P16 and [TG] expression.	JUNB	cyclin D1	0	UNDEFINED	False
8386	8517	15707600:0:SMAD7:FSHB	Cloning of Smad2, Smad3, Smad4, and [TF] from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish [TG] promoter activity.	Smad7	FSHbeta	0	UNDEFINED	False
8388	8519	15710329:4:TP53:CDKN1A	Chromatin immunoprecipitation assays demonstrate that MUC1 coprecipitates with [TF] on the p53-responsive elements of the [TG] gene promoter and coactivates p21 gene transcription.	p53	p21	1	ACTIVATION	False
8389	8520	15711548:0:STAT5A:BCL6	[TF] regulates the self-renewal capacity and differentiation of human memory B cells and controls [TG] expression.	STAT5	Bcl-6	0	UNDEFINED	False
8390	8521	15713664:1:NFKB:PTGS2	[TF] plays a critical role mediating [TG] expression in renal medullary interstitial cells (RMICs).	NFkappaB	COX2	1	ACTIVATION	False
8391	8522	15713664:15:CEBPB:PTGS2	These studies indicate [TF] is required for the transcriptional activation of [TG] by NFkappaB, suggesting a dominant role for the C/EBPbeta pathway in regulating induction of RMIC COX2 by hypertonicity.	C/EBPbeta	COX2	1	ACTIVATION	False
8392	8523	15716278:5:SMAD6:SERPINE1	The effect of [TF] on the [TG] promoter appeared to be the result of increase binding of the forkhead winged helix factor FoxD1 to a TGF-beta-responsive element.	Smad6s	PAI-1	0	UNDEFINED	False
8393	8524	15716956:0:MITF:CDKN1A	[TF] cooperates with Rb1 and activates [TG] expression to regulate cell cycle progression.	Mitf	p21Cip1	1	ACTIVATION	False
8394	8525	15716956:3:MITF:CDKN1A	Here we show that [TF] can act as a novel anti-proliferative transcription factor able to induce a G1 cell-cycle arrest that is dependent on Mitf-mediated activation of the p21(Cip1) ([TG]) cyclin-dependent kinase inhibitor gene.	Mitf	CDKN1A	1	ACTIVATION	False
8395	8526	15716956:5:MITF:CDKN1A	The results indicate that [TF]-mediated activation of [TG] expression and consequent hypophosphorylation of Rb1 will contribute to cell cycle exit and activation of the differentiation programme.	Mitf	p21Cip1	1	ACTIVATION	False
8396	8527	15722554:5:HOXA1:RHOB	We have characterized in detail these Hoxa1(-/-) ES cells by performing microarray analyses, and by this technique we have identified a number of putative [TF] target genes, including genes involved in bone development (e.g. Col1a1, Postn/Osf2, and the bone sialoprotein gene or BSP), genes that are expressed in the developing brain (e.g. Nnat, Wnt3a, BDNF, [TG], and Gbx2), and genes involved in various cellular processes (e.g. M-RAS, Sox17, Cdkn2b, LamA1, Col4a1, Foxa2, Foxq1, Klf5, and Igf2).	Hoxa-1	RhoB	0	UNDEFINED	False
8397	8528	15728246:9:IFI16:CDKN1A	Moreover, binding to [TF] resulted in its transcriptional activation as shown by an increase in the activity of a reporter gene driven by p53-responsive sequences derived from the [TG](WAF1) promoter, along with an increase in the p21 mRNA and protein levels.	IFI16	p21	1	ACTIVATION	False
8398	8529	15728246:9:TP53:CDKN1A	Moreover, binding to IFI16 resulted in its transcriptional activation as shown by an increase in the activity of a reporter gene driven by [TF]-responsive sequences derived from the [TG](WAF1) promoter, along with an increase in the p21 mRNA and protein levels.	p53	p21	1	ACTIVATION	False
8399	8530	15728492:9:NFKB:PTGS2	Taken together our results suggest a model in which IFN-gamma-induced TNF activates [TF], which is required for full [TG] expression.	NF-kappaB	COX-2	1	ACTIVATION	False
8400	8531	15728509:7:NFKB:CCND1	As one potential mechanism for this increase in proliferation, an [TF]-specific activation of [TG] was observed.	NF-kappaB	cyclin D1	1	ACTIVATION	False
8401	8532	15734731:13:SNAI2:BRCA2	It thus appears that [TF] is a negative regulator for [TG] gene expression.	SLUG	BRCA2	2	REPRESSION	False
8402	8533	15734732:2:BACH1:NQO1	In this report, we demonstrate that overexpression of the transcription factor [TF] in Hep-G2 cells negatively regulated [TG] gene expression and induction in response to antioxidant t-BHQ.	Bach1	NQO1	2	REPRESSION	False
8403	8534	15734732:5:BACH1:NQO1	Heme, a negative regulator of [TF] relieved the Bach1 repression of [TG] gene expression in transfected cells.	Bach1	NQO1	2	REPRESSION	False
8404	8535	15737464:6:EGR1:VEGFA	Deletion and mutation analysis identified a GC-rich region in the proximal region of the [TG] promoter that constitutively bound Sp1 and PRL-induced [TF].	Egr-1	VEGF	0	UNDEFINED	False
8405	8536	15737464:9:EGR1:VEGFA	Our results indicate that PRL induces [TG] expression through [TF], and implicates VEGF as an intermediary of PRL-regulated angiogenesis.	Egr-1	VEGF	1	ACTIVATION	False
8406	8537	15737994:12:JUN:CCNA2	Using a dominant negative [TF] mutant, TAM67, we showed that this transcriptional activation of [TG] requires c-Jun.	c-Jun	cyclin A2	1	ACTIVATION	False
8407	8538	15737994:5:JUN:CCNA2	Chromatin immunoprecipitation demonstrated that [TF] bound directly to the [TG] promoter.	c-Jun	cyclin A2	0	UNDEFINED	False
8408	8540	15741164:0:USF2:PRKG1	Upstream stimulatory factors (USF-1/[TF]) regulate [TG] gene expression in vascular smooth muscle cells.	USF-2	human cGMP-dependent protein kinase I	0	UNDEFINED	False
8409	8541	15741235:3:TP53:BTG2	As can be expected owing to its dominant-negative effect, DeltaNp73alpha inhibits Waf1/p21 gene expression, but equally importantly, it upregulates BTG2TIS21/[TG], another [TF] target gene.	p53	PC3	0	UNDEFINED	False
8410	8542	15741235:3:TP53:CDKN1A	As can be expected owing to its dominant-negative effect, DeltaNp73alpha inhibits [TG]/p21 gene expression, but equally importantly, it upregulates BTG2TIS21/PC3, another [TF] target gene.	p53	Waf1	0	UNDEFINED	True
8411	8543	15743888:13:NFKB:ERBB2	These findings suggest that PARP-1 is involved in the expression of [TG] in concert with [TF], which might be associated with the proliferation of RA synovial cells.	NF-kappaB	ERBB2	1	ACTIVATION	True
8412	8544	15743888:3:NFKB:ERBB2	Recent findings have suggested that poly(ADP-ribose) polymerase-1 (PARP-1) is involved in the transactivation of [TF]-dependent genes such as [TG].	NF-kappaB	ERBB2	1	ACTIVATION	False
8413	8545	15752068:7:CEBPA:CES1	Co-transfection with [TF] cDNA and [TG] promoter constructs in 3T3-L1 pre-adipocytes demonstrated that C/EBPalpha increased TGH promoter activity.	C/EBPalpha	TGH	1	ACTIVATION	False
8414	8546	15752068:8:CEBPA:CES1	Ectopic expression of [TF] in NIH 3T3 cells activated [TG] mRNA expression without causing differentiation into adipocytes.	C/EBPalpha	TGH	1	ACTIVATION	False
8415	8547	15755876:8:RELA:CCND1	Moreover, a chromatin immunoprecipitation assay shows that trichostatin A treatment inhibits endogenous [TG] gene transcription by preventing [TF] binding to the cyclin D1 promoter.	p65	cyclin D1	1	ACTIVATION	False
8416	8548	15757899:6:NFKB:GDF15	The expression of [TF] p65 induced [TG] promoter activity, and chromatin immunoprecipitation assay for p65 showed that NF-kappa B binds the NAG-1 promoter in LNCaP cells.	NF-kappa B	NAG-1	1	ACTIVATION	False
8417	8549	15757899:6:RELA:GDF15	The expression of NF-kappa B [TF] induced [TG] promoter activity, and chromatin immunoprecipitation assay for p65 showed that NF-kappa B binds the NAG-1 promoter in LNCaP cells.	p65	NAG-1	1	ACTIVATION	False
8418	8550	15767783:6:E2F1:CCNE2	Immunoblot study of E2F target genes showed that multiple passages of [TF]-deficient cells resulted in preferential increase of [TG] expression.	E2F-1	cyclin E2	2	REPRESSION	True
8419	8551	15777790:7:FOS:TIMP1	A role for [TF] was confirmed by over-expression of c-Jun and c-fos in confluent MDA-MB-231 cells, showing with c-Jun increased MMP-2 (5-fold), MMP-3 (1.6-fold), and MMP-9 (160-fold) expression, as well as enhanced invasive potential, while [TG] expression was down-regulated (2-fold) when compared to vector controls.	AP-1	TIMP-1	2	REPRESSION	False
8420	8552	15778351:5:STAT1:TAP1	We also show that this cytokine-dependent expression of [TG] transcripts depends on [TF] and IFN regulatory factor-2 (IRF-2), but not on IRF-1, and provide evidence that IRF-2 constitutively binds to the TAP1 gene promoter and enhances TAP1 promoter activity.	STAT1	TAP1	1	ACTIVATION	False
8421	8553	15778351:6:STAT1:TAP1	We show that IRF-2 forms a complex with [TF] and the cytokine-responsive region of the [TG] promoter in any TPO or IFN-gamma target cells tested.	STAT1	TAP1	0	UNDEFINED	False
8422	8554	15778351:8:STAT1:TAP1	Overall, our data indicate that TPO and IFN-gamma activate the expression of [TG] via a new mechanism that involves functional cooperation between [TF] and IRF-2 on the TAP1 promoter.	STAT1	TAP1	1	ACTIVATION	False
8423	8555	15789036:11:AP1:BCL2L1	Downmodulation of the ERK1/2 and NF-kappa B pathways inhibits the transcriptional activity of [TF] and NF-kappa B transcription factors, respectively, both of which lead to the downregulation of Bcl-(xL) ([TG] related gene (long alternatively spliced variant of Bcl-x gene)) transcription and expression and sensitization to drug-induced apoptosis.	AP-1	Bcl-2	1	ACTIVATION	True
8424	8556	15790310:4:SP2:CDKN1A	We found that Sp1 and Sp3, but not [TF], co-operate functionally with p53, p73 and p63 for the synergistic transactivation of the [TG] promoter in Drosophila Schneider SL2 cells that lack endogenous Sp factors.	Sp2	p21Cip1	1	ACTIVATION	False
8425	8557	15790310:4:SP3:CDKN1A	We found that Sp1 and [TF], but not Sp2, co-operate functionally with p53, p73 and p63 for the synergistic transactivation of the [TG] promoter in Drosophila Schneider SL2 cells that lack endogenous Sp factors.	Sp3	p21Cip1	1	ACTIVATION	False
8426	8558	15790310:4:TP53:CDKN1A	We found that Sp1 and Sp3, but not Sp2, co-operate functionally with [TF], p73 and p63 for the synergistic transactivation of the [TG] promoter in Drosophila Schneider SL2 cells that lack endogenous Sp factors.	p53	p21Cip1	1	ACTIVATION	False
8427	8559	15790310:5:SP1:BBC3	We also found that [TF] strongly transactivated the [TG] promoter synergistically with p53, whereas deletion of the Sp1-binding sites abolished the transactivation by p53.	Sp1	PUMA	1	ACTIVATION	False
8428	8560	15790310:6:SP3:CDKN1A	Using p53 mutant forms in GST (glutathione S-transferase) pull-down assays, we found that the C-terminal 101 amino acids of p53, which include the oligomerization and regulatory domains of the protein, are required for the physical interactions with Sp1 and [TF], and that deletion of this region abolished transactivation of the [TG] promoter.	Sp3	p21Cip1	1	ACTIVATION	False
8429	8561	15790310:6:TP53:CDKN1A	Using [TF] mutant forms in GST (glutathione S-transferase) pull-down assays, we found that the C-terminal 101 amino acids of p53, which include the oligomerization and regulatory domains of the protein, are required for the physical interactions with Sp1 and Sp3, and that deletion of this region abolished transactivation of the [TG] promoter.	p53	p21Cip1	1	ACTIVATION	False
8430	8562	15792957:0:PBX1:REN	Activation of the rat [TG] promoter by HOXD10.[TF].PREP1, Ets-1, and the intracellular domain of notch.	PBX1b	renin	1	ACTIVATION	False
8431	8563	15792957:0:PKNOX1:REN	Activation of the rat [TG] promoter by HOXD10.PBX1b.[TF], Ets-1, and the intracellular domain of notch.	PREP1	renin	1	ACTIVATION	False
8432	8564	15792957:8:HOXD10:REN	Finally, we show that the intracellular domain of Notch1, Ets-1, and [TF].PBX1b.PREP1 activate the rat [TG] promoter cooperatively in COS-7 cells.	HOXD10	renin	1	ACTIVATION	False
8433	8565	15792957:8:PBX1:REN	Finally, we show that the intracellular domain of Notch1, Ets-1, and HOXD10.[TF].PREP1 activate the rat [TG] promoter cooperatively in COS-7 cells.	PBX1b	renin	1	ACTIVATION	False
8434	8566	15792957:8:PKNOX1:REN	Finally, we show that the intracellular domain of Notch1, Ets-1, and HOXD10.PBX1b.[TF] activate the rat [TG] promoter cooperatively in COS-7 cells.	PREP1	renin	1	ACTIVATION	False
8435	8567	15794755:0:ELF3:PTGS2	The Ets transcription factor [TF] mediates induction of the [TG] gene by LPS in monocytes.	ESE-1	COX-2	1	ACTIVATION	False
8436	8568	15794755:3:ELF3:PTGS2	We present here a novel role for the Ets transcription factor [TF] in regulating the [TG] gene in response to endotoxin and other pro-inflammatory stimuli.	ESE-1	COX-2	0	UNDEFINED	False
8437	8569	15794755:4:ELF3:PTGS2	We report that the induction of [TG] expression by lipopolysaccharide (LPS) and pro-inflammatory cytokines correlates with [TF] induction in monocyte/macrophages.	ESE-1	COX-2	1	ACTIVATION	True
8438	8570	15794755:6:ELF3:PTGS2	In vitro analysis demonstrates that [TF] binds to and activates the [TG] promoter to levels comparable to LPS-mediated induction.	ESE-1	COX-2	1	ACTIVATION	False
8439	8571	15794755:8:ELF3:PTGS2	The effect of [TF] on the [TG] promoter is further enhanced by cooperation with other transcription factors such as nuclear factor-kappa B and nuclear factor of activated T cells.	ESE-1	COX-2	0	UNDEFINED	False
8440	8572	15794924:3:HIF1A:LDHA	In order to monitor HIF-1 transcriptional activity, we have developed [TF]-responsive reporter constructs, in which lacZ gene expression is driven by minimal Hsp70 gene promoter or minimal immediate early promoter of cytomegalovirus (CMV) and a combination of hypoxia response elements from regulatory regions of PGK1, ENO1 and [TG] genes.	HIF-1alpha	LDHA	0	UNDEFINED	True
8441	8573	15798085:6:NFKB:CCND1	Moreover, inhibition of [TF] caused a pronounced reduction of EGF-induced [TG] promoter activity.	NF-kappaB	cyclin D1	1	ACTIVATION	False
8442	8574	15798204:5:POU2F1:CSN2	Chromatin immunoprecipitation, RNA interference, promoter mutagenesis, and transient expression analyses were used to demonstrate that the Runx2/[TF] complex contributes to the transcriptional regulation of the [TG] gene.	Oct-1	beta-casein	0	UNDEFINED	False
8443	8575	15798204:7:POU2F1:CSN2	[TF] stimulates the recruitment of Runx2 to the [TG] promoter by interacting with the C-terminal region of Runx2, suggesting that Oct-1 stimulates Runx2 recruitment by relieving the autoinhibition of Runx2 DNA binding.	Oct-1	beta-casein	0	UNDEFINED	False
8444	8577	15798216:5:AP1:RASGRF1	We show that c-Jun/[TF] can bind and activate the [TG] promoter in vivo.	AP-1	Ras-GRF1	1	ACTIVATION	False
8445	8579	15798764:5:LEF1:CCND1	Furthermore, activation of beta-catenin-dependent transcription by gastrin was confirmed by an increase in [TF] reporter activity, as well as enhanced [TG] promoter activity.	LEF-1	cyclin D1	1	ACTIVATION	True
8446	8580	15808844:8:TAF1:SLC2A1	Our data indicate that phenylephrine induces the expression of the TBP-associated factor [TF] mRNA, which increases in parallel to the expression of [TG], suggesting that altering the expression of basal transcription factors could be one mechanism by which phenylephrine may regulate the activity of the GLUT1 promoter.	TAF(II)250	GLUT1	0	UNDEFINED	False
8447	8581	15808852:8:SP1:CXCL12	Binding of [TF] to the promoter was confirmed by electrophoretic mobility shift assay, and its importance in [TG] gene expression verified by in vitro mutagenesis.	Sp1	SDF1	1	ACTIVATION	True
8448	8582	15811856:0:E2F4:FGFR1	Dynamic transcriptional regulatory complexes, including [TF], p107, p130, and Sp1, control [TG] gene expression during myogenesis.	E2F4	fibroblast growth factor receptor 1	0	UNDEFINED	False
8449	8583	15811856:1:E2F4:FGFR1	Developmentally controlled transcriptional regulation of myogenic cell proliferation and differentiation via expression of the [TG] (FGFR1) gene is positively regulated by Sp1 and negatively regulated by [TF]-based transcriptional complexes.	E2F4	fibroblast growth factor receptor 1	2	REPRESSION	False
8450	8584	15811856:2:E2F4:FGFR1	We report that p107 and p130 formed transcriptional complexes with [TF] on the [TG] promoter and repressed FGFR1 gene transcription in myogenic cells.	E2F4	FGFR1	0	UNDEFINED	True
8451	8585	15812237:6:CEBPD:SAA2	Indeed, both NaBu and IL-1beta led to increased recruitment of NF-kappa B p65, C/EBPbeta, and [TF], and decreased NF-kappa B p50 and C/EBP alpha DNA-binding to the proximal [TG] promoter, as assessed by chromatin immunoprecipitation assays.	C/EBP delta	SAA2	0	UNDEFINED	False
8452	8586	15812824:10:CUX1:CDKN1A	These results suggest that increased expression of [TF] may play a role in the activation of hepatic stem cells, possibly through the repression of the cyclin kinase inhibitor [TG].	Cux-1	p21	2	REPRESSION	False
8453	8587	15814298:5:SP1:AKR1C3	Forskolin stimulated the promoter activity of the [TG] gene through this [TF]/Sp3 binding site.	Sp1	HSD17B5	1	ACTIVATION	False
8454	8588	15814298:5:SP3:AKR1C3	Forskolin stimulated the promoter activity of the [TG] gene through this Sp1/[TF] binding site.	Sp3	HSD17B5	1	ACTIVATION	False
8455	8589	15817812:7:NR1H4:NR0B2	Both ICAM-1 and [TG] expression were induced in a dose- and time-dependent manner by treatment with the [TF]-selective agonist GW4064.	FXR	SHP	1	ACTIVATION	False
8456	8590	15829514:6:NR0B1:AMH	Similarly, [TG] expression was reduced in both Sf1 and [TF] single mutants at E11.5, and it was not rescued by the Sf1/Dax1 double mutant.	Dax1	Amh	1	ACTIVATION	False
8457	8591	15829514:6:NR5A1:AMH	Similarly, [TG] expression was reduced in both [TF] and Dax1 single mutants at E11.5, and it was not rescued by the Sf1/Dax1 double mutant.	Sf1	Amh	1	ACTIVATION	False
8458	8592	15831456:3:NR5A2:POU5F1	Here we report that the orphan nuclear receptor [TF], which is expressed in undifferentiated ES cells, can bind to SF-1 response elements in the proximal promoter and proximal enhancer of the [TG] gene and activate Oct4 reporter gene expression.	LRH-1	Oct4	1	ACTIVATION	False
8459	8593	15833826:6:ATF2:FASLG	Studies addressing the mechanism of action of Ad-mda7-induced tumor cell apoptosis revealed early activation of the transcription factors c-Jun and [TF], which in turn stimulated the transcription of an immediate downstream target, the death-inducer [TG] (FasL), and its cognate receptor Fas.	activating transcription factor 2	Fas ligand	1	ACTIVATION	False
8460	8594	15840840:10:STAT5A:SLCO1B3	PRL enhanced the binding of [TF] to the [TG] promoter and DNA-protein binding was inhibited in competition assays by excess OATP1B3 and Stat5 consensus oligomers but not by mutant Stat5 oligomers.	Stat5a	OATP1B3	0	UNDEFINED	False
8461	8595	15843409:5:TBX20:MEF2C	[TF] could activate promoters/enhancers of several genes in cultured cells, including the [TG] AHF enhancer and the Nkx2-5 cardiac enhancer.	Tbx20	Mef2c	1	ACTIVATION	False
8462	8596	15843409:8:GATA4:MEF2C	Tbx20 synergized with Isl1 and [TF] to activate both the [TG] and Nkx2-5 enhancers, thus providing a unifying mechanism for gene activation by Tbx20 in the AHF.	Gata4	Mef2c	1	ACTIVATION	False
8463	8597	15843409:8:TBX20:MEF2C	[TF] synergized with Isl1 and Gata4 to activate both the [TG] and Nkx2-5 enhancers, thus providing a unifying mechanism for gene activation by Tbx20 in the AHF.	Tbx20	Mef2c	1	ACTIVATION	False
8464	8598	15854045:0:SP1:PADI2	Regulation of the expression of peptidylarginine deiminase type II gene ([TG]) in human keratinocytes involves [TF] and Sp3 transcription factors.	Sp1	PADI2	0	UNDEFINED	False
8465	8599	15854045:0:SP3:PADI2	Regulation of the expression of peptidylarginine deiminase type II gene ([TG]) in human keratinocytes involves Sp1 and [TF] transcription factors.	Sp3	PADI2	0	UNDEFINED	False
8466	8600	15855772:10:E2F3:CCNB1	In both the [TF] and E2F4 transgenic lenses, cyclin A2 and [TG] expression were upregulated.	E2F3a	cyclin B1	1	ACTIVATION	False
8467	8601	15855772:10:E2F4:CCNB1	In both the E2F3a and [TF] transgenic lenses, cyclin A2 and [TG] expression were upregulated.	E2F4	cyclin B1	1	ACTIVATION	False
8468	8602	15856770:4:TWIST1:CDKN1A	In addition, E2A-dependent activation of [TG] promoter can be inhibited by another bHLH factor, [TF].	TWIST	p21	2	REPRESSION	False
8469	8603	15857826:0:RELA:REN	Role of CREB1 and NF{kappa}B-[TF] in the down-regulation of [TG] gene expression by tumor necrosis factor {alpha}.	p65	renin	2	REPRESSION	False
8470	8604	15857826:2:NFKB:REN	We have found that TNFalpha suppresses [TG] transcription via transcription factor [TF], which targets a cAMP responsive element (CRE) in the renin promoter.	NFkappaB	renin	2	REPRESSION	False
8471	8605	15857826:6:RELA:REN	Our results suggest that TNFalpha inhibits [TG] gene expression by decreasing the transactivating capacity of NFkappaB-[TF] and partially by attenuating CREB1 binding to CRE.	p65	renin	1	ACTIVATION	False
8472	8606	15860260:0:TP53:VEGFA	[TF]-dependent inhibition of progestin-induced [TG] expression in human breast cancer cells.	p53	VEGF	2	REPRESSION	False
8473	8607	15860260:11:TP53:CDKN1A	PRIMA-1 induced activation of [TF] in tumor cell lines was confirmed with a p53-responsive [TG] reporter plasmid and by detecting increased levels of p21 proteins in cell lysates.	p53	p21	1	ACTIVATION	True
8474	8608	15860260:14:TP53:VEGFA	These results are consistent with the hypothesis that wild-type [TF] blocks progestin-dependent induction of [TG] in breast cancer cells and this may be a novel anti-angiogenic mechanism for controlling the growth of progestin-dependent tumors.	p53	VEGF	2	REPRESSION	False
8475	8609	15860571:4:JUND:TIMP1	In coimmunoprecipitation, electromobility shift, and transactivation experiments, FXR activation/overexpression caused a SHP-dependent inhibition of [TF] binding to its consensus element in the [TG] promoter.	JunD	TIMP-1	0	UNDEFINED	False
8476	8610	15860735:12:STAT3:ICAM1	The Sp1-[TF] complex appears to play an important role in the upregulation of [TG] transcription after reoxygenation or reperfusion.	Stat3	ICAM-1	1	ACTIVATION	False
8477	8611	15864740:3:TFAP2A:PIGR	We have previously shown in cultured tumor cell-lines that basal transcription of the [TG] gene is regulated by the transcription factors USF1, USF2 and [TF].	AP2	PIGR	1	ACTIVATION	True
8478	8612	15867358:10:E2F1:PTGS2	Taken together, these results suggest activation of a transcriptional cascade by which [TF] regulates [TG] expression through the c-myb oncogene.	E2F1	COX-2	0	UNDEFINED	False
8479	8613	15867358:7:E2F1:PTGS2	[TG] promoter studies reveal that [TF] transcriptionally activates COX-2, which is dependent on the transactivation and DNA-binding domains of E2F1.	E2F1	COX-2	1	ACTIVATION	False
8481	8615	15870071:5:NFE2L2:HMOX1	[TG] induction was abolished by transfection of astrocytes with a dominant-negative mutant [TF], indicating that FGF-1 regulates HO-1 expression through Nrf2.	Nrf2	HO-1	1	ACTIVATION	False
8482	8616	15870277:0:TP53:BUB1B	Transcriptional control of [TG] by [TF] and suppression of centrosome amplification by BubR1.	p53	BubR1	0	UNDEFINED	False
8483	8617	15870875:10:RELA:CCND1	Nuclear translocation of [TF] NF-kappaB is involved in the expression of [TG] mRNA.	p65	cyclin D1	1	ACTIVATION	True
8484	8618	15883203:0:SP4:VEGFA	Cyclooxygenase-2 inhibitors decrease [TG] expression in colon cancer cells by enhanced degradation of Sp1 and [TF] proteins.	Sp4	vascular endothelial growth factor	1	ACTIVATION	False
8485	8619	15883213:11:SMAD2:CTGF	Transient transfection with Smad7, which interferes with receptor-mediated activation of [TF], diminished Ang II-induced [TG] promoter activation, gene and protein expression, and fibronectin and type-1 procollagen overexpression, showing that Smad activation is involved in Ang II-induced fibrosis.	Smad2	CTGF	1	ACTIVATION	True
8488	8622	15899793:3:SPZ1:PCNA	In addition, through an interaction with proliferating cell nuclear antigen ([TG]) promoter, [TF] induced cell proliferation concomitant with an increase in PCNA gene expression.	Spz1	PCNA	1	ACTIVATION	False
8489	8623	15899840:0:TRERF1:CDKN1A	[TF] controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21[TG]/Cip1 and p27Kip1.	TReP-132	WAF1	0	UNDEFINED	False
8490	8624	15899840:10:TRERF1:CDKN1A	Together, these results identify [TF] as a basal cell cycle regulatory protein acting, at least in part, by interacting with Sp1 to activate the [TG] and p27 gene promoters.	TReP-132	p21	1	ACTIVATION	False
8491	8625	15902299:5:HIF1A:ITGAM	Of importance, the transient transfection of [TF] cDNA induced U937 cells to develop the differentiation-related alterations such as growth arrest and increased [TG] expression.	HIF-1 alpha	CD11b	1	ACTIVATION	False
8492	8626	15919789:7:SREBF1:SLC2A2	An electrophoretic mobility shift assay and mutational analysis of the [TG] promoter revealed that [TF] binds to the -84/-76 region of the GLUT2 promoter.	SREBP-1c	GLUT2	0	UNDEFINED	False
8493	8627	15919789:9:SREBF1:SLC2A2	These results indicate that [TF] mediates glucose-stimulated [TG] gene expression in hepatocytes.	SREBP-1c	GLUT2	1	ACTIVATION	False
8494	8628	15920551:3:JUNB:TNFRSF8	Recent evidence suggests that Hodgkin and Reed-Sternberg cells overexpress JunB and that JunB facilitates constitutive [TG] expression by binding to an [TF] site in the CD30 promoter.	AP-1	CD30	1	ACTIVATION	False
8495	8629	15922656:6:HIF1A:ABCA1	The [TG] promoter is further stimulated by the ubiquitous factor Sp1 and the hypoxia-induced factor 1 ([TF]), which bind to GC-boxes and the E-box, respectively.	HIF1	ABCA1	1	ACTIVATION	False
8496	8630	15922873:7:MYB:CCND1	We show that B-[TF] is a potent activator of the [TG] promoter and that this activation is not mediated by Myb binding sites but rather by a group of Sp1 binding sites which have previously been shown to be crucial for cyclin D1 promoter activity.	Myb	cyclin D1	1	ACTIVATION	False
8497	8631	15930297:11:ARNT:VEGFA	Topotecan blocked the IGF-I-stimulated increase in HIF-1alpha but not [TF], and this resulted in a decrease in [TG] in four neuroblastoma cell lines tested.	HIF-1beta	VEGF	1	ACTIVATION	True
8498	8632	15939554:10:NFKB:IKBKE	Also the gel shift assay suggested that [TF] p65 is responsible for activation of the [TG] promoter.	NFkappaB	IKKi	1	ACTIVATION	False
8499	8633	15939554:10:RELA:IKBKE	Also the gel shift assay suggested that NFkappaB [TF] is responsible for activation of the [TG] promoter.	p65	IKKi	1	ACTIVATION	False
8500	8634	15939554:9:NFKB:IKBKE	Over-expression of [TF] p65 mimics the TNFalpha-induced activation of the [TG] promoter.	NFkappaB	IKKi	1	ACTIVATION	False
8501	8635	15939554:9:RELA:IKBKE	Over-expression of NFkappaB [TF] mimics the TNFalpha-induced activation of the [TG] promoter.	p65	IKKi	1	ACTIVATION	False
8502	8636	15955564:7:CEBPB:CD200	EMSA documented clear evidence for [TF] as being important in transcriptional regulation of [TG].	C/EBPbeta	CD200	0	UNDEFINED	False
8503	8637	15958553:7:TP53:COL18A1	We found that [TF] activates the [TG] gene encoding the precursor for the antiangiogenic factor endostatin.	p53	COL18A1	1	ACTIVATION	False
8504	8638	15961275:5:MITF:SERPINE1	[TF] isoforms regulated TGF-beta1-induced transcription of [TG] differently; MITF-E-mediated transcription was further increased by TGF-beta1, whereas transcriptional activation by TGF-beta1 was blocked by MITF-M or MITF-mc expression.	MITF	PAI-1	1	ACTIVATION	False
8506	8640	15964844:6:NFKB:NR4A1	Analysis of the murine and human [TG] promoters revealed two highly conserved [TF] response elements.	NF-kappaB	Nur77	0	UNDEFINED	False
8507	8641	15967108:1:TP53:PLK4	Chip profiling of a [TF] temperature-sensitive tumor model identified [TG] (Snk/Plk-akin kinase), encoding a new member of polo-like kinases (PLKs), as a gene strongly repressed by wild-type p53.	p53	SAK	2	REPRESSION	False
8508	8642	15967108:4:CREB1:PLK4	Transcriptional analysis with luciferase reporters driven by [TG] promoter deletion fragments identified SP-1 and [TF] binding sites, which together conferred a two-fold SAK repression by p53.	CREB	SAK	2	REPRESSION	False
8509	8643	15967108:4:SP1:PLK4	Transcriptional analysis with luciferase reporters driven by [TG] promoter deletion fragments identified [TF] and CREB binding sites, which together conferred a two-fold SAK repression by p53.	SP-1	SAK	2	REPRESSION	False
8510	8644	15967108:4:TP53:PLK4	Transcriptional analysis with luciferase reporters driven by [TG] promoter deletion fragments identified SP-1 and CREB binding sites, which together conferred a two-fold SAK repression by [TF].	p53	SAK	2	REPRESSION	False
8511	8645	15967803:8:HNF4A:PDK4	Hepatic nuclear factor 4 ([TF]), which activates many genes in the liver, will induce [TG] expression.	HNF4	PDK4	1	ACTIVATION	False
8512	8646	15976391:0:EGR1:SLC9A2	Zinc finger transcription factor [TF] is involved in stimulation of [TG] gene expression by phorbol 12-myristate 13-acetate.	Egr-1	NHE2	1	ACTIVATION	False
8513	8647	15976391:10:EGR1:SLC9A2	In cotransfection experiments, [TF] was able to transactivate the [TG] promoter.	Egr-1	NHE2	1	ACTIVATION	False
8514	8648	15976391:11:EGR1:SLC9A2	Our data indicate that [TF] may play a key role in regulated expression of the human [TG] gene.	Egr-1	NHE2	0	UNDEFINED	True
8515	8649	15985438:5:TP53:CDKN1A	In addition, expression of the ICD fragment increased [TF] activity toward the [TG] promoter in a luciferase reporter assay.	p53	p21	1	ACTIVATION	False
8516	8650	15986483:5:TBX6:DLL1	Previously, we have shown that expression of [TG], which encodes a Notch ligand, is lost in the [TF] mutant and that Tbx6 and Dll1 genetically interact, indicating that Dll1 may be a direct target of Tbx6 in the paraxial mesoderm.	Tbx6	Dll1	1	ACTIVATION	False
8517	8651	15991006:5:HIF1A:CCND1	In RCCs harbouring VHL mutations/hypermethylation, over-expression of [TF] was parallelled by up-regulation of [TG] and CDK4 and down-regulation of p21 and p27.	HIF1alpha	cyclin D1	1	ACTIVATION	False
8518	8652	15993752:5:CREB1:IL2	We found that T-cell activation caused a significant increase in [TF] phosphorylation furthermore, inhibition of the PKC pathway by GF109203 reduced CREB activation by 50% and inhibition of the PKA pathway caused a total block of CREB phosphorylation and significantly reduced IFN(gamma), [TG] and IL-2R(alpha) gene expression by approximately 40% (p<0.001).	CREB	IL-2	1	ACTIVATION	False
8519	8653	15994290:0:ETS1:LMO2	Fli1, Elf1, and [TF] regulate the proximal promoter of the [TG] gene in endothelial cells.	Ets1	LMO2	0	UNDEFINED	True
8520	8654	15994313:11:JUN:CCND1	HDAC inhibitors suppressed the induction of both [TG] and collagenase-1 transcription by inhibiting the binding of [TF] to the respective promoters.	c-Jun	cyclin D1	1	ACTIVATION	False
8521	8655	15994827:3:IRF3:TNFSF10	We show that [TF] is involved in the transcriptional induction of [TG], a key player in the apoptosis pathway.	IRF-3	TRAIL	1	ACTIVATION	False
8522	8656	15994827:4:IRF3:TNFSF10	[TF] upregulates [TG] transcription following viral infection and binds an interferon-stimulated response element in the TRAIL promoter.	IRF-3	TRAIL	1	ACTIVATION	False
8523	8657	15994929:5:STAT3:CCND1	We also found that these interactions played a mechanistic role in the positive regulation of [TF] transcription from synthetic promoters and endogenous target genes such as [TG], c-myc, and c-fos.	STAT3	cyclin D1	1	ACTIVATION	False
8524	8658	16000406:7:FOS:WEE1	Light also elicits chromatin remodeling by stimulating hyperacetylation at Lys-14 of histone H3 at both [TG] and zCry1a promoters, as assessed by chromatin immunoprecipitation assays by using anti-[TF] antibody.	Fos	zWee1	0	UNDEFINED	False
8525	8659	16001969:11:NFKB:PTGS2	The importance of [TF] and AP-1 in [TG] promoter and protein induction was corroborated by using pharmacological NF-kappaB, p38 and JNK inhibitors.	NF-kappaB	COX-2	1	ACTIVATION	False
8526	8660	16001969:7:NFKB:PTGS2	However, transfection of p65/relA [TF] was not enough to induce [TG] transcription, suggesting that NF-kappaB was necessary but not sufficient to control COX-2 transcription induced by gp120.	NF-kappaB	COX-2	1	ACTIVATION	False
8527	8661	16001969:7:RELA:PTGS2	However, transfection of [TF]/relA NF-kappaB was not enough to induce [TG] transcription, suggesting that NF-kappaB was necessary but not sufficient to control COX-2 transcription induced by gp120.	p65	COX-2	1	ACTIVATION	False
8528	8662	16006736:3:NFKB:PTGS2	Reporter gene assays showed that Mao reduced LPS-inducible [TF]-dependent transcription that plays a crucial role in induction of [TG] gene expression.	NF-kappaB	COX-2	1	ACTIVATION	False
8529	8663	16007171:4:ATF2:PTGS2	We found that in cancer cells, three transcription factors (TFs) - cAMP response element-binding protein (CREB), [TF] (ATF-2) and c-jun, bound the CRE in the [TG] promoter, and their activities were increased by addition of the NO donor, S-nitroso-N-acetyl-D,L-penicillamine (SNAP).	activating transcription factor-2	COX-2	0	UNDEFINED	True
8530	8664	16007255:12:NR1H3:REN	In conclusion, we show herein that [TF]) and LXR(beta) regulate [TG] expression in vivo by directly interacting with the renin promoter and that the cAMP/LXR(alpha) signaling pathway is required for the adrenergic control of the renin-angiotensin system.	LXR(alpha	renin	0	UNDEFINED	False
8531	8665	16007255:6:NR1H3:REN	In vivo, LXRs colocalized in juxtaglomerular cells, in which [TF]) was specifically enriched, and interacted with the [TG] promoter.	LXR(alpha	renin	0	UNDEFINED	False
8532	8666	16020662:5:AR:GUCY1A3	Third, MSA inhibition of five [TF]-regulated genes implicated in prostate carcinogenesis (PSA, KLK2, ABCC4, DHCR24, and [TG]) is significantly attenuated by androgen receptor overexpression.	androgen receptor	GUCY1A3	0	UNDEFINED	True
8533	8667	16023836:6:AP1:MMP13	The in vitro studies confirmed the apparent in vivo glucocorticoid-mediated response of [TG] mRNA and implicated the [TF] site of the MMP-13 promoter in this regulation.	AP-1	MMP-13	0	UNDEFINED	False
8534	8668	16050801:6:NFKB:PTGS2	The Electrophoretic Mobility Shift Assay (EMSA) showed that silica induced the direct binding of [TF] on the putative binding site in [TG] promoter.	NF-kB	COX-2	0	UNDEFINED	False
8535	8669	16054710:8:SP1:KLF6	Furthermore, ectopic expression of [TF] increased the transcriptional activity of the [TG] promoter.	Sp1	KLF6	1	ACTIVATION	False
8536	8670	16055503:8:SMAD3:E2F2	Abrogation of the phosphorylation by replacement of Ser371 and Ser743 with alanine residues resulted in enhanced complex formation between TFII-I and [TF], and enhanced cooperation between TFII-I and Smad3 in transcriptional regulation, as evaluated by a microarray-based measurement of expression of endogenous cyclin D2, cyclin D3, and [TG] genes, and by a luciferase reporter assay.	Smad3	E2F2	0	UNDEFINED	False
8537	8671	16061648:4:TP53:CDKN1A	In addition, FIP200 significantly induced [TG] promoter activity in MCF-7 cells and this response was abolished upon deletion of [TF] binding sites within p21 promoter.	p53	p21	1	ACTIVATION	False
8538	8672	16077994:10:POU2F1:SOX2	SOX9, TCF/LEF, [TF] and COMP1 binding sites were conserved among human [TG] promoter, rat Sox2 promoter, and mouse Sox2 promoter.	POU2F1	SOX2	0	UNDEFINED	False
8539	8673	16086669:5:PPARA:G0S2	Transactivation, gel shift and chromatin immunoprecipitation assays indicated that [TG] is a direct PPARgamma and probable [TF] target gene with a functional PPRE (PPAR-responsive element) in its promoter.	PPARalpha	G0S2	0	UNDEFINED	False
8540	8674	16091746:0:AHR:MYC	The [TF] constitutively represses [TG] transcription in human mammary tumor cells.	aryl hydrocarbon receptor	c-myc	2	REPRESSION	False
8542	8676	16093364:5:IRF4:TLR4	Endotoxemia in animals caused the similar inducible interaction between PU.1 and [TF] and the [TG] promoter in lung tissue of mice that was treated with a single intraperitoneal injection of endotoxin.	IRF4	TLR4	0	UNDEFINED	False
8543	8677	16100571:5:FOXO1:ANG	Whereas angiopoietin 2 ([TG]) was exclusively regulated by [TF], eNOS, which is essential for postnatal neovascularization, was regulated by Foxo1 and Foxo3a.	Foxo1	Ang2	0	UNDEFINED	True
8544	8678	16100571:5:FOXO3:ANG	Whereas angiopoietin 2 ([TG]) was exclusively regulated by Foxo1, eNOS, which is essential for postnatal neovascularization, was regulated by Foxo1 and [TF].	Foxo3a	Ang2	0	UNDEFINED	False
8545	8679	16102021:4:KLF5:SERPINE1	[TF] activates many genes inducible during cardiovascular remodeling, such as platelet-derived growth factor (PDGF)-A/B, Egr-1, plasminogen activator inhibitor-1 ([TG]), inducible nitric oxide synthase (iNOS), and vascular endothelial growth factor (VEGF) receptors.	KLF5	PAI-1	1	ACTIVATION	False
8546	8680	16103054:6:EGR1:PDGFA	The maximal basal and HGF-induced promoter activity for the [TG] gene existed within -630 bp of the promoter region, and overexpression of [TF] significantly increased such activity.	Egr-1	PDGFA	1	ACTIVATION	False
8547	8681	16103874:10:TP53:FEN1	In cotransfection experiments, [TF] stimulated the expression of a [TG] promoter-reporter construct.	p53	fen1	1	ACTIVATION	False
8548	8682	16103879:8:SP3:CDKN1A	Furthermore, the introduction of mutation in Sp1/[TF] binding sites of the [TG] gene promoter abolished the SYT-SSX1-induced transcriptional activity of its promoter.	Sp3	p21	1	ACTIVATION	False
8549	8683	16105028:0:AP1:SERPINE1	MAPK/[TF]-dependent regulation of [TG] gene expression by TGF-beta in rat mesangial cells.	AP-1	PAI-1	0	UNDEFINED	False
8550	8684	16107692:0:STAT3:TP53	Role of [TF] in regulating [TG] expression and function.	Stat3	p53	0	UNDEFINED	False
8551	8685	16107692:4:STAT3:TP53	We show here that oncogenic signaling pathways inhibit the [TG] gene transcription rate through a mechanism involving [TF], which binds to the p53 promoter in vitro and in vivo.	Stat3	p53	2	REPRESSION	False
8552	8686	16107692:5:STAT3:TP53	Site-specific mutation of a [TF] DNA-binding site in the [TG] promoter partially abrogates Stat3-induced inhibition.	Stat3	p53	2	REPRESSION	False
8553	8687	16107883:1:TP53:CDKN1A	In response to DNA damage, [TF] activates a G1 cell cycle checkpoint, in part through induction of the cyclin-dependent kinase inhibitor p21([TG]/Cip1).	p53	Waf1	1	ACTIVATION	False
8554	8688	16109482:2:SP3:ATP2A3	The 5'-flanking region of the SERCA3 gene ([TG]) contains numerous binding sites for the transcription factors Sp1 and [TF].	Sp3	ATP2A3	0	UNDEFINED	False
8555	8689	16110474:10:SMAD7:MSTN	Consistent with these results, a decrease in [TF] mRNA and concomitant increase in [TG] expression is seen in myotubes that express non functional myostatin.	Smad7	myostatin	2	REPRESSION	False
8556	8690	16110474:8:SMAD7:MSTN	Auto-regulation by [TG] appears to be signaled through [TF], since the expression of the inhibitory Smad7 is induced by myostatin and the over-expression of Smad7 in turn inhibits the myostatin promoter activity (P < 0.001).	Smad7	myostatin	0	UNDEFINED	True
8557	8691	16110474:9:SMAD7:MSTN	In contrast down regulation of [TF] by siRNA results in increased [TG] mRNA indicating that Smad7 is a negative regulator of myostatin gene expression.	Smad7	myostatin	2	REPRESSION	False
8558	8692	16116232:13:POU2F1:CRP	Combined data from luciferase transactivation assays and EMSA lead us to conclude that the binding of [TF] to the promoter, facilitated by p50-p50 in a novel way, represses, whereas replacement of OCT-1 by p50-p65 induces [TG] transcription in cooperation with C/EBPbeta.	OCT-1	CRP	2	REPRESSION	True
8559	8693	16118348:12:NFKB:CDX2	We found that CA activates [TG] promoter via [TF] and stimulates production of Cdx2 protein in oesophageal keratinocytes with production of intestinal-type mucin.	NFkappaB	Cdx2	1	ACTIVATION	False
8560	8694	16122887:14:SP3:FKBP1B	The DNA/protein complex on [TG] promoter was competed out by Sp1 consensus probe and the complex was supershifted by anti-[TF] antibodies.	Sp3	FKBP12.6	0	UNDEFINED	False
8561	8695	16123160:12:SREBF1:CYP51A1	Interestingly, when CREB is not limiting, the increasing amounts of [TF] fail to transactivate the [TG] promoter above the CREB-only level, suggesting that hormones might have an important role in regulating cholesterogenesis in vivo.	SREBP-1a	CYP51	1	ACTIVATION	False
8562	8696	16131836:6:TP53:CDKN1A	In this report, we show that Dnmt3a interacts with [TF] directly and represses p53-mediated transactivation of the [TG] gene.	p53	p21	1	ACTIVATION	False
8563	8697	16149048:8:SP1:POU5F1	An overexpression study showed that [TF] and Sp3 positively and negatively regulate h[TG] promoter activity.	Sp1	Oct4	0	UNDEFINED	True
8564	8698	16149048:8:SP3:POU5F1	An overexpression study showed that Sp1 and [TF] positively and negatively regulate h[TG] promoter activity.	Sp3	Oct4	0	UNDEFINED	True
8566	8700	16157598:4:ETS1:PCYT1A	The results indicate the formation of a ternary complex with [TF] binding at -49/-47 and Sp1 binding at -58/-54 of the [TG] promoter that is important for activating CTalpha transcription.	Ets-1	Pcyt1a	1	ACTIVATION	False
8567	8701	16164412:5:ATF4:ASNS	Previous studies revealed that the basic region leucine zipper (bZIP) transcription factor CREB2/[TF] is involved in the nutrient deprivation-induced upregulation of [TG] gene transcription.	ATF4	asparagine synthetase	1	ACTIVATION	False
8568	8702	16164412:8:ATF4:ASNS	Overexpression of the C/EBP homologous transcription factor CHOP impaired transcriptional activation of the [TG] promoter following amino acid deprivation or over-expression of ATF5 or CREB2/[TF].	ATF4	asparagine synthetase	1	ACTIVATION	False
8569	8703	16166633:4:NR6A1:POU5F1	Inactivation of the gene encoding the orphan nuclear receptor [TF] showed that it plays an important role in the repression of [TG] expression in somatic cells during early embryonic development.	GCNF	Oct4	2	REPRESSION	False
8570	8704	16170349:2:TP53:MST1	We report that mutant [TF] suppresses the expression of the MSP ([TG]/HGFL) gene, encoding the ligand of the receptor tyrosine kinase RON, implicated in a variety of cellular responses.	p53	MST-1	1	ACTIVATION	False
8571	8705	16170349:3:TP53:MST1	Mutant [TF] associates with the [TG] gene promoter and represses its transcriptional activity, leading to a decrease in mRNA levels and a subsequent decrease in the levels of secreted MSP protein.	p53	MSP	1	ACTIVATION	False
8575	8709	16171862:0:CREB1:PBK	Expression of [TG] (PBK) is regulated by cell cycle-specific transcription factors E2F and [TF]/ATF.	CREB	PDZ-binding kinase	0	UNDEFINED	False
8576	8710	16172134:8:IRF4:TNFSF10	This dominant negative action of [TF] over IRF-1 was also observed in a natural promoter context, such as the [TG] gene.	IRF-4	TRAIL	2	REPRESSION	True
8577	8711	16173915:12:POU2F1:OLR1	In conclusion, the present study strongly suggests that ox-LDL, by activating [TF], induces [TG] promoter activation.	Oct-1	LOX-1	1	ACTIVATION	False
8578	8712	16186125:0:POU2F1:AHSP	GATA-1 and [TF] are required for expression of the human [TG]-stabilizing protein gene.	Oct-1	alpha-hemoglobin	1	ACTIVATION	True
8579	8713	16186125:5:POU2F1:AHSP	In vitro studies using transfection of promoter/reporter plasmids in human tissue culture cell lines, DNase I footprinting analyses and gel mobility shift assays, identified an [TG] gene erythroid promoter with functionally important binding sites for GATA-1- and [TF]-related proteins.	Oct-1	AHSP	0	UNDEFINED	False
8580	8714	16189269:4:ETS1:PDGFD	[TF], but not Ets-1 bearing only the DNA-binding domain, activates the [TG] promoter and mRNA expression in SMCs.	Ets-1	PDGF-D	1	ACTIVATION	False
8581	8715	16197915:10:NR1H4:SLC1A5	These results show that the stimulation of [TG] expression in response to glutamine in part involves binding of [TF]/RXR to the ASCT2 promoter.	FXR	ASCT2	1	ACTIVATION	False
8582	8716	16213225:0:NR0B2:PPARGC1A	The orphan nuclear receptor [TF] regulates [TG] expression and energy production in brown adipocytes.	SHP	PGC-1alpha	0	UNDEFINED	False
8583	8717	16213225:2:NR0B2:PPARGC1A	We have found that the orphan nuclear receptor SHP ([TF]) is a negative regulator of [TG] expression in brown adipocytes.	NR0B2	PGC-1alpha	2	REPRESSION	False
8584	8718	16213225:6:NR0B2:PPARGC1A	The orphan nuclear receptor ERRgamma is expressed in BAT and its transactivation of the [TG] promoter is potently inhibited by [TF].	SHP	PGC-1alpha	2	REPRESSION	False
8585	8719	16221171:5:HNF1B:PKHD1	[TF] directly regulates the [TG] promoter.	HNF-1beta	Pkhd1	0	UNDEFINED	False
8586	8720	16221171:6:HNF1B:PKHD1	[TF] mutant mice show decreased expression of [TG], the gene that is mutated in humans with autosomal-recessive polycystic kidney disease (ARPKD).	HNF-1beta	Pkhd1	1	ACTIVATION	False
8587	8721	16227528:8:ATF1:MUC2	CREB/[TF] and c-Jun were shown to bind to an oligonucleotide encompassing a distal, conserved CREB/AP1 site in the 5'-flanking region of the [TG] gene, and this cis element was shown to mediate promoter reporter activation by VIP.	ATF1	MUC2	1	ACTIVATION	False
8588	8722	16227528:8:CREB1:MUC2	[TF]/ATF1 and c-Jun were shown to bind to an oligonucleotide encompassing a distal, conserved CREB/AP1 site in the 5'-flanking region of the [TG] gene, and this cis element was shown to mediate promoter reporter activation by VIP.	CREB	MUC2	1	ACTIVATION	False
8590	8724	16236134:6:RELA:SAA1	The formation of a complex with STAT3, NF-kappaB [TF], and p300 is thus essential for the synergistic induction of the [TG] gene by IL-1+6 stimulation.	p65	SAA	1	ACTIVATION	False
8591	8725	16237061:7:STAT1:SCGB3A1	IFN-gamma-activated [TF] binds to the same SBE in the [TG] gene promoter to which STAT6 binds and decreases the binding of STAT6 to this site.	STAT1	Ugrp2	0	UNDEFINED	False
8592	8726	16245312:9:FLI1:TNC	Overexpression of Sp1, Ets1, or Ets2 activated the [TG] promoter and superinduced TN-C promoter activity stimulated by PDGF, whereas overexpression of [TF] inhibited the effects of PDGF on TN-C expression.	Fli1	TN-C	2	REPRESSION	False
8593	8727	16254027:13:ESR1:OXTR	These results support the hypothesis that the antiluteolytic effects of IFNT are mediated by direct inhibition or silencing of [TF] gene transcription, thereby precluding ESR1/SP1 from stimulating [TG] gene transcription.	ESR1	OXTR	1	ACTIVATION	False
8595	8729	16256955:5:NFKB:PTGS2	Transfections with various [TG] promoter reporter constructs revealed that the inhibitory effects of 6-MITC on COX-2 gene expression were directed by the core promoter elements including nuclear factor kappaB ([TF]), CCAAT/enhancer-binding protein (C/EBP) and cyclic AMP-response element (CRE) sites.	NF-kappaB	COX-2	2	REPRESSION	True
8596	8730	16258268:0:TP63:CDKN1C	Regulation of the cyclin-dependent kinase inhibitor [TG] expression by [TF].	p63	p57Kip2	0	UNDEFINED	False
8597	8731	16258268:4:TP63:CDKN1C	By ChIP we determined that in the HaCaT cell line the DeltaN[TF]alpha protein is associated to three different regions of the [TG] gene.	p63	p57Kip2	0	UNDEFINED	False
8598	8732	16258268:7:TP63:CDKN1C	These data suggests that [TF] play an important role in the regulation of [TG] expression and that this regulation is subverted in AEC p63 mutants.	p63	p57Kip2	0	UNDEFINED	False
8599	8733	16260603:2:ELK1:TAGLN	In the current study, overexpression of [TF] in SMCs down-regulated expression of several endogenous smooth muscle-restricted proteins, including telokin, [TG], and smooth muscle alpha-actin.	Elk-1	SM22alpha	2	REPRESSION	False
8600	8734	16260603:4:ELK1:TAGLN	Consistent with this, overexpression of the DNA binding domain of [TF], which acts as a dominant-negative protein by displacing endogenous Elk-1, enhanced the expression of telokin and [TG] without affecting expression of smooth muscle alpha-actin.	Elk-1	SM22alpha	2	REPRESSION	True
8601	8735	16260626:9:RELB:CCND1	Inhibition of [TF] in breast cancer cells repressed [TG] and c-Myc levels and growth in soft agar.	RelB	cyclin D1	1	ACTIVATION	False
8602	8736	16260626:9:RELB:MYC	Inhibition of [TF] in breast cancer cells repressed cyclin D1 and [TG] levels and growth in soft agar.	RelB	c-Myc	1	ACTIVATION	False
8603	8737	16261846:3:SP3:PLAUR	We previously identified the -148/-124 promoter region, bound with Sp1 and [TF], as regulatory for [TG] expression in vitro.	Sp3	uPAR	0	UNDEFINED	False
8604	8738	16262603:8:NFKB:SAT1	Aspirin treatment led to the activation of [TF] signalling and increased binding at these NF-kappaB sites in the [TG] promoter, hence providing a potential mechanism for the induction of SSAT by aspirin in these cells.	NF-kappaB	SSAT	1	ACTIVATION	False
8605	8739	16264271:6:AP1:NR4A1	Herein, we report that PKCtheta targets AP-1 like response element in the [TG] promoter where [TF] constitutively binds.	JunD	Nur77	0	UNDEFINED	False
8606	8741	16267388:6:FUBP1:MYC	Those features include the use of an expanded proximal promoter, the averaging of input from dozens of transcription factors, and real-time feedback using the supercoil-deformable Far UpStream Element (FUSE) as physical sensor of ongoing transcriptional activity, and the FUSE binding protein ([TF]) as well as the FBP interacting repressor (FIR) as effectors to enforce normal transcription from the [TG] promoter.	FBP	c-myc	1	ACTIVATION	False
8607	8742	16278683:6:TP53:HTT	Moreover, gamma-irradiation, which activates [TF], increases [TG] gene expression in the striatum and cortex of mouse brain, the major pathological sites for Huntington's disease, in p53+/+ but not the isogenic p53-/- mice.	p53	huntingtin	1	ACTIVATION	False
8608	8743	16278805:6:POU2F1:CDX2	Furthermore, we evaluated [TF] binding by electrophoretic mobility shift assay and activation of the [TG] promoter by co-transfecting a CDX2 promoter/reporter construct with an OCT-1 expression vector in two gastric carcinoma cell lines, GP220 and MKN45.	OCT-1	CDX2	1	ACTIVATION	False
8609	8744	16279946:11:NFKB:SERPINE1	We show that activation of [TG] gene by TNFalpha and reactive oxygen species is mediated by interaction of [TF] with the cis-acting element located in the -675 4G/5G insertion/deletion in the PAI-1 promoter.	NF-kappaB	PAI-1	1	ACTIVATION	False
8610	8745	16285960:0:STAT3:AGT	[TF] NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of [TG].	STAT3	angiotensinogen	1	ACTIVATION	False
8611	8746	16287845:3:EGR1:ARC	Here, we show that [TF] and Egr3 directly regulate the plasticity-associated activity-regulated cytoskeletal-related ([TG]) gene, a synaptic activity-induced effector molecule which is also required for L-LTP and hippocampus-dependent learning and memory processing.	Egr1	Arc	0	UNDEFINED	False
8612	8747	16287845:3:EGR3:ARC	Here, we show that Egr1 and [TF] directly regulate the plasticity-associated activity-regulated cytoskeletal-related ([TG]) gene, a synaptic activity-induced effector molecule which is also required for L-LTP and hippocampus-dependent learning and memory processing.	Egr3	Arc	0	UNDEFINED	False
8613	8748	16288017:7:SP1:FOSL1	Syk interacts with transcription factor [TF] at the Sp1 DNA-binding site in the [TG] promoter to repress Sp1-activated FRA1 transcription.	Sp1	FRA1	0	UNDEFINED	True
8614	8749	16288208:6:TFAP2A:CDKN1A	Although both wild-type and L350P alleles facilitated binding of [TF] to the [TG] promoter, the L350P allele was significantly reduced in its ability to induce the endogenous p21 gene, demonstrating a striking difference in activity comparing reporter assays with activation of endogenous p53 target genes.	AP2alpha	p21	0	UNDEFINED	False
8615	8750	16288208:7:TFAP2A:CDKN1A	Interestingly, expression of AP2 in the absence of radiation repressed p53-mediated induction of [TG] and this effect was explained by a reduction in p53 stability induced by [TF] overexpression.	AP2alpha	p21	2	REPRESSION	True
8616	8751	16294212:5:ETS1:GATA1	Overexpression of [TF] in erythroid cells blocks maturation at the polychromatophilic stage, increases GATA-2 and decreases both [TG] and erythropoietin receptor expression.	Ets-1	GATA-1	2	REPRESSION	False
8617	8752	16294212:7:ETS1:GATA2	We show that [TF] binds to and activates the [TG] promoter, in vitro and in vivo, indicating that one of the pathways through which Ets-1 blocks erythroid and promotes MK differentiation is via upmodulation of GATA-2 expression.	Ets-1	GATA-2	1	ACTIVATION	False
8618	8753	16301649:10:STAT1:TBX21	Finally, we show that [TF] directly regulates the expression of [TG] by binding to the T-bet promoter.	Stat1	T-bet	0	UNDEFINED	False
8619	8754	16301994:0:CREB1:CCND2	Regulation of [TG] and the cyclin D2 promoter by protein kinase A and [TF] in lymphocytes.	CREB	cyclin D2	0	UNDEFINED	False
8621	8756	16303758:3:PPARG:PRODH	The peroxisome proliferator-activated receptor gamma ([TF]) ligand troglitazone was found to activate the [TG] promoter in colon cancer cells.	PPARgamma	POX	1	ACTIVATION	False
8622	8757	16303758:5:PPARG:PRODH	In HCT116 cells expressing a wild-type [TF], troglitazone enhanced the binding of PPARgamma to PPAR-responsive element in the [TG] promoter and increased endogenous POX expression.	PPARgamma	POX	1	ACTIVATION	False
8623	8758	16303758:6:PPARG:PRODH	Blocking of [TF] activation either by antagonist GW9662 or deletion of PPAR-responsive element in the [TG] promoter only partially decreased the POX promoter activation in response to troglitazone, indicating also the involvement of PPARgamma-independent mechanisms.	PPARgamma	POX	1	ACTIVATION	False
8624	8759	16303758:8:PPARG:PRODH	In HCT15 cells, with both mutant p53 and mutant [TF], there was no effect of troglitazone on [TG] activation, whereas in HT29 cells, with a mutant p53 and wild type PPARgamma, increased activation was observed by ligand stimulation, indicating that both PPARgamma-dependent and -independent mechanisms are involved in the troglitazone-induced POX expression.	PPARgamma	POX	1	ACTIVATION	False
8625	8760	16303760:0:HSF1:XAF1	[TF] down-regulates [TG] through transcriptional regulation.	HSF1	XAF1	2	REPRESSION	False
8626	8761	16303760:11:HSF1:XAF1	Moreover, pretreatment with antioxidants suppressed [TF] binding activity and increased the transcriptional activity and expression of [TG].	HSF1	XAF1	2	REPRESSION	False
8627	8762	16303760:6:HSF1:XAF1	Stress stimuli, including heat, hypo-osmolarity, and H2O2, significantly suppressed the expression of [TG], whereas the alteration of [TF] expression negatively correlated with XAF1 expression.	HSF1	XAF1	2	REPRESSION	True
8629	8764	16310515:2:ETS1:HMOX1	We investigated the role of the putative Ets-binding sites (EBSs) in the transactivation of the proximal promoter of rat heme oxygenase 1 ([TG]) gene by the Ets oncoproteins Fli-1, Erg-2, and [TF] in mesangial cells.	Ets-1	hmox1	1	ACTIVATION	True
8630	8765	16310515:2:FLI1:HMOX1	We investigated the role of the putative Ets-binding sites (EBSs) in the transactivation of the proximal promoter of rat heme oxygenase 1 ([TG]) gene by the Ets oncoproteins [TF], Erg-2, and Ets-1 in mesangial cells.	Fli-1	hmox1	1	ACTIVATION	True
8631	8766	16314465:6:YY1:TAGLN	Consistent with these data siRNA-mediated down-regulation of [TF] in C2C12 cells increased [TG] expression and inhibited cell proliferation.	YY1	SM22-alpha	2	REPRESSION	False
8632	8767	16314495:0:ESRRA:PDK4	PGC-1alpha coactivates [TG] gene expression via the orphan nuclear receptor [TF]: a mechanism for transcriptional control of muscle glucose metabolism.	ERRalpha	PDK4	1	ACTIVATION	False
8633	8768	16314495:7:ESRRA:PDK4	Chromatin immunoprecipitation assays confirmed that PGC-1alpha and [TF] occupied the m[TG] promoter in C(2)C(12) myotubes.	ERRalpha	PDK4	0	UNDEFINED	False
8634	8769	16314495:8:ESRRA:PDK4	Additionally, transfection studies using [TF]-null primary fibroblasts demonstrated that ERRalpha is required for PGC-1alpha-mediated activation of the m[TG] promoter.	ERRalpha	PDK4	1	ACTIVATION	False
8635	8770	16314510:7:SRF:SERPINE1	Net represses [TG] promoter activity and binds to a specific region of the promoter containing Ets binding sites in the absence of [TF].	SRF	PAI-1	0	UNDEFINED	False
8636	8771	16324689:5:TFAP2C:KRT14	Furthermore, we show that, in the absence of [TF], TAp63alpha fails to induce [TG] expression in vitro.	AP-2gamma	K14	1	ACTIVATION	False
8637	8772	16326073:5:NFKB:PTGS2	Inhibition of [TF] activation diminished IL-1beta-mediated transcriptional activation of [TG].	NF-kappaB	COX-2	1	ACTIVATION	False
8638	8773	16328781:0:AP1:VEGFA	Hyperbaric oxygen induces [TG] expression through ERK, JNK and c-Jun/[TF] activation in human umbilical vein endothelial cells.	AP-1	VEGF	1	ACTIVATION	False
8639	8774	16328781:10:AP1:VEGFA	To verify that the [TG] expression induced by HBO is through the [TF] trans-activation and VEGF promoter, both the VEGF promoter and AP-1 driving luciferase activity were found increased by the cells treated with HBO.	AP-1	VEGF	1	ACTIVATION	False
8640	8775	16328781:5:AP1:VEGFA	Since there are several [TF] sites in the [TG] promoter, and the c-Jun/AP-1 is activated through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) and extracellular signal regulated kinase (ERK), we further examined the c-Jun, JNK and ERK that might be involved in the VEGF induced by HBO.	AP-1	VEGF	0	UNDEFINED	True
8641	8777	16330554:2:USF2:SERPINE1	The transcription factor [TF] was shown to be a negative regulator for rat [TG] expression, and therefore it was the aim of this study to evaluate the role of USF-2 for human PAI-1 expression.	USF-2	PAI-1	2	REPRESSION	False
8642	8778	16330554:3:USF2:SERPINE1	We found in human hepatoma cells (HepG2) that [TF] induced human [TG] expression via two classical E-boxes and the hypoxia-responsive element (HRE) within the promoter.	USF-2	PAI-1	1	ACTIVATION	False
8643	8779	16330554:5:USF2:SERPINE1	By contrast, [TF] inhibited [TG] promoter activity in primary rat hepatocytes suggesting that PAI-1 expression depends on either the promoter context or USF activity which might be cell type-specific.	USF-2	PAI-1	2	REPRESSION	False
8644	8780	16330554:6:USF2:SERPINE1	Cotransfection of human or rat [TG] promoter luciferase constructs with expression vectors for wild-type [TF] or USF-2 mutants in human HepG2 and rat H4IIE cells as well as in primary rat hepatocytes revealed that the effects of USF on PAI-1 expression depend on the cell type rather than the promoter context and that the USF-specific region domain of USF accounts for the observed cell type-specific effects.	USF-2	PAI-1	0	UNDEFINED	False
8645	8781	16331275:4:NFKB:CCND1	Importantly, activation of [TF] was required for estrogen-induced proliferation and [TG] expression.	NF-kappaB	cyclin D1	1	ACTIVATION	False
8647	8783	16336210:0:HSF2:CLU	Up-regulation of the [TG] gene after proteotoxic stress: implication of HSF1-[TF] heterocomplexes.	HSF2	clusterin	1	ACTIVATION	False
8648	8784	16343439:8:MAF:CTGF	Chromatin immunoprecipitation analysis showed that c-[TF] binds to the promoter region of the [TG] gene, indicating that Maf directly activates the CTGF gene.	Maf	CTGF	1	ACTIVATION	False
8649	8785	16343439:9:MAF:CTGF	Taken together, these data indicate that the [TG] gene is a target of c-[TF] and Lc-Maf in cartilage development.	Maf	CTGF	0	UNDEFINED	False
8650	8786	16352814:4:POU2F1:SPI1	ATRA-induced activation was mediated by a region in the [TG] promoter to which CEBPB and [TF] binding were induced.	OCT-1	PU.1	1	ACTIVATION	False
8652	8788	16357063:0:SREBF1:HDC	Yin yang 1 (YY1) represses [TG] gene expression with [TF] in part through an upstream Sp1 site.	SREBP-1a	histidine decarboxylase	2	REPRESSION	False
8653	8789	16357063:0:YY1:HDC	Yin yang 1 ([TF]) represses [TG] gene expression with SREBP-1a in part through an upstream Sp1 site.	YY1	histidine decarboxylase	2	REPRESSION	False
8654	8790	16357063:3:YY1:HDC	In the current study, Yin Yang 1 ([TF]), a pleiotropic transcriptional factor, was also shown in cotransfection assays to repress [TG] promoter activity through the upstream GC box.	YY1	HDC	2	REPRESSION	False
8655	8791	16357063:5:SREBF1:HDC	In addition, sterol-responsive element-binding protein 1a ([TF]), a transcriptional factor that binds YY1, represses the [TG] promoter.	SREBP-1a	HDC	2	REPRESSION	False
8656	8792	16357063:5:YY1:HDC	In addition, sterol-responsive element-binding protein 1a (SREBP-1a), a transcriptional factor that binds [TF], represses the [TG] promoter.	YY1	HDC	2	REPRESSION	True
8657	8793	16357063:8:SREBF1:HDC	Taken together, these results suggest that YY1 and [TF] form a complex to inhibit [TG] gene expression through both the upstream GC box and downstream gastrin-responsive elements and gastrin-induced activation of HDC gene expression is mediated at least partly through downregulation of transcriptional repressors such as SREBPs.	SREBP-1a	HDC	2	REPRESSION	False
8658	8794	16357063:8:YY1:HDC	Taken together, these results suggest that [TF] and SREBP-1a form a complex to inhibit [TG] gene expression through both the upstream GC box and downstream gastrin-responsive elements and gastrin-induced activation of HDC gene expression is mediated at least partly through downregulation of transcriptional repressors such as SREBPs.	YY1	HDC	2	REPRESSION	False
8659	8795	16357834:2:TLX1:ALDH1A1	The precise mechanism of [TF] function remains poorly understood, although it is known that it can act as both a transcriptional activator and repressor and can downregulate the [TG] gene in embryonic mouse spleen.	TLX1	Aldh1a1	2	REPRESSION	False
8660	8796	16368886:0:RUNX1:IER3	Thrombopoietin regulates [TG] gene expression through ERK-induced [TF] phosphorylation.	AML1	IEX-1	0	UNDEFINED	False
8661	8797	16368886:6:RUNX1:IER3	The direct involvement of [TF] in the regulation of [TG] gene expression was shown by both the use of AML1 mutants and by shRNA experiments targeting endogenous AML1.	AML1	IEX-1	0	UNDEFINED	False
8662	8798	16374477:12:AP1:IVL	These studies suggest that [TF], Sp1, and C/EBP transcription factors are required for appropriate differentiation-dependent [TG] expression, and that the mechanism of regulation is similar in most surface epithelia.	AP1	involucrin	1	ACTIVATION	False
8663	8799	16380218:7:STAT1:TRIP6	Electrophoretic mobility shift assay (EMSA) further confirmed activated [TF] binding to the [TG] gene promoter sequence suggesting that IFN-gamma regulates OIP-1 gene expression in OCL precursor cells through a Stat-1 dependent signaling pathway.	Stat-1	OIP-1	0	UNDEFINED	False
8664	8800	16384861:3:KLF9:SLPI	Here we examined the role of [TF] in PR-mediated signaling in endometrial epithelial cells using Ishikawa human endocarcinoma cells and the P-responsive secretory leukocyte protease inhibitor ([TG]) gene.	BTEB1	SLPI	0	UNDEFINED	False
8665	8801	16384861:6:KLF9:SLPI	Forced expression of [TF], either by stable or transient transfections of BTEB1 expression constructs in endometrial carcinoma cells, enhanced [TG] promoter activity.	BTEB1	SLPI	1	ACTIVATION	False
8666	8802	16387740:8:NFKB:CCND1	Moreover, inhibition of IKKbeta/[TF] signal pathway by overexpression of its dominant negative mutant, IKKbeta-KM, also significantly blocked arsenite-induced [TG] expression.	NFkappaB	cyclin D1	1	ACTIVATION	False
8667	8803	16391805:9:ETS1:MMP2	These results indicate that EMT induces [TF] expression, which activates the [TG] promoter, but Ets-1 by itself has no activity to induce EMT in SCC cells.	Ets-1	MMP-2	1	ACTIVATION	False
8668	8804	16397226:3:HIF1A:PTGS2	In this study, we sought to determine the role of [TF] in the induction of [TG] expression during hypoxia.	HIF-1	COX-2	1	ACTIVATION	False
8669	8805	16397226:4:HIF1A:PTGS2	Through sequence comparison of hypoxia-responsive genes, [TG] promoter deletion analysis, and site-directed mutagenesis, we identified a hypoxia-responsive element within the COX-2 promoter that interacts with [TF] and underlies the mechanism of hypoxic activation of COX-2 in lung cancer cells.	HIF-1alpha	COX-2	1	ACTIVATION	False
8670	8806	16399783:0:CEBPB:PTGS2	The role of [TF] in the transcriptional regulation of [TG] in human amnion.	CCAAT/enhancer-binding protein beta	COX-2	0	UNDEFINED	False
8671	8807	16399783:4:NFKB:PTGS2	We have previously shown that, in amnion, the [TF] DNA-binding sites in the [TG] promoter are essential for gene expression and that there is an increase in NF-kappaB activity in amnion with the onset of labour.	NF-kappaB	COX-2	1	ACTIVATION	False
8672	8808	16399783:5:CEBPB:PTGS2	In this study, we demonstrate that in primary human amnion cells, [TF] (C/EBPbeta) DNA-binding sites are crucial for the function of the [TG] gene promoter.	CCAAT/enhancer-binding protein beta	COX-2	0	UNDEFINED	True
8673	8809	16399783:9:CEBPB:PTGS2	This suggests that although [TF] plays an essential constitutive role in the expression of [TG], C/EBPbeta may not be directly involved in its regulation in association with human labour.	C/EBPbeta	COX-2	1	ACTIVATION	False
8674	8810	16403775:10:SP1:GIPR	These results indicate that cell-specific expression of [TG] is associated with the binding of the transcription factors [TF] and Sp3 to the GIPR promoter.	Sp1	GIPR	1	ACTIVATION	False
8675	8811	16403775:10:SP3:GIPR	These results indicate that cell-specific expression of [TG] is associated with the binding of the transcription factors Sp1 and [TF] to the GIPR promoter.	Sp3	GIPR	1	ACTIVATION	False
8676	8812	16407140:5:NFE2L2:HMOX1	In turn, [TF] binds to antioxidant/electrophile-responsive elements of the [TG] promoter to induce HO-1 expression.	Nrf2	HO-1	1	ACTIVATION	False
8677	8813	16413503:5:SMAD3:CILP	TGF-beta1 induction of [TG] is mediated by [TF], which acts directly through cis-elements in the CILP promoter region.	Smad3	CILP	1	ACTIVATION	False
8678	8814	16413538:6:IRF1:CD274	Our findings support a critical role of [TF] in the regulation of constitutive and IFN-gamma-induced expression of [TG] in cancer cells.	IRF-1	B7-H1	0	UNDEFINED	True
8679	8815	16413606:6:SP3:ANG	This modification of [TF] causes decreased binding of the repressor complex to a glucose-responsive GC box in the angiopoietin-2 promoter, resulting in increased [TG] expression.	Sp3	Ang-2	2	REPRESSION	False
8680	8816	16418168:9:ATF2:PTEN	The phosphorylation/activation of [TF] and its binding to [TG] promoter were increased by resistin treatment.	ATF-2	PTEN	0	UNDEFINED	False
8681	8817	16423881:5:NCOA1:SERPINE1	Surprisingly, [TF] and GRIP-1 also enhanced TGFbeta-induced activation from the TGFbeta-responsive sequence of the [TG] gene by a GR-independent mechanism.	SRC-1	PAI-1	1	ACTIVATION	False
8682	8818	16423881:5:NCOA2:SERPINE1	Surprisingly, SRC-1 and [TF] also enhanced TGFbeta-induced activation from the TGFbeta-responsive sequence of the [TG] gene by a GR-independent mechanism.	GRIP-1	PAI-1	1	ACTIVATION	False
8683	8819	16423881:7:NCOA1:SERPINE1	Thus, the GR coactivators, [TF] and GRIP-1, act as both corepressors of the glucocorticoid repression of [TG] gene transcription, and coactivators of TGFbeta-induced activation of the PAI-1 promoter.	SRC-1	PAI-1	2	REPRESSION	True
8684	8820	16423881:7:NCOA2:SERPINE1	Thus, the GR coactivators, SRC-1 and [TF], act as both corepressors of the glucocorticoid repression of [TG] gene transcription, and coactivators of TGFbeta-induced activation of the PAI-1 promoter.	GRIP-1	PAI-1	2	REPRESSION	True
8685	8821	16424113:6:ATF1:IL6	DON induced phosphorylation of CREB at Ser-133 and [TF] at Ser-63 as well as intranuclear binding of phospho-CREB/ATF1 to the cis element of the [TG] promoter in control macrophages, whereas both activities were inhibited in macrophages from DHA-fed mice.	ATF1	IL-6	0	UNDEFINED	False
8686	8822	16426580:12:AP1:ERCC1	In response to cisplatin treatment, decreased MZF1 and increased [TF] binding activities appear to be the leading mechanism of up-regulation of [TG] expression.	AP1	ERCC1	1	ACTIVATION	False
8687	8823	16434701:2:VDR:CDKN1A	To identify [TF] responding regions, we analyzed 20 overlapping regions covering the first 7.1 kb of the p21([TG]/cip1) promoter in MCF-7 human breast cancer cells using chromatin immuno-precipitation assays (ChIP) with antibodies against p53 and VDR.	VDR	waf1	0	UNDEFINED	False
8688	8824	1644814:0:NFKB:MYC	Transactivation of the [TG] promoter by human T cell leukemia virus type 1 tax is mediated by [TF].	NF kappa B	c-myc	1	ACTIVATION	False
8689	8825	16449968:3:TP63:S100A2	Here, we show that [TG] gene, whose transcript and protein are induced during keratinocyte differentiation of HaCaT cells, is a direct transcriptional target of p73beta and DeltaN[TF]alpha and is required for proper keratinocyte differentiation.	p63	S100A2	0	UNDEFINED	False
8690	8826	16449968:4:TP73:S100A2	Transactivation assays reveal that [TF]beta and DeltaNp63alpha exert opposite transcriptional effects on [TG] gene.	p73	S100A2	0	UNDEFINED	False
8691	8827	16449968:6:TP73:S100A2	Silencing of [TF] impairs the induction of [TG] during the differentiation of HaCaT cells.	p73	S100A2	1	ACTIVATION	False
8692	8828	16452181:6:MYC:CDKN1A	Induction of p21([TG]/CIP1) is specifically dependent on prior repression of [TF], but repression of E2F-responsive genes is dissociable from the regulation of c-myc and p21(WAF1/CIP1).	c-myc	WAF1	2	REPRESSION	False
8694	8830	16452236:8:CEBPB:PTGS2	Moreover, CDK2 inhibition blocks IL-1beta-induced binding to the [TF] of the [TG] promoter and inhibits transcription of the COX-2 gene.	NF-IL6 element	COX-2	1	ACTIVATION	True
8695	8831	16453281:0:AP1:NOS3	Role of [TF] element in the activation of human [TG] promoter by lysophosphatidylcholine.	AP1	eNOS	1	ACTIVATION	False
8696	8832	16455805:8:HNF4A:NR0B2	The human [TG] promoter was stimulated by [TF] and PGC-1alpha.	HNF4alpha	SHP	1	ACTIVATION	False
8697	8833	16456000:4:ELK3:HMOX1	The present study demonstrates that of several ternary complex factor subfamily members, only [TF] represses [TG] promoter activity in macrophages.	Elk-3	HO-1	2	REPRESSION	False
8698	8834	16456000:9:ELK3:HMOX1	Taken together, our data reveal that [TF] serves as an important repressor of [TG] gene transcription and contributes to the tight control of HO-1 gene regulation in the setting of inflammatory stimuli.	Elk-3	HO-1	2	REPRESSION	False
8699	8835	16456100:5:FOXC2:SERPINE1	We found that in adipocytes and endothelial cells [TF] mediates insulin action competing with another Forkhead protein, FOXO1, via the insulin response element, and simultaneously cooperate with the TGF-beta/Smad pathway to transactivate [TG].	Foxc2	PAI-1	1	ACTIVATION	False
8700	8836	16456100:7:FOXC2:SERPINE1	Taken together, we propose that [TF] is a key molecule to regulate [TG] gene expression.	Foxc2	PAI-1	0	UNDEFINED	False
8701	8837	16456537:0:SRF:EGR1	Suppression of [TG] transcription through targeting of the [TF] by oncogenic H-Ras.	serum response factor	Egr-1	2	REPRESSION	True
8702	8838	16456537:5:SRF:EGR1	Aberrant activation of PI3K signaling by oncogenic Ras decreased the level of serum response factor ([TF]) protein through the acceleration of proteolysis, which resulted in decreased SRF binding to the serum response element (SRE) sites within the [TG] promoter, leading to the suppression of Egr-1 transcription.	SRF	Egr-1	1	ACTIVATION	False
8703	8839	16469114:6:ETS1:CTGF	Endogenous [TF] binds this element of the [TG] promoter, and dominant negative Ets-1 and specific Ets-1 small interfering RNA block induction of CCN2 expression by TGFbeta.	Ets-1	CCN2	1	ACTIVATION	False
8704	8840	16469114:7:ETS1:CTGF	In the absence of added TGFbeta1, [TF], but not the related fli-1, synergizes with Smad 3 to activate the [TG] promoter.	Ets-1	CCN2	1	ACTIVATION	False
8705	8841	16469114:7:SMAD3:CTGF	In the absence of added TGFbeta1, Ets-1, but not the related fli-1, synergizes with [TF] to activate the [TG] promoter.	Smad 3	CCN2	1	ACTIVATION	False
8706	8842	16469114:8:ETS1:CTGF	Whereas the ability of transfected [TF] to activate the [TG] promoter is dependent on protein kinase C (PKC), Ets-1 in the presence of co-transfected Smad3 does not require PKC, suggesting that the presence of Smad3 bypasses the requirement of Ets-1 for PKC to activate target promoter activity.	Ets-1	CCN2	1	ACTIVATION	False
8707	8843	16469114:9:ETS1:CTGF	Our results are consistent with the notion that Smad3 and [TF] cooperate in the induction of the [TG] promoter by TGFbeta1.	Ets-1	CCN2	1	ACTIVATION	False
8708	8844	16469114:9:SMAD3:CTGF	Our results are consistent with the notion that [TF] and Ets-1 cooperate in the induction of the [TG] promoter by TGFbeta1.	Smad3	CCN2	1	ACTIVATION	False
8709	8845	16474009:10:RELA:MYLK	Additionally, siRNA silencing of NF-kappaB [TF] also prevented the TNF-alpha increase in [TG] promoter activity.	p65	MLCK	1	ACTIVATION	False
8710	8846	16474009:11:RELA:MYLK	In conclusion, our findings indicated that the TNF-alpha-induced increase in intestinal epithelial TJ permeability was mediated by NF-kappaB p50/[TF] binding and activation of the [TG] promoter.	p65	MLCK	1	ACTIVATION	False
8711	8847	16474009:12:RELA:MYLK	NF-kappaB p50/[TF] activation of the [TG] promoter then leads to a stepwise increase in MLCK transcription, expression and activity, and MLCK-mediated opening of the intestinal TJ barrier.	p65	MLCK	1	ACTIVATION	False
8712	8848	16474009:9:RELA:MYLK	The TNF-alpha-induced activation of [TG] promoter was mediated by binding of the activated NF-kappaB p50/[TF] dimer to the downstream kappaB binding site (-84 to -75) on the MLCK promoter region; deletion of the kappaB binding site prevented the TNF-alpha increase in promoter activity.	p65	MLCK	1	ACTIVATION	False
8713	8849	16478829:7:NFE2L2:AKR1C2	Transient transfection with [TF] increased the transcriptional activity of the ARE of [TG] comparable with that observed with phase II inducers.	Nrf2	AKR1C2	1	ACTIVATION	False
8714	8850	16480751:7:NFE2L2:HMOX1	[TF] is a transcription factor involved in the induction of [TG] through an antioxidant response element (ARE) in the promoter region of the HO-1 gene.	Nrf2	HO-1	1	ACTIVATION	False
8715	8851	16484587:0:ELF1:ENG	[TG] expression in the endothelium is regulated by Fli-1, Erg, and [TF] acting on the promoter and a -8-kb enhancer.	Elf-1	Endoglin	0	UNDEFINED	True
8716	8852	16484599:9:NFKB:OLR1	This study strongly suggests that Ang II, by activating [TF], induces [TG] promoter activation.	NF-kappaB	LOX-1	1	ACTIVATION	False
8717	8853	16489025:10:AHR:BRCA1	We propose that the ligand status of the [TF] modulates activation of the [TG] promoter by estrogen.	AhR	BRCA-1	0	UNDEFINED	True
8718	8854	16489025:5:AHR:BRCA1	Here, we report that activation of [TG] transcription by E2 requires occupancy of the BRCA-1 promoter by the unliganded aromatic hydrocarbon receptor ([TF]).	AhR	BRCA-1	1	ACTIVATION	False
8719	8855	16489025:7:AHR:BRCA1	These results suggest that the physical interaction between the unliganded [TF] and the liganded ER alpha plays a positive role in E2-dependent activation of [TG] transcription.	AhR	BRCA-1	1	ACTIVATION	False
8720	8856	16494848:5:AP1:MMP7	However, Stat3 does not bind to the [TG] promoter, but activates MMP7 gene expression indirectly via [TF].	AP-1	MMP7	1	ACTIVATION	False
8721	8857	16494848:5:STAT3:MMP7	However, [TF] does not bind to the [TG] promoter, but activates MMP7 gene expression indirectly via AP-1.	Stat3	MMP7	1	ACTIVATION	False
8722	8858	16497989:7:CREB1:EGR1	Electrophoretic mobility shift assays reveal that the DNA-binding activities of both [TF] and SRF to the CRE and SRE motifs of the [TG] promoter are markedly elevated in response to LPA.	CREB	Egr-1	0	UNDEFINED	False
8723	8859	16497989:7:SRF:EGR1	Electrophoretic mobility shift assays reveal that the DNA-binding activities of both CREB and [TF] to the CRE and SRE motifs of the [TG] promoter are markedly elevated in response to LPA.	SRF	Egr-1	0	UNDEFINED	False
8724	8860	16503642:8:CREB1:CCND1	We have shown recently that E2-mediated ROS production controls the promoter activity of [TG] by post-translational modification of calcium sensitive transcription factor [TF].	CREB	cyclin D1	0	UNDEFINED	False
8725	8861	16508013:5:YBX3:CCND1	For proliferative cell nuclear antigen and [TG] genes, we show that increased mRNA levels resulted in increased protein levels and we identified [TF]-responsive elements in their promoters by using different approaches, including chromatin immunoprecipitation assays.	ZONAB	cyclin D1	0	UNDEFINED	True
8726	8862	16508969:7:NFKB:PTGS2	The effect of EGCG on [TG] expression resulted in decreased COX-2 promoter activity via inhibition of nuclear factor kappaB ([TF]) activation.	NF-kappaB	COX-2	1	ACTIVATION	True
8727	8863	16510571:5:STAT3:CCND1	Mutagenesis of [TF] binding sites within the [TG] promoter and chromatin immunoprecipitation studies showed an association between STAT3 and the transcriptional regulation of the human cyclin D1 gene.	STAT3	cyclin D1	0	UNDEFINED	False
8728	8864	16510599:5:NFKB:VEGFA	Consistent with these results, we found that the down-regulation of Notch-1 reduced [TF] DNA-binding activity and [TG] expression.	NF-kappaB	VEGF	1	ACTIVATION	True
8729	8865	16510599:7:NFKB:VEGFA	Taken together, we conclude that the down-regulation of Notch-1 could be an effective approach for the down-regulation and inactivation of [TF] and its target genes, such as MMP-9 and [TG] expression, resulting in the inhibition of invasion and metastasis.	NF-kappaB	VEGF	0	UNDEFINED	True
8730	8866	16512786:0:STAT1:PSMB9	Intracellular HIV-1 Tat protein represses constitutive [TG] transcription increasing proteasome activity by interfering with the binding of IRF-1 to [TF].	STAT1	LMP2	1	ACTIVATION	False
8732	8868	16513826:0:PPARG:PPARGC1A	Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls [TG] expression in adipocytes via [TF] coactivation.	peroxisome proliferator-activated receptor-gamma	PGC-1alpha	1	ACTIVATION	False
8733	8869	16513826:7:PPARG:PPARGC1A	This is due to the presence of a [TF]-responsive element in the distal region of the [TG] gene promoter that binds PPARgamma/retinoid X receptor heterodimers.	PPARgamma	PGC-1alpha	0	UNDEFINED	False
8734	8870	16513841:5:ELF1:NFKB1	An initial NF-kappaB activation event enhances the recruitment of p65 and [TF] to the [TG] promoter, leading to p65- and ELF1-dependent synthesis of p105/p50, which promotes an exchange of NF-kappaB complexes to p50-containing complexes with an increased DNA-binding activity to certain NF-kappaB target elements.	ELF1	NFKB1	0	UNDEFINED	True
8735	8871	16515822:11:POU2F1:NPFF	We postulate that [TF], PDX1, Pit-1, MEIS and DREAM are likely transcriptional regulators of [TG] gene expression.	Oct-1	NPFF	0	UNDEFINED	False
8736	8872	16517010:2:ETS1:NPR1	In the present study, we have examined the role of trans-acting factor [TF] in transcriptional regulation of [TG] gene (coding for NPRA).	Ets-1	Npr1	0	UNDEFINED	False
8737	8873	16517010:4:ETS1:NPR1	Overexpression of [TF] in mouse mesangial cells (MMCs) enhanced [TG] gene transcription by 12-fold.	Ets-1	Npr1	1	ACTIVATION	False
8738	8874	16517010:7:ETS1:NPR1	Collectively, the present results demonstrate that [TF] greatly stimulates [TG] gene promoter activity, implicating its critical role in the regulation and function of NPRA at the molecular level.	Ets-1	Npr1	1	ACTIVATION	False
8739	8875	16518416:0:STAT3:JAK3	Granulocyte colony-stimulating factor-induced upregulation of [TG] transcription during granulocytic differentiation is mediated by the cooperative action of Sp1 and [TF].	Stat3	Jak3	1	ACTIVATION	False
8740	8876	16518416:6:STAT3:JAK3	Together, these results demonstrate that activation of [TG] transcription during G-CSF- induced granulocytic differentiation is mediated by the combined action of Sp1 and [TF], a mechanism also shown to be important in IL-6-induced monocytic differentiation.	Stat3	Jak3	1	ACTIVATION	False
8741	8877	16522740:5:AP1:REG3A	Analysis of the [TG] promoter suggested that candidate regulators of INGAP expression include the transcription factors PDX-1, NeuroD, PAN-1, STAT and [TF].	AP-1	INGAP	0	UNDEFINED	True
8742	8878	16522740:7:AP1:REG3A	Induction of [TF] activity or STAT activity using PMA or LIF stimulation respectively, or direct expression of PAN-1 specifically up-regulates [TG] promoter activity.	AP-1	INGAP	1	ACTIVATION	False
8743	8879	16522741:9:CREB1:CCND1	Taken together, EX-induced [TG] expression is largely dependent on the cAMP/PKA signaling pathway, and EX increases the level of phosphorylated [TF] and more potently trans-activates cyclin D1 gene through binding of the CREB to the putative CRE site, implicating a potential mechanism underlying beta-cell proliferation by EX.	CREB	cyclin D1	1	ACTIVATION	False
8745	8881	16533812:8:SP3:CDKN1A	Concurrent with its effect on cell growth, overexpression of HDAC3 and other Class I HDACs inhibited basal and butyrate-induced [TG] transcription in a Sp1/[TF]-dependent manner, whereas silencing of HDAC3 stimulated p21 promoter activity and expression.	Sp3	p21	2	REPRESSION	True
8746	8882	16537893:6:EWSR1:UPP1	[TF] activates the expression of [TG] mRNA, is directly bound to the UPP promoter, and transforms 3T3 fibroblasts; in contrast, a C-terminally truncated mutant form of EWS-Fli1 that cannot cooperatively bind DNA with Fos-Jun is defective in all of these properties.	EWS-Fli1	UPP	1	ACTIVATION	False
8747	8883	16537893:6:FLI1:UPP1	EWS-[TF] activates the expression of [TG] mRNA, is directly bound to the UPP promoter, and transforms 3T3 fibroblasts; in contrast, a C-terminally truncated mutant form of EWS-Fli1 that cannot cooperatively bind DNA with Fos-Jun is defective in all of these properties.	Fli1	UPP	1	ACTIVATION	False
8748	8884	16537893:6:FOS:UPP1	EWS-Fli1 activates the expression of [TG] mRNA, is directly bound to the UPP promoter, and transforms 3T3 fibroblasts; in contrast, a C-terminally truncated mutant form of EWS-Fli1 that cannot cooperatively bind DNA with [TF]-Jun is defective in all of these properties.	Fos	UPP	1	ACTIVATION	True
8750	8886	16551619:8:NFE2L2:HMOX1	[TF] up-regulated the expression of [TG], glutathione peroxidase, glutathione S-transferase A1, NAD(P)H: quinone oxidoreductase and glutamate-cysteine ligase and protected against hydrogen peroxide-induced glutathione depletion and cell death, whereas co-expression of active GSK-3beta attenuated both phase II gene expression and oxidant protection.	Nrf2	HO-1	1	ACTIVATION	False
8751	8887	16554298:7:FOSL1:MMP9	Ectopic expression of p65, c-Fos, c-Jun, and [TF] induced [TG] promoter activity.	Fra-1	MMP9	1	ACTIVATION	False
8752	8888	16557594:7:TP53:ID1	Furthermore, we establish a direct causal relationship between p21, [TG] and ID2 overexpression, increased acetylation of histones H3 and H4 and binding of [TF] to their promoters as a result of 5-FU treatment.	p53	ID1	1	ACTIVATION	False
8753	8889	16565071:2:JUN:ACTG1	This astrocyte-specific regulation involves activatory protein-1 ([TF]) because overexpression of dominant-negative c-jun(TAM67) abolishes [TG] expression in glioma cells.	AP-1	ACT	1	ACTIVATION	False
8754	8890	16569740:6:AP1:OXTR	Using computer-based analysis and EMSA studies, we have identified three [TF], nine C/EBP, and three NF-kappaB DNA-binding sites in the [TG] promoter.	AP-1	OTR	0	UNDEFINED	False
8755	8891	16572591:7:USF1:NPHS2	Consensus analysis for homology of the -52 region with regulatory factors revealed homology for [TF] and the sum of experiments with gel retardation and with cells silenced for USF1 confirmed that this factor regulates [TG] expression at this site.	USF1	NPHS2	0	UNDEFINED	False
8756	8892	16573655:4:NFKB:SLC1A2	Pharmacological studies suggest that phosphatidylinositol 3-kinase (PI-3K) and the nuclear transcription factor-kappaB ([TF]) may be involved in the induction of [TG] expression.	NF-kappaB	GLT-1	1	ACTIVATION	False
8757	8893	16574738:10:VDR:TRPV6	A final ChIP assay revealed that [TF]/RXR heterodimer binding to the [TG] gene was accompanied by both the recruitment of steroid receptor coactivator 1 as well as a broad change in histone 4 acetylation.	VDR	TRPV6	0	UNDEFINED	True
8758	8894	16574740:5:RORB:OPN1SW	[TF] lacks a known physiological ligand and activates the [TG] promoter modestly alone but strongly in synergy with the retinal cone-rod homeobox factor (CRX), suggesting a cooperative means of enhancing RORbeta activity.	RORbeta	Opn1sw	1	ACTIVATION	False
8759	8895	16580749:2:E2F1:CDCA7	Here, we report the identification of JPO1/[TG] as a direct transcriptional target of transcription factor [TF].	E2F1	CDCA7	0	UNDEFINED	False
8760	8896	16581947:14:NFKB:TGFA	In the HCV core transfectants, [TF] bound to the kappaB site in the [TG] proximal promoter region, resulting in an increase in TGFalpha transcription.	NF-kappaB	TGFalpha	1	ACTIVATION	False
8761	8897	16581947:19:NFKB:TGFA	These results suggest that the HCV core protein promotes proliferation of human hepatoma cells by activation of the MAPK/ERK pathway through up regulation of [TG] transcription via activation of [TF].	NF-kappaB	TGFalpha	1	ACTIVATION	False
8762	8898	16582636:2:TP53:CDC25C	Two independent mechanisms contribute to the [TF]-dependent repression of the [TG] gene.	p53	cdc25C	2	REPRESSION	False
8763	8899	16582636:3:TP53:CDC25C	First, an element in the [TG] promoter consisting of a binding site for [TF] plus an adjacent 8 base pairs confers p53-dependent repression.	p53	cdc25C	2	REPRESSION	False
8764	8900	16582636:8:TP53:CDC25C	These results support a model for [TF] downregulating [TG] expression, in part, by direct binding to a promoter element that is likely to require cooperation with an additional cellular factor.	p53	cdc25C	2	REPRESSION	False
8765	8901	16585567:8:EGR1:SELP	Furthermore, [TF]-deficient thymuses have increased [TG] expression.	Egr1	P-selectin	2	REPRESSION	True
8766	8902	16585567:9:EGR1:SELP	The data suggest that [TF] mediates a feedback mechanism whereby the number of resident double negative thymocytes controls the entry of new progenitors into the thymus by regulating [TG] expression on thymic endothelial cells.	Egr1	P-selectin	0	UNDEFINED	True
8767	8903	16585602:9:STAT5A:PTGS2	Transient transfection with JAK2 short-interferring RNA reduced [TG] promoter activity and JAK2 phosphorylation, while RNA interference of STAT isoforms showed that [TF] predominantly mediates SP-induced COX-2 promoter activity.	STAT5	COX-2	1	ACTIVATION	False
8768	8904	16603733:0:SP3:HAS2	Sp1 and [TF] mediate constitutive transcription of the [TG] gene.	Sp3	human hyaluronan synthase 2	1	ACTIVATION	False
8769	8905	16611863:11:HIF1A:TGFB3	Inhibition of EGLN activity increased [TF] stability in villous explants and stimulated [TG] (TGFB3) expression consistent with promoter analyses showing that HIF1A transactivates TGFB3.	HIF1A	transforming growth factor beta 3	1	ACTIVATION	False
8770	8906	16614080:3:SREBF1:PFKFB1	Transient transfection of HepG2 cells with deleted gene promoter constructs and electrophoretic mobility shift assays allowed us to identify a sterol regulatory element (SRE) to which SRE binding protein-1a ([TF]) binds and transactivates [TG] gene transcription.	SREBP-1a	PFKFB1	1	ACTIVATION	False
8771	8907	16614080:8:SREBF1:PFKFB1	Our findings demonstrate involvement of [TF] in the transcriptional activation of [TG], and we conclude that SREBP-1a may exert a key role mediating postprandial activation of PFKFB1 transcription.	SREBP-1a	PFKFB1	1	ACTIVATION	False
8772	8908	16618413:12:NFKB:CDX2	Moreover, a dominant negative construct for [TF] prevented deoxycholate-induced p50 nuclear translocation and activation of the [TG] promoter.	NF-kappaB	Cdx2	1	ACTIVATION	False
8774	8911	16618731:2:STAT5A:ID1	We show here that expression of the helix-loop-helix transcription factor [TG] is enhanced by BCR/ABL in a signal transducer and activator of transcription 5 ([TF])-dependent manner.	STAT5	Id1	1	ACTIVATION	False
8775	8912	16622840:6:USF2:SERPINE1	This reciprocal and growth state-dependent residence of USF family members (USF-1 vs. [TF]) at PE1/PE2 region chromatin characterized the G0 --> G1 transition period and the transcriptional status of the [TG] gene.	USF-2	PAI-1	0	UNDEFINED	False
8776	8913	16623704:0:ESRRA:PDK4	Identification of [TF] as a specific partner of PGC-1alpha for the activation of [TG] gene expression in muscle.	ERRalpha	PDK4	1	ACTIVATION	False
8777	8914	16623704:3:ESRRA:PDK4	Here, we show that the two mechanisms are independent, and that [TF] is directly involved in PPARalpha-independent transcriptional activation of the [TG] gene with PGC-1alpha as a specific partner.	ERRalpha	PDK4	1	ACTIVATION	False
8778	8915	16627584:0:JUN:LHB	Gonadotropin-releasing hormone activation of [TF], but not early growth response factor-1, stimulates transcription of a [TG]-subunit gene.	c-jun	luteinizing hormone beta	1	ACTIVATION	False
8779	8916	1663213:11:FOS:POMC	Furthermore, cotransfection experiments with the [TG] promoter linked to the chloramphenicol acetyl transferase reporter gene along with an expression vector coding for [TF] showed efficient stimulation of POMC gene transcription by cFOS.	cFOS	POMC	1	ACTIVATION	False
8780	8917	1663213:12:FOS:POMC	In summary, c-fos mRNA accumulation is an early genomic signal in pituitary cells in response to CRF, and [TF] may represent a signal controlling [TG] gene expression.	cFOS	POMC	0	UNDEFINED	False
8781	8918	16636146:6:OVOL1:MYC	We present molecular evidence that [TG] expression is up-regulated in [TF]-deficient suprabasal cells and that Ovol1 represses c-myc transcription by directly binding to its promoter.	Ovol1	c-myc	2	REPRESSION	False
8782	8919	16637064:11:NFKB:SAT1	These results taken together suggest that the inhibition of IkappaB and activation of [TF] activate [TG].	NFkappaB	SSAT	1	ACTIVATION	False
8783	8920	16637064:9:NFKB:SAT1	Chromatin immunoprecipitation (ChIP) assay showed that [TF] was indeed bound to the [TG] promoter after CHX treatment.	NFkappaB	SSAT	0	UNDEFINED	False
8784	8921	16637071:0:ZBTB16:PBX1	[TF] regulates [TG] transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.	PLZF	Pbx1	0	UNDEFINED	False
8785	8922	16651411:6:AP1:TFF1	Mutation of the activator protein 1 (AP-1) binding site abrogated the TPA-induced transcriptional response of the luciferase reporter gene under the control of the [TG] promoter, showing the requirement for the [TF].	AP-1 site	TFF1	1	ACTIVATION	False
8786	8923	16670091:9:FOXO1:SLC2A4	We suggest a novel paradigm to increase insulin sensitivity in adipocytes in which [TF] repression of PPARgamma, the latter being a repressor of the [TG] promoter, consequently leads to GLUT4 derepression/up-regulation, thus enhancing cellular insulin sensitivity.	FOXO1	GLUT4	1	ACTIVATION	True
8787	8924	16676006:0:JUN:PTEN	[TF] promotes cellular survival by suppression of [TG].	c-Jun	PTEN	2	REPRESSION	False
8788	8925	16676006:6:JUN:PTEN	c-Jun was found to suppress [TG] expression by binding to a variant [TF] site found in the 5' upstream sequences of PTEN promoter.	AP-1	PTEN	2	REPRESSION	True
8789	8926	16682957:2:NFKB:PTGS2	Here we show that the tumor suppressor p53 upregulated [TG] in esophageal and colon cancer cell lines by inducing the binding of nuclear factor-kappaB ([TF]) to its response element in the COX-2 promoter.	NF-kappaB	Cox-2	1	ACTIVATION	False
8790	8927	16682957:2:TP53:PTGS2	Here we show that the tumor suppressor [TF] upregulated [TG] in esophageal and colon cancer cell lines by inducing the binding of nuclear factor-kappaB (NF-kappaB) to its response element in the COX-2 promoter.	p53	Cox-2	1	ACTIVATION	False
8791	8928	16682957:3:NFKB:PTGS2	Inhibition of [TF] prevented p53 induction of [TG] expression.	NF-kappaB	Cox-2	1	ACTIVATION	False
8792	8929	16682957:3:TP53:PTGS2	Inhibition of NF-kappaB prevented [TF] induction of [TG] expression.	p53	Cox-2	1	ACTIVATION	False
8793	8930	16682957:7:NFKB:PTGS2	These results suggest that p53 and [TF] cooperate in upregulating [TG] expression, promoting cell survival in inflammatory precursor lesions such as BE.	NF-kappaB	Cox-2	1	ACTIVATION	False
8794	8931	16682957:7:TP53:PTGS2	These results suggest that [TF] and NF-kappaB cooperate in upregulating [TG] expression, promoting cell survival in inflammatory precursor lesions such as BE.	p53	Cox-2	1	ACTIVATION	False
8795	8932	16684505:0:ETS1:ITGA10	Regulation of [TG] expression in chondrocytes by the transcription factors AP-2epsilon and [TF].	Ets-1	integrin alpha10	0	UNDEFINED	False
8796	8933	16684505:8:ETS1:ITGA10	Additionally, [TF] was shown to be a positive regulator of the [TG] expression whereas Sox9 was irrelevant.	Ets-1	integrin alpha10	1	ACTIVATION	False
8797	8934	16684505:9:ETS1:ITGA10	Taken together, these results suggest that AP-2epsilon and [TF] are involved in the regulation of [TG] transcription in chondrocytes.	Ets-1	integrin alpha10	0	UNDEFINED	False
8798	8935	16684536:3:NFKB:EPO	To identify molecular mechanisms of this reaction we investigated three transcription factors ([TF], GATA-2 and HIF-1) that control the [TG] gene.	NF-kappaB	Epo	0	UNDEFINED	False
8799	8936	16684536:4:NFKB:EPO	Western blot analyses and electrophoretic mobility shift assays (EMSAs) revealed that IL-1 strongly activated [TF], which is a likely suppressor of the [TG] promoter.	NF-kappaB	Epo	2	REPRESSION	False
8800	8937	16684540:0:NFKB:VEGFA	Platelet-activating factor-induced [TF] activation enhances [TG] expression through a decrease in p53 activity.	NF-kappaB	VEGF	1	ACTIVATION	False
8801	8938	16684540:0:TP53:VEGFA	Platelet-activating factor-induced NF-kappaB activation enhances [TG] expression through a decrease in [TF] activity.	p53	VEGF	2	REPRESSION	False
8802	8939	16684540:4:TP53:VEGFA	PAF-induced increase in [TG] expression was correlated with decreased [TF] activity.	p53	VEGF	2	REPRESSION	False
8803	8940	16684540:5:TP53:VEGFA	These data suggest that NF-kappaB-dependency of the PAF-induced increase in [TG] expression is due to decreased [TF] activity, which is reciprocally regulated by increased NF-kappaB activity.	p53	VEGF	2	REPRESSION	False
8804	8941	16688168:0:ATF3:TLR4	Systems biology approaches identify [TF] as a negative regulator of [TG].	ATF3	Toll-like receptor 4	2	REPRESSION	False
8805	8942	16690042:10:AP1:NPPA	Over-expression of JunD in cardiomyocytes caused enhanced [TF] protein-DNA binding, without increasing the transcriptional response from AP-1 or [TG] luciferase reporter plasmids at baseline or upon PE stimulation.	AP-1	ANP	1	ACTIVATION	True
8806	8944	16690042:9:JUND:NPPA	Adenoviral over-expression of wild-type [TF] blunted PE-induced hypertrophic growth and expression of [TG] mRNA.	JunD	ANP	2	REPRESSION	False
8807	8945	16690749:8:FOXO3:IGFBP3	Endogenous [TG] expression was confirmed to be dependent on the GR-SGK-1-[TF] signaling pathway.	FOXO3a	IGFBP-3	1	ACTIVATION	False
8808	8946	16699180:8:CEBPB:PTGS2	Both morpholino knockdown of [TF] in APC mutant zebrafish and silencing of C/EBP-beta using small interfering RNA in HT29 colon cancer cells robustly decrease [TG] expression.	C/EBP-beta	COX-2	1	ACTIVATION	False
8809	8947	16703666:8:STAT1:PSMB9	Intracellular Tat sequesters IRF-1 (interferon-regulatory factor-1) from its cognate promoter element, where normally it associates with STAT1 ([TF]) to activate basal transcription of the [TG] gene.	signal transducer and activator of transcription 1	LMP2	1	ACTIVATION	False
8810	8948	16705184:0:ID2:CDKN1C	E Proteins and [TF] converge on [TG] to regulate cell cycle in neural cells.	Id2	p57Kip2	0	UNDEFINED	True
8811	8949	16705184:6:TCF3:CDKN1C	Through the use of global gene expression analysis in neuroblastoma cells engineered to acutely express the E protein [TF] and Id2, we find that [TG] is a target of E47.	E47	p57Kip2	0	UNDEFINED	False
8812	8950	16705184:7:ID2:CDKN1C	Consistent with the role of Id proteins, [TF] prevents activation of [TG] expression, and the retinoblastoma tumor suppressor protein, a known Id2 inhibitor, counters this activity.	Id2	p57Kip2	2	REPRESSION	False
8813	8951	16706751:0:MYC:CDKN1A	Polyamine-modulated [TF] expression in normal intestinal epithelial cells regulates [TG] transcription through a proximal promoter region.	c-Myc	p21Cip1	0	UNDEFINED	False
8814	8952	16706751:7:MYC:CDKN1A	Ectopic expression of wild-type [TF] not only inhibited basal levels of [TG] transcription in control cells, but also prevented increased p21Cip1 in polyamine-deficient cells.	c-myc	p21Cip1	2	REPRESSION	False
8815	8953	16706751:8:MYC:CDKN1A	Experiments using different [TG] promoter mutants showed that transcriptional repression of p21Cip1 by [TF] was mediated through Miz-1- and Sp1-binding sites within the proximal region of the p21Cip1 promoter in normal IECs.	c-Myc	p21Cip1	2	REPRESSION	False
8817	8955	16707502:5:NFKB:CTGF	Chromatin immunoprecipitation assays showed that [TF] binds to the endogenous [TG] promoter in both stretched cells and mechanically overloaded bladder tissues.	NF-kappaB	CCN2	0	UNDEFINED	False
8818	8956	16707502:9:NFKB:CTGF	Thus, mechanical stretch-induced changes in actin dynamics mediate [TF] activation and induce [TG] gene expression, which probably initiates the fibrotic reactions observed in mechanical overload-associated pathologies.	NF-kappaB	CCN2	1	ACTIVATION	True
8820	8958	16709572:6:NFKB:TRPC1	Using [TG] promoter-deletion mutant constructs, we showed that [TF] binding sites located between -1623 and -871 in the TRPC1 5'-regulatory region were required for thrombin-induced TRPC1 expression.	NF-kappaB	TRPC1	1	ACTIVATION	False
8821	8959	16714766:4:NANOG:ZFP42	Knockdown of [TF] in embryonic stem cells resulted in a reduction of [TG] expression, whereas forced expression of Nanog in P19 stimulated Rex-1 expression.	Nanog	Rex-1	1	ACTIVATION	False
8822	8960	16717057:6:CIC:ETV5	Indeed, [TF]-DUX4 directly binds the [TG] promoter by recognizing a novel target sequence and significantly up-regulates its expression.	CIC	ERM	1	ACTIVATION	False
8823	8961	16717057:6:DUX4:ETV5	Indeed, CIC-[TF] directly binds the [TG] promoter by recognizing a novel target sequence and significantly up-regulates its expression.	DUX4	ERM	1	ACTIVATION	False
8824	8962	16725311:10:NFKB:E2F1	The results demonstrate a novel mechanism for transcriptional regulation of [TG] and identify the functional role of nucleophosmin/B23 in modulating the binding of [TF], E2F1 and pRB to activate E2F1 promoter.	NF-kappaB	E2F1	1	ACTIVATION	False
8825	8963	16725311:3:NFKB:E2F1	In identifying physiologically important factors that may occupy [TG] promoter and regulate its activity in vivo, we found that the pattern of [TF], E2F1 and pRB recruitment to E2F1 promoter changed in a strikingly dynamic fashion as cells progressed from quiescence into serum-stimulated growth.	NF-kappaB	E2F1	0	UNDEFINED	False
8826	8964	16728472:3:MESP2:EPHA4	A gene candidate that is activated by [TF] is [TG], as its expression pattern resembles Mesp2 and is absent in Mesp2-null embryos.	Mesp2	Epha4	1	ACTIVATION	False
8827	8965	16728472:6:MESP2:EPHA4	We also show that [TF] directly binds to the enhancer sequence of [TG].	Mesp2	Epha4	0	UNDEFINED	False
8829	8967	16738884:8:MYC:CDKN1A	Suppression of [TF] by PA is followed by increased mRNA levels of [TG], an effect that is mediated by PA activation of the p21 promoter.	c-myc	p21	2	REPRESSION	False
8830	8968	16738884:9:MYC:CDKN1A	Forced overexpression of [TF] through co-transfection of MCF-7 cells with a c-myc expression plasmid prevented PA upregulation of [TG] promoter activity.	c-myc	p21	2	REPRESSION	False
8831	8969	16741617:10:FOXA2:SLCO1B3	This study demonstrated that the transcription of the [TG] gene is regulated by three transcription factors, FXR, HNF1alpha, and [TF].	HNF3beta	LST-2	0	UNDEFINED	True
8832	8970	16741617:10:HNF1A:SLCO1B3	This study demonstrated that the transcription of the [TG] gene is regulated by three transcription factors, FXR, [TF], and HNF3beta.	HNF1alpha	LST-2	0	UNDEFINED	False
8833	8971	16757381:8:SP1:PDK4	The p300/CBP may enhance acetylation of histones bound to the h[TG] promoter and cooperate with [TF] and CBF to stimulate transcription of the hPDK4 gene in response to RA and TSA.	Sp1	PDK4	1	ACTIVATION	False
8834	8972	16757480:6:NFKB:SAT1	Stable overexpression of a mutant, dominant negative IkappaBalpha protein led to the suppression of [TG] induction by TNFalpha in these cells, thereby substantiating a role of [TF] in the induction of SSAT by TNFalpha.	NFkappaB	SSAT	1	ACTIVATION	False
8835	8973	16757480:7:NFKB:SAT1	[TG] promoter deletion constructs led to the identification of three potential [TF] response elements in the SSAT gene.	NFkappaB	SSAT	0	UNDEFINED	False
8836	8974	16757577:10:CEBPB:DDIT3	[TF] is selective and binding to the [TG] promoter precedes that of XBP-1, ATF6 and CHOP.	C/EBPbeta	CHOP	0	UNDEFINED	False
8837	8975	16757577:10:XBP1:DDIT3	C/EBPbeta is selective and binding to the [TG] promoter precedes that of [TF], ATF6 and CHOP.	XBP-1	CHOP	0	UNDEFINED	False
8838	8976	16766264:3:SMAD3:BCL2	This protection is conferred by [TF]'s ability to promote apoptosis by repressing [TG] transcription in vivo through a GC-rich element in the Bcl-2 promoter.	Smad3	Bcl-2	2	REPRESSION	False
8839	8977	16772530:11:NFKB:PTGS2	Based on these findings, we propose that PR may inhibit [TF] activation of [TG] gene expression and uterine contractility via ligand-dependent and ligand-independent mechanisms.	NF-kappaB	COX-2	1	ACTIVATION	False
8840	8978	16772530:2:NFKB:PTGS2	In the present study, we tested the hypothesis that progesterone/PR inhibits uterine contractility by blocking nuclear factor kappaB ([TF]) activation and induction of cyclooxygenase-2 ([TG]), a contractile gene that is up-regulated in labor.	NF-kappaB	COX-2	1	ACTIVATION	False
8841	8979	16772530:7:NFKB:PTGS2	Using chromatin immunoprecipitation, we observed that IL-1beta stimulated recruitment of [TF] p65 to both proximal and distal NF-kappaB elements of the [TG] promoter; these effects were diminished by coincubation with progesterone.	NF-kappaB	COX-2	0	UNDEFINED	False
8842	8980	16773182:3:AP1:MUC5AC	Promoter deletion constructs and EMSA studies revealed that transcription factors Sp1 and [TF] are both involved in basal transcription of the [TG] gene.	AP-1	MUC5AC	1	ACTIVATION	False
8843	8981	16773182:8:AP1:MUC5AC	Our studies indicate that Sp1 is involved in basal [TG] promoter activity while [TF] is involved in basal and PMA-induced MUC5AC promoter activation in pancreatic cancer cells.	AP-1	MUC5AC	1	ACTIVATION	False
8844	8982	16776654:0:ID2:MYC	[TF] leaves the chromatin of the E2F4-p130-controlled [TG] promoter during hepatocyte priming for liver regeneration.	Id2	c-myc	0	UNDEFINED	False
8845	8983	16776654:6:ID2:MYC	Moreover, as the G0-G1 transition progresses, [TF] and HDAC again bind the [TG] promoter concomitantly with the repression of this gene.	Id2	c-myc	2	REPRESSION	False
8846	8984	16776654:9:ID2:MYC	In this case, the pattern of [TF] presence in the [TG] promoter parallels that found in regenerating liver.	Id2	c-myc	0	UNDEFINED	False
8847	8985	16778175:4:TP53:DUSP4	Moreover, we identify a 10-bp perfect palindrome motif (CTGGCGCCAG) in the [TG] promoter as a new binding site for [TF] to activate the MKP2 gene.	p53	MKP2	1	ACTIVATION	False
8848	8986	16784892:10:NFKB:FAS	These findings demonstrate that the TNF-alpha autocrine-paracrine loop is involved in the constitutive activation of the transcription factors [TF] and YY1 in the tumor cells and this loop leads to inhibition of [TG] expression and resistance to FasL-induced apoptosis.	NF-kappaB	Fas	2	REPRESSION	False
8850	8988	16784892:4:NFKB:FAS	Thus, we hypothesized that tumor-derived TNF-alpha induces the activation of [TF] and the transcription repressor YY1, both of which negatively regulate [TG] expression and sensitivity to FasL-induced apoptosis.	NF-kappaB	Fas	2	REPRESSION	True
8851	8989	16784892:7:NFKB:FAS	In contrast, blocking the binding of secreted TNF-alpha on PC-3 cells with soluble recombinant sTNF-RI resulted in significant inhibition of constitutive [TF] and YY1 DNA-binding activity, downregulation of YY1 expression, upregulation of [TG] expression and sensitization of tumor cells to CH-11-induced apoptosis.	NF-kappaB	Fas	2	REPRESSION	False
8852	8990	16785237:6:SMAD7:TERT	Expression of the Smad3 antagonist, [TF], also interrupts TGF-beta-mediated Smad3-induced repression of the [TG] gene.	Smad7	TERT	1	ACTIVATION	True
8853	8991	16786175:6:CEBPB:PTGS2	Transient transfection experiments suggested that the [TF] response element in the proximal promoter (-327 to 59) is involved in Ox-HDL3-mediated [TG] expression.	NF-IL6	Cox-2	1	ACTIVATION	False
8854	8992	16786175:7:CEBPB:PTGS2	These data suggest that Ox-HDL induce [TG] expression in endothelial cells through a PI3K/[TF]-dependent pathway.	NF-IL6	Cox-2	1	ACTIVATION	False
8855	8993	16786196:7:USF2:RUNX2	Thus, we suggest that [TF] might be one of the regulators for the expression of the [TG] gene in D1 cells.	USF2	Runx2	0	UNDEFINED	True
8856	8994	16797880:4:SP1:FLNA	Mechanical stress applied to Rat-2 cells increased promoter activity of the [TF] target gene [TG] by >5-fold; activation was blocked by mutations to Sp1 binding sites in the filamin A promoter.	Sp1	filamin A	1	ACTIVATION	True
8857	8995	16797880:7:SP1:FLNA	[TF] that was phosphorylated at Thr453 and Thr739 by constitutively active p38 bound to the [TG] promoter more effectively than un-phosphorylated Sp1.	Sp1	filamin A	0	UNDEFINED	False
8858	8996	16807237:0:TP53:CDC25C	DNA damage-induced down-regulation of human [TG] and Cdc2 is mediated by cooperation between [TF] and maintenance DNA (cytosine-5) methyltransferase 1.	p53	Cdc25C	2	REPRESSION	False
8859	8997	16807237:7:TP53:CDC25C	Chromatin immunoprecipitation of doxorubicin treated wild-type HCT116 cells showed the presence of DNMT1, [TF], H3K9me2, and the transcriptional repressor HDAC1 on the [TG] and Cdc2 promoters, suggesting their involvement as repressive complexes in Cdc25C and Cdc2 gene silencing.	p53	Cdc25C	2	REPRESSION	False
8860	8998	16807381:0:SP1:HSD17B2	[TF] and SP3 mediate progesterone-dependent induction of the [TG] gene in human endometrium.	SP1	17beta hydroxysteroid dehydrogenase type 2	1	ACTIVATION	False
8861	8999	16807381:11:SP1:HSD17B2	Taken together, these data suggest that [TG] expression in endometrial epithelial cells, and, therefore, estrogen inactivation, is regulated by [TF] and SP3, which are downstream targets of progesterone-dependent paracrine signals originating from endometrial stromal cells.	SP1	HSD17B2	0	UNDEFINED	False
8862	9000	16807381:9:SP1:HSD17B2	CM markedly enhanced, whereas anti-[TF]/SP3 antibodies inhibited, binding of nuclear proteins to this region of the [TG] promoter.	SP1	HSD17B2	0	UNDEFINED	False
8863	9001	16810128:0:SP3:CDKN1A	Up-regulation of [TG]WAF1 expression is mediated by Sp1/[TF] transcription factors in TGFbeta1-arrested malignant B cells.	Sp3	p21	1	ACTIVATION	False
8864	9002	16810128:13:SP3:CDKN1A	The results indicated that [TG]WAF1 over-expression in TGFbeta1-arrested malignant B cells is mediated by binding of Sp1/[TF] transcription factors to the (-92/-71), (-77/-58), and (-65/-45) elements of the promoter region of the p21 gene.	Sp3	p21	1	ACTIVATION	False
8865	9003	16818642:6:HIF1A:PTGS2	Oligonucleotide pull-down and chromatin immunoprecipitation assays reveal that [TF] binds a hypoxia-responsive element on the [TG] promoter.	HIF-1alpha	COX-2	0	UNDEFINED	False
8866	9004	16819511:0:STAT5A:BCL6	[TF] represses [TG] expression by binding to a regulatory region frequently mutated in lymphomas.	STAT5	BCL6	2	REPRESSION	False
8867	9005	16819511:8:STAT5A:BCL6	[TF] can bind inducibly and regulate transcription at one of these regions, identifying [TG] as a STAT5 target gene.	STAT5	BCL6	0	UNDEFINED	False
8868	9006	16819512:5:SRF:CDKN1A	Furthermore, we demonstrated that overexpression of [TF] markedly decreases the level of Smad3 complex binding to the promoters of Smad3 target genes, p15(INK4b) and p21([TG]).	SRF	Cip1	0	UNDEFINED	False
8869	9007	16820889:0:CEBPB:PTGS2	PC-SPES down-regulates [TG] via inhibition of NF-kappaB and [TF] in non-small cell lung cancer cells.	C/EBPbeta	COX-2	1	ACTIVATION	False
8870	9008	16829517:2:ETS1:CTGF	This study investigated regulation of [TG] gene expression by Ets family of transcription factors, focusing on two members, Fli1 and [TF], with deregulated expression during fibrosis and tumorigenesis.	Ets1	CCN2	0	UNDEFINED	False
8871	9009	16829517:2:FLI1:CTGF	This study investigated regulation of [TG] gene expression by Ets family of transcription factors, focusing on two members, [TF] and Ets1, with deregulated expression during fibrosis and tumorigenesis.	Fli1	CCN2	0	UNDEFINED	False
8872	9010	16829517:3:ETS1:CTGF	We show that [TF] and Fli1 have opposite effects on [TG] gene expression.	Ets1	CCN2	0	UNDEFINED	False
8873	9011	16829517:3:FLI1:CTGF	We show that Ets1 and [TF] have opposite effects on [TG] gene expression.	Fli1	CCN2	0	UNDEFINED	False
8874	9012	16829517:4:ETS1:CTGF	[TF] functions as an activator of [TG] transcription, whereas Fli1 acts as a repressor.	Ets1	CCN2	1	ACTIVATION	False
8875	9013	16829517:4:FLI1:CTGF	Ets1 functions as an activator of [TG] transcription, whereas [TF] acts as a repressor.	Fli1	CCN2	2	REPRESSION	False
8876	9014	16829517:7:ETS1:CTGF	The contrasting functions of [TF] and Fli1 in regulation of the [TG] gene were confirmed by suppressing their endogenous levels using adenoviral vectors expressing specific small interfering RNAs.	Ets1	CCN2	0	UNDEFINED	False
8877	9015	16829517:7:FLI1:CTGF	The contrasting functions of Ets1 and [TF] in regulation of the [TG] gene were confirmed by suppressing their endogenous levels using adenoviral vectors expressing specific small interfering RNAs.	Fli1	CCN2	0	UNDEFINED	False
8878	9016	16829517:8:ETS1:CTGF	Additional experiments using chromatin immunoprecipitation assays have revealed that in fibroblasts both [TF] and Fli1 occupy the [TG] promoter.	Ets1	CCN2	0	UNDEFINED	False
8879	9017	16829517:8:FLI1:CTGF	Additional experiments using chromatin immunoprecipitation assays have revealed that in fibroblasts both Ets1 and [TF] occupy the [TG] promoter.	Fli1	CCN2	0	UNDEFINED	False
8880	9018	16829517:9:FLI1:CTGF	TGF-beta stimulation resulted in displacement of [TF] from the [TG] promoter and a transient inhibition of Fli1 synthesis.	Fli1	CCN2	0	UNDEFINED	False
8881	9019	16835303:6:TP53:VEGFA	These data disclose an unexpected function of endogenous E2F1: regulation of angiogenic activity via [TF]-dependent transcriptional control of [TG] expression.	p53	VEGF	0	UNDEFINED	False
8882	9020	16840354:4:ELK1:EGR1	Zta not only binds to the [TG] promoter but also activates the ERK signaling pathway to trigger binding of [TF] to the Egr-1 promoter.	Elk-1	Egr-1	0	UNDEFINED	False
8883	9021	16840440:3:ETS1:CXCR4	In HGF-treated MCF-7 cells, the DNA binding of [TF] activated by MAPK1/ERK1/2 transduction pathway as well as the DNA binding of NF-kappaB played a critical role in [TG] transcription and protein induction.	Ets1	CXCR4	1	ACTIVATION	False
8884	9022	16840717:10:STAT3:PROS1	IL-6 exerts its effect through [TF] (STAT3) that interacts with the [TG] promoter at a binding site in between nucleotides 229 to 207 upstream from the translational start.	Signal Transducer and Activator of Transcription 3	PROS1	0	UNDEFINED	False
8885	9023	16840740:12:SP1:PTGS2	An altered [TF]/Sp3 binding to the -765 region may contribute to the mechanism by which -765G>C reduces [TG] expression.	Sp1	PTGS2	1	ACTIVATION	True
8886	9024	16840740:12:SP3:PTGS2	An altered Sp1/[TF] binding to the -765 region may contribute to the mechanism by which -765G>C reduces [TG] expression.	Sp3	PTGS2	1	ACTIVATION	False
8887	9025	16841079:2:NFKB:PTGS2	Our current study aimed to investigate the involvement of nuclear factor-kappa B ([TF]), a pivotal transcriptional regulator of [TG], in the upregulation of COX-2 expression by HSV-tk.	NF-kappaB	COX-2	1	ACTIVATION	False
8888	9026	16841079:4:NFKB:PTGS2	Treatment of HSV-tk-transduced MC38 cells with sulfasalazine, a potent [TF] inhibitor, led to dose-dependent inhibition of NF-kappaB activity, IkappaB phosphorylation and nuclear translocation of NF-kappaB, accompanied by significantly decreased [TG] expression and reduced release of prostaglandin E2.	NF-kappaB	COX-2	1	ACTIVATION	False
8889	9027	16841079:5:NFKB:PTGS2	Transient transfection experiments with [TG] promoter constructs fused to luciferase reporter gene revealed that mutation in [TF]-responsive element of COX-2 promoter significantly reduced promoter activity in HSV-tk-transduced MC38 and COS-7 cells, whereas it had no effect on promoter activity in the respective wild-type cells.	NF-kappaB	COX-2	1	ACTIVATION	False
8890	9028	16846370:6:NANOG:TDGF1	As an example, results from ChIP-on-chip studies show that OCT4, SOX2, and [TF] co-occupy SOX2, OCT4, [TG], GJA1, SET, and DPPA4 genes.	NANOG	TDGF1	0	UNDEFINED	False
8891	9029	16846370:6:SOX2:TDGF1	As an example, results from ChIP-on-chip studies show that OCT4, [TF], and NANOG co-occupy SOX2, OCT4, [TG], GJA1, SET, and DPPA4 genes.	SOX2	TDGF1	0	UNDEFINED	False
8892	9030	16849326:11:EGR1:DUSP4	These results suggest that the inhibition of hepatic gluconeogenesis by AMPK may, in part, be mediated by an immediate early gene response involving [TF] and its target, [TG].	EGR1	DUSP4	0	UNDEFINED	False
8893	9031	16849326:6:EGR1:DUSP4	AMPK also induces the immediate early transcription factor Egr1 ([TF]), a known transcriptional activator of [TG], and it directly binds the Dusp4 promoter at its known binding site.	early growth response 1	Dusp4	1	ACTIVATION	False
8894	9032	16849326:9:EGR1:DUSP4	In Fao cells, small interfering RNA targeted [TF] also depletes [TG] expression following treatment with AICAR, further supporting a direct link between EGR1 and DUSP4 activation.	EGR1	DUSP4	1	ACTIVATION	False
8895	9033	16849549:6:NFKB:SHH	We showed that blockade of [TF] suppressed constitutive expression of [TG] mRNA in pancreatic cancer cells.	NF-kappaB	Shh	1	ACTIVATION	False
8896	9034	16855208:9:NFKB:PTGFR	These results are consistent with the proposal that proinflammatory cytokines directly regulate uterine activation genes and that the transcription factor [TF] is involved in both basal and IL1beta-stimulated transcription of the [TG] gene.	NFkappaB	PTGFR	1	ACTIVATION	False
8897	9035	16860316:8:JUN:CCND1	(3) Over-expression of BRCA1-IRIS in breast cells over-activates JNK/[TF]; this leads to the induction of [TG] expression and cellular proliferation.	c-Jun	cyclin D1	1	ACTIVATION	False
8898	9036	16862183:7:RELA:ZEB1	In transient transfection assays, [TF] increased [TG] promoter activity.	p65	ZEB-1	1	ACTIVATION	False
8899	9037	16862184:10:ZBTB16:PBX1	Reverse transcription-polymerase chain reaction analysis demonstrated that repression of [TG] by [TF] reduces the expression of HoxB7 target genes, including tumor-associated neoangiogenesis factors such as basic fibroblast growth factor, angiopoietin-2 and matrix metalloprotease 9.	PLZF	Pbx1	2	REPRESSION	True
8900	9038	16867219:6:TFAP2A:CDKN1A	[TF]gamma binding to the [TG] promoter was observed in vivo, and the absence of growth inhibition in response to AP-2gamma expression in p21(-/-) cells demonstrated that p21 caused, at least in part, AP-2-induced cell cycle arrest.	AP-2	p21	0	UNDEFINED	False
8901	9039	16868967:12:ZNF384:MMP13	These data suggest that the binding of p130(cas) and [TF] to the AGRE site regulates [TG] expression and may trigger the change in human chondrocytes from the L-OA state to the H-OA state.	NMP-4	MMP-13	0	UNDEFINED	False
8902	9040	16878156:8:YY1:MYC	[TF] regulated negatively the [TG] activity through a direct interaction with the Myc/Max and deacetylase complexes.	YY1	Myc	2	REPRESSION	False
8903	9041	16885156:8:SREBF1:CYP7A1	We conclude that insulin has dual effects on human [TG] gene transcription; physiological concentrations of insulin rapidly inhibit FoxO1 activity leading to stimulation of the human CYP7A1 gene, whereas prolonged insulin treatment induces [TF], which inhibits human CYP7A1 gene transcription.	SREBP-1c	CYP7A1	2	REPRESSION	False
8904	9042	16887796:10:STAT3:NOS3	Transfection of [TG] promoter mutants revealed that the SIE at -1024 mediates [TF] inhibition of eNOS promoter activity.	Stat3	eNOS	2	REPRESSION	False
8905	9043	16887796:13:STAT3:NOS3	Our data show that IL-6 has direct effects upon endothelial cells, inhibiting [TG] expression in part through [TF].	Stat3	eNOS	2	REPRESSION	False
8906	9044	16887796:9:STAT3:NOS3	We identified four consensus sequences for [TF] binding (SIE) in the [TG] promoter at positions -1520, -1024, -840, and -540.	Stat3	eNOS	0	UNDEFINED	False
8907	9045	16891311:6:ATF2:TGFB3	Furthermore, by using chromatin immunoprecipitation assays, we demonstrated that CREB-1, [TF], and c-Jun bound constitutively at the [TG] promoter (-100 to +1), whereas Smad3 bound at this site only after TGFbeta stimulation.	ATF-2	TGFbeta3	0	UNDEFINED	False
8908	9046	16891311:6:JUN:TGFB3	Furthermore, by using chromatin immunoprecipitation assays, we demonstrated that CREB-1, ATF-2, and [TF] bound constitutively at the [TG] promoter (-100 to +1), whereas Smad3 bound at this site only after TGFbeta stimulation.	c-Jun	TGFbeta3	0	UNDEFINED	False
8909	9047	16891311:6:SMAD3:TGFB3	Furthermore, by using chromatin immunoprecipitation assays, we demonstrated that CREB-1, ATF-2, and c-Jun bound constitutively at the [TG] promoter (-100 to +1), whereas [TF] bound at this site only after TGFbeta stimulation.	Smad3	TGFbeta3	0	UNDEFINED	False
8910	9048	16899215:8:LEF1:SALL4	The [TG] promoter was strongly activated not only by [TF] but also by TCF4E.	LEF1	SALL4	1	ACTIVATION	False
8911	9049	16899237:6:HES1:CDKN1C	Inactivation of [TF] results in the upregulation of [TG] expression in progenitors, leading to cell cycle arrest, precocious differentiation and depletion of the progenitor pool.	Hes1	p57	2	REPRESSION	False
8912	9050	16901903:10:SP1:ULBP1	Additionally, we demonstrated that AP-2alpha repressed the expression of [TG] in HeLa cells by interfering with the binding of Sp3 and [TF] to the ULBP1 promoter.	Sp1	ULBP1	1	ACTIVATION	True
8913	9051	16901903:10:SP3:ULBP1	Additionally, we demonstrated that AP-2alpha repressed the expression of [TG] in HeLa cells by interfering with the binding of [TF] and Sp1 to the ULBP1 promoter.	Sp3	ULBP1	1	ACTIVATION	True
8914	9052	16901903:10:TFAP2A:ULBP1	Additionally, we demonstrated that [TF] repressed the expression of [TG] in HeLa cells by interfering with the binding of Sp3 and Sp1 to the ULBP1 promoter.	AP-2alpha	ULBP1	2	REPRESSION	False
8915	9053	16901903:9:SP3:ULBP1	Experiments in SL2 cells showed that the [TG] promoter was inactive in the absence of the Sp proteins and indicate that [TF] is the essential activator of ULBP1 transcription, because the overexpression of Sp3 up-regulated its promoter activity > 500-fold.	Sp3	ULBP1	1	ACTIVATION	False
8916	9054	16902410:0:NFKB2:SKP2	IKKalpha controls [TF]/RelB at the [TG] gene promoter to regulate G1- to S-phase progression.	p52	skp2	0	UNDEFINED	False
8917	9055	16902410:0:RELB:SKP2	IKKalpha controls p52/[TF] at the [TG] gene promoter to regulate G1- to S-phase progression.	RelB	skp2	0	UNDEFINED	False
8918	9056	16902410:7:RELB:SKP2	Additionally, we demonstrate that IKKalpha signaling regulates the transcription of the [TG] gene by controlling the composition of a [TF]-containing NF-kappaB complex.	RelB	skp2	0	UNDEFINED	False
8919	9057	16902410:8:NFKB2:SKP2	Together, this work defines a novel IKKalpha-regulated growth pathway involving the [TF]/RelB-dependent transcriptional regulation of the [TG] gene.	p52	skp2	0	UNDEFINED	False
8920	9058	16902410:8:RELB:SKP2	Together, this work defines a novel IKKalpha-regulated growth pathway involving the p52/[TF]-dependent transcriptional regulation of the [TG] gene.	RelB	skp2	0	UNDEFINED	False
8921	9059	16908542:5:CREB1:CYCS	Previous work indicated that PRC activation of [TG] expression occurs through cis-acting elements that bind both NRF-1 and [TF].	CREB	cytochrome c	1	ACTIVATION	True
8922	9060	16908542:5:NRF1:CYCS	Previous work indicated that PRC activation of [TG] expression occurs through cis-acting elements that bind both [TF] and CREB.	NRF-1	cytochrome c	1	ACTIVATION	False
8923	9061	16912181:6:STAT3:CCND1	Overexpression of WT1 and [TF]CA in NIH 3T3 increases the expression level of STAT3 target genes, including [TG] and Bcl-xL, which results in an advantage of cell proliferation.	STAT3	cyclin D1	1	ACTIVATION	False
8924	9062	16917105:0:PPARA:CCND1	Inhibition of smooth muscle proliferation by urea-based alkanoic acids via [TF]-dependent repression of [TG].	peroxisome proliferator-activated receptor alpha	cyclin D1	2	REPRESSION	False
8925	9063	16920108:4:RXRA:LDLR	Moreover, the [TG] promoter contained an LXR response element that was recognized by LXRalpha/[TF] (retinoid X receptor alpha) heterodimers in hepatoblastoma cells.	RXRalpha	LDLR	0	UNDEFINED	False
8926	9064	16921166:5:SOX10:MITF	These [TF] mutant proteins showed impaired transactivation activity on the [TG] promoter.	SOX10	MITF	1	ACTIVATION	False
8927	9065	16940415:6:NFKB:FAS	When we investigated the role of DRE and [TF], we observed varying levels of luciferase induction (9 +/- 2-fold for DRE and 8 +/- 2-fold for NF-kappaBs of [TG] promoter and 6 +/- 3-fold for NF-kappaBs of FasL promoter).	NF-kappaB	Fas	1	ACTIVATION	False
8929	9067	16948474:4:NFE2L2:NQO1	Fluorescent microscopic analysis in combination with transfection experiments with plasmids harboring different segments of the 5'-flanking region of [TG] gene linked to a reporter provided evidence that the modulation of NQO1 gene expression by resveratrol involved the antioxidant response element ARE, accompanied by an increase in the state of phosphorylation of transcription factor [TF] and its re-distribution to the nucleus.	Nrf2	NQO1	0	UNDEFINED	False
8930	9068	16949670:7:CEBPB:TRIB3	Subsequent studies reveal that fibrates upregulate [TF] and CHOP in lymphocytes and mutation of potential C/EBPbeta and CHOP consensus sequences abrogates the ability of fibrates to upregulate [TG] promoter activity.	C/EBPbeta	TRB3	1	ACTIVATION	False
8931	9069	16949670:8:CEBPB:TRIB3	Accordingly, fibrates enhance the recruitment of [TF] and CHOP to the proximal [TG] promoter.	C/EBPbeta	TRB3	0	UNDEFINED	False
8932	9070	16949687:0:STAT1:AGT	Upregulation of human angiotensinogen ([TG]) gene transcription by interferon-gamma: involvement of the [TF]-binding motif in the AGT promoter.	STAT1	AGT	1	ACTIVATION	False
8933	9071	16949687:12:STAT1:AGT	In contrast to the clear synergism between dexamethasone and IL 6 in the upregulation of the [TG] promoter (through interaction between GR and STAT3), the combination of IFN gamma with IL 6 or with dexamethasone did not further increase AGT promoter activity suggesting that the IFN gamma/[TF] pathway represents a separate signaling mechanism.	STAT1	AGT	1	ACTIVATION	False
8934	9072	16949687:12:STAT3:AGT	In contrast to the clear synergism between dexamethasone and IL 6 in the upregulation of the [TG] promoter (through interaction between GR and [TF]), the combination of IFN gamma with IL 6 or with dexamethasone did not further increase AGT promoter activity suggesting that the IFN gamma/STAT1 pathway represents a separate signaling mechanism.	STAT3	AGT	1	ACTIVATION	False
8935	9073	16950772:6:BCL11B:CDKN1C	Finally, the NuRD complex and [TF] were found to co-occupy the promoter template of [TG], a gene encoding a cyclin-dependent kinase inhibitor, and identified herein as a novel transcriptional target of CTIP2 in SK-N-MC cells.	CTIP2	p57KIP2	0	UNDEFINED	False
8936	9074	16951197:1:NFE2L2:HMOX1	Exposure of sulforaphane to HepG2 cells increased [TG] (HO-1) expression by activating antioxidant response element (ARE) through induction of [TF] and suppression of Kelch-like ECH-associated protein 1 (Keap1).	Nrf2	heme oxygenase-1	1	ACTIVATION	False
8937	9075	16951334:9:PPARG:CAT	Moreover, [TF] regulates ROS through its coordinated transcriptional control of proteins and enzymes involved in ROS scavenging, including uncoupling protein 2, [TG], and copper zinc superoxide dismutase.	PPARgamma	catalase	0	UNDEFINED	False
8938	9076	16952553:8:ZNF148:CDKN1A	Chromatin immunoprecipitation and DNA affinity precipitation assays showed that both [TF] and ATM are recruited to the GC-rich DNA elements of the p21([TG]) promoter with HDACi treatment.	ZBP-89	waf1	0	UNDEFINED	False
8939	9077	16959849:12:STAT3:REN	We conclude that in As4.1 cells, IL-1beta down-regulates [TG] gene expression via a mechanism involving the Erk-[TF] pathway.	STAT3	renin	2	REPRESSION	False
8940	9078	16959875:0:STAT3:A2M	The role of interleukin-11 in pregnancy involves up-regulation of [TG] gene through janus kinase 2-[TF] pathway in the decidua.	signal transducer and activator of transcription 3	alpha2-macroglobulin	1	ACTIVATION	False
8941	9079	16963428:4:YBX1:TP53	It has been demonstrated that [TF] represses transcription of the [TG] promoter in a sequence-specific manner using specifically reporter assays.	YB-1	p53	2	REPRESSION	False
8942	9080	16965262:0:POU2F1:CSN2	Involvement of the ubiquitous [TF] transcription factor in hormonal induction of [TG] gene expression.	Oct-1	beta-casein	1	ACTIVATION	False
8943	9081	16965262:10:POU2F1:CSN2	The results of the present study provide biochemical evidence that the ubiquitous [TF] transcription factor may be involved in hormonally regulated, tissue-specific [TG] gene expression.	Oct-1	beta-casein	1	ACTIVATION	True
8944	9082	16965262:3:POU2F1:CSN2	Our previous studies have identified a binding site for the ubiquitous [TF] (octamer-binding transcription factor 1) protein in the lactogenic hormonal regulatory region of the mouse [TG] promoter.	Oct-1	beta-casein	0	UNDEFINED	False
8945	9083	16965262:4:POU2F1:CSN2	In the present study, we report that [TF] is indeed expressed and binds to the [TG] promoter in mammary epithelial cells.	Oct-1	beta-casein	0	UNDEFINED	False
8946	9084	16965262:5:POU2F1:CSN2	[TF] activates hormonally induced [TG] promoter activity in a dose-dependent manner.	Oct-1	beta-casein	1	ACTIVATION	False
8947	9085	16965262:8:POU2F1:CSN2	In transient transfection experiments, [TF] collaboratively transactivated the [TG] gene promoter with STAT5 and/or GR in the presence of Prl receptor in cells treated with the lactogenic hormones.	Oct-1	beta-casein	1	ACTIVATION	False
8948	9086	16966329:7:GATA4:SLC8A1	Chromatin immunoprecipitation assays in adult cardiocytes demonstrate that SRF and [TF] are associated with the proximal region of the endogenous [TG] promoter.	GATA4	Ncx1	0	UNDEFINED	False
8949	9087	16966329:7:SRF:SLC8A1	Chromatin immunoprecipitation assays in adult cardiocytes demonstrate that [TF] and GATA4 are associated with the proximal region of the endogenous [TG] promoter.	SRF	Ncx1	0	UNDEFINED	False
8950	9088	16969516:6:MTA1:VEGFA	Moreover, [TF] increased the transcriptional activity of HIF-1alpha and enhanced the expression of [TG], a target molecule of HIF-1alpha.	MTA1	vascular endothelial growth factor	1	ACTIVATION	False
8951	9089	16980581:7:NFIC:CCND1	Taken together, our results reveal an estrogen-regulated combinatorial network including cell-specific cis- and trans-regulators of [TG] expression where ERalpha collaborates with other transcription factors associated with the ER-positive breast cancer phenotype, including FoxA1 and [TF].	NFIC	CCND1	0	UNDEFINED	False
8952	9090	16981245:3:CEBPB:PTGS2	We also assessed the effect of [TF] on [TG] expression.	C/EBPbeta	COX-2	0	UNDEFINED	False
8953	9091	16981245:8:CEBPB:PTGS2	Using GC cell lines we show that [TF] can regulate the expression of endogenous [TG] and transactivate the promoter of the COX-2 gene, depending on its methylation status.	C/EBPbeta	COX-2	1	ACTIVATION	False
8954	9092	16981245:9:CEBPB:PTGS2	These results suggest that [TF] may be a marker of neoplastic transformation and also play an active role in gastric tumourigenesis by regulating [TG] expression.	C/EBPbeta	COX-2	0	UNDEFINED	False
8955	9093	16982744:3:RELB:BIRC3	Daxx interacts with [TF] and inhibits RelB-mediated transcriptional activation of the human [TG] gene promoter.	RelB	cIAP2	1	ACTIVATION	False
8956	9094	16982744:4:RELB:BIRC3	Daxx also forms complexes with [TF] while bound to its target sites in the [TG] promoter, as shown by electrophoretic mobility shift assays and chromatin immunoprecipitation experiments.	RelB	cIAP2	0	UNDEFINED	False
8957	9095	16987240:0:EGR1:CHGB	Molecular basis of neuroendocrine cell type-specific expression of the [TG] gene: Crucial role of the transcription factors CREB, AP-2, [TF] and Sp1.	Egr-1	chromogranin B	1	ACTIVATION	False
8958	9096	16987240:4:EGR1:CHGB	Co-transfection of expression plasmids for CREB, activator protein-2 (transcription factor) (AP-2), early growth response protein (transcription factor) ([TF]) or specificity protein 1 (transcription factor) (Sp1) with the [TG] promoter constructs trans-activated expression of the Chgb gene.	Egr-1	Chgb	1	ACTIVATION	False
8959	9097	16987240:8:EGR1:CHGB	We conclude that the neuroendocrine-specific expression of [TG] is mediated by the CRE and G/C boxes in cis and the transcription factors CREB, AP-2, [TF] and Sp1 in trans.	Egr-1	Chgb	1	ACTIVATION	False
8960	9098	16989287:14:AP1:SNCG	[TF] in the first intron play an important role in control of [TG] transcription.	AP1 domains	BCSG1	0	UNDEFINED	False
8962	9100	16990795:2:NFKB2:CCND1	Here, we demonstrate that endogenous [TF] is a direct regulator of [TG] expression.	p52	Cyclin D1	0	UNDEFINED	False
8964	9102	16997394:0:HNF4A:ABCC6	[TF] and NF-E2 are key transcriptional regulators of the murine [TG] gene expression.	HNF4alpha	Abcc6	0	UNDEFINED	False
8965	9103	16997394:0:NFE2:ABCC6	HNF4alpha and [TF] are key transcriptional regulators of the murine [TG] gene expression.	NF-E2	Abcc6	0	UNDEFINED	False
8966	9104	16997917:0:NOBOX:POU5F1	Characterization of [TF] DNA binding specificity and its regulation of Gdf9 and [TG] promoters.	NOBOX	Pou5f1	0	UNDEFINED	False
8967	9105	16997917:5:NOBOX:POU5F1	[TF] binds to these putative NOBOX binding elements with high affinity and augmented transcriptional activity of luciferase reporter driven by mouse [TG] and Gdf9 promoters containing the NOBOX binding elements.	NOBOX	Pou5f1	1	ACTIVATION	False
8968	9106	16997917:6:NOBOX:POU5F1	In chromatin immunoprecipitation assays, DNA sequences from [TG] and Gdf9 promoters co-precipitated with anti-[TF] antibody.	NOBOX	Pou5f1	0	UNDEFINED	False
8969	9107	1700011:9:JUN:SLC26A3	Thus, c-Fos/[TF] heterodimers might contribute to the repression of [TG] gene expression.	c-Jun	DRA	2	REPRESSION	False
8970	9108	17001309:5:E2F4:BRCA1	Mechanistically, we have found that hypoxia induces substantial p130 dephosphorylation and nuclear accumulation, leading to the formation of [TF]/p130 complexes and increased occupancy of E2F4 and p130 at the RAD51 and [TG] promoters.	E2F4	BRCA1	0	UNDEFINED	False
8971	9109	17003378:4:THAP1:RRM1	Silencing of endogenous [TF] through RNA interference similarly inhibited EC proliferation and G1/S cell-cycle progression, and resulted in down-regulation of several pRB/E2F cell-cycle target genes, including [TG], a gene required for S-phase DNA synthesis.	THAP1	RRM1	1	ACTIVATION	False
8972	9110	17003378:5:THAP1:RRM1	Chromatin immunoprecipitation assays in proliferating ECs showed that endogenous [TF] associates in vivo with a consensus THAP1-binding site found in the [TG] promoter, indicating that RRM1 is a direct transcriptional target of THAP1.	THAP1	RRM1	0	UNDEFINED	False
8973	9111	17012241:4:SP1:PTGS2	Two proximal specific [TF] and Sp3 binding sites are responsible for the [TG] promoter activity under normal as well as oxidative stress conditions through enhanced Sp1 and Sp3 DNA binding activity.	Sp1	COX-2	0	UNDEFINED	True
8974	9112	17012241:4:SP3:PTGS2	Two proximal specific Sp1 and [TF] binding sites are responsible for the [TG] promoter activity under normal as well as oxidative stress conditions through enhanced Sp1 and Sp3 DNA binding activity.	Sp3	COX-2	1	ACTIVATION	False
8975	9113	17012241:7:SP1:PTGS2	The dominant negative form of [TF] abrogated the oxidative stress-induced promoter activity and expression of [TG].	Sp1	COX-2	1	ACTIVATION	False
8976	9114	17015480:8:TRERF1:CDKN1A	[TF] synergizes with progesterone-bound PR to trans activate the [TG] and p27 gene promoters at proximal Sp1-binding sites.	TReP-132	p21	1	ACTIVATION	False
8977	9115	17021248:11:HNF1B:GSTA1	These findings indicate that IL-1beta represses [TG] transcription via a mechanism involving overexpression of v[TF]C.	HNF-1	GSTA1	2	REPRESSION	False
8978	9116	17023536:4:STAT3:POMC	We find that [TG] expression is diminished in the mutant mice, suggesting that [TF] is required for Pomc transcription.	Stat3	Pomc	1	ACTIVATION	False
8979	9117	17023536:7:STAT3:POMC	These results demonstrate a requirement for [TF] in transcriptional regulation of [TG] but indicate that this circuit is only one of several components that underlie the neuronal response to leptin and the role of Stat3 in that response.	Stat3	Pomc	0	UNDEFINED	False
8980	9118	17030610:0:NR6A1:POU5F1	Differential recruitment of methylated CpG binding domains by the orphan receptor [TF] initiates the repression and silencing of [TG] expression.	GCNF	Oct4	2	REPRESSION	False
8981	9119	17030610:11:NR6A1:POU5F1	Thus, recruitment of MBD3 and MBD2 by [TF] links two events, gene-specific repression and DNA methylation, which occur differentially at the [TG] promoter.	GCNF	Oct4	2	REPRESSION	False
8982	9120	17030610:12:NR6A1:POU5F1	[TF] initiates the repression and epigenetic modification of [TG] gene during ES cell differentiation.	GCNF	Oct4	2	REPRESSION	False
8983	9121	17042743:5:ATF4:TRPV6	Transfection experiments in control and mutant cells, and chromatin immunoprecipitations showed that [TF] activates, whereas ATF3 represses [TG] transcription, via an AARE (amino acid response element), TGATGAAAC, in the first exon of the cat-1 gene, which functions both in the endogenous and in a heterologous promoter.	ATF4	cat-1	1	ACTIVATION	False
8984	9122	17043650:7:CREB1:CCND2	Our results indicate that the downregulation of [TG] expression by PTEN is mediated by the GSK3beta/beta-catenin/TCF pathway in cooperation with [TF], and suggest a convergence from the PI-3 kinase/PTEN pathway and the Wnt pathway in modulation of cyclin D2 expression.	CREB	cyclin D2	2	REPRESSION	False
8985	9123	17046816:4:BACH2:PRDM1	The reporter gene of the Blimp-1 gene ([TG]) was repressed by the overexpression of [TF] in B cell lines.	Bach2	Prdm1	2	REPRESSION	False
8986	9124	17046816:5:BACH2:PRDM1	The heterodimer of [TF]/MafK bound to the Maf recognition element located upstream of the [TG] promoter in an electrophoretic mobility shift assay.	Bach2	Prdm1	0	UNDEFINED	False
8987	9125	17046816:5:MAFK:PRDM1	The heterodimer of Bach2/[TF] bound to the Maf recognition element located upstream of the [TG] promoter in an electrophoretic mobility shift assay.	MafK	Prdm1	0	UNDEFINED	False
8988	9126	17046972:5:NFKB:STAT4	Cloning and functional analysis of the [TG] promoter showed that a [TF] binding site, localized at -969/-959 bp upstream of the transcriptional start site, is involved in the regulation of this gene in primary human DC.	NF-kappaB	STAT-4	0	UNDEFINED	False
8989	9127	17049495:6:SP1:DDIT3	Using a combination of the [TF] cDNA transfection, the luciferase reporter assay and Sp1 inhibitor assay, we found that Sp1 site is required for resveratrol-mediated activation of the [TG] promoter.	Sp1	CHOP	1	ACTIVATION	False
8990	9128	17049831:7:NFKB:IGF1R	Lycopene also significantly inhibited the binding abilities of [TF] and Sp1 and decreased, to some extent, the expression of [TG] (IGF-1R) and the intracellular level of reactive oxygen species (P<.05).	NF-kappaB	insulin-like growth factor-1 receptor	1	ACTIVATION	False
8991	9129	17050003:0:GATA4:GJA5	The human [TG] promoter polymorphism -44G-->A differentially affects transcriptional regulation by Sp1 and [TF].	GATA4	Cx40	0	UNDEFINED	False
8992	9130	17050003:5:GATA4:GJA5	Using electrophoretic mobility shift assays and luciferase reporter assays in various cell types, we show that Sp1 and [TF] are important regulators of human [TG] gene transcription and that the -44 G-->A polymorphism negatively affects the promoter regulation by the transcription factors Sp1 and GATA4.	GATA4	Cx40	0	UNDEFINED	False
8993	9131	17050003:5:SP1:GJA5	Using electrophoretic mobility shift assays and luciferase reporter assays in various cell types, we show that [TF] and GATA4 are important regulators of human [TG] gene transcription and that the -44 G-->A polymorphism negatively affects the promoter regulation by the transcription factors Sp1 and GATA4.	Sp1	Cx40	0	UNDEFINED	False
8994	9132	17050536:0:ZBTB17:NDRG2	The repression of human differentiation-related gene [TG] expression by Myc via [TF]-dependent interaction with the NDRG2 core promoter.	Miz-1	NDRG2	2	REPRESSION	False
8995	9133	17050536:7:MYC:NDRG2	We further identified the core promoter region of [TG] that is required for [TF] repression on NDRG2 transcription, and we verified the interaction of Myc with the core promoter region both in vitro and in vivo.	Myc	NDRG2	2	REPRESSION	False
8996	9134	17050536:8:MYC:NDRG2	Moreover, the [TF]-mediated repression of [TG] requires association with Miz-1, and possibly the recruitment of other epigenetic factors, such as histone deacetylases, to the promoter.	c-Myc	NDRG2	2	REPRESSION	False
8997	9135	17050536:8:ZBTB17:NDRG2	Moreover, the c-Myc-mediated repression of [TG] requires association with [TF], and possibly the recruitment of other epigenetic factors, such as histone deacetylases, to the promoter.	Miz-1	NDRG2	2	REPRESSION	False
8998	9136	17058229:0:SMAD2:NOS3	Endoglin increases [TG] expression by modulating [TF] protein levels and Smad2-dependent TGF-beta signaling.	Smad2	eNOS	0	UNDEFINED	False
8999	9137	17065555:9:NFKB:VEGFA	Deletion of putative [TF]-binding sites from the [TG] promoter did not affect LPS/NECA-induced VEGF promoter activity, suggesting that NF-kappaB is not directly involved in VEGF transcription.	NF-kappaB	VEGF	1	ACTIVATION	False
9000	9138	17070520:7:JUN:CFLAR	Furthermore, activation of [TF] and suppression of NF-kappaB by sodium arsenite resulted in upregulation of the endogenous TRAIL and downregulation of the [TG] gene expression (which encodes one of the main anti-apoptotic proteins in melanomas) followed by cFLIP protein degradation and, finally, by acceleration of TRAIL-induced apoptosis.	cJun	cFLIP	2	REPRESSION	True
9001	9139	17070520:7:NFKB:TNFSF10	Furthermore, activation of cJun and suppression of [TF] by sodium arsenite resulted in upregulation of the endogenous [TG] and downregulation of the cFLIP gene expression (which encodes one of the main anti-apoptotic proteins in melanomas) followed by cFLIP protein degradation and, finally, by acceleration of TRAIL-induced apoptosis.	NF-kappaB	TRAIL	2	REPRESSION	False
9002	9140	17079227:7:ESRRA:PDK4	Here we report that [TF] and ERRgamma stimulate the [TG] gene in hepatoma cells, suggesting a novel role for ERRs in controlling pyruvate metabolism.	ERRalpha	PDK4	1	ACTIVATION	False
9003	9141	17079227:9:ESRRA:PDK4	Insulin, which decreases the expression of the [TG] gene, inhibits the induction of PDK4 by [TF] and ERRgamma.	ERRalpha	PDK4	1	ACTIVATION	False
9004	9142	17079232:7:ZNF350:CDKN1A	We also show that occupancy of [TF] response elements located at the [TG] promoter by ZBRK1.KAP1 is independent of KAP1 sumoylation.	ZBRK1	p21	0	UNDEFINED	False
9005	9143	17082637:7:ATF1:FOSL1	ERK inhibition not only blocked phosphorylation of Elk1, CREB, and [TF], which constitutively bind to the [TG] promoter, but also suppressed the recruitment of c-Jun to the promoter.	ATF1	FRA-1	0	UNDEFINED	False
9006	9144	17082637:7:CREB1:FOSL1	ERK inhibition not only blocked phosphorylation of Elk1, [TF], and ATF1, which constitutively bind to the [TG] promoter, but also suppressed the recruitment of c-Jun to the promoter.	CREB	FRA-1	0	UNDEFINED	False
9007	9145	17085443:5:TFE3:BEST1	A yeast one-hybrid screen using bait containing E-box 1 identified clones encoding MITF, [TF], and TFEB, and chromatin immunoprecipitation with antibodies against these proteins enriched the [TG] proximal promoter.	TFE3	VMD2	0	UNDEFINED	False
9008	9146	17085443:5:TFEB:BEST1	A yeast one-hybrid screen using bait containing E-box 1 identified clones encoding MITF, TFE3, and [TF], and chromatin immunoprecipitation with antibodies against these proteins enriched the [TG] proximal promoter.	TFEB	VMD2	0	UNDEFINED	False
9009	9147	17085443:8:TFE3:BEST1	Sequential transfection of a luciferase construct with expression vectors following MITF siRNA revealed that [TF] and TFEB can also transactivate the [TG] promoter.	TFE3	VMD2	1	ACTIVATION	False
9010	9148	17085443:8:TFEB:BEST1	Sequential transfection of a luciferase construct with expression vectors following MITF siRNA revealed that TFE3 and [TF] can also transactivate the [TG] promoter.	TFEB	VMD2	1	ACTIVATION	False
9011	9149	17085785:4:RELA:SOD2	In the present study, we demonstrate that TNF-alpha activates NF-kappaB activity in neuronal, SH-SY5Y, cells and preferentially enhances the binding of p50 and [TF] to the promoter/enhancer regions of the [TG] gene.	p65	MnSOD	0	UNDEFINED	False
9012	9150	17088079:3:ETS1:MMP2	Promoter analysis and gel shift assay showed that p53 and [TF] were involved in [TG] expression in ornithine decarboxylase overexpressing transfectants.	Ets-1	MMP-2	1	ACTIVATION	False
9013	9151	17088079:3:TP53:MMP2	Promoter analysis and gel shift assay showed that [TF] and Ets-1 were involved in [TG] expression in ornithine decarboxylase overexpressing transfectants.	p53	MMP-2	1	ACTIVATION	False
9014	9152	17090534:7:SP5:CDKN1A	Finally, our data strongly suggest that [TF] has the same DNA binding specificity as Sp1 and represses Sp1 target genes such as [TG].	Sp5	p21	2	REPRESSION	False
9015	9153	17094106:4:HOXC8:NKD2	Introduction of exogenous [TF] into NIH3T3 cell lines lacking wild-type Hoxc8 dramatically reduced expression of [TG] mRNA.	Hoxc8	mNkd2	2	REPRESSION	False
9016	9154	17097050:0:AP1:IL2	Inhibition of AMP-activated protein kinase suppresses [TG] expression through down-regulation of NF-AT and [TF] activation in Jurkat T cells.	AP-1	IL-2	1	ACTIVATION	False
9017	9155	17097063:6:SP1:AQP5	Taken together, our data indicate that atRA increases [TG] expression through transactivation of [TF], leading to an increase in plasma membrane water permeability.	Sp1	AQP5	1	ACTIVATION	False
9018	9156	17098279:8:NFKB1:CCND1	Features of Notch1 activation as measured by intracellular Notch1, high levels of Jagged1, Hes1 and Cdk9 were paralleled by nuclear translocation of both [TF] p50 and p65 with target gene expression (IkappaB-alpha, Bcl-2, and [TG]) in human cervical cancer sections.	NF-kappaB	CyclinD1	1	ACTIVATION	True
9019	9157	17098279:8:RELA:CCND1	Features of Notch1 activation as measured by intracellular Notch1, high levels of Jagged1, Hes1 and Cdk9 were paralleled by nuclear translocation of both NF-kappaB p50 and [TF] with target gene expression (IkappaB-alpha, Bcl-2, and [TG]) in human cervical cancer sections.	p65	CyclinD1	1	ACTIVATION	True
9020	9158	17098936:7:E2F3:CCNB1	Chromatin immunoprecipitation analysis showed that Bdbd significantly inhibited binding of TATA-binding protein, TBP to both [TG] and Aurora A promoters, but did not inhibit binding of [TF] activator to Cyclin B1 promoter.	E2F3	Cyclin B1	0	UNDEFINED	False
9021	9159	17099248:8:NRF1:CYCS	In support of our hypothesis, binding of the transcription factor nuclear respiratory factor 1 ([TF]) to the [TG] promoter and NRF-2 to the cytochrome oxidase subunit 4 promoter increased in response to exercise prior to an increase in PGC-1alpha protein.	NRF-1	cytochrome c	0	UNDEFINED	True
9022	9160	17106239:5:E2F1:BRCA1	Intriguingly, our data suggest that [TF] and E2F4 bind the [TG] proximal promoter simultaneously at the two E2F sites, although E2F4 appears to be the predominant E2F bound in log-phase cells.	E2F1	BRCA1	0	UNDEFINED	False
9023	9161	17106239:5:E2F4:BRCA1	Intriguingly, our data suggest that E2F1 and [TF] bind the [TG] proximal promoter simultaneously at the two E2F sites, although E2F4 appears to be the predominant E2F bound in log-phase cells.	E2F4	BRCA1	0	UNDEFINED	False
9024	9162	17106239:9:E2F4:BRCA1	Furthermore, the identification of [TF] and p130/p107 complexes as basal repressors of [TG] expression may facilitate the development of strategies based on disruption of these interactions to rescue BRCA1 expression in human tumors.	E2F4	BRCA1	2	REPRESSION	False
9025	9163	17108007:11:AP1:NFATC4	[TG] promoter containing the core NFAT cis-element without [TF] binding site failed to show activation by H(2)O(2) treatment.	AP-1	NFAT3	1	ACTIVATION	False
9026	9164	17108111:6:MEF2A:ATF3	Mutagenesis analysis of the [TG] promoter identified the regulatory motifs cyclic AMP-responsive element binding protein/ATF and [TF] as being responsible for the TPA-induced activation of ATF3.	MEF2	ATF3	1	ACTIVATION	False
9027	9165	17113054:1:NFE2L2:SLC7A11	The transcription factor NF-E2-related factor ([TF]) regulates the induction of phase 2 detoxifying enzymes by oxidative stress, including synthesis of the catalytic subunit ([TG]) of the heterodimeric cystine-glutamate exchanger (system xc-).	Nrf2	xCT	1	ACTIVATION	True
9028	9166	17113054:5:NFE2L2:SLC7A11	Thus, while [TF] is a transcriptional regulator of [TG] and capable of protecting cells from oxidative stress, following Nrf2 gene deletion this role can be partially compensated by other mechanisms and methamphetamine-induced oxidative stress and dopamine toxicity does not significantly involve Nrf2.	Nrf2	xCT	0	UNDEFINED	False
9029	9167	17114344:6:KLF11:MYC	In TGFbeta-stimulated normal epithelial cells, nuclear [TF], in concert with Smad3, binds to and represses transcription from the core region of the TGFbeta-inhibitory element (TIE) of the [TG] promoter.	KLF11	c-myc	2	REPRESSION	False
9030	9168	17116388:0:STAT1:CTGF	Inhibitory effects of interferon-gamma on activation of rat pancreatic stellate cells are mediated by [TF] and involve down-regulation of [TG] expression.	STAT1	CTGF	2	REPRESSION	False
9031	9169	17117479:8:EGR1:IL12A	Finally, we show that activated ERK induced increased expression of the [TF] transcription factor, which then bound to the promoter region of [TG].	Egr-1	p35	0	UNDEFINED	False
9032	9170	17121828:9:E2F4:CCNA2	The antisense-mediated decrease in [TF] protein was reflected by reduced E2F4 association with specific target genes, including [TG], CDC2, PCNA, and Rad54.	E2F4	CCNA2	0	UNDEFINED	False
9033	9171	1712444:0:MYB:PCNA	Effect of the [TF] gene product on expression of the [TG] gene in fibroblasts.	myb	PCNA	0	UNDEFINED	False
9034	9172	17130157:0:NFIC:CDKN1A	Transcriptional regulation of the [TG] (p21) gene by [TF] in proliferating human cells.	NFI	cyclin-dependent kinase inhibitor 1A	0	UNDEFINED	False
9035	9173	17130157:3:NFIC:CDKN1A	By conducting both ligation-mediated PCR (LMPCR) and chromatin immunoprecipitation (ChIP) in vivo, we identified a functional target site for the transcription factor, nuclear factor I ([TF]), in the basal promoter from the [TG] gene.	NFI	p21	0	UNDEFINED	False
9037	9175	17130157:5:NFIC:CDKN1A	Inhibition of [TF] in human skin fibroblasts through RNAi considerably increased [TG] promoter activity suggesting that NFI is a key repressor of p21 transcription.	NFI	p21	2	REPRESSION	False
9038	9176	17130157:6:NFIC:CDKN1A	Over-expression of each of the four [TF] isoforms in HCT116 cells established that each of them contribute to various extend to the repression of the [TG] gene.	NFI	p21	2	REPRESSION	False
9040	9178	17130524:8:VDR:CYP24A1	These results suggest that in addition to the increased ER and [TF] expression, the intact VDR signaling machinery as present in ER-positive, vitamin D-sensitive cells is essential for the antiproliferative action of vitamin D, whereas the direct VDR target genes such as [TG] can remain responsive to augmented VDR expression.	VDR	CYP24	0	UNDEFINED	False
9041	9179	17130833:5:TP53:CXCR4	Short-interfering RNA-mediated depletion of [TF] increased endogenous [TG] expression in MCF-7 breast cancer cells that contain wild-type p53.	p53	CXCR4	2	REPRESSION	False
9042	9180	17130833:6:TP53:CXCR4	Basal [TG] promoter activity in HCT116 colon carcinoma cells deleted of [TF] [HCT116(p53KO)] was 10-fold higher compared to that in parental HCT116 cells with functional wild-type p53.	p53	CXCR4	2	REPRESSION	False
9044	9182	17132729:2:E2F4:MYC	Smad4 mediates this inhibitory effect of TGF-beta by forming a complex with Smad3, [TF], and p107 at the TGF-beta inhibitory element (TIE) element on the [TG] promoter.	E2F4/5	c-myc	2	REPRESSION	False
9045	9183	17133482:1:JUND:TIMP1	[TF] is implicated in the regulation of hepatic stellate cell (HSC) activation and liver fibrosis via its transcriptional regulation of the tissue inhibitor of metalloproteinases-1 ([TG]) gene.	JunD	TIMP-1	0	UNDEFINED	False
9046	9184	17141225:0:NFKB:TERT	A major role of PKC theta and [TF] in the regulation of h[TG] in human T lymphocytes.	NFkappaB	TERT	0	UNDEFINED	False
9047	9185	17141225:5:NFKB:TERT	Analysis of the h[TG] promoter occupancy in vivo using chromatin immunoprecipitation assays, however, did not detect an increased binding of [TF] to the hTERT promoter in the activated T cells, although an increased binding of cMyc and Sp1 was detected.	NFkappaB	TERT	0	UNDEFINED	False
9048	9186	17142562:7:NFKB:SLC22A4	Furthermore, overexpression of nuclear factor-kappaB ([TF]) activated promoter activity of [TG].	NF-kappaB	OCTN1	1	ACTIVATION	False
9049	9187	17142966:7:NFKB:ST3GAL1	The results indicated that constitutive promoter activities were detected at nt -120 5'-flanking translation initiation site and TNFalpha enhanced [TG] gene expression through [TF] binding sites in HT-29 cells.	NFkappaB	ST3Gal I	1	ACTIVATION	False
9050	9188	17149750:7:NFKB:CCND1	Truncation of the [TF] binding site in the [TG] promoter fully abrogated the transcription of cyclin D1, suggesting that the cyclin D1 transcription is dependent on NF-kappaB.	NF-kappaB	cyclin D1	1	ACTIVATION	False
9051	9189	17150967:11:EGR1:PDX1	Our data indicate that [TF] regulates expression of [TG] in pancreatic beta-cells by both direct and indirect activation of the pdx-1 promoter.	Egr-1	PDX-1	1	ACTIVATION	False
9052	9190	17158876:3:NR5A2:IL1RN	Here we have shown, using adenovirus-mediated [TF] overexpression and gene-silencing experiments, that the [TG] (IL-1RA) gene is a novel LRH-1 target gene in hepatic cells.	LRH-1	interleukin-1 receptor antagonist	0	UNDEFINED	False
9053	9191	17158876:4:NR5A2:IL1RN	Promoter mapping and chromatin immunoprecipitation experiments revealed that [TF] regulates [TG] gene expression under inflammatory conditions at the transcriptional level via the binding to an LRH-1 response element.	LRH-1	IL-1RA	0	UNDEFINED	False
9054	9192	17158876:6:NR5A2:IL1RN	Finally, RNA interference experiments indicate that [TF] blocks the hepatic acute phase response by, at least in part, inducing [TG] expression.	LRH-1	IL-1RA	1	ACTIVATION	True
9055	9193	17160023:4:WT1:CDKN1A	Induction of [TF] (-Ex5/-KTS) upregulated [TG], causing a slowing of proliferation and a G2-phase cell cycle arrest.	WT1	p21	1	ACTIVATION	False
9056	9194	17166846:3:AP1:CCND1	E2 treatment stimulated ER loading on the estrogen response element (ERE) in the pS2 promoter and on the [TF] motif in the [TG] promoter.	AP-1	cyclin D1	0	UNDEFINED	False
9057	9195	17166846:9:AP1:CCND1	Notably, ER knockdown reduced the association of ER, E6L, Mdm2, Carm, and pol II with [TF] and resulted in down-regulation of [TG] expression.	AP-1	cyclin D1	1	ACTIVATION	True
9058	9196	17167174:2:E2F1:CDKN1A	Using a conditional gene-targeting approach, we show that the targeted disruption of the entire E2F activator subclass composed of [TF], E2f2, and E2f3 in mouse embryonic fibroblasts leads to the activation of p53 and the induction of p53 target genes, including p21([TG]).	E2f1	CIP1	2	REPRESSION	True
9059	9197	17167174:2:E2F2:CDKN1A	Using a conditional gene-targeting approach, we show that the targeted disruption of the entire [TF] activator subclass composed of E2f1, E2f2, and E2f3 in mouse embryonic fibroblasts leads to the activation of p53 and the induction of p53 target genes, including p21([TG]).	E2F	CIP1	2	REPRESSION	True
9060	9198	17173070:5:E2F3:DDB2	Furthermore, we show that endogenous E2F1 and [TF] bind to [TG] promoter and that treatment with E2F1-antisense or E2F1-small interfering RNA (siRNA) decreases DDB2 transcription, demonstrating that E2F1 is a transcriptional regulator for DDB2.	E2F3	DDB2	0	UNDEFINED	True
9061	9199	17186551:6:USF2:PTGS2	Electrophoretic mobility shift assays with supershifting antibodies were used to identify USF-1, [TF], and CREB as proteins binding to the ATF/CRE-Ebox responsive element of the [TG] promoter.	USF-2	COX-2	0	UNDEFINED	False
9062	9200	17189429:9:ATF2:GADD45A	Thus, [TF] acts as a tumor susceptibility gene of mammary tumors, at least partly, by activating a group of target genes, including Maspin and [TG].	ATF-2	Gadd45alpha	1	ACTIVATION	False
9063	9201	17195845:4:RUNX3:IFNG	Both T-bet and [TF] bind to the [TG] promoter and the Il4 silencer, and deletion of the silencer decreases the sensitivity of Il4 to repression by either factor.	Runx3	Ifng	2	REPRESSION	False
9064	9202	17197385:9:NFKB:EDN1	HIV-Tat regulated [TG] at the transcriptional level through [TF] (NF-kappaB)-responsive sites in the ET-1 promoter.	NF-kappaB	ET-1	0	UNDEFINED	False
9065	9203	17197388:0:CEBPA:SERPINE1	Molecular regulation of the [TG] gene by hypoxia: contributions of Egr-1, HIF-1alpha, and [TF].	C/EBPalpha	PAI-1	0	UNDEFINED	False
9066	9204	17200120:0:IRF8:NF1	PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/[TF]) cooperate to activate [TG] transcription in differentiating myeloid cells.	IRF8	NF1	1	ACTIVATION	False
9067	9205	17202796:5:ESRRA:PDK4	In this study, we show that the two mechanisms are independent, at least in the mouse skeletal muscle, and that [TF] (ERRalpha) is directly involved in the PPARalpha-independent transcriptional activation of the [TG] gene with peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) as a specific partner.	estrogen-related receptor alpha	PDK4	1	ACTIVATION	False
9068	9206	17202796:8:ESRRA:PDK4	3) Specific binding of [TF] to the identified PGC-1alpha-responsive sequence of the mouse [TG] promoter was confirmed in the electrophoresis mobility shift assay using anti-ERRalpha antibodies.	ERRalpha	PDK4	0	UNDEFINED	False
9069	9207	17204240:0:ARNTL:NR0B2	Synergistic regulation of the mouse orphan nuclear receptor [TG] gene promoter by CLOCK-[TF] and LRH-1.	BMAL1	SHP	0	UNDEFINED	True
9070	9208	17204240:0:NR5A2:NR0B2	Synergistic regulation of the mouse orphan nuclear receptor [TG] gene promoter by CLOCK-BMAL1 and [TF].	LRH-1	SHP	0	UNDEFINED	False
9071	9209	17204240:3:ARNTL:NR0B2	Transient transfection of the m[TG] promoter demonstrated that CLOCK-[TF], core circadian clock components, bound to E-box (CACGTG), and stimulated the promoter activity by 4-fold.	BMAL1	SHP	1	ACTIVATION	False
9072	9210	17204240:4:ARNTL:NR0B2	Liver receptor homologue-1 (LRH-1; NR5A2) stimulated the m[TG] promoter, and CLOCK-[TF] synergistically enhanced the LRH-1-mediated transactivation.	BMAL1	SHP	1	ACTIVATION	False
9073	9211	17204240:4:NR5A2:NR0B2	Liver receptor homologue-1 (LRH-1; [TF]) stimulated the m[TG] promoter, and CLOCK-BMAL1 synergistically enhanced the LRH-1-mediated transactivation.	NR5A2	SHP	1	ACTIVATION	False
9076	9214	17204476:0:JUNB:HMOX1	[TF] and JunD regulate human [TG] gene expression in renal epithelial cells.	JunB	heme oxygenase-1	0	UNDEFINED	False
9077	9215	17204476:0:JUND:HMOX1	JunB and [TF] regulate human [TG] gene expression in renal epithelial cells.	JunD	heme oxygenase-1	0	UNDEFINED	False
9080	9218	17205062:9:AP1:IVL	This regulation is associated with increased expression of [TF] and JunD, activator protein-1 transcription factors known to be required for [TG] expression.	Fra-1	involucrin	1	ACTIVATION	False
9081	9220	17205062:9:JUND:IVL	This regulation is associated with increased expression of Fra-1 and [TF], activator protein-1 transcription factors known to be required for [TG] expression.	JunD	involucrin	1	ACTIVATION	False
9082	9221	17210690:7:TP53:MCM5	Northern and Western blot analyses revealed that the expression of [TG] and its transcriptional regulator, E2F1, is negatively regulated by [TF].	p53	MCM5	2	REPRESSION	False
9083	9222	17213320:8:NFKB:TSLP	Taken together, these results demonstrate that the inflammatory mediators IL-1beta and TNF-alpha regulate human [TG] gene expression in an [TF]-dependent manner.	NFkappaB	TSLP	0	UNDEFINED	False
9085	9224	17215322:13:SRF:CTGF	These findings provide novel evidence that monomeric actin is the connecting link between alterations in the cytoskeleton and [TG] gene expression and demonstrate the importance of [TF] in regulating CTGF transcription.	SRF	CTGF	0	UNDEFINED	False
9086	9225	17218407:9:NFKB:PTGS2	Chromatin immunoprecipitation studies confirmed that stretch increased binding of [TF] to the [TG] promoter in vivo.	NF-kappaB	COX-2	0	UNDEFINED	False
9087	9226	17219413:0:ATF2:BCL2	[TF] controls [TG] promoter activity in growth plate chondrocytes.	Activating transcription factor 2	Bcl-2	0	UNDEFINED	False
9088	9227	17219413:11:ATF2:BCL2	We show here that the absence of [TF] in growth plate chondrocytes corresponds to a decline in [TG] promoter activity, as well as a reduction in Bcl-2 protein levels.	ATF-2	Bcl-2	1	ACTIVATION	False
9089	9228	17219413:12:ATF2:BCL2	In addition, we show that [TF] as well as CREB, a transcription factor that can heterodimerize with ATF-2, bind to the CRE within the [TG] promoter.	ATF-2	Bcl-2	0	UNDEFINED	False
9090	9229	17220278:3:AP1:NOTCH4	The signal-dependent transcription factor activator protein 1 ([TF]) activates [TG] transcription in endothelial cells, but other factors/signals that regulate Notch4 are largely unknown.	AP-1	Notch4	1	ACTIVATION	False
9091	9230	17220278:4:AP1:NOTCH4	We demonstrate that, unlike the established transrepression mechanism in which the glucocorticoid receptor (GR) antagonizes [TF], AP-1 and GR synergistically activated [TG] transcription in endothelial cells.	AP-1	Notch4	1	ACTIVATION	False
9092	9231	17220375:10:YY1:PTGS2	These data suggest that in response to LPS, [TF] dissociates from p300 and binds to the [TG] promoter, contributing to COX-2 expression in an inflammatory milieu.	YY1	COX-2	1	ACTIVATION	False
9093	9232	17220375:3:YY1:PTGS2	We investigated whether [TF] regulates [TG] expression.	YY1	COX-2	0	UNDEFINED	False
9094	9233	17220375:6:YY1:PTGS2	To show biological relevance, we performed chromatin immunoprecipitation assays showing that lipopolysaccharide (LPS) treatment induced [TF] binding to the cognate site in the endogenous [TG] promoter.	YY1	COX-2	0	UNDEFINED	False
9095	9234	17233566:14:SP1:TLR4	At least one [TF] transcriptional regulatory element is present within the murine [TG] promoter (range -750 bp to -250 bp).	Sp1	TLR4	0	UNDEFINED	False
9096	9235	17234971:12:FOXO3:CYR61	These data suggest that [TF] is a negative transcription factor of [TG] and that suppression of CYR61 is among several mechanisms by which FOXO3a inhibits VSMC proliferation and neointimal hyperplasia.	FOXO3a	CYR61	2	REPRESSION	False
9097	9236	17234971:3:FOXO3:CYR61	We hypothesized that the forkhead transcription factor [TF] may regulate [TG] expression in VSMCs and investigated the CYR61-modulating effect of FOXO3a in the process of vascular response to vasoactive signals and vascular injury.	FOXO3a	CYR61	0	UNDEFINED	False
9098	9237	17234971:4:FOXO3:CYR61	To evaluate the effect of [TF] on [TG] expression, rat VSMCs were infected with adenoviral vectors expressing constitutively active FOXO3a (Ad-TM-FOXO3a).	FOXO3a	CYR61	0	UNDEFINED	False
9099	9238	17234971:5:FOXO3:CYR61	Constitutively active [TF] gene transduction suppressed [TG] expression.	FOXO3a	CYR61	2	REPRESSION	False
9101	9240	17234971:7:FOXO3:CYR61	Serum and angiotensin II rapidly induced [TG] expression, which was significantly reduced by Ad-TM-[TF].	FOXO3a	CYR61	2	REPRESSION	True
9102	9241	17237427:4:MAZ:VEGFA	We present molecular evidence that [TG] expression is increased in [TF]-transgenic mice and that SAF-1 induces VEGF transcription by directly binding to its promoter.	SAF-1	VEGF	1	ACTIVATION	False
9103	9242	17237427:5:MAZ:VEGFA	Deletion of [TF] binding elements from the [TG] promoter as well as knockdown of endogenous SAF-1 markedly inhibited IL-1beta- and TGF-beta-mediated induction of VEGF expression in chondrocyte cells.	SAF-1	VEGF	1	ACTIVATION	False
9104	9243	17237427:6:MAZ:VEGFA	By chromatin immunoprecipitation assay, in vivo, markedly higher levels of [TF] interaction with the [TG] promoter was detected in the cartilage tissues of arthritic mice as well as human osteoarthritic patients.	SAF-1	VEGF	0	UNDEFINED	False
9105	9244	17239350:8:USF1:CEBPA	These findings suggest that [TF] and 2 play roles in [TG] expression, whereas the AP-4 represses it.	USF-1	C/EBPalpha	1	ACTIVATION	True
9106	9245	17242210:0:MYB:CCNB1	c-[TF] contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of [TG] expression.	Myb	cyclin B1	0	UNDEFINED	False
9107	9246	17242210:3:MYB:CCNB1	Herein, we report experiments which demonstrate that c-[TF] upregulates [TG] expression in normal and malignant human hematopoietic cells.	Myb	cyclin B1	1	ACTIVATION	False
9108	9247	17242210:6:MYB:CCNB1	Chromatin immunoprecipitation assays, mutation analysis, and luciferase reporter assays revealed that c-[TF] bound the [TG] promoter preferentially at a site just downstream of the transcriptional start site.	Myb	cyclin B1	0	UNDEFINED	False
9109	9248	17242210:7:MYB:CCNB1	The biological significance of c-[TF], versus B-Myb, binding the [TG] promoter was demonstrated by the fact that expression of inducible dominant negative c-Myb in K562 cells accelerated their exit from M phase.	Myb	cyclin B1	0	UNDEFINED	False
9110	9249	17253961:0:JUND:CDK4	Induced [TF] in intestinal epithelial cells represses [TG] transcription through its proximal promoter region following polyamine depletion.	JunD	CDK4	2	REPRESSION	False
9111	9250	17253961:4:JUND:CDK4	In the present study, we show that induced [TF] in IECs (intestinal epithelial cells) is a transcriptional repressor of the [TG] gene following polyamine depletion.	JunD	CDK4	2	REPRESSION	False
9112	9251	17253961:5:JUND:CDK4	Increased [TF] in polyamine-deficient cells was associated with a significant inhibition of [TG] transcription, as indicated by repression of CDK4-promoter activity and decreased levels of CDK4 mRNA and protein, all of which were prevented by using specific antisense JunD oligomers.	JunD	CDK4	2	REPRESSION	False
9113	9252	17253961:8:JUND:CDK4	These results indicate that induced [TF] in IECs represses [TG] transcription through its proximal promoter region following polyamine depletion.	JunD	CDK4	2	REPRESSION	False
9114	9253	17254333:5:CEBPA:FOS	[TF] and NeuroD co-operatively activated the [TG] promoter in transfection assays.	C/EBPalpha	Fos	1	ACTIVATION	False
9115	9254	17257585:2:BACH1:HMOX1	We examined whether the induction by SnMP is mediated by a de-repression of [TF], a transcription factor that suppresses the [TG] gene.	Bach1	HO-1	2	REPRESSION	False
9116	9255	17257585:5:BACH1:HMOX1	Transfection of [TF] shRNA in Hepa cells raised basal [TG] expression significantly, and SnMP treatment further increased HO-1 mRNA.	Bach1	HO-1	2	REPRESSION	False
9117	9256	17257585:6:BACH1:HMOX1	In conclusion, SnMP induces [TG] expression not only by de-repressing the HO-1 promoter by binding [TF], but also by accelerating Bach1 degradation.	Bach1	HO-1	2	REPRESSION	False
9118	9257	17259176:5:DLX2:NRP2	Herein, we show that [TG] is a specific DLX1 and [TF] transcriptional target by applying chromatin immunoprecipitation to embryonic forebrain tissues.	DLX2	Neuropilin-2	0	UNDEFINED	False
9119	9258	17259176:7:DLX1:NRP2	Furthermore, the homeodomain of [TF] and DLX2 is necessary for DNA binding and this binding is essential for Dlx repression of [TG] expression.	DLX1	Nrp-2	2	REPRESSION	False
9120	9259	17259176:7:DLX2:NRP2	Furthermore, the homeodomain of DLX1 and [TF] is necessary for DNA binding and this binding is essential for Dlx repression of [TG] expression.	DLX2	Nrp-2	2	REPRESSION	False
9121	9260	17263687:4:NKX6-1:GCG	To understand the mechanism by which [TF] suppresses [TG] gene expression, we studied its effect on the glucagon gene promoter activity in non-islet cells using transient transfections and gel-shift analyses.	Nkx6.1	glucagon	2	REPRESSION	False
9122	9261	17264218:0:PRDM1:TP53	[TF] regulates cell growth through repression of [TG] transcription.	BLIMP1	p53	2	REPRESSION	False
9123	9262	17264218:2:PRDM1:TP53	Here we report that [TF] acts in an autoregulatory feedback loop that controls [TG] activity through repression of p53 transcription.	BLIMP1	p53	2	REPRESSION	True
9124	9263	17264218:7:PRDM1:TP53	We further demonstrate that [TF] binds to the [TG] promoter and represses p53 transcription, and this provides a mechanistic explanation for the induction of p53 response in cells depleted of BLIMP1.	BLIMP1	p53	2	REPRESSION	False
9126	9266	17287278:5:ETS1:ANG	Mechanistically, KSHV activated the [TG] promoter via AP-1 and [TF] transcriptional factors, which were mediated by ERK, JNK, and p38 mitogen-activated protein kinase (MAPK) pathways.	Ets1	Ang-2	1	ACTIVATION	False
9127	9267	17287852:6:YY1:MYC	In contrast, [TF] recruited CBP and increased histone acetylation at the [TG] promoter.	YY1	c-myc	0	UNDEFINED	False
9129	9269	17289052:9:NFKB:TRPC1	We found [TF] binding sites in the 5'-regulatory region of the human [TG] gene.	NF-kappaB	TRPC1	0	UNDEFINED	False
9130	9270	17289878:7:NFYA:CCNB2	A dominant-negative form of [TF] effectively inhibited the [TG] promoter activity, and NF-Y was found to bind three conserved CCAAT boxes in the cyclin B2 promoter in colorectal adenocarcinoma cells.	NF-YA	cyclin B2	1	ACTIVATION	False
9131	9271	17296613:0:NFKB:CREB3	Regulation of human [TG] expression by [TF] and its involvement in monocyte cell migration induced by Lkn-1.	NF-kappaB	LZIP	0	UNDEFINED	False
9132	9272	17296613:10:NFKB:CREB3	We also demonstrated that [TF] binds to the [TG] promoter and that the binding is specific, as revealed by an electrophoretic mobility shift assay and a mutation analysis.	NF-kappaB	LZIP	0	UNDEFINED	False
9133	9273	17296613:12:NFKB:CREB3	Our findings suggest that transcription factor [TF] plays an important role in regulation of [TG] expression, and LZIP expression regulates the monocyte cell migration induced by Lkn-1.	NF-kappaB	LZIP	0	UNDEFINED	False
9134	9274	17296613:9:NFKB:CREB3	Results from an inhibitor assay showed that [TF] is involved in Lkn-1-induced [TG] expression, but Sp-1 is not.	NF-kappaB	LZIP	1	ACTIVATION	False
9135	9275	17297470:9:SP3:PLAUR	Pdcd4-transfected cells showed an increase in [TF] binding to [TG] promoter region -152/-135, the deletion of which reduces the ability of Pdcd4 to suppress u-PAR promoter activity.	Sp3	u-PAR	2	REPRESSION	False
9136	9276	17300785:3:TCF3:INSM1	The ngn3/[TF] heterodimer selectively binds and activates the E-box3 of the [TG] promoter.	E47	INSM1	1	ACTIVATION	False
9137	9277	17313370:4:NFE2L2:HMOX1	Furthermore, the deletion of Neh5 markedly repressed CBP [CREB (cAMP-response-element-binding protein)-binding protein] and BRG1 (Brahma-related gene 1) from associating with [TF], diminishing their co-operative enhancement of [TG] promoter activity.	Nrf2	HO-1	1	ACTIVATION	False
9138	9279	17316622:3:POU2F1:CDKN2B	[TF] specifically interacts with this binding site in vitro and in vivo and SMRT and HDAC1 are present in the [TG] proximal promoter region.	Oct-1	p15(INK4b)	0	UNDEFINED	False
9139	9280	17316622:5:POU2F1:CDKN2B	Treatment with a histone deacetylase (HDAC) inhibitor has activated the expression of [TG] in wild-type MEFs but has no effect in MEFs lacking [TF], suggesting that Oct-1 represses p15(INK4b) gene expression in an HDAC-dependent manner.	Oct-1	p15(INK4b)	2	REPRESSION	False
9140	9281	17316622:7:POU2F1:CDKN2B	Taken together, these results suggest that [TF] is an important transcriptional repressor for [TG] gene and the transcriptional repression of the p15(INK4b) gene by Oct-1 may be one of the regulatory mechanisms of cellular senescence.	Oct-1	p15(INK4b)	2	REPRESSION	False
9141	9282	17317207:0:FOXO1:SLC2A4	Transcriptional regulation of the [TG] gene: from PPAR-gamma and [TF] to FFA and inflammation.	FOXO1	GLUT4	1	ACTIVATION	False
9142	9283	17317207:4:FOXO1:SLC2A4	Based on our studies of the interplay between PPAR-gamma, [TF] and free fatty acids, and inflammation in regulating [TG] transcription in sickness and in health, we suggest a novel paradigm to increase insulin sensitivity in bona fide insulin target cells.	FOXO1	GLUT4	0	UNDEFINED	False
9143	9284	17317669:11:AP1:TFF1	Binding of the phosphorylated [TF] complex to the pS2/[TG] promoter allows recruitment of the chromatin remodeling factor Brg1 followed by binding of ERalpha via its interaction with c-Jun.	AP1	TFF1	0	UNDEFINED	False
9144	9286	17317773:10:NFKB1:DRD2	Thus, [TG] transcription mediated by [TF]/c-Rel is supported mainly by the D2-kappaB2 site, whereas both sites are necessary to support the full transcriptional activity mediated by p50/p65 complexes.	p50	D2R	1	ACTIVATION	False
9145	9287	17317773:10:REL:DRD2	Thus, [TG] transcription mediated by p50/[TF] is supported mainly by the D2-kappaB2 site, whereas both sites are necessary to support the full transcriptional activity mediated by p50/p65 complexes.	c-Rel	D2R	1	ACTIVATION	False
9146	9288	17317773:10:RELA:DRD2	Thus, [TG] transcription mediated by p50/c-Rel is supported mainly by the D2-kappaB2 site, whereas both sites are necessary to support the full transcriptional activity mediated by p50/[TF] complexes.	p65	D2R	1	ACTIVATION	False
9147	9289	17317773:11:NFKB:DRD2	A correlation was found between [TF] activity and [TG] expression in the pituitary and pituitary-derived cells but not in the striatum, suggesting that NF-kappaB regulation of D2R expression could be a pituitary-specific mechanism.	NF-kappaB	D2R	0	UNDEFINED	False
9148	9290	17327484:0:CREB1:CD14	1alpha,25-dihydroxycholecalciferol activates binding of [TF] to a CRE site in the [TG] promoter and drives promoter activity in a phosphatidylinositol-3 kinase-dependent manner.	CREB	CD14	1	ACTIVATION	False
9149	9291	17330131:0:STAT5A:IVL	[TF]/PPARgamma pathway regulates [TG] expression in keratinocyte differentiation.	STAT5a	involucrin	0	UNDEFINED	False
9150	9292	17330131:5:STAT5A:IVL	We found that dn-[TF] inhibited [TG] expression in keratinocytes.	STAT5a	involucrin	1	ACTIVATION	False
9151	9293	17332355:9:JUN:CFLAR	We show that c-Fos heterodimerizes with [TF] to repress transcription of [TG].	c-Jun	c-FLIP(L)	2	REPRESSION	False
9152	9294	17335903:5:CEBPB:CRP	We previously demonstrated that in vivo c-Rel plays a novel regulatory role in that it appears to be in complex with [TF] when C/EBPbeta is bound to the [TG] gene promoter following cytokine stimulation, but is not itself bound to DNA.	C/EBPbeta	CRP	0	UNDEFINED	False
9153	9295	17336302:4:TP53:CKS2	[TF] downregulates transcription from the [TG] promoter in a dose-dependent manner and in all cell types tested.	p53	Cks2	2	REPRESSION	False
9154	9296	17336302:5:TP53:CKS2	This repression appears to be independent of [TF] binding to the [TG] promoter.	p53	Cks2	0	UNDEFINED	False
9155	9297	17336302:6:TP53:CKS2	In contrast to [TF], neither p63 nor p73 proteins can repress [TG] transcription.	p53	Cks2	2	REPRESSION	False
9156	9298	17341613:6:MEF2A:ASPH	The most interesting result emerging from studies focused on the P2 promoter is that the calcium-dependent transcriptional factor [TF] activates the transcription of [TG], junctate, and AbetaH in excitable tissues and, to a lesser extent, in kidney.	MEF-2	junctin	1	ACTIVATION	False
9157	9299	17341624:3:JUN:VEGFA	Using [TF](-/-) and junB(-/-) mouse embryonic fibroblasts, we demonstrate that both c-Jun and JunB are required for the hypoglycemia-mediated induction of [TG] expression.	c-jun	VEGF	1	ACTIVATION	False
9158	9300	17341624:3:JUNB:VEGFA	Using c-jun(-/-) and [TF](-/-) mouse embryonic fibroblasts, we demonstrate that both c-Jun and JunB are required for the hypoglycemia-mediated induction of [TG] expression.	junB	VEGF	1	ACTIVATION	False
9159	9301	17346710:0:STAT1:BAX	[TF] regulates p73-mediated [TG] gene expression.	STAT1	Bax	0	UNDEFINED	False
9160	9302	17346710:3:STAT1:BAX	This study presents the first report physically linking [TF] and TA-p73 signalling and highlights the modulation of the [TG] promoter in the context of IFN-gamma stimulation.	STAT1	Bax	0	UNDEFINED	False
9161	9303	17360752:6:ZBTB16:MYC	Coexpression of Np9 and Rec with [TF] abrogates the transcriptional repression of the c-myc gene promoter by PLZF and results in [TG] overproduction, altered expression of c-Myc-regulated genes, and corresponding effects on cell proliferation and survival.	PLZF	c-Myc	0	UNDEFINED	True
9162	9304	17360796:1:LEF1:CCND1	We found that [TF] (LEF-1) is a decisive transcription factor in granulopoiesis controlling proliferation, proper lineage commitment, and granulocytic differentiation via regulation of its target genes C/EBP-alpha, [TG], c-myc, and survivin.	lymphoid enhancer-binding factor 1	cyclin D1	0	UNDEFINED	False
9163	9305	17360981:0:STAT5A:PDK4	The [TF]-mediated induction of [TG] expression by prolactin or growth hormone in adipocytes.	STAT5A	pyruvate dehydrogenase kinase 4	1	ACTIVATION	False
9164	9306	17360981:7:STAT5A:PDK4	In addition, we identified a hormone-responsive region in the murine [TG] promoter and characterized a [TF] in this region that mediates the PRL (sheep) and GH (porcine) induction in PDK4 expression in 3T3-L1 adipocytes.	STAT5 binding site	PDK4	1	ACTIVATION	False
9165	9307	17360982:7:FOS:SPP1	Moreover, c-Fos and phospho-c-Jun protein expression was inhibited by PPARalpha agonists, indicating that PPARalpha ligands suppress [TG] expression through negative cross talk with [TF]-dependent transactivation of the OPN promoter.	AP-1	OPN	1	ACTIVATION	False
9166	9308	17363596:7:RELA:BTG2	Consistent with these observations, chromatin immunoprecipitation assays showed recruitment of both phospho-Smad1 and [TF] to the Gro-beta promoter in vivo, whereas p65, but not phospho-Smad1, was recruited to the [TG] promoter.	p65	BTG2	0	UNDEFINED	False
9167	9309	17370299:2:ETS1:CDKN2A	Little is known about the mechanisms of [TG] regulation in normal and malignant cells apart from that many transcription factors such as [TF], Ets2, SP1, SP3, JunB and the polycomb protein Bmi1 have the potential to induce or repress p16 expression.	Ets1	p16	0	UNDEFINED	False
9168	9310	17370299:2:ETS2:CDKN2A	Little is known about the mechanisms of [TG] regulation in normal and malignant cells apart from that many transcription factors such as Ets1, [TF], SP1, SP3, JunB and the polycomb protein Bmi1 have the potential to induce or repress p16 expression.	Ets2	p16	0	UNDEFINED	False
9169	9311	17372985:5:EGR1:CDC20	Our findings indicate that expression of the [TG] gene is down-regulated by [TF] in neuronal cells, and provide new evidence that altered expression of proteasome-regulatory genes following zif268 induction may be a key component of long-lasting CNS plasticity.	zif268	cdc20	2	REPRESSION	False
9170	9312	17373631:0:SP1:BRCA1	Insulin-like growth factor-I controls [TG] gene expression through activation of transcription factor [TF].	Sp1	BRCA1	0	UNDEFINED	False
9171	9313	17384033:0:NFKB:PTGS2	Role of [TF] in TNF-alpha-induced [TG] expression in synovial fibroblasts from human TMJ.	NF-kappaB	COX-2	1	ACTIVATION	False
9172	9314	17384033:6:NFKB:PTGS2	Pre-treatment with pyrolidine dithiocarbamate (PDTC), one of the [TF] inhibitors, prevented binding to the [TG] promoter and expression of COX-2 protein in response to TNF-alpha.	NF-kappaB	COX-2	1	ACTIVATION	False
9173	9315	1738590:0:JUND:JUNB	EGF-induced [TG]-expression in transfected P19 embryonal carcinoma cells expressing EGF-receptors is dependent on [TF].	Jun D	jun B	1	ACTIVATION	False
9174	9316	17390339:3:ETV4:CAV1	We tested ERM and polyomavirus enhancer activator 3 ([TF]) for their ability to increase endogenous [TG] transcripts and to activate caveolin-1 promoter fragments containing the -865 Ets cis-element.	PEA3	caveolin-1	1	ACTIVATION	False
9175	9317	1740417:10:SP1:DHFR	We conclude that most single base mutations in the GC box severely cripple or eliminate promoter function by inhibiting binding of transcription factors to this regulatory sequence and that [TF] is likely to be involved in [TG] transcription in vivo.	Sp1	dhfr	0	UNDEFINED	True
9177	9319	17408602:8:NFE2L2:HMOX1	NO also increased [TF] mRNA expression, total and nuclear Nrf2 levels, and the binding of Nrf2 to the [TG] promoter.	Nrf2	HO-1	0	UNDEFINED	False
9178	9320	17409099:0:ATF1:THBS1	[TF]-mediated hepatocyte growth factor-induced down-regulation of [TG] expression leads to thyroid cancer cell invasion.	Activating transcription factor-1	thrombospondin-1	2	REPRESSION	False
9179	9321	17409099:10:ATF1:THBS1	Taken together, our results indicate that HGF-induced down-regulation of [TG] expression is mediated by the interaction of [TF] with the CRE binding site in the TSP-1 promoter and that this transcription factor plays a crucial role for tumor invasiveness in papillary carcinoma of the thyroid triggered by HGF.	ATF-1	TSP-1	2	REPRESSION	False
9180	9322	17409099:9:ATF1:THBS1	[TF] knockdown prevented HGF-induced down-regulation of [TG] promoter activity and protein expression and also reduced HGF-dependent tumor cell invasion.	ATF-1	TSP-1	2	REPRESSION	False
9181	9323	17409403:7:IRF1:CCND1	Activation of [TF] decreased [TG] expression and cyclin-dependent kinase 4 kinase activity concomitant with change in the levels of hyperphosphorylated retinoblastoma protein.	IRF-1	cyclin D1	2	REPRESSION	False
9182	9324	17413033:3:PPARA:HMOX1	We show that treatment of human vascular endothelial and smooth muscle cells with [TF] ligands leads to expression of [TG].	PPAR	HO-1	1	ACTIVATION	False
9183	9325	17413033:4:PPARA:HMOX1	Analysis of the human [TG] promoter in transient transfection experiments together with mutational analysis and gel shift assays revealed a direct transcriptional regulation of HO-1 by [TF] and PPARgamma via 2 PPAR responsive elements.	PPARalpha	HO-1	0	UNDEFINED	False
9184	9326	17413033:7:PPARA:HMOX1	We demonstrate that [TG] expression is transcriptionally regulated by [TF] and PPARgamma, indicating a mechanism of anti-inflammatory and antiproliferative action of PPAR ligands via upregulation of HO-1.	PPARalpha	HO-1	1	ACTIVATION	False
9185	9327	17413038:6:ARNT:VEGFA	Furthermore, the DNA binding activity of the HIF-1alpha-[TF] complex as well as the association of HIF-1alpha and ARNT with the [TG] gene promoter were increased by ischemia to a greater extent in AHR-null mice than in wild-type animals.	ARNT	VEGF	0	UNDEFINED	False
9186	9328	17413042:8:FOS:SPP1	Moreover, gel-supershift and sequential chromatin immunoprecipitation assays suggested that CREB was associated with c-Fos on the [TF] sites of the [TG] promoter.	AP-1	OPN	0	UNDEFINED	False
9187	9329	17419679:0:JUND:TCIRG1	Differential binding of poly(ADP-Ribose) polymerase-1 and [TF]/Fra2 accounts for RANKL-induced [TG] gene expression during osteoclastogenesis.	JunD	Tcirg1	1	ACTIVATION	True
9188	9332	17433257:7:CEBPB:CES4A	[TG] and nuclear extracts formed a specific complex, which was supershifted by anti-[TF] antibody, and in vitro translated C/EBPbeta specifically bound to CES6.	C/EBPbeta	CES6	0	UNDEFINED	True
9189	9333	17434929:8:YY1:MYC	Taken together, these results suggest that the N1IC enhances the human [TG] promoter activity that is partially modulated by [TF] through a CBF1-independent pathway.	YY1	c-myc	0	UNDEFINED	False
9190	9334	17438144:6:SMAD7:SERPINE1	An oligonucleotide precipitation assay revealed that [TF] can specifically bind to the Smad-responsive element via its MH2 domain, and DNA-binding activity was further confirmed in vivo with the promoter of [TG], a TGF-beta target gene, by chromatin immunoprecipitation.	Smad7	PAI-1	0	UNDEFINED	False
9191	9335	17439953:7:SREBF1:PTGDS	The results of electrophoretic mobility shift assay and chromatin immunoprecipitation assay revealed that LRH-1 and [TF] bound to their respective binding elements in the promoter of [TG] gene.	SREBP-1c	L-PGDS	0	UNDEFINED	False
9192	9336	17439953:9:SREBF1:PTGDS	These results indicate that [TG] gene expression is activated by LRH-1 in preadipocytes and by [TF] in adipocytes.	SREBP-1c	L-PGDS	1	ACTIVATION	False
9193	9337	17442952:5:JUN:IL7R	[TF]-deficient immature T cells failed to efficiently repress transcription of [TG], resulting in augmented IL-7Ralpha mRNA and surface levels.	C-jun	IL-7Ralpha	2	REPRESSION	True
9194	9338	17442952:6:JUN:IL7R	Chromatin immunoprecipitation assays revealed binding of c-Jun to [TF] binding sites present in the [TG] promoter, indicating direct transcriptional regulation.	AP-1	IL-7Ralpha	0	UNDEFINED	False
9195	9339	17442952:7:JUN:IL7R	Thus, [TF] controls the transcription of [TG] and is a novel regulator of the alphabeta/gammadelta T cell development.	c-Jun	IL-7Ralpha	0	UNDEFINED	False
9196	9340	17446175:6:AP1:RELB	Recently, we characterized a new de novo synthesis pathway for the RelB NF-kappaB subunit, induced by the cytomegalovirus IE1 protein, in which binding of p50/p65 NF-kappaB and c-Jun/[TF] AP-1 complexes to the [TG] promoter works in synergy to potently activate transcription (Wang, X., and Sonenshein, G. E. (2005) J. Virol. 79, 95-105).	Fra-2	relB	1	ACTIVATION	False
9197	9342	17446175:8:AP1:RELB	Cotransfection of [TF] with the Jun AP-1 subunits and p50/c-Rel NF-kappaB led to synergistic activation of the [TG] promoter.	Fra-2	relB	1	ACTIVATION	False
9198	9344	17446190:5:USF1:LGALS3BP	Transfection with [TF] and USF2 cDNAs increases constitutive promoter activity, attenuates the ability of TSH/cAMP plus insulin/IGF-I to decrease constitutive or gamma-IFN-increased [TG] gene expression but does not abrogate the ability of gamma-IFN itself to increase 90K gene expression.	USF1	90K	1	ACTIVATION	False
9199	9345	17452331:6:E2F1:DUSP4	We found that [TF] is physically associated with the [TG] promoter and can transactivate the promoter of the MKP-2 gene.	E2F-1	MKP-2	1	ACTIVATION	False
9200	9346	17452331:7:E2F1:DUSP4	Specifically, [TF] binds to a perfect palindromic motif in the [TG] promoter.	E2F-1	MKP-2	0	UNDEFINED	False
9201	9347	17452331:9:E2F1:DUSP4	Our findings demonstrate that [TF] is a transcriptional activator of [TG] and that MKP-2 is an essential cell death mediator in the E2F-1 pathway.	E2F-1	MKP-2	1	ACTIVATION	False
9202	9348	17452529:5:NFKB:CCNB2	Furthermore, selective inhibition of [TF] at G2-M phases substantially delayed mitotic entry and inhibited transcription of G2-M-specific genes, including cyclin B1, [TG], Plk-1, and cdc25B.	NFkappaB	cyclin B2	1	ACTIVATION	False
9203	9349	17452529:5:NFKB:PLK1	Furthermore, selective inhibition of [TF] at G2-M phases substantially delayed mitotic entry and inhibited transcription of G2-M-specific genes, including cyclin B1, cyclin B2, [TG], and cdc25B.	NFkappaB	Plk-1	1	ACTIVATION	False
9204	9350	17452746:7:SREBF2:HMOX1	We analyzed the [TG] promoter and found one SREBP binding site of the E-box type, which was required for regulation by SREBP-1a and SREBP-1c but was insensitive to [TF].	SREBP-2	HMOX1	0	UNDEFINED	False
9205	9351	17460772:7:STAT3:MMP1	Experimentally induced [TF] activity in CRC cell lines enhanced both the level of [TG] mRNA and secreted MMP-1 enzymatic activity.	STAT3	MMP-1	1	ACTIVATION	False
9206	9352	17460772:8:STAT3:MMP1	A direct connection of [TF] activity and transcription from the [TG] promoter was shown by reporter gene experiments.	STAT3	MMP-1	0	UNDEFINED	True
9207	9353	17464208:4:CREB1:VEGFA	It also increased the promoter activity of a mouse reporter driven by the [TG] promoter, while a dominant negative [TF] (DN-CREB) abrogated the activity, suggesting that CREB mediates VEGF transcription.	CREB	VEGF	1	ACTIVATION	False
9208	9354	17464208:7:CREB1:VEGFA	These results indicate that PKA phosphorylates [TF] and so induces [TG] gene expression.	CREB	VEGF	1	ACTIVATION	False
9209	9355	17464208:8:CREB1:VEGFA	An analysis of mutant promoters revealed that one of the putative [TF] responsive elements (CREs), at 399 approximately 388 in the promoter, is critical for CREB-mediated [TG] promoter activity, and the significance of this CRE was confirmed by chromatin immunoprecipitation assays.	CREB	VEGF	1	ACTIVATION	False
9210	9356	17464329:4:CEBPA:ANXA1	Induction of [TG] mRNA was associated with histone acetylation in ANXA1 promoter and reversal of the HDAC-dependent suppression of [TF] by AML1-ETO with direct recruitment of C/EBPalpha to ANXA1 promoter.	C/EBPalpha	ANXA1	1	ACTIVATION	True
9211	9357	17464329:4:RUNX1:ANXA1	Induction of [TG] mRNA was associated with histone acetylation in ANXA1 promoter and reversal of the HDAC-dependent suppression of C/EBPalpha by [TF]-ETO with direct recruitment of C/EBPalpha to ANXA1 promoter.	AML1	ANXA1	2	REPRESSION	True
9212	9358	17468517:7:CDX2:CCND1	Moreover, transfected [TF] could inhibit beta-catenin/TCF4-mediated transcriptional activation of target genes, including p14(ARF) and [TG], probably through indirect mechanisms.	Cdx2	cyclin D1	2	REPRESSION	False
9213	9359	17471234:5:E2F1:KLF6	We show that ectopic [TF] increases expression of [TG] at both transcriptional and translational levels in breast cancer cells.	E2F-1	PAC1	1	ACTIVATION	False
9214	9360	17471234:6:E2F1:KLF6	[TF] physically interacts with the promoter of [TG], binds to its consensus sequence in the promoter and transactivates the PAC1 promoter.	E2F-1	PAC1	1	ACTIVATION	False
9215	9361	17471492:6:FOXA2:AQP3	These results suggest that [TF] is one of the transcriptional regulators for [TG] gene expression regulated by insulin.	Foxa2	AQP3	0	UNDEFINED	True
9216	9362	17475670:5:HNF1A:AGT	Our chromatin immunoprecipitation (ChIP) assay shows that [TF] binds to this region of the h[TG] gene promoter and its recruitment is increased in the presence of IL-6 in Hep3B cells.	HNF-1alpha	AGT	0	UNDEFINED	False
9217	9363	17477349:7:AP1:CCND1	Thereby, we show that blockade of [TF] transcriptional activity has a negative impact on [TG] transcription.	AP-1	cyclin D1	1	ACTIVATION	False
9218	9364	17481938:12:POU2F1:CYP4A11	These findings implicate c-Jun and [TF] as potentially important constitutive factors that modulate the transactivation of the [TG] gene promoter.	oct-1	CYP4A2	1	ACTIVATION	True
9219	9365	17481938:7:POU2F1:CYP4A11	The -31/-25 element mediated the suppression of [TG] transactivation by octamer binding protein-1 ([TF]).	oct-1	CYP4A2	2	REPRESSION	True
9220	9366	17482685:4:E2F1:FOXO3	We found that expression of endogenous FOXO1 and [TG] is induced by [TF].	E2F-1	FOXO3a	1	ACTIVATION	False
9221	9367	17496887:7:JUN:CCND1	Moreover, [TG] was induced by p73 expression in a [TF]-dependent manner, and was required for p73-mediated cell survival.	c-Jun	cyclinD1	1	ACTIVATION	False
9222	9368	17501623:13:AP1:CCND1	[TF] and CRE double mutants completely abolished the PTHrP effect of [TG] transcription.	AP-1	cyclin D1	0	UNDEFINED	True
9223	9369	17505916:7:ELK1:PTGS2	Among these factors, cyclic AMP response-element binding protein (CREB), Ets family members Ets-1 and [TF] can positively regulate [TG] promoter activity.	Elk-1	COX-2	1	ACTIVATION	False
9224	9370	17505916:7:ETS1:PTGS2	Among these factors, cyclic AMP response-element binding protein (CREB), Ets family members [TF] and Elk-1 can positively regulate [TG] promoter activity.	Ets-1	COX-2	1	ACTIVATION	False
9225	9371	17507182:6:HNF1A:NR1H4	Over-expression of [TF] up-regulated [TG] expression in HepG2 cells.	HNF1alpha	FXR	1	ACTIVATION	False
9226	9372	17510411:6:AP1:DNAJB4	Overexpression of either YY1 at promoter or [TF] at enhancer results in a 3-fold increase in the transcriptional activity of [TG].	AP-1	HLJ1	1	ACTIVATION	False
9227	9373	17510411:8:AP1:DNAJB4	The combined expression of [TF] and YY1 enhances [TG] expression by more than five times and inhibits in vitro cancer cell invasion.	AP-1	HLJ1	1	ACTIVATION	False
9228	9374	17513606:6:RELA:SKP2	Chromatin immunoprecipitation assay suggested that Tubocapsanolide A suppressed [TG] expression by inhibiting the binding of [TF] to the nuclear factor-kappaB site of Skp2 gene promoter.	Rel A	Skp2	1	ACTIVATION	False
9229	9375	17516505:0:SP1:CDKN1A	[TF] and Smad3 are required for high glucose-induced p21([TG]) gene transcription in LLC-PK1 cells.	Sp1	WAF1	1	ACTIVATION	False
9230	9376	17516505:7:SP1:CDKN1A	The DNA element in the 5' regulatory region of p21([TG]) gene essential for high glucose-induced p21(WAF1) gene transcription was identified as [TF] by a series of the 5' regulatory region of p21(WAF1) gene deletion mutants.	Sp1	WAF1	1	ACTIVATION	False
9231	9377	17516505:9:SP1:CDKN1A	High glucose also increased the [TF]-dependent transcriptional activity of p21([TG]) gene.	Sp1	WAF1	1	ACTIVATION	False
9232	9378	17525531:0:ERF:CDK1	Differential repression of c-myc and [TG] gene expression by [TF] and PE-1/METS.	ERF	cdc2	2	REPRESSION	False
9233	9379	17546045:0:NFKB:CDKN2A	Repression of Dmp1 and [TG] transcription by anthracyclins: critical roles of the [TF] subunit p65.	NF-kappaB	Arf	2	REPRESSION	False
9234	9380	17546045:0:RELA:CDKN2A	Repression of Dmp1 and [TG] transcription by anthracyclins: critical roles of the NF-kappaB subunit [TF].	p65	Arf	2	REPRESSION	False
9235	9381	17548471:2:TP53:PLAU	Expression of [TF] protein in p53(-/-) cells suppressed basal and urokinase ([TG])-induced cell surface uPAR protein and increased uPAR mRNA degradation.	p53	uPA	2	REPRESSION	True
9237	9383	17551956:4:TCF21:CTGF	Overexpression of [TF] and E2A resulted in increased smooth muscle and myofibroblast gene expression including calponin, SM22alpha, alphaSMA, fibronectin, and connective tissue growth factor ([TG]) compared with overexpression of E2A alone.	Pod1	CTGF	1	ACTIVATION	False
9238	9384	17551956:4:TCF21:TAGLN	Overexpression of [TF] and E2A resulted in increased smooth muscle and myofibroblast gene expression including calponin, [TG], alphaSMA, fibronectin, and connective tissue growth factor (CTGF) compared with overexpression of E2A alone.	Pod1	SM22alpha	1	ACTIVATION	False
9239	9385	17551956:4:TCF3:CTGF	Overexpression of Pod1 and [TF] resulted in increased smooth muscle and myofibroblast gene expression including calponin, SM22alpha, alphaSMA, fibronectin, and connective tissue growth factor ([TG]) compared with overexpression of E2A alone.	E2A	CTGF	1	ACTIVATION	False
9240	9386	17551956:4:TCF3:TAGLN	Overexpression of Pod1 and [TF] resulted in increased smooth muscle and myofibroblast gene expression including calponin, [TG], alphaSMA, fibronectin, and connective tissue growth factor (CTGF) compared with overexpression of E2A alone.	E2A	SM22alpha	1	ACTIVATION	False
9241	9387	17551956:5:TCF21:CTGF	Suppression of [TF] by siRNA resulted in increased cell proliferation and reduced expression of alphaSMA, fibronectin, and [TG], and myofibroblast secreted proteins including pro-fibrotic cytokines and inhibitors of matrix metalloproteinases.	Pod1	CTGF	1	ACTIVATION	False
9242	9388	17556365:1:VDR:TRPV6	In this report, we explore the interaction of the [TF] (VDR) at regulatory sites within both the Cyp24a1 and the [TG] genes using chromatin immunoprecipitation techniques in a mouse model in vivo.	vitamin D receptor	Trpv6	0	UNDEFINED	False
9243	9389	17556653:7:CEBPB:PTGS2	p300 binding to [TG] promoter was inhibited by IFNgamma in a manner comparable to C-Jun and [TF] binding.	C/EBPbeta	COX-2	0	UNDEFINED	False
9244	9390	17556657:11:TFAP2A:ABCA1	We thus concluded that [TF] negatively regulates the [TG] gene transcription.	AP2alpha	ABCA1	2	REPRESSION	False
9245	9391	17556657:6:TFAP2A:ABCA1	Overexpression of [TF] inhibited [TG] transcription in a dose-dependent fashion.	AP2alpha	ABCA1	2	REPRESSION	False
9246	9392	17556657:9:TFAP2A:ABCA1	Chromatin immunoprecipitation and gel shift assays revealed that doxazosin reduced specific binding of [TF] to the [TG] promoter, as it suppressed phosphorylation of AP2alpha.	AP2alpha	ABCA1	0	UNDEFINED	False
9247	9393	17556661:5:YY1:TK1	Conversely, suppression of endogenous [TF] elevates levels of p21(WAF1/Cip1), PCNA, pRb(Ser249/Thr252) and [TG], and increases intimal thickening.	YY1	TK-1	2	REPRESSION	False
9248	9394	17556661:6:SP1:CDKN1A	YY1 binds [TF] and prevents its occupancy of a distinct element in the p21([TG]/Cip1) promoter without YY1 itself binding the promoter.	Sp1	WAF1	0	UNDEFINED	False
9250	9396	17559081:8:CREB1:PTGS2	Inhibition of [TF] expression using two separate RNAi methods blocked [TG] expression by Ang II and EGF.	CREB	COX-2	1	ACTIVATION	False
9251	9397	17565448:10:STAT1:CASP8	Suppression of [TF] expression attenuated NO-induced elevation of [TG] mRNA.	STAT-1	caspase-8	1	ACTIVATION	False
9252	9398	17565448:11:STAT1:CASP8	These studies demonstrate that a NO-dependent increase in [TG] mRNA levels is associated with phosphorylation of STAT-1 at Ser-727 and [TF] binding to the caspase-8 promoter in cultured PAEC.	STAT1	caspase-8	1	ACTIVATION	False
9253	9399	17565448:7:STAT1:CASP8	AG490 attenuated NO-induced phosphorylation of [TF] at Ser 727 and expression of [TG] mRNA, suggesting JAK2 plays a role in the induction of caspase-8 mRNA.	STAT-1	caspase-8	1	ACTIVATION	False
9254	9400	17572495:0:FOSL1:MMP9	[TF] and Stat3 synergistically regulate activation of human [TG] gene.	Fra-1	MMP-9	1	ACTIVATION	False
9255	9401	17572495:3:FOSL1:MMP9	To clarify the capability of [TF] in activating transcription of [TG] gene, we analyzed the transcriptional activity of the MMP-9 promoter through the measure of luciferase activities in the MCF-7 cells transiently transfected with Fra-1.	Fra-1	MMP-9	1	ACTIVATION	False
9256	9402	17572495:4:FOSL1:MMP9	The positive regulation of [TF] on [TG] promoter was not detectable.	Fra-1	MMP-9	1	ACTIVATION	False
9257	9403	17572495:7:FOSL1:MMP9	DNA affinity precipitation assay confirmed the binding of Stat3 and [TF] to the elements of [TG] promoter and also revealed c-Jun recruited to Stat3-Fra-1 complex.	Fra-1	MMP-9	0	UNDEFINED	False
9258	9404	17575072:4:STAT1:TBX21	Luciferase reporter assay showed that both Stat4 and [TF] activate reporter gene expression from constructs containing a wild-type but not mutated [TG] enhancer.	Stat1	T-bet	1	ACTIVATION	False
9259	9405	17585873:0:VDR:CYP24A1	Constitutive androstane receptor-[TF] crosstalk: consequence on [TG] gene expression.	vitamin D receptor	CYP24	0	UNDEFINED	False
9260	9406	17585873:1:NR1I2:CYP24A1	We previously reported that the pregnane X receptor ([TF]) interferes with vitamin D receptor (VDR) target genes, notably [TG], by targeting the same responsive elements.	PXR	CYP24	0	UNDEFINED	False
9261	9407	17585873:1:VDR:CYP24A1	We previously reported that the pregnane X receptor (PXR) interferes with [TF] (VDR) target genes, notably [TG], by targeting the same responsive elements.	vitamin D receptor	CYP24	0	UNDEFINED	False
9262	9408	17585873:4:NR1I2:CYP24A1	In conclusion, CAR/[TF] and VDR bind to and transactivate the same response elements in [TG] promoter.	PXR	CYP24	1	ACTIVATION	False
9263	9409	17585873:4:NR1I3:CYP24A1	In conclusion, [TF]/PXR and VDR bind to and transactivate the same response elements in [TG] promoter.	CAR	CYP24	1	ACTIVATION	False
9264	9410	17585873:4:VDR:CYP24A1	In conclusion, CAR/PXR and [TF] bind to and transactivate the same response elements in [TG] promoter.	VDR	CYP24	1	ACTIVATION	False
9265	9411	17591797:8:ATF2:PTGS2	The reduction of [TF] expression in AZ-521 cells transformed with ATF-2-small interfering RNA duplexes resulted in suppression of [TG] expression.	ATF-2	COX-2	1	ACTIVATION	False
9266	9412	17599098:4:CREB1:SPRY2	We identified the transcription factors [TF] and SP1 as important regulators of the BDNF activation of the [TG] promoter.	CREB	spry2	1	ACTIVATION	False
9267	9413	17599098:4:SP1:SPRY2	We identified the transcription factors CREB and [TF] as important regulators of the BDNF activation of the [TG] promoter.	SP1	spry2	1	ACTIVATION	False
9268	9414	17600309:10:SP1:MUC5B	These results suggested an Sp1-based transcriptional mechanism with [TF] as the regulator of basal [TG] promoter activity and Sp1-2 as the regulator of PMA-induced MUC5B gene expression in the human airway epithelial cells.	Sp1-1	MUC5B	0	UNDEFINED	False
9269	9415	17609438:10:FOXO3:SOCS3	We conclude that regulation of [TG] expression by GH in a pro-B cell involves not only the pSRE, but also a transcriptionally active complex involving cAMP response element binding protein/c-Fos/c-Jun and [TF].	FOXO3a	SOCS3	0	UNDEFINED	False
9270	9416	17609438:10:JUN:SOCS3	We conclude that regulation of [TG] expression by GH in a pro-B cell involves not only the pSRE, but also a transcriptionally active complex involving cAMP response element binding protein/c-Fos/[TF] and FOXO3a.	c-Jun	SOCS3	0	UNDEFINED	False
9271	9417	17609438:6:JUN:SOCS3	In addition, GH activation of the [TG] promoter required a nearby activator protein (AP) 1/cAMP response element (CRE), which bound cAMP response element binding protein, c-Fos, and [TF].	c-Jun	SOCS3	1	ACTIVATION	False
9272	9418	17609438:8:AP1:SOCS3	Importantly, GH stimulation increased binding of FOXO3a to the [TG] promoter at a site overlapping the [TF]/CRE response element, and overexpression of FOXO3a in these cells augmented SOCS3 promoter activation.	AP1	SOCS3	0	UNDEFINED	True
9273	9419	17609438:8:FOXO3:SOCS3	Importantly, GH stimulation increased binding of [TF] to the [TG] promoter at a site overlapping the AP1/CRE response element, and overexpression of FOXO3a in these cells augmented SOCS3 promoter activation.	FOXO3a	SOCS3	1	ACTIVATION	False
9274	9420	17609438:9:AP1:SOCS3	In addition, we show a direct interaction between FOXO3a and STAT5 in these cells, which may provide a link between STAT5 and the [TF] transcription factors on the [TG] promoter.	AP1	SOCS3	0	UNDEFINED	False
9277	9423	17612627:7:ETV4:MMP13	Furthermore, transcription regulatory sites in the [TG] promoter, specifically AP-1 and [TF], were shown to act in conjunction to mediate ERbeta effects.	PEA-3	MMP-13	0	UNDEFINED	False
9279	9425	17616668:10:SP1:PTGS2	Thus, EGFR activation in malignant gliomas can transcriptionally activate [TG] expression in a process that requires p38-MAPK and [TF]/Sp3.	Sp1	COX-2	1	ACTIVATION	False
9280	9426	17616668:10:SP3:PTGS2	Thus, EGFR activation in malignant gliomas can transcriptionally activate [TG] expression in a process that requires p38-MAPK and Sp1/[TF].	Sp3	COX-2	1	ACTIVATION	False
9281	9427	17616668:6:SP1:PTGS2	The p38-MAPK pathway can activate the [TF]/Sp3 transcription factors and this seems necessary for EGFR-dependent transactivation of the [TG] promoter.	Sp1	COX-2	1	ACTIVATION	False
9282	9428	17616668:6:SP3:PTGS2	The p38-MAPK pathway can activate the Sp1/[TF] transcription factors and this seems necessary for EGFR-dependent transactivation of the [TG] promoter.	Sp3	COX-2	1	ACTIVATION	False
9283	9429	17616668:7:SP1:PTGS2	Analysis of [TG] promoter/luciferase constructs revealed that transcriptional activation of the COX-2 promoter by EGFR requires the [TF] binding site located at -245/-240.	Sp1	COX-2	1	ACTIVATION	False
9284	9430	17626016:0:SP1:AKAP12	v-Src-mediated down-regulation of [TG] metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-[TF]-Sp3 complex.	Sp1	SSeCKS	2	REPRESSION	True
9285	9431	17626016:0:SP3:AKAP12	v-Src-mediated down-regulation of [TG] metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-[TF] complex.	Sp3	SSeCKS	2	REPRESSION	False
9286	9432	17626016:0:USF1:AKAP12	v-Src-mediated down-regulation of [TG] metastasis suppressor gene promoter by the recruitment of HDAC1 into a [TF]-Sp1-Sp3 complex.	USF1	SSeCKS	2	REPRESSION	False
9287	9433	17626252:7:AP1:MMP13	Overexpression of nucleolin in human HeLa cervical carcinoma cells significantly represses [TF] dependent gene transactivation of a minimal AP-1 reporter construct and of an [TG] promoter reporter sequence.	AP-1	MMP-13	1	ACTIVATION	False
9288	9434	17627037:12:NFKB:PTGS2	Thus, our results indicate that gp120 induced [TG] transcription through [TF] activation in astrocytoma cells.	NF-kappaB	COX-2	1	ACTIVATION	False
9289	9435	17631285:0:EGR1:ID2	Interleukin-1 beta-induced [TG] gene expression is mediated by [TF] in vascular smooth muscle cells.	Egr-1	Id2	1	ACTIVATION	False
9290	9436	17631285:6:EGR1:ID2	Overexpression of [TF] transactivated the [TG] promoter in reporter assays dependent on the presence of intact putative Egr-1 binding sites as determined by mutagenesis.	Egr-1	Id2	1	ACTIVATION	False
9292	9438	17632414:5:FOXP3:LIF	We compared the effect of wt-[TF] versus mutant DeltaE251-Foxp3, which lacks transcriptional activity, on transcript levels of axotrophin, [TG], and suppressor of cytokine signaling-3 (SOCS-3; a feedback inhibitor of LIF) in the Jurkat human T-cell line.	Foxp3	LIF	0	UNDEFINED	False
9293	9439	17632414:6:FOXP3:LIF	Unexpectedly, a 50-fold increase in SOCS-3 transcripts occurred in the DeltaE251-[TF] cells, coincident with a dramatic decrease in [TG] transcription.	Foxp3	LIF	1	ACTIVATION	True
9294	9440	17634427:3:JUN:ETV1	Interestingly, [TF] can transactivate the cloned [TG] promoter also in the absence of ligand-activated AR, suggesting two mechanisms by which c-Jun can induce ETV1 expression.	c-Jun	ETV1	1	ACTIVATION	False
9296	9442	17635106:0:CREB1:G6PC	Human nuclear pregnane X receptor cross-talk with [TF] to repress cAMP activation of the [TG] gene.	CREB	glucose-6-phosphatase	2	REPRESSION	True
9297	9443	17637565:0:NFATC2:CCNA2	The [TF] transcription factor is a repressor of [TG] gene expression.	NFAT1	cyclin A2	2	REPRESSION	False
9298	9444	17637565:5:NFATC2:CCNA2	Ectopic expression of [TF] in CHO cells decreases [TG] levels.	NFAT1	cyclin A2	2	REPRESSION	False
9299	9445	17637565:6:NFATC2:CCNA2	Indeed, [TF] binds to a consensus binding site found at the mouse [TG] promoter in vitro and in vivo.	NFAT1	cyclin A2	0	UNDEFINED	False
9300	9446	17637565:7:NFATC2:CCNA2	Luciferase reporter assays show that [TF] downregulates [TG] expression by directly binding to the cyclin A2 promoter.	NFAT1	cyclin A2	2	REPRESSION	False
9301	9447	17637565:8:NFATC2:CCNA2	Together, these results indicate that the [TF] transcription factor represses [TG] expression in lymphocytes, and may act as a silencer of gene transcription during the cell cycle.	NFAT1	cyclin A2	2	REPRESSION	False
9302	9448	17637746:5:TP63:GDF15	Luciferase reporter assay and reverse transcription-PCR analysis demonstrated that enforced expression of TA[TF]alpha significantly increases the luciferase activity driven by [TG] promoter and the expression of GDF15.	p63	GDF15	1	ACTIVATION	False
9303	9449	17637826:0:PPARD:HBEGF	[TF] enhances keratinocyte proliferation in psoriasis and induces [TG].	PPARdelta	heparin-binding EGF-like growth factor	1	ACTIVATION	False
9304	9450	17637826:8:PPARD:HBEGF	Finally, [TG] (HB-EGF), known to induce epidermal hyperplasia and itself overexpressed in psoriasis, was identified as a direct target gene of [TF].	PPARdelta	heparin-binding EGF-like growth factor	0	UNDEFINED	False
9305	9451	17641042:0:NFKB:TNFRSF4	[TG] gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and [TF].	NF-kappa B binding sites	OX40	0	UNDEFINED	False
9306	9452	17641042:0:YY1:TNFRSF4	[TG] gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, [TF], and NF-kappa B binding sites.	YY1	OX40	0	UNDEFINED	False
9307	9453	17641042:5:NFKB:TNFRSF4	[TF] (p50 and p65) also binds to the [TG] promoter region, but the level of direct enhancement of the OX40 promoter activity by this transcription factor is not sufficient to account for the observed up-regulation of OX40 mRNA expression associated with activation.	NF-kappaB	OX40	1	ACTIVATION	False
9308	9454	17641042:6:NFKB:TNFRSF4	We have detected by chromatin immunoprecipitation that histone H4 molecules in the [TG] promoter region are highly acetylated by activation and [TF] binds to the OX40 promoter in vivo.	NF-kappaB	OX40	0	UNDEFINED	False
9309	9455	17641042:7:NFKB:TNFRSF4	These findings suggest that [TG] gene expression is regulated by chromatin remodeling, and that [TF] might be involved in initiation of chromatin remodeling in the OX40 promoter region in activated T cells.	NF-kappaB	OX40	0	UNDEFINED	False
9310	9456	17646159:7:RELB:TNF	[TF], which acts as a repressor of [TG] transcription, remained bound to the promoter during silencing.	RelB	TNFalpha	2	REPRESSION	False
9311	9457	17653093:7:HIF1A:LEP	By using reverse chromatin precipitation, we determined that loading of [TF] on the proximal [TG] promoter concurred with the recruitment of p300, the major HIF coactivator, suggesting that the HIF/p300 complex is involved in leptin transcription.	HIF-1alpha	leptin	1	ACTIVATION	False
9312	9458	17656649:4:CEBPB:CXCL12	Moreover, we also demonstrate that activation of transcription factor [TF] by ATRA regulates [TG] expression in U937 cells.	C/EBPbeta	SDF-1	0	UNDEFINED	True
9313	9459	17664270:5:ATF2:TLR1	We also show that the proximal promoter region of the human [TG] gene contains an AP-1 binding site that is subjected to regulation by the kinase and binds two complexes that involve the JNK substrates c-Jun, JunD, and [TF].	ATF-2	tlr1	0	UNDEFINED	False
9314	9460	17664270:5:JUN:TLR1	We also show that the proximal promoter region of the human [TG] gene contains an AP-1 binding site that is subjected to regulation by the kinase and binds two complexes that involve the JNK substrates [TF], JunD, and ATF-2.	c-Jun	tlr1	0	UNDEFINED	False
9315	9461	17664270:5:JUND:TLR1	We also show that the proximal promoter region of the human [TG] gene contains an AP-1 binding site that is subjected to regulation by the kinase and binds two complexes that involve the JNK substrates c-Jun, [TF], and ATF-2.	JunD	tlr1	0	UNDEFINED	False
9316	9462	17666529:5:LEF1:CCND1	Conversely, overexpression of HIPK2 suppresses [TF]/beta-catenin-mediated transcriptional activation of [TG] expression.	LEF1	cyclin D1	1	ACTIVATION	False
9317	9463	17670745:8:JUN:CCND1	Our data suggest that inhibitory TRE/CRE-[TF]-BAD complexes are present at the [TG] promoter in quiescent cells.	c-Jun	cyclin D1	2	REPRESSION	True
9318	9464	17670746:6:SP3:ANG	This modification of [TF] causes decreased binding to a glucose-responsive GC-box in the angiopoietin-2 ([TG]) promoter, resulting in increased Ang-2 expression.	Sp3	Ang-2	2	REPRESSION	False
9319	9465	17671423:6:HIF1A:CDC25A	In accordance with the [TF]-Myc pathway, hypoxia requires HIF-1alpha for [TG] repression, resulting in a selective displacement of an activating Myc from the CDC25A promoter without affecting a canonical Myc binding in the intron.	HIF-1alpha	CDC25A	2	REPRESSION	False
9320	9466	17680631:6:VDR:CDKN1A	Elimination of the [TF] response element from [TG]-luc eliminated response to the hormone combination, showing that the effect on p21 was through the VDR.	VDR	p21	0	UNDEFINED	False
9321	9467	17690688:2:TP53:BTG3	In a search for DNA damage-inducible, CHK1-modulated genes, we have identified [TG] (B-cell translocation gene 3) as a direct [TF] target.	p53	BTG3	0	UNDEFINED	False
9322	9468	17699159:6:E2F4:MYC	Chromatin immunoprecipitations in primary cells suggest that ERF specifically binds on the [TG] promoter in an [TF]-dependent manner and only under conditions that the physiological c-Myc transcription is stopped.	E2F4/5	c-Myc	0	UNDEFINED	True
9323	9469	17699159:6:ERF:MYC	Chromatin immunoprecipitations in primary cells suggest that [TF] specifically binds on the [TG] promoter in an E2F4/5-dependent manner and only under conditions that the physiological c-Myc transcription is stopped.	ERF	c-Myc	0	UNDEFINED	True
9324	9470	17700520:0:ATF2:GADD45A	[TF] controls transcription of Maspin and [TG] genes independently from p53 to suppress mammary tumors.	ATF-2	GADD45 alpha	0	UNDEFINED	False
9325	9471	17700520:5:ATF2:GADD45A	[TF] and p53 independently activate the [TG] transcription.	ATF-2	GADD45alpha	1	ACTIVATION	False
9326	9472	17706602:0:ESRRG:PLK2	[TG] gene expression is regulated by the orphan nuclear receptor [TF] (ERRgamma).	estrogen receptor-related receptor gamma	Polo-like kinase 2	0	UNDEFINED	True
9327	9473	17706602:4:ESRRG:PLK2	Northern blot analysis showed that overexpression of [TF] induced [TG] expression in cancer cell lines.	ERRgamma	Plk2	1	ACTIVATION	False
9328	9474	17706602:5:ESRRG:PLK2	[TF] activated the [TG] gene promoter, and deletion and mutational analysis of the Plk2 promoter revealed that the ERRgamma-response region is located between nucleotides (nt) -2327 and -2229 and -441 and -432 (relative to the transcriptional start site at +1).	ERRgamma	Plk2	1	ACTIVATION	False
9329	9475	17706602:6:ESRRG:PLK2	Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) analysis demonstrated that [TF] binds directly to the [TG] promoter.	ERRgamma	Plk2	0	UNDEFINED	False
9330	9476	17706602:7:ESRRG:PLK2	Overexpression of [TF] in the presence of the mitotic inhibitor nocodazole significantly decreased apoptosis, and induced S-phase cell cycle progression through the induction of [TG] expression.	ERRgamma	Plk2	1	ACTIVATION	False
9331	9477	17709512:8:XBP1:POU2AF1	Gel shift assays suggest that [TF](S) binding occurs through a UPR element conserved in both murine and human [TG]/BOB-1/OCA-B promoters as opposed to endoplasmic reticulum stress response elements.	XBP-1	OBF-1	0	UNDEFINED	False
9332	9478	17720185:12:JUN:MYH6	Over-expression of c-fos and [TF] in cardiomyocytes inhibited [TG] promoter activity in a concentration dependent manner.	c-jun	alpha-MHC	2	REPRESSION	False
9333	9479	17721610:9:CREB1:SERPINE1	Thus, [TF] binding to the HIF-1 responsive elements in [TG] promoter mediates the glucagon effect in the liver.	CREB	PAI-1	0	UNDEFINED	False
9334	9480	17726260:4:ETS1:ITGA10	Further, we demonstrated that expression of [TG] is controlled by AP-2 and [TF], two transcription factors known to be involved in melanoma development and progression.	Ets-1	integrin alpha10	0	UNDEFINED	True
9335	9481	17726260:8:ETS1:ITGA10	In summary, these data indicate that AP-2 and [TF] regulated expression of [TG] plays a role in migration of malignant melanoma cells.	Ets-1	integrin alpha10	0	UNDEFINED	True
9336	9482	17761837:10:YY1:SLC26A3	Our studies provide evidence for the involvement of HNF-4, [TF], and GATA transcription factors in [TG] expression in intestinal differentiated epithelial cells.	YY1	DRA	0	UNDEFINED	True
9337	9483	17761837:7:YY1:SLC26A3	Although hepatic nuclear factor HNF-4 is involved in the basal activity of [TG] promoter, sodium butyrate induces its activity in LS174T cells via the binding of Yin Yang 1 ([TF]) and GATA transcription factors to their respective cis-elements in promoter region.	YY1	DRA	1	ACTIVATION	False
9338	9484	17761947:9:STAT3:CCND1	Chromatin immunoprecipitation studies indicate that expression of LKB1 reduces the binding of [TF] to its target promoters and suppresses STAT3-mediated expression of [TG], VEGF, and Bcl-xL.	STAT3	Cyclin D1	1	ACTIVATION	False
9339	9485	17762884:9:PITX1:GDF15	Depletion of endogenous h[TF] by small interfering RNA (siRNA) in MCF-7 cells resulted in decreased basal expression of p53 and consequently of p21 and placental transforming growth factor beta ([TG]).	Pitx1	PTGF-beta	1	ACTIVATION	False
9340	9486	17764926:4:SP3:ATF3	We found that [TF] contributed to the basal expression of the [TG] gene, whereas EGR-1 played an important role in ECG-induced ATF3 expression in HCT-116 cells, as assessed by EMSA and co-transfection experiments.	Sp3	ATF3	1	ACTIVATION	False
9341	9487	17785433:0:MYC:HK2	Hypoxia-inducible factor 1 and dysregulated [TF] cooperatively induce vascular endothelial growth factor and metabolic switches [TG] and pyruvate dehydrogenase kinase 1.	c-Myc	hexokinase 2	1	ACTIVATION	False
9342	9488	17785633:0:PPARG:REN	[TF] is involved in the control of [TG] gene expression.	Peroxisome proliferator-activated receptor-gamma	renin	0	UNDEFINED	False
9343	9489	17785633:7:PPARG:REN	In summary, [TF] was identified as a novel intracellular mediator involved in the upregulation of [TG] transcription.	PPARgamma	renin	1	ACTIVATION	False
9346	9492	17786924:13:NFKB:SLC16A1	Our results demonstrate the involvement of [TF] pathway in the regulation of [TG] promoter activity by butyrate.	NF-kappaB	MCT1	0	UNDEFINED	False
9347	9493	17822556:10:MYB:MCM4	Our work identifies the chicken [TG] gene as a novel [TF] target gene and presents evidence for the co-localization of two novel origins of DNA replication with Myb-regulated genes.	Myb	Mcm4	0	UNDEFINED	False
9348	9494	17822788:4:AP1:MMP13	YB-1 binds in vitro in DNA affinity chromatography to the activator protein-1 ([TF]) DNA sequence within the [TG] promoter.	AP-1	MMP-13	0	UNDEFINED	False
9349	9495	17826030:6:NFKB:PTGS2	VIP downregulates [TF]-dependent gene activation of the [TG] promoter.	NFkappaB	COX-2	1	ACTIVATION	False
9350	9496	17851584:10:MZF1:PADI1	These data indicate that [TF] and Sp1/Sp3 binding to the promoter region drive the [TG] expression.	MZF1	PADI1	1	ACTIVATION	False
9351	9497	17853270:2:EGR1:NR3C1	Low maternal care resulted in increased methylation of the nerve growth factor-inducible protein A (NGFI-A, [TF]) binding site located in the hippocampal glucocorticoid receptor gene ([TG]) exon 1(7) promoter, leading to decreased Nr3c1 expression, which results in a reduced efficiency of glucocorticoid-mediated negative feedback on hypothalamus-pituitary-adrenal axis activity.	EGR1	Nr3c1	1	ACTIVATION	True
9352	9498	17854385:3:ATF2:PER2	The present study shows that cAMP-responsive element-binding protein (CREB) and [TF] (ATF-2) bind to the promoter region of the [TG] gene in the chick pineal gland.	activating transcription factor-2	Period2	0	UNDEFINED	False
9353	9499	17875680:6:TFAP2C:GPER1	Furthermore, [TF] controlled the expression of [TG].	TFAP2C	GPR30	0	UNDEFINED	False
9354	9500	17875680:7:TFAP2A:CDKN1A	In distinct contrast, [TF], a related factor expressed in breast cancer, was not involved in estrogen-mediated pathways but regulated expression of genes controlling cell cycle arrest and apoptosis including p21([TG]) and IGFBP-3.	TFAP2A	CIP1	0	UNDEFINED	False
9355	9501	17881732:6:MYC:CCND1	[TF] was found to bind the E box present in the [TG] promoter, and the overexpression of c-Myc augmented the inhibition generated by ZO-2 transfection.	c-Myc	cyclin D1	0	UNDEFINED	True
9356	9502	17881732:9:MYC:CCND1	We conclude that ZO-2 down-regulates [TG] transcription by interacting with the [TF]/E box element and by recruiting HDAC1.	c-Myc	cyclin D1	2	REPRESSION	True
9357	9503	17885207:0:MYC:CDKN1A	Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein [TF] for control of the p21/[TG] promoter.	c-Myc	WAF1	0	UNDEFINED	False
9358	9504	17885207:4:HNF4A:CDKN1A	Although HNF4alpha1 also binds two additional regions containing putative [TF], HNF4alpha1 mutants deficient in DNA binding activate the [TG] promoter to the same extent as wild-type HNF4alpha1, indicating that direct DNA binding by HNF4alpha1 is not necessary for p21 activation.	HNF4alpha binding sites	p21	1	ACTIVATION	False
9359	9506	17890327:0:AP1:SERPINE1	Glutathione suppresses TGF-beta-induced [TG] expression by inhibiting p38 and JNK MAPK and the binding of [TF], SP-1, and Smad to the PAI-1 promoter.	AP-1	PAI-1	1	ACTIVATION	True
9360	9507	17890327:4:AP1:SERPINE1	Interestingly, although exogenous GSH does not affect phosphorylation and/or nuclear translocation of Smad2/3 and Smad4, it completely eliminates TGF-beta-induced binding of transcription factors to not only [TF] and SP-1 but also Smad cis elements in the [TG] promoter.	AP-1	PAI-1	0	UNDEFINED	False
9361	9508	17890327:8:AP1:SERPINE1	In composite, these findings suggest that GSH inhibits TGF-beta-stimulated [TG] expression in fibroblasts by blocking the JNK/p38 pathway, probably by reducing ROS, which leads to an inhibition of the binding of transcription factors to the [TF], SP-1, and Smad cis elements in the PAI-1 promoter.	AP-1	PAI-1	0	UNDEFINED	False
9362	9509	17893273:3:YBX1:CCL5	Analysis of the [TG] promoter revealed potential binding sites for [TF], and interaction of YB-1 with a sequence at position -204/-173 was confirmed by DNA binding assays.	YB-1	CCL5	0	UNDEFINED	False
9363	9510	17898080:9:NFKB1:HIF1A	In line, gel shift analysis and chromatin immunoprecipitation confirmed binding of p50 and p65 [TF] subunits to the [TG] promoter under hypoxia.	NFkappaB	HIF-1alpha	0	UNDEFINED	False
9364	9511	17898080:9:RELA:HIF1A	In line, gel shift analysis and chromatin immunoprecipitation confirmed binding of p50 and [TF] NFkappaB subunits to the [TG] promoter under hypoxia.	p65	HIF-1alpha	0	UNDEFINED	False
9365	9512	17909010:0:STAT3:TWIST1	Epidermal growth factor receptor cooperates with [TF] to induce epithelial-mesenchymal transition in cancer cells via up-regulation of [TG] gene expression.	signal transducer and activator of transcription 3	TWIST	1	ACTIVATION	False
9366	9513	17909010:10:STAT3:TWIST1	Deletion/mutation studies further show that a 26-bp promoter region contains putative [TF] elements required for the EGF-responsiveness of the [TG] promoter.	STAT3	TWIST	0	UNDEFINED	False
9367	9514	17909010:9:STAT3:TWIST1	Furthermore, constitutively active [TF] significantly activates the [TG] promoter, whereas the JAK/STAT3 inhibitor and dominant-negative STAT3 suppressed TWIST promoter.	STAT3	TWIST	1	ACTIVATION	False
9368	9515	17909017:0:EGR1:NDRG1	[TF] mediates hypoxia-inducible transcription of the [TG] gene through an overlapping Egr-1/Sp1 binding site in the promoter.	Egr-1	NDRG1	1	ACTIVATION	False
9369	9516	17909017:0:SP1:NDRG1	Egr-1 mediates hypoxia-inducible transcription of the [TG] gene through an overlapping Egr-1/[TF] binding site in the promoter.	Sp1	NDRG1	1	ACTIVATION	False
9370	9517	17909017:9:EGR1:NDRG1	These results showed for the first time that [TF] regulates [TG] transcription through an overlapping Egr-1/Sp1 binding site that acts as a major site of positive regulation of the NDRG1 promoter by hypoxia signaling.	Egr-1	NDRG1	1	ACTIVATION	False
9371	9518	17909017:9:SP1:NDRG1	These results showed for the first time that Egr-1 regulates [TG] transcription through an overlapping Egr-1/[TF] binding site that acts as a major site of positive regulation of the NDRG1 promoter by hypoxia signaling.	Sp1	NDRG1	0	UNDEFINED	True
9372	9519	17910039:6:TSC22D3:PTGS2	Consistent to these results, overexpression of [TF] also inhibits NF-kappaB-mediated [TG] promoter activity.	GILZ	COX-2	2	REPRESSION	False
9373	9520	17910039:7:NFKB:PTGS2	Finally, we show that GILZ inhibits [TG] expression by blocking [TF] nuclear translocation.	NF-kappaB	COX-2	1	ACTIVATION	False
9374	9521	17910039:7:TSC22D3:PTGS2	Finally, we show that [TF] inhibits [TG] expression by blocking NF-kappaB nuclear translocation.	GILZ	COX-2	2	REPRESSION	False
9375	9522	17916431:4:EGR1:NGFR	Here, we identify the early growth response (Egr) transcriptional regulators, [TF] and Egr3, as direct modulators of [TG] gene expression.	Egr1	p75(NTR)	0	UNDEFINED	False
9376	9523	17919072:10:AP1:NOS3	We therefore conclude that NDGA antioxidant activity regulates [TG] expression via [TF] and that antioxidant therapy could potentially be used to increase eNOS expression in diseases, such as persistent pulmonary hypertension of the newborn, where eNOS expression and activity are known to be reduced.	AP-1	eNOS	0	UNDEFINED	False
9378	9525	17922032:0:MTA1:BRCA1	[TF]-mediated transcriptional repression of [TG] tumor suppressor gene.	MTA1	BRCA1	2	REPRESSION	False
9379	9526	17922032:3:MTA1:BRCA1	[TF]-NuRD complex was found to negatively regulate [TG] transcription by physically associating with an atypical estrogen-responsive element (ERE) on the BRCA1 promoter.	MTA1	BRCA1	2	REPRESSION	False
9380	9527	17922032:4:MTA1:BRCA1	Moreover, [TF] and HDAC complex recruited to the ERE of [TG] promoter in an ER alpha-dependent manner.	MTA1	BRCA1	0	UNDEFINED	False
9381	9528	17922032:6:MTA1:BRCA1	[TF]'s strong repressive effects on [TG] expression was supported by our observation that cells stably overexpressing MTA1 showed centrosome amplification which has been long implicated as a phenotype for BRCA1 repression.	MTA1	BRCA1	2	REPRESSION	False
9382	9529	17922191:9:AP1:CASP8	In summary MMC controls [TG] expression via a c-jun/[TF] element in its promoter region.	AP1	caspase-8	0	UNDEFINED	False
9383	9530	17922653:3:EGR1:RAG2	Thus, the concerted action of the transcription factors [TF] and NFAT2 can play a crucial role in regulation of the T cell differentiation in vitro due to the cooperative regulation of Id3 and [TG] gene expression.	Egr1	Rag2	0	UNDEFINED	True
9384	9532	17933457:13:AP1:NOS3	Hence, our data show that c-Jun/[TF] regulates [TG] transcription involving the proximal AP-1 site in the 5'-regulatory region of the sheep NOS3 gene.	AP-1	NOS3	0	UNDEFINED	False
9385	9534	17933457:2:AP1:NOS3	According to the sheep [TG] promoter sequence isolated in our laboratory, we hypothesize that the activator protein-1 ([TF]) site in the proximal sheep NOS3 promoter (TGAGTCA, -682 to -676) is important for NOS3 expression.	AP-1	NOS3	1	ACTIVATION	False
9386	9535	17933457:3:JUN:NOS3	We developed a c-Jun adenoviral expression system to overexpress c-Jun protein into UAEC to investigate the effects of c-Jun/[TF] on [TG] expression.	AP-1	NOS3	0	UNDEFINED	False
9387	9536	17933457:9:JUN:NOS3	Transient transfections showed that c-Jun overexpression augmented the transactivation of the sheep [TG] promoter-driven luciferase/reporter constructs with the [TF] site but not of deletion constructs without the AP-1 site.	AP-1	NOS3	1	ACTIVATION	False
9388	9537	17942419:3:BACH1:HMOX1	Here, we describe the dynamic roles of [TF] and NRF2 in the transcription of the [TG] (HMOX1) gene.	BACH1	heme oxygenase-1	0	UNDEFINED	False
9389	9538	17942419:3:NFE2L2:HMOX1	Here, we describe the dynamic roles of BACH1 and [TF] in the transcription of the [TG] (HMOX1) gene.	NRF2	heme oxygenase-1	0	UNDEFINED	False
9390	9539	17942419:5:BACH1:HMOX1	[TF] repression is dominant over NRF2-mediated [TG] transcription and inactivation of BACH1 is a prerequisite for HMOX1 induction.	BACH1	HMOX1	2	REPRESSION	False
9393	9542	17945188:0:LEF1:PTGS2	[TF] regulates [TG] transcription in chondrocytes.	Lef1	COX-2	0	UNDEFINED	False
9394	9543	17945188:3:LEF1:PTGS2	Our results show that co-overexpression of [TF] and beta-catenin synergistically upregulates [TG] expression.	Lef1	COX-2	1	ACTIVATION	False
9395	9544	17945188:7:LEF1:PTGS2	Moreover, binding of [TF] and beta-catenin to the Lef1-binding site transactivates [TG] promoter activity.	Lef1	COX-2	1	ACTIVATION	False
9396	9545	17945188:8:LEF1:PTGS2	Our results indicate a pivotal role of [TF] in the regulation of [TG] transcription in arthritic chondrocytes.	Lef1	COX-2	0	UNDEFINED	False
9397	9546	17950112:6:NFKB:PTPN11	Advanced glycation end product stimulation increased luciferase activity in cells transfected with [TG] promoter region including [TF] binding sites (P < .05) and increased SHP2 expression (P < .05).	NF-kappaB	SHP2	1	ACTIVATION	True
9398	9547	17950112:8:NFKB:PTPN11	Activated [TF] binds to sites on the [TG] promoter, resulting in increased SHP2 expression, SHP2 activity, and, ultimately, SMC proliferation.	NF-kappaB	SHP2	1	ACTIVATION	False
9399	9548	17952119:5:ATF3:FN1	We present evidence that [TF] binds to the endogenous promoters and regulates the transcription of the TWIST1, [TG], Snail and Slug genes.	ATF3	FN-1	0	UNDEFINED	False
9400	9549	17955499:7:CREB1:USF2	By using the luciferase-promoter deletion assay, site-directed mutagenesis, and transactivation assay, we identified a glucose-responsive element in the [TG] gene promoter (-1,740 to -1,620, relative to the transcription start site) and demonstrated that glucose-induced USF2 expression is mediated through a cAMP-response element-binding protein ([TF])-dependent transactivation of the USF2 promoter.	CREB	USF2	1	ACTIVATION	False
9401	9550	1795697:1:CTCF:MYC	To identify the regions in the [TG] promoter that are necessary for the binding of a nuclear trans-acting factor [TF]--the potential oncogene activator--we used a synthetic analog of the natural binding site that contains three correctly spaced CCCTC-repeats that are known to be involved in CTCF-binding.	CTCF	chicken c-myc	0	UNDEFINED	False
9402	9551	17964630:3:NFKB:PTGS2	We also showed that transcription factor [TF] is required for the activation of [TG] regulated by NS3.	NF-kappaB	COX-2	1	ACTIVATION	False
9404	9553	17967787:6:ELK1:EGR1	Hemin activated [TF], SRF, and NF-kappaB and promoted their interaction with the [TG] promoter.	Elk-1	Egr-1	0	UNDEFINED	False
9405	9554	17967787:6:SRF:EGR1	Hemin activated Elk-1, [TF], and NF-kappaB and promoted their interaction with the [TG] promoter.	SRF	Egr-1	0	UNDEFINED	False
9407	9556	17971297:3:LEF1:MMP13	[TF] and beta-catenin synergistically upregulated [TG] transcription while knock-down of Lef1 using Lef1 siRNA downregulated IL-1beta-mediated MMP13 expression.	Lef1	MMP13	1	ACTIVATION	False
9408	9557	17971297:5:LEF1:MMP13	Furthermore, [TF]/beta-catenin binding to the Lef1 binding site transactivated [TG] promoter activity.	Lef1	MMP13	1	ACTIVATION	False
9409	9558	17973082:3:YY1:PPARD	In this report, we show that [TF] specifically interacts with the [TG] promoter.	YY1	PPARdelta	0	UNDEFINED	False
9410	9559	17973082:4:YY1:PPARD	Overexpression of [TF] in Hela and NIH 3T3 cells repressed the activity of the [TG] promoter, while the PPARdelta promoter activity was enhanced when YY1 was knocked down by siRNA YY1.	YY1	PPARdelta	2	REPRESSION	False
9411	9560	17973082:5:YY1:PPARD	We also show that [TF] in nuclear extracts was able to bind the [TG] promoter directly.	YY1	PPARdelta	0	UNDEFINED	False
9412	9561	17973082:6:YY1:PPARD	These results suggest that [TF] might be a negative regulator of [TG] gene expression through its direct interaction with the PPARdelta promoter.	YY1	PPARdelta	2	REPRESSION	False
9413	9562	17973241:4:AP1:TNFRSF8	The discovery of both an activating [TF] site and an upstream microsatellite that represses transcriptional activity of [TG] suggests that this region is involved in dysregulation of CD30 expression.	AP1	CD30	1	ACTIVATION	False
9414	9563	17974960:9:KLF4:MYC	Database search revealed presence of a consensus sequence for zinc finger protein gut-enriched Kruppel-like factor ([TF]) in OA-responsive region of the [TG] promoter.	GKLF	c-myc	0	UNDEFINED	False
9415	9564	17975004:8:SRF:FHL2	Androgen induction of [TG] depended on active transcription of the FHL2 gene, mediated by action of serum response factor ([TF]) on its proximal promoter.	SRF	FHL2	1	ACTIVATION	False
9416	9565	17981798:8:SMAD2:HES1	The repression of Notch3 was mediated by SMAD activity and p38 mitogen-activated protein (MAP) kinase, whereas analysis of the [TG] promoter revealed direct activation by [TF] but not Smad3.	Smad2	Hes1	1	ACTIVATION	False
9417	9566	17986608:0:EGR1:CDKN1C	PAX3-FOXO1 controls expression of the [TG] cell-cycle regulator through degradation of [TF].	EGR1	p57Kip2	0	UNDEFINED	False
9418	9567	17986608:0:PAX3:CDKN1C	[TF]-FOXO1 controls expression of the [TG] cell-cycle regulator through degradation of EGR1.	PAX3	p57Kip2	0	UNDEFINED	False
9419	9568	17997399:5:STAT3:CCND1	Our conclusion is supported (i) by siRNA-mediated depletion of [TF] in Trps1-deficient chondrocytes, which normalized the expression of [TG] and Bcl2, (ii) by overexpression of Trps1 in ATDC5 chondrocytes, which diminished Stat3 levels and increased proliferation and apoptosis, and (iii) by mutational analysis of the GATA-binding sites in the Stat3 gene, which revealed that their integrity is critical for the direct association with Trps1 and for Trps1-mediated repression of Stat3.	Stat3	cyclin D1	0	UNDEFINED	False
9420	9569	18003659:3:SMAD3:SFTPB	Repression is mediated by [TF] through interactions with NKX2.1 and FOXA1, two key transcription factors that are positive regulators of [TG] transcription.	SMAD3	SpB	2	REPRESSION	False
9421	9570	18005957:9:FOXO3:CDKN1A	We provide evidence that [TF], which has been shown to translocate into the nucleus to act as a transcriptional co-activator of TGFbeta-dependent upregulation of [TG], is strategically expressed to be involved in controlling p21 expression in CR neurons.	Foxo3a	p21	1	ACTIVATION	False
9422	9571	18006113:4:NFE2L2:HMOX1	Transfection studies with siRNA specific for [TF] and NF-kappaB revealed that [TG] expression in A549 cells is mediated by transcriptional activation of Nrf2, but not NF-kappaB.	Nrf2	HO-1	1	ACTIVATION	False
9423	9572	18006811:6:NFATC2:PTGS2	Further studies revealed that Rho-GDI beta regulates [TG] gene at least partly on the transcriptional level, most likely by activating nuclear factor of activated T cells 1 ([TF]).	NFAT-1	Cox-2	0	UNDEFINED	False
9424	9573	18021292:0:SP1:VEGFA	Ectopic decorin expression up-regulates [TG] expression in mouse cerebral endothelial cells via activation of the transcription factors [TF], HIF1alpha, and Stat3.	Sp1	VEGF	1	ACTIVATION	False
9425	9574	18024476:6:CEBPA:VEGFA	Correspondingly, [TF] overexpression significantly inhibited the DNA-binding ability of HIF-1 and expressions of hypoxia-responsive element-driven luciferase and HIF-1-targeted genes [TG], glucose transporter-1 and phosphoglycerate kinase 1.	C/EBPalpha	vascular endothelial growth factor	2	REPRESSION	False
9426	9575	18038118:7:TP53:DNMT1	Furthermore, loss of suppression function of mutant [TF] to [TG] in WTK1 was caused by the attenuation of its binding ability to the DNMT1 promoter.	p53	DNMT1	2	REPRESSION	False
9427	9576	18038766:10:NFE2L2:ABCG2	When HepG2 cells were treated with Keap1-specifc siRNA, a significant increase was observed in mRNA levels of ABCC1, ABCC2, and [TG] as well as gamma-GCSI, suggesting that induction of ABCC2 and ABCG2 by tBHQ is mediated by the [TF]/Keap1 system, whereas the induction of ABCC1 may involve a Keap1-dependent but Nrf2-independent mechanism.	Nrf2	ABCG2	1	ACTIVATION	False
9428	9577	18042711:6:E2F1:PMAIP1	This requirement for c-MYC was found in a variety of tumor cell types, in marked contrast with dispensable roles of p53, HIF-1alpha, and [TF] (classical proteasomal targets that can regulate [TG] mRNA under stress).	E2F-1	NOXA	0	UNDEFINED	False
9429	9578	18056793:7:KLF9:LDLR	Transient transfection of KLF4, [TF], and KLF13 suppressed [TG]/luc, StAR/luc, and CYP11A/luc by 80-90% (P < 0.001).	KLF9	LDLR	2	REPRESSION	False
9430	9579	18057093:7:ATF3:IRS2	[TF] binds to the [TG] promoter in vivo, and the binding of ATF3 correlates with decreased IRS2 gene transcription.	ATF3	IRS2	2	REPRESSION	False
9431	9580	18064384:4:CUX1:DHFR	The generation of [TF]/Cux p110 stimulates the expression of reporter plasmid containing the promoter sequences of some S phase-specific-genes such as DNA polymerase a gene, [TG] gene, carbamoyl-phosphate synthase/aspartate carbamoyl-transferase/dihydroorotase gene, and cyclin A gene.	CDP	dihydrofolate reductase	1	ACTIVATION	False
9432	9581	18068676:3:EGR1:SREBF1	Intact SP1-binding sites are essential for promoter activity, whereas [TF] suppresses the transcription of the human [TG] promoter.	EGR-1	SREBP-1a	2	REPRESSION	False
9433	9582	18070924:7:HIF3A:EDN1	The expression of [TG] and platelet-derived growth factor beta was increased in the lung endothelial cells of NEPAS/[TF]-null mice.	HIF-3alpha	endothelin 1	2	REPRESSION	False
9434	9583	18071305:4:ESRRB:CDKN1A	Stable [TF] expression suppressed significantly cell proliferation and tumorigenicity of LNCaP and DU145 cells, accompanied by an S-phase suppression and increased [TG] expression.	ERRbeta	p21	1	ACTIVATION	False
9435	9584	18071305:5:ESRRB:CDKN1A	Reporter and chromatin immunoprecipitation assays showed that [TF] could directly transactivate [TG] gene promoter, which could be further enhanced by peroxisome proliferator-activated receptor-gamma coactivator-1alpha.	ERRbeta	p21	1	ACTIVATION	False
9436	9585	18073142:2:TLX1:ALDH1A1	Previous studies have shown that [TF] can regulate target genes including [TG] and FHL1.	TLX1	ALDH1A1	0	UNDEFINED	False
9437	9586	18078517:0:JUND:TERT	HTLV-1 HBZ cooperates with [TF] to enhance transcription of the [TG] gene (hTERT).	JunD	human telomerase reverse transcriptase	1	ACTIVATION	False
9438	9587	18081698:7:NFKB:TNIP3	This revealed that the LPS- and TNF-inducible expression of [TG] is dependent on the binding of [TF] to a specific B site in the ABIN-3 promoter.	NF-kappaB	ABIN-3	1	ACTIVATION	False
9439	9588	18082154:0:NFKB:NRG1	Characterization of a [TG] gene promoter: positive regulation of type I isoforms by [TF].	NF-kappaB	neuregulin-1	1	ACTIVATION	False
9440	9589	18082256:3:TLX1:ALDH1A1	Here, we confirm regulation of [TG] transcription by [TF] and show that ALDH1A1 can profoundly perturb murine hematopoiesis by promoting myeloid differentiation at the expense of lymphopoiesis.	TLX1	ALDH1A1	0	UNDEFINED	False
9441	9590	18084253:9:AP1:CCND1	By transfection experiments, the cytoplasmic portion of E-cadherin was found to activate the [TF] transcription factor pathway and induced [TG] promoter activity, but beta-catenin/Tcf transcription activity was unaffected.	AP-1	cyclin D1	1	ACTIVATION	False
9443	9592	18091336:4:NFKB:MUC5B	We hypothesized that in vitro stimulation of a recently developed model system, murine middle ear epithelial cells (MEEC), with cigarette smoke condensate (CSC) activates [TF] and subsequently induces [TG] gene expression.	NF-kappa B	Muc5b	1	ACTIVATION	False
9444	9593	18092359:3:YY1:REST	Here, by combining bioinformatics analysis and experimental studies, we report that the transcription factor Yin Yang 1 ([TF]) bound to a conserved YY1 binding site in the promoter of the mouse [TG] gene and positively regulated activity of this promoter in SH-SY5Y cells.	YY1	REST	1	ACTIVATION	False
9445	9594	18092359:5:YY1:REST	Overall, this study suggests that [TF] directly regulates expression of the [TG] gene.	YY1	REST	0	UNDEFINED	False
9446	9595	18160048:12:LYL1:ID1	In the [TG] promoter, [TF] complexes direct transcriptional activation.	Lyl1	Id1	1	ACTIVATION	False
9447	9596	18160048:13:CREB1:BRCA1	We also found that in addition to Id1, over-expressed Lyl1 can activate other [TF] target promoters such as Id3, cyclin D3, [TG], Btg2 and Egr1.	CREB1	Brca1	0	UNDEFINED	False
9448	9597	18160048:13:ID1:BRCA1	We also found that in addition to [TF], over-expressed Lyl1 can activate other CREB1 target promoters such as Id3, cyclin D3, [TG], Btg2 and Egr1.	Id1	Brca1	1	ACTIVATION	False
9449	9598	18160048:13:LYL1:BRCA1	We also found that in addition to Id1, over-expressed [TF] can activate other CREB1 target promoters such as Id3, cyclin D3, [TG], Btg2 and Egr1.	Lyl1	Brca1	1	ACTIVATION	False
9450	9599	18172009:5:ETS1:MDM4	Activated K-Ras and insulin-like growth factor 1 induce [TG] expression at the transcriptional level through mechanisms that involve the mitogen-activated protein kinase and [TF] transcription factors.	c-Ets-1	MDMX	1	ACTIVATION	False
9451	9600	18174238:0:RELA:CCND1	Jun D cooperates with [TF] to activate the proximal kappaB site of the [TG] promoter: role of PI3K/PDK-1.	p65	cyclin D1	1	ACTIVATION	False
9452	9601	18174238:10:NFKB:CCND1	Taken together, our data demonstrate a PI3K/PDK-1-dependent functional cooperation of [TF] and JunD in the transcriptional regulation of [TG] by serum.	NF-kappaB	CCND1	0	UNDEFINED	False
9453	9602	18174258:0:AR:HMMR	[TF] regulates [TG] expression and signaling in prostate cancer.	Androgen receptor	CD168	0	UNDEFINED	False
9455	9604	18177740:0:TEAD1:IFITM3	Transcriptional enhancer factor 1 ([TF]/TEAD1) mediates activation of [TG] gene by BRGl.	TEF-1	IFITM3	1	ACTIVATION	False
9456	9605	18177740:3:TEAD1:IFITM3	[TF] knock-down reduced the BAF complex-mediated activation of [TG] promoter.	TEF-1	IFITM3	1	ACTIVATION	False
9457	9606	18177740:4:TEAD1:IFITM3	In the absence of the BAF complex, [TF] is repressive to [TG] expression.	TEF-1	IFITM3	2	REPRESSION	False
9458	9607	18177748:0:GATA6:TNC	[TF] is a novel transcriptional repressor of the [TG] gene expression in fibroblasts.	GATA-6	human Tenascin-C	2	REPRESSION	False
9459	9608	18177748:1:GATA6:TNC	In this study we show that [TF] is a novel repressor of [TG] gene expression.	GATA-6	TN-C	2	REPRESSION	False
9460	9609	18177748:3:GATA6:TNC	A [TF] response element was mapped to position -467 to -460 of the [TG] promoter.	GATA-6	TN-C	0	UNDEFINED	False
9461	9610	18178561:11:NFKB:IGF1R	Thus, TRAIL may play an important role in atherosclerosis by regulating [TG] expression in VSMC in an [TF]-dependent manner.	NF-kappaB	IGF1R	0	UNDEFINED	False
9462	9611	18178561:8:NFKB:IGF1R	Consistent with this, ammonium pyrrolidine dithiocarbamate, a pharmacological inhibitor of [TF], blocks TRAIL-induced [TG] expression, and p65 overexpression increases IGF1R protein levels.	NF-kappaB	IGF1R	1	ACTIVATION	False
9463	9612	18178561:9:NFKB:IGF1R	In addition, [TF] binds a novel TRAIL-responsive element on the [TG] promoter.	NF-kappaB	IGF1R	0	UNDEFINED	False
9464	9613	18180316:9:NFKB:CD14	Taken together, this study has demonstrated a robust augmentation by high glucose of LPS-stimulated [TG] expression through AP-1 and [TF] transcriptional activity enhancement, elucidating a new mechanism by which hyperglycemia boosts LPS-elicited gene expression involved in inflammation and tissue destruction.	NFkappaB	CD14	1	ACTIVATION	False
9465	9614	18187666:9:AP1:OSM	Using different [TG] promoter deletion mutant constructs we show that the putative [TF] element is responsible for activation of OSM promoter activity by C5a.	AP-1	OSM	1	ACTIVATION	False
9466	9615	18194215:8:AP1:SNAP25	Several putative cis-acting elements including SP1, hypoxia inducible factor (HIF), cAMP-response element binding protein, T-cell factor/lymphocyte enhancer factor 1 (TCF/LEF1), [TF] and the signal transducer and activator of transcription-6 (STAT6) are found in the 5' flanking region of [TG] gene.	AP1	SNAP-25	0	UNDEFINED	False
9467	9616	18194839:4:TP63:AQP3	Chromatin immunoprecipitation and reporter assay revealed PAI-1 and [TG] as direct [TF] transcriptional targets.	p63	AQP3	0	UNDEFINED	False
9468	9617	18195003:10:FOXO3:PRDX3	In contrast, overexpression of [TF] increased [TG] promoter activity.	FOXO3A	Prx III	1	ACTIVATION	False
9469	9618	18195003:12:FOXO3:PRDX3	We conclude that [TF] mediates [TG] expression, and this may play a critical role in the resistance to oxidative stress in cardiac fibroblasts.	FOXO3A	Prx III	1	ACTIVATION	False
9470	9619	18195003:4:FOXO3:PRDX3	We hypothesized that [TF] also regulates the expression of [TG], the mitochondrial peroxiredoxin, in human cardiac fibroblasts.	FOXO3A	Prx III	0	UNDEFINED	True
9471	9620	18195003:7:FOXO3:PRDX3	Next, we identified two putative [TF] DNA binding sites in [TG] promoter at -267 and -244 nucleotides relative to the start codon.	FOXO3A	Prx III	0	UNDEFINED	False
9472	9621	18195003:8:FOXO3:PRDX3	We demonstrated that both sequences are required for binding of endogenous [TF] to the [TG] promoter by performing electromobility shift assays and chromatin immunoprecipitation assays.	FOXO3A	Prx III	0	UNDEFINED	False
9473	9622	18195003:9:FOXO3:PRDX3	Inhibition of endogenous [TF] by insulin growth factor 1 prevented binding of FOXO3A to [TG] promoter.	FOXO3A	Prx III	0	UNDEFINED	False
9474	9623	18196534:9:JUN:FASLG	Chromatin immunoprecipitation results showed binding of [TF] to the promoters of both Fas and [TG] in alpha-TEA treated cells.	c-Jun	FasL	0	UNDEFINED	False
9475	9624	1820211:5:SP1:DHFR	In contrast, the addition of [TF] to 47 degrees C heat-treated extract did not result in transcriptional activity from the [TG] promoter.	Sp1	DHFR	1	ACTIVATION	False
9476	9625	18202149:8:SP1:CDKN1A	Hormone-induced complexes containing [TF] and wild-type PR-B, but not S345A or mPro PR-B, were recruited to Sp1 sites within the endogenous [TG] promoter.	Sp1	p21	0	UNDEFINED	False
9477	9626	18202225:8:NFE2L2:HMOX1	We further demonstrated that [TF] was activated by TNF under NF-kappaB-inhibited conditions, to play the major role in up-regulating [TG] expression and ultimately the fate of AML cells.	Nrf2	HO-1	1	ACTIVATION	False
9478	9627	18204072:5:TBP:PTGS2	The TATA-box was occupied by TATA-binding protein ([TF]) demonstrating that the [TG] gene was transcriptionally active before and after labour.	TBP	PGHS-2	1	ACTIVATION	False
9479	9628	18204075:8:SP1:CDKN1C	Moreover, both the treatments reduce the [TG] transcription in untreated cells, suggesting that [TF] is required for the constitutive cki expression.	Sp1	p57(Kip2)	1	ACTIVATION	False
9480	9629	18204200:10:EGR1:GSN	Gel shift experiments indicated that [TF] can directly bind to the [TG] promoter.	Egr-1	gelsolin	0	UNDEFINED	False
9482	9631	18204200:4:EGR1:GSN	Reporter assays and gel shift were used to study the transcriptional activity of [TF] on the regulation of [TG].	Egr-1	gelsolin	0	UNDEFINED	False
9483	9632	18204200:7:EGR1:GSN	Induction of [TF] by serum stimulation accompanied the increase of [TG] expression.	Egr-1	gelsolin	1	ACTIVATION	False
9484	9633	18204200:8:EGR1:GSN	In cells lacking the induction of [TF] in response to serum stimulation, [TG] expression remained unchanged.	Egr-1	gelsolin	0	UNDEFINED	False
9485	9634	18210215:2:SP1:CDKN1A	Previously, we had demonstrated that opposing effects of ERK1/2 and JNK on [TG] expression in response to arsenic trioxide (As(2)O(3)) are mediated through the [TF] responsive elements of the p21 promoter in A431 cells.	Sp1	p21	0	UNDEFINED	False
9486	9635	18210215:5:TGIF1:CDKN1A	We suggest that, after As(2)O(3 )treatment, the N-terminal domain of c-Jun phosphorylation by JNK recruits [TF]/HDAC1 to the Sp1 sites and then represses [TG] expression.	TGIF	p21	2	REPRESSION	False
9487	9636	18210215:6:TGIF1:CDKN1A	That is, [TF] is involved in As(2)O(3)-inhibited [TG] expression, and then blocks the cell cycle arrest.	TGIF	p21	2	REPRESSION	False
9488	9637	18211587:5:MYOD1:CDKN1A	Ectopic TWIST2 suppressed the [TG] and MCK promoters activated by the exogenous addition of E2A and [TF] and this inhibitory effect of TWIST2 was cancelled by the introduction of short hairpin RNA (shRNA) against TWIST2.	MyoD	p21	1	ACTIVATION	False
9489	9638	18211587:5:TWIST2:CDKN1A	Ectopic [TF] suppressed the [TG] and MCK promoters activated by the exogenous addition of E2A and MyoD and this inhibitory effect of TWIST2 was cancelled by the introduction of short hairpin RNA (shRNA) against TWIST2.	TWIST2	p21	2	REPRESSION	False
9490	9639	18213392:5:E2F4:DTL	By measuring the luciferase activity in A549 cells, the intergenic human sequence was shown to be able to drive the reporter gene expression in either direction and notably, among transcription factors E2F, E2F1 approximately [TF], but not E2F5 and E2F6, this sequence clearly up-regulated the reporter gene expression exclusively in the direction of the [TG] gene.	E2F4	CDT2	1	ACTIVATION	False
9491	9640	18216175:0:MEIS1:CCND1	[TF] regulates [TG] and c-myc expression, and controls the proliferation of the multipotent cells in the early developing zebrafish eye.	meis1	cyclin D1	0	UNDEFINED	False
9492	9641	18216175:0:MEIS1:MYC	[TF] regulates cyclin D1 and [TG] expression, and controls the proliferation of the multipotent cells in the early developing zebrafish eye.	meis1	c-myc	0	UNDEFINED	False
9493	9642	18216175:7:MEIS1:CCND1	This role in cell cycle control is mediated by [TF] regulating [TG] and c-myc transcription.	meis1	cyclin D1	0	UNDEFINED	False
9494	9643	18216175:7:MEIS1:MYC	This role in cell cycle control is mediated by [TF] regulating cyclin D1 and [TG] transcription.	meis1	c-myc	0	UNDEFINED	False
9495	9644	18218085:12:TFAP2C:ERBB2	Transfection of siRNAs targeting AP-2alpha and [TF] mRNAs in the BT-474 breast cancer cell line repressed the expression of the endogenous [TG] gene at both the mRNA and protein levels.	AP-2gamma	ERBB2	1	ACTIVATION	False
9496	9645	18222924:9:MEF2A:PPARGC1A	[TF] also bound the MEF2A and PPARGC1A promoters in ChIP, placing it within a feedback loop with [TG] in controlling NRF1 activity.	MEF2A	PGC1alpha	0	UNDEFINED	True
9497	9646	18227154:0:CREB1:CYCS	[TF]alpha is recruited to and mediates upregulation of the [TG] promoter during enhanced mitochondrial biogenesis accompanying skeletal muscle differentiation.	CREB-1	cytochrome c	1	ACTIVATION	False
9498	9647	18227154:4:CREB1:CYCS	Detailed analysis of the [TG] promoter by luciferase reporter, binding affinity, and electrophoretic mobility shift assays as well as mutagenesis studies revealed a critical role for cyclic AMP responsive element binding protein 1 ([TF]) for promoter activation.	CREB-1	cytochrome c	1	ACTIVATION	False
9499	9648	18227154:6:CREB1:CYCS	Chromatin immunoprecipitation assays confirmed preferential binding of [TF]alpha in situ to the [TG] promoter in myotubes.	CREB-1	cytochrome c	0	UNDEFINED	False
9500	9649	18227805:9:SPI1:CD14	Overexpression of [TF] in chorionic mesodermal cells increased the expression of [TG] mRNA and protein.	PU.1	CD14	1	ACTIVATION	False
9501	9650	18230613:8:STAT3:PFN1	Also 7-ketocholesterol in cultured endothelial cells and diabetes in the aorta elicited the recruitment of [TF] and relevant coregulatory factors to the oxysterol-responsive region of the [TG] promoter.	STAT3	profilin-1	0	UNDEFINED	False
9502	9651	18233956:0:BHLHE41:VEGFA	Basic-helix-loop-helix (bHLH) transcription factor [TF] negatively regulates [TG] expression.	DEC2	vascular endothelial growth factor	2	REPRESSION	False
9503	9652	18233956:4:BHLHE41:VEGFA	In the present study, we showed that [TF], but not DEC1, suppressed [TG] gene expression under hypoxic conditions.	DEC2	VEGF	2	REPRESSION	False
9504	9653	18233956:6:BHLHE41:VEGFA	The binding of HIF-1alpha to the hypoxia response element (HRE) in the [TG] promoter was decreased by [TF] over-expression, and increased by DEC2 knockdown.	DEC2	VEGF	0	UNDEFINED	True
9505	9654	18233956:9:BHLHE41:VEGFA	We conclude that [TF] negatively regulates [TG] expression and plays an important role in the pathological conditions in which VEGF is involved.	DEC2	VEGF	2	REPRESSION	False
9506	9655	18239137:9:RBPJ:SMN1	However, HRT suppresses NotchICD/[TF] binding to the [TG] promoter, as measured by chromatin immunoprecipitation, and transactivation of an SMA promoter reporter spanning sequences -124/+32.	CBF-1	SMA	0	UNDEFINED	False
9507	9656	18245483:4:STAT3:EME1	After treatment, this signaling cascade induced the activation of [TF] and the binding of the transcription factor to the promoter of the [TG] gene.	STAT3	Eme1	0	UNDEFINED	False
9508	9657	18245483:6:STAT3:EME1	These results suggest a model by which the [TF]-mediated activation of [TG] prevents DNA damage and enhances cell survival in response to topoisomerase inhibition.	STAT3	Eme1	1	ACTIVATION	False
9509	9658	18252774:7:MAZ:MYB	Our findings show that the T:H:H:T G-quadruplex-forming region in the [TG] promoter is a critical cis-acting element and may repress c-myb promoter activity through [TF] interaction with G-quadruplexes in the c-myb promoter.	MAZ	c-myb	2	REPRESSION	False
9510	9659	18259611:5:HIF1A:DIO3	Using ChIP, we found that [TF] interacted specifically with the [TG] promoter, indicating that DIO3 may be a direct transcriptional target of HIF-1.	HIF-1alpha	DIO3	0	UNDEFINED	False
9511	9660	18269916:2:RELA:CDKN1A	Here we show that knockdown of [TF] by IkappaBSR or p65 siRNA decreased the cytotoxic effect of DOX on HCT116 (p53+/+) cells, correlating with increased induction of [TG].	p65	p21	2	REPRESSION	False
9512	9661	18269916:6:RELA:CDKN1A	We present evidence that in p53-null tumor cells treated with DOX, [TF] was involved in induction of [TG] expression by directly binding to the p21 promoter.	p65	p21	1	ACTIVATION	False
9513	9662	18269916:7:RELA:CDKN1A	Our data suggested that both p53 and [TF] limited each other's ability to stimulate [TG] induction and this mutual repression mechanism was consistent with a model in which both factors were competing for limiting pool of p300/CBP coactivator protein complexes.	p65	p21	1	ACTIVATION	True
9514	9663	18281274:9:NFKB:PTPN1	Actinomycin D treatment blocked, and high dose salicylate treatment inhibited by 80%, TNFalpha-induced [TG] expression in adipocyte cell lines, suggesting TNFalpha may induce PTP1B transcription via nuclear factor kappaB ([TF]) activation.	NFkappaB	PTP1B	1	ACTIVATION	False
9515	9664	18281521:6:AR:UGT2B17	Using casodex, an [TF] (AR) antagonist, and AR-specific small interfering RNA probes, we show that calcitriol requires a functional AR to inhibit the expression of the [TG] gene in LNCaP cells.	androgen receptor	UGT2B17	2	REPRESSION	False
9516	9665	18288196:6:ESRRA:VEGFA	Instead, PGC-1alpha coactivates the orphan nuclear receptor [TF] (oestrogen-related receptor-alpha) on conserved binding sites found in the promoter and in a cluster within the first intron of the [TG] gene.	ERR-alpha	VEGF	0	UNDEFINED	True
9517	9666	18292289:0:NFKB:BTK	Proteasome-dependent autoregulation of [TG] (Btk) promoter via [TF].	NF-kappaB	Bruton tyrosine kinase	0	UNDEFINED	False
9518	9667	18292289:4:NFKB:BTK	We here present strong evidence indicating that [TF] is required for efficient transcription of the [TG] gene.	NF-kappaB	Btk	1	ACTIVATION	False
9519	9668	18292289:5:NFKB:BTK	First, we found that proteasome blockers and inhibitors of [TF] signaling suppress [TG] transcription and intracellular expression.	NF-kappaB	Btk	1	ACTIVATION	False
9520	9669	18294451:6:AP1:VEGFA	These results imply that Pin1 stimulates [TG] expression by activating HIF-1alpha and [TF], and suggest that Pin1 is a potential therapeutic target of angiogenesis during cancer development.	AP-1	VEGF	1	ACTIVATION	False
9521	9670	18296632:4:NFKB:MYOCD	Here we show that [TF](p65) represses [TG] activation of cardiac and smooth muscle genes in a CArG-box-dependent manner.	NF-kappaB	myocardin	2	REPRESSION	True
9522	9671	18296632:4:RELA:MYOCD	Here we show that NF-kappaB([TF]) represses [TG] activation of cardiac and smooth muscle genes in a CArG-box-dependent manner.	p65	myocardin	2	REPRESSION	False
9523	9672	18301748:5:FOXO1:TXNIP	This set includes the gene for [TG] (TXNIP), the expression of which is directly repressed by [TF].	FOXO1a	thioredoxin-interacting protein	2	REPRESSION	False
9524	9673	18305377:8:CEBPA:CES1	A reporter gene assay and electrophoretic mobility shift assay demonstrated that Sp1 and [TF] could bind to each responsive element of the [TG]1 promoter but that the Sp1 and C/EBP could not bind to the responsive element of the CES1A2 promoter.	C/EBPalpha	CES1A	0	UNDEFINED	False
9525	9674	18305377:8:SP1:CES1	A reporter gene assay and electrophoretic mobility shift assay demonstrated that [TF] and C/EBPalpha could bind to each responsive element of the [TG]1 promoter but that the Sp1 and C/EBP could not bind to the responsive element of the CES1A2 promoter.	Sp1	CES1A	0	UNDEFINED	False
9526	9675	18310076:8:SMAD4:MST1R	We further determined that [TF]-dependent signaling regulated [TG] expression at the transcriptional level by real-time reverse transcription PCR and RON promoter luciferase reporter assays.	Smad4	RON	0	UNDEFINED	False
9527	9676	18312651:12:FOXO3:CDKN1A	Moreover, we found that [TF] upregulated the expression of the cyclin-dependent kinase inhibitors [TG], p27Kip1, and p57Kip2.	FOXO3a	p21Cip1	1	ACTIVATION	False
9528	9677	18319327:4:ETS2:SETDB1	Nested deletion and mutational analysis of the [TG] promoter further demonstrated that the [TF] transcription factor regulates transcriptional activity of the ESET gene.	Ets-2	ESET	0	UNDEFINED	False
9529	9678	18319327:6:ETS2:SETDB1	Our results suggest that CBP is a transcriptional repressor of [TG] gene expression by limiting [TF] transcriptional activity, while CBP siRNA enhances basal and Ets-2-dependent ESET transcriptional activity.	Ets-2	ESET	1	ACTIVATION	True
9530	9679	18321244:5:ETS2:DUSP6	Furthermore, we show that this response is mediated by a conserved binding site for the Ets (E twenty-six) family of transcriptional regulators and that the [TF] protein, a known target of ERK signalling, binds to the endogenous DUSP6/[TG] promoter.	Ets2	MKP-3	0	UNDEFINED	False
9531	9680	18326497:9:NFKB:SLC1A2	The specific [TF] binding site at the -272 position of the [TG] promoter was responsible for ceftriaxone-mediated EAAT2 induction.	NF-kappaB	EAAT2	1	ACTIVATION	False
9532	9681	18328811:9:SP1:CES1	These results suggest that the [TF] binding site variation in the [TG]A2 promoter is functional, and are good candidates for the pharmacogenetic studies of CES1-activated drugs.	Sp1	CES1	0	UNDEFINED	False
9533	9682	18335503:0:SMAD3:CSN2	TGF-beta inhibits prolactin-induced expression of [TG] by a [TF]-dependent mechanism.	Smad3	beta-casein	2	REPRESSION	False
9534	9683	18335503:11:SMAD3:CSN2	Taken together, our results demonstrate that TGF-beta abrogates prolactin-stimulated [TG] gene expression in mammary epithelial cells through, at least in part, a [TF]-dependent mechanism.	Smad3	beta-casein	2	REPRESSION	False
9535	9684	18336786:0:FOXA1:MUC2	Forkhead box transcription factors [TF] and Foxa2 are important regulators of [TG] mucin expression in intestinal epithelial cells.	Foxa1	Muc2	0	UNDEFINED	True
9536	9685	18336786:0:FOXA2:MUC2	Forkhead box transcription factors Foxa1 and [TF] are important regulators of [TG] mucin expression in intestinal epithelial cells.	Foxa2	Muc2	0	UNDEFINED	False
9537	9686	18336786:8:FOXA1:MUC2	In conclusion, this work identifies [TF] and Foxa2 as important regulators of [TG] expression in the intestine.	Foxa1	Muc2	0	UNDEFINED	True
9538	9687	18336786:8:FOXA2:MUC2	In conclusion, this work identifies Foxa1 and [TF] as important regulators of [TG] expression in the intestine.	Foxa2	Muc2	0	UNDEFINED	False
9539	9688	18339704:12:SP1:SLC5A1	Thus this report demonstrates that [TF] and HNF1 transcription factors act in concert to regulate [TG] transcription in the chronically inflamed intestine.	Sp1	SGLT1	0	UNDEFINED	False
9540	9689	18341653:9:NFKB:CCND1	These results strongly suggest that daintain/AIF-1 can promote the growth of breast tumors via activating [TF] signaling, which consequently up-regulates the expression of [TG], implying that daintain/AIF-1 may be a novel target molecule for the prognosis and therapy of breast cancer.	NF-kappaB	cyclin D1	1	ACTIVATION	False
9541	9690	1834700:0:SP1:DHFR	Mithramycin inhibits [TF] binding and selectively inhibits transcriptional activity of the [TG] gene in vitro and in vivo.	SP1	dihydrofolate reductase	1	ACTIVATION	False
9542	9691	18353772:6:SP1:KLF8	Disruption of an [TF] binding site in the [TG] promoter abolishes the FAK- or Sp1-mediated promoter activation.	Sp1	KLF8	1	ACTIVATION	False
9543	9692	18353772:7:SP1:KLF8	[TF] knockdown prevents the [TG] promoter from being activated by Sp1 or CA-Akt, and expression of CA-Akt enhances Sp1 expression in SKOV3ip1 cells.	Sp1	KLF8	1	ACTIVATION	False
9544	9693	18353772:8:SP1:KLF8	Chromatin immunoprecipitation and oligonucleotide precipitation results show that [TF] binds to the [TG] promoter.	Sp1	KLF8	0	UNDEFINED	False
9545	9694	18353772:9:SP1:KLF8	Taken together, our data suggest that FAK induces [TG] expression in human ovarian cancer cells by activating the PI3K-Akt signaling pathway, leading to the activation of KLF8 promoter by [TF].	Sp1	KLF8	1	ACTIVATION	False
9546	9695	18356167:7:CUX1:MYC	Chromatin affinity purification experiments confirmed the direct interaction of [TF] with the [TG] and p27 promoters.	Cux1	c-myc	0	UNDEFINED	False
9547	9696	18372249:7:ARNT:VEGFA	Ectopically expressed [TF] reversed the inhibition of HIF activity by Cul2 siRNA in the [TG] promoter, suggesting that CUL2 regulates HIF activation through ARNT.	ARNT	VEGF	1	ACTIVATION	False
9548	9697	18374905:4:JUN:PSEN1	SP600125 efficiently suppressed basal JNK activity in SK-N-SH cell line as shown by inhibition of phosphor-JNK and phosphor-[TF], and also decreased [TG] expression.	c-jun	PS1	1	ACTIVATION	True
9549	9698	18377656:9:SP1:BRCA1	We report that in the [TG] promoter the AP-1 site is flanked upstream by an element (5'-GGGGCGGAA-3') that recruits [TF], Sp3, and Sp4 factors, and downstream by a half CRE-binding motif (5'-CGTAA-3') that binds CRE-binding protein.	Sp1	BRCA1	0	UNDEFINED	False
9550	9699	18377656:9:SP3:BRCA1	We report that in the [TG] promoter the AP-1 site is flanked upstream by an element (5'-GGGGCGGAA-3') that recruits Sp1, [TF], and Sp4 factors, and downstream by a half CRE-binding motif (5'-CGTAA-3') that binds CRE-binding protein.	Sp3	BRCA1	0	UNDEFINED	False
9551	9700	18378698:3:PGR:HSD11B2	Chromatin immunoprecipitation has identified two different mechanisms of hormone-induced [TF] (PR) recruitment to the [TG] promoter: (i) direct PR binding to DNA at the proximal promoter, abrogated when PR contains a mutated DNA binding domain (DBD), and (ii) STAT5A (signal transducer and activator of transcription 5A)-mediated recruitment of PR to an upstream distal region, impaired by AG490, a JAK/STAT pathway inhibitor.	progesterone receptor	11beta-HSD2	0	UNDEFINED	False
9552	9701	18378698:3:STAT5A:HSD11B2	Chromatin immunoprecipitation has identified two different mechanisms of hormone-induced progesterone receptor (PR) recruitment to the [TG] promoter: (i) direct PR binding to DNA at the proximal promoter, abrogated when PR contains a mutated DNA binding domain (DBD), and (ii) STAT5A ([TF])-mediated recruitment of PR to an upstream distal region, impaired by AG490, a JAK/STAT pathway inhibitor.	signal transducer and activator of transcription 5A	11beta-HSD2	0	UNDEFINED	False
9553	9702	18381655:6:NFE2L2:HMOX1	Nuclear factor E2-related factor 2 ([TF]), a transcription factor, and phosphatidylinositol 3-kinase (PI3K) and Akt pathways appear to mediate [TG] expression.	Nrf2	HO-1	1	ACTIVATION	False
9554	9703	18385139:6:NR0B2:PPARGC1A	We also show that transactivation of [TG] and LRH-1 is repressed by the small heterodimer partner ([TF]).	SHP	PGC-1alpha	2	REPRESSION	False
9555	9704	18387357:6:GATA4:CEBPB	In [TF] expressing intestinal epithelial cells, GATA-4 led to decreased [TG] and C/EBPdelta protein levels, and decreased thiostatin expression in response to IL-1beta and dexamethasone.	GATA-4	C/EBPbeta	2	REPRESSION	False
9556	9705	18388192:8:SP1:ADCY4	These studies demonstrate roles for [TF]/Sp3 and SF1 in [TG] expression in Y1 cells and establish a repressor function for SF1 in certain promoter contexts.	Sp1	Adcy4	0	UNDEFINED	False
9557	9706	18388192:8:SP3:ADCY4	These studies demonstrate roles for Sp1/[TF] and SF1 in [TG] expression in Y1 cells and establish a repressor function for SF1 in certain promoter contexts.	Sp3	Adcy4	0	UNDEFINED	False
9558	9707	18388194:3:FOXO3:NR2C2	Here we identify a daf-16 family protein-binding element (DBE; 5'-TGTTTAC-3') in the [TG] promoter that can be recognized by the forkhead transcriptional factor [TF], a key stress-responsive factor, through which TR4 gene expression is activated.	FOXO3a	TR4	1	ACTIVATION	False
9559	9708	18388194:5:FOXO3:NR2C2	Activation of [TF] by oxidative stress and phosphatidylinositol 3-kinase inhibitor induced [TG] expression; in contrast, suppression of FOXO3a by small interfering RNA can reduce oxidative stress-induced TR4 expression.	FOXO3a	TR4	1	ACTIVATION	False
9561	9710	18391984:0:FOXO3:CFLAR	[TF] mediates the androgen-dependent regulation of [TG] and contributes to TRAIL-induced apoptosis of LNCaP cells.	FOXO3a	FLIP	0	UNDEFINED	False
9562	9711	18391984:6:FOXO3:CFLAR	A [TF] binding site was identified in the [TG] promoter and shown necessary for the combined effects of androgens and FOXO3a on FLIP transcription.	FOXO3a	FLIP	0	UNDEFINED	False
9563	9712	18393939:5:NFKB:HIF1A	The [TG] promoter is responsive to selective [TF] subunits.	NF-kappaB	HIF-1alpha	0	UNDEFINED	True
9564	9713	18395010:6:TTF1:AGT	Additionally, [TF] was involved in the regulation of [TG] (Aogen) transcription under a hyperosmotic condition through specific binding domains in the Aogen promoter.	TTF-1	angiotensinogen	0	UNDEFINED	False
9565	9714	18396013:7:NFKB:VEGFA	The increase in [TG] expression by LPA is mediated by the activation of c-Jun N-terminal Kinase (JNK) and transcription factor [TF] since blocking JNK or NFkappaB activation inhibited LPA induced VEGF expression.	NFkappaB	VEGF	1	ACTIVATION	False
9566	9715	18396140:4:KLF4:CEBPB	Knockdown of [TF] inhibits adipogenesis and downregulates [TG] levels.	KLF4	C/EBPbeta	1	ACTIVATION	False
9567	9716	18396140:5:KLF4:CEBPB	[TF] binds directly to the [TG] (Cebpb) promoter as shown by chromatin immunoprecipitation and gel shift assays and, together with Krox20, cooperatively transactivates a C/EBPbeta reporter.	KLF4	C/EBPbeta	1	ACTIVATION	False
9569	9718	18411043:0:STAT3:MMP7	HER2-dependent [TG] expression is mediated by activated [TF].	STAT3	MMP-7	1	ACTIVATION	False
9570	9719	18411043:10:STAT3:MMP7	The data indicate that HRG-induced HER2-dependent transcriptional upregulation and protein secretion of [TG] are mediated by activated [TF].	STAT3	MMP-7	1	ACTIVATION	False
9571	9720	18411043:6:STAT3:MMP7	[TG] promoter activity was remarkably induced in MCF-7 cells expressing the constitutively activated [TF] (MCF-7/STAT3C).	STAT3	MMP-7	1	ACTIVATION	False
9572	9721	18411043:8:STAT3:MMP7	Binding of [TF] to [TG] promoter was verified by ChIP and the critical STAT3 element within the MMP-7 promoter identified by the mutagenesis of the core STAT3 recognition sequence.	STAT3	MMP-7	0	UNDEFINED	False
9573	9722	18413612:6:EWSR1:CCND1	We show that, although both [TF] and EWS-FLI1 enhance [TG] gene expression, they regulate the D1b/D1a transcript ratio in an opposite manner.	EWS	cyclin D1	1	ACTIVATION	False
9574	9723	18413612:6:FLI1:CCND1	We show that, although both EWS and EWS-[TF] enhance [TG] gene expression, they regulate the D1b/D1a transcript ratio in an opposite manner.	FLI1	cyclin D1	1	ACTIVATION	False
9575	9724	18419600:8:SP1:CDKN1A	In HCT116 p53(+)/(+) cells, we found (i) remarkably increased acetylated H4 around both p21([TG]) promoter regions, especially at the [TF] site; (ii) increased acetylation of p53 at lysines 320 and 382;(iii) displacement of HDAC1 from the Sp1 site, thus inhibiting its repression effect and increasing p53 binding.p53 seems to trigger H4-acetylation around the p21(WAF1) promoter because there was nearly no H4 acetylation in HCT116 p53(-)/(-) cells.	Sp1	WAF1	0	UNDEFINED	False
9576	9725	18424262:0:NFKB:CASP14	Transcription of the [TG] gene in human epidermal keratinocytes requires AP-1 and [TF].	NFkappaB	caspase-14	1	ACTIVATION	False
9577	9726	18424262:5:NFKB:CASP14	Our data reveal the basic organization of the human [TG] promoter and suggest an important role of AP-1 and [TF] in the transcriptional control of caspase-14.	NFkappaB	caspase-14	0	UNDEFINED	False
9578	9727	18424439:7:FOXO3:ATM	Our studies demonstrate that [TF] represses ROS in part via regulation of [TG] and that this repression is required for maintenance of the hematopoietic stem cell pool.	Foxo3	ATM	0	UNDEFINED	False
9579	9728	18426912:10:GATA4:DIO1	Taken together, these results suggest that HNF4alpha regulates thyroid hormone homeostasis through transcriptional regulation of the mouse [TG] gene with [TF] and KLF9.	GATA4	Dio1	0	UNDEFINED	False
9580	9729	18426912:10:HNF4A:DIO1	Taken together, these results suggest that [TF] regulates thyroid hormone homeostasis through transcriptional regulation of the mouse [TG] gene with GATA4 and KLF9.	HNF4alpha	Dio1	0	UNDEFINED	False
9581	9730	18426912:10:KLF9:DIO1	Taken together, these results suggest that HNF4alpha regulates thyroid hormone homeostasis through transcriptional regulation of the mouse [TG] gene with GATA4 and [TF].	KLF9	Dio1	0	UNDEFINED	False
9582	9731	18426912:4:HNF4A:DIO1	Promoter analysis of the mouse [TG] gene demonstrated that [TF] plays a key role in the transactivation of the mouse Dio1 gene.	HNF4alpha	Dio1	1	ACTIVATION	False
9583	9732	18426912:8:GATA4:DIO1	Furthermore, KLF9 functions together with HNF4alpha and [TF] to synergistically activate the mouse [TG] promoter, suggesting that Dio1 is regulated by thyroid hormone in the mouse through an indirect mechanism requiring prior KLF9 induction.	GATA4	Dio1	1	ACTIVATION	False
9584	9733	18426912:8:HNF4A:DIO1	Furthermore, KLF9 functions together with [TF] and GATA4 to synergistically activate the mouse [TG] promoter, suggesting that Dio1 is regulated by thyroid hormone in the mouse through an indirect mechanism requiring prior KLF9 induction.	HNF4alpha	Dio1	1	ACTIVATION	False
9585	9734	18426912:8:KLF9:DIO1	Furthermore, [TF] functions together with HNF4alpha and GATA4 to synergistically activate the mouse [TG] promoter, suggesting that Dio1 is regulated by thyroid hormone in the mouse through an indirect mechanism requiring prior KLF9 induction.	KLF9	Dio1	1	ACTIVATION	False
9586	9735	18434015:4:ELK1:EGR1	In this study, we wanted to address whether [TF] activates or represses [TG] promoter in neuroblastoma cells, and using a combination of RNA interference and reporter analyses, we present evidence that egr-1 gene is repressed by Elk-1 in normally cycling SH-SY5Y neuroblastoma cell line in a SUMO (small ubiquitin-related modifier)-dependent manner, a potential mechanism used by these cells to bypass apoptosis.	Elk-1	egr-1	2	REPRESSION	False
9587	9736	18436815:8:POU2F1:ALDH3A1	Pax6, [TF], and p300 synergistically activate the [TG] promoter approximately 116-fold.	Oct1	Aldh3a1	1	ACTIVATION	False
9589	9738	18444174:5:CEBPB:PTGS2	Cholic acid enhanced [TG] upregulation in AOM tumors, whereas UDCA inhibited this increase and concomitantly decreased [TF] (C/EBPbeta), a transcriptional regulator of Cox-2.	CCAAT/enhancer binding protein beta	Cox-2	1	ACTIVATION	True
9590	9739	18444242:0:FOXO1:CAV1	Wild-type APC regulates [TG] expression in human colon adenocarcinoma cell lines via [TF] and C-myc.	FOXO1a	caveolin-1	0	UNDEFINED	True
9591	9740	18444242:5:FOXO1:CAV1	The [TF] protein, which is increased by wild-type APC expression, induces [TG] promoter-reporter activity and binds directly to a FKHR consensus binding sequence in the caveolin-1 promoter.	FOXO1a	caveolin-1	1	ACTIVATION	False
9592	9741	18445785:0:SFPQ:DYX1C1	The complex of TFII-I, PARP1, and [TF] proteins regulates the [TG] gene implicated in neuronal migration and dyslexia.	SFPQ	DYX1C1	0	UNDEFINED	False
9594	9743	18454179:7:SP1:VEGFA	We propose that Nox1 mediates oncogenic Ras-induced upregulation of [TG] and angiogenesis by activating [TF] through Ras-ERK-dependent phosphorylation of Sp1.	Sp1	VEGF	1	ACTIVATION	False
9595	9744	18455888:4:MYC:NDRG2	We previously identified human [TG] and demonstrated that this gene is transcriptionally down-regulated by [TF] via Miz-1-dependent interaction with the core promoter region of NDRG2.	Myc	NDRG2	2	REPRESSION	False
9596	9745	18455888:4:ZBTB17:NDRG2	We previously identified human [TG] and demonstrated that this gene is transcriptionally down-regulated by Myc via [TF]-dependent interaction with the core promoter region of NDRG2.	Miz-1	NDRG2	2	REPRESSION	False
9597	9746	18455888:7:MYCN:NDRG1	The data revealed that both [TF] and c-Myc can repress human [TG] at the transcriptional level.	N-Myc	NDRG1	2	REPRESSION	False
9598	9747	18456656:5:SOX2:CCND1	Using cell culture experiments, tissue analysis, molecular profiling, and animal studies, we report here that [TF] promotes cell proliferation and tumorigenesis by facilitating the G(1)/S transition and through its transcription regulation of the [TG] gene in breast cancer cells.	SOX2	CCND1	0	UNDEFINED	False
9599	9748	18458340:0:MLX:TXNIP	Glucose sensing by MondoA:[TF] complexes: a role for hexokinases and direct regulation of [TG] expression.	Mlx	thioredoxin-interacting protein	0	UNDEFINED	False
9600	9750	18458340:10:MLX:TXNIP	We identify [TG] (TXNIP) as a direct and glucose-regulated MondoA:[TF] transcriptional target.	Mlx	thioredoxin-interacting protein	0	UNDEFINED	False
9601	9752	18461473:6:NFKB1:WNT1	Chromatin immunoprecipitation assay ascertained the direct binding of [TF]-p50 to the [TG] promoter.	NF-kappaB	Wnt-1	0	UNDEFINED	False
9602	9753	18467525:7:CEBPB:PPARGC1A	These findings identify [TF] as a direct activator of [TG] in the regenerating liver.	C/EBPbeta	PGC-1alpha	1	ACTIVATION	False
9603	9754	18471437:4:STAT3:NR0B1	In this study, we found that [TF] and Oct3/4, essential transcription factors for ES cell self-renewal, are involved in the regulation of [TG] expression.	STAT3	Dax1	0	UNDEFINED	False
9604	9755	18471910:11:CREB1:SERPINE1	These results suggest that BPS increases VEGF and decreases [TG] gene expression through PKA/[TF]-dependent mechanisms in vascular smooth muscle cells.	CREB	PAI-1	2	REPRESSION	False
9605	9756	18471910:8:CREB1:SERPINE1	Overexpression of [TF] (cAMP-responsive element binding protein) induces VEGF promoter and reduces [TG] promoter activities.	CREB	PAI-1	2	REPRESSION	False
9606	9757	18471910:8:CREB1:VEGFA	Overexpression of [TF] (cAMP-responsive element binding protein) induces [TG] promoter and reduces PAI-1 promoter activities.	CREB	VEGF	1	ACTIVATION	False
9607	9758	18472212:10:AP1:KLF16	The present observations suggest that [TG] auto-regulates its own promoter by competing with Sp1 and that both [TF] and AP2 modulate expression of this gene.	AP1	DRRF	0	UNDEFINED	False
9608	9759	18472212:10:TFAP2A:KLF16	The present observations suggest that [TG] auto-regulates its own promoter by competing with Sp1 and that both AP1 and [TF] modulate expression of this gene.	AP2	DRRF	0	UNDEFINED	False
9609	9760	18483152:0:PPARG:REN	The Pal3 promoter sequence is critical for the regulation of human [TG] gene transcription by [TF].	peroxisome proliferator-activated receptor-gamma	renin	0	UNDEFINED	False
9610	9761	18483152:4:PPARG:REN	Neither the human [TG] HRE nor the consensus PPRE was sufficient to attain the maximal stimulation of renin promoter activity by the [TF] agonist rosiglitazone.	PPARgamma	renin	1	ACTIVATION	True
9611	9762	18483244:6:MYC:ID2	We show that [TF] represses transcription of target genes [TG] and Gadd153 by a process that involves histone deacetylation.	Myc	Id2	2	REPRESSION	False
9612	9763	18483254:3:IKZF1:LDLR	The DNA-binding Ikaros isoform [TF] binds and enhances activity of the [TG] promoter.	Ik1	LDL-R	1	ACTIVATION	False
9613	9764	18483254:4:IKZF1:LDLR	[TF] decreases methylation and increases acetylation of histone H3 (Lys(9)) at the [TG] promoter.	Ik1	LDL-R	0	UNDEFINED	False
9614	9765	18483411:7:KLF4:CDKN1A	Consistent with these findings, cultured SMCs overexpressing [TF] showed reduced cellular proliferation, in part, through the induction of the cell cycle inhibitor, p21([TG]/Cip1) via increased binding of Klf4 and p53 to the p21(WAF1/Cip1) promoter/enhancer.	Klf4	WAF1	1	ACTIVATION	False
9615	9766	18483411:8:KLF4:CDKN1A	In vivo chromatin immunoprecipitation assays also showed increased [TF] binding to the promoter/enhancer regions of the p21([TG]/Cip1) gene and SMC differentiation marker genes following vascular injury.	Klf4	WAF1	0	UNDEFINED	False
9616	9767	18483557:7:HOXA13:TEK	ChIP analysis of [TF]-DNA complexes in the placenta confirmed that HOXA13 binds the [TG] and Foxf1 promoters in vivo.	HOXA13	Tie2	0	UNDEFINED	False
9617	9768	18483557:8:HOXA13:TEK	In vitro, [TF] binds sequences present in the [TG] and Foxf1 promoters with high affinity (K(d) = 27-42 nM) and HOXA13 can use these bound promoter regions to direct gene expression.	HOXA13	Tie2	1	ACTIVATION	False
9618	9769	18490439:11:YY1:MYC	These results indicate that the activated Notch1 receptor and alpha-enolase or MBP-1 cooperate in controlling [TG] expression through binding the [TF] response element of the c-myc promoter to regulate tumorigenesis.	YY1	c-myc	0	UNDEFINED	False
9619	9770	18490439:3:YY1:MYC	The complex of N1IC and transcription factor [TF] binds to the human [TG] promoter to enhance c-myc expression in a CBF1-independent manner.	YY1	c-myc	1	ACTIVATION	False
9620	9771	18490439:6:YY1:MYC	The [TF] response element in front of the P2 [TG] promoter was essential and sufficient for the modulation of c-myc by N1IC and alpha-enolase or MBP-1.	YY1	c-myc	0	UNDEFINED	False
9621	9772	18490439:7:YY1:MYC	Furthermore, N1IC, [TF], and alpha-enolase or MBP-1 but not CBF1 bound to the [TG] promoter through associating with the YY1 response element.	YY1	c-myc	0	UNDEFINED	False
9622	9773	18492810:9:ETV5:PTGS2	Indeed, we found that addition of [TF] increases the transcriptional activity of the 3.2-kb mouse [TG] promoter by 2.5-fold in luciferase reporter assays.	Etv5	Ptgs2	1	ACTIVATION	False
9623	9774	18495115:8:CREB1:AQP3	These results suggest that signal transducers, adenylyl cyclase, protein kinase A (PKA), mitogen-activated protein kinase 1/2 (MEK1/2), and mitogen- and stress-activated protein kinase 1 (MSK1), were involved in the signaling pathway for regulating transcription of the [TG] gene and [TF] is one of the transcriptional regulators for aquaporin 3 gene expression mediated by magnesium ion.	CREB	aquaporin 3	0	UNDEFINED	False
9624	9775	18498120:10:SMAD1:CDX2	A 9.3 kb [TG] promoter could be transactivated by SMAD4 and [TF] in a cell-dependent manner.	SMAD1	CDX2	1	ACTIVATION	False
9625	9776	18498120:10:SMAD4:CDX2	A 9.3 kb [TG] promoter could be transactivated by [TF] and SMAD1 in a cell-dependent manner.	SMAD4	CDX2	1	ACTIVATION	False
9626	9777	18498120:8:SMAD4:MUC2	On the other hand, [TF] knock-down led to decreased endogenous CDX2, [TG], and LI-cadherin in AGS.	SMAD4	MUC2	1	ACTIVATION	False
9627	9778	18498249:5:NFKB:HIF1A	More recently, [TF] binding to this site in the [TG] promoter has been shown also under hypoxic conditions.	NF-kappaB	HIF-1alpha	0	UNDEFINED	False
9628	9779	18508759:5:NFKB:DUSP1	NF-kappaB [TF]/p50 heterodimer was recruited to [TG] gene promoter to induce MKP-1 transcription.	RelA	MKP-1	1	ACTIVATION	False
9629	9780	18508759:6:NFKB:DUSP1	Deletion of the [TF]-binding site or inactivation of NF-kappaB by its small interfering RNA significantly decreased the radiation-induced [TG] promoter activity.	NF-kappaB	MKP-1	1	ACTIVATION	False
9630	9781	18509005:6:SP1:CDKN1A	The [TF] inhibitor mithramycin silenced the [TG]/WAF1 promoter activity suggesting an important role of Sp1 in mediating BRL activation.	Sp1	p21Cip1	1	ACTIVATION	False
9631	9782	18509005:7:SP1:CDKN1A	The electrophoretic mobility shift and chromatin immunoprecipitation (ChIP) assays evidenced a functional interaction between PPARgamma and [TF] in regulating [TG]/WAF1.	Sp1	p21Cip1	0	UNDEFINED	False
9633	9784	18513743:0:EGR1:CDKN1C	Regulation of [TG] during muscle differentiation: role of [TF], Sp1 and DNA hypomethylation.	Egr1	p57(KIP2)	0	UNDEFINED	False
9634	9785	18513743:7:SP1:CDKN1C	We also suggest that the role of MyoD-induced p73 consists in promoting the binding of [TF] to [TG] promoter.	Sp1	p57(kip2)	0	UNDEFINED	False
9635	9786	18513743:8:EGR1:CDKN1C	Moreover, we show that [TF] and Sp1 are concomitantly recruited to [TG] promoter in vivo only in differentiation conditions and only in responsive cells.	Egr1	p57	0	UNDEFINED	False
9636	9787	18513743:8:SP1:CDKN1C	Moreover, we show that Egr1 and [TF] are concomitantly recruited to [TG] promoter in vivo only in differentiation conditions and only in responsive cells.	Sp1	p57	0	UNDEFINED	False
9637	9788	18521215:10:MYOD1:CDKN1A	Tumors that express significant amounts of [TF] fail to express [TG].	MyoD	p21	2	REPRESSION	True
9638	9789	18521215:4:MYOD1:CDKN1A	It was recently shown that during myogenesis, [TF] activates the expression of the cyclin-dependent kinase inhibitor (CDKi), [TG], which itself plays a critical role in normal muscle development.	MyoD	p21	1	ACTIVATION	False
9639	9790	18523482:8:AP1:OPRM1	We propose that the opioid-induced regulation of [TG] mRNA expression is mediated by reduced binding of the transcription factors NFkappaB and [TF] to the promoter region on the MOR gene.	AP-1	MOR	0	UNDEFINED	False
9640	9791	18523482:8:NFKB:OPRM1	We propose that the opioid-induced regulation of [TG] mRNA expression is mediated by reduced binding of the transcription factors [TF] and AP-1 to the promoter region on the MOR gene.	NFkappaB	MOR	0	UNDEFINED	False
9642	9793	18537191:6:NR0B2:CCND1	Embryonic fibroblasts lacking [TF] showed enhanced proliferation and produced increased [TG] messenger RNA and protein, and SHP was shown to be a direct negative regulator of cyclin D1 gene transcription.	SHP	cyclin D1	2	REPRESSION	False
9643	9794	18541630:5:NFKB:TERT	A mechanistic study revealed that [TF] becomes functionally activated upon radiation exposure and mediates the upregulation of telomerase activity by binding to the kappaB-binding region in the promoter region of the [TG] gene.	NF-kappaB	TERT	1	ACTIVATION	False
9644	9795	18541673:0:TP53:ANXA1	Upregulation of [TG] expression by butyrate in human colon adenocarcinoma cells: role of [TF], NF-Y, and p38 mitogen-activated protein kinase.	p53	annexin A1	1	ACTIVATION	False
9646	9797	18542060:7:YY1:MYC	These and other results suggest that in quiescent cells the C-terminal region of p300 provides corepressor function and facilitates the recruitment of p300 and HDAC3 to the [TF]-binding site and represses the [TG] promoter.	YY1	c-Myc	2	REPRESSION	False
9647	9798	18544633:6:PPARG:CDKN2A	[TF] can bind to the p16 promoter and induce its transcription, and, after treatment with a selective PPARgamma agonist, we observed more-robust expression of [TG] in senescent cells than in young cells.	PPARgamma	p16(INK4alpha)	1	ACTIVATION	False
9649	9800	18550526:0:BACH1:HMOX1	[TF] is a specific repressor of [TG] that is inactivated by arsenite.	BACH1	HMOX1	2	REPRESSION	False
9650	9801	18550526:6:BACH1:HMOX1	We show that [TF] is inactivated at low micromolar arsenite concentrations and that BACH1 inactivation is necessary and sufficient for transcriptional induction of [TG].	BACH1	HMOX1	2	REPRESSION	False
9651	9802	18552212:6:SPIB:PRDM1	By chromatin immunoprecipitation and assays using an inducible [TF] construct [TG] and XBP-1 were identified as direct target genes of Spi-B mediated repression.	Spi-B	BLIMP1	2	REPRESSION	False
9653	9806	18562694:8:HIF1A:AURKA	These results show that [TG] gene transcription can be regulated by hypoxia and [TF] via HRE-2 of the STK15 promoter.	HIF-1	STK15	0	UNDEFINED	False
9654	9807	18566134:11:USF1:FSHR	In summary, this study provides the first in vivo evidence that [TF] and USF2 bind the [TG] promoter and revealed differences between Sertoli and granulosa cells in compensatory responses to USF loss and the USF dimeric composition required for Fshr transcription.	USF1	Fshr	1	ACTIVATION	False
9655	9808	18566134:11:USF2:FSHR	In summary, this study provides the first in vivo evidence that USF1 and [TF] bind the [TG] promoter and revealed differences between Sertoli and granulosa cells in compensatory responses to USF loss and the USF dimeric composition required for Fshr transcription.	USF2	Fshr	0	UNDEFINED	True
9656	9809	18566134:4:USF1:FSHR	In the present study, chromatin immunoprecipitation demonstrated specific binding of [TF] and USF2 to the [TG] promoter in both Sertoli and granulosa cells, in vivo.	USF1	Fshr	0	UNDEFINED	False
9657	9810	18566134:4:USF2:FSHR	In the present study, chromatin immunoprecipitation demonstrated specific binding of USF1 and [TF] to the [TG] promoter in both Sertoli and granulosa cells, in vivo.	USF2	Fshr	0	UNDEFINED	False
9658	9811	18566134:6:USF1:FSHR	Evaluation of [TG] expression in [TF] and Usf2 null mice further explored USF's role in Fshr transcription.	Usf1	Fshr	0	UNDEFINED	False
9659	9812	18566134:6:USF2:FSHR	Evaluation of [TG] expression in Usf1 and [TF] null mice further explored USF's role in Fshr transcription.	Usf2	Fshr	0	UNDEFINED	False
9660	9813	18567745:9:NFE2L2:HMOX1	We also showed using ChIP that exposure to enterolactone increased the binding of [TF] to the promoter region of [TG].	Nrf2	HO-1	0	UNDEFINED	False
9661	9814	18571793:10:JUN:SOCS3	OSM stimulation led to a time-dependent recruitment of the transcription factors STAT-3, c-Fos, [TF], and Sp1 and the coactivators CREB-binding protein (CBP) and p300 to the endogenous [TG] promoter.	c-Jun	SOCS-3	0	UNDEFINED	False
9662	9815	18571793:7:AP1:SOCS3	Analysis of the [TG] promoter revealed that an [TF], two IFN-gamma activation sequence (GAS) elements, and a GC-rich region are crucial for SOCS-3 gene expression.	AP-1 element	SOCS-3	1	ACTIVATION	False
9663	9816	18576389:13:NFKB:GADD45B	[TF] overexpression increased [TG] promoter activity, and siRNA-GADD45beta decreased cell survival per se and enhanced tumor necrosis factor alpha-induced cell death in human articular chondrocytes.	NF-kappaB	GADD45beta	1	ACTIVATION	False
9664	9817	18579531:11:ATF1:UCP3	In conclusion, [TF], via p38 MAP kinase activation, functions as a novel regulatory pathway driving [TG] expression.	ATF-1	UCP3	1	ACTIVATION	False
9665	9818	18579531:7:ATF1:UCP3	Site-directed mutagenesis and chromatin immunoprecipitation assays identify a 10-bp region required for [TF] induction of [TG] promoter activity.	ATF-1	UCP3	1	ACTIVATION	False
9666	9819	18579560:0:SP1:BBC3	[TF] and p73 activate [TG] following serum starvation.	Sp1	PUMA	1	ACTIVATION	False
9667	9820	18579560:4:SP1:BBC3	Following serum starvation, the binding of [TF] to the [TG] promoter significantly increased, whereas inhibition of Sp1 completely abrogated PUMA induction.	Sp1	PUMA	1	ACTIVATION	False
9668	9821	18579560:6:SP1:BBC3	[TF] and p73beta appeared to cooperatively activate [TG] transcription, which is inhibited by the phosphoinsitide 3-kinase (PI3K)-protein kinase B (AKT) pathway.	Sp1	PUMA	1	ACTIVATION	False
9670	9823	18586005:5:AP1:LOXL4	Deletion mapping of the [TG] promoter indicated that the TGF-beta1 regulation of LOXL4 expression is mediated through the binding of [TF] transcription factor to a conserved region of the promoter.	AP1	LOXL4	0	UNDEFINED	False
9671	9824	18586007:5:NFE2L2:HMOX1	siRNA knock down of [TF] significantly inhibited EGC-induced [TG] expression.	Nrf2	HO-1	1	ACTIVATION	False
9672	9825	18586551:6:AP1:SOD1	[TG] reduction is most probably due to an increased DNA binding capacity of [TF], which seems to play a negative role in the capacity of Sp1 to bind to the sod1 gene promoter.	AP-1	SOD1	0	UNDEFINED	True
9673	9826	18586672:10:RELA:SGK1	Chromatin immunoprecipitation showed that LPS increased [TF] binding to two NF-kappaB sites along the [TG] promoter.	p65	SGK1	0	UNDEFINED	False
9674	9827	18586672:11:NFKB:SGK1	In conclusion, we show that activation of the [TF] pathway down-regulates [TG] expression, which might lead to decreased ENaC alpha-subunit expression, ultimately resulting in decreased Na(+) transport.	NF-kappaB	SGK1	2	REPRESSION	False
9675	9828	18591257:7:GATA4:CCNA2	We show that [TF] is required for cyclin D2, [TG], and Cdk4 expression in the right ventricle and that the Cyclin D2 and Cdk4 promoters are bound and activated by GATA4 via multiple consensus GATA binding sites in each gene's proximal promoter.	GATA4	cyclin A2	1	ACTIVATION	False
9676	9829	18593902:5:FOXA2:HPGD	We confirmed the regulation of [TG] expression by [TF] in a number of systems and showed direct binding of HNF3beta to 15-PGDH promoter elements.	HNF3beta	15-PGDH	0	UNDEFINED	True
9677	9830	18593918:6:RELA:MST1R	Using chromatin immunoprecipitation analysis and site-directed mutagenesis of the [TG] promoter, we have confirmed the binding of [TF] to the RON promoter.	p65	RON	0	UNDEFINED	False
9678	9831	18594176:8:STAT3:LGALS3BP	We also identified that (-2,366/-2,356) on [TG] promoter is a putative [TF] binding site and suppression of STAT3 with STAT3 specific siRNA increased the Mac-2BP level, suggesting the role of STAT3 as a negative regulator, in contrast to hTERT, which is known as a positive regulator.	STAT3	Mac-2BP	2	REPRESSION	False
9679	9832	18594176:9:STAT3:LGALS3BP	EGF signal is critical for the [TG] expression, and more importantly, [TF] could work as a negative regulator, while hTERT as a positive regulator in Mac-2BP transcription.	STAT3	Mac-2BP	2	REPRESSION	False
9680	9833	18600430:10:AP1:MMP7	Our data suggest that HRG-beta-induced [TG] expression was regulated by HER2-mediated [TF] activation in MCF-7 cells.	AP-1	MMP-7	1	ACTIVATION	False
9681	9834	18604866:7:EGR1:PRDM1	These studies together characterize for the first time the basal activity of the human [TG] promoter, through which several factors, including SP1, SP3 and [TF], modulate its expression through a conserved GC-box.	early growth response 1	PRDM1	0	UNDEFINED	True
9682	9835	18604866:7:SP1:PRDM1	These studies together characterize for the first time the basal activity of the human [TG] promoter, through which several factors, including [TF], SP3 and early growth response 1, modulate its expression through a conserved GC-box.	SP1	PRDM1	0	UNDEFINED	False
9683	9836	18604866:7:SP3:PRDM1	These studies together characterize for the first time the basal activity of the human [TG] promoter, through which several factors, including SP1, [TF] and early growth response 1, modulate its expression through a conserved GC-box.	SP3	PRDM1	1	ACTIVATION	False
9684	9837	18615188:2:KLF6:TGFB1	This review will introduce the novel mechanism associated with the inhibition of the [TG]1 gene by PPARgamma activation, which regulates the dephosphorylation of [TF] transcription factor.	Zf9	TGFbeta	0	UNDEFINED	True
9685	9838	18616672:13:STAT3:ICAM1	Consistent with inhibition of IL-6-induced [TF] DNA binding in alcohol-pretreated cells, the levels of IL-6-dependent genes, MCP-1 and [TG], was reduced after IL-6 stimulation.	STAT3	ICAM-1	1	ACTIVATION	False
9686	9839	18625721:0:USF1:DUSP1	Retinoic acid utilizes CREB and [TF] in a transcriptional feed-forward loop in order to stimulate [TG] expression in human immunodeficiency virus-infected podocytes.	USF1	MKP1	1	ACTIVATION	False
9687	9840	18625721:4:USF1:DUSP1	atRA stimulated CREB and [TF] binding to the [TG] gene promoter, as shown by gel shifting and chromatin immunoprecipitation assays.	USF1	MKP1	0	UNDEFINED	False
9688	9841	18628250:0:SP3:CDKN1A	Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances [TF] binding on the [TG]WAF1 promoter.	Sp3	P21	0	UNDEFINED	False
9689	9842	18628250:6:SP3:CDKN1A	Chromatin immunoprecipitation assays confirmed the presence of hyperacetylated histone H3 on the [TG]WAF1 gene promoter within 4 h of AM exposure, and there was increased binding of the transcription factor [TF].	Sp3	P21	0	UNDEFINED	False
9690	9843	18628250:8:SP3:CDKN1A	These findings suggest a primary role for [TF] in driving [TG] gene expression after HDAC inhibition by AM, followed by the subsequent recruitment of p53.	Sp3	P21	1	ACTIVATION	False
9691	9844	18632605:6:MYC:HIF1A	In addition, overexpression of [TF] led to down-regulation of [TG] and induction of miR-17-92, the latter of which was previously reported to be a transcriptional activation activity, suggesting that the induction of miR-17-92 may play a role at least in part in c-myc-mediated repression of HIF-1 alpha.	c-myc	HIF-1 alpha	2	REPRESSION	False
9692	9845	18632621:7:SP1:VEGFA	Using promoter deletion constructs, we found that CsA-mediated [TG] transcription was primarily [TF] dependent.	Sp1	VEGF	1	ACTIVATION	False
9693	9846	18634911:0:POU2F1:FABP2	Analysis of the transcriptional regulation of the [TG] promoter haplotypes by PPARgamma/RXRalpha and [TF].	Oct-1	FABP2	0	UNDEFINED	False
9694	9847	18634911:5:POU2F1:FABP2	As shown by EMSA and promoter-reporter assays, [TF] interacts with the -471 region of [TG] promoters, induces the activities of both FABP2 promoter haplotypes and abolishes the different activities of haplotypes induced by rosiglitazone activated PPARgamma/RXRalpha.	Oct-1	FABP2	1	ACTIVATION	False
9695	9848	18634911:6:POU2F1:FABP2	In conclusion, our findings suggest a functional role of PPARgamma/RXRalpha and [TF] in the regulation of the [TG] gene.	Oct-1	FABP2	0	UNDEFINED	False
9696	9849	18636159:0:MYC:CDKN1A	De-repression of the [TG] promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and [TF].	c-Myc	p21	2	REPRESSION	True
9698	9851	18636203:4:CREB1:S100P	Using a series of the promoter constructs analyzed by dual luciferase reporter assay, we identified SMAD, STAT/[TF] and SP/KLF binding sites as critical cis-elements required for [TG] expression in cancer cells.	CREB	S100P	1	ACTIVATION	False
9699	9852	18638447:10:JUNB:NOX1	These results suggest that the ERK1/2-[TF] pathway is a key regulator of the inducible expression of the [TG] gene in vascular smooth muscle cells.	JunB	NOX1	1	ACTIVATION	True
9700	9853	18638447:6:AP1:NOX1	A consensus activator protein-1 ([TF]) site was found at -98/-92 in the 5'-flanking region of the rat [TG] gene.	AP-1	NOX1	0	UNDEFINED	False
9701	9854	18644981:9:FOSB:TNFSF10	Furthermore, with tRNA interference targeting Smad4, junD, [TF], we could abolish [TG] expression and, subsequently, TGF-beta-induced TRAIL-mediated apoptosis in hepatoma cells.	FosB	TRAIL	1	ACTIVATION	False
9702	9855	18644981:9:JUND:TNFSF10	Furthermore, with tRNA interference targeting Smad4, [TF], FosB, we could abolish [TG] expression and, subsequently, TGF-beta-induced TRAIL-mediated apoptosis in hepatoma cells.	junD	TRAIL	1	ACTIVATION	False
9703	9856	18644981:9:SMAD4:TNFSF10	Furthermore, with tRNA interference targeting [TF], junD, FosB, we could abolish [TG] expression and, subsequently, TGF-beta-induced TRAIL-mediated apoptosis in hepatoma cells.	Smad4	TRAIL	1	ACTIVATION	False
9704	9857	18644986:10:ATF3:CDKN1A	Chromatin immunoprecipitation analyses show that TAp73beta and [TF] are recruited directly to the [TG] and Bax promoter.	ATF3	p21	0	UNDEFINED	False
9705	9858	18645021:5:KLF4:CDKN1A	Analysis of the [TG] promoter in p53-dependent RKO cells showed that 5,5'-dibromoDIM activated p21 gene expression through the proximal GC-rich sites 1 and 2, and chromatin immunoprecipitation assays showed that [TF] and p53 bound to this region of the promoter, whereas in HT-29 cells unidentified upstream cis-elements were required for induction of p21.	KLF4	p21	1	ACTIVATION	True
9706	9859	18650268:0:CEBPB:PTGS2	Corticosteroids induce [TG] expression in cardiomyocytes: role of glucocorticoid receptor and [TF].	C/EBP-beta	COX-2	1	ACTIVATION	False
9707	9860	18650268:11:CEBPB:PTGS2	Small interfering RNA against [TF] prevented CT from activating [TG] promoter or elevating COX-2 protein.	C/EBP-beta	COX-2	1	ACTIVATION	False
9708	9861	18650268:8:CEBPB:PTGS2	[TG] gene promoter deletion and mutation studies indicate a role of [TF] (C/EBP-beta) in CT-induced COX-2 gene expression.	CCAAT/enhancer binding protein-beta	COX-2	1	ACTIVATION	False
9709	9862	18650268:9:CEBPB:PTGS2	Chromatin immunoprecipitation assays revealed that CT caused the binding of both GR and [TF] to [TG] promoter, while MF pretreatment blocked such binding.	C/EBP-beta	COX-2	0	UNDEFINED	False
9710	9863	18651838:3:ETS1:NPR1	The objective of the present study was to elucidate the mechanism by which [TF] [Ets (E twenty-six) transformation-specific sequence] contributes to the regulation of [TG] gene transcription and expression.	Ets-1	Npr1	0	UNDEFINED	True
9711	9864	18651838:4:ETS1:NPR1	Chromatin immunoprecipitation and gel-shift assays confirmed the in vivo and in vitro binding of [TF] to the [TG] promoter.	Ets-1	Npr1	0	UNDEFINED	False
9713	9866	18652825:13:NFKB:STC1	This is the first study to show that histone hyper-acetylation and the recruitment of activated [TF] stimulated [TG] gene expression.	NFkappaB	STC1	1	ACTIVATION	False
9714	9867	18652825:8:NFKB:STC1	ChIP assay also demonstrated that TSA treatment increased while TSA/parthenolide cotreatment decreased [TF] p65 binding to [TG] gene promoter.	NFkappaB	STC1	0	UNDEFINED	False
9715	9868	18652825:8:RELA:STC1	ChIP assay also demonstrated that TSA treatment increased while TSA/parthenolide cotreatment decreased NFkappaB [TF] binding to [TG] gene promoter.	p65	STC1	0	UNDEFINED	False
9716	9869	18653705:10:FOS:FSHB	A dominant-negative Fos protein dose dependently inhibited GnRH1-stimulated [TG] transcription, confirming a role for endogenous [TF] proteins.	AP-1	FSHB	1	ACTIVATION	False
9717	9870	18656622:11:HNF1A:SLC5A1	[TF] and HNF 1 beta are important transcription factors for endogenous [TG] expression by cultured enterocytes.	HNF 1 alpha	SGLT1	1	ACTIVATION	False
9718	9871	18656622:11:HNF1B:SLC5A1	HNF 1 alpha and [TF] are important transcription factors for endogenous [TG] expression by cultured enterocytes.	HNF 1 beta	SGLT1	1	ACTIVATION	False
9719	9872	18656622:12:CDX2:SLC5A1	GATA-5 and [TF] also regulate [TG] promoter activity and show cooperativity with the HNF1s.	CDX2	SGLT1	0	UNDEFINED	False
9720	9873	18656622:12:GATA5:SLC5A1	[TF] and CDX2 also regulate [TG] promoter activity and show cooperativity with the HNF1s.	GATA-5	SGLT1	0	UNDEFINED	False
9721	9874	18656622:2:HNF1A:SLC5A1	Hepatocyte nuclear factors 1 alpha and beta ([TF] and HNF 1 beta) activate the [TG] promoter, whereas GATA-binding protein 5 (GATA-5) and caudal-type homeobox protein 2 (CDX2) regulate transcription of other intestinal genes.	HNF 1 alpha	SGLT1	1	ACTIVATION	False
9722	9875	18656622:2:HNF1B:SLC5A1	Hepatocyte nuclear factors 1 alpha and beta (HNF 1 alpha and [TF]) activate the [TG] promoter, whereas GATA-binding protein 5 (GATA-5) and caudal-type homeobox protein 2 (CDX2) regulate transcription of other intestinal genes.	HNF 1 beta	SGLT1	1	ACTIVATION	False
9723	9876	18656622:7:GATA5:SLC5A1	HNF 1 alpha, [TF], and HNF 1 beta significantly activated the [TG] promoter (P < .05).	GATA-5	SGLT1	1	ACTIVATION	False
9724	9877	18656622:7:HNF1A:SLC5A1	[TF], GATA-5, and HNF 1 beta significantly activated the [TG] promoter (P < .05).	HNF 1 alpha	SGLT1	1	ACTIVATION	False
9725	9878	18656622:7:HNF1B:SLC5A1	HNF 1 alpha, GATA-5, and [TF] significantly activated the [TG] promoter (P < .05).	HNF 1 beta	SGLT1	1	ACTIVATION	False
9726	9879	18656622:9:HNF1B:SLC5A1	[TG] expression was significantly reduced in HNF 1 alpha or [TF] knockdowns (P < .001).	HNF 1 beta	SGLT1	1	ACTIVATION	False
9727	9880	18664273:10:SMAD4:LAMA3	Whereas [TF] is essential for positive regulation of all three genes, the molecular mechanisms are significantly divergent between the [TG] promoter as compared to the LAMB3 and LAMC2 promoters.	Smad4	LAMA3	1	ACTIVATION	False
9728	9881	18664273:10:SMAD4:LAMB3	Whereas [TF] is essential for positive regulation of all three genes, the molecular mechanisms are significantly divergent between the LAMA3 promoter as compared to the [TG] and LAMC2 promoters.	Smad4	LAMB3	1	ACTIVATION	True
9729	9882	18664273:10:SMAD4:LAMC2	Whereas [TF] is essential for positive regulation of all three genes, the molecular mechanisms are significantly divergent between the LAMA3 promoter as compared to the LAMB3 and [TG] promoters.	Smad4	LAMC2	1	ACTIVATION	False
9730	9883	18667418:6:E2F1:PDK4	Furthermore, inactivation of Rb, the repressor of E2F-dependent transcription, markedly induces [TG] and triggers the enrichment of [TF] occupancy onto the PDK4 promoter as detected by chromatin immunoprecipitation analysis.	E2F1	PDK4	0	UNDEFINED	False
9731	9884	18667418:9:E2F1:PDK4	Taken together, our data illustrate how the [TF] mitogen directly regulates [TG] levels and influences cellular bioenergetics, namely mitochondrial glucose oxidation.	E2F1	PDK4	0	UNDEFINED	False
9732	9885	18676374:11:ETS1:MUC5AC	The effects of exogenous ATP on [TG] gene expression are mediated by a complex regulatory cascade controlling interactions between CREB and [TF] that bind to a promoter element in the MUC5AC gene enhancing MUC5AC gene transcription.	c-Ets1	MUC5AC	1	ACTIVATION	False
9733	9886	18676374:12:ETS1:MUC5AC	ATP-dependent activation of [TG] gene expression via CREB-[TF] may contribute to mucous cell hypersecretion associated with common respiratory disorders.	c-Ets1	MUC5AC	1	ACTIVATION	False
9734	9887	18676374:6:ETS1:MUC5AC	ATP-induced [TG] mRNA levels were regulated by CREB via direct interaction with [TF] on the MUC5AC gene promoter (located -938 to -930).	c-Ets1	MUC5AC	1	ACTIVATION	False
9735	9888	18676374:9:ETS1:MUC5AC	Stimulation with ATP caused the direct binding of CREB and [TF] to the [TG] promoter, increasing the phosphorylation of c-Ets1.	c-Ets1	MUC5AC	0	UNDEFINED	False
9736	9889	18682402:0:ZBTB7A:FASN	Proto-oncogene [TF] (Pokemon) and SREBP-1 synergistically activate transcription of [TG] gene (FASN).	FBI-1	fatty-acid synthase	1	ACTIVATION	False
9737	9890	18682850:11:SMAD1:OLIG2	We also show that SMAD4, which acts as a common partner for receptor-regulated Smads including [TF], associates with a Smad binding site in the [TG] promoter and dissociates from it upon differentiation.	SMAD1	Olig2	0	UNDEFINED	False
9738	9891	18682850:12:SMAD1:OLIG2	Taken together, these results suggest that FGF can promote OPC generation from embryonic NPCs by counteracting BMP signalling at the [TF] transcription factor level and that Smad-containing transcriptional complexes may be involved in direct regulation of the [TG] promoter.	Smad1	Olig2	0	UNDEFINED	False
9739	9892	18687676:6:KLF3:KLF8	Chromatin immunoprecipitation experiments confirm that [TF] occupies both [TG] promoters in vivo.	Klf3	Klf8	0	UNDEFINED	False
9740	9893	18687676:7:KLF1:KLF8	Interestingly, in Klf3 knock-out tissue [TF] gains access, binds, and activates both [TG] promoters.	Klf1	Klf8	1	ACTIVATION	False
9741	9894	18687676:7:KLF3:KLF8	Interestingly, in [TF] knock-out tissue Klf1 gains access, binds, and activates both [TG] promoters.	Klf3	Klf8	1	ACTIVATION	False
9744	9897	18692059:6:NFKB:NTN1	Binding of [TF] to [TG] promoter and effect of NF-kappaB activation to the proapoptotic activity of UNC5H2 were also analyzed.	NF-kappaB	netrin-1	0	UNDEFINED	False
9745	9898	18692155:0:AR:CCND1	A cross-talk between the [TF] and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and [TG] expression in prostate and lung cancer cells.	androgen receptor	cyclinD1	1	ACTIVATION	False
9746	9899	18694725:0:YY1:DDIT3	Transcription factor [TF] promotes adipogenesis via inhibiting [TG] expression.	YY1	CHOP-10	2	REPRESSION	False
9747	9900	18694725:3:YY1:DDIT3	In the present study, we reported that FBS induced the expression of [TF], which bound to [TG] promoter via two adjacent YY1-binding sites, suppressing its expression.	YY1	CHOP-10	2	REPRESSION	False
9748	9901	18698092:0:EGR1:TBXA2R	Regulation of the [TG] gene by Sp1, [TF], NF-E2, GATA-1, and Ets-1 in megakaryocytes.	Egr1	human thromboxane A2 receptor	0	UNDEFINED	False
9749	9902	18701496:8:SP1:TNFSF10	Taken together, our results indicate that induction of [TG] by the combined treatments with MS275 and Adriamycin is mediated by [TF] and suggest that transcription factor Sp1 is an important target for the development of novel anticancer agents.	Sp1	TRAIL	1	ACTIVATION	False
9750	9903	18704831:5:NFE2L2:HMOX1	The transcription factor, NF-E2 related factor 2 ([TF]), regulates the antioxidant response element (ARE) of the phase 2 detoxifying and antioxidant enzymes, resulting in modulation of [TG] expression.	Nrf2	HO-1	0	UNDEFINED	False
9751	9904	18708082:7:NFKB:PLA2G4A	MAPKs together with [TF]-activated p300 recruited to [TG] promoter thus facilitating the binding of NF-kappaB to cPLA2 promoter region and expression of cPLA2 mRNA.	NF-kappaB	cPLA2	1	ACTIVATION	False
9752	9905	18713830:0:CREB1:CCND1	VRK1 phosphorylates [TF] and mediates [TG] expression.	CREB	CCND1	1	ACTIVATION	False
9753	9906	18713968:0:FOXO1:SELL	[TF] regulates [TG] and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase.	FOXO1	L-Selectin	0	UNDEFINED	False
9754	9907	18713968:2:FOXO1:SELL	We now report that [TF] controls the expression of [TG], an essential homing molecule, in human T lymphocytes.	FOXO1	L-selectin	0	UNDEFINED	False
9755	9908	18715197:6:REL:CXCL10	Chromatin immunoprecipitation (ChIP) and real-time PCR assays confirmed that [TF] directly binds to the promoters of several ISGs, including [TG], Isg15, Gbp2, Ifit3, and Ifi203, and regulates their expression.	cRel	Cxcl10	0	UNDEFINED	False
9756	9909	18715197:6:REL:IFIT3	Chromatin immunoprecipitation (ChIP) and real-time PCR assays confirmed that [TF] directly binds to the promoters of several ISGs, including Cxcl10, Isg15, Gbp2, [TG], and Ifi203, and regulates their expression.	cRel	Ifit3	0	UNDEFINED	False
9757	9910	18715197:6:REL:ISG15	Chromatin immunoprecipitation (ChIP) and real-time PCR assays confirmed that [TF] directly binds to the promoters of several ISGs, including Cxcl10, [TG], Gbp2, Ifit3, and Ifi203, and regulates their expression.	cRel	Isg15	0	UNDEFINED	False
9758	9911	18718863:5:CREB1:EGR1	Whatever the differentiation state of 1C11 cells, the PrP(C)-dependent [TF] activation triggers [TG] and c-fos transcription, two immediate early genes that relay CREB's role in cell survival and proliferation as well as in neuronal plasticity.	CREB	Egr-1	1	ACTIVATION	False
9759	9912	18719026:8:NFKB1:IGF1	Cotransfection of CWSV-1 cells with expression vectors for p65 alone or [TF] and p65 together inhibited GH-inducible Spi 2.1 and [TG] promoter activity.	p50	IGF-I	2	REPRESSION	False
9760	9913	18719026:8:RELA:IGF1	Cotransfection of CWSV-1 cells with expression vectors for [TF] alone or p50 and p65 together inhibited GH-inducible Spi 2.1 and [TG] promoter activity.	p65	IGF-I	2	REPRESSION	False
9761	9914	18719026:9:RELA:IGF1	Cotransfection with a C-terminal [TF] deletion (1-450) enhanced GH-inducible promoter activity, whereas the N-terminal deletion (31-551) was inhibitory for [TG] but not Spi 2.1.	p65	IGF-I	2	REPRESSION	True
9762	9915	18720385:10:HIF1A:ANG	We also show that hypoxic regulation of [TG] is HIF-dependent and demonstrate that [TF] binds in human microvascular endothelial cells (HMVEC) to an evolutionary conserved Hypoxia-Responsive Element (HRE) located in the first intron of the Ang-2 gene.	HIF-1alpha	Ang-2	0	UNDEFINED	False
9763	9916	18726998:8:VDR:CYP24A1	In addition, we found that 1,25(OH)(2)D(3)-induced association of [TF] with chromatin and with the [TG] promoter was lower in proliferating cells.	VDR	CYP24	0	UNDEFINED	False
9764	9917	18727915:5:NFKB:KIAA0101	We found that the nuclear protein rh[TF] (p50) could bind to the [TG] promoter and the binding region contained within a 156 bp (nucleotides -5 to -161bp) immediately upstream of the transcription initiation site.	NF-kappaB	NS5ATP9	0	UNDEFINED	False
9765	9919	18727915:6:NFKB:KIAA0101	Our results suggest that [TF] could participate in the regulation of [TG] gene expression in carcinogenesis.	NF-kappaB	NS5ATP9	0	UNDEFINED	False
9766	9920	18752316:9:NFKB:NQO1	These results clearly demonstrate that activation of [TF] negatively regulates the expression of [TG] by heavy metals, whereas AP-1 signaling pathways differentially modulates the heavy metal-mediated effects.	NF-kappaB	Nqo1	2	REPRESSION	False
9767	9921	18752821:6:RELA:PTGS2	Overexpression of IkappaBalpha completely abrogated [TG] induction, and transfection of p65/[TF] NF-kappaB induced COX-2 transcription.	relA	COX-2	1	ACTIVATION	False
9769	9923	18757399:6:FOS:PDPN	Direct [TF] protein binding to the [TG] promoter was shown by chromatin immunoprecipitation and a TPA-induced complex at a TPA-responsive element-like motif in the proximal promoter was identified by electrophoretic mobility shift assays.	Fos	Pdpn	0	UNDEFINED	False
9770	9924	18757425:4:EWSR1:CDKN1A	Studying 6 ESFT cell lines, silencing of [TF]-FLI1 in a wild-type p53 context resulted in increased p53 and p21([TG]/CIP1) levels, causing cell cycle arrest.	EWS	WAF1	2	REPRESSION	False
9771	9925	18757425:4:FLI1:CDKN1A	Studying 6 ESFT cell lines, silencing of EWS-[TF] in a wild-type p53 context resulted in increased p53 and p21([TG]/CIP1) levels, causing cell cycle arrest.	FLI1	WAF1	2	REPRESSION	True
9772	9926	18761727:10:ETS1:SELE	We show that K1-3 induced [TG] expression via AP1 and [TF] binding to the proximal E-selectin promoter (-356/+1), which was positively mediated by JNK activation.	Ets-1	E-selectin	1	ACTIVATION	False
9773	9927	18765639:5:CTCFL:BRCA1	RNA interference (RNAi) knockdown of BAT3, as well as SET1A, decreased Myc and [TG] gene expression but did not affect the binding properties of [TF], but RNAi knockdown of BORIS prevented the assembly of BAT3 and SET1A at the Myc and BRCA1 promoters.	BORIS	BRCA1	0	UNDEFINED	False
9774	9928	18765639:5:CTCFL:MYC	RNA interference (RNAi) knockdown of BAT3, as well as SET1A, decreased [TG] and BRCA1 gene expression but did not affect the binding properties of [TF], but RNAi knockdown of BORIS prevented the assembly of BAT3 and SET1A at the Myc and BRCA1 promoters.	BORIS	Myc	0	UNDEFINED	False
9775	9929	18765668:0:TP53:BRCA2	Estrogen receptor (ER) beta or [TF] attenuates ERalpha-mediated transcriptional activation on the [TG] promoter.	p53	BRCA2	2	REPRESSION	False
9776	9930	18765668:3:MYOD1:BRCA2	During estrogen treatment, ERalpha interacted with CREB-binding protein/p300, p68/p72, and [TF] and formed an activating transcriptional complex that could bind to many Sp1 sites on the [TG] promoter and activate its transcription by inducing histone acetylations.	MyoD	BRCA2	1	ACTIVATION	False
9777	9931	18765668:5:TP53:BRCA2	ERbeta or [TF] attenuated ERalpha-mediated transcriptional activation by preventing the recruitment of ERalpha transcriptional complex and histone acetylations on the [TG] promoter.	p53	BRCA2	2	REPRESSION	False
9778	9933	18768464:7:RUNX1:FHL2	Importantly, TRAF6 recognizes FHL2 and [TF] in osteoclast nuclei, and the three molecules form a DNA-binding complex that recognizes and transactivates the RUNX1 response element in the [TG] promoter.	RUNX1	fhl2	1	ACTIVATION	False
9779	9934	18769028:0:NR1H4:SLC2A4	Farnesoid X receptor induces [TG] expression through [TF] response element in the GLUT4 promoter.	FXR	GLUT4	1	ACTIVATION	False
9780	9935	18769160:8:NFKB:SP1	Transient transfections of CDK4, Rad51, E2F-DP1, p21 and Stat3 increased mRNA expression from the endogenous [TG] gene in HeLa cells whereas overexpression of [TF], and p53 decreased Sp1 mRNA levels.	NF kappaB	Sp1	2	REPRESSION	False
9781	9936	18769717:13:NFE2L2:PPP1R15B	Genes predicted as novel [TF] targets include Atf1, Srxn1, Prnp, Sod2, Als2, Nfkbib, and [TG].	Nrf2	Ppp1r15b	0	UNDEFINED	False
9782	9937	18769717:13:NFE2L2:PRNP	Genes predicted as novel [TF] targets include Atf1, Srxn1, [TG], Sod2, Als2, Nfkbib, and Ppp1r15b.	Nrf2	Prnp	0	UNDEFINED	False
9783	9938	18771089:0:NFE2L2:HMOX1	[TF]-dependent induction of human ABC transporter ABCG2 and [TG] in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy.	Nrf2	heme oxygenase-1	1	ACTIVATION	False
9784	9939	18771089:6:NFE2L2:ABCG2	[TF]-specific siRNA treatments suppressed the induction of both [TG] and HO-1 after the photoactivation of porphyrins, suggesting that Nrf2 is a common regulator for transcriptional activation of the ABCG2 and HO-1 genes.	Nrf2	ABCG2	1	ACTIVATION	False
9785	9940	18771089:6:NFE2L2:HMOX1	[TF]-specific siRNA treatments suppressed the induction of both ABCG2 and [TG] after the photoactivation of porphyrins, suggesting that Nrf2 is a common regulator for transcriptional activation of the ABCG2 and HO-1 genes.	Nrf2	HO-1	1	ACTIVATION	False
9786	9941	18771089:8:BACH1:HMOX1	This induction may be attributed to inactivation of [TF], a repressor for the [TG] gene, by those compounds.	Bach1	HO-1	2	REPRESSION	False
9787	9942	18771702:8:NFKB:PTGS2	We conclude that G-Gly induced signalling involves a JAK2/PI3-kinase/Akt/[TF] sequence leading to [TG] transcription.	NF-kappaB	COX-2	1	ACTIVATION	False
9788	9943	18772349:2:NFKB:SHH	We identify putative [TF] binding sites in the human [TG] promoter region that specifically bind NF-kappaB complexes.	NF-kappaB	Shh	0	UNDEFINED	False
9789	9944	18772349:3:RELA:SHH	Further, NF-kappaB activation by tumor necrosis factor alpha (TNF-alpha) or [TF] overexpression stimulates [TG] promoter activity and p65 binds to Shh promoter in vivo.	p65	Shh	1	ACTIVATION	False
9790	9945	18772349:4:NFKB:SHH	[TF]-mediated transcriptional activation of [TG] is mapped to a minimal NF-kappaB consensus site at position +139 of Shh promoter.	NF-kappaB	Shh	1	ACTIVATION	False
9791	9946	18772349:6:NFKB:SHH	Specific [TF] inhibition by inhibitory NF-kappaBalpha (Ikappa-Balpha) superrepressor or p65 knockdown inhibits NF-kappaB-induced [TG] promoter activation and Shh expression.	NF-kappaB	Shh	1	ACTIVATION	False
9792	9947	18772349:6:RELA:SHH	Specific NF-kappaB inhibition by inhibitory NF-kappaBalpha (Ikappa-Balpha) superrepressor or [TF] knockdown inhibits NF-kappaB-induced [TG] promoter activation and Shh expression.	p65	Shh	1	ACTIVATION	False
9793	9948	18779317:0:TP53:TLR3	[TF] regulates [TG] expression and function in human epithelial cell lines.	p53	Toll-like receptor 3	0	UNDEFINED	False
9794	9949	18779317:10:TP53:TLR3	These results suggest that [TF] influences [TG] expression and function and highlight a role of p53 in innate immune response in epithelial cells.	p53	TLR3	0	UNDEFINED	False
9795	9950	18779317:4:TP53:TLR3	[TG] expression was lower in HCT116 [TF](-/-) cells than in HCT116 p53(+/+) cells.	p53	TLR3	1	ACTIVATION	False
9796	9951	18779317:5:TP53:TLR3	Activation of [TF] by 5-fluorouracil increased the [TG] mRNA in epithelial cell lines with wild-type p53 but not in cell lines harboring mutant p53.	p53	TLR3	1	ACTIVATION	False
9797	9952	18779317:6:TP53:TLR3	Knockdown of [TF] by small interfering RNA decreased the [TG] expression.	p53	TLR3	1	ACTIVATION	False
9798	9953	18779345:6:EGR2:CDKN1A	We found that the expression of cyclin-dependent kinase inhibitor [TG] was impaired in [TF]-deficient T cells, whereas the expression of IFN-gamma and IL-17 in response to T cell receptor ligation was significantly increased, suggesting that Egr-2 activates the expression of genes involved in the negative regulation of T cell proliferation and inflammation.	Egr-2	p21cip1	1	ACTIVATION	False
9799	9954	18780286:3:EGR1:UCP1	Promoter deletion assay identified binding sites for [TF] (Egr-1) and serum response factor (SRF) in the [TG] promoter.	early growth response-1	UCP	0	UNDEFINED	False
9800	9955	18780286:6:EGR1:UCP1	By electrophoretic mobility shift and chromatin immunoprecipitation assays, sequence-specific DNA-binding of [TF] and SRF to the [TG] promoter was detected in nuclear extracts from HeLa cells treated with EGF and serum, respectively.	Egr-1	UCP	0	UNDEFINED	False
9801	9956	18780286:7:EGR1:UCP1	Overexpression of [TF] or SRF increased [TG] expression.	Egr-1	UCP	1	ACTIVATION	False
9802	9957	18780286:9:EGR1:UCP1	Systemic delivery of EGF into mice also increased [TG] expression following early induction of [TF] expression in mouse liver.	Egr-1	UCP	1	ACTIVATION	False
9803	9958	18793746:5:GATA1:WNK4	Analysis of the transcriptional activity of a series of the truncated h[TG] promoters by luciferase assay indicated that the region -484 to -337 of the hWNK4 promoter was sensitive to TSA, and a [TF] binding motif was identified at position -426 using TRANSFAC-TESS program.	GATA-1	WNK4	0	UNDEFINED	False
9804	9959	18793746:8:GATA1:WNK4	These findings indicate that TSA induces h[TG] expression, at least in part, by increasing [TF] acetylation, and thereby its binding to the GATA-1 responsive element, within the hWNK4 promoter.	GATA-1	WNK4	1	ACTIVATION	False
9805	9960	18793823:4:STAT5B:CDKN1A	Our results demonstrate that [TF] is involved in GBM cell growth, cell cycle progression, invasion and migration through regulation of gene expression, such as Bcl-2, p21([TG]/cip1), p27(kip1), FAK and VEGF.	STAT5b	waf1	0	UNDEFINED	False
9806	9961	18794798:4:SOX9:CEACAM1	Moreover, [TG] expression is reduced in colon of [TF]-deficient mouse, suggesting an important function for SOX9 in the transcriptional activation of the CEACAM1 gene.	SOX9	CEACAM1	1	ACTIVATION	False
9807	9962	18794798:5:SOX9:CEACAM1	We further identified [TF]-binding sequences in the human and rat [TG] promoters, and an electrophoretic mobility shift together with a chromatin immunoprecipitation provided an additional evidence of the SOX9 binding to the human promoter.	SOX9	CEACAM1	0	UNDEFINED	False
9808	9963	18798339:3:MYC:CDC20	Moreover, the TCPOBOP-induced cell cycle program (Cdc2, cyclins, MCM proteins, [TG], and genes implicated in the spindle assembly checkpoint) is severely impaired in [TF] mutant livers.	c-Myc	Cdc20	0	UNDEFINED	True
9809	9964	18800033:5:YBX1:CCL5	Among three possible [TF] binding sites in the [TG] promoter, a critical element was mapped at -28/-10 bps.	YB-1	CCL5	0	UNDEFINED	False
9810	9965	18800033:8:YBX1:CCL5	We show that [TF] is a cell-type specific regulator of [TG] expression in infiltrating T-cells and monocytes/macrophages and acts as an adaptive controller of inflammation during kidney allograft rejection.	YB-1	CCL5	0	UNDEFINED	False
9812	9967	18802055:7:ATF2:CDKN2A	Chromosomal DNA immunoprecipitation assays revealed that SMAD-3 and [TF] bind to the endogenous [TG] promoter in RAW264.7 cells and SJL/J SPM following challenge with TMEV.	ATF-2	p19	0	UNDEFINED	False
9813	9968	18802113:6:ATF3:MMP1	IFN-gamma strongly enhanced TLR-induced expression of the transcriptional repressor activating transcription factor ([TF]) in a STAT1-dependent manner, which correlated with recruitment of ATF-3 to the endogenous [TG] promoter as detected by chromatin immunoprecipitation assays.	ATF-3	MMP-1	0	UNDEFINED	False
9814	9969	18802113:7:ATF3:MMP1	RNA interference experiments further supported a role for [TF] in suppression of [TG] expression.	ATF-3	MMP-1	2	REPRESSION	False
9815	9970	18805405:8:NR1I3:CYP3A4	Furthermore, [TF] and GR were also involved in the induction of [TG]4 expression by tanshinones, though their roles seemed not as important as PXR.	CAR	CYP3A	1	ACTIVATION	False
9816	9971	18805419:10:FOXL2:CYP19A1	Altogether, these results suggest that [TF] probably plays a very important role in ovarian differentiation of R. rugosa by possibly regulating [TG] expression.	Foxl2	CYP19	0	UNDEFINED	True
9817	9972	18805788:0:FOXO1:G6PC	A combination of HNF-4 and [TF] is required for reciprocal transcriptional regulation of glucokinase and [TG] genes in response to fasting and feeding.	Foxo1	glucose-6-phosphatase	0	UNDEFINED	False
9818	9973	18805788:0:FOXO1:GCK	A combination of HNF-4 and [TF] is required for reciprocal transcriptional regulation of [TG] and glucose-6-phosphatase genes in response to fasting and feeding.	Foxo1	glucokinase	0	UNDEFINED	True
9819	9974	18805788:0:HNF4A:GCK	A combination of [TF] and Foxo1 is required for reciprocal transcriptional regulation of [TG] and glucose-6-phosphatase genes in response to fasting and feeding.	HNF-4	glucokinase	0	UNDEFINED	False
9820	9975	18805960:7:SRF:TAGLN	Analysis by chromatin immunoprecipitation showed that the binding of the transcriptional regulator serum response factor ([TF]) to the promoters of SmMHC, [TG], and calponin genes was increased in ILK-depleted tissues and decreased in tissues overexpressing ILK.	SRF	SM22alpha	0	UNDEFINED	False
9821	9976	18806759:0:E2F1:SRSF2	[TF] controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor [TG].	E2F1	SC35	1	ACTIVATION	False
9822	9977	18806825:5:MYC:CCND1	Mechanistic investigations revealed that TCEAL7 associates with [TG] promoter containing [TF] E-box sequence and transcriptionally represses cyclin D1 expression.	Myc	cyclin D1	0	UNDEFINED	True
9823	9978	18806825:6:MAX:ODC1	Moreover, downregulation of TCEAL7 promotes DNA-binding activity of Myc-[TF], and upregulates the promoter activity of c-Myc-target gene, ornithine decarboxylase ([TG]), whereas enhanced expression of TCEAL7 inhibits Myc-induced promoter activity of ODC.	Max	ODC	1	ACTIVATION	True
9824	9979	18806825:6:MYC:ODC1	Moreover, downregulation of TCEAL7 promotes DNA-binding activity of Myc-Max, and upregulates the promoter activity of [TF]-target gene, ornithine decarboxylase ([TG]), whereas enhanced expression of TCEAL7 inhibits Myc-induced promoter activity of ODC.	c-Myc	ODC	1	ACTIVATION	True
9825	9980	18811981:0:SP1:BBC3	[TF] is involved in H2O2-induced [TG] gene expression and apoptosis in colorectal cancer cells.	Sp1	PUMA	1	ACTIVATION	False
9826	9981	18811981:7:SP1:BBC3	Deletion of the [TF]-binding sites also decreased the transactivation of [TG] promoter by H2O2.	Sp1	PUMA	1	ACTIVATION	False
9827	9982	18811981:8:SP1:BBC3	Furthermore, induction of [TG] promoter activity by H2O2 was abrogated by PFT-alpha (a p53 inhibitor) and Mithramycin A (a [TF] inhibitor), as compared with PFT-alpha alone.	Sp1	PUMA	1	ACTIVATION	False
9828	9983	18814180:0:CREB1:EGR1	Elk-1, [TF], and MKP-1 regulate [TG] expression in gonadotropin-releasing hormone stimulated gonadotrophs.	CREB	Egr-1	0	UNDEFINED	False
9829	9984	18814180:0:ELK1:EGR1	[TF], CREB, and MKP-1 regulate [TG] expression in gonadotropin-releasing hormone stimulated gonadotrophs.	Elk-1	Egr-1	0	UNDEFINED	False
9830	9985	18818403:4:PPARA:TERT	[TF] activation inhibited mitogen-induced telomerase activity by repressing the catalytic subunit [TG] (TERT) through negative cross-talk with an E2F-1-dependent trans-activation of the TERT promoter.	PPARalpha	telomerase reverse transcriptase	2	REPRESSION	True
9831	9986	18820298:9:CEBPD:PTGS2	In light of the above, our data suggest that the su[TF] and suLAP1 are involved in the repression of [TG] transcription through the recruitment of HDAC4.	CEBPD	COX-2	2	REPRESSION	False
9832	9987	18826952:7:NRF1:MT2A	In contrast, expression of metallothionein-1 and -2 ([TG] and MT2) genes, each of which harbors at least one ARE in its regulatory region, was decreased in the [TF]-null mutant mice.	Nrf1	MT1	1	ACTIVATION	False
9833	9988	18832669:2:NFKB:TSLP	We have shown that the human [TG] gene is regulated in a [TF]-dependent manner; however the factors that negatively regulate TSLP expression are not known.	NF-kappaB	TSLP	0	UNDEFINED	True
9834	9989	18832669:4:NFKB:TSLP	This inhibition is manifested as a block in the IL-1beta-mediated recruitment of [TF] to the human [TG] promoter.	NF-kappaB	TSLP	0	UNDEFINED	False
9835	9990	18834982:3:VDR:VEGFA	In this work, we demonstrated binding of [TF] to two response elements in the [TG] promoter.	vitamin D receptor	VEGF	0	UNDEFINED	False
9836	9991	18834982:6:VDR:VEGFA	Therefore, the increase in [TG] expression and secretion induced by 1,25(OH)(2)D(3) in VSMC in vitro could be explained by direct binding of the [TF], as a transcription factor, to VEGF promoter.	vitamin D receptor	VEGF	1	ACTIVATION	False
9837	9992	18836240:10:MAZ:VEGFA	[TF] is identified as a major regulator of increased synthesis of MMP-1 and -9 and pro-angiogenic factor, vascular endothelial growth factor ([TG]).	SAF-1	VEGF	1	ACTIVATION	False
9838	9993	18842581:7:EGR1:ID1	The ability of PGE(2) to activate [TG] transcription was mediated by enhanced binding of [TF] to the Id-1 promoter.	Egr-1	Id-1	1	ACTIVATION	False
9839	9994	18842595:3:NR1H4:NR0B2	[TF] interaction with p300 and their recruitment to the [TG] promoter and acetylated histone levels at the promoter were increased by FXR agonists in mouse liver and HepG2 cells.	FXR	SHP	0	UNDEFINED	False
9840	9995	18842595:8:NR1H4:NR0B2	Down-regulation of p300 by siRNA decreased acetylated [TF] and acetylated histone levels, and occupancy of FXR at the promoter, resulting in substantial inhibition of [TG] expression.	FXR	SHP	1	ACTIVATION	True
9841	9996	18845538:5:JUN:KIF11	Instead, Parkin represses [TG] gene transcription by blocking [TF] binding to the activator protein 1 site present in the Eg5 promoter.	c-Jun	Eg5	1	ACTIVATION	False
9842	9997	18845787:1:TFAP2A:ABCA1	Activator protein (AP) 2alpha negatively regulates expression of [TG] gene through Ser-phosphorylation of [TF] (Circ Res. 2007;101:156-165).	AP2alpha	ABCA1	2	REPRESSION	False
9843	9998	18845787:5:TFAP2A:ABCA1	These reactions and [TF]-induced suppression of the [TG] promoter activity were reversed by mutation of Ser258 more than Ser326 mutation.	AP2alpha	ABCA1	2	REPRESSION	False
9844	9999	18845787:8:TFAP2A:ABCA1	PKD phosphorylates [TF] to negatively regulate expression of [TG] gene to increase HDL biogenesis.	AP2alpha	ABCA1	2	REPRESSION	False
9846	10001	18848838:8:AP1:TXNIP	The interference of PPARalpha/retinoid X receptor alpha with the [TF] transcription factor elements c-Jun/c-Fos resulted in the inhibition of AP-1 binding and down-regulation of the [TG] gene expression.	AP-1	VDUP-1	1	ACTIVATION	False
9847	10004	18850004:5:SP3:CDKN1A	HDAC4 interacts with Sp1, binds and reduces histone H3 acetylation at the Sp1/[TF] binding site-rich p21([TG]/Cip1) proximal promoter, suggesting a key role for Sp1 in HDAC4-mediated repression of p21(WAF1/Cip1).	Sp3	WAF1	0	UNDEFINED	True
9848	10005	18852285:7:KLF1:E2F2	Chromatin immunoprecipitation analysis demonstrated [TF] occupancy at the proximal [TG] promoter in vivo.	EKLF	E2f2	0	UNDEFINED	False
9849	10006	18852285:8:KLF1:E2F2	Consistent with the role of [TF] as a chromatin modifier, EKLF binding sites in the [TG] promoter were located in a region of EKLF-dependent DNase I sensitivity in early erythroid progenitor cells.	EKLF	E2f2	0	UNDEFINED	False
9850	10007	18923650:6:FOS:PADI3	PIE is a strong enhancer of the [TG] promoter in Ca2+-differentiated epidermal keratinocytes, and requires bound [TF] factors, namely c-Jun and c-Fos.	AP-1	PADI3	1	ACTIVATION	False
9851	10009	18940792:5:ATF4:ASNS	Conversely, CHOP suppressed the induction of the endogenous [TG] (ASNS) gene and inhibited transcription from a reporter gene driven by the ASNS promoter following activation by [TF] or amino acid deprivation.	ATF4	asparagine synthetase	1	ACTIVATION	False
9852	10010	18940792:8:DDIT3:TRPV6	Interestingly, chromatin immunoprecipitation also showed that [TF] was associated with the C/EBP-ATF composite site regions of the SNAT2, VEGF, and [TG] genes, despite no significant effect on their expression after exogenous CHOP overexpression.	CHOP	CAT-1	0	UNDEFINED	False
9853	10011	18940803:0:ZKSCAN3:VEGFA	Unbiased screening for transcriptional targets of [TF] identifies integrin beta 4 and [TG] as downstream targets.	ZKSCAN3	vascular endothelial growth factor	0	UNDEFINED	False
9854	10012	18940814:4:YY1:MMP9	In this study, we show that in the unstimulated rat hippocampus in vivo, as well as in the nondepolarized brain neurons in primary culture, the transcriptional regulator Yin Yang 1 ([TF]) is bound to the proximal [TG] promoter and strongly represses Mmp-9 transcription.	YY1	Mmp-9	2	REPRESSION	False
9855	10013	18948081:5:ETS1:EREG	A chromatin immunoprecipitation assay demonstrated that [TF] was bound to human [TG] promoter, and this binding was abolished by PD98059.	Ets-1	epiregulin	0	UNDEFINED	False
9857	10015	18955504:5:TFAP2A:CDKN1A	We identified novel Smad binding sites in the [TG] gene where Smad2/3 binding was regulated by ETS1 and [TF].	TFAP2A	CDKN1A	0	UNDEFINED	False
9858	10016	18957281:7:TFDP1:HMOX1	By contrast, either [TF] agonist or antagonist caused only marginal influence on [TG] expression.	DP1	HO-1	0	UNDEFINED	False
9859	10017	18957281:8:TFDP2:HMOX1	Moreover, transient expression assays showed the [TF] agonist activated the [TG]-gene promoter in the enhancer-dependent manner.	DP2	HO-1	1	ACTIVATION	False
9860	10018	18957414:0:ESRRB:POU5F1	[TF] activates [TG] transcription and sustains self-renewal and pluripotency in embryonic stem cells.	Esrrb	Oct4	1	ACTIVATION	False
9861	10019	18957421:11:CREB1:CCND1	Differences between [TF] binding to the two genes correlated with increasing methylation of the Wnt10b promoter following Bt(2)cAMP treatment, whereas no methylation of the [TG] promoter was observed.	CREB	cyclin D1	0	UNDEFINED	False
9862	10020	18957421:13:CREB1:CCND1	We conclude that cAMP stimulates phosphorylation and binding of [TF] to the [TG] gene promoter.	CREB	cyclin D1	0	UNDEFINED	False
9863	10021	18957421:7:CREB1:CCND1	These results suggest that [TF] activates transcription from both the [TG] and Wnt10b gene promoters.	CREB	cyclin D1	1	ACTIVATION	False
9864	10022	18972406:0:HNF4A:SEPP1	[TG] expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and [TF] transcription factors.	hepatocyte nuclear factor 4alpha	Selenoprotein P	0	UNDEFINED	True
9865	10023	18972406:8:HNF4A:SEPP1	In a brain-derived neuroblastoma cell line with low basal [TG] expression, SeP transcription was stimulated by PGC-1alpha together with FoxO1a, and overexpression of [TF] potentiated this effect.	HNF-4alpha	SeP	1	ACTIVATION	False
9867	10025	18974883:3:NFKB:PPARGC1A	A 2.2 kb fragment of the human [TG] promoter was cloned and sequence analysis revealed that this TATA-less sequence houses putative consensus sites including a GC-box, a CRE, several IRSs, a SRE, binding sites for GATA, MEF2, p 53, [TF], and EBox binding proteins.	NF-kappaB	PGC-1alpha	0	UNDEFINED	False
9868	10026	18974883:7:USF1:PPARGC1A	Supershift analyses identified [TF] as a DNA binding transcription factor potentially involved in regulating [TG] promoter activity, which was confirmed in vivo by ChIP.	USF-1	PGC-1alpha	0	UNDEFINED	False
9869	10027	18974883:8:USF1:PPARGC1A	Overexpression of either GATA-4 or [TF] alone increased the p851 [TG] promoter activity by 1.7- and 2.0-fold respectively, while co-expression of GATA-4 and USF-1 led to an additive increase in PGC-1alpha promoter activity.	USF-1	PGC-1alpha	1	ACTIVATION	False
9870	10028	18976709:0:JUNB:MMP9	[TF] is a repressor of [TG] transcription in depolarized rat brain neurons.	JunB	MMP-9	2	REPRESSION	False
9871	10029	18978794:5:FOXO1:SELL	Deletion of [TF] in peripheral B cells led to fewer lymph node B cells due to lower expression of [TG] and failed class-switch recombination due to impaired upregulation of the gene encoding activation-induced cytidine deaminase.	Foxo1	L-selectin	1	ACTIVATION	False
9872	10030	18981260:2:NR1I2:CYP24A1	In the absence of vitamin D(3), [TF] activates the [TG] gene by directly binding to and transactivating vitamin D-response elements (VDREs) within its promoter.	PXR	CYP24A1	1	ACTIVATION	False
9873	10031	18981289:7:NR1H4:CCND1	The results showed that [TF] deficiency resulted in increased colon cell proliferation, which was accompanied by an up-regulation in the expression of genes involved in cell cycle progression and inflammation, including [TG] and interleukin-6.	FXR	cyclin D1	2	REPRESSION	False
9874	10032	18988190:0:CREB1:CCND1	Evidence that leptin through STAT and [TF] signaling enhances [TG] expression and promotes human endometrial cancer proliferation.	CREB	cyclin D1	1	ACTIVATION	False
9875	10033	18990703:2:ELF1:BRCA2	Three transcription factors that activate (USF, NF-kappaB, and [TF]) and a single factor that represses (SLUG) [TG] promoter activity have been reported.	Elf1	BRCA2	1	ACTIVATION	True
9876	10034	18991020:8:PGR:ABCG2	Therefore, it was thought that the [TG] promoter responded to stimulation of the [TF] (PR)-Sp1 pathway in T47D cells.	progesterone receptor	ABCG2	0	UNDEFINED	True
9877	10035	18992716:5:RXRB:ALDH1A1	Here we report that the RARalpha/retinoid X receptor beta ([TF]) complex binds to the mouse retinaldehyde dehydrogenase 1 ([TG]) promoter at a non-consensus RA response element (RARE) with similar affinity to that of the consensus RARE.	RXRbeta	Raldh1	0	UNDEFINED	False
9878	10036	18996961:0:CEBPB:NR4A1	Transcriptional cooperation between NF-kappaB p50 and [TF] regulates [TG] transcription in Leydig cells.	CCAAT/enhancer binding protein beta	Nur77	0	UNDEFINED	True
9879	10037	18996961:0:NFKB1:NR4A1	Transcriptional cooperation between [TF] p50 and CCAAT/enhancer binding protein beta regulates [TG] transcription in Leydig cells.	NF-kappaB	Nur77	0	UNDEFINED	False
9880	10038	18996961:3:CEBPB:NR4A1	Here, we report that the transcription factor [TF] can activate the [TG] promoter as revealed by transient transfections in MA-10 Leydig cells.	C/EBPbeta	Nur77	1	ACTIVATION	False
9881	10039	18996961:4:CEBPB:NR4A1	Through 5' progressive deletions and site-directed mutagenesis, the [TF]-mediated activation of the [TG] promoter was found to be dependent on a novel species-conserved C/EBP element located at -110 bp.	C/EBPbeta	Nur77	1	ACTIVATION	False
9882	10040	19008924:9:THAP11:MYC	Chromatin immunoprecipitations and EMSA assay suggest that [TF] directly binds to the [TG] promoter.	THAP11	c-Myc	0	UNDEFINED	False
9883	10041	19010785:0:JARID2:CCND1	A jumonji ([TF]) protein complex represses [TG] expression by methylation of histone H3-K9.	Jarid2	cyclin D1	2	REPRESSION	False
9884	10042	19010785:10:JARID2:CCND1	Inactivation of both G9a and GLP, but not of only G9a, inhibited the methylation of H3-K9 in the [TG] promoter and repression of cyclin D1 expression by [TF].	Jmj	cyclin D1	2	REPRESSION	False
9885	10043	19010785:11:JARID2:CCND1	These results suggest that [TF] methylates H3-K9 and represses [TG] expression through G9a and GLP, and that Jmj family proteins can regulate gene expression by not only histone demethylation but also other histone modification.	Jmj	cyclin D1	2	REPRESSION	False
9886	10044	19010785:5:JARID2:CCND1	Independently of these studies, we previously showed that [TF] binds to the [TG] promoter and represses the transcription of cyclin D1.	Jmj	cyclin D1	2	REPRESSION	False
9887	10045	19010785:6:JARID2:CCND1	Here, we show the mechanisms by which [TF] represses the transcription of [TG].	Jmj	cyclin D1	2	REPRESSION	False
9888	10046	19014879:10:ETV4:MMP13	Activated [TF] binds to [TG] promoter and activates its expression.	PEA3	MMP-13	1	ACTIVATION	False
9889	10047	19015127:2:TP53:PPM1D	In cells containing wild-type [TF], the levels of [TG] mRNA and protein increase following exposure to genotoxic stress, but the mechanism of regulation by p53 was unknown.	p53	PPM1D	1	ACTIVATION	False
9890	10048	19020709:5:ARNT:VEGFA	Using chromatin immunoprecipitation assay, we tested whether guggulsterone affects the recruitment of STAT3, [TF] and HIF-1alpha to the human [TG] promoter.	ARNT	VEGF	0	UNDEFINED	False
9891	10049	19031424:5:TP53:BTG2	Analysis of the [TG] functional promoter region by transfection of various deletion constructs into HepG2 cells indicated that the [TF] and NFY biding sites on BTG2 are important for the response to DNA damage.	p53	BTG2 gene	0	UNDEFINED	False
9892	10050	19038372:9:FOS:MMP13	Moreover, BMP-2 increased the binding of c-Fos and c-Jun to the [TF] element on the [TG] promoter.	AP-1	MMP-13	0	UNDEFINED	False
9893	10051	19046253:10:STAT1:IL18BP	Altogether, data presented herein indicate that direct action of [TF] on the [TG] promoter at the proximal GAS element is key to IL-18BP expression by IFN-gamma-stimulated DLD-1 colon carcinoma cells.	STAT1	IL-18BP	1	ACTIVATION	False
9894	10052	19049975:0:STAT3:POMC	FoxO1 inhibits leptin regulation of [TG] promoter activity by blocking [TF] interaction with specificity protein 1.	STAT3	pro-opiomelanocortin	0	UNDEFINED	False
9895	10053	19049975:5:STAT3:POMC	We show that phospho-[TF] activates [TG] promoter in response to leptin signaling through a mechanism that requires an SP1-binding site in the POMC promoter.	STAT3	POMC	1	ACTIVATION	False
9896	10054	19054556:3:SP1:ASNS	The 14-bp sequence is similar to the three GC-boxes (GC-I, -II, and -III) found in the promoter region of the [TG] gene, as well as, the binding site of transcription factor [TF].	Sp-1	ASNS	0	UNDEFINED	False
9897	10055	19056481:5:POU2F1:FDPS	We have characterized functionally the minimal basal promoter of the human [TG] gene by means of deletion mutants and we have identified two cis-acting elements which modulate the FDPS gene expression and are recognized by Pax5 and [TF] transcription factors.	OCT-1	FDPS	0	UNDEFINED	False
9898	10056	19056485:8:NFE2L2:HMOX1	Protandim-mediated [TG] induction involved the presence of ARE sites in the HO-1 promoter and nuclear translocalization of the transcription factor [TF], which binds to ARE sites.	Nrf2	HO-1	1	ACTIVATION	False
9899	10057	19056926:0:IRF1:XAF1	c-Jun N-terminal kinase (JNK1) upregulates [TG] (XAF1) through interferon regulatory factor 1 ([TF]) in gastrointestinal cancer.	IRF-1	XIAP-associated factor 1	1	ACTIVATION	False
9900	10058	19056926:12:IRF1:XAF1	JNK1 stimulated and mediated the effects of IFN and TNF-alpha on [TG] expression through transcriptional regulation by induction of [TF].	IRF-1	XAF1	0	UNDEFINED	True
9901	10059	19058140:10:POU2F1:TGM2	Consistent with this, siRNA knockdown of [TF] increased the DHT-mediated enhancer activity of transfected reporters as well as an endogenous AR target gene, [TG].	Oct1	transglutaminase 2	2	REPRESSION	False
9902	10060	19060217:3:SALL4:POU5F1	[TF] plays an important role in governing the fate of stem cells through transcriptional regulation of both [TG] and Nanog.	Sall4	Oct4	0	UNDEFINED	False
9903	10061	19060337:0:ATF3:CDC25A	Dual regulation of [TG] by Chk1 and p53-[TF] in DNA replication checkpoint control.	ATF3	Cdc25A	0	UNDEFINED	False
9904	10062	19060337:5:ATF3:CDC25A	We show that activation of tumor suppressor p53 by DNA damage results in inhibition of [TG] transcription as a result of activation of transcriptional repressor [TF] that directly binds to the Cdc25A promoter.	ATF3	Cdc25A	2	REPRESSION	False
9905	10063	19060337:8:ATF3:CDC25A	Although Chk1 affects [TG] via rapid phosphorylation and protein turnover, inhibition of Cdc25A transcription by p53-[TF] is required for the maintenance of cell cycle arrest.	ATF3	Cdc25A	2	REPRESSION	False
9906	10064	19064501:8:STAT3:SLC9A3	[TF] inhibition by overexpression of dominant-negative Stat3-D mutant in MDCK cells or by small interfering RNA-mediated knockdown in Caco-2 cells resulted in inhibition of the cell density-induced [TG] expression, Sp1/Sp3 binding, and NHE3 promoter activity and in decreased dome formation.	Stat3	NHE3	1	ACTIVATION	False
9907	10065	19073601:5:ATF4:S100P	The celecoxib-mediated up-regulation of [TG] was suppressed by the transfection of cells with small interfering RNA for [TF] (ATF4), a transcription factor involved in the endoplasmic reticulum stress response.	activating transcription factor 4	S100P	1	ACTIVATION	False
9908	10066	19073601:6:ATF4:S100P	Furthermore, deletion of [TF] binding consensus sequence located in the promoter of the [TG] gene resulted in inhibition of celecoxibmediated transcriptional activation of the gene.	ATF4	S100P	1	ACTIVATION	False
9909	10067	19074849:11:ELF3:EGR1	These results show that activation of [TF] via enhanced nuclear translocation mediates tolfenamic acid-induced [TG] expression, which plays a critical role in the activation of apoptosis.	ESE-1	EGR-1	1	ACTIVATION	False
9910	10068	19079342:6:ID1:CCND1	The glycogen synthase kinase-3beta phosphorylation at Ser9, stabilization and nuclear localization of beta-catenin, T-cell factor (TCF)/lymphoid enhancer factor transactivation activity and [TG] expression were enhanced by [TF].	Id-1	cyclin D1	1	ACTIVATION	False
9911	10069	19079362:6:SMAD3:ID1	Chromatin immunoprecipitation assay confirms that [TF] and Smad4 bind to the upstream region of the [TG] gene.	Smad3	Id1	0	UNDEFINED	False
9912	10070	19082571:7:SREBF1:UCP2	PGC-1beta as well as [TF] and -2 increased transcription from the [TG] promoter in INS-1E cells.	SREBP-1c	UCP2	1	ACTIVATION	False
9913	10071	19088198:4:STAT3:CD274	NPM/ALK induces [TG] expression by activating its key signal transmitter, transcription factor [TF].	STAT3	CD274	1	ACTIVATION	False
9914	10072	19088198:5:STAT3:CD274	[TF] binds to the CD274 gene promoter in vitro and in vivo, as shown in the gel electromobility shift and chromatin immunoprecipitation assays, and is required for the [TG] gene expression, as demonstrated by siRNA-mediated STAT3 depletion.	STAT3	PD-L1	1	ACTIVATION	False
9915	10073	19088796:7:AP1:SERPINE1	In addition, we also found that the inhibition of [TG] synthesis by antisense oligonucleotide to PAI-1 mRNA results in markedly increased u-PAR expression and that NF-kappaB and [TF] are involved in this regulation.	AP-1	PAI-1	0	UNDEFINED	True
9916	10074	19089994:8:TP63:CDKN1C	Further studies show that DeltaN[TF] silencing results in the upregulation of CKIs, including p27(kip1) and [TG] in both mRNA and protein levels.	p63	p57(kip2)	2	REPRESSION	False
9917	10075	19095770:9:JUN:PTPRO	Chromatin immunoprecipitation assay showed association of c-Fos and [TF] with [TG] promoter in untreated cells, which was augmented by tamoxifen-mediated recruitment of ERbeta to the promoter.	c-Jun	PTPRO	0	UNDEFINED	False
9918	10076	19105596:10:SP1:NOS3	As previously reported, mutation of the [TF] consensus lead to the complete loss of [TG] promoter activity, confirming the key role of Sp1 in regulating basal eNOS promoter activity.	Sp1	eNOS	1	ACTIVATION	False
9919	10077	19106633:0:TP53:TNFSF10	[TG] (TRAIL), a [TF] target gene that mediates p53-dependent cell  death.	p53	TNFSF10	0	UNDEFINED	False
9920	10078	19106818:7:HIF1A:PTGS2	In addition, our studies have confirmed that evodiamine inhibited [TF], which accounted for the transcriptional activity of [TG], rather than nuclear factor kappaB in RAW264.7 cells.	HIF-1alpha	COX-2	1	ACTIVATION	False
9921	10079	19108712:6:NFKB:PTGS2	In contrast, genes regulated by [TF], such as [TG] (cyclooxygenase-2), IL8 and BCL2A1, responded nearly identically in bystander and irradiated cells.	NFkappaB	PTGS2	0	UNDEFINED	False
9922	10080	19118090:8:STAT3:NOS3	Transfection of cells with a dominant negative mutant of [TF] enhanced [TG] promoter activity and nitric oxide production in response to shear.	STAT3	eNOS	2	REPRESSION	False
9923	10081	19118090:9:STAT3:NOS3	Finally, we found that mutating the [TF] binding site sequence within the [TG] promoter increased promoter activity in response to shear and that this was no longer inhibited by bryostatin.	STAT3	eNOS	2	REPRESSION	False
9924	10082	19118657:0:POU2F1:CDKN1A	Involvement of [TF] in the regulation of [TG] in response to clinically relevant doses of ionizing radiation.	Oct-1	CDKN1A	0	UNDEFINED	False
9925	10083	19118657:7:POU2F1:CDKN1A	Functional involvement of [TF] was confirmed by RNA interference targeting the Oct-1 gene, which suppressed both the basal and IR-inducible components of the [TG] expression.	Oct-1	CDKN1A	1	ACTIVATION	False
9926	10084	19118657:8:POU2F1:CDKN1A	Thus, our results reveal that [TF] is crucial to the TP53-mediated regulation of the [TG] gene promoter following exposure to clinically relevant doses of IR.	Oct-1	CDKN1A	0	UNDEFINED	False
9927	10085	19124655:9:EGR1:RCAN1	Biochemical and genetic evidence suggested that [TF] controls [TG] expression.	Egr1	Rcan1	0	UNDEFINED	True
9928	10086	19124747:5:STAT1:FOXP3	This study shows [TF] binding elements within the proximal part of the human [TG] promoter, which we previously hypothesized to function as a key regulatory unit.	STAT1	FOXP3	0	UNDEFINED	False
9929	10087	19124747:6:STAT1:FOXP3	Direct binding of [TF] to the [TG] promoter following IL-27 stimulation increases its transactivation process and induces permissive histone modifications in this key region of the FOXP3 promoter, suggesting that FOXP3 expression is promoted by IL-27 by two mechanisms.	STAT1	FOXP3	1	ACTIVATION	False
9930	10088	19126648:7:AP1:MMP13	Moreover, Cyr61 increased the binding of c-Fos and c-Jun to the [TF] element on the [TG] promoter.	AP-1	MMP-13	0	UNDEFINED	False
9931	10090	19127412:0:FOXA1:BCL2	Role of [TF] in regulation of [TG] expression during oxidative-stress-induced apoptosis in A549 type II pneumocytes.	Foxa1	bcl2	0	UNDEFINED	False
9932	10091	19127542:8:SP1:CLEC2D	The promoter contains several potential [TF] binding sites, and cotransfection of a shRNA expression plasmid that knockdowns Sp1 significantly reduced [TG] promoter activity and endogenous gene expression and moreover, overexpressing Sp7, a Sp1 family member that also binds to Sp1 binding sequence, increased OCIL promoter activity and gene expression, suggesting a role of Sp1 family proteins in regulation of OCIL transcription.	Sp1	OCIL	1	ACTIVATION	False
9933	10092	19127542:8:SP7:CLEC2D	The promoter contains several potential Sp1 binding sites, and cotransfection of a shRNA expression plasmid that knockdowns Sp1 significantly reduced [TG] promoter activity and endogenous gene expression and moreover, overexpressing [TF], a Sp1 family member that also binds to Sp1 binding sequence, increased OCIL promoter activity and gene expression, suggesting a role of Sp1 family proteins in regulation of OCIL transcription.	Sp7	OCIL	1	ACTIVATION	False
9934	10093	19129183:9:IRF5:CDKN1A	In addition, vIRF-3 antagonized [TF]-mediated activation of the [TG] promoter.	IRF-5	p21	1	ACTIVATION	False
9935	10094	19129222:9:NR1I2:CYP4F12	In conclusion, our findings indicate that [TF] is involved in the regulation of [TG] and that PXR along with SRC1 binds to a broad range of promoters but that many of these are not inducible by rifampicin.	PXR	CYP4F12	0	UNDEFINED	False
9936	10095	19129951:0:ETV4:VEGFA	[TF] activates [TG] transcription in T47D and SKBR3 breast cancer cells.	PEA3	VEGF	1	ACTIVATION	False
9937	10096	19129951:2:ETV4:VEGFA	In this study, we found that overexpression of [TF] could increase [TG] mRNA levels and VEGF promoter activity in human T47D and SKBR3 breast cancer cells.	PEA3	VEGF	1	ACTIVATION	False
9938	10097	19129951:3:ETV4:VEGFA	Chromatin immunoprecipitation assay demonstrated that [TF] could bind to the [TG] promoter in the cells transfected with PEA3 expression vector.	PEA3	VEGF	0	UNDEFINED	False
9939	10098	19129951:4:ETV4:VEGFA	[TF] small interfering RNA attenuated [TG] promoter activity and the binding of PEA3 to the VEGF promoter in T47D and SKBR3 cells.	PEA3	VEGF	1	ACTIVATION	False
9940	10099	19131506:9:JUN:CGA	Finally, overexpression of TCFDN attenuates GnRH regulation of [TG] promoter activity, a known downstream target of [TF].	JUN	Cga	0	UNDEFINED	False
9941	10100	19131575:6:NR2C1:POU5F1	Knocking down [TF] and TR4 mRNAs decreased the expression of [TG] and Nanog genes.	TR2	Oct-3/4	1	ACTIVATION	False
9942	10101	19131575:6:NR2C2:POU5F1	Knocking down TR2 and [TF] mRNAs decreased the expression of [TG] and Nanog genes.	TR4	Oct-3/4	1	ACTIVATION	False
9943	10102	19131575:7:NR2C2:POU5F1	Mechanism dissection suggests that TR2 and [TF] may affect the [TG] gene by binding to a direct repeat-1 element located in its promoter region, which is influenced by retinoic acid.	TR4	Oct-3/4	0	UNDEFINED	False
9944	10103	19131967:7:SALL2:CDKN1A	Overexpression of [TF] activates p21([TG]/CIP1), induces growth arrest, and promotes neurite outgrowth independently of NGF.	Sall2	WAF1	1	ACTIVATION	False
9945	10104	19132220:6:USF2:SERPINE1	E-box motifs (CACGTG) in the PE1/PE2 promoter regions of the human [TG] gene, moreover, are platforms for a MAP kinase-directed USF subtype switch (USF-1-->[TF]) in response to growth factor addition suggesting that the EGFR-->MEK/ERK axis impacts PAI-1 expression, at least partly, through USF-dependent transcriptional controls.	USF-2	PAI-1	0	UNDEFINED	False
9946	10105	19132225:8:NFKB:HIF1A	In line, RacG12V enhanced [TG] promoter activity, and this response was dependent on nuclear factor-kappaB ([TF]) binding to the HIF-1alpha promoter.	NFkappaB	HIF-1alpha	1	ACTIVATION	True
9947	10106	19135978:4:STAT1:SCGB3A1	IFN-gamma induced the phosphorylation of [TF], which binds to a STAT-binding element (SBE) in the [TG] gene promoter, leading to decreased transcriptional activation of this gene.	STAT1	SCGB3A1	2	REPRESSION	False
9948	10107	19136512:2:NFKB:CDX2	We previously reported that bile acids activate the [TG] promoter via nuclear factor kappa B ([TF]) and stimulate production of Cdx2 protein in oesophageal keratinocytes with a resulting production of intestinal type mucin.	NF-kappaB	Cdx2	1	ACTIVATION	False
9949	10108	19136962:3:FOXO1:SELL	In naive T cells, [TF] controlled the expression of the adhesion molecule [TG], the chemokine receptor CCR7 and the transcription factor Klf2, and its deletion was sufficient to alter lymphocyte trafficking.	Foxo1	L-selectin	0	UNDEFINED	True
9950	10109	19137013:5:EGR1:BAX	Gel shift analysis and chloramphenicol acetyl transferase (CAT) reporter assays indicate that [TF] transactivates the promoter of the [TG] gene.	EGR-1	Bax	1	ACTIVATION	False
9951	10110	19137013:6:EGR1:BAX	Interaction of [TF] and Yes kinase-associated protein 1 (YAP-1) through the WW domain of YAP-1 enhances the transcriptional activity of EGR-1 on the [TG] promoter as shown by chromatin immunoprecipitation and reporter assays.	EGR-1	Bax	1	ACTIVATION	False
9952	10111	19139378:10:YY1:NPPB	Collectively these findings demonstrate that [TF] plays an important role in regulating the transcriptional activity of the h[TG] gene promoter.	YY1	BNP	0	UNDEFINED	False
9953	10112	19139378:11:YY1:NPPB	These data suggest a model in which [TF] activates h[TG] transcription through interaction with histone deacetylase 2.	YY1	BNP	1	ACTIVATION	False
9954	10113	19139378:7:YY1:NPPB	Overexpression of wild-type [TF] increased both basal and endothelin-stimulated h[TG] promoter activity, whereas a carboxy-terminal deletion mutant of YY1 was devoid of activity.	YY1	BNP	1	ACTIVATION	False
9955	10114	19141476:0:FOXA1:PDX1	Dynamic regulation of [TG] enhancers by [TF] and Foxa2 is essential for pancreas development.	Foxa1	Pdx1	0	UNDEFINED	False
9956	10115	19141476:11:FOXA1:PDX1	Thus, the regulation of [TG] expression by [TF] and Foxa2 is a key early event controlling the expansion and differentiation of the pancreatic primordia.	Foxa1	Pdx1	0	UNDEFINED	False
9957	10116	19147588:5:SOX4:DLL1	Direct transcriptional targets of [TF] include several key cellular regulators, such as EGFR, HSP70, Tenascin C, Frizzled-5, Patched-1, and [TG].	SOX4	Delta-like 1	0	UNDEFINED	False
9958	10117	19147588:5:SOX4:TNC	Direct transcriptional targets of [TF] include several key cellular regulators, such as EGFR, HSP70, [TG], Frizzled-5, Patched-1, and Delta-like 1.	SOX4	Tenascin C	0	UNDEFINED	False
9959	10118	19147754:0:SP1:VEGFA	[TF] and c-Myc mediate lysophosphatidic acid-induced expression of [TG] in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism.	Sp-1	vascular endothelial growth factor	1	ACTIVATION	False
9960	10119	19164283:0:AP1:EZR	Sp1 and [TF] regulate expression of the human gene [TG] in esophageal carcinoma cells.	AP-1	VIL2	0	UNDEFINED	False
9961	10120	19164449:0:CEBPB:TRIB3	Insulin regulates [TG] and other stress-responsive gene expression through induction of [TF].	C/EBPbeta	TRB3	0	UNDEFINED	True
9962	10121	19164449:2:CEBPB:TRIB3	In this report, we have investigated the mechanism under which insulin regulates [TG] gene expression and demonstrated that insulin induces TRB3 expression via [TF].	C/EBPbeta	TRB3	1	ACTIVATION	False
9963	10122	19164449:3:CEBPB:TRIB3	We found that in Fao hepatoma and 3T3-L1 adipocytes, [TF] expression induced by insulin preceded that of [TG] and that mutation of the C/EBPbeta binding site in TRB3 promoter abolished the responsiveness of the TRB3 gene to insulin.	C/EBPbeta	TRB3	1	ACTIVATION	False
9964	10123	19164449:4:CEBPB:TRIB3	We further showed that ectopic expression of [TF] augmented, whereas knockdown of C/EBPbeta reduced, [TG] expression induced by insulin.	C/EBPbeta	TRB3	1	ACTIVATION	False
9965	10124	19164757:7:ATF3:PMAIP1	We show that [TF] and ATF4 form a complex capable of binding to the [TG] promoter, which is required for NOXA activation.	ATF3	NOXA	1	ACTIVATION	False
9966	10125	19164757:7:ATF4:PMAIP1	We show that ATF3 and [TF] form a complex capable of binding to the [TG] promoter, which is required for NOXA activation.	ATF4	NOXA	1	ACTIVATION	False
9967	10126	19168148:11:ETS2:PCYT1A	These results suggest that the induction of [TF] is important for [TG] transcription by TPA and macrophage-colony stimulating factor.	Ets2	CTalpha	1	ACTIVATION	False
9968	10127	19168148:2:ETS1:PCYT1A	Previously, we reported that [TF] enhanced and Net repressed CTalpha transcription by binding at the Ets binding site (-49/-47) in the [TG] promoter.	Ets1	Pcyt1a	1	ACTIVATION	False
9969	10128	19168148:3:ETS1:PCYT1A	In this study, we asked if an [TF] analogue, Ets2, also regulates [TG] transcription and investigated the importance of its nuclear localization signal (NLS) and nuclear export signal (NES).	Ets1	CTalpha	0	UNDEFINED	False
9970	10129	19168148:3:ETS2:PCYT1A	In this study, we asked if an Ets1 analogue, [TF], also regulates [TG] transcription and investigated the importance of its nuclear localization signal (NLS) and nuclear export signal (NES).	Ets2	CTalpha	0	UNDEFINED	False
9972	10131	19174556:10:MYC:CDKN1A	Together, our results suggest that mechanisms of WIF1-induced G(1) arrest include (a) SKP2 down-regulation leading to p27/Kip1 accumulation and (b) [TF] down-regulation releasing p21/[TG] transcription.	c-myc	WAF1	2	REPRESSION	False
9973	10132	19174556:9:LEF1:SKP2	Chromatin immunoprecipitation/real-time PCR analysis revealed that both WIF1 and dominant-negative [TF] expression decreased the in vivo binding of TCF4 and beta-catenin to the [TG] promoter.	LEF1	SKP2	0	UNDEFINED	False
9974	10133	19179380:0:ETS2:BCL2L1	Activation of [TF] by oxidative stress induces [TG] expression and accounts for glial survival in amyotrophic lateral sclerosis.	Ets-2	Bcl-xL	1	ACTIVATION	False
9975	10134	19179380:4:ETS2:BCL2L1	Chromatin immunoprecipitation (ChIP) analysis verified that [TF] preferentially occupies the Ets-2 binding element in the promoter of [TG] in primary astrocytes under oxidative stress conditions as well as in G93A spinal cords.	Ets-2	Bcl-xL	0	UNDEFINED	False
9976	10135	19179380:7:ETS2:BCL2L1	Our findings suggest that [TF] transcription factor activation of [TG] gene may protect glia from constitutive oxidative stress that is thought to be a key mechanism contributing to the pathogenesis of ALS.	Ets-2	Bcl-xL	1	ACTIVATION	False
9977	10136	1918021:11:FOS:EDN1	Additional experiments investigated the role of Jun and [TF] in [TG] transcription.	Fos	ET1	0	UNDEFINED	False
9978	10137	19188603:6:CDX1:KRT20	Deletion and mutation analysis of the [TG] promoter showed that the minimum regulatory region for the control of KRT20 expression by [TF] is within 246 bp upstream of the KRT20 transcription start site.	CDX1	KRT20	0	UNDEFINED	False
9979	10138	19188603:7:CDX1:KRT20	ChIP analysis confirmed that [TF] binds to the predicted CDX elements in this region of the [TG] promoter in vivo.	CDX1	KRT20	0	UNDEFINED	False
9980	10139	19188603:9:CDX1:KRT20	In summary, our observations strongly imply that [TG] is directly regulated by [TF], and therefore suggest a role for CDX1 in maintaining differentiation in intestinal epithelial cells.	CDX1	KRT20	0	UNDEFINED	True
9981	10140	19189974:11:EWSR1:GLI1	Our results establish [TG] as a direct transcriptional target of [TF]-FLI1 and suggest a potential role for GLI1 in ESFT tumorigenesis.	EWS	GLI1	0	UNDEFINED	False
9982	10141	19189974:11:FLI1:GLI1	Our results establish [TG] as a direct transcriptional target of EWS-[TF] and suggest a potential role for GLI1 in ESFT tumorigenesis.	FLI1	GLI1	0	UNDEFINED	True
9983	10142	19189974:6:EWSR1:GLI1	Recent evidence suggests that [TF]-FLI1 increases expression of [TG] by an unknown mechanism.	EWS	GLI1	1	ACTIVATION	False
9984	10143	19189974:6:FLI1:GLI1	Recent evidence suggests that EWS-[TF] increases expression of [TG] by an unknown mechanism.	FLI1	GLI1	1	ACTIVATION	False
9985	10144	19189974:7:EWSR1:GLI1	Our data from chromatin immunoprecipitation and promoter reporter studies indicated [TG] as a direct transcriptional target of [TF]-FLI1.	EWS	GLI1	0	UNDEFINED	True
9986	10145	19189974:7:FLI1:GLI1	Our data from chromatin immunoprecipitation and promoter reporter studies indicated [TG] as a direct transcriptional target of EWS-[TF].	FLI1	GLI1	0	UNDEFINED	False
9987	10146	19193899:0:SRF:ARC	The [TF] and a putative novel transcription factor regulate expression of the immediate-early gene Arc/[TG] in neurons.	serum response factor	Arg3.1	0	UNDEFINED	False
9988	10147	19193899:9:SRF:ARC	This element binds [TF], which is recruited by synaptic activity to regulate [TG].	serum response factor	Arc	0	UNDEFINED	False
9989	10148	19197985:7:SP3:CDKN1A	Inhibition of HDAC activity by AM was associated with increased histone acetylation and [TF] transcription factor binding to the promoter region of the P21WAF1 gene, resulting in elevated [TG] protein expression and cell cycle arrest.	Sp3	p21	1	ACTIVATION	False
9990	10149	19205872:5:ETS1:CRYAB	Chromatin immunoprecipitation analyses showed that endogenous [TF] binds to the [TG] promoter in basal-like breast cancer cells in vivo.	Ets1	alphaB-crystallin	0	UNDEFINED	False
9991	10150	19211927:0:HIF1A:AGT	JunD and [TF] mediate transcriptional activation of [TG] by TGF-beta1 in human lung fibroblasts.	HIF-1alpha	angiotensinogen	1	ACTIVATION	False
9992	10151	19211927:0:JUND:AGT	[TF] and HIF-1alpha mediate transcriptional activation of [TG] by TGF-beta1 in human lung fibroblasts.	JunD	angiotensinogen	1	ACTIVATION	False
9993	10152	19219071:1:FUBP1:MYC	[TF] (FBP-1) binds to an upstream element of the [TG] promoter and regulates the c-myc mRNA level.	Far upstream element-binding protein-1	c-myc	0	UNDEFINED	True
9994	10153	19219072:6:NFKB2:MMP9	Interestingly, MLL1 and MLL2 H3K4 methyltransferase complexes are tethered by [TF] on the [TG] but not on the IkappaBalpha promoter, and the H3K4 trimethyltransferase activity recruited on the MMP9 promoter is impaired in p52-depleted HUT-78 cells.	p52	MMP9	0	UNDEFINED	False
9995	10154	1922043:5:IKZF1:VPREB1	Moreover, [TF] binds to the promoters for the lymphocyte-specific genes lambda 5, [TG], and lck, all of which we speculate have additional features in common with the TdT promoter.	LyF-1	VpreB	0	UNDEFINED	False
9996	10155	19220857:5:STAT5B:AGT	Likewise, angiotensin II resulted in similar enhancements of the DNA-binding activity of [TF] and c-Jun in angiotensin II-induced [TG] expression.	STAT5B	angiotensinogen	1	ACTIVATION	False
9997	10156	19220857:7:STAT5B:AGT	Our findings support a model in which co-operative interaction of [TF] and activator protein 1 bound to the the promoter region provides maximal activation of [TG] expression by angiotensin II in vascular smooth muscle cells.	STAT5B	angiotensinogen	1	ACTIVATION	False
9998	10157	19222990:4:NFKB:SUMO4	More importantly, a putative [TF] binding motif has been characterized within the [TG] promoter.	NFkappaB	SUMO4	0	UNDEFINED	False
9999	10158	19222990:6:NFKB:SUMO4	ChIP assays showed that [TF] binds to [TG] promoter and activates its transcription.	NFkappaB	SUMO4	1	ACTIVATION	False
10000	10159	19229324:9:CEBPB:CDKN1C	Luciferase-reporter and electrophoretic mobility shift assays identified the core responsive element of [TF] in the [TG] promoter between -150 and -130 bp region containing a putative C/EBP motif.	C/EBPbeta	p57(Kip2)	0	UNDEFINED	False
10003	10162	19233164:4:USF2:PPARGC1A	We therefore hypothesized that metoprolol represses CPT-1B by increasing [TF]-mediated repression of [TG].	USF-2	PGC1alpha	2	REPRESSION	False
10004	10163	19236911:8:AP1:AKR1B10	Motif analysis recognized multiple putative oncogenic and tumor suppressor protein binding sites in the [TG] promoter, including c-Ets-1, C/EBP, [TF], and p53, but osmolytic response elements were not found.	AP-1	AKR1B10	0	UNDEFINED	False
10005	10164	19236911:8:ETS1:AKR1B10	Motif analysis recognized multiple putative oncogenic and tumor suppressor protein binding sites in the [TG] promoter, including [TF], C/EBP, AP-1, and p53, but osmolytic response elements were not found.	c-Ets-1	AKR1B10	0	UNDEFINED	False
10006	10165	19236911:8:TP53:AKR1B10	Motif analysis recognized multiple putative oncogenic and tumor suppressor protein binding sites in the [TG] promoter, including c-Ets-1, C/EBP, AP-1, and [TF], but osmolytic response elements were not found.	p53	AKR1B10	0	UNDEFINED	False
10007	10166	19240179:11:ETS1:CDKN2A	[TG] elevation in p53(-/-) cells is, at least partially, mediated by [TF], a known positive regulator of p16(INK4a), as p53 deficiency up-regulated Ets1 through protein stabilization and knockdown of Ets1 down-regulated p16(INK4a) expression in p53(-/-) mouse embryonic fibroblasts.	Ets1	p16(INK4a)	1	ACTIVATION	False
10008	10167	19244234:0:SP1:CDKN1A	Proto-oncogene FBI-1 represses transcription of [TG] by inhibition of transcription activation by p53 and [TF].	Sp1	p21CIP1	1	ACTIVATION	False
10009	10168	19246513:5:MLX:TXNIP	[TF] and MondoA are transcription factors previously shown to stimulate glucose-dependent [TG] expression and are shown here to convey stimulatory signals from extracellular adenosine-containing molecules to the Txnip promoter.	Max-like protein X	Txnip	1	ACTIVATION	False
10010	10169	19248099:12:CEBPB:MMP13	ChIP assays revealed that TNFalpha treatment enhanced the binding of [TF] to the [TG] promoter.	C/EBPbeta	MMP-13	0	UNDEFINED	False
10011	10170	19250608:5:RUNX2:SMPD3	The [TF]-responsive element (RRE) encoded within the -562 to -557 region is important for activation of the [TG] promoter by Runx2.	Runx2	smpd3	1	ACTIVATION	False
10012	10171	19254740:10:NFKB:SOX9	Deletion, mutagenesis, and tandem-repeat analyses identified the core region responsive to [TF] at the NF-kappaB binding motif to be around -250bp of the human [TG] promoter, and this was confirmed to show specific binding to RelA.	RelA	SOX9	0	UNDEFINED	False
10013	10173	19254740:12:NFKB:SOX9	We have identified [TF] as a transcriptional factor for [TG] induction and chondrogenic differentiation via binding to an NF-kappaB binding motif in the SOX9 promoter.	RelA	SOX9	1	ACTIVATION	False
10014	10175	19258312:10:TP53:CXCL1	Taken together, our findings define a novel mechanism by which mutant [TF] acquires its gain of function via transactivating the [TG] gene in cancer cells.	p53	GRO1	1	ACTIVATION	True
10016	10177	19258312:6:TP53:CXCL1	We found that knockdown of mutant [TF] inhibits [TG] expression, whereas ectopic expression of mutant R175H in p53-null HCT116 cells increases GRO1 expression.	p53	GRO1	2	REPRESSION	True
10017	10178	19258312:7:TP53:CXCL1	In addition, we found that endogenous mutant [TF] is capable of binding to and activating the [TG] promoter.	p53	GRO1	2	REPRESSION	False
10018	10180	19266165:0:POU2F1:CSN2	[TF] functions as a transactivator in the hormonal induction of [TG] gene expression.	Oct-1	beta-casein	1	ACTIVATION	False
10020	10182	19269978:6:BARX2:SMN1	We found that [TF] binds to the HBS element and potentiates up-regulation of [TG] promoter activity by MyoD.	Barx2	SMA	1	ACTIVATION	False
10021	10183	19269978:7:BARX2:SMN1	We also show that [TF], MyoD, and serum response factor simultaneously occupy the [TG] promoter in cells and that Barx2 interacts with MyoD.	Barx2	SMA	0	UNDEFINED	False
10022	10184	19270520:3:MYC:CDKN1A	Recently, we reported a novel mechanism which allows [TF] to repress [TG]: c-MYC triggers a transcriptional cascade by directly inducing the gene encoding the bHLH-LZ transcription factor AP4 (TFAP4), which binds to recognition motifs located in the vicinity of the p21 promoter and mediates transcriptional repression of p21.	c-MYC	p21	2	REPRESSION	False
10023	10185	19272383:10:CEBPA:CPS1	YB-1 inhibited [TF]-induced transcription from the [TG] promoter via the Y-box near the C/EBPalpha-binding site.	C/EBPalpha	CPS1	1	ACTIVATION	False
10024	10186	19272383:10:YBX1:CPS1	[TF] inhibited C/EBPalpha-induced transcription from the [TG] promoter via the Y-box near the C/EBPalpha-binding site.	YB-1	CPS1	2	REPRESSION	False
10025	10187	19272383:12:CEBPA:CPS1	YB-1 is a key regulator of ammonia detoxification by negatively regulating [TG] expression via suppression of [TF] function.	C/EBPalpha	CPS1	1	ACTIVATION	False
10026	10188	19272383:12:YBX1:CPS1	[TF] is a key regulator of ammonia detoxification by negatively regulating [TG] expression via suppression of C/EBPalpha function.	YB-1	CPS1	2	REPRESSION	True
10027	10189	19272383:6:YBX1:CPS1	The role of [TF] in [TG] expression was investigated by overexpression of YB-1 in mouse fetal liver culture and luciferase reporter assays using the CPS1 promoter.	YB-1	CPS1	0	UNDEFINED	False
10029	10191	19279113:2:YY1:MYC	We demonstrated that p300 and HDAC3 cooperate with the transcription factor [TF] at an upstream YY1 binding site and repress the [TG] promoter.	YY1	Myc	2	REPRESSION	False
10030	10192	19287971:3:NFKB:PTGS2	Sulforaphane (5-20 microM) induced nuclear translocation of [TF] and reduced its binding to the [TG] promoter, a key mechanism for suppressing COX-2 expression by sulforaphane.	NF-kappaB	COX-2	0	UNDEFINED	True
10031	10193	19287971:7:NFKB:PTGS2	Furthermore, SB202190 alone induced [TF] translocation to the nucleus, promoted NF-kappaB binding to the [TG] promoter and resulted in up-regulation of COX-2 expression.	NF-kappaB	COX-2	1	ACTIVATION	False
10032	10194	19289167:4:ID2:MYC	Using chromatin immunoprecipitation we found that 3 h after BSO treatment the repressing complexes [TF] and Sin3A (part of a histone-deacetylase complex) were released from the [TG] promoter.	Id2	c-myc	2	REPRESSION	False
10033	10195	19289167:6:STAT3:MYC	Consequently, [TF] was acetylated and bound to the [TG] promoter and histone H3 became hyperacetylated.	STAT3	c-myc	0	UNDEFINED	False
10034	10196	19289495:7:JUNB:MMP2	Chromatin immunoprecipitation analyses revealed changes in [TF] composition with increased Fra-2 and decreased Fra-1 and JunB binding to the regulatory regions of Gcm1 and [TG] genes in MEKK4 kinase-inactive TS cells.	AP-1	MMP2	0	UNDEFINED	False
10035	10197	19289499:0:RELA:BECN1	p65/[TF] modulates [TG] transcription and autophagy.	RelA	BECN1	0	UNDEFINED	False
10036	10198	19290921:5:NFKB:BTK	In B cells, [TF] was shown to bind to the [TG] promoter and induce transcription, whereas the B-cell receptor-dependent NF-kappaB signaling pathway requires functional Btk.	NF-kappaB	Btk	1	ACTIVATION	False
10037	10199	19302822:11:SP1:FGF2	These results indicate that expression of [TG] in neonatal rat cardiomyocytes is associated with [TF] binding to the FGF-2 promoter.	Sp1	FGF-2	1	ACTIVATION	False
10038	10200	19306294:0:RUNX2:MGP	Sp proteins and [TF] mediate regulation of [TG] (MGP) expression by parathyroid hormone.	Runx2	matrix gla protein	0	UNDEFINED	False
10039	10201	19309720:4:SMAD2:CTGF	In this context, emphasis is also placed on the differential roles of [TF] and Smad3 in the TGF-beta-dependent transactivation of the endogenous [TG] gene and the CTGF gene reporter, as investigated following adenoviral infection of wild-type and dominant negative Smad2/3 or treatment with the specific inhibitor of Smad3 or ALK5-specific (SB-431542) inhibitor.	Smad2	CTGF	0	UNDEFINED	False
10040	10202	19309720:4:SMAD3:CTGF	In this context, emphasis is also placed on the differential roles of Smad2 and [TF] in the TGF-beta-dependent transactivation of the endogenous [TG] gene and the CTGF gene reporter, as investigated following adenoviral infection of wild-type and dominant negative Smad2/3 or treatment with the specific inhibitor of Smad3 or ALK5-specific (SB-431542) inhibitor.	Smad3	CTGF	0	UNDEFINED	True
10041	10203	19321451:4:HES1:CDKN1A	Here we show that the FA core complex contributes to transcriptional regulation of [TF]-responsive genes, including HES1 and the cyclin-dependent kinase inhibitor p21(cip1/[TG]).	HES1	waf1	0	UNDEFINED	False
10042	10204	19322021:3:RELA:NR0B2	In this study, c-Jun and [TF] were shown to mediate the transcriptional activation of the [TG] promoter.	p65	SHP	1	ACTIVATION	False
10043	10205	19324885:8:FOXO3:PPARGC1A	We also demonstrate that [TF] is a direct transcriptional regulator of [TG], suggesting that an auto-regulatory cycle regulates Foxo3a/PGC-1alpha control of the oxidative stress response.	Foxo3a	PGC-1alpha	0	UNDEFINED	True
10044	10206	19324905:3:REL:CCL20	This induction is caused by transcriptional activation of [TG] gene, which is mediated by binding of the p65, p50, and [TF] subunits of the transcription factor nuclear factor-kappaB (NF-kappaB) to an atypical NF-kappaB-binding site present in the CCL20 gene promoter.	c-Rel	CCL20	1	ACTIVATION	False
10045	10207	19330905:5:AP1:OLR1	A pyrrole-imidazole polyamide was designed to target the [TF] binding site of the [TG] gene and synthesized by solid phase methods.	AP-1	LOX-1	0	UNDEFINED	False
10046	10208	19342447:2:RUNX2:DHCR7	We show here that the osteogenic transcription factor [TF] controls genes involved in sterol/steroid metabolism, including Cyp11a1, Cyp39a1, Cyp51, Lss, and [TG] in murine osteoprogenitor cells.	Runx2	Dhcr7	0	UNDEFINED	False
10047	10209	19342457:14:REST:CACNA1H	In conclusion, [TF]/NRSE controls aldosterone and cortisol synthesis by regulating CYP11B2 and CYP11B1 gene transcription mainly through NRSF/NRSE-mediated enhancement of the [TG] gene.	NRSF	CACNA1H	1	ACTIVATION	False
10048	10210	19342459:0:RUNX1:PTGS2	[TF] regulates luteinized hormone-induced [TG] expression in rat periovulatory granulosa cells.	Runt-related transcription factor 1	prostaglandin-endoperoxide synthase 2	0	UNDEFINED	True
10049	10211	19342459:10:RUNX1:PTGS2	Taken together, these findings provide experimental evidence that the LH-dependent induction of [TG] expression results, in part, from [TF]-mediated transactivation of the Ptgs2 promoter.	RUNX1	Ptgs2	1	ACTIVATION	False
10050	10212	19342459:11:RUNX1:PTGS2	The results of the present study assign potential significance for LH-induced [TF] in the ovulatory process via regulating [TG] gene expression.	RUNX1	Ptgs2	0	UNDEFINED	False
10051	10213	19342459:4:RUNX1:PTGS2	In the present study, we investigated the role of [TF] in mediating the LH-induced expression of [TG] in periovulatory granulosa cells.	RUNX1	Ptgs2	1	ACTIVATION	False
10052	10214	19342459:5:RUNX1:PTGS2	We first determined whether the suppression of [TF] expression or activity affects [TG] expression using cultured preovulatory granulosa cells isolated from immature rat ovaries primed with pregnant mare serum gonadotropin for 48 h.	Runx1	Ptgs2	0	UNDEFINED	False
10053	10215	19342459:6:RUNX1:PTGS2	Knockdown of human chorionic gonadotropin-induced [TF] expression by small interfering RNA or inhibition of endogenous RUNX activities by dominant-negative RUNX decreased human chorionic gonadotropin or agonist-stimulated [TG] expression and transcriptional activity of Ptgs2 promoter reporter constructs.	Runx1	Ptgs2	1	ACTIVATION	False
10054	10216	19345188:0:TWIST1:PPARGC1A	[TF] is a PPARdelta-inducible, negative-feedback regulator of [TG] in brown fat metabolism.	Twist-1	PGC-1alpha	2	REPRESSION	False
10055	10217	19366843:2:KLF15:AKR1C3	We present evidence for [TF] as a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene ([TG]) and its potential role in the pathogenesis of hyperandrogenism.	KLF15	HSD17B5	0	UNDEFINED	False
10056	10218	19366843:6:KLF15:AKR1C3	Overexpression of [TF] increased [TG] promoter activity and testosterone formation at least 3-fold in cultured H295R cells.	KLF15	HSD17B5	1	ACTIVATION	False
10057	10219	19367472:7:IRF3:ISG15	Chromatin immunoprecipitation assays showed that [TF] can bind to the promoter of the b[TG] gene.	IRF-3	ISG15	0	UNDEFINED	False
10058	10220	19367472:9:IRF3:ISG15	The luciferase assay showed that the over-expression of bovine [TF] could activate the promoter of b[TG] gene.	IRF-3	ISG15	1	ACTIVATION	False
10059	10221	19376136:11:ATF5:PPARGC1A	In human hepatoma cells (HepG2), but not in human cervical carcinoma cells (HeLa), forced expression of [TF] and Cebpg cooperatively stimulated [TG] promoter activity, suggesting that hepatic Pgc-1alpha could be induced by Atf5 and Cebpg in cooperation with other hepatic factors.	Atf5	Pgc-1alpha	1	ACTIVATION	False
10060	10222	19376136:11:CEBPG:PPARGC1A	In human hepatoma cells (HepG2), but not in human cervical carcinoma cells (HeLa), forced expression of Atf5 and [TF] cooperatively stimulated [TG] promoter activity, suggesting that hepatic Pgc-1alpha could be induced by Atf5 and Cebpg in cooperation with other hepatic factors.	Cebpg	Pgc-1alpha	1	ACTIVATION	False
10061	10223	19376210:8:AP1:RAC2	However, [TF] binding to the endogenous [TG] promoter exhibits a lag of 5-9 h, which correlates with reduced histone H3-Lys9 methylation, increased histone H3 acetylation, and increased nuclease accessibility within the 135 bp Rac2 gene regulatory region.	AP1	Rac2	0	UNDEFINED	False
10062	10224	19385047:0:RELA:CTGF	TNF-alpha suppressed TGF-beta-induced [TG] expression by switching the binding preference of p300 from Smad4 to [TF].	p65	CTGF	2	REPRESSION	True
10063	10225	19385047:0:SMAD4:CTGF	TNF-alpha suppressed TGF-beta-induced [TG] expression by switching the binding preference of p300 from [TF] to p65.	Smad4	CTGF	1	ACTIVATION	True
10064	10226	19385047:7:SMAD4:CTGF	Moreover, the TGF-beta-induced binding of p300 and acetylated H4, but not [TF] to the [TG] promoter was disturbed by TNF-alpha treatment.	Smad4	CTGF	0	UNDEFINED	False
10065	10227	19386363:10:IRF1:CD200	All the above findings suggest that IFN-gamma and TNF-alpha induce [TG] expression through a 5' upstream enhancer and that NF-kappaB, STAT1 and [TF] play pivotal roles in this process.	IRF-1	CD200	1	ACTIVATION	False
10066	10228	19386363:10:NFKB:CD200	All the above findings suggest that IFN-gamma and TNF-alpha induce [TG] expression through a 5' upstream enhancer and that [TF], STAT1 and IRF-1 play pivotal roles in this process.	NF-kappaB	CD200	1	ACTIVATION	False
10067	10229	19386363:10:STAT1:CD200	All the above findings suggest that IFN-gamma and TNF-alpha induce [TG] expression through a 5' upstream enhancer and that NF-kappaB, [TF] and IRF-1 play pivotal roles in this process.	STAT1	CD200	1	ACTIVATION	False
10068	10230	19386363:3:CEBPB:CD200	We previously documented evidence for [TF] as being important in the regulation of constitutive expression of [TG].	C/EBP beta	CD200	0	UNDEFINED	False
10069	10231	19390056:10:STAT3:BMPR2	Finally, we showed that persistent activation of [TF] leads to repressed protein expression of [TG].	STAT3	BMPR2	2	REPRESSION	False
10070	10232	19394332:8:TCF4:CDKN1A	[TF]B induces cell cycle arrest and regulates the expression of p21(Cip1) via newly identified E-boxes in the [TG] gene, independently of p53.	ITF-2	CDKN1A	0	UNDEFINED	False
10071	10233	19411629:5:ETS1:BCL2L1	Analysis of [TF]/Ets2 target genes in isolated embryonic endothelial cells demonstrated down-regulation of Mmp9, [TG], and cIAP2 in double mutants versus controls, and chromatin immunoprecipitation revealed that both Ets1 and Ets2 were loaded at target promoters.	Ets1	Bcl-X(L)	1	ACTIVATION	True
10072	10234	19411629:5:ETS2:BCL2L1	Analysis of Ets1/[TF] target genes in isolated embryonic endothelial cells demonstrated down-regulation of Mmp9, [TG], and cIAP2 in double mutants versus controls, and chromatin immunoprecipitation revealed that both Ets1 and Ets2 were loaded at target promoters.	Ets2	Bcl-X(L)	1	ACTIVATION	False
10073	10235	19414801:6:NFKB:HIF1A	[TG] expression is under control of [TF] and increased DNA binding of the p52 subunit of NF-kappaB was found in tolerant cells.	NF-kappaB	HIF-1alpha	0	UNDEFINED	False
10074	10236	19417216:1:ELK1:EGR1	Transcript elongation by polymerase II paused at the [TG] promoter is activated by mitogen-activated protein kinase phosphorylation of the ternary complex factor (TCF) [TF] bound at multiple upstream sites and subsequent phospho-ELK1 interaction with mediator through the MED23 subunit.	ELK1	Egr1	1	ACTIVATION	False
10075	10237	19419315:10:FOSL1:MGP	We further showed that primary osteoblasts from [TF]-deficient mice failed to exhibit a Pi-dependent stimulation of [TG] expression.	Fra-1	MGP	1	ACTIVATION	False
10076	10238	19419315:8:FOSL1:MGP	In addition, using in vitro DNA binding and chromatin immunoprecipitation assays, we showed that [TF] interacts with the [TG] promoter in response to Pi in MC3T3-E1 cells.	Fra-1	MGP	0	UNDEFINED	False
10077	10239	19419955:7:SMAD4:CDKN2B	Failure in KLF5 acetylation not only prevented p300-assembled [TF]-KLF5 complex formation on [TG] promoter but also affected the binding of Smad4 and FOXO3 on the p15 promoter in vivo.	Smad4	p15	0	UNDEFINED	False
10078	10240	19423711:0:PLAGL1:SORD	[TF] is up-regulated by hypertonicity and decreases [TG] expression, allowing accumulation of sorbitol in kidney cells.	ZAC1	sorbitol dehydrogenase	2	REPRESSION	False
10079	10241	19423764:9:USF1:FSHR	Together, these studies suggest that stimulation of Sertoli cells with FSH transiently decreases expression of the [TF] activator and induces accumulation of the ID2 repressor, to block USF binding to the [TG] promoter and delay activation of Fshr transcription.	USF1	Fshr	1	ACTIVATION	False
10080	10242	19429439:0:ESRRA:VEGFA	[TF] induces the expression of [TG] in breast cancer cells.	Estrogen-related receptor alpha	vascular endothelial growth factor	1	ACTIVATION	False
10081	10243	19429439:8:ESRRA:VEGFA	The induction of [TG] results from the interaction of [TF] with specific ERR-responsive elements within the VEGF promoter.	ERRalpha	VEGF	1	ACTIVATION	False
10082	10244	19433777:6:NFKB:REN	The tumor necrosis factor-alpha-induced decrease in [TG] mRNA was partially reversed by either N-acetylcysteine or panepoxydone, a nuclear factor kappaB ([TF]) inhibitor.	NFkappaB	renin	2	REPRESSION	False
10083	10245	19437620:0:YY1:OCLN	Transcriptional control of [TG] expression in vascular endothelia: regulation by Sp3 and [TF].	YY1	occludin	0	UNDEFINED	False
10084	10246	19437620:6:YY1:OCLN	The work identified a group of transcription factors including Sp3 and [TF], which differentially interact with the [TG] promoter to induce expression of occludin in brain endothelium and repression in other endothelia.	YY1	occludin	1	ACTIVATION	False
10085	10247	19437620:7:YY1:OCLN	The mechanism controlling [TG] expression is similar to that which controls tissue-specific expression of the transferrin receptor in brain endothelium, leading to a scheme for endothelial differentiation, in which activation or repression of tissue-specific proteins is maintained by a set of transcription factors which include Sp3 and [TF].	YY1	occludin	0	UNDEFINED	True
10086	10248	19439223:1:BACH1:HMOX1	[TF] is a transcriptional repressor of the [TG] gene.	Bach1	heme oxygenase (HO)-1	2	REPRESSION	False
10087	10249	19447888:7:PARP1:OPRM1	Furthermore, [TF] inhibitor (benzamide) decreased PARP-1 binding to G(-172) --> T without affecting mRNA or protein expression level of PARP-1 and down-regulated the subsequent [TG] gene expression in SH-SY5Y cells.	PARP-1	MOR	1	ACTIVATION	False
10088	10250	19454702:0:NFE2L2:HMOX1	Inhibition and genetic deficiency of p38 MAPK up-regulates [TG] gene expression via [TF].	Nrf2	heme oxygenase-1	1	ACTIVATION	True
10089	10251	19454702:10:NFE2L2:HMOX1	Taken together, it is demonstrated that pharmacological inhibition and genetic deficiency of p38 induce [TG] gene expression via a [TF]-dependent mechanism in monocytic cells and MEF.	Nrf2	HO-1	1	ACTIVATION	False
10090	10252	19454702:7:NFE2L2:HMOX1	Accordingly, inhibitors of p38 induced binding of nuclear proteins to a [TF] target sequence of the [TG] promoter, but did not affect HO-1 protein expression and promoter activity in Nrf2(-/-) MEF.	Nrf2	HO-1	0	UNDEFINED	False
10091	10253	19457859:6:KLF1:E2F2	The [TG] enhancer was occupied by [TF] in vivo.	EKLF	E2f2	0	UNDEFINED	False
10092	10254	19458474:0:RELA:BECN1	p65/[TF] binds and activates the [TG] promoter.	RelA	beclin 1	1	ACTIVATION	False
10093	10255	19458474:1:RELA:BECN1	We unveiled novel p65/[TF] consensus sites in the promoter of the [TG] gene and demonstrate that p65/RelA positively modulates canonical autophagy in various human cell lines both under basal conditions and upon induction by ceramide.	RelA	beclin 1	0	UNDEFINED	True
10094	10256	19458474:2:RELA:BECN1	Interestingly, we find that T cell receptor-dependent activation of Jurkat cells triggers an increase in the binding of p65/[TF] to the [TG] promoter accompanied by enhanced autophagy, suggesting that p65/RelA could regulate T-cell activation and homeostasis through autophagy.	RelA	beclin 1	0	UNDEFINED	False
10095	10257	19466541:5:SP1:BRCA1	To test the hypothesis that methylation of CpG sites may affect accessibility of the [TG] promoter to transcription factors and consequently cause down-regulation of BRCA1, we analyzed the binding of four transcription factors (CTCF, [TF], E2F1 and E2F6) to the BRCA1 promoter using chromatin immunoprecipitation assay (ChIP) and quantitative PCR.	Sp1	BRCA1	0	UNDEFINED	False
10096	10258	19466541:6:CTCF:BRCA1	[TF] and E2F1 were enriched at the unmethylated [TG] promoter in MCF-7 cells.	CTCF	BRCA1	0	UNDEFINED	False
10097	10259	19466541:6:E2F1:BRCA1	CTCF and [TF] were enriched at the unmethylated [TG] promoter in MCF-7 cells.	E2F1	BRCA1	0	UNDEFINED	False
10098	10260	19466541:8:E2F1:BRCA1	Following demethylating drug treatment, [TF] was enriched at the [TG] promoter in the demethylated UACC3199 cells.	E2F1	BRCA1	0	UNDEFINED	False
10099	10261	19473970:12:FOXO3:TNFRSF1B	We conclude that [TF] regulates oxygen-dependent changes in expression of [TG] in HDMECs, controlling sensitivity to TNF-mediated apoptosis.	FOXO3a	TNFR2	0	UNDEFINED	False
10100	10262	19473970:5:FOXO3:TNFRSF1B	We identified a potential [TF] binding site in the 5' enhancer region of the [TG] gene.	FOXO3a	TNFR2	0	UNDEFINED	False
10103	10265	19474327:12:STAT3:SOD2	Our study demonstrates that [TF] is a novel transcription factor of the mouse [TG] gene and plays a crucial role as a neuroprotectant in regulating levels of reactive oxygen species in the mouse brain.	STAT3	Mn-SOD	0	UNDEFINED	False
10104	10266	19474327:4:STAT3:SOD2	In this study, we identified the [TF] (STAT3) as a transcription factor of the mouse [TG] gene, and elucidated the mechanism of O(2)(*-) overproduction after transient focal cerebral ischemia (tFCI).	signal transducer and activator of transcription 3	Mn-SOD	0	UNDEFINED	True
10105	10267	19474327:6:STAT3:SOD2	We also found that activated [TF] is usually recruited into the mouse [TG] promoter and upregulates transcription of the mouse Mn-SOD gene in the normal brain.	STAT3	Mn-SOD	1	ACTIVATION	False
10106	10268	19474327:7:STAT3:SOD2	However, at early postreperfusion periods after tFCI, [TF] was rapidly downregulated, and its recruitment into the [TG] promoter was completely blocked.	STAT3	Mn-SOD	0	UNDEFINED	False
10107	10269	19478207:10:HNF4A:ACAT2	We identified [TF] as an important regulator of the hepatocyte-specific expression of the human [TG] promoter.	HNF4alpha	ACAT2	0	UNDEFINED	False
10108	10270	19478207:8:HNF4A:ACAT2	Mutagenesis revealed one important [TF] in the human [TG] promoter.	HNF4 binding site	ACAT2	0	UNDEFINED	False
10109	10271	19478552:8:NFKB:PLD1	In addition, triptolide inhibited activation of [TF] which increased [TG] expression.	NFkB	PLD1	1	ACTIVATION	False
10110	10272	19479035:7:SOX17:CCND1	Notably, [TF] enhanced [TG] expression in vivo and activated cyclin D1 promoter activity in vitro.	Sox17	cyclin D1	1	ACTIVATION	False
10111	10273	19479035:8:SOX17:CDKN1A	[TF] decreased the expression of transforming growth factor-beta (TGF-beta)-responsive cell cycle inhibitors in the adult mouse lung, including p15, [TG], and p57, and inhibited TGF-beta1-mediated transcriptional responses in vitro.	Sox17	p21	2	REPRESSION	False
10112	10274	19479035:8:SOX17:CDKN1C	[TF] decreased the expression of transforming growth factor-beta (TGF-beta)-responsive cell cycle inhibitors in the adult mouse lung, including p15, p21, and [TG], and inhibited TGF-beta1-mediated transcriptional responses in vitro.	Sox17	p57	2	REPRESSION	False
10113	10275	19487584:1:ETS1:NPR1	The objective of the present study was to gain insight into the cooperative roles of [TF] and p300 in transcriptional regulation and expression of the [TG] gene (coding for guanylyl cyclase-A/natriuretic peptide receptor-A).	Ets-1	Npr1	0	UNDEFINED	False
10114	10276	19487584:2:ETS1:NPR1	Overexpression of [TF] and p300 in mouse mesangial cells increased [TG] promoter activity by 12-fold, natriuretic peptide receptor-A mRNA levels by 5-fold, and ANP-dependent intracellular accumulation of cGMP by 26-fold.	Ets-1	Npr1	1	ACTIVATION	False
10115	10277	19487584:3:ETS1:NPR1	Knockdown of [TF] and p300 expression by small interfering RNA inhibited [TG] gene transcription by 90%.	Ets-1	Npr1	1	ACTIVATION	False
10116	10278	19487584:7:ETS1:NPR1	The results indicate that [TG] gene transcription is critically controlled by histone acetyltransferase p300 and [TF].	Ets-1	Npr1	0	UNDEFINED	True
10117	10279	19487697:9:ATF2:IL13	Thus, [TF] might be one of the transcriptional factors for the expression of [TG] in Der f 2-treated BEAS-2B cells.	ATF-2	IL-13	1	ACTIVATION	True
10118	10280	19490965:10:HIF1A:PLAU	CHIP assay further confirmed that the induction of PAI-1 involved the binding of [TF] to the PAI-1 promoter, while the enhancement or silencing of HIF-1alpha did not affect the expression of urokinase type PA ([TG]), tissue type PA (tPA) or uPA receptor (uPAR).	HIF-1alpha	uPA	1	ACTIVATION	False
10119	10281	19491401:2:CEBPB:PPARGC1A	We have previously reported that [TF] specifically binds to the CRE on the proximal [TG] promoter and increases forskolin-sensitive Pgc-1alpha and Ucp1 expression in white 3T3-L1 preadipocytes.	C/EBPbeta	Pgc-1alpha	1	ACTIVATION	False
10120	10282	19494233:5:NFKB:PTGS2	Inhibitor of [TF] (IkappaBalpha) is degraded following particle treatment, permitting active NF-kappaB to translocate to the nucleus where it interacts with the [TG] promoter and drives transcription.	NF-kappaB	COX-2	1	ACTIVATION	False
10121	10283	19497660:8:E2F1:BIRC5	We conclude that [TG] is induced via a functional cooperation between MYCN and [TF].	E2F1	BIRC5	1	ACTIVATION	False
10123	10285	19499154:10:AP1:CCND1	Its overexpression can inhibit the expression of transcription factors [TF] and Ets-1, and down-regulate the transcriptional activity of the [TG] promoter in human CRC.	AP-1	cyclin D1	1	ACTIVATION	True
10124	10286	19500568:3:SREBF2:SRD5A2	The three fold increase in [TG] mRNA mediated by L/E treatment was accompanied by the induction of [TF] binding to the Srd5a2 promoter detected by a ChIP-chip assay in liver.	SREBP-2	Srd5a2	1	ACTIVATION	False
10125	10287	19500568:4:SREBF2:SRD5A2	We identified a [TF] responsive region within the first 300 upstream bases of the mouse [TG] promoter by co-transfection assays which contain a site that bound SREBP-2 in vitro by an EMSA.	SREBP-2	Srd5a2	0	UNDEFINED	False
10126	10288	19502595:7:VDR:CYP24A1	Snail2 reduces the ligand-induced [TF] transcriptional activation of a consensus response element and of the [TG] promoter.	VDR	CYP24	1	ACTIVATION	False
10127	10289	19506034:6:STAT3:CCND1	In the nucleus, the acetylated [TF] dimer remains associated with CD44 and binds to the [TG] promoter, leading to increased cyclin D1 expression and cell proliferation.	STAT3	cyclin D1	1	ACTIVATION	False
10128	10290	19521989:10:NFKB:PTGS2	The transfection of ECRG4 gene in ESCC cells inhibited the expression of [TF] and nuclear translocation, in addition to the expression of [TG], a NF-kappaB target gene, was attenuated.	NF-kappaB	COX-2	1	ACTIVATION	False
10129	10291	19522704:4:BHLHE40:PPARGC1A	We demonstrate that [TF] binds to the promoters of [TG] and myogenic genes in vivo and that Bhlhe40 represses the MyoD-mediated transactivation of these promoters.	Bhlhe40	PGC-1alpha	2	REPRESSION	False
10130	10292	19523687:2:CEBPA:TNFRSF1A	In this report we demonstrate that both [TF] and C/EBPbeta activate the promoter driving transcription of the tumor necrosis factor receptor 1 ([TG]).	C/EBPalpha	TNFR1	1	ACTIVATION	False
10131	10293	19523687:2:CEBPB:TNFRSF1A	In this report we demonstrate that both C/EBPalpha and [TF] activate the promoter driving transcription of the tumor necrosis factor receptor 1 ([TG]).	C/EBPbeta	TNFR1	1	ACTIVATION	False
10132	10294	19523687:5:CEBPA:TNFRSF1A	Here we have identified a specific C/EBP binding site within the [TG] promoter, and shown that this site is required for both [TF] and C/EBPbeta activation of the promoter in reporter gene assays.	C/EBPalpha	TNFR1	1	ACTIVATION	False
10133	10295	19523687:6:CEBPA:TNFRSF1A	Furthermore, we show that both [TF] and C/EBPbeta are bound to the [TG] promoter in cells using chromatin immunoprecipitation assays.	C/EBPalpha	TNFR1	0	UNDEFINED	False
10134	10296	19523687:6:CEBPB:TNFRSF1A	Furthermore, we show that both C/EBPalpha and [TF] are bound to the [TG] promoter in cells using chromatin immunoprecipitation assays.	C/EBPbeta	TNFR1	0	UNDEFINED	False
10135	10297	19526316:0:EGR1:VEGFA	Hepatocyte growth factor induced up-regulations of [TG] through [TF] in hepatocellular carcinoma cells.	Egr-1	VEGF	1	ACTIVATION	False
10136	10298	19526316:11:EGR1:VEGFA	[TF] knockdown reduced the luciferase activities increased by HGF not in the IL-8 promoter, but in the [TG] promoter.	Egr-1	VEGF	1	ACTIVATION	False
10137	10299	19526316:8:EGR1:VEGFA	HGF-induced up-regulation of [TG] and IL-8 were repressed by [TF] knockdown.	Egr-1	VEGF	1	ACTIVATION	False
10138	10300	19526316:9:EGR1:VEGFA	HGF enhanced the binding activity of [TF] to the [TG] promoter in control cells, but not in the Egr-1-shRNA cells.	Egr-1	VEGF	0	UNDEFINED	False
10139	10301	19535790:10:SMAD3:FSHR	When [TF] was introduced into Smad3-deficient granulosa cells with adenovirus vectors, FSH responsiveness was restored, and FSH was able to upregulate [TG] expression.	Smad3	Fshr	1	ACTIVATION	False
10140	10302	19535790:11:SMAD3:FSHR	Furthermore, [TF] interacts with a palindromic SMAD binding element in the [TG] promoter, and TGFB can activate promoter constructs containing this element.	SMAD3	Fshr	1	ACTIVATION	False
10141	10303	19541765:8:HES1:CDKN1C	Furthermore, pituitaries lacking [TF] have increased cell cycle exit, shown by significant increases in the cyclin-dependent kinase inhibitors, p27 and [TG], from e10.5 to e14.5.	Hes1	p57	2	REPRESSION	False
10142	10305	19551855:4:TP53:BTG2	Luciferase reporter gene analyses revealed that [TG] repression takes place at the transcriptional level and is dependent on the integrity of the major [TF]-response element within the BTG2 promoter.	p53	BTG2	2	REPRESSION	True
10143	10306	19553068:0:AP1:VEGFA	JNK/[TF] pathway is involved in tumor necrosis factor-alpha induced expression of [TG] in MCF7 cells.	AP-1	vascular endothelial growth factor	1	ACTIVATION	False
10144	10307	19553068:10:AP1:VEGFA	These data suggest that the pro-inflammatory cytokine TNF-alpha is a critical regulator of [TG] expression in breast cancer cells, at least partially via a JNK and [TF] dependent pathway.	AP-1	VEGF	0	UNDEFINED	False
10145	10308	19553068:9:JUN:VEGFA	Finally using chromatin immunoprecipitation (CHIP) assays, we found that p-[TF] bound to the [TG] promoter and regulated VEGF transcription directly.	c-Jun	VEGF	0	UNDEFINED	False
10146	10309	19553673:5:SREBF1:LPIN1	Using a luciferase assay, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay, we demonstrated that these elements are responsible for the transcription of [TG] gene, mediated by [TF] (sterol regulatory element-binding protein 1) and nuclear factor Y.	SREBP-1	LPIN1	1	ACTIVATION	False
10147	10310	19558368:3:RREB1:TP53	In the present study we demonstrate that RREB-1 ([TF]) efficiently binds to the [TG] promoter via the p53 core promoter element and transactivates p53 expression.	Ras-responsive-element-binding protein-1	p53	1	ACTIVATION	False
10148	10311	19562690:7:NFKB:PTGS2	Chromatin immunoprecipitation (ChIP) assays reveal that TXNIP over-expression in EC abolishes H3K9 tri-methylation, a marker for gene inactivation, and increases H3K9 acetylation, an indicator of gene induction, at proximal [TG] promoter bearing the [TF]-binding site.	NF-kappaB	Cox2	0	UNDEFINED	False
10149	10312	19564408:8:CEBPA:AGT	The data further show that repression of resistin and [TG] expression involves recruitment of CtBP1/2, directed by [TF], to the minimal promoter of the corresponding genes in response to the PPARgamma ligand.	C/EBPalpha	angiotensinogen	2	REPRESSION	False
10150	10313	19564408:8:PPARG:AGT	The data further show that repression of resistin and [TG] expression involves recruitment of CtBP1/2, directed by C/EBPalpha, to the minimal promoter of the corresponding genes in response to the [TF] ligand.	PPARgamma	angiotensinogen	2	REPRESSION	False
10151	10314	19566924:0:YY1:CBX5	The role of [TF] in reduced [TG] gene expression in invasive human breast cancer cells.	YY1	HP1alpha	2	REPRESSION	False
10152	10315	19566924:11:YY1:CBX5	[TF] knockdown in MCF7 cells resulted in a decreased level of [TG] mRNA, indicating that YY1 positively regulates HP1alpha expression.	YY1	HP1alpha	1	ACTIVATION	False
10153	10316	19566924:12:YY1:CBX5	Chromatin immunoprecipitation experiments verified [TF] occupancy at the [TG] gene promoter in MCF7 cells but not HS578T cells.	YY1	HP1alpha	0	UNDEFINED	False
10154	10317	19566924:14:YY1:CBX5	Our data suggests that a reduction of [TF] expression in breast cancer cells could contribute to the acquisition of an invasive phenotype through increased cell migration as well as by reduced expression of [TG].	YY1	HP1alpha	1	ACTIVATION	False
10155	10318	19566924:9:YY1:CBX5	The transcription factor yin yang 1 ([TF]) was found to play a role in differential transcriptional activity of the [TG] gene.	YY1	HP1alpha	0	UNDEFINED	False
10156	10319	19568426:0:CTCF:MYC	Targeted deletion of multiple [TF]-binding elements in the human [TG] gene reveals a requirement for CTCF in C-MYC expression.	CTCF	C-MYC	1	ACTIVATION	False
10157	10320	19578162:5:PPARG:PTGS2	[TF]-dependent suppression of [TG] promoter activity was observed in response to carvacrol treatment.	PPARgamma	COX-2	2	REPRESSION	False
10158	10321	19581932:2:BCL11B:CDKN1A	Here, we report that COUP-TF-interacting protein 2 ([TF]), recruited to the [TG] gene promoter, silenced p21 gene transcription through interactions with histone deacetylases and methyltransferases.	CTIP2	p21	2	REPRESSION	False
10159	10322	19582394:11:LEF1:GIP	Lithium favours [TF]/beta-catenin binding to [TG] promoter and diminishes ChIP through T cell factor-4 and histone deacetylase 1.	lymphoid enhancer factor-1	Gip	0	UNDEFINED	False
10160	10323	19584258:4:NR4A1:CDKN1A	Activation of [TG] promoter constructs by DIM-C-pPhOCH3 required the GC-rich proximal region of the promoter, and results of RNA interference studies showed that [TF]-dependent activation of the p21 promoter involved interactions with Sp1 and Sp4 but not Sp3.	Nur77	p21	1	ACTIVATION	False
10161	10324	19584258:4:SP1:CDKN1A	Activation of [TG] promoter constructs by DIM-C-pPhOCH3 required the GC-rich proximal region of the promoter, and results of RNA interference studies showed that Nur77-dependent activation of the p21 promoter involved interactions with [TF] and Sp4 but not Sp3.	Sp1	p21	1	ACTIVATION	False
10162	10325	19584258:4:SP4:CDKN1A	Activation of [TG] promoter constructs by DIM-C-pPhOCH3 required the GC-rich proximal region of the promoter, and results of RNA interference studies showed that Nur77-dependent activation of the p21 promoter involved interactions with Sp1 and [TF] but not Sp3.	Sp4	p21	1	ACTIVATION	False
10163	10326	19584258:5:NR4A1:CDKN1A	Interactions of [TF] with the [TG] promoter in Panc1 cells treated with DIM-C-pPhOCH3 were also confirmed in chromatin immunoprecipitation assays.	Nur77	p21	0	UNDEFINED	False
10164	10327	19585511:4:AP1:DUSP1	Mutagenesis experiments of the proximal element determined that CRE/[TF] is required for LPS- or M-CSF-induced activation of the [TG] gene.	AP-1	MKP-1	1	ACTIVATION	False
10165	10328	19615968:4:TP63:FAS	The intronic element conferred transcriptional activation by p53, TA[TF] and TAp73 and cooperated with the p53-REs in the promoter of the [TG] gene.	p63	CD95	1	ACTIVATION	False
10166	10329	19616560:10:ETS1:CD79A	Pax5 counteracts autoinhibition and increases binding of [TF] of the [TG] promoter by >1000-fold.	Ets-1	mb-1	0	UNDEFINED	False
10167	10330	19616560:13:ETS1:CD79A	Pax5 wild type and Q22A each recruited GA-binding protein alpha/beta1 to the [TG] promoter with similar affinities, but recruitment was less efficient than that of [TF] (reduced by approximately 8-fold).	Ets-1	mb-1	0	UNDEFINED	False
10168	10331	19620287:9:CREB1:MEIS1	Loss of Hoxa9 resulted in a decrease in Creb1 and Pknox1 mRNA, and forced expression of [TF] in Hoxa9(-/-) bone marrow cells increased [TG] mRNA almost as well as HOXA9, suggesting that CREB1 may mediate HOXA9 modulation of Meis1 expression.	CREB1	Meis1	1	ACTIVATION	False
10169	10332	19621387:5:SP3:CDC25A	We demonstrate by RNA interference that Sp1, [TF] and Sp4 all play a role in regulating [TG] expression and proliferation in human breast cancer cells.	Sp3	CDC25A	0	UNDEFINED	False
10170	10333	19621387:5:SP4:CDC25A	We demonstrate by RNA interference that Sp1, Sp3 and [TF] all play a role in regulating [TG] expression and proliferation in human breast cancer cells.	Sp4	CDC25A	0	UNDEFINED	False
10172	10335	19628677:0:KLF5:CDKN1A	Angiotensin II stimulates [TF] phosphorylation and its interaction with c-Jun leading to suppression of [TG] expression in vascular smooth muscle cells.	KLF5	p21	2	REPRESSION	False
10173	10336	19628677:1:KLF5:CDKN1A	Krppel-like factor 5 ([TF]) and c-Jun are involved in angiotensin II (Ang II)-induced cell proliferation and play an important role in [TG] expression.	KLF5	p21	0	UNDEFINED	False
10174	10337	19628677:2:KLF5:CDKN1A	But the direct and functional implications of [TF] and c-Jun in regulating [TG] expression in vascular smooth muscle cells (VSMCs) are unclear.	KLF5	p21	0	UNDEFINED	False
10176	10339	19628677:6:KLF5:CDKN1A	Reporter analysis showed that both [TF] and c-Jun cooperatively repressed the promoter of [TG].	KLF5	p21	2	REPRESSION	False
10177	10340	19628677:7:KLF5:CDKN1A	Furthermore, [TF] bound to its cis-elements in the [TG] promoter, and meanwhile interacted with c-Jun in Ang II-induced VSMCs.	KLF5	p21	0	UNDEFINED	True
10178	10341	19628677:8:KLF5:CDKN1A	These results suggest that Ang II induces [TF] phosphorylation mediated by the ERK signalling in VSMCs, which in turn stimulates the interaction of KLF5 with c-Jun, subsequently leads to the suppression of [TG] expression.	KLF5	p21	2	REPRESSION	False
10180	10343	19637235:4:HIF1A:S100A4	The expressions of the annexin A1, CapG and [TG] genes were significantly induced by hypoxia in five adherent cell lines tested besides U937 cells, while their expressions were blocked by the short hairpin RNA specifically against [TF].	HIF-1alpha	S100A4	1	ACTIVATION	False
10181	10344	19637235:5:HIF1A:S100A4	Further luciferase reporter assay and chromatin immunoprecipitation showed that [TF] directly bound to three hypoxia-responsive elements located at intron 1 of [TG] gene and hypoxia-responsive element at -350 to -346 of CapG gene, which are essential for HIF-1-induced expression.	HIF-1alpha	S100A4	1	ACTIVATION	False
10182	10345	19638343:6:AP1:BBC3	Palmitate-mediated [TG] expression was inhibited by a dominant negative [TF], and direct binding of a phosphorylated c-Jun containing the activator protein 1 complex to the PUMA promoter was identified by electrophoretic mobility shift assay and a chromatin immunoprecipitation assay.	c-Jun	PUMA	1	ACTIVATION	True
10183	10346	19638401:6:NKX2-5:SLC8A1	We show that [TF] recruits HDAC5 to the [TG] promoter, where HDAC5 complexes with HDAC1.	Nkx2.5	Ncx1	0	UNDEFINED	False
10184	10347	19638401:7:NKX2-5:SLC8A1	[TF] also interacts with transcriptional activator p300, which is recruited to the [TG] promoter.	Nkx2.5	Ncx1	0	UNDEFINED	False
10186	10349	19650108:8:RUNX2:LEF1	We determined that the [TG]DeltaN p2 promoter is active in osteoblasts and [TF] regulates its activity.	Runx2	Lef1	0	UNDEFINED	False
10187	10350	19651778:4:AP1:PCK1	[TF] competed with HNF4alpha for binding to this site and also decreased HNF4alpha stimulation of transcription from the [TG] gene promoter.	AP-1	PEPCK-C	2	REPRESSION	False
10188	10351	19651901:4:PDX1:SLC2A2	Chromatin immunoprecipitation reveals that HMGN3 and the transcription factor [TF] mutually reinforce their specific binding to the chromatin in the promoter of the Glut2 gene, thereby regulating [TG] protein levels in pancreatic islets and in beta cells.	PDX1	GLUT2	0	UNDEFINED	False
10189	10352	19661285:7:SP1:MAOA	Coimmunoprecipitation and ChIP assays showed that SRY and [TF] form a transcriptional complex and synergistically activate [TG] transcription.	Sp1	MAO A	1	ACTIVATION	False
10190	10353	19666541:5:NR2C2:CD36	Both electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipitation (ChIP) assays demonstrate that [TF] binds to the TR4 response element located on the [TG] 5'-promoter region for the induction of CD36 expression.	TR4	CD36	1	ACTIVATION	False
10191	10354	19668226:7:YY1:KLK3	However, ectopic [TF] expression in LNCaP cells did not further enhance the reporter driven by the [TG] promoter, suggesting that an optimal level of YY1 is already established in prostate tumor cells.	YY1	PSA	1	ACTIVATION	False
10192	10355	19668226:8:YY1:KLK3	Consistently, [TF] depletion in LNCaP cells reduced endogenous [TG] levels, but overexpressed YY1 did not significantly increase PSA expression.	YY1	PSA	1	ACTIVATION	False
10193	10356	19679681:7:NFE2L2:HMOX1	Co-transfection studies and bandshift analyses confirmed binding of the antioxidative transcription factor NF-E2-related factor 2 ([TF])-which was stabilized by proteasome inhibition as shown by immunoblots-to the ARE site of [TG].	Nrf2	HO1	0	UNDEFINED	False
10194	10357	19684017:4:KLF5:MYC	Knockdown of [TF] significantly reduced [TG] expression in the HaCaT epidermal epithelial cells.	KLF5	MYC	1	ACTIVATION	False
10195	10358	19689405:4:HIF1A:HK2	In cancer cells, [TF] induces over-expression and increased activity of several glycolytic protein isoforms that differ from those found in non-malignant cells, including transporters (GLUT1, GLUT3) and enzymes (HKI, [TG], PFK-L, ALD-A, ALD-C, PGK1, ENO-alpha, PYK-M2, LDH-A, PFKFB-3).	HIF-1alpha	HKII	1	ACTIVATION	False
10196	10359	19690166:12:CREBZF:PDK4	GSK5182 and adenoviral overexpression of [TF] cooperate to repress ERRgamma-induced [TG] gene expression, and this repression is released by overexpression of a catalytically defective SIRT1 mutant.	SMILE	PDK4	2	REPRESSION	False
10197	10360	19690214:6:NFKB:VASP	Studies in the putative human [TG] promoter identified [TF] as a key regulator of VASP transcription.	NF-kappaB	VASP	0	UNDEFINED	False
10198	10361	19702536:5:NR1I2:CYP2C9	Several drug-activated nuclear receptors including CAR, [TF], VDR, and GR recognize drug responsive elements within the 5' flanking promoter region of [TG] genes to mediate the transcriptional upregulation of these genes in response to xenobiotics and steroids.	PXR	CYP2C	1	ACTIVATION	False
10199	10362	19702536:5:NR1I3:CYP2C9	Several drug-activated nuclear receptors including [TF], PXR, VDR, and GR recognize drug responsive elements within the 5' flanking promoter region of [TG] genes to mediate the transcriptional upregulation of these genes in response to xenobiotics and steroids.	CAR	CYP2C	1	ACTIVATION	False
10200	10363	19703515:8:ESRRA:PDK4	Previously, we found that the [TF] (ERRalpha) stimulates the expression of [TG].	estrogen related receptor alpha	PDK4	1	ACTIVATION	False
10201	10364	19703903:3:CREB1:MCAM	We found that PAR1 silencing with small hairpin RNA inhibits [TG] expression in metastatic melanoma cells by inhibiting [TF] phosphorylation, activity, and binding to the MUC18 promoter.	CREB	MUC18	1	ACTIVATION	False
10202	10365	19703903:3:NR1I2:MCAM	We found that [TF] silencing with small hairpin RNA inhibits [TG] expression in metastatic melanoma cells by inhibiting CREB phosphorylation, activity, and binding to the MUC18 promoter.	PAR1	MUC18	1	ACTIVATION	False
10203	10366	19703903:4:NR1I2:MCAM	We further demonstrate that the PAF/PAFR pathway mediates [TG] expression downstream of [TF].	PAR1	MUC18	1	ACTIVATION	False
10204	10367	19703903:5:NR1I2:MCAM	Indeed, [TF] silencing down-regulates PAFR expression and PAF production, PAFR silencing blocks [TG] expression, and re-expression of PAFR in PAR1-silenced cells rescues MUC18 expression.	PAR1	MUC18	1	ACTIVATION	False
10205	10368	19706488:3:MLX:TXNIP	By mediating glucose-induced activation of [TG] (TXNIP), MondoA:[TF] complexes directly repress glucose uptake.	Mlx	thioredoxin-interacting protein	1	ACTIVATION	True
10206	10369	19706488:8:MLX:TXNIP	Together our data suggest that glutamine-dependent mitochondrial anapleurosis dictates glucose uptake and aerobic glycolysis by blocking MondoA:[TF]-dependent transcriptional activation of [TG].	Mlx	TXNIP	1	ACTIVATION	False
10207	10371	19706729:5:NFIC:CYP3A7	In contrast, cotransfection of [TF]B2, NFIC1, NFIC2, NFIX1, and NFIX2 reduced the expression of luciferase under the control of the [TG] gene promoter.	NFI	CYP3A7	2	REPRESSION	False
10208	10372	19706766:5:NFKB:BCL2L1	We show that [TF] p65 and MUC1-C constitutively occupy the promoter of the [TG] gene in carcinoma cells and that MUC1-C contributes to NF-kappaB-mediated transcriptional activation.	NF-kappaB	Bcl-xL	1	ACTIVATION	False
10211	10375	19706769:5:NFKB:G0S2	We found that the gene undergoing maximal transcriptional induction following TNF-alpha treatment was [TG] (G0S2), the activation of which also required [TF].	NF-kappaB	G(0)-G(1) switch gene 2	1	ACTIVATION	False
10212	10376	19710929:9:PPARA:HMGCS2	Most of the genes commonly regulated in mouse and human were involved in lipid metabolism and many represented known [TF] targets, including CPT1A, [TG], FABP1, ACSL1, and ADFP.	PPARalpha	HMGCS2	0	UNDEFINED	False
10213	10377	19718047:7:EWSR1:GSTM4	We found that [TF]/FLI directly binds the [TG] promoter, and regulates GSTM4 expression through a GGAA-microsatellite in its promoter.	EWS	GSTM4	0	UNDEFINED	True
10214	10378	19720831:6:USF1:NR0B2	We demonstrated that upstream stimulatory factor-1 ([TF]) specifically mediated HGF effect on [TG] gene expression, and inhibition of USF-1 by dominant negative USF-1 significantly abrogated HGF-mediated activation of the SHP promoter.	USF-1	SHP	1	ACTIVATION	False
10215	10379	19720831:7:USF1:NR0B2	Elucidation of the mechanism showed that [TF] bound to E-box-1 in the [TG] promoter, and HGF increased USF-1 DNA binding on the SHP promoter via AMPK and DNA-dependent protein kinase-mediated pathways.	USF-1	SHP	0	UNDEFINED	False
10216	10380	19721135:4:EGR1:GDNF	Sequence analysis of the rat [TG] gene identified three overlapping [TF]-binding sites between positions -185 and -163 of the rat Gdnf promoter.	Egr-1	Gdnf	0	UNDEFINED	False
10217	10381	19721135:5:EGR1:GDNF	Transfection studies using a series of deleted [TG] promoters revealed that these [TF]-binding sites are required for maximal activation of the Gdnf promoter by FGF2.	Egr-1	Gdnf	1	ACTIVATION	False
10218	10382	19721135:6:EGR1:GDNF	Chromatin immunoprecipitation analysis indicated that [TF] binds to the [TG] promoter.	Egr-1	Gdnf	0	UNDEFINED	False
10219	10383	19721135:8:EGR1:GDNF	Additionally, we found that stimulation of the ERK and JNK pathways by FGF2 is functionally linked to [TG] expression through the induction of [TF].	Egr-1	Gdnf	1	ACTIVATION	True
10220	10384	19722712:5:HNF1A:SLC5A1	On the other hand, [TF] binding on the region around transcription start site of the [TG] gene was not altered in each jejunoileal segment by feeding rats an RS diet.	HNF-1	SGLT1	0	UNDEFINED	False
10221	10385	19722712:6:HNF1A:SLC5A1	Our results suggest that a shift of the expressional peak of the [TG] gene from the upper jejunum toward the ileum by dietary RS is associated with a change of histone H3 acetylation rather than that of [TF] binding on the gene.	HNF-1	SGLT1	0	UNDEFINED	False
10222	10386	19725955:6:SOX9:CCND1	Arg-methylation of [TF] by CARM1 disrupts interaction of Sox9 with beta-catenin, regulating [TG] expression and cell cycle progression of chondrocytes.	Sox9	Cyclin D1	0	UNDEFINED	False
10223	10387	19730435:7:YBX3:CCND1	GEF-H1 and [TF] are required for expression of endogenous [TG], a crucial RhoA signalling target gene, and GEF-H1-stimulated cyclin D1 promoter activity requires ZONAB.	ZONAB	cyclin D1	1	ACTIVATION	False
10225	10389	19735946:8:NKX2-2:CD52	Gel shift analysis revealed that [TF], a transcriptional factor, binds to the promoter region of the [TG] gene.	NKX2.2	Cd52	0	UNDEFINED	False
10226	10390	19736317:5:POU5F1:SOX17	This switch allows the cells to turn off the pluripotency [TF]-Sox2 loop and to turn on the [TG] promoter.	Oct4	Sox17	2	REPRESSION	True
10227	10391	19748502:6:SOX10:JAG1	We provide genetic evidences that [TF], in a concentration-dependant manner, could play a role in the regulation of [TG], a gene known to be important for inner ear prosensory development.	Sox10	Jagged1	0	UNDEFINED	False
10228	10392	19748606:7:NFATC1:PTGS2	In this study, we hypothesized that [TF] is activated in response to mechanical stimulation and mediates [TG] expression.	NFAT2	Cox2	1	ACTIVATION	False
10229	10393	19749795:0:SPI1:TNFSF10	[TF] induces apoptosis in myeloma cells through direct transactivation of [TG].	PU.1	TRAIL	1	ACTIVATION	False
10230	10394	19749795:5:SPI1:TNFSF10	In both U266 and KMS12PE cells expressing [TF], PU.1 directly bound to a region 30 bp downstream of the transcription start site of the [TG] gene.	PU.1	TRAIL	0	UNDEFINED	False
10231	10395	19749795:6:SPI1:TNFSF10	Upregulation of [TF]-induced transactivation of the [TG] promoter in reporter assays, and disruption of the PU.1-binding site in the TRAIL promoter eliminated this transactivation.	PU.1	TRAIL	1	ACTIVATION	False
10232	10396	19749795:7:SPI1:TNFSF10	Therefore, we conclude that [TF] is capable of inducing apoptosis in certain myeloma cells by direct transactivation of [TG].	PU.1	TRAIL	1	ACTIVATION	False
10233	10397	19752193:8:RARA:ABCA1	Chromatin immunoprecipitation assays demonstrated increased binding of [TF] and NFATc2 to the [TG] promoter in IRAK-1(-/-) macrophages compared to wild-type macrophages.	RARalpha	ABCA1	0	UNDEFINED	False
10234	10398	19752329:6:RELA:HMOX1	Chromatin immunoprecipitation analysis of mouse hearts provided direct evidence that nuclear factor-kappaB subunits p50 and [TF] were recruited to the [TG] gene promoter (-468 to -459 bp) 48 hours after iNOS gene transfer.	p65	HO-1	0	UNDEFINED	False
10235	10399	19754268:12:STAT3:NOS3	This results in activation of PKCdelta, which phosphorylates [TF], increasing its binding to the [TG] promoter.	STAT3	eNOS	0	UNDEFINED	False
10236	10400	19754268:9:STAT3:NOS3	The increase in [TF] activity and decrease in [TG] promoter activity were inhibited by the overexpression of dominant negative mutants of PKCdelta or STAT3.	STAT3	eNOS	2	REPRESSION	True
10237	10402	19762916:4:AP1:XYLT1	Members of the activator protein 1 ([TF]) and specificity protein 1 (Sp1) family of transcription factors are necessary for the transcriptional regulation of the [TG] gene, which was proven by curcumin, tanshinone IIA, mithramycin A, and short interference RNA treatment.	AP-1	XYLT1	0	UNDEFINED	True
10238	10403	19762916:4:SP1:XYLT1	Members of the activator protein 1 (AP-1) and specificity protein 1 ([TF]) family of transcription factors are necessary for the transcriptional regulation of the [TG] gene, which was proven by curcumin, tanshinone IIA, mithramycin A, and short interference RNA treatment.	Sp1	XYLT1	0	UNDEFINED	False
10240	10405	19766716:8:ONECUT1:CTGF	[TF](Delta panc) pancreata displayed increased ductal cell proliferation and metaplasia, as well as characteristics of pancreatitis, including up-regulation of [TG], MMP7, and p8/Nupr1.	HNF6	CTGF	2	REPRESSION	False
10241	10406	19766716:8:ONECUT1:MMP7	[TF](Delta panc) pancreata displayed increased ductal cell proliferation and metaplasia, as well as characteristics of pancreatitis, including up-regulation of CTGF, [TG], and p8/Nupr1.	HNF6	MMP7	2	REPRESSION	False
10242	10407	19766716:8:ONECUT1:NUPR1	[TF](Delta panc) pancreata displayed increased ductal cell proliferation and metaplasia, as well as characteristics of pancreatitis, including up-regulation of CTGF, MMP7, and p8/[TG].	HNF6	Nupr1	2	REPRESSION	False
10243	10408	19783986:5:E2F1:ID4	The protein complex mutant p53-[TF] assembles on specific regions of the [TG] promoter and positively controls ID4 expression.	E2F1	ID4	0	UNDEFINED	True
10244	10409	19798679:0:EGR1:GCLC	Quercetin-induced upregulation of human [TG] gene is mediated by cis-regulatory element for [TF] (EGR1) in INS-1 beta-cells.	early growth response protein-1	GCLC	1	ACTIVATION	False
10245	10410	19798679:10:EGR1:GCLC	Therefore, we concluded that [TF] was bound to GC-rich region of the [TG] gene promoter, which was prerequisite for the transactivation of the GCLC gene by quercetin.	EGR1	GCLC	1	ACTIVATION	False
10246	10411	19798679:8:EGR1:GCLC	Additionally, the transient overexpression of [TF] significantly increased basal activity of the [TG] promoter.	EGR1	GCLC	1	ACTIVATION	False
10248	10413	19799869:4:LEF1:NPPA	[TF] binds directly to the [TG] promoter via this sequence, which shows functional significance, and PE stimulation enhances recruitment of beta-catenin onto the Anf promoter.	LEF1	Anf	0	UNDEFINED	False
10249	10414	19800042:6:NFKB:CCND1	P53 can inhibit [TG] promoter activity via an [TF] site-dependent manner and its binding activity increased after heat shock.	NF-kappaB	cyclin D1	2	REPRESSION	True
10250	10415	19800042:7:RELA:CCND1	Importantly, p53 overexpression can prevent [TG] promoter activation by [TF].	p65	cyclin D1	1	ACTIVATION	False
10251	10416	19801665:6:STAT1:BAX	In addition, SPE B and G308S increased binding of serine-phosphorylated [TF] to the [TG] promoter and Bax expression, which was decreased by SB203580.	STAT1	Bax	0	UNDEFINED	True
10252	10417	19804198:4:CEBPB:LDLR	This transcriptional activation is achieved through interactions of the sterol-independent regulatory element of [TG] promoter and transcription factors Egr1 and [TF], and is dependent upon the activation of the extracellular signal-regulated kinase signaling cascade by OM.	c/EBPbeta	LDL-receptor	1	ACTIVATION	False
10253	10418	19805133:3:CREB1:CEBPB	We report that deletion of two [TF]-binding sites from the [TG] promoter abrogates Cebpb induction upon macrophage activation.	CREB	Cebpb	1	ACTIVATION	False
10254	10419	19808645:10:PPARG:TXNIP	Hence, [TG] expression and promoter activity are mediated via divergent effects of KLF6 and [TF] transcriptional regulation.	PPAR-gamma	Txnip	0	UNDEFINED	False
10255	10420	19808645:5:PPARG:TXNIP	KLF6 overexpression increased [TG] expression and promoter activity, which was inhibited by concurrent exposure to [TF] agonists.	PPAR-gamma	Txnip	2	REPRESSION	False
10256	10421	19808898:7:POU1F1:CCND1	We also found that [TF] raises [TG] expression before increasing PRL levels, suggesting a PRL-independent effect of Pit-1 on cell proliferation.	Pit-1	cyclin D1	1	ACTIVATION	False
10257	10422	19809364:7:SRY:AGT	The largest effect was seen with [TF]3, which increased activity of [TG] promoter by 1.7-fold, renin promoter by 1.3-fold, ACE promoter by 2.6-fold and decreased activity of ACE2 promoter by 0.5-fold.	Sry	angiotensinogen	1	ACTIVATION	False
10258	10423	19819950:0:HIF1A:VEGFA	Inhibition of oxygen-induced [TF] degradation unmasks estradiol induction of [TG] expression in ECC-1 cancer cells in vitro.	hypoxia-inducible factor-1alpha	vascular endothelial growth factor	0	UNDEFINED	True
10259	10424	19828131:0:ARNT:ABCA1	[TF] determines [TG] expression under hypoxia in human macrophages.	HIF-1beta	ABCA1	1	ACTIVATION	False
10260	10425	19828131:4:HIF1A:ABCA1	We found that the hypoxia-inducible factor 1 ([TF]) specifically binds to the HIF-1 response element of the [TG] promoter and the HIF-1 complex increases ABCA1 promoter activity along with ABCA1 expression.	HIF-1	ABCA1	1	ACTIVATION	False
10261	10426	19829305:4:ETS1:FLI1	We show that the [TG] promoter is upregulated by Ets factors [TF], Ets2, Fli1 and Elf1 either alone or in combination with GATA factors, but is inhibited by Tel.	Ets1	Fli1	1	ACTIVATION	False
10262	10427	19829305:4:ETS2:FLI1	We show that the [TG] promoter is upregulated by Ets factors Ets1, [TF], Fli1 and Elf1 either alone or in combination with GATA factors, but is inhibited by Tel.	Ets2	Fli1	1	ACTIVATION	False
10263	10428	19829305:7:ETS1:FLI1	Furthermore, we show similar binding of Ets factors to the endogenous mouse and human [TG] promoters in T cells and knocking down [TF] results in an upregulation of Fli1 expression.	Ets1	Fli1	2	REPRESSION	False
10264	10429	19830706:9:SPDEF:PLAU	Furthermore, chromatin immunoprecipitation studies show that p21 and [TG] (uPA) are direct [TF] transcriptional targets.	PDEF	urokinase plasminogen activator	0	UNDEFINED	False
10265	10430	19837943:5:TFDP1:PTTG1	Transfection of E2F1 and its partner [TF] dose-dependently activated h[TG] transcription up to 3-fold in p53-devoid H1299 cells but not in p53-replete HCT116 cells.	DP1	PTTG1	1	ACTIVATION	False
10266	10431	19841186:5:NFKB:MUC5AC	These effects were attenuated by the small molecule inhibitor [TF] inhibitor III, as well as p65 small-interfering RNA, suggesting that the regulation of [TG] expression by these cytokines is via an NF-kappaB-based transcriptional mechanism.	NF-kappaB	MUC5AC	0	UNDEFINED	False
10267	10432	19841186:5:RELA:MUC5AC	These effects were attenuated by the small molecule inhibitor NF-kappaB inhibitor III, as well as [TF] small-interfering RNA, suggesting that the regulation of [TG] expression by these cytokines is via an NF-kappaB-based transcriptional mechanism.	p65	MUC5AC	0	UNDEFINED	False
10268	10433	19841186:6:NFKB:MUC5AC	Further investigation of the promoter region identified a putative [TF] binding site at position-3594/-3582 in the promoter of [TG] as critical for the regulation of MUC5AC expression by both IL-1beta and IL-17A.	NF-kappaB	MUC5AC	0	UNDEFINED	False
10270	10435	19843519:3:NFKB:PDGFD	[TF] p65, induced by IL-1beta, interacts with a novel element in the [TG] promoter and inhibits PDGF-D transcription.	NF-kappaB	PDGF-D	2	REPRESSION	False
10271	10436	19843539:5:SP3:NXNL1	By transfection of selected candidate transcription factors, chosen based upon their expression pattern, we identified the homeodomain proteins CHX10/VSX2, VSX1 and PAX4, as well as the zinc finger protein [TF], as factors that can stimulate both the mouse and human [TG] promoter.	SP3	Nxnl1	1	ACTIVATION	False
10272	10437	19847806:5:NR1I2:CCND1	We demonstrated that thrombin activation of [TF] promotes [TG] expression at the transcriptional level by stimulating c-Fos expression, mediated by PI3K, MAPK ERK1/2, and conventional PKC activity.	PAR-1	cyclin D1	1	ACTIVATION	False
10273	10438	19850938:9:NFKB:PLA2G2A	Previous reports showed that interleukin (IL)-1beta up-regulates [TG] gene transcription via C/EBPbeta and [TF].	NFkappaB	Pla2g2a	1	ACTIVATION	False
10274	10439	19851330:0:IRF1:BBC3	[TF] transcriptionally upregulates [TG], which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells.	IRF-1	PUMA	1	ACTIVATION	False
10275	10440	19851330:8:IRF1:BBC3	[TF] binds to distinct sites in the promoter of [TG] and activates PUMA transcription.	IRF-1	PUMA	1	ACTIVATION	False
10276	10441	19855079:4:RARA:MYC	PLZF-[TF] binds to a region of the [TG] promoter overlapping a functional PLZF site and antagonizes PLZF-mediated repression, suggesting that PLZF-RARalpha may act as a dominant-negative version of PLZF by affecting the regulation of shared targets.	RARalpha	c-MYC	1	ACTIVATION	True
10277	10442	19855079:4:ZBTB16:MYC	[TF]-RARalpha binds to a region of the [TG] promoter overlapping a functional PLZF site and antagonizes PLZF-mediated repression, suggesting that PLZF-RARalpha may act as a dominant-negative version of PLZF by affecting the regulation of shared targets.	PLZF	c-MYC	2	REPRESSION	False
10278	10443	19859911:8:NR2C2:CDKN1A	The interaction between [TF] and TR may enhance regulation of genes targeted by TR, such as furin, fibrinogen, cdk2 and [TG] expression.	TR4	p21	0	UNDEFINED	True
10279	10444	19861119:5:NR4A2:FABP5	[TG] expression was up-regulated by Nurr1 and other [TF] NRs in HEK293 cells, and Nurr1 was shown to activate and bind to the FABP5 promoter, supporting that FABP5 is a direct downstream target of NR4A NRs.	NR4A	FABP5	1	ACTIVATION	False
10280	10445	19864258:0:NFE2L2:ATF3	Expression of stress-response [TG] is mediated by [TF] in astrocytes.	Nrf2	ATF3	1	ACTIVATION	False
10281	10446	19864258:5:NFE2L2:ATF3	We further demonstrated that the consensus ARE in the [TG] promoter is critical for [TF]-mediation by promoter analyses using an ATF3 promoter-driven luciferase construct and a chromatin immunoprecipitation assay.	Nrf2	ATF3	0	UNDEFINED	False
10282	10447	19882681:5:CREB1:BRCA1	In sham-exposed cells, binding of [TF] to the promoter of [TG] was increased by estradiol and subsequently diminished by treatment with melatonin.	CREB	BRCA-1	0	UNDEFINED	False
10283	10448	19887561:11:FOXO1:EDN1	We conclude that EGCG decreases [TG] expression and secretion from endothelial cells, in part, via Akt- and AMPK-stimulated [TF] regulation of the ET-1 promoter.	FOXO1	ET-1	2	REPRESSION	True
10284	10449	19887561:3:FOXO1:EDN1	We hypothesized that the phosphatidylinositol 3-kinase-dependent transcription factor [TF] may mediate effects of EGCG to regulate expression of [TG] in endothelial cells.	FOXO1	ET-1	0	UNDEFINED	True
10286	10451	19887897:9:AP1:SERPINE1	These results suggest that SHP inhibits [TG] expression in VSMCs through the suppression of TGF-beta/Smad3 and [TF] activity.	AP-1	PAI-1	1	ACTIVATION	False
10287	10452	19896523:5:RUNX2:MGP	In A6 cells, [TF] was found to modulate [TG] transcription and deletion analysis of MGP distal and proximal promoter-luciferase constructs identified cis-regulatory regions.	Runx2	MGP	0	UNDEFINED	False
10288	10453	19896523:9:RUNX2:MGP	Although only type I and type II could transactivate Xl[TG], the truncated isoforms identified in this study, which result from alternative splicing, could be involved in negative regulation of MGP expression, as described for other [TF] truncated isoforms acting in other target genes.	RUNX2	MGP	2	REPRESSION	False
10289	10454	1990263:7:NFKB:PENK	Thus, it appears that the T-cell-specific activation of the [TG] promoter is mediated by [TF].	NF-kappa B	proenkephalin	1	ACTIVATION	False
10290	10455	19906305:10:TFAP2C:ERBB2	Ku siRNAs also inhibited the activity of this reporter vector in BT-474 and SKBR3 cell lines and the activity of the [TG] promoter was further reduced by combining Ku siRNAs with AP-2alpha and [TF] siRNAs.	AP-2gamma	ERBB2	1	ACTIVATION	False
10291	10456	19906842:0:ATF4:IHH	[TF] regulates chondrocyte proliferation and differentiation during endochondral ossification by activating [TG] transcription.	Atf4	Ihh	1	ACTIVATION	False
10292	10457	19906842:7:ATF4:IHH	Furthermore, forced expression of [TF] in chondrocytes induces endogenous [TG] mRNA, and Atf4 directly binds to the Ihh promoter and activates its transcription.	Atf4	Ihh	1	ACTIVATION	False
10293	10458	19906842:9:ATF4:IHH	This study thus identifies [TF] as a novel transcriptional activator of [TG] in chondrocytes that paces longitudinal bone growth by controlling growth plate chondrocyte proliferation and differentiation.	Atf4	Ihh	1	ACTIVATION	False
10294	10459	19907922:0:TP53:LIF	[TF] Regulates [TG] expression in human medulloblastoma cells.	p53	LIF	0	UNDEFINED	False
10295	10460	19907922:3:TP53:LIF	Recent work has shown that the basal level of [TF] plays an important role in maternal reproduction by maintaining the expression of [TG] in the uterus.	p53	LIF	1	ACTIVATION	False
10296	10461	19907922:7:TP53:LIF	In the [TF] wild-type medulloblastoma cell line D283MED chromatin immunoprecipitation experiments showed p53 binding to the [TG] gene.	p53	LIF	0	UNDEFINED	False
10297	10462	19908244:3:NFKB:OLFM4	Transient transfection studies with serial deletion constructs and close examination of the sequences identified a putative [TF] binding sequence between -442 and -430, which could be responsible for efficient expression of the [TG] gene.	NF kappaB	GW112	1	ACTIVATION	False
10298	10463	19908244:4:RELA:OLFM4	Indeed, [TG] gene was found to be regulated by NF kappaB signals including overexpressed [TF] and I kappaB alpha, IKK inhibitor, and proteasome inhibitor.	p65	GW112	0	UNDEFINED	False
10299	10464	19908244:6:NFKB:OLFM4	These results suggest that [TF] is an essential regulatory factor for [TG] transcription.	NF kappaB	GW112	0	UNDEFINED	False
10300	10465	19910471:7:JUN:PDK1	The identification of [TF] as a transcriptional regulator of [TG] expression highlights key mechanisms underlying c-Jun oncogenic activity, and provides new insight into the nature of up-regulated Akt and PKC in melanoma.	c-Jun	PDK1	0	UNDEFINED	False
10301	10466	19913854:8:STAT3:SREBF1	Consistent with these findings, we found that the human [TG] promoter was positively regulated by insulin and negatively regulated by [TF].	STAT3	SREBP-1c	2	REPRESSION	False
10302	10467	19914232:10:FOXJ3:MEF2C	Together, these studies support the hypothesis that [TF] is an important regulator of myofiber identity and muscle regeneration through the transcriptional activation of the [TG] gene.	Foxj3	Mef2c	1	ACTIVATION	False
10304	10469	19915177:8:SREBF2:DDAH1	The role of [TF] in the activation of the [TG] was supported by chromatin immunoprecipitation studies demonstrating increased binding of SREBP2 to the DDAH1 promoter upon simvastatin stimulation.	SREBP2	DDAH1	1	ACTIVATION	False
10305	10470	19920132:9:AP1:IGF1	Together, these observations suggest in contrast to previous in vitro studies of [TG] regulation involving [TF] motifs that direct ER alpha-DNA interaction is required to increase Igf1 transcription.	AP1	IGF-1	0	UNDEFINED	True
10306	10471	19931411:4:NFE2L2:HMOX1	The transcription factor NF-E2-related factor 2 ([TF]) is a critical regulator of [TG], achieved by binding to the antioxidant response element (ARE).	Nrf2	HO-1	0	UNDEFINED	False
10307	10472	19931411:7:NFE2L2:HMOX1	Eckol activated both Erk and Akt, and treatments with U0126 (an Erk kinase inhibitor), LY294002 (a PI3K inhibitor), specific Erk1 siRNA, and Akt siRNA suppressed the eckol-induced activation of [TF], resulting in a decrease in [TG] expression.	Nrf2	HO-1	1	ACTIVATION	False
10308	10473	19939245:8:ETS2:MMP2	Inhibition of [TF] and p53 reduced [TG] expression, secretion and invasiveness of Forskolin treated cells.	Ets-2	MMP-2	1	ACTIVATION	False
10309	10474	19945464:5:AP1:SLC8A1	beta-AR-stimulated [TG] expression is mediated by activator protein 1 ([TF]) factors and is independent of cAMP-response element-binding protein (CREB) activation.	AP-1	Ncx1	1	ACTIVATION	False
10310	10475	19945464:7:AP1:SLC8A1	Chromatin immunoprecipitation demonstrates that beta-AR stimulation activates the ordered recruitment of JunB homodimers, which then are replaced by c-Jun homodimers binding to the proximal [TF] elements of the endogenous [TG] promoter.	AP-1	Ncx1	0	UNDEFINED	False
10311	10478	19945465:12:RELA:HSPD1	TNFalpha increased [TG] expression, and this could be prevented by pretreatment with siRNA inhibiting [TF] expression.	p65	HSP60	1	ACTIVATION	False
10312	10479	19945465:4:NFKB:HSPD1	We hypothesized that HSF-1 is not activated in heart failure and that the increased expression of [TG] was driven by [TF] activation.	NFkappaB	HSP60	1	ACTIVATION	False
10313	10480	19955655:4:SMAD3:MDM2	In this study, we report that TGF-beta1-activated SMA- and MAD3 ([TF]/4) transcription factors specifically bound to the second promoter region of [TG], leading to increased HDM2 protein expression and destabilization of p53 in human cancer cell lines.	Smad3	HDM2	1	ACTIVATION	False
10314	10481	19956440:8:AP1:MUC5AC	Moreover, transcriptional factor [TF] acts as a key regulator for both of the positive and negative regulation of [TG] mucin expression as evidenced by mutagenesis analysis of two AP-1 sites in the promoter region of human MUC5AC mucin gene.	AP-1	MUC5AC	0	UNDEFINED	False
10315	10482	19956687:7:ID1:CTSK	Additionally, we found increased expression of osteoclast genes, TRAP, Oscar, and [TG] in the [TF](-/-) bone marrow microenvironment.	Id1	CTSK	2	REPRESSION	False
10316	10483	19959471:0:AP1:CDKN1B	Mitogenic regulation of [TG] gene is mediated by [TF] transcription factors.	AP-1	p27(Kip1)	0	UNDEFINED	False
10317	10484	19959471:10:AP1:CDKN1B	Collectively, our studies present the first evidence demonstrating the role of the [TF] complex in transcriptional down-regulation of the [TG] gene following mitogenic stimulation.	AP-1	p27(Kip1)	2	REPRESSION	False
10319	10486	19965638:4:POU2F1:GFI1B	HMGB2 binds to the [TG] promoter in vivo and up-regulates its trans-activation most likely by enhancing the binding of [TF] and, to a lesser extent, of GATA-1 and NF-Y to the GFI1B promoter.	Oct-1	GFI1B	1	ACTIVATION	False
10320	10487	19965784:0:EGR1:IGF1R	Mechano-sensitive transcriptional factor [TF] regulates [TG] expression and contributes to neointima formation in vein grafts.	Egr-1	insulin-like growth factor-1 receptor	0	UNDEFINED	False
10321	10488	19965784:9:EGR1:IGF1R	[TF] is a mechano-sensitive transcriptional factor that stimulates [TG] transcription, resulting in vascular remodeling of vein grafts.	Egr-1	IGF-1R	1	ACTIVATION	False
10322	10489	19965921:6:OTX2:GNRH1	The wild-type [TF] (OTX2) protein transactivated the [TG] promoter as well as the HESX1, POU1F1, and IRBP (interstitial retinoid-binding protein) promoters, whereas the p.K74fsX103-OTX2 and p.A72fsX86-OTX2 proteins had no transactivation functions and the p.G188X-OTX2 protein had reduced ( approximately 50%) transactivation functions for the four promoters, with no dominant-negative effect.	Orthodenticle homeobox 2	GNRH1	1	ACTIVATION	False
10323	10490	19994725:0:SP1:PLD1	Mutated ras induced [TG] gene expression through increased [TF] transcription factor.	Sp1	PLD1	1	ACTIVATION	False
10324	10491	19994725:7:SP1:PLD1	Furthermore, overexpression of [TF] in drosophila SL2 cells lacking Sp family proteins increased [TG] promoter activity.	Sp1	PLD1	1	ACTIVATION	False
10325	10492	20001745:6:NFKB:HIF1A	Activation of PAK-1 stimulated HIF activity and [TG] expression involving ROS and [TF], enhanced the expression of the HIF-1 target gene plasminogen activator inhibitor-1, and stimulated PASMC proliferation.	NF-kappaB	HIF-1alpha	1	ACTIVATION	False
10326	10493	20002786:6:HIF1A:TLR4	To determine the underlying mechanism, we investigated the role of hypoxia-inducible factor 1 ([TF]) in the regulation of [TG] expression.	HIF-1	TLR4	0	UNDEFINED	False
10327	10494	20006311:11:ATF2:IFNG	ESAT-6 reduced [TG] mRNA levels by inhibiting the expression of the transcription factors, [TF], c-Jun and CREB, which upregulate IFN-gamma gene expression in T cells through binding to the IFN-gamma proximal promoter.	ATF-2	IFN-gamma	1	ACTIVATION	False
10328	10495	20006311:11:JUN:IFNG	ESAT-6 reduced [TG] mRNA levels by inhibiting the expression of the transcription factors, ATF-2, [TF] and CREB, which upregulate IFN-gamma gene expression in T cells through binding to the IFN-gamma proximal promoter.	c-Jun	IFN-gamma	1	ACTIVATION	False
10330	10498	20006635:7:AP1:IVL	Alteration of [TF] transcription factors was also examined in response to treatment with four metal containing compounds (chromate, vanadate, hemin, divalent cadmium) that also suppress [TG] transcription.	AP1	involucrin	0	UNDEFINED	True
10331	10499	20007689:6:HIF1A:CXCR4	Moreover, chromatin immunoprecipitation (ChIP) analysis showed endogenous [TF] binding to the [TG] promoter that was enhanced by acidification.	HIF-1alpha	CXCR4	0	UNDEFINED	False
10332	10500	20007970:3:NFKB:PPM1D	In this study, we identify an additional oncogene, [TG], which encodes for Wip1, as a transcriptional target of [TF] in breast cancer cells.	NF-kappaB	PPM1D	0	UNDEFINED	False
10333	10501	20015448:4:AP1:VEGFA	We also demonstrated that R+VE significantly decreased the binding capacity of nuclear factor-activator protein-1 ([TF]) to the [TG] gene promoter and decreased the expression of c-Jun protein.	AP-1	VEGF	0	UNDEFINED	True
10334	10502	20015448:7:AP1:VEGFA	Thus, the present results indicate that R in combination with VE attenuates [TG] expression in HL-60 cells and that this effect is mediated by a decreased binding activity of [TF] through down-regulation of protein expression of insulin-like growth factor 1 receptor (IGF1-R)/IRS-1, while the antioxidant activity of R+VE appears to play a minor role.	AP-1	VEGF	1	ACTIVATION	True
10335	10503	20037604:4:JUN:CCND1	The luciferase assay and chromatin immunoprecipitation were used to detect the relationship between KLF5 and [TF] in transactivation of [TG] gene expression.	c-Jun	cyclin D1	1	ACTIVATION	False
10336	10504	20037604:8:JUN:CCND1	Cotransfection of KLF5 and [TF] expression vectors significantly increased [TG] promoter activity.	c-Jun	cyclin D1	1	ACTIVATION	False
10338	10506	20043076:0:POU5F1:CXCR4	Integrative genomic analyses of [TG]: transcriptional regulation of CXCR4 based on TGFbeta, Nodal, Activin signaling and [TF], FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors.	POU5F1	CXCR4	0	UNDEFINED	False
10339	10507	20043076:0:SOX17:CXCR4	Integrative genomic analyses of [TG]: transcriptional regulation of CXCR4 based on TGFbeta, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, [TF], and GFI1 transcription factors.	SOX17	CXCR4	0	UNDEFINED	False
10340	10508	20043814:3:HIF1A:CDKN1A	Here, we show that M30 activates the hypoxia-inducible factor (HIF)-1alpha signaling pathway, thus promoting [TF] mRNA and protein expression levels, as well as increasing transcription of HIF-1alpha-dependent genes, including vascular endothelial growth factor, erythropoietin, enolase-1, [TG] and tyrosine hydroxylase in rat primary cortical cells.	HIF-1alpha	p21	1	ACTIVATION	False
10342	10510	20053736:10:ATF1:PDLIM7	Chromatin immunoprecipitation indicated decreased binding of CREB-[TF] to the CRE site in the [TG] promoter after inhibition of the p38 pathway in EREB2.5 cells.	ATF1	LMP1	0	UNDEFINED	False
10343	10511	20054233:0:EGR1:SOX18	[TF] acts as an activator of [TG] promoter.	Early growth response protein 1	SOX18	1	ACTIVATION	False
10344	10512	20060848:0:SP1:SLC5A1	Cadmium down-regulation of kidney [TF] binding to mouse [TG] and SGLT2 gene promoters: possible reaction of cadmium with the zinc finger domain of Sp1.	Sp1	SGLT1	0	UNDEFINED	False
10345	10513	20060848:12:SP1:SLC5A1	We conclude that Cd can replace Zn in [TF] DNA binding domain to reduce its binding to GC sites in mouse [TG] and SGLT2 promoters.	Sp1	SGLT1	0	UNDEFINED	False
10347	10515	20067556:8:MITF:CDKN1A	As the [TG] gene is a known transcriptional target of [TF], the reciprocal stimulation of transcription may constitute a positive-feedback loop reinforcing MITF expression in melanoma cells.	MITF	p21	1	ACTIVATION	False
10348	10516	20068070:3:FOXM1:BRCA2	A close correlation was observed between [TF] and the expression of its proposed downstream targets that are involved in DNA repair; breast cancer-associated gene 2 ([TG]) and X-ray cross-complementing group 1 (XRCC1) were expressed at higher levels in the resistant cell lines compared with the sensitive MCF-7 cells.	FOXM1	BRCA2	0	UNDEFINED	False
10349	10517	20068070:3:FOXM1:XRCC1	A close correlation was observed between [TF] and the expression of its proposed downstream targets that are involved in DNA repair; breast cancer-associated gene 2 (BRCA2) and X-ray cross-complementing group 1 ([TG]) were expressed at higher levels in the resistant cell lines compared with the sensitive MCF-7 cells.	FOXM1	XRCC1	0	UNDEFINED	False
10350	10518	20068145:8:E2F1:BRCA1	Tandem chromatin immmunoprecipitation studies show that [TG] is regulated by a dynamic coregulatory complex containing BRCA1, [TF], and Rb at the BRCA1 promoter that is disrupted by DNA-damaging agents to increase its transcription.	E2F1	BRCA1	2	REPRESSION	True
10351	10519	20068148:7:SRF:CDKN1A	Chromatin immunoprecipitation and DNA-protein binding assays showed that myocardin indirectly bound to the CArG box in the [TG] promoter through the interaction with [TF].	SRF	p21	0	UNDEFINED	False
10353	10521	20079629:3:YBX1:CDC6	Treatment with [TF] siRNA caused a marked suppression of cell proliferation and expression of a cell cycle related gene, [TG] by cancer cells.	YB-1	CDC6	1	ACTIVATION	False
10354	10522	20079629:6:YBX1:CDC6	ChIP assay demonstrated that [TF] binds to a Y-box located in the promoter region of the [TG] gene.	YB-1	CDC6	0	UNDEFINED	False
10355	10523	20080630:4:TP53:FLT1	To address the generality of concerted transactivation by [TF] and ER, the 1/2 site in the [TG] promoter was replaced with a variety of 1/2 sites, as well as canonical weak and strong p53 REs of human target genes.	p53	FLT1	1	ACTIVATION	False
10356	10524	20082134:11:FOXO1:CAV1	Our results indicate that carrier protein CRM197-mediated delivery across the BBB is involved in the induction of [TF] transcriptional activity and upregulation of [TG] expression.	FOXO1A	caveolin-1	1	ACTIVATION	False
10357	10525	20083128:10:BACH1:HMOX1	We showed that arsenite promoted dissociation of [TF] (a transcriptional repressor) from the [TG] enhancers and increased Nrf2 binding to these elements.	Bach1	HO-1	2	REPRESSION	False
10358	10526	20083128:10:NFE2L2:HMOX1	We showed that arsenite promoted dissociation of Bach1 (a transcriptional repressor) from the [TG] enhancers and increased [TF] binding to these elements.	Nrf2	HO-1	0	UNDEFINED	False
10359	10527	20088826:7:FOXO1:CTSL	Moreover, we found [TF]-binding sites in both the mouse Ctsl and human [TG] promoters.	FOXO1	CTSL1	0	UNDEFINED	False
10360	10528	20093361:3:JUN:PPM1D	Here, we show that [TF] directly binds to and activates the [TG] promoter in response to UV irradiation.	c-Jun	Wip1	1	ACTIVATION	False
10362	10530	20118482:3:NR1H3:REN	Previously, we have shown that the nuclear hormone receptor liver X receptor-alpha ([TF]) is a major transcriptional regulator of the expression of [TG], c-myc, and other genes involved with growth/differentiation.	LXRalpha	renin	0	UNDEFINED	False
10363	10531	20118482:8:NR1H3:REN	In conclusion, the activation of [TF] stimulates [TG] expression and induces MSCs differentiation into renin-secreting, JG-like cells.	LXRalpha	renin	1	ACTIVATION	False
10364	10532	20121949:0:EGR1:CDKN2B	Snail associates with [TF] and SP-1 to upregulate transcriptional activation of [TG].	EGR-1	p15INK4b	1	ACTIVATION	False
10365	10533	20121949:13:EGR1:CDKN2B	In conclusion, Snail associates with [TF] and SP-1 to mediate TPA-induced transcriptional upregulation of [TG] in HepG2.	EGR-1	p15(INK4b)	1	ACTIVATION	False
10366	10534	20121949:4:EGR1:CDKN2B	Using deletion mapping, the TPA-responsive element on the [TG] promoter was located between 77 and 228 bp upstream of the transcriptional initiation site, within which the putative binding regions of [TF] (EGR-1) and stimulatory protein 1 (SP-1) were found.	early growth response gene 1	p15(INK4b)	0	UNDEFINED	False
10367	10535	20123992:6:SMAD3:SMN1	Surprisingly, [TF] inhibits MRTF-driven activation of the [TG] promoter, and Smad3 silencing renders injury sufficient to induce SMA expression.	Smad3	SMA	2	REPRESSION	False
10369	10537	20124477:0:STAT5A:BCL6	Prolactin inhibits [TG] expression in breast cancer through a [TF]-dependent mechanism.	Stat5a	BCL6	2	REPRESSION	False
10370	10538	20124515:4:GFI1B:TGFBR3	We further identify in this cell population the type III transforming growth factor-beta receptor gene, [TG], as a direct target of [TF].	Gfi-1B	TGFBR3	0	UNDEFINED	False
10371	10539	20133805:7:YBX3:CCND1	Virus-mediated restoration of claudin-2 expression was found to restore nuclear expression of [TF] in HT29DeltaSym cells and to rescue the phenotypic alterations induced by symplekin down-regulation of cell polarity, paracellular transport, ZONAB localization, [TG] expression, proliferation, and anchorage-independent growth.	ZONAB	cyclin D1	1	ACTIVATION	True
10372	10540	20136501:5:CREB1:SERPINE1	[TG] promoter reporter gene assays revealed that the peroxide and FOXO4-dependent induction was mediated through the HIF-1 and [TF]-binding HRE within the PAI-1 promoter.	CREB	PAI-1	1	ACTIVATION	False
10373	10541	20136501:7:CREB1:SERPINE1	Chromatin immunoprecipitations showed that FOXO4 did not bind the [TG] promoter, whereas [TF] binding was enhanced on FOXO4 overexpression.	CREB	PAI-1	0	UNDEFINED	False
10374	10542	20136501:9:CREB1:SERPINE1	Together, these findings provide the first evidence that oxidative stress and FOXO4 induce [TG] expression through an indirect mechanism involving modulation of HIF-1alpha and [TF] protein levels and that enhanced CREB binding to the PAI-1 promoter is critical for the PAI-1 induction under oxidative stress.	CREB	PAI-1	1	ACTIVATION	False
10375	10543	20137375:7:NFKB:CREB1	p65 cotransfection and RNAi-mediated gene knockdown were used to determine the corepressor involved in the inhibition of PEPCK by [TF] p65 and the transcriptional regulation of [TG] by NF-kappaB p65.	NF-kappaB	CREB	2	REPRESSION	True
10376	10544	20139077:0:SPDEF:CDKN1A	Transcriptional regulation of p21/[TG] cell cycle inhibitor by [TF] controls cell proliferation and mammary tumor progression.	PDEF	CIP1	0	UNDEFINED	False
10377	10545	20143420:8:JUN:PPARGC1A	In conclusion, these results suggest that down-expression of [TG] partially mediated by activation of JNK/[TF] may be through the binding of c-Jun to the CRE site in the PGC-1alpha promoter, and it might be involved in potassium deprivation-induced apoptosis in CGNs.	c-Jun	PGC-1alpha	2	REPRESSION	False
10378	10546	20145154:4:FOXQ1:CDKN1A	A microarray analysis revealed that the knockdown of [TF] using small interfering RNA resulted in a decrease in p21(CIP1/[TG]) expression, and a reporter assay and a chromatin immunoprecipitation assay showed that p21 was one of the target genes of FOXQ1.	FOXQ1	WAF1	1	ACTIVATION	False
10379	10547	20149866:13:SMAD3:LHB	Together, our results suggest a model in which activin A inhibits GNRH1-induction of human [TG] transcription via an interaction between [TF] and EGR1 that inhibits the latter's recruitment to the proximal promoter.	SMAD3	LHB	2	REPRESSION	False
10380	10548	20149866:14:SMAD3:LHB	In contrast, in mouse, the presence of SBEs in the promoter allows [TF] and EGR1 to function synergistically to regulate [TG] transcription.	SMAD3	Lhb	0	UNDEFINED	False
10381	10549	20150555:10:NFKB:TNFSF10	Furthermore, increased [TF] expression after injury transactivated the [TG] promoter.	NFkappaB	TRAIL	1	ACTIVATION	False
10382	10550	20150555:9:SP1:TNFSF10	Mutational studies confirmed a role for [TF] in injury- and FGF-2-inducible [TG] transcription.	Sp1	TRAIL	1	ACTIVATION	False
10383	10551	20153576:7:EWSR1:CDKN1A	Furthermore, using serial deletion constructs of the [TF] fusion protein, we determined that EWS-Fli1 binding to p53 as well as inhibition of [TG] and mdm2 promoter activities was mediated by its N-terminal domain (amino acid residues 65-109).	EWS-Fli1	p21	2	REPRESSION	False
10384	10552	20153576:7:FLI1:CDKN1A	Furthermore, using serial deletion constructs of the EWS-[TF] fusion protein, we determined that EWS-Fli1 binding to p53 as well as inhibition of [TG] and mdm2 promoter activities was mediated by its N-terminal domain (amino acid residues 65-109).	Fli1	p21	2	REPRESSION	False
10385	10553	20154722:13:GATA3:CCND1	Silencing of [TF] resulted in reduced [TG] promoter activity and reduced Cyclin D1 mRNA and protein levels.	GATA3	Cyclin D1	1	ACTIVATION	False
10386	10554	20155429:8:CREB1:S100P	Functional analysis of [TG] promoter identified SMAD, STAT/[TF] and SP/KLF binding sites as key regulatory elements participating in transcriptional activation of S100P gene in cancer cells.	CREB	S100P	1	ACTIVATION	False
10387	10555	20160059:10:STAT3:CCND1	Our study suggest that ZIP4 overexpression causes increased IL-6 transcription through CREB, which in turn activates [TF] and leads to increased [TG] expression, resulting in increased cell proliferation and tumor progression in pancreatic cancer.	STAT3	cyclin D1	1	ACTIVATION	False
10388	10556	20171739:5:PARP1:CXCL10	Here we demonstrate that [TF] deficiency in embryonic fibroblasts results in diminished IFN-gamma-induced [TG] expression despite normal STAT1 activation and IP-10 promoter activity.	Parp-1	IP-10	1	ACTIVATION	False
10389	10557	20176957:8:IRF5:PRDM1	[TF] stimulates transcription of the [TG] gene encoding Blimp-1 and binds to the IRF site in the Prdm1 promoter.	IRF-5	Prdm1	1	ACTIVATION	False
10390	10558	20179096:6:SOX9:VEGFA	Searching for the molecular mechanism of [TF]-induced inhibition of cartilage vascularization, we discovered that SOX9 is able to directly suppress [TG] expression by binding to SRY sites in the Vegfa gene.	SOX9	Vegfa	2	REPRESSION	False
10391	10559	20179204:4:HIF1A:CCND1	Overexpression of the dominant negative mutant of [TF] (DN-HIF) significantly enhanced [TG] expression upon hypoxia or arsenite exposure, suggesting the negative regulation of cyclin D1 by HIF-1.	HIF-1alpha	cyclin D1	2	REPRESSION	False
10392	10560	20179204:5:HIF1A:CCND1	Furthermore, we found that the impairment of [TF] increased [TG] expression in A549 pulmonary cancer cells, which in turn promoted G1-S cell cycle transition and cell proliferation.	HIF-1	cyclin D1	2	REPRESSION	False
10393	10561	20179204:7:HIF1A:CCND1	Chromatin immunoprecipitation assay revealed that [TF] was able to directly bind to the promoter region of [TG], which indicates that the negative regulation of cyclin D1 by HIF-1 is through a direct mechanism.	HIF-1	cyclin D1	2	REPRESSION	False
10394	10562	20179204:8:HIF1A:CCND1	Inhibition of histone deacetylase (HDAC) by pretreatment of cells with trichostatin A or specific knockdown of HDAC7 by its shRNA antagonized the suppression of [TG] by [TF], suggesting that HDAC7 is required for HIF-1-mediated cyclin D1 downregulation.	HIF-1	cyclin D1	2	REPRESSION	False
10395	10563	20179320:7:SP3:SREBF1	Promoter analysis indicated that PKCbeta activates [TG] promoter through replacement of [TF] by Sp1 for binding to the GC box in the sterol regulatory element (SRE) complex, a key cis-element of SREBP-1c promoter.	Sp3	SREBP-1c	2	REPRESSION	True
10396	10564	20180024:2:SP1:CENPW	To understand the transcriptional regulation of [TG], we analyzed its TATA-less promoter and identified a GC-rich putative [TF] binding site located at -46 to -36 that was critical in CENP-W expression.	Sp1	CENP-W	1	ACTIVATION	False
10397	10565	20180024:4:SP3:CENPW	Moreover, we found that [TG] was highly induced by serum stimulation followed by serum deprivation, with Sp1 and [TF] transcription factors involved in this transactivation.	Sp3	CENP-W	1	ACTIVATION	False
10399	10567	20181929:0:ATF2:CDK4	Induced [TF] represses [TG] transcription through dimerization with JunD inhibiting intestinal epithelial cell growth after polyamine depletion.	ATF-2	CDK4	2	REPRESSION	False
10400	10568	20181929:0:JUND:CDK4	Induced ATF-2 represses [TG] transcription through dimerization with [TF] inhibiting intestinal epithelial cell growth after polyamine depletion.	JunD	CDK4	2	REPRESSION	False
10401	10569	20181929:4:ATF2:CDK4	Here, we reported that induced [TF] following polyamine depletion repressed [TG] gene transcription in IECs by increasing formation of the ATF-2/JunD heterodimers.	ATF-2	CDK4	2	REPRESSION	False
10402	10570	20181929:4:JUND:CDK4	Here, we reported that induced ATF-2 following polyamine depletion repressed [TG] gene transcription in IECs by increasing formation of the ATF-2/[TF] heterodimers.	JunD	CDK4	2	REPRESSION	False
10403	10571	20181929:7:ATF2:CDK4	Polyamine depletion increased [TF]/JunD complex and inhibited [TG] transcription as indicated by a decrease in the levels of CDK4-promoter activity and its mRNA.	ATF-2	CDK4	2	REPRESSION	False
10404	10572	20181929:7:JUND:CDK4	Polyamine depletion increased ATF-2/[TF] complex and inhibited [TG] transcription as indicated by a decrease in the levels of CDK4-promoter activity and its mRNA.	JunD	CDK4	2	REPRESSION	False
10405	10573	20181929:8:ATF2:CDK4	[TF] silencing not only prevented inhibition of [TG] transcription in polyamine-deficient cells but also abolished repression of CDK4 expression induced by ectopic JunD overexpression.	ATF-2	CDK4	2	REPRESSION	False
10406	10574	20181929:8:JUND:CDK4	ATF-2 silencing not only prevented inhibition of [TG] transcription in polyamine-deficient cells but also abolished repression of CDK4 expression induced by ectopic [TF] overexpression.	JunD	CDK4	2	REPRESSION	False
10407	10575	20185790:7:NFE2L2:VEGFA	Knockdown of [TF] inhibited OxPL-induced elevation of [TG] mRNA and endothelial cell sprout formation.	NRF2	VEGF	1	ACTIVATION	False
10408	10576	20185821:5:NR1H4:NR0B2	[TF] induces expression of small heterodimer partner ([TG]), an orphan nuclear receptor and transcriptional corepressor, which in turn results in repression of p53, a key activator of the miR-34a gene, by inhibiting p53 occupancy at the promoter.	FXR	SHP	1	ACTIVATION	False
10409	10577	20185827:5:POU2F1:NTHL1	The ability of BRCA1 to stimulate the expression of the three BER enzymes and to enhance [TG] promoter activity was dependent upon the octamer-binding transcription factor [TF].	OCT1	NTH1	1	ACTIVATION	False
10410	10578	20187950:7:FOXM1:MAPK14	[TF] upregulation in primary human keratinocytes triggered pro-apoptotic/DNA-damage checkpoint response genes such as p21, [TG] MAPK, p53 and PARP, however, without causing significant cell cycle arrest or cell death.	FOXM1	p38	1	ACTIVATION	False
10411	10579	20190815:0:GFI1:CDKN1A	A role of Miz-1 in [TF]-mediated transcriptional repression of [TG].	Gfi-1	CDKN1A	2	REPRESSION	False
10412	10580	20190815:6:GFI1:CDKN1A	Interestingly, [TF] and c-Myc, through Miz-1, form a ternary complex on the [TG] promoter, and function in collaboration to repress CDKN1A.	Gfi-1	CDKN1A	2	REPRESSION	False
10413	10581	20190815:6:MYC:CDKN1A	Interestingly, Gfi-1 and [TF], through Miz-1, form a ternary complex on the [TG] promoter, and function in collaboration to repress CDKN1A.	c-Myc	CDKN1A	2	REPRESSION	False
10414	10582	20198339:0:CREB1:MUC2	Bile acid regulates [TG] transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/[TF], PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway.	CREB	MUC2	1	ACTIVATION	False
10415	10583	20198339:4:CREB1:MUC2	Chemical inhibitors, mutant reporter constructs and EMSA showed that DCA upregulates [TG] transcription via multiple pathways involving activation of EGFR/PKC/Ras/Raf-1/MEK1/ERK/[TF], PI3/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB while DCA induced MUC2 transcription is inhibited by JNK/c-Jun/AP-1 pathway.	CREB	MUC2	1	ACTIVATION	False
10416	10584	20198350:0:TP53:XAF1	Identification of a functional [TF] responsive element within the promoter of [TG] gene in gastrointestinal cancer cells.	p53	XAF1	0	UNDEFINED	False
10417	10585	20198350:12:TP53:XAF1	Suppression of [TF] not only decreased the binding capacity of p53 responsive halfsite but also increased [TG] transcription.	p53	XAF1	2	REPRESSION	False
10418	10586	20198350:2:TP53:XAF1	Our purpose was to clarify the regulatory mechanism of [TF] on [TG] expression.	p53	XAF1	0	UNDEFINED	False
10419	10587	20198350:3:TP53:XAF1	The effects of overexpressed wild-type and mutant [TF] on [TG] expression were evaluated.	p53	XAF1	0	UNDEFINED	False
10420	10588	20198350:6:TP53:XAF1	The protein expression and promoter activities of [TG] in cells with null [TF] were higher than that with wild-type and mutant p53.	p53	XAF1	2	REPRESSION	False
10421	10589	20198350:7:TP53:XAF1	Ectopic overexpression of wild-type [TF] suppressed [TG] expression.	p53	XAF1	2	REPRESSION	False
10422	10590	20200942:7:JUNB:CCND1	Indeed, Smurf1-deficient MSCs have higher proliferation rates, consistent with the facts that [TG] mRNA and protein both are increased in Smurf1(-/-) cells and [TF] can induce cyclinD1 promoter.	JunB	cyclin D1	1	ACTIVATION	False
10423	10591	20220142:6:AP1:CCND1	CAGE-induced expression of cyclins D1 and E was found to be mediated by [TF] and E2F-1 transcription factors, and among the AP-1 members, c-Jun and JunD appeared to participate in CAGE-mediated up-regulation of [TG].	AP-1	cyclin D1	1	ACTIVATION	False
10424	10593	20221394:10:XBP1:VEGFA	Our results reveal that the IRE1alpha-[TF], PERK-ATF4, and ATF6alpha pathways constitute novel upstream regulatory pathways of angiogenesis by modulating [TG] transcription.	XBP-1	VEGF	0	UNDEFINED	False
10425	10594	20222112:12:SMAD3:CTGF	TGFbeta, through [TF] and AP-1, serves as a positive regulator of [TG] expression in the nucleus pulposus.	Smad3	CTGF	1	ACTIVATION	False
10426	10595	20222112:8:SMAD3:CTGF	Further evidence of [TF] and AP-1 involvement was seen when DN-Smad3, SiRNA-Smad3, Smad7, and DN-AP-1 suppressed TGFbeta-mediated activation of the [TG] promoter.	Smad3	CTGF	1	ACTIVATION	False
10428	10597	20223820:5:NFKB:MAP2K3	In addition, we found that the studied p53 mutants regulate [TG] gene expression through the involvement of the transcriptional cofactors NF-Y and [TF].	NF-kappaB	MAP2K3	0	UNDEFINED	False
10429	10598	20223820:5:TP53:MAP2K3	In addition, we found that the studied [TF] mutants regulate [TG] gene expression through the involvement of the transcriptional cofactors NF-Y and NF-kappaB.	p53	MAP2K3	0	UNDEFINED	False
10430	10599	20230799:7:SP1:GDF15	Furthermore, pretreatment with the specific [TF] inhibitor mithramycin A completely reversed the LYR-8-induced [TG] expression in both HCT116 and HT29 cells.	Sp1	NAG-1	1	ACTIVATION	False
10433	10602	20301197:5:SP1:CDKN1A	Using the chromatin immunoprecipitation (ChIP) assay, we show that estradiol stimulation resulted in the recruitment of transcription factors ER alpha, [TF], and Sp3 to the p21([TG]/Cip1) upstream promoter element.	Sp1	Waf1	0	UNDEFINED	False
10434	10603	20301197:5:SP3:CDKN1A	Using the chromatin immunoprecipitation (ChIP) assay, we show that estradiol stimulation resulted in the recruitment of transcription factors ER alpha, Sp1, and [TF] to the p21([TG]/Cip1) upstream promoter element.	Sp3	Waf1	0	UNDEFINED	False
10435	10604	20301197:6:SP1:CDKN1A	The [TF] inhibitor mithramycin A abrogated Sp1, and to a lesser extent Sp3 binding, and markedly reduced the estradiol stimulated p21([TG]/Cip1) gene expression.	Sp1	Waf1	1	ACTIVATION	False
10436	10605	20301197:6:SP3:CDKN1A	The Sp1 inhibitor mithramycin A abrogated Sp1, and to a lesser extent [TF] binding, and markedly reduced the estradiol stimulated p21([TG]/Cip1) gene expression.	Sp3	Waf1	1	ACTIVATION	False
10437	10606	20303354:6:NFKB:CDX2	Inhibition of [TF] abolished the increase in [TG] promoter activity.	NF-kappaB	CDX2	1	ACTIVATION	False
10438	10607	20303354:7:NFKB1:CDX2	Increased [TG] promoter activity was associated with nuclear translocation of [TF], which bound to the promoter.	p50	CDX2	1	ACTIVATION	False
10439	10608	20304921:7:STAT3:STEAP4	Interestingly, the regulation of [TG] in both feeding and fasting and the obese state appears to require the transcription factor CCAAT/enhancer-binding protein alpha that may act in concert with [TF] as they both bind to the proximal steap4 promoter in vivo.	STAT3	STEAP4	0	UNDEFINED	False
10440	10609	20308529:4:JUN:AREG	Treatment of granulosa cells with forskolin to mimic the effects of LH increases [TG] promoter activity in a RIP140-dependent manner that 1) requires an intact cAMP response element in the proximal promoter region of the Areg gene and 2) involves its actions as a coactivator for cAMP response element-binding protein/[TF] transcription factors.	c-Jun	AREG	1	ACTIVATION	False
10441	10610	20332343:3:PPARG:GIPR	We investigated the role of [TF] in [TG] transcription.	PPARgamma	GIP-R	0	UNDEFINED	False
10442	10611	20332343:6:PPARG:GIPR	In vitro studies of INS-1 cells confirmed that [TF] binds to the putative PPRE sequence and regulates [TG] transcription.	PPAR-gamma	GIP-R	0	UNDEFINED	False
10443	10612	20332458:7:STAT3:CCND1	In addition, CADPE effectively deacetylated histone 4 and prevented [TF] recruitment to the [TG] promoter, consistent with a role for the CADPE target, STAT3, in the regulation of cyclin D1 transcription.	STAT3	cyclin D1	0	UNDEFINED	False
10444	10613	20336373:6:LEF1:FAIM2	In Western blots, RT-PCR and by small interfering RNA directed against [TF], we demonstrated that [TG] expression correlates with GSK3beta and LEF-1 activation.	LEF-1	LFG	1	ACTIVATION	False
10445	10614	20345481:10:BACH1:HMOX1	These and other results show that [TF] plays a critical role in regulating [TG] gene expression in AML cells and its expression suppresses their survival by downregulating HO-1 expression.	Bach1	HO-1	2	REPRESSION	False
10446	10615	20345481:3:BACH1:HMOX1	Here we investigated the expression of [TG] in primary and established AML cells as well as other types of leukemic cells and normal monocytes, and its regulatory mechanism by the transcriptional repressor, BTB and CNC homology 1 ([TF]), and the activator, nuclear factor erythroid-derived 2 related factor 2 (Nrf2).	Bach1	HO-1	2	REPRESSION	False
10447	10616	20345481:3:NFE2L2:HMOX1	Here we investigated the expression of [TG] in primary and established AML cells as well as other types of leukemic cells and normal monocytes, and its regulatory mechanism by the transcriptional repressor, BTB and CNC homology 1 (Bach1), and the activator, nuclear factor erythroid-derived 2 related factor 2 ([TF]).	Nrf2	HO-1	1	ACTIVATION	False
10448	10617	20345481:8:BACH1:HMOX1	Chromatin immunoprecipitation assay of these cells revealed the preferential binding of Nrf2 over [TF] to Maf-recognition elements, the enhancer regions of the [TG] gene.	Bach1	HO-1	0	UNDEFINED	False
10449	10618	20345481:8:NFE2L2:HMOX1	Chromatin immunoprecipitation assay of these cells revealed the preferential binding of [TF] over Bach1 to Maf-recognition elements, the enhancer regions of the [TG] gene.	Nrf2	HO-1	0	UNDEFINED	False
10451	10620	20346941:8:ETV4:DUSP6	Conserved [TF] ETS binding sites were identified within the Dusp6 promoter, and reporter assays showed that one of these sites is required for [TG] induction by FGFs.	Pea3	dusp6	1	ACTIVATION	False
10452	10621	20348279:11:ELK1:HMOX1	Moreover, silencing of C/EBPalpha in macrophages prevented induction of [TG] promoter activity by either [TF] or PGN.	Elk-1	HO-1	1	ACTIVATION	False
10453	10622	20348279:8:ELK3:HMOX1	We showed previously that Ets factors (activators Ets-2 and Ets-1 and repressor [TF]) regulate [TG] expression by Gram-negative endotoxin.	Elk-3	HO-1	2	REPRESSION	True
10454	10623	20348279:8:ETS1:HMOX1	We showed previously that Ets factors (activators Ets-2 and [TF] and repressor Elk-3) regulate [TG] expression by Gram-negative endotoxin.	Ets-1	HO-1	1	ACTIVATION	False
10455	10624	20348279:8:ETS2:HMOX1	We showed previously that Ets factors (activators [TF] and Ets-1 and repressor Elk-3) regulate [TG] expression by Gram-negative endotoxin.	Ets-2	HO-1	1	ACTIVATION	False
10456	10625	20348948:0:EGR1:NDRG1	T-box 2 represses [TG] through an [TF]-dependent mechanism to drive the proliferation of breast cancer cells.	EGR1	NDRG1	2	REPRESSION	False
10457	10626	20348948:5:EGR1:NDRG1	We show that TBX2 targets [TG] through a previously undescribed mechanism involving the recruitment of [TF] (EGR1).	early growth response 1	NDRG1	0	UNDEFINED	False
10458	10627	20348948:5:TBX2:NDRG1	We show that [TF] targets [TG] through a previously undescribed mechanism involving the recruitment of early growth response 1 (EGR1).	TBX2	NDRG1	0	UNDEFINED	False
10459	10628	20348948:7:EGR1:NDRG1	We show that TBX2 interacts with [TF] and that TBX2 requires EGR1 to target the [TG] proximal promoter.	EGR1	NDRG1	0	UNDEFINED	False
10460	10629	20348948:7:TBX2:NDRG1	We show that [TF] interacts with EGR1 and that TBX2 requires EGR1 to target the [TG] proximal promoter.	TBX2	NDRG1	0	UNDEFINED	False
10461	10630	20351094:0:SP1:HMOX1	[TF] regulates chromatin looping between an intronic enhancer and distal promoter of the human [TG] gene in renal cells.	Sp1	heme oxygenase-1	0	UNDEFINED	False
10462	10633	20351696:11:AP1:CDX2	Functional analysis of human [TG] promoter also revealed its upregulation by HB-EGF stimulation, showing the role of potential responsive elements ([TF] and NF-kappaB) for its transcriptional activation.	AP-1	Cdx2	1	ACTIVATION	False
10463	10634	20351696:11:NFKB:CDX2	Functional analysis of human [TG] promoter also revealed its upregulation by HB-EGF stimulation, showing the role of potential responsive elements (AP-1 and [TF]) for its transcriptional activation.	NF-kappaB	Cdx2	1	ACTIVATION	False
10464	10635	20364308:0:MYB:BRCA1	Involvement of MyoD and [TF] in regulation of basal and estrogen-induced transcription activity of the [TG] gene.	c-myb	BRCA1	1	ACTIVATION	True
10465	10636	20364308:0:MYOD1:BRCA1	Involvement of [TF] and c-myb in regulation of basal and estrogen-induced transcription activity of the [TG] gene.	MyoD	BRCA1	1	ACTIVATION	True
10467	10638	20364308:2:MYOD1:BRCA1	In the present report, we find that [TF] expression and [TG] expression is correlated in sporadic breast tumors, overexpression of MyoD and c-myb stimulates BRCA1 expression, knockdown of MyoD and c-myb attenuates BRCA1 expression and attenuates the ability of BRCA1 to protect cells against hydrogen peroxide.	MyoD	BRCA1	1	ACTIVATION	False
10468	10639	20364308:3:MYB:BRCA1	MyoD and [TF] interact with p300 and PCAF, forming activating transcriptional complexes which bind to E-box and c-myb sites on the [TG] promoter and activate its transcription by inducing histone acetylation.	c-myb	BRCA1	1	ACTIVATION	False
10469	10640	20364308:3:MYOD1:BRCA1	[TF] and c-myb interact with p300 and PCAF, forming activating transcriptional complexes which bind to E-box and c-myb sites on the [TG] promoter and activate its transcription by inducing histone acetylation.	MyoD	BRCA1	1	ACTIVATION	False
10470	10641	20364308:4:MYB:BRCA1	Regulation of [TG] expression by MyoD and [TF] complexes may be part of an integral signaling pathway that determines and explains breast cancer susceptibility.	c-myb	BRCA1	0	UNDEFINED	False
10471	10642	20368269:4:PPARA:HMOX1	We found interaction of [TF] with PPRE on the [TG] promoter in nuclear extracts from pravastatin-treated NRK-52E cells and by chromatin immunoprecipitation.	PPARalpha	HO-1	0	UNDEFINED	False
10473	10644	20368355:0:KLF1:CDKN1A	[TF] directly activates the p21[TG]/CIP1 gene by proximal promoter and novel intronic regulatory regions during erythroid differentiation.	EKLF	WAF1	1	ACTIVATION	False
10474	10645	20371606:11:AP1:NOS3	[TF] inhibition suppressed FGF2 stimulation of [TG] expression in human umbilical vein EC and uterine artery endothelial cells.	AP-1	NOS3	1	ACTIVATION	False
10475	10646	20371606:12:AP1:NOS3	Thus, FGF2 induction of [TG] expression is mainly mediated by AP-1-dependent transcription involving JunB and [TF] up-regulation via sustained ERK2/1 activation in endothelial cells.	Fra1	NOS3	1	ACTIVATION	False
10476	10647	20372826:9:STAT1:IFNLR1	The [TF] sites in the promoter region of [TG] implied a specific mechanism for the amplifying effects of IFN-lambdas.	STAT1 binding	IL28RA	0	UNDEFINED	False
10477	10648	20375015:10:SP1:BMP7	Together, these data suggest that Gpr54 regulates [TG] expression through NFAT2 and [TF] and plays an important role in embryonic kidney branching morphogenesis and glomerular development.	Sp1	Bmp7	0	UNDEFINED	False
10478	10649	20375098:6:NR5A2:NR0B2	[TF]-mediated activation of CYP7A1 and [TG] gene transcription was significantly repressed by both SHP and SIRT1 whereas inhibition of SIRT1 activity by inhibitors or dominant negative SIRT1 or knockdown of SHP led to a significant release of this inhibitory effect.	LRH1	SHP	1	ACTIVATION	False
10479	10650	20376080:8:E2F1:PIN1	Induction of C/EBPalpha-p30 results in recruitment of [TF] in the [TG] promoter.	E2F1	PIN1	0	UNDEFINED	False
10480	10651	20382893:3:MYC:PKLR	[TF] is also required for the glucose response of the [TG] gene, although the relationship between c-Myc and ChREBP has not been defined.	c-Myc	Pklr	0	UNDEFINED	False
10481	10652	20388495:5:HLTF:SERPINE1	[TF] modulates basal expression of [TG] involved in regulation of cell migration.	HLTF	PAI-1	0	UNDEFINED	False
10482	10653	20388495:6:HLTF:SERPINE1	Consistently, overexpression of CHFR inhibits cell migration, resulting from reduced [TF] followed by decreased [TG] expression.	HLTF	PAI-1	1	ACTIVATION	False
10483	10654	20388787:7:MYC:ID1	Docetaxel dose-dependently induced [TG] transcription, which was mediated by ID1 promoter E-box chromatin modification and [TF] binding.	c-Myc	ID1	1	ACTIVATION	False
10484	10655	20396959:0:HSF1:FAS	[TF] is a transcription factor of [TG] gene.	Heat shock factor 1	Fas	0	UNDEFINED	False
10485	10656	20396959:6:HSF1:FAS	Moreover, RNA interference-mediated [TF] gene-silencing attenuated [TG] expression in a heat-induced model.	HSF1	Fas	1	ACTIVATION	False
10486	10657	20396959:7:HSF1:FAS	Our results suggested that [TF] is an important transcription factor of [TG] gene.	HSF1	Fas	0	UNDEFINED	False
10487	10658	20407011:0:STAT1:SKP2	[TF] represses [TG] gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.	STAT1	Skp2	2	REPRESSION	False
10488	10659	20407011:5:STAT1:CDKN1B	Previous work established the antitumor function of [TF] in Ras-transformed cells through the induction of [TG] at the transcriptional level.	STAT1	p27(Kip1)	1	ACTIVATION	False
10489	10660	20407011:7:STAT1:SKP2	Specifically, we show that [TF] impedes [TG] gene transcription by binding to Skp2 promoter DNA in vitro and in vivo.	STAT1	Skp2	2	REPRESSION	False
10490	10661	20409024:11:NFKB:CTGF	After stimulation with LPS, the p65 subunit of [TF] was shown to be bound to the [TG] promoter in vitro and in situ.	NF-kappaB	CTGF	0	UNDEFINED	False
10491	10662	20410211:12:NFKB:USF2	Taken together, these data suggest that glycated albumin upregulated [TG] gene transcription in MCs through [TF]-dependent transactivation of the USF2 promoter.	NF-kappaB	USF2	1	ACTIVATION	False
10492	10663	20410211:9:NFKB:USF2	By using the luciferase-promoter deletion assay, site-directed mutagenesis, and transactivation assay, we identified a glycated albumin-responsive region in the [TG] gene promoter (-837 to -430, relative to the transcription start site) and demonstrated that glycated albumin-induced USF2 expression was mediated through [TF]-dependent transactivation of the USF2 promoter.	NF-kappaB	USF2	1	ACTIVATION	False
10493	10664	20414733:3:EGR1:GFAP	We have also shown that the Tat-induced [TG] expression in astrocytes is regulated by p300 and that deletion of the [TF] (Egr-1) cis-transacting element within the p300 promoter abolishes Tat-induced GFAP expression.	early growth response 1	GFAP	1	ACTIVATION	False
10494	10665	20417179:1:EGR1:SPP1	Previous studies identified a positive feedback loop in rat vascular smooth muscle cells (VSMCs) in which early growth response factor-1 ([TF]) binds to the osteopontin ([TG]) promoter and upregulates OPN expression, and OPN upregulates Egr-1 expression via the extracellular signal-regulated protein kinase (ERK) signaling pathway.	Egr-1	OPN	1	ACTIVATION	False
10495	10666	20417179:2:EGR1:SPP1	The current study examined whether transforming growth factor-beta (TGF-beta) activity contributes to [TF] binding to the [TG] promoter, and whether other signaling pathways act downstream of OPN to regulate Egr-1 expression.	Egr-1	OPN	0	UNDEFINED	False
10496	10667	20417179:7:EGR1:SPP1	Taken together, the results of the current study show that [TF] binding to the [TG] promoter is positively regulated by TGF-beta, and that the p38 MAPK, JNK, and ERK pathways are involved in OPN-mediated Egr-1 upregulation.	Egr-1	OPN	0	UNDEFINED	True
10497	10668	20420878:0:NFKB2:CCND1	[TF]-Bcl3 complex promotes [TG] expression in BEAS-2B cells in response to low concentration arsenite.	p52	cyclin D1	1	ACTIVATION	False
10498	10669	20424164:7:NFKB:FABP5	In turn, [TF] induces the expression of [TG] through two cognate response elements in the promoter of this gene.	NF-kappaB	FABP5	1	ACTIVATION	False
10499	10670	20425755:5:CDX2:MGAM	We showed that the HS-diet increased acetylation of histones, bindings of a coactivator, Creb binding protein (CREBBP), and the transcriptional factors caudal type homeobox 2 ([TF]) and HNF1 homeobox (HNF1) in the promoter/enhancer and transcriptional regions of [TG] gene.	CDX2	Mgam	0	UNDEFINED	False
10500	10671	20425755:5:HNF1A:MGAM	We showed that the HS-diet increased acetylation of histones, bindings of a coactivator, Creb binding protein (CREBBP), and the transcriptional factors caudal type homeobox 2 (CDX2) and [TF] homeobox (HNF1) in the promoter/enhancer and transcriptional regions of [TG] gene.	HNF1	Mgam	0	UNDEFINED	False
10501	10672	20425755:6:CDX2:MGAM	This suggests that the increase in the jejunal activity of maltase and glucoamylase caused by a HS-diet in mice is regulated at the mRNA level through histone acetylation and binding of CREBBP, [TF] and HNF1 in the promoter/enhancer and transcriptional regions of [TG] gene.	CDX2	Mgam	0	UNDEFINED	False
10502	10673	20425755:6:HNF1A:MGAM	This suggests that the increase in the jejunal activity of maltase and glucoamylase caused by a HS-diet in mice is regulated at the mRNA level through histone acetylation and binding of CREBBP, CDX2 and [TF] in the promoter/enhancer and transcriptional regions of [TG] gene.	HNF1	Mgam	0	UNDEFINED	True
10503	10674	20427269:6:ETS1:FOXP3	Valproate treatment induced binding of [TF] and Ets-2 to the [TG] promoter and acted positively on its expression, by increasing the acetylation of histone H4 lysines.	Ets-1	FOXP3	1	ACTIVATION	False
10504	10675	20427269:6:ETS2:FOXP3	Valproate treatment induced binding of Ets-1 and [TF] to the [TG] promoter and acted positively on its expression, by increasing the acetylation of histone H4 lysines.	Ets-2	FOXP3	1	ACTIVATION	False
10505	10676	20427719:6:NFKB:HSD11B2	Key transcription factors that can affect [TG] expression include transcriptional enhancers specificity protein 1 (SP1) and [TF] p65 and transcriptional repressors early growth response factor (Egr-1) and NF-kappaB p50.	NF-kappaB	11beta-HSD2	1	ACTIVATION	True
10506	10678	20427719:6:SP1:HSD11B2	Key transcription factors that can affect [TG] expression include transcriptional enhancers specificity protein 1 ([TF]) and NF-kappaB p65 and transcriptional repressors early growth response factor (Egr-1) and NF-kappaB p50.	SP1	11beta-HSD2	0	UNDEFINED	True
10508	10680	20430872:0:AP1:BBC3	CHOP and [TF] cooperatively mediate [TG] expression during lipoapoptosis.	AP-1	PUMA	1	ACTIVATION	False
10509	10681	20430872:0:DDIT3:BBC3	[TF] and AP-1 cooperatively mediate [TG] expression during lipoapoptosis.	CHOP	PUMA	1	ACTIVATION	False
10510	10682	20435036:3:SP1:VEGFA	Using arsenic trioxide-responsive KU7 and non-responsive 253JB-V bladder cancer cells as models, we show that in KU7 cells, < or =5 microM arsenic trioxide decreased [TF], Sp3 and Sp4 and several Sp-dependent genes and responses including cyclin D1, epidermal growth factor receptor, bcl-2, survivin and [TG], whereas at concentrations up to 15 microM, minimal effects were observed in 253JB-V cells.	Sp1	vascular endothelial growth factor	1	ACTIVATION	True
10511	10683	20435036:3:SP3:CCND1	Using arsenic trioxide-responsive KU7 and non-responsive 253JB-V bladder cancer cells as models, we show that in KU7 cells, < or =5 microM arsenic trioxide decreased Sp1, [TF] and Sp4 and several Sp-dependent genes and responses including [TG], epidermal growth factor receptor, bcl-2, survivin and vascular endothelial growth factor, whereas at concentrations up to 15 microM, minimal effects were observed in 253JB-V cells.	Sp3	cyclin D1	1	ACTIVATION	True
10512	10684	20435036:3:SP3:VEGFA	Using arsenic trioxide-responsive KU7 and non-responsive 253JB-V bladder cancer cells as models, we show that in KU7 cells, < or =5 microM arsenic trioxide decreased Sp1, [TF] and Sp4 and several Sp-dependent genes and responses including cyclin D1, epidermal growth factor receptor, bcl-2, survivin and [TG], whereas at concentrations up to 15 microM, minimal effects were observed in 253JB-V cells.	Sp3	vascular endothelial growth factor	1	ACTIVATION	True
10513	10685	20435036:3:SP4:CCND1	Using arsenic trioxide-responsive KU7 and non-responsive 253JB-V bladder cancer cells as models, we show that in KU7 cells, < or =5 microM arsenic trioxide decreased Sp1, Sp3 and [TF] and several Sp-dependent genes and responses including [TG], epidermal growth factor receptor, bcl-2, survivin and vascular endothelial growth factor, whereas at concentrations up to 15 microM, minimal effects were observed in 253JB-V cells.	Sp4	cyclin D1	1	ACTIVATION	False
10514	10686	20435036:3:SP4:VEGFA	Using arsenic trioxide-responsive KU7 and non-responsive 253JB-V bladder cancer cells as models, we show that in KU7 cells, < or =5 microM arsenic trioxide decreased Sp1, Sp3 and [TF] and several Sp-dependent genes and responses including cyclin D1, epidermal growth factor receptor, bcl-2, survivin and [TG], whereas at concentrations up to 15 microM, minimal effects were observed in 253JB-V cells.	Sp4	vascular endothelial growth factor	1	ACTIVATION	True
10515	10687	20439537:5:FOXO3:FOXP3	A [TF]-binding motif is present in a proximal region of the [TG] promoter, and is required for Foxo3a association.	Foxo3a	Foxp3	0	UNDEFINED	False
10516	10688	20440542:5:VDR:CYP24A1	[TF] overexpression in MCF-7 cells and MDA-MB231 cells decreased [TG] mRNA expression levels and CYP24 promoter activity.	VDR	CYP24	2	REPRESSION	False
10517	10689	20440542:7:VDR:CYP24A1	We also found that overexpression of [TF] with a polymorphic site (FokI-FF) at its AF-1 domain, which makes VDR shorter by three amino acids, failed to repress [TG] promoter activity.	VDR	CYP24	2	REPRESSION	False
10518	10690	20452972:2:NFE2L2:SQSTM1	Induction of the [TG] gene by oxidative stress is mediated by NF-E2-related factor 2 ([TF]) and, at the same time, p62 protein contributes to the activation of NRF2, but hitherto the mechanisms involved were not known.	NRF2	p62	1	ACTIVATION	False
10520	10692	20460526:7:JUND:SAT1	Using a vector containing a luciferase reporter gene connected to the [TG] promoter and a [TF]-silenced LNCaP cell line, we show that JunD is essential for androgen-induced SSAT gene expression.	JunD	SSAT	1	ACTIVATION	False
10521	10693	20460526:8:JUND:SAT1	The elucidation of [TF]-AR complex inducing [TG] expression leading to polyamine oxidation establishes the mechanistic basis of androgen-induced ROS production in CaP cells and opens up a new prostate-specific target for CaP chemopreventive/chemotherapeutic drug development.	JunD	SSAT	1	ACTIVATION	False
10522	10694	20463007:0:HNF4A:ABCC6	The ERK1/2-[TF] axis regulates human [TG] gene expression in hepatocytes.	hepatocyte nuclear factor 4alpha	ABCC6	0	UNDEFINED	False
10523	10695	20463007:7:HNF4A:ABCC6	We demonstrated that [TF] regulates the expression of [TG], acts through the putative binding site, and determines its cell type-specific expression.	HNF4alpha	ABCC6	0	UNDEFINED	False
10524	10696	20463008:8:JUN:MMP1	Silencing of c-fos and [TF] expression was sufficient to abrogate IL-1 + OSM-stimulated collagenase gene induction, and overexpression of both c-fos and c-jun was sufficient to drive transcription from the [TG] promoter in the absence of a stimulus.	c-jun	MMP1	1	ACTIVATION	False
10525	10697	20463961:12:ZFP42:MAP2K3	The direct binding of [TF] to the [TG] gene was confirmed by a chromatin immunoprecipitation (ChIP) assay.	REX1	MKK3	0	UNDEFINED	False
10526	10698	20463961:13:ZFP42:MAP2K3	These findings showed that [TF] regulates the proliferation/differentiation of hMSCs through the suppression of p38 MAPK signaling via the direct suppression of [TG].	REX1	MKK3	2	REPRESSION	False
10527	10699	2046665:9:POU1F1:GH1	Thus, in contrast to the predominant role of [TF]/GHF-1 in transcription of the [TG] and prolactin genes, the control of an early pituitary gene, POMC, appears to depend on the synergistic interaction of several regulatory elements which bind different nuclear proteins.	Pit-1	growth hormone	0	UNDEFINED	False
10528	10700	2046665:9:POU1F1:PRL	Thus, in contrast to the predominant role of [TF]/GHF-1 in transcription of the growth hormone and [TG] genes, the control of an early pituitary gene, POMC, appears to depend on the synergistic interaction of several regulatory elements which bind different nuclear proteins.	Pit-1	prolactin	0	UNDEFINED	False
10529	10701	20466759:8:PPARA:CDKN1A	Quantitative real time polymerase chain reaction validation and chromatin immunoprecipitation assays both confirmed that elevated NCOR1 disrupted the ability of [TF] to regulate key target genes ([TG] and TGFBRAP1).	PPARalpha/gamma	CDKN1A	0	UNDEFINED	False
10530	10702	20466877:7:MYOD1:MYOG	TAZ additionally enhances the interaction of [TF] with the [TG] gene promoter.	MyoD	myogenin	0	UNDEFINED	False
10531	10703	20479004:8:EGR1:MAP1LC3A	Moreover, PD98059, a specific inhibitor of MEK1/2, and juglone, a potent Pin1 inhibitor, significantly suppressed the TPA-induced expression of E2F-4 as well as [TF] transcription factors, which control [TG] gene expression.	Egr-1	LC-3	0	UNDEFINED	False
10532	10704	20482821:12:JUN:CCND1	Furthermore, using [TF] stable lines we showed that BEX2 expression is required for c-Jun mediated induction of [TG] and cell proliferation.	c-Jun	cyclin D1	1	ACTIVATION	False
10533	10705	20484742:4:GCM1:MFSD2A	In this study to understand the regulation of syncytin 2 and [TG] expression in placenta, we found that syncytin 2 gene is epigenetically silenced in nonplacental cells by cytosine-phosphate-guanine (CpG) dinucleotide methylation and that expression of syncytin 2 and MFSD2A genes are regulated by the placental transcription factor [TF] in placental cells.	GCM1	MFSD2A	0	UNDEFINED	False
10535	10707	20484742:7:GCM1:MFSD2A	Interestingly, ectopic expression of [TF] activated syncytin 2 and [TG] expression in MCF-7 breast cancer cells and facilitated MCF-7 cell fusion.	GCM1	MFSD2A	1	ACTIVATION	False
10536	10708	20484742:9:GCM1:MFSD2A	Our results suggest that [TF] is a critical factor in controlling placental cell fusion through transcriptional regulation of syncytin 2 and [TG] gene expression in placenta.	GCM1	MFSD2A	0	UNDEFINED	False
10537	10709	20486760:6:JUN:HMOX1	The c-Fos, an activator protein 1 ([TF]) subunit, was upregulated by activation of NF-B and c-Jun, which bound to [TG] promoter and thereby turned on transcription of HO-1 gene.	AP-1	HO-1	1	ACTIVATION	False
10538	10710	20486760:8:JUN:HMOX1	Taken together, these results suggested that in RBA-1 cells, activation of ERK/NF-B and JNK/c-Jun cascades by a Nox/ROS-dependent event enhancing c-Fos/[TF] activity is essential for [TG] upregulation and activation induced by BK.	AP-1	HO-1	1	ACTIVATION	False
10539	10711	20489156:4:EGR1:VEGFA	Hypoxic culture, siRNA experiment, luciferase assays, chromatin immunoprecipitation, electrophoretic mobility shift assays, and quantitative RT-PCR using [TF]-inducible lung cancer cells demonstrated that EGR-1 binds to the proximal region of the [TG] promoter, activates VEGF-A expression, and enhances hypoxia inducible factor 1alpha (HIF-1alpha)-mediated VEGF-A expression.	EGR-1	VEGF-A	1	ACTIVATION	False
10540	10712	20495378:0:GATA1:CDKN1A	[TF] directly regulates [TG] gene expression during erythroid differentiation.	GATA-1	p21	0	UNDEFINED	False
10541	10713	20495378:7:GATA1:CDKN1A	We now report that [TF] directly regulates transcription of the [TG] gene in both erythroleukemia cells and normal erythroid progenitors.	GATA-1	p21	0	UNDEFINED	False
10542	10714	20495378:8:GATA1:CDKN1A	Using reporter, electrophoretic mobility shift, and chromatin immunoprecipitation assays, we show that [TF] stimulates [TG] gene transcription by binding to consensus binding sites in the upstream region of the p21 gene promoter.	GATA-1	p21	1	ACTIVATION	False
10543	10715	20501657:4:BACH1:HMOX1	[TF] depletion by small interfering RNAs or by deletion of Bach1 enhanced [TG] expression in the absence of H(2)O(2), indicating that Bach1 is a critical repressor of HO-1 in keratinocytes.	Bach1	HO-1	2	REPRESSION	False
10544	10716	20504995:0:YY1:SLC25A4	The MeCP2/[TF] interaction regulates [TG] expression at 4q35: novel hints for Rett syndrome pathogenesis.	YY1	ANT1	0	UNDEFINED	False
10545	10717	20504995:6:YY1:SLC25A4	We show that MeCP2 cooperates with [TF] in repressing the [TG] gene encoding a mitochondrial adenine nucleotide translocase.	YY1	ANT1	2	REPRESSION	False
10546	10718	20505821:9:SALL4:POU5F1	Our findings, when taken together, indicate that [TF] is a master regulator that controls its own expression and the expression of [TG].	SALL4	OCT4	0	UNDEFINED	False
10547	10719	20506344:8:CEBPB:PTGS2	C/EBP delta inhibition by TSA resulted in increased binding of C/EBP alpha and [TF] to the [TG] promoter.	C/EBP beta	COX-2	0	UNDEFINED	False
10548	10720	20506344:9:CEBPB:PTGS2	Therefore, TSA has a positive effect on LPS-induced [TG] since it decreases the C/EBP delta level by reducing c-Jun recruitment by Sp1 to the C/EBP delta promoter, resulting in increased the recruitment of C/EBP alpha and [TF] to the COX-2 promoter.	C/EBP beta	COX-2	0	UNDEFINED	False
10549	10721	20508969:5:ARNT:CDKN1A	Moreover, [TF] knockdown also inhibited other EGF-induced c-Jun/Sp1 mediated gene expression, such as p21( [TG]/CIP1 ).	ARNT	WAF1	1	ACTIVATION	False
10550	10722	20511722:0:DDIT3:CDKN1A	[TF]-dependent regulation of p21/[TG] during ER stress.	CHOP	waf1	0	UNDEFINED	False
10551	10723	20516069:8:STAT3:EME1	Importantly, the cdk5-[TF] pathway reduced DNA damage in response to topoisomerase I inhibition through the up-regulation of [TG], an endonuclease involved in DNA repair.	STAT3	Eme1	1	ACTIVATION	False
10552	10724	20519630:9:KLF4:CXCL10	In addition, we found that [TF] negatively regulates [TG], CD86, and MSC/ABF-1 genes.	KLF4	CXCL10	2	REPRESSION	False
10553	10725	20525792:0:YY1:LEF1	A role for [TF] in repression of dominant negative [TG] expression in colon cancer.	YY1	LEF-1	2	REPRESSION	False
10554	10726	20525792:9:YY1:LEF1	We propose that [TF] plays an important role in preventing dn[TG] expression and growth inhibition in colon cancer.	YY1	LEF-1	2	REPRESSION	False
10555	10727	20530484:4:SOX10:BEST1	Here, we show that yeast one-hybrid screen with bait corresponding to [TG] -120 to -88 bp identified the SOX-E factors, SOX8, SOX9, and [TF].	SOX10	BEST1	0	UNDEFINED	False
10556	10728	20530581:6:PRDM1:PMAIP1	Knockdown of [TF] blocks activation of [TG] and inhibits apoptosis, whereas ectopic expression of PRDM1 alone leads to apoptosis in MCL.	PRDM1	NOXA	1	ACTIVATION	False
10557	10729	20530581:7:PRDM1:MKI67	Two novel direct targets of [TF] were identified in MCL cells: [TG] (Ki67) and proliferating cell nuclear antigen (PCNA).	PRDM1	MKI67	0	UNDEFINED	False
10558	10730	20530581:9:PRDM1:PCNA	Chromatin immunoprecipitation and knockdown studies reveal that specific repression of MKI67 and [TG] is mediated by [TF] in response to bortezomib.	PRDM1	PCNA	2	REPRESSION	False
10559	10731	20531301:0:AP1:CCNA2	Inhibition of [TF] by SARI negatively regulates transformation progression mediated by [TG].	AP-1	CCN1	1	ACTIVATION	True
10560	10732	20531301:7:AP1:CCNA2	These results illustrate that SARI inhibits [TF] transactivating factor binding to the cis-element of the [TG] promoter, possibly through its interaction with c-Jun.	AP-1	CCN1	0	UNDEFINED	False
10561	10733	20531301:7:BATF2:CCNA2	These results illustrate that [TF] inhibits AP-1 transactivating factor binding to the cis-element of the [TG] promoter, possibly through its interaction with c-Jun.	SARI	CCN1	0	UNDEFINED	False
10562	10735	20540995:11:SP1:TESC	Mithramycin A, an inhibitor of [TF]-DNA interaction, reduced [TG] promoter activity in msc-1 cells in a dose-dependent manner.	Sp1	Tesc	1	ACTIVATION	False
10563	10736	20540995:13:SP1:TESC	However, when [TF] and Sp3 were coexpressed, they transactivated the [TG] promoter in a synergistic manner.	Sp1	Tesc	1	ACTIVATION	False
10564	10737	20540995:13:SP3:TESC	However, when Sp1 and [TF] were coexpressed, they transactivated the [TG] promoter in a synergistic manner.	Sp3	Tesc	1	ACTIVATION	False
10565	10738	20540995:15:SP3:TESC	Taken together, the data demonstrated that Sp1 and [TF] transcription factors cooperate positively in the regulation of [TG] promoter, and that the putative ZF5 motif is critical for its activation.	Sp3	Tesc	1	ACTIVATION	False
10566	10739	20540995:15:ZBTB14:TESC	Taken together, the data demonstrated that Sp1 and Sp3 transcription factors cooperate positively in the regulation of [TG] promoter, and that the putative [TF] motif is critical for its activation.	ZF5	Tesc	1	ACTIVATION	False
10567	10740	20546888:8:NFKB:PTGS2	LPS treatment promoted specific binding of [TF] to both [TG] and mPGES-1 promoters.	NF-kappaB	COX-2	0	UNDEFINED	False
10568	10741	20547753:7:FOXO3:PPARGC1A	[TF] is also a direct transcriptional regulator of [TG], and we found that a functional FoxO binding site in the PGC-1 alpha promoter is also a NO response element.	Foxo3a	PGC-1 alpha	0	UNDEFINED	True
10569	10742	20558128:13:NFE2L2:HMOX1	It is hence likely that piceatannol modifies specific cysteine residues of Keap1, which allows [TF] to translocate into the nucleus and bind to ARE, leading to enhancement of the expression of [TG].	Nrf2	HO-1	1	ACTIVATION	False
10570	10743	20558128:4:NFE2L2:HMOX1	A redox-sensitive transcription factor NF-E2-related factor ([TF]) plays a pivotal role in induced expression of many cytoprotective enzymes including [TG].	Nrf2	HO-1	1	ACTIVATION	False
10571	10744	20561910:4:ESRRA:CYCS	In consistence, the over-expression of PGC-1 beta stimulates its target genes such as [TG], ATP synthase beta and ALAS-1 by its interaction with two transcriptional factors, NRF-1 and [TF].	ERR alpha	cytochrome c	1	ACTIVATION	False
10572	10745	2056282:3:NFKB:TNF	Although three sites in the [TG] promoter (kappa 1, kappa 2, and kappa 3) specifically bind the transcription factor [TF] in lymphoid nuclear extracts, TNF-alpha mRNA induction by PMA does not correlate with NF-kappa B binding activities displayed by different T and B cell lines.	NF-kappa B	TNF-alpha	0	UNDEFINED	True
10573	10746	20566634:0:JUN:HSPA4	p27 suppresses arsenite-induced Hsp27/[TG] expression through inhibiting JNK2/[TF]- and HSF-1-dependent pathways.	c-Jun	Hsp70	1	ACTIVATION	False
10574	10747	20568114:1:USF1:AKAP12	The SSeCKS/Gravin/[TG] gene, encoding a kinase scaffolding protein with metastasis-suppressing activity, is transcriptionally downregulated in Src-transformed cells through the recruitment of HDAC1 to a Src-responsive proximal promoter site charged with Sp1, Sp3 and [TF].	USF1	AKAP12	2	REPRESSION	True
10575	10748	20570896:3:SP1:DNMT1	Here, we showed that wild-type p53 negatively regulated [TG] expression by forming a complex with specificity protein 1 ([TF]) protein and chromatin modifiers on the DNMT1 promoter.	Sp1	DNMT1	2	REPRESSION	False
10576	10749	20570896:3:TP53:DNMT1	Here, we showed that wild-type [TF] negatively regulated [TG] expression by forming a complex with specificity protein 1 (Sp1) protein and chromatin modifiers on the DNMT1 promoter.	p53	DNMT1	2	REPRESSION	False
10577	10750	20570896:5:SP1:DNMT1	Low level of exogenous [TF] enhanced the repressive activity of endogenous p53 on the [TG] promoter whereas high level of Sp1 upregulated DNMT1 gene expression level in A549 (p53 wild-type) cells.	Sp1	DNMT1	0	UNDEFINED	True
10578	10751	20570896:5:TP53:DNMT1	Low level of exogenous Sp1 enhanced the repressive activity of endogenous [TF] on the [TG] promoter whereas high level of Sp1 upregulated DNMT1 gene expression level in A549 (p53 wild-type) cells.	p53	DNMT1	2	REPRESSION	False
10579	10752	20581311:6:STAT3:MYC	Moreover, [TF] and C/EBP coregulate [TG] through interactions with the c-myc promoter that control the duration of C/EBP occupancy during demand-driven granulopoiesis.	STAT3	c-Myc	0	UNDEFINED	False
10580	10753	20581838:7:SRF:IVL	Knockdown of [TF] or its co-factor MAL inhibited differentiation, whereas overexpression of MAL stimulated SRF activity and [TG] expression.	SRF	involucrin	1	ACTIVATION	False
10581	10754	20587593:5:RELA:NRF1	EMSA and ChIP assays confirmed [TF] and CREB binding to the [TG] promoter and p65 binding to intron 1.	p65	NRF1	0	UNDEFINED	False
10582	10755	20596645:7:NFKB:BAD	The binding of [TF] to the [TG] promoter was confirmed by chromatin-immunoprecipitation.	NF-kappaB	BAD	0	UNDEFINED	False
10583	10756	20598227:0:TP53:MAP2	Role of acetylated [TF] in regulating the expression of [TG] in retinoic acid-induced P19 cells.	p53	map2	0	UNDEFINED	False
10584	10757	20598227:7:TP53:MAP2	[TF] was recruited to the promoter of [TG] gene in acetylated form and thereby enhanced its promoter activity.	p53	map2	1	ACTIVATION	False
10585	10758	20598227:8:TP53:MAP2	p300/CBP associated factor (PCAF) was found induced in RA-treated cells and enriched in the nucleus, which might contribute to the acetylation of [TF] in the regulation of [TG] gene.	p53	map2	0	UNDEFINED	False
10586	10759	20598227:9:TP53:MAP2	Acetylated [TF] may participate in regulating the expression of [TG] in RA-induced differentiation of P19 cells.	p53	map2	0	UNDEFINED	False
10587	10760	20599763:0:LEF1:ENAM	Beta-catenin/[TF] activated [TG] expression in ameloblast-like cells.	LEF1	enamelin	1	ACTIVATION	False
10588	10761	20599763:4:LEF1:ENAM	In this study, the role of beta-catenin/[TF] in [TG] expression was investigated.	LEF1	enamelin	0	UNDEFINED	False
10589	10762	20599763:9:LEF1:ENAM	The results suggested that Wnt/beta-catenin signaling could function in [TG] gene expression by direct interaction through two conserved [TF] responsive elements on the enamelin gene in ameloblast-like cells.	LEF1	enamelin	0	UNDEFINED	False
10590	10763	20600004:0:TP53:ABCG2	Transcriptional suppression of breast cancer resistance protein ([TG]) by wild-type [TF] through the NF-kappaB pathway in MCF-7 cells.	p53	BCRP	2	REPRESSION	False
10591	10764	20600004:2:TP53:ABCG2	Here, we investigate the effects of wild-type and mutant [TF], and nuclear factor kappa-B (NF-kappaB) (p50) on [TG] promoter activity in MCF-7 cells.	p53	BCRP	0	UNDEFINED	False
10592	10765	20600004:6:TP53:ABCG2	We conclude that wild-type [TF] acts as a negative regulator of [TG] gene transcription.	p53	BCRP	2	REPRESSION	False
10593	10766	20600102:11:HNF1A:SLC5A1	TG(T400N) hearts had increased binding activity of the transcription factors [TF] and Sp1 to the promoter of the gene encoding [TG].	HNF-1	SGLT1	0	UNDEFINED	False
10594	10767	20600102:11:SP1:SLC5A1	TG(T400N) hearts had increased binding activity of the transcription factors HNF-1 and [TF] to the promoter of the gene encoding [TG].	Sp1	SGLT1	0	UNDEFINED	False
10595	10768	20607723:3:SP1:FHL2	Meanwhile, suppression of [TF] by siRNA or chemical inhibitor, mithramycin A (MIT) inhibited the promoter activity and [TG] expression.	Sp1	FHL2	1	ACTIVATION	False
10596	10769	20607723:7:SP1:FHL2	These data identified a functional [TF] positively regulatory element (-1058nt to -1049nt) within [TG] promoter, and the positive correlation between Sp1 and FHL2 in expressing pattern and signal mechanism strongly suggested their synergized effect in carcinogenesis and progression of GI cancers.	Sp1	FHL2	1	ACTIVATION	False
10597	10770	20615956:5:TBR1:AUTS2	[TF] implements frontal identity in part by direct promoter binding and activation of [TG], a frontal cortex gene implicated in autism.	Tbr1	Auts2	1	ACTIVATION	False
10598	10771	20629094:2:TFAP2C:ERBB2	Previous studies established a role for [TF] in the regulation of ESR1 (ERalpha) and [TG] (Her2) in breast carcinomas.	TFAP2C	ERBB2	0	UNDEFINED	False
10599	10772	20629094:8:TFAP2C:GREB1	The identification of ESR1, WWOX, [TG], and FOXA1 as primary targets confirmed the role of [TF] in hormone response.	TFAP2C	GREB1	0	UNDEFINED	False
10600	10773	20631257:5:NFKB:PTGS2	PRDX1 knockdown attenuated [TG] expression by reducing [TF] occupancy at its upstream promoter element in MDA-MB-231 but not in MCF7 cells.	NF-kappaB	COX-2	1	ACTIVATION	False
10601	10774	20631312:7:IRF1:TRIM22	Moreover, overexpression of [TF] significantly induced [TG] expression, whereas silencing of IRF-1 with specific short interference RNA abolished IFN-gamma-induced TRIM22 expression in HepG2 cells, indicating an IRF-1-dependent expression of TRIM22.	IRF-1	TRIM22	1	ACTIVATION	False
10602	10775	20631312:8:IRF1:TRIM22	Taken together, it was demonstrated in this study that a novel cis-element, 5' eISRE, was crucial for the IFN-gamma-induced transcriptional activity of the [TG] gene via interaction with [TF].	IRF-1	TRIM22	1	ACTIVATION	False
10603	10776	20631324:10:AHR:BRCA1	These results support the hypothesis that epigenetic silencing of the [TG] gene by the [TF] is preventable with Res and provide the molecular basis for the development of dietary strategies based on natural AhR antagonists.	AhR	BRCA-1	2	REPRESSION	False
10604	10777	20631324:6:AHR:BRCA1	We report that activation and recruitment of the [TF] to the [TG] promoter hampers 17 beta -estradiol (E2)-dependent stimulation of BRCA-1 transcription and protein levels.	AhR	BRCA-1	2	REPRESSION	False
10605	10778	20631324:9:AHR:BRCA1	The [TF]-dependent repression of [TG] expression is reversed by small interference for the AhR and DNMT1 or pretreatment with Res, which reduces TCDD-induced DNA strand breaks.	AhR	BRCA-1	2	REPRESSION	False
10606	10779	20637099:4:POU2F1:CDX2	[TF] binds to [TG] promoter and represses its expression.	Oct-1	Cdx-2	2	REPRESSION	False
10607	10780	20639455:0:KLF5:ABCG2	[TF] is not required for K-RasG12D lung tumorigenesis, but represses [TG] expression and is associated with better disease-specific survival.	Kruppel-like factor 5	ABCG2	2	REPRESSION	False
10609	10782	20639906:5:E2F1:SRSF2	We further show that, strikingly, [TF] alters the ratio of pro-VEGF(xxx) versus anti-VEGF(xxx)b angiogenic isoforms, favouring the antiangiogenic isoforms, by a mechanism involving the induction of [TG] expression.	E2F1	SC35	1	ACTIVATION	False
10610	10783	20643109:7:BACH1:HMOX1	In particular, it is discussed how redox-dependent transcriptional activators such as NF-E2 related factor 2 (Nrf2), NF-B and AP-1 along with the transcription repressor BTB and CNC homologue 1 ([TF]) control the inducible [TG] gene expression.	Bach1	HO-1	2	REPRESSION	True
10611	10784	20643109:7:NFE2L2:HMOX1	In particular, it is discussed how redox-dependent transcriptional activators such as NF-E2 related factor 2 ([TF]), NF-B and AP-1 along with the transcription repressor BTB and CNC homologue 1 (Bach1) control the inducible [TG] gene expression.	Nrf2	HO-1	1	ACTIVATION	False
10612	10785	20643408:12:PREB:ABCA1	In summary, our data showed that [TF] regulates the cAMP-mediated transcription of the [TG] gene in vascular SMCs.	PREB	ABCA1	0	UNDEFINED	False
10613	10786	20643408:9:PREB:ABCA1	In addition, [TF] stimulated the activity of the luciferase reporter protein that was under the control of the [TG] promoter.	PREB	ABCA1	1	ACTIVATION	False
10614	10787	20650879:11:NR5A1:MC2R	By mapping the [TG] promoter, we provide evidence that distal [TF] response elements (-1410 and -975) are required for synergistic activation by FOXL2 and NR5A1.	NR5A1	Mc2r	1	ACTIVATION	False
10615	10788	20654631:0:ATF5:DDIT3	Regulation of the human [TG] gene promoter by the stress response transcription factor [TF] via the AARE1 site in human hepatoma HepG2 cells.	ATF5	CHOP	0	UNDEFINED	False
10616	10789	20654631:4:ATF5:DDIT3	We used a transient transfection system to express [TF] and analyzed the regulation of [TG] gene promoter in human hepatoma, HepG2 cells.	ATF5	CHOP	0	UNDEFINED	False
10617	10790	20654631:6:ATF5:DDIT3	We showed that [TF] activates the [TG] gene promoter in HepG2 cells.	ATF5	CHOP	1	ACTIVATION	False
10618	10791	20656951:3:AP1:TSLP	The variant enhances [TF] binding to the regulatory element, and increases the promoter--reporter activity of [TG] in response to polyinosinic-polycytidylic acid (poly[I:C]) stimulation in normal human bronchial epithelium (NHBE).	AP-1	TSLP	1	ACTIVATION	False
10619	10792	20682644:0:NFE2L2:ABCG2	Expression of [TG] (BCRP) is regulated by [TF] in cancer cells that confers side population and chemoresistance phenotype.	Nrf2	ABCG2	0	UNDEFINED	False
10620	10793	20682644:10:NFE2L2:ABCG2	Thus, [TF]-mediated regulation of [TG] expression maintains the SP fraction and confers chemoresistance.	Nrf2	ABCG2	0	UNDEFINED	False
10621	10794	20682644:9:NFE2L2:ABCG2	As expected, overexpression of [TF] cDNA in lung epithelial cells led to an increase in [TG] expression and a 2-fold higher SP fraction.	Nrf2	ABCG2	1	ACTIVATION	False
10622	10795	20684234:4:ZXDC:CDKN1C	The expression of most of these genes is significantly increased in the kidney cell line HEK293 with overexpression of transcription factor [TF], in particular EGR2, BDNF, [TG] and IL5Ra genes.	ZXDC	CDKN1C	1	ACTIVATION	False
10624	10797	20686606:7:STAT3:ROR1	In CLL cells, EMSA and ChIP studies determined that phosphorylated Stat3 bound to the [TG] promoter at those two ROR1 promoter sites, and ChIP analysis showed that Stat3 co-immunoprecipitated DNA of [TF], ROR1, and several Stat3-regulated genes.	STAT3	ROR1	0	UNDEFINED	False
10625	10798	20686606:9:STAT3:ROR1	Our data suggest that constitutively activated [TF] binds to the [TG] promoter and activates ROR1 in CLL cells.	Stat3	ROR1	1	ACTIVATION	False
10626	10799	20694003:0:SRF:ARC	[TF] binding to SRE 6.9 in the [TG] promoter is essential for LTD in cultured Purkinje cells.	SRF	Arc	0	UNDEFINED	False
10627	10800	20694003:7:SRF:ARC	Thus, [TF] binding to SRE 6.9 in the [TG] promoter is required for the late phase of cerebellar LTD.	SRF	Arc	0	UNDEFINED	False
10628	10801	20695017:0:SOX10:GJC2	Disrupted [TF] regulation of [TG] transcription causes Pelizaeus-Merzbacher-like disease.	SOX10	GJC2	0	UNDEFINED	False
10629	10802	20695017:3:SOX10:GJC2	Functionally, this mutation completely abolished the [TF] binding and attenuated [TG] promoter activity.	SOX10	GJC2	1	ACTIVATION	False
10631	10804	20702711:8:JUN:DUSP1	We also show that [TF] and ATF2 bind to two conserved ATF binding sites in the [TG] promoter in vitro and in chromatin.	c-Jun	mkp1	0	UNDEFINED	False
10632	10805	20711187:2:FUBP1:MYC	First, the [TF] transcriptional activator binds to the FUSE DNA element upstream of the [TG] promoter.	FBP	c-myc	1	ACTIVATION	True
10633	10806	20713602:5:E2F4:PPARGC1A	Chromatin immunoprecipitation revealed binding of p107 and [TF] to the [TG] proximal promoter, and this binding repressed promoter activity in transient transcription assays.	E2F4	PGC-1alpha	2	REPRESSION	False
10634	10807	2071571:11:EGR1:MYH6	These results define a physiological target for the [TF] transcription factor and delineate a novel mechanism for regulation of the [TG] gene.	Egr-1	alpha-MHC	0	UNDEFINED	False
10635	10808	2071571:3:EGR1:MYH6	Here we report that [TF] transactivates rat cardiac [TG] gene expression.	Egr-1	alpha-MHC	1	ACTIVATION	False
10636	10809	20727996:0:ELK1:SERPINE1	Epidermal growth factor regulates [TG] expression via activation of the transcription factor [TF].	Elk-1	PAI-1	0	UNDEFINED	True
10637	10810	20727996:3:ELK1:SERPINE1	Here we report that EGF, which promotes breast cancer tumour growth and survival, rapidly induces [TG] expression in the breast adenocarcinoma cell line MCF-7 through the activation of the transcription factor [TF].	Elk-1	PAI-1	1	ACTIVATION	False
10638	10811	20732443:0:SMAD3:SLC5A8	Activin A induces [TG] expression through the [TF] signaling pathway in human colon cancer RKO cells.	Smad3	SLC5A8	1	ACTIVATION	False
10639	10812	20735474:3:FOXM1:TTR	The site-directed mutagenesis of HNF-4, HNF-1, [TF] and HNF-6 binding sites in the [TG] proximal promoter dramatically decreases transthyretin promoter activity.	HNF-3	transthyretin	1	ACTIVATION	False
10640	10813	20735474:3:HNF1A:TTR	The site-directed mutagenesis of HNF-4, [TF], HNF-3 and HNF-6 binding sites in the [TG] proximal promoter dramatically decreases transthyretin promoter activity.	HNF-1	transthyretin	1	ACTIVATION	False
10641	10814	20735474:6:HNF1A:TTR	In a cytokine-induced acute phase response cell culture model, we observed a significant reduction in the binding of HNF-4, [TF], HNF-3 and HNF-6 to the [TG] promoter, which correlates with a decrease in transthyretin expression after injury.	HNF-1	transthyretin	1	ACTIVATION	False
10642	10815	20735474:6:HNF4A:TTR	In a cytokine-induced acute phase response cell culture model, we observed a significant reduction in the binding of [TF], HNF-1, HNF-3 and HNF-6 to the [TG] promoter, which correlates with a decrease in transthyretin expression after injury.	HNF-4	transthyretin	1	ACTIVATION	False
10643	10816	20735474:6:ONECUT1:TTR	In a cytokine-induced acute phase response cell culture model, we observed a significant reduction in the binding of HNF-4, HNF-1, HNF-3 and [TF] to the [TG] promoter, which correlates with a decrease in transthyretin expression after injury.	HNF-6	transthyretin	1	ACTIVATION	False
10644	10817	20736951:6:SP3:PLAUR	Luciferase/chromatin immunoprecipitation analysis showed that Enz transcriptionally controls urokinase-type plasminogen activator receptor ([TG]) expression by promoter inhibition through Sp1, [TF], and c-Jun(AP-1).	Sp3	u-PAR	2	REPRESSION	False
10645	10818	20739403:5:SP1:SMAD3	We provide evidence that DHT down-regulates the promoter activity of [TG] in various prostate cancer cell lines, including NRP-154+AR, DU145+AR, LNCaP, and VCaP, at least partly through androgen-dependent inactivation of [TF].	Sp1	Smad3	1	ACTIVATION	False
10646	10819	20802137:9:ELK1:TAGLN	The increased expression of PKG in vascular SMCs inhibited [TF] binding to SMC-specific promoters, [TG] and smooth muscle myosin heavy chain, as measured by EMSA and chromatin immunoprecipitation assay, and PKG suppressed the Elk-1 inhibition of SM22 reporter gene expression.	Elk-1	SM22	0	UNDEFINED	True
10647	10820	20802531:0:JDP2:CCNA2	Suppression of cell-cycle progression by [TF] (JDP2) involves downregulation of [TG].	Jun dimerization protein-2	cyclin-A2	2	REPRESSION	False
10648	10821	20802531:6:JDP2:CCNA2	Cells lacking [TF] had elevated levels of [TG] mRNA.	Jdp2	cyclin-A2	2	REPRESSION	False
10649	10822	20803090:6:TCF7L2:ACVRL1	The binding of [TF] to [TG] promoter was confirmed by chromatin immunoprecipitation assay.	TCF7L2	ALK1	0	UNDEFINED	False
10650	10823	20803090:7:TCF7L2:ACVRL1	Furthermore, [TF] induced promoter activity of [TG].	TCF7L2	ALK1	1	ACTIVATION	False
10651	10824	20803090:9:TCF7L2:ACVRL1	Overexpression of [TF] increased the expressions of [TG] and Smad1.	TCF7L2	ALK1	1	ACTIVATION	False
10652	10825	20805990:6:TFAP2A:CDKN1A	Upregulation of [TF] expression following CREB silencing increases endogenous p21([TG]) and decreases MCAM/MUC18, both known to be downstream target genes of AP-2alpha involved in melanoma progression.	AP-2alpha	Waf1	1	ACTIVATION	False
10654	10827	20807761:5:LEF1:POU1F1	[TF] directly targets and represses the [TG] promoter.	Lef-1	Pit-1	2	REPRESSION	False
10655	10828	20816801:11:PITX2:CDKN1A	The ability of Tbx1 to repress [TF] activation of [TG] may promote cell proliferation.	PITX2	p21	1	ACTIVATION	False
10656	10829	20816801:11:TBX1:CDKN1A	The ability of [TF] to repress PITX2 activation of [TG] may promote cell proliferation.	Tbx1	p21	2	REPRESSION	False
10657	10830	20816801:12:PITX2:CDKN1A	In addition, [TF] regulation of [TG] reveals a new role for PITX2 in repressing cell proliferation.	PITX2	p21	0	UNDEFINED	False
10658	10831	20816801:5:TBX1:CDKN1A	These data suggest that [TF] inhibits [TG] expression to allow for cell proliferation in the dental epithelial cervical loop, however Tbx1 does not directly regulate p21 expression.	Tbx1	p21	2	REPRESSION	False
10659	10832	20816801:6:PITX2:CDKN1A	A new molecular mechanism has been identified where Tbx1 inhibits [TF] transcriptional activity and decreases the expression of Pitx2 target genes, [TG], Lef-1 and Pitx2c.	Pitx2	p21	1	ACTIVATION	False
10660	10833	20816801:8:PITX2:CDKN1A	Tbx1 attenuates [TF] activation of endogenous [TG] expression and Tbx1 null MEFs reveal increased Pitx2a and activation of Pitx2c isoform expression.	PITX2	p21	1	ACTIVATION	False
10661	10834	20816801:8:TBX1:CDKN1A	[TF] attenuates PITX2 activation of endogenous [TG] expression and Tbx1 null MEFs reveal increased Pitx2a and activation of Pitx2c isoform expression.	Tbx1	p21	2	REPRESSION	False
10662	10835	20816801:9:PITX2:CDKN1A	Tbx1 physically interacts with the [TF] C-terminus and represses PITX2 transcriptional activation of the [TG], LEF-1, and Pitx2c promoters.	PITX2	p21	1	ACTIVATION	False
10663	10836	20816838:0:XBP1:BHLHA15	[TF] controls maturation of gastric zymogenic cells by induction of [TG] and expansion of the rough endoplasmic reticulum.	XBP1	MIST1	1	ACTIVATION	False
10664	10837	20817730:0:PARP1:PHEX	Cooperative role of NF-{kappa}B and [TF] (PARP-1) in the TNF-induced inhibition of [TG] expression in osteoblasts.	poly(ADP-ribose) polymerase 1	PHEX	2	REPRESSION	False
10665	10838	20817730:6:AP1:PHEX	Transfecting UMR-106 cells with a series of deletion constructs of the proximal [TG] promoter identified a region located within -74 nucleotides containing NF-B and [TF].	AP-1 binding sites	Phex	0	UNDEFINED	False
10666	10840	20817730:9:PARP1:PHEX	We identified [TF] (PARP-1) binding immediately upstream of the NF-B sites and showed that TNF induced poly(ADP-ribosyl)ation of RelA when bound to the [TG] promoter.	poly(ADP-ribose) polymerase 1	Phex	0	UNDEFINED	False
10667	10841	20817730:9:RELA:PHEX	We identified poly(ADP-ribose) polymerase 1 (PARP-1) binding immediately upstream of the NF-B sites and showed that TNF induced poly(ADP-ribosyl)ation of [TF] when bound to the [TG] promoter.	RelA	Phex	0	UNDEFINED	False
10668	10842	20818070:10:NFKB:MUC5AC	Neutrophil elastase (NE) could increase the expression of luciferase reporter gene plasmid containing mutated [TF] version (P<0.05 vs. control) of [TG] promoter in the transfected A549 cells.	NF-kappaB	MUC5AC	2	REPRESSION	True
10669	10843	20818429:3:E2F4:BRCA1	We found that CtBP1 represses [TG] transcription by binding to the [TF] site of the Brca1 promoter.	E2F4	Brca1	2	REPRESSION	True
10670	10844	20831799:7:ELF5:CCND2	Here we focus on one putative target of [TF], the [TG] gene that appeared in our screen.	Elf5	Ccnd2	0	UNDEFINED	False
10671	10845	20831799:8:ELF5:CCND2	We identify a novel [TF]-binding segment upstream of the [TG] gene and demonstrate that Elf5 can transcriptionally repress Ccnd2 by directly binding to the proximal promoter region.	Elf5	Ccnd2	2	REPRESSION	False
10672	10846	20833713:5:JUND:HMOX1	Additionally, JunD but not JunB formed an activator protein-1 ([TF]) oligomeric complex to augment [TG] promoter activity.	AP-1	HO-1	1	ACTIVATION	False
10673	10847	20833713:7:JUN:HMOX1	Furthermore, livers of ethanol-fed c-Jun(fl/fl) mice showed reduced levels of mRNA for [TG] but not of NQO1 compared with ethanol-fed control rats, supporting the role of c-Jun or the [TF] transcriptional complex in ethanol-induced HO-1 expression.	AP-1	HO-1	1	ACTIVATION	False
10674	10848	20833730:0:STAT1:CXCL10	TNF and IFN synergistically enhance transcriptional activation of [TG] in human airway smooth muscle cells via [TF], NF-B, and the transcriptional coactivator CREB-binding protein.	STAT-1	CXCL10	1	ACTIVATION	False
10675	10849	20847229:5:AP1:NR4A1	In studying the mechanism by which [TG] was regulated in colon cancer cells, we found that -catenin was involved in induction of Nur77 expression through its activation of the transcriptional activity of [TF] (c-Fos/c-Jun) that bound to and transactivated the Nur77 promoter.	AP-1	Nur77	1	ACTIVATION	False
10676	10851	20852387:3:SMAD2:HGF	In the present study, we found that mice with keratinocyte-specific deletion of the TGF- signaling mediator [TF] (referred to herein as K5.Smad2(-/-) mice), which have increased susceptibility to squamous cell carcinomas (SCCs), exhibited angiogenesis associated with epithelial overexpression of HGF and endothelial activation of the [TG] c-Met.	Smad2	HGF receptor	2	REPRESSION	False
10677	10852	20852387:7:SMAD2:HGF	Consistent with this, knocking down [TF] in human keratinocytes caused increased levels of [TG], which were abrogated by concomitant knockdown of Smad3 and Smad4.	Smad2	HGF	2	REPRESSION	False
10678	10853	20852387:7:SMAD3:HGF	Consistent with this, knocking down Smad2 in human keratinocytes caused increased levels of [TG], which were abrogated by concomitant knockdown of [TF] and Smad4.	Smad3	HGF	1	ACTIVATION	False
10679	10854	20852387:7:SMAD4:HGF	Consistent with this, knocking down Smad2 in human keratinocytes caused increased levels of [TG], which were abrogated by concomitant knockdown of Smad3 and [TF].	Smad4	HGF	1	ACTIVATION	False
10680	10855	20852387:9:SMAD2:HGF	We therefore conclude that [TF] loss causes [TG] upregulation via loss of Smad2-mediated transcriptional repression and enhanced Smad3/4-mediated transactivation.	Smad2	HGF	2	REPRESSION	False
10681	10856	20852387:9:SMAD3:HGF	We therefore conclude that Smad2 loss causes [TG] upregulation via loss of Smad2-mediated transcriptional repression and enhanced [TF]/4-mediated transactivation.	Smad3	HGF	1	ACTIVATION	False
10682	10857	20857481:3:MYBL2:CCNB2	Here we show that siRNA silencing of [TF] in proliferating Caco-2 cells increases expression of the cell-cycle regulators cdk2, cyclin D2, and c-myc and decreases expression of cdc25B and [TG] with a consequent 10% increase of cells in G2/M and a complementary 10% decrease in G1.	Mybl2	cyclin B2	1	ACTIVATION	True
10684	10859	20857481:4:MYBL2:CCNB2	[TF] occupies sequences upstream of transcriptional start sites of cyclin D2, c-myc, [TG], and cdc25B and regulates reporter activity driven by upstream regions of cdk2, cyclin D2, and c-myc.	Mybl2	cyclin B2	0	UNDEFINED	False
10685	10860	20857481:4:MYBL2:CCND2	[TF] occupies sequences upstream of transcriptional start sites of [TG], c-myc, cyclin B2, and cdc25B and regulates reporter activity driven by upstream regions of cdk2, cyclin D2, and c-myc.	Mybl2	cyclin D2	0	UNDEFINED	False
10686	10861	20860770:5:ZNF143:CDC6	Among these [TF] targets, 41 genes (27%) were associated with cell cycle and DNA replication including cell division cycle 6 homolog ([TG]), polo-like kinase 1 (PLK1) and minichromosome maintenance complex component (MCM) DNA replication proteins.	ZNF143	CDC6	0	UNDEFINED	False
10687	10862	20860770:5:ZNF143:PLK1	Among these [TF] targets, 41 genes (27%) were associated with cell cycle and DNA replication including cell division cycle 6 homolog (CDC6), [TG] (PLK1) and minichromosome maintenance complex component (MCM) DNA replication proteins.	ZNF143	polo-like kinase 1	0	UNDEFINED	False
10688	10863	20861353:9:NFKB:FGF10	Chromatin immunoprecipitation and nuclear coimmunoprecipitation studies demonstrated that the [TF] subunit of NF-B and Sp1 physically interact at the [TG] promoter.	RelA	FGF-10	0	UNDEFINED	False
10689	10864	20864529:3:ETS1:NPR1	The present study was conducted to examine the interactive roles of all-trans retinoic acid (ATRA), [TF], Sp1, and histone acetylation on the transcriptional regulation and function of the [TG] gene.	Ets-1	Npr1	0	UNDEFINED	False
10690	10865	20864529:5:ETS1:NPR1	As confirmed by gel shift and chromatin immunoprecipitation assays, ATRA enhanced the binding of both [TF] and Sp1 to the [TG] promoter.	Ets-1	Npr1	0	UNDEFINED	False
10691	10866	20864529:6:ETS1:NPR1	The retinoic acid receptor  (RAR) was recruited by [TF] and Sp1 to form a transcriptional activator complex with their binding sites in the [TG] promoter.	Ets-1	Npr1	1	ACTIVATION	False
10692	10867	20864529:7:ETS1:NPR1	Interestingly, ATRA also increased the acetylation of histones H3 and H4 and enhanced their recruitment to [TF] and Sp1 binding sites within the [TG] promoter.	Ets-1	Npr1	0	UNDEFINED	False
10693	10868	20868648:0:PARP1:PTGS2	Identification of [TF] as one of the transcription factors binding to the repressor element in the promoter region of [TG].	PARP-1	COX-2	2	REPRESSION	True
10694	10869	20868648:6:PARP1:PTGS2	Furthermore, overexpression of [TF] significantly inhibited promoter activity and decreased [TG] expression.	PARP-1	COX-2	2	REPRESSION	False
10695	10870	20868648:7:PARP1:PTGS2	Conversely, repression of [TF] by RNAi upregulated [TG] expression.	PARP-1	COX-2	2	REPRESSION	False
10696	10871	20868648:8:PARP1:PTGS2	These data suggest that [TF] plays an important role in the regulation of [TG] expression via binding to the inhibitory element.	PARP-1	COX-2	0	UNDEFINED	False
10697	10872	20876643:9:POU2F1:CDX2	We present evidence that [TG], which is expressed at high levels in trophoblast stem cells, is a direct transcriptional target of [TF].	Oct1	Cdx2	0	UNDEFINED	False
10698	10873	20877461:5:E2F1:RASSF1	We demonstrated that [TF] bound to the potential transcriptionally important CpG sites in [TG] gene of a normal lung cell line expressing RASSF1A transcripts, whereas loss of E2F1 binding to RASSF1A in A549 cancer cell line was the result of DNA methylation.	E2F1	RASSF1A	0	UNDEFINED	False
10699	10874	20878079:4:MYC:CDKN1A	Since [TF] is a potent transcriptional repressor of [TG], these findings suggest that c-Myc may negatively modulate p21 expression through an additional pathway except transcriptional suppression.	c-Myc	p21	2	REPRESSION	False
10700	10875	20878079:5:MYC:CDKN1A	In the study presented here, we compared [TG] mRNA in the nucleus and cytoplasm of [TF] stable transfectants with its control, which indicated further repression of p21 by c-Myc at the post-transcriptional level.	c-Myc	p21	2	REPRESSION	False
10701	10876	20878079:8:MYC:CDKN1A	These results suggest [TF] could further repress [TG] expression at the post-transcriptional level through some, but not all, members of miR-17 family.	c-Myc	p21	2	REPRESSION	False
10702	10877	20882567:7:SP1:MBP	Our results show that there is more [TF] binding to the [TG] promoter in differentiating OLs.	Sp1	MBP	0	UNDEFINED	False
10703	10878	20889500:0:TCF7L2:PMEPA1	Requirement of [TF] for TGF-beta-dependent transcriptional activation of the [TG] gene.	TCF7L2	TMEPAI	1	ACTIVATION	False
10704	10879	20890108:9:CREB1:S100P	RNA(i)-mediated knockdown of [TF] inhibits endogenous [TG] expression.	CREB	S100P	1	ACTIVATION	False
10705	10880	20922712:5:E2F1:PIN1	Transfection of [TF] caused transactivation of [TG], indicating control by E2F1/Rb pathways.	E2F1	Pin1	1	ACTIVATION	False
10706	10881	20922712:7:NFKB:CCND1	Overexpression also caused an increase in the stability of nuclear [TF], leading to enhancement of NF-B-mediated transactivation of the [TG] gene, in contrast to minimal inhibition of -catenin/TCF4 transcription activity.	p65	cyclin D1	1	ACTIVATION	False
10707	10883	20933505:3:EWSR1:CDKN1C	[TF]-Fli1 knockdown increased expression of genes such as DKK1 and [TG] that are known to be repressed by EWS-Fli1 fusion protein.	EWS	p57	2	REPRESSION	False
10708	10884	20933505:3:FLI1:CDKN1C	EWS-[TF] knockdown increased expression of genes such as DKK1 and [TG] that are known to be repressed by EWS-Fli1 fusion protein.	Fli1	p57	2	REPRESSION	False
10709	10885	20935193:4:NFKB:MUC5B	[TG] induction by these cytokines was both time- and dose-dependent, and was attenuated by the small molecule inhibitor, NF-B inhibitor III, as well as [TF] small interfering RNA, suggesting that the regulation of MUC5B expression by these cytokines is via an NF-B-based transcriptional mechanism.	p65	MUC5B	1	ACTIVATION	False
10710	10887	20935676:6:SP1:CDKN1A	Depending on the E1A conserved region 3, E1B-defective adenovirus impaired the ability of the transcription factor [TF] to bind the [TG] promoter.	Sp1	p21	0	UNDEFINED	False
10711	10889	20939893:6:STAT3:MMP7	Mutagenesis of three [TF] binding sites in [TG] promoter failed to repress the transactivation of MMP-7 promoter and silencing STAT3 expression was not effective in preventing isoproterenol-induced MMP-7 expression.	STAT3	MMP-7	1	ACTIVATION	False
10712	10890	20940258:6:MYOD1:CCND1	Chromatin immunoprecipitation analysis revealed that the CLP-1/[TF]/HDAC complex binds to the promoter of the [TG] gene, which is downregulated in differentiated muscle cells.	MyoD	cyclin D1	0	UNDEFINED	False
10713	10891	20940401:4:MYC:XRCC2	Chromatin immunoprecipitation studies showed that [TF] associates with several DSB repair gene promoters including Rad51, Rad51B, Rad51C, [TG], Rad50, BRCA1, BRCA2, DNA-PKcs, XRCC4, Ku70, and DNA ligase IV.	MYC	XRCC2	0	UNDEFINED	False
10714	10892	20943203:8:AP1:WNK4	In summary, these data document that E(2)/ER regulates h[TG] expression partly through [TF] binding to the hWNK4 promoter.	AP-1	WNK4	0	UNDEFINED	True
10715	10893	20943815:0:NR0B1:POU5F1	[TF] up-regulates [TG] expression in mouse embryonic stem cells via LRH-1 and SRA.	Dax1	Oct4	1	ACTIVATION	False
10716	10894	20943815:8:NR0B1:POU5F1	Chromatin immunoprecipitation localized [TF] to the [TG] promoter at the LRH-1 binding site, and luciferase assays together with Dax1 overexpression and knockdown experiments revealed that, rather than repress, Dax1 accentuated LRH-1-mediated activation of the Oct4 gene.	Dax1	Oct4	1	ACTIVATION	False
10717	10895	20943815:8:NR5A2:POU5F1	Chromatin immunoprecipitation localized Dax1 to the [TG] promoter at the [TF] binding site, and luciferase assays together with Dax1 overexpression and knockdown experiments revealed that, rather than repress, Dax1 accentuated LRH-1-mediated activation of the Oct4 gene.	LRH-1	Oct4	1	ACTIVATION	False
10718	10896	20946687:13:KLF4:PTGS2	Knockdown of [TF] resulted in decreased levels of the pro-inflammatory cytokines TNF-, MCP-1 and IL-6, along with a significant decrease in iNOS and [TG] expression.	Klf4	Cox-2	1	ACTIVATION	False
10719	10897	20946687:15:KLF4:PTGS2	We found that [TF] can potentially interact with pNF-B and is important for iNOS and [TG] promoter activity in vitro.	Klf4	Cox-2	1	ACTIVATION	False
10720	10898	20947822:10:TP53:EDN1	Conversely, overexpression of [TF] suppressed endothelial NO synthase and thrombomodulin expression and stimulated plasminogen activator inhibitor 1 and [TG] expression.	p53	endothelin-1	1	ACTIVATION	False
10722	10900	20958264:3:CREB1:HK2	Activation of PKA (cAMP-dependent protein kinase) by androgen increased phosphorylation of [TF] [CRE (cAMP-response element)-binding protein], which in turn bound to CRE on the promoter of the [TG] gene resulting in transcriptional activation of the HK2 gene.	CREB	HK2	1	ACTIVATION	False
10723	10901	20963645:0:SP1:MKI67	A critical role of [TF] transcription factor in regulating the human [TG] gene expression.	Sp1	Ki-67	0	UNDEFINED	False
10724	10902	20963645:10:SP1:MKI67	Our results suggest that [TF] is essential for basal promoter activity of the human [TG] gene.	Sp1	Ki-67	1	ACTIVATION	False
10725	10903	20963645:5:SP1:MKI67	Deletion mutagenesis and firefly luciferase reporter gene assay demonstrated the essential contribution of [TF] on transcriptional activation of the [TG] gene.	Sp1	Ki-67	1	ACTIVATION	False
10726	10904	20963645:7:SP1:MKI67	Two [TF] sites (one at position -159 to -145 nt and the other at position -14 to +12 nt) are mainly involved in transcriptional regulation of the [TG] gene.	Sp1	Ki-67	0	UNDEFINED	False
10727	10905	20963645:8:SP1:MKI67	Overexpression of [TF] can enhance the [TG] promoter activity.	Sp1	Ki-67	1	ACTIVATION	False
10728	10906	20965886:9:STAT3:UBE2G1	In [TF]-KO hearts Ube2i and [TG] expression were markedly reduced.	STAT3	Ube2g1	1	ACTIVATION	False
10729	10907	20971808:10:CEBPD:DDIT3	Furthermore, increased level of [TF] attenuates E2F1-induced cancer cell proliferation and partially rescues RB/E2F1-mediated repression of PPARG2 and [TG] transcription.	CEBPD	GADD153	1	ACTIVATION	False
10730	10908	20971808:10:E2F1:DDIT3	Furthermore, increased level of CEBPD attenuates [TF]-induced cancer cell proliferation and partially rescues RB/E2F1-mediated repression of PPARG2 and [TG] transcription.	E2F1	GADD153	2	REPRESSION	False
10731	10909	21029732:0:AP1:CCNA2	Regulation of Cyr61/[TG] expression by hypoxia through cooperation of c-Jun/[TF] and HIF-1 in retinal vascular endothelial cells.	AP-1	CCN1	0	UNDEFINED	False
10732	10910	21029732:0:AP1:CYR61	Regulation of [TG]/CCN1 expression by hypoxia through cooperation of c-Jun/[TF] and HIF-1 in retinal vascular endothelial cells.	AP-1	Cyr61	0	UNDEFINED	True
10734	10914	21037234:5:NFE2L2:HMOX1	AICAR also induced a significant rise in [TG] promoter activity that was abolished by mutating the antioxidant responsive elements of the HO-1 promoter or by the overexpression of dominant negative [TF].	Nrf2	HO-1	1	ACTIVATION	False
10735	10915	21037234:7:NFE2L2:HMOX1	In conclusion, AMPK stimulates [TG] gene expression in human ECs via the [TF]/antioxidant responsive element signaling pathway.	Nrf2	HO-1	1	ACTIVATION	False
10736	10916	21038417:0:STAT5A:CDKN1A	The transcription factors [TF] (STAT5A) and STAT5B negatively regulate cell proliferation through the activation of cyclin-dependent kinase inhibitor 2b (Cdkn2b) and [TG] expression.	signal transducer and activator of transcription 5A	Cdkn1a	1	ACTIVATION	False
10737	10917	21038417:0:STAT5B:CDKN1A	The transcription factors signal transducer and activator of transcription 5A (STAT5A) and [TF] negatively regulate cell proliferation through the activation of cyclin-dependent kinase inhibitor 2b (Cdkn2b) and [TG] expression.	STAT5B	Cdkn1a	1	ACTIVATION	False
10738	10918	21039465:2:STAT1:IFI30	The key factor involved in the regulation of [TG] expression upon cell stimulation with interferon- (IFN-) is [TF] (STAT1).	signal transducer and activator of transcription 1	GILT	0	UNDEFINED	False
10739	10919	21039465:3:STAT1:IFI30	In this study, we examined the role of [TF] in regulating the constitutive expression of [TG].	STAT1	GILT	0	UNDEFINED	False
10740	10920	21039465:4:STAT1:IFI30	We showed that [TF] interacts with the [TG] promoter, even in the absence of IFN-, and that STAT1 represses GILT expression.	STAT1	GILT	2	REPRESSION	False
10741	10921	21044622:8:JUN:PON1	The [TG] upstream region contained a consensus binding site for [TF], and the electrophoretic mobility shift assay and chromatin immunoprecipitation analysis indicated that the AP1 factors, especially c-Jun, bind to the upstream sequence of the PON1 promoter upon berberine treatment.	AP1	PON1	0	UNDEFINED	False
10742	10922	21044962:6:SNAI2:CCND1	Knockdown of UbcH5c in the [TF]-deficient human breast cells elevated the level of [TG] as well as the rates of proliferation and invasiveness of these cells.	SLUG	cyclin D1	2	REPRESSION	False
10743	10923	21051540:3:POU2F1:CDX2	Using purified murine T cells and the Il2 target locus, and a colon cancer cell line and the [TG] target locus, we show that [TF] recruits the NuRD chromatin-remodeling complex to promote a repressed state, but in a regulated manner can switch to a different capacity and mediate Jmjd1a recruitment to block repression.	Oct1	Cdx2	2	REPRESSION	True
10744	10926	2106065:0:NFKB:AGT	An inducible 50-kilodalton [TF]-like protein and a constitutive protein both bind the acute-phase response element of the [TG] gene.	NF kappa B	angiotensinogen	0	UNDEFINED	False
10745	10927	21060808:6:POU2F1:RPTOR	Using expression quantification, chromatin immunoprecipitation (ChIP), and reporter gene assays, we demonstrate that [TF] and RARA do bind upstream of the [TG] gene to regulate its expression in response to retinoids; this regulation is affected by the allele status at rs11868112 with the derived allele resulting in lower expression levels.	POU2F1	RPTOR	0	UNDEFINED	False
10746	10928	21069809:8:AP1:IL6	Deletion analysis of the [TG] promoter indicated that activator protein-1 ([TF]), nuclear factor for IL-6 (NF-IL-6) and nuclear factor B (NF-B) binding sites were important for gAd-induced IL-6 transcription.	AP-1	IL-6	1	ACTIVATION	False
10747	10929	21076612:8:SP1:PLAU	[TG] promoter deletion analysis indicated that the promoter proximal [TF] sites were required for GATA6 activation of the uPA promoter.	Sp1	uPA	1	ACTIVATION	False
10748	10930	21076612:9:SP1:PLAU	Accordingly, GATA6 physically associated with [TF] and siRNA knockdown of Sp1 decreased GATA6 activation of the [TG] promoter activity suggesting that Sp1 recruits GATA6 to the uPA promoter and mediates GATA6 induced activation of the uPA promoter activity.	Sp1	uPA	1	ACTIVATION	False
10749	10931	21081708:7:NR0B2:PDK4	After the gene is upregulated, [TF] can feed back and repress FoxO1- and Sirt1-activated G6pc and [TG] gene expression.	Nr0b2	Pdk4	2	REPRESSION	False
10750	10932	21084835:0:TFAP2A:CDKN1A	Dual association by [TF] during activation of the p21cip/[TG] promoter.	TFAP2A	CDKN1A	1	ACTIVATION	False
10751	10933	21084835:8:TFAP2A:CDKN1A	This pattern of promoter interaction by [TF] is distinct from that seen for the TFAP2C family member which represses [TG] expression.	TFAP2A	CDKN1A	0	UNDEFINED	True
10753	10935	21088000:2:VDR:CDKN1A	[TF] dynamically induced individual histone modification patterns at three VDR binding sites (R1, 2, 3) on the [TG] promoter.	VDR	CDKN1A	0	UNDEFINED	False
10754	10936	21088000:6:VDR:MCM7	In parallel, [TF] binding to the [TG] gene induced H3K9ac enrichment associated with rapid mRNA up-regulation to generate miR-106b and consequently regulate p21((waf1/cip1)) expression.	VDR	MCM7	0	UNDEFINED	False
10756	10938	21093383:4:TP63:CDKN1A	Although expression of [TF] and its positively regulated basal cell targets is maintained in Hdac1/2-deficient ectoderm, targets of p63-mediated repression, including [TG], 14-3-3, and p16/INK4a, are ectopically expressed, and HDACs bind and are active at their promoter regions in normal undifferentiated keratinocytes.	p63	p21	2	REPRESSION	False
10757	10939	21093383:4:TP63:CDKN2A	Although expression of [TF] and its positively regulated basal cell targets is maintained in Hdac1/2-deficient ectoderm, targets of p63-mediated repression, including p21, 14-3-3, and p16/[TG], are ectopically expressed, and HDACs bind and are active at their promoter regions in normal undifferentiated keratinocytes.	p63	INK4a	2	REPRESSION	False
10758	10940	21094641:0:STAT3:SOX6	[TF] is essential for neuronal differentiation through direct transcriptional regulation of the [TG] gene.	Stat3	Sox6	0	UNDEFINED	False
10759	10941	21094641:3:STAT3:SOX6	We demonstrate that in response to ligand stimulation, [TF] binds to the [TG] promoter and induces its expression.	Stat3	Sox6	1	ACTIVATION	False
10760	10942	21097520:7:NFE2L2:NQO1	ChIP and real-time PCR assays revealed that FynY213A mutant caused decreased binding of [TF] to the promoter of defensive gene NAD(P)H:quinone oxidoreductase 1 ([TG]) and decreased NQO1 expression by 5-fold (P<0.0001) compared to wild-type Fyn.	Nrf2	NQO1	0	UNDEFINED	True
10761	10943	21098664:7:STAT3:SOCS3	We conclude that the lysine methylation of promoter-bound [TF] leads to biologically important down-regulation of the dependent responses and that SET9, which is known to help provide an activating methylation mark to H3K4, is recruited to the newly activated [TG] promoter by STAT3.	STAT3	SOCS3	1	ACTIVATION	True
10762	10944	21104068:2:ALX3:INS	In previous studies we determined that aristaless-like homeobox 3 ([TF]) is produced in islet cells, binds to the promoter of the [TG] gene and regulates its expression.	ALX3	insulin	0	UNDEFINED	False
10763	10945	21104991:5:AHR:IL6	The current study provides evidence that several head and neck squamous cell carcinoma cell lines have a level of constitutively bound [TF] at the [TG] promoter, allowing for higher basal and readily inducible IL6 transcription.	AHR	IL6	1	ACTIVATION	False
10764	10946	21106530:7:JUN:BRF1	Induction of TBP, [TG], and RNA pol III-dependent gene expression is driven by enhanced [TF] expression.	c-Jun	Brf1	1	ACTIVATION	False
10765	10947	21106530:8:JUN:BRF1	Ethanol promotes a marked increase in the direct recruitment of [TF] to TBP, [TG], and tRNA gene promoters.	c-Jun	Brf1	0	UNDEFINED	False
10766	10948	21115498:0:SP1:VEGFA	Heme oxygenase-1/carbon monoxide induces [TG] expression via p38 kinase-dependent activation of [TF].	Sp1	vascular endothelial growth factor	1	ACTIVATION	False
10767	10949	21115498:6:SP1:VEGFA	[TG] promoter-luciferase reporter assays, electrophoretic mobility shift assays, supershift assay, and chromatin immunoprecipitation showed that CO-induced VEGF promoter activation requires the binding of the [TF] transcriptional factor to a cis-regulatory sequence located at the VEGF promoter.	Sp1	VEGF	1	ACTIVATION	False
10768	10950	21115498:8:SP1:VEGFA	Overexpression of [TF] protein with an alanine mutation at Thr-453 or Thr-739 suppressed CO-induced Sp1 binding to the [TG] promoter and its transcriptional activation.	Sp1	VEGF	1	ACTIVATION	False
10769	10951	21123297:5:VDR:DDIT4	Chromatin immunoprecipitation PCR using 1,25(OH)(2)D(3)-treated osteoblasts confirmed that [TF] and VDRE-BP compete for binding to the [TG] gene promoter.	VDR	DDIT4	0	UNDEFINED	False
10770	10952	21126317:0:TTF1:MUC5B	The mouse [TG] mucin gene is transcriptionally regulated by thyroid transcription factor-1 ([TF]) and GATA-6 transcription factors.	TTF-1	Muc5b	0	UNDEFINED	False
10771	10953	21126317:8:GATA4:MUC5B	By RT-PCR, co-transfection studies and gel-shift assays, we show that [TG] promoter activity is completely inhibited by TTF-1, whereas factors of the GATA family ([TF]/GATA-5/GATA-6) are activators.	GATA-4	Muc5b	1	ACTIVATION	False
10772	10954	21126317:8:GATA6:MUC5B	By RT-PCR, co-transfection studies and gel-shift assays, we show that [TG] promoter activity is completely inhibited by TTF-1, whereas factors of the GATA family (GATA-4/GATA-5/[TF]) are activators.	GATA-6	Muc5b	1	ACTIVATION	False
10773	10955	21126317:9:GATA6:MUC5B	Together, these results demonstrate, for the first time, that [TG] is a target gene of transcription factors (TTF-1, [TF]) involved in lung differentiation programs during development and carcinogenesis, and identify TTF-1 as a strong repressor of Muc5b.	GATA-6	Muc5b	0	UNDEFINED	False
10774	10956	21126317:9:TTF1:MUC5B	Together, these results demonstrate, for the first time, that [TG] is a target gene of transcription factors ([TF], GATA-6) involved in lung differentiation programs during development and carcinogenesis, and identify TTF-1 as a strong repressor of Muc5b.	TTF-1	Muc5b	0	UNDEFINED	True
10775	10957	21134476:8:TFAP2A:CXCL1	We identified three potential AP-2 binding sites within the [TG] promoter and performed luciferase assays, indicating that an [TF] (AP-2.2) ranging from position -135 to -144 bp relative to the translation start is responsive to AP-2.	AP-2 binding motif	CXCL1	0	UNDEFINED	False
10776	10958	21135252:0:AP1:CCND1	[TF] regulates [TG] and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation.	AP-1	cyclin D1	0	UNDEFINED	True
10777	10959	21138961:7:MTF1:CDC25C	[TF] overexpression can cause cytoplasmic accumulation of [TG].	Mtf1	Cdc25	1	ACTIVATION	False
10778	10960	21147283:9:USF1:NR0B2	Moreover, upstream stimulatory factor-1 ([TF]) specifically mediated metformin-induced [TG] gene expression.	USF-1	SHP	1	ACTIVATION	False
10779	10961	21148792:6:AP1:TSLP	Interestingly, TNF- induced the [TG] promoter activity (P < 0.05; n = 4) in HASM that was mediated by upstream NF-B and activator protein-1 ([TF]) binding sites.	AP-1	TSLP	1	ACTIVATION	False
10780	10962	21148801:3:ETS1:IL7R	In this study, we report that the transcription factor [TF] is required for maintaining the expression of [TG] in murine peripheral T cells.	Ets-1	CD127	1	ACTIVATION	False
10782	10964	21148801:8:ETS1:IL7R	Taken together, our data identify [TF] as a critical regulator of [TG] expression in T cells.	Ets-1	CD127	0	UNDEFINED	False
10783	10965	21150337:3:DDIT3:PTGS2	Using the endogenous ChIP analysis, we further found that the C/EBP, NF-kB, NF-Y ([TF]), PEA3 (ETS), and Np63 proteins bound to the specific area (-550 to -130) of the [TG] promoter, while forming multiple protein complexes in lung cancer cells exposed to MSE and SSE.	CHOP	COX-2	0	UNDEFINED	False
10784	10966	21150337:3:NFKB:PTGS2	Using the endogenous ChIP analysis, we further found that the C/EBP, [TF], NF-Y (CHOP), PEA3 (ETS), and Np63 proteins bound to the specific area (-550 to -130) of the [TG] promoter, while forming multiple protein complexes in lung cancer cells exposed to MSE and SSE.	NF-kB	COX-2	0	UNDEFINED	False
10785	10967	21152300:7:AP1:TLR10	We screened the [TG] promoter and found putative binding sites for transcription factors (TFs), such as NF-B, NF-AT and [TF].	AP-1	TLR10	0	UNDEFINED	False
10786	10968	21156794:0:MTA1:TGM2	[TF] coregulation of [TG] expression and function during inflammatory response.	MTA1	transglutaminase 2	0	UNDEFINED	False
10787	10969	21159964:4:ATF4:BBC3	[TG] is known to be a key transcriptional target of p53, but we have found that ER stress triggers PUMA induction and cell death through a p53-independent mechanism mediated by the ER-stress-inducible transcription factor ATF4 ([TF]).	activating transcription factor 4	PUMA	1	ACTIVATION	False
10788	10970	21159964:5:ATF4:BBC3	Specifically, we demonstrate that ectopic expression of [TF] sensitizes mouse cortical neurons to ER-stress-induced apoptosis and that ATF4-deficient neurons exhibit markedly reduced levels of [TG] expression and cell death.	ATF4	PUMA	1	ACTIVATION	False
10789	10971	21159964:7:DDIT3:BBC3	Rather, we found that ATF4 induces expression of the transcription factor [TF] (C/EBP homologous protein) and that CHOP in turn activates [TG] induction.	CHOP	PUMA	1	ACTIVATION	False
10790	10972	21159964:8:DDIT3:BBC3	Specifically, we demonstrate that [TF] binds to the [TG] promoter during ER stress and that CHOP knockdown attenuates PUMA induction and neuronal apoptosis.	CHOP	PUMA	1	ACTIVATION	False
10791	10973	21163886:10:STAT3:CCND1	Furthermore, overexpression of constitutively active [TF] imparted significant protection against BITC-mediated inhibition of [TG] transactivation, whereas RNA interference of Stat3 resulted in a significant increase in BITC-mediated inhibition of cyclin D1 transactivation in the presence of leptin.	Stat3	cyclin D1	1	ACTIVATION	True
10792	10974	21163886:9:STAT3:CCND1	The BITC treatment efficiently inhibited [TF] and SRC1 recruitment to [TG] promoter in a chromatin immunoprecipitation analysis.	Stat3	cyclin D1	0	UNDEFINED	False
10793	10975	21167754:3:FOXO1:CTLA4	The loss of function included diminished CTLA-4 receptor expression as the [TG] gene was a direct target of [TF].	Foxo1	Ctla4	0	UNDEFINED	False
10794	10976	21170267:0:AR:TFF3	ERG cooperates with [TF] in regulating [TG] in prostate cancer disease progression.	androgen receptor	trefoil factor 3	0	UNDEFINED	False
10795	10977	21170267:3:ERG:TFF3	Conventional chromatin immunoprecipitation (ChIP)-polymerase chain reaction and ChIP followed by DNA sequencing (ChIP-seq) revealed direct binding of [TF] to ETS binding sites in the [TG] promoter in ERG-rearranged prostate cancer cell lines.	ERG	TFF3	0	UNDEFINED	False
10796	10978	21184768:5:SP1:CDKN1A	Stat3 activity as a coactivator of PR was observed in both the classical and nonclassical ligand activated-PR transcriptional mechanisms, since the effects described were identified in the bcl-X promoter which contains a progesterone responsive element and in the p21([TG]) promoter which carries [TF] binding sites where PR is recruited via the transcription factor Sp1.	Sp1	CIP1	0	UNDEFINED	False
10797	10979	21185807:2:FOXO1:SEPP1	In addition to these biological functions, [TF] is a key player in the oxidative stress response by stimulating the expression of metal-containing anti-oxidant proteins such as manganese superoxide dismutase, [TG], and catalase.	FOXO1	selenoprotein P	1	ACTIVATION	False
10798	10980	21185807:3:FOXO1:CP	Evidence in the literature suggests that [TF] may also be capable of regulating the expression of the anti-oxidant protein [TG] (Cp), a six-copper-containing protein synthesized and secreted mainly by the liver.	FOXO1	Ceruloplasmin	0	UNDEFINED	False
10799	10981	21192937:4:MLX:TXNIP	Hypoxia caused reduced binding of the glucose responsive MondoA:[TF] transcription factor to the carbohydrate response elements (ChoREs) in the [TG] promoter.	Mlx	Txnip	0	UNDEFINED	False
10800	10983	21199807:7:RBPJ:PLAU	Through mutational analysis we identified a [TF] site in the [TG] promoter that is required for direct transcriptional regulation by Notch.	CBF-1 binding	uPA	0	UNDEFINED	False
10801	10984	21203563:6:ATF2:TRIB3	Using transient transfection and chromatin immunoprecipitation approaches in hepatoma cells, we report the characterization of a functional Amino Acid Response Element (AARE) in the [TG] promoter and the binding of ATF4, [TF] and C/EBP to this AARE sequence.	ATF2	TRB3	0	UNDEFINED	False
10802	10985	21212137:6:NFIL3:AREG	Overexpression of [TF] in granulosa cells inhibited the induction of prostaglandin-endoperoxide synthase 2 (Ptgs2), progesterone receptor (Pgr), epiregulin (Ereg), and [TG] (Areg) and down-regulated levels of prostaglandin E2.	NFIL3	amphiregulin	2	REPRESSION	False
10803	10986	21212137:6:NFIL3:EREG	Overexpression of [TF] in granulosa cells inhibited the induction of prostaglandin-endoperoxide synthase 2 (Ptgs2), progesterone receptor (Pgr), [TG] (Ereg), and amphiregulin (Areg) and down-regulated levels of prostaglandin E2.	NFIL3	epiregulin	2	REPRESSION	False
10804	10987	21219856:0:MYC:TP53INP1	[TF] inhibits [TG] expression via promoter methylation in esophageal carcinoma.	c-Myc	TP53INP1	2	REPRESSION	False
10805	10988	21220691:4:IRF1:TLR3	In this study, we show that IRF-8 negatively controls [TG] gene expression by suppressing [TF]- and/or polyinosinic-polycytidylic acid-stimulated TLR3 expression in primary human monocyte-derived DCs (MDDCs).	IRF-1	TLR3	1	ACTIVATION	False
10806	10989	21220691:6:IRF1:TLR3	We found that both [TF] and IRF-8 bind the human [TG] promoter during MDDC differentiation in vitro and in vivo but with different kinetic and functional effects.	IRF-1	TLR3	0	UNDEFINED	False
10807	10990	21220691:8:IRF1:TLR3	Indeed, Src homology 2 domain-containing protein tyrosine phosphatase-dephosphorylated IRF-8 bound to the human [TG] promoter competing with [TF] and quashing its activity by recruitment of histone deacetylase 3.	IRF-1	TLR3	1	ACTIVATION	False
10809	10992	21239258:3:FOS:EDN1	Transcriptional regulation of the [TG] gene depends upon the cis-acting elements of the ET-1 promoter and their interaction with the protooncogene products [TF] and Jun as well as other DNA-binding proteins.	Fos	ET-1	0	UNDEFINED	True
10810	10993	21244365:7:ATF4:PTGS2	We confirmed that [TF] binding to the [TG] promoter plays a critical role in HBx-mediated COX2 induction.	ATF4	COX2	1	ACTIVATION	False
10811	10994	21244711:9:ETS2:MMP1	Chromatin immunoprecipitation (ChIP) experiments indicated that the transcription factors (TFs) ETS1, [TF] and GATA3, bind to the [TG] promoter in the region of this polymorphism and may contribute to the bimodal expression.	ETS2	MMP1	0	UNDEFINED	True
10812	10995	21252292:10:NFYB:TOP2A	We thus hypothesized that hsa-miR-485-3p mediates drug responsiveness by decreasing [TF] expression, which in turn negatively regulates [TG] expression.	NF-YB	Top2	1	ACTIVATION	True
10813	10996	21252292:11:NFYB:TOP2A	To test this, we overexpressed miR-485-3p in CEM/VM-1-5 cells and found that this led to reduced expression of [TF], a corresponding up-regulation of [TG], and increased sensitivity to the Top2 inhibitors.	NF-YB	Top2	2	REPRESSION	False
10814	10997	21252292:2:NFYB:TOP2A	Our previous work suggested that [TF] may be a mediator of topoisomerase II ([TG]), working through the Top2 promoter.	NF-YB	Top2	0	UNDEFINED	True
10815	10998	21255642:7:POU2F1:CAPN6	Transcription factor binding sites in the [TG] promoter were mutated and the results showed that AP1, [TF], and FoxD3 were the critical transcription factors in regulation of CAPN6 expression.	Oct-1	CAPN6	0	UNDEFINED	False
10816	10999	21257751:4:ELK1:EGR1	Expression of a dominant-negative mutant of [TF], a key regulator of gene transcription driven by a serum response element, attenuated [TG] expression following stimulation, indicating that Elk-1 or related ternary complex factors connect the transcription of the Egr-1 gene with the pregnenolone sulfate-induced intracellular signaling cascade elicited by the initial influx of Ca(2+).	Elk-1	Egr-1	1	ACTIVATION	False
10817	11000	21257751:5:EGR1:CHGB	The newly synthesized [TF] was biologically active and bound under physiological conditions to the regulatory regions of the Pdx-1, Synapsin I, and [TG] genes.	Egr-1	Chromogranin B	0	UNDEFINED	False
10818	11001	21261996:8:MYB:CXCR4	We studied one target gene, [TG], in detail, showing that [TF] associated with the CXCR4 gene promoter and activated a CXCR4 reporter gene in transfection assays.	c-Myb	CXCR4	1	ACTIVATION	False
10819	11002	21268011:10:STAT3:CD274	Those findings indicate a pivotal role of [TF] in regulating [TG] expression.	STAT-3	PD-L1	0	UNDEFINED	True
10820	11003	21268011:7:STAT3:CD274	[TG] expression was regulated in a MAPK/cytokine/[TF]-dependent manner: high levels of IL-6 and IL-10 that signal via STAT-3 were produced by TLR-APCs.	STAT-3	PD-L1	0	UNDEFINED	False
10821	11004	21268011:9:STAT3:CD274	Moreover, chromatin immunoprecipitation revealed direct binding of [TF] to the [TG] promoter.	STAT-3	PD-L1	0	UNDEFINED	False
10822	11005	21277289:14:NFE2L2:AKR1B10	These results suggest that [TF] is one of the major factors involved in the [TG] gene regulation.	Nrf2	AKR1B10	0	UNDEFINED	False
10823	11006	21281810:8:NFE2:ABCC6	We studied the transcriptional regulation of the [TG] gene in wild-type and Hbb(th3/+) mice, and we identified the erythroid transcription factor [TF] as the main cause of the transcriptional down-regulation using transcription factor arrays and chromatin immunoprecipitation.	NF-E2	Abcc6	2	REPRESSION	False
10824	11007	21284604:8:PGR:PLD1	Next, to investigate the regulator of the [TG] gene at the transcriptional level, a promoter assay using deletion mutants of the PLD1 promoter was performed; the result indicated that PR ([TF]) was a possible regulator of the PLD1 gene.	progesterone receptor	PLD1	0	UNDEFINED	False
10825	11008	21296878:6:FOXO1:HYOU1	[TF] (FOXO1) was identified as the critical transcription factor regulating [TG] expression because silencing FOXO1 expression prevented the induction of ORP150 expression by AMPK.	Forkhead box O1	ORP150	1	ACTIVATION	False
10826	11009	21296878:7:FOXO1:HYOU1	In contrast, overexpression of [TF]-ADA promoted [TG] expression in hepatocytes.	FOXO1	ORP150	1	ACTIVATION	False
10827	11010	21296878:8:FOXO1:HYOU1	[TF] bound directly to the [TG] promoter, which was enhanced in the presence of AICAR.	FOXO1	ORP150	0	UNDEFINED	False
10828	11011	21300803:6:ATF3:SLC11A1	RNAi-mediated depletion of [TF] or BRG1 markedly decreased [TG] gene expression and its promoter activity induced by PMA.	ATF-3	SLC11A1	1	ACTIVATION	False
10829	11012	21304052:6:CTCF:CDKN1C	Transient depletion of [TF] by small interfering RNA increased [TG] expression and significantly reduced the estrogen-mediated repression of CDKN1C.	CTCF	CDKN1C	2	REPRESSION	False
10830	11013	21304988:9:ATF3:WNT7B	In vitro knockdown of [TF] expression results in significant decreases in expression of [TG], Tcf7, Snai2 and Jun, suggesting that these genes may be direct transcriptional targets of ATF3 protein.	Atf3	Wnt7b	1	ACTIVATION	False
10831	11014	21308742:9:YBX1:BMP7	These studies identify [TF] as a transcriptional activator of [TG] and helps to explain the progressive decline in renal BMP7 in diabetic nephropathy and other kidney diseases.	YB1	BMP7	1	ACTIVATION	False
10832	11015	21311680:7:E2F4:CDKN1A	Moreover, decreased (cyclin A) and increased ([TG] and p27) expression of these [TF] downstream genes by curcumin was restored by pretreatment of cells with NAC and E2F4 overexpression which is induced by doxycycline.	E2F4	p21	1	ACTIVATION	True
10833	11016	21311948:3:SP1:CDKN1A	Our results showed that the transcriptional activation of [TG] by SP600125 is mediated through the proximal regions of multiple [TF] sites in the p21 promoter following ERK-dependent phosphorylation of Sp1.	Sp1	p21	1	ACTIVATION	False
10834	11017	21325288:9:SP1:CDKN1A	DDX3 deregulation by the E6-inactivated p53 pathway could promote cell proliferation and the ability to form colonies via reduced [TF] binding activity on the [TG] promoter.	Sp1	p21	0	UNDEFINED	False
10835	11018	21325822:2:TP53:VEGFA	In this study, we attempted to characterize the mechanism by which [TF] activity negatively regulates PAF-induced [TG] expression.	p53	VEGF	2	REPRESSION	False
10836	11019	21336277:5:CTCF:SYT8	[TG]-INS interaction and SYT8 transcription are attenuated by [TF] depletion.	CTCF	SYT8	1	ACTIVATION	True
10837	11020	21344396:7:TP53:LRP1	Furthermore, coimmunoprecipitation and chromatin immunoprecipitation showed [TF] could bind to the Y-box of the [TG] promoter through interaction of p53 with YB-1.	p53	LRP	0	UNDEFINED	False
10838	11021	21354136:10:STAT3:ICAM1	Trans-Chalcone also blocked ischemia-induced VEGF and [TG] expression and this effect correlated with inhibition of activated [TF] and NF-B.	STAT3	ICAM-1	1	ACTIVATION	False
10839	11022	21354245:2:EGR1:GDNF	The present study explored [TF] (EGR-1) transcriptional regulation of imipramine-induced glial cell line-derived neurotrophic factor ([TG]) expression in astrocytes.	early growth response 1	GDNF	0	UNDEFINED	False
10840	11023	21354245:3:EGR1:GDNF	After we observed the induction of [TG] mRNA expression in rat astrocytes in response to imipramine, deletion mutant studies showed that the proximal region between -493 and -114 of the GDNF promoter, which contains three binding sites for [TF], was essential for maximal imipramine-induced activation of GDNF promoter.	EGR-1	GDNF	1	ACTIVATION	False
10841	11024	21354245:4:EGR1:GDNF	The dose-dependent upregulation of [TF] by imipramine, the activation of [TG] by the over-expression of EGR-1 without imipramine and the reduction in the imipramine-induced GDNF mRNA expression after silencing of endogenous EGR-1 demonstrated that EGR-1 is upregulated by imipramine to activate the GDNF promoter.	EGR-1	GDNF	1	ACTIVATION	False
10842	11025	21362474:8:ELK1:SMN1	We have further identified the survival-of-motor neuron-1 ([TG]) gene as a novel target of [TF], and show that the ets motifs in the SMN1 promoter are involved in this regulation.	Elk-1	SMN1	0	UNDEFINED	False
10843	11026	21362508:7:SALL2:CDKN1A	[TF], a known activator of the CDK inhibitor p21(Cip1/[TG]) (p21), binds to regions of the human p21 promoter that contain variations of the consensus sequence in multiple copies.	p150(Sal2)	Waf1	1	ACTIVATION	False
10844	11027	21367864:0:AP1:RGS4	Selective genomic targeting by [TF]/FOSL2 transcription factor: regulation of the [TG] gene is mediated by a variant activator protein 1 (AP-1) promoter sequence/CREB-binding protein (CBP) mechanism.	FRA-2	Rgs4	0	UNDEFINED	False
10845	11028	21371435:0:JUNB:FOXP3	[TF] and c-Rel cooperatively enhance [TG] expression during induced regulatory T cell differentiation.	JunB	Foxp3	1	ACTIVATION	False
10846	11029	21371435:0:REL:FOXP3	JunB and [TF] cooperatively enhance [TG] expression during induced regulatory T cell differentiation.	c-Rel	Foxp3	1	ACTIVATION	False
10847	11030	21371435:5:JUNB:FOXP3	Under this condition, stimulation-dependent recruitment of [TF] together with c-Rel enhanced [TG] expression.	JunB	Foxp3	1	ACTIVATION	False
10848	11031	21371435:7:JUNB:FOXP3	Collectively our results suggest that TCR signaling together with TGF-/IL-2 stimulation cooperatively enhance [TG] gene expression by maintaining accessible chromatin structure and by actively recruiting key transcription factors [TF] and c-Rel.	JunB	Foxp3	1	ACTIVATION	False
10849	11032	21371435:7:REL:FOXP3	Collectively our results suggest that TCR signaling together with TGF-/IL-2 stimulation cooperatively enhance [TG] gene expression by maintaining accessible chromatin structure and by actively recruiting key transcription factors JunB and [TF].	c-Rel	Foxp3	1	ACTIVATION	False
10850	11033	21372379:5:ZEB1:FXYD3	In addition, expression level of [TG] mRNA was up-regulated by the silencing of [TF]/EF1 transcriptional repressor which was a down-stream target gene of TGF- and an inducer of EMT.	ZEB1	FXYD3	2	REPRESSION	False
10851	11034	21383775:5:KLF5:CDKN1A	Here, we show that, under basal conditions, RAR forms a complex with histone deacetylase 2 (HDAC2) and Krppel-like factor 5 ([TF]) at the [TG] promoter to inhibit its expression.	Klf5	p21	2	REPRESSION	False
10852	11035	21383775:9:KLF5:CDKN1A	Interference with HDAC2 phosphorylation by either CK2 knockdown or the use of phosphorylation-deficient mutant of HDAC2 prevents the dissociation of [TF] from the [TG] promoter and impairs RAR agonist-induced p21 activation.	Klf5	p21	2	REPRESSION	True
10853	11036	21393444:7:SMAD4:POR	Cotransfection of vectors for these transcription factors and [TG] promoter-reporter constructs into both cell types followed by hormonal treatment showed that T(3) exerts major tropic effects via TR, with TR, estrogen receptor-, Smad3, and [TF] exerting lesser, modulatory effects.	Smad4	POR	0	UNDEFINED	False
10854	11040	21402709:13:SMAD3:MYOCD	Moreover, [TF] inhibited Nkx2.5-activated [TG] promoter activity in a dose-dependent manner.	Smad3	Myocd	2	REPRESSION	False
10855	11041	21402709:14:SMAD3:MYOCD	Taken together, our results reveal a novel mechanism for [TF]-mediated inhibition of [TG] in the initiation phase of SMC differentiation.	Smad3	Myocd	2	REPRESSION	False
10856	11042	21402709:7:SMAD3:MYOCD	Overexpression of [TF], but not Smad2, inhibited [TG] promoter activity.	Smad3	Myocd	2	REPRESSION	False
10857	11043	21402709:8:SMAD3:MYOCD	Conversely, shRNA knockdown of [TF] allowed TGF- to activate the [TG] promoter in the initial phase of induction.	Smad3	Myocd	2	REPRESSION	False
10858	11044	21406062:10:YY1:MAT2A	[TF] represses [TG] expression.	YY1	MAT2A	2	REPRESSION	False
10859	11045	21408158:8:NR1D1:NUPR1	Several genes co-targeted by NR2E3 and [TF] were identified that include: Nr2c1, Recoverin, Rgr, Rarres2, Pde8a, and [TG].	NR1D1	Nupr1	0	UNDEFINED	False
10860	11046	21408158:8:NR1D1:RARRES2	Several genes co-targeted by NR2E3 and [TF] were identified that include: Nr2c1, Recoverin, Rgr, [TG], Pde8a, and Nupr1.	NR1D1	Rarres2	0	UNDEFINED	False
10861	11047	21408158:8:NR2E3:NUPR1	Several genes co-targeted by [TF] and NR1D1 were identified that include: Nr2c1, Recoverin, Rgr, Rarres2, Pde8a, and [TG].	NR2E3	Nupr1	0	UNDEFINED	False
10862	11048	21408158:8:NR2E3:RARRES2	Several genes co-targeted by [TF] and NR1D1 were identified that include: Nr2c1, Recoverin, Rgr, [TG], Pde8a, and Nupr1.	NR2E3	Rarres2	0	UNDEFINED	False
10863	11049	21410405:0:STAT3:MMP1	[TF] controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the [TG] promoter.	STAT3	MMP-1	0	UNDEFINED	False
10864	11050	21411560:0:SP1:HSD11B2	The [TF] transcription factor is crucial for the expression of [TG] in human placental trophoblasts.	Sp1	11beta-hydroxysteroid dehydrogenase type 2	1	ACTIVATION	False
10865	11051	21421043:10:ATF3:TREM1	5. We found using binding site prediction and ChIP assays that the TFs EGR3 and [TF] indeed bound to the [TG] promoter, PU.1 bound to both the TREM-1 and DAP12 promoter.	ATF3	TREM-1	0	UNDEFINED	True
10866	11052	21421043:11:ATF3:TREM1	In this study, we provide evidence that [TG] gene expression is significantly increased in monocytes of SCZ and BD patients and that the TREM-1 gene is a target gene of the TFs [TF] and EGR3.	ATF3	TREM-1	0	UNDEFINED	False
10867	11053	21423212:6:FOXO1:NOV	Promoter, electrophoretic mobility shift assay and chromatin immunoprecipitation analyses confirmed that the [TG] gene was a direct target for PAX3-[TF] transcriptional activation through a paired-domain DNA sequence in the first intron of the CCN3 gene.	FKHR	CCN3	1	ACTIVATION	False
10868	11054	21425416:6:ETV2:TEK	Moreover, [TF] was shown to be required for [TG] expression, which contributes to HSC maintenance.	Er71	Tie2	1	ACTIVATION	False
10869	11055	21428455:1:HOXB9:REN	Homeobox gene [TF] is a critical player in development of mammary gland and sternum and in regulation of [TG] which is closely linked with blood pressure control.	HOXB9	renin	0	UNDEFINED	False
10870	11056	21436258:7:SP1:SERPINE2	Serpinin and a cAMP analog, 8-bromo-cAMP, promoted the translocation of the transcription factor [TF] into the nucleus, which is known to drive [TG] expression.	Sp1	PN-1	1	ACTIVATION	False
10871	11057	21445336:0:SMAD7:GAST	IL1B induced [TF] negatively regulates [TG] expression.	Smad 7	gastrin	2	REPRESSION	False
10872	11058	21445336:12:SMAD7:GAST	Pro-inflammatory cytokine IL1B repress [TG] expression by activating [TF] and subsequent inhibition of nuclear localization of Smad 3/4 complex.	Smad 7	gastrin	2	REPRESSION	False
10873	11059	21445336:13:SMAD7:GAST	Polymorphic promoter variants of IL1B gene can modulate the IL1B expression which resulted in differential activation [TF] and consequent repression of [TG] expression, respectively.	Smad 7	gastrin	2	REPRESSION	False
10874	11060	21445336:5:SMAD7:GAST	[TF] resulted in transcriptional repression of [TG] promoter by about 6.5 fold when co-transfected with Smad 7 expression vector and gastrin-promoter luciferase in AGS cells.	Smad 7	gastrin	2	REPRESSION	False
10875	11061	21445336:9:SMAD7:GAST	This differential activation of [TF] by IL1B promoter variants translated into differential downregulation of [TG] expression.	Smad 7	gastrin	2	REPRESSION	False
10878	11064	21453717:10:E2F1:SLC11A1	These results indicate that [TF] plays a crucial role in transcriptional control of the human [TG] gene and the decrease of Lsh expression in senescent cells is related to the repression of E2F1.	E2F1	Lsh	0	UNDEFINED	True
10879	11065	21453717:6:E2F1:SLC11A1	Ectopic [TF] increases expression of [TG] at both transcriptional and translational levels.	E2F1	Lsh	1	ACTIVATION	False
10880	11066	21453717:7:E2F1:SLC11A1	[TF] physically interacts with the [TG] promoter by binding to each of the two putative binding sites and transactivates the Lsh promoter.	E2F1	Lsh	1	ACTIVATION	False
10881	11067	21454593:0:CEBPA:IL4	[TF] (C/EBPalpha) is critical for [TG] expression in response to FcepsilonRI receptor cross-linking.	CCAAT/enhancer-binding protein alpha	interleukin-4	1	ACTIVATION	False
10882	11068	21459093:3:NR0B2:DNMT1	The induction of [TG] by ERR is repressed by [TF] through SHP inhibition of ERR transactivity, diminishing ERR recruitment to the Dnmt1 promoter, and altering the conformation of local chromatin from an active mode by ERR to an inactive mode.	SHP	Dnmt1	2	REPRESSION	False
10883	11069	21461405:6:AP1:MMP13	We conclude that there was no synergy found between RUNX2 and [TF] in the regulation of the [TG] expression and that these transcription factors may be independently regulated in these cells.	AP-1	MMP13	0	UNDEFINED	False
10884	11070	21465479:5:MSX2:ABCG2	Comprehensive analysis of the [TF]-target gene has identified [TG] as the responsible gene.	MSX2	ABCG2	0	UNDEFINED	False
10885	11071	21465479:6:MSX2:ABCG2	Since previous studies reported the pivotal role of [TG] as a determining factor of cancer stem cells, the detailed regulatory mechanism of ABCG2 expression by [TF] was investigated.	MSX2	ABCG2	0	UNDEFINED	False
10887	11073	21465479:8:MSX2:ABCG2	Finally, we identified the functional cooperation of [TF] and SP1 in the transcriptional regulation of [TG] via the SP1 binding elements within the ABCG2 promoter.	MSX2	ABCG2	0	UNDEFINED	False
10888	11074	21465479:8:SP1:ABCG2	Finally, we identified the functional cooperation of MSX2 and [TF] in the transcriptional regulation of [TG] via the SP1 binding elements within the ABCG2 promoter.	SP1	ABCG2	0	UNDEFINED	False
10889	11075	21471200:2:FOXO1:BGLAP	We showed that [TF] inhibited Runx2-dependent transcriptional activity and osteocalcin mRNA expression and [TG] promoter activity in MC-4 preosteoblasts.	Foxo1	Bglap2	2	REPRESSION	False
10890	11077	21471203:11:SMAD1:MSX2	These results indicate that the Notch intracellular domainRBPJk complex enhances the BMP2-induced [TG] gene expression by cooperating with [TF] and suggest that Notch signaling makes vascular SMC responsive to BMP2 and promotes vascular calcification.	Smad1	Msx2	1	ACTIVATION	False
10891	11078	21473742:12:JUND:RHOH	Collectively, these data indicate that [TF] is an inhibitor of [TG] gene expression.	JunD	RHOH	2	REPRESSION	False
10892	11079	21473742:9:JUND:RHOH	When [TF] is overexpressed, the endogenous [TG] gene is repressed; however, when JUND is inhibited, expression of endogenous RHOH is induced both in the Raji cell line and AML (acute myeloid leukaemia) cells.	JUND	RHOH	2	REPRESSION	False
10893	11080	21486951:7:FOSL1:CEBPA	Strikingly, [TG] was downregulated in the [TF]-overexpressing cells and Fra-1 could bind to the Cebpa promoter and directly suppress its activity.	Fra-1	Cebpa	2	REPRESSION	False
10894	11081	21490060:10:E2F1:NEUROG3	We show that [TF] binds and activates the [TG] promoter to modulate Ngn3 expression levels in the embryonic pancreas in a Cdk4-dependent manner.	E2f1	Ngn3	1	ACTIVATION	False
10895	11082	21494603:14:GLI1:REG4	[TF] promotes [TG] transcription by binding to the RegIV gene promoter in pancreatic cancer.	GLI1	RegIV	1	ACTIVATION	False
10896	11083	21501655:0:FOXO1:ANGPTL2	Tumor necrosis factor- increases [TG] gene expression by activating [TF] in 3T3-L1 adipocytes.	Foxo1	angiopoietin-like protein 2	1	ACTIVATION	False
10897	11084	21501655:7:FOXO1:ANGPTL2	Furthermore, lentivirus-mediated knockdown of [TF] expression inhibited the transcriptional activity of [TG] promoter and decreased Angptl2 mRNA expression.	Foxo1	Angptl2	1	ACTIVATION	False
10898	11085	21501655:8:FOXO1:ANGPTL2	Finally, TNF- inhibited [TF] phosphorylation and enhanced its transcriptional activity, through which TNF- increased the expression of [TG] in adipocytes.	Foxo1	Angptl2	1	ACTIVATION	True
10899	11086	21504746:0:SP1:DOK7	The transcription factor [TF] plays a crucial role in [TG] gene expression.	Sp1	dok-7	1	ACTIVATION	False
10900	11087	21504746:6:SP1:DOK7	We further demonstrate that the transcription factor [TF] activates [TG] gene expression through interaction with these two Sp1 sites.	Sp1	dok-7	1	ACTIVATION	False
10901	11088	21504746:7:SP1:DOK7	Taken together, these results indicate that [TF] plays a crucial role in the regulation of the [TG] gene.	Sp1	dok-7	0	UNDEFINED	False
10902	11089	21506108:9:EGR1:ID1	We also demonstrate direct interaction of [TF] with [TG] promoter in vitro and in cell culture.	Egr-1	Id-1	0	UNDEFINED	True
10903	11090	21521937:12:PREB:ABCA1	[TF] mediates Ex-4-stimulated transcription of the [TG] gene in pancreatic  cells.	PREB	ABCA1	1	ACTIVATION	False
10904	11091	21521937:9:PREB:ABCA1	[TF] stimulated the activity of the luciferase reporter protein that was under the control of the [TG] promoter.	PREB	ABCA1	1	ACTIVATION	False
10905	11092	21526180:8:SALL4:ABCG2	Using chromatin-immunoprecipitation (ChIP), quantitative reverse transcription polymerase chain reaction (qRT-PCR) and electrophoretic mobility shift assay(EMSA), we demonstrated that [TF] was able to bind to the promoter region of ABCA3 and activate its expression while regulating the expression of [TG] indirectly.	SALL4	ABCG2	0	UNDEFINED	True
10907	11094	21527555:6:TP63:BBC3	Cisplatin chemotherapy, a mainstay of SCC treatment, promotes dissociation of [TF] and HDAC from the [TG] promoter, leading to increased histone acetylation, PUMA activation, and apoptosis.	p63	PUMA	0	UNDEFINED	True
10908	11095	21533167:9:FOXO1:PDX1	In our study, the decrease in [TG] protein level was related to its reduced stability, overexpression of DN-[TF] could partially reverse the inhibition of Pdx-1 expression.	Foxo1	Pdx-1	2	REPRESSION	True
10909	11096	21549688:7:REL:DLGAP5	By using real-time PCR and chromatin immunoprecipitation assays, we observed that the NF-B family member [TF] represents a putative transcription factor that activates [TG] gene expression.	c-Rel	HURP	1	ACTIVATION	False
10910	11097	21551321:11:LEF1:CHGA	Coexpression experiments show functional effects of [TF] and CTNNB1 on [TG] promoter.	LEF1	CHGA	0	UNDEFINED	False
10911	11098	21552291:9:TP53:HMOX1	Consistently, [TF], but not its homologue p73, activated [TG] expression and was bound to the HO-1 promoter specifically only upon H(2)O(2) treatment.	p53	HO-1	1	ACTIVATION	False
10912	11099	21555589:3:JUN:CDKN2A	MTA1 transactivates [TG] transcription by recruiting the transcription factor [TF] onto the ARF promoter in a p53-independent manner.	c-Jun	ARF	1	ACTIVATION	False
10913	11100	21565167:2:ATF2:RHOB	It is known that UV-induced [TG] expression results from the binding of [TF] (ATF2) via NF-Y to the inverted CCAAT box (-23) of the RhoB promoter.	activating transcription factor 2	RhoB	1	ACTIVATION	False
10914	11101	21566082:8:KLF5:CDT1	[TF] is essential for Pg to up-regulate the expression of cell cycle genes, including CyclinA, [TG], and E2F3.	KLF5	Cdt1	1	ACTIVATION	False
10915	11102	21567400:8:SP1:PLAU	Inhibition of [TF] and AP-1 activation blocked the SDF-1-induced expression and activity of the [TG] promoter.	Sp1	uPA	1	ACTIVATION	False
10916	11103	21573184:3:STAT3:MYC	Significantly, chromatin immunoprecipitation (ChIP) analyses reveal the nuclear EGFR, Src and [TF] complex is bound to the [TG] promoter.	Stat3	c-Myc	0	UNDEFINED	False
10917	11104	21586575:0:CEBPB:PDK4	Regulation of [TG] (PDK4) by [TF] (C/EBPbeta).	CCAAT/enhancer-binding protein beta	pyruvate dehydrogenase kinase 4	0	UNDEFINED	False
10918	11105	21586669:6:RUNX3:AGTRAP	Chromatin immunoprecipitation assay also supported the binding of [TF] to the [TG] promoter in renal distal convoluted tubule cells.	Runx3	ATRAP	0	UNDEFINED	False
10919	11106	2159816:9:FOS:TIMP1	This response was associated with enhanced activity of a transfected recombinant reporter plasmid containing binding sites for the jun/fos transcription factor complex ([TF]) similar to the TPA-responsive element (TRE) sequence we found in the [TG]/TIMP gene promoter.	AP-1	EPA	1	ACTIVATION	True
10920	11107	21603612:8:SP1:TNFSF10	Knockdown of NFATc1 increased [TF] transcription factor binding to the [TG] promoter and, importantly, inhibition of Sp1, by chemical inhibition or RNA interference, increased TRAIL expression.	Sp1	TRAIL	0	UNDEFINED	True
10923	11111	21608077:3:NR6A1:POU5F1	Here, we show that the orphan nuclear receptor germ cell nuclear factor ([TF]) initiates [TG] repression and DNA methylation by the differential recruitment of methyl-CpG binding domain (MBD) and DNA methyltransferases (Dnmts) to the Oct4 promoter.	GCNF	Oct4	2	REPRESSION	False
10924	11112	21608077:6:MBD2:POU5F1	Upon differentiation, endogenous GCNF binds to the [TG] proximal promoter and differentially recruits MBD3 and [TF] as well as Dnmt3A.	MBD2	Oct4	0	UNDEFINED	True
10926	11114	21608077:9:MBD2:POU5F1	Thus, recruitment of MBD3, [TF], and Dnmt3A by GCNF links two events: gene-specific repression and DNA methylation, which occur differentially at the [TG] promoter.	MBD2	Oct4	2	REPRESSION	False
10927	11115	21608077:9:NR6A1:POU5F1	Thus, recruitment of MBD3, MBD2, and Dnmt3A by [TF] links two events: gene-specific repression and DNA methylation, which occur differentially at the [TG] promoter.	GCNF	Oct4	2	REPRESSION	False
10928	11116	21610149:7:NFKB:PLK1	Moreover, we showed that, through direct binding to the [TG] promoter, the NF-B subunit [TF] transcriptionally activates PLK1, which inhibits the ubiquitination and degradation of -catenin.	RelA	PLK1	1	ACTIVATION	False
10929	11118	21612856:6:SMAD3:RUNX2	Herein we show that [TF], whose expression is stimulated by RA, relays the effects of RA on differentiation by initiating the displacement of C/EBP from the [TG] promoter.	Smad3	Runx2	0	UNDEFINED	False
10930	11119	21612856:8:SMAD3:RUNX2	While not sufficient to promote osteoblastogenesis, knockdown of [TF] using a specific shRNA prevented the RA-mediated stimulation of differentiation and displacement of C/EBP from the [TG] P1 promoter.	Smad3	Runx2	0	UNDEFINED	False
10931	11120	21613609:14:SMAD2:RGCC	These results demonstrate that [TF] regulation of [TG] transcription is essential for SMC differentiation from neural crest cells.	Smad2	RGC-32	0	UNDEFINED	False
10932	11121	21613609:8:SMAD2:RGCC	Biochemically, TGF- stimulated recruitment of [TF], Smad4, and PEA3 to the [TG] promoter, as revealed by gel shift and chromatin immunoprecipitation analyses.	Smad2	RGC-32	0	UNDEFINED	False
10933	11122	21613609:8:SMAD4:RGCC	Biochemically, TGF- stimulated recruitment of Smad2, [TF], and PEA3 to the [TG] promoter, as revealed by gel shift and chromatin immunoprecipitation analyses.	Smad4	RGC-32	0	UNDEFINED	False
10934	11123	21613609:9:SMAD2:RGCC	Functionally, [TF], but not Smad3, activated [TG] promoter.	Smad2	RGC-32	1	ACTIVATION	False
10935	11124	21613675:7:HIF1A:SLC8A1	Using luciferase reporter assay we observed increase in the [TG] promoter activity after DMOG treatment and using wild-type mouse embryonic fibroblast (MEF)-[TF](+/+) and HIF-1-deficient MEF-HIF-1(-/-) cells we have clearly shown that in the promoter region, HIF-1 is involved in DMOG induced upregulation of the NCX1.	HIF-1	NCX1	1	ACTIVATION	False
10936	11125	21617857:10:STAT5A:PTGS2	DN-[TF] also blocked [TG] promoter activity.	STAT5	COX-2	1	ACTIVATION	False
10937	11126	21617857:7:STAT5A:PTGS2	[TF] siRNA was found to inhibit [TG] expression in resting A549 cells despite the absence of detectable activated phosphorylated STAT5.	STAT5	COX-2	1	ACTIVATION	False
10939	11128	21617857:9:STAT5A:PTGS2	The overexpression of DN-[TF] significantly inhibited EGF-induced [TG] expression, and we found that EGF induced the tyrosine phosphorylation of STAT5 and up- regulated COX-2 expression.	STAT5	COX-2	1	ACTIVATION	False
10940	11129	21622714:4:STAT3:CAV1	[TG] promoter activity and gene expression were increased by overexpressing an activated form of [TF] but decreased by attenuation of Stat3 activity or expression.	Stat3	Cav-1	1	ACTIVATION	False
10941	11130	21622714:5:STAT3:CAV1	We identified putative [TF]-binding elements in the [TG] promoter and showed a direct repression of Cav-1 transcription by Stat3.	Stat3	Cav-1	2	REPRESSION	False
10942	11131	21625432:5:E2F1:PDK4	Interestingly, a recent study has demonstrated that the transcription factor [TF], which is crucial for cell cycle control, may regulate [TG] expression.	E2F1	PDK4	0	UNDEFINED	False
10943	11132	21625432:6:E2F1:PDK4	Given that NF-B may antagonize the transcriptional activity of [TF] in cardiac myocytes, we sought to study whether inflammatory processes driven by NF-B can downregulate [TG] expression in human cardiac AC16 cells through E2F1 inhibition.	E2F1	PDK4	1	ACTIVATION	True
10944	11133	21625455:8:SMAD3:FOXA2	[TF] binding of [TG] promoter and changed expression were confirmed.	SMAD3	FOXA2	0	UNDEFINED	False
10945	11134	21628060:5:AIRE:TLR3	Using chromatin immunoprecipitation and a luciferase activity assay, we also found that [TF] interacted with the TLR1, [TG], and TLR8 promoters and increased the luciferase transcriptional activity of these promoters in RAW264.7 cells.	Aire	TLR3	1	ACTIVATION	False
10946	11135	21640141:8:FOSL1:MMP1	Activated c-Jun and [TF] were essential for [TG] gene expression in 143B cells.	Fra-1	MMP-1	1	ACTIVATION	False
10947	11136	21642427:0:ELK1:CDKN1A	The ETS family transcription factor [TF] regulates induction of the cell cycle-regulatory gene p21([TG]/Cip1) and the BAX gene in sodium arsenite-exposed human keratinocyte HaCaT cells.	ELK-1	Waf1	1	ACTIVATION	True
10948	11137	21642427:3:ELK1:CDKN1A	Here, we show that [TF] directly trans-activates the [TG] gene, independently of p53 and EGR-1, in sodium arsenite (NaASO(2))-exposed HaCaT cells.	ELK-1	p21	1	ACTIVATION	False
10949	11138	21642427:5:ELK1:CDKN1A	Chromatin immunoprecipitation and electrophoretic mobility shift analyses confirmed the specific binding of [TF] to its putative binding sequence within the [TG] promoter.	ELK-1	p21	0	UNDEFINED	False
10950	11139	21642427:8:ELK1:CDKN1A	Although [TF] was activated by ERK, JNK, and p38 MAPK in response to NaASO(2), ELK-1-mediated activation of the [TG] promoter was largely dependent on ERK.	ELK-1	p21	1	ACTIVATION	False
10951	11140	21652709:10:KLF4:CDKN1A	PKC increases [TF] expression leading to enhanced KLF4 interaction with the GC-rich elements in the p21([TG] promoter to activate transcription.	KLF4	Cip1)	1	ACTIVATION	False
10952	11141	21652709:8:KLF4:CDKN1A	PKC increases [TF] mRNA and protein level and KLF4 binding to the GC-rich elements in the p21([TG] proximal promoter.	KLF4	Cip1)	0	UNDEFINED	False
10953	11142	21659477:0:TGIF1:FSHB	Gonadotropin-releasing hormone pulse sensitivity of [TG] gene is mediated by differential expression of positive regulatory activator protein 1 factors and corepressors SKIL and [TF].	TGIF1	follicle-stimulating hormone-beta	2	REPRESSION	True
10954	11143	21659477:4:JUN:FSHB	By mining a previous microarray data set, we found that mRNA for positive regulators of [TG] expression, such as Fos and [TF], were up-regulated at slower pulse frequencies than a number of potential negative regulators, such as the corepressors Skil, Crem, and Tgif1.	Jun	Fshb	1	ACTIVATION	False
10955	11144	21659477:8:FOS:FSHB	Chromatin immunoprecipitation analysis showed that [TF], SKIL, and TGIF1 occupy the [TG] promoter in a cyclical manner after GnRH stimulation.	FOS	FSH	0	UNDEFINED	False
10956	11145	21659501:8:STAT1:IL17RA	It is noteworthy that we show that IL-17 mediates significant and reproducible enhancement of IL-1/interferon (IFN)--induced and tumor necrosis factor (TNF)-/IFN--induced apoptosis in human islets, rat -cells, and INS-1E cells, in association with significant upregulation of -cell [TG] expression via activation of the transcription factors [TF] and nuclear factor (NF)-B.	STAT1	IL17RA	1	ACTIVATION	False
10957	11146	21664250:6:SREBF1:FGF21	Unexpectedly, overexpression of [TF] in HepG2 cells could also inhibit the endogenous [TG] transcription.	SREBP1c	FGF21	2	REPRESSION	False
10958	11147	21664250:7:SREBF1:FGF21	Further experiments demonstrated that [TF] could significantly attenuate the promoter activity of [TG].	SREBP1c	FGF21	2	REPRESSION	False
10959	11148	21664354:8:KLF2:KPNA2	Our results suggest that [TF] and Klf4 function redundantly to drive high level of [TG] expression in ES cells.	Klf2	Kpna2	1	ACTIVATION	False
10960	11149	21664354:8:KLF4:KPNA2	Our results suggest that Klf2 and [TF] function redundantly to drive high level of [TG] expression in ES cells.	Klf4	Kpna2	1	ACTIVATION	False
10961	11150	21665940:10:MAZ:VEGFA	Suppression of [TF] activity in these cells can inhibit [TG] expression, providing a possible new method to control angiogenesis.	SAF-1	VEGF	1	ACTIVATION	False
10962	11151	21665940:5:MAZ:VEGFA	Inhibition of [TF] by antisense short hairpin RNA profoundly reduces [TG] expression along with reduction in endothelial cell proliferation and migration.	SAF-1	VEGF	1	ACTIVATION	False
10963	11152	21665940:6:MAZ:VEGFA	By both in vitro and in vivo molecular studies, we show that the effect of [TF] is mediated through its direct interaction with the [TG] promoter.	SAF-1	VEGF	0	UNDEFINED	False
10964	11153	21665940:9:MAZ:VEGFA	Taken together, these findings reveal that [TF] is a hitherto unrecognized participant in inducing [TG] expression in triple-negative breast cancer cells, an aggressive form of breast cancer that currently lacks effective treatment options.	SAF-1	VEGF	1	ACTIVATION	False
10965	11154	21666725:4:YY1:BRCA1	[TF] binds to the promoter of [TG], and its overexpression resulted in increased expression of BRCA1 and a number of BRCA1 downstream genes.	YY1	BRCA1	1	ACTIVATION	False
10966	11155	21666725:7:YY1:BRCA1	Taken together, these findings suggest that [TF] is a key regulator of [TG] expression and may be causally linked to the molecular etiology of human breast cancer.	YY1	BRCA1	0	UNDEFINED	False
10967	11156	21679465:8:AP1:NOTCH4	A [TG] luciferase reporter was used to confirm that endogenous PEA3 or [TF] activated the Notch-4 promoter region.	AP-1	Notch-4	1	ACTIVATION	False
10968	11157	21683060:4:IRF1:TRIM22	Furthermore, it was revealed that BRG1 absence, per se, did not impair IFN--induced [TF] expression, but blocked its access to [TG] promoter, and BRG1-dependent induction of TRIM22 perfectly correlated with BRG1-dependent recruitment of IRF-1 to TRIM22 promoter.	IRF-1	TRIM22	0	UNDEFINED	True
10970	11159	21689639:5:LEF1:NANOG	Deletion or mutation of the Tcf/Lef element within the enhancer region of the human [TG] gene completely abrogated [TF]-induced NANOG promoter activity.	Lef1	NANOG	1	ACTIVATION	False
10971	11160	21701496:7:TEAD4:CTGF	In contrast, [TF] represses expression of the growth factor [TG] (connective tissue growth factor) to promote differentiation.	TEAD4	CTGF	2	REPRESSION	False
10972	11161	21705668:0:SRF:TNC	The transcriptional regulator megakaryoblastic leukemia-1 mediates [TF]-independent activation of [TG] transcription by mechanical stress.	serum response factor	tenascin-C	1	ACTIVATION	False
10973	11162	21705668:5:SRF:TNC	Part of the induction was dependant on [TF] and a newly identified atypical CArG box in the [TG] promoter.	SRF	TNC	1	ACTIVATION	False
10974	11163	21713995:10:FOXO3:RUNX2	Ectopic overexpression or silencing of SIRT1/[TF] expression regulated [TG] promoter activity, suggesting an important role for SIRT1-FOXO3A complex in regulating resveratrol-induced RUNX2 gene transcription.	FOXO3A	RUNX2	0	UNDEFINED	False
10975	11164	21713995:12:FOXO3:RUNX2	Taken together, our results describe a novel mechanism of resveratrol in promoting osteogenesis of human mesenchymal stem cells by upregulating [TG] gene expression via the SIRT1/[TF] axis.	FOXO3A	RUNX2	1	ACTIVATION	False
10976	11165	21723253:6:RUNX1:CTSK	Finally, overexpression of [TF] and concomitant decrease in SERPINB13 expression led to increased activity of [TG], an enzyme inhibited by SERPINB13.	RUNX1	cathepsin K	1	ACTIVATION	False
10977	11166	21725089:11:NR0B2:EGR1	Both HNF4 and [TG] expression were dramatically increased in [TF](-/-) mice with bile duct ligation and in human cirrhotic livers, which was inversely correlated with diminished SHP expression.	SHP	Egr-1	2	REPRESSION	False
10978	11167	21725089:5:NR0B2:EGR1	HNF4 activity, as well as its enrichment on the [TG] promoter, were markedly repressed by small heterodimer partner ([TF]) co-expression.	SHP	Egr-1	2	REPRESSION	False
10979	11168	21734262:6:USF1:FSHR	In vitro studies revealed that [TF] and USF2 DNA-binding activity also increased at 11 days for the promoters of four potential target genes, [TG], Gata4, Nr5a1, and Shbg.	USF1	Fshr	0	UNDEFINED	False
10980	11169	21734262:6:USF2:FSHR	In vitro studies revealed that USF1 and [TF] DNA-binding activity also increased at 11 days for the promoters of four potential target genes, [TG], Gata4, Nr5a1, and Shbg.	USF2	Fshr	0	UNDEFINED	False
10981	11170	21734262:9:USF1:NR5A1	Transient transfection of [TF] and USF2 expression vectors up-regulated [TG] and Shbg promoter activity.	USF1	Nr5a1	1	ACTIVATION	False
10982	11171	21734262:9:USF1:SHBG	Transient transfection of [TF] and USF2 expression vectors up-regulated Nr5a1 and [TG] promoter activity.	USF1	Shbg	1	ACTIVATION	False
10983	11172	21734262:9:USF2:NR5A1	Transient transfection of USF1 and [TF] expression vectors up-regulated [TG] and Shbg promoter activity.	USF2	Nr5a1	1	ACTIVATION	False
10984	11173	21734262:9:USF2:SHBG	Transient transfection of USF1 and [TF] expression vectors up-regulated Nr5a1 and [TG] promoter activity.	USF2	Shbg	1	ACTIVATION	False
10985	11174	21736709:3:AHR:MFSD2A	Analysis of three single-nucleotide polymorphisms (SNPs) mapping in the [TG] 5'-regulatory region using a luciferase reporter system showed that SNP rs12072037, in linkage disequilibrium with the MYCL1-EcoRI polymorphism and polymorphic in Asians but not in Caucasians, modulated transcriptional activity of the MFSD2A promoter in cell lines expressing [TF] and ARNT transcription factors, which potentially bind to the SNP site.	AHR	MFSD2A	0	UNDEFINED	False
10986	11175	21736709:3:ARNT:MFSD2A	Analysis of three single-nucleotide polymorphisms (SNPs) mapping in the [TG] 5'-regulatory region using a luciferase reporter system showed that SNP rs12072037, in linkage disequilibrium with the MYCL1-EcoRI polymorphism and polymorphic in Asians but not in Caucasians, modulated transcriptional activity of the MFSD2A promoter in cell lines expressing AHR and [TF] transcription factors, which potentially bind to the SNP site.	ARNT	MFSD2A	0	UNDEFINED	False
10987	11176	21741415:6:ETS1:CXCR4	Microenvironmental stimuli activating c-Src might influence [TF] binding to [TG] promoter and consequent transactivation, as well as CXCR4 post-translational regulatory mechanisms such as phosphorylation.	Ets1	CXCR4	1	ACTIVATION	False
10988	11177	21743036:0:FOXO1:PNPLA2	SIRT1 controls lipolysis in adipocytes via [TF]-mediated expression of [TG].	FOXO1	ATGL	1	ACTIVATION	False
10989	11178	21761347:0:GATA3:AURKA	Estrogen-induced [TG] (AURKA) gene expression is activated by [TF] in estrogen receptor-positive breast cancer cells.	GATA-3	aurora kinase-A	1	ACTIVATION	False
10990	11179	21763782:9:KLF4:CDKN1A	Treatment with TSA or transfection of [TF] increased the expression of both [TG] and p27 and promoter activity.	KLF4	p21	1	ACTIVATION	False
10991	11180	21765927:5:E2F1:CDKN2D	In this paper, we demonstrate that [TG] is transcriptionally regulated by [TF] through two response elements present in the p19INK4d promoter.	E2F1	p19INK4d	0	UNDEFINED	True
10992	11181	21777672:4:SRF:GLIPR1	Using the MatInspector software, we identified a [TF] binding site on the [TG] promoter.	SRF	RTVP-1	0	UNDEFINED	False
10993	11182	21777672:5:SRF:GLIPR1	Chromatin immunoprecipitation (ChIP) assay revealed that [TF] binds to the [TG] promoter in U87 cells, and that this binding was significantly increased in response to serum addition.	SRF	RTVP-1	0	UNDEFINED	False
10994	11183	21777672:6:SRF:GLIPR1	Moreover, silencing of [TF] blocked the induction of [TG] expression in response to serum.	SRF	RTVP-1	1	ACTIVATION	False
10995	11184	21777672:7:SRF:GLIPR1	We found that overexpression of PKC and PKC increased the activity of the [TG] promoter and the binding of [TF] to the promoter.	SRF	RTVP-1	0	UNDEFINED	True
10996	11185	21777672:9:SRF:GLIPR1	[TF] regulated the migration of glioma cells and its effect was partially mediated by [TG].	SRF	RTVP-1	0	UNDEFINED	True
10997	11186	21784102:10:SMAD3:TNFSF13	Taken together, these results demonstrate that activin A can enhance [TG] expression through two different pathways, [TF] and ERK/CREB.	Smad3	APRIL	1	ACTIVATION	False
10998	11187	21784102:6:SMAD3:TNFSF13	These results indicate that activin A enhances [TG] expression through both activin receptor-like kinase 4 (ALK4) and [TF].	Smad3	APRIL	1	ACTIVATION	False
10999	11188	21786021:7:FOXA2:NEUROG3	We found that GLIS3 binds to specific GLIS3-response elements in the [TG] promoter, activating Neurog3 gene transcription both directly, and synergistically with hepatic nuclear factor 6 and [TF].	forkhead box A2	Neurog3	1	ACTIVATION	False
11000	11189	21786021:7:GLIS3:NEUROG3	We found that [TF] binds to specific GLIS3-response elements in the [TG] promoter, activating Neurog3 gene transcription both directly, and synergistically with hepatic nuclear factor 6 and forkhead box A2.	GLIS3	Neurog3	1	ACTIVATION	False
11001	11190	21791614:2:ATF5:EGR1	We demonstrate here that [TF] interacts with the transcriptional coactivator p300, which acetylates ATF5 at lysine-29 (K29), which in turn enhances the interaction between ATF5 and p300 and binding of the ATF5/p300 complex to the ATF5 response element (ARE) region of the [TG] promoter.	ATF5	Egr-1	0	UNDEFINED	False
11002	11191	21791614:3:ELK1:EGR1	ARE-bound ATF5/p300 acetylates lysine-14 (K14) of nucleosomal histone H3 at both the ARE and serum response element (SRE) of the [TG] promoter, which facilitates binding of extracellular signal-regulated kinase (ERK)-phosphorylated [TF] to the SRE, activating the Egr-1 promoter.	Elk-1	Egr-1	1	ACTIVATION	False
11003	11192	21792176:0:TP53:BNIP3	[TF] directly suppresses [TG] expression to protect against hypoxia-induced cell death.	p53	BNIP3	2	REPRESSION	False
11004	11193	21792176:2:TP53:BNIP3	In this study, we showed that [TF] suppressed [TG] expression by directly binding to the p53-response element motif and recruiting corepressor mSin3a to the BNIP3 promoter.	p53	BNIP3	2	REPRESSION	False
11005	11194	21792176:3:TP53:BNIP3	The DNA-binding site of [TF] must remain intact for the protein to suppress the [TG] promoter.	p53	BNIP3	2	REPRESSION	False
11006	11195	21796333:15:POU2F1:OLR1	Data suggests that [TF]-mediated up-regulation of transcription is an early event in the stimulation of [TG] by ox-LDL.	Oct-1	LOX-1	1	ACTIVATION	False
11007	11196	21798735:2:SMAD3:PLAU	In the present study, we analysed the role of TGF-1-induced [TF] activation in the [TG] (uPA) production, as well as in cell migration and E-cadherin downregulation in transformed PDV keratinocyte cell line.	Smad3	urokinase type plasminogen activator	1	ACTIVATION	True
11008	11197	21798735:5:SMAD3:PLAU	The inhibition of [TF] strongly reduced the capacity of TGF-1 to stimulate [TG] expression, in parallel decreasing the uPA inhibitor plasminogen activator inhibitor type 1 (PAI-1) expression.	Smad3	uPA	1	ACTIVATION	False
11009	11198	21798735:9:SMAD3:PLAU	Taken together, our results suggest that the TGF-1-induced activation of [TF] is the critical step for the [TG] upregulation and E-cadherin downregulation, which are the key events preceding the induction of cell migration by TGF-1 in transformed cells.	Smad3	uPA	1	ACTIVATION	False
11010	11199	21804543:5:FOXO1:POU5F1	This function is probably mediated through direct control by [TF] of [TG] and SOX2 gene expression through occupation and activation of their respective promoters.	FOXO1	OCT4	1	ACTIVATION	True
11011	11200	21807940:8:ETS2:FLT4	Furthermore, we found that both Prox1 and [TF] bind to the [TG] promoter in intact chromatin.	Ets-2	VEGFR3	0	UNDEFINED	False
11012	11201	21813016:4:CTCF:CDKN1A	To directly investigate the relationship between tiRNAs and [TF] we examined tiRNAs originating near the intronic CTCF binding site in the human tumor suppressor gene, p21 ([TG] gene, also known as CDKN1A).	CTCF	cyclin-dependent kinase inhibitor 1A	0	UNDEFINED	False
11013	11202	21813016:5:CTCF:CDKN1A	Inhibition of [TF]-proximal tiRNAs resulted in increased CTCF localization and increased [TG] expression, while overexpression of CTCF-proximal tiRNA mimics decreased CTCF localization and p21 expression.	CTCF	p21	2	REPRESSION	True
11014	11203	21814878:2:ARNT:VEGFA	[TF], a heterodimer of HIF-1 and HIF-1, binds to the hypoxia responsive element (HRE) present in the promoter regions of hypoxia responsive genes, such as vascular endothelial growth factor ([TG]).	HIF-1	VEGF	0	UNDEFINED	False
11015	11204	21816850:6:ETV5:CXCR4	Notably, [TF] was identified as a regulator of Brachyury (T) and CXC chemokine receptor, type 4 ([TG]), and we showed that ETV5 binding to the Brachyury (T) gene promoter region is associated with an active state of transcription.	ETV5	Cxcr4	1	ACTIVATION	False
11018	11207	21821004:10:ATF3:PDX1	Collectively, these results demonstrate that [TF] represses [TG] expression via binding to an ATF3-responsive element in its promoter, which plays an important role in suppression of pancreatic -cells function.	ATF3	PDX-1	2	REPRESSION	False
11019	11208	21821004:3:ATF3:PDX1	In this study, we analyzed the mouse [TG] promoter to characterize the effects of [TF] on PDX-1 expression in pancreatic -cells.	ATF3	PDX-1	0	UNDEFINED	False
11020	11209	21821004:6:ATF3:PDX1	Transfection studies with 5' deleted-reporters showed that [TF] repressed the activity of 0.9Kb [TG] promoter, whereas it did not affect the activity of 0.7 Kb PDX-1 promoter, suggesting that ATF3 responsive element is located between the -903 and -702.	ATF3	PDX-1	2	REPRESSION	False
11021	11210	21825130:4:IRX3:GJA5	Loss of [TF] resulted in disruption of the rapid coordinated spread of ventricular excitation, reduced levels of [TG], and ectopic Cx43 expression in the proximal bundle branches.	Irx3	Cx40	1	ACTIVATION	False
11022	11211	21825130:5:IRX3:GJA5	[TF] directly represses Cx43 transcription and indirectly activates [TG] transcription.	Irx3	Cx40	1	ACTIVATION	False
11023	11212	21826097:5:EGR1:SPRY1	Binding sites for Wilm's tumor (WT1) transcription factors [TF], EGR3 and WTE are highly conserved between the mouse and human [TG] promoter regions, suggesting an evolutionary conserved mechanism(s) involving WT1 and EGR in Spry1 regulation.	EGR1	Spry1	0	UNDEFINED	False
11024	11213	21826652:0:NFIL3:PHEX	PTHrP(1-34)-mediated repression of the [TG] gene in osteoblastic cells involves the transcriptional repressor [TF].	E4BP4	PHEX	2	REPRESSION	False
11026	11215	21826652:4:NFIL3:PHEX	PTH also activates the transcriptional repressor [TF] through the same pathway, suggesting that PTH or PTHrP-mediated repression of [TG] expression could involve E4BP4.	E4BP4	PHEX	2	REPRESSION	False
11027	11216	21826652:9:NFIL3:PHEX	Finally, DNA pull-down and luciferase assays showed that two [TF] response elements located in [TG] promoter were functional.	E4BP4	PHEX	0	UNDEFINED	False
11028	11217	21829621:5:ISL1:CCND1	Using HIT-T15 and primary adult islet cells as cell models, we show that [TF] promoted adult pancreatic islet cell proliferation with increased c-Myc and [TG] transcription, while knockdown of ISL1 increased the proportion of cells in G(1) phase and decreased the proportion of cells in G(2)/M and S phases.	ISL1	CyclinD1	1	ACTIVATION	False
11029	11218	21829621:5:ISL1:MYC	Using HIT-T15 and primary adult islet cells as cell models, we show that [TF] promoted adult pancreatic islet cell proliferation with increased [TG] and CyclinD1 transcription, while knockdown of ISL1 increased the proportion of cells in G(1) phase and decreased the proportion of cells in G(2)/M and S phases.	ISL1	c-Myc	1	ACTIVATION	False
11030	11219	21829621:6:ISL1:CCND1	Further investigation shows that [TF] activated both c-Myc and [TG] transcription through direct binding on their promoters.	ISL1	CyclinD1	1	ACTIVATION	False
11031	11220	21831961:0:ETV4:CXCR4	[TF] activates [TG] transcription in MDA-MB-231 and MCF7 breast cancer cells.	PEA3	CXCR4	1	ACTIVATION	False
11032	11221	21831961:2:ETV4:CXCR4	In this study, we found that overexpression of [TF] (PEA3) could elevate [TG] mRNA level and CXCR4 promoter activity in human MDA-MB-231 and MCF-7 breast cancer cells.	ets variant gene 4	CXCR4	1	ACTIVATION	False
11033	11222	21831961:3:ETV4:CXCR4	[TF] promoted [TG] expression and breast cancer metastasis.	PEA3	CXCR4	1	ACTIVATION	False
11034	11224	21831961:5:ETV4:CXCR4	[TF] siRNA attenuated [TG] promoter activity and the binding of PEA3 to the CXCR4 promoter in MDA-MB-231 and MCF-7 cells.	PEA3	CXCR4	1	ACTIVATION	False
11035	11225	21835891:0:AP1:MYC	Estrogen induces [TG] gene expression via an upstream enhancer activated by the estrogen receptor and the [TF] transcription factor.	AP-1	c-myc	1	ACTIVATION	False
11036	11226	21835891:9:AP1:MYC	TAM67, the [TF] dominant negative, partially inhibited estrogen induction of [TG] expression and suppressed estrogen-induced cell cycle progression.	AP-1	c-myc	1	ACTIVATION	False
11037	11227	21841808:10:ETS1:CCND3	Transfection of the promoter deletion constructs containing mutant [TF] binding sites enhanced [TG] promoter activity.	c-Ets1	cyclin D3	2	REPRESSION	False
11038	11228	21842277:5:VDR:BMP7	In addition, since [TG] has a vitamin D receptor ([TF]) response element in the promoter region, we also investigated whether VDR is involved in the BMP7 response to mechanical loading.	VDR	BMP7	0	UNDEFINED	False
11039	11229	21846717:10:ELK1:SLC2A1	In conclusion, FGF21 induces [TG] expression and glucose uptake through sequential activation of ERK1/2 and SRF/[TF], which in turn triggers the transcriptional activation of GLUT1 in adipocytes.	Elk-1	GLUT1	1	ACTIVATION	False
11040	11230	21846717:6:ELK1:SLC2A1	A chromatin immunoprecipitation assay demonstrated that the transcription factors serum response factor (SRF) and Ets-like protein-1 ([TF]) were recruited to the [TG] promoter upon FGF21 stimulation.	Elk-1	GLUT1	0	UNDEFINED	False
11041	11231	21846717:6:SRF:SLC2A1	A chromatin immunoprecipitation assay demonstrated that the transcription factors serum response factor ([TF]) and Ets-like protein-1 (Elk-1) were recruited to the [TG] promoter upon FGF21 stimulation.	SRF	GLUT1	0	UNDEFINED	False
11042	11232	21846717:8:ELK1:SLC2A1	In C57 lean mice, a single intravenous injection of FGF21 induced phosphorylation of [TF] at Ser(383) and SRF at Ser(103) and also led to the recruitment of Elk-1 and SRF to the [TG] promoter in epididymal fats.	Elk-1	GLUT1	0	UNDEFINED	False
11043	11233	21846717:8:SRF:SLC2A1	In C57 lean mice, a single intravenous injection of FGF21 induced phosphorylation of Elk-1 at Ser(383) and [TF] at Ser(103) and also led to the recruitment of Elk-1 and SRF to the [TG] promoter in epididymal fats.	SRF	GLUT1	0	UNDEFINED	False
11044	11234	21849497:10:NRL:MEF2C	We conclude that [TG] expression from an alternative promoter in the retina is regulated by [TF].	NRL	Mef2c	0	UNDEFINED	False
11045	11235	21849497:8:NRL:MEF2C	[TF] also activated the [TG] alternative promoter in vitro and in vivo.	NRL	Mef2c	1	ACTIVATION	False
11046	11236	21852380:7:YY1:SLC1A2	Gain- and loss-of-function studies in normal primary human fetal astrocytes and T98G glioblastoma multiforme cells revealed that AEG-1 repressed [TG] expression at a transcriptional level by inducing [TF] activity to inhibit CBP function as a coactivator on the EAAT2 promoter.	YY1	EAAT2	2	REPRESSION	False
11047	11237	21858056:8:PLAG1:EGR1	Furthermore, deletion of sequence 81-96 in the [TG] promoter region abolished the effect of [TF] on Egr1 upregulation.	Plag1	Egr1	1	ACTIVATION	False
11048	11238	21858218:6:SP1:CDKN1A	Binding of [TF], p53 and p300 to the [TG] promoter was enhanced in PTTG1(-/-) cells after treatment, suggesting transcriptional regulation of p21.	Sp1	p21	0	UNDEFINED	False
11049	11239	21860419:0:FOXM1:VEGFA	FOXO3a represses [TG] expression through [TF]-dependent and -independent mechanisms in breast cancer.	FOXM1	VEGF	2	REPRESSION	False
11050	11240	21860419:0:FOXO3:VEGFA	[TF] represses [TG] expression through FOXM1-dependent and -independent mechanisms in breast cancer.	FOXO3a	VEGF	2	REPRESSION	False
11051	11241	21860419:4:FOXO3:VEGFA	Lapatinib treatment of BT474 or SKBR3 cells resulted in nuclear translocation and activation of [TF], followed by a reduction in [TG] expression.	FOXO3a	VEGF	2	REPRESSION	False
11052	11242	21860419:5:FOXM1:VEGFA	Transient transfection and inducible expression experiments showed that FOXO3a represses the proximal [TG] promoter, whereas another Forkhead member, [TF], induces VEGF expression.	FOXM1	VEGF	1	ACTIVATION	False
11053	11243	21860419:5:FOXO3:VEGFA	Transient transfection and inducible expression experiments showed that [TF] represses the proximal [TG] promoter, whereas another Forkhead member, FOXM1, induces VEGF expression.	FOXO3a	VEGF	2	REPRESSION	False
11054	11244	21860419:6:FOXM1:VEGFA	Chromatin immunoprecipitation and oligonucleotide pull-down assays showed that both FOXO3a and [TF] bind a consensus Forkhead response element (FHRE) in the [TG] promoter.	FOXM1	VEGF	0	UNDEFINED	False
11055	11245	21860419:6:FOXO3:VEGFA	Chromatin immunoprecipitation and oligonucleotide pull-down assays showed that both [TF] and FOXM1 bind a consensus Forkhead response element (FHRE) in the [TG] promoter.	FOXO3a	VEGF	0	UNDEFINED	False
11056	11246	21860419:7:FOXM1:VEGFA	Upon lapatinib stimulation, activated FOXO3a displaces [TF] bound to the FHRE before recruiting histone deacetylase 2 (HDAC2) to the promoter, leading to decreased histones H3 and H4 acetylation, and concomitant transcriptional inhibition of [TG].	FOXM1	VEGF	1	ACTIVATION	True
11057	11247	21860419:7:FOXO3:VEGFA	Upon lapatinib stimulation, activated [TF] displaces FOXM1 bound to the FHRE before recruiting histone deacetylase 2 (HDAC2) to the promoter, leading to decreased histones H3 and H4 acetylation, and concomitant transcriptional inhibition of [TG].	FOXO3a	VEGF	2	REPRESSION	True
11058	11248	21860419:8:FOXM1:VEGFA	These results show that FOXO3a-dependent repression of target genes in breast cancer cells, such as [TG], involves competitive displacement of DNA-bound [TF] and active recruitment of transcriptional repressor complexes.	FOXM1	VEGF	1	ACTIVATION	True
11059	11249	21860419:8:FOXO3:VEGFA	These results show that [TF]-dependent repression of target genes in breast cancer cells, such as [TG], involves competitive displacement of DNA-bound FOXM1 and active recruitment of transcriptional repressor complexes.	FOXO3a	VEGF	2	REPRESSION	False
11060	11250	21862578:6:CDX2:TLR4	Overexpression of [TF] in an IEC line decreased the methylation level of the [TG] gene, increased transcriptional promoter activity of the gene, and increased responsiveness to the TLR4 ligand.	CDX2	TLR4	1	ACTIVATION	False
11061	11251	21862591:3:TP53:SLC2A12	We showed that [TF] binds to the promoters of metabolic genes and represses their expression, including glucose transporters [TG] (GLUT12) and SLC2A1 (GLUT1).	p53	SLC2A12	2	REPRESSION	False
11062	11252	21873191:0:TFAP4:CD4	[TF] modulates reversible and epigenetic silencing of the [TG] gene.	Transcription factor AP4	Cd4	2	REPRESSION	True
11063	11253	21873191:7:TFAP4:CD4	Furthermore, although [TF]-deficient CD8(+) T cells appeared to normally down-regulate [TG] expression, AP4 deficiency significantly increased the frequency of CD4-expressing effector/memory CD8(+) T cells in mice harboring point mutations in the Cd4 silencer.	AP4	CD4	2	REPRESSION	False
11064	11254	21873191:8:TFAP4:CD4	Our results suggest that [TF] contributes to Cd4 silencing both in DN and CD8(+) T cells by enforcing checkpoints for appropriate timing of [TG] expression and its epigenetic silencing.	AP4	CD4	2	REPRESSION	False
11065	11255	21873234:7:BATF:SIRT1	These results suggest that [TF] promotes effector CD8 T-cell differentiation by regulating both epigenetic remodeling and energy metabolism through [TG] expression.	BATF	Sirt1	0	UNDEFINED	False
11066	11256	21880723:6:SP1:ELN	Importantly, we have established that elevation of Thr(P)-821-Rb promotes Rb binding to the [TF] transcription factor and that successive binding of the Rb-Sp1 complex to the retinoblastoma control element within the [TG] gene promoter stimulates tropoelastin transcription.	Sp1	elastin	1	ACTIVATION	False
11067	11257	21896759:6:CTCF:VEGFA	Here we show that the chromatin insulator-binding factor [TF] binds to the proximal promoter of [TG].	CTCF	VEGF	0	UNDEFINED	False
11068	11258	21896759:7:CTCF:VEGFA	Consistent with the enhancer-blocking mode of chromatin insulators, [TF] has little effect on basal expression of [TG] but specifically affects its activation by enhancers.	CTCF	VEGF	0	UNDEFINED	False
11069	11259	21897365:3:DLX2:CDKN1A	[TF] counteracts TGF-induced cell-cycle arrest and apoptosis in mammary epithelial cells by at least two molecular mechanisms: Dlx2 acts as a direct transcriptional repressor of TGF receptor II (TGFRII) gene expression and reduces canonical, Smad-dependent TGF signalling and expression of the cell-cycle inhibitor p21([TG]) and increases expression of the mitogenic transcription factor c-Myc.	Dlx2	CIP1	2	REPRESSION	False
11070	11260	21897365:3:DLX2:MYC	[TF] counteracts TGF-induced cell-cycle arrest and apoptosis in mammary epithelial cells by at least two molecular mechanisms: Dlx2 acts as a direct transcriptional repressor of TGF receptor II (TGFRII) gene expression and reduces canonical, Smad-dependent TGF signalling and expression of the cell-cycle inhibitor p21(CIP1) and increases expression of the mitogenic transcription factor [TG].	Dlx2	c-Myc	1	ACTIVATION	False
11071	11261	21900211:8:ATF3:SERPINE2	In addition, regulation of LIF, CLDN1, [TG], HSD17B2, ITGA7 and PODXL by [TF] mediated the increased proliferation capacity of CAFs.	ATF3	SERPINE2	0	UNDEFINED	False
11072	11262	21901172:1:STAT5A:LIF	A search for genes potentially regulated by [TF] identified leukemia inhibitory factor ([TG]) as a good candidate.	STAT5	LIF	0	UNDEFINED	False
11074	11266	21917910:8:VDR:CYP24A1	Unlike in HEK293 cells, ADTT increased [TG] expression in HCT116 cells and increased the association of [TF] and SMRT on the CYP24A1 promoter.	VDR	CYP24A1	0	UNDEFINED	False
11075	11267	21949397:7:MYC:CDKN1A	[TF] suppression was accompanied by deregulation of the MYC transcriptome, including potent reactivation of the [TG] tumor suppressor.	MYC	p21	2	REPRESSION	False
11076	11268	21953514:3:SREBF1:LPIN1	Here, we tested the hypothesis that AMPK-[TF] signaling may be involved in ethanol-mediated up-regulation of [TG] gene expression.	SREBP-1	lipin-1	1	ACTIVATION	False
11077	11269	21957244:9:NR2E1:CDKN1A	[TF] regulates [TG] expression in a p53-dependent manner, and acute removal of p53 can rescue the proliferation defect of TLX-null NSCs in culture.	TLX	p21	0	UNDEFINED	False
11078	11270	21957254:4:SOX17:CCND1	[TF] knockdown also increases the levels of [TG], Axin2, and activated -catenin.	Sox17	cyclin D1	2	REPRESSION	False
11079	11271	21957254:8:SOX17:CCND1	[TF] overexpression inhibited PDGF-induced TOPFLASH and [TG] promoter activity, and decreased endogenous cyclin D1, activated -catenin, as well as total -catenin levels.	Sox17	cyclin D1	2	REPRESSION	False
11080	11272	21963718:4:AP1:MMP9	Trx-1 augmented [TG] transcription through NF-B, [TF] and SP1 elements; stimulated p50/p65 NF-B activity and recruitment to the MMP-9 promoter; and facilitated MMP-9 promoter-accessibility to NF-B by preventing HDAC recruitment and maintaining MMP-9 promoter histone acetylation.	AP-1	MMP-9	1	ACTIVATION	True
11082	11274	21965288:3:SMAD3:SMN1	Because we recently showed that [TF] inhibits myocardin-related transcription factor (MRTF), the driver of the [TG] promoter and many other CC(A/T)-rich GG element (CArG) box-dependent cytoskeletal genes, we asked whether AJ components might affect SMA expression through interfering with Smad3.	Smad3	SMA	2	REPRESSION	False
11083	11275	21966428:8:AP1:F2R	c) galectin-3 directly interacts with [TF] transcriptional factor, and this complex binds to [TG] promoter and drives PAR-1 transcription.	AP-1	PAR-1	1	ACTIVATION	False
11084	11276	21966468:7:IRF7:PPARGC1A	Nuclear [TF] levels in TLR2(-/-) and TLR4(-/-) mice decreased and increased respectively post-inoculation and IRF-7 DNA-binding at the [TG] promoter was demonstrated by chromatin immunoprecipitation.	IRF-7	Ppargc1a	0	UNDEFINED	False
11085	11277	21966511:8:JUNB:IVL	Chromatin immunoprecipitation confirmed that ANGPTL4 stimulated the activation and binding of [TF] and c-JUN to the promoter region of [TG] and transglutaminase type 1 genes, respectively.	JUNB	human involucrin	0	UNDEFINED	True
11086	11278	21966512:5:ATF4:DDIT3	[TF] (ATF4) protein binds and activates the AARE regulatory sites of the [TG] promoter.	Activating transcription factor 4	CHOP	1	ACTIVATION	False
11087	11279	21969564:7:AP1:SERPINE1	MAP3K1 inactivation reduces [TF] activity and [TG] expression both in cells and developing eyelids.	AP-1	PAI-1	1	ACTIVATION	False
11088	11280	21973168:0:YY1:PLP1	[TF] negatively regulates mouse myelin proteolipid protein ([TG]) gene expression in oligodendroglial cells.	YY1	Plp1	2	REPRESSION	False
11089	11281	21973168:2:YY1:PLP1	Previous studies have shown that [TF] modulates the activity of reporter genes driven by the myelin PLP (proteolipid protein) (PLP1/[TG]) promoter.	YY1	Plp1	0	UNDEFINED	False
11090	11282	21973168:8:YY1:PLP1	Nevertheless, the current study suggests that [TF] functions as a repressor (not an activator) of [TG] gene expression in immature oligodendrocytes.	YY1	Plp1	2	REPRESSION	False
11091	11283	21976141:11:RBPJ:PTGS2	Furthermore, N2IC bound to [TG] promoter and induced COX-2 expression through a [TF]-dependent manner in SC-M1 cells.	CBF1	COX-2	1	ACTIVATION	False
11092	11284	21977911:6:YY1:RTCB	Gel shift assays confirmed the specific interaction between Yin Yang-1 ([TF]) and the potential element in the proximal region of the [TG] promoter.	YY1	FAAP	0	UNDEFINED	False
11093	11285	21977911:7:YY1:RTCB	Site mutation, truncation, RNAi, and overexpression analyses suggested that [TF] is an important regulator of the [TG] promoter.	YY1	FAAP	0	UNDEFINED	False
11094	11286	21980470:0:LEF1:IDO1	Identification of a variable number of tandem repeats polymorphism and characterization of [TF] response elements in the promoter of the [TG] gene.	LEF-1	IDO1	0	UNDEFINED	False
11095	11287	21982894:0:BACH1:HMOX1	[TG] is induced by miR-155 via reduced [TF] translation in endothelial cells.	BACH1	Heme oxygenase 1	2	REPRESSION	False
11097	11289	21983879:3:TBX21:IL4	When IL-12 is produced by antigen-presenting cells, [TF] expression is induced, causing direct stimulation of ifng gene transcription while simultaneously acting as a transcriptional repressor of the [TG] gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.	T-bet	IL4	2	REPRESSION	False
11098	11290	21985966:4:POU2F1:CAT	In this report, we show that [TF] acts as an activator of [TG], by binding to the catalase promoter in hepatocellular carcinoma (HCC) cell lines.	Oct-1	catalase	1	ACTIVATION	False
11099	11291	21986102:3:RUNX2:CTGF	In this study, we investigated the hypothesis that [TF] modulates [TG] gene expression via the regulation of TGF- signaling.	Runx2	CTGF	0	UNDEFINED	False
11100	11292	21986102:5:RUNX2:CTGF	Forced expression of [TF] decreased and the reduction of Runx2 expression by small interfering RNA enhanced both basal and TGF--stimulated [TG] gene expression in HASMCs.	Runx2	CTGF	2	REPRESSION	False
11101	11293	21986102:9:RUNX2:CTGF	These results for the first time demonstrate that [TF]/Smad3 complex negatively regulates endogenous and TGF--induced [TG] gene expression in VSMCs.	Runx2	CTGF	2	REPRESSION	False
11102	11294	21986102:9:SMAD3:CTGF	These results for the first time demonstrate that Runx2/[TF] complex negatively regulates endogenous and TGF--induced [TG] gene expression in VSMCs.	Smad3	CTGF	2	REPRESSION	False
11103	11295	21986577:13:CREB1:IL10	CHIP assays revealed increased phospho-[TF] binding to the [TG] promoter.	CREB	IL10	0	UNDEFINED	False
11104	11296	21987172:3:YBX1:CLU	We report that [TF] (YB-1) directly binds to [TG] promoter regions to transcriptionally regulate clusterin expression.	Y-box binding protein-1	CLU	0	UNDEFINED	False
11105	11297	21994466:11:STAT3:TNFRSF1B	Collectively, these studies show that IL-6- and TNF-induced [TG] expression in colon cancer cells is mediated primarily by [TF] and provide evidence that TNFR2 may contribute to the tumor-promoting roles of STAT3.	STAT3	TNFR2	1	ACTIVATION	False
11106	11298	21994466:7:STAT3:TNFRSF1B	Chromatin immunoprecipitation (ChIP) revealed cooperative effects of IL-6 + TNF to induce [TF] binding to a -1,578 STAT response element in the [TG] promoter but no effect on NFB binding to consensus sites.	STAT3	TNFR2	0	UNDEFINED	False
11107	11299	21994466:8:STAT3:TNFRSF1B	Constitutively active [TF] was sufficient to induce [TG] expression.	STAT3	TNFR2	1	ACTIVATION	False
11108	11300	21994466:9:STAT3:TNFRSF1B	Overexpression of SOCS3, a cytokine-inducible [TF] inhibitor, which reduces tumorigenesis in preclinical models of colitis-associated cancer, decreased cytokine-induced [TG] expression and STAT3 binding to the -1,578 STAT response element.	STAT3	TNFR2	1	ACTIVATION	False
11109	11301	21994612:4:TP53:TLR3	Interestingly, recent studies also indicate that several IFN-inducible genes such as interferon regulatory factor 9 (IRF9), IRF5, IFN-stimulated gene 15 (ISG15) and toll-like receptor 3 ([TG]) are in fact, [TF] direct transcriptional targets.	p53	TLR3	0	UNDEFINED	False
11110	11302	21995436:3:EGR1:CYR61	To investigate the regulatory potential of [TF] on expression of [TG] by smoking, this study examined the hypothesis that cigarette smoke-induced Egr-1 induces expression of Cyr61 in human skin dermal fibroblasts (HSDF).	Egr-1	Cyr61	1	ACTIVATION	False
11111	11303	21995436:7:EGR1:CYR61	Following transfection with an [TF] overexpression vector, HSDF showed increased activity of the [TG] promoter in a dose-dependent manner.	Egr-1	Cyr61	1	ACTIVATION	False
11112	11304	21995449:7:POU5F1:HSPD1	Moreover, our study shows that [TF] regulates [TG] expression and controls hATSC survival and self-renewal after binding to the HSP60 gene.	Oct4	HSP60	0	UNDEFINED	False
11113	11305	21995960:4:AP1:CLU	Luciferase reporter assay indicates that the [TF] transcription factor complex is involved in gastrin-mediated activation of the [TG] promoter.	AP-1	clusterin	1	ACTIVATION	False
11114	11306	21996423:5:JUN:CASP3	Destroying [TF]:ATF2 heterodimers with dominant negative mutants of c-Jun and ATF2 or knockdown by small RNA interference reduced [TG] promoter activity and mRNA level.	c-Jun	caspase-3	1	ACTIVATION	False
11115	11307	21996423:6:JUN:CASP3	Furthermore, chromatin immunoprecipitation showed increased binding of [TF]:ATF2 heterodimers to the [TG] promoter in response to activity deprivation in vivo.	c-Jun	caspase-3	0	UNDEFINED	False
11116	11308	21996678:7:FOSB:CTGF	[TF] silencing attenuated the expression of the profibrotic factors tenascin C (TNC) and connective tissue growth factor ([TG]), whereas forced expression of Jun~FosB stimulated TNC and CTGF promoter activity.	FosB	CTGF	1	ACTIVATION	False
11117	11309	22001392:5:FOS:PTPRO	We first demonstrate that [TF] activation by 12-O-tetradecanoylphorbol-13-acetate induces [TG] expression with concurrent recruitment of c-fos and c-jun to its promoter.	AP-1	PTPROt	1	ACTIVATION	False
11118	11311	22001392:6:AP1:PTPRO	The [TG] promoter is also responsive to over- and underexpression of [TF], confirming the role of AP-1 in PTPROt expression.	AP-1	PTPROt	1	ACTIVATION	True
11119	11312	22001392:7:JUN:PTPRO	Next, we demonstrate that TCL1 can repress the [TG] promoter by altering c-fos expression and [TF] activation state.	c-jun	PTPROt	0	UNDEFINED	True
11120	11313	22001409:4:SP1:CDKN1A	In the present study, our data show that Zac1 is able to interact directly with the [TF]-responsive element in the p21([TG]/Cip1) gene promoter and enhance the transactivation activity of Sp1 through direct physical interaction.	Sp1	WAF1	1	ACTIVATION	False
11121	11314	22001409:6:SP1:CDKN1A	Finally, the synergistic regulation of p21([TG]/Cip1) gene expression by Zac1 and [TF] is mediated by endogenous p53 protein and p53-responsive elements in HeLa cells.	Sp1	WAF1	0	UNDEFINED	False
11122	11315	22005459:0:YY1:VIM	CpG methylation prevents [TF]-mediated transcriptional activation of the [TG] promoter.	YY1	vimentin	1	ACTIVATION	False
11123	11316	22005459:6:YY1:VIM	Electrophoretic mobility shift assay (EMSA) and transient transfection experiments demonstrated that [TF] is a key transcriptional activator regulating [TG] expression and that CpG methylation is sufficient to prevent the binding of YY1 to the vimentin promoter.	YY1	vimentin	1	ACTIVATION	False
11124	11317	22005459:7:YY1:VIM	These data suggest that the inability of [TF] to access the hypermethylated promoter may be one of the mechanisms that mediate [TG] downregulation.	YY1	vimentin	1	ACTIVATION	True
11125	11318	22005519:4:TCF7L2:CCND1	TCF-dependent transcriptional activity and [TG] promoter activity were revealed to be inhibited via suppression of transcription factor 7-like 2 ([TF]) expression.	TCF7L2	cyclin D1	1	ACTIVATION	False
11126	11319	22005519:6:TCF7L2:CCND1	Moreover, RNAi-mediated depletion of endogenous [TF] resulted in reduced [TG] promoter activity and protein expression, and the overexpression of TCF7L2 overrode the inhibition of the TCF-dependent transcriptional activity and cyclin D1 promoter activity induced by DIF-1.	TCF7L2	cyclin D1	1	ACTIVATION	False
11127	11320	22022540:7:LEF1:FASLG	Co-transfection of [TF] and -catenin transcription factors significantly increased [TG] promoter activities, suggesting that FasL is a target gene of the -catenin/T-cell factor pathway.	LEF-1	FasL	1	ACTIVATION	False
11128	11321	22039255:9:DMTF1:CDKN1A	Steady-state expression and Induction of [TG] (p21) and Arf were impaired in HSCs from [TF](-/-) mice.	Dmtf1	CDKN1a	1	ACTIVATION	False
11129	11322	22046379:10:ATF3:CDKN1A	Cancer-associated [TF], by contrast, represses these pro-apoptotic genes in addition to [TG]/p21.	ATF3	CDKN1A	2	REPRESSION	False
11130	11323	22046489:4:YY1:WNT1	Gold-2a promoted the association of [TF] and suppressor of zeste 12 (Suz12; a component of the polycomb repressor complex 2) with the [TG] promoter.	YY1	WNT1	0	UNDEFINED	False
11131	11324	22046489:6:YY1:WNT1	Gold-2a promoted the nuclear accumulation and abolished the nuclear exportation of [TF], resulting in a persistent inhibition of [TG] expression and a cell cycle arrest at G1/S phase.	YY1	WNT1	2	REPRESSION	True
11132	11325	22046489:8:YY1:WNT1	Thus, the present study extends the understanding of the anti-tumor mechanism of gold-2a to the epigenetic level, which involves the modulation of the dynamic interactions between [TF] and a specific region of the [TG] promoter.	YY1	WNT1	0	UNDEFINED	False
11133	11326	22052014:12:EGR1:SLC9A2	Furthermore, we show that transcription factor [TF] acts as an intermediate effector molecule that links the upstream signaling cues to the long-term stimulation of [TG] expression by PMA in C2BBe1 cells.	Egr-1	NHE2	1	ACTIVATION	False
11134	11327	22052014:2:EGR1:SLC9A2	Our earlier studies have shown that mitogenic agent phorbol 12-myristate 13-acetate (PMA) induces the expression of [TG] through activation of transcription factor [TF] (Egr-1) and its interactions with the NHE2 promoter.	early growth response-1	NHE2	1	ACTIVATION	False
11135	11328	22056786:8:ETS1:GATA4	We found that [TF], FLI1, and ERG were strongly expressed in the heart at embryonic day 8.5 and that ETS1 and ERG bound to the endogenous [TG] enhancer in cultured endothelial cells.	ETS1	Gata4	0	UNDEFINED	False
11136	11329	22069189:7:PITX3:ALDH1A1	Furthermore, we show that regulation of Ahd2-mediated RA signaling represents only one aspect of the [TF] downstream cascade, as Vmat2, Dat, Ahd2 ([TG]), En1, En2 and Cck were unaffected by RA treatment and are (subset) specifically modulated by Pitx3.	Pitx3	Aldh1a1	0	UNDEFINED	False
11137	11330	22072987:10:SMAD1:SMAD6	While [TG] was one of [TF] target genes to be upregulated by BMP2 exposure, Smad6 repression in Ras-activated cells with increased enrichment of Ezh2 and gain of H3K27me3 suggested epigenetic disruption of negative feedback by Polycomb.	Smad1	Smad6	0	UNDEFINED	True
11138	11331	22076197:10:ARNT:VEGFA	The recruitment of STAT3, [TF] and HIF-1 to the [TG] promoter was inhibited by eupatilin treatment.	ARNT	VEGF	0	UNDEFINED	False
11139	11332	22076197:6:ARNT:VEGFA	Using a chromatin immunoprecipitation assay, we tested whether eupatilin affects the recruitment of signal transducer and activator of transcription 3 (STAT3), [TF] (ARNT) and hypoxia-inducible factor-1 (HIF-1) to the human [TG] promoter.	aryl hydrocarbon receptor nuclear translocator	VEGF	0	UNDEFINED	False
11140	11333	22083261:7:AP1:IFNB1	[TG] is transcriptionally upregulated by interferon regulatory factor 3 (IRF-3), NF-kB and activator protein-1 ([TF]), and the binding of IFN-beta to IFN-alpha/beta receptor (IFNAR) stimulates the transcription of IFN-alpha genes or other interferon stimulated genes (ISGs), which induces host antiviral activities, whereas host transcription suppression including IFN-beta gene by NSs prevents the gene upregulations of those ISGs in response to viral replication although IRF-3, NF-kB and activator protein-1 (AP-1) can be activated by RVFV7.	AP-1	IFN-beta	1	ACTIVATION	False
11141	11334	22083261:7:NFKB:IFNB1	[TG] is transcriptionally upregulated by interferon regulatory factor 3 (IRF-3), [TF] and activator protein-1 (AP-1), and the binding of IFN-beta to IFN-alpha/beta receptor (IFNAR) stimulates the transcription of IFN-alpha genes or other interferon stimulated genes (ISGs), which induces host antiviral activities, whereas host transcription suppression including IFN-beta gene by NSs prevents the gene upregulations of those ISGs in response to viral replication although IRF-3, NF-kB and activator protein-1 (AP-1) can be activated by RVFV7.	NF-kB	IFN-beta	1	ACTIVATION	False
11142	11335	22086850:5:E2F1:MMP15	Chromatin immunoprecipitation assays showed the association of [TF] with the MMP9, MMP14, and [TG] promoters, and transient transfection experiments showed that these promoters are E2F responsive.	E2F1	MMP15	0	UNDEFINED	True
11143	11336	22095691:6:CEBPB:MMP13	Human genetic studies failed to show the association of human [TF] gene polymorphisms with knee OA, nor was there a genetic variation around the identified responsive region in the human [TG] promoter.	CEBPB	MMP13	0	UNDEFINED	True
11144	11337	22101269:7:MYB:BCL2	Transfection with [TF] siRNAs blocked the increase of Slug (SNAI2) and [TG] expression and reversed the decrease in E-cadherin expression induced by TGF- treatment.	c-Myb	Bcl-2	1	ACTIVATION	False
11145	11338	22107958:2:NFE2L2:HMOX1	The role of [TF] in up-regulation of [TG] and other phase II genes is well established.	Nrf2	HO-1	1	ACTIVATION	False
11146	11339	22107958:7:BACH1:HMOX1	Overexpression of [TF], together with MafK, represses basal and UVA-mediated [TG] protein expression, whereas silencing of the Bach1 gene by Bach1-specific siRNAs causes robust enhancement of constitutive HO-1 levels.	Bach1	HO-1	2	REPRESSION	False
11147	11340	22107958:7:MAFK:HMOX1	Overexpression of Bach1, together with [TF], represses basal and UVA-mediated [TG] protein expression, whereas silencing of the Bach1 gene by Bach1-specific siRNAs causes robust enhancement of constitutive HO-1 levels.	MafK	HO-1	2	REPRESSION	False
11148	11341	22108192:6:STAT3:PLK1	[TF] directly activated transcription of [TG] in esophageal cancer cells and mouse embryonic fibroblast cell NIH3T3.	Stat3	PLK1	1	ACTIVATION	False
11149	11342	22110141:0:SP7:VEGFA	Transcriptional regulation of Vascular Endothelial Growth Factor ([TG]) by osteoblast-specific transcription factor [TF] (Osx) in osteoblasts.	Osterix	VEGF	0	UNDEFINED	False
11150	11343	22115574:8:KLF3:WEE1	Therefore, we concluded that [TF] is a transcriptional repressor for [TG] gene.	KLF3	wee1	2	REPRESSION	False
11151	11344	22115966:2:EGR1:IGF1R	Here we report that [TF] transcriptionally regulates the expression of [TG] (IGF-1R), which is highly expressed in primary prostate cancer.	EGR-1	insulin-like growth factor-1 receptor	0	UNDEFINED	False
11152	11345	22115966:3:EGR1:IGF1R	We find that ectopic expression of [TF] causes increase in [TG] expression, while knockdown of EGR-1 leads to dramatically decrease in IGF-1R expression.	EGR-1	IGF-1R	1	ACTIVATION	False
11153	11346	22115966:4:EGR1:IGF1R	Results from chromatin immunoprecipitation (ChIP) and reporter assay show that the [TF] directly binds to the human [TG] gene and triggers the target gene expression.	EGR-1	IGF-1R	1	ACTIVATION	False
11154	11347	22115966:5:EGR1:IGF1R	[TF] activates Erk and Akt pathway through regulation of [TG], and thus promote prostate cancer cell growth.	EGR-1	IGF-1R	0	UNDEFINED	True
11155	11348	22115966:6:EGR1:IGF1R	Taken together, these results suggest that [TF] may stimulate prostate cancer cell growth through up-regulation of [TG] and indicate that down-regulation of EGR-1 could be an effective therapeutic approach against prostate cancer.	EGR-1	IGF-1R	1	ACTIVATION	False
11156	11349	22120521:3:STAT3:NOX1	We demonstrate the capacity of [TF] (STAT3) to activate [TG]'s transcription, as well as cooperative regulation by janus kinase 1 and 3 (JAK1 and JAK3).	signal transducer and activator of transcription 3	Nox1	1	ACTIVATION	False
11157	11350	22120521:4:STAT3:NOX1	We find that regulator of G-protein signaling 2 (RGS2) inhibits [TF]-mediated [TG] transcription, and can itself be repressed by TLR2; Nox1 induction upon RGS2 down-regulation is controlled by protein kinase C- (PKC-) and phospholipase D2 (PLD2).	STAT3	Nox1	1	ACTIVATION	False
11158	11351	22120721:6:MYCN:CCNE1	Moreover, [TF], an oncoprotein in the pathogenesis of high-risk neuroblastomas, is able to counteract the death-inducing effect of BMI1 knockdown by activating [TG] transcription.	MYCN	CCNE1	1	ACTIVATION	False
11159	11352	22125028:0:SP1:MKI67	Analysis of human [TG] gene promoter and identification of the [TF] binding sites for Ki-67 transcription.	Sp1	Ki-67	0	UNDEFINED	True
11160	11353	22125028:6:SP1:MKI67	The deletion mutagenesis, together with the dual luciferase reporter assay, indicated that these [TF] binding sites, particularly the region from -170 to -145 nt, were involved in positive regulation of the [TG] gene expression.	Sp1	Ki-67	1	ACTIVATION	False
11161	11354	22125028:7:SP1:MKI67	Collectively, it was demonstrated that the region from -223 to +12 nt could drive the transcription of the [TG] gene, and the [TF] binding site is essential to transcriptional regulation of the Ki-67 gene.	Sp1	Ki-67	0	UNDEFINED	False
11162	11355	22128168:2:AP1:MMP13	Here we show by reporter assay that the activator protein 1 ([TF]) (binding site in the promoter region of [TG] gene is primarily responsible for its transcriptional activation by Wnt5a-Ror2 signaling in osteosarcoma cell lines SaOS-2 and U2OS.	AP1	MMP-13	1	ACTIVATION	False
11163	11356	22130069:8:SMAD4:PAK1	In fact, [TF]-expressed cancer tissues not only show the elevated expression of [TG], but also support our hypothesis that Smad4 induces PUMA-mediated cell death through PAK1 suppression.	Smad4	PAK1	1	ACTIVATION	False
11164	11357	22134960:0:SP1:CTSE	Role of the transcription factor [TF] in regulating the expression of the [TG] gene.	Sp1	murine cathepsin E	0	UNDEFINED	False
11165	11358	22138107:0:NFKB:CLDN5	TNF-alpha induced NFB signaling and p65 ([TF]) overexpression repress [TG] promoter in mouse brain endothelial cells.	RelA	Cldn5	2	REPRESSION	False
11166	11360	22138107:6:NFKB:CLDN5	Overexpression of the NFB subunit p65 ([TF]) alone repressed [TG] promoter activity in mouse brain endothelial cells.	RelA	Cldn5	2	REPRESSION	False
11167	11362	22138223:7:GATA1:PLK2	In summary, these data demonstrate that acetylation plays a crucial role in [TG] expression and acetylation of [TF] by TSA treatment may upregulate their DNA-binding affinities, resulting in the activation of Plk2 promoter.	GATA-1	Plk2	1	ACTIVATION	False
11168	11363	22138754:5:JUN:EPO	At the molecular level, we show that the PDGF-BB-PDGFR-b signaling system activates the [TG] promoter, acting in part through transcriptional regulation by the transcription factor Atf3, possibly through its association with two additional transcription factors, [TF] and Sp1.	c-Jun	EPO	1	ACTIVATION	False
11169	11364	22140473:7:STAT3:ENPP2	An association between [TF] and the [TG] promoter, which contains a number of putative Stat3 binding sites, was determined by chromatin immunoprecipitation.	Stat3	ATX	0	UNDEFINED	False
11170	11365	22140473:8:STAT3:ENPP2	These observations suggest that activated [TF] may regulate the migration of breast cancer cells through the regulation of [TG].	Stat3	ATX	0	UNDEFINED	False
11171	11366	22154382:11:JUN:IRAK3	Specifically, phosphoinositide 3-kinase activation led to [TF] binding to human [TG] gene promoter and IRAK-M upregulation.	c-Jun	IRAK-M	1	ACTIVATION	False
11172	11367	22155889:11:NR0B2:ACAT2	Peroxisome proliferator-activated receptor gamma coactivator 1 (PCG1), a coactivator of HNF4, increased [TG] expression, while small heterodimer partner ([TF]), a corepressor of HNF4, decreased ACAT2 expression.	SHP	ACAT2	2	REPRESSION	False
11173	11368	22158614:0:ELF3:MMP13	E74-like factor 3 ([TF]) impacts on matrix metalloproteinase 13 ([TG]) transcriptional control in articular chondrocytes under proinflammatory stress.	ELF3	MMP13	0	UNDEFINED	False
11174	11369	22158614:3:AP1:MMP13	Here we report that ELF3 directly controls [TG] promoter activity by targeting an E26 transformation-specific sequence binding site at position -78 bp and by cooperating with [TF].	AP-1	MMP13	0	UNDEFINED	False
11175	11370	22158614:3:ELF3:MMP13	Here we report that [TF] directly controls [TG] promoter activity by targeting an E26 transformation-specific sequence binding site at position -78 bp and by cooperating with AP-1.	ELF3	MMP13	0	UNDEFINED	True
11176	11371	22158614:4:ELF3:MMP13	In addition, ELF3 binding to the proximal [TG] promoter is enhanced by IL-1 stimulation in chondrocytes, and the IL-1-induced MMP13 expression is inhibited in primary human chondrocytes by siRNA-ELF3 knockdown and in chondrocytes from [TF](-/-) mice.	Elf3	MMP13	1	ACTIVATION	False
11177	11372	22158614:5:ELF3:MMP13	Further, we found that MEK/ERK signaling enhances [TF]-driven [TG] transactivation and is required for IL-1-induced ELF3 binding to the MMP13 promoter, as assessed by chromatin immunoprecipitation.	ELF3	MMP13	1	ACTIVATION	False
11178	11373	22159222:3:MYC:RHOA	miR-34a was also found to repress [TG] expression by suppressing the [TF]-Skp2-Miz1 transcriptional complex that activates RhoA.	c-Myc	RhoA	1	ACTIVATION	False
11179	11374	22159222:4:MYC:RHOA	Overexpression of [TF] reversed miR-34a suppression of [TG] expression and inhibition of cell invasion, suggesting that miR-34a inhibits invasion by suppressing RhoA through c-Myc.	c-Myc	RhoA	1	ACTIVATION	False
11180	11375	22162832:5:YY1:GBP1	Moreover, we identified [TF] (Yin Yang 1) as the downstream transcriptional regulator regulating EGFR-driven [TG] expression.	YY1	GBP1	0	UNDEFINED	False
11181	11376	22166975:8:FOXO1:MEN1	A major PI3K/Akt substrate, [TF], was shown to enhance menin transcription levels by binding the promoter region of the [TG] gene.	Foxo1	Men1	1	ACTIVATION	False
11182	11377	22168911:10:LEF1:MMP2	Both Wnt3a treatment and [TF] overexpression induced [TG] transcription but this effect was completely abrogated in the presence of Lef1 siRNA.	Lef1	MMP2	1	ACTIVATION	False
11183	11378	22168911:11:LEF1:MMP2	Inhibition of [TF] also reduced basal [TG] levels suggesting that Lef1 regulates MMP2 expression even in the absence of exogenous Wnt pathway activation.	Lef1	MMP2	1	ACTIVATION	False
11184	11379	22168911:14:LEF1:MMP2	The Wnt target [TF] specifically regulates [TG] expression in these cells and promotes endothelial cell invasion.	Lef1	MMP2	0	UNDEFINED	False
11185	11380	22172947:0:ARID3A:CDKN1A	Cooperation between [TF] and p53 in the transcriptional activation of p21[TG] in response to DNA damage.	ARID3A	WAF1	1	ACTIVATION	False
11186	11381	22172947:9:ARID3A:CDKN1A	These results indicate both cooperative and interdependent roles for [TF] and p53 in the transcriptional activation of p21([TG]) in response to DNA damage.	ARID3A	WAF1	1	ACTIVATION	False
11187	11382	22174042:2:EGR1:GCLC	We recently reported that quercetin increased catalytic subunit of -glutamylcysteine ligase ([TG]) via the interaction of [TF] to GCLC promoter in INS-1 beta-cells.	EGR-1	GCLC	1	ACTIVATION	False
11188	11383	22174410:3:JUND:GCM1	Here we show that Nfe2 represses [TF] DNA-binding activity to the [TG] promoter during syncytiotrophoblast differentiation.	JunD	Gcm1	0	UNDEFINED	True
11189	11384	22174410:6:JUND:GCM1	Nfe2 modulates [TF] binding to the [TG] promoter via acetylation, as reducing JunD acetylation using the histone acetyltransferase inhibitor curcumin reverses the increased JunD DNA-binding activity observed in the absence of Nfe2.	JunD	Gcm1	0	UNDEFINED	False
11190	11385	22174936:4:TTF1:PTGS2	Promoter assays and electrophoretic mobility shift assays showed that [TF] inhibited [TG] transcription by binding to specific binding domains in the COX-2 promoter.	TTF-1	COX-2	2	REPRESSION	False
11191	11386	22174936:6:TTF1:PTGS2	These results suggest that [TF] is physiologically involved in the control of thermogenesis by regulating [TG] transcription in the brain.	TTF-1	COX-2	0	UNDEFINED	False
11192	11387	22174951:12:NFKB:VEGFA	Chromatin immunoprecipitation assays demonstrated an interaction of [TF] with the [TG] promoter in stretched primary cardiomyocytes.	NFkB	VEGF	0	UNDEFINED	False
11194	11389	22184616:0:TP53:SLC16A1	Regulation of monocarboxylate transporter [TG] expression by [TF] mediates inward and outward lactate fluxes in tumors.	p53	MCT1	0	UNDEFINED	False
11195	11390	22184616:3:TP53:SLC16A1	In this study, we identified a direct link between [TF] function and [TG] expression.	p53	MCT1	0	UNDEFINED	False
11196	11391	22184616:5:TP53:SLC16A1	[TF] interacted directly with the [TG] gene promoter and altered MCT1 mRNA stabilization.	p53	MCT1	0	UNDEFINED	False
11197	11392	22185819:7:E2F1:CDK2	Moreover, constitutive expression of exogenous [TF] prevented the artemisinin-induced cell cycle arrest and downregulation of [TG] and cyclin E gene expression.	E2F1	CDK2	1	ACTIVATION	True
11198	11393	22197621:7:AHR:BRCA1	Additionally, we found that TCDD enhanced the association of the [TF]; DNA methyl transferase (DNMT)1, DNMT3a and DNMT3b; methyl binding protein (MBD)2; and trimethylated H3K9 (H3K9me3) with the [TG] promoter.	AhR	BRCA-1	0	UNDEFINED	False
11199	11394	22198213:3:TP53:FOSL1	In addition, we found that [TF] indirectly regulates [TG] expression via a miR-34a-dependant manner in colon cancer cells.	p53	Fra-1	0	UNDEFINED	False
11201	11396	22198213:8:TP53:FOSL1	Taken together, our in vitro data suggest that [TF] regulates [TG] expression, and eventually cell migration/invasion, via a miR-34a-dependent manner.	p53	Fra-1	0	UNDEFINED	False
11203	11398	22203674:2:MTA1:HMMR	Here, we found for the first time that [TF] (metastatic tumor antigen 1), a master chromatin modifier, regulates the expression of [TG] and, consequently, its function in breast cancer cell motility and invasiveness.	MTA1	HMMR	0	UNDEFINED	False
11204	11399	22203674:4:MTA1:HMMR	Furthermore, [TF] is required for optimal expression of [TG].	MTA1	HMMR	1	ACTIVATION	False
11205	11400	22203674:5:JUN:HMMR	The underlying mechanism includes interaction of the MTA1RNA polymerase II[TF] coactivator complex with the [TG] promoter to stimulates its transcription.	c-Jun	HMMR	1	ACTIVATION	False
11206	11401	22203674:5:MTA1:HMMR	The underlying mechanism includes interaction of the [TF]RNA polymerase IIc-Jun coactivator complex with the [TG] promoter to stimulates its transcription.	MTA1	HMMR	1	ACTIVATION	False
11207	11402	22203674:7:MTA1:HMMR	These findings reveal a regulatory role for [TF] as an upstream coactivator of [TG] expression and resulting biological phenotypes.	MTA1	HMMR	1	ACTIVATION	False
11208	11403	22205655:12:YBX1:E2F1	[TF] regulated expression of an [TG] promoter-reporter construct in A549 cells (eg, relative E2F1 promoter activity with control siRNA = 4.04; with YB-1 siRNA = 1.40, difference= -2.64, 95% confidence interval = -3.57 to -1.71, P < .001) and bound to the promoters of several well-defined E2F1 target genes.	YB-1	E2F1	0	UNDEFINED	True
11209	11404	22206000:5:MEOX1:CDKN1A	We compared the ability of [TF] and MEOX2 to activate p21(CIP1/[TG]) and p16(INK4a) expression and induce endothelial cell cycle arrest.	MEOX1	WAF1	1	ACTIVATION	False
11210	11405	22206000:6:MEOX1:CDKN1A	Our results demonstrate for the first time that [TF] regulates the MEOX2 target genes p21(CIP1/[TG]) and p16(INK4a).	MEOX1	WAF1	0	UNDEFINED	False
11211	11406	22214764:2:ZNF148:CDKN1A	p53 mutants may interact with [TF] that transcriptionally regulates p21([TG]) (p21).	ZBP-89	Waf1	0	UNDEFINED	False
11212	11407	22231735:5:SOX4:CDKN1A	Cells stably overexpressing [TF] showed significant decreases in proliferation rate, along with increases in expression of p21([TG]), as well as TCF4, in contrast to increased cell growth observed with knockdown.	Sox4	WAF1	1	ACTIVATION	False
11213	11408	22234186:3:ZBTB18:ID1	Here, we report that a transcriptional factor, [TF], negatively regulates all four Id genes ([TG]-Id4) in developing cerebral cortex.	RP58	Id1	2	REPRESSION	False
11214	11409	22234868:3:KLF10:PTTG1	We hypothesized [TF] could be a novel candidate gene in the pathogenesis of genotype negative HCM in humans, possibly through a loss of its repression on [TG] expression.	TIEG1	PTTG1	2	REPRESSION	False
11215	11410	22234868:6:KLF10:PTTG1	The effect of [TF] mutations on SMAD7 and [TG] promoters was studied using transient transfection and luciferase-assays.	TIEG1	PTTG1	0	UNDEFINED	False
11216	11411	22235332:6:MYC:RHOA	miR-34a was found to repress [TG], a regulator of cell migration and invasion, by suppressing [TF]-Skp2-Miz1 transcriptional complex that activates RhoA.	c-Myc	RhoA	1	ACTIVATION	False
11217	11412	22235332:7:MYC:RHOA	Overexpression of [TF] reversed miR-34a suppression of [TG] expression, suggesting that miR-34a inhibits invasion by suppressing RhoA through c-Myc.	c-Myc	RhoA	1	ACTIVATION	False
11218	11413	22239089:4:EGR1:NGB	Overexpression and knockdown of transcription factors p65, p50, [TF] or Sp1 (specificity protein 1) increased and decreased [TG] expression respectively.	Egr1	Ngb	1	ACTIVATION	True
11219	11414	22239089:5:EGR1:NGB	Experimental assessments with transfections of mutational [TG] gene promoter constructs, as well as EMSA (electrophoretic mobility-shift assay) and ChIP (chromatin immunoprecipitation) assays, demonstrated that NF-B family members (p65, p50 and cRel), [TF] and Sp1 bound in vitro and in vivo to the proximal promoter region of the Ngb gene.	Egr1	Ngb	0	UNDEFINED	False
11220	11415	22239089:9:EGR1:NGB	In conclusion, we have identified that NF-B, [TF] and Sp1 played important roles in the regulation of basal [TG] expression via specific interactions with the mouse Ngb promoter.	Egr1	Ngb	0	UNDEFINED	True
11221	11416	22240023:4:E2F1:SELE	Further, chromatin immunoprecipitations show that [TG] is an [TF] responsive gene and nicotine stimulation results in increased recruitment of E2F1 on E-selectin promoter.	E2F1	E-selectin	0	UNDEFINED	True
11222	11417	22240023:5:E2F1:SELE	Inhibiting [TF] activity using RRD-251, a disruptor of the Rb-Raf-1 kinase interaction, could significantly inhibit the nicotine-induced recruitment of E2F1 to the [TG] promoter as well as E-selectin expression.	E2F1	E-selectin	1	ACTIVATION	False
11223	11418	22252296:0:STAT3:SKP2	[TF] induces oncogenic [TG] expression in human cervical carcinoma cells.	Stat3	Skp2	1	ACTIVATION	False
11224	11419	22252296:6:STAT3:SKP2	Using luciferase reporter and ChIP assays, we show that [TF] binds to the promoter region of [TG] and promotes its activity through recruiting P300.	Stat3	Skp2	1	ACTIVATION	False
11227	11422	22275273:10:NR4A2:MMP13	[TF] directly transactivated the proximal [TG] promoter, and a point mutation in the DNA binding domain of NR4A2 abolished transcriptional activation.	NR4A2	MMP-13	1	ACTIVATION	False
11228	11423	22278040:11:NR2F2:REN	We conclude that both [TF] and Nr2f6 negatively regulate [TG] promoter activity, but may do so by divergent mechanisms.	Nr2f2	renin	2	REPRESSION	False
11229	11424	22278040:4:NR2F2:REN	Here, we determined whether another nuclear receptor, [TF] (Coup-TFII, Arp-1), identified in a screen of proteins that bind the HRE, also regulates [TG] expression.	Nr2f2	renin	0	UNDEFINED	False
11230	11425	22278040:5:NR2F2:REN	Luciferase assays indicate that [TF] negatively regulates the [TG] promoter more potently than Nr2f6.	Nr2f2	renin	2	REPRESSION	False
11231	11426	22278040:6:NR2F2:REN	Gel-shift and chromatin immunoprecipitation (ChIP) indicate that [TF] and Nr2f6 can bind directly to the [TG] enhancer through the HRE.	Nr2f2	renin	0	UNDEFINED	False
11232	11427	22278040:8:NR2F2:REN	Interestingly, however, knockdown of [TF] augmented the induction of [TG] expression caused by retinoic acid.	Nr2f2	renin	2	REPRESSION	False
11233	11428	22278040:9:NR2F2:REN	These data indicate that both Nr2f6 and [TF] can negatively regulate the [TG] promoter, under baseline conditions and in response to physiological queues, respectively.	Nr2f2	renin	2	REPRESSION	False
11236	11431	22291912:5:STAT3:SOCS2	Transcription factors [TF], 5 and 6 displayed putative binding sites in the promoter regions of the human [TG] gene.	STAT3	SOCS2	0	UNDEFINED	False
11237	11432	22291912:8:STAT3:SOCS2	In conclusion, our results suggest that TLR4 signaling indirectly increases [TG] in late phase mainly via the production of endogenous type I IFN, and that subsequent IFN receptor signaling activates SOCS2 via [TF] and STAT5.	STAT3	SOCS2	1	ACTIVATION	False
11238	11433	22292060:2:NEUROD1:ATOH1	We have previously shown that neuronal cell fate can be altered towards hair cell fate by eliminating [TF] mediated repression of [TG] expression in neurons.	Neurod1	Atoh1	2	REPRESSION	False
11239	11434	22292066:8:SOX2:ATOH1	However, besides activating [TG], [TF] also promotes the expression of Atoh1 negative regulators and the temporal profile of Atoh1 activation by Sox2 is transient suggesting that Sox2 triggers an incoherent feed-forward loop.	Sox2	Atoh1	1	ACTIVATION	False
11240	11435	22292946:17:EGR1:SREBF1	The highly abundant [TF] bound to the [TG] promoter and contributed to the steatosis observed in the LE rat model.	EGR1	SREBP1c	0	UNDEFINED	False
11241	11436	22296504:0:NFKB:TNFSF13	Transcription of promoter from the human [TG] gene regulated by Sp1 and [TF].	NF-kB	APRIL	0	UNDEFINED	False
11242	11437	22296504:5:NFKB:TNFSF13	Overexpression of Sp1 or [TF] increased the activity of the [TG] promoter.	NF-kB	APRIL	1	ACTIVATION	False
11243	11438	22296504:6:NFKB:TNFSF13	Mithramycin A (inhibitor of Sp1) and Bay11-7082 (inhibitor of [TF]) exhibited an inhibitory activity to [TG] promoter.	NF-kB	APRIL	1	ACTIVATION	False
11244	11439	22305266:2:RELA:CDKN1A	Our previous study indicates that DOX-induced [TF] is able to bind the [TG] promoter to activate its transactivation in the cells.	p65	p21	1	ACTIVATION	False
11245	11440	22305621:0:STAT1:OAS1	Activation of Oas1a gene expression by type I IFN requires both [TF] and STAT2 while only STAT2 is required for [TG] activation.	STAT1	Oas1b	1	ACTIVATION	True
11246	11441	22305621:0:STAT2:OAS1	Activation of Oas1a gene expression by type I IFN requires both STAT1 and [TF] while only STAT2 is required for [TG] activation.	STAT2	Oas1b	1	ACTIVATION	False
11247	11442	22310285:7:FOXO3:SKP2	[TF] is found to be a transcriptional repressor of [TG] gene expression by directly binding to the Skp2 promoter, thereby inhibiting Skp2 protein expression.	Foxo3a	Skp2	2	REPRESSION	False
11248	11443	22318732:0:TCF7L2:CCND1	MUC1-C oncoprotein induces [TF] transcription factor activation and promotes [TG] expression in human breast cancer cells.	TCF7L2	cyclin D1	1	ACTIVATION	False
11249	11444	22318732:5:TCF7L2:CCND1	[TF] and MUC1-C form a complex on the [TG] gene promoter and MUC1-C promotes TCF7L2-mediated transcription by the recruitment of -catenin and p300.	TCF7L2	cyclin D1	1	ACTIVATION	False
11250	11445	22326662:3:SP1:VEGFA	We demonstrate for the first time that LPLI enhances DNA-binding and transactivation activity of [TF] on [TG] promoter in vascular endothelial cells.	Sp1	VEGF	1	ACTIVATION	False
11251	11446	22326662:5:SP1:VEGFA	Activated ERK by LPLI translocates from cytoplasm to nuclear and leads to increasing interaction with [TF], triggering a progressive phosphorylation of Sp1 on Thr453 and Thr739, resulting in the upregulation of [TG] expression.	Sp1	VEGF	1	ACTIVATION	False
11252	11447	22326952:0:FOSL2:LEP	[TF] promotes [TG] gene expression in human and mouse adipocytes.	FOSL2	leptin	1	ACTIVATION	False
11253	11448	22326952:5:FOSL2:LEP	Knockdown of [TF] in human adipocytes decreased LEP expression, and overexpression of Fosl2 increased [TG] expression in mouse adipocytes.	FOSL2	Lep	1	ACTIVATION	False
11254	11449	22326952:6:FOSL2:LEP	Moreover, the elevated LEP expression observed in obesity correlated well with increased [TF] levels in mice and humans, and adipocyte-specific genetic deletion of Fosl2 in mice reduced [TG] expression.	FOSL2	Lep	1	ACTIVATION	False
11255	11450	22326952:7:FOSL2:LEP	Taken together, these data identify [TF] as a critical regulator of [TG] expression in adipocytes.	FOSL2	leptin	0	UNDEFINED	True
11256	11451	22329800:3:AP1:AKR1B10	The present study showed that [TG] is induced by mitogen EGF (epidermal growth factor) and insulin through the [TF] (activator protein-1) signalling pathway.	AP-1	AKR1B10	1	ACTIVATION	False
11257	11452	22329991:5:SMAD3:CTGF	Expression of [TG] in MM cells was induced by the formation of a YAP-TEAD4-[TF]-p300 complex on the CTGF promoter.	Smad3	CTGF	1	ACTIVATION	False
11258	11453	22329991:5:TEAD4:CTGF	Expression of [TG] in MM cells was induced by the formation of a YAP-[TF]-Smad3-p300 complex on the CTGF promoter.	TEAD4	CTGF	1	ACTIVATION	False
11259	11454	22330135:3:STAT3:IKBKE	Ectopic expression of constitutively active [TF] increased [TG] mRNA and protein levels, whereas inhibition of STAT3 reduced IKBKE expression.	STAT3	IKBKE	1	ACTIVATION	False
11260	11455	22330139:11:MYC:TNFSF11	siRNA suppression of [TF] expression markedly decreased CXCL13-induced [TG] and NFATc3 expression in preosteoblast cells.	c-Myc	RANKL	1	ACTIVATION	False
11261	11456	22330139:13:MYC:TNFSF11	In summary, [TF] activation through CXCL13-CXCR5 signaling axis stimulates [TG] expression in stromal/preosteoblast cells.	c-Myc	RANKL	1	ACTIVATION	False
11262	11457	22331133:0:SP1:FASN	Kr-pok increases [TG] expression by modulating the DNA binding of SREBP-1c and [TF] at the proximal promoter.	Sp1	FASN	0	UNDEFINED	False
11263	11458	22333584:0:NFATC2:MYC	Transcriptional regulation of the [TG] promoter by [TF] involves negative and positive NFAT-responsive elements.	NFAT1	c-Myc	0	UNDEFINED	False
11264	11459	22333584:6:NFATC2:MYC	In addition to the proximal site, [TF] directly binds to distal sites in the [TG] promoter with different affinities.	NFAT1	c-Myc	0	UNDEFINED	False
11265	11460	22333584:8:NFATC2:MYC	Furthermore, we demonstrate that cooperation with partner proteins, such as p300, enhances [TF]-mediated transactivation of the [TG] promoter.	NFAT1	c-Myc	1	ACTIVATION	False
11266	11461	22334075:6:PPARG:HK2	[TF] binds to [TG] and pyruvate kinase M promoters to activate transcription.	Peroxisome proliferator-activated receptor gamma	hexokinase 2	1	ACTIVATION	False
11267	11462	22334683:6:FOSB:SERPINB2	This site specifically binds [TF] in [TG]-expressing U937 cells but not in HeLa cells that do not express PAI-2, and overexpression of FosB, c-Fos, or c-Jun in HeLa cells is sufficient to cause derepression of transcription from the SERPINB2 promoter.	FosB	PAI-2	1	ACTIVATION	False
11268	11463	22334683:6:JUN:SERPINB2	This site specifically binds FosB in [TG]-expressing U937 cells but not in HeLa cells that do not express PAI-2, and overexpression of FosB, c-Fos, or [TF] in HeLa cells is sufficient to cause derepression of transcription from the SERPINB2 promoter.	c-Jun	PAI-2	1	ACTIVATION	False
11269	11464	22334683:7:FOSB:SERPINB2	Although [TF] is likely to be involved in transactivator-mediated derepression of [TG] transcription in macrophage-like cells, as exemplified by the U937 cell line, c-Jun may be functional in other cell types.	FosB	PAI-2	1	ACTIVATION	True
11271	11466	2233710:8:AP1:GZMB	Consensus [TF], AP-2, and cAMP response elements are found upstream from the [TG] gene (as are several T-cell-specific consensus elements), but the roles of these elements in CSP-B gene activation have yet to be determined.	AP-1	CSP-B	1	ACTIVATION	True
11272	11467	22345554:9:NR1H4:NR0B2	Set7/9 overexpression in Huh-7 cells significantly enhanced transactivation of the [TG] and BSEP promoters in a ligand-dependent fashion by wild-type [TF] but not the K206R mutant FXR.	FXR	SHP	1	ACTIVATION	False
11273	11468	22347460:7:HSF1:PTGS2	As shown by ChIP analysis, [TF] is recruited to the [TG] promoter rapidly after heat treatment; by using shRNA-mediated HSF1 suppression and HSE-deletion from the COX-2 promoter, we demonstrate that HSF1 plays a central role in the transcriptional control of COX-2 by heat.	HSF1	COX-2	0	UNDEFINED	False
11275	11470	22349830:6:STAT3:CCND1	Electrophoretic mobility shift assay and chromatin immunoprecipitation assays showed inhibited [TF] DNA-binding activity and recruitment at [TG] and c-Myc promoters in pM-treated cells.	Stat3	CyclinD1	0	UNDEFINED	False
11276	11471	22349830:6:STAT3:MYC	Electrophoretic mobility shift assay and chromatin immunoprecipitation assays showed inhibited [TF] DNA-binding activity and recruitment at CyclinD1 and [TG] promoters in pM-treated cells.	Stat3	c-Myc	0	UNDEFINED	False
11277	11472	22353356:11:RARA:ABCA1	In conclusion, [TF] ligands increase [TG]/G1 expression and apoA-I/HDL-mediated cholesterol efflux from macrophages, and modulate ABCG1 promoter activity via LXRE-dependent mechanisms.	RAR	ABCA1	1	ACTIVATION	False
11278	11473	22354042:7:STAT3:HK2	First, miR-155 promotes [TG] transcription by activation of [TF] (STAT3), a transcriptional activator for hk2.	signal transducer and activator of transcription 3	hk2	1	ACTIVATION	False
11279	11474	22354960:13:ETS2:SYK	In conclusion, c-Jun in cooperation with [TF] increases the expression of [TG] and contributes to Syk-mediated heightened calcium responses in SLE T cells.	Ets2	Syk	1	ACTIVATION	False
11280	11475	22354960:13:JUN:SYK	In conclusion, [TF] in cooperation with Ets2 increases the expression of [TG] and contributes to Syk-mediated heightened calcium responses in SLE T cells.	c-Jun	Syk	1	ACTIVATION	False
11281	11476	22354960:4:ETS2:SYK	In the present study, we found that [TG] is regulated by the transcription factor c-Jun in cooperation with [TF].	Ets2	Syk	0	UNDEFINED	True
11282	11477	22355284:7:ARX:PHLDA1	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, [TG], Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Phlda1	1	ACTIVATION	False
11283	11478	22355284:7:ARX:RASGEF1B	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, [TG], and Slit2) in cortical migrating neurons.	Arx	Rasgef1b	2	REPRESSION	False
11284	11479	22355284:7:ARX:TGFB3	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, [TG], and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Tgfb3	1	ACTIVATION	False
11285	11480	22359570:10:LEF1:CTNNAL1	The activation of AP-2 and [TF], followed by [TG] expression, showed a correlation during a 16-hour time course.	LEF-1	CTNNAL1	1	ACTIVATION	False
11286	11481	22359570:11:LEF1:CTNNAL1	Our data suggest that a robust transcriptional [TG] up-regulation occurs during acute ozone-induced stress and is mediated at least in part by ozone-induced recruitments of [TF] and AP-2 to the human CTNNAL1 promoter.	LEF-1	CTNNAL1	1	ACTIVATION	False
11287	11482	22359570:11:TFAP2A:CTNNAL1	Our data suggest that a robust transcriptional [TG] up-regulation occurs during acute ozone-induced stress and is mediated at least in part by ozone-induced recruitments of LEF-1 and [TF] to the human CTNNAL1 promoter.	AP-2	CTNNAL1	1	ACTIVATION	False
11288	11483	22359570:6:LEF1:CTNNAL1	Chromatin immunoprecipitation (ChIP) assay verified that AP-2  and [TF] could be recruited to the [TG] promoter.	LEF-1	CTNNAL1	0	UNDEFINED	False
11289	11484	22359570:6:TFAP2A:CTNNAL1	Chromatin immunoprecipitation (ChIP) assay verified that [TF]  and LEF-1 could be recruited to the [TG] promoter.	AP-2	CTNNAL1	0	UNDEFINED	False
11290	11485	22359570:9:LEF1:CTNNAL1	Pre-treatment with ASOs targeting [TF] AP-2 yielded significant reduction of ozone-stress-induced [TG] expression.	LEF-1and	CTNNAL1	1	ACTIVATION	False
11291	11486	22359570:9:TFAP2A:CTNNAL1	Pre-treatment with ASOs targeting LEF-1and [TF] yielded significant reduction of ozone-stress-induced [TG] expression.	AP-2	CTNNAL1	1	ACTIVATION	False
11292	11487	22362755:4:MTF1:DNMT1	Zinc treatment induces [TG] transcription by increasing the occupancy of [TF] on the Dnmt1 promoter while decreasing SHP expression.	MTF-1	Dnmt1	1	ACTIVATION	False
11294	11489	22371483:0:MYC:CDKN1A	Histone demethylase KDM5B collaborates with TFAP2C and [TF] to repress the cell cycle inhibitor p21(cip) ([TG]).	Myc	CDKN1A	2	REPRESSION	False
11295	11490	22371483:3:MYC:CDKN1A	We demonstrated that while TFAP2C and [TF] can downregulate the [TG] promoter independently, KDM5B acts as a corepressor dependent on the other two proteins.	Myc	CDKN1A	2	REPRESSION	False
11296	11491	22371483:5:MYC:CDKN1A	Silencing of TFAP2C-KDM5B-[TF] led to increased H3K4me3 at the endogenous promoter and full induction of [TG] expression.	Myc	CDKN1A	2	REPRESSION	False
11297	11492	22375010:5:KLF11:DRD2	Here we report the characterization of two antagonistic, chromatin-mediated mechanisms by which [TF], also known as TIEG2 (transforming growth factor--inducible early gene 2) and MODY VII (maturity onset diabetes of the young VII), regulates transcription of the fopamine D2 receptor ([TG]) gene.	KLF11	Drd2	0	UNDEFINED	False
11298	11493	22390138:7:ATF3:EGR1	This resulted from direct binding of [TF] to the [TG] promoter.	Atf3	Egr1	0	UNDEFINED	False
11299	11494	22393465:6:MYB:MYADM	The combination of these 2 approaches, as well as additional validation such as cloning and testing the promoters in reporter assays, confirmed that [TG], LMO2, GATA2, STAT5A, and IKZF1 are target genes of [TF].	c-Myb	MYADM	0	UNDEFINED	False
11300	11495	22400069:7:FOXO1:SCN5A	This finding led us to hypothesize that [TF] regulates Na(V)1.5 expression by directly binding the [TG] promoter and affecting its transcriptional activity.	Foxo1	SCN5a	0	UNDEFINED	True
11301	11496	22406686:4:BCL6:PRDM1	T(H)1 cells increased their [TF]/T-bet ratio in response to limiting IL-2 conditions, which allowed excess Bcl-6 to repress its direct target [TG] (which encodes the transcriptional repressor Blimp-1).	Bcl-6	Prdm1	2	REPRESSION	False
11302	11497	22415301:3:MAZ:VEGFA	Here we report that miR-125b is down-regulated in glioblastoma-associated endothelial cells, resulting in increased expression of its target, [TF] (MAZ), a transcription factor that regulates [TG].	myc-associated zinc finger protein	VEGF	0	UNDEFINED	False
11303	11498	22415975:0:SP1:TNFSF10	[TF], acetylated histone-3 and p300 regulate [TG] transcription: mechanisms of PDGF-BB-mediated VSMC proliferation and migration.	Sp1	TRAIL	0	UNDEFINED	False
11304	11499	22415975:10:SP1:TNFSF10	Furthermore, PDGF-BB treatment increased the physical interaction of [TF], p300 and ac-H3, while chromatin immunoprecipitation studies revealed Sp1, p300 and ac-H3 enrichment on the [TG] promoter.	Sp1	TRAIL	0	UNDEFINED	False
11305	11500	22415975:11:SP1:TNFSF10	Taken together, our studies demonstrate for the first time that PDGF-BB-induced [TG] transcriptional activity requires the cooperation of [TF], ac-H3 and p300, mediating increased expression of TRAIL which is important for VSMC proliferation and migration.	Sp1	TRAIL	1	ACTIVATION	False
11306	11501	22415975:5:SP1:TNFSF10	[TG] mRNA, protein and promoter activity was increased by PDGF-BB and subsequently inhibited by dominant-negative [TF], suggesting that the transcription factor Sp1 plays a role.	Sp1	TRAIL	1	ACTIVATION	False
11307	11502	22415975:6:SP1:TNFSF10	[TF] bound multiple Sp1 sites on the [TG] promoter, including two established (Sp1-1 and -2) and two novel Sp1-5/6 and -7 sites.	Sp1	TRAIL	0	UNDEFINED	False
11308	11503	22415975:9:SP1:TNFSF10	p300 overexpression increased [TG] promoter activity, which was blocked by dominant-negative [TF].	Sp1	TRAIL	1	ACTIVATION	False
11309	11504	22419845:14:MITF:VEGFA	Our results indicate that Tfe3, in conjunction with other [TF]-Tfe members, regulates [TG] expression in the RPE and are consistent with the hypothesis that VEGF expression in RPE cells is regulated as part of their differentiation.	MITF	VEGF	0	UNDEFINED	False
11310	11505	22419845:14:TFE3:VEGFA	Our results indicate that [TF], in conjunction with other MITF-Tfe members, regulates [TG] expression in the RPE and are consistent with the hypothesis that VEGF expression in RPE cells is regulated as part of their differentiation.	Tfe3	VEGF	0	UNDEFINED	False
11311	11506	22427654:8:SP1:CDKN1A	This study indicates that SFN increases p21([TG]) promoter transcription via a mechanism that involves SFN-dependent stabilization of p53 and increased p53 and [TF] binding to their respective response elements in the p21(Cip1) promoter.	Sp1	Cip1	1	ACTIVATION	True
11312	11507	22437631:6:FOSL1:MMP1	Moreover, silencing of galectin-3 inhibited binding of [TF] and c-Jun to promoter sites of [TG] gene.	fra-1	MMP-1	0	UNDEFINED	False
11313	11508	22438909:9:AP1:PRDM1	Further, chromatin immunoprecipitation assays confirmed binding to identified [TF] elements in the [TG] promoter of ectopically expressed c-Jun and of endogenous AP-1 subunits following serum stimulation.	AP-1	BLIMP1	0	UNDEFINED	False
11315	11511	22446105:8:ETS2:CGA	When human embryonic stem cells differentiate in response to bone morphogenetic protein-4 and concentrations of POU5F1 fall and hCG and DLX3 rise, [TF] then occupies its binding site on the [TG] promoter.	ETS2	CGA	0	UNDEFINED	False
11316	11512	22461910:3:FOXM1:HELLS	We have previously shown that [TF] regulates [TG], a SNF2/helicase involved in DNA methylation, implicating FOXM1 in epigenetic regulation.	FOXM1	HELLS	0	UNDEFINED	False
11317	11513	22466652:8:ATF3:SORT1	Moreover, the ER stress target [TF] acted at the SORT1 promoter region as a transcriptional repressor, whereas knockdown of Atf3 mRNA in ob/ob mice led to increased hepatic [TG] levels and decreased apoB and triglyceride secretion.	Atf3	sortilin-1	2	REPRESSION	False
11318	11514	22475487:6:HIF1A:ARC	Using luciferase reporter and ChIP assay, we showed that [TF] directly bound to hypoxia-responsive element located at -419 to -414 of [TG] gene, which is essential for HIF-1-induced expression.	HIF-1	ARC	1	ACTIVATION	False
11319	11515	22476863:6:E2F1:CDKN2D	Moreover, evidence is presented that demonstrates that [TF] is involved in the induction of [TG] following UV treatment, as it is prevented by E2F1 protein ablation and DNA-binding inhibition.	E2F1	p19INK4d	1	ACTIVATION	False
11320	11516	22479354:13:STAT1:GLS	Together, these data indicate that both HIV-1 infection and IFN- treatment increase glutaminase expression through [TF] phosphorylation and by binding to the [TG] promoter.	STAT1	GLS1	1	ACTIVATION	False
11321	11517	22479354:8:STAT1:GLS	IFN- stimulation of [TG] promoter activity correlated to [TF] phosphorylation and was reduced by fludarabine, a chemical that inhibits STAT1 phosphorylation.	STAT1	GLS1	1	ACTIVATION	False
11322	11518	22479354:9:STAT1:GLS	Interestingly, [TF] was found to directly bind to the [TG] promoter in MDM, an effect that was dependent on STAT1 phosphorylation and significantly enhanced by IFN- treatment.	STAT1	GLS1	0	UNDEFINED	False
11323	11519	22488473:7:ASCL1:TGFB1	We find that [TF] directly binds to the regulatory regions of alpha smooth muscle actin (SMA), collagen I, tissue inhibitor of metalloproteinase-1 (TIMP1) and [TG] (TGF1) in activated HSCs while depletion of ASH1 caused broad suppression of fibrogenic gene expression.	ASH1	transforming growth factor beta1	1	ACTIVATION	True
11324	11520	22488648:11:CREM:CCND1	[TF] was found to efficiently repress the expression of [TG] in R545 cells due to the binding of ICER to the CRE in the cyclin D1 promoter.	ICER	cyclin D1	2	REPRESSION	False
11325	11521	22493456:3:E2F1:CASP3	Simultaneous reduction of RB1 and -tubulin protein levels results in an [TF]-dependent up-regulation of apoptotic genes such as [TG].	E2F1	caspase 3	1	ACTIVATION	False
11326	11522	22493480:6:PATZ1:BCL6	Moreover, we show that [TF] is able to bind the [TG] regulatory region, where BCL6 itself acts as a negative regulator, and to contribute to negatively modulate its activity.	PATZ	BCL6	2	REPRESSION	False
11327	11523	22495295:6:CTCF:HMOX1	Transcription factors such as USF1/2, JunB, Sp1, and [TF] were found to associate with regulatory regions of the human [TG] gene in the kidney following rhabdomyolysis.	CTCF	HO-1	0	UNDEFINED	False
11328	11524	22496417:7:SMAD7:APC	We show that [TF] and p38 mitogen-activated protein kinase together regulate the expression of [TG] and cell migration in prostate cancer cells in response to TGF stimulation.	Smad7	APC	0	UNDEFINED	False
11329	11525	22505473:5:CREB1:MMP13	Using electrophoretic mobility shift assays, we identified [TF] as the regulating factor able to only bind to the [TG] promoter when the -104 CpG is demethylated, and confirmed this binding by chromatin immunoprecipitation.	CREB	MMP13	0	UNDEFINED	False
11330	11526	22505473:6:CREB1:MMP13	Finally, we demonstrated that [TF] induces [TG] expression only following treatment of SW1353 with 0.5 M Ca(2+) ionophore A23187.	CREB	MMP13	1	ACTIVATION	False
11331	11527	22507839:5:ATF4:TNC	Overexpression of [TF] increased transcript levels of the four [TG] isoforms in rat vascular SMCs, and ATF-4 knockdown inhibited PDGF-BB-inducible TN-C expression in vitro and injury-inducible TN-C protein expression in the balloon-injured rat artery wall.	ATF-4	TN-C	1	ACTIVATION	False
11332	11528	22508987:6:E2F1:CCNB1	The negative regulation of [TG] by AR is mediated through switching between [TF] and E2F4 on the promoter of cyclin B1.	E2F1	cyclin B1	1	ACTIVATION	True
11333	11529	22508987:6:E2F4:CCNB1	The negative regulation of [TG] by AR is mediated through switching between E2F1 and [TF] on the promoter of cyclin B1.	E2F4	cyclin B1	2	REPRESSION	True
11334	11530	22508987:7:E2F1:CCNB1	[TF] binds to the [TG] promoter and maintains its expression and subsequent cell cycle progression in AR-negative stromal cells or AR-positive stromal cells when androgens are depleted.	E2F1	cyclin B1	1	ACTIVATION	False
11335	11531	22508987:8:E2F1:CCNB1	Upon stimulation with androgen in AR-positive stromal cells, [TF] is displaced from the binding site by AR and replaced with E2F4, leading to the recruitment of the silencing mediator for retinoid and thyroid hormone receptor (SMRT)/histone deacetylase 3 (HDAC3) corepressor complex and repression of [TG] at the chromatin level.	E2F1	cyclin B1	1	ACTIVATION	True
11336	11532	22508987:8:E2F4:CCNB1	Upon stimulation with androgen in AR-positive stromal cells, E2F1 is displaced from the binding site by AR and replaced with [TF], leading to the recruitment of the silencing mediator for retinoid and thyroid hormone receptor (SMRT)/histone deacetylase 3 (HDAC3) corepressor complex and repression of [TG] at the chromatin level.	E2F4	cyclin B1	2	REPRESSION	False
11337	11533	22508987:9:E2F1:CCNB1	The switch between [TF] and E2F4 at the E2F binding site of the [TG] promoter coincides with an androgen-dependent interaction between AR and E2F1 as well as the cytoplasmic-to-nuclear translocation of E2F4.	E2F1	cyclin B1	0	UNDEFINED	False
11338	11534	22508987:9:E2F4:CCNB1	The switch between E2F1 and [TF] at the E2F binding site of the [TG] promoter coincides with an androgen-dependent interaction between AR and E2F1 as well as the cytoplasmic-to-nuclear translocation of E2F4.	E2F4	cyclin B1	0	UNDEFINED	False
11339	11535	22509890:5:SP1:POLI	We further identified [TF] and Oct-1 binding sites present in the [TG] promoter.	Sp1	POLI	0	UNDEFINED	False
11340	11536	22514284:10:FOSL1:MMP9	Interestingly, [TF] controls the expression of matrix metalloproteinases [TG] and MMP13, which are critical modulators of stromal extracellular matrix remodeling.	FRA-1	MMP9	0	UNDEFINED	True
11341	11537	22514284:8:ESR1:FOSL1	Furthermore, chromatin immunoprecipitation demonstrated direct recruitment of [TF] to an estrogen response element in the [TG] promoter.	ESR1	Fra-1	0	UNDEFINED	False
11342	11538	22514348:10:FOSL1:MMP9	In addition, we found an association of LMP2A with [TG] expression in NPC tumor biopsy specimens, where [TF] was a major mediation factor.	Fra-1	MMP9	0	UNDEFINED	True
11343	11539	22521346:10:RARA:TNFRSF12A	Demonstration of the involvement of cytoplasmic AFP in [TF]-mediated expression of the [TG] gene strongly indicates AFP plays a signal molecule-like role in the regulation of hepatocellular carcinoma growth.	RAR	Fn14	1	ACTIVATION	False
11344	11540	22521346:5:RARA:TNFRSF12A	[TF] is able to interact with cytoplasmic AFP and binds to the element of the regulatory region of the [TG] gene in the neoplastic tissue of HCC patients.	RAR	Fn14	0	UNDEFINED	False
11346	11542	22528488:12:STAT3:PROK2	We propose that such a role of [TF] reflects at least in part its ability to regulate [TG] expression.	Stat3	Bv8	0	UNDEFINED	False
11347	11543	22528488:7:STAT3:PROK2	Moreover, chromatin immunoprecipitation studies indicate that G-CSF significantly induces binding of phospho-[TF] to the [TG] promoter, which was abolished by pretreatment with the Stat3 inhibitor WP1066.	Stat3	Bv8	0	UNDEFINED	False
11348	11544	22528488:8:STAT3:PROK2	Luciferase assay confirmed that the phospho-[TF] binding site is a functional enhancer of the [TG] promoter.	Stat3	Bv8	1	ACTIVATION	False
11349	11545	22533991:0:FOXO1:CPT1A	[TG] (CPT1A): a transcriptional target of PAX3-[TF] and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cells.	FKHR	Carnitine palmitoyltransferase 1A	0	UNDEFINED	True
11350	11546	22533991:11:FOXO1:CPT1A	Taken together, we have identified [TG] as a novel transcriptional target of PAX3-[TF] and revealed the novel function of CPT1A in promoting cell motility.	FKHR	CPT1A	0	UNDEFINED	True
11351	11547	22533991:8:FOXO1:CPT1A	We found that when PAX3-[TF] was downregulated, the expression of [TG] (CPT1A) decreased.	FKHR	carnitine palmitoyltransferase 1A	1	ACTIVATION	False
11352	11548	22533991:9:FOXO1:CPT1A	We showed that PAX3-[TF] binds to a paired-domain binding-site in the [TG] promoter region, indicating that CPT1A is a novel transcriptional target of PAX3-FKHR.	FKHR	CPT1A	0	UNDEFINED	False
11353	11549	22536409:4:YY1:PSCA	In the present study, we identified the multi-functional transcription factor Yin Yang 1 ([TF]) as a modulator of [TG] expression in prostate epithelial cell lines.	YY1	PSCA	0	UNDEFINED	False
11354	11550	22536409:7:YY1:PSCA	We identified two direct [TF] binding sites within the [TG] promoter, and showed that the upstream site inhibited, while the downstream site, proximal to the androgen-responsive element, stimulated PSCA promoter activity.	YY1	PSCA	0	UNDEFINED	True
11355	11551	22538237:8:SP1:PPP1R14A	[TF] binding to the region was more prominent in intact aorta tissues, compared with the SM cell culture, where the [TG] gene is repressed.	Sp1	CPI-17	0	UNDEFINED	False
11356	11552	22541814:15:NR1I2:HMOX1	Our results suggest that the interaction between thrombin and [TF]/PAR3 increases [TG] expression in human synovial fibroblasts through the PKC, c-Src, and Nrf2 signaling pathways.	PAR1	HO-1	1	ACTIVATION	False
11357	11553	22542550:0:PGR:CCND1	[TF] and SRC-1 participate in the regulation of VEGF, EGFR and [TG] expression in human astrocytoma cell lines.	Progesterone receptor	Cyclin D1	0	UNDEFINED	False
11358	11554	22545125:13:AP1:RGS4	Gel shift and chromatin immunoprecipitation assays validated that IL-1 increased the in vitro and ex vivo binding activities of [TF] within rabbit [TG] promoter.	AP1	Rgs4	0	UNDEFINED	False
11360	11556	22546552:9:ETS1:ORMDL3	Our findings indicate that [TF], p300 and CREB binding to the promoter region drive the [TG] transcription.	Ets-1	ORMDL3	1	ACTIVATION	False
11361	11557	22546605:11:AP1:CLDN2	Furthermore, the activity was decreased by the deletion or mutation of the [TF] binding site of [TG] promoter.	AP-1	claudin-2	1	ACTIVATION	False
11362	11558	22547438:9:USF2:AGT	Our data from chromatin immunoprecipitation assays suggests that this decrease in h[TG] is attributed to decreased [TF] binding to the hAGT promoter.	USF2	AGT	1	ACTIVATION	True
11363	11559	22547683:6:NEUROG2:CCNE2	The use of [TF]VP16 and NEUROG2EnR, acting as the constitutive activator and repressor, respectively, indicates that NEUROG2 indirectly represses CCND1 and [TG] but opens the possibility that CCNE2 is also repressed by a direct mechanism.	NEUROG2	CCNE2	2	REPRESSION	False
11364	11560	22550000:9:FOXO3:SDC2	[TF] overexpression resulted in increased [TG] expression in sensitive and resistant-derived cells.	Foxo3a	syndecan-2	1	ACTIVATION	False
11365	11561	22550166:8:JUN:CCND1	Molecular studies revealed that this may be due in part to direct steroid regulation of c-jun-NH(2)-kinase (JNK), signaling to [TF] and Fos at the [TG] promoter.	Jun	cyclin D1	0	UNDEFINED	False
11366	11562	22553215:0:AHR:CD55	Selective [TF] modulator-mediated repression of [TG] expression induced by cytokine exposure.	aryl hydrocarbon receptor	CD55	2	REPRESSION	False
11367	11563	22561086:6:MLX:TXNIP	The binding of Mondo:[TF] to the [TG] gene promoter is reduced, suggesting that the transcription of the Txnip gene is repressed by metformin.	MLX	Txnip	0	UNDEFINED	False
11368	11564	22563476:6:FOXO3:IRS2	JNK3 silencing also decreases the activity of the transcription factor [TF] (FoxO3A) that is known to control [TG] expression, in addition to increasing c-Jun levels that are known to inhibit insulin gene expression.	Forkhead BoxO3A	IRS2	0	UNDEFINED	True
11369	11565	22564737:7:TCF3:ID1	Silencing of [TF] in prostate cancer cells DU145 and PC3 led to a significant reduction in proliferation due to G1 arrest that was in part mediated by increased CDKN1A(p21) and decreased [TG], Id3 and c-myc.	E2A	Id1	1	ACTIVATION	False
11370	11566	22566696:0:STAT3:CCND1	Novel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 ([TF]) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of [TG], with first phase influencing cell migration and second phase directing cell proliferation.	Signal Transducer and Activator of Transcription-3	cyclin D1	1	ACTIVATION	False
11371	11567	22566696:2:STAT3:CCND1	Although both phases of [TG] expression require binding of the newly identified cooperative complex, NFATc1[TF], to its promoter, the second phase, which is more robust, depends on NFATc1-mediated recruitment of p300 onto the complex and the subsequent acetylation of STAT-3.	STAT-3	cyclin D1	1	ACTIVATION	False
11372	11568	22566696:4:STAT3:CCND1	Furthermore, interference with acetylation of [TF] by overexpression of acetylation null STAT-3 mutant led to the loss of the late phase of [TG] expression.	STAT-3	cyclin D1	1	ACTIVATION	False
11373	11569	22566696:5:STAT3:CCND1	EMSA analysis and reporter gene assays revealed that NFATc1[TF] complex binding to the [TG] promoter led to an enhanceosome formation and facilitated cyclin D1 expression.	STAT-3	cyclin D1	1	ACTIVATION	False
11374	11570	22570239:0:AP1:AREG	Polycystin-1 regulates [TG] expression through CREB and [TF] signalling: implications in ADPKD cell proliferation.	AP1	amphiregulin	0	UNDEFINED	False
11375	11571	22570239:0:CREB1:AREG	Polycystin-1 regulates [TG] expression through [TF] and AP1 signalling: implications in ADPKD cell proliferation.	CREB	amphiregulin	0	UNDEFINED	False
11376	11572	22576977:11:SMAD2:CTGF	The [TG] promoter activity was synergistically enhanced by overexpressed Smad3 in stretched inner meniscus cells, but was not by [TF].	Smad2	CCN2	1	ACTIVATION	False
11377	11573	22576977:12:SMAD3:CTGF	Chromatin immunoprecipitation revealed that CTS increased the association between [TF] and the Smad-binding element on the [TG] proximal promoter in inner meniscus cells.	Smad3	CCN2	0	UNDEFINED	False
11378	11574	22577344:5:CREB1:FOXA1	In one process, ErbB2 signaling genes [TF] and c-Fos regulate [TG] transcription, and in another process, AP2 regulates the expression of both FOXA1 and ErbB2.	CREB1	FOXA1	0	UNDEFINED	False
11379	11575	22577844:9:CEBPA:C10orf2	ChIP-PCR and cDNA over-expression revealed that [TF] binds to the [TG] proximal promoter to upregulate ATXN8 expression in neuroblastoma SK-N-SH cells.	CCAAT/enhancer-binding protein alpha	ATXN8	1	ACTIVATION	False
11380	11576	22587838:0:HSF4:RAD51	[TF] is involved in DNA damage repair through regulation of [TG].	HSF4	Rad51	0	UNDEFINED	False
11381	11577	22587838:7:HSF4:RAD51	We verify that DNA damage repair is mediated by the binding of [TF] to a heat shock element in the [TG] promoter, a gene which assists in the homologous recombination (HR) repair of DNA strand breaks.	HSF4	Rad51	0	UNDEFINED	False
11382	11578	22593050:8:EGR1:PPP1R1B	Moreover, overexpression of [TF] in primary striatal neurons induced the expression of [TG], whereas a dominant-negative Egr-1 blocked DARPP-32 induction by BDNF.	Egr-1	DARPP-32	1	ACTIVATION	False
11383	11579	22593050:9:EGR1:PPP1R1B	Together, this study identifies [TF] as a transcriptional activator of the [TG] gene and provides insight into the molecular mechanisms that regulate medium spiny neuron maturation.	Egr-1	Ppp1r1b	1	ACTIVATION	False
11384	11580	22593802:7:ELK1:EGR1	In vivo chromatin immunoprecipitation assays demonstrated that [TF] binding at the SRE sites of the [TG] promoter was enhanced by EGF treatment in PC3 cells.	Elk-1	EGR1	0	UNDEFINED	False
11385	11581	22593802:8:ELK1:EGR1	Overexpression of [TF] was sufficient to activate the EGF-responsive region of [TG] promoter in PC3 cells and, similarly, a dominant-negative Elk-1 suppressed EGR1 promoter activity.	Elk-1	EGR1	1	ACTIVATION	False
11386	11582	22596188:0:AHR:CCNG2	FOXA1 is essential for [TF]-dependent regulation of [TG].	aryl hydrocarbon receptor	cyclin G2	0	UNDEFINED	False
11387	11583	22596188:0:FOXA1:CCNG2	[TF] is essential for aryl hydrocarbon receptor-dependent regulation of [TG].	FOXA1	cyclin G2	0	UNDEFINED	False
11388	11584	22596188:9:FOXA1:CCNG2	These findings show that [TF], but not ER, is essential for AHR-dependent regulation of [TG], assigning a role for FOXA1 in AHR action.	FOXA1	CCNG2	0	UNDEFINED	False
11389	11585	22605338:5:TP53:SESN2	Guided by the gene expression profile analyses with YW3-56, we found that PAD4 functions as a corepressor of [TF] to regulate [TG] expression by histone citrullination in cancer cells.	p53	SESN2	2	REPRESSION	False
11390	11586	22607375:9:CREB1:ATF3	A gene expression analysis revealed that increased expression of [TF] but not that of mCREB in hippocampal neurons led to elevated expression levels of bdnf as well as that of several members of a previously characterized set of Activity-regulated Inhibitor of Death (AID) genes, which include [TG], btg2, gadd45, and gadd45.	CREB	atf3	1	ACTIVATION	False
11391	11587	22607375:9:CREB1:BTG2	A gene expression analysis revealed that increased expression of [TF] but not that of mCREB in hippocampal neurons led to elevated expression levels of bdnf as well as that of several members of a previously characterized set of Activity-regulated Inhibitor of Death (AID) genes, which include atf3, [TG], gadd45, and gadd45.	CREB	btg2	1	ACTIVATION	False
11392	11588	22609358:0:SP1:KLF6	Regulatory mechanism of [TG] gene expression via [TF] by nerve growth factor in PC12 cells.	Sp1	PAC1	0	UNDEFINED	False
11393	11589	22610349:4:SMAD3:SIRT1	Furthermore, [TF] was found to be a transcription factor to positively regulate a protein deacetylase sirtuin 1 ([TG]) by binding to an AP-1 site of SIRT1 promoter.	Smad3	SIRT1	1	ACTIVATION	False
11394	11590	22610349:5:JUN:SIRT1	A synergistic regulatory effect on [TG] expression was also detected between Smad3 and [TF].	c-Jun	SIRT1	0	UNDEFINED	False
11395	11591	22610349:6:SMAD3:SIRT1	Consistently, [TF] knockout lung at P28 had reduced [TG] expression, which in turn resulted in increased acetylation of histone H3 at the transcription factor activator protein 1 (AP-1), NF-B, and Pea3 binding sites of MMP9 promoter and increased acetylation of NF-B.	Smad3	SIRT1	1	ACTIVATION	False
11396	11592	22628303:0:ATF2:REN	Identification of [TF] as a transcriptional regulator of [TG] gene.	ATF2	renin	0	UNDEFINED	False
11397	11593	22628303:6:ATF2:REN	Knockdown of [TF] attenuated the suppression of [TG] gene expression by MG132, thus demonstrating that ATF2 mediates the inhibitory effect of MG132.	ATF2	renin	2	REPRESSION	False
11398	11594	22628303:9:ATF2:REN	These data suggest that [TF] represses [TG] expression by drifting the transcriptional control of renin gene away from CREB.	ATF2	renin	2	REPRESSION	False
11399	11595	22645130:8:NFKB:SLC1A2	G1 also enhanced cAMP response element-binding protein (CREB), as well as both NF-B p50 and NF-B [TF] binding to the [TG] promoter.	p65	GLT-1	0	UNDEFINED	False
11400	11596	22645130:8:NFKB1:SLC1A2	G1 also enhanced cAMP response element-binding protein (CREB), as well as both NF-B [TF] and NF-B p65 binding to the [TG] promoter.	p50	GLT-1	0	UNDEFINED	False
11401	11598	22645147:0:FOXC1:MMP7	The forkhead box transcription factor [TF] promotes breast cancer invasion by inducing matrix metalloprotease 7 ([TG]) expression.	FOXC1	MMP7	1	ACTIVATION	False
11402	11599	22645147:6:FOXC1:MMP7	Transient expression of [TF] in nontransformed mammary epithelial cell lines resulted in significantly increased expression of [TG] and an MMP7-dependent increase in invasiveness.	FOXC1	MMP7	1	ACTIVATION	False
11403	11600	22649503:4:AP1:IVL	[TG] is a marker of keratinocyte differentiation that is expressed in the suprabasal epidermis and this expression requires [TF] factor interaction at the AP1-5 site in the promoter.	AP1	Involucrin	1	ACTIVATION	False
11404	11601	22652451:6:AP1:MMP12	In addition, inhibition of activator protein-1 ([TF]) reduced MMP-1, MMP-9 and [TG] gene expression.	AP-1	MMP-12	1	ACTIVATION	False
11405	11602	22653339:7:DDIT3:CCL5	[TF] KD resulted in reduced cytokine-induced NF-B activity and expression of key NF-B target genes involved in apoptosis and inflammation, including iNOS, FAS, IRF-7, IL-15, [TG] and CXCL10.	CHOP	CCL5	2	REPRESSION	True
11406	11603	22653339:7:DDIT3:CXCL10	[TF] KD resulted in reduced cytokine-induced NF-B activity and expression of key NF-B target genes involved in apoptosis and inflammation, including iNOS, FAS, IRF-7, IL-15, CCL5 and [TG].	CHOP	CXCL10	2	REPRESSION	True
11407	11604	22653339:7:DDIT3:FAS	[TF] KD resulted in reduced cytokine-induced NF-B activity and expression of key NF-B target genes involved in apoptosis and inflammation, including iNOS, [TG], IRF-7, IL-15, CCL5 and CXCL10.	CHOP	FAS	2	REPRESSION	True
11408	11605	22668877:2:TWIST1:CLDN4	In this study, we aimed to determine the role of [TF] in the regulation of [TG] expression and investigate its specific mechanisms and clinical implications using human esophageal carcinoma cell lines and tissues.	Twist1	claudin-4	0	UNDEFINED	False
11409	11606	22668877:6:TWIST1:CLDN4	Our results indicate that [TF] induces the repression of [TG] expression during the epithelial-mesenchymal transition in esophageal carcinoma.	Twist1	claudin-4	2	REPRESSION	False
11410	11607	22669972:12:NFKB:FAS	Moreover, although canonical NF-B protected mouse embryo fibroblast (MEF) cells from TNF-induced apoptosis, knocking out [TF] diminished [TG] expression in MEF cells, resulting in inhibition of FasL-induced caspase 8 activation and apoptosis.	p65	Fas	1	ACTIVATION	False
11411	11609	22669972:13:NFKB2:FAS	In contrast, knocking out [TF] increased [TG] expression in MEF cells.	p52	Fas	2	REPRESSION	False
11413	11611	22683342:4:NR1H4:NR0B2	In the mammalian one-hybrid and transient transfection reporter assays, both triterpenes transactivated [TF] to modulate promoter action including GAL4, [TG], CYP7A1, and PLTP promoters in dose-dependent manner, while they exhibited similar agonistic activity as chenodeoxycholic acid (CDCA), an endogenous FXR agonist.	FXR	SHP	0	UNDEFINED	False
11414	11612	22691366:7:NFE2L2:DDIT3	In addition, we demonstrated that NF-E2-related factor 2 ([TF]) was also implicated in the induction of [TG] by precluding the binding of ATF4 to the CHOP promoter.	Nrf2	CHOP	1	ACTIVATION	False
11415	11613	22698918:9:NR0B2:PDK4	[TF] directly inhibited STAT5 association on the [TG] gene promoter.	SHP	PDK4	0	UNDEFINED	False
11416	11614	22698918:9:STAT5A:PDK4	SHP directly inhibited [TF] association on the [TG] gene promoter.	STAT5	PDK4	0	UNDEFINED	False
11417	11615	22698995:3:BACH1:HMOX1	Our aims were to determine whether let-7 miRNA directly regulates [TF], a transcriptional repressor of the [TG] gene, and whether indirect up-regulation of HMOX1 by let-7 miRNA attenuates oxidant injury in human hepatocytes.	Bach1	HMOX1	2	REPRESSION	False
11418	11616	22698995:8:BACH1:HMOX1	In conclusion, let-7 miRNA directly acts on the 3'-UTR of [TF] and negatively regulates expression of this protein, and thereby up-regulates [TG] gene expression.	Bach1	HMOX1	2	REPRESSION	False
11419	11617	22700767:10:STAT5B:RASD1	Prolactin inhibited the stimulatory effect of GR/[TF] complex on [TG] transcription.	STAT5b	Rasd1	1	ACTIVATION	False
11420	11618	22700767:12:STAT5B:RASD1	Prolactin negatively regulates this pathway by inhibiting GR/[TF] transcriptional activity on the [TG] gene.	STAT5b	Rasd1	1	ACTIVATION	False
11421	11619	22700767:9:STAT5B:RASD1	Chromatin immunoprecipitation experiments revealed that glucocorticoid receptor (GR) and [TF] (STAT5b) cooperatively mediate glucocorticoid-induced [TG] expression in islets.	signal transducer and activator of transcription 5b	Rasd1	1	ACTIVATION	False
11423	11621	22705236:0:HES1:CDKN1C	[TG]/P57 is regulated by the Notch target gene [TF] and induces senescence in human hepatocellular carcinoma.	Hes1	CDKN1C	0	UNDEFINED	False
11424	11622	22705236:3:HES1:CDKN1C	In line with these data, we report that [TG]/P57 is a target of transcriptional repression by the Notch effector, [TF].	Hes1	CDKN1C	2	REPRESSION	False
11425	11623	22706665:8:MYC:GPC3	The exogenous overexpression of [TF] increased the endogenous messenger RNA (mRNA) and protein levels of [TG].	c-Myc	GPC3	1	ACTIVATION	False
11426	11624	22706665:9:MYC:GPC3	Chromatin immunoprecipitation experiments revealed the binding of [TF] to the endogenous [TG] promoter, indicating that c-Myc can directly transcriptionally activate GPC3.	c-Myc	GPC3	1	ACTIVATION	False
11427	11625	22710759:7:SMAD4:CDKN2B	Overexpression of Tob1 in MKN28 and AGS cells induced the expression of [TF], leading to the increased expression and the promoter activity of [TG], which was diminished by silencing of Tob1 using specific siRNA.	Smad4	p15	1	ACTIVATION	False
11429	11627	22714536:6:ETS1:CDKN2A	From this interaction analysis, the residues of [TF] involved in interaction with the [TG] promoter were found to be targeted by ID1.	ETS-1	p16(INK4a)	0	UNDEFINED	False
11430	11628	22719258:6:STAT5A:PROX1	In BECs, KSHV upregulates IL3R and phosphorylates [TF], which binds and activates the [TG] promoter.	STAT5	PROX1	1	ACTIVATION	False
11431	11629	22735309:0:BACH1:HMOX1	Phenylpropanoid glycosides from plant cell cultures induce [TG] gene expression in a human keratinocyte cell line by affecting the balance of NRF2 and [TF] transcription factors.	BACH1	heme oxygenase 1	0	UNDEFINED	False
11432	11630	22736142:0:MYC:LAT	[TF] is crucial for the expression of [TG] in MIA Paca-2 human pancreatic             cancer cells.	c-Myc	LAT1	1	ACTIVATION	False
11433	11631	22736142:10:MYC:LAT	The [TG] promoter has a canonical [TF] binding sequence and overexpression of c-Myc increased LAT1 promoter activity, whereas mutation of c-Myc binding site diminished this effect.	c-Myc	LAT1	1	ACTIVATION	False
11434	11632	22736142:7:MYC:LAT	Here, we show that a proto-oncogene, [TF], is a critical positive regulator of [TG] expression in MIA Paca-2 human pancreatic cancer cells.	c-Myc	LAT1	1	ACTIVATION	False
11435	11633	22747445:10:TP53:S100A2	Together our findings highlight an important link between the TGF-1-induced MAPK and [TF] signalling pathways in the regulation of [TG] expression and pro-tumorigenic actions.	p53	S100A2	0	UNDEFINED	False
11436	11634	22747445:4:AP1:S100A2	Characterization of the [TG] promoter revealed an [TF] (activator protein-1) element at positions -1161 to -1151 as being the most critical factor for the TGF-1 response.	AP-1	S100A2	0	UNDEFINED	True
11437	11635	22747445:5:AP1:S100A2	Chromatin immunoprecipitation and electrophoretic mobility-shift assays confirmed the functional binding of the [TF] complex, predominantly JunB, to the [TG] promoter in response to TGF-1 in HaCaT keratinocytes.	AP-1	S100A2	0	UNDEFINED	False
11438	11637	22747445:6:JUNB:S100A2	[TF] overexpression markedly stimulated the [TG] promoter which was blocked by the dominant-negative JunB and MEK1 [MAPK (mitogen-activated protein kinase)/ERK (extracellular-signal-regulated kinase) kinase 1] inhibitor, PD98059.	JunB	S100A2	1	ACTIVATION	False
11439	11638	22749810:0:NFE2L2:SESN2	[TF]-ARE pathway regulates induction of [TG] expression.	Nrf2	Sestrin-2	1	ACTIVATION	False
11440	11639	22749810:11:NFE2L2:SESN2	Our results suggest that the [TF]-ARE pathway is critical for [TG] gene expression and might protect against oxidative stress.	Nrf2	Sesn2	1	ACTIVATION	False
11441	11640	22749810:2:NFE2L2:SESN2	NF-E2-related factor-2 ([TF]) is an essential transcription factor that regulates expression of a variety of antioxidant genes via binding to the antioxidant-response element (ARE), but the role of Nrf2 in [TG] gene expression has not been elucidated yet.	Nrf2	Sesn2	0	UNDEFINED	False
11442	11641	22749810:3:NFE2L2:SESN2	The present study investigated whether the [TF]-ARE pathway regulates [TG] gene expression and the identification of the molecular mechanism.	Nrf2	Sesn2	0	UNDEFINED	False
11443	11642	22749810:4:NFE2L2:SESN2	The [TF] activators, tert-butylhydroquinone (t-BHQ) and sulforaphane (SFN), up-regulated [TG] expression in a dose- and time-dependent manner in hepatocytes.	Nrf2	Sesn2	1	ACTIVATION	False
11444	11643	22750006:0:SP7:VEGFA	Osteoblast-specific transcription factor [TF] (Osx) and HIF-1 cooperatively regulate gene expression of vascular endothelial growth factor ([TG]).	Osterix	VEGF	0	UNDEFINED	False
11445	11644	22750226:11:POU2F1:CRP	Similarly, deletion of the [TF] site reduced the induction of [TG] expression in response to overexpressed C/EBP, and overexpressed Oct-1 inhibited C/EBP-induced CRP expression through the promoter lacking the Oct-1 site.	Oct-1	CRP	2	REPRESSION	True
11446	11645	22750226:12:POU2F1:CRP	We conclude that [TF] acts as a transcriptional repressor of [TG] expression and it does so by occupying its cognate site on the promoter and also via other transcription factors by an as yet undefined mechanism.	Oct-1	CRP	2	REPRESSION	False
11447	11646	22750226:7:POU2F1:CRP	The aim of this study was to investigate the functions of [TF] in regulating [TG] expression.	Oct-1	CRP	0	UNDEFINED	False
11448	11647	22751440:0:CREB1:CCND1	Chenodeoxycholic acid through a TGR5-dependent [TF] signaling activation enhances [TG] expression and promotes human endometrial cancer cell proliferation.	CREB	cyclin D1	1	ACTIVATION	False
11449	11648	22761689:0:FOXM1:KRT15	Two mechanisms regulate [TG] expression in keratinocytes: role of PKC/AP-1 and [TF] mediated signalling.	FOXM1	keratin K15	0	UNDEFINED	False
11450	11649	22761689:11:FOXM1:KRT15	Using chromatin immunoprecipitation, we have identified a single [TF] binding motif in the [TG] promoter.	FOXM1	K15	0	UNDEFINED	False
11451	11650	22761689:14:FOXM1:KRT15	We propose that there are two mechanisms regulating [TG] expression in stratified epithelia; differentiation-specific involving PKC/AP-1 pathway, and basal-specific mediated by [TF], and therefore the use of K15 expression as a marker of stem cells must be viewed with caution.	FOXM1	K15	0	UNDEFINED	False
11452	11651	22767506:7:NFATC2:TNFRSF12A	Thus, we identify LCN2 and [TG]-TWEAK as crucial downstream effectors of [TF] that regulate breast cancer cell motility and invasive capacity.	NFAT1	TWEAKR	0	UNDEFINED	False
11453	11652	22771493:7:E2F1:ATAD2	Furthermore, we could show that several genes overexpressed in prostate cancer and potentially involved in several aspects of tumor development have an ARBS and an [TF] binding site in their regulatory regions and exhibit the same mechanism of regulation by both transcription factors as [TG].	E2F1	ATAD2	0	UNDEFINED	True
11454	11653	22777360:6:RELB:CDKN1A	Mechanistic studies indicate that [TF] regulates the transcription of the p53 tumor-suppressor gene through direct recruitment to the p53 promoter, thus increasing both p53 protein levels and expression of p53 target genes such as [TG].	RelB	p21	1	ACTIVATION	False
11455	11654	22777360:6:RELB:TP53	Mechanistic studies indicate that [TF] regulates the transcription of the [TG] tumor-suppressor gene through direct recruitment to the p53 promoter, thus increasing both p53 protein levels and expression of p53 target genes such as p21.	RelB	p53	1	ACTIVATION	False
11456	11655	22778220:8:PAX6:GIPR	We demonstrated that [TF] directly binds and activates specific elements on the promoter region of the GPR40, GCK, and [TG] genes.	Pax6	GIPR	1	ACTIVATION	False
11457	11656	22778220:9:PAX6:GIPR	Finally, through site-directed mutagenesis experiments, we showed that disruption of [TF] binding on the GCK, GPR40, and [TG] gene promoters led to specific decreases of their activities in the TC1.9 glucagon-producing cell line.	Pax6	GIPR	1	ACTIVATION	False
11458	11657	22778267:5:SMAD3:ZYX	We show that TGF-1 treatment of lung cancer cells caused rapid phospho-[TF]-dependent expression of [TG].	Smad3	zyxin	1	ACTIVATION	False
11459	11658	22799764:7:ZIC1:CCND1	The modulation of G1/S checkpoint by [TF] is mainly mediated through the regulation of cyclin-dependent kinases (p21(Waf1/Cip1), p27(Kip1) and [TG]).	ZIC1	cyclin D1	0	UNDEFINED	False
11460	11659	22799764:7:ZIC1:CDKN1A	The modulation of G1/S checkpoint by [TF] is mainly mediated through the regulation of cyclin-dependent kinases (p21([TG]/Cip1), p27(Kip1) and cyclin D1).	ZIC1	Waf1	0	UNDEFINED	False
11461	11660	22801218:0:MYC:MAP4K1	Pdcd4 knockdown up-regulates [TG] expression and activation of AP-1 dependent transcription through [TF].	c-Myc	MAP4K1	1	ACTIVATION	False
11462	11661	22801218:3:MYC:MAP4K1	Over-expression of [TF] in HEK293 cells increases the levels of [TG], MAP4K1 promoter activity, and phospho-c-Jun.	c-Myc	MAP4K1	1	ACTIVATION	False
11463	11662	22801218:6:MYC:MAP4K1	Down-regulation of [TF] reverses [TG] expression and AP-1 activation in Pdcd4 knockdown cells.	c-Myc	MAP4K1	1	ACTIVATION	False
11464	11663	22801218:8:MYC:MAP4K1	Thus, activation of -catenin/Tcf dependent transcription in Pdcd4 knockdown cells up-regulates [TG] expression and AP-1 activity via [TF].	c-Myc	MAP4K1	1	ACTIVATION	False
11465	11664	22801367:3:YY1:JAK2	Here, we report that the H3K9 methyltransferase G9a negatively regulated [TG] transcription in histone methyltransferase activity and in a [TF]-dependent manner during ATRA-mediated leukemia cell differentiation.	YY1	JAK2	2	REPRESSION	False
11466	11665	22801367:5:YY1:JAK2	We demonstrated that G9a interacts with [TF] and is recruited to the [TG] promoter along with corepressors, including histone deacetylase, that induced H3K9-me2.	YY1	JAK2	2	REPRESSION	True
11467	11666	22805310:7:IRF8:STAT1	Mechanistic investigations revealed that [TF] suppressed [TG] transcription by binding the STAT1 promoter.	IRF8	STAT1	2	REPRESSION	False
11468	11667	22808166:0:STAT1:APOC2	[TF] interacts with RXR to upregulate [TG] gene expression in macrophages.	STAT1	ApoCII	1	ACTIVATION	False
11469	11668	22808166:5:STAT1:APOC2	We found that siRNA-mediated inhibition of [TF] gene expression significantly decreased the [TG] levels, while STAT1 overexpression in RAW 264.7 macrophages increased apoCII gene expression.	STAT1	apoCII	1	ACTIVATION	False
11470	11669	22808166:6:STAT1:APOC2	Using transient transfections, DNA pull down and chromatin immunoprecipitation assays, we revealed a novel [TF] binding site in the -500/-493 region of the [TG] promoter, which mediates apoCII promoter upregulation by STAT1.	STAT1	apoCII	1	ACTIVATION	False
11471	11670	22814619:5:MYC:CDKN1A	Moreover, CITED2 inhibited cellular quiescence by enhancing [TF]-mediated suppression of p21([TG]).	MYC	CIP1	2	REPRESSION	False
11472	11671	22820919:4:ONECUT1:NEUROG3	Previous studies showed that the distal region and proximal region of [TG] promoter contains various transcription binding sites, including binding sites for pancreatic and duodenal homeobox 1 (Pdx1), Hnf1 and [TF].	Hnf6	Ngn3	0	UNDEFINED	False
11473	11672	22820919:5:GLIS3:NEUROG3	Interestingly, putative [TF] binding sites (Glis3BS) were found in the distal region of [TG] promoter close to the Hnf6 binding sites.	Glis3	Ngn3	0	UNDEFINED	False
11474	11673	22820919:5:ONECUT1:NEUROG3	Interestingly, putative Glis3 binding sites (Glis3BS) were found in the distal region of [TG] promoter close to the [TF] binding sites.	Hnf6	Ngn3	0	UNDEFINED	False
11475	11674	22820919:6:GLIS3:NEUROG3	This suggested that along with Hnf6, [TF] may also be involved in the regulation of [TG] expression.	Glis3	Ngn3	0	UNDEFINED	False
11476	11675	22820919:6:ONECUT1:NEUROG3	This suggested that along with [TF], Glis3 may also be involved in the regulation of [TG] expression.	Hnf6	Ngn3	0	UNDEFINED	False
11477	11676	22820919:7:GLIS3:NEUROG3	This hypothesis is supported by data showing that [TF] can bind to the [TG] promoter directly and activate Ngn3 transcriptional activity.	Glis3	Ngn3	1	ACTIVATION	False
11478	11677	22827437:0:ETS1:PPP2R1B	The [TG]-A gene is regulated by multiple transcriptional factors including [TF], SP1/SP3, and RXR/.	Ets-1	PP2A	0	UNDEFINED	True
11479	11678	22827437:10:ETS1:PPP2R1B	Co-expression of the cDNAs encoding [TF], SP1/SP3, or RXR/ and the luciferase reporter gene driven by [TG]-A promoter further confirm their control over the PP2A-A promoter.	Ets-1	PP2A	0	UNDEFINED	False
11480	11679	22827437:11:ETS1:PPP2R1B	Finally, ChIP assays demonstrate that [TF], SP1/SP3, and RXR/ can all bind to the [TG]-A gene promoter.	Ets-1	PP2A	0	UNDEFINED	False
11481	11680	22827437:7:ETS1:PPP2R1B	Our results demonstrate that three major cis-elements, including the binding sites for [TF], SP1/SP3, and RXR/, are present in the proximal promoter of the mouse [TG]-A gene.	Ets-1	PP2A	0	UNDEFINED	False
11482	11681	22827437:8:ETS1:PPP2R1B	Gel mobility shifting assays reveal that [TF], SP1/SP3, and RXR/ all bind to [TG]-A gene promoter.	Ets-1	PP2A	0	UNDEFINED	False
11483	11682	22827437:9:ETS1:PPP2R1B	In vitro mutagenesis and reporter gene activity assays demonstrate that while [TF] displays negative regulation, SP1/SP3 and RXR/ positively regulate the promoter of the [TG]-A gene.	Ets-1	PP2A	2	REPRESSION	False
11484	11683	22827438:7:TP53:PROX1	Third, exogenous [TF] induces dose-dependent expression of the luciferase report gene driven by both c-Maf and [TG] promoters, and p53 binds to both promoters in the ChIP assays.	p53	Prox1	1	ACTIVATION	False
11485	11684	22835384:5:NFKB:CCND1	Enhancement of the NF-B activity with [TF] significantly increased the cell proliferation and the transcription of [TG], whereas inhibition of the NF-B activity with I kappa B alpha mutant (IBM) and pyrroline dithiocarbamate (PDTC) abrogated cell proliferation and transcription of cyclin D1.	p65	cyclin D1	1	ACTIVATION	False
11486	11686	2284094:9:SP1:MYC	Removal of 110 bp sequence binding both CTCF and [TF] proteins leads to a 4 to 8-fold increase in transcription of stably transfected [TG] fusion constructs in chicken embryonic fibroblasts, suggesting that the CTCF is likely to be one of multiple nuclear factors involved in the transcriptional regulation of the chicken c-myc gene.	Sp1-like	c-myc	2	REPRESSION	True
11487	11687	22848740:0:FOXO3:STK11	[TF] is a glucocorticoid receptor target and regulates [TG] and its own expression based on cellular AMP levels via a positive autoregulatory loop.	FOXO3	LKB1	0	UNDEFINED	True
11488	11688	22848740:9:FOXO3:STK11	In that way, [TF] acts as a metabolic stress sensor that coordinates expression of [TG], the master upstream kinase involved in metabolic sensing, depending on the energy status of the cell.	FOXO3	LKB1	0	UNDEFINED	True
11490	11690	22853846:10:AP1:CCND1	Moreover, CpG-ODN promoted nuclear translocation and activation of [TF], which appeared to be required for TLR-9-mediated [TG] expression and subsequently cell proliferation, but seemed to have little impact on NF-B activity.	AP-1	cyclin D1	1	ACTIVATION	False
11491	11691	22854048:8:EGR1:KLF4	At the mechanistic level, ChIP analysis validated a direct binding of [TF] to the [TG] promoter to induce KLF4 transcription; in turn, EGR-1-induced KLF4 binds to its own promoter, thus creating a positive feedback mechanism to sustain KLF4 expression and the resultant cell scattering.	EGR-1	KLF4	1	ACTIVATION	False
11492	11692	22860098:6:JUN:PES1	We then explored the mechanism by which [TG] expression is controlled in human colon cancers and demonstrated that [TF], but not JunB, JunD, c-Fos, or mutant c-Jun, positively regulated PES1 promoter transcription activity.	c-Jun	PES1	1	ACTIVATION	False
11493	11693	22861165:4:TP53:PPARGC1A	We found that upon GSH shortage, induced either by its chemical depletion or by metabolic stress (i.e., fasting), [TF] binds to the [TG] promoter of both human and mouse genes, and this event is positively related to increased PGC-1 expression.	p53	PPARGC1A	1	ACTIVATION	False
11494	11694	22865884:5:FOXO1:LHB	We also showed that [TF] repressed basal transcription and gonadotropin-releasing hormone (GnRH) induction of both the murine and human [TG] genes in LT2 cells, suggesting that FOXO1 regulation of LHB transcription may be conserved between rodents and humans.	FOXO1	LHB	2	REPRESSION	False
11495	11695	22865884:8:FOXO1:LHB	Additionally, [TF] blocked induction of the [TG] promoter with overexpressed SF1, PTX1, and EGR1, indicating that FOXO1 repression occurs via these transcription factors but not through regulation of their promoters.	FOXO1	Lhb	2	REPRESSION	False
11496	11696	22865884:9:FOXO1:LHB	In summary, we demonstrate that [TF] phosphorylation and cellular localization is regulated by insulin signaling in gonadotropes and that FOXO1 inhibits [TG] transcription.	FOXO1	Lhb	2	REPRESSION	False
11497	11697	22867868:7:DNMT3A:POU5F1	Based on these findings and previous reports, we hypothesize that a repressor complex containing methyl CpG-binding domain protein 2 (MBD2), [TF] and HDAC1 binds to the hyper-methylated regulatory regions of [TG] gene to facilitate forming a close chromatin which results in the suppression of Oct4 transcription in cervical cells.	DNMT3A	Oct4	2	REPRESSION	False
11498	11698	22867868:7:MBD2:POU5F1	Based on these findings and previous reports, we hypothesize that a repressor complex containing [TF] (MBD2), DNMT3A and HDAC1 binds to the hyper-methylated regulatory regions of [TG] gene to facilitate forming a close chromatin which results in the suppression of Oct4 transcription in cervical cells.	methyl CpG-binding domain protein 2	Oct4	2	REPRESSION	False
11499	11699	22869588:7:NFE2L2:TXNIP	[TF] suppressed the basal expression of [TG] in the heart and blocked induction of Txnip by high glucose by binding to an antioxidant response element (ARE) (-1286 to -1276) of the Txnip promoter.	Nrf2	Txnip	2	REPRESSION	False
11500	11700	22878616:12:TFAP2C:RET	[TF] regulates expression of the [TG] proto-oncogene through five AP-2 regulatory sites in the RET promoter.	TFAP2C	RET	0	UNDEFINED	False
11501	11701	22878616:2:TFAP2C:RET	We sought to determine if [TF] regulates [TG] expression directly or indirectly through ER.	TFAP2C	Ret	0	UNDEFINED	False
11502	11702	22878616:3:TFAP2C:RET	Chromatin immunoprecipitation sequencing (ChIP-Seq) and gel-shift assay were used to identify [TF] binding sites in the [TG] promoter in four breast cancer cell lines.	TFAP2C	RET	0	UNDEFINED	False
11503	11703	22878616:6:TFAP2C:RET	ChIP-Seq identified five main binding peaks for [TF] in the [TG] promoter at -101.5 kb, -50.7 kb, -32.5 kb, +5.0 kb, and +33.6 from the RET transcriptional start site.	TFAP2C	RET	0	UNDEFINED	False
11504	11704	22878616:7:TFAP2C:RET	Binding at three of the AP-2 sites was conserved across all four cell lines, whereas the [TG] -101.5 and RET +33.6 sites were each found to be unbound by [TF] in one cell line.	TFAP2C	RET	0	UNDEFINED	True
11505	11705	22878616:9:TFAP2C:RET	Knockdown of [TF] by siRNA in ER-positive MCF-7 cells resulted in significant down regulation of [TG] mRNA compared to nontargeting (NT) siRNA (0.09 vs. 1.0, P < 0.001).	TFAP2C	Ret	1	ACTIVATION	False
11506	11706	22879594:10:ATF4:IHH	These results suggest that GABA(B)R1 positively regulates chondrogenesis through a mechanism relevant to the acceleration of nuclear translocation of [TF] for [TG] expression in chondrocytes.	ATF4	Ihh	1	ACTIVATION	False
11507	11707	22880094:6:NFKB2:ENPP2	Chromatin immunoprecipitation (ChIP) assays showed in p100(-/-) MEFs direct binding of [TF] and RelB to the promoter of the Enpp2 gene encoding [TG]/Autotaxin, a protein with an important role in lymphocyte homing and cell migration.	p52	ENPP2	0	UNDEFINED	False
11508	11708	22880094:6:RELB:ENPP2	Chromatin immunoprecipitation (ChIP) assays showed in p100(-/-) MEFs direct binding of p52 and [TF] to the promoter of the Enpp2 gene encoding [TG]/Autotaxin, a protein with an important role in lymphocyte homing and cell migration.	RelB	ENPP2	0	UNDEFINED	False
11509	11709	22885335:8:FOXM1:SCGB1A1	In co-transfection experiments, [TF] directly bound to and induced transcriptional activity of [TG] and Sox2 promoters.	Foxm1	Scgb1a1	1	ACTIVATION	False
11510	11710	22885662:6:EGR1:MMP2	Using [TG] reporter gene and chromatin immunoprecipitation analyses, we found that [TF] binds to the MMP-2 promoter and inhibits its activity.	Egr-1	MMP-2	2	REPRESSION	False
11511	11711	22890222:4:RELA:TREM1	Chromatin immunoprecipitation assay confirmed that curcumin inhibits the binding of [TF] to [TG] promoter in response to LPS.	p65	TREM-1	0	UNDEFINED	False
11512	11712	22890831:0:IRF1:MKI67	[TF] suppresses [TG] promoter activity through interfering with Sp1 activation.	IRF1	Ki-67	2	REPRESSION	False
11513	11713	22890831:0:SP1:MKI67	IRF1 suppresses [TG] promoter activity through interfering with [TF] activation.	Sp1	Ki-67	1	ACTIVATION	False
11514	11714	22890831:4:IRF1:MKI67	[TF] repressed [TG] gene transcription in a dose-dependent manner in human Ketr-3 and 786-O renal carcinoma cells.	IRF1	Ki-67	2	REPRESSION	False
11515	11715	22890831:6:SP1:MKI67	Mutation of the two [TF] binding sites abrogated Sp1-dependent enhancement of [TG] promoter activity.	Sp1	Ki-67	1	ACTIVATION	False
11516	11716	22896337:5:TWIST1:CLU	By binding to E-boxes in the distal promoter region of [TG] gene, [TF] regulated basal and TGF--induced CLU transcription.	Twist1	CLU	1	ACTIVATION	True
11517	11717	22897851:4:TCF12:TRIB2	One of the critical downstream targets in this circuitry is the [TG] gene, which is oppositely regulated by TAL1 and E2A/[TF] and is essential for the survival of T-ALL cells.	HEB	TRIB2	0	UNDEFINED	True
11518	11718	22897851:4:TCF3:TRIB2	One of the critical downstream targets in this circuitry is the [TG] gene, which is oppositely regulated by TAL1 and [TF]/HEB and is essential for the survival of T-ALL cells.	E2A	TRIB2	0	UNDEFINED	False
11519	11719	22903062:0:E2F7:VEGFA	[TF] and E2F8 promote angiogenesis through transcriptional activation of [TG] in cooperation with HIF1.	E2F7	VEGFA	1	ACTIVATION	False
11520	11720	22903062:0:E2F8:VEGFA	E2F7 and [TF] promote angiogenesis through transcriptional activation of [TG] in cooperation with HIF1.	E2F8	VEGFA	1	ACTIVATION	False
11521	11721	22903062:6:E2F7:VEGFA	We show that [TF]/8 directly bind and stimulate the [TG] promoter independent of canonical E2F binding elements.	E2F7	VEGFA	1	ACTIVATION	False
11522	11722	22903062:7:E2F7:VEGFA	Instead, [TF]/8 form a transcriptional complex with the hypoxia inducible factor 1 (HIF1) to stimulate [TG] promoter activity.	E2F7	VEGFA	1	ACTIVATION	False
11523	11723	22905217:0:BHLHE40:CCND1	SUMO modification of [TF] is required for repression of [TG] expression and cellular growth arrest.	Stra13	cyclin D1	2	REPRESSION	False
11524	11724	22905217:3:BHLHE40:CCND1	In this study, we provide evidence that post-translational modification of [TF] by Small Ubiquitin-like Modifier (SUMO) dramatically potentiates its ability to transcriptionally repress [TG] and mediate G(1) cell cycle arrest in fibroblast cells.	Stra13	cyclin D1	2	REPRESSION	False
11525	11725	22911364:0:E2F1:STMN1	The [TF] transactives [TG] in hepatocellular carcinoma.	E2F transcription factor 1	stathmin 1	1	ACTIVATION	False
11526	11726	22911364:10:E2F1:STMN1	The promoter activity of [TG] gene increased with overexpression of both [TF] and TFDP1 genes (P < .05); however, it decreased when mutations were introduced in the E2F1-binding sites (P < .05).	E2F1	STMN1	1	ACTIVATION	False
11527	11727	22911364:10:TFDP1:STMN1	The promoter activity of [TG] gene increased with overexpression of both E2F1 and [TF] genes (P < .05); however, it decreased when mutations were introduced in the E2F1-binding sites (P < .05).	TFDP1	STMN1	1	ACTIVATION	False
11529	11729	22911364:7:E2F1:STMN1	In HCC-derived cell lines, [TF] was elevated before [TG] mRNA during the cell cycle.	E2F1	STMN1	1	ACTIVATION	True
11530	11730	22911364:8:E2F1:STMN1	Exogenous expression of [TF] or both transcription factor DP-1 (TFDP1) and E2F1 genes induced E2F1 and [TG] mRNA (P < .01).	E2F1	STMN1	1	ACTIVATION	False
11531	11731	22911364:8:TFDP1:STMN1	Exogenous expression of E2F1 or both [TF] (TFDP1) and E2F1 genes induced E2F1 and [TG] mRNA (P < .01).	transcription factor DP-1	STMN1	1	ACTIVATION	False
11532	11734	22913986:12:ARNTL:LDLR	Taken together, these results suggest that [TG] expression is under circadian control involving CLOCK/[TF] and Hes family members Hes1 and Hes6.	BMAL1	LDLR	0	UNDEFINED	True
11533	11735	22913986:12:HES1:LDLR	Taken together, these results suggest that [TG] expression is under circadian control involving CLOCK/BMAL1 and Hes family members [TF] and Hes6.	Hes1	LDLR	0	UNDEFINED	False
11534	11736	22913986:12:HES6:LDLR	Taken together, these results suggest that [TG] expression is under circadian control involving CLOCK/BMAL1 and Hes family members Hes1 and [TF].	Hes6	LDLR	0	UNDEFINED	False
11535	11737	22914732:0:ETS1:ATXN2	[TF] regulates the expression of [TG].	ETS1	ATXN2	0	UNDEFINED	True
11536	11738	22914732:11:ETS1:ATXN2	We verified that endogenous [TF] interacted with the [TG] promoter by an electromobility supershift assay and chromatin immunoprecipitation polymerase chain reaction.	ETS1	ATXN2	0	UNDEFINED	False
11537	11739	22914732:12:ETS1:ATXN2	[TF] overexpression increased [TG]-luc (ATXN2-luciferase) as well as endogenous ATXN2 expression.	ETS1	ATXN2	1	ACTIVATION	False
11538	11740	22919060:10:CREB1:PTGS2	A chromatin immunoprecipitation assay showed that the binding of [TF] to the [TG] promoter was increased by PGF2 and PMA in amnion fibroblasts.	CREB1	COX-2	0	UNDEFINED	False
11539	11741	22929025:9:YY1:GDF5	Knockdown of [TF] led to a significant reduction in [TG] expression, supporting YY1 as a GDF5 activator.	YY1	GDF5	1	ACTIVATION	False
11540	11742	22935140:9:FOXO3:PIK3IP1	We therefore conclude that neural progenitors are particularly vulnerable to [TF]-induced apoptosis, which is mediated by [TG], a negative PI3 kinase regulator.	FOXO3	PIK3IP1	0	UNDEFINED	True
11541	11743	22936800:5:ARNTL:IHH	In [TF]-null mice, a predominant decrease was seen in [TG] expression in the growth plate with a smaller body size than in wild-type mice.	BMAL1	Ihh	1	ACTIVATION	False
11543	11745	22937159:10:YY1:PARP1	Together with our previous findings these results expand the [TG] autoregulatory loop principle by [TF] actions, implying rigid limitation of muPARP-1 expression.	YY1	PARP-1	0	UNDEFINED	True
11544	11746	22937159:7:YY1:PARP1	Transfection experiments with a reporter gene under the control of the mu[TG] promoter revealed that [TF] binding to BM1 and BM4 independently repressed the promoter.	YY1	PARP-1	2	REPRESSION	False
11545	11747	22956576:0:SPIB:BLNK	Regulation of [TG] transcription by PU.1 and [TF] in murine B cell acute lymphoblastic leukemia.	Spi-B	B cell linker protein	0	UNDEFINED	False
11546	11748	22961837:11:MAFB:MMP13	These results support a role for [TF] as a regulator of chondrocyte gene expression and matrix formation via control of aggrecan, MMP3 and [TG] expression, and indicate an important role for RA in the regulation of MafB.	MafB	MMP13	0	UNDEFINED	False
11547	11749	22962574:10:STAT3:S100A9	Moreover, we found that phospho-[TF] binds directly to the [TG] promoter.	STAT3	S100A9	0	UNDEFINED	False
11548	11750	22964636:10:SMAD1:PDGFA	Collectively, our studies establish that loss of [TF]/5 leads to upregulation of [TG] in ovarian granulosa cells, and that a novel regulatory interaction exists between the BR-SMADs and Sp1 in controlling PDGFA expression during granulosa cell tumorigenesis.	SMAD1	PDGFA	2	REPRESSION	False
11549	11751	22964636:9:SMAD1:PDGFA	Further, [TF]/5 antagonize the activity of the transcription factor Sp1, a well-known positive regulator of [TG], by inhibiting its occupancy at a key regulatory site on the proximal PDGFA promoter.	SMAD1	PDGFA	2	REPRESSION	False
11550	11752	22967044:8:NFKB:BHLHE40	Thus, we conclude that EGCG induces the expression of the rat [TG] gene via both the PI3K pathway and degradation of the NF-B [TF] protein.	p65	SHARP-2	2	REPRESSION	True
11551	11753	22972545:4:TCF3:FGFR2	We showed that Twist1 stimulated [TG] and Fgf10 expression in a mesenchymal cell line and that it formed heterodimers with ubiquitously expressed E12 (together with E47 encoded by [TF] gene) and upregulated Fgfr2 and Fgf10 promoter activities in a dental mesenchyme-derived cell line.	E2A	Fgfr2	1	ACTIVATION	False
11552	11754	22972545:6:TWIST1:FGFR2	Although Runx2 had no apparent effects on [TG] and Fgf10 promoter activities, it inhibited the stimulatory activity of [TF] on Fgfr2 promoter.	Twist1	Fgfr2	1	ACTIVATION	False
11553	11755	22975311:2:AP1:ENPP2	Here, we characterise a novel [TG] transcriptional mechanism, utilised by both cell lines, that is restricted to the first 285bp of the Atx promoter and involves [TF] and SP transcription factors, acting through a CRE/AP-1-like element at position -142 to -149 and a GAbox at position -227 to -235 relative to the Atx translational start site.	AP-1	Atx	0	UNDEFINED	False
11554	11756	22982090:4:JUN:SESN2	In the present study, we identify JNK as a regulator of autophagy in nasopharyngeal carcinoma cell lines CNE1 and CNE2 exposed to excisanin A or serum deprivation and demonstrate that activation of JNK can cause upregulation of [TG] expression, which could be blocked by specific siRNAs directed against JNK1/2 or [TF].	c-Jun	sestrin 2	1	ACTIVATION	False
11555	11757	22982991:7:FOXO3:IRF7	Genome-wide location analysis combined with gene deletion studies identified the [TG] gene as a critical target of [TF].	FOXO3	Irf7	0	UNDEFINED	False
11556	11759	22990073:5:JUND:ITGAX	The direct interaction of [TF] and Fra2 with the [TG] promoter was further confirmed by a chromatin immunoprecipitation assay using CD11c-positive cells purified from BMDCs.	JunD	CD11c	0	UNDEFINED	False
11557	11760	22990073:7:JUND:ITGAX	These results indicate that [TF] composed with JunD and Fra2 protein plays a primary role in enhancing the transcription level of the [TG] gene in DC.	AP-1	CD11c	1	ACTIVATION	False
11558	11761	22992725:5:SP1:VEGFA	Furthermore, dominant negative [TF], mithramycin A, and SP-1 shRNA decreased [TG] promoter activity, whereas overexpression of SP-1 increased VEGF promoter activity.	SP-1	VEGF	1	ACTIVATION	False
11559	11762	22992725:6:SP1:VEGFA	Chromatin immunoprecipitation assays demonstrated [TF], p300, and PCA/F histone acetyltransferase binding and histone H4 hyperacetylation at the [TG] promoter in NSCLC cells.	SP-1	VEGF	0	UNDEFINED	False
11560	11763	23000165:1:NR5A2:POU5F1	We demonstrate the regulation of [TG] gene expression mediated by liver receptor homolog-1 ([TF]) in human embryonic carcinoma cells.	LRH-1	OCT4	0	UNDEFINED	False
11561	11764	23000165:9:NR5A2:POU5F1	Taken together, our study indicates that [TF] acts as a transcriptional activator in the regulation of [TG] gene expression through the cooperative interaction with three binding sites directly or/and indirectly.	LRH-1	OCT4	1	ACTIVATION	False
11562	11765	23002205:4:FOXM1:BUB1B	Furthermore, using a chromatin immunoprecipitation assay, we found that [TG] is a direct transcriptional target of [TF] (FoxM1).	Forkhead Box M1	Bub1b	0	UNDEFINED	False
11563	11766	23036195:5:E2F1:LHX2	Intriguingly, transcription factor [TF] also activates [TG] gene via direct binding to the same -229 to -126 region.	E2F1	Lhx2	1	ACTIVATION	False
11564	11767	23036195:7:E2F1:LHX2	This study provides evidence that the histone modification and [TF] binding are integral parts of the mechanism for [TG] gene expression.	E2F1	Lhx2	1	ACTIVATION	True
11565	11768	23037503:6:RELA:CDKN1A	In parthenolide-treated cells, [TG] transcription correlated with relaxed chromatin and [TF]/NF-B binding at the p21 promoter.	p65	p21	0	UNDEFINED	False
11566	11769	23037713:2:FOXM1:PLK1	One key target for [TF] is the gene encoding the protein kinase [TG] and PLK1 itself acts in a positive feedback loop to phosphorylate and activate FOXM1.	FOXM1	PLK1	1	ACTIVATION	False
11567	11770	23051594:4:FOXL2:CLU	We show that human gonadotroph cell pituitary tumors, unlike other secreting tumor types, express high levels of gonadotroph-specific forkhead transcription factor FOXL2, and both PTTG and [TF] (FOXL2) stimulate gonadotroph clusterin ([TG]) expression.	Forkhead box protein L2	Clu	1	ACTIVATION	False
11568	11771	23051594:6:FOXL2:CLU	[TF] directly stimulates the [TG] gene promoter, and we show that PTTG triggers ataxia telangiectasia mutated kinase/IGF-I/p38MAPK DNA damage/chromosomal instability signaling, which in turn also induces Clu expression.	FOXL2	Clu	1	ACTIVATION	False
11569	11772	23051594:8:FOXL2:PTTG1	[TF] binds and suppresses the [TG] promoter, and Clu also suppresses PTTG expression, thus neutralizing protumorigenic PTTG gonadotroph tumor cell properties.	FOXL2	PTTG	2	REPRESSION	False
11570	11773	23056173:4:NR1H4:NDRG2	Gene reporter assays and Chromatin Immunoprecipitation data support that [TF] directly controls [TG] transcription via IR1-type element(s) identified in the first introns of the human, mouse and rat NDRG2 genes.	FXR	NDRG2	0	UNDEFINED	False
11571	11774	23056173:7:NR1H4:NDRG2	Ectopic expression of [TF] in SK-Hep1 cells reduced tumor growth and metastasis potential of corresponding cells and increased the anti-tumor efficacy of FXR agonists, which may be partly mediated via increased [TG] expression.	FXR	NDRG2	1	ACTIVATION	False
11572	11775	23056300:12:STAT3:GREB1	Constitutively expressing active [TF] construct (STAT3-C) dramatically decreased [TG] transcription.	STAT3	GREB1	2	REPRESSION	False
11573	11776	23059951:4:ELK1:EGR1	Expression of a dominant-negative mutant of the ternary complex factor (TCF) [TF], a key transcriptional regulator of serum response element (SRE)-driven gene transcription, prevented [TG] expression.	Elk-1	Egr-1	1	ACTIVATION	False
11574	11777	23063436:4:ELK4:EGR1	Knockdown of [TF] decreased expression of the immediate early genes [TG] and fos and subsequent proliferation normally present with high adhesion, whereas knockdown of Net rescued egr1 and fos expression and proliferation normally suppressed by low adhesion.	Sap-1	egr1	1	ACTIVATION	False
11575	11778	23063436:5:ELK4:EGR1	Chromatin immunoprecipitation studies showed increased occupancy of [TG] and fos promoters by [TF] with high adhesion, whereas low adhesion increased Net occupancy.	Sap-1	egr1	0	UNDEFINED	False
11576	11779	23063436:7:ELK4:EGR1	Increasing adhesion enhanced serum-induced JNK activity while suppressing p38 activity, leading to increased [TF] phosphorylation and Net dephosphorylation, and switching Net with Sap-1 at [TG] and fos promoters to support proliferation.	Sap-1	egr1	0	UNDEFINED	False
11577	11780	23063463:4:TP53:SERPINE1	ROS generation in response to TGF-1 stimulation is rapid and precedes [TG] induction; engagement of non-SMAD (e.g., EGFR, Src kinase, MAP kinases, [TF]) and SMAD2/3 pathways are both required for PAI-1 expression and are ROS-dependent.	p53	PAI-1	1	ACTIVATION	False
11578	11781	23063463:5:TP53:SERPINE1	Recent findings suggest a novel role for [TF] in TGF-1-induced [TG] transcription that involves ROS generation and p53/SMAD interactions.	p53	PAI-1	1	ACTIVATION	False
11579	11782	23064471:3:HOXA1:PRLR	Microarray analysis identified that the [TG] receptor (PRLR) was significantly upregulated by forced expression of [TF] in mammary carcinoma cells.	HOXA1	prolactin	1	ACTIVATION	False
11580	11783	23064471:5:HOXA1:PRLR	Forced expression of [TF] in MCF-7 cells increased [TG] mRNA and protein expression.	HOXA1	PRLR	1	ACTIVATION	False
11583	11786	23066038:3:SP1:CDKN1A	Electrophoretic mobility shift and antibody super-shift assays confirmed the specific binding of [TF]/Sp3, and showed that the oxaliplatin-mediated derepression of [TG] transcription was associated with an increased Sp1/Sp3 phosphorylation and binding affinity to the oxaliplatin-responsive element.	Sp1	p21	1	ACTIVATION	False
11584	11787	23066038:3:SP3:CDKN1A	Electrophoretic mobility shift and antibody super-shift assays confirmed the specific binding of Sp1/[TF], and showed that the oxaliplatin-mediated derepression of [TG] transcription was associated with an increased Sp1/Sp3 phosphorylation and binding affinity to the oxaliplatin-responsive element.	Sp3	p21	1	ACTIVATION	False
11585	11788	23066038:7:SP1:CDKN1A	Taken together, our results revealed, for the first time, this evolutionarily conserved [TF]/Sp3 palindrome element in the proximal [TG] promoter that serves as a regulatory repressor to maintain p21 basal level expression.	Sp1	p21	2	REPRESSION	True
11586	11789	23066038:7:SP3:CDKN1A	Taken together, our results revealed, for the first time, this evolutionarily conserved Sp1/[TF] palindrome element in the proximal [TG] promoter that serves as a regulatory repressor to maintain p21 basal level expression.	Sp3	p21	2	REPRESSION	True
11588	11791	23074094:0:BCL6:EREG	Demethylation of [TG] gene by histone demethylase FBXL11 and [TF] corepressor inhibits osteo/dentinogenic differentiation.	BCL6	epiregulin	0	UNDEFINED	True
11589	11792	23076342:8:ETV1:MMP7	Together, these results showed that [TG] is a bona fide [TF] target gene, implicating that MMP-7 upregulation is partially responsible for the oncogenic effects of ETV1 in the prostate.	ETV1	MMP-7	1	ACTIVATION	False
11590	11793	23086815:8:ARNT:VEGFA	Moreover, FHL1 blocked [TF]-HIF1 heterodimerization and HIF1 recruitment to the [TG] promoter.	HIF1	VEGF	0	UNDEFINED	False
11591	11794	23087083:4:VDR:CDKN1A	This was evident in [TF] target genes including VDR, [TG] (encodes p21( (waf1/cip1) )) and GADD45A; NCOR1 knockdown alleviated this malignant transrepression.	VDR	CDKN1A	0	UNDEFINED	False
11593	11796	23091071:5:EGR1:PTRF	Cav1 phosphorylation reduces [TF] binding to Cav1 and [TG] promoters and stimulates their activity.	Egr1	cavin-1	2	REPRESSION	False
11595	11798	23091071:6:EGR1:PTRF	In MDA-231 breast carcinoma cells that express elevated levels of Cav1 and caveolae, [TF] regulated Cav1, and [TG] promoter activity was dependent on actin, Cav1, Src, and Rho-associated kinase as well as downstream protein kinase C (PKC) signaling.	Egr1	cavin-1	0	UNDEFINED	True
11596	11799	23091415:5:DLX4:TWIST1	Overexpression of [TF] increased expression of [TG] expression in cancer cell lines, resulting in increased migratory and invasive capacity.	DLX4	TWIST	1	ACTIVATION	False
11597	11800	23091415:7:DLX4:TWIST1	[TF] bound to regulatory regions of the [TG] gene.	DLX4	TWIST	0	UNDEFINED	False
11598	11801	23091415:9:DLX4:TWIST1	Taken together, these data from both cell models and tumor tissues demonstrate that [TF] not only upregulates [TG] expression but also induces EMT and tumor metastasis.	DLX4	TWIST	1	ACTIVATION	False
11599	11802	23096114:6:E2F7:CDKN1A	We also demonstrate that [TF] binds the cyclin-dependent kinase inhibitor p21(CIP1/[TG] (cyclin-dependent kinase inhibitor 1A) promoter repressing its expression.	E2F7	WAF1)	2	REPRESSION	False
11600	11803	23098564:9:SP1:ICAM1	Inhibition of [TF], C/EBP- and NF-B activations by specific siRNA blocked the SDF-1-induced [TG] promoter activity and expression.	Sp1	ICAM-1	1	ACTIVATION	False
11601	11804	23105117:6:NFATC2:PTGS2	This [TF] hyperactivation by VRK2 increases [TG] gene expression through the proximal NFAT1 binding site in the COX-2 gene promoter.	NFAT1	COX-2	1	ACTIVATION	False
11602	11805	23108140:7:E2F1:BRCA1	RBL2/E2F4 formation in turn led to a shift in [TG] promoter occupancy from complexes containing activator [TF] to complexes containing repressor E2F4, downregulating BRCA1 expression.	E2F1	BRCA1	1	ACTIVATION	True
11603	11806	23108140:7:E2F4:BRCA1	RBL2/[TF] formation in turn led to a shift in [TG] promoter occupancy from complexes containing activator E2F1 to complexes containing repressor E2F4, downregulating BRCA1 expression.	E2F4	BRCA1	2	REPRESSION	False
11604	11807	23110084:8:SMAD2:SMARCD3	TGF1 activates [TG] via the direct binding of [TF] complexes to the Baf60c promoter region.	SMAD2/3	Baf60c	1	ACTIVATION	False
11605	11808	23110939:3:STAT1:OAS1	ChIP-PCR demonstrated the presence of receptor subunits IFNAR1 and IFNAR2 along with TYK2, [TF], and H3pY41 specifically at the promoter of the [TG] gene in IFN treated cells.	STAT1	OAS1	0	UNDEFINED	False
11606	11809	23121767:3:EGR1:SLC4A2	The upregulated species of [TG] mRNA originates from the classical upstream promoter of the AE2 gene (here referred to as AE2a1) which provides the binding site for transcription factors [TF] (EGR1) and SP1.	early growth response 1	AE2	1	ACTIVATION	False
11607	11810	23121767:4:EGR1:SLC4A2	[TF] upregulated the [TG] expression that can be competitively inhibited by SP1 in co-transfection experiments.	EGR1	AE2	1	ACTIVATION	False
11608	11811	23121767:6:EGR1:SLC4A2	Overexpression or knockdown of [TF] consistently increased or decreased the expression of [TG].	EGR1	AE2	1	ACTIVATION	True
11609	11812	23131154:0:PITX2:CDKN1A	[TF] expression promotes [TG] expression and cell cycle exit in neural stem cells.	Pitx2	p21	1	ACTIVATION	False
11610	11813	23131154:7:PITX2:CDKN1A	In addition, [TF] bound directly to the [TG] promoter as assessed by chromatin immunoprecipitation (ChIP) in NSCs.	Pitx2	p21	0	UNDEFINED	False
11611	11814	23131154:9:PITX2:CDKN1A	Our results suggest that [TF] promotes [TG] expression and induces cell cycle exit in neural progenitors.	Pitx2	p21	1	ACTIVATION	False
11612	11815	23131565:0:HIF1A:PRNP	Transcriptional regulation of specific protein 1 (SP1) by hypoxia-inducible factor 1 alpha ([TF]) leads to [TG] expression and neuroprotection from toxic prion peptide.	HIF-1	PRNP	1	ACTIVATION	True
11613	11816	23133314:0:FOXO1:SELL	[TF] Up-Regulates Human [TG] Expression Through Binding to a Consensus FOXO1 Motif.	FOXO1	L-selectin	1	ACTIVATION	False
11614	11817	23133314:11:FOXO1:SELL	We conclude that [TF] regulates [TG] expression through targeting its promoter.	FOXO1	L-selectin	0	UNDEFINED	True
11615	11818	23133598:10:CDX2:REG4	Chromatin immunoprecipitation assays showed that [TF] binds directly to the 5'-flanking region of [TG].	CDX2	REG4	0	UNDEFINED	False
11616	11819	23133598:11:CDX2:REG4	These results indicate that [TF] protein directly regulates [TG] expression.	CDX2	Reg IV	0	UNDEFINED	False
11617	11820	23133598:4:CDX2:REG4	In the present study, we investigated whether [TF] regulates [TG] expression in gastric cancer (GC) cells.	CDX2	Reg IV	0	UNDEFINED	False
11618	11821	23133598:8:CDX2:REG4	Using an estrogen receptor-regulated form of [TF], rapid induction of [TG] expression was observed in HT-29 cells.	CDX2	Reg IV	1	ACTIVATION	False
11619	11824	23142053:12:SP1:DNMT1	Our study suggests that miR-29b negatively regulates [TG] expression by targeting [TF] in T cells.	sp1	DNMT1	1	ACTIVATION	True
11620	11825	23144749:0:RELA:IL2RA	Forkhead transcription factor FOXP3 upregulates [TG] expression through cooperation with [TF]/NF-B.	RelA	CD25	1	ACTIVATION	False
11621	11826	23144749:3:RELA:IL2RA	Here we describe that FOXP3, induced by CD28 signals in human CD4(+)CD25(-) T lymphocytes, synergizes with [TF] on a regulatory region of [TG] promoter to mediate the transcriptional activation of Cd25 gene.	RelA	Cd25	1	ACTIVATION	False
11622	11827	23155052:11:NR1I2:KDR	We conclude that MMP-1 promotes [TG] expression and proliferation of endothelial cells through stimulation of [TF] and activation of NF-B.	PAR-1	VEGFR2	1	ACTIVATION	False
11623	11828	23159633:7:RUNX2:FOSL1	Transient transfection assay showed that [TF] activates [TG] promoter-reporter activity, suggesting that Fra-1 may be a direct target of Runx2.	Runx2	Fra-1	1	ACTIVATION	False
11624	11829	23159633:8:RUNX2:FOSL1	To determine the minimal region of the [TG] promoter that was activated by [TF], a series of Fra-1 promoter deletion constructs were made.	Runx2	Fra-1	1	ACTIVATION	False
11625	11830	23161884:4:JUN:SIRT1	We now know that Smad3 cooperates with c-Jun to synergistically regulate a protein deacetylase [TG], by binding to an [TF] site in the SIRT1 promoter.	AP-1	SIRT1	0	UNDEFINED	False
11626	11831	23161884:4:SMAD3:SIRT1	We now know that [TF] cooperates with c-Jun to synergistically regulate a protein deacetylase [TG], by binding to an AP-1 site in the SIRT1 promoter.	Smad3	SIRT1	0	UNDEFINED	False
11627	11832	23161884:5:SMAD3:SIRT1	Consistently, [TF] knockout lung at postnatal day 28 had reduced [TG] expression, which in turn resulted in increased histone acetylation at the binding sites of the transcription factors AP-1, NF-B, and Pea3 on the MMP9 promoter, as well as increased acetylation of NF-B.	Smad3	SIRT1	1	ACTIVATION	False
11628	11833	23161884:6:JUN:SIRT1	Thus, upon TGF- activation, phosphorylated Smad3 can be translocated into the nucleus with Smad4, whereat Smad3 in turn collaborates with [TF] to activate [TG] transcription.	c-Jun	SIRT1	1	ACTIVATION	False
11630	11835	23175522:7:HIF1A:EIF4EBP1	In the present study, we found that [TG] gene promoter contains a hypoxia-responsive element (HRE) that mediates 4E-BP1 gene upregulation via the [TF] (HIF-1) transcription factor.	hypoxia-inducible factor-1 alpha	4E-BP1	1	ACTIVATION	False
11631	11836	23178160:0:PGR:CDKN1A	Progestin drives breast cancer growth by inducing p21([TG]) expression through the assembly of a transcriptional complex among Stat3, [TF] and ErbB-2.	progesterone receptor	CIP1	1	ACTIVATION	False
11632	11837	23178160:6:PGR:CDKN1A	Interestingly, we determined that progestin drives p21([TG]) transcriptional activation via a novel nonclassical transcriptional mechanism in which [TF] is recruited along with Stat3 and ErbB-2 to a Stat3 binding site at p21(CIP1) promoter.	progesterone receptor	CIP1	1	ACTIVATION	False
11633	11838	23178493:7:STAT3:ICAM1	Chromatin immunopreicipitation and promoter luciferase activity assays confirmed the critical role of adjacent NF-B (+399) and [TF] (+479) binding motifs in the proximal intron-1 in elevating IR-induced [TG] expression.	Stat3	ICAM-1	1	ACTIVATION	False
11634	11839	23178572:0:HIC1:CDKN1A	Identification of p21 (CIP1/[TG]) as a direct target gene of [TF] (Hypermethylated In Cancer 1).	HIC1	WAF1	0	UNDEFINED	False
11635	11840	23178572:5:HIC1:CDKN1A	Through promoter luciferase activity and chromatin immunoprecipitation (ChIP), we demonstrate that [TF] is a direct transcriptional repressor of [TG].	HIC1	p21	2	REPRESSION	False
11636	11841	23181698:4:TWIST1:ALX3	We found that the [TG] promoter contains two E-box regulatory elements, named EB1 and EB2, that provide binding sites for the basic helix-loop-helix transcription factors [TF], E47, USF (upstream stimulatory factor) 1 and USF2.	Twist1	Alx3	0	UNDEFINED	False
11637	11842	23181698:4:USF2:ALX3	We found that the [TG] promoter contains two E-box regulatory elements, named EB1 and EB2, that provide binding sites for the basic helix-loop-helix transcription factors Twist1, E47, USF (upstream stimulatory factor) 1 and [TF].	USF2	Alx3	0	UNDEFINED	False
11638	11843	23181698:6:TWIST1:ALX3	Integrity of both EB1 and EB2 is required for [TF]-mediated transactivation of the [TG] promoter, even though Twist1 does not bind to EB1, indicating that binding of USF1 and USF2 to this element is required for Twist1-dependent Alx3 promoter activity.	Twist1	Alx3	1	ACTIVATION	False
11639	11844	23181698:6:USF1:ALX3	Integrity of both EB1 and EB2 is required for Twist1-mediated transactivation of the [TG] promoter, even though Twist1 does not bind to EB1, indicating that binding of [TF] and USF2 to this element is required for Twist1-dependent Alx3 promoter activity.	USF1	Alx3	1	ACTIVATION	False
11640	11845	23181698:6:USF2:ALX3	Integrity of both EB1 and EB2 is required for Twist1-mediated transactivation of the [TG] promoter, even though Twist1 does not bind to EB1, indicating that binding of USF1 and [TF] to this element is required for Twist1-dependent Alx3 promoter activity.	USF2	Alx3	1	ACTIVATION	False
11641	11846	23184467:0:SP1:CDKN1A	Stat6 cooperates with [TF] in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/[TG]) and p27          (Kip1).	Sp1	WAF1	0	UNDEFINED	False
11642	11847	23184467:0:STAT6:CDKN1A	[TF] cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/[TG]) and p27          (Kip1).	Stat6	WAF1	0	UNDEFINED	False
11643	11848	23184467:15:SP1:CDKN1A	Together, these results identify Stat6 as an important cell differentiation regulatory protein functioning, at least in part, by interacting with [TF] to activate the [TG] and p27 gene promoters in breast cancer cells.	Sp1	p21	1	ACTIVATION	False
11644	11849	23184467:15:STAT6:CDKN1A	Together, these results identify [TF] as an important cell differentiation regulatory protein functioning, at least in part, by interacting with Sp1 to activate the [TG] and p27 gene promoters in breast cancer cells.	Stat6	p21	1	ACTIVATION	False
11645	11850	23185316:10:NFKB:HIF1A	The TG2/[TF](NF-B) complex binds to the [TG] promoter and induced its transcriptional regulation.	p65	HIF-1	1	ACTIVATION	True
11646	11852	23185615:4:PRRX1:VEGFA	Inhibition of [TF] by CaP cells resulted in reduced expression of [TG], diminished tumor vasculature and retarded tumor growth.	Prx1	VEGF	1	ACTIVATION	False
11647	11853	23185615:5:PRRX1:VEGFA	The mechanism by which [TF] regulates [TG] expression in normoxic conditions was investigated in the current study.	Prx1	VEGF	0	UNDEFINED	False
11648	11854	23185615:6:PRRX1:VEGFA	Our results show that incubation of mouse vascular endothelial cells with recombinant [TF] caused increases in [TG] expression that was dependent upon TLR4 and required hypoxia inducible factor-1 (HIF-1) interaction with the VEGF promoter.	Prx1	VEGF	1	ACTIVATION	False
11649	11855	23185615:7:PRRX1:VEGFA	The induction of [TG] was also dependent upon NF-B; however, NF-B interaction with the VEGF promoter was not required for [TF] induction of VEGF suggesting that NF-B was acting indirectly to induce VEGF expression.	Prx1	VEGF	1	ACTIVATION	False
11650	11856	23185634:0:SP7:MMP13	Matrix metalloproteinase 13 ([TG]) is a direct target of osteoblast-specific transcription factor [TF] (Osx) in osteoblasts.	osterix	MMP13	0	UNDEFINED	False
11651	11857	23187734:0:ATF3:SLC11A1	Transcription factor [TF] regulates allele variation phenotypes of the human [TG] gene.	ATF-3	SLC11A1	0	UNDEFINED	False
11652	11858	23187734:5:ATF3:SLC11A1	The aim of the study was to characterize the transcriptional mechanisms controlling different alleles of [TG] expression by [TF] and c-Jun.	ATF-3	SLC11A1	0	UNDEFINED	False
11653	11859	23212346:0:NONO:POU5F1	[TF] binds to the CpG island of [TG] promoter and functions as a transcriptional activator of oct4 gene expression.	NonO	oct4	1	ACTIVATION	False
11654	11860	23212346:12:NONO:POU5F1	In summary, we purified [TF], a novel protein that binds to the CpG island of [TG] promoter, and positively regulates oct4 gene expression in ES cells.	NonO	oct4	1	ACTIVATION	False
11655	11861	23212346:5:NONO:POU5F1	EMSA with specific competitors revealed that [TF] specifically binds to the conserved CCGGTGAC sequence in the [TG] promoter.	NonO	oct4	0	UNDEFINED	False
11656	11862	23212346:7:NONO:POU5F1	Chromatin immunoprecipitation analysis confirmed that [TF] binds to the unmethylated [TG] promoter.	NonO	oct4	0	UNDEFINED	False
11657	11863	23212346:9:NONO:POU5F1	The transcriptional role of [TF] in [TG] gene expression was evaluated by luciferase assays and knockdown experiments.	NonO	oct4	0	UNDEFINED	False
11658	11864	23212942:11:EGR1:NDRG1	We found that [TF], a transcription factor that binds to the [TG] promoter, was mediated in the NDRG1 expression regulation by PKD2.	early growth response 1	NDRG1	0	UNDEFINED	True
11659	11865	23213445:5:NR2E1:VEGFA	Upon hypoxia, [TF] increases in the nucleus where it binds in close proximity of the HIF-response element on the [TG]-promoter chromatin, and, together with HIF-2, recruits RNA polymerase II to induce VEGF expression.	TLX	VEGF	1	ACTIVATION	False
11660	11866	23219836:7:NFKB:VCAM1	Ang-(1-7) also inhibited the Ang II-induced [TG] promoter activity driven by transcription factor [TF].	NF-KappaB	VCAM-1	1	ACTIVATION	False
11661	11867	23223231:6:AP1:XYLT1	Transactivation and chromatin immunoprecipitation assays indicated that [TF] is a potent transactivator of [TG] promoter and that IL-1-induced activity is mediated through increased recruitment of AP-1 to the promoter.	AP-1	XT-I	1	ACTIVATION	False
11662	11868	23223231:7:SP3:XYLT1	Finally, we show that [TF] is a repressor of [TG] promoter and bring evidence that the repressive effect of IL-1 during the late phase is mediated through Sp3 recruitment to the promoter.	Sp3	XT-I	2	REPRESSION	False
11663	11869	23226549:9:IRF2:IFI35	These findings provide the first evidence that IRF-1 and [TF] are involved in constitutive [TG] expression in HeLa cells, while IRF-1 also activates IFP35 expression in an IFN--inducible manner.	IRF-2	IFP35	1	ACTIVATION	False
11664	11870	23228483:0:STAT3:HSP90AA1	Leptin increases HER2 protein levels through a [TF]-mediated up-regulation of [TG] in breast cancer cells.	STAT3	Hsp90	1	ACTIVATION	False
11665	11871	23235480:6:SP1:CDKN1A	Chromatin immunoprecipitation assays showed that TGF-1 treatment led to a time-dependent enrichment of histone H3-lysine9/14-acetylation (H3K9/14Ac) and p300/CBP occupancies around Smad and [TF] binding sites at the PAI-1 and [TG] promoters.	Sp1	p21	0	UNDEFINED	False
11666	11872	23240008:2:FOXM1:CDC25A	Previous studies have suggested that [TF] regulates [TG] gene transcription, but the mechanism remains unknown.	FOXM1	CDC25A	0	UNDEFINED	True
11667	11873	23243310:6:SMAD3:BBC3	[TG] was a direct TGF- target gene in B-cells, and we identify a putative Smad-binding region within the human PUMA promoter that recruits [TF] and Smad4 in cells in response to TGF- signaling.	Smad3	PUMA	0	UNDEFINED	False
11668	11874	23243310:6:SMAD4:BBC3	[TG] was a direct TGF- target gene in B-cells, and we identify a putative Smad-binding region within the human PUMA promoter that recruits Smad3 and [TF] in cells in response to TGF- signaling.	Smad4	PUMA	0	UNDEFINED	False
11669	11875	23249750:5:SMAD3:CTGF	The unexpected effects of miR-18a on [TG] transcription are mediated in part by direct targeting of [TF] and ensuing weakening of TGF signaling.	Smad3	CTGF	0	UNDEFINED	False
11670	11876	23251702:11:E2F1:RASSF1	This study demonstrates that simultaneous targeting of DNA and [TF] methylation is an effective epigenetic treatment that reactivates [TG] expression and induces apoptosis in breast cancer cells.	E2F1	RASSF1A	1	ACTIVATION	True
11671	11877	23251702:6:E2F1:RASSF1	Chromatin immunoprecipitation (ChIP) assays were employed to confirm that this combination induced chromatin remodelling of the [TG] promoter and increased the occupancy of [TF] at the promoter of this tumour suppressor gene.	E2F1	RASSF1A	0	UNDEFINED	False
11672	11878	23255602:4:SMAD7:CASP8	[TF] was able to activate the [TG] promoter through recruitment of the interferon regulatory factor 1 (IRF1) transcription factor to the interferon-stimulated response element (ISRE) site.	Smad7	caspase 8	1	ACTIVATION	False
11673	11879	23255602:5:SMAD7:CASP8	Interaction of [TF] on the [TG] promoter was confirmed with electrophoretic mobility shift assay and chromatin immunoprecipitation experiment.	Smad7	caspase 8	0	UNDEFINED	False
11674	11880	23255602:7:SMAD7:CASP8	These results support that [TF] recruits IRF1 protein on the [TG] promoter and functions as a transcriptional coactivator.	Smad7	caspase 8	1	ACTIVATION	False
11675	11881	23259454:4:SMAD2:NKX2-1	Activin-A directly mediates the induction of [TG] by interacting with ALK4, leading to phosphorylation of [TF], which binds directly to the NKX2-1 promoter and activates its expression.	SMAD2	NKX2-1	1	ACTIVATION	False
11676	11882	23259454:7:SMAD2:NKX2-1	These results suggest that direct binding of Activin-A-responsive [TF] to the [TG] promoter plays essential role during respiratory endoderm specification.	SMAD2	NKX2-1	0	UNDEFINED	False
11677	11883	23261458:3:SMAD3:ANGPTL2	Here we demonstrate that TGF-1 induces expression of the [TG] gene through a [TF]-dependent pathway in RAW264.7 macrophage cells, primary peritoneal macrophages, and differentiated 3T3-L1 adipocytes.	Smad3	Angptl2	1	ACTIVATION	False
11678	11884	23261458:4:SMAD3:ANGPTL2	Transcriptional induction of the [TG] gene by TGF-1 was dependent on the [TF] protein which binds to the Smad Binding Element (SBE) region located on the Angptl2 promoter.	Smad3	Angptl2	1	ACTIVATION	False
11679	11885	23262099:5:RARA:ABCG2	Signaling pathways, such as Sonic hedgehog (Shh), Notch and [TF]/RXR pathways, may also involve in the transcriptional regulation of [TG].	RAR	BCRP	0	UNDEFINED	False
11681	11887	23274526:12:JUN:VEGFA	Treatment of OASF with HG increased the accumulation of phosphorylated c-Jun in the nucleus, [TF]-luciferase activity, and c-Jun binding to the AP-1 element on the [TG] promoter.	AP-1	VEGF	0	UNDEFINED	False
11682	11888	23274526:13:AP1:VEGFA	Our results suggest that the HG increases [TG] expression in human synovial fibroblasts via the ROS, PI3K, Akt, c-Jun and [TF] signaling pathway.	AP-1	VEGF	1	ACTIVATION	False
11683	11889	23275439:0:GATA6:PPP1R14A	[TF] and NF-B activate [TG] gene transcription and regulate Ca2+ sensitization of smooth muscle contraction.	GATA-6	CPI-17	1	ACTIVATION	False
11684	11890	23275439:3:GATA6:PPP1R14A	[TF] and NF-B upregulated [TG] expression in cultured human and mouse bladder smooth muscle (BSM) cells in an additive manner.	GATA-6	CPI-17	1	ACTIVATION	False
11685	11891	23275439:8:GATA6:PPP1R14A	Our data provide insight into how [TF] and NF-B mediate [TG] transcription, PKC-mediated signaling, and BSM remodeling associated with lower urinary tract symptoms in patients with BPH.	GATA-6	CPI-17	1	ACTIVATION	False
11686	11892	23277454:6:MYC:PARP1	Notably, the endogenous [TG] and PARylation activity was enhanced by overexpression of [TF] and repressed by c-Myc knockdown.	c-Myc	Parp1	1	ACTIVATION	False
11687	11893	23277454:7:MYC:PARP1	A chromatin immunoprecipitation assay revealed a direct interaction of [TF] with the [TG] promoter.	c-Myc	Parp1	0	UNDEFINED	False
11688	11894	23288701:7:TFE3:UPP1	As validation of this approach to identify genuine ASPSCR1-[TF] target genes, two up-regulated genes bound by ASPSCR1-TFE3, CYP17A1 and [TG], were shown by multiple lines of evidence to be direct, endogenous targets of transactivation by ASPSCR1-TFE3.	TFE3	UPP1	1	ACTIVATION	False
11689	11895	23291318:0:WT1:USP18	Ubiquitin specific protease 18 ([TG]) is a [TF] transcriptional target.	WT1	Usp18	0	UNDEFINED	False
11690	11896	23291318:6:WT1:USP18	Conversely, knockdown of [TF] led to the upregulation of [TG].	WT1	Usp18	2	REPRESSION	False
11691	11897	23291318:7:WT1:USP18	Furthermore, direct binding of [TF] to the [TG] promoter was demonstrated by ChIP assay.	WT1	Usp18	0	UNDEFINED	False
11692	11898	23295648:10:ETS1:DAXX	Our results reveal a novel possible mechanism: by competitively binding to the Sp1 and [TF] consensus sequences, BBR inhibits the transcription of [TG], thus inducing cancer cell apoptosis through a p53-dependent pathway.	Ets1	DAXX	0	UNDEFINED	True
11693	11899	23295648:6:ETS1:DAXX	We confirmed that Sp1 and [TF] bound to the core promoter region of [TG] and stimulated DAXX transcriptional activity.	Ets1	DAXX	1	ACTIVATION	False
11694	11900	23295648:8:ETS1:DAXX	Following studies demonstrated a possible mechanism that BBR inhibited the [TG] promoter activity through blocking or disrupting the association of Sp1 or [TF] and their consensus sequences in the promoter.	Ets1	DAXX	1	ACTIVATION	True
11695	11901	23300383:3:ELF5:FOXA1	[TF] suppressed ER and [TG] expression and broadly suppressed ER-driven patterns of gene expression including sets of genes distinguishing the luminal molecular subtype.	ELF5	FOXA1	2	REPRESSION	False
11696	11902	23300383:4:ELF5:FOXA1	Direct transcriptional targets of [TF], which included [TG], EGFR, and MYC, accurately classified a large cohort of breast cancers into their intrinsic molecular subtypes, predicted ER status with high precision, and defined groups with differential prognosis.	ELF5	FOXA1	0	UNDEFINED	True
11697	11903	23303185:5:CTCF:MUC2	Next, siRNA-mediated depletion of [TF] was shown to increase [TG] expression in A549 lung carcinoma cells and both MUC6 and MUC5AC expression in LS180 colon carcinoma cells.	CTCF	MUC2	2	REPRESSION	False
11698	11904	23303185:5:CTCF:MUC5AC	Next, siRNA-mediated depletion of [TF] was shown to increase MUC2 expression in A549 lung carcinoma cells and both MUC6 and [TG] expression in LS180 colon carcinoma cells.	CTCF	MUC5AC	2	REPRESSION	False
11699	11905	23307555:3:POU5F1:CCNF	[TF] drives the expression of Nipp1 and [TG] that inhibit the activity of the protein phosphatase 1 (PP1) complex to establish hyperphosphorylation of the retinoblastoma protein 1 (pRb) as a hallmark feature of self-renewing mESCs.	Oct4	Ccnf	1	ACTIVATION	False
11700	11906	23308270:11:GFI1B:MEIS1	Transfection experiments further demonstrated specific repression of [TG] promoter driven reporters by wild type [TF] but neither by a SNAG domain mutant nor by a DNA binding deficient one, thus confirming direct functional regulation of this promoter by the Gfi1b transcriptional complex.	Gfi1b	meis1	2	REPRESSION	False
11701	11907	23314702:3:ZKSCAN7:POU5F1	Herein, we describe a novel designer zinc finger protein ([TF]) capable of upregulating the endogenous [TG] promoter in a panel of breast and ovarian cell lines carrying a silenced gene.	ZFP	Oct4	1	ACTIVATION	False
11702	11908	23316056:12:ETS1:IFT20	We also determined that Mxi1 regulates [TG] promoter activity via [TF] binding to the Ift20 promoter.	Ets-1	Ift20	0	UNDEFINED	False
11703	11909	23318274:0:FOXA1:FABP1	The human liver fatty acid binding protein ([TG]) gene is activated by [TF] and PPAR; and repressed by C/EBP: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease.	FOXA1	FABP1	1	ACTIVATION	False
11704	11910	23318274:10:FOXA1:FABP1	We conclude that human [TG] has a complex mechanism of regulation where C/EBP displaces HNF4 and hampers activation by [TF] and PPAR.	FOXA1	FABP1	1	ACTIVATION	False
11705	11911	23318274:8:FOXA1:FABP1	[TF] activated the [TG] promoter through binding to a cluster of elements between -229 and -592bp, whereas PPAR operated through a conserved proximal element at -59bp.	FOXA1	FABP1	1	ACTIVATION	False
11706	11912	23329648:5:STAT3:CCND1	Expression of a [TF]S727A vector, which carries a serine-to-alanine substitution at codon 727, shows that Stat3Ser727 phosphorylation is required for full transcriptional activation of [TG] gene expression by progestins and for in vivo Stat3 recruitment on cyclin D1 promoter.	Stat3	cyclin D1	1	ACTIVATION	False
11707	11913	23329847:0:SP1:CDKN1A	Regulation of the [TG] gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor [TF] binding.	Sp1	cyclin-dependent kinase inhibitor 1A	0	UNDEFINED	False
11708	11914	23329847:4:SP1:CDKN1A	BOZF1 repressed the transcription of p21WAF/[TG] by acting on the proximal promoter concentrated with [TF]-binding GC boxes.	Sp1	CDKN1A	0	UNDEFINED	False
11709	11915	23331079:6:AP1:FGF2	Treatment of IL-1-stimulated human CEC with either [TF] or NF-B antagonists decreased [TG] expression and resulted in reduced IL-1-enhanced cell migration.	AP-1	FGF2	1	ACTIVATION	False
11710	11916	23331079:8:AP1:FGF2	Chromatin immunoprecipitation assays demonstrated that [TF] and NF-B directly bind to the [TG] promoter following IL-1 stimulation.	AP-1	FGF2	0	UNDEFINED	False
11711	11917	23331079:9:AP1:FGF2	The results show that binding of IL-1 to its receptor in human CEC leads to parallel activation of [TF] and NF-B pathways, leading, in turn, to [TG] expression and enhanced cell migration.	AP-1	FGF2	1	ACTIVATION	False
11712	11918	23334421:5:TP53:ME1	We show that [TF] represses the expression of the tricarboxylic-acid-cycle-associated malic enzymes [TG] and ME2 in human and mouse cells.	p53	ME1	2	REPRESSION	False
11714	11920	23340304:6:ZEB1:PLAU	[TF] regulates [TG] and PAI-1 in opposite directions: induces uPA and inhibits PAI-1.	ZEB1	uPA	0	UNDEFINED	True
11715	11921	23340304:9:ZEB1:PLAU	[TF] binds to the [TG] promoter and activates its transcription through a mechanism implicating the histone acetyltransferase p300.	ZEB1	uPA	1	ACTIVATION	False
11716	11922	23342162:13:PAX6:HAS2	Moreover, we examined differentially expressed transcripts between E9.5 wild type and [TF]/ lens placodes that suggested Efnb2, Fat4, [TG], Nav1, and Trpm3 as novel Pax6-direct targets.	Pax6	Has2	0	UNDEFINED	False
11717	11923	23353822:5:E2F3:SLC1A5	The Rb-controlled transcription factor [TF] altered glutamine uptake by direct regulation of [TG] mRNA and protein expression, and E2F-3 was observed to associate with the ASCT2 promoter.	E2F-3	ASCT2	0	UNDEFINED	False
11718	11924	23369005:7:SP1:VEGFA	Similarly, suppression of [TF] binding by Mithramycin A treatment significantly reduced [TG] expression.	Sp1	VEGF	1	ACTIVATION	False
11719	11925	23370526:10:STAT3:POMC	Finally, RELA binds to [TF] and inhibits STAT3-mediated promoter activity, suggesting that RELA, possibly together with forkhead box-containing protein 1 (FOXO1), may prevent STAT3-mediated leptin activation of the [TG] promoter.	STAT3	Pomc	1	ACTIVATION	False
11720	11926	23372731:11:IRF7:NR1H4	A putative [TF] response element was detected in the [TG] promoter and its functional characterization revealed that IRF7 is recruited on the FXR promoter under TLR9 stimulation.	IRF7	FXR	0	UNDEFINED	False
11721	11927	23382383:8:FOXO3:ARC	Moreover, we showed that [TF] activates [TG] expression by directly binding to its promoter.	Foxo3a	ARC	1	ACTIVATION	False
11722	11928	23382383:9:FOXO3:ARC	This study reveals that [TF] maintains calcium homeostasis and inhibits cardiac apoptosis through trans-activation of the [TG] promoter.	Foxo3a	ARC	1	ACTIVATION	False
11723	11929	23382863:8:NFKB:STC1	Further, we showed that NF-B [TF] protein directly bound to [TG] promoter and activated the expression of STC1 in cervical cancer cells.	p65	STC1	1	ACTIVATION	False
11724	11931	23385061:6:JUN:CCNA2	Chromatin immunoprecipitation and reporter assays revealed that tylophorine enhanced the c-Jun downregulation of the [TG] promoter activity upon increased binding of c-Jun to the deregulation [TF] site and decreased binding to the upregulation activating transcription factor (ATF) site in the cyclin A2 promoter, thereby reducing cyclin A2 expression.	AP1	cyclin A2	2	REPRESSION	True
11725	11934	23386688:9:NFKB:SOCS3	Using pharmacological inhibition of NF-B and inducible knockdown of NF-B [TF], we found that JSI-124-induced expression of IL-6, IL-8, and [TG] was significantly inhibited, showing an NF-B-dependent mechanism.	p65	SOCS3	1	ACTIVATION	False
11726	11936	23388456:6:HSF1:SESN3	In the present study we have found that Ras-induced repression of [TG] expression and ROS upregulation is mediated via the modifications of transcriptional activity of [TF].	HSF1	SESN3	1	ACTIVATION	True
11727	11937	23388456:7:HSF1:SESN3	Interestingly, mutant Ras overexpression altered the activity of [TF] in opposite directions in different cell contexts, in particular in human normal fibroblasts and HaCaT immortalized keratinocytes, but these opposite changes caused similar repression of [TG] expression followed by elevation of ROS content and inhibition of cell proliferation in corresponding cell types.	HSF1	SESN3	2	REPRESSION	False
11728	11938	23390317:5:NFATC4:VEGFA	The transcriptional factor [TF] functions as a downstream target of p85 to mediate the induction of [TG] expression in the UVB response.	NFAT3	VEGF	1	ACTIVATION	False
11729	11939	23390498:13:SMAD3:SLC5A2	Although HG itself does not regulate [TG] expression in our model, TGF increases SGLT2 expression through [TF].	phosphorylated smad3	SGLT2	1	ACTIVATION	False
11730	11940	23390498:7:SMAD3:SLC5A2	A chromatin immunoprecipitation assay was used to determine the binding of [TF] to the promoter region of the [TG] gene.	phosphorylated smad3	SGLT2	0	UNDEFINED	False
11731	11941	23390498:8:SMAD3:SLC5A2	Our data showed that TGF1 but not HG increased [TG] expression and this occurred via [TF].	phosphorylated smad3	SGLT2	1	ACTIVATION	False
11732	11942	23391827:4:RELA:SAA1	The present study defines a novel STAT3 non-consensus TFBS at nt -75/-66 downstream of the NF-B RE in the [TG] promoter region that is required for NF-B [TF] and STAT3 to activate SAA1 transcription in human HepG2 liver cells.	p65	SAA1	1	ACTIVATION	False
11733	11943	23401853:0:SP3:CDKN1A	Transcription factor [TF] represses expression of [TG]CIP via inhibition of productive elongation by RNA polymerase II.	Sp3	p21	2	REPRESSION	False
11734	11944	23401853:3:SP3:CDKN1A	Here we report that the transcription factor [TF] inhibits basal p21([TG]) gene expression by promoter-bound RNA PolII.	Sp3	CIP1	2	REPRESSION	False
11735	11945	23401853:4:SP3:CDKN1A	Knockdown of [TF] led to increased p21([TG]) mRNA levels and reduced occupancy of the negative elongation factor (NELF) at the p21(CIP1) promoter, although the level of binding of the positive transcription elongation factor b (P-TEFb) kinase was not increased.	Sp3	CIP1	2	REPRESSION	False
11736	11946	23401853:7:SP3:CDKN1A	Analysis of other targets of [TF]-mediated repression suggests that, in addition to previously described SUMO modification-dependent chromatin-silencing mechanisms, inhibition of the transition of paused RNA PolII to productive elongation, described here for p21([TG]), is a general mechanism by which transcription factor Sp3 fine-tunes gene expression.	Sp3	CIP1	2	REPRESSION	False
11737	11947	23414097:5:LITAF:VEGFA	Cells cotransfected with a series of [TG] promoter deletions along with truncated forms of m[TF] and/or mSTAT6B identified a DNA binding site (between -338 and -305 upstream of the transcription site) important in LITAF and/or STAT6B-mediated transcriptional regulation of VEGF.	LITAF	VEGF	0	UNDEFINED	False
11738	11948	23414097:5:STAT6:VEGFA	Cells cotransfected with a series of [TG] promoter deletions along with truncated forms of mLITAF and/or m[TF] identified a DNA binding site (between -338 and -305 upstream of the transcription site) important in LITAF and/or STAT6B-mediated transcriptional regulation of VEGF.	STAT6B	VEGF	0	UNDEFINED	False
11739	11949	23416929:14:RELA:IGF1R	Knockdown of [TF] suppressed the AGEs-induced increase in calcium deposition, and rescued the [TG] expression.	p65	IGF1R	2	REPRESSION	False
11740	11950	23416975:11:STAT3:PTTG1	These results elucidate a mechanism for tumor cell [TG] regulation, whereby [TF] induces PTTG expression to facilitate tumor growth and metastasis, and further support the rationale for targeting PTTG to abrogate colorectal cancer growth.	STAT3	PTTG	1	ACTIVATION	False
11741	11951	23416975:5:STAT3:PTTG1	[TF] specifically bound the human [TG] promoter and induced PTTG transcriptional activity (twofold) as assessed by chromatin immunoprecipitation and luciferase reporter assays.	STAT3	PTTG	1	ACTIVATION	False
11742	11952	23416975:6:STAT3:PTTG1	[TF] transfection increased [TG] mRNA and protein abundance twofold in HCT116 human colon cancer cells, and induction was further enhanced (threefold) by constitutively active STAT3 (STAT3-C), whereas strongly abrogated by dominant-negative STAT3 (STAT3-DN).	STAT3	PTTG	1	ACTIVATION	False
11743	11953	23423781:7:GLI1:ABCG2	The underlying mechanism is a direct association of [TF] with a specific consensus sequence located in the promoter region of ABCB1 and [TG] genes.	Gli1	ABCG2	0	UNDEFINED	False
11744	11954	23433111:0:EGR1:BRCA1	[TF] regulates the transcription of the [TG] gene by etoposide.	Egr-1	BRCA1	0	UNDEFINED	False
11745	11955	23433111:6:EGR1:BRCA1	Forced expression of [TF] stimulated the [TG] promoter activity.	Egr-1	BRCA1	1	ACTIVATION	False
11746	11956	23433111:7:EGR1:BRCA1	EMSA data showed that [TF] bound directly to the EBS within the [TG] gene.	Egr-1	BRCA1	0	UNDEFINED	False
11747	11957	23433111:9:EGR1:BRCA1	We conclude that [TF] targets the [TG] gene in HeLa cells exposed to etoposide.	Egr-1	BRCA1	0	UNDEFINED	False
11748	11958	23433354:0:POU5F1:CCND1	[TF] increases BIRC5 and [TG] expression and promotes cancer progression in hepatocellular carcinoma.	OCT4	CCND1	1	ACTIVATION	False
11749	11959	23433354:6:POU5F1:CCND1	An octamer motif for [TF] in the [TG] promoter has directly and partly participated in the regulation of CCND1 promoter activity, suggesting that OCT4 also could upregulated the expression of CCND1.	OCT4	CCND1	1	ACTIVATION	False
11750	11960	23433354:8:POU5F1:CCND1	[TF] can upregulate BIRC5 and [TG] expression by increasing their promoter activity.	OCT4	CCND1	1	ACTIVATION	False
11751	11961	23441162:13:ATF4:EDN1	This study identified [TF] as a novel activator of the [TG] gene.	ATF4	ET-1	1	ACTIVATION	False
11752	11962	23443045:3:FOXA1:CDKN2A	Here, we report that [TF] (FOXA1) is significantly upregulated in both replicative and oncogene-induced senescence, and in turn activates transcription of [TG] through multiple mechanisms.	Forkhead box A1 protein	p16(INK4a)	1	ACTIVATION	False
11753	11963	23443045:4:FOXA1:CDKN2A	In addition to acting as a classic sequence-specific transcriptional activator, [TF] binding leads to a decrease in nucleosome density at the [TG] promoter in senescent fibroblasts.	FOXA1	p16(INK4a)	1	ACTIVATION	False
11754	11964	23443045:5:FOXA1:CDKN2A	Moreover, [TF], itself a direct target of Polycomb-mediated repression, antagonizes Polycomb function at the [TG] locus.	FOXA1	p16(INK4a)	0	UNDEFINED	True
11755	11965	23443045:7:FOXA1:CDKN2A	Overall, our findings establish several mechanisms by which [TF] controls [TG] expression during cellular senescence.	FOXA1	p16(INK4a)	0	UNDEFINED	False
11756	11966	23447091:0:CREB1:CCND1	[TF] participates in the IGF-I-stimulation [TG] transcription.	CREB	cyclin D1	1	ACTIVATION	False
11757	11967	23447091:8:CREB1:CCND1	ChIP assays revealed that IGF-1 increased the association of [TF] with the [TG] promoter.	CREB	cyclin D1	0	UNDEFINED	False
11758	11968	23447091:9:CREB1:CCND1	Taken together, our data indicate that IGF-I upregulates [TG] transcription partially by inducing [TF] phosphorylation through the ERK-MAP kinase pathway, and thus increasing its recruitment to the cyclin D1 promoter.	CREB	cyclin D1	1	ACTIVATION	False
11759	11969	23447579:0:TOX3:BRCA1	[TF] downregulates [TG] expression and promotes breast cancer aggressiveness.	TNRC9	BRCA1	2	REPRESSION	False
11760	11970	23447579:8:CREB1:BRCA1	Notably, we found that TNRC9 bound to both the [TG] promoter and the cAMP-responsive element-binding protein ([TF]) complex, a regulator of BRCA1 transcription.	CREB	BRCA1	0	UNDEFINED	False
11761	11971	23447579:8:TOX3:BRCA1	Notably, we found that [TF] bound to both the [TG] promoter and the cAMP-responsive element-binding protein (CREB) complex, a regulator of BRCA1 transcription.	TNRC9	BRCA1	0	UNDEFINED	False
11762	11972	23449391:0:TP53:VEGFA	[TF] promotes [TG] expression and angiogenesis in the absence of an intact p21-Rb pathway.	p53	VEGF	1	ACTIVATION	False
11764	11974	23451132:6:POU5F1:MEIS1	Chromatin immunoprecipitation (ChIP) and luciferase reporter analysis showed that [TF] enhanced [TG] expression via direct binding to the Meis1 promoter accompanying histone H3 acetylation and appearance of 5-hydoxymethylcytosine (5hmC), while Meis1a suppressed Oct4 expression via direct association with the Oct4 promoter together with histone deacetylase 1 (HDAC1).	Oct4	Meis1a	1	ACTIVATION	False
11765	11975	23451207:5:KLF4:EDN1	Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct [TF] target genes, including E-cadherin (Cdh1), N-cadherin (Cdh2), vimentin (Vim), -catenin (Ctnnb1), VEGF-A (Vegfa), endothelin-1 ([TG]) and Jnk1 (Mapk8).	Klf4	Edn1	0	UNDEFINED	False
11766	11976	23451207:5:KLF4:VEGFA	Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct [TF] target genes, including E-cadherin (Cdh1), N-cadherin (Cdh2), vimentin (Vim), -catenin (Ctnnb1), [TG] (Vegfa), endothelin-1 (Edn1) and Jnk1 (Mapk8).	Klf4	VEGF-A	0	UNDEFINED	False
11767	11977	23457487:5:RELA:DNMT1	Mechanistically, curcumin reduced the expression of positive regulators of [TG], [TF] and Sp1, which correlated with a reduction in binding of these transcription factors to the DNMT1 promoter in AML cell lines.	p65	DNMT1	1	ACTIVATION	False
11768	11978	23457487:5:SP1:DNMT1	Mechanistically, curcumin reduced the expression of positive regulators of [TG], p65 and [TF], which correlated with a reduction in binding of these transcription factors to the DNMT1 promoter in AML cell lines.	Sp1	DNMT1	1	ACTIVATION	False
11769	11979	23479260:7:BACH1:HMOX1	This discrepancy was found to be the result of an increased nuclear expression of [TF], a known repressor of [TG] transcription, which blocked the binding of Nrf2 to the HO-1 promoter.	Bach1	HO-1	2	REPRESSION	False
11770	11980	23482931:5:FOSL2:SOX4	[TF]/JUND efficiently activated the [TG] promoter via an AP-1 site.	FRA-2	SOX4	1	ACTIVATION	False
11772	11982	23487742:5:RUNX1:CDKN1C	Conversely, we find that Runx1 ([TF]), which is known for promoting HFSC proliferation, represses p21, p27, [TG], and p15 transcription in HFSC in vivo.	runt related transcription factor 1	p57	2	REPRESSION	False
11773	11983	23508109:6:KLF15:MT2A	Coherent feed-forward gene regulation by GR and [TF] was characterized by combinatorial activation of linked GR-KLF15 regulatory elements by both factors and increased GR occupancy, while expression of KLF15 reduced GR occupancy at the incoherent target, [TG].	KLF15	MT2A	0	UNDEFINED	False
11774	11984	23523789:7:ID3:EGR1	Finally, we demonstrated that [TF] significantly repressed arsenite-stimulated transcription of the immediate-early gene [TG] and that this repression activity was inversely correlated with the arsenite-induced nuclear export.	Id3	Egr-1	2	REPRESSION	False
11775	11985	23525112:10:RELA:TRPC6	In agreement with a major role of [TF], chromatin immunoprecipitation assays showed that PMA treatment induced p65 binding to the [TG] promoter.	p65	TRPC6	0	UNDEFINED	False
11776	11986	23525112:11:RELA:TRPC6	Moreover, PMA treatment increased the association of [TF] with histone deacetylase (HDAC) and decreased histone acetylation at the [TG] promoter.	p65	TRPC6	0	UNDEFINED	False
11777	11987	23525112:9:RELA:TRPC6	Furthermore, specific knockdown of [TF], but not p50, prevented an H2O2 inhibitory effect on [TG] protein expression, suggesting p65 as a predominant NF-B subunit repressing TRPC6.	p65	TRPC6	2	REPRESSION	False
11778	11988	23527134:0:SIX1:CCND1	[TF] promotes proliferation of pancreatic cancer cells via upregulation of [TG] expression.	Six1	cyclin D1	1	ACTIVATION	False
11779	11989	23527134:8:SIX1:CCND1	Overexpression of [TF] upregulates [TG] mRNA and protein, and significantly enhances the activity of the cyclin D1 promoter in PANC-1 cells.	Six1	cyclin D1	1	ACTIVATION	False
11780	11990	23527134:9:SIX1:CCND1	We demonstrate that [TF] promotes cell cycle progression and proliferation by upregulation of [TG].	Six1	cyclin D1	1	ACTIVATION	False
11781	11991	23536182:7:MEF2A:NR4A1	Importantly, [TF] constitutively binds to the [TG] promoter in neurons under basal conditions.	MEF2	Nur77	0	UNDEFINED	False
11782	11992	23536558:10:ATF3:GSN	We identified six [TF] regulatory elements in the first intron of the [TG] gene confirmed by chromatin immunoprecipitation analysis.	ATF3	GSN	0	UNDEFINED	False
11783	11993	23541942:2:NR1H4:NDRG2	Knockdown of [TF] abolished the induction by CDCA, whereas overexpression of a constitutively active form of FXR increased [TG] expression.	FXR	NDRG2	1	ACTIVATION	False
11784	11994	23542171:4:E2F1:CTSV	We showed that [TF] directly binds to [TG] promoter and that CTSL2 is regulated by both exogenous and endogenous E2F1.	E2F1	CTSL2	0	UNDEFINED	False
11785	11995	23546875:12:NR1H4:NR0B2	Expression of Sumo1 markedly inhibited the ligand-dependent, transactivation of BSEP and [TG] promoters by [TF]/retinoid X receptor  (RXR) in HepG2 cells.	FXR	SHP	1	ACTIVATION	False
11786	11996	23546875:13:NR1H4:NR0B2	In contrast, mutations that abolished SUMOylation of [TF] or siRNA knockdown of Sumo1 expression augmented the transactivation of BSEP and [TG] promoters by FXR.	FXR	SHP	1	ACTIVATION	True
11787	11997	23552426:0:ETS1:FLT4	[TF] is required for the activation of [TG] during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.	Ets-1	VEGFR3	1	ACTIVATION	False
11788	11998	23552426:10:ETS1:FLT4	Thus, [TF] is a novel regulator of [TG] and is involved in the induction of angiogenic phenotypes by KSHV.	Ets-1	VEGFR3	0	UNDEFINED	False
11789	11999	23552426:7:ETS1:FLT4	[TF] is required for KSHV-induced expression of [TG], a lymphatic endothelial-cell-specific receptor important for lymphangiogenesis, and Ets-1 activates the promoter of VEGFR3.	Ets-1	VEGFR3	1	ACTIVATION	False
11790	12000	23552426:8:ETS1:FLT4	[TF] knockdown does not alter the expression of another lymphatic-specific gene, the podoplanin gene, but does inhibit the expression of [TG] in uninfected lymphatic endothelium, indicating that Ets-1 is a novel cellular regulator of VEGFR3 expression.	Ets-1	VEGFR3	1	ACTIVATION	False
11791	12003	23555309:5:TWIST1:PHOX2B	[TF] interacts with the pro-neural factor Sox10 via its Twist-box domain and binds to the [TG] promoter to repress transcriptional activity.	Twist1	Phox2b	2	REPRESSION	False
11792	12004	23558680:11:RELA:FGF10	These data suggested that inhibition of [TG] by inflammatory signaling involves the NF-B-dependent interactions between [TF], SP3, and the Fgf-10 promoter.	RELA	FGF-10	2	REPRESSION	False
11793	12005	23558708:7:GATA4:CCND1	Thus, miR-200b targets [TF] to downregulate the expression of [TG] and myosin heavy chain (MHC), thereby regulating cell growth and differentiation.	GATA-4	cyclin D1	1	ACTIVATION	True
11794	12006	23574718:7:FOXO1:CDKN2A	Knockdown of p21 resulted in molecular compensation via [TF]-dependent upregulation of numerous FOXO1 target genes (p15, [TG], p27) and an increased rate of senescence.	FOXO1	p16	1	ACTIVATION	False
11795	12007	23576453:6:RELA:SDC4	Chromatin immunoprecipitation assays clearly showed that [TF] and phosphorylated p65, but not p50 or c-Rel, bound to the [TG] promoter.	p65	SDC4	0	UNDEFINED	False
11796	12008	23576453:8:NFKB:SDC4	These data suggest that NF-B [TF] could be a key mediator of syndecan-4 upregulation by TNF- through two binding sites in the [TG] promoter, but other NF-B-p65 independent pathways might also be involved through transcriptional elongation.	p65	SDC4	1	ACTIVATION	False
11798	12011	23583651:6:GATA6:CX3CL1	Endothelial [TF] is a direct transcriptional regulator of genes controlling vascular tone [endothelin-1, endothelin-1 receptor type A, and endothelial nitric oxide synthase (eNOS)], pro-inflammatory genes, [TG] (fractalkine), 5-lipoxygenease-activating protein, and markers of vascular remodeling, including PAI-1 and RhoB.	GATA-6	CX3CL1	0	UNDEFINED	False
11799	12012	23583651:6:GATA6:SERPINE1	Endothelial [TF] is a direct transcriptional regulator of genes controlling vascular tone [endothelin-1, endothelin-1 receptor type A, and endothelial nitric oxide synthase (eNOS)], pro-inflammatory genes, CX3CL1 (fractalkine), 5-lipoxygenease-activating protein, and markers of vascular remodeling, including [TG] and RhoB.	GATA-6	PAI-1	0	UNDEFINED	False
11800	12013	23584475:4:NFKB:ZEB1	MUC1-C occupies the [TG] promoter with NF-B [TF] and thereby promotes ZEB1 transcription.	p65	ZEB1	1	ACTIVATION	False
11801	12015	23592398:9:NFKB:SOX9	Additionally, we found a potential NF-B binding site located in the [TG] promoter and determined that the NF-B subunit [TF] positively regulates SOX9 expression by binding to its promoter directly.	p65	SOX9	1	ACTIVATION	False
11802	12017	23592778:0:POU2F1:SLC7A11	A novel transcription mechanism activated by ethanol: induction of [TG] gene expression via inhibition of the DNA-binding activity of transcriptional repressor octamer-binding transcription factor 1 ([TF]).	OCT-1	Slc7a11	2	REPRESSION	False
11803	12018	23592778:11:POU2F1:SLC7A11	Results from this study suggest that [TF] functions as a repressor on the [TG] promoter and that ethanol inhibits OCT-1 binding to the Slc7a11 promoter, thereby increasing Slc7a11 expression.	OCT-1	Slc7a11	2	REPRESSION	False
11804	12019	23598278:10:KLF4:FOXM1	Finally, we identified an Sp1- and [TF]-binding site in the [TG] promoter and showed that both Sp1 and KLF4 protein bound directly to it.	KLF4	FOXM1	0	UNDEFINED	False
11805	12020	23598278:11:KLF4:FOXM1	Deletion mutation of this binding site significantly attenuated the transcriptional regulation of the [TG] promoter positively by Sp1 and negatively by [TF].	KLF4	FOXM1	2	REPRESSION	False
11806	12021	23598278:9:KLF4:FOXM1	Also, Sp1 mechanistically activated the [TG] promoter, whereas Krppel-like factor 4 ([TF]) repressed its activity.	KLF4	FOXM1	2	REPRESSION	False
11807	12022	23598283:0:AR:MEF2C	Testosterone enhances cardiomyogenesis in stem cells and recruits the [TF] to the [TG] and HCN4 genes.	androgen receptor	MEF2C	0	UNDEFINED	False
11808	12023	23599428:3:KLF4:IVL	In the present study, we explore the impact of [TF] on expression of [TG], a gene that is specifically expressed in differentiated keratinocytes.	KLF4	involucrin	0	UNDEFINED	False
11809	12024	23599428:7:KLF4:IVL	Overexpression of [TF] augments the PKC-dependent increase in [TG] expression, whereas KLF4 knockdown attenuates this response.	KLF4	involucrin	1	ACTIVATION	False
11810	12025	23604035:5:RELA:FAS	In these cells, p65 ([TF]) was associated with the [TG] promoter, and inhibition of the NF-B pathway by an IKK inhibitor (BAY11-7082) or lentiviral expression of a nondegradable mutant of IB (ISR) blocked Fas expression.	RELA	FAS	1	ACTIVATION	False
11811	12026	23604035:7:RELA:FAS	Azacitidine rescued [TF] binding on [TG] promoter in vitro, and subsequently Fas expression in SW480 cells.	p65	FAS	1	ACTIVATION	False
11812	12027	23604529:10:STAT3:DIRAS3	Finally, chromatin immunoprecipitation (ChIP) and IP analysis indicated that acetylated [TF] bound to the [TG] promoter and recruited DNA methyltransferase 1 for genetic modification.	STAT3	ARHI	0	UNDEFINED	False
11813	12028	23610061:9:MITF:PAX4	Chromatin immunoprecipitation analysis shows that [TF] binds to [TG] and Pax6 regulatory regions, suggesting that Mitf represses their transcription in wild-type -cells.	Mitf	Pax4	2	REPRESSION	False
11814	12029	23610368:7:E2F1:KIF2C	We also predict [TG] is a target gene for ER-/HER2- breast cancer and is positively regulated by [TF].	E2F1	KIF2C	1	ACTIVATION	False
11815	12030	23612979:6:MYC:ATF4	[TF] subsequently bound to the [TG] promoter, suggesting direct involvement of an mTORC1/c-MYC-driven signaling pathway in the activation of the UPR.	c-MYC	ATF4	0	UNDEFINED	True
11816	12031	23623921:0:STAT3:TWIST1	[TF] mediates TGF-1-induced [TG] expression and prostate cancer invasion.	STAT3	TWIST1	1	ACTIVATION	False
11817	12032	23623921:6:STAT3:TWIST1	In addition, [TF] and HIF-1 up-regulated [TG] expression by direct binding to a TWIST1 promoter.	STAT3	TWIST1	1	ACTIVATION	False
11818	12033	23625920:0:NKX2-1:HMGA2	MicroRNA-33a mediates the regulation of [TG] gene (HMGA2) by thyroid transcription factor 1 (TTF-1/[TF]).	NKX2-1	high mobility group AT-hook 2	0	UNDEFINED	False
11819	12034	23625920:0:TTF1:HMGA2	MicroRNA-33a mediates the regulation of [TG] gene (HMGA2) by thyroid transcription factor 1 ([TF]/NKX2-1).	TTF-1	high mobility group AT-hook 2	0	UNDEFINED	False
11820	12035	23625963:6:SRF:EDN1	Depletion of [TF] blocked MKL1 recruitment and blunted [TG] transactivation by hypoxia.	SRF	ET-1	1	ACTIVATION	False
11821	12037	23630076:6:NFIL3:TNFSF10	[TF], which we found to be overexpressed in different cancers, supported tumor cell survival largely through repression of [TG] and antagonized hydrogen peroxide-induced cell death.	NFIL3	TRAIL	2	REPRESSION	False
11822	12038	23635401:8:SP1:PTGS2	Instead, FOXM1 forms a cooperative interaction with [TF] at the Sp1-binding site (-245/-240 relative to the start site) of the [TG] promoter to mediate EGF-induced COX-2 expression.	Sp1	COX-2	1	ACTIVATION	False
11823	12039	23637192:5:FOXA1:TH	Deletion of both [TF] and Foxa2 resulted in a significant reduction in the number of [TG] (TH)-positive mDA neurons.	Foxa1	tyrosine hydroxylase	1	ACTIVATION	False
11824	12040	23646894:10:REL:NOS2	Knockdown of OGT reduced the [TF] O-GlcNAcylation and c-Rel-p50 interaction in response to LPS, but did not affect either the binding of c-Rel to the [TG] promoter or the transcriptional activity of c-Rel.	c-Rel	iNOS	0	UNDEFINED	False
11825	12041	23646894:7:REL:NOS2	LPS stimulated the activation of [TF], increased the O-GlcNAcylation of c-Rel and enhanced the binding of c-Rel to the NF-B site in the [TG] promoter; GlcN attenuated these effects of LPS.	c-Rel	iNOS	0	UNDEFINED	False
11826	12042	23650051:0:NFE2L2:ABCG2	Role of [TF] in cancer photodynamic therapy: regulation of human ABC transporter [TG].	Nrf2	ABCG2	0	UNDEFINED	False
11827	12043	23650051:3:NFE2L2:ABCG2	Recent studies have provided evidence that [TF] regulates the transcription of the human ABC transporter [TG] gene, which is critically involved in the cellular accumulation of porphyrins in PDT.	Nrf2	ABCG2	0	UNDEFINED	False
11828	12044	23650051:4:NFE2L2:ABCG2	[TF] interacts with the antioxidant responsive element (ARE) located in the promoter region of human [TG] gene.	Nrf2	ABCG2	0	UNDEFINED	False
11829	12045	23650051:7:NFE2L2:ABCG2	Since patients have demonstrated individual differences in their response to PDT, [TF]-mediated transcriptional activation of the [TG] gene in cancer may affect patients' responses to PDT as well as chemotherapy.	Nrf2	ABCG2	1	ACTIVATION	False
11830	12046	23650552:4:TP53:KIF23	We showed that [TF] reduces expression of [TG] on the mRNA as well as the protein level in different cell types.	p53	KIF23	2	REPRESSION	False
11831	12047	23650552:7:TP53:KIF23	Furthermore, we identified the highly conserved cell cycle genes homology region (CHR) in the [TG] promoter to be strictly required for [TF]-dependent repression as well as for cell cycle-dependent expression of KIF23.	p53	KIF23	2	REPRESSION	False
11832	12048	23650552:8:TP53:KIF23	Cell cycle- and [TF]-dependent regulation of [TG] appeared to be controlled by differential binding of DREAM and MMB complexes to the CHR element.	p53	KIF23	0	UNDEFINED	False
11833	12049	23652833:5:SP1:VEGFA	Furthermore, resistin enhanced DNA-binding activity of [TF] with [TG] promoter in a PI3K/Akt-dependent manner.	Sp1	VEGF	0	UNDEFINED	False
11834	12050	23652833:6:SP1:VEGFA	PI3K/Akt activated by resistin led to increasing interaction with [TF], triggering a progressive phosphorylation of Sp1 on Thr453 and Thr739, resulting in the upregulation of [TG] expression.	Sp1	VEGF	1	ACTIVATION	False
11835	12051	23652833:8:SP1:VEGFA	Our findings suggest that the PI3K/Akt-[TF] pathway is involved in resistin-induced [TG] expression in HO-8910 cells and indicates that antiangiogenesis therapy may be beneficial treatment against ovarian epithelial carcinoma, especially in obese patients.	Sp1	VEGF	1	ACTIVATION	False
11836	12052	23653383:7:USF2:AGTRAP	Furthermore, the results of siRNA transfection in mouse distal convoluted tubule cells and those of unilateral ureteral obstruction in the afflicted mouse kidney suggest that Usf1 decreases but [TF] increases the [TG] gene expression by binding to the E-box.	Usf2	Agtrap	1	ACTIVATION	False
11837	12053	2365694:7:AP1:SERPINB3	DNase I footprinting and gel mobility shift analyses of these 424 base pairs defined several interactions between nuclear proteins and the [TG] promoter, including footprints centered over the [TF], over a sequence at -120, and over the sequences (-70 and -40) that resemble 21-hydroxylase promoter elements.	AP-1 motif	SCC	0	UNDEFINED	False
11838	12054	23659673:2:IRF1:TRIM22	We previously demonstrated that interferon regulatory factor-1 ([TF]) played a central role in IFN--induced [TG] expression via binding to a special cis-element named 5' extended IFN-stimulating response element (5'eISRE).	IRF-1	TRIM22	1	ACTIVATION	False
11839	12055	23665346:6:TP53:SERPINE1	ATII cells from mice with BLM injury showed augmented binding of [TF] to uPA, uPA receptor (uPAR), and [TG] mRNA.	p53	PAI-1	0	UNDEFINED	False
11840	12056	23665346:7:TP53:SERPINE1	[TF]-binding sequences from uPA, uPAR, and [TG] mRNA 3' untranslated regions neither interfered with p53 DNA binding activity nor p53-mediated promoter transactivation.	p53	PAI-1	0	UNDEFINED	False
11841	12057	23670564:0:IRF1:TRIM22	p300, but not PCAF, collaborates with [TF] in stimulating [TG] expression independently of its histone acetyltransferase activity.	IRF-1	TRIM22	1	ACTIVATION	False
11842	12058	23670564:2:IRF1:TRIM22	We previously demonstrated that IFN regulatory factor-1 ([TF]) was crucial for constitutive and IFN-induced [TG] expression via binding to a special cis-element named 5' extended IFN-stimulating response element.	IRF-1	TRIM22	1	ACTIVATION	False
11843	12059	23670564:4:IRF1:TRIM22	Using an in vitro DNA affinity binding assay and an in vivo chromatin immunoprecipitation assay, we found that IFN- stimulation significantly enhanced the binding of p300 and p300/CBP-associated factor, but not other co-activators such as general control nondepressible 5, steroid receptor co-activator-1, and activator of thyroid and retinoic, to the 5' extended IFN-stimulating response element containing [TG] promoter region together with [TF].	IRF-1	TRIM22	0	UNDEFINED	False
11844	12060	23676218:5:SP3:CDKN1A	In contrast, [TF] promoted binding of the protein phosphatase PP1 to the p21([TG]) promoter, suggesting that Sp3-dependent regulation of the local balance between kinase and phosphatase activities may contribute to gene expression.	Sp3	CIP1	0	UNDEFINED	False
11845	12061	23677069:4:STAT3:WASF3	First, we show that [TF] binds directly to the [TG] promoter and increases transcription levels, which correlates with increased migration potential.	STAT3	WASF3	1	ACTIVATION	False
11846	12062	23681230:0:STAT3:GADD45G	SIRT1 activation enhances HDAC inhibition-mediated upregulation of [TG] by repressing the binding of NF-B/[TF] complex to its promoter in malignant lymphoid cells.	STAT3	GADD45G	2	REPRESSION	False
11847	12063	23681230:11:STAT3:GADD45G	These data suggest that [TF] is a corepressor with NF-B of the [TG] gene and provides in vitro proof-of-concept for the combination of HDACi with SIRT1 activators as a potential new therapeutic strategy in lymphoid malignancies.	STAT3	GADD45G	2	REPRESSION	True
11848	12064	23681230:8:STAT3:GADD45G	Furthermore, EMSA revealed that NF-B binds directly to the [TG] promoter, while [TF] binds indirectly in complexes with NF-B.	STAT3	GADD45G	0	UNDEFINED	False
11849	12065	23689131:4:ATF2:PLD1	IL-1 enhanced the binding of NF-B and [TF] to the [TG] promoter, thereby enhancing PLD1 expression.	ATF-2	PLD1	1	ACTIVATION	False
11850	12066	23690481:7:STAT3:ICAM1	Results from reporter and chromatin immunoprecipitation assays revealed that CCL15 activates transcription from the IFN- activation site promoter and stimulates binding of [TF] to the [TG] promoter.	STAT3	ICAM-1	0	UNDEFINED	False
11851	12067	23693077:7:ATF3:CDC25A	Knockdown of [TF] inhibited the RB-induced expression changes of cell cycle- and apoptosis-related genes such as DR5, DDIT4, [TG], GADD45A, and partially blocked RB-mediated inhibition on cell proliferation and induction of apoptosis, suggesting the crucial involvement of ATF3 in this event.	ATF3	CDC25A	1	ACTIVATION	True
11852	12068	23708702:0:ELK3:SERPINE1	Cell density-dependent nuclear accumulation of [TF] is involved in suppression of [TG] expression.	ELK3	PAI-1	2	REPRESSION	False
11853	12069	23708702:3:ELK3:SERPINE1	In this study, we showed that the mRNA levels of plasminogen activator inhibitor type 1 ([TG]) decreased drastically at high cell density, and that [TF], a member of the Ets transcription factor family, repressed PAI-1 expression.	ELK3	PAI-1	2	REPRESSION	False
11854	12070	23708702:5:ELK3:SERPINE1	Furthermore, we found that ETS1, a [TG] activator, occupied the [TF]-binding site within the PAI-1 promoter at low cell density, while it was released at high cell density.	ELK3	PAI-1	0	UNDEFINED	True
11855	12071	23708702:5:ETS1:SERPINE1	Furthermore, we found that [TF], a [TG] activator, occupied the ELK3-binding site within the PAI-1 promoter at low cell density, while it was released at high cell density.	ETS1	PAI-1	1	ACTIVATION	False
11856	12072	23708702:6:ELK3:SERPINE1	These results suggest that at high cell density, the switching of binding of transcription factors from ETS1 to [TF] occurs at a specific binding site of the [TG] promoter, leading to the cell-density dependent suppression of PAI-1 expression.	ELK3	PAI-1	0	UNDEFINED	True
11857	12073	23708702:6:ETS1:SERPINE1	These results suggest that at high cell density, the switching of binding of transcription factors from [TF] to ELK3 occurs at a specific binding site of the [TG] promoter, leading to the cell-density dependent suppression of PAI-1 expression.	ETS1	PAI-1	0	UNDEFINED	True
11858	12074	23714368:6:FOXO6:MYC	[TF] induces [TG] expression by associating to HNF4 and mediating histone acetylation, and the dissociation of HDAC3 from the promoter of the C-myc gene.	FOXO6	C-myc	1	ACTIVATION	False
11859	12075	23715499:12:MYC:MGMT	Here, we showed for the first time that [TF] binds to the [TG] promoter with consequent recruitment of DNA (cytosine-5)-methyltransferase 3A, regulating the levels of MGMT promoter methylation.	c-Myc	MGMT	0	UNDEFINED	False
11860	12076	23715499:13:MYC:MGMT	The results of this study suggest that GSK3 inhibition enhances temozolomide effect by silencing [TG] expression via [TF]-mediated promoter methylation.	c-Myc	MGMT	2	REPRESSION	False
11861	12077	23715499:9:MYC:MGMT	[TF] and DNA (cytosine-5)-methyltransferase 3A binding to the [TG] promoter was estimated by chromatin immunoprecipitation assay.	c-Myc	MGMT	0	UNDEFINED	False
11862	12078	23716595:7:STAT5A:BCL6	[TF], in contrast, represses [TG] expression below basal levels and decreases the association of RNA polymerase II at the gene.	STAT5	BCL6	2	REPRESSION	False
11863	12079	23727578:0:TP53:GBP1	Identification of [TG] gene (hGBP1) as a direct transcriptional target gene of [TF].	p53	human guanylate-binding protein 1	0	UNDEFINED	False
11864	12080	23737527:0:BACH1:HMOX1	Transforming growth factor- induces transcription factors MafK and [TF] to suppress expression of the [TG] gene.	Bach1	heme oxygenase-1	2	REPRESSION	False
11865	12081	23737527:0:MAFK:HMOX1	Transforming growth factor- induces transcription factors [TF] and Bach1 to suppress expression of the [TG] gene.	MafK	heme oxygenase-1	2	REPRESSION	False
11866	12082	23737527:7:BACH1:HMOX1	Knockdown of MafK and [TF] by siRNA abolished TGF--dependent suppression of [TG].	Bach1	HO-1	2	REPRESSION	False
11867	12083	23737527:7:MAFK:HMOX1	Knockdown of [TF] and Bach1 by siRNA abolished TGF--dependent suppression of [TG].	MafK	HO-1	2	REPRESSION	False
11868	12084	23740952:0:STAT1:CXCL10	Synergistic expression of the [TG] gene in response to IL-1 and IFN- involves NF-B, phosphorylation of [TF] at Tyr701, and acetylation of histones H3 and H4.	STAT1	CXCL10	1	ACTIVATION	False
11869	12085	23740952:10:STAT1:CXCL10	We conclude that the synergism of IL-1 and IFN- to induce expression of the [TG] gene requires NF-B, [TF] phosphorylated at Tyr(701), recruitment of coactivators, and acetylation of histones H3 and H4.	STAT1	CXCL10	1	ACTIVATION	False
11870	12086	23740952:4:STAT1:CXCL10	Small interfering RNA-mediated suppression of NF-B p65 markedly inhibited the ability of cytokines to induce the expression of the [TG] gene, whereas targeting [TF] only diminished the synergy provided by IFN-.	STAT1	CXCL10	1	ACTIVATION	False
11871	12087	23740952:8:STAT1:CXCL10	Using these recombinant adenoviruses, we determined that overexpression of either the single- or double-mutant [TF] decreased the IFN--mediated potentiation of [TG] gene expression, promoter activity, and secretion of protein.	STAT1	CXCL10	1	ACTIVATION	True
11872	12088	23752226:4:TFAP4:FN1	Besides many genes involved in the control of proliferation, the [TF] target genes included markers of stemness (LGR5 and CD44) and epithelial-mesenchymal transition (EMT) such as SNAIL, E-cadherin/CDH1, OCLN, VIM, [TG], and the Claudins 1, 4, and 7.	AP4	FN1	0	UNDEFINED	False
11873	12089	23763570:1:FOXO1:ABCC2	Our previous studies have shown that multidrug resistance protein 2 ([TG]) is overexpressed in tamoxifen-resistant MCF-7 breast cancer cells (TAMR-MCF-7 cells) and [TF] (FoxO1), functions as a key regulator of multidrug resistance 1 (MDR1) gene transcription.	forkhead box-containing protein, O subfamily1	MRP2	0	UNDEFINED	False
11875	12091	23774321:5:NPAS4:MCU	Specifically, synaptic activity transcriptionally represses [TG], via a mechanism involving the nuclear Ca(2+) and CaM kinase-mediated induction of [TF], resulting in the inhibition of NMDA receptor-induced mitochondrial Ca(2+) uptake and preventing excitotoxic death.	Npas4	Mcu	2	REPRESSION	False
11876	12092	23776572:2:YY1:UBC	Our previous studies revealed that the 5'-UTR intron of human [TG] (UbC) gene is responsible for the boost of reporter gene expression and is able to bind, in vitro, Yin Yang 1 ([TF]) trans-acting factor.	YY1	ubiquitin C	1	ACTIVATION	True
11877	12093	23798383:7:SHOX2:ADRB3	Conversely, overexpression of [TF] leads to a repression of [TG] expression and decrease lipolytic rate.	Shox2	Adrb3	2	REPRESSION	False
11878	12094	23800081:14:ATF2:CDKN1A	Notably, downregulation of [TF] caused a switch from cell cycle arrest to reinforced apoptosis, presumably via p21([TG]) downregulation, confirming the importance of ATF2 in the establishment of cell cycle arrest.	ATF2	WAF1	1	ACTIVATION	False
11879	12095	23801966:10:FOXO3:SESN3	Importantly, [TF] simultaneously also activates ROS-detoxification via induction of [TG].	FOXO3	SESN3	1	ACTIVATION	False
11880	12096	23803610:4:FOXO1:TXNIP	We now have found that [TF] binds to the [TG] promoter in vivo in human islets and INS-1 beta cells and significantly decreases TXNIP expression.	FOXO1	TXNIP	2	REPRESSION	False
11881	12097	23804320:0:FOXM1:CDKN1A	Activated ERK/[TF] pathway by low-power laser irradiation inhibits UVB-induced senescence through down-regulating [TG] expression.	FOXM1	p21	2	REPRESSION	False
11882	12098	23804320:10:MYC:CDKN1A	Nuclear translocation enhanced FOXM1 transcriptional activity and promoted its downstream target gene [TF] expression that could inhibit [TG] expression.	c-Myc	p21	2	REPRESSION	False
11883	12099	23804320:6:FOXM1:CDKN1A	The senescence-associated -galactosidase (SA--Gal) activity and [TG] expression, hallmarks of senescent cells, were decreased in the Forkhead box transcription factor [TF]-dependent manner under treatment with LPLI.	FOXM1	p21	2	REPRESSION	False
11884	12100	23804453:12:SP1:SCNN1A	In summary, [TF] binding to a cis-element at +222/+229 represents the first identified constitutive driver of [TG] transcription, and it contributes to maximal aldosterone trans-activation of ENaC.	Sp1	ENaC	1	ACTIVATION	False
11885	12101	23804715:4:IRF4:IFIT3	Coexpression of [TF] with vFLIP significantly increased [TG] (IFIT3) and Cig5 (RSAD2) transcription that was dependent on the ability of vFLIP to activate NF-B.	IRF4	ISG60	1	ACTIVATION	False
11886	12102	23808420:7:NKRF:PTGS2	Through targeting [TF], miR-301a affected the activity of NF-B and the expression of pro-inflammatory genes downstream of NF-B such as [TG], prostaglandin E2 and interleukin-6.	NKRF	COX-2	0	UNDEFINED	False
11887	12103	23812424:4:FOXM1:CCND1	[TF] directly activates transcription of [TG] and cyclin B1, resulting in the enhancement of cell cycle progression and cell proliferation.	FOXM1	cyclin D1	1	ACTIVATION	False
11888	12104	23816566:0:EGR1:PER2	[TF] regulates lithium-induced transcription of the Period 2 ([TG]) gene.	Egr1	PER2	0	UNDEFINED	True
11889	12105	23816566:10:EGR1:PER2	In conclusion, lithium stimulates [TG] transcription through the ERK/Elk1/[TF] pathway in neuronal cells, indicating a connection between the ERK-Egr1 pathway and a circadian gene system in the mechanism of action of lithium.	Egr1	PER2	1	ACTIVATION	True
11890	12106	23816566:4:EGR1:PER2	Promoter reporter analyses using serial deletions of the [TG] promoter revealed that two early growth response 1 ([TF])-binding sites (EBS) between positions -180 and -100 are required for maximal activation of the PER2 promoter by lithium.	Egr1	PER2	1	ACTIVATION	False
11891	12107	23816566:6:EGR1:PER2	Electrophoretic mobility shift assays and chromatin immunoprecipitation indicated that [TF] bound directly to the [TG] promoter.	Egr1	PER2	0	UNDEFINED	False
11892	12108	23818617:6:SOX18:DLL4	Furthermore, triple knockdown of sox7, [TF] and rbpj also results in ablation of endogenous [TG] expression.	sox18	dll4	1	ACTIVATION	False
11893	12109	23818898:12:ELK1:PTGS2	Moreover, [TF], the transcriptional regulator of [TG] expression, will be a potential target for the prevention of  -cell dysfunction mediated by PGE2.	Elk-1	COX-2	0	UNDEFINED	False
11894	12110	23818898:4:ELK1:PTGS2	We previously demonstrated that transcription factor [TF] significantly upregulated [TG] gene promoter activity.	Elk-1	COX-2	1	ACTIVATION	False
11895	12111	23818898:7:ELK1:PTGS2	We thus undertook to study the binding of [TF] to its putative binding sites in the [TG] promoter.	Elk-1	COX-2	0	UNDEFINED	False
11896	12112	23818898:9:ELK1:PTGS2	Our results demonstrate that [TF] efficiently upregulates [TG] expression at least partly through directly binding to the -82/-69 region of COX-2 promoter.	Elk-1	COX-2	1	ACTIVATION	False
11897	12113	23818969:10:AP1:PAK3	Our study is a first to describe a role for [TF] in regulating [TG] expression and suggest that PAK3 is an AP-1 target required for actin organization and migration observed in transformed cells.	AP-1	PAK3	0	UNDEFINED	True
11898	12114	23818969:5:AP1:PAK3	In this study, we investigate [TF] regulation of [TG] expression and the role of PAK3 in cJun/AP-1-associated cellular transformation.	AP-1	PAK3	0	UNDEFINED	False
11899	12115	23818969:7:AP1:PAK3	Elevated [TG] expression in cJun/[TF] over-expressing cells associated with a significant increase in PAK3 promoter activation.	AP-1	PAK3	1	ACTIVATION	False
11900	12116	23825360:7:MYC:SMAD2	Remarkably, the transcriptional regulatory network of the [TG] promoter is dramatically altered in human aneurysmal VSMCs in vitro and in situ with a switch from [TF]-dependent repression of SMAD2 in normal vessel to a p53-dependent activation of SMAD2 in aneurysms.	Myc	SMAD2	2	REPRESSION	True
11901	12117	23837456:8:TP63:JAG1	The knockdown of N[TF], using specific siRNA, decreased the expression of 11 out of 21 genes associated with epithelial repair and differentiation, including -catenin, epidermal growth factor receptor, and [TG].	p63	Jagged1	1	ACTIVATION	False
11902	12118	23838170:0:TP53:ABCG2	Survivin up-regulates the expression of breast cancer resistance protein ([TG]) through attenuating the suppression of [TF] on NF-B expression in MCF-7/5-FU cells.	p53	BCRP	2	REPRESSION	True
11903	12119	23838170:10:TP53:ABCG2	In conclusion, through down regulation of [TF] expression, Survivin attenuates the suppressing effect of p53 on NF-B(p50) expression and then enhances [TG] expression.	p53	BCRP	2	REPRESSION	False
11905	12121	23839046:2:E2F1:FMN2	We showed that increased expression of the [TG] gene following p14ARF induction is caused, at the transcriptional level, by relief of repression by RelA and [TF], which, under non-induced conditions, bind the FMN2 promoter.	E2F1	FMN2	2	REPRESSION	True
11906	12122	23839046:2:RELA:FMN2	We showed that increased expression of the [TG] gene following p14ARF induction is caused, at the transcriptional level, by relief of repression by [TF] and E2F1, which, under non-induced conditions, bind the FMN2 promoter.	RelA	FMN2	2	REPRESSION	True
11907	12123	23851505:0:GATA3:CCND1	[TF] cooperates with PARP1 to regulate [TG] transcription through modulating histone H1 incorporation.	GATA3	CCND1	0	UNDEFINED	False
11908	12124	23851505:5:GATA3:CCND1	We showed that PARP1 acts as a transcription coactivator for [TF] in breast cancer cells and demonstrated that GATA3 cooperates with PARP1 in transactivation of the [TG] gene.	GATA3	CCND1	1	ACTIVATION	False
11909	12125	23852366:7:STAT6:BCL6	We confirmed [TF] binding to the [TG] promoter in vitro and in vivo by band shift / super shift assays and chromatin immunoprecipitations.	STAT6	BCL6	0	UNDEFINED	False
11910	12126	23858058:5:EGR1:PNPLA2	One member of the family, [TF], is induced by insulin and nutrients and directly inhibits activity of the [TG] promoter in vitro and expression of ATGL in cultured adipocytes.	Egr1	ATGL	2	REPRESSION	False
11912	12128	23860410:10:HES1:MUC5AC	Furthermore, ChIP assays confirmed that [TF] binds to the [TG] promoter both in mouse mtCC1-2 cells and in human NCI-H292 cells.	Hes1	MUC5AC	0	UNDEFINED	False
11913	12129	23861801:8:KLF4:CCND1	Moreover, the [TF] overexpression arrested the cell cycle progress at the G1/S phase transition by upregulating p21 (WAF1/CIP1) expression and downregulating [TG] expression, KLF4 knockdown in HKC cells did the opposite.	KLF4	cyclin D1	2	REPRESSION	False
11914	12130	23861960:4:TP63:PRODH	We established that over-expression of TAp73 or TA[TF] is sufficient to induce [TG] expression in p53-null cells and that PRODH expression parallels the modulation of endogenous p73 by genotoxic drugs in several cell lines.	p63	PRODH	1	ACTIVATION	False
11915	12131	23861960:4:TP73:PRODH	We established that over-expression of TA[TF] or TAp63 is sufficient to induce [TG] expression in p53-null cells and that PRODH expression parallels the modulation of endogenous p73 by genotoxic drugs in several cell lines.	p73	PRODH	1	ACTIVATION	False
11916	12132	23867003:10:RELA:PDK1	Our results show that NAC inhibits [TG] expression through PPAR-mediated induction of p53 and inhibition of [TF] protein expression.	p65	PDK1	1	ACTIVATION	False
11917	12133	23867003:9:RELA:PDK1	Silencing of p53 and overexpression of [TF] blocked the effect of NAC on [TG] promoter activity and protein expression.	p65	PDK1	0	UNDEFINED	False
11918	12134	23867798:2:NKX3-1:RAMP1	Herein, we identify the receptor activity-modifying protein 1 ([TG]) as a direct [TF] target gene through analysis of chromatin immunoprecipitation coupled to massively parallel sequencing and gene expression data.	NKX3.1	RAMP1	0	UNDEFINED	False
11920	12136	23877711:7:SP1:CDKN1A	The important key regulators in the cell cycle such as p27 and [TG] were up-regulated by HK-mediated down-regulation of [TF], whereas anti-apoptotic proteins including Mcl-1 and survivin were decreased, resulting in caspase-dependent apoptosis.	Sp1	p21	2	REPRESSION	False
11921	12137	23884787:4:KLF4:CCND1	We found that EGCG treatment results in increased expression of [TF] and alters expression of the KLF4 target genes p21, CDK4, and [TG].	KLF4	cyclin D1	0	UNDEFINED	False
11922	12138	23884787:4:KLF4:CDKN1A	We found that EGCG treatment results in increased expression of [TF] and alters expression of the KLF4 target genes [TG], CDK4, and cyclin D1.	KLF4	p21	0	UNDEFINED	False
11923	12139	2388628:11:GATA1:EDN1	We conclude that a nuclear factor with binding specificity for a GATA motif similar to that of the transcriptional activator [TF] is necessary for the efficient and cell-specific expression of the human [TG] gene.	GF-1	PPET-1	1	ACTIVATION	False
11924	12140	23892628:0:GATA2:NRP2	[TF] and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of [TG].	GATA2	neuropilin-2	0	UNDEFINED	False
11925	12141	23892628:0:LMO2:NRP2	GATA2 and [TF] control angiogenesis and lymphangiogenesis via direct transcriptional regulation of [TG].	Lmo2	neuropilin-2	0	UNDEFINED	False
11926	12142	23892628:10:LMO2:NRP2	In conclusion, our results demonstrate that GATA2 and [TF] cooperatively regulate VEGF-induced angiogenesis and lymphangiogenesis via [TG].	Lmo2	NRP2	0	UNDEFINED	True
11929	12145	23915402:7:FOXA2:MUC5B	Electrophoretic mobility shift assay (EMSA) was used to examine the ability of modified [TF] to bind the promoter of [TG] mucin gene.	FOXA2	MUC5B	0	UNDEFINED	False
11930	12146	23916609:4:SOX4:BBC3	In this study, we found that the transcription factor [TF] increased [TG] expression in response to trichostatin A (TSA), a histone deacetylase inhibitor in the p53-null human lung cancer cell line H1299.	Sox4	PUMA	1	ACTIVATION	False
11931	12147	23916609:5:SOX4:BBC3	Ectopic expression of [TF] led to the induction of [TG] expression at the mRNA and protein levels, and TSA-mediated up-regulation of PUMA transcription was repressed by the knockdown of Sox4.	Sox4	PUMA	1	ACTIVATION	False
11932	12148	23916609:6:SOX4:BBC3	Using luciferase assays and chromatin immunoprecipitation, we also determined that [TF] recruits p300 on the [TG] promoter region and increases PUMA gene expression in response to TSA treatment.	Sox4	PUMA	1	ACTIVATION	False
11933	12149	23917222:10:AP1:NOTCH4	This effect is mediated by activator protein-1 ([TF]) occupancy of the [TG] promoter.	AP-1	Notch-4	0	UNDEFINED	False
11934	12150	23919806:0:YY1:HMOX1	Upregulation of Ying Yang 1 ([TF]) suppresses esophageal squamous cell carcinoma development through [TG].	YY1	heme oxygenase-1	0	UNDEFINED	True
11935	12151	23919806:12:YY1:HMOX1	Taken together, we demonstrated overexpression of [TF] in esophageal carcinoma and identified [TG] as its target.	YY1	HO-1	0	UNDEFINED	False
11936	12152	23919806:8:YY1:HMOX1	Moreover, besides P21, [TG] (HO-1) was identified as a [TF] downstream effector, as YY1 stimulated HO-1 expression in esophageal cancer cells.	YY1	heme oxygenase-1	1	ACTIVATION	False
11937	12153	23926105:0:KLF4:VEGFA	Loss of epigenetic Kruppel-like factor 4 histone deacetylase ([TF]-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor ([TG]) expression in breast cancer.	KLF-4	VEGF	2	REPRESSION	False
11938	12154	23926105:3:KLF4:VEGFA	Here, we show that SAF-1-mediated induction of [TG] is repressed by [TF] transcription factor.	KLF-4	VEGF	2	REPRESSION	False
11939	12155	23926105:3:MAZ:VEGFA	Here, we show that [TF]-mediated induction of [TG] is repressed by KLF-4 transcription factor.	SAF-1	VEGF	1	ACTIVATION	False
11941	12157	23926105:5:MAZ:VEGFA	In the human [TG] promoter, [TF]- and KLF-4-binding elements are overlapping, whereas SAF-1 induces and KLF-4 suppresses VEGF expression.	SAF-1	VEGF	0	UNDEFINED	True
11942	12158	23926105:6:KLF4:VEGFA	Ectopic overexpression of [TF] and RNAi-mediated inhibition of endogenous KLF-4 supported the role of KLF-4 as a transcriptional repressor of [TG] and an inhibitor of angiogenesis in breast cancer cells.	KLF-4	VEGF	2	REPRESSION	False
11943	12159	23926105:7:KLF4:VEGFA	We show that [TF] recruits histone deacetylases (HDACs) -2 and -3 at the [TG] promoter.	KLF-4	VEGF	0	UNDEFINED	False
11944	12160	23926105:9:KLF4:VEGFA	Co-transfection of [TF] and HDAC expression plasmids in breast cancer cells results in synergistic repression of [TG] expression and inhibition of angiogenic potential of these carcinoma cells.	KLF-4	VEGF	2	REPRESSION	False
11945	12161	23929524:7:EGR1:CACNA1H	Electrophoresis mobility shift assay and chromatin immunoprecipitation assays revealed that [TF] bound to the TAB-responding element of [TG].	Egr1	Cav3.2	0	UNDEFINED	False
11946	12162	23933487:8:ETS1:THBS1	Bioinformatic and deletion studies identified a 5' region of the [TG] promoter repressed by NR4A2 and proangiogenic transcription factors, including NF-B and [TF].	Ets1/2	TSP-1	2	REPRESSION	False
11947	12163	23939908:5:ZFP42:CCNB1	[TF] positively regulates the transcriptional activity of [TG] through binding to their promoters.	REX1	cyclin B1/B2	1	ACTIVATION	False
11948	12164	23939942:5:STAT3:GADD45B	[TF] (STAT3) was found to be a repressor of the [TG] gene through binding to upstream regulatory elements.	Signal transducer and activator of transcription 3	Gadd45b	2	REPRESSION	False
11949	12165	23939942:6:STAT3:GADD45B	The role of [TF] in control of [TG] was confirmed using liver-specific Stat3-null mice.	STAT3	Gadd45b	0	UNDEFINED	False
11950	12166	23939942:7:STAT3:GADD45B	Wy-14,643 treatment stimulated [TF] ubiquitination leading to activation of the [TG] gene as a result of loss of Gadd45b repression by STAT3.	STAT3	Gadd45b	2	REPRESSION	True
11952	12168	23950841:11:STAT3:CCND1	Addition of a [TF] inhibitor led to suppression of [TG] promoter activity and cell growth arrest.	STAT3	cyclin D1	1	ACTIVATION	False
11953	12169	23955341:8:NFKB:SLC1A2	Furthermore, TX recruited the NF-B subunits [TF] and p50 to the NF-B binding domain of the [TG] promoter.	p65	GLT-1	0	UNDEFINED	False
11954	12170	23955341:8:NFKB1:SLC1A2	Furthermore, TX recruited the NF-B subunits p65 and [TF] to the NF-B binding domain of the [TG] promoter.	p50	GLT-1	0	UNDEFINED	False
11956	12173	23967200:12:STAT3:MMP3	(3) Phosphorylated [TF] binds to the [TG] promoter in HBVEC cells, STAT3 transcribed MMP3 and induced MMP3 protein expression in HBVEC cells.	STAT3	MMP3	1	ACTIVATION	False
11957	12174	23967259:0:FOXO3:PRNP	IGF-1-induced enhancement of [TG] expression depends on the negative regulation of transcription factor [TF].	FOXO3a	PRNP	2	REPRESSION	False
11958	12175	23967259:4:FOXO3:PRNP	Here, we demonstrate that forkhead box O3a ([TF]) negatively regulates [TG] expression by binding to the PRNP promoter, which is negatively regulated by insulin-like growth factor 1 (IGF-1).	FOXO3a	PRNP	2	REPRESSION	False
11959	12176	23967259:6:FOXO3:PRNP	The activation of Akt then induces the phosphorylation of [TF], leading to its translocation from the nucleus to the cytoplasm and preventing its binding to the [TG] promoter.	FOXO3a	PRNP	0	UNDEFINED	False
11960	12177	23967259:7:FOXO3:PRNP	Treatment with the PI3K-Akt inhibitor LY294002 induces the nuclear retention of [TF], which leads to a decrease in [TG] expression.	FOXO3a	PRNP	2	REPRESSION	True
11961	12178	23967259:8:FOXO3:PRNP	We present a new IGF-1-PI3K-Akt-[TF] pathway, which influences [TG] expression.	FOXO3a	PRNP	0	UNDEFINED	False
11962	12179	23975424:2:THAP1:CCAR1	Here, we report that the cooperative synergy between prostate apoptosis response factor-4 (Par-4) and [TF] induces cell cycle and apoptosis regulator 1 ([TG]) gene expression and cellular apoptosis in human T-ALL cell line Jurkat cells, CEM cells and primary cultured neoplastic T lymphocytes from children with T-ALL.	THAP1	CCAR1	1	ACTIVATION	False
11963	12180	23978400:4:SP1:PLAU	Here, we demonstrated that TMPRSS4 induced the transcription of the [TG] (uPA) gene through activating the transcription factors [TF], Sp3, and AP-1 in mainly a JNK-dependent manner and that the induction of uPA was required for TMPRSS4-mediated cancer cell invasion and signaling events.	Sp1	urokinase-type plasminogen activator	1	ACTIVATION	False
11964	12181	23978400:4:SP3:PLAU	Here, we demonstrated that TMPRSS4 induced the transcription of the [TG] (uPA) gene through activating the transcription factors Sp1, [TF], and AP-1 in mainly a JNK-dependent manner and that the induction of uPA was required for TMPRSS4-mediated cancer cell invasion and signaling events.	Sp3	urokinase-type plasminogen activator	1	ACTIVATION	False
11965	12182	23982216:11:TWIST1:HOXA9	Mechanistically, [TF] bound to the [TG] promoter and positively regulated Hoxa9 expression in prostate cancer cells.	Twist1	Hoxa9	1	ACTIVATION	False
11966	12183	23988382:4:PGR:ABCG2	To investigate the role of PROG in the regulation of [TG] expression, two constructs encoding full-length BCRP driven by either an endogenous PRE promoter or a constitutive CMV promoter, were transfected into T47D cells that express the [TF] (PR) or into PR-negative MDA-MB-231 cells.	progesterone receptor	BCRP	0	UNDEFINED	False
11967	12184	23994556:7:AHR:MT2A	Moreover, chromatin immunoprecipitation assays indicated that [TF] was recruited to the glucocorticoid response element in the [TG] promoter.	AHR	MT2A	0	UNDEFINED	False
11968	12185	23996530:0:SP1:ABCG2	Transcription factors [TF] and Sp3 regulate expression of human [TG] gene and chemoresistance phenotype.	Sp1	ABCG2	0	UNDEFINED	False
11969	12186	23996530:0:SP3:ABCG2	Transcription factors Sp1 and [TF] regulate expression of human [TG] gene and chemoresistance phenotype.	Sp3	ABCG2	0	UNDEFINED	False
11970	12187	23996530:3:SP1:ABCG2	Binding of [TF] and Sp3 transcription factors to the [TG] promoter in vitro and in vivo was elucidated by electrophoretic mobility shift assay and chromatin immunoprecipitation assay.	Sp1	ABCG2	0	UNDEFINED	False
11971	12188	23996530:3:SP3:ABCG2	Binding of Sp1 and [TF] transcription factors to the [TG] promoter in vitro and in vivo was elucidated by electrophoretic mobility shift assay and chromatin immunoprecipitation assay.	Sp3	ABCG2	0	UNDEFINED	False
11972	12189	23996530:8:SP1:ABCG2	Collectively, our results demonstrate that [TF] and Sp3 transcription factors are the primary determinants for activating basal transcription of the [TG] gene and play an important role in maintaining the side population phenotype of lung cancer cells.	Sp1	ABCG2	1	ACTIVATION	False
11973	12190	23996530:8:SP3:ABCG2	Collectively, our results demonstrate that Sp1 and [TF] transcription factors are the primary determinants for activating basal transcription of the [TG] gene and play an important role in maintaining the side population phenotype of lung cancer cells.	Sp3	ABCG2	1	ACTIVATION	False
11974	12191	24009751:7:NFKB:GAST	Ectopic expression of [TF] p65 in AGS cells resulted in about nine-fold transcriptional repression of [TG] both in the presence and absence of IL1B.	NFkB	gastrin	2	REPRESSION	False
11975	12192	24009751:7:RELA:GAST	Ectopic expression of NFkB [TF] in AGS cells resulted in about nine-fold transcriptional repression of [TG] both in the presence and absence of IL1B.	p65	gastrin	2	REPRESSION	False
11976	12193	24009751:8:NFKB:GAST	The S536A mutant of [TF] p65 is significantly less effective in repressing [TG].	NFkB	gastrin	2	REPRESSION	False
11977	12194	24009751:8:RELA:GAST	The S536A mutant of NFkB [TF] is significantly less effective in repressing [TG].	p65	gastrin	2	REPRESSION	True
11978	12195	24014887:8:E2F1:PDGFB	Our findings delineate an as yet unrecognized function of [TF] as enhancer of angiogenesis via regulation of VEGF-C/VEGFR-3 signaling in tumors to cooperatively activate [TG] expression.	E2F1	PDGF-B	1	ACTIVATION	False
11979	12196	24025864:8:NFKB1:DNMT1	Acid-induced increases in [TG] mRNA expression and promoter activity were significantly decreased by knockdown of NOX5-S and NF-B1 [TF].	p50	DNMT1	1	ACTIVATION	False
11980	12197	24025864:9:NFKB1:DNMT1	Conversely, overexpression of NOX5-S, [TF], or p65 significantly increased [TG] promoter activity.	p50	DNMT1	1	ACTIVATION	False
11981	12198	24025864:9:RELA:DNMT1	Conversely, overexpression of NOX5-S, p50, or [TF] significantly increased [TG] promoter activity.	p65	DNMT1	1	ACTIVATION	False
11982	12199	24029702:4:NR6A1:POU5F1	[TF] has been found to be a transcriptional repressor, through specific binding to DR0 response elements, which is found in the [TG] proximal promoter for example.	GCNF	Oct4	2	REPRESSION	False
11983	12200	24037087:10:TFE3:TXNIP	[TG] expression in mouse models of diabetes was decreased by Ad-[TF] administration, suggesting that TFE3 may play a negative role through competition with ChREBP at the E-box of the Txnip promoter.	Tfe3	Txnip	2	REPRESSION	False
11984	12201	24037087:6:TFE3:TXNIP	Luciferase reporter assays and chromatin immunoprecipitation using the [TG] promoter were performed to elucidate the interrelationship between carbohydrate response element-binding protein (ChREBP) and [TF] (TFE3) in the regulation of Txnip expression.	transcription factor E3	Txnip	0	UNDEFINED	False
11985	12202	24038073:8:TFDP2:MYC	Notably, miR-122 also repressed [TG] transcription by targeting transcriptional activator E2f1 and coactivator [TF], as evident from ectopic expression and knockdown studies and luciferase reporter assays in mouse and human hepatic cells.	Tfdp2	c-Myc	1	ACTIVATION	True
11987	12204	24038081:6:NR0B2:HES6	The [TG] promoter is specifically activated by the retinoic acid receptor (RAR) in response to its natural agonist ligand, all-trans retinoic acid (atRA), and is repressed by [TF].	SHP	Hes6	2	REPRESSION	False
11988	12205	24038081:6:RARA:HES6	The [TG] promoter is specifically activated by the retinoic acid receptor ([TF]) in response to its natural agonist ligand, all-trans retinoic acid (atRA), and is repressed by SHP.	RAR	Hes6	1	ACTIVATION	False
11989	12206	24047441:8:NR4A1:CCND1	Overexpression of [TF] inhibited 5-HT-induced PASMC proliferation, as well as the expression of [TG] and proliferating cell nuclear antigen.	Nur77	cyclin D1	2	REPRESSION	False
11990	12207	24047441:8:NR4A1:PCNA	Overexpression of [TF] inhibited 5-HT-induced PASMC proliferation, as well as the expression of cyclin D1 and [TG].	Nur77	proliferating cell nuclear antigen	2	REPRESSION	False
11991	12208	24047559:9:EGR1:ACVR1	Our results showed that several transcription factors such as [TF], Egr-2, ZBTB7A/LRF, and Hey1, regulate the [TG] promoter by binding to the -762/-308 region, which is essential to confer maximal transcriptional activity.	Egr-1	ACVR1	1	ACTIVATION	True
11992	12209	24049731:5:STAT1:LCN2	In the [TG] promoter, one NF-B binding site and four [TF] binding sites were identified by in silico and in vitro approaches.	STAT1	LCN2	0	UNDEFINED	False
11993	12210	2405250:5:NFKB:IL6	These results indicate that a nuclear factor indistinguishable from [TF] is involved in the transcriptional activation of the [TG] gene by IL-1 and TNF-alpha.	NF-kappa B	IL-6	1	ACTIVATION	False
11994	12211	24062466:10:NFE2L2:DLL4	[TF] activation in ECs suppressed [TG] expression under normoxia and hypoxia and inhibited Dll4-induced Notch signaling.	Nrf2	Dll4	2	REPRESSION	False
11995	12212	24062466:7:NFE2L2:DLL4	[TF] deletion resulted in increased delta-like ligand 4 ([TG]) expression and Notch activity in ECs.	Nrf2	Dll4	2	REPRESSION	False
11996	12213	24064218:11:ETS1:CD44	Furthermore, knockdown of [TF] inhibits the S1P-induced [TG] expression and cell migration.	ETS-1	CD44	1	ACTIVATION	False
11997	12214	24064218:7:ETS1:CD44	Promoter analysis suggests that the [TG] promoter contains binding sites of the [TF] (v-ets erythroblastosis virus E26 oncogene homolog 1) transcriptional factor.	ETS-1	CD44	0	UNDEFINED	False
11998	12215	24064218:8:ETS1:CD44	ChIP assay confirms that S1P treatment stimulates the binding of [TF] to the [TG] promoter region.	ETS-1	CD44	0	UNDEFINED	False
11999	12216	24065533:8:CREB1:CCND1	The results suggested that HBZ suppressed [TG] transcription through interactions with [TF] and along with other viral protein, HBZ may play a causal role for leukemogenesis.	CREB	cyclin D1	2	REPRESSION	False
12000	12217	24065703:2:FOXO1:LHB	Recently, we reported that insulin regulates [TF] phosphorylation and cellular localization in pituitary gonadotropes and that FOXO1 overexpression inhibits [TG] transcription.	FOXO1	Lhb	2	REPRESSION	False
12001	12218	24066135:6:STAT3:SOX6	Constitutive activation of the transcription factor [TF] results in up-regulation of [TG] expression and chromatin immunoprecipitation analysis showed that MIF increases Stat3 binding to the Sox6 promoter in NSPCs, indicating that Stat3 stimulates Sox6 expression downstream of MIF.	Stat3	Sox6	1	ACTIVATION	False
12002	12219	24069250:7:ETS2:UCA1	Deletion and mutation analysis suggested that an [TF] binding site was critical for [TG] gene promoter activity.	Ets-2	UCA1	1	ACTIVATION	False
12003	12220	24069250:8:ETS2:UCA1	Further analysis of this site by gel shifting, chromatin immune precipitation (ChIP), and co-transfection experiments showed that transcription factor [TF] directly bound to the [TG] promoter region and stimulated UCA1 promoter activity in bladder cancer cells.	Ets-2	UCA1	1	ACTIVATION	False
12004	12221	24069250:9:ETS2:UCA1	Taking into account the anti-apoptosis function of [TF], our data suggested that Ets-2 regulates apoptosis process by regulating the expression of [TG], moreover UCA1 may be involved in the activation of Akt signaling pathway by Ets-2 in bladder cancer cells.	Ets-2	UCA1	0	UNDEFINED	False
12005	12222	24071582:7:E2F4:PLK4	We identify CDE and CHR sites in the [TG] promoter, which are necessary for binding of the DREAM (DP, RB-like, [TF] and MuvB) complex and for mediating repression in G0/G1.	E2F4	Plk4	2	REPRESSION	False
12006	12223	24086752:3:STAT1:GLS	However, there are multiple putative [TF] binding sites in human [TG]1 promoter, the exact molecular mechanism of how HIV-1 or IFN- regulates human GLS1 promoter remains unclear.	STAT1	GLS	0	UNDEFINED	False
12007	12224	24097101:5:STAT1:KDM6B	While knockdown of individual Stat had little effect on the expression of tested genes, knockdown of both [TF] and Stat3 inhibited the expression of [TG] and inflammatory genes.	Stat1	Jmjd3	1	ACTIVATION	False
12008	12225	24112473:15:FOXO1:TXNIP	MK-801 dephosphorylated Thr24 in [TF] and induced its nuclear translocation, thus increasing transcription of [TG], a tumor suppressor gene.	FOXO1	TXNIP	1	ACTIVATION	True
12009	12226	24113181:3:NFKB:NOTCH1	Our data revealed that AKT1 mRNA and protein expression were induced by doxorubicin (a chemotherapeutic agent); the doxorubicin-induced AKT1 expression and activation increased the binding of [TF] on [TG] DNA promoter and then promoted the Notch1 transcription and expression; enhanced expression of Notch1 further upregulated PTEN expression through CBF-1 binding to PTEN DNA promoter; and inhibition of AKT1 expression and activity sensitized the gastric cancer cell to doxorubicin treatment in cultured gastric cancer cell lines and xenograft nude mice gastric cancer model.	NF-kappaB	Notch1	1	ACTIVATION	False
12010	12227	24117128:6:TP63:BBC3	siRNA-mediated knockdown of [TF] resulted in partial protection from spontaneous apoptosis accompanied by reductions in PMAIP1 (NOXA), [TG] (PUMA), and BAX mRNA in CLL cells and increased proliferation of Raji lymphoma cells.	TP63	BBC3	1	ACTIVATION	False
12011	12228	24123203:0:JUN:GFAP	Traumatic scratch injury in astrocytes triggers calcium influx to activate the JNK/c-Jun/[TF] pathway and switch on [TG] expression.	AP-1	GFAP	1	ACTIVATION	False
12012	12229	24123203:5:JUN:GFAP	Using the calcium blocker BAPTA-AM and the JNK inhibitor SP600125, we demonstrated that the calcium wave triggered the activation of JNK, which then phosphorylated the transcription factor c-Jun to facilitate the binding of [TF] to the [TG] gene promoter to switch on GFAP upregulation.	AP-1	GFAP	1	ACTIVATION	False
12013	12230	24124001:7:GATA3:TGFBR3	In summary, our findings suggest that methylation in the [TF] promoter region may inhibit the expression of GATA3 mRNA, which leads to the reduced expression of [TG] mRNA in BUC.	GATA3	TGFBR3	1	ACTIVATION	False
12014	12231	24127737:6:HSF1:JUN	We found that [TF] bound to the [TG] promoter and was necessary for its efficient response to heat shock.	HSF1	JUN	0	UNDEFINED	False
12016	12233	24136149:6:AP1:PRKDC	Activator protein 1 ([TF]) binding to [TG] promoter was evaluated by chromatin immunoprecipitation.	AP-1	DNA-PKcs	0	UNDEFINED	False
12017	12234	24136232:8:RUNX2:HBEGF	[TF] specifically binds to the [TG] promoter, suggesting that Hbegf transcription is directly inhibited by Runx2.	Runx2	Hbegf	2	REPRESSION	False
12018	12235	24140069:8:PRDM1:IFNL1	We identified ZEB1 and [TF] as transcription factors that strongly inhibited [TG] expression in SW480 cells.	BLIMP-1	IFNL1	2	REPRESSION	False
12019	12236	24140069:8:ZEB1:IFNL1	We identified [TF] and BLIMP-1 as transcription factors that strongly inhibited [TG] expression in SW480 cells.	ZEB1	IFNL1	2	REPRESSION	False
12022	12239	24140127:8:NFKB1:PADI4	Finally, we used chromatin immunoprecipitation (ChIP) to determine NF-B enrichment at the [TG] promoter and the [TF] subunit of NF-B was more highly enriched than p65 at the PAD4 promoter.	p50	PAD4	0	UNDEFINED	False
12023	12240	24140127:9:NFKB1:PADI4	These results suggest that the [TF] subunit of NF-B may play a role in the repression of [TG] transcription during inflammation.	p50	PAD4	2	REPRESSION	False
12024	12241	24141789:13:FOXM1:NBN	The physiological relevance of the regulation of [TG] expression by [TF] is further underscored by the strong and significant correlation between nuclear FOXM1 and total NBS1 expression in breast cancer patient samples, further suggesting that NBS1 as a key FOXM1 target gene involved in DNA damage response, genotoxic drug resistance and DNA damage-induced senescence.	FOXM1	NBS1	0	UNDEFINED	True
12025	12242	24141789:4:FOXM1:NBN	We also demonstrate that [TF] regulates [TG] at the transcriptional level through an forkhead response element on its promoter.	FOXM1	NBS1	0	UNDEFINED	False
12026	12243	24141789:6:FOXM1:NBN	Consistently, overexpression of [TF] augmented and FOXM1 depletion reduced [TG] expression and epirubicin-induced ataxia-telangiectasia mutated (ATM)phosphorylation in breast cancer cells.	FOXM1	NBS1	1	ACTIVATION	False
12027	12244	24141789:7:FOXM1:NBN	Together these findings suggest that [TF] increases [TG] expression and ATM phosphorylation, possibly through increasing the levels of the MRN(MRE11/RAD50/NBS1) complex.	FOXM1	NBS1	1	ACTIVATION	False
12028	12245	24144697:10:ATF2:SOX9	Additionally, we found that [TF] directly binds the [TG] promoter in response to BMP signaling and that this effect is dependent upon TAK1 kinase activity.	ATF2	Sox9	0	UNDEFINED	False
12029	12246	24155921:3:FOXP3:VEGFA	[TF] downregulated LCK-induced MMP9, SKP2, and [TG] expression.	FOXP3	VEGF-A	2	REPRESSION	False
12030	12247	24163148:10:NEUROG3:CCND1	Pak3 acts downstream of [TF] to promote cell cycle exit and differentiation in the embryo by a mechanism that might involve repression of [TG].	Ngn3	Ccnd1	2	REPRESSION	False
12031	12248	24163369:11:TP53:NEK2	These results identify [TG] as a novel [TF]-repressed gene, illustrate that its repression by 5aza-dC is specific and associated with nucleosome reorganization, and provide evidence that identification of partially methylated regions can reveal novel p53 target genes.	p53	NEK2	2	REPRESSION	False
12032	12249	24163369:7:TP53:NEK2	Stabilization of endogenous [TF] by doxorubicin or ectopic expression of p53, but not a p53 DNA-binding mutant, decreased [TG] expression.	p53	NEK2	2	REPRESSION	False
12033	12250	24163369:9:TP53:NEK2	Luciferase reporters confirmed that this region is required for [TF]-mediated repression of [TG] promoter activity.	p53	NEK2	2	REPRESSION	False
12034	12251	24172143:10:TSC22D3:PTGS2	Dexamethasone-induced upregulation of [TF] not only inhibits the hypoxic-evoked induction of [TG] expression and cell invasion but further blocks the HIF-1 pathway by destabilizing HIF-1 expression.	GILZ	COX-2	2	REPRESSION	False
12035	12252	24173679:8:USF1:MVP	Using a chromatin immunoprecipitation (ChIP) assay, [TF] bound the [TG] promoter in SW620 cells.	USF1	MVP	0	UNDEFINED	False
12036	12253	24173679:9:USF1:MVP	These findings suggest that [TF] binding to an E-box element may be critical for basal [TG] promoter activation.	USF1	MVP	1	ACTIVATION	False
12037	12254	24174222:6:MYB:S100A4	[TF] and C/EBp but not Ap2 and Msx-1 were confirmed by EMSA and ChIP as transcription factors of [TG].	c-Myb	S100A4	0	UNDEFINED	False
12039	12256	24190040:7:JUN:CCND1	[TF] is required for progression through the G1 phase, the mechanism by which involves transcriptional control of the [TG] gene.	c-Jun	cyclin D1	0	UNDEFINED	False
12040	12257	24191285:10:CEBPA:AGT	Taken together, [TF] binding initiates chromatin relaxation and transcription, which are followed by DNA demethylation around a CEBP binding site and a transcription start site in the [TG] promoter.	CEBP	AGT	0	UNDEFINED	False
12041	12258	24191285:3:CEBPA:AGT	We demonstrate that stimulatory signals can change the DNA methylation status at a CCAAT/enhancer binding protein ([TF]) binding site and a transcription start site and activate expression of the angiotensinogen gene ([TG]).	CEBP	AGT	1	ACTIVATION	False
12043	12260	24214128:8:EGR1:RRM2B	Furthermore, [TF] also directly bound to the [TG] promoter and repressed RRM2B transcription, thereby establishing a negative regulatory feedback loop.	Egr-1	RRM2B	2	REPRESSION	False
12044	12261	24216509:4:MYCN:TGFBR3	In vitro, TRIII expression was epigenetically suppressed by [TF]-mediated recruitment of histone deacetylases to regions of the [TG] promoter.	MYCN	TGFBR3	2	REPRESSION	False
12045	12262	24217921:7:NFKB:DAPK1	STAT3 and p52-[TF] transcription factors have been shown to down-regulate [TG] expression.	NFkB	DAPK	2	REPRESSION	False
12046	12263	24217921:7:NFKB2:DAPK1	STAT3 and [TF]-NFkB transcription factors have been shown to down-regulate [TG] expression.	p52	DAPK	2	REPRESSION	False
12047	12264	24244341:4:CREB1:AGTR1	We hypothesized that the transcription of the [TG] gene occurs via an orchestration of transcription factor interactions including NF-B, [TF], and Elk-1.	CREB	AT1R	1	ACTIVATION	True
12048	12265	24250222:6:NRF1:CYCS	The set of ChIP-Seq-based [TF] target genes included known NRF1 targets such as EIF2S1, EIF2S2, [TG], FMR1, FXR2, E2F6, CD47, and TOMM34.	NRF1	CYCS	0	UNDEFINED	False
12049	12266	24255720:6:FOXO1:HMOX1	Previous study showed that [TF] induces [TG] expression by binding to HO-1 promoter.	FOXO1	HO-1	1	ACTIVATION	False
12050	12267	24255720:8:FOXO1:HMOX1	Cobalt protoporphyrin enhances the expression of [TF] and facilitates FOXO1 binding to [TG] promoter and increasing its transcriptional activity without influencing the FOXO1 protein stability.	FOXO1	HO-1	1	ACTIVATION	False
12051	12268	24257750:8:FOXO1:SEPP1	Transfection with siRNAs for Foxo3a, but not for [TF], cancelled metformin-induced luciferase activity suppression of the metformin-response element of the [TG] promoter.	Foxo1	SEPP1	2	REPRESSION	True
12052	12269	24257750:8:FOXO3:SEPP1	Transfection with siRNAs for [TF], but not for Foxo1, cancelled metformin-induced luciferase activity suppression of the metformin-response element of the [TG] promoter.	Foxo3a	SEPP1	2	REPRESSION	True
12053	12270	24269672:9:ATF2:YTHDC2	Collectively, these data show that [TG] plays an important role in tumor cells growth and activation/recruitment of c-Jun and [TF] to the YTHDC2 promoter is necessary for the transcription of YTHDC2, and that HDAC activity is required for the efficient expression of YTHDC2 in both of hepatocyte and HCC cells.	ATF-2	YTHDC2	1	ACTIVATION	False
12054	12271	24276245:4:E2F1:ABCG2	Here we report that the major multidrug transporter [TG] (BCRP/MXR) is directly and specifically activated by the transcription factor [TF]--a factor perturbed in the majority of human cancers.	E2F1	ABCG2	1	ACTIVATION	False
12055	12272	24276245:5:E2F1:ABCG2	[TF] regulates [TG] expression in multiple cell systems, and, importantly, we have identified a significant correlation between elevated E2F1 and ABCG2 expression in human lung cancers.	E2F1	ABCG2	0	UNDEFINED	True
12056	12273	24279793:11:MEF2D:CDKN1A	We find that exogenous [TF] expression can activate muscle specific luciferase constructs, up regulate [TG] expression and increase muscle specific gene expression including the expression of myosin heavy chain, a marker for skeletal muscle differentiation.	MEF2D	p21	1	ACTIVATION	False
12057	12274	24285265:6:STAT1:SLPI	Our data demonstrate that [TF] regulates [TG] transcription in epithelial cells and slpi protein in the lungs of mice.	STAT1	SLPI	0	UNDEFINED	False
12058	12275	24287565:7:STAT3:CCND2	Moreover, we identified [TF] (STAT3) as a direct target of miR-124, and over expression of miR-124 not only induced changes in STAT3 expression but also altered expression of its target genes, [TG] and matrix metalloproteinase 2, in the human endometrial carcinoma cell line HEC-1B.	signal transducer and activator of transcription 3	cyclin D2	0	UNDEFINED	False
12059	12276	24288524:0:PPARG:REN	[TF]-Dependent Control of [TG] Expression: Molecular Mechanisms and Pathophysiological Relevance.	PPARgamma	Renin	0	UNDEFINED	False
12060	12277	24288524:1:PPARG:REN	During the last years accumulating evidence demonstrated that the nuclear receptor peroxisome proliferator-activated receptor-gamma ([TF]) regulates the expression of [TG] gene and thus the overall renin production.	PPARgamma	renin	0	UNDEFINED	False
12061	12278	24288524:4:PPARG:REN	Furthermore, I discuss the need for generating of additional transgenic animal models which are more appropriate with regard to the role of the [TF]-dependent regulation of the [TG] gene expression in human diseases such as arterial hypertension and metabolic syndrome.	PPARgamma	renin	0	UNDEFINED	False
12062	12279	24291305:0:FOXO1:RETN	The forkhead transcription factor [TF] stimulates the expression of the adipocyte [TG] gene.	FOXO1	resistin	1	ACTIVATION	False
12063	12280	24291305:2:FOXO1:RETN	It can be regulated by transcriptional factors, but the possible role of forkhead transcription factor [TF] in regulating [TG] gene expression is still unknown.	FOXO1	resistin	0	UNDEFINED	False
12064	12281	24291305:7:FOXO1:RETN	A chromatin immunoprecipitation assay also showed that [TF] bound the [TG] promoter at nucleotide regions of -1539 to -1366bp and -1016 to -835bp, but not at the regions of -795 to -632bp.	FOXO1	resistin	0	UNDEFINED	False
12065	12282	24291305:8:FOXO1:RETN	Results of this study suggest that [TF] transcription factor likely activates the expression of adipocyte [TG] gene via direct association with the upstream resistin promoter.	FOXO1	resistin	1	ACTIVATION	False
12066	12283	24291639:6:NFATC3:PTGS2	Furthermore, cyclosporin A (CsA) and knockdown of [TF] (NFATc3) inhibited the expression of [TG] induced by ET-1, and NFATc3 could also bound to the -GGAAA- sequence in the promoter region of rat COX-2 gene, indicating that calcineurin/NFATc3 signaling participated in the transcriptional regulation of COX-2 following ET-1 treatment.	nuclear factor of activated T-cells c3	COX-2	1	ACTIVATION	False
12067	12284	24301678:8:NRL:RHO	NonO and its interactors can activate [TG] promoter in HEK293 cells and function synergistically with [TF] and CRX.	NRL	rhodopsin	1	ACTIVATION	False
12068	12285	24308961:0:FOXP3:PTGS2	[TF] inhibits NF-B activity and hence [TG] expression in gastric cancer cells.	FOXP3	COX2	2	REPRESSION	False
12069	12286	24308961:9:FOXP3:PTGS2	Knockdown of [TF] could increase NF-B activity, [TG] expression, and cell migration.	FOXP3	COX2	2	REPRESSION	False
12070	12287	24316970:9:RELB:BECN1	[TF] directly increased expression of [TG], a key autophagy regulator, by binding to its promoter.	RelB	BECN1	1	ACTIVATION	False
12071	12288	24316979:5:CUX1:PIK3IP1	We demonstrate that [TF] deficiency activates phosphoinositide 3-kinase (PI3K) signaling through direct transcriptional downregulation of the PI3K inhibitor PIK3IP1 ([TG]), leading to increased tumor growth and susceptibility to PI3K-AKT inhibition.	CUX1	phosphoinositide-3-kinase interacting protein 1	1	ACTIVATION	True
12072	12289	24321096:0:SREBF2:FGF19	[TF] negatively regulates FXR-dependent transcription of [TG] in human intestinal cells.	SREBP-2	FGF19	2	REPRESSION	False
12073	12290	24321096:9:SREBF2:FGF19	These results suggest that [TF] negatively regulates the FXR-mediated transcriptional activation of the [TG] gene in human intestinal cells.	SREBP-2	FGF19	2	REPRESSION	False
12074	12291	24333653:9:PARP1:PTGS2	"At a protein level, [TF]UNCL and PARP-1(24) decreased iNOS (and lower levels of iNOS transcript) and [TG], and increased Bcl-xL The increased levels of NF-kB and iNOS transcriptional activities, seen with cytotoxic PARP-189, were accompanied by higher protein expression of COX-2 and iNOS (and higher levels of INOS transcript) and lower protein expression of Bcl-xL Taken together, these findings suggest that PARP-1 cleavage products may regulate cellular viability and inflammatory responses in opposing ways during in vitro models of ""ischemia""."	PARP-1	COX-2	2	REPRESSION	True
12075	12292	24335393:11:VDR:SULT1C2	Further, we determined that responsive regions for LXR and [TF] are likely contained within intron 1 of the [TG]2 gene.	VDR	SULT1C	0	UNDEFINED	False
12076	12293	24336126:7:GATA1:MYC	Chromatin Immunoprecipitation Sequencing (ChIP-seq) indicated reduced [TF]s occupancy at the [TG] promoter.	GATA1	MYC	0	UNDEFINED	False
12077	12294	24339999:7:TP53:PRNP	We have further defined that, in N2a cells, Dpl induces oxidative stress and apoptosis, which stimulate ataxia-telangiectasia mutated (ATM)-modulating bindings of transcription factors, [TF] and p21, to Prnp promoter, resulting the [TG](C) elevation for counteraction of the Dpl cytotoxicity; in contrast, in GC-1 spg cells, phosphorylation of p21 and N-terminal truncated PrP may play roles in the control of Dpl-induced apoptosis, which may benefit the physiological function of Dpl in the male reproduction system.	p53	PrP	1	ACTIVATION	False
12078	12295	24343129:8:NFKB:PDCD5	3-Cl-AHPC mediated apoptosis in MDA-MB-468 had three related effects on [TG]: NF-B [TF] binding to the PDCD5 gene, enhanced PDCD5 promoter activity, and increased PDCD5 protein expression.	p65	PDCD5	1	ACTIVATION	False
12079	12297	24343129:9:NFKB:PDCD5	Furthermore, 3-Cl-AHPC increased orphan nuclear receptor small heterodimer partner (SHP) mRNA expression, increased SHP protein bound to NF-B [TF], and found the SHP/NF-B p65 complex attached to the [TG] gene.	p65	PDCD5	0	UNDEFINED	False
12080	12299	24344197:3:HIF1A:ARC	Chromatin immunoprecipitation (ChIP) and reporter assays also indicate that the [TG] gene is regulated by direct binding of [TF] to a hypoxia response element (HRE) located at bp -190 upstream of the transcription start site.	HIF1	ARC	0	UNDEFINED	False
12081	12300	24353279:0:SREBF2:CYP51A1	FoxO4 interacts with the sterol regulatory factor [TF] and the hypoxia inducible factor HIF2 at the [TG] promoter.	SREBP2	CYP51	0	UNDEFINED	False
12082	12301	24353279:8:SREBF2:CYP51A1	Electromobility shift, chromatin immunoprecipitation, pull-down, and coimmunoprecipitation assays show that FoxO4 interacts with [TF] and HIF2 to modulate [TG] promoter activity.	SREBP2	CYP51	0	UNDEFINED	False
12083	12302	24360823:6:REL:NOS2	Instead, LPS-mediated NF-B activation and DNA bindings of p65, p50 and [TF] to the NF-B binding site of [TG] promoter were inhibited by HBU-47.	c-Rel	iNOS	0	UNDEFINED	True
12084	12303	24366007:1:TP53:HMOX1	A recent study reported that [TF] can induce [TG] by directly binding to the putative p53 responsive element in the HO-1 promoter.	p53	HO-1	1	ACTIVATION	False
12085	12304	24367622:0:POU2F1:HMGA1	Transcriptional regulation of the [TG] gene by octamer-binding proteins [TF] and Oct-2.	Oct-1	HMGA1	0	UNDEFINED	False
12086	12305	24367622:8:POU2F1:HMGA1	Overall, our results provide insight into the transcriptional regulation of the [TG] gene, revealing a differential control exerted by both [TF] and Oct-2.	Oct-1	HMGA1	0	UNDEFINED	False
12087	12306	24379358:6:TP53:AREG	Ser46-phosphorylated [TF] selectively binds to the promoter region of [TG] gene, indicating that the p53 modification changes target genes by altering its binding affinity to the promoter.	p53	AREG	0	UNDEFINED	False
12088	12307	24380854:6:AHR:CCND1	Chromatin immunoprecipitation (ChIP), followed by Q-PCR indicated that IGF-2 promoted (P<.001) a 7-fold increase in [TF] binding on the [TG] promoter.	AHR	CCND1	0	UNDEFINED	False
12089	12308	24380854:9:AHR:CCND1	Collectively, our findings have revealed a new regulatory mechanism by which IGF-2 induction of [TF] promotes the expression of [TG] and the proliferation of MCF-7 cells.	AHR	CCND1	1	ACTIVATION	False
12090	12309	24390282:4:HOXB13:RFX6	The risk-associated T allele at rs339331 increases binding of [TF] to a transcriptional enhancer, conferring allele-specific upregulation of the rs339331-associated gene [TG].	HOXB13	RFX6	1	ACTIVATION	False
12091	12310	24390282:8:HOXB13:RFX6	Together, our results suggest that rs339331 affects prostate cancer risk by altering [TG] expression through a functional interaction with the prostate cancer susceptibility gene [TF].	HOXB13	RFX6	0	UNDEFINED	False
12092	12311	24390737:7:MEF2D:CDKN1A	Mechanistic investigations revealed that [TF]-silencing triggered G2-M arrest in a manner associated with direct downregulation of the cell-cycle regulatory genes RPRM, GADD45A, GADD45B, and [TG].	MEF2D	CDKN1A	1	ACTIVATION	False
12093	12312	24391115:5:STAT1:LCN2	Knockdown experiments also demonstrated that [TF] is required for IFN-induced [TG] expression in murine adipocytes.	STAT1	lipocalin-2	1	ACTIVATION	False
12094	12313	24391115:9:STAT1:LCN2	Our results suggest that these same mechanisms occur in humans as we observed [TF] and NF-B binding to the human [TG] promoter in chromatin immunoprecipitation assays performed in human fat cells.	STAT1	LCN2	0	UNDEFINED	False
12095	12314	24395801:4:BACH1:PEBP1	Here we demonstrate that [TF] acts in a double-negative (overall positive) feedback loop to inhibit [TG] transcription in breast cancer cells.	BACH1	RKIP	2	REPRESSION	False
12096	12315	24396065:5:TCF4:CDKN1C	[TF] upregulation enhances the expression of the cyclin-dependent kinase inhibitor gene p57([TG]), a paternally imprinted Tcf4 target gene, and increases the number of cells in G1 phase.	Tcf4	Kip2	1	ACTIVATION	False
12097	12316	24407240:0:NFYA:PLK1	Association of p21 with [TF] suppresses the expression of [TG] and prevents mitotic death in response to DNA damage.	NF-YA	Polo-like kinase 1	2	REPRESSION	False
12098	12317	24407240:8:NFYA:PLK1	Knockdown of [TF] decreased the amount of [TG] promoter-associated p21 and abolished p21-mediated PLK1 repression in cells treated with ADR.	NF-YA	PLK1	2	REPRESSION	False
12099	12318	24418603:4:ATF4:GPT2	5'-deletion analysis of [TG] promoter in transiently transfected HepG2 cells and site-directed mutagenesis allowed us to identify [TF] as a new factor involved in the transcriptional regulation of ALT2 expression.	ATF4	ALT2	0	UNDEFINED	False
12100	12319	24451137:0:EGR1:SIVA1	[TF] upregulates [TG] expression and induces cardiac fibroblast apoptosis.	Egr-1	Siva-1	1	ACTIVATION	False
12101	12320	24451137:8:EGR1:SIVA1	These findings suggest a previously unknown role for [TF] and transcriptional regulation of [TG] in the control of cardiac accessory cell death.	Egr-1	Siva-1	0	UNDEFINED	False
12102	12321	24451377:3:SP1:CDKN1A	Here we demonstrate that YHL-14 inhibits bladder and colon cancer cell growth through up-regulation of [TG] expression in an [TF]-dependent manner.	Sp1	p21	1	ACTIVATION	False
12103	12322	24455684:0:STAT3:LGR4	[TF] upregulates [TG] expression in osteosarcoma cells.	Stat3	leucine-rich repeat-containing g protein-coupled receptor 4	1	ACTIVATION	False
12104	12323	24455684:2:STAT3:LGR4	In the present study, according to PCR-based microarrays using cDNA prepared from interleukin-6 (IL-6) treated osteosarcoma cells, we found that leucine-rich repeat-containing G protein-coupled receptor 4 ([TG]) was a transcriptional target of [TF].	Stat3	LGR4	0	UNDEFINED	False
12105	12324	24455684:3:STAT3:LGR4	Overexpression of [TF] promoted [TG] expression, while its deficiency using small interfering RNA (siRNA) reduced LGR4 expression.	Stat3	LGR4	1	ACTIVATION	False
12106	12325	24465681:7:E2F1:DSCC1	RNAi-mediated reduction of [TF] reduced expression of [TG] in colorectal cancer cells.	E2F1	DSCC1	1	ACTIVATION	False
12107	12326	24469401:4:YY1:SLC1A2	[TF] overexpression in astrocytes reduced [TG] promoter activity, while YY1 knockdown or mutation of the YY1 consensus site of the EAAT2 promoter increased its promoter activity and attenuated the Mn-induced repression of EAAT2.	YY1	EAAT2	2	REPRESSION	False
12108	12327	24469401:6:YY1:SLC1A2	This led to increased [TF] binding to the [TG] promoter region.	YY1	EAAT2	0	UNDEFINED	False
12109	12328	24469401:7:YY1:SLC1A2	Epigenetically, histone deacetylase (HDAC) classes I and II served as corepressors of [TF], and, accordingly, HDAC inhibitors increased [TG] promoter activity and reversed the Mn-induced repression of EAAT2 promoter activity.	YY1	EAAT2	2	REPRESSION	False
12110	12329	24469401:8:YY1:SLC1A2	Taken together, our findings suggest that [TF], with HDACs as corepressors, is a critical negative transcriptional regulator of [TG] and mediates Mn-induced EAAT2 repression.	YY1	EAAT2	2	REPRESSION	False
12111	12330	24470589:4:ATF3:CXCL1	[TF] deletion was associated with increased lipopolysaccharide (LPS)-driven airway epithelia production of [TG], but not CXCL2, findings concordant with a consensus ATF3-binding site identified solely in the Cxcl1 promoter.	ATF3	CXCL1	2	REPRESSION	False
12112	12331	24487391:3:LEF1:SOX2	We discovered that [TG] expression is repressed as [TF] is induced within airway SMG placodes.	Lef-1	Sox2	2	REPRESSION	True
12113	12332	24491388:0:TWIST1:CLU	Insulin-like growth factor-I induces [TG] expression through [TF] to promote prostate cancer growth.	Twist1	CLU	1	ACTIVATION	False
12114	12333	24491388:10:STAT3:CLU	Collectively, this study indicates that IGF-I induces [TG] expression through sequential activation of [TF] and Twist1, and suggests that this signaling cascade plays a critical role in prostate cancer pathogenesis.	STAT3	CLU	1	ACTIVATION	False
12115	12334	24491388:10:TWIST1:CLU	Collectively, this study indicates that IGF-I induces [TG] expression through sequential activation of STAT3 and [TF], and suggests that this signaling cascade plays a critical role in prostate cancer pathogenesis.	Twist1	CLU	1	ACTIVATION	False
12116	12335	24491388:5:STAT3:TWIST1	In response to IGF-I, [TF] was phosphorylated, translocated to the nucleus and bound to the [TG] promoter to activate Twist1 transcription.	STAT3	Twist1	1	ACTIVATION	False
12117	12336	24491388:6:TWIST1:CLU	In turn, [TF] bound to E-boxes on the [TG] promoter and activated CLU transcription.	Twist1	CLU	1	ACTIVATION	False
12118	12337	24498423:10:NR1H4:NR0B2	[TF]-mediated activation of the h[TG] promoter was primarily dependent on the -122/-69 region.	FXR	SHP	1	ACTIVATION	False
12119	12338	24498423:13:NR1H4:NR0B2	LRH-1 did not increase [TF]/RXR-mediated activation of h[TG] promoter activity.	FXR	SHP	1	ACTIVATION	False
12120	12339	24499623:0:STAT3:CCND1	Epstein-Barr Virus encoded LMP1 regulates [TG] promoter activity by nuclear EGFR and [TF] in CNE1 cells.	STAT3	cyclin D1	0	UNDEFINED	False
12121	12340	24499623:6:STAT3:CCND1	LMP1 promoted both EGFR and [TF] binding to the promoter region of [TG], in turn, enhancing the promoter activity of cyclin D1.	STAT3	cyclin D1	1	ACTIVATION	False
12122	12341	24509533:10:NFE2L2:ATF3	Activated [TF] directly binds to [TG] promoter, thus inducing its expression.	NRF2	ATF3	1	ACTIVATION	False
12123	12342	24512687:6:CUX2:DLL1	In addition, our results show that up-regulation of [TF], either BMP-induced or ectopically over-expressed, reduce [TG] expression and suppress proliferation.	Cux2	Delta1	2	REPRESSION	False
12124	12343	24516045:4:E2F1:TRIB2	Further analyses revealed that [TF]-mediated [TG] expression was repressed by C/EBP-p42, and in normal granulocyte/macrophage progenitor cells, we detect C/EBP bound to the Trib2 promoter.	E2F1	Trib2	1	ACTIVATION	False
12125	12344	24516045:6:E2F1:TRIB2	Our work proposes a novel paradigm whereby [TF] plays a key role in the regulation of [TG] expression important for AML cell proliferation control.	E2F1	Trib2	0	UNDEFINED	True
12126	12345	24548444:8:TLX1:MEIS1	[TF] maybe a negative regulator of [TG] gene.	HOX11	MEIS1	2	REPRESSION	False
12127	12346	24550138:6:ATF3:BECN1	The results from molecular and biochemical analyses, including chromatin immune-precipitation and in vitro /in vivo promoter assays, showed that [TF] bound to the ATF/cAMP response element of the [TG] promoter and that ATF3 reduced autophagy via suppression of the Beclin-1-dependent pathway.	ATF3	Beclin-1	2	REPRESSION	False
12128	12347	24556685:4:TP53:S100A2	Consequently, mutation of the Np63/[TF] response element within the [TG] promoter completely abrogates the ability of BRCA1 to upregulate S100A2.	p53	S100A2	1	ACTIVATION	True
12129	12348	24576667:0:ETS1:FLVCR1	Hypoxia controls [TG] gene expression in Caco2 cells through HIF2 and [TF].	ETS1	Flvcr1	0	UNDEFINED	True
12130	12349	24576667:5:ETS1:FLVCR1	Chromatin immunoprecipitation analysis demonstrated that HIF2 and HIF-dependent transcription factor [TF] (v-ets avian erythroblastosis virus E26 oncogene homolog 1) bind at the region -318/+39 of the [TG] promoter.	ETS1	Flvcr1	0	UNDEFINED	False
12131	12350	24576667:6:ETS1:FLVCR1	Analysis of Caco2 cells in which HIF2 or [TF] were silenced or overexpressed demonstrated that, both HIF2 and ETS1 are involved in the transcriptional regulation of [TG]a and that HIF2 is absolutely required for Flvcr1a induction upon hypoxia.	ETS1	Flvcr1	1	ACTIVATION	False
12132	12351	24586690:10:RUNX1:LAT2	However, the enhanced binding of [TF] to the [TG] promoter could not repress the LAT2 expression when the BV2 microglia cells were treated with HDACi, indicating that Runx1t1 requires HDACs to transcriptionally repress the expression of LAT2.	Runx1t1	LAT2	2	REPRESSION	False
12133	12352	24586690:9:RUNX1:LAT2	This was confirmed by chromatin immunoprecipitation (ChIP) assay, which revealed that [TF] binds to the promoter region of [TG] and this binding increased upon microglial activation.	Runx1t1	LAT2	0	UNDEFINED	False
12134	12353	24587342:13:STAT5A:FOSL2	Taken together, our data suggest that [TG] is a novel [TF] target gene, regulated by IL-2 in activated CD4 T cells.	STAT5	FRA2	0	UNDEFINED	False
12135	12354	24589735:9:SP1:CDKN1A	Chromatin immunoprecipitation (ChIP) assays confirmed the Dux4-induced binding of [TF] to [TG] promoter in vivo.	Sp1	p21	0	UNDEFINED	False
12136	12355	24595984:0:TRPS1:VEGFA	[TF] expression promotes angiogenesis and affects [TG] expression in breast cancer.	TRPS1	VEGFA	0	UNDEFINED	False
12137	12356	24595984:5:TRPS1:VEGFA	We further investigated whether [TF] induces human umbilical vein endothelial cell (HUVEC) migration and [TG] expression of breast cancer cells.	TRPS1	VEGFA	1	ACTIVATION	False
12138	12357	24595984:7:TRPS1:VEGFA	In contrast, knockdown of [TF] decreased the induction of HUVEC migration and significantly down-regulated [TG] expression.	TRPS1	VEGFA	1	ACTIVATION	False
12139	12358	24595984:8:TRPS1:VEGFA	Furthermore, endogenous [TF] was present in the [TG] promoter, as determined by chromatin immunoprecipitation assay.	TRPS1	VEGFA	0	UNDEFINED	False
12140	12359	24595984:9:TRPS1:VEGFA	Taken together, this study showed that [TF] promotes angiogenesis and affects [TG] expression in breast cancer.	TRPS1	VEGFA	0	UNDEFINED	False
12141	12360	24607904:4:SOX5:TWIST1	Furthermore, depletion of [TF] in breast cancer cells caused a dramatic decrease in [TG] and chromosome immunoprecipitation assay showed that Sox5 can bind directly to the Twist1 promoter, suggesting that Sox5 transactivates Twist1 expression.	Sox5	Twist1	1	ACTIVATION	False
12142	12361	24607904:6:SOX5:TWIST1	Our study suggests that [TF] transactivates [TG] expression and plays an important role in the regulation of breast cancer progression.	Sox5	Twist1	1	ACTIVATION	False
12143	12362	24613343:0:POU2F1:IL17A	[TF] regulates [TG] expression by directing interchromosomal associations in conjunction with CTCF in T cells.	Oct-1	IL-17	0	UNDEFINED	False
12144	12363	24613343:6:POU2F1:IL17A	RHS6 and the [TG] promoter both bear [TF] binding sites.	Oct-1	IL-17	0	UNDEFINED	False
12145	12364	24619556:9:NR0B2:EGR1	Chromatin immunoprecipitation assays further confirmed the association of E2F1, [TF], and EID1 proteins with the [TG] promoter, and their direct protein interactions were determined by glutathione S-transferase pull-down assays.	SHP	Egr-1	0	UNDEFINED	False
12146	12365	24623314:10:SP2:CCND1	Moreover, we found that miR-638 overexpression and [TF]-siRNA markedly suppressed cell proliferation with decreasing expression of [TG] and inducing G1-phase cell-cycle arrest in vitro; inhibition of miR-638 significantly promoted cell proliferation by increasing expression of cyclin D1 and leading more cells into the S and G2/M phase.	Sp2	cyclin D1	1	ACTIVATION	False
12147	12366	24623314:11:SP2:CCND1	Our results demonstrated that miR-638 suppressed GC cell proliferation by targeting [TF] with influence on the expression of [TG].	Sp2	cyclin D1	0	UNDEFINED	False
12148	12367	24631292:10:JUN:SMURF1	Taken together, these results suggest that EGF increases [TG] expression via the activation of JNK and ERK and the subsequent binding of [TF] and Runx2 to the Smurf1 promoter and that Smurf1 mediates the inhibitory effect of EGF on BMP2-induced osteoblast differentiation.	c-Jun	Smurf1	1	ACTIVATION	False
12149	12368	24631292:6:JUN:SMURF1	Chromatin immunoprecipitation and [TG] promoter assays demonstrated that [TF] and Runx2 play roles in the EGF induction of Smurf1 transcription.	c-Jun	Smurf1	1	ACTIVATION	False
12150	12369	24647893:3:SMAD5:DLX3	Considering the important roles of [TF] and p38 in osteoblast differentiation, we hypothesized that Smad5 and p38 mediated BMP-2-induced [TG] transcription in osteoblasts.	Smad5	Dlx3	1	ACTIVATION	False
12151	12370	24647893:5:SMAD5:DLX3	Both [TF] and p38 were able to activate [TG] promoter activity and p38/Smad5 response elements were located from -698 to -368 in Dlx3 promoter.	Smad5	Dlx3	1	ACTIVATION	False
12152	12371	24652950:3:EZH2:PTGS2	Chromatin immunoprecipitation (ChIP) and re-ChIP assays demonstrated marked increases in H3K9me3, H3K27me3, and DNA methylation, together with their respective modifying enzymes G9a, [TF], and DNA methyltransferases (Dnmts) and respective binding proteins heterochromatin protein 1 (HP1), polycomb protein complex 1 (PRC1) and methyl CpG binding protein 2 (MeCP2), at the [TG] promoter in lung fibroblasts from patients with IPF (F-IPFs) compared with fibroblasts from nonfibrotic lungs.	EZH2	COX-2	0	UNDEFINED	False
12153	12372	24652950:5:DNMT1:PTGS2	G9a and EZH2 inhibitors and small interfering RNAs and the [TF] inhibitor markedly reduced H3K9me3 (49-79%), H3K27me3 (44-81%), and DNA methylation (61-97%) at the [TG] promoter.	Dnmt1	COX-2	0	UNDEFINED	False
12154	12373	24652950:5:EZH2:PTGS2	G9a and [TF] inhibitors and small interfering RNAs and the Dnmt1 inhibitor markedly reduced H3K9me3 (49-79%), H3K27me3 (44-81%), and DNA methylation (61-97%) at the [TG] promoter.	EZH2	COX-2	0	UNDEFINED	False
12155	12374	24659782:0:CTCF:ANG	Transcription of [TG] and ribonuclease 4 is regulated by RNA polymerase III elements and a [TF] (CTCF)-dependent intragenic chromatin loop.	CCCTC binding factor	angiogenin	0	UNDEFINED	False
12156	12375	24661562:8:GATA6:FZD2	Finally, we found that HMGA2 directly regulates [TF] and thereby modulates [TG] expression.	Gata6	Fzd2	0	UNDEFINED	False
12157	12376	24664678:7:NRL:KCNV2	Using bioinformatic prediction and chromatin immunoprecipitation (ChIP), we identified two Crx binding sites (CBS) and one [TF] binding site (NBS) in the [TG] promoter.	Nrl	Kcnv2	0	UNDEFINED	False
12158	12377	24705165:7:SOX9:AMH	Furthermore, we found coordinated expression patterns for Sox9 and the anti-Mllerian hormone gene, [TG], suggesting that [TF] could directly or indirectly regulate Amh expression, as it occurs in mammals.	SOX9	Amh	0	UNDEFINED	False
12159	12378	24706823:5:NKX6-1:CCNE1	Overexpression of [TF] and the Nr4a receptors results in increased expression of key cell cycle inducers E2F transcription factor 1 and [TG].	Nkx6.1	cyclin E1	1	ACTIVATION	False
12160	12379	24716865:7:CREB3L1:CHST3	A C-terminal deletion mutant [TF] over-expressed in rat C6 glioma cells increased [TG] transcription by interacting with the first intron region.	OASIS	C6ST1	2	REPRESSION	False
12161	12380	24727028:8:ETV2:TEK	Consistent with this, we report that Fli1 binds to the conserved Ets-binding sites within promoter and enhancer regions of other [TF]-regulated endothelial genes, including [TG], to control their expression at and beyond midgestation.	Etv2	Tie2	0	UNDEFINED	True
12162	12381	24727028:8:FLI1:TEK	Consistent with this, we report that [TF] binds to the conserved Ets-binding sites within promoter and enhancer regions of other Etv2-regulated endothelial genes, including [TG], to control their expression at and beyond midgestation.	Fli1	Tie2	0	UNDEFINED	False
12164	12383	24739390:6:SMAD4:BCL2	Activation of the TGF pathway induces GLI1-[TF] complex binding to the [TG] promoter whereas disruption of the complex through SMAD4 RNAi depletion impairs GLI1-mediated transcription of BCL2 and cellular survival.	SMAD4	BCL2	1	ACTIVATION	False
12165	12384	24742676:5:EGR1:PNPLA2	FSP27 suppresses the activity of the [TG] promoter in vitro, and the proximal [TF] binding site is responsible for this effect.	Egr1	ATGL	2	REPRESSION	True
12166	12385	24742676:6:EGR1:PNPLA2	FSP27 co-immunoprecipitates with [TF] and increases its association with and inhibition of the [TG] promoter.	Egr1	ATGL	2	REPRESSION	True
12167	12386	24747435:0:SATB1:CDKN1A	[TF] overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing [TG].	SATB1	p21	2	REPRESSION	False
12168	12387	24747435:4:SATB1:CDKN1A	Our findings show that [TF] silencing in CD30(+)LPD cells leads to G1 cell cycle arrest mediated by [TG] activation.	SATB1	p21	2	REPRESSION	True
12169	12388	24747959:8:STAT3:S100A9	Chromatin immunoprecipitation assays confirmed that LXR activation and HDAC inhibition balanced the recruitment of [TF] to the [TG] promoter, which involved distinct post-translational modifications of STAT3.	STAT3	S100A9	0	UNDEFINED	False
12170	12389	24755082:12:JUN:HMOX1	The results suggest that Nrf2 and [TF] regulate [TG] expression via their coordinated interaction in tBHQ-treated rat primary astrocytes.	c-Jun	HO-1	0	UNDEFINED	False
12171	12390	24755082:7:JUN:HMOX1	Small interfering RNA (siRNA) experiments demonstrated that Nrf2 and [TF] are involved in the differential modulation of [TG] expression.	c-Jun	HO-1	0	UNDEFINED	False
12172	12391	24760274:0:STAT3:BECN1	[TF] inhibits [TG] expression through recruitment of HDAC3 in nonsmall cell lung cancer cells.	Stat3	Beclin 1	2	REPRESSION	False
12173	12392	24769335:0:NR1I3:FOXO1	[TF]-mediated repression of [TG] transcriptional activity regulates the cell cycle inhibitor p21 in mouse livers.	CAR	Foxo1	2	REPRESSION	False
12174	12393	24769335:5:NR1I3:CDKN1A	Thus, we identified [TF]-mediated repression of cell cycle inhibitor [TG], as mediated by repression of FOXO1 expression and transcriptional activity.	CAR	p21	2	REPRESSION	False
12175	12394	24769335:5:NR1I3:FOXO1	Thus, we identified [TF]-mediated repression of cell cycle inhibitor p21, as mediated by repression of [TG] expression and transcriptional activity.	CAR	FOXO1	2	REPRESSION	False
12176	12395	24782182:7:STAT3:ARID5A	IL-6 induced the expression of [TG] in CD4+ T cells during Th17 cell differentiation by a [TF]-dependent mechanism, whereas IL-6-induced ARID-5A expression was not affected by the absence of RORt, a lineage-specifying transcription factor of Th17 cells.	STAT-3	ARID-5A	1	ACTIVATION	False
12177	12396	24792354:8:LMO2:CD4	[TF] knockdown decreased [TG] expression, while inhibition of intracellular NOTCH1 or histone deacetylase activity induced CD4 expression.	Lmo2	CD4	1	ACTIVATION	False
12178	12397	24792354:9:RUNX1:CD4	Enforced expression of [TF] repressed [TG] expression.	RUNX1	CD4	2	REPRESSION	False
12179	12398	24821727:7:SP1:CDKN1A	PLZF binds to the proximal [TF]-binding GC-box 5/6 and the distal p53-responsive elements of the [TG] promoter to repress transcription.	Sp1	CDKN1A	0	UNDEFINED	True
12180	12399	24836425:4:LEF1:CD4	Furthermore, loss of TCF-1 and [TF] unexpectedly caused derepression of [TG] expression in T cells committed to the CD8(+) lineage without affecting the expression of Runx transcription factors.	LEF-1	CD4	2	REPRESSION	False
12181	12400	24845569:6:ISL1:MYC	We also found that [TF] could activate [TG] transcription not only in pancreatic -cells but also in DLBCL cells.	ISL-1	c-Myc	1	ACTIVATION	False
12182	12401	24847057:4:STAT3:HAS2	Inhibition of JAK2, [TF], or Gi-coupled receptors blocked the induction of [TG] expression by UDP-Glc, the latter inhibitor suggesting that the signaling was triggered by the UDP-sugar receptor P2Y14.	STAT3	HAS2	1	ACTIVATION	False
12183	12402	24849358:3:HSF1:TTR	We now show that [TG] expression in SH-SY5Y human neuroblastoma cells, primary hippocampal neurons and the hippocampus of APP23 mice, is significantly enhanced by heat shock factor 1 ([TF]).	HSF1	TTR	1	ACTIVATION	False
12184	12403	24849358:5:HSF1:TTR	Treating SH-SY5Y human neuroblastoma cells with heat shock or the [TF] stimulator celastrol increased [TG] transcription in parallel with that of HSP40, HSP70, and HSP90.	HSF1	TTR	1	ACTIVATION	False
12185	12404	24849358:6:HSF1:TTR	With both treatments, ChIP showed increased occupancy of heat shock elements in the [TG] promoter by [TF].	HSF1	TTR	0	UNDEFINED	False
12186	12405	24849358:8:HSF1:TTR	Transfection of a human [TF] construct into SH-SY5Y cells increased [TG] transcription and protein production, which could be blocked by shHSF1 antisense.	HSF1	TTR	1	ACTIVATION	False
12188	12407	24872416:7:IRF6:CCL5	Gene silencing in epithelial cells along with gene promoter reporter assays showed that IRAK1 mediates TLR2-inducible [TG] gene expression at least in part by promoting [TF] activation.	IRF6	CCL5	1	ACTIVATION	False
12189	12408	24891320:6:STAT3:KLRK1	Lastly, we show binding of [TF] to a predicted STAT3 binding site upstream of the [TG] gene, which is enhanced by IL-10 and IL-21 and decreased by STAT3 inhibition.	STAT3	NKG2D	0	UNDEFINED	True
12190	12409	24891320:7:STAT3:KLRK1	Taken together, these data show that [TG] expression in NK cells is regulated at the transcriptional level by [TF], resulting in a functional NK cell defect in patients with STAT3 mutations.	STAT3	NKG2D	0	UNDEFINED	False
12191	12410	24895120:7:DNMT3A:TNFRSF12A	Abundance of [TF] (Dnmt3a) and its interaction with [TG] promoter are repressed in denervated skeletal muscle of mice.	DNA methyltransferase 3a	Fn14	0	UNDEFINED	False
12192	12411	24907345:9:STAT1:HTRA1	Dual luciferase reporter assay and chromatin immunoprecipitation analysis showed that [TF] could directly bind to [TG] promoter after IFN- stimulation.	STAT1	HTRA1	0	UNDEFINED	False
12193	12412	24929016:13:GATA4:DLL1	Finally, we found that [TF] occupies chromatin near the [TG] transcription start site suggesting direct regulation of Dll1 by GATA4.	GATA4	Dll1	0	UNDEFINED	False
12194	12413	24946209:4:SP1:SOD1	The transcription factor [TF], which is a major element of the proximal region of the [TG] promoter, was slightly downregulated at the transcriptional level during IAV infection, and subsequently modulated by post-translational control.	Sp1	sod1	0	UNDEFINED	False
12195	12414	24971534:0:ELF3:POU5F1	Transcriptional regulation of [TG] by the ETS transcription factor [TF] in NCCIT human embryonic carcinoma cells.	ESE-1	OCT4	0	UNDEFINED	False
12196	12415	24971534:3:ELF3:POU5F1	In this study, we invested the molecular mechanism by which [TF] regulates transcription of [TG] in NCCIT human embryonic carcinoma cells.	ESE-1	OCT4	0	UNDEFINED	False
12197	12416	24971534:6:ELF3:POU5F1	Promoter-reporter assays revealed that induced [TG] promoter activity in NCCIT cells was significantly down-regulated by [TF] overexpression in a dose-dependent manner.	ESE-1	OCT4	2	REPRESSION	False
12198	12417	24971534:9:ELF3:POU5F1	[TF] interacted with the EBS element in CR2 and enrichment of CR2 significantly increased upon RA-mediated differentiation of NCCIT cells, suggesting that this binding is likely to be involved in ESE-1-mediated repression of [TG] promoter activity upon differentiation.	ESE-1	OCT4	2	REPRESSION	False
12199	12418	24978307:4:MYB:DUSP6	A transfection study using a series of [TG] promoter deletion constructs revealed that the [TF] binding site is required for Ras-induced transcriptional activation of the MKP-3 gene promoter.	c-Myb	MKP-3	1	ACTIVATION	False
12200	12419	24978307:5:MYB:DUSP6	Furthermore, we show that [TF] directly binds to the [TG] promoter, as revealed by electrophoretic mobility shift assay and chromatin immunoprecipitation.	c-Myb	MKP-3	0	UNDEFINED	False
12201	12420	24978307:7:MYB:DUSP6	These findings propose a novel mechanism through which Ras signaling activates [TF]-dependent transcriptional activation of the [TG] gene.	c-Myb	MKP-3	1	ACTIVATION	False
12202	12421	25005473:6:HES1:CDKN1C	Finally, we identify a muscle-specific regulatory element of [TG] directly activated by MRFs in myoblasts but repressed by the Notch targets [TF]/Hey1 in progenitor cells.	Hes1	p57(kip2)	2	REPRESSION	False
12203	12422	25005473:6:HEY1:CDKN1C	Finally, we identify a muscle-specific regulatory element of [TG] directly activated by MRFs in myoblasts but repressed by the Notch targets Hes1/[TF] in progenitor cells.	Hey1	p57(kip2)	2	REPRESSION	False
12204	12423	25024203:7:ETS2:PLA2G16	ChIP analysis revealed that several mutant p53 proteins bind the [TG] promoter at E26 transformation-specific (ETS) binding motifs and knockdown of [TF] suppressed mutant p53 induction of Pla2g16.	ETS2	Pla2g16	1	ACTIVATION	False
12205	12424	25031021:7:GATA6:PPP1R14A	The stretch-induced increase in [TG] expression occurs at the transcriptional level and is associated with CPI-17 promoter binding by [TF] and NF-B, the transcription factors responsible for CPI-17 gene transcription.	GATA-6	CPI-17	1	ACTIVATION	False
12207	12426	25092871:8:NRF1:SLC7A11	Thus, stress-inducible expression of [TG] is a two-step process: under homeostatic conditions, [TF] effectively suppresses nonspecific transactivation of xCT, but when cells encounter severe oxidative/electrophilic stress, Nrf1 is displaced from an antioxidant response element (ARE) in the gene promoter while Nrf2 is recruited to the ARE.	Nrf1	xCT	2	REPRESSION	False
12208	12427	25111898:6:KLF17:CCND1	[TF] suppresses cell migration and invasion by decreasing CD44, PAI-1 and [TG] expressions.	KLF17	Cyclin-D1	2	REPRESSION	False
12209	12428	25111898:6:KLF17:SERPINE1	[TF] suppresses cell migration and invasion by decreasing CD44, [TG] and Cyclin-D1 expressions.	KLF17	PAI-1	2	REPRESSION	False
12210	12429	2512642:4:FOS:PENK	[TF]-Jun complexes bound specifically to a regulatory sequence in the 5' control region of the [TG] gene.	Fos	proenkephalin	0	UNDEFINED	False
12211	12430	25128069:0:POU5F1:CCND1	Transcription factor [TF] promotes cell cycle progression by regulating [TG] expression in esophageal carcinoma.	OCT4	CCND1	0	UNDEFINED	False
12212	12431	25128069:3:POU5F1:CCND1	By analyzing the 5'-UTR region of the [TG] gene, we found that this region contains an octamer motif (ATTTTGCAT), which suggests that the expression of CCND1 might be directly associated with octamer-binding transcription factor 4 ([TF]).	OCT4	CCND1	0	UNDEFINED	False
12213	12432	25128069:4:POU5F1:CCND1	In this study, the wild-type and the octamer motif-mutanted [TG] promoters were cloned, and their corresponding luciferase reporter vectors were then constructed to study the molecular mechanism by which [TF] regulates the expression of CCND1 and influences the biological behaviors of esophageal cancer cells.	OCT4	CCND1	0	UNDEFINED	False
12214	12433	25128069:6:POU5F1:CCND1	Suppression of [TF] expression significantly decreased the wild-type [TG] promoter activity and down-regulated the expression of CCND1, but did not affect the activity of the mutant promoter.	OCT4	CCND1	1	ACTIVATION	False
12216	12435	25128069:8:POU5F1:CCND1	The results revealed and confirmed that [TF] is the upstream factor that directly binds to the [TG] promoter to regulate CCND1 expression, then to promote cell cycle progression and accelerate the proliferation and invasion of esophageal cancer cells.	OCT4	CCND1	0	UNDEFINED	False
12217	12436	25339983:6:FOSL1:MMP1	Overexpression of [TF] also caused increased [TG] expression.	Fra-1	MMP-1	1	ACTIVATION	False
12218	12437	25379405:6:CREB1:CDKN1A	Mechanistically, we find that [TF] regulates expression of the pro-apoptotic gene p21 ([TG]) in -cells, thus demonstrating that CREB is essential to mediating this critical aspect of GLP-1 receptor signaling.	CREB	Cdkn1a	0	UNDEFINED	False
12219	12438	2690103:8:FOS:PADI4	These findings suggest that four mechanisms may participate in the regulation of the [TG] gene: the stress-related heat shock; the [TF]/Fos binding; the GC-rich element, and the possible methylation of the CpG region.	AP-1	PAD	0	UNDEFINED	False
12220	12439	2786140:3:FOXM1:TTR	One of these new factors, hepatocyte nuclear factor 3 ([TF]), binds to two sites that are crucial in [TG] expression as well as to two additional sites in the alpha 1-AT proximal enhancer region.	HNF-3	TTR	1	ACTIVATION	False
12221	12440	3945313:0:SP1:DHFR	Transcription factor [TF] recognizes a DNA sequence in the [TG] promoter.	Sp1	mouse dihydrofolate reductase	0	UNDEFINED	False
12222	12441	3945313:6:SP1:DHFR	Our results suggest that in addition to its interactions with the SV40 viral promoter, one function of [TF] is to direct the expression of the cellular [TG] gene.	Sp1	DHFR	1	ACTIVATION	False
12223	12442	7479001:6:TP53:SERPINE1	In contrast, wild-type but not mutant [TF] specifically binds to and activates the promoter of the plasminogen activator inhibitor type-1 ([TG]) gene.	p53	PAI-1	1	ACTIVATION	False
12224	12443	7479001:7:TP53:SERPINE1	Interestingly, one of the [TF] mutants (273his) inhibited [TG] promoter activity.	p53	PAI-1	1	ACTIVATION	False
12225	12444	7487103:7:AP1:SLC2A2	Several potential binding sites for transcription factors such as C/EBP, Sp1, [TF], HNF-5, and UPE were observed and they may be responsible for the regulation of [TG] gene expression.	AP1	GLUT2	0	UNDEFINED	False
12226	12445	7524494:8:FOXM1:IGFBP1	[TF] binding at this site may play an important role in the multihormonal regulation of hepatic [TG] gene expression.	HNF-3	IGFBP-1	0	UNDEFINED	False
12227	12446	7526316:0:MYC:CCND1	[TF] induces [TG] expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle.	Myc	cyclin D1	1	ACTIVATION	False
12228	12447	7543095:7:CEBPB:FAS	The results suggest that [TF] is activated upon influenza virus infection through post-translational modification and that the modified factor stimulates the transcription of the [TG] gene.	NF-IL6	human FAS	1	ACTIVATION	False
12229	12448	7556883:3:AP1:CRABP1	Using a lacZ reporter system, it was determined that a DNA fragment containing a putative [TF] in the promoter region of [TG] gene is required for the up-regulation of CRABP-I gene transcription.	AP-1 binding site	CRABP-I	1	ACTIVATION	False
12230	12449	7557993:8:SP1:RRM1	The data presented suggest that [TF] is involved in the transcription of [TG].	Sp1	RRM1	0	UNDEFINED	True
12231	12450	7559449:0:REL:SELP	Regulation of the human [TG] promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/[TF] family.	Rel	P-selectin	0	UNDEFINED	False
12232	12451	7559449:8:REL:SELP	Mutations that eliminated binding to NF-kappa B/[TF] proteins reduced by approximately 40% the expression of a reporter gene driven by the [TG] promoter in transfected bovine aortic endothelial cells.	Rel	P-selectin	1	ACTIVATION	False
12233	12452	7559553:7:SP1:MYB	We showed that WT1, EGR-1, and [TF] bound to this site, and that mutation of this site increased the activity of the [TG] promoter by 3.2-fold.	Sp1	c-myb	2	REPRESSION	False
12234	12453	7592627:9:FOXM1:PROC	Transient transfection experiments demonstrated that the binding of [TF] to the [TG] promoter is of physiological significance.	HNF-3	protein C	0	UNDEFINED	False
12236	12455	7623817:0:GATA2:EDN1	Cooperative interaction of [TF] and AP1 regulates transcription of the [TG] gene.	GATA-2	endothelin-1	0	UNDEFINED	False
12237	12456	7636248:10:RELA:IL2RA	The data support the model that c-rel/p50 or [TF] can cooperate with SRF to specifically target the expression of the [TG] gene in activated T cells.	p65	IL-2R alpha	0	UNDEFINED	False
12238	12457	7678251:6:NFKB:ITGAX	Several putative binding sequences for ubiquitous (Sp1, AP-1, AP-2, and [TF]) and leukocyte-specific (PU.1) transcription factors have been identified in the proximal region of the [TG] promoter which may participate in the regulation of the expression of p150,95.	NF-kB	CD11c	0	UNDEFINED	False
12239	12458	7680653:6:POU2F1:CR2	Cross competition experiments with an octamer sequence from the Ig heavy chain promoter, the BAT box, and a TA-rich sequence present in the [TG] promoter revealed that all three sequences bound the same nuclear proteins suggesting that the BAT box binding proteins were [TF] and Oct-2.	Oct-1	CD21	0	UNDEFINED	False
12240	12459	7699993:0:POU1F1:REN	A [TF] binding site in the human [TG] gene promoter stimulates activity in pituitary, placental and juxtaglomerular cells.	Pit-1	renin	1	ACTIVATION	False
12241	12460	7699993:5:POU1F1:REN	Thus, [TF] may be play a role in directing the expression of [TG] to primate lactotrope cells.	Pit-1	renin	1	ACTIVATION	False
12242	12461	7700652:0:MAX:MYC	Analysis of c-Myc and [TF] binding to the [TG] promoter: evidence that autosuppression occurs via an indirect mechanism.	Max	c-myc	0	UNDEFINED	True
12243	12462	7706280:6:RELA:SAA1	Activated C/EBP and [TF] form a RelA-C/EBP heteromeric complex that associates with varying affinity to NF-kappa B and C/EBP elements of the [TG] gene.	RelA	SAA	0	UNDEFINED	False
12244	12463	7721872:7:CREB1:PCNA	Using DNA binding gel mobility shift assay we demonstrated that rapamycin potently inhibited the binding of [TF]/ATF transcription factors to CRE elements in the murine proximal [TG] promoter.	CREB	PCNA	0	UNDEFINED	False
12246	12465	7753559:7:SP1:MYC	Finally, we found that [TF] and E2F-1/DP-1 cooperatively trans-activate [TG] promoter.	Sp1	c-myc	1	ACTIVATION	False
12247	12466	7753559:7:TFDP1:MYC	Finally, we found that Sp1 and E2F-1/[TF] cooperatively trans-activate [TG] promoter.	DP-1	c-myc	1	ACTIVATION	False
12248	12467	7760814:0:MAZ:CD4	A [TF] binding site is one of four important functional regions in the [TG] promoter.	Myc-associated zinc finger protein	CD4	0	UNDEFINED	False
12249	12468	7760814:7:MAZ:CD4	We therefore believe that the [TF] transcription factor is also likely to play an important role in the control of developmental expression of the [TG] gene.	MAZ	CD4	0	UNDEFINED	False
12250	12469	7772049:10:HNF1A:C4BPA	We speculate that this extreme requirement of [TF] for the activity of the human [TG]A promoter is related to the fact that this promoter lacks a TATA box.	HNF1	C4BP	1	ACTIVATION	False
12251	12470	7772049:9:HNF1A:C4BPA	This region is absolutely required for the activity of this promoter, suggesting that [TF] is essential for the hepatic activity of the [TG]A promoter.	HNF1	C4BP	1	ACTIVATION	False
12252	12471	7862129:10:FOXA1:TTR	In acute-phase livers, we observed a dramatic reduction in [TF] expression which correlates with a decrease in the expression of its target gene, the [TG] gene.	HNF-3 alpha	TTR	1	ACTIVATION	False
12254	12473	7862129:4:AP1:TTR	In the current study, we identify an activating protein 1 ([TF]) site which partially overlaps the HNF-3S sequence in the [TG] promoter.	AP-1	TTR	0	UNDEFINED	False
12255	12474	7862129:4:FOXM1:TTR	In the current study, we identify an activating protein 1 (AP-1) site which partially overlaps the [TF]S sequence in the [TG] promoter.	HNF-3	TTR	0	UNDEFINED	False
12256	12475	7869034:10:NFKB1:MYC	In cotransfection analysis, p65 and c-Rel expression potently and modestly transactivated the [TG] promoter, respectively, whereas, overexpression of the [TF] subunit caused a significant drop in its activity.	p50	c-myc	2	REPRESSION	False
12257	12476	7869034:10:REL:MYC	In cotransfection analysis, p65 and c-[TF] expression potently and modestly transactivated the [TG] promoter, respectively, whereas, overexpression of the p50 subunit caused a significant drop in its activity.	Rel	c-myc	1	ACTIVATION	False
12258	12477	7869034:10:RELA:MYC	In cotransfection analysis, [TF] and c-Rel expression potently and modestly transactivated the [TG] promoter, respectively, whereas, overexpression of the p50 subunit caused a significant drop in its activity.	p65	c-myc	1	ACTIVATION	False
12259	12478	7887961:1:AP1:VEGFA	In this study, we investigated the functional role of the transcription factor [TF] in hypoxia-induced expression of the vascular endothelial growth factor ([TG]) by using dexamethasone as an inhibitor of AP-1 activity.	AP-1	VEGF	1	ACTIVATION	True
12261	12480	7923608:4:POU1F1:REN	Accordingly, the binding site for the pituitary-specific transcription factor ([TF]) was the major determinant of [TG] promoter activity in both pituitary and placental cells.	Pit-1	renin	1	ACTIVATION	False
12262	12481	7925656:8:FOXM1:TTR	[TF] beta stimulation upon visceral endoderm differentiation is accompanied by the activation of HNF-3 target genes such as [TG], suggesting that HNF-3 beta is involved in the developmental activation of this gene.	HNF-3	transthyretin	1	ACTIVATION	False
12263	12482	7945330:0:POU2F1:ZFP42	The octamer motif present in the [TG] promoter binds [TF] and Oct-3 expressed by EC cells and ES cells.	Oct-1	Rex-1	0	UNDEFINED	False
12264	12483	7957928:0:REL:ICAM1	Synergistic activation of intercellular adhesion molecule 1 ([TG]) by TNF-alpha and IFN-gamma is mediated by p65/p50 and p65/[TF] and interferon-responsive factor Stat1 alpha (p91) that can be activated by both IFN-gamma and IFN-alpha.	c-Rel	ICAM-1	1	ACTIVATION	False
12265	12484	7959007:5:RELA:SAA3P	The results show that, while the expression of [TF] alone strongly transactivated a [TG] gene, p50 did not induce a significant transactivation, and NFIL-6 and C/EBP-alpha induced only a marginal transactivation when expressed alone.	p65	SAA3	1	ACTIVATION	False
12266	12485	7969116:9:JUND:NR4A1	(ii) [TF], but not other Fos/Jun family members, specifically transactivates the [TG] promoter through the NAP elements (iii) A dominant-negative mutant of JunD effectively abolishes the activation of nur77 by either NGF treatment or membrane depolarization.	JunD	nur77	1	ACTIVATION	False
12267	12486	7998973:10:CREB1:LDHA	This study emphasizes a fundamental role of several modules including Sp1 and [TF] binding sites in regulating basal and cAMP-mediated transcriptional activity of the [TG] gene.	CREB	LDH A	0	UNDEFINED	False
12268	12487	8016102:0:TFAP2A:HMOX1	Identification of binding sites for transcription factors NF-kappa B and [TF] in the promoter region of the [TG] gene.	AP-2	human heme oxygenase 1	0	UNDEFINED	False
12269	12488	8029022:9:FOXA1:TTR	[TF] stimulation upon visceral endoderm differentiation is accompanied by the activation of HNF-3 target genes such as [TG], suggesting that HNF-3 alpha is involved in the developmental activation of this gene.	HNF-3 alpha	transthyretin	1	ACTIVATION	False
12270	12489	8029022:9:FOXM1:TTR	[TF] alpha stimulation upon visceral endoderm differentiation is accompanied by the activation of HNF-3 target genes such as [TG], suggesting that HNF-3 alpha is involved in the developmental activation of this gene.	HNF-3	transthyretin	1	ACTIVATION	False
12271	12490	8051100:8:CEBPB:DDIT3	Support for the functional role of this C/EBP-binding site and its interaction with C/EBPs in regulating [TG] expression was obtained with cultured HepG2 hepatoma cells in which overexpression of [TF] was found to transactivate expression of a plasmid containing the GADD153 promoter linked to a reporter gene.	C/EBP beta	GADD153	1	ACTIVATION	False
12272	12491	8065357:0:YY1:SAA1	[TF] represses [TG] gene transcription and is antagonized by NF-kappa B during acute-phase response.	YY1	rat serum amyloid A1	2	REPRESSION	False
12273	12492	8065357:7:YY1:SAA1	Consistent with its presumed antagonistic role to NF-kappa B, [TF] exerted a negative effect on [TG] expression, whereas disruption of its binding in the promoter elevated basal and cytokine-induced activities.	YY1	SAA1	2	REPRESSION	False
12274	12493	8101632:5:FOXA1:TAT	Analyses with the dedifferentiated hepatoma cell line HTC suggested that [TF]/or -gamma, but not HNF3 beta, are involved in activating the [TG] gene via the -11-kb enhancer.	HNF3 alpha and	tyrosine aminotransferase	1	ACTIVATION	False
12275	12494	8108142:0:TP53:VEGFA	Mutant [TF] potentiates protein kinase C induction of [TG] expression.	p53	vascular endothelial growth factor	2	REPRESSION	False
12276	12495	8108142:5:TP53:VEGFA	Mutant [TF] specifically increases TPA induction of [TG] without affecting the expression of other TPA inducible genes.	p53	VEGF	2	REPRESSION	False
12277	12496	8119953:3:ATF2:TGFB2	Recently, we demonstrated that pRb activates expression of the [TG] gene through [TF].	ATF-2	human transforming growth factor-beta 2	1	ACTIVATION	False
12278	12497	8123590:6:JUN:NPY	Competition for DNA binding using [TF], AP-2, and Sp1 consensus sequences and an anti-cJun antibody, respectively, revealed cooperative interactions between AP-1, AP-2, and Sp1 transcription factors and the [TG] promoter.	AP-1	NPY	0	UNDEFINED	False
12279	12498	8123597:3:JUN:PLAU	p26 m[TF] was able to block both 12-O-tetradecanoylphorbol-13-acetate (TPA) and okadaic acid induced expression of the mouse stromelysin gene in 10Gy5 cells and TPA induced expression of the [TG] gene in PDV cells as determined by Northern analyses.	JUN	urokinase-type plasminogen activator	1	ACTIVATION	True
12280	12499	8164678:8:EWSR1:MYC	We show that [TF]-FLI-1 is a transactivator of the [TG] promoter, suggesting that upregulation of c-myc expression is under control of EWS-FLI-1.	EWS	c-myc	1	ACTIVATION	False
12281	12500	8164678:8:FLI1:MYC	We show that EWS-[TF] is a transactivator of the [TG] promoter, suggesting that upregulation of c-myc expression is under control of EWS-FLI-1.	FLI-1	c-myc	1	ACTIVATION	False
12282	12501	8196642:3:MYC:CCND1	In particular, we found that association with Max is not required for repression of [TG] by [TF] in vivo.	MYC	cyclin D1	2	REPRESSION	False
12283	12502	8196642:9:MYC:CCND1	Taken together, our data define a new pathway for gene regulation by [TF] and show that the [TG] gene is a target gene for repression by MYC.	MYC	cyclin D1	2	REPRESSION	False
12284	12503	8206951:6:JUN:IGF1	In conclusion, our present observations demonstrate that the chicken [TG] gene promoter is controlled by estrogen through a unique pathway involving Fos, [TF], and the DNA binding domain of ER.	Jun	IGF-I	0	UNDEFINED	False
12285	12504	8216221:7:FOXM1:SCGB1A1	Taken together, these results suggest a role for [TF] in mediating cell-specific [TG] gene expression within the bronchiolar epithelium.	HNF-3	CCSP	1	ACTIVATION	False
12286	12505	8246978:1:CTCF:MYC	A novel sequence-specific DNA-binding protein, [TF], which interacts with the chicken [TG] gene promoter, has been identified and partially characterized (V. V. Lobanenkov, R. H. Nicolas, V. V. Adler, H. Paterson, E. M. Klenova, A. V. Polotskaja, and G. H. Goodwin, Oncogene 5:1743-1753, 1990).	CTCF	c-myc	0	UNDEFINED	False
12287	12506	8247540:0:POU2F1:ETS1	PEA3, [TF] and Oct 2 positively regulate the human [TG] promoter.	Oct 1	ETS1	1	ACTIVATION	False
12288	12507	8247540:0:POU2F2:ETS1	PEA3, Oct 1 and [TF] positively regulate the human [TG] promoter.	Oct 2	ETS1	1	ACTIVATION	False
12289	12508	8247540:1:SP1:ETS1	The promoter of the human [TG] gene contains binding site motifs for transcription factors [TF], Ap1, Ap2, ETS, PEA3 and Oct.	Sp1	ETS1	0	UNDEFINED	False
12290	12509	8247540:6:POU2F1:ETS1	Reporter plasmids containing different deletion mutants of the [TG] promoter were used to examine the effect of different transcription factors (PEA3, [TF] and Oct 2) upon the expression of the ETS1 gene.	Oct 1	ETS1	0	UNDEFINED	False
12291	12510	8247540:6:POU2F2:ETS1	Reporter plasmids containing different deletion mutants of the [TG] promoter were used to examine the effect of different transcription factors (PEA3, Oct 1 and [TF]) upon the expression of the ETS1 gene.	Oct 2	ETS1	0	UNDEFINED	False
12292	12511	8268720:5:EGR4:SERPINE2	The rat GDN/[TG] promoter contains five SP1 consensus sites, four consensus sites for the MyoD1 transcription factor, and one binding site for the transcription factors NGFI-A, [TF], Krox-20, and Wilms tumor factor.	NGFI-C	PN-1	0	UNDEFINED	False
12293	12512	8268720:5:SP1:SERPINE2	The rat GDN/[TG] promoter contains five [TF], four consensus sites for the MyoD1 transcription factor, and one binding site for the transcription factors NGFI-A, NGFI-C, Krox-20, and Wilms tumor factor.	SP1 consensus sites	PN-1	0	UNDEFINED	False
12294	12513	8270002:2:MYB:CDK1	Our DNA sequencing data indicate that the promoter region of the [TG] gene contains putative E2F-like binding sites which are recognized by Rb and binding sites for [TF], Sp1, and ATF, and that the promoter region of the cyclin A gene contains binding sites for p53, Sp1, and ATF.	c-myb	p34cdc2	0	UNDEFINED	False
12295	12516	8289783:6:SP1:POU5F1	We identified a novel cis element in the [TG] promoter harbors a putative [TF] binding site and a RA-responsive element (designated RAREoct), which are juxtaposed to one another.	Sp1	Oct-3/4	0	UNDEFINED	False
12296	12518	8289784:7:NFKB:MYC	Classical [TF] (p65/p50) was a potent transcriptional activator of the [TG] promoter.	NF-kappa B	c-myc	1	ACTIVATION	False
12297	12520	8289784:7:RELA:MYC	Classical NF-kappa B ([TF]/p50) was a potent transcriptional activator of the [TG] promoter.	p65	c-myc	1	ACTIVATION	False
12298	12521	8289793:7:NR2F6:POU5F1	Cotransfected orphan receptors COUP-TF1, ARP-1, and [TF] were able to repress the activity of [TG] promoter-driven reporters in P19 EC cells, albeit with different efficiencies.	EAR-2	Oct4	2	REPRESSION	False
12299	12522	8342330:9:AP1:SERPINE1	Gel electrophoresis of double stranded -65 to -50 oligonucleotides of the [TG] promoter region and nuclear extracts from HeLa cells produced a gel shift pattern, similar to that obtained with a [TF] consensus oligomer, and excess unlabeled AP-1 oligomer reverted binding suggesting that this region of the PAI-1 promoter is an AP-1-like binding site.	AP-1	PAI-1	0	UNDEFINED	False
12300	12523	8355705:0:TCF12:CD4	A heterodimer of [TF] and an E12-related protein interacts with the [TG] enhancer and regulates its activity in T-cell lines.	HEB	CD4	0	UNDEFINED	False
12301	12524	8375015:4:FOS:NQO1	The high level of expression of the [TG] gene and its induction by beta-NF and BHA require the presence of an [TF] binding site contained within the human Antioxidant Response Element (hARE) and are mediated by products of proto-oncogenes, Jun and Fos.	AP1	NQO1	1	ACTIVATION	False
12302	12525	8413214:9:EGR1:NR4A1	Furthermore, we show that [TF] can activate transcription of the [TG] promoter, suggesting that it may play a role in the delayed-early expression of nur77.	Zif268	nur77	1	ACTIVATION	False
12303	12526	8417355:6:JUN:NPPA	In transient cotransfection assays, [TF] and fos were able to trans-repress the [TG] promoter in both quiescent and alpha 1-adrenergic stimulated myocytes.	jun	ANF	2	REPRESSION	False
12304	12527	8420924:5:POU1F1:REN	Transfection of a [TF] expression construct into HeLa cells, where activity of the human [TG] promoter is low, stimulates expression of cotransfected renin-luciferase constructs.	Pit-1	renin	1	ACTIVATION	False
12305	12528	8420924:7:POU1F1:REN	Taken together, these data strongly suggest that [TF] activates pituitary [TG] gene expression.	Pit-1	renin	1	ACTIVATION	False
12306	12529	8420924:8:POU1F1:REN	This finding raises the possibility that member(s) of the POU family of transcription factors, of which [TF] is an archetypal member, may direct [TG] expression in other tissues, including the kidney.	Pit-1	renin	1	ACTIVATION	False
12307	12530	8420994:0:MYB:CDK1	c-myb transactivates [TG] expression via [TF] binding sites in the 5'-flanking region of the human cdc2 gene.	Myb	cdc2	1	ACTIVATION	False
12308	12531	8430069:7:RELA:IL2RA	Together, these findings suggest that one function of c-Rel is as a physiologic repressor of the HIV-1 LTR and [TG] promoters, serving to efficiently counter the strong transcriptional activating effects of [TF].	p65	IL-2R alpha	1	ACTIVATION	True
12309	12532	8437848:8:SP1:MYC	The data suggest that the high transcription level of the endogenous [TG] gene in Xenopus oocytes is mediated by [TF] or a related transcription factor.	Sp1	c-myc	1	ACTIVATION	False
12310	12533	8439327:0:AP1:IGF1	An [TF] mediates TPA-induced transcriptional activation of the chicken [TG] gene.	AP-1 enhancer	insulin-like growth factor I	1	ACTIVATION	False
12311	12534	8510925:0:ETS1:GATA1	Transactivation of [TG] promoter with [TF], ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.	ETS1	GATA-1	1	ACTIVATION	False
12312	12535	8510925:10:ETS1:GATA1	Additionally, we show that the transcription of a reporter gene (CAT) either linked to the [TG] EBS palindrome or GATA-1 promoter can be activated by cotransfection with [TF], alternatively-spliced ETS1, ETS2 or ERGB/Hu-FLI-1 expression vectors.	ETS1	GATA-1	1	ACTIVATION	False
12313	12536	8521408:0:TP53:VEGFA	Wild-type [TF] and v-Src exert opposing influences on human [TG] gene expression.	p53	vascular endothelial growth factor	0	UNDEFINED	False
12314	12537	8521408:4:TP53:VEGFA	Wild-type [TF] down-regulated endogenous [TG] mRNA level, as well as VEGF promoter activity, in a dose-dependent manner, whereas mutant forms of p53 had no effect.	p53	VEGF	2	REPRESSION	False
12315	12538	8530399:3:WT1:EGR1	We found that the transcriptional effect of [TF] on the [TG] promoter could be modulated by the use of expression vectors containing different promoters.	WT1	Egr1	0	UNDEFINED	False
12316	12539	8530399:4:WT1:EGR1	[TF] activated the [TG] promoter when expression of WT1 was driven by the Rous sarcoma virus promoter.	WT1	Egr1	1	ACTIVATION	False
12317	12540	8530399:5:WT1:EGR1	In contrast, a cytomegalovirus (CMV) promoter-containing [TF] expression vector repressed the [TG] promoter.	WT1	Egr1	2	REPRESSION	False
12318	12541	8530399:7:WT1:EGR1	Co-transfection of the parental CMV-based vector strongly depressed the basal activity of the [TG]-CAT reporter, suggesting that the CMV promoter competes with the Egr1 promoter for transcription factors or co-factors which may be required for activation by [TF].	WT1	Egr1	1	ACTIVATION	False
12319	12542	8550592:6:POU1F1:TSHB	While [TF] appears necessary for [TG] promoter activity in thyrotropes, this transcription factor is not alone sufficient for promoter activity in pituitary-derived cells.	Pit-1	TSH beta	1	ACTIVATION	False
12320	12543	8552092:10:SP1:DHFR	Together, these results indicate that [TF] and the species of E2F that binds TTTGGCGC participate in the formation of a basal transcription complex, while the species of E2F that binds TTTCGCGC regulates [TG] gene expression during the G1-to-S phase transition.	Sp1	dhfr	0	UNDEFINED	False
12321	12544	8552398:10:MYC:CCND1	Our results support a cross-regulatory mechanism between [TF], pRb and [TG] and suggest a novel role for cyclin D1 in tumorigenesis.	Myc	cyclin D1	0	UNDEFINED	False
12322	12545	8552602:0:NRL:RHO	The basic motif-leucine zipper transcription factor [TF] can positively regulate [TG] gene expression.	Nrl	rhodopsin	1	ACTIVATION	False
12323	12546	8554386:0:TEAD1:IVL	Repression of [TG] gene expression by transcriptional enhancer factor 1 ([TF]).	TEF-1	involucrin	2	REPRESSION	False
12324	12547	8554386:5:TEAD1:IVL	To examine the possible regulatory mechanism of [TG] gene expression by [TF] protein, we analysed involucrin promoter activity of the INV-CAT vector, which was constructed by connecting the 5' upstream region of the involucrin gene (-801 bp upstream from the transcription start site and downstream including the untranslated first exon) to the chloramphenicol acetyltransferase (CAT) reporter gene.	TEF-1	involucrin	0	UNDEFINED	False
12325	12548	8554386:9:TEAD1:IVL	This suggests that [TF]-induced repression is due to interference/squelching of a limiting transcriptional intermediary factor that is essential for [TG] expression.	TEF-1	involucrin	2	REPRESSION	False
12326	12549	8554599:6:NFKB:SELE	Electrophoretic mobility gel shift analysis confirmed increased binding of nuclear proteins from irradiated endothelial cells to the [TF] binding sequence from the [TG] promoter.	NFkB	E-selectin	0	UNDEFINED	False
12327	12550	8557686:7:AP1:TIMP1	These results suggest that [TF] tethers c-Ets-1 to the [TG] promoter via protein-protein interaction to achieve Ets-dependent transcriptional regulation.	AP-1	TIMP-1	0	UNDEFINED	False
12328	12551	8557703:0:SP1:CDKN1A	The role of the transcription factor [TF] in regulating the expression of the [TG]/CIP1 gene in U937 leukemic cells.	Sp1	WAF1	0	UNDEFINED	False
12329	12552	8557703:8:SP1:CDKN1A	The [TG]/CIP1 promoter is also highly induced by exogenous [TF] in the Sp1-deficient Drosophila Schnieder SL 2 cell line.	Sp1	WAF1	1	ACTIVATION	False
12330	12553	8557703:9:SP1:CDKN1A	These results suggest that phorbol ester and okadaic acid activate transcription of the [TG]/CIP1 promoter through a complex of proteins that includes [TF] and basal transcription factors.	Sp1	WAF1	1	ACTIVATION	False
12331	12554	8559663:5:AP1:TIMP1	Binding sites for both [TF] and STAT3 are necessary for full responsiveness of the [TG] promoter to IL-6/OSM, as shown by deletion and mutation analysis.	AP-1	TIMP-1	1	ACTIVATION	False
12332	12555	8559663:5:STAT3:TIMP1	Binding sites for both AP-1 and [TF] are necessary for full responsiveness of the [TG] promoter to IL-6/OSM, as shown by deletion and mutation analysis.	STAT3	TIMP-1	1	ACTIVATION	False
12333	12556	8564971:12:TP53:BAX	Cotransfection assays with wild-type or mutant [TF] expression plasmids and a reporter gene plasmid that utilized the [TG] gene promoter to drive transcription of chloramphenicol acetyltransferase were consistent with the role of p53 in regulation of bax expression in these cells.	p53	bax	0	UNDEFINED	False
12334	12557	8592520:10:FOS:POMC	However, deletion of this major exonic [TF] site from the [TG] constructs greatly reduced the effect of c-fos overexpression but did not suppress POMC stimulation by CRH, indicating that CRH stimulates POMC transcription by one or more cFos-independent mechanism(s).	AP1	POMC	1	ACTIVATION	False
12335	12558	8592520:3:FOS:POMC	Using the corticotrope-derived AtT20 cell line, we have previously shown that overexpression of c[TF] stimulates [TG] transcription.	Fos	POMC	1	ACTIVATION	False
12336	12559	8602863:4:FOXE1:TPO	The transcriptional activities of [TG] promoter mutants impaired in either [TF] or HNF-3beta binding suggest that both factors participate in regulating transcription from the TPO promoter.	TTF-2	TPO	0	UNDEFINED	False
12337	12560	8613256:0:RELA:AGT	Tumor necrosis factor activates [TG] gene expression by the [TF] transactivator.	Rel A	angiotensinogen	1	ACTIVATION	False
12338	12561	8613256:16:NFKB1:AGT	We conclude that Rel A:[TF] is a crucial cytokine-inducible transcription factor complex regulating [TG] gene synthesis in hepatocytes and may be involved in controlling the activity of the renin-angiotensin system.	NF-kappaB1	angiotensinogen	0	UNDEFINED	False
12339	12562	8613256:16:RELA:AGT	We conclude that [TF]:NF-kappaB1 is a crucial cytokine-inducible transcription factor complex regulating [TG] gene synthesis in hepatocytes and may be involved in controlling the activity of the renin-angiotensin system.	Rel A	angiotensinogen	0	UNDEFINED	False
12340	12563	8621550:7:HNF4A:MST1	Gel mobility shift experiments with antibodies against hepatocyte nuclear factor-4 ([TF]) and transactivation of the [TG] promoter by a HNF-4 cDNA expression vector suggest that HNF-4 binds to the -135/-105 region and is responsible for the liver-specific expression of HGFL.	HNF-4	HGFL	1	ACTIVATION	False
12341	12564	8622648:6:SP1:DHFR	This effect was reflected in the hyperoxidative repression of transcription from promoters with essential [TF] binding sites, including the simian virus 40 early region, glycolytic enzyme, and [TG] genes.	Sp-1	dihydrofolate reductase	2	REPRESSION	False
12342	12565	8628294:1:FUBP1:MYC	The far-upstream element-binding protein ([TF]) is one of several recently described factors which bind to a single strand of DNA in the 5' region of the [TG] gene.	FBP	c-myc	0	UNDEFINED	False
12343	12566	8628294:2:FUBP1:MYC	Although cotransfection of [TF] increases expression from a far-upstream element-bearing [TG] promoter reporter, the mechanism of this stimulation is heretofore unknown.	FBP	c-myc	1	ACTIVATION	False
12344	12567	8632147:7:FOS:PENK	These results suggest that Fos and/or other components of [TF] transcription factors, rather than CREB or other preexisting proteins, play a specific role in the induction of the [TG] gene in bovine chromaffin cells.	AP-1	proenkephalin	1	ACTIVATION	False
12345	12568	8632766:8:POU2F1:CYP1A1	The results indicate that [TF] binds to the rat [TG] promoter NRE and is a negative regulator of rat CYP1A1 expression.	Oct-1	CYP1A1	2	REPRESSION	False
12346	12569	8645191:0:POU1F1:REN	Transcriptional induction of the human [TG] gene by cyclic AMP requires cyclic AMP response element-binding protein (CREB) and a factor binding a pituitary-specific trans-acting factor ([TF]) motif.	Pit-1	renin	1	ACTIVATION	False
12347	12570	8645191:5:POU1F1:REN	Taken together, these results demonstrate that the cAMP response of the human [TG] gene may involve CREB binding the CRE and tissue-specific factors, different from [TF], that interact with the Pit-1 response DNA elements.	Pit-1	renin	0	UNDEFINED	False
12348	12571	8648097:12:MYC:CDK2	These results suggest that [TF] may be a component of the signaling pathway that induces cyclin E and [TG] expression.	c-myc	cdk2	1	ACTIVATION	False
12349	12572	8649389:10:CTCF:MYC	Gel shift assays utilizing successively deleted Zn finger domains indicate that [TF] Zn fingers 2 to 7 are involved in binding to the chicken [TG] promoter, while fingers 3 to 11 mediate CTCF binding to the human promoter.	CTCF	c-myc	0	UNDEFINED	False
12350	12573	8649389:6:CTCF:MYC	Mutational analysis of the P2-proximal [TF] binding site and transient-cotransfection experiments demonstrate that CTCF is a transcriptional repressor of the human [TG] gene.	CTCF	c-myc	2	REPRESSION	False
12351	12574	8649389:7:CTCF:MYC	Although there is 100% sequence identity in the DNA binding domains of the avian and human [TF] proteins, the regulatory sequences recognized by CTCF in chicken and human [TG] promoters are clearly diverged.	CTCF	c-myc	0	UNDEFINED	False
12352	12575	8649389:8:CTCF:MYC	Mutating the contact nucleotides confirms that [TF] binding to the human [TG] P2 promoter requires a number of unique contact DNA bases that are absent in the chicken c-myc CTCF binding site.	CTCF	c-myc	0	UNDEFINED	False
12353	12576	8649821:6:ETS1:TP53	This report shows that the EBS palindrome of the human [TG] promoter has a high affinity for [TF] and ETS2 and that such binding interaction intracellularly is able to activate the transcription of a CAT reporter gene by 5-10-fold using COS cells.	ETS1	p53	1	ACTIVATION	False
12354	12577	8649821:6:ETS2:TP53	This report shows that the EBS palindrome of the human [TG] promoter has a high affinity for ETS1 and [TF] and that such binding interaction intracellularly is able to activate the transcription of a CAT reporter gene by 5-10-fold using COS cells.	ETS2	p53	1	ACTIVATION	False
12356	12579	8662954:9:CEBPB:DDIT3	Forced expression of [TF] was found to be capable of transactivating the [TG] promoter in PC12 cells cotransfected with plasmids expressing a GADD153 reporter gene and C/EBP-beta protein.	C/EBP-beta	GADD153	1	ACTIVATION	False
12357	12580	8666932:7:EGR1:ICAM1	A direct effect of [TF] on the [TG] promoter is suggested by the ability of EGR1 expressed from an SV40-driven expression vector transactivate the wild-type Icam-1 promoter, whereas mutation of the EGR1 mutation of the EGR1 binding motif at -701 bp markedly compromises this induction.	EGR1	Icam-1	1	ACTIVATION	False
12358	12581	8672239:5:HLTF:SERPINE1	In vitro transcription from the [TG] promoter in HeLa cell extracts was inhibited by [TF] antibodies and by the HLTF DNA binding domain.	HLTF	PAI-1	1	ACTIVATION	False
12359	12582	8729008:9:POU2F1:CYP1A1	HepG2 human hepatoma cells were transfected with both pMCoLUC+ which contains the luciferase gene as a reporter gene driven by the [TG] promoter (including the NRE), and an [TF] expression vector.	Oct-1	CYP1A1	0	UNDEFINED	True
12360	12583	8756616:10:ARNT:VEGFA	[TG] mRNA was not induced by hypoxia in mutant cells that do not express the [TF] (ARNT) subunit.	HIF-1beta	VEGF	1	ACTIVATION	False
12361	12584	8764572:10:CREM:ADRB1	These data demonstrate that [TF] can interact at the [TG] promoter to repress transcription.	ICER	beta1AR	2	REPRESSION	False
12362	12585	8764572:2:CREM:ADRB1	Our studies characterize the regulation of [TF] in C6 glioma cells and investigate its role in repressing transcription of the [TG] (beta1AR) gene.	ICER	beta1-adrenergic receptor	2	REPRESSION	False
12363	12586	8764573:11:SP1:SERPINE2	Cotransfection experiments into the [TF]-deficient Drosophila SL2 cell line also showed that Sp1 activates [TG] promoter activity in a dose-dependent fashion.	Sp1	PN-1	1	ACTIVATION	False
12364	12587	8764573:9:SP1:SERPINE2	Electrophoretic mobility shift analysis confirmed that [TF] specifically binds this region of the [TG] promoter.	Sp1	PN-1	0	UNDEFINED	False
12365	12588	8773576:6:EGR1:ICAM1	Finally, potential targets of regulation by the zinc-finger transcription factor encoded by [TF] include the interleukin-2, CD44, [TG], and tumor necrosis factor genes.	egr-1	ICAM-1	0	UNDEFINED	False
12366	12589	8793851:1:FOS:POMC	Recent studies have shown that corticotropin releasing factor (CRF) stimulates c-[TF] gene expression in the AtT-20 corticotroph cell line, and that overexpression of c-Fos results in activation of [TG] gene transcription.	fos	POMC	1	ACTIVATION	False
12367	12590	8798512:11:JUND:PLAUR	Expression of a vector encoding a wild-type [TF] cDNA increased [TG] promoter activity in GEO cells.	Jun-D	u-PAR	1	ACTIVATION	False
12368	12591	8798512:12:JUND:PLAUR	Conversely, transfection of RKO cells with a transactivation domain-lacking [TF] expression construct resulted in a dose-dependent decrease in [TG] promoter activity.	Jun-D	u-PAR	1	ACTIVATION	False
12370	12593	8798756:7:JUNB:DCN	Supershift assays with various [TF] antibodies identified c-Jun, Jun-B, and Fra-1 as components of the complex binding to the [TG] promoter.	AP-1	decorin	0	UNDEFINED	False
12371	12594	8817653:10:FOXM1:IGFBP1	We conclude that [TF] proteins and this novel C/EBP-related DNA/protein complex may play an important role in mediating interactions between glucocorticoids and insulin in the regulation of [TG] and perhaps multiple hepatic genes.	HNF-3	IGFBP-1	0	UNDEFINED	False
12372	12595	8817653:5:FOXM1:IGFBP1	We now report that IRSs from the [TG] and PEPCK, as well as an IRS which also binds [TF] in the rat tyrosine aminotransferase (TAT) gene, also interact with another DNA/protein complex in gel shift studies.	HNF-3	IGFBP-1	0	UNDEFINED	True
12373	12596	8830676:4:STAT1:CSN2	Upon IL-10 treatment [TF], 3, and 5 bind to the GRR of the FcgammaRI gene, activated Stat1 and 3 bind to the SIE sequence of the c-fos promoter and transcriptionally active Stat5 assembles at the PRL-STAT consensus sequence of the [TG] gene.	Stat1	beta-casein	0	UNDEFINED	False
12374	12597	8833654:0:RELA:AGT	[TG] gene activation by angiotensin II is mediated by the [TF] (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes.	rel A	Angiotensinogen	1	ACTIVATION	False
12375	12598	8833654:10:RELA:AGT	Transient overexpression of [TF](1-551) activates the [TG] multihormone-inducible enhancer.	Rel A	AGT	1	ACTIVATION	True
12376	12599	8844723:8:MAZ:MYC	These findings are consistent with the established role for [TF] in regulating [TG] gene expression.	MAZ	c-myc	0	UNDEFINED	False
12377	12600	8846003:3:EGR1:NGFR	Expression of the low-affinity p75 [TG] (NGFRp75) by Schwann cells after nerve injury closely correlated with the [TF] expression profile, and Zif268 transactivated the NGFRp75 promoter in transient transfection assays.	zif268	nerve growth factor receptor	1	ACTIVATION	False
12379	12602	8846003:5:EGR1:NGFR	Moreover, nuclear proteins corresponding to [TF] bound to the [TG]p75 promoter by Southwestern blotting, indicating that a direct interaction of Zif268 with the NGFR gene is required for its expression in Schwann cells.	Zif268	NGFR	1	ACTIVATION	False
12380	12603	8846003:5:EGR1:TNFRSF1B	Moreover, nuclear proteins corresponding to [TF] bound to the NGFR[TG] promoter by Southwestern blotting, indicating that a direct interaction of Zif268 with the NGFR gene is required for its expression in Schwann cells.	Zif268	p75	1	ACTIVATION	False
12381	12604	8877730:3:TP53:IL4	We investigated the possibility that wild-type (wt) [TF], a nuclear tumor suppressor protein, might serve to repress IL-2 and [TG] gene expression in murine E14 T lymphoma and in human Jurkat cells.	p53	IL-4	2	REPRESSION	False
12382	12605	8887657:8:ONECUT1:SI	[TF] binding activity was also found in the intestinal epithelial cell line HT29, and potential HNF-6 binding sites were present in intestinal [TG], cdx-2 homeodomain protein, and intestinal fatty acid binding protein promoter regions.	HNF-6	sucrase isomaltase	0	UNDEFINED	False
12383	12606	8892753:5:TP53:DDIT3	This possibility was confirmed by the finding that disruption of [TF] function by transfection with dominant-negative vectors expressing HPV E6, mutant p53, or SV40 T Ag reduced the induction of GADD45 and [TG] as measured by increases in mRNA and protein levels in human lines with wild-type p53.	p53	GADD153	1	ACTIVATION	False
12384	12607	8892753:9:TP53:DDIT3	Interestingly, induction of reporter constructs driven by the GADD45 or [TG] promoters was substantially reduced in human cells transfected with mutant [TF] or E6 expression vectors or in cells lacking p53 following treatment with MMS, UV radiation, or starvation.	p53	GADD153	1	ACTIVATION	False
12385	12608	8910439:10:AP1:VEGFA	The promoter activity of the [TG] gene, which contains five SP-1 binding sites and one [TF] binding site but not hypoxia regulatory elements, was enhanced by bFGF or TNF-alpha but not by hypoxia.	AP-1	VEGF	0	UNDEFINED	True
12386	12609	8910439:12:SP1:VEGFA	These data indicated that the expression of the [TG] gene enhanced by bFGF or TNF-alpha appeared to be mediated in part through the transcription factor [TF], suggesting a different mechanism from that for hypoxia-induced activation of the VEGF gene.	SP-1	VEGF	1	ACTIVATION	False
12387	12610	8910439:8:SP1:VEGFA	Mithramycin, an inhibitor of [TF], at 1-10 nM inhibited activation of the [TG] gene by bFGF or TNF-alpha but not that by hypoxia.	SP-1	VEGF	1	ACTIVATION	False
12388	12611	8914017:3:POU1F1:REN	Transient DNA transfection studies on chorionic cells implicated the CRE and [TF] consensus sites in the regulation of [TG] gene transcription by cAMP.	Pit-1	renin	0	UNDEFINED	False
12389	12612	8917435:11:JUN:SERPINE1	Together with the finding that both antisense [TF] and antisense c-fos oligodeoxynucleotides reduced the amount of c-Jun homodimer, we conclude that binding of c-Jun homodimer to the TRE at positions -58 to -50 is important in the basal activity and PMA activation of the [TG] promoter in HepG2 cells.	c-jun	PAI-1	1	ACTIVATION	False
12390	12613	8917435:4:JUN:SERPINE1	An essential role of c-Jun and c-Fos in basal and PMA-stimulated transcription of the [TG] gene is demonstrated by our finding that antisense [TF] and c-fos oligodeoxynucleotides both strongly reduced basal and PMA-stimulated PAI-1 synthesis.	c-jun	PAI-1	1	ACTIVATION	False
12391	12614	8917510:4:AP1:CCND1	In these studies, small t antigen stimulated [TG] promoter activity 7-fold, primarily through an [TF] at -954 with additional contributions from a CRE site at -57.	AP-1 binding site	cyclin D1	1	ACTIVATION	False
12392	12615	8931989:11:FOXA1:TTR	We propose that the HNF-3 beta-specific binding site in the [TG] enhancer may play a role in maintaining TTR gene expression during the acute phase response in spite of the dramatic reduction in [TF] protein levels.	HNF-3 alpha	TTR	1	ACTIVATION	False
12393	12616	8931989:2:HNF4A:TTR	Previous analyses have characterized the binding of a number of liver-enriched transcription factors of the [TG] promoter including hepatocyte nuclear factors one (HNF-1), [TF], and three distinct HNF-3 proteins (alpha, beta, and gamma), which are members of the winged helix (fork head) family.	HNF-4	TTR	0	UNDEFINED	False
12394	12617	8934542:9:SPI1:BTK	In addition Spi-B as well as [TF] were able to transactivate [TG] expression.	PU.1	Btk	1	ACTIVATION	False
12395	12618	8943340:5:ETS2:JUNB	The upregulation of [TG] is the result of a direct interaction of [TF] with ets binding sites of the junB promoter, since transient or constitutive Ets2 expression in M1D+ cells activates junB transcription via ets binding sites.	Ets2	junB	1	ACTIVATION	False
12396	12619	8943340:6:ETS2:JUNB	In addition, transfection of a dominant negative mutant of [TF], devoid of its transcriptional activation domain, greatly reduces transcriptional activities of the [TG] promoter in M1ets2 cells.	Ets2	junB	1	ACTIVATION	False
12397	12620	8945631:9:FOXM1:PROC	Viewed as a whole, these results indicate that HNF-1, [TF], and NF-I/CTF play critical roles in transcriptional regulation of the [TG] gene.	HNF-3	protein C	0	UNDEFINED	True
12398	12621	8955189:3:EGR1:PECAM1	The 5'-flanking region of the [TG] gene lacks a consensus TATA box, but contains consensus motifs for Sp1, [TF], ets, helix-loop-helix (HLH) box, GATA, AP-2, C/EBP, YY1, CCACC, LyF-1, imperfect octamer, heptamer, high mobility group proteins (HMG) box, and nuclear factor-kappaB, as well as shear stress-, retinoic acid-, glucocorticoid-, and acute phase-responsive elements, and an Alu sequence.	EGR1	PECAM-1	0	UNDEFINED	False
12399	12622	8988173:0:TFAP2A:CDKN1A	[TF] inhibits cancer cell growth and activates p21WAF1/[TG] expression.	AP2	CIP1	1	ACTIVATION	False
12400	12623	8988173:5:TFAP2A:CDKN1A	In a search for cellular factors that could activate [TG] during phorbol ester (TPA)-induced differentiation, we identified [TF] as a regulator of p21 expression.	AP2	p21	1	ACTIVATION	False
12401	12624	8995303:5:NFKB:PTGS2	Using electrophoretic mobility shift assays with antibody supershifting, we also found that hypoxia causes increased binding of NF-kappaB p65 ([TF]) to the one out of the two NF-kappaB consensus elements in the [TG] promoter which is closest to the transcription start site of the COX-2 gene.	Rel A	COX-2	0	UNDEFINED	False
12402	12626	8995303:9:NFKB:PTGS2	Thus, the intracellular signaling mechanism that leads to induction of [TG] by hypoxia includes binding of p65 to the relatively 3' [TF] consensus element in the COX-2 upstream promoter region in human vascular endothelial cells.	NF-kappaB	COX-2	1	ACTIVATION	False
12403	12627	8995437:0:SP3:CDKN1A	Involvement of the [TF] transcription factor in induction of [TG]/WAF1 in keratinocyte differentiation.	Sp3	p21Cip1	1	ACTIVATION	False
12404	12628	8995437:5:SP1:CDKN1A	Expression studies established that both [TF] and Sp3 activate the [TG] promoter, but showed that only Sp3 overexpression enhances promoter inducibility during differentiation.	Sp1	p21	1	ACTIVATION	False
12405	12629	8995437:5:SP3:CDKN1A	Expression studies established that both Sp1 and [TF] activate the [TG] promoter, but showed that only Sp3 overexpression enhances promoter inducibility during differentiation.	Sp3	p21	1	ACTIVATION	False
12406	12630	8995437:8:SP1:CDKN1A	These findings show that both [TF] and Sp3 can contribute to the basal activity of the [TG] promoter, and establish Sp3 as a specific transcription factor involved in the induction of p21 promoter during keratinocyte differentiation.	Sp1	p21	1	ACTIVATION	False
12407	12631	8995437:8:SP3:CDKN1A	These findings show that both Sp1 and [TF] can contribute to the basal activity of the [TG] promoter, and establish Sp3 as a specific transcription factor involved in the induction of p21 promoter during keratinocyte differentiation.	Sp3	p21	1	ACTIVATION	False
12408	12632	8997237:0:FOS:GAST	[TF] is required for EGF stimulation of the [TG] promoter.	Fos	gastrin	1	ACTIVATION	False
12409	12633	8997237:3:FOS:GAST	Therefore, to determine whether [TF] is required for stimulation of the [TG] promoter, a c-fos sense expression vector was coexpressed with a gastrin reporter construct in a GH4 rat pituitary cell line.	Fos	gastrin	1	ACTIVATION	False
12410	12634	8997237:4:FOS:GAST	We found that epidermal growth factor (EGF) and tumor necrosis factor-alpha (TNF-alpha) transiently stimulate an increase in [TF] protein that precedes stimulation of the [TG] promoter.	Fos	gastrin	1	ACTIVATION	False
12411	12635	9013589:9:FOXM1:CYP7A1	Gel retardation experiments demonstrated binding of [TF] to the segment from -80 to -70 and of hepatocyte nuclear factor HNF-4 (and ARP-1) to the segment from -148 to -127 of the [TG] promoter.	HNF-3	human CYP7	0	UNDEFINED	False
12412	12636	9020035:4:USF1:MT1A	The [TG] promoter was also activated three- to fourfold by recombinant [TF], a helix-loop-helix-leucine zipper DNA binding transcription factor that recognizes the major late transcription factor (MLTF) binding site on the MT-I promoter.	USF1	MT-I	1	ACTIVATION	False
12413	12637	9037208:0:AP1:SERPINB2	Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 ([TG]) gene promoter in HT-1080 cells utilises [TF] binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA.	AP-1	PAI-2	1	ACTIVATION	False
12414	12638	9037208:4:AP1:SERPINB2	This increase in [TF] activity correlated with a transactivation of the [TG] gene promoter in transiently transfected HT-1080 cells.	AP-1	PAI-2	1	ACTIVATION	False
12415	12639	9041934:10:NFKB:PTGS2	Pretreatment of RA synoviocytes with [TF] p65 antisense oligonucleotides resulted in decreased binding to the [TG] promoter and decreased COX-2 protein expression.	NF-kappa B	COX-2	1	ACTIVATION	False
12416	12640	9041934:10:RELA:PTGS2	Pretreatment of RA synoviocytes with NF-kappa B [TF] antisense oligonucleotides resulted in decreased binding to the [TG] promoter and decreased COX-2 protein expression.	p65	COX-2	1	ACTIVATION	False
12417	12641	9053449:5:EGR1:NFKB1	Characterization of the [TG] promoter identified an [TF] site which was found to be essential for both the PMA/PHA-mediated induction as well as the synergistic activation observed after the expression of the RelA subunit of NF-kappa B and Egr-1.	Egr-1	NF-kappa B1	1	ACTIVATION	False
12418	12642	9053449:6:EGR1:NFKB1	Furthermore, [TF] induction was required for endogenous [TG] gene expression, since PMA/PHA-stimulated T cell lines expressing antisense Egr-1 RNA were inhibited in their ability to upregulate NF-kappa B1 transcription.	Egr-1	NF-kappa B1	1	ACTIVATION	False
12419	12643	9053449:7:EGR1:NFKB1	Our studies indicate that transcriptional synergy mediated by activation of both [TF] and NF-kappa B may have important ramifications in T cell development by upregulating [TG] gene expression.	Egr-1	NF-kappa B1	1	ACTIVATION	False
12420	12644	9056676:0:REL:ICAM1	Regulation of [TG] gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/[TF] in the absence of p50.	c-Rel	intercellular adhesion molecule-1	0	UNDEFINED	False
12421	12645	9066006:7:MYOD1:PLAU	Moreover, the conversion of fibroblasts to muscle-like cells upon acquisition of [TF] resulted in a dramatic increase of [TG] mRNA, which was partially due to transcriptional activation of the uPA gene.	MyoD	uPA	1	ACTIVATION	False
12422	12646	9066006:8:MYOD1:PLAU	These results indicate that the increase in [TG] expression prior to fusion and differentiation occurs via a [TF]-mediated mechanism whereas the normal MyoD expression requires the plasminogen activation-dependent activity of this protease.	MyoD	uPA	1	ACTIVATION	False
12423	12647	9092633:0:YY1:NPM1	Isolation and characterization of the human nucleophosmin/B23 ([TG]) gene: identification of the [TF] binding site at the 5' enhancer region.	YY1	NPM	0	UNDEFINED	False
12424	12648	9092633:12:YY1:NPM1	These results suggest that [TF] may play a role in [TG] gene expression.	YY1	NPM	0	UNDEFINED	False
12425	12649	9113979:2:HLF:VEGFA	The HIF1alpha-like factor ([TF]) encoded by the isolated cDNA bound the hypoxia-response element (HRE) found in enhancers of genes for erythropoietin, vascular endothelial growth factor ([TG]), and various glycolytic enzymes, and activated transcription of a reporter gene harboring the HRE.	HLF	VEGF	1	ACTIVATION	False
12426	12650	9115370:9:SP1:ODC1	These results demonstrate that [TG] is positively regulated by [TF] and negatively regulated by Sp3, suggesting that the ratio of these transcription factors may be an important determinant of ODC expression during development or transformation.	Sp1	ODC	1	ACTIVATION	False
12427	12651	9115370:9:SP3:ODC1	These results demonstrate that [TG] is positively regulated by Sp1 and negatively regulated by [TF], suggesting that the ratio of these transcription factors may be an important determinant of ODC expression during development or transformation.	Sp3	ODC	2	REPRESSION	False
12428	12652	9136992:7:JUND:MMP9	Mobility shift assays indicated c-Fos and [TF] bound to this motif and transfection of the cells with a mutated c-Jun, which quenches the function of endogenous Jun and Fos proteins, decreased [TG] promoter activity by 80%.	Jun-D	MMP-9	1	ACTIVATION	True
12429	12653	9147818:0:FOS:PENK	Transactivation of [TG] gene by HTLV-1 tax1 protein in glial cells: involvement of Fos/Jun complex at an [TF] element in the proenkephalin gene promoter.	AP-1	proenkephalin	1	ACTIVATION	False
12430	12654	9147818:10:FOS:PENK	The tax1 induced c-Fos protein levels and the concurrently increased association of c-Fos/c-Jun transcription factors at the [TF] site imply a strong functional significance in the activation of [TG] gene expression in tax1 expressing glial cells.	AP-1	proenkephalin	1	ACTIVATION	False
12431	12655	9154819:8:NFKB:TNC	Furthermore, as demonstrated by gel shift experiments and cotransfections of the reporter plasmid and expression vectors encoding the p65 subunit of [TF] and c-Jun, the two transcription factors bind and synergistically transactivate the [TG] promoter.	NF-kappaB	tenascin-C	1	ACTIVATION	False
12432	12656	9174161:0:OTX2:TNC	The [TF] binds to the human [TG] promoter and trans-represses its activity in transfected cells.	human homeodomain protein OTX2	tenascin-C	2	REPRESSION	False
12433	12657	9182717:6:AP1:TIMP3	The deletion construct containing about 500 nt 5' to the transcriptional start, but no [TF] sites, showed lower but significant activity, suggesting both AP-1-dependent and -independent regulation of the mouse [TG] promoter.	AP-1	TIMP-3	0	UNDEFINED	False
12434	12658	9183012:10:SP1:CDKN1A	Longer exposure to TPA may activate p21([TG]/cip1) gene transcription through an [TF]-dependent mechanism, while Et2Mal treatment gradually inhibits p21(waf1/cip1) gene transcription through oxidative changes that affect Sp1 binding to DNA.	Sp1	waf1	1	ACTIVATION	False
12435	12659	9191053:6:E2F1:CDKN1A	In a first step toward elaborating the mechanism for cyclin D1-mediated induction of [TG] gene expression we show that co-expression of [TF] and DP-1 can specifically transactivate the p21 promoter.	E2F-1	p21	1	ACTIVATION	False
12436	12660	9191053:6:TFDP1:CDKN1A	In a first step toward elaborating the mechanism for cyclin D1-mediated induction of [TG] gene expression we show that co-expression of E2F-1 and [TF] can specifically transactivate the p21 promoter.	DP-1	p21	1	ACTIVATION	False
12437	12661	9199295:0:CREB1:CEBPB	[TF] controls LAP/[TG] transcription.	CREB	C/EBP beta	0	UNDEFINED	False
12438	12662	9211894:4:AP1:KLK3	Overexpression of [TF] (jun and fos proteins) also inhibited androgen-induced [TG] promoter activity.	AP-1	PSA	2	REPRESSION	False
12439	12663	9219563:8:TFAP2A:IVL	These results lend support to the working hypothesis that arsenate suppresses [TG] expression, and, more generally, keratinocyte programming, by altering the transcription factors AP1 and [TF].	AP2	involucrin	0	UNDEFINED	False
12440	12664	9242190:7:EGR1:PDGFA	[TF] bound to the FGF-1 response element in the proximal [TG] promoter in a specific and time-dependent manner.	Egr-1	PDGF-A	0	UNDEFINED	False
12441	12665	9247737:4:POU1F1:REN	Taken together, these results show that the cAMP response of the [TG] gene may involve CREB binding the CRE and tissue-specific factors (from chorionic and kidney cell origin), different from [TF], that interact with the Pit-1 response DNA elements.	Pit-1	human renin	0	UNDEFINED	False
12442	12666	9256061:7:TFEC:HMOX1	By transient coexpression assays, we showed that [TF] is able to activate or inhibit transcription of a reporter gene linked to either the tyrosinase or the [TG] gene promoter, depending on cell types.	TFECL	heme oxygenase-1	0	UNDEFINED	True
12443	12667	9256279:4:AP1:VEGFA	In contrast, nitric oxide (NO) donors inhibit PKC-induced [TG] upregulation by interfering with binding of the transcription factor activator protein-1 ([TF]) to the VEGF promoter.	AP-1	VEGF	1	ACTIVATION	False
12444	12668	9264407:7:SP1:VEGFA	Gel shift and antibody supershift analyses showed that [TF] and Sp3 interact constitutively with the [TG] promoter element.	Sp1	VEGF	0	UNDEFINED	False
12445	12669	9264407:7:SP3:VEGFA	Gel shift and antibody supershift analyses showed that Sp1 and [TF] interact constitutively with the [TG] promoter element.	Sp3	VEGF	0	UNDEFINED	False
12446	12670	9264407:8:SP1:VEGFA	Our data strongly suggest that enhanced [TG] gene expression in PDGF-induced NIH3T3 cells is mediated by [TF] and/or Sp3 transcription factors bound to the -85 to -50 promoter region of the VEGF gene.	Sp1	VEGF	1	ACTIVATION	False
12447	12671	9264407:8:SP3:VEGFA	Our data strongly suggest that enhanced [TG] gene expression in PDGF-induced NIH3T3 cells is mediated by Sp1 and/or [TF] transcription factors bound to the -85 to -50 promoter region of the VEGF gene.	Sp3	VEGF	1	ACTIVATION	False
12448	12672	9266823:0:NFKB:PTGS2	Evidence for involvement of [TF] in the transcriptional control of [TG] gene expression by IL-1beta.	NF-kappaB	COX-2	0	UNDEFINED	False
12449	12673	9266823:3:NFKB:PTGS2	IL-1beta produces a 10-fold induction of [TG] mRNA and an 8-fold increase in COX-2 transcription that was temporally preceded by activation of the transcription factor nuclear factor-kappaB ([TF]).	NF-kappaB	COX-2	1	ACTIVATION	False
12450	12674	9266823:4:NFKB:PTGS2	The protein-tyrosine phosphatase inhibitor phenylarsine oxide (PAO) prevented both [TF] activation and induction of [TG] mRNA.	NF-kappaB	COX-2	1	ACTIVATION	False
12451	12675	9266823:5:NFKB1:PTGS2	We show that two putative [TF] motifs, kappaBu (-447/-438) and kappaBd (-224/-214), from the [TG] promoter bind p50/p65 NF-kappaB heterodimers in an IL-1beta-dependent manner and that the upstream element has the greater affinity.	NF-kappaB	COX-2	0	UNDEFINED	False
12452	12676	9266823:5:RELA:PTGS2	We show that two putative NF-kappaB motifs, kappaBu (-447/-438) and kappaBd (-224/-214), from the [TG] promoter bind p50/[TF] NF-kappaB heterodimers in an IL-1beta-dependent manner and that the upstream element has the greater affinity.	p65	COX-2	0	UNDEFINED	False
12453	12677	9266823:7:NFKB:PTGS2	We conclude that IL-1beta stimulates PG production via transcriptional activation of [TG] and provide evidence that this may involve [TF].	NF-kappaB	COX-2	1	ACTIVATION	False
12454	12678	9271438:0:SP1:VEGFA	The von Hippel-Lindau tumor suppressor gene product interacts with [TF] to repress [TG] promoter activity.	Sp1	vascular endothelial growth factor	2	REPRESSION	False
12455	12679	9271438:8:SP1:VEGFA	In Drosophila cells, cotransfected VHL represses [TF]-mediated activation but not basal activity of the [TG] promoter.	Sp1	VEGF	1	ACTIVATION	False
12456	12680	9294605:1:MAZ:MYC	To investigate whether MAZ ([TF]) affects the expression of the [TG] gene during the retinoic acid-induced (RA-induced) neuroectodermal differentiation of P19 embryonal carcinoma (EC) cells, we introduced a CAT reporter construct, human c-myc promoter/CAT (pMyc2CAT), and a mutant CAT derivative that lacked an ME1a1 site (pMyc1CAT) into P19EC cells to monitor the promoter activity of the c-myc gene.	Myc-associated zinc finger protein	c-myc	0	UNDEFINED	False
12457	12681	9295358:5:JUN:NPPA	Furthermore, transfection with an expression vector for [TF], a substrate for JNK, also activated the [TG] promoter, and the combination of pacing and c-Jun was synergystic, consistent with roles for JNK and c-Jun in calcium-activated ANF expression.	c-Jun	ANF	1	ACTIVATION	False
12458	12682	9295358:6:JUN:NPPA	Proximal serum response factor and Sp1 binding sites were required for the effects of pacing or [TF] on the [TG] promoter.	c-Jun	ANF	0	UNDEFINED	False
12459	12683	9297634:9:JUNB:VGF	The [TF]-related binding activities were transiently induced by NGF, suggesting that part of the mechanism utilized by NGF to activate [TG] transcription includes increased synthesis of a V2 binding protein.	JunB	VGF	1	ACTIVATION	False
12461	12685	9317150:0:JUN:SELE	TNF initiates [TG] transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-[TF]/ATF2 pathways.	c-Jun	E-selectin	1	ACTIVATION	False
12462	12686	9317150:1:JUN:SELE	TNF acts on the [TG] gene promoter at three kappa B elements and at a variant cAMP-responsive element that binds ATF2/[TF].	c-Jun	E-selectin	0	UNDEFINED	False
12463	12687	9317150:7:JUN:SELE	These data suggest that TNF activates parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-[TF]/ATF2 pathways to initiate [TG] transcription.	c-Jun	E-selectin	1	ACTIVATION	False
12464	12688	9321833:9:EGR1:PDGFA	Displacement of Sp1 and Sp3 by [TF] is correlated with inducible [TG] A-chain expression in the vessel wall.	Egr-1	PDGF	1	ACTIVATION	False
12465	12689	9334243:9:AP1:CLU	Together these results indicate that TGFbeta regulates [TG] gene expression through an [TF] site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.	AP-1	clusterin	0	UNDEFINED	True
12466	12690	9351401:5:EGR1:PDGFA	The induction of [TG] expression by shear was preceded by rapid and transient induction in the expression of the immediate-early gene, [TF], which binds to GC-rich sequences.	egr-1	PDGF-A	1	ACTIVATION	False
12467	12691	9351401:6:EGR1:PDGFA	Gel shift studies indicated that shear-induced [TF] bound to the proximal [TG] promoter in a specific and time-dependent manner, displacing Sp1 from their overlapping recognition elements.	Egr-1	PDGF-A	0	UNDEFINED	False
12468	12692	9351401:8:EGR1:PDGFA	These findings define the [TF] binding site in the proximal [TG] promoter as a shear-stress-responsive element and suggest that shear-stimulated Egr-1 gene expression may be a unifying theme in the induction of various other endothelial genes exposed to biomechanical forces.	Egr-1	PDGF-A	1	ACTIVATION	False
12469	12693	9359835:6:EGR1:PKD2	Transfection experiments also demonstrate that [TF] is able to enhance [TG] promoter activity.	EGR-1	PC2	1	ACTIVATION	False
12470	12694	9361018:8:SP1:SEPP1	By transfection of promoter-deletion constructs, a TATA box and a putative [TF] were identified to be necessary for [TG] transcription.	SP1 site	selenoprotein P	1	ACTIVATION	False
12471	12695	9363748:3:SP1:DHFR	Using gel-mobility assays performed with DNA probes from the minimal promoter of the hamster [TG] gene and nuclear extracts from cultured hamster cells (CHO K1) we show that the binding of [TF] to the dhfr promoter is cell-growth-phase regulated.	Sp1	dhfr	0	UNDEFINED	False
12472	12696	9363748:7:SP1:DHFR	It is concluded that [TF] progressively binds to the hamster [TG] promoter after stimulation of cell proliferation, which can account for the transcriptional regulation of the dhfr gene during the cell cycle.	Sp1	dhfr	0	UNDEFINED	False
12473	12697	9367892:4:YY1:PARP1	In this study Alu-retroposon-associated binding sites for [TF] located in the distal region of the promoter of the human [TG] gene have been identified suggesting a possible involvement of this protein in the regulation of ADPRT-gene expression.	YY1	ADPRT	0	UNDEFINED	False
12474	12698	9377555:2:TP53:VEGFA	Based on its effects when overexpressed in transient transfection assays, [TF] has been proposed to repress [TG] transcription.	p53	VEGF	2	REPRESSION	False
12475	12699	9377555:5:TP53:VEGFA	Our data provide no evidence for a causal relationship between the loss of [TF] activity and increased [TG] expression that is observed during tumor progression.	p53	VEGF	2	REPRESSION	False
12476	12700	9388195:0:TP53:APC	Activation of adenomatous polyposis coli ([TG]) gene expression by the DNA-alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine requires [TF].	p53	APC	1	ACTIVATION	False
12477	12701	9388195:5:TP53:APC	A necessary role for [TF] in [TG] gene regulation is supported by the failure of MNNG to induce APC expression in cell lines either expressing very low levels of p53 (HeLa cells) or no p53 (K562 erythroleukemia cells).	p53	APC	0	UNDEFINED	False
12478	12702	9388195:6:TP53:APC	The overexpression of wild-type [TF] gene into HCT-116 cells mimicked the effect of MNNG-induced expression of [TG] mRNA.	p53	APC	1	ACTIVATION	False
12479	12703	9388195:7:TP53:APC	A direct causal role for [TF] in [TG] gene regulation was further evaluated by transfecting the wild-type p53 gene into K562 cells and observing a 5-fold increase in the APC gene expression.	p53	APC	1	ACTIVATION	False
12481	12705	9408078:9:PGR:MYC	A 3507 bp HindIII-XbaI fragment of the 5' flanking region of the [TG] gene, -2327 to +1180, containing the progestin regulatory region and the c-myc promoter, confers progestin responsiveness to the CAT (chloramphenicol acetyl transferase) reporter gene in [TF] (PR)-rich T47D human breast cancer cells, but not in PR-negative MDA-MB-231 cells.	progesterone receptor	c-myc	0	UNDEFINED	False
12482	12706	9417054:3:ELF3:TGFBR2	Using constructs of the transforming growth factor-beta (TGF-beta) type II receptor (RII) promoter linked to the luciferase gene, we have demonstrated that [TF] activates transcription of the [TG] gene through the 5'-TTTCCTGTTTCC-3' response element spanning nucleotides +13 to +24 and multiple additional ETS binding sites between -1816 and -82 of the TGF-beta RII promoter.	ERT	TGF-beta RII	1	ACTIVATION	False
12483	12707	9421459:0:SREBF1:LEP	Nutritional and insulin regulation of fatty acid synthetase and [TG] gene expression through ADD1/[TF].	SREBP1	leptin	0	UNDEFINED	False
12484	12708	9421459:5:SREBF1:LEP	We also show that the promoters for both [TG] and FAS are transactivated by ADD1/[TF].	SREBP1	leptin	1	ACTIVATION	False
12485	12709	9422727:5:ATF2:HSPA5	The involvement of p38(MAPK) in the activation of [TF], which leads to the transactivation of rat [TG], is confirmed by electrophoretic mobility shift assay using a probe containing the CRE-like sequence as well as by transient transfection assays with a plasmid containing a 710-base pair stretch of the grp78 promoter.	ATF-2	grp78	1	ACTIVATION	False
12486	12710	9424084:4:AP1:IVL	We have explored whether the [TF] regulated expression of the keratin 5, transglutaminase 1, [TG], and loricrin genes reflects the distribution of the AP1 factors in the epidermis.	AP1	involucrin	0	UNDEFINED	False
12487	12711	9427542:2:STAT2:SERPINE1	[TF] binds to a 7-bp consensus TNF-response element and a 30-bp fragment from mouse [TG] promoter (-88/-59).	P113	PAI-1	0	UNDEFINED	False
12488	12712	9427542:8:STAT2:SERPINE1	Using Northern blot analysis and the [TG] promoter/luciferase system, we demonstrated that [TF] is a transcription factor that activates the transcription of the PAI-1 gene in 30A5 cells.	P113	PAI-1	1	ACTIVATION	False
12489	12713	9442377:0:REL:ICAM1	NF-kappa B/[TF] family members regulating the [TG] promoter in monocytic THP-1 cells.	Rel	ICAM-1	0	UNDEFINED	False
12490	12714	9445037:6:ATF1:PDLIM7	Overexpression of [TF] and CREB-1 in the cells by expression vectors demonstrated that homodimeric as well as heterodimeric forms of the factors transactivate the [TG] promoter in an EBNA2-independent manner.	ATF-1	LMP1	1	ACTIVATION	False
12491	12715	9453298:11:EGR1:PDGFA	Thus, GC-rich regions in the proximal 92 bp of the [TG] promoter contain mechanical strain-responsive elements that bind [TF] and possibly Sp-1.	Egr-1	PDGF-A	0	UNDEFINED	False
12493	12717	9456329:9:NFKB:ITGA2	The inhibition of [TF] activity by SN50 greatly blocked the contraction, suggesting its critical role in not only the induction of [TG] gene expression by three-dimensional collagen lattice, but also alpha2beta1-mediated tissue-remodeling process.	NF-kappaB	integrin alpha2	1	ACTIVATION	False
12494	12718	9468519:11:NFKB:VCAM1	These results suggest that AP-1 proteins may mediate the effect of TNF-alpha in the regulation of [TG] expression through interaction with [TF] factors in endothelial cells.	NF-kappaB	VCAM-1	0	UNDEFINED	False
12495	12719	9478976:9:FOS:TIMP1	Thus, OSM (but not IL-6) stimulates c-[TF], which participates in maximal activation of [TG] transcription, likely in cooperation with other factors such as SP1 or as yet unidentified mechanisms involving the +1 to +47 region of the promoter.	Fos	TIMP-1	1	ACTIVATION	False
12496	12720	9492315:7:SP1:MYC	Run-off transcription experiments in vitro showed that the effect of elsamicin A on [TF] binding is followed by the maintenance or a relative rise in transcription levels from the P1 promoter of [TG], while actinomycin D always inhibited the transcription from the P1 c-myc promoter in a concentration-dependent manner.	Sp1	c-myc	0	UNDEFINED	True
12497	12721	9494121:11:SP1:F2R	Competition for shared binding sites by [TF] and Sp3 might differentially regulate [TG] expression in vascular endothelial cells.	Sp1	HTR	0	UNDEFINED	False
12498	12722	9494121:8:SP1:F2R	To test the individual abilities of [TF] and Sp3 to activate or repress [TG] transcription, we conducted co-transfection experiments with wild-type or mutated HTR-promoter-luciferase constructs.	Sp1	HTR	2	REPRESSION	True
12499	12723	9494121:8:SP3:F2R	To test the individual abilities of Sp1 and [TF] to activate or repress [TG] transcription, we conducted co-transfection experiments with wild-type or mutated HTR-promoter-luciferase constructs.	Sp3	HTR	1	ACTIVATION	True
12500	12724	9514889:7:NFKB:PTGS2	These results suggest that the [TF] site is involved in both the LPS-induced expression of the [TG] gene and its suppression by DEX and herbimycin A in a differentiation-dependent manner.	NF-kappa B	COX-2	0	UNDEFINED	True
12501	12725	9528858:7:CREB1:BRCA1	One such methylated CpG occurs at a putative [TF] (cAMP-responsive element binding) transcription factor binding site in the [TG] promoter.	CREB	BRCA1	0	UNDEFINED	False
12502	12727	9545321:9:FOXA1:SCGB1A1	These studies demonstrate that transcription from the rabbit uteroglobin/[TG] promoter in lung epithelium is controlled by the combinatorial action of the cell-specific factor [TF] and the ubiquitous factor Sp1.	HNF3alpha	CC10	0	UNDEFINED	False
12503	12728	9553133:0:SP1:CDKN1A	Progesterone regulates transcription of the p21([TG]) cyclin- dependent kinase inhibitor gene through [TF] and CBP/p300.	Sp1	WAF1	0	UNDEFINED	False
12504	12729	9571207:0:NR1I2:DBP	Regulation of the [TG] promoter by [TF] proteins and in leukemic cells bearing an E2A/HLF translocation.	PAR	DBP	0	UNDEFINED	False
12505	12730	9571207:2:CEBPA:DBP	This paper examines the regulation of the [TG] promoter by [TF] and examines the role of autoregulation in its expression.	C/EBP alpha	DBP	0	UNDEFINED	False
12506	12731	9572272:7:EGR1:NPY	These results show that transcription factors AP-1, AP-2alpha, and [TF] are involved in activated [TG] transcription during the onset of neuronal differentiation.	NGFI-A	NPY	1	ACTIVATION	False
12507	12732	9575225:0:POU2F1:IL1B	Transcriptional regulation of [TG] gene by interleukin-1beta itself is mediated in part by [TF] in thymic stromal cells.	Oct-1	interleukin-1beta	0	UNDEFINED	False
12508	12733	9580699:3:SP1:CDKN1A	Analyses of the human p15 and [TG] promoters have led to the identification of GC-rich sequences capable of binding to [TF] transcription factors as necessary elements for the TGF-beta induction of both promoters.	Sp1	p21	1	ACTIVATION	True
12509	12734	9591776:10:SP1:DHFR	Thus, the activation by Rb of the [TG] gene may be exerted through [TF].	Sp1	dhfr	1	ACTIVATION	False
12510	12735	9596659:11:NFKB1:MYC	In nuclear extracts from day 10 BFU-E-derived cells, p50, p52, and p65 were able to form complexes, which bound to kappaB sites in the promoters of both the c-myb and [TG] genes, suggesting that c-myb and c-myc may be among the kappaB-containing genes regulated by [TF] factors in normal erythroid cells.	NF-kappaB	c-myc	0	UNDEFINED	False
12511	12736	9596659:11:NFKB2:MYC	In nuclear extracts from day 10 BFU-E-derived cells, p50, [TF], and p65 were able to form complexes, which bound to kappaB sites in the promoters of both the c-myb and [TG] genes, suggesting that c-myb and c-myc may be among the kappaB-containing genes regulated by NF-kappaB factors in normal erythroid cells.	p52	c-myc	0	UNDEFINED	False
12512	12737	9596659:11:RELA:MYC	In nuclear extracts from day 10 BFU-E-derived cells, p50, p52, and [TF] were able to form complexes, which bound to kappaB sites in the promoters of both the c-myb and [TG] genes, suggesting that c-myb and c-myc may be among the kappaB-containing genes regulated by NF-kappaB factors in normal erythroid cells.	p65	c-myc	0	UNDEFINED	False
12513	12738	9605774:4:ETS2:PLAU	In addition, ras/[TF] responsive genes such as the [TG] (uPA) were activated in these four cell lines.	ets-2	urokinase plasminogen activator	1	ACTIVATION	False
12514	12739	9605774:5:ETS2:PLAU	Transient transfection assays indicated that the compound ets-AP1 oncogene responsive enhancer present in the [TG] gene was the target of ras signaling in ovarian tumor cells and that the combination of activated ras and [TF] could superactivate the uPA enhancer element.	ets-2	uPA	1	ACTIVATION	False
12515	12740	9616225:2:EGR1:PDGFA	[TF] binds to a sequence found in the promoters of genes involved in vascular injury, such as [TG] and tissue factor, and trans-activates their expression in endothelial cells in response to fluid shear stress.	Egr-1	PDGF-A	1	ACTIVATION	False
12516	12741	9618481:0:SP1:CDKN1A	Regulation of the human p21/[TG]/Cip1 promoter in hepatic cells by functional interactions between [TF] and Smad family members.	Sp1	WAF1	0	UNDEFINED	False
12517	12742	9632673:8:STAT1:TAP1	Whereas binding of either interferon regulatory factor 1 or [TF] to the overlapping interferon consensus sequence-2/GAS is sufficient for regulating transcription of the [TG] gene, binding of both factors is required for LMP2 gene transcription.	Stat1	TAP1	0	UNDEFINED	True
12518	12743	9651473:7:SP1:GPC3	Additionally, [TF] specifically transactivated transcription in Sp1-deficient Drosophila SL2 cells, demonstrating the functionality of Sp1 on the [TG] promoter.	Sp1	GPC3	1	ACTIVATION	False
12519	12744	9660938:0:AP1:FASLG	DNA damaging agents induce expression of [TG] and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and [TF].	AP-1	Fas ligand	1	ACTIVATION	False
12520	12745	9660938:2:AP1:FASLG	We report that activation of the two transcription factors NF-kappa B and [TF] is crucially involved in [TG] expression induced by etoposide, teniposide, and UV irradiation.	AP-1	FasL	1	ACTIVATION	False
12521	12746	9668124:11:HNF4A:MST1	These results suggest the binding of HNF-4 to the proximal [TF]binding site directs the basal transcription of the [TG] gene, and the maximal promoter activity may depend on the direct association between HNF-4 and NF-Y.	HNF-4-	MSP	1	ACTIVATION	False
12522	12747	9671480:0:HNF1B:PLAU	Role of tissue-specific transcription factor [TF] in a cyclic AMP-responsive enhancer of the [TG] gene in LLC-PK1 cells.	LFB3	urokinase-type plasminogen activator	0	UNDEFINED	True
12523	12748	9685261:3:FOXA1:HNF1A	Regulation of HNF-4/[TG] expression by [TF] and HNF-3beta was studied in embryoid bodies in which one or both HNF-3alpha or HNF-3beta alleles were inactivated.	HNF-3alpha	HNF-1	0	UNDEFINED	False
12524	12749	9685261:3:FOXA1:HNF4A	Regulation of [TG]/HNF-1 expression by [TF] and HNF-3beta was studied in embryoid bodies in which one or both HNF-3alpha or HNF-3beta alleles were inactivated.	HNF-3alpha	HNF-4	0	UNDEFINED	False
12525	12750	9690917:6:STAT1:CXCL10	Taken together these results suggest that gamma-interferon mediated cell activation is responsible for [TF]-induced transcription of the [TG] gene in THP-1 macrophages as well as in monocytes from II-2.	STAT1alpha	IP-10	1	ACTIVATION	False
12526	12751	9704924:8:TFDP1:E2F1	CAT reporter assays have shown that [TG] in association with its partner [TF] transactivates its own promoter, whereas p105Rb inhibits the E2F-1 promoter.	DP-1	E2F-1	1	ACTIVATION	True
12527	12752	9705897:9:STAT3:MT1A	Therefore, the synergistic activation of the [TG] gene by IL-6 and glucocorticoid may require not only that signal transducers and activators 3 ([TF]) and the glucocorticoid receptor (GR) bind to their respective responsive elements, but also that Stat3 and the GR physically interact with one another.	Stat3	mMT-I	1	ACTIVATION	False
12528	12753	9710122:5:NFKB:PTGS2	These data suggested that HMG I(Y) proteins interact with [TF] p65 to induce [TG] promoter activity.	NF-kappaB	COX-2	1	ACTIVATION	False
12529	12754	9710122:5:RELA:PTGS2	These data suggested that HMG I(Y) proteins interact with NF-kappaB [TF] to induce [TG] promoter activity.	p65	COX-2	1	ACTIVATION	False
12530	12755	9710625:6:ATF2:FASLG	Transient transfection of interfering c-Jun and [TF] mutants, which lack the consensus JNK phosphorylation sites, abrogated the transcriptional activation of the [TG] promoter, demonstrating the involvement of these transcription factors in the regulation of the FasL promoter.	ATF2	FasL	1	ACTIVATION	False
12531	12756	9710625:6:JUN:FASLG	Transient transfection of interfering [TF] and ATF2 mutants, which lack the consensus JNK phosphorylation sites, abrogated the transcriptional activation of the [TG] promoter, demonstrating the involvement of these transcription factors in the regulation of the FasL promoter.	c-Jun	FasL	1	ACTIVATION	False
12532	12757	9714058:0:EGR1:BCL2	Suppression of human fibrosarcoma cell growth by transcription factor, [TF], involves down-regulation of [TG].	Egr-1	Bcl-2	2	REPRESSION	False
12533	12758	9714058:3:EGR1:BCL2	We show that transfected [TF] in human fibrosarcoma cells HT1080 leads to down-regulation of [TG].	Egr-1	Bcl-2	2	REPRESSION	False
12534	12759	9714058:4:EGR1:BCL2	Transient CAT transfection assays reveal that expression of [TF] suppresses [TG] promoter activity in a dose-dependent manner.	Egr-1	Bcl-2	2	REPRESSION	False
12535	12760	9714058:6:EGR1:BCL2	Our results suggest that suppression of tumor cell proliferation by [TF] may be at least partially mediated through the down-regulation of [TG].	Egr-1	Bcl-2	2	REPRESSION	False
12536	12761	9726429:8:NFKB:PTGS2	These data suggest that basic gene induction mechanisms, which have been conserved over long periods of evolution, that increase [TF]-DNA binds ing may be fundamental in driving transcription from inflammation-related genes, such as [TG], that operate in stressed tissues, in normally aging cell lines, and in neurodegenerative disorders that include AD brain.	NF-kappaB	COX-2	1	ACTIVATION	False
12537	12762	9729288:0:FOS:TH	Role of c-fos in hypoxia-induced [TF] cis-element activity and [TG] gene expression.	AP-1	tyrosine hydroxylase	0	UNDEFINED	False
12538	12763	9731508:7:AP1:MGMT	The results indicate [TF] to be involved in regulation of [TG] expression.	AP-1	MGMT	0	UNDEFINED	True
12539	12764	9731508:8:AP1:MGMT	This hypothesis was supported by showing [TF] binding to two target sequences of the [TG] promoter and transactivation of the MGMT promoter upon cotransfection with c-fos and c-jun in F9 cells.	AP-1	MGMT	1	ACTIVATION	False
12540	12766	9731757:13:STAT1:IDO1	Furthermore, gel mobility shift assays indicated that TGF-beta did not inhibit the induction of [TF] and IRF-1 binding activity to their cognate DNA recognition sites in the [TG] gene promoter.	stat1	IDO	0	UNDEFINED	False
12541	12767	9756936:2:REST:SYN1	Transfection experiments of neuroblastoma cells using a [TF] expression vector revealed that [TG] promoter activity is controlled by REST.	REST	synapsin I	0	UNDEFINED	False
12543	12769	9758209:7:NFKB:PTGS2	These results provide convincing evidence that [TF] may mediate the IL-1beta stimulation of [TG] gene expression as well as the dexamethasone inhibition of the IL-1beta induction process in WISH cells.	NF-kB	PGHS-2	1	ACTIVATION	False
12544	12770	9763470:11:PHOX2A:DBH	Collectively, this study emphasizes a critical role of [TF] as well as its functional synergism with other transcription factors (e.g., CREB, AP2, and Sp1) in transcriptional activation of the [TG] gene.	Phox2a	DBH	1	ACTIVATION	False
12545	12771	9763470:11:SP1:DBH	Collectively, this study emphasizes a critical role of Phox2a as well as its functional synergism with other transcription factors (e.g., CREB, AP2, and [TF]) in transcriptional activation of the [TG] gene.	Sp1	DBH	1	ACTIVATION	False
12546	12772	9763470:11:TFAP2A:DBH	Collectively, this study emphasizes a critical role of Phox2a as well as its functional synergism with other transcription factors (e.g., CREB, [TF], and Sp1) in transcriptional activation of the [TG] gene.	AP2	DBH	1	ACTIVATION	False
12547	12773	9765209:3:TFE3:SERPINE1	To identify proteins that participate in TGF-beta-induced gene expression, we developed a novel retrovirus-mediated expression cloning strategy; and using this approach, we established that transcription factor microE3 ([TF]) is involved in TGF-beta-induced activation of the [TG] promoter.	TFE3	PAI-1	1	ACTIVATION	False
12548	12774	9765209:4:TFE3:SERPINE1	We showed that [TF] binds to an E-box sequence in PE2, a 56-bp promoter fragment of the [TG] promoter, and that mutation of this sequence abolishes both TFE3 binding as well as TGF-beta-dependent activation.	TFE3	PAI-1	1	ACTIVATION	False
12549	12775	9765209:5:SMAD3:ERF	TFE3 and [TF] synergistically activate the [TG] promoter and phosphorylated Smad3 and Smad4 bind to a sequence adjacent to the TFE3-binding site in this promoter.	Smad3	PE2	1	ACTIVATION	False
12550	12776	9774418:4:AP1:IL2	Overexpression of a dominant-negative mutant of PI 3-kinase and pharmacological inhibitors of PI 3-kinase prevented transcriptional activation of [TF] and NF-AT, transcription factors regulated by ERK-2 and pivotal for [TG] gene expression.	AP-1	IL-2	1	ACTIVATION	False
12551	12777	9774680:8:SOX9:AMH	We propose that the two transcription factors [TF] and SF-1 could both be involved in the expression of the [TG] gene, in part as a result of their respective binding to the AMH promoter and in part because of their ability to interact with each other.	SOX9	AMH	0	UNDEFINED	True
12552	12779	9788252:6:SREBF1:LPL	Furthermore, co-expression of an active sterol regulatory element binding protein ([TF]), with Sp1, but not with Sp3, synergistically activated the [TG] promoter in SL2 cells.	SREBP-1	LPL	1	ACTIVATION	False
12553	12780	9788252:8:SREBF1:LPL	In this study, we showed that this substitution results in reduced binding affinity to Sp1/Sp3 and in diminished transactivation by Sp1/Sp3 alone and by the synergistic action of Spl and [TF] In conclusion, recruitment of Sp1/Sp3 by the CT element may play an important role in expression of the [TG] gene.	SREBP-1	human lipoprotein lipase	1	ACTIVATION	False
12554	12781	9790921:1:CEBPA:LEP	[TF] binds a C/EBP consensus site in the [TG] promoter and activates transcription in vitro.	C/EBP-alpha	leptin	1	ACTIVATION	False
12555	12782	9794404:6:IRF9:CXCL10	An h[TG] promoter-reporter mutant (mISRE3) that was relatively deficient for binding a related factor, IFN regulatory factor-1 (IRF-1) but competent for binding [TF], was induced as well as the wild-type hIP-10 promoter, supporting the interpretation that p48 played a necessary and sufficient role in hIP-10 transcription.	p48	IP-10	1	ACTIVATION	False
12556	12783	9794452:2:AP1:FSHB	Recent studies on transcriptional regulation of the ovine FSH beta-subunit gene (o[TG]) have defined two functional activating protein-1 ([TF]) enhancers in the proximal promoter (located at -120 and -83 bp) that are probably physiologically important for FSHbeta expression.	AP-1	FSHbeta	1	ACTIVATION	False
12557	12784	9795195:9:TFAP2A:PNMT	While the mechanisms by which Egr-1 and the GR and Egr-1, [TF] and the GR function cooperatively to stimulate [TG] promoter activity remain to be elucidated, this synergistic stimulation of the PNMT promoter by these factors may provide important in vivo and in vitro regulatory control of the PNMT gene.	AP-2	PNMT	1	ACTIVATION	False
12558	12785	9799805:10:FOXM1:CYP7A1	[TF] was required for both basal transcriptional activity and stimulation of the rat [TG] promoter activity by retinoic acid.	HNF-3	CYP7A	1	ACTIVATION	False
12560	12787	9819384:0:SP1:CDKN1A	p21([TG]/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and [TF]-responsive element: involvement of the small GTPase rhoA.	Sp1	WAF1	1	ACTIVATION	False
12561	12788	9819384:8:SP1:CDKN1A	These results suggest that GGTI-298-mediated upregulation of p21([TG]/CIP1) involves both an increase in the amount of DNA-bound [TF]-Sp3 and enhancement of Sp1 transcriptional activity.	Sp1	WAF1	1	ACTIVATION	False
12562	12789	9819384:8:SP3:CDKN1A	These results suggest that GGTI-298-mediated upregulation of p21([TG]/CIP1) involves both an increase in the amount of DNA-bound Sp1-[TF] and enhancement of Sp1 transcriptional activity.	Sp3	WAF1	1	ACTIVATION	False
12563	12790	9819390:0:TLX1:ALDH1A1	The T-cell oncogenic protein [TF] activates [TG] expression in NIH 3T3 cells but represses its expression in mouse spleen development.	HOX11	Aldh1	0	UNDEFINED	True
12564	12791	9819390:8:TLX1:ALDH1A1	This result suggests that expression of [TG] protein is negatively regulated by [TF] and that abnormal expression of Aldh1 in Hox11 null mice may cause loss of splenic precursor cells by aberrant retinoic acid metabolism.	Hox11	Aldh1	2	REPRESSION	False
12568	12797	9857074:2:AP1:GZMB	[TG] gene transcription is induced in activated lymphocytes upon antigenic stimulation, and several regulatory regions including CBF, [TF], and Ikaros binding sites have been shown to be essential in the control of granzyme B promoter activation.	AP-1	Granzyme B	1	ACTIVATION	False
12569	12798	9867825:6:ETS1:FOXD1	These results are compatible with the hypothesis that [TF] acts as an upstream regulator of [TG] expression during kidney development.	Ets-1	FREAC-4	0	UNDEFINED	False
12570	12799	9874564:5:STAT3:MYC	We show that [TF] binds to a region overlapping with the E2F site in the [TG] promoter and this site is critical for the c-myc gene promoter- driven transcriptional activation by IL-6 or gp130 signals.	STAT3	c-myc	1	ACTIVATION	False
12571	12800	9878062:4:JUN:CCND1	We show that in fibroblasts, [TF] is required for progression through the G1 phase of the cell cycle; c-Jun-mediated G1 progression occurs by a mechanism that involves direct transcriptional control of the [TG] gene, establishing a molecular link between growth factor signaling and cell cycle regulators.	c-Jun	cyclin D1	0	UNDEFINED	False
12572	12801	9880553:0:STAT1:HSPA4	[TF] and heat shock factor-1 interact and activate the transcription of the [TG] and Hsp-90beta gene promoters.	Signal transducer and activator of transcription-1	Hsp-70	1	ACTIVATION	False
12573	12802	9880553:1:STAT3:HSP90AA1	We have previously demonstrated that interleukin-6 (IL-6) increases the levels of the heat shock protein 90 ([TG]) and activates the Hsp-90beta promoter via the IL-6-activated transcription factors NF-IL6 and [TF] (STAT-3).	signal transducer and activator of transcription-3	Hsp-90	1	ACTIVATION	False
12574	12803	9880553:2:STAT1:HSPA4	Here, we show that interferon-gamma (IFN-gamma) treatment increases the levels of [TG] and Hsp-90 and also enhances the activity of the Hsp-70 and Hsp-90beta promoters with these effects being dependent on activation of the [TF] transcription factor by IFN-gamma.	STAT-1	Hsp-70	1	ACTIVATION	False
12575	12804	9880553:4:STAT1:HSPA4	The effect of IFN-gamma/[TF] was mediated via a short region of the [TG]/Hsp-90 promoters, which also mediates the effects of NF-IL6 and STAT-3 and can bind STAT-1.	STAT-1	Hsp-70	0	UNDEFINED	False
12576	12805	9880553:4:STAT3:HSP90AA1	The effect of IFN-gamma/STAT-1 was mediated via a short region of the Hsp-70/[TG] promoters, which also mediates the effects of NF-IL6 and [TF] and can bind STAT-1.	STAT-3	Hsp-90	0	UNDEFINED	False
12578	12807	9886825:6:HNF4A:MST1	These results suggest that [TG] gene expression requires CBP, and competition for limiting amounts of CBP by retinoic acid receptor may be a means of modifying the activity of [TF] at the HGFL gene promoter.	HNF-4	HGFL	0	UNDEFINED	True
12579	12808	9891062:2:FOXM1:AFP	By dissecting regulatory mechanisms through electromobility gel shift, transient-transfection, Western blot, and in vitro transcription analyses, we find that [TG] gene expression is controlled in part by mutually exclusive binding of two trans-acting factors, p53 and hepatic nuclear factor 3 ([TF]).	HNF-3	AFP	0	UNDEFINED	False
12580	12809	9915860:9:EGR1:PGP	Ectopic overexpression of [TF] in H35 cells decreased [TG] expression and selectively increased vinblastine sensitivity.	Egr-1	Pgp	2	REPRESSION	False
12581	12810	9927198:7:WT1:IGF2	Through this work we identified a number of novel target genes for the WT1 transcription factor, including uvomorulin, integrin alpha8 and perlecan, and suggest that [TF] may activate the [TG] gene, also implicated in the development of Wilms' tumor.	WTI	IGF-II	1	ACTIVATION	False
12582	12811	9973253:3:POU1F1:TSHB	[TF], a POU-homeo domain transcription factor, is specifically expressed in the anterior pituitary and is required both for the normal development of anterior pituitary cell types, somatotrophs, lactotrophs, and thyrotrophs, and for the expression of their hormones: GH, PRL, and [TG].	Pit-1	TSHbeta	1	ACTIVATION	False
12583	12812	9973262:10:STAT5A:CSN2	Enhancement of [TF] activity by GR is, therefore, one component of the transcriptional synergy exhibited by STAT5 and GR at the [TG] promoter and is an example of how transcription factors at a composite response element may modulate each other's activity.	STAT5	beta-casein	0	UNDEFINED	False
12584	12813	9973374:3:IRF1:PIGR	We previously reported that IFN-gamma and TNF-alpha induce production of the transcription factor IFN regulatory factor-1 ([TF]) in HT-29 cells and that IRF-1 binds to an element in exon 1 of the [TG] gene.	IRF-1	PIGR	0	UNDEFINED	False
12585	12814	9973374:6:IRF1:PIGR	Our findings indicate a major role for the [TF] transcription factor in regulation of the [TG] gene and suggest a model for regulation of important genes in the mucosal immune system by proinflammatory cytokines.	IRF-1	PIGR	0	UNDEFINED	False
12586	12815	9988237:2:TP53:ABCB1	The mutant tumour-suppressor [TF] protein has been shown to activate the [TG] promoter, whereas the wild-type p53 represses this activity in cultured cells.	p53	MDR1	2	REPRESSION	True
12587	12816	9988750:9:AP1:PTGS2	Treatment of cells with decoy oligonucleotides corresponding to [TG] promoter elements implicated the [TF] and NF-kappaB-2 but not the NF-kappaB-1 in the transcription of COX-2.	AP-1	COX-2	1	ACTIVATION	False
12588	12817	9988750:9:NFKB2:PTGS2	Treatment of cells with decoy oligonucleotides corresponding to [TG] promoter elements implicated the AP-1 and [TF] but not the NF-kappaB-1 in the transcription of COX-2.	NF-kappaB-2	COX-2	1	ACTIVATION	False
12589	12818	9990041:6:ATF2:CCND1	[TF] is present in nuclear extracts from chondrogenic cell lines and binds, as a complex with a CRE-binding protein (CREB)/CRE modulator protein, to the cAMP response element (CRE) in the [TG] promoter.	ATF-2	cyclin D1	0	UNDEFINED	False
12590	12819	9990041:6:CREB1:CCND1	ATF-2 is present in nuclear extracts from chondrogenic cell lines and binds, as a complex with a CRE-binding protein ([TF])/CRE modulator protein, to the cAMP response element (CRE) in the [TG] promoter.	CREB	cyclin D1	0	UNDEFINED	False
12591	12820	9990287:5:NFKB:IGFBP2	From examination of the [TG] gene promoter sequence which revealed the presence of four potential binding sites for transcription factors of the [TF]/Rel family, we hypothesized that NF-kappa B might be involved in the transcriptional activation of IGFBP-2 in oxidant-exposed cells.	NF-kappa B	IGFBP-2	1	ACTIVATION	False
12592	12821	9990287:6:NFKB:IGFBP2	Data reported herein demonstrated that [TF] activated [TG] promoter in transient transfection assays, and that exposure of cells to hyperoxia was associated with accumulation of the active form of NF-kappa B.	NF-kappa B	IGFBP-2	1	ACTIVATION	False
12594	12823	23287548:8:RUNX2:SLPI	Furthermore, a [TF] mutant lacking the nuclear matrix-targeting sequence (Runx2deltaNMTS) bound to the [TG] gene less efficiently than the wild-type protein and a Runx2 mutant that is deficient in its ability to bind to DNA (Runx2K120A) accumulated largely in the nuclear matrix.	Runx2	ALP	0	UNDEFINED	False
12595	12824	24836425:0:RUNX3:CD4	TCF-1 and LEF-1 act upstream of Th-POK to promote the [TG](+) T cell fate and interact with [TF] to silence Cd4 in CD8(+) T cells.	Runx3	CD4	2	REPRESSION	False
12596	12825	17324942:2:SOX2:POU5F1	Other studies have shown that [TF] and [TG] work together cooperatively to stimulate the transcription of their own genes as well as a network of genes required for embryogenesis.	Sox2	Oct-3/4	1	ACTIVATION	True
12597	12826	19306868:4:SOX9:RUNX2	In the present study, the transcriptional repressor vertebrate homolog of Drosophila bagpipe (Bapx1) was found to be a direct target of [TF] for repression of [TG] expression in chondrocytes.	Sox9	Runx2	2	REPRESSION	False
12599	12828	22031759:8:AP1:IL8	In conclusion, the results highlight a novel role for RSK1/2 and HSP27 phosphoproteins and of the cooperative role of the TFs NF-B, NF-IL6, [TF], CHOP, and CREB in P. aeruginosa-dependent induction of transcription of the [TG] gene in human bronchial epithelial cells.	AP-1	IL-8	1	ACTIVATION	True
12600	12830	10908602:7:FOSL2:DBH	The functional link between [TF] and regulation of tyrosine hydroxylase and [TG] transcription was confirmed in PC12 cells coexpressing this factor and the corresponding promoter-reporter gene constructs.	Fra2	dopamine beta-hydroxylase	0	UNDEFINED	False
12601	12831	10908602:7:FOSL2:TH	The functional link between [TF] and regulation of [TG] and dopamine beta-hydroxylase transcription was confirmed in PC12 cells coexpressing this factor and the corresponding promoter-reporter gene constructs.	Fra2	tyrosine hydroxylase	0	UNDEFINED	False
12602	12832	11313996:7:FOSL2:SPRR1B	In untreated cells, [TG] promoter is predominantly occupied by JunD and [TF].	Fra2	SPRR1B	0	UNDEFINED	False
12603	12833	11336976:2:NR1I2:CYP3A4	Recently, a novel orphan nuclear receptor, termed pregnane X receptor ([TF]), has been implicated to play a key role in the regulation of [TG] genes by xenobiotics.	PXR	CYP3A	0	UNDEFINED	False
12604	12835	12970370:7:NR4A1:POMC	We have previously shown that corticotropin-releasing hormone action is also exerted at the [TG] promoter through the orphan nuclear receptor [TF] and its recruitment of SRC co-activators.	NGFI-B	POMC	1	ACTIVATION	True
12605	12836	13679379:11:FOSL2:FOSL1	Chromatin immunoprecipitation assays revealed an enhanced recruitment of c-Jun, Jun-D, and [TF] to the endogenous [TG] promoter upon TPA stimulation.	Fra-2	fra-1	0	UNDEFINED	False
12606	12839	16237153:0:NR4A1:INSL3	The orphan nuclear receptor [TF] regulates [TG] gene transcription in Leydig cells.	NR4A1	insulin-like 3	0	UNDEFINED	False
12607	12840	16237153:7:NR4A1:INSL3	In the present study, we have identified the orphan nuclear receptor [TF] as a novel regulator of [TG] transcription in Leydig cells.	NR4A1	INSL3	0	UNDEFINED	False
12608	12841	16595694:3:NR4A1:ZNF461	Here, we demonstrate that orphan nuclear receptor [TF] regulates [TG] gene expression in testicular Leydig cell lines and that GIOT-1 acts as a novel corepressor of the orphan nuclear receptor steroidogenic factor 1 (SF-1).	Nur77	GIOT-1	0	UNDEFINED	True
12609	12843	17419679:0:FOSL2:TCIRG1	Differential binding of poly(ADP-Ribose) polymerase-1 and JunD/[TF] accounts for RANKL-induced [TG] gene expression during osteoclastogenesis.	Fra2	Tcirg1	1	ACTIVATION	True
12610	12844	17977826:5:NR5A2:APOM	Taken together, our results demonstrate that [TF] is a novel regulator of [TG] transcription and further extend the role of this orphan nuclear receptor in lipoprotein metabolism and cholesterol homeostasis.	LRH-1	APOM	0	UNDEFINED	False
12611	12846	18088579:6:FOSL2:IBSP	Promoter activity experiments in combination with DNA mobility shift assays demonstrated that [TG] promoter activity is under the control of the CRE element, through CREB-1, JunD and [TF] binding, in MDA-MB-231, MCF-7 and in Saos-2 cells.	Fra-2	BSP	0	UNDEFINED	False
12613	12851	21146499:0:NR4A1:PRL	The orphan nuclear receptor [TF] regulates decidual [TG] expression in human endometrial stromal cells.	Nur77	prolactin	0	UNDEFINED	False
12614	12856	22174013:3:NR2E3:ESR1	We demonstrated that orphan nuclear receptor [TF] regulates [TG] via direct binding to the ESR1 promoter with concomitant recruitment of PIAS3 to the promoter in breast cancer cells, and is essential for physiological cellular activity of ESR1 in estrogen receptor (ER)-positive breast cancer cells.	NR2E3	ESR1	0	UNDEFINED	False
12615	12857	22761936:0:NR4A1:AR	Orphan nuclear receptor [TF] regulates [TG] gene expression in mouse ovary.	Nur77	androgen receptor	0	UNDEFINED	False
12616	12858	22990073:0:FOSL2:ITGAX	Transcriptional regulation of the mouse [TG] promoter by AP-1 complex with JunD and [TF] in dendritic cells.	Fra2	CD11c	0	UNDEFINED	False
12617	12859	22990073:5:FOSL2:ITGAX	The direct interaction of JunD and [TF] with the [TG] promoter was further confirmed by a chromatin immunoprecipitation assay using CD11c-positive cells purified from BMDCs.	Fra2	CD11c	0	UNDEFINED	False
12618	12860	23028064:1:NR4A1:INSL3	Nuclear receptor subfamily 4 group A member1 ([TF]), an orphan nuclear receptor, is involved in the transcriptional regulation of thecal cell androgen biosynthesis and paracrine factor [TG] (INSL3) expression.	NR4A1	insulin-like 3	0	UNDEFINED	False
12619	12861	23339184:0:FOSL2:BRCA1	Microenvironmental regulation of [TG] gene expression by c-Jun and [TF] in premalignant human ovarian surface epithelial cells.	Fra2	BRCA1	0	UNDEFINED	False
12621	12864	23836374:0:NR4A1:INHA	FSH modulates the expression of [TG] and the secretion of inhibins via orphan nuclear receptor [TF] in ovarian granulosa cells.	NUR77	inhibin-alpha	0	UNDEFINED	False
12622	12865	7559437:0:HNF4A:F7	Orphan nuclear receptor [TF] binds to the human coagulation [TG] promoter.	HNF-4	factor VII	0	UNDEFINED	False
12623	12866	9614069:1:EGR1:LHB	Recent in vivo and in vitro studies have implicated the orphan nuclear receptor, steroidogenic factor-1 (SF-1), and the [TF] (Egr-1) in the transcriptional regulation of the luteinizing hormone beta-subunit ([TG]) gene.	early growth response protein 1	LHbeta	0	UNDEFINED	False
12624	12867	9651314:0:FOSL2:LAMA3	Three activator protein-1-binding sites bound by the [TF].JunD complex cooperate for the regulation of murine laminin alpha3A ([TG]) promoter activity by transforming growth factor-beta.	Fra-2	lama3A	0	UNDEFINED	False
12625	12868	10908602:6:FOSL2:DBH	The induction of [TF] and increased AP1-like binding activity was reflected in sustained transcriptional activation of tyrosine hydroxylase and [TG] genes after repeated episodes of stress.	Fra2	dopamine beta-hydroxylase	1	ACTIVATION	False
12626	12870	11174853:5:NR4A1:POMC	[TF], an orphan nuclear receptor that exerts positive regulatory effects on the [TG] gene is also known to bind to this DNA element.	Nur77	POMC	1	ACTIVATION	False
12627	12871	11254751:0:FOSL2:IVL	Cholesterol sulfate stimulates [TG] transcription in keratinocytes by increasing Fra-1, [TF], and Jun D.	Fra-2	involucrin	1	ACTIVATION	False
12628	12873	11256950:0:NR1I3:CYP2B6	Xenobiotic induction of cytochrome P450 2B1 ([TG]) is mediated by the orphan nuclear receptor constitutive androstane receptor ([TF]) and requires steroid co-activator 1 (SRC-1) and the transcription factor Sp1.	CAR	CYP2B1	1	ACTIVATION	False
12629	12874	11331284:0:NR5A2:CETP	The orphan nuclear receptor [TF] potentiates the sterol-mediated induction of the human [TG] gene by liver X receptor.	LRH-1	CETP	1	ACTIVATION	False
12630	12875	11331284:3:NR5A2:CETP	In this study we show that the orphan nuclear receptor [TF] also transactivates the [TG] promoter by binding to a proximal promoter element distinct from the DR4 site.	LRH-1	CETP	1	ACTIVATION	False
12631	12876	12072427:2:NR1I2:CYP3A4	Many inducers of human [TG], such as rifampicin, bind to the orphan nuclear receptor [TF] (steroid and xenobiotic receptor) as ligands and stimulate transcription on xenobiotic response elements located in the CYP3A4 promoter.	SXR	CYP3A4	1	ACTIVATION	False
12632	12881	12514743:5:HNF4A:CYP3A4	Here we show that the orphan nuclear receptor hepatocyte nuclear factor-4alpha (HNF4alpha; [TF]) is critically involved in the PXR- and CAR-mediated transcriptional activation of [TG]4.	HNF4A	CYP3A	1	ACTIVATION	False
12633	12882	12514743:5:NR1I2:CYP3A4	Here we show that the orphan nuclear receptor hepatocyte nuclear factor-4alpha (HNF4alpha; HNF4A) is critically involved in the [TF]- and CAR-mediated transcriptional activation of [TG]4.	PXR	CYP3A	1	ACTIVATION	False
12634	12883	12514743:5:NR1I3:CYP3A4	Here we show that the orphan nuclear receptor hepatocyte nuclear factor-4alpha (HNF4alpha; HNF4A) is critically involved in the PXR- and [TF]-mediated transcriptional activation of [TG]4.	CAR	CYP3A	1	ACTIVATION	False
12635	12884	12954636:2:NR2C2:APOE	Here we demonstrate that the [TF] orphan nuclear receptor (TR4) can induce [TG] expression in HepG2 cells.	TR4	apoE	1	ACTIVATION	False
12636	12885	15121760:0:NR5A2:ABCG5	The orphan nuclear receptor [TF] activates the [TG]/ABCG8 intergenic promoter.	LRH-1	ABCG5	1	ACTIVATION	False
12637	12886	15121760:0:NR5A2:ABCG8	The orphan nuclear receptor [TF] activates the ABCG5/[TG] intergenic promoter.	LRH-1	ABCG8	1	ACTIVATION	False
12638	12887	15121760:2:NR5A2:ABCG5	Here, we identify a binding site for the orphan nuclear receptor liver receptor homolog-1 ([TF]) at nt 134-142 of the [TG]/ABCG8 intergenic region necessary for the activity of both the ABCG5 and ABCG8 promoters.	LRH-1	ABCG5	1	ACTIVATION	False
12639	12888	15121760:2:NR5A2:ABCG8	Here, we identify a binding site for the orphan nuclear receptor liver receptor homolog-1 ([TF]) at nt 134-142 of the ABCG5/[TG] intergenic region necessary for the activity of both the ABCG5 and ABCG8 promoters.	LRH-1	ABCG8	1	ACTIVATION	False
12640	12889	15670754:0:NR2C2:APOE	Induction of [TG] expression by [TF] orphan nuclear receptor via 5' proximal promoter region.	TR4	apolipoprotein E	1	ACTIVATION	False
12641	12890	15701640:6:NR4A1:POMC	In vivo, NeuroD is found in a complex that includes Rb and also the orphan nuclear receptor [TF], which mediates corticotropin-releasing hormone activation of [TG] transcription.	NGFI-B	POMC	1	ACTIVATION	False
12642	12891	16087728:3:EGR1:LHB	One of these factors, pituitary homeobox 1 (Pitx1), has been shown to stimulate [TG] gene promoter activity, both alone and in synergy with the orphan nuclear receptor, steroidogenic factor-1 (SF-1), and the [TF] (Egr-1).	early growth response gene 1	LHbeta	1	ACTIVATION	False
12643	12892	16087728:3:PITX1:LHB	One of these factors, pituitary homeobox 1 ([TF]), has been shown to stimulate [TG] gene promoter activity, both alone and in synergy with the orphan nuclear receptor, steroidogenic factor-1 (SF-1), and the early growth response gene 1 (Egr-1).	Pitx1	LHbeta	1	ACTIVATION	False
12644	12893	16574740:4:RORB:OPN1SW	We report that the orphan nuclear receptor [TF] (retinoid-related orphan receptor beta) activates the S opsin gene ([TG]) through binding sites upstream of the gene.	RORbeta	Opn1sw	1	ACTIVATION	False
12645	12896	17182554:3:REL:IL23A	We report, in this study, that murine dendritic cells deficient in [TF], a member of the NF-kappaB family, are severely compromised in their ability to transcribe the p19 gene, one of the two genes that encode the [TG] protein.	c-Rel	IL-23	1	ACTIVATION	False
12647	12898	17226773:3:NR5A1:POU5F1	In this study, we demonstrate that the orphan nuclear receptor steroidogenic factor-1 ([TF]) behaves as a transcriptional activator of human [TG] (hOct4) through direct interaction with a SF-1 binding element in the hOct4 proximal promoter.	SF-1	Oct4	1	ACTIVATION	False
12648	12903	18071306:0:FOSL2:CCR4	Aberrant expression of [TF] promotes [TG] expression and cell proliferation in adult T-cell leukemia.	Fra-2	CCR4	1	ACTIVATION	False
12649	12904	18071306:6:FOSL2:CCR4	Consistently, the [TF]/JunB and Fra-2/JunD heterodimers strongly activated the [TG] promoter in Jurkat cells.	Fra-2	CCR4	1	ACTIVATION	False
12650	12905	18088579:8:FOSL2:IBSP	Over-expression of JunD and [TF] increased [TG] promoter activity and upregulated endogenous BSP protein expression in MCF-7 and Saos-2 cells while siRNA-mediated inhibition of both factors expression significantly reduced BSP protein level in MDA-MB-231.	Fra-2	BSP	1	ACTIVATION	False
12651	12906	19264843:0:ESRRA:SFTPA1	cAMP enhances [TF] (ERRalpha) transcriptional activity at the [TG] promoter by increasing its interaction with protein kinase A and steroid receptor coactivator 2 (SRC-2).	estrogen-related receptor alpha	SP-A	1	ACTIVATION	False
12652	12907	19264843:2:ESRRA:SFTPA1	Furthermore, protein kinase A (PKA) up-regulates [TF] activation of the h[TG] promoter.	ERRalpha	SP-A	1	ACTIVATION	False
12653	12908	19462000:7:ESRRA:TFF1	Also, ERalpha (ESR1) mRNA levels were not affected upon treatment with the [TF] antagonist, but other ERRalpha (ESRRA) target genes such as pS2 ([TG]), osteopontin (SPP1), and aromatase (CYP19A1) mRNA levels decreased.	ERRalpha	TFF1	1	ACTIVATION	True
12654	12910	20059973:0:NR4A1:APOA5	Orphan nuclear receptor [TF] participates in [TG] gene expression.	Nur77	human apolipoprotein A5	1	ACTIVATION	False
12655	12911	20427335:0:FOSL2:TGFB1	[TF] mediates oxygen-sensitive induction of [TG] in cardiac fibroblasts.	Fra-2	transforming growth factor beta	1	ACTIVATION	False
12656	12912	20427335:8:FOSL2:TGFB1	Knockdown of [TF] significantly blunted O(2)-induced expression of [TG]1 as well as TGFbeta3 in CF.	Fra-2	TGFbeta	1	ACTIVATION	False
12657	12913	20427335:8:FOSL2:TGFB3	Knockdown of [TF] significantly blunted O(2)-induced expression of TGFbeta1 as well as [TG] in CF.	Fra-2	TGFbeta3	1	ACTIVATION	False
12658	12915	22359603:0:NR5A2:GREB1	The orphan nuclear receptor [TF] and ER activate [TG] expression to induce breast cancer cell proliferation.	LRH-1	GREB1	1	ACTIVATION	False
12659	12916	22492284:9:FOSL2:IBSP	The results of gel shift showed that 0.1 g/ml decreased while 0.01 g/ml A. actinomycetemcomitans LPS increased CRE-, FRE-, and HOX-binding protein complexes formation at 6 h, and revealed that 0.01 g/ml A. actinomycetemcomitans LPS induced [TG] transcription through CREB1, JunD, [TF], c-Fos, Runx2, Dlx5, and Smad1 targeting those response elements.	Fra2	BSP	1	ACTIVATION	False
12661	12919	24885573:3:NR4A1:FGF21	In the present study, we investigated whether the fasting-induced activation of the orphan nuclear receptor [TF] increases hepatic [TG] expression.	Nur77	FGF21	1	ACTIVATION	False
12662	12920	9315653:4:NR4A1:POMC	Our recent identification of the orphan nuclear receptor [TF] as a mediator of CRH induction of [TG] transcription led us, in the present work, to show that Gc antagonize this positive signal at two levels.	Nur77	POMC	1	ACTIVATION	False
12663	12921	9727070:3:NR1I2:CYP3A4	We report the identification of a human (h) orphan nuclear receptor, termed the pregnane X receptor ([TF]), that binds to a response element in the [TG]4 promoter and is activated by a range of drugs known to induce CYP3A4 expression.	PXR	CYP3A	1	ACTIVATION	False
12664	12922	9746364:7:FOSL2:CYP11B1	Furthermore, when components of AP-1 factors were overexpressed by transfecting Y1 cells with their expression vectors, a paired expression of AP-1 components such as c-Jun and c-Fos, which were inducible by corticotropin, transactivated the [TG] promoter more strongly in the absence of corticotropin than other combinations such as JunD and [TF] expressed constitutively.	Fra-2	CYP11B1	1	ACTIVATION	False
12665	12923	9799805:7:HNF4A:CYP7A1	Cotransfection of [TF] plasmid with another orphan nuclear receptor, chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII), synergistically activated the [TG] transcription by 80-fold.	HNF-4	CYP7A	1	ACTIVATION	False
12666	12927	15618352:8:FOSL2:GJA1	Because expression of [TF] increases earlier than other Fos family members and confers the highest transcriptional drive to the [TG] promoter, our data suggest that Fra-2 is a central component in the regulation of Cx43 expression during labor.	Fra-2	Cx43	1	ACTIVATION	False
12667	12928	17655826:0:NR2C2:BCL2	[TF] orphan nuclear receptor functions as an apoptosis modulator via regulation of [TG] gene expression.	TR4	Bcl-2	0	UNDEFINED	True
12668	12931	22127978:0:IRF3:IL23A	Enhanced [TF] binding to the [TG]p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus.	interferon regulatory factor 3	interleukin-23	1	ACTIVATION	False
12669	12932	18593980:10:TCF4:COPS5	PPARgamma ligands troglitazone and rosiglitazone down-regulated [TG] expression in HCC cells, and troglitazone directly suppressed Jab1 promoter activity by inhibiting Sp1- and [TF]-mediated transcription.	Tcf4	Jab1	1	ACTIVATION	False
12671	12935	11030332:4:NR0B2:CYP7A1	[TF] represses expression of [TG] by inhibiting the activity of liver receptor homolog 1 (LRH-1), an orphan nuclear receptor that is known to regulate CYP7A1 expression positively.	SHP-1	CYP7A1	2	REPRESSION	False
12672	12937	11030332:4:NR5A2:CYP7A1	SHP-1 represses expression of [TG] by inhibiting the activity of liver receptor homolog 1 ([TF]), an orphan nuclear receptor that is known to regulate CYP7A1 expression positively.	LRH-1	CYP7A1	1	ACTIVATION	True
12673	12939	11861672:6:FOSL2:ABCA1	Co-transfection of USF1 and USF2 enhanced, but [TF] repressed, [TG] promoter activity.	Fra2	ABCA1	2	REPRESSION	False
12674	12940	11861672:7:FOSL2:ABCA1	Thus, a complex consisting of USF1, USF2, and [TF] binds the E-box motif 147 bp upstream of the transcriptional start site and facilitates repression of the human [TG] promoter.	Fra2	ABCA1	2	REPRESSION	False
12675	12942	16224068:5:FOSL2:ABCA1	Ang II treatment reduced [TG] promoter activity of in vitro cultured mouse peritoneal macrophages, inducing fos-related antigen 2 ([TF]) protein binding to an ABCA1 promoter E-box motif, a site known to negatively regulate macrophage ABCA1 transcription.	Fra2	ABCA1	2	REPRESSION	False
12676	12943	16224068:6:FOSL2:ABCA1	Valsartan pretreatment blocked [TF] binding to the [TG] promoter, and Fra2 small interfering RNA pretreatment attenuated Ang II-mediated ABCA1 transcriptional inhibition, confirming the role of Fra2 in this process.	Fra2	ABCA1	2	REPRESSION	False
12677	12944	17030610:3:NR6A1:POU5F1	Here we show that the orphan nuclear receptor [TF] initiates [TG] repression and DNA methylation by the differential recruitment of MBD (methylated CpG binding domain) factors to the promoter.	GCNF	Oct4	2	REPRESSION	True
12678	12945	16267049:5:ESRRA:PCK2	Suppression of [TF] expression by small interfering RNA leads to reduced binding of ERRalpha to the endogenous [TG] gene, and an increase in promoter occupancy by PGC-1alpha, suggesting that part of the ERRalpha function at this gene is to antagonize the action of PGC-1alpha.	ERRalpha	PEPCK	0	UNDEFINED	True
12680	12947	17636245:10:RELA:IL8	Taken together, these data suggest that DON-induced [TG] expression is likely to be mediated at the transcriptional level by NF-kappaB, specifically [TF], but does not appear to involve mRNA stabilization.	p65	IL-8	1	ACTIVATION	True
12681	12948	19668231:6:RELA:IL8	Pin1 knockdown decreases the amount of activated, phosphorylated [TF] in the nucleus, resulting in inhibition of the transcriptional program of the [TG] gene.	p65	IL-8	1	ACTIVATION	True
12682	12949	22848596:5:RELA:IL8	ChIP assays clearly revealed that ExoU promotes [TF] binding to NF-B site in [TG] promoter and the treatment of cultures with the NF-B inhibitor Bay 11-7082 led to a significant reduction in IL-8 mRNA levels and protein secretion induced by ExoU.	p65	IL-8	1	ACTIVATION	True
12684	12951	16684540:5:NFKB:VEGFA	These data suggest that [TF]-dependency of the PAF-induced increase in [TG] expression is due to decreased p53 activity, which is reciprocally regulated by increased NF-kappaB activity.	NF-kappaB	VEGF	1	ACTIVATION	True
12685	12952	16957179:0:NR1H4:FASN	Coordinated control of bile acids and lipogenesis through [TF]-dependent regulation of [TG].	FXR	fatty acid synthase	0	UNDEFINED	False
12686	12953	21996678:7:FOSB:TNC	[TF] silencing attenuated the expression of the profibrotic factors tenascin C ([TG]) and connective tissue growth factor (CTGF), whereas forced expression of Jun~FosB stimulated TNC and CTGF promoter activity.	FosB	TNC	1	ACTIVATION	False
12687	12954	22140532:9:ERG:CCNB1	The up-regulation of PIM1 induced by t[TF] over-expression significantly modified [TG] levels and increased the percentage of aneuploid cells in the RWPE-1 cell line after taxane-based treatment.	ERG	Cyclin B1	0	UNDEFINED	True
12688	12955	22190458:6:TEAD2:ME1	Using chromatin immunoprecipitation (ChIP), we show that TAZ is directly recruited to a majority of [TG] gene promoters in a complex with [TF].	TEAD2	MES	0	UNDEFINED	False
12689	12956	22359570:10:TFAP2A:CTNNAL1	The activation of [TF] and LEF-1, followed by [TG] expression, showed a correlation during a 16-hour time course.	AP-2	CTNNAL1	1	ACTIVATION	False
12690	12957	9058591:4:RARG:IVL	When compared with normal keratinocytes or other squamous cell carcinoma lines that display normal levels of [TF], several measures of cellular response to retinoic acid are altered in SCC 12F cells, including inhibition of cornified envelope formation, reduction of [TG] mRNA expression, and transcriptional regulation of the involucrin gene.	RARgamma	involucrin	1	ACTIVATION	True
12691	12958	22495934:5:EMX2:SOX2	In vivo, loss of one [TF] allele increased [TG] levels in the medial telencephalic wall, including the hippocampal primordium.	Emx2	Sox2	2	REPRESSION	False
12692	12959	15774940:9:CDX2:IAPP	Cdx1 activates the [TG] gene via a novel cis element, whereas [TF] inhibits the Cdx1 effects.	Cdx2	IAP	2	REPRESSION	False
12693	12960	11997022:3:CDX2:CDX1	Reciprocally, the paralogue homeobox gene [TF] exerts an inhibitory effect on the basal and on the beta-catenin-stimulated activity of the [TG] promoter.	Cdx2	Cdx1	2	REPRESSION	False
12694	12962	15013430:6:CDX2:PTGS2	The ectopic expression of [TF] was found to suppress PMA-induced [TG] promoter activity in a dose-dependent manner.	CDX2	COX-2	2	REPRESSION	False
12695	12963	15013430:9:CDX2:PTGS2	These results suggest that reduced [TF] expression may be involved in colorectal carcinogenesis by enhancing NF-kappaB-mediated inflammatory genes such as [TG].	CDX2	COX-2	2	REPRESSION	False
12696	12964	15229229:8:ETV6:STAT3	Confirming these results, overexpression of [TF] repressed [TG] transcriptional activity.	TEL	Stat3	2	REPRESSION	False
12697	12965	17060321:7:CUX1:RUNX2	Our studies further show regulation of the [TG] gene by several homeodomain proteins: MSX2 and [TF]/cut repress whereas DLX3 and DLX5 activate endogenous Runx2 expression and promoter activity in non-osseous cells and osteoblasts.	CDP	Runx2	2	REPRESSION	False
12698	12966	17297462:0:CDX2:IGFBP3	[TF] promotes anchorage-independent growth by transcriptional repression of [TG].	CDX2	IGFBP-3	2	REPRESSION	False
12699	12967	17297462:3:CDX2:IGFBP3	Here, we present evidence that [TF] negatively regulates the well-documented growth inhibitor [TG] (IGFBP-3).	CDX2	insulin-like growth factor binding protein-3	2	REPRESSION	False
12700	12968	17297462:4:CDX2:IGFBP3	Specifically, [TF] binds to the [TG] gene promoter and can repress IGFBP-3 transcription, protein expression and secretion.	CDX2	IGFBP-3	2	REPRESSION	False
12701	12969	17579210:5:CEBPB:RUNX2	In the present study, we show that [TF] (C/EBPbeta) is a negative regulator of [TG] expression and acts by directly binding a C/EBP element located at -591/-576 within the osteoblast-specific Runx2 P1 promoter.	CCAAT/enhancer binding protein beta	Runx2	2	REPRESSION	False
12702	12970	17876541:0:CDX2:PTGS2	Homeobox protein [TF] reduces [TG] transcription by inactivating the DNA-binding capacity of nuclear factor-kappaB.	CDX2	Cox-2	2	REPRESSION	False
12703	12971	17876541:8:CDX2:PTGS2	[TF] decreased expression of [TG] mRNA and protein at the transcriptional level in the human colon cancer Caco-2 cell line.	CDX2	COX-2	2	REPRESSION	False
12704	12972	18396140:6:CEBPB:KLF4	[TF] knockdown increases levels of [TG] and Krox20, suggesting that C/EBPbeta normally suppresses Krox20 and KLF4 expression via a tightly controlled negative feedback loop.	C/EBPbeta	KLF4	2	REPRESSION	False
12705	12973	18430739:7:EZH2:RUNX3	Immunofluorescence staining confirmed restoration of expression of the [TG] protein after knockdown of [TF] and its restoration resulted in decreased cell proliferation.	EZH2	RUNX3	2	REPRESSION	False
12706	12974	19127412:6:FOXA1:BCL2	Moreover, [TF] overexpression decreased the expression of [TG], while Foxa1 depletion increased the expression of bcl2.	Foxa1	bcl2	2	REPRESSION	False
12707	12976	19127412:9:FOXA1:BCL2	These results indicate that [TF] plays a pro-apoptotic role by inhibiting the expression of anti-apoptotic gene [TG].	Foxa1	bcl2	2	REPRESSION	False
12709	12978	19607821:10:FOXA1:HELT	[TF] and Foxa2 also inhibit GABAergic neuron differentiation by repressing the [TG] gene in the ventral midbrain.	Foxa1	Helt	2	REPRESSION	False
12710	12979	19607821:7:FOXA1:NKX2-2	Our studies show that [TF] and Foxa2 positively regulate Lmx1a and Lmx1b expression and inhibit [TG] expression in mesodiencephalic dopaminergic progenitors.	Foxa1	Nkx2.2	2	REPRESSION	False
12711	12980	20199401:8:CDX2:SHH	In conclusion, [TF] reduced [TG] expression by binding to the unmethylated Shh promoter in the intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach.	Cdx2	Shh	2	REPRESSION	False
12712	12981	20485553:0:CDX2:POU5F1	Brg1 is required for [TF]-mediated repression of [TG] expression in mouse blastocysts.	Cdx2	Oct4	2	REPRESSION	False
12713	12982	20485553:2:CDX2:POU5F1	Evidence indicates that suppression of [TG] expression in the trophectoderm is mediated by [TF].	Cdx2	Oct4	2	REPRESSION	False
12714	12983	20485553:4:CDX2:POU5F1	Here we show that the chromatin remodeling protein Brg1 is required for [TF]-mediated repression of [TG] expression in mouse blastocysts.	Cdx2	Oct4	2	REPRESSION	False
12715	12984	20966395:4:ERG:ICAM1	By using human umbilical vein endothelial cells (HUVECs), we showed that [TF] overexpression by adenovirus (AdErg) repressed basal and TNF--induced expression of intercellular adhesion molecule-1 ([TG]), vascular cell adhesion molecule (VCAM), and interleukin 8 (IL-8).	Erg	ICAM-1	2	REPRESSION	False
12716	12985	20966395:5:ERG:ICAM1	[TF] inhibited TNF--dependent activation of the [TG] promoter, nuclear factor (NF)-B activity, and NF-B p65 phosphorylation.	Erg	ICAM-1	2	REPRESSION	False
12717	12986	21395583:9:ELK1:SPAST	Over-expression of [TF] showed that it repressed the [TG] promoter and also decreased spastin protein level in SHSY-5Y cells.	Elk1	SPG4	2	REPRESSION	False
12718	12987	21612856:5:CEBPB:RUNX2	We have shown previously in mesenchymal stem cells that RA acts to stimulate osteoblastogenesis by interfering with the actions of the bzip transcription factor [TF] (C/EBP), where it binds to a negative regulatory element within the [TG] promoter and inhibits its expression.	CCAAT/Enhancer Binding Protein beta	Runx2	2	REPRESSION	False
12719	12988	22203039:7:FOXA1:SNAI2	We show that KLF4 and another epithelial determinant, [TF], are direct transcriptional inhibitors of [TG] expression in mouse and human prostate cancer cells.	FOXA1	SLUG	2	REPRESSION	False
12720	12989	22337883:5:ERG:ICAM1	Focusing on intercellular adhesion molecule 1(ICAM)-1 as a model, we identify two ETS binding sites (EBS -118 and -181) within the [TG] promoter required for [TF]-mediated repression.	Erg	ICAM-1	2	REPRESSION	False
12721	12990	22337883:7:ERG:ICAM1	Interestingly, inhibition of [TF] expression in quiescent EC results in increased NF-B-dependent [TG] expression, indicating that Erg represses basal NF-B activity.	Erg	ICAM-1	2	REPRESSION	False
12722	12991	23649632:8:CDX2:POU5F1	Additionally, induction of [TF] expression, as a result of decreased Smad2 expression, leads to repression of [TG] expression, which, together with the decreased Nanog expression, accelerates the loss of pluripotency.	Cdx2	Oct4	2	REPRESSION	False
12723	12992	24321385:5:CTCF:RUNX1	Cohesin initiates expression of [TG] in the posterior lateral mesoderm and influences promoter use, while [TF] represses its expression in the newly emerging cells of the tail bud.	CTCF	runx1	2	REPRESSION	False
12726	12995	20005806:4:FOXL2:SOX9	Inducible deletion of [TF] in adult ovarian follicles leads to immediate upregulation of testis-specific genes including the critical SRY target gene [TG].	Foxl2	Sox9	2	REPRESSION	False
12727	12996	20199401:7:CDX2:SHH	[TF] also down-regulated transcription of the [TG] gene in the human gastric carcinoma cell lines AGS, MKN45 and MKN74.	Cdx2	Shh	2	REPRESSION	False
12729	12998	22495934:7:EMX2:SOX2	Electrophoresis mobility shift assays and transfection indicated that [TF] represses the activities of both [TG] enhancers.	Emx2	Sox2	2	REPRESSION	False
12730	12999	10191264:7:ELK1:SOD1	These results suggest that the transcription factors [TF] and YY1, binding in the PRE and NRE respectively, co-ordinate the expression of the [TG] gene.	Elk1	SOD1	1	ACTIVATION	False
12731	13000	10506141:2:CDX2:GCG	The homeodomain transcription factors brain-4, pax-6, and [TF] have been shown to bind to these sites and to transactivate [TG] gene expression.	cdx-2	glucagon	1	ACTIVATION	False
12732	13001	10506141:4:CDX2:GCG	In transient transfection-expression experiments, we found that the transactivating effects of [TF] and pax-6 on the [TG] gene were greatly enhanced by the additional expression of p300.	cdx-2	glucagon	1	ACTIVATION	False
12733	13002	10506141:8:CDX2:GCG	Further, we found that the presence of [TF] enhanced the interaction of pax-6 with p300, thus establishing a molecular complex of transcription factors implicated in tissue-specific [TG] gene expression with the basal transcriptional machinery.	cdx-2	glucagon	1	ACTIVATION	False
12734	13003	10574717:8:ERG:ICAM2	Furthermore, an [TF] cDNA transactivated the [TG] promoter when transiently transfected into both HeLa cells and HUVEC.	Erg	ICAM-2	1	ACTIVATION	False
12735	13004	10669750:10:BACH2:FGF4	In transfection assays using fibroblast cells, the [TG] gene was upregulated in the presence of both MAZR and [TF] in a BTB/POZ domain-dependent manner.	Bach2	fgf4	1	ACTIVATION	False
12736	13005	10677375:0:CDX2:LCT	Interaction between the homeodomain proteins [TF] and HNF1alpha mediates expression of the [TG]-phlorizin hydrolase gene.	Cdx2	lactase	1	ACTIVATION	False
12737	13006	10692454:11:CDX2:BCL2	A strong induction of [TG] P2 promoter activity was observed in cotransfection studies of DHL-4 cells with the A-Myb and [TF] expression vectors, and increased endogenous Bcl-2 protein expression was observed in B cells transfected with A-Myb and/or Cdx2 expression constructs.	Cdx2	bcl-2	1	ACTIVATION	False
12738	13007	11340077:12:ELK1:PRL	Finally, antisense mediated reduction of [TF] in GH4 cells decreased insulin-increased [TG] gene expression and confirmed the requirement for Elk-1 for insulin-increased prolactin gene expression.	Elk-1	prolactin	1	ACTIVATION	False
12739	13008	11521200:6:CDX2:KLF4	We show that wild-type [TF] activates the [TG] promoter and that the mutated CDX2 has a dominant negative effect on wild-type function.	CDX2	GKLF	1	ACTIVATION	False
12740	13009	11593430:2:ETV1:MMP1	Further, the oncoprotein HER2/Neu synergizes with [TF] to stimulate [TG] transcription.	ER81	MMP-1	1	ACTIVATION	False
12741	13010	11934881:3:CDX2:CLDN2	Both Cdx1 and [TF] activated the [TG] promoter in the human intestinal epithelial cell line Caco-2.	Cdx2	claudin-2	1	ACTIVATION	False
12742	13011	11934881:4:CDX2:CLDN2	HNF-1alpha augmented the [TF]-induced but not Cdx1-induced transcriptional activation of the human [TG] promoter.	Cdx2	claudin-2	1	ACTIVATION	False
12744	13013	12554743:8:ERG:COL11A2	Treatment of cells with the histone deacetylase inhibitor trichostatin A enabled [TF] to transactivate the [TG] promoter, therefore abolishing the differential effects of EWS/ERG and ERG.	ERG	COL11A2	1	ACTIVATION	False
12745	13014	12559945:6:CDX2:MUC2	These results suggest that [TF], but not CDX1, interacts with the [TG] promoter and activates MUC2 transcription, and plays an important role in the differentiation of goblet cells.	CDX2	MUC2	1	ACTIVATION	False
12746	13015	12750007:7:ETV1:PSEN1	We show that in vitro translated [TF] indeed binds specifically to the -10 region of the [TG] promoter and that ER81 activates by two- to threefold the basal transcription of a presenilin-1 promoter-chloramphenicol acetyltransferase reporter synthetic gene (-119, +178)PS1CAT in transient infection assays in neuroblastoma cells (SK-N-SH).	ER81	PS1	1	ACTIVATION	False
12747	13016	12815054:0:DLX5:RUNX2	BMP-2-induced [TG] expression is mediated by [TF], and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression.	Dlx5	Runx2	1	ACTIVATION	False
12748	13017	12855703:8:CDX2:B3GALT5	Four factors, Cdx1, [TF], HNF1alpha, and HNF1beta, could bind to GCE and transcriptionally activate the [TG] gene.	Cdx2	beta3Gal-T5	1	ACTIVATION	False
12749	13018	12947087:4:ETV1:SMAD7	[TF] binds to two ETS sites within the [TG] promoter, and mutation of one of these ETS sites greatly decreases Smad7 induction by HER2/Neu and ER81.	ER81	Smad7	1	ACTIVATION	False
12750	13019	12970742:0:CDX2:CDKN1A	[TF], a homeobox transcription factor, upregulates transcription of the p21/[TG]/CIP1 gene.	CDX2	WAF1	1	ACTIVATION	False
12751	13020	12970742:8:CDX2:CDKN1A	Moreover, overexpression of [TF] increased the mRNA expression of [TG] in HT-29 colon carcinoma cells, as demonstrated by reverse transcription-polymerase chain reaction.	CDX2	p21	1	ACTIVATION	False
12752	13021	14525978:7:CDX2:MUC2	Only simultaneous mutation of the two sites resulted in inhibition of [TF]-mediated transactivation of [TG] promoter, implying that both Cdx-2 sites are active.	Cdx-2	MUC2	1	ACTIVATION	False
12753	13022	14525978:8:CDX2:MUC2	Finally, stable expression of [TF] in a gastric cell line initially not expressing Cdx-2, led to induction of [TG] expression.	Cdx-2	MUC2	1	ACTIVATION	False
12754	13023	14525978:9:CDX2:MUC2	In conclusion, this work demonstrates that [TF] activates the expression of [TG] mucin gene in gastric cells, inducing an intestinal transdifferentiation phenotype that parallels what is observed both in intestinal metaplasia and some gastric carcinomas.	Cdx-2	MUC2	1	ACTIVATION	False
12755	13024	15327990:2:CDX2:MOK	Using cDNA differential display, we identified [TG], a member of the mitogen-activated protein kinase superfamily, as one of the genes induced by a caudal-related homeobox transcription factor, [TF].	Cdx2	MOK	1	ACTIVATION	False
12756	13025	15383550:11:DLX5:RUNX2	Thus, [TF] transactivates ALP expression, directly by binding to its cognate response element and/or indirectly by stimulating [TG] expression, and Msx2 counteracts the direct transactivation of Dlx5.	Dlx5	Runx2	1	ACTIVATION	False
12757	13026	15631623:6:FOXA1:GCG	[TF] was shown to be an essential activator of [TG] gene expression in vivo.	Foxa1	glucagon	1	ACTIVATION	False
12758	13027	15825077:9:CDX2:HEPH	Activation of [TF] rapidly induced [TG] expression, and RNA interference-mediated inhibition of CDX2 led to lower HEPH expression.	CDX2	HEPH	1	ACTIVATION	False
12759	13028	16002547:8:CDX2:INS	[TF] bound to the [TG] gene promoter enhancer elements, and stimulated the expression of a luciferase reporter gene driven by these enhancer elements.	Cdx-2	insulin	1	ACTIVATION	False
12761	13030	16087863:6:FOXA1:TFF1	We found that ablation of [TF] expression in MCF-7 cells suppressed ERalpha binding to the prototypic [TG] promoter (which contains a FOXA1 binding site), hindered the induction of TFF1 expression by E2, and prevented hormone-induced reentry into the cell cycle.	FOXA1	TFF1	1	ACTIVATION	False
12762	13031	16274362:4:CDX2:ACAT2	Results of luciferase reporter and electrophoretic mobility shift assays show that [TF] and HNF1alpha exert a synergistic effect, enhancing the [TG] promoter activity through binding to these cis-elements.	CDX2	ACAT2	1	ACTIVATION	False
12763	13032	16297876:4:ELK1:PRKCA	After screening seven transcription factors in the putative cis-acting regulatory elements of human [TG] promoters, only [TF] and MZF-1 antisense oligonucleotide showed a significant reduction in the PKCalpha mRNA level.	Elk-1	PKCalpha	1	ACTIVATION	False
12764	13033	16331276:13:FOXA1:CDKN1B	In summary, we identified a [TF] binding site within the BRCA1-responsive element of the [TG] promoter and showed that FOXA1 activated the promoter alone and in conjunction with BRCA1.	FOXA1	p27(Kip1)	1	ACTIVATION	False
12765	13034	16331276:5:FOXA1:CDKN1B	In transient transfection reporter assays, [TF] could activate the [TG] promoter.	FOXA1	p27(Kip1)	1	ACTIVATION	False
12766	13035	16331276:6:FOXA1:CDKN1B	Cotransfection of BRCA1 and [TF] resulted in a synergistic activation of the [TG] promoter.	FOXA1	p27(Kip1)	1	ACTIVATION	False
12767	13036	16616718:4:CDX2:SLC15A1	In the present study, we investigated the effect of the intestinal transcription factors on the transcription of the [TG] gene and found that only [TF] markedly trans-activated the PEPT1 promoter.	Cdx2	PEPT1	1	ACTIVATION	False
12768	13037	16678147:4:FOXC1:DLL4	Notably, consistent with this observation, overexpression of Foxc genes in vitro induces expression of arterial markers such as Notch1 and its ligand Delta-like 4 ([TG]), and [TF] and Foxc2 directly activate the Dll4 promoter via a Foxc-binding site.	Foxc1	Dll4	1	ACTIVATION	False
12769	13038	16788384:8:CDX2:UGT2B7	[TF] activates the [TG] proximal promoter by binding to two adjacent sites.	Cdx2	UGT2B7	1	ACTIVATION	False
12770	13039	17000708:4:FOXC1:FGF19	[TF] positively regulates [TG] expression in corneal and periocular mesenchymal cells in cell culture and in zebrafish embryos.	FOXC1	FGF19	1	ACTIVATION	False
12771	13040	17060321:4:DLX3:RUNX2	Here we show that BMP2 induces [TF], a homeodomain protein that activates [TG] gene transcription.	DLX3	Runx2	1	ACTIVATION	False
12772	13041	17060321:7:DLX3:RUNX2	Our studies further show regulation of the [TG] gene by several homeodomain proteins: MSX2 and CDP/cut repress whereas [TF] and DLX5 activate endogenous Runx2 expression and promoter activity in non-osseous cells and osteoblasts.	DLX3	Runx2	1	ACTIVATION	False
12773	13042	17182120:7:CDX2:TFF3	These results suggest that [TF] plays a key role in the expression of [TG] in the intestine and perhaps in intestinal metaplasia of the stomach.	CDX2	TFF3	1	ACTIVATION	False
12774	13043	17433257:6:CEBPB:SOX6	Overexpressed [TF] activated the [TG] promoter, and mutant 4xCES6 constructs lacking the C/EBP motif lost their basal activity.	C/EBPbeta	Sox6	1	ACTIVATION	False
12775	13044	17468517:8:CDX2:CDKN1A	These data suggest that over-expression of [TF] mediated by nuclear beta-catenin and Cdx2 itself can cause an inhibition of Em Ca cell proliferation through up-regulation of p21([TG]) expression, modulating beta-catenin/TCF4-mediated transcription.	Cdx2	Waf1	1	ACTIVATION	False
12776	13045	17626048:0:ELK1:NR1H2	[TF] and SRF transcription factors convey basal transcription and mediate glucose response via their binding sites in the [TG] gene promoter.	Elk1	human LXRB	1	ACTIVATION	False
12777	13046	17901057:2:CDX2:GCG	Although it is known that multiple transcription factors such as Pax-6, [TF], c-Maf, Maf-B, and Brain-4 can activate the [TG] gene promoter through G1, their relative importance in vivo is unknown.	Cdx-2/3	glucagon	1	ACTIVATION	False
12778	13047	17901057:7:CDX2:GCG	Although Pax-6, [TF], Maf-B, and c-Maf were all able to bind G1 by themselves, we showed that Pax-6 could interact with Maf-B, c-Maf, and Cdx-2/3 and activate transcription of the [TG] gene promoter.	Cdx-2/3	glucagon	1	ACTIVATION	False
12779	13048	18003659:3:FOXA1:SFTPB	Repression is mediated by SMAD3 through interactions with NKX2.1 and [TF], two key transcription factors that are positive regulators of [TG] transcription.	FOXA1	SpB	1	ACTIVATION	False
12780	13049	18096076:7:ETV1:NAB2	Analysis of the [TG] promoter showed that it is also activated by ETS proteins (Ets2 and [TF]/ER81) and is bound by Ets2 in vivo.	Etv1	Nab2	1	ACTIVATION	False
12781	13050	18187037:4:FOXC1:CXCR4	Here we show that [TF] and Foxc2 directly induce [TG] expression by activating its promoter in endothelial cells.	Foxc1	CXCR4	1	ACTIVATION	False
12782	13051	18187037:5:FOXC1:CXCR4	Furthermore, [TF]-deficient endothelial cells show a significant reduction in [TG] expression as well as CXCL12-stimulated migration.	Foxc1	CXCR4	1	ACTIVATION	False
12783	13052	18240315:6:ELK1:MMP9	Phospho-[TF] bound to [TG] promoter and thereby induced transcription of MMP-9.	Elk-1	MMP-9	1	ACTIVATION	False
12784	13053	18506761:5:EGR1:HIF1A	We also provide evidence that the binding of [TF] is necessary for the trans-activation of the [TG] promoter.	Egr1	HIF-1alpha	1	ACTIVATION	False
12785	13054	18545664:6:FOXC1:HEY2	We found that [TF] and Foxc2 directly activate the [TG] promoter via Foxc binding elements.	Foxc1	Hey2	1	ACTIVATION	False
12786	13055	18769450:6:BACH2:IL2	Decreased [TG] gene transcription in UCB CD4(+) T cells transfected with [TF] siRNA was confirmed by a human IL-2 luciferase assay.	BACH2	IL-2	1	ACTIVATION	False
12787	13056	18819935:0:CDX2:DSC2	Repression of the [TG] gene expression in human colon cancer cells is relieved by the homeodomain transcription factors Cdx1 and [TF].	Cdx2	desmocollin 2	1	ACTIVATION	False
12788	13057	18819935:15:CDX2:DSC2	We conclude that the homeodomain transcription factors Cdx1 and [TF] regulate [TG] gene expression in intestinal epithelia by reversing the actions of a transcriptional repressor.	Cdx2	DSC2	1	ACTIVATION	False
12789	13058	19017640:7:ELK1:RUNX2	Similarly, exogenous expression of wild type [TF], but not a defective mutant that cannot be phosphorylated, enhances [TG] gene expression.	ELK1	Runx2	1	ACTIVATION	False
12790	13059	19486887:3:FOXA1:HSPA1A	The results showed overexpression of [TF] promoted the expression of [TG], while Foxa1 depletion, induced by antisense oligonucleotides, decreased the expression of HSP72 in MCF-7 cells under normal and heat stress condition.	Foxa1	HSP72	1	ACTIVATION	False
12791	13060	19486887:5:FOXA1:HSPA1A	Luciferase reporter showed that [TF] also increased the transcription activity of [TG] promoter.	Foxa1	HSP72	1	ACTIVATION	False
12793	13062	19607821:7:FOXA1:LMX1A	Our studies show that [TF] and Foxa2 positively regulate [TG] and Lmx1b expression and inhibit Nkx2.2 expression in mesodiencephalic dopaminergic progenitors.	Foxa1	Lmx1a	1	ACTIVATION	False
12794	13063	19607821:7:FOXA1:LMX1B	Our studies show that [TF] and Foxa2 positively regulate Lmx1a and [TG] expression and inhibit Nkx2.2 expression in mesodiencephalic dopaminergic progenitors.	Foxa1	Lmx1b	1	ACTIVATION	False
12795	13064	19620725:8:ELK1:BRF1	Reducing [TF] expression decreases [TG] expression.	Elk-1	Brf1	1	ACTIVATION	False
12796	13066	19890878:6:CDX2:BMP4	[TF] in turn binds to an FGF4-responsive enhancer element of the promoter region of [TG], leading to production and secretion of Bmp4.	Cdx2	Bmp4	1	ACTIVATION	False
12797	13067	19900445:10:CDX2:SLC5A8	CDX1 and [TF] bind the promoter region of [TG] and up-regulate its expression in cultured cells and in colonic epithelium.	CDX2	SLC5A8	1	ACTIVATION	False
12798	13068	19900445:8:CDX2:SLC5A8	Consistently, [TG] expression was significantly reduced in colons of Cdx1(-/-) or [TF](+/-) mice compared with wild-type mice.	Cdx2	Slc5a8	1	ACTIVATION	False
12799	13069	20127720:11:CDX2:ELMO3	Furthermore, we showed here that [TF] and SP1 can activate the [TG] promoter.	CDX2	ELMO3	1	ACTIVATION	False
12800	13070	20137095:8:ELK1:ZC3H12A	We conclude that the transcription factor [TF] plays an important role in the activation of [TG] expression in response to IL-1beta stimulation.	Elk-1	ZC3H12A	1	ACTIVATION	False
12801	13071	20448047:7:EGR1:HIF1A	Additionally, the Egr-1-mediated induction of [TG] and FLAP promoters was reduced to basal levels by [TF] small interfering RNA.	EGR-1	HIF-1alpha	1	ACTIVATION	False
12802	13072	20563261:6:ERG:CXCR4	We hypothesized that androgen-dependent regulation of the [TF] transcription factor could induce [TG] expression in PC cells.	ERG	CXCR4	1	ACTIVATION	False
12804	13074	20600580:10:ELF1:MEIS1	Moreover, small interfering RNA-mediated knockdown of [TF] in K562 cells was associated with a decreased [TG] expression.	ELF1	MEIS1	1	ACTIVATION	False
12805	13075	20600580:11:ELF1:MEIS1	We conclude that the ETS transcription factor [TF] is an important positive regulator of [TG] expression.	ELF1	MEIS1	1	ACTIVATION	False
12806	13076	20628005:6:FOXA1:UGT2B17	Using gene reporter, electromobility shift, and chromatin immunoprecipitation analyses, we show that [TF] binds to this site and stimulates the [TG] promoter.	FOXA1	UGT2B17	1	ACTIVATION	False
12807	13077	20699370:8:CDX2:ABCB1	RNA interference-mediated inhibition of [TF] decreased endogenous [TG] expression.	CDX2	MDR1	1	ACTIVATION	False
12808	13078	20736324:7:FOXA1:UGT2B15	Silencing of [TF] expression by small interfering RNA significantly reduced [TG] transcript levels, further confirming a crucial role of FOXA1 in controlling UGT2B15 gene expression.	FOXA1	UGT2B15	1	ACTIVATION	False
12809	13079	20933081:3:CDX2:CDX4	We have now found that [TG] expression is significantly down regulated in [TF](-/-) mutants suggesting previously unrecognized cross-regulatory interactions.	Cdx2	Cdx4	1	ACTIVATION	False
12810	13080	20933081:7:CDX2:CDX4	Electrophoretic mobility shift assays showed that [TF] bound to predicted Cdx response elements in the [TG] promoter which, when mutated, significantly reduced activity.	Cdx2	Cdx4	1	ACTIVATION	False
12811	13081	21036460:10:CDX2:SOX2	[TF] increased the transcriptional activity of the [TG] gene, and Sox2 increased the transcriptional activity of the Muc5Ac gene, which was reduced by cotransfecion of Cdx2 together with Sox2 in the human gastric carcinoma cell line AGS.	Cdx2	Sox2	1	ACTIVATION	False
12812	13082	21284881:11:CDX2:DPP4	[TG] mRNA and protein levels increase in a confluence-dependent manner in colon carcinoma cell lines, with c-Myc acting as a repressor and [TF] acting as an enhancer of CD26 expression.	Cdx2	CD26	1	ACTIVATION	False
12813	13083	21284881:8:CDX2:DPP4	In contrast, transfection of a siRNA targeted to [TF] resulted in decreased [TG] level.	Cdx2	CD26	1	ACTIVATION	False
12814	13084	21362474:7:ELK1:MCL1	It was shown that [TF] regulated the Mcl-1 gene expression required for survival, and that RNAi-mediated degradation of endogenous Elk-1 resulted in elimination of the [TG] message.	Elk-1	mcl-1	1	ACTIVATION	False
12815	13085	21622576:6:ETV1:POMC	We further show that [TF] enhances [TG] transcription on its own and in synergy with Tpit.	Etv1	POMC	1	ACTIVATION	False
12816	13086	21622576:9:ETV1:POMC	Furthermore, [TF] is present at the [TG] promoter, and siRNA-mediated knockdown of Etv1 in AtT-20 cells produces a significant decrease in POMC expression.	Etv1	POMC	1	ACTIVATION	False
12817	13087	21784897:5:FOXC1:TFAM	Conversely, inhibition of [TF] expression decreased mitochondrial mass, downregulated mitochondrial proteins, and PGC-1-regulated transcription factors, including nuclear respiratory factor 1 and mitochondrial transcription factor A ([TG]), and reduced activity of the TFAM promoter.	IHG-1	TFAM	1	ACTIVATION	False
12818	13088	22016432:9:CDX2:SLC10A2	In conclusion, the human [TG] promoter is activated transcriptionally by CDX1 and [TF].	CDX2	ASBT	1	ACTIVATION	False
12819	13089	22326557:0:CDX2:MEP1A	TNF--induced down-regulation of [TF] suppresses [TG] expression in colitis.	CDX2	MEP1A	1	ACTIVATION	False
12820	13090	22326557:12:CDX2:MEP1A	Finally, TNF- impaired the ability of [TF] to interact and activate its own, as well as the [TG] expression.	CDX2	MEP1A	1	ACTIVATION	True
12821	13091	22586032:8:AP1:STAT3	PKC--mediated activation of the [TG] promoter was inhibited by dominant-negative [TF] and IB kinase-, but stimulated by WT AP-1 and IB kinase-, suggesting that PKC- stimulates Stat3 transcription via the AP-1 and NF-B pathways.	AP-1	Stat3	1	ACTIVATION	False
12822	13092	22586091:5:ETV1:TIAM1	BDNF up-regulated both the NR2C and [TG] genes via the TrkB-Erk cascade and this up-regulation was blocked not only by inhibition of the activity-dependent signaling mechanisms but also by suppression of [TF] expression with Etv1 siRNA.	Etv1	Tiam1	1	ACTIVATION	False
12823	13093	22719836:10:CDX2:CLDN1	Interestingly, co-expression of activated -catenin further induced the [TF]-dependent upregulation of [TG] promoter activity while expression of the dominant negative (dn)-TCF-4 abrogated this activation.	Cdx2	claudin-1	1	ACTIVATION	False
12824	13094	22983443:3:ERG:RUNX1	In addition, we demonstrate that [TF] and FLI1 bind the RUNX1 promoter and that shRNA-mediated silencing of ERG leads to reduced expression of RUNX1 and [TG]-ETO, consistent with a role of ERG in transcriptional activation of these proteins.	ERG	AML1	1	ACTIVATION	False
12825	13095	23063436:4:ELK4:FOS	Knockdown of [TF] decreased expression of the immediate early genes egr1 and [TG] and subsequent proliferation normally present with high adhesion, whereas knockdown of Net rescued egr1 and fos expression and proliferation normally suppressed by low adhesion.	Sap-1	fos	1	ACTIVATION	False
12826	13096	23145080:8:FOXC1:MSX2	Using a luciferase reporter assay, we demonstrate that [TF] can stimulate the activity of the both human and mouse [TG] promoters.	FOXC1	MSX2	1	ACTIVATION	False
12827	13097	23319146:10:ERG:TDRD1	Our findings show [TG] as the first identified upregulated direct [TF] target gene that is strongly associated with ERG overexpression in primary prostate cancer.	ERG	TDRD1	1	ACTIVATION	False
12828	13098	23319146:8:ERG:TDRD1	In the prostate cancer cell line VCaP, downregulation of [TF] by shRNA lead to a lower expression level of [TG] and resulted in a decreased activity of the TDRD1 promoter.	ERG	TDRD1	1	ACTIVATION	False
12829	13099	23393221:6:CDX2:APC	Transfection of intestinal and non-intestinal cell lines demonstrated that [TF] activated [TG] and AXIN2 promoter activities via intestinal cell-specific enhancer elements.	CDX2	APC	1	ACTIVATION	False
12830	13100	23393221:6:CDX2:AXIN2	Transfection of intestinal and non-intestinal cell lines demonstrated that [TF] activated APC and [TG] promoter activities via intestinal cell-specific enhancer elements.	CDX2	AXIN2	1	ACTIVATION	False
12831	13101	23852341:7:BACH2:TP53	Chromatin immunoprecipitation sequencing and gene expression analyses carried out by us revealed that [TF] competes with BCL6 for promoter binding and reverses BCL6-mediated repression of [TG] and other cell cycle checkpoint-control genes.	BACH2	p53	1	ACTIVATION	False
12832	13102	23918819:5:ERG:CXCR4	Using multiple molecular strategies, it was demonstrated that (i) [TF] expressed in TMPRSS2-ERG fusion positive VCaP cells selectively binds to specific ERG/Ets bindings sites in the [TG] promoter; (ii) distal binding sites mediate promoter activation; (iii) exogenously expressed ERG promotes CXCR4 expression; (iv) ERG is phosphorylated at Serine-81 and -215, by both IKK and Akt kinases, and Akt mediates CXCR4 expression; (v) ERG-induced CXCR4 drives CXCL12-dependent adhesion to fibronectin; and (vi) ERG and CXCR4 were coexpressed in human prostate cancer tissue, consistent with ERG-mediated transcriptional activation of CXCR4.	ERG	CXCR4	1	ACTIVATION	False
12833	13103	23918819:6:ERG:CXCR4	These data demonstrate that [TF] activates [TG] expression by binding to specific ERG/Ets responsive elements and via intracellular kinases that phosphorylate ERG at discrete serine residues.	ERG	CXCR4	1	ACTIVATION	False
12834	13104	24075908:1:ELK1:PRL	Insulin increases [TG] gene expression in GH4 cells through phosphorylation of [TF] (Jacob and Stanley, 2001).	Elk-1	prolactin	1	ACTIVATION	False
12835	13105	24075908:10:ELK1:PRL	Our studies suggest that insulin activates [TG] gene transcription by activating [TF] that recruits the NuA4 complex to the promoter.	Elk-1	prolactin	1	ACTIVATION	False
12836	13106	24239897:10:CDX2:UGT1A10	Moreover, overexpression of HNF1 and [TF] further increased [TG] expression only in the presence of 5-Aza-dC.	Cdx2	UGT1A10	1	ACTIVATION	False
12837	13107	24239897:11:CDX2:UGT1A10	Collectively, we found that DNA hypermethylation would interfere with the binding of HNF1 and [TF], resulting in the defective expression of [TG] in human liver.	Cdx2	UGT1A10	1	ACTIVATION	False
12838	13108	24244341:4:ELK1:AGTR1	We hypothesized that the transcription of the [TG] gene occurs via an orchestration of transcription factor interactions including NF-B, CREB, and [TF].	Elk-1	AT1R	0	UNDEFINED	True
12839	13109	25109552:4:ETV1:FGF10	[TF] and Ewsr1 stimulated transcription from the [TG] promoter in the sub-AER mesenchyme of mouse and chick limb buds in a conserved AGAAAR cluster-dependent manner.	Etv1	Fgf10	1	ACTIVATION	False
12840	13110	25109552:5:ETV1:FGF10	We found that both [TF] and Ewsr1 were necessary for [TG] expression and elongation of the limb bud.	Etv1	Fgf10	1	ACTIVATION	False
12841	13111	25109552:6:ETV1:FGF10	In addition, [TF] and AER-FGF synergistically stimulated [TG] promoter activity in an Ewsr1-dependent manner.	Etv1	Fgf10	1	ACTIVATION	False
12842	13112	25109552:9:ETV1:FGF10	Our results suggest that [TF] and Ewsr1 transactivate [TG] directly and cooperatively in response to AER-FGFs.	Etv1	Fgf10	1	ACTIVATION	False
12843	13114	8895512:7:ERG:VIM	Among members of the ETS transcription factor family only [TF] showed ability to transactivate [TG] promoter besides PEA3.	Erg	vimentin	1	ACTIVATION	False
12844	13115	9006959:7:FOXA1:SFTPB	Mutation of any one of the transcription factor binding sites caused a significant reduction in [TG] promoter activity suggesting that Sp1, Sp3, and TTF-1 and [TF] interact cooperatively with SP-B promoter to activate gene transcription.	HNF-3alpha	SP-B	1	ACTIVATION	False
12845	13116	9880563:7:ELK1:MCL1	Thus, the mechanism of the TPA-induced increase in [TG] expression seen in myelomonocytic cells at early stages of differentiation involves signal transduction through ERKs and transcriptional activation through SRF/[TF].	Elk-1	MCL1	1	ACTIVATION	False
12846	13117	11283019:7:CDX2:SI	The binding of [TF] to the [TG] promoter and its transcriptional activity were significantly reduced by SB203580.	CDX2	sucrase-isomaltase	1	ACTIVATION	False
12847	13118	16788384:11:CDX2:UGT2B7	In addition, [TF] was shown to cooperatively activate the [TG] promoter in conjunction with hepatocyte nuclear factor 1alpha (HNF1alpha), a mechanism previously observed to regulate other intestine-specific genes.	Cdx2	UGT2B7	1	ACTIVATION	False
12848	13119	18506761:4:EGR1:HIF1A	To elucidate the mechanism of the transcriptional upregulation of the [TG] gene, we have shown that [TF] is able to directly bind to the HIF-1alpha promoter using chromatin immunoprecipitation.	Egr1	HIF-1alpha	1	ACTIVATION	False
12849	13120	15774940:1:CDX2:IAPP	We have examined the role that the caudal-related homeobox transcription factors Cdx1 and [TF] play in activating the enterocyte differentiation marker gene intestinal alkaline phosphatase ([TG]).	Cdx2	IAP	1	ACTIVATION	False
12850	13121	10677375:4:CDX2:LCT	In the present study, we examined whether [TF] and HNF1alpha physically interact and co-operatively activate transcription from the [TG]-phlorizin hydrolase promoter.	Cdx2	lactase	1	ACTIVATION	False
12851	13122	12554743:4:ERG:COL11A2	To investigate a potential role for EWS/[TF] in [TG] gene expression, we characterized the COL11A2 promoter and tested the ability of wild-type ERG and EWS/ERG sarcoma fusion protein to transactivate COL11A2 promoter using a luciferase assay.	ERG	COL11A2	1	ACTIVATION	False
12852	13123	12947087:7:ETV1:SMAD7	Moreover, we show that TAK1, a TGF-beta-activated protein kinase, stimulates [TF] via the p38 mitogen-activated protein kinase pathway and thereby induces the [TG] promoter.	ER81	Smad7	1	ACTIVATION	False
12853	13124	14765989:7:CDX2:GCG	c-Maf protein stimulated [TG] promoter activity in a transient luciferase assay, and activation of the glucagon promoter by c-Maf was more efficient than by the other alpha-cell-enriched transcription factors, [TF], Pax6, and Isl-1.	Cdx2	glucagon	1	ACTIVATION	False
12854	13125	15828872:7:FOXA1:GCG	In contrast with previously identified Foxa-binding sites in the [TG] promoter, which bind nuclear Foxa2, the novel Foxa site was found to bind preferentially [TF] in nuclear extracts of a glucagon-producing pancreatic islet alpha-cell line, offering a mechanism that explains the decrease in glucagon gene expression in Foxa1-deficient mice.	Foxa1	glucagon	1	ACTIVATION	False
12855	13126	16118348:11:CDX2:MUC2	Furthermore, transfection of the [TF] expression vector in cultured rat oesophageal keratinocytes induced production of intestinal-type mucin, [TG], in cells that expressed Cdx2.	Cdx2	MUC2	1	ACTIVATION	False
12856	13127	16618413:13:CDX2:GUCY2C	Transformation associated with reflux at the gastroesophageal junction reflects activation by bile acid and acid of a transcriptional program involving NF-kappaB and [TF], which mediate intestinal metaplasia and ectopic expression of [TG].	Cdx2	GC-C	1	ACTIVATION	False
12857	13128	17263687:6:CDX2:GCG	In BHK21 cells, Nkx6.1 inhibited by 93% Pax6-mediated activation of the [TG] promoter, whereas [TF] and Maf stimulations were unaltered.	Cdx2/3	glucagon	1	ACTIVATION	False
12858	13129	19917777:0:ETS1:RUNX3	The transcription factor [TF] is important for CD4 repression and [TG] up-regulation during CD8 T cell differentiation in the thymus.	Ets1	Runx3	1	ACTIVATION	True
12859	13130	20145255:8:ELK4:INSIG2	Moreover, our findings suggest that insulin activated the human [TG] promoter in a process mediated by phosphorylated [TF].	SAP1a	INSIG2	1	ACTIVATION	False
12860	13131	20628005:8:FOXA1:UGT2B17	The binding of [TF] and subsequent stimulation of the [TG] promoter is greatly reduced in the presence of the -155G allele compared with the -155A allele.	FOXA1	UGT2B17	1	ACTIVATION	False
12861	13132	20980682:6:ERG:VWF	In vitro assays implicated a role for [TF]-binding ETS motif at -56 in mediating basal expression of [TG].	ERG	VWF	1	ACTIVATION	False
12862	13133	21258408:12:ELK1:MCL1	These results indicate that the EGF induced activation of [TF] is an important mediator of [TG] expression and cell survival and therefore a potential therapeutic target in breast cancer.	Elk-1	Mcl-1	1	ACTIVATION	False
12863	13134	21804543:5:FOXO1:SOX2	This function is probably mediated through direct control by [TF] of OCT4 and [TG] gene expression through occupation and activation of their respective promoters.	FOXO1	SOX2	1	ACTIVATION	False
12864	13135	22433566:8:ELK1:ZFP36	We show that [TF] regulates [TG] expression by two mechanisms: by binding the ZFP36 promoter directly through ETS-binding site (+ 883 to +905 bp) and by inducing expression of EGR-1, which in turn increases ZFP36 expression through sequences located between -111 and -103 bp.	ELK-1	ZFP36	1	ACTIVATION	False
12865	13136	23158473:12:ELK1:MCL1	These results indicate that ascites-induced ERK1/2/[TF] signaling is critical for [TG] expression and for the ascites-mediated attenuation of TRAIL-induced apoptosis.	Elk-1	Mcl-1	1	ACTIVATION	False
12866	13137	23816566:10:ELK1:PER2	In conclusion, lithium stimulates [TG] transcription through the ERK/[TF]/Egr1 pathway in neuronal cells, indicating a connection between the ERK-Egr1 pathway and a circadian gene system in the mechanism of action of lithium.	Elk1	PER2	1	ACTIVATION	False
12867	13138	24075908:3:ELK1:PRL	A number of the components of the TIP60/NuA4 complex interacted with [TF] suggesting that Elk-1 might activate transcription by recruiting the TIP60 chromatin-remodeling complex to the [TG] promoter.	Elk-1	prolactin	1	ACTIVATION	False
12868	13139	9006959:6:FOXA1:SFTPB	We found that in addition to thyroid transcription factor 1 (TTF-1) and hepatocyte nuclear factor 3alpha ([TF]) binding sites, two spatially separate DNA sequences that bind Sp1 and Sp3 factors are necessary for the maintenance of [TG] promoter activity.	HNF-3alpha	SP-B	1	ACTIVATION	False
12869	13140	16115867:0:DLX5:RUNX2	[TF] specifically regulates [TG] type II expression by binding to homeodomain-response elements in the Runx2 distal promoter.	Dlx5	Runx2	0	UNDEFINED	False
12870	13141	20736324:3:FOXA1:UGT2B17	We recently reported that [TF] (FOXA1) regulates the basal expression of the [TG] gene in prostate cancer cells.	Forkhead box protein A1	UGT2B17	0	UNDEFINED	False
12871	13142	20736324:4:FOXA1:UGT2B15	In this study, we show that [TF] also regulates basal expression of the [TG] gene in the prostate cell line LNCaP (lymph node carcinoma of the prostate).	FOXA1	UGT2B15	0	UNDEFINED	False
12872	13143	20933081:10:CDX2:CDX4	These findings suggest that, while both canonical Wnt and [TF] can regulate the activity of the [TG] promoter, they appear to operate through distinct mechanisms.	Cdx2	Cdx4	0	UNDEFINED	False
12873	13144	22235125:0:ERG:CLDN5	ETS-related gene ([TF]) controls endothelial cell permeability via transcriptional regulation of the claudin 5 ([TG]) gene.	ERG	CLDN5	0	UNDEFINED	False
12874	13145	22240898:3:CDX2:ATRX	[TG] expression was elevated in both a cell line model and transgenic model of HD, and [TF] occupancy of the ATRX promoter was increased in HD.	Cdx-2	ATRX	0	UNDEFINED	True
12875	13146	22719836:0:CDX2:CLDN1	[TF] cooperates with Wnt pathway to regulate [TG] expression in colon cancer cells.	Caudal homeobox protein Cdx-2	claudin-1	0	UNDEFINED	False
12876	13147	22719836:11:CDX2:CLDN1	Taken together, we conclude that homeodomain transcription factors Cdx1, [TF] and GATA4 regulate [TG] gene expression in human colon cancer cells.	Cdx2	claudin-1	0	UNDEFINED	False
12877	13148	23533340:7:ELK1:FUT1	These results suggest that a defined region in the 5'-flanking region of [TG] is critical for FUT1 transcription and that constitutive gene expression of FUT1 is regulated by [TF] in DLD-1 cells.	Elk-1	FUT1	1	ACTIVATION	True
12878	13149	8455618:1:FOXA1:ALB	The liver-specific enhancer of the [TG] gene contains an essential segment, designated eH, which binds the hepatocyte nuclear factor 3 alpha ([TF]) and ubiquitous nuclear factor 1/CCAAT transcription factor (NF1/CTF) proteins in tight apposition.	HNF3 alpha	serum albumin	0	UNDEFINED	False
12880	13151	21642427:0:ELK1:BAX	The ETS family transcription factor [TF] regulates induction of the cell cycle-regulatory gene p21(Waf1/Cip1) and the [TG] gene in sodium arsenite-exposed human keratinocyte HaCaT cells.	ELK-1	BAX	1	ACTIVATION	True
12881	13152	8612644:8:CDX2:CA1	We propose that [TF] plays an important role in the intestine-specific expression of [TG].	Cdx-2	CA1	0	UNDEFINED	True
12882	13153	10749119:4:ERG:TGFBR2	Here, we also examined effects of EWS-ETV1 and EWS-[TF] on expression of the [TG] gene.	ERG	TGF-beta RII	0	UNDEFINED	False
12883	13154	10749119:4:ETV1:TGFBR2	Here, we also examined effects of EWS-[TF] and EWS-ERG on expression of the [TG] gene.	ETV1	TGF-beta RII	0	UNDEFINED	False
12884	13155	10913190:3:ELK1:TNF	In LPS-stimulated macrophages, the ERK substrates Ets and [TF] bind to the [TG] promoter in vivo.	Elk-1	TNF-alpha	0	UNDEFINED	False
12886	13157	11450701:0:CDX2:VDR	The polymorphism in the caudal-related homeodomain protein [TF] binding element in the human [TG] gene.	Cdx-2	vitamin D receptor	0	UNDEFINED	False
12887	13158	11450701:2:CDX2:VDR	In a previous study, we indicated-that the caudal-related homeodomain [TF] played an important role in the intestine-specific transcription of the human [TG] gene.	Cdx-2	VDR	0	UNDEFINED	False
12888	13159	11684084:6:CDX2:GUCY2C	The present study examined the nucleotide requirements in the consensus binding site and flanking regions in the cis element that mediates specific [TF] binding to the promoter of [TG].	CDX2	GC-C	0	UNDEFINED	False
12889	13160	12518221:0:CDX2:ACAT2	Preparation of an anti-[TF] antibody for analysis of different species Cdx-2 binding to [TG] promoter.	Cdx-2	acat2	0	UNDEFINED	False
12890	13161	12518221:5:CDX2:ACAT2	Most notably, we found that the [TF] in human intestine cell line Caco-2 is expressed in a differentiation-dependent manner and can efficiently bind to the mouse and human [TG] (acyl-coenzyme A: cholesterol acyltransferase 2) promoter regions, suggesting that the transcriptional factor Cdx-2 may play a role in regulating the acat2 expression in the intestinal cells.	Cdx-2	acat2	0	UNDEFINED	False
12891	13162	12554743:9:ERG:COL11A2	Taken together, these findings indicate that the [TG] gene is regulated both by potential [TF] association with a histone deacetylase complex and by direct EWS/ERG recruitment of RNA polymerase II.	ERG	COL11A2	0	UNDEFINED	False
12892	13163	12559945:0:CDX2:MUC2	Homeodomain protein [TF] regulates goblet-specific [TG] gene expression.	CDX2	MUC2	0	UNDEFINED	False
12893	13166	12788937:0:ELK1:CCT8	Transcriptional regulation of the cytosolic chaperonin theta subunit gene, [TG], by Ets domain transcription factors [TF], Sap-1a, and Net in the absence of serum response factor.	Elk-1	Cctq	0	UNDEFINED	False
12894	13168	12928043:10:ELK1:PSEN1	We also confirmed the specific DNA binding properties of the factors identified by showing that the proteins produced by in vitro translation of the entire cDNAs from [TF] and ER81 indeed binds specifically to the -10 region of the [TG] promoter.	Elk1	PS1	0	UNDEFINED	False
12895	13169	12928043:10:ETV1:PSEN1	We also confirmed the specific DNA binding properties of the factors identified by showing that the proteins produced by in vitro translation of the entire cDNAs from Elk1 and [TF] indeed binds specifically to the -10 region of the [TG] promoter.	ER81	PS1	0	UNDEFINED	False
12896	13170	14521963:5:FOXA1:ALB	Besides known [TF]-regulated genes such as [TG] and alpha-fetoprotein genes, the genes newly identified as the HNF-3alpha-regulated ones include three encoding CDP-diacylglycerol-inositol 3-phosphatidyltransferase, phosphatidylserine decarboxylase, and phospholipase A2, which are located en suite in the lipid metabolic pathway in liver.	HNF-3alpha	albumin	0	UNDEFINED	False
12897	13171	14525978:4:CDX2:MUC2	To evaluate the role of Cdx-1 and [TF] in [TG] transcription we performed co-transfection experiments with expression vectors encoding Cdx-1 and Cdx-2.	Cdx-2	MUC2	0	UNDEFINED	False
12898	13172	14660636:3:BACH1:HBB	To investigate the involvement of [TF] in the heme-dependent regulation of the expression of the [TG] gene, mouse erythroleukemia (MEL) cells were cultured with succinylacetone (SA), a specific inhibitor of heme biosynthesis, and the level of beta-globin mRNA was examined.	Bach1	beta-globin	0	UNDEFINED	False
12899	13173	14706452:4:AP1:CTNNB1	Several [TF] were confirmed in the promoters of all three species using mobility shift and reporter assays, and one putative TCF/LEF site also was observed in the promoter of [TG].	AP1 binding sites	CTNNB1	0	UNDEFINED	True
12900	13174	15013430:0:CDX2:PTGS2	Homeodomain protein [TF] regulates [TG] expression in colorectal cancer.	CDX2	COX-2	0	UNDEFINED	False
12901	13175	15327990:0:CDX2:MOK	[TF] homeodomain protein regulates the expression of [TG], a member of the mitogen-activated protein kinase superfamily, in the intestinal epithelial cells.	Cdx2	MOK	0	UNDEFINED	False
12902	13176	15327990:3:CDX2:MOK	Analysis of the 5'-flanking region of the [TG] gene led to the identification of primary [TF] responsive element, and an electrophoretic mobility shift assay indicated that Cdx2 binds to that element.	Cdx2	MOK	0	UNDEFINED	False
12903	13177	15364550:6:CDX2:UGT1A8	[TF] regulates the [TG] and 1A10 promoters in cooperation with hepatocyte nuclear factor 1alpha (HNF1alpha).	Cdx2	UGT1A8	0	UNDEFINED	False
12904	13178	15774940:0:CDX2:ALPI	Differential regulation of [TG] gene expression by Cdx1 and [TF].	Cdx2	intestinal alkaline phosphatase	0	UNDEFINED	False
12905	13179	15809770:12:ELK1:FZD8	Match program revealed that [TF]- and PAX4-binding sites were conserved between rat Fzd8 and human [TG] promoters.	ELK1	FZD8	0	UNDEFINED	False
12906	13180	15825077:10:CDX2:HEPH	Studies with [TG] reporter gene constructs and chromatin-immunoprecipitation approaches suggested that [TF] directly regulates HEPH transcription.	CDX2	HEPH	0	UNDEFINED	False
12907	13181	15825077:13:CDX2:HEPH	[TF] has a key role in regulating [TG] expression and iron levels in intestinal cells.	CDX2	HEPH	0	UNDEFINED	False
12908	13182	15908194:12:CEBPZ:SOX9	Together, these studies show that the [TG] promoter is regulated by [TF] through its interaction with two functional CCAAT boxes.	CBF	Sox9	0	UNDEFINED	False
12909	13183	16002547:10:CDX2:INS	We suggest that [TF] may mediate the second messenger cAMP in regulating [TG] gene transcription.	Cdx-2	insulin	0	UNDEFINED	False
12910	13184	16002547:2:CDX2:INS	To explore further the role of [TF] in regulating both [TG] and proglucagon gene expression, we established an ecdysone-inducible Cdx-2 expression system.	Cdx-2	insulin	0	UNDEFINED	False
12911	13185	16115867:9:DLX5:RUNX2	Moreover, Msx2 specifically suppressed the [TG] P1 promoter, and the responsible region overlaps with that recognized by [TF].	Dlx5	Runx2	0	UNDEFINED	False
12912	13186	16239403:0:CDX2:FURIN	The [TF] transcription factor regulates [TG] expression during intestinal epithelial cell differentiation.	CDX2	furin	0	UNDEFINED	False
12913	13187	16239403:11:CDX2:FURIN	These results suggest that [TF] regulates [TG] expression in intestinal epithelial cells.	CDX2	furin	0	UNDEFINED	False
12914	13188	16274362:3:CDX2:ACAT2	To investigate the molecular mechanism(s) responsible for the tissue-specific expression of [TG], we identified five cis-elements within the human ACAT2 promoter, four for the intestinal-specific transcription factor [TF] (caudal type homeobox transcription factor 2), and one for the transcription factor HNF1alpha (hepatocyte nuclear factor 1alpha).	CDX2	ACAT2	0	UNDEFINED	True
12915	13189	16480684:1:CDX2:LCT	The homeobox gene [TF] is involved in the regulation of the expression of intestine specific markers such as sucrase-isomaltase and [TG]-phlorizin hydrolase.	Cdx2	lactase	0	UNDEFINED	False
12916	13190	16480684:1:CDX2:SI	The homeobox gene [TF] is involved in the regulation of the expression of intestine specific markers such as [TG] and lactase-phlorizin hydrolase.	Cdx2	sucrase-isomaltase	0	UNDEFINED	False
12917	13191	16484587:0:ERG:ENG	[TG] expression in the endothelium is regulated by Fli-1, [TF], and Elf-1 acting on the promoter and a -8-kb enhancer.	Erg	Endoglin	0	UNDEFINED	False
12918	13192	16616718:10:CDX2:SLC15A1	Taken together, the present study suggests that [TF] plays a key role in the transcriptional regulation of the intestine-specific expression of [TG], possibly through interaction with Sp1.	Cdx2	PEPT1	0	UNDEFINED	False
12919	13193	16616718:7:CDX2:SLC15A1	These results raise the possibility that [TF] modulates the [TG] promoter by interaction with Sp1.	Cdx2	PEPT1	0	UNDEFINED	False
12920	13194	16788384:13:CDX2:UGT2B7	The demonstration that [TF] and HNF1alpha are important regulators of [TG] expression will aid in defining pathways for coordinate control of drug metabolism in the gastrointestinal tract.	Cdx2	UGT2B7	0	UNDEFINED	False
12921	13195	17000708:2:FOXC1:FGF19	Using nickel agarose chromatin enrichment with human anterior segment cells, we previously identified the [TG] (FGF19) locus as a gene potentially regulated by [TF].	FOXC1	fibroblast growth factor 19	0	UNDEFINED	False
12922	13196	17074809:5:ELK1:TBP	JNK-mediated regulation of [TG] expression occurs at the transcriptional level through their ability to target [TF], which directly regulates the TBP promoter in response to epidermal growth factor stimulation.	Elk-1	TBP	0	UNDEFINED	False
12923	13197	17074809:6:ELK1:TBP	JNK1 increases, whereas JNK2 decreases, the phosphorylation state of [TF], which differentially affects Elk-1 occupancy at a defined site within the [TG] promoter.	Elk-1	TBP	0	UNDEFINED	False
12924	13198	17082637:7:ELK1:FOSL1	ERK inhibition not only blocked phosphorylation of [TF], CREB, and ATF1, which constitutively bind to the [TG] promoter, but also suppressed the recruitment of c-Jun to the promoter.	Elk1	FRA-1	0	UNDEFINED	False
12925	13199	17289023:0:CREB1:SOX9	Regulation of the human [TG] promoter by Sp1 and [TF].	CREB	SOX9	0	UNDEFINED	False
12926	13200	17289023:6:CREB1:SOX9	Chromatin immunoprecipitation (ChIP) assay demonstrated that both Sp1 and [TF] interact with the [TG] promoter in vivo.	CREB	SOX9	0	UNDEFINED	False
12927	13201	17499043:5:ELK1:TBP	Maf1 targets an [TF]-binding site in the [TG] promoter, and its occupancy of this region is reciprocal with that of Elk-1.	Elk-1	TBP	0	UNDEFINED	False
12928	13202	17579210:7:CEBPB:RUNX2	In nondifferentiating cells, [TF] can be found occupying the C/EBP negative response element within the [TG] P1 promoter.	C/EBPbeta	Runx2	2	REPRESSION	True
12929	13203	17579210:9:CEBPB:RUNX2	Thus, ATRA initiates osteoblastic differentiation of C3H10T1/2 cells, at least in part, by triggering the dissociation of [TF] from the [TG] promoter.	C/EBPbeta	Runx2	0	UNDEFINED	False
12931	13205	17901057:6:CDX2:GCG	We then demonstrated the in vivo interactions of Pax-6, [TF], Maf-B, and c-Maf but not Brain-4 with the [TG] gene promoter in glucagon-producing cells.	Cdx-2/3	glucagon	0	UNDEFINED	False
12932	13206	17993506:0:FOXC1:FOXO1	[TF] is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of [TG].	FOXC1	FOXO1A	0	UNDEFINED	False
12933	13207	17993506:3:FOXC1:FOXO1	[TF] regulates the expression of [TG] and binds to a conserved element in the FOXO1A promoter in vivo.	FOXC1	FOXO1A	0	UNDEFINED	False
12934	13208	18003659:0:FOXA1:SFTPB	SMAD3 prevents binding of NKX2.1 and [TF] to the [TG] promoter through its MH1 and MH2 domains.	FOXA1	SpB	0	UNDEFINED	False
12935	13209	18073493:10:ELK1:LRP5	Functional studies are necessary to elucidate the role of this SNP on the effect of [TF] transcriptional activity of [TG] gene.	Elk-1 binding element	LRP5	0	UNDEFINED	False
12936	13210	18314487:7:ELK1:PYGO2	In vitro DNA pull-down assays and proteomic analyses identified the Ets family members [TF] and E74-like factor-1 (Elf-1) as potential [TG] promoter binding factors, whereas in vivo chromatin immunoprecipitation assays verified that only Elf-1 specifically bound to the hPygo2 promoter in MCF-7 cells.	Elk-1	hPygo2	0	UNDEFINED	False
12937	13211	18430739:3:EZH2:RUNX3	Chromatin immunoprecipitation assay showed an association between [TF] bound to the [TG] gene promoter, and trimethylated histone H3 at lysine 27, and HDAC1 (histone deacetylase 1) bound to the RUNX3 gene promoter in cancer cells.	EZH2	RUNX3	0	UNDEFINED	False
12938	13212	18469865:5:FOXA1:ELK4	However, merely the ARE2 that cooperates with a proximal [TF] was critical for the AR-dependent activation of [TG] promoter in prostate cancer cells.	forkhead box A1-binding site	ELK4	1	ACTIVATION	True
12939	13213	18506761:0:EGR1:HIF1A	The transcription factor [TF] regulates the [TG] gene during hypoxia.	Egr1	HIF-1alpha	0	UNDEFINED	False
12940	13214	18819935:7:CDX2:DSC2	We now show that the [TG] gene is a transcriptional target for Cdx1 and [TF].	Cdx2	DSC2	0	UNDEFINED	False
12941	13215	18929412:5:BACH2:BCL2	This indicates that [TF] may be partially responsible for regulation of [TG] expression from the t(14;18)(q21;q34) translocation.	BACH2	BCL2	0	UNDEFINED	False
12942	13216	19096034:5:FOXA1:SFTPB	Of the transcription factors involved in [TG] gene expression, neither cell type expressed TTF-1, [TF], or HNF3beta, but both cell types expressed Sp1 and Sp3.	HNF3alpha	SP-B	0	UNDEFINED	False
12944	13218	19127412:7:FOXA1:BCL2	Electrophoretic mobility shift assay and chromatin immunoprecipitation revealed that [TF] bound to [TG] promoter, and H(2)O(2) promoted its DNA binding activity.	Foxa1	bcl2	0	UNDEFINED	False
12945	13219	19439223:8:BACH1:IL6	In addition, a chromatin immunoprecipitation analysis revealed the binding of [TF] to the [TG] promoter and its detachment after oxidative stress.	Bach1	IL-6	0	UNDEFINED	False
12946	13220	19486887:4:FOXA1:HSPA1A	Electrophoretic mobility shift assay and chromatin immunoprecipitation revealed that [TF] bound to [TG] promoter, and heat stress promoted its DNA binding activity.	Foxa1	HSP72	0	UNDEFINED	False
12947	13221	19486887:6:FOXA1:HSPA1A	These results indicate an important role for [TF] as a novel regulator of expression of [TG].	Foxa1	HSP72	0	UNDEFINED	False
12948	13222	19536094:9:ELK1:DAP3	[TF] and ESRRA may be considered as potential regulators of the [TG] gene expression.	ELK1	DAP3	0	UNDEFINED	False
12949	13223	19620725:9:ELK1:BRF1	Decreasing JNK1 expression reduces [TF] occupancy at the [TG] promoter, while decreasing JNK2 expression enhances recruitment of Elk-1 to the Brf1 promoter.	Elk-1	Brf1	0	UNDEFINED	False
12950	13224	19725873:11:CDX2:CDX1	Chromatin immunoprecipitation assay and electrophoretic mobility shift assay showed that [TF] was bound to the [TG] promoter region in the intestinal metaplasia and the normal intestine.	Cdx2	Cdx1	0	UNDEFINED	False
12951	13225	19725873:6:CDX2:CDX1	DNA methylation profile analysis was performed by bisulfite sequencing, and the interaction of [TF] with the [TG] promoter was examined by chromatin immunoprecipitation assay, electrophoretic mobility shift assay, and luciferase reporter assays.	Cdx2	Cdx1	0	UNDEFINED	False
12952	13226	20042388:4:EN1:GLI3	The result from P-Match software prediction showed that only one of the three possible [TF] binding sites in [TG] promoter region was interacted directly with En1 in vivo, which was confirmed by ChIP analysis.	En1	Gli3	0	UNDEFINED	False
12953	13227	20137095:0:ELK1:ZC3H12A	Transcription factors [TF] and SRF are engaged in IL1-dependent regulation of [TG] expression.	Elk-1	ZC3H12A	0	UNDEFINED	False
12954	13228	20179090:0:BACH1:SLC40A1	Heme controls ferroportin1 ([TG]) transcription involving [TF], Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter.	Bach1	FPN1	0	UNDEFINED	False
12955	13229	20199401:6:CDX2:SHH	This was not due to hypermethylation of the [TG] promoter, but instead we showed that [TF] directly bound to the TATA box region of the Shh promoter.	Cdx2	Shh	0	UNDEFINED	False
12956	13230	20238301:2:FOXC1:DLL4	For arterial specification, vascular endothelial growth factor (VEGF) induces expression of Notch signaling genes, including Notch1 and its ligand, Delta-like 4 ([TG]), and [TF] and Foxc2 transcription factors directly regulate Dll4 expression.	Foxc1	Dll4	0	UNDEFINED	False
12957	13231	20448047:8:EGR1:HIF1A	The binding of [TF] to [TG] promoter was corroborated by electrophoretic mobility shift assay and chromatin immunoprecipitation assay, which showed increased Egr-1 binding to the HIF-1alpha promoter in response to PlGF stimulation.	Egr-1	HIF-1alpha	0	UNDEFINED	False
12958	13232	20516218:0:ERG:GFI1	[TG] expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/Tal1, Gata2, PU.1, [TF], Meis1, and Runx1 acting as upstream regulators in early hematopoietic cells.	Erg	Gfi1	0	UNDEFINED	False
12959	13233	20568120:0:CDX2:CDH17	HNF1 and [TF] transcriptional factors bind to cadherin-17 ([TG]) gene promoter and modulate its expression in hepatocellular carcinoma.	CDX2	CDH17	0	UNDEFINED	False
12960	13234	20568120:8:CDX2:CDH17	In summary, we identified the minimal promoter region of [TG] that is regulated by HNF1 and [TF] transcriptional factors.	CDX2	CDH17	0	UNDEFINED	False
12961	13235	20600580:8:ELF1:MEIS1	Of the three ETS family members tested, only [TF] was enriched on the [TG] promoter as assessed by both electrophoretic mobility shift assay and chromatin immunoprecipitation experiments in K562.	ELF1	MEIS1	0	UNDEFINED	False
12962	13236	20628005:11:FOXA1:UGT2B17	In summary, this work identifies [TF] as an important regulator of [TG] expression in prostate cancer LNCaP cells and identifies a polymorphism that alters this regulation.	FOXA1	UGT2B17	0	UNDEFINED	False
12963	13237	20631058:5:EZH2:RUNX3	We assessed the effect of efficient RNA interference-mediated knockdown of [TF] on [TG] levels, cell viability and H3K27 trimethylation of the RUNX3 promoter using chromatin immunoprecipitation.	EZH2	RUNX3	0	UNDEFINED	False
12965	13239	20699370:11:CDX2:ABCB1	These data indicate that [TF] directly regulates [TG] gene expression through binding to elements in the promoter region.	CDX2	MDR1	0	UNDEFINED	False
12966	13240	20699370:7:CDX2:ABCB1	Evidence that the [TG] gene was a direct transcriptional target of [TF] was obtained, including analyses with MDR1 reporter gene constructs and chromatin immunoprecipitation assays.	CDX2	MDR1	0	UNDEFINED	False
12967	13241	20736324:0:FOXA1:UGT2B15	[TF] regulates [TG] gene transcription in LNCaP prostate cancer cells.	Forkhead box protein A1	UDP-glucuronosyltransferase 2B15	0	UNDEFINED	False
12968	13242	20808444:0:ERG:EGFL7	VE-statin/[TG] expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of [TF] and GATA-2.	Erg	egfl7	0	UNDEFINED	False
12969	13243	20933081:5:CDX2:CDX4	We therefore investigated the means by which [TF] impacted on [TG] expression and assessed potential interaction between Cdx2 and canonical Wnt signaling on the Cdx4 promoter.	Cdx2	Cdx4	0	UNDEFINED	False
12970	13244	20933081:6:CDX2:CDX4	We found that the [TG] promoter was regulated by [TF] in transient transfection assays.	Cdx2	Cdx4	0	UNDEFINED	False
12971	13245	21242973:5:ERG:WNT2	Notably, [TF]-enriched targets included WNT signaling genes: WNT11, [TG], WNT9A, CCND1 and FZD7.	ERG	WNT2	0	UNDEFINED	False
12972	13246	21242973:6:ERG:WNT11	Furthermore, chromatin immunoprecipitation (ChIP) of normal and primary leukemia bone marrow material also confirmed [TG] as a target of [TF] in six of seven patient samples.	ERG	WNT11	0	UNDEFINED	False
12973	13247	21245161:4:ERG:RUNX1	We show that, from the fetal period, [TF] acts as a direct upstream regulator of Gata2 and [TG] gene activity.	ERG	Runx1	0	UNDEFINED	False
12974	13248	21281751:7:FOXO1:RUNX2	Moreover, chromatin immunoprecipitation assays revealed a direct interaction of [TF] with the [TG] promoter.	FOXO1	RUNX2	0	UNDEFINED	False
12975	13249	21317430:9:ETS1:ZEB1	Both Twist and [TF] bind to the [TG] promoter although to different elements: whereas Ets1 interacts with the proximal promoter, Twist does it with a 700-bp sequence upstream of the transcription start site.	Ets1	ZEB1	0	UNDEFINED	False
12976	13250	21378168:6:DNMT1:PAX2	Moreover, WT1 also interacts with DNA methyltransferase 1 ([TF]), and recruits DNMT1 to the [TG] promoter, resulting in hypermethylation of CpG in the Pax2 promoter.	DNMT1	Pax2	0	UNDEFINED	False
12977	13251	21395583:8:ELK1:SPAST	In addition, we identified the binding sites of [TF] on the [TG] promoter by EMSA.	Elk1	SPG4	0	UNDEFINED	False
12979	13253	21814574:8:ERG:CRISP3	Furthermore, immunohistochemistry results showed [TG] protein overexpression in 63% of the carcinomas and chromatin immunoprecipitation with an anti-[TF] antibody showed that CRISP3 is a direct target of the transcription factor ERG.	ERG	CRISP3	0	UNDEFINED	False
12980	13254	22056786:8:ERG:GATA4	We found that ETS1, FLI1, and [TF] were strongly expressed in the heart at embryonic day 8.5 and that ETS1 and ERG bound to the endogenous [TG] enhancer in cultured endothelial cells.	ERG	Gata4	0	UNDEFINED	False
12981	13255	22140532:8:ERG:PIM1	Chromatin Immunoprecipitation experiments showed that t[TF] directly binds to [TG] promoter in the RWPE-1 prostate cell line, suggesting that tERG could be a direct regulator of PIM1 expression.	ERG	PIM1	0	UNDEFINED	False
12982	13256	22274925:6:DNMT1:RUNX3	H(2)O(2) treatment resulted in DNA methyltransferase 1 ([TF]) and histone deacetylase 1 (HDAC1) up-regulation with increased expression and activity, increased binding of DNMT1 to HADC1, and increased DNMT1 binding to the [TG] promoter.	DNMT1	RUNX3	0	UNDEFINED	False
12983	13258	22337883:8:ERG:ICAM1	[TF] prevents NF-B p65 from binding to the [TG] promoter, suggesting a direct mechanism of interference.	Erg	ICAM-1	0	UNDEFINED	False
12984	13259	22719836:5:CDX2:CLDN1	Our further studies using full length and/or deletion mutant constructs in two different human colon cancer cell lines, SW480 and HCT116, showed key role of Cdx1, [TF] and GATA4 in the regulation of [TG] mRNA expression.	Cdx2	claudin-1	0	UNDEFINED	False
12985	13260	22719836:8:CDX2:CLDN1	Chromatin immunoprecipitation (ChIP) assay confirmed the [TF] binding with [TG] promoter in vivo.	Cdx2	claudin-1	0	UNDEFINED	False
12986	13261	22719836:9:CDX2:CLDN1	Using [TF] deletion mutant constructs, we further mapped the Cdx2 C-terminus domain to be important in the regulation of [TG] promoter activity.	Cdx2	claudin-1	0	UNDEFINED	False
12987	13262	22815676:7:CDX2:NR1I2	Finally, reduction of gastrointestinal inflammation requires the binding of [TF] to a specific proximal site on the [TG] promoter.	Cdx2	PXR	0	UNDEFINED	False
12988	13263	22904677:5:ERG:TDRD1	Interestingly, we demonstrate that the expression of [TG], the topmost overexpressed gene of our list of [TF]-specific candidate targets, is inversely correlated with the methylation levels of a CpG island found at -66 bp of the transcription start site in PCa and that TDRD1 expression is regulated by direct binding of ERG to the CpG island in VCaP cells.	ERG	TDRD1	0	UNDEFINED	False
12990	13265	23063436:5:ELK4:FOS	Chromatin immunoprecipitation studies showed increased occupancy of egr1 and [TG] promoters by [TF] with high adhesion, whereas low adhesion increased Net occupancy.	Sap-1	fos	0	UNDEFINED	False
12991	13266	23063436:7:ELK4:FOS	Increasing adhesion enhanced serum-induced JNK activity while suppressing p38 activity, leading to increased [TF] phosphorylation and Net dephosphorylation, and switching Net with Sap-1 at egr1 and [TG] promoters to support proliferation.	Sap-1	fos	0	UNDEFINED	False
12992	13267	23145080:7:FOXC1:MSX2	Chromatin immunoprecipitation experiments reveal that [TF] occupies a conserved element in the [TG] promoter.	FOXC1	MSX2	0	UNDEFINED	False
12994	13269	23313509:7:CDX2:SLC46A1	These results suggest that the activity of [TG] promoter is basically induced by KLF4 and the gradiented expression profile of PCFT may be at least in part accounted for by those of HNF4, [TF] and C/EBP.	CDX2	PCFT	0	UNDEFINED	False
12995	13270	23358112:7:FOXA1:TTF1	BRN2 and [TF]/2 binding to the [TG] promoter was confirmed through chromatin immunoprecipitation experiments, and TTF1 expression in SCLC cells was considerably downregulated after BRN2 knockdown.	FOXA1	TTF1	0	UNDEFINED	True
12997	13272	23393221:0:CDX2:AXIN2	Regulation of APC and [TG] expression by intestinal tumor suppressor [TF] in colon cancer cells.	CDX2	AXIN2	0	UNDEFINED	False
12998	13273	23393221:4:CDX2:APC	The aim was to investigate the role of decreased [TF] level on the expression of [TG], AXIN2 and GSK3 in migrating colon cancer cells at the invasive front.	CDX2	APC	0	UNDEFINED	False
12999	13274	23454483:0:ELK1:TBP	[TF] AP-1 sites in the [TG] promoter mediate alcohol-induced deregulation of Pol III-dependent genes.	Elk1 and	TBP	0	UNDEFINED	False
13000	13275	23454483:11:ELK1:TBP	Together, these studies demonstrate that, for the first time, alcohol increases Pol III gene transcription through a response element, which is composed of the overlapping [TF] AP-1 binding sites of the [TG] promoter and affected by alcohol.	Elk1 and	TBP	0	UNDEFINED	False
13001	13276	23533340:6:ELK1:FUT1	Furthermore, transfection of the dominant negative [TF] gene, and the chromatin immunoprecipitation (CHIp) assay, supported Elk-1-dependent transcriptional regulation of [TG] gene expression in DLD-1 cells.	Elk-1	FUT1	0	UNDEFINED	False
13002	13277	23555854:0:ERG:TDRD1	[TF] induces epigenetic activation of Tudor domain-containing protein 1 ([TG]) in ERG rearrangement-positive prostate cancer.	ERG	TDRD1	1	ACTIVATION	True
13003	13278	23918819:3:ERG:CXCR4	Previously, we and others have shown that the transcription factor [TF] regulates [TG] expression in prostate cancer cells and that androgens modulate CXCR4 expression via increasing ERG expression.	ERG	CXCR4	0	UNDEFINED	False
13004	13279	24075908:9:ELK1:PRL	Finally, ChIP experiments demonstrate the insulin-dependent occupancy of the [TG] promoter by [TF] and TIP60.	Elk-1	prolactin	0	UNDEFINED	False
13005	13280	24755985:11:DNMT1:KLF4	Hemodynamics influence endothelial [TG] expression through [TF] enrichment/myocyte enhancer factor-2 inhibition mechanisms of KLF4 promoter CpG methylation with regional consequences for atherosusceptibility.	DNMT	KLF4	0	UNDEFINED	False
13006	13281	24755985:8:DNMT3A:KLF4	Contributory mechanisms included DF-induced increase of [TF] protein (1.7-fold), DNMT3A enrichment (11-fold) on the [TG] promoter, and competitive blocking of a myocyte enhancer factor-2 binding site in the KLF4 promoter near the transcription start site.	DNMT3A	KLF4	0	UNDEFINED	False
13007	13282	7499246:9:ELK1:PRL	Finally, the Ets-related proteins Sap and [TF] bind to the [TG], somatostatin, and thymidine kinase insulin-response elements.	Elk-1	prolactin	0	UNDEFINED	False
13008	13283	7499246:9:ELK1:SST	Finally, the Ets-related proteins Sap and [TF] bind to the prolactin, [TG], and thymidine kinase insulin-response elements.	Elk-1	somatostatin	0	UNDEFINED	False
13009	13284	8612644:0:CDX2:CA1	The caudal-type homeobox protein [TF] binds to the colon promoter of the [TG] gene.	Cdx-2	carbonic anhydrase 1	0	UNDEFINED	False
13010	13285	9933478:12:CDX2:VDR	These findings suggest that [TF] plays an important role in the intestine-specific transcription of the h[TG] gene.	Cdx-2	VDR	0	UNDEFINED	False
13011	13286	9933478:7:CDX2:VDR	With the EMSA, we found that [TF] (a homeodomain protein-related caudal) binds to the sequence 5'-ATAAAAACTTAT-3' at -3731 to -3720 bp (hVD-SIF1) relative to the transcription start site of the h[TG] promoter.	Cdx-2	VDR	0	UNDEFINED	False
13012	13287	17196161:5:HSF4:ABCC3	Deletion of the [TF] element significantly increased transcriptional activity of the [TG] gene when exposed to TNF-alpha.	HSF4	mrp3	2	REPRESSION	False
13013	13288	19628735:10:HSF4:VIM	These findings indicate that [TF] represses [TG] gene expression via the HSE-like element.	HSF4	vimentin	2	REPRESSION	False
13014	13289	19628735:9:HSF4:VIM	EMSA, luciferase assay, and ChIP assay validated that [TF] had DNA-binding ability to [TG] promoter and repressed vimentin expression.	HSF4	vimentin	2	REPRESSION	False
13015	13290	21061442:0:IRF4:RUNX3	[TF] regulates thymocyte differentiation by repressing [TG] expression.	Interferon regulatory factor 4	Runx3	2	REPRESSION	False
13016	13291	21577203:0:GLI1:CYLD	[TF]-dependent transcriptional repression of [TG] in basal cell carcinoma.	GLI1	CYLD	2	REPRESSION	False
13017	13292	21577203:6:GLI1:CYLD	Our data suggest that [TF]-mediated suppression of [TG] has a significant role in basal cell carcinoma progression.	GLI1	CYLD	2	REPRESSION	False
13019	13294	22042697:4:GFI1:RUNX2	We found that BMSCs from both MM-bearing mice and MM patients had increased levels of the transcriptional repressor [TF] compared with controls and that Gfi1 was a novel transcriptional repressor of the critical OB transcription factor [TG].	Gfi1	Runx2	2	REPRESSION	False
13020	13295	22496449:5:GLI2:MITF	Using transient cell transfection experiments with M-[TG] promoter constructs, chromatin immunoprecipitation, site-directed mutagenesis, and electrophoretic mobility shift assays, we identified a [TF] binding site within the -334/-296 region of the M-MITF promoter, critical for GLI2-driven transcriptional repression.	GLI2	MITF	2	REPRESSION	False
13021	13296	22496449:8:GLI2:MITF	Increased [TF] binding to its cognate cis-element, associated with reduced CREB-dependent transcription, allowed maximal inhibition of the M-[TG] promoter via two distinct mechanisms.	GLI2	MITF	2	REPRESSION	False
13022	13297	23110168:13:GLI2:GAST	Using a mouse model of constitutively active epithelial [TF] expression, we found that activated GLI2 repressed [TG] expression but induced Il-1 gene expression and proliferation in the gastric antrum, along with a reduction of the number of G-cells.	GLI2	Gast	2	REPRESSION	False
13023	13298	23110168:14:GLI2:GAST	In summary, epithelial [TF] expression was sufficient to stimulate Il-1 expression, repress [TG] gene expression and increase proliferation, leading to antral hyperplasia.	Gli2	Gast	2	REPRESSION	False
13024	13299	23890107:0:GLI2:CDH1	[TF] cooperates with ZEB1 for transcriptional repression of [TG] expression in human melanoma cells.	GLI2	CDH1	2	REPRESSION	False
13025	13300	23890107:2:GLI2:CDH1	Herein, we provide evidence that [TF] represses E-cadherin gene ([TG]) expression in melanoma cells via distinct mechanisms, enhancing transcription of the EMT-activator ZEB1 and cooperative repression of CDH1 gene transcription via direct binding of both GLI2 and ZEB1 to two closely positioned Kruppel-like factor-binding sites within the CDH1 promoter.	GLI2	CDH1	2	REPRESSION	False
13026	13301	23890107:3:GLI2:CDH1	[TF] silencing rescued [TG] expression except in melanoma cell lines in which the CDH1 promoter was hypermethylated.	GLI2	CDH1	2	REPRESSION	False
13027	13302	24165159:3:GLI2:MLH1	Here, we showed that GLI1 and [TF] indirectly suppressed the expression of [TG] in PDAC cells.	GLI2	MLH1	2	REPRESSION	False
13028	13303	24165159:5:GLI1:MLH1	Consistent with a previous report that BHLHE41 suppresses the [TG] promoter activity, we found that the activation of [TF] led to the BHLHE41-dependent suppression of MLH1, and a double knockdown of GLI1 and GLI2 conversely increased the MLH1 protein in PDAC cells.	GLI1	MLH1	2	REPRESSION	False
13029	13304	24165159:5:GLI2:MLH1	Consistent with a previous report that BHLHE41 suppresses the [TG] promoter activity, we found that the activation of GLI1 led to the BHLHE41-dependent suppression of MLH1, and a double knockdown of GLI1 and [TF] conversely increased the MLH1 protein in PDAC cells.	GLI2	MLH1	2	REPRESSION	False
13030	13305	8972228:7:HSF4:HSPB1	Constitutive overexpression of h[TF] in HeLa cells results in reduced expression of the endogenous hsp70, hsp90, and [TG] genes.	HSF4	hsp27	2	REPRESSION	False
13031	13306	24165159:3:GLI1:MLH1	Here, we showed that [TF] and GLI2 indirectly suppressed the expression of [TG] in PDAC cells.	GLI1	MLH1	2	REPRESSION	False
13032	13307	14555646:11:GLI1:BCL2	The N terminus of gli-3 inhibited [TF] transactivation of the [TG] promoter.	gli-1	bcl-2	1	ACTIVATION	False
13033	13308	15087129:5:GLI1:PTCH1	We demonstrate that only one of two putative Gli-binding sites that were identified in the promoter region of [TG] is functional, and that the transactivating Gli proteins, [TF], Gli2 and GLI3, bind and enhance transcription through this site.	GLI1	PTCH1	1	ACTIVATION	False
13034	13309	15087129:5:GLI2:PTCH1	We demonstrate that only one of two putative Gli-binding sites that were identified in the promoter region of [TG] is functional, and that the transactivating Gli proteins, GLI1, [TF] and GLI3, bind and enhance transcription through this site.	Gli2	PTCH1	1	ACTIVATION	False
13035	13310	15175043:0:GLI2:GLI1	[TF] is expressed in normal human epidermis and BCC and induces [TG] expression by binding to its promoter.	GLI2	GLI1	1	ACTIVATION	False
13036	13311	15367491:4:GLI2:FOXE1	Moreover, expression of a dominant-negative form of [TF] in skin results in complete suppression of [TG] expression in the hair follicle, whereas transcriptionally active Gli2 stimulates activity of the Foxe1 promoter.	Gli2	Foxe1	1	ACTIVATION	False
13037	13312	15520176:0:GLI2:BCL2	Activation of the [TG] promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by [TF].	GLI2	BCL2	1	ACTIVATION	False
13038	13313	15520176:6:GLI2:BCL2	We found that one of these binding sites is critical for conferring [TF]-specific activation of the human [TG] promoter and that the selective induction of BCL2 expression depends on the zinc finger DNA binding domain of GLI2.	GLI2	BCL2	1	ACTIVATION	False
13039	13315	16880529:5:GLI2:BMP2	In the present study, we show that overexpression of [TF] enhances [TG] promoter activity and mRNA expression in osteoblast precursor cells.	Gli2	BMP-2	1	ACTIVATION	False
13040	13316	16880529:6:GLI2:BMP2	In contrast, knocking down [TF] expression by Gli2 small interfering RNA or genetic ablation of the Gli2 gene results in significant inhibition of [TG] gene expression in osteoblasts.	Gli2	BMP-2	1	ACTIVATION	False
13041	13317	17035233:7:GLI1:SFRP1	In human gastric cancer cells, inhibition of Hh signaling reduces the level of [TG] transcript, whereas ectopic expression of [TF] increases the level of sFRP-1 transcript.	Gli1	sFRP-1	1	ACTIVATION	False
13042	13318	18231642:5:GLI1:NHLH1	[TG] promoter was found to be bound and activated by [TF] transcription factor.	Gli1	Nhlh1	1	ACTIVATION	False
13044	13320	19074878:6:HMGA1:STAT3	[TF] also binds directly to a conserved region of the [TG] promoter in vivo in human leukemia cells by chromatin immunoprecipitation and activates transcription of the STAT3 promoter in transfection experiments.	HMGA1a	STAT3	1	ACTIVATION	False
13045	13322	19179606:10:HMGA2:SNAI1	Transcriptional repressors of the E-cadherin gene, such as [TG], decreased after [TF] knockdown since HMGA2 directly activated the SNAlL gene promoter.	HMGA2	SNAIL	1	ACTIVATION	False
13047	13324	19264802:4:GLIS3:INS	We demonstrate that insulin 2 ([TG]) mRNA expression in rat insulinoma 832/13 cells is markedly increased by wild-type [TF] overexpression, but not by the NDH1 mutant.	Glis3	Ins2	1	ACTIVATION	False
13048	13326	19736394:0:GLI1:IGFBP6	[TF] maintains cell survival by up-regulating [TG] and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells.	Gli1	IGFBP6	1	ACTIVATION	False
13049	13327	19736394:9:GLI1:BCL2	Our study reveals that [TF] maintained cell survival by binding the promoter regions and facilitating transcription of IGFBP6 and [TG] genes in a parallel manner in pancreatic cancer cells and suggests it may be one of the mechanisms of Shh-Gli1 signaling pathway in pancreatic cancer.	Gli1	Bcl-2	1	ACTIVATION	False
13050	13328	19736394:9:GLI1:IGFBP6	Our study reveals that [TF] maintained cell survival by binding the promoter regions and facilitating transcription of [TG] and Bcl-2 genes in a parallel manner in pancreatic cancer cells and suggests it may be one of the mechanisms of Shh-Gli1 signaling pathway in pancreatic cancer.	Gli1	IGFBP6	1	ACTIVATION	False
13051	13329	19930158:7:GLI1:SFRP1	Ectopic expression of glioma-associated oncogene-1 ([TF]) increased the level of [TG] (SFRP1) transcript, whereas inhibition of GLI1 reduced the level of SFRP1 transcript.	GLI1	secreted frizzled related protein-1	1	ACTIVATION	False
13052	13330	20074681:4:GLI1:SOX14	Further, we have shown that human [TG] expression is [TF] dependent in U87MG cells and SHH-N dependent in U87MG and HepG2 cell lines.	GLI1	SOX14	1	ACTIVATION	False
13053	13331	20620219:10:HSF4:HSPB1	However, in contrast to activating Hsf1, Daxx can repress Hsf4b-induced expression of [TG] in the mLEC/[TF]-/- cell line.	hsf4	Hsp25	1	ACTIVATION	False
13054	13332	20647328:6:GLI1:CDK2	We show that [TF] is upregulated during esophageal carcinogenesis, and GLI1 can bind to the [TG] promoter and activate its expression.	GLI1	CDK2	1	ACTIVATION	False
13055	13333	20972463:5:GLI1:MUC5AC	Overexpression of [TF] enhanced [TG] expression, and a double knockdown of GLI1 and GLI2 suppressed endogenous MUC5AC expression in PDA cells.	GLI1	MUC5AC	1	ACTIVATION	False
13056	13334	20972463:5:GLI2:MUC5AC	Overexpression of GLI1 enhanced [TG] expression, and a double knockdown of GLI1 and [TF] suppressed endogenous MUC5AC expression in PDA cells.	GLI2	MUC5AC	1	ACTIVATION	False
13057	13335	21559470:8:GLI2:ASCL1	In addition, [TF] activated the [TG]/Mash1 promoter in vitro.	Gli2	Ascl1	1	ACTIVATION	False
13058	13336	21606631:5:GATA2:CDX2	In transient transfection analyses of the upstream region of bovine CSH1, and IFNT or the intron 1 region of [TG] gene, over-expression of [TF] induced transactivation of these trophoblast-specific genes in bovine non-trophoblast ear fibroblast EF cells, but over-expression of GATA3 did not substantially affect their transactivation.	GATA2	CDX2	1	ACTIVATION	False
13060	13338	21940310:8:GLI1:BCL2	It may be one of the mechanisms that [TF] maintained cell survival by binding the promoter regions and facilitating transcription of IGFBP6 and [TG] genes.	Gli1	Bcl-2	1	ACTIVATION	False
13061	13339	21940310:8:GLI1:IGFBP6	It may be one of the mechanisms that [TF] maintained cell survival by binding the promoter regions and facilitating transcription of [TG] and Bcl-2 genes.	Gli1	IGFBP6	1	ACTIVATION	False
13062	13340	22276142:9:HMGA1:TWIST1	In metastatic colon cancer cells, [TF] induces expression of [TG], a gene involved in embryogenesis, EMT, and tumor progression, while HMGA1 represses E-cadherin, a gene that is down-regulated during EMT and metastatic progression.	HMGA1	Twist1	1	ACTIVATION	False
13063	13341	23482931:5:JUND:SOX4	FRA-2/JUND efficiently activated the [TG] promoter via an [TF] site.	AP-1	SOX4	1	ACTIVATION	False
13064	13342	23507146:5:HSF4:DNASE2B	In this study, we found that [TF] promoted the expression and DNase activity of [TG] by directly binding to the DLAD promoter.	HSF4	DLAD	1	ACTIVATION	False
13065	13343	23507146:6:HSF4:DNASE2B	In contrast, [TF] cataract causative mutations failed to bind to the [TG] promoter, abrogating the expression and DNase activity of DLAD.	HSF4	DLAD	1	ACTIVATION	False
13066	13344	23507146:7:HSF4:DNASE2B	These results were confirmed by [TF] knockdown in zebrafish, which led to incomplete de-nucleation of the lens and decreased expression and activity of [TG].	HSF4	DLAD	1	ACTIVATION	False
13067	13345	23507146:8:HSF4:DNASE2B	Together, our results suggest that [TF] exerts its function on lens differentiation via positive regulation of [TG] expression and activity, thus facilitating de-nucleation of lens fiber cells.	HSF4	DLAD	1	ACTIVATION	False
13068	13346	23507146:9:HSF4:DNASE2B	Our demonstration that [TF] cataract causative mutations abrogate the induction of [TG] expression reveals a novel molecular mechanism regarding how HSF4 mutations cause cataractogenesis.	HSF4	DLAD	1	ACTIVATION	False
13069	13347	23530031:11:GLI2:IFITM5	Osterix was a weak activator but acted cooperatively with Sp1 and [TF] to synergistically induce the [TG] promoter.	GLI2	BRIL	1	ACTIVATION	False
13070	13348	23927931:2:GLIS3:INS	Recently, the Krppel-like transcription factor, Gli-similar 3 ([TF]), was shown to bind the [TG] (INS) promoter and positively influence insulin transcription.	Glis3	insulin	1	ACTIVATION	False
13071	13349	24036067:3:GLI2:MYF5	We show that Pax3 synergizes with both [TF] and Zic1 in transactivating the [TG] epaxial somite (ES) enhancer in concert with the Myf5 promoter.	Gli2	Myf5	1	ACTIVATION	False
13072	13350	24058673:6:GLI1:SOCS1	The transcription factors [TF] and GLI2 activate the [TG] promoter, which contains five putative GLI binding sites, and GLI2 binding to the promoter was shown by chromatin immunoprecipitation.	GLI1	SOCS1	1	ACTIVATION	False
13073	13351	24058673:6:GLI2:SOCS1	The transcription factors GLI1 and [TF] activate the [TG] promoter, which contains five putative GLI binding sites, and GLI2 binding to the promoter was shown by chromatin immunoprecipitation.	GLI2	SOCS1	1	ACTIVATION	False
13074	13352	24165159:4:GLI1:BHLHE41	Through [TF] target gene screening, we found that GLI1 and GLI2 activated the expression of a basic helix-loop-helix type suppressor [TG]/DEC2/SHARP1 through a GLI-binding site in the promoter.	GLI1	BHLHE41	1	ACTIVATION	False
13075	13353	24165159:4:GLI2:BHLHE41	Through GLI1 target gene screening, we found that GLI1 and [TF] activated the expression of a basic helix-loop-helix type suppressor [TG]/DEC2/SHARP1 through a GLI-binding site in the promoter.	GLI2	BHLHE41	1	ACTIVATION	False
13076	13354	24332177:6:HMGA2:SOX2	We further show that [TF] enhances [TG] expression by directly binding to the Sox2 promoter.	HMGA2	Sox2	1	ACTIVATION	False
13077	13355	24739390:3:GLI1:BCL2	TGF stimulates [TF] activity in cancer cells and requires its transcriptional activity to induce [TG] expression.	GLI1	BCL2	1	ACTIVATION	False
13078	13356	9926923:6:JUN:CDX2	This decline results from a PKC-dependent decrease in the relative expression of [TF], an activator of [TG] transcription, compared to c-Fos, an inhibitor of Cdx-2.	c-Jun	Cdx-2	1	ACTIVATION	False
13079	13357	23927931:3:GLIS3:INS	In this report, we examined in detail the synergistic activation of [TG] transcription by [TF] with coregulators, CREB-binding protein (CBP)/p300, pancreatic and duodenal homeobox 1 (Pdx1), neuronal differentiation 1 (NeuroD1), and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MafA).	Glis3	insulin	1	ACTIVATION	False
13080	13358	23927931:8:GLIS3:INS	Taken together, these results indicate that [TF] plays a pivotal role in the transcriptional regulation of [TG] and may serve as an important therapeutic target for the treatment of diabetes.	Glis3	insulin	0	UNDEFINED	True
13081	13359	15520176:4:GLI1:BCL2	We show here that expression of the key antiapoptotic factor [TG] is predominantly activated by GLI2 compared with [TF].	GLI1	BCL2	1	ACTIVATION	True
13082	13360	21543335:5:GLIS3:INS	We further showed that SUFU is able to inhibit the activation of the [TG] promoter by [TF] but not the activation by a Glis3 mutant deficient in its ability to bind SUFU, suggesting that the inhibitory effect is dependent on the interaction between the two proteins.	Glis3	insulin	1	ACTIVATION	False
13083	13361	21666711:0:GLI1:CD24	Upregulation of VEGF-A and [TG] gene expression by the t[TF] transcription factor contributes to the aggressive behavior of breast cancer cells.	GLI1	CD24	1	ACTIVATION	False
13084	13362	23927931:4:GLIS3:INS	Our data show that [TF] expression, the binding of Glis3 to GlisBS, and its recruitment of CBP are required for optimal activation of the [TG] promoter in pancreatic -cells not only by Glis3, but also by Pdx1, MafA, and NeuroD1.	Glis3	insulin	1	ACTIVATION	False
13085	13363	14555646:14:GLI1:BCL2	Together, these findings provide consistent evidence that gli proteins can transcriptionally regulate the [TG] promoter and that gli-3 can inhibit transactivation by [TF].	gli-1	bcl-2	1	ACTIVATION	True
13086	13364	16880529:4:GLI2:BMP2	We hypothesize that [TF] regulates [TG] gene transcription and thus osteoblast differentiation.	Gli2	BMP-2	0	UNDEFINED	False
13087	13365	17488195:0:GLIS3:FGF18	Krppel-like zinc finger protein [TF] promotes osteoblast differentiation by regulating [TG] expression.	Glis3	FGF18	0	UNDEFINED	False
13088	13366	18832382:8:HMGA2:SNAI1	We demonstrate that [TF] directly binds to the [TG] promoter and acts as a transcriptional regulator of SNAIL1 expression.	HMGA2	SNAIL1	0	UNDEFINED	False
13089	13367	18927476:0:GLI2:SOX2	[TF] is a novel regulator of [TG] expression in telencephalic neuroepithelial cells.	Gli2	sox2	0	UNDEFINED	False
13090	13369	19264802:3:GLIS3:INS	Our aim was to examine the role of [TF] in beta cells, specifically with regard to regulation of [TG] gene transcription.	Glis3	insulin	0	UNDEFINED	False
13091	13370	19264802:7:GLIS3:INS	Deletion analysis of [TG] promoter identifies a sequence (5'-GTCCCCTGCTGTGAA-3') from -255 to -241 as the [TF] response element and binding occur specifically via the Glis3 zinc finger region as revealed by mobility shift assays.	Glis3	Ins2	0	UNDEFINED	False
13092	13372	19805515:7:GLIS3:INS	In addition, we provide evidence that [TF] regulates [TG] gene expression through two Glis-binding sites in its proximal promoter, indicating that Glis3 also regulates beta-cell function.	Glis3	insulin	0	UNDEFINED	False
13093	13373	21559470:7:GLI2:ASCL1	Using chromatin immunoprecipitation assays, we showed that [TF] bound to multiple regulatory regions in the [TG] gene, including promoter and enhancer regions during Gli2-induced neurogenesis.	Gli2	Ascl1	0	UNDEFINED	False
13094	13374	22821892:4:ID1:RUNX2	We showed that [TF] controls the expression of the [TG] isoform I and that this transcription factor plays a central role in mediating the Id1 proinvasive function in thyroid tumor cells.	Id1	Runx2	0	UNDEFINED	False
13095	13375	22986531:2:GATA6:CDX2	We have previously established that several endodermal transcription factors, including HNF4 and [TF], are involved in [TG] regulation in the normal gut.	GATA6	Cdx2	0	UNDEFINED	False
13096	13376	23482563:9:GLI1:IL6	Sonic hedgehog induces [TF] binding to the [TG] promoter and increases IL-6 expression in fibroblasts in a paracrine manner.	GLI1	IL-6	0	UNDEFINED	True
13097	13377	23507146:0:HSF4:DNASE2B	[TF] regulates [TG] expression and promotes lens de-nucleation.	HSF4	DLAD	0	UNDEFINED	False
13098	13378	23927931:0:GLIS3:INS	The Krppel-like protein Gli-similar 3 ([TF]) functions as a key regulator of [TG] transcription.	Glis3	insulin	0	UNDEFINED	False
13099	13379	23927931:7:GLIS3:INS	We therefore propose that recruitment of CBP/p300 by [TF] provides a scaffold for the formation of a larger transcriptional regulatory complex that stabilizes the binding of Pdx1, NeuroD1, and MafA complexes to their respective binding sites within the [TG] promoter.	Glis3	insulin	0	UNDEFINED	False
13100	13380	23580656:2:GLI1:AKT1	Here, we report that canonical Hedgehog signaling modulates the transcriptional expression of AKT genes and that [TG] is a direct transcriptional target of [TF].	GLI1	AKT1	0	UNDEFINED	False
13101	13381	18279667:7:GLI2:FGF19	These findings suggest that the repressor form of [TF] preferentially binds to the GliREs to control [TG] expression.	Gli2	Fgf15	0	UNDEFINED	False
13102	13382	19736394:7:GLI1:BCL2	The transcription factor [TF] bound to promoter regions of [TG] and IGFBP6 genes and the levels of IGFBP6, proliferating cell nuclear antigen (PCNA) and Bcl-2 messenger RNA (mRNA) were decreased as well as Gli1 mRNA significantly by cyclopamine or RNAi in cultured pancreatic cancer cells (p < 0.01).	Gli1	Bcl-2	0	UNDEFINED	False
13103	13383	19736394:7:GLI1:IGFBP6	The transcription factor [TF] bound to promoter regions of Bcl-2 and [TG] genes and the levels of IGFBP6, proliferating cell nuclear antigen (PCNA) and Bcl-2 messenger RNA (mRNA) were decreased as well as Gli1 mRNA significantly by cyclopamine or RNAi in cultured pancreatic cancer cells (p < 0.01).	Gli1	IGFBP6	0	UNDEFINED	False
13104	13384	21940310:6:GLI1:BCL2	[TF] bound to promoter regions of [TG] and IGFBP6 genes, cyclopamine inhibited proliferation and induced apoptosis through inhibiting the transcriptions of IGFBP6 (p=0.003), proliferating cell nuclear antigen (PCNA) (p=0.014) and Bcl-2 (p=0.013), and increasing that of BCL2-associated X protein (Bax) and BCL2-antagonist/killer 1 (Bak1) (p=0.003 and 0.001, respectively) in SW116 cells.	Gli1	Bcl-2	0	UNDEFINED	False
13105	13385	15175043:4:GLI2:GLI1	Using band shift and luciferase reporter assays, we now show that [TF] binds the GLI-binding consensus sequence in the [TG] promoter.	GLI2	GLI1	0	UNDEFINED	False
13106	13386	16328026:4:GLI1:DKK2	Here, we searched for the [TF]-binding site within the promoter region of genes encoding secreted-type WNT signal inhibitors, including SFRP1, SFRP2, SFRP3, SFRP4, SFRP5, DKK1, [TG], DKK3, DKK4, and WIF1.	GLI	DKK2	0	UNDEFINED	False
13107	13387	16328026:4:GLI1:DKK3	Here, we searched for the [TF]-binding site within the promoter region of genes encoding secreted-type WNT signal inhibitors, including SFRP1, SFRP2, SFRP3, SFRP4, SFRP5, DKK1, DKK2, [TG], DKK4, and WIF1.	GLI	DKK3	0	UNDEFINED	False
13108	13388	16328026:4:GLI1:DKK4	Here, we searched for the [TF]-binding site within the promoter region of genes encoding secreted-type WNT signal inhibitors, including SFRP1, SFRP2, SFRP3, SFRP4, SFRP5, DKK1, DKK2, DKK3, [TG], and WIF1.	GLI	DKK4	0	UNDEFINED	False
13109	13389	16328026:4:GLI1:FRZB	Here, we searched for the [TF]-binding site within the promoter region of genes encoding secreted-type WNT signal inhibitors, including SFRP1, SFRP2, [TG], SFRP4, SFRP5, DKK1, DKK2, DKK3, DKK4, and WIF1.	GLI	SFRP3	0	UNDEFINED	False
13110	13390	16328026:7:GLI1:SFRP1	The [TF]-binding site of the human [TG] promoter was conserved in chimpanzee SFRP1, mouse Sfrp1, and rat Sfrp1 promoters.	GLI	SFRP1	0	UNDEFINED	False
13111	13391	16880529:7:GLI2:BMP2	Promoter analyses, including chromatin immunoprecipitation and electrophoretic mobility shift assays, provided direct evidence that [TF] physically interacts with the [TG] promoter.	Gli2	BMP-2	0	UNDEFINED	False
13112	13392	17035233:8:GLI1:SFRP1	Results from chromatin immunoprecipitation indicate that [TF] is involved in transcriptional regulation of [TG].	Gli1	sFRP-1	0	UNDEFINED	False
13113	13393	19124651:5:GLI2:HES1	We also show using chromatin immunoprecipitation that [TF] binds to the [TG] promoter, which suggests that Hes1 is a Hh-dependent direct target of Gli2 signaling.	Gli2	Hes1	0	UNDEFINED	False
13114	13394	19264802:6:GLIS3:INS	[TF] binds to the [TG] promoter in the cell, detected by chromatin immunoprecipitation.	Glis3	Ins2	0	UNDEFINED	False
13115	13396	19264802:9:GLIS3:INS	[TF] also may indirectly affect [TG] promoter activity through upregulation of MafA and downregulation of Nkx6-1.	Glis3	insulin	0	UNDEFINED	False
13116	13397	19736394:3:GLI1:BCL2	We studied the relationship of Shh-[TF] signaling pathway with proliferation and apoptosis of pancreatic cancer cells and the regulation of transcription factor Gli1 to insulin-like growth factor binding protein 6 (IGFBP6) and [TG] genes at the level of transcription.	Gli1	Bcl-2	0	UNDEFINED	False
13117	13398	19736394:3:GLI1:IGFBP6	We studied the relationship of Shh-[TF] signaling pathway with proliferation and apoptosis of pancreatic cancer cells and the regulation of transcription factor Gli1 to [TG] (IGFBP6) and Bcl-2 genes at the level of transcription.	Gli1	insulin-like growth factor binding protein 6	0	UNDEFINED	False
13118	13399	21940310:6:GLI1:IGFBP6	[TF] bound to promoter regions of Bcl-2 and [TG] genes, cyclopamine inhibited proliferation and induced apoptosis through inhibiting the transcriptions of IGFBP6 (p=0.003), proliferating cell nuclear antigen (PCNA) (p=0.014) and Bcl-2 (p=0.013), and increasing that of BCL2-associated X protein (Bax) and BCL2-antagonist/killer 1 (Bak1) (p=0.003 and 0.001, respectively) in SW116 cells.	Gli1	IGFBP6	0	UNDEFINED	False
13119	13400	22072985:8:GLI2:COL10A1	[TF] and GLI3 bound to the [TG] regulatory element but not to the enhancer of Col2a1.	GLI2	Col10a1	0	UNDEFINED	False
13120	13401	22281533:7:GLI2:SOX8	We also show using chromatin immunoprecipitation that [TF] binds to the [TG] promoter, suggesting that Sox8 is an Hh-dependent direct target of Gli2.	Gli2	Sox8	0	UNDEFINED	False
13121	13402	23423781:7:GLI1:ABCB1	The underlying mechanism is a direct association of [TF] with a specific consensus sequence located in the promoter region of [TG] and ABCG2 genes.	Gli1	ABCB1	0	UNDEFINED	False
13122	13403	24886827:13:GLI1:PDGFRA	Interestingly, analysis of the [TG] promoter revealed a canonical Gli-binding site where [TF] resides.	Gli1	Pdgfra	0	UNDEFINED	False
13123	13404	23451207:7:KLF4:MAPK8	Specifically, increased expression of [TG] (Mapk8) upon down-regulation of its transcriptional repressor [TF] is required for EMT cell migration and for the induction of apoptosis.	Klf4	Jnk1	2	REPRESSION	False
13124	13405	24470523:7:KLF4:SELE	Moreover, [TF]-cKO mice exhibited an augmented proliferation rate, enhanced accumulation of macrophages and T lymphocytes, and elevated expression of cell adhesion molecules including vascular cell adhesion molecule-1 (Vcam1) and [TG] in injured arteries.	Klf4	E-selectin	2	REPRESSION	False
13126	13407	19005469:3:PAX2:ERBB2	We implicate the [TF] gene product (PAX2), in a previously unrecognized role, as a crucial mediator of ER repression of [TG] by the anti-cancer drug tamoxifen.	paired box 2	ERBB2	2	REPRESSION	False
13127	13408	21880579:6:PAX2:L1CAM	Notably, the downregulation of [TF] led to an increased [TG] expression, which was accompanied by a massive metalloprotease-mediated release of soluble L1-CAM.	PAX2	L1-CAM	2	REPRESSION	False
13128	13409	12036432:7:KLF16:CYP1A1	Also, we show that both BTEB3 and [TF] repress the [TG] gene promoter via the BTE site in HepG2 and BxPC3 cells.	BTEB4	CYP1A1	2	REPRESSION	False
13129	13410	12087069:7:KLF4:ID3	[TG] down-regulation is induced via binding of [TF] to the Id3 promotor and concomitantly reduced Id3 gene transcription rate.	GKLF	Id3	2	REPRESSION	False
13130	13411	12087155:5:KLF5:KLF4	However, while [TG] activates the promoter of its own gene, [TF] suppresses the Klf4 promoter.	Klf5	Klf4	2	REPRESSION	False
13131	13412	12186428:8:KLF4:GSTP1	Moreover, transfection analyses revealed that BTEB2, [TF], and TIEGI repressed the [TG] promoter activity.	EZF	GST-P	2	REPRESSION	False
13132	13413	12297499:6:KLF4:ODC1	Reporter gene transfection studies and electrophoretic mobility gel shift assays demonstrated that [TF] repressed [TG] promoter activity and that these effects appeared to be mediated through interaction with a GC box in the proximal portion of the promoter.	GKLF	ODC	2	REPRESSION	False
13133	13414	12297499:7:KLF4:ODC1	Transfection studies using reporter constructs and chromatin immunoprecipitation assays also demonstrated that [TF] inhibited transactivation of the [TG] gene by interfering with the binding of Sp1 to the ODC promoter.	GKLF	ODC	2	REPRESSION	False
13134	13415	12297499:8:KLF4:ODC1	These results indicate that [TF] may function as a G(1)/S checkpoint regulator and exert its growth arrest effect through down-regulation of [TG] gene expression.	GKLF	ODC	2	REPRESSION	False
13135	13416	12297499:9:KLF4:ODC1	Furthermore, [TF] is a transcriptional repressor of the [TG] gene, and these effects are mediated by interaction with the GC-rich region on the promoter.	GKLF	ODC	2	REPRESSION	False
13136	13417	12391164:0:RUNX2:CDKN1A	Runx2 ([TF], AML-3) interacts with histone deacetylase 6 and represses the [TG](CIP1/WAF1) promoter.	Cbfa1	p21	2	REPRESSION	False
13137	13418	12391164:11:RUNX2:CDKN1A	Finally, we show that HDAC6 is expressed in differentiating osteoblasts and that the [TF] carboxy terminus is necessary for maximal repression of the [TG] promoter in preosteoblasts.	Runx2	p21	2	REPRESSION	False
13138	13419	12796513:9:RUNX3:CD4	The results provide information on the role of [TF] and Runx1 in thymopoiesis and suggest that both act as transcriptional repressors of [TG] expression during T cell lineage decisions.	Runx3	CD4	2	REPRESSION	False
13139	13420	14500656:7:RUNX3:CD4	Using this approach, we show here that the transcription factor [TF] is involved in silencing of [TG] expression during CD8 T cell differentiation.	Runx3	CD4	2	REPRESSION	False
13140	13421	14627709:10:KLF4:CCNB1	Co-transfection experiments showed that [TF] repressed the [TG] promoter through a specific GC-rich element.	KLF4	cyclin B1	2	REPRESSION	False
13141	13422	14627709:12:KLF4:CCNB1	We conclude that [TF] is essential in preventing mitotic entry following gamma-irradiation and does so by inhibiting [TG] expression.	KLF4	cyclin B1	2	REPRESSION	False
13142	13423	14670968:0:KLF4:HDC	Kruppel-like factor 4 ([TF]) represses [TG] gene expression through an upstream Sp1 site and downstream gastrin responsive elements.	KLF4	histidine decarboxylase	2	REPRESSION	False
13143	13424	14670968:6:KLF4:HDC	In addition, transient cotransfection experiments showed that overexpression of [TF] dose dependently and specifically inhibited [TG] promoter activity.	KLF4	HDC	2	REPRESSION	False
13144	13425	14670968:8:KLF4:HDC	We further showed that [TF] inhibits [TG] promoter activity by competing with Sp1 at the upstream GC box and also independently by binding the three downstream gastrin responsive elements.	KLF4	HDC	2	REPRESSION	False
13145	13426	14670968:9:KLF4:HDC	Taken together, these results indicate that [TF] can act to repress [TG] gene expression by Sp1-dependent and -independent mechanisms.	KLF4	HDC	2	REPRESSION	False
13146	13427	15034051:3:RUNX3:CD4	This effect arises from Runx1- or [TF]-mediated repression of [TG] expression, and is independent of positively selecting signals.	Runx3	CD4	2	REPRESSION	False
13147	13428	15107836:10:RUNX2:CDKN1A	Consistent with these data, the [TF] gene was a strong repressor of the promoter of the cyclin-dependent kinase inhibitor, p21([TG]), while RUNX2Delta8 was a competitive inhibitor of RUNX2 and exhibited weak repression activity.	RUNX2	CIP1	2	REPRESSION	False
13148	13429	15561714:4:KLF4:ITGAD	Transfection of [TF]/GKLFa in myeloid cells reduced [TG] promoter activity, whereas, down-regulation of GKLF/GKLFa with small interfering RNAs led to up-regulation of CD11d expression.	GKLF	CD11d	2	REPRESSION	False
13150	13431	15623517:9:KLF4:MYOCD	Taken together, results indicate that [TF] represses SMC genes by both down-regulating [TG] expression and preventing serum response factor/myocardin from associating with SMC gene promoters, and suggest that KLF4 may be a key effector of PDGF-BB and injury-induced phenotypic switching of SMC.	KLF4	myocardin	2	REPRESSION	False
13151	13432	15703179:3:NKX3-2:RUNX2	We identify the [TF] as a potent sequence-specific repressor of the [TG] promoter that acts through a regulatory element 0.1 kb upstream from the site of transcriptional initiation.	homeodomain protein Nkx3.2	Runx2	2	REPRESSION	False
13152	13433	15756676:11:RUNX3:ABCB1	Luciferase reporter assay suggested that [TF] inhibited the promoter activity of the [TG] MRP-1 promoter in SGC7901 cells.	Runx3	MDR-1 and	2	REPRESSION	False
13153	13434	15756676:11:RUNX3:ABCC1	Luciferase reporter assay suggested that [TF] inhibited the promoter activity of the MDR-1 and [TG] promoter in SGC7901 cells.	Runx3	MRP-1	2	REPRESSION	False
13154	13435	15756676:8:RUNX3:BCL2	Semiquantitative RT-PCR and Western blot suggested that [TF] downregulated expression of [TG], MDR-1 (P-gp) and MRP-1.	Runx3	Bcl-2	2	REPRESSION	False
13155	13436	15778373:10:RUNX3:KIR3DL1	The present study suggests that [TF] acts as a repressor of [TG] expression in mature NK cells and opens the possibility that AML factors and associated cofactors are involved in regulation of KIR expression during NK cell development.	AML-2	KIR	2	REPRESSION	False
13156	13437	16027362:3:RUNX3:CCR7	When [TF] is lost, i.e., in Runx3 knockout mice, expression of [TG] is enhanced, resulting in increased migration of alveolar DC to the lung-draining lymph nodes.	Runx3	CCR7	2	REPRESSION	False
13157	13438	16115867:9:MSX2:RUNX2	Moreover, [TF] specifically suppressed the [TG] P1 promoter, and the responsible region overlaps with that recognized by Dlx5.	Msx2	Runx2	2	REPRESSION	False
13158	13439	16118513:6:MSX2:SOX2	[TF] has an inhibitory effect, whereas Six3 does not affect the [TG] promoter.	Msx2	Sox2	2	REPRESSION	False
13159	13440	16244670:7:KLF4:TP53	Consistently, [TF] depletion from breast cancer cells restores [TG] levels and causes p53-dependent apoptosis.	KLF4	p53	2	REPRESSION	False
13160	13441	16631587:5:PAX2:NPHS1	[TF] activation caused repression of the podocyte key regulator molecule Wt1 and consequently a dramatic reduction of [TG] expression.	PAX2	nephrin	2	REPRESSION	False
13161	13442	17043312:1:NR3C1:POMC	Negative feedback regulation of the [TG] (POMC) gene by the [TF] (GR) is a critical feature of the hypothalamo-pituitary-adrenal axis, and it is in part exerted by trans-repression between GR and the orphan nuclear receptors related to NGFI-B.	glucocorticoid (Gc) receptor	proopiomelanocortin	2	REPRESSION	False
13162	13443	17060321:7:MSX2:RUNX2	Our studies further show regulation of the [TG] gene by several homeodomain proteins: [TF] and CDP/cut repress whereas DLX3 and DLX5 activate endogenous Runx2 expression and promoter activity in non-osseous cells and osteoblasts.	MSX2	Runx2	2	REPRESSION	False
13163	13444	17195845:2:RUNX3:IL4	Here we show that the transcription factor [TF] is induced in T helper type 1 (T(H)1) cells in a T-bet-dependent manner, and that both transcription factors T-bet and Runx3 are required for maximal production of interferon-gamma (IFN-gamma) and silencing of the gene encoding interleukin 4 ([TG]) in T(H)1 cells.	Runx3	Il4	2	REPRESSION	False
13164	13445	17195845:4:RUNX3:IL4	Both T-bet and [TF] bind to the Ifng promoter and the [TG] silencer, and deletion of the silencer decreases the sensitivity of Il4 to repression by either factor.	Runx3	Il4	2	REPRESSION	False
13165	13446	17308127:4:KLF4:TP53	Previous work has shown that the Kruppel-like factor 4 ([TF]) transcription factor represses [TG] transcription by binding to the PE21 element.	KLF4	p53	2	REPRESSION	False
13166	13447	17352650:19:RUNX2:TERT	These studies suggest that [TF] may act as a repressor of early stem cell markers such as h[TG] as one possible mechanism for facilitating cellular differentiation.	Cbfa1	TERT	2	REPRESSION	False
13167	13448	17352650:3:RUNX2:TERT	We showed that [TF] acts as a partial repressor of [TG], which may facilitate cellular differentiation.	Cbfa1	TERT	2	REPRESSION	False
13168	13449	17352693:0:RUNX3:SP7	[TF] negatively regulates [TG] expression in dental pulp cells.	Runx3	Osterix	2	REPRESSION	False
13169	13450	17352693:6:RUNX3:SP7	[TF] down-regulates [TG] expression in mouse DPCs (dental pulp cells).	Runx3	Osterix	2	REPRESSION	False
13170	13451	17352693:8:RUNX3:SP7	Enforced expression of [TF] down-regulated the activity of the [TG] promoter in the human embryonic kidney 293 cell line.	Runx3	Osterix	2	REPRESSION	False
13171	13452	17352693:9:RUNX3:SP7	When the [TF] responsive element on the [TG] promoter, located at -713 to -707 bp (site 3, AGTGGTT) relative to the cap site, was mutated, this down-regulation was abrogated.	Runx3	Osterix	2	REPRESSION	True
13172	13453	17438369:10:RUNX2:CDKN1A	The [TF](P409A) mutant retained the ability to bind DNA and repress the p21([TG]) promoter as shown by DNA precipitation and luciferase-reporter assays, respectively, but was not able to relieve repression of the p21(CIP1) promoter.	RUNX2	CIP1	2	REPRESSION	True
13173	13454	17584746:3:RUNX3:NTRK2	Here, we show that [TF] abolished mRNA induction of [TG] expression, and concomitantly altered the neurotrophin response in a differentiating neuroblastoma cell line.	RUNX3	TRKB	2	REPRESSION	False
13174	13455	17584746:9:RUNX3:NTRK2	Taken together, [TF] determines TrkC positive sensory neuron identities through the transcriptional repression of [TG] when Trk-BTrkC double positive neurons differentiate into TrkC single positive neurons.	Runx3	TrkB	2	REPRESSION	False
13175	13456	17827213:0:KLF4:HDC	Tip60 functions as a potential corepressor of [TF] in regulation of [TG] promoter activity.	KLF4	HDC	2	REPRESSION	True
13176	13457	17827213:2:KLF4:HDC	Previously we have demonstrated that [TF] represses [TG] promoter activity in a gastric cell line through both an upstream Sp1 binding GC box and downstream gastrin responsive elements.	KLF4	HDC	2	REPRESSION	False
13177	13458	17827213:3:KLF4:HDC	However, the mechanism by which [TF] inhibits [TG] promoter is not well defined.	KLF4	HDC	2	REPRESSION	False
13178	13459	17878336:4:RUNX3:CD4	We demonstrate that, although Zbtb7b does not enhance [TG] expression on its own, it antagonizes the CD4 repression mediated by the transcription factor [TF], which is normally up-regulated during CD8 differentiation and promotes CD4 silencing.	Runx3	CD4	2	REPRESSION	False
13179	13460	18474616:4:L3MBTL1:RUNX1	We determined that this histone code is involved in a transcriptional regulatory pathway in vivo whereby monomethylated H4K20 binds the [TF] repressor protein to repress specific genes, including [TG], a critical regulator of hematopoietic differentiation.	L3MBTL1	RUNX1	2	REPRESSION	False
13180	13461	18474616:5:L3MBTL1:RUNX1	The selective loss of monomethylated H4K20 at the [TG] promoter resulted in the displacement of [TF] and a concomitant increase in RUNX1 transcription.	L3MBTL1	RUNX1	2	REPRESSION	False
13181	13462	18579517:0:LEF1:IL4	[TF] negatively controls [TG] expression through a proximal promoter regulatory element.	LEF-1	interleukin-4	2	REPRESSION	False
13182	13463	18579517:6:LEF1:IL4	We identified a high affinity [TF]binding site in the negative regulatory element of the [TG] promoter.	LEF-1-	IL-4	2	REPRESSION	True
13183	13464	18804520:5:RUNX2:OSR1	[TG] promoter activity was suppressed by cotransfection with [TF]- and Ikzf1-expressing vectors in a dose-dependent manner.	Runx2	Osr1	2	REPRESSION	False
13184	13465	19005469:5:PAX2:ERBB2	The repression of [TG] by ER-[TF] links these two breast cancer subtypes and suggests that aggressive ERBB2-positive tumours can originate from ER-positive luminal tumours by circumventing this repressive mechanism.	PAX2	ERBB2	2	REPRESSION	False
13185	13466	19179305:6:RUNX2:CSF1R	Sustained [TF] expression hinders myeloid progenitor differentiation capacity and represses expression of CBF targets [TG], Mpo, Cebpd, the cell cycle inhibitor Cdkn1a, and myeloid markers Cebpa and Gfi1.	Runx2	Csf1R	2	REPRESSION	False
13186	13467	19403666:6:RUNX3:RUNX1	The TLE binding VWRPY sequence from the C terminus of [TF] was found to be required for repression of the [TG] P1 promoter in a B-lymphoma cell line.	RUNX3	RUNX1	2	REPRESSION	False
13187	13468	19491109:7:KLF2:HIF1A	Conversely, knockdown of [TF] increased expression of [TG] and its targets.	KLF2	HIF-1alpha	2	REPRESSION	False
13188	13469	19729022:5:KLF4:NPPA	SK-induced repression of [TG] promoter activity was attenuated when the [TF]-binding element was deleted or disrupted.	KLF4	Nppa	2	REPRESSION	False
13189	13470	19917777:3:RUNX3:CD4	We further show that Ets1 promotes expression of [TF], a transcription factor important for CD8 T cell differentiation and the cessation of [TG] gene expression.	Runx3	Cd4	2	REPRESSION	False
13190	13471	20357224:3:RUNX2:FSHB	[TF] is expressed within the murine pituitary gland and dramatically represses activin-induced [TG] promoter activity, without affecting basal expression in LbetaT2 cells, an immortalized mouse gonadotrope cell line.	Runx2	FSHbeta	2	REPRESSION	False
13191	13472	20357224:8:RUNX2:FSHB	In summary, the present study provides evidence for [TF]-mediated repression of activin-induced [TG] gene expression and reveals the context dependence of Runx2 action in hormonal regulation of the gonadotropin genes.	Runx2	FSHbeta	2	REPRESSION	False
13192	13473	20363964:6:LEF1:CD1D	Overexpression of [TF] in K562 or Jurkat cells suppresses [TG] promoter activity and downregulates endogenous CD1D transcripts, whereas knockdown of LEF-1 using LEF-1-specific small interfering RNA increases CD1D transcripts in K562 and Jurkat cells but there are different levels of surface CD1d on these two cell types.	LEF-1	CD1D	2	REPRESSION	False
13193	13474	20363964:8:LEF1:CD1D	Knockdown of [TF] using small interfering RNA potentiates an acetylation state of histone H3/H4, supporting the notion that LEF-1 acts as a transcriptional repressor for the [TG] gene.	LEF-1	CD1D	2	REPRESSION	False
13194	13475	20442780:5:KLF4:NOTCH1	This finding is likely to be of biological significance, as [TF] and, to a lesser extent, Sp3 are up-regulated in a number of cancer cells where [TG] expression is down-modulated, and Klf4 over-expression in normal cells is sufficient to down-modulate Notch1 gene transcription.	Klf4	Notch1	2	REPRESSION	False
13195	13476	21531817:0:KLF4:IFITM3	[TF]-mediated negative regulation of [TG] expression plays a critical role in colon cancer pathogenesis.	KLF4	IFITM3	2	REPRESSION	False
13196	13477	21531817:7:KLF4:IFITM3	Restored expression of [TF], a putative tumor suppressor, downregulated [TG] expression in colon cancer cells in vitro.	KLF4	IFITM3	2	REPRESSION	False
13197	13478	21637926:11:RUNX3:JAG1	Reporter assays, ChIP assays and EMSAs revealed that [TF] directly bound to the transcriptional regulatory region of [TG] and suppressed JAG1 transcription.	RUNX3	JAG1	2	REPRESSION	False
13198	13479	21637926:14:RUNX3:JAG1	[TF] expression suppressed [TG] expression and resulted in downregulation of tumorigenesis by suppression of JAG1-mediated CSCs.	RUNX3	JAG1	2	REPRESSION	False
13199	13480	22203039:7:KLF4:SNAI2	We show that [TF] and another epithelial determinant, FOXA1, are direct transcriptional inhibitors of [TG] expression in mouse and human prostate cancer cells.	KLF4	SLUG	2	REPRESSION	False
13200	13481	22231444:5:RUNX3:AKT1	Knockdown of [TF] upregulates protein and mRNA expression of [TG] in normal gastric epithelial cell line, GES-1.	RUNX3	Akt1	2	REPRESSION	False
13201	13482	22231444:7:RUNX3:AKT1	We identified two [TF]-binding sites in [TG] promoter and the binding of RUNX3 on Akt1 promoter significantly inhibits Akt1 expression.	RUNX3	Akt1	2	REPRESSION	False
13202	13483	22537242:6:RUNX2:GDF10	The chromatin immunoprecipitation studies identified that the mechanism of [TF]-mediated suppression of [TG] is due to the recruitment of Runx2 and histone H3K9-specific methyltransferase Suv39h1 to BMP-3B proximal promoter and a concomitant increase in histone methylation (H3K9) status.	Runx2	BMP-3B	2	REPRESSION	False
13203	13484	22537242:7:RUNX2:GDF10	The knockdown of [TF] in H1299 cells resulted in decreased histone H3K9 methylation on [TG] promoter and increased BMP-3B expression levels.	Runx2	BMP-3B	2	REPRESSION	False
13204	13485	22713854:4:RUNX2:PTGS2	The knockdown of the agonist-stimulated [TF] expression increased Runx1, [TG], and Tnfaip6 expression and PGE(2) levels in luteinizing granulosa cells.	Runx2	Ptgs2	2	REPRESSION	False
13205	13486	22713854:4:RUNX2:TNFAIP6	The knockdown of the agonist-stimulated [TF] expression increased Runx1, Ptgs2, and [TG] expression and PGE(2) levels in luteinizing granulosa cells.	Runx2	Tnfaip6	2	REPRESSION	False
13206	13487	22713854:7:RUNX2:RUNX1	The knockdown and overexpression of [TF] increased and decreased [TG] promoter activity, respectively.	Runx2	Runx1	2	REPRESSION	False
13207	13488	22937066:14:KLF4:SNAI2	Our data suggest that [TF] acts as a tumor suppressor in HCC cells, in part by suppressing [TG] transcription.	KLF4	SLUG	2	REPRESSION	False
13208	13489	22982861:3:PROX1:TWIST1	We demonstrate that [TF] directly binds to proximal promoter of [TG] gene to repress its transcription and inhibits its downstream target gene AKT2 expression which leads to reduction of cell migration and invasion.	PROX1	TWIST1	2	REPRESSION	False
13209	13490	22991339:11:RBPJ:SOX9	The association of the [TF]/NICD complex with the [TG] promoter is associated with transcriptional repression of Sox9 in a cellular model of chondrocyte differentiation.	Rbpj	Sox9	2	REPRESSION	False
13210	13491	23145006:10:OTX2:SOX2	Here, we suggest that [TF] prevents the presumptive RPE region from forming the NR by repressing the expression of both Fgf8 and [TG] which induce the NR cell fate.	Otx2	Sox2	2	REPRESSION	False
13211	13492	23266329:6:KLF5:SOX9	[TF]-deletion blocked the decrease in FoxA1 and [TG] expression that accompanies normal villus morphogenesis.	Klf5	Sox9	2	REPRESSION	True
13212	13493	23300083:4:RUNX2:AXIN2	[TG] levels are elevated in [TF](-/-) calvarial cells, and Runx2 represses transcription of Axin2 mRNA, suggesting a direct relationship between these factors in vivo.	Runx2	Axin2	2	REPRESSION	False
13213	13494	23300083:5:RUNX2:AXIN2	Here we demonstrate that [TF] binds several regions of the [TG] promoter and that Runx2-mediated repression of Axin2 transcription depends on Hdac3.	Runx2	Axin2	2	REPRESSION	False
13214	13495	23310955:7:RUNX3:CD4	Furthermore, whereas [TF] represses [TG], we show that Gata3 promotes Cd4 expression in Thpok-deficient thymocytes.	Runx3	Cd4	2	REPRESSION	False
13215	13496	23368843:6:NKX3-1:TWIST1	We show that [TF] binds to the [TG] promoter and that NKX3-1 over-expression reduces the activity of a TWIST1 promoter reporter construct, whereas NKX3-1 siRNA up-regulates endogenous TWIST1 mRNA in prostate cancer cells.	NKX3-1	TWIST1	2	REPRESSION	False
13216	13497	23368843:7:NKX3-1:TWIST1	Our finding that [TF] represses [TG] expression emphasizes the functional importance of NKX3-1 in regulating TWIST1 expression during prostate cancer progression to metastatic disease.	NKX3-1	TWIST1	2	REPRESSION	False
13217	13498	23370975:7:KLF4:SOD1	The expression of [TG] in both mRNA and protein levels was found to be decreased by overexpressing [TF], while increased by knockdown of KLF4.	KLF4	superoxide dismutase (SOD) 1	2	REPRESSION	False
13218	13499	23370975:9:KLF4:SOD1	All the results indicated that [TF] promoted the neurotoxicity of MPP + via inhibiting the transcription of [TG], suggesting a potential mechanism of increased oxidative stress and cell death in Parkinson's disease.	KLF4	SOD1	2	REPRESSION	False
13219	13500	23447599:7:NEUROD1:SOX2	Furthermore, we provide evidence that Ngn1 and [TF] inhibit [TG] transcription through a phylogenetically conserved Sox2 enhancer to mediate neurogenesis.	Neurod1	Sox2	2	REPRESSION	False
13220	13501	23447599:7:NEUROG1:SOX2	Furthermore, we provide evidence that [TF] and Neurod1 inhibit [TG] transcription through a phylogenetically conserved Sox2 enhancer to mediate neurogenesis.	Ngn1	Sox2	2	REPRESSION	False
13221	13502	23743205:3:POU5F1:CDX2	During normal embryogenesis, cell fate of late-stage blastcyst is regulated by a reciprocal repression of the key transcriptional factors; [TF] dominancy inhibits [TG] expression in inner cell mass (ICM) and leads them to epiblast/primitive ectoderm but Cdx2 dominancy in trophectoderm (TE) leads them to trophoblast lineage.	Oct3/4	Cdx2	2	REPRESSION	False
13222	13503	23774402:9:RUNX3:SPP1	The binding of [TF] to the [TG] promoter significantly decreased OPN promoter activity.	RUNX3	OPN	2	REPRESSION	False
13224	13505	24060351:9:KLF4:MYOCD	Moreover, ChIP analysis established that PDGF-BB-induced repression of [TG] gene expression is most likely regulated by enhanced binding of [TF] and Klf5 to a lesser extent, to the PRR of PrmM.	Klf4	Myocd	2	REPRESSION	False
13225	13506	24167250:8:OSR1:SOX9	Furthermore, we show that [TF] binds to the [TG] gene promoter and that overexpression of Osr1 suppressed expression of endogenous Sox9 mRNAs and Sox9 promoter-driven reporter.	Osr1	Sox9	2	REPRESSION	False
13226	13507	24220291:5:KLF17:TWIST1	In contrast, [TF] suppression reversed EMT, diminished cell invasion, restored drug sensitivity and suppressed [TG] expression.	KLF17	TWIST1	1	ACTIVATION	True
13227	13508	24440658:13:KLF5:SOX9	Lentiviral-mediated knockdown of [TF] and exogenous expression of KLF5 in colorectal cancer cell lines confirm that [TG] expression is negatively regulated by KLF5.	KLF5	Sox9	2	REPRESSION	False
13228	13509	24470523:7:KLF4:VCAM1	Moreover, [TF]-cKO mice exhibited an augmented proliferation rate, enhanced accumulation of macrophages and T lymphocytes, and elevated expression of cell adhesion molecules including vascular cell adhesion molecule-1 ([TG]) and E-selectin in injured arteries.	Klf4	Vcam1	2	REPRESSION	False
13229	13510	24470523:8:KLF4:VCAM1	Mechanistic analyses in cultured ECs revealed that [TF] inhibited tumor necrosis factor--induced expression of [TG] through blocking the binding of nuclear factor-B to the Vcam1 promoter.	Klf4	Vcam1	2	REPRESSION	False
13230	13511	24577083:5:LEF1:CYLD	Chromatin immunoprecipitation assays revealed that lymphoid enhancer factor-1 ([TF]) dissociated from the [TG] promoter upon selenite treatment, thus abolishing suppression of CYLD gene expression.	LEF1	CYLD	2	REPRESSION	False
13231	13512	9651398:11:KLF4:CYP1A1	These findings indicate that [TF] is a negative regulator of the [TG] promoter in a BTE-dependent fashion and that this inhibitory effect is in part mediated by physical interaction with Sp1.	GKLF	CYP1A1	2	REPRESSION	False
13232	13513	9651398:5:KLF4:CYP1A1	Cotransfection studies in Chinese hamster ovary cells showed that [TF] inhibited the [TG] promoter in a dose- and BTE-dependent manner.	GKLF	CYP1A1	2	REPRESSION	False
13233	13514	9651398:8:KLF4:CYP1A1	Additional cotransfection studies showed that [TF] inhibited Sp1-mediated activation of the [TG] promoter.	GKLF	CYP1A1	2	REPRESSION	False
13234	13515	14634001:7:KLF4:LAMA1	Interestingly, two Krppel-like factors [TF] and KLF5 exhibit opposing effects on the [TG] promoter activity that are decreased and increased, respectively, in the intestinal epithelial cells.	KLF4	Lama1	2	REPRESSION	True
13235	13516	16169848:10:KLF4:SERPINE1	In contrast, [TF] inhibited the TGF-beta1/Smad3 induction of the [TG] promoter independent of KLF4 DNA binding through a novel antagonistic competition with Smad3 for the C terminus of the coactivator p300/CBP.	KLF4	PAI-1	2	REPRESSION	False
13236	13517	24060351:0:KLF4:MYOCD	Identification of a [TF]-dependent upstream repressor region mediating transcriptional regulation of the [TG] gene in human smooth muscle cells.	Klf4	myocardin	2	REPRESSION	True
13237	13518	12297499:3:KLF4:ODC1	In the present study, we showed that induction of [TF] mRNA and protein expression by interferon-gamma treatment was associated with reduction of ornithine decarboxylase ([TG]) gene expression and enzyme activity in colon cancer HT-29 cells.	GKLF	ODC	2	REPRESSION	True
13238	13519	12721955:7:PAX6:PAX2	Four of the detected mutations affected [TF]-mediated transcriptional repression of the [TG] promoter in a reporter assay.	PAX6	PAX2	2	REPRESSION	False
13239	13520	15703179:5:NKX3-2:RUNX2	We demonstrate that induction of the chondrogenic phenotype and endogenous [TF] expression is accompanied by a repression of [TG] gene activity.	Nkx3.2	Runx2	2	REPRESSION	True
13240	13521	10640701:10:PAX2:EN2	This result demonstrates that the two [TF]binding sites that were deleted, while being required for mid-hindbrain expression in the context of a 1.0 kb [TG] enhancer, are only required for proper initiation of expression of the endogenous En2 gene.	Pax2/5/8-	En2	1	ACTIVATION	False
13241	13522	10747853:3:LEF1:MITF	The melanocyte-specific promoter of the human MITF gene ([TG] promoter) contains a functional [TF]-binding site, which is bound in vitro by LEF-1 and confers the preferential expression on a reporter gene in melanocytes and melanoma cells, as judged by the transient transfection assays.	LEF-1	MITF-M	1	ACTIVATION	False
13243	13524	10938089:0:PAX2:GCG	The paired homeodomain transcription factor [TF] is expressed in the endocrine pancreas and transactivates the [TG] gene promoter.	Pax-2	glucagon	1	ACTIVATION	False
13244	13525	11551969:7:KLF4:LAMA3	Transient transfection of a plasmid expressing [TF] activates transcription from the [TG] promoter in breast cancer cells.	KLF4	LAMA3A	1	ACTIVATION	False
13247	13528	11940591:7:PAX2:GCG	Transient transfection studies revealed that PTIP is a strong inhibitor of the trans-activation activities of Pax2A and [TF] on the [TG] gene promoter, which was chosen as a model because it is a target of the Pax2A and Pax2B transcription factors.	Pax2B	glucagon	1	ACTIVATION	False
13248	13529	12034813:10:KLF4:LAMC1	Thus, the Sp1-[TF] synergistic activation of the LAMC1 promoter may be one of the avenues for expression of [TG] chain when laminin is needed to regulate cell differentiation.	GKLF	laminin gamma1	1	ACTIVATION	False
13249	13530	12135607:6:RREB1:FSHR	Transfection studies indicated that ZNF202 repressed ovine [TG] promoter activity whereas [TF] was likely to function as an activator.	RREB-1	FSHR	1	ACTIVATION	False
13250	13531	12200151:0:PAX2:ROBO3	[TF] interacts with RB and reverses its repression on the promoter of [TG], a Robo member.	Pax-2	Rig-1	1	ACTIVATION	False
13251	13532	12200151:6:PAX2:ROBO3	[TF] interacts with RB and reverses its transcriptional suppression on the [TG] promoter.	Pax-2	Rig-1	1	ACTIVATION	False
13252	13534	12444107:6:MITF:SNAI2	We further show that [TF] is present in Slug-deficient cells and transactivates the [TG] promoter, and that Slugh and Kit genetically interact in vivo.	Mitf	SLUG	1	ACTIVATION	False
13253	13535	12609849:8:MEIS1:PF4	[TF] and PBXs bind to the TME as MEIS1/PBX complexes and activate the [TG] promoter.	MEIS1	PF4	1	ACTIVATION	False
13254	13536	12753399:4:LEF1:DCT	In addition, functional cooperation of MITF-M with [TF] could lead to transcriptional activation of the M promoter and the dopachrome tautomerase ([TG]) gene, an early melanoblast marker.	LEF-1	DCT	1	ACTIVATION	False
13255	13537	12756174:4:PAX2:MITF	Furthermore, both, [TF] and Pax6 bind to and activate a MITF RPE-promoter element in vitro, whereas prolonged expression of Pax6 in the Pax2-positive optic stalk leads to ectopic [TG] expression and RPE differentiation in vivo.	Pax2	Mitf	1	ACTIVATION	False
13256	13538	12853980:4:KLF4:GPA33	In this report, we demonstrate that gut-enriched Krppel-like factor ([TF]) binds to the promoter region of [TG] gene in colonic carcinoma cells and that mutations in the GKLF binding sequence in this region lead to diminished expression of A33 antigen.	GKLF	A33 antigen	1	ACTIVATION	False
13257	13539	12853980:6:KLF4:GPA33	These results suggest that [TF] is a critical regulator in inducing the expression of [TG] in intestinal epithelium.	GKLF	A33 antigen	1	ACTIVATION	False
13258	13540	12919939:5:KLF4:IAPP	Transient transfections with [TG]-luciferase reporter constructs were used to characterize the mechanisms by which [TF] activates IAP transcription.	KLF4	IAP	1	ACTIVATION	False
13259	13541	12919939:7:KLF4:IAPP	RKO cells induced to overexpress [TF] demonstrated a corresponding dose-dependent increase in [TG] expression, and EMSA with nuclear extract from these cells confirmed that KLF4 binds to the IF-III element.	KLF4	IAP	1	ACTIVATION	False
13260	13542	12919939:8:KLF4:IAPP	Transient transfections revealed that [TF] transactivated the [TG] gene largely via a critical segment in the IAP promoter that includes the IF-III cis-element.	KLF4	IAP	1	ACTIVATION	False
13261	13543	12919939:9:KLF4:IAPP	Mutant [TF] constructs failed to fully activate [TG].	KLF4	IAP	1	ACTIVATION	False
13262	13544	14551209:4:LEF1:MSX2	[TF] can synergize with Smad4 and Smad1 to activate [TG] promoter, and this transcriptional complex is assembled on the endogenous promoter in response to BMP2.	Lef1	Msx2	1	ACTIVATION	False
13263	13545	14594802:7:LEF1:ELANE	We find that [TF] and CBFalpha co-activate [TG] expression.	LEF-1	ELA2	1	ACTIVATION	False
13264	13546	14739291:0:RUNX2:SOST	[TF]/RUNX2 directs specific expression of the sclerosteosis gene ([TG]).	Cbfa1	SOST	1	ACTIVATION	False
13265	13547	14751232:8:LEF1:CLDN2	Expression of [TF] and beta-catenin both enhanced [TG] promoter activity.	LEF-1	claudin-2	1	ACTIVATION	False
13266	13548	15051730:5:RUNX2:TIMP1	Overexpression of full-length RUNX1B isoform in HSC repressed [TG] promoter activity, whereas the truncated RUNX1A isoform and [TF] functioned as stimulators.	RUNX2	TIMP1	1	ACTIVATION	False
13267	13549	15107406:8:RUNX2:IHH	Adenoviral introduction of [TF] in Runx2(-/-) chondrocyte cultures strongly induced [TG] expression.	Runx2	Ihh	1	ACTIVATION	False
13268	13550	15136142:6:RUNX2:FGF3	FGF-soaked beads failed to induce [TG] expression in [TF] mutant dental mesenchyme whereas in wild-type mesenchyme they induced Fgf3 in all explants indicating a requirement of Runx2 for transduction of FGF signals.	Runx2	Fgf3	1	ACTIVATION	False
13270	13552	15187018:2:MEIS1:PF4	We previously demonstrated that the homeodomain proteins (myeloid ecotropic integration site 1 [[TF]], Pbx-regulating protein 1 [PREP1], and pre-B-cell leukemia transcription factors [PBXs]) bind to the novel regulatory element tandem repeat of MEIS1 binding element [TME] and transactivate the rat [TG] promoter.	MEIS1	PF4	1	ACTIVATION	False
13271	13553	15190888:7:RUNX2:PTTG1IP	The [TG] promoter binds [TF] in a sequence specific manner, and Runx2 is able to transactivate the Pttg lip promoter in MC3T3-El cells.	Runx2	Pttg1ip	1	ACTIVATION	False
13272	13554	15564063:4:RUNX2:MMP13	Inhibitors of MEK/ERK were assayed for their ability to block FGF2 and [TF] up-regulation of the [TG] promoter.	RUNX2	MMP-13	1	ACTIVATION	False
13273	13555	15728254:11:PITX2:LEF1	Furthermore, beta-catenin in combination with [TF] synergistically activates the [TG] promoter and this activation is independent of the Wnt-responsive element.	PITX2	LEF-1	1	ACTIVATION	False
13274	13556	15728254:4:PITX2:LEF1	Consistent with these results we show that the human 2.5 kb [TG] promoter is activated by [TF].	PITX2	LEF-1	1	ACTIVATION	False
13275	13557	15728254:5:PITX2:LEF1	Furthermore, the [TG] promoter is differentially activated by [TF] isoforms, which are co-expressed in dental epithelium.	PITX2	LEF-1	1	ACTIVATION	False
13276	13558	15765505:10:RUNX2:BMP2	These results indicate that [TF] is an important mediator of the expression of [TG] in response to FGF stimulation in cranial bone development.	Runx2	Bmp2	1	ACTIVATION	False
13277	13559	15983061:3:MITF:HIF1A	Interestingly, we report that the melanocyte-specific transcription factor, microphthalmia-associated transcription factor ([TF]), binds to the [TG] promoter and strongly stimulates its transcriptional activity.	MITF	Hif1a	1	ACTIVATION	False
13278	13560	16034110:6:RUNX3:ITGAE	We demonstrate that [TF] is necessary not only to repress CD4, but also to induce [TG] expression during development of CD8 SP T cells.	Runx3	CD103	1	ACTIVATION	False
13279	13561	16034110:9:RUNX3:ITGAE	Overexpression of [TF] also up-regulated [TG] expression on a subpopulation of CD4 SP T cells with characteristics of regulatory T cells.	Runx3	CD103	1	ACTIVATION	False
13280	13562	16118513:5:PAX6:SOX2	Taking our data together, AP2, [TF] and PROX1 can activate the [TG] promoter.	Pax6	Sox2	1	ACTIVATION	False
13281	13563	16118513:5:PROX1:SOX2	Taking our data together, AP2, Pax6 and [TF] can activate the [TG] promoter.	PROX1	Sox2	1	ACTIVATION	False
13282	13564	16135801:10:RUNX3:CDKN1A	Our results suggest that at least part of the tumor suppressor activity of [TF] is associated with its ability to induce [TG] expression.	RUNX3	p21	1	ACTIVATION	False
13283	13565	16135801:5:RUNX3:CDKN1A	Here we show that [TF] is required for the TGF-beta-dependent induction of [TG] expression in stomach epithelial cells.	RUNX3	p21	1	ACTIVATION	False
13284	13566	16135801:7:RUNX3:CDKN1A	In cooperation with SMADs, [TF] synergistically activates the [TG] promoter.	RUNX3	p21	1	ACTIVATION	False
13285	13567	16164020:5:RUNX3:ITGA4	We now provide evidence that [TF] also transactivates the [TG] gene promoter, and that the increased expression of CD49d mRNA and CD49d integrins on mature monocyte-derived dendritic cells correlates with an up-regulation of RUNX3 mRNA.	RUNX3	CD49d	1	ACTIVATION	False
13286	13568	16166639:7:RUNX2:MMP9	We show by mutational analysis that the [TF] site mediates transactivation of the [TG] promoter in osteoblasts (MC3T3-E1) and nonosseous (HeLa) cells.	Runx2	MMP9	1	ACTIVATION	False
13287	13569	16166639:9:RUNX2:MMP13	The knockdown of [TF] by RNA interference decreases MMP9 expression, as well as that of other Runx2 target genes, including the genes for [TG] and vascular endothelial growth factor.	Runx2	MMP13	1	ACTIVATION	False
13288	13570	16166639:9:RUNX2:MMP9	The knockdown of [TF] by RNA interference decreases [TG] expression, as well as that of other Runx2 target genes, including the genes for MMP13 and vascular endothelial growth factor.	Runx2	MMP9	1	ACTIVATION	False
13289	13571	16166639:9:RUNX2:VEGFA	The knockdown of [TF] by RNA interference decreases MMP9 expression, as well as that of other Runx2 target genes, including the genes for MMP13 and [TG].	Runx2	vascular endothelial growth factor	1	ACTIVATION	False
13290	13572	16237704:9:RUNX2:KLK3	RUNX1 and [TF] activated the [TG] regulatory region alone or cooperatively with prostate-derived ETS factor (PDEF) and RUNX1 physically associated with PDEF.	RUNX2	PSA	1	ACTIVATION	False
13291	13573	16297665:7:LEF1:CTLA4	The (-318) SNP modifies a putative binding site for [TF] so that it alters the stimulating effect of LEF1 on the expression ability of the [TG] promoter.	LEF1	CTLA-4	1	ACTIVATION	False
13292	13574	16368682:0:PAX2:WNT4	[TF] activates [TG] expression during mammalian kidney development.	PAX2	WNT4	1	ACTIVATION	False
13293	13575	16368682:11:PAX2:WNT4	We speculated that a key function of [TF] is to activate [TG] gene expression in metanephric mesenchymal cells as they differentiate to form elements of the renal tubules.	PAX2	WNT4	1	ACTIVATION	False
13294	13576	16368682:4:PAX2:WNT4	In this study we hypothesized that [TF] activates expression of [TG], a secreted glycoprotein known to be critical for successful nephrogenesis.	PAX2	WNT4	1	ACTIVATION	False
13295	13577	16368682:6:PAX2:WNT4	[TF] activated [TG] promoter activity 5-fold in co-transfection assays with JTC12 cells derived from the proximal tubule.	PAX2	WNT4	1	ACTIVATION	False
13296	13578	16636074:9:RUNX2:MMP13	Silencing of [TF] mRNA blocked [TG] expression without interfering with endogenous NO production, confirming its role in NO-induced MMP-13 expression by MC3T3-E1 cells.	Cbfa-1	MMP-13	1	ACTIVATION	False
13297	13579	16735463:7:PAX2:NAIP	[TF] activates [TG] gene transcription (7-fold) in vitro and NAIP transcript level is increased fourfold in HEK293 cells stably transfected with PAX2.	PAX2	NAIP	1	ACTIVATION	False
13298	13580	16954384:6:KLF4:LEFTY1	By functional screening of ES-specific transcription factors, we found that Krppel-like factor 4 ([TF]) cooperates with Oct3/4 and Sox2 to activate [TG] expression, and that Klf4 acts as a mediating factor that specifically binds to the proximal element of the Lefty1 promoter.	Klf4	Lefty1	1	ACTIVATION	False
13299	13581	17042739:20:RUNX2:NELL1	[TF] directly binds to the OSE2 elements and transactivates the human [TG] promoter.	Runx2	NELL-1	1	ACTIVATION	False
13300	13582	17042739:3:RUNX2:NELL1	Forced expression of [TF] induces [TG] expression in rat calvarial cells.	Runx2	NELL-1	1	ACTIVATION	False
13301	13583	17068080:4:LEF1:MSX2	A [TF] beta-catenin-dependent isoform minimally activates the [TG] promoter and a Lef-1 beta-catenin-independent isoform is inactive, however co-expression of Dlx2 and both Lef-1 isoforms synergistically activate the Msx2 promoter.	Lef-1	Msx2	1	ACTIVATION	False
13302	13584	17132729:8:LEF1:MYC	Two tumor-derived mutant Smad4 proteins that fail to mediate TGF-beta responses were still competent to cooperate with [TF] to activate the [TG] promoter.	LEF1	c-myc	1	ACTIVATION	False
13303	13585	17141338:6:KLF4:LAMA1	Furthermore, we showed that Krppel-like factors [TF] and KLF6 also activate transcription of the human [TG] gene.	KLF4	LAMA1	1	ACTIVATION	False
13304	13586	17158875:7:RUNX2:FGF18	Partially overlapping the TCF/Lef binding site is a [TF] binding site and experiments showed that Runx2 and TCF/Lef work cooperatively to induce [TG] expression.	Runx2	fgf18	1	ACTIVATION	False
13305	13587	17178831:7:MEIS2:EPHA8	[TF] and Pbx2 synergistically bind the [TG] regulatory sequence in vitro, and this interaction is critical for the transcriptional activation of a reporter construct bearing the ephA8 regulatory region in the presence of histone deacetylase inhibitor.	Meis2	ephA8	1	ACTIVATION	False
13307	13589	17324942:2:POU5F1:SOX2	Other studies have shown that [TG] and [TF] work together cooperatively to stimulate the transcription of their own genes as well as a network of genes required for embryogenesis.	Oct-3/4	Sox2	1	ACTIVATION	True
13308	13590	17620326:8:KLF4:CLMP	In particular, co-transfection studies showed that Sp1 could significantly abolish the [TF]-induced transactivation of the [TG] gene, suggesting that KLF4 and Sp1 might compete for the same binding site on the CLMP promoter.	KLF4	CLMP	1	ACTIVATION	False
13309	13591	17659301:8:KLF4:TP53	[TF] overexpression led to an enhanced [TG] promoter activity and increased p53 mRNA and protein expression (luciferase reporter assay, real-time PCR, Western blot).	GKLF	p53	1	ACTIVATION	False
13310	13592	17719562:5:KLF4:IL10	The results showed that treatment of RAW264.7 macrophages with LPS resulted in a dose- and time-dependent increase in [TF] protein levels; KLF4 overexpression increased the expression of [TG], while KLF4 inhibition decreased the expression of IL-10.	KLF4	IL-10	1	ACTIVATION	False
13311	13593	17719562:6:KLF4:IL10	The overexpression of [TF] promoted the transcription and DNA binding activities of KLF4 to the [TG] promoter.	KLF4	IL-10	1	ACTIVATION	False
13313	13595	18223689:0:RUNX2:BAX	[TF]-mediated activation of the [TG] gene increases osteosarcoma cell sensitivity to apoptosis.	Runx2	Bax	1	ACTIVATION	False
13314	13596	18223689:3:RUNX2:BAX	Our data demonstrate that [TF] directly binds to two Runx-specific regulatory elements on the human bax promoter thereby inducing [TG] expression.	Runx2	Bax	1	ACTIVATION	False
13315	13597	18280717:5:LEF1:COL11A1	Here we report that [TF] activates the [TG] promoter.	Lef1	Col11a1	1	ACTIVATION	False
13316	13598	18280717:9:LEF1:COL11A1	These results suggest that [TF] is an activator of the [TG] promoter and that Col11a1 suppresses terminal osteoblast differentiation.	Lef1	Col11a1	1	ACTIVATION	False
13317	13599	18287938:4:PAX6:SOX2	We confirmed that [TF] could bind to the [TG] promoter by chromatin immunoprecipitation assay and activate Sox2 expression by a luciferase reporter gene assay.	Pax6	Sox2	1	ACTIVATION	False
13318	13600	18379898:8:KLF4:HSPA8	In addition, knockdown of endogenous [TF] expression by morpholino antisense oligonucleotides significantly decreased both [TG] mRNA and protein levels under normal conditions.	KLF4	HSP73	1	ACTIVATION	False
13319	13601	18430783:4:RUNX2:ZFP64	[TG] expression is under the control of [TF], and is upregulated by direct transactivation of its promoter.	Runx2	Zfp64	1	ACTIVATION	False
13320	13602	18435741:4:KLF4:CD55	Overexpression of [TF] and KLF5 robustly induced transcriptional activity of the [TG] promoter.	KLF4	DAF	1	ACTIVATION	False
13321	13603	18438928:0:RUNX2:LGALS3	[TF] is expressed in human glioma cells and mediates the expression of [TG].	Runx2	galectin-3	1	ACTIVATION	False
13322	13604	18559508:5:KLF4:CDKN1B	Overexpression of [TF] also led to significant induction of [TG] expression, at both the RNA and protein levels, in a dose- and time-dependent manner, indicating that KLF4 transcriptionally regulates the expression of p27(Kip1).	KLF4	p27(Kip1)	1	ACTIVATION	False
13323	13605	18831784:5:KLF4:CTBP2	This network suggests that Oct4, Sox2 and [TF] indirectly repress lineage specific differentiation genes by activating transcriptional repressors of [TG], Rest and Mtf2.	Klf4	Ctbp2	2	REPRESSION	True
13324	13606	18831784:5:KLF4:MTF2	This network suggests that Oct4, Sox2 and [TF] indirectly repress lineage specific differentiation genes by activating transcriptional repressors of Ctbp2, Rest and [TG].	Klf4	Mtf2	1	ACTIVATION	False
13325	13607	19020999:0:RUNX2:LGALS3	RUNX1 and [TF] upregulate [TG] expression in human pituitary tumors.	RUNX2	Galectin-3	1	ACTIVATION	False
13326	13608	19020999:6:RUNX2:LGALS3	[TG] promoter was further cloned into a luciferase reporter, and the experiments showed that both RUNX1 and [TF] upregulated LGALS3.	RUNX2	LGALS3	1	ACTIVATION	False
13327	13609	19020999:7:RUNX2:LGALS3	Knock-down of either RUNX1 or [TF] by siRNA resulted in a significant downregulation of [TG] expression and decreased cell proliferation in the HP 75 cell line.	RUNX2	Galectin-3	1	ACTIVATION	False
13328	13610	19116917:8:RUNX2:COL10A1	Human [TG] promoter activity was enhanced by [TF] alone and more potently by RUNX-2 in combination with the coactivator core-binding factor beta in all 3 human cell lines examined.	RUNX-2	COL10A1	1	ACTIVATION	False
13329	13611	19121369:7:RUNX2:MMP13	Moreover, transient overexpression of [TF] significantly increased luciferase activity in C6 glioma cells transfected with the reporter plasmid linked to a wild-type Runx2 binding element in the [TG] promoter, but not in cells with a mutated element.	Runx2	MMP13	1	ACTIVATION	False
13330	13612	19168440:8:KLF4:COL8A1	POVPC-induced activation of [TG] gene expression was reduced by small interfering RNA-mediated suppression of Krppel-like factor 4 ([TF]) and Sp1, and was abolished in Klf4-knockout VSMCs.	Klf4	Col8a1	1	ACTIVATION	False
13331	13613	19229297:6:RUNX3:SLC22A17	We find that [TG] expression is regulated by Runx transcription factors, and that BCR-ABL induces a switch in binding from [TF], an activator of 24p3R expression, to Runx1, a repressor of 24p3R expression, through a Ras signalling pathway.	Runx3	24p3R	1	ACTIVATION	False
13332	13614	19259985:5:RUNX2:EXT1	[TF] increases expression of the glycosyltransferase Exostosin-1 ([TG]) and heparanase, as well as alters the relative expression of N-linked sulfotransferases (Ndst1 = Ndst2 > Ndst3) and enzymes mediating O-linked sulfation of heparan sulfate (Hs2st > Hs6st) or chondroitin sulfate (Cs4st > Cs6st).	Runx2	Ext1	1	ACTIVATION	False
13333	13615	19327128:0:KLF4:GHRL	[TF] positively regulates human [TG] expression.	KLF4	ghrelin	1	ACTIVATION	False
13334	13616	19327128:11:KLF4:GHRL	Finally, deletion of the -1165/-1146 region abrogated [TF]-induced transactivation of the [TG] promoter.	KLF4	ghrelin	1	ACTIVATION	False
13335	13617	19327128:12:KLF4:GHRL	Collectively, these results indicate that [TF] positively regulates human [TG] expression via binding to a KLF-responsive region in the promoter.	KLF4	ghrelin	1	ACTIVATION	False
13336	13618	19327128:5:KLF4:GHRL	Furthermore, treatment with butyrate, an inducer of [TF] expression, stimulated [TG] expression, and fasting, which induces ghrelin expression, also increased KLF4 expression, suggesting that ghrelin expression is associated with KLF4.	KLF4	ghrelin	1	ACTIVATION	False
13337	13619	19327128:7:KLF4:GHRL	[TF] expression specifically stimulated human [TG]-promoter activity in a dose-dependent manner in human gastric-cancer AGS cells.	KLF4	ghrelin	1	ACTIVATION	False
13338	13620	19423655:8:RUNX2:MMP13	Overall, our studies suggest that without altering the gross chromatin structure, PTH stimulates acetylation of histones H3 and H4 via recruitment of p300 to [TF] bound to the [TG] promoter, resulting in gene activation.	Runx2	MMP-13	1	ACTIVATION	False
13339	13621	19522013:6:KLF4:NANOG	In addition, overexpression of [TF] and PBX1 upregulated [TG] promoter activity and also the endogenous NANOG protein expression in hESCs.	KLF4	NANOG	1	ACTIVATION	False
13340	13622	19522013:9:KLF4:NANOG	We also showed that specific members of the SP/KLF and PBX family are functionally redundant at the [TG] promoter and that [TF] and PBX1 cooperated with OCT4 and SOX2, and transactivated synergistically the NANOG promoter activity.	KLF4	NANOG	1	ACTIVATION	False
13341	13623	19551868:12:KLF4:GPA33	This indicates that PPARgamma activation induces [TF] expression, which in turn increases [TG] expression.	KLF4	GPA33	1	ACTIVATION	False
13343	13625	19620402:7:LEF1:ELANE	We found that transduction of hematopoietic cells with [TF] cDNA resulted in the up-regulation of [TG]/NE synthesis, whereas inhibition of LEF-1 by shRNA led to a marked reduction in the levels of ELA2/NE.	LEF-1	ELA2	1	ACTIVATION	False
13344	13626	19649655:4:RUNX2:COL1A2	During osteoblast differentiation, [TF] upregulates the expression of bone matrix protein genes including Col1a1, Spp1, Ibsp, Bglap, and Fn1 in vitro and activates many promoters including those of Col1a1, [TG], Spp1, Bglap, and Mmp13.	RUNX2	Col1a2	1	ACTIVATION	False
13345	13627	19649655:4:RUNX2:FN1	During osteoblast differentiation, [TF] upregulates the expression of bone matrix protein genes including Col1a1, Spp1, Ibsp, Bglap, and [TG] in vitro and activates many promoters including those of Col1a1, Col1a2, Spp1, Bglap, and Mmp13.	RUNX2	Fn1	1	ACTIVATION	False
13346	13628	19649655:4:RUNX2:MMP13	During osteoblast differentiation, [TF] upregulates the expression of bone matrix protein genes including Col1a1, Spp1, Ibsp, Bglap, and Fn1 in vitro and activates many promoters including those of Col1a1, Col1a2, Spp1, Bglap, and [TG].	RUNX2	Mmp13	1	ACTIVATION	False
13347	13629	19649655:4:RUNX2:SPP1	During osteoblast differentiation, [TF] upregulates the expression of bone matrix protein genes including Col1a1, [TG], Ibsp, Bglap, and Fn1 in vitro and activates many promoters including those of Col1a1, Col1a2, Spp1, Bglap, and Mmp13.	RUNX2	Spp1	1	ACTIVATION	False
13348	13630	19669938:5:KLF4:HSP90AB1	Here, we also presented data that overexpression of [TF] resulted in enhanced promoter activities of [TG].	KLF4	HSP84	1	ACTIVATION	False
13349	13631	19717984:5:KLF4:NOTCH1	Chromatin immunoprecipitation assay shows that [TF] binds to the proximal [TG] promoter in human mammary epithelial cells, and siRNA-mediated suppression of KLF4 in human mammary cancer cells results in reduced expression of Notch1.	KLF4	Notch1	1	ACTIVATION	False
13350	13632	19903460:6:RUNX2:SPP1	Downregulation of [TF] by siRNA repressed the basal and FGF-2-stimulated expression of the [TG] gene in RASMC.	Runx2	OPN	1	ACTIVATION	False
13351	13633	20197312:10:RUNX2:ABCB1	[TF] knockdown resulted in reduced levels of mRNA for Rgc32, Ptgds, Fabp6, Mmp13, and [TG] genes.	Runx2	Abcb1a	1	ACTIVATION	False
13352	13634	20375011:4:KLF4:TGFBR1	This activity of TGF-beta1 was accompanied by up-regulation of [TF], with concomitant increase in [TG] (TGF-beta type I receptor) expression.	KLF4	TbetaRI	1	ACTIVATION	False
13353	13635	20375239:0:RUNX2:TG	[TF] deficiency in mice causes decreased [TG] expression and hypothyroidism.	Runx2	thyroglobulin	1	ACTIVATION	False
13354	13636	20382893:2:MLXIPL:PKLR	Carbohydrate response element-binding protein (ChREBP) and its binding partner, [TF], mediate glucose-regulated gene expression by binding to carbohydrate response elements on target genes, such as the prototypical glucose-responsive gene, liver-type pyruvate kinase ([TG]).	Mlx	Pklr	1	ACTIVATION	False
13355	13637	20385121:0:KLF4:GDF15	MCC-555-induced [TG] expression is mediated in part by [TF].	KLF4	NAG-1	1	ACTIVATION	False
13356	13638	20385121:6:KLF4:GDF15	We confirmed that PPARgamma agonists-induced [TG] expression was abolished using [TF] siRNA in HCT-116 cells.	KLF4	NAG-1	1	ACTIVATION	False
13357	13639	20599712:12:RUNX3:CDKN1A	ATBF1 and [TF] up-regulated p21Waf1/[TG] promoter activity synergistically.	RUNX3	Cip1	1	ACTIVATION	False
13358	13640	20711222:10:KLF4:MFN2	ATRA induces [TF] acetylation by p300 and increases the ability of KLF4 to transactivate the [TG] promoter in VSMCs.	KLF4	mfn-2	1	ACTIVATION	False
13359	13641	20711222:4:KLF4:MFN2	The luciferase assay and chromatin immunoprecipitation were used to detect the transactivation of [TF] on [TG] gene expression.	KLF4	mfn-2	1	ACTIVATION	False
13360	13642	20711222:7:KLF4:MFN2	[TF] bound directly to the [TG] promoter and activated its transcription.	KLF4	mfn-2	1	ACTIVATION	False
13361	13643	20711222:9:KLF4:MFN2	[TF] acetylation by p300 increased its activity to transactivate the [TG] promoter.	KLF4	mfn-2	1	ACTIVATION	False
13362	13644	20713445:6:RUNX2:SPP1	The vitamin D receptor (VDR)- and [TF]-mediated expression of [TG], as well as Mediator recruitment to the Opn promoter, was specifically attenuated in the Med1(-/-) MEFs.	Runx2	OPN	1	ACTIVATION	False
13363	13645	20718868:5:KLF4:SCARB1	The results showed that induction of [TF] by high-density lipoproteins could promote the expression of [TG], resulting from the binding to putative KLF4 binding element on the promoter of SR-BI.	KLF4	SR-BI	1	ACTIVATION	False
13364	13646	20808819:11:MEIS1:KRT19	We find specific binding of [TF] and MEIS2 to the [TG] promoter using IP-EMSA, and siRNA mediated silencing of Meis1, but not Meis2, reduces transcriptional activation of Krt19 in primary pancreatic ductal cells.	MEIS1	Krt19	1	ACTIVATION	False
13365	13647	20870727:11:RUNX2:MMP13	PCAF cooperates with p300 and [TF] to mediate PTH activation of [TG] transcription.	Runx2	MMP-13	1	ACTIVATION	False
13366	13648	20946687:13:KLF4:CCL2	Knockdown of [TF] resulted in decreased levels of the pro-inflammatory cytokines TNF-, [TG] and IL-6, along with a significant decrease in iNOS and Cox-2 expression.	Klf4	MCP-1	1	ACTIVATION	True
13367	13649	20980461:4:KLF4:AGRP	We found that the Krppel-like factor 4 ([TF]) is a potent activator of [TG] by binding to a specific CACCC-box in its minimal promoter.	Klf4	Agrp	1	ACTIVATION	False
13368	13650	21297014:4:PAX9:BMP4	We also found that Msx1 by itself represses transcription from this proximal [TG] promoter, and that, in combination with [TF], it acts as a potentiator of Pax9-induced Bmp4 transactivation.	Pax9	Bmp4	1	ACTIVATION	False
13369	13651	21297014:5:PAX9:BMP4	This synergism of Msx1 with [TF] is significant, because it is currently the only documented mechanism for Msx1-mediated activation of [TG].	Pax9	Bmp4	1	ACTIVATION	False
13370	13652	21471200:2:RUNX2:BGLAP	We showed that Foxo1 inhibited [TF]-dependent transcriptional activity and osteocalcin mRNA expression and [TG] promoter activity in MC-4 preosteoblasts.	Runx2	Bglap2	1	ACTIVATION	False
13371	13653	21523770:7:RUNX3:IL1B	The distal promoter-derived, 33 kDa isoform of [TF] increased the activity of transcription factor nuclear factor kappa B (NF-B), which had been activated by Helicobacter pylori infection, a risk factor for intestinal-type gastric cancer, and the expression of the interleukin-1 gene ([TG]), an NF-B target genetically and functionally associated with gastric cancer.	RUNX3	IL1B	1	ACTIVATION	False
13372	13654	21523770:8:RUNX3:IL1B	In contrast, the proximal promoter-derived, 44 kDa isoform of [TF] decreased both NF-B activity and [TG] expression.	RUNX3	IL1B	2	REPRESSION	True
13373	13655	21536859:5:LYL1:ERG	We further demonstrate that [TG] expression in primary human T-ALL cells is mediated by the binding of other T-cell oncogenes SCL/TAL1, LMO2, and [TF] in concert with ERG, FLI1, and GATA3 to the ERG +85 enhancer.	LYL1	ERG	1	ACTIVATION	False
13374	13656	21544627:0:LEF1:UTP3	A strong promoter activity of pre-B cell stage-specific [TG] gene is caused by one distal [TF] and multiple proximal Ets sites.	LEF-1	Crlz1	1	ACTIVATION	False
13375	13657	21559363:5:KLF10:RUNX2	Transient transfection and chromatin immunoprecipitation assays reveal that [TF] directly binds to and activates the [TG] promoter.	TIEG1	Runx2	1	ACTIVATION	False
13376	13658	21586669:5:RUNX3:AGTRAP	The results of RBE-decoy transfection and endogenous knockdown by small interference RNA showed that the runt-related transcription factor [TF] is involved in [TG] gene expression.	Runx3	ATRAP	1	ACTIVATION	False
13377	13659	21586669:9:RUNX3:AGTRAP	These findings indicate that [TF] plays a role in [TG] gene expression in renal distal tubular cells both in vitro and in vivo.	Runx3	ATRAP	1	ACTIVATION	True
13378	13660	21586797:8:KLF4:PFKP	In conclusion, it is suggested that [TF] plays a role in maintenance of high glycolytic metabolism by transcriptional activation of the [TG] gene in breast cancer cells.	KLF4	PFKP	1	ACTIVATION	False
13379	13661	21685331:8:KLF4:IL17A	Finally, we demonstrated that [TF] directly binds to the promoter of [TG] and positively regulates its expression.	KLF4	Il17a	1	ACTIVATION	False
13380	13662	21793044:0:RUNX2:VEGFA	Physical and functional interactions between [TF] and HIF-1 induce [TG] gene expression.	Runx2	vascular endothelial growth factor	1	ACTIVATION	False
13381	13663	21793044:6:RUNX2:VEGFA	[TF] over-expression in mesenchymal cells increased [TG] mRNA and protein under both normoxic and hypoxic conditions.	Runx2	VEGF	1	ACTIVATION	False
13382	13664	21887706:10:RUNX2:COL10A1	Additional cooperative/repressive elements within the 5'- or 3'-sequences of this 150-bp promoter are needed to work with [TF] together to mediate cell-specific [TG] expression.	Runx2	Col10a1	1	ACTIVATION	False
13383	13665	21931789:2:RUNX2:NELL1	Our previous study showed that [TF], the key transcription factor in osteoblast differentiation, transactivates the [TG] promoter.	Runx2	NELL-1	1	ACTIVATION	False
13384	13666	22095691:5:RUNX2:MMP13	C/EBP and [TF] cooperatively enhanced promoter activity of [TG] through specific binding to a C/EBP-binding motif and an osteoblast-specific cis-acting element 2 motif as a protein complex.	RUNX2	MMP13	1	ACTIVATION	False
13385	13667	22243224:7:RUNX2:KLK4	In contrast, [TG] mRNA was up-regulated by both Dlx3 and [TF].	Runx2	Klk4	1	ACTIVATION	False
13386	13668	22253230:6:RELA:TWIST1	In support of this likelihood, we defined a functional NF-B-binding site in the [TG] promoter, and overexpression of [TF] was sufficient to induce transcriptional upregulation of Twist1 along with EMT in mammary epithelial cells.	p65	Twist1	1	ACTIVATION	False
13387	13669	22282354:4:KLF4:AGTR1	Coimmunoprecipitation, chromatin immunoprecipitation, and luciferase assays were performed, with the results suggesting that Sp1 forms a complex with [TF] bound to the TCE of the [TG] promoter and cooperatively activates AT1R transcription in vascular smooth muscle cells under basal conditions.	KLF4	AT1R	1	ACTIVATION	False
13388	13670	22306741:6:KLF4:DLK2	We also show that [TF], a transcription factor critical for the control of early adipogenesis, binds directly to the [TG] promoter and increases Dlk2 expression in response to IBMX.	KLF4	Dlk2	1	ACTIVATION	False
13389	13671	22306741:7:KLF4:DLK2	Overexpression of [TF] leads to an increase in DLK2 expression levels, whereas KLF4 knockdown downregulates the transcriptional activity of the [TG] promoter.	KLF4	Dlk2	1	ACTIVATION	False
13390	13672	22337869:5:RARA:KLF4	A luciferase assay for the [TG] promoter showed that three GC boxes in the proximal Klf4 promoter were indispensible for ATRA-induced Klf4 transcription and that [TF] enhanced Klf4 promoter activity in a GC box-dependent manner.	RAR	Klf4	1	ACTIVATION	False
13392	13674	22351759:6:RUNX2:VEGFA	Furthermore, overexpression of [TF] resulted in the significant enhancement of vascular endothelial growth factor ([TG]) promoter reporter activity and protein secretion.	Runx2	VEGF	1	ACTIVATION	False
13393	13675	22552444:6:PAX2:GDNF	Gene suppression of [TF] decreased the expression of the PAX2 transcriptional target [TG] in Daoy cells and had a profound cytotoxic effect in vitro on Daoy medulloblastoma and T98G glioma cells.	PAX2	GDNF	1	ACTIVATION	False
13394	13676	22552774:8:LEF1:VIM	We also observed that phthalates increased expression of the PP1/HDAC6 complex and caused Akt activation and GSK3 inactivation, leading to transcriptional activation of [TG] through the -catenin-TCF-4/[TF] pathway.	LEF1	vimentin	1	ACTIVATION	False
13395	13677	22653776:8:KLF4:IL10	[TF] is recruited to the il10 promoter, and small-interfering RNA-mediated knockdown of KLF4 expression blocked [TG] expression during pneumococcal infection.	KLF4	IL-10	1	ACTIVATION	False
13396	13679	22992721:5:PBX1:SOX3	Conversely, [TF]-d transduction reduced the expression of [TG], a gene strongly transactivated by Pbx1, and Pbx1-d did not bind the Sox3 promoter.	Pbx1	Sox3	1	ACTIVATION	True
13397	13680	23018457:8:RUNX3:CD8A	Importantly, forced G(1) extension cancels the functions of [TF] to repress Th-POK and CD4 and to reactivate [TG].	Runx3	CD8	1	ACTIVATION	True
13398	13681	23042144:10:RUNX2:SMURF1	Overexpression of [TF] transactivated the [TG] promoter in a dose-dependent manner.	Runx2	Smurf1	1	ACTIVATION	False
13399	13682	23068092:7:RUNX2:NEU2	PC-3 cells were characterized by high expression of [TF] and Sp3, and their silencing reduced [TG], suggesting regulatory roles.	Runx2	NEU2	1	ACTIVATION	False
13401	13684	23355395:8:PRRX1:SOX9	Intriguingly, the [TF]b isoform, which is also induced in ADM, binds the [TG] promoter and positively regulates Sox9 expression.	Prrx1	Sox9	1	ACTIVATION	False
13402	13685	23376077:7:RUNX2:GJA1	Risedronate as well as the pro-osteogenic transcription factors, [TF], Osterix or Dlx5, increased transcriptional activity of the [TG] promoter in a dose-dependent manner.	Runx2	Cx43	1	ACTIVATION	False
13403	13686	23430263:9:KLF4:DSPP	First, [TF] and OSX bind to their motifs in [TG] and Dmp1 gene promoters and up-regulate their transcription thereby inducing odontoblast differentiation.	KLF4	Dspp	1	ACTIVATION	False
13404	13687	23558921:11:KLF4:DMP1	Our data confirmed our hypothesis that [TF] promotes the differentiation of odontoblasts via the up-regulation of [TG].	Klf4	Dmp1	1	ACTIVATION	False
13405	13688	23558921:6:KLF4:DSPP	Overexpression of [TF] significantly up-regulated odontoblast-related genes, such as Dmp1, [TG], and Alp, and promoted the accumulation of mineral nodules.	Klf4	Dspp	1	ACTIVATION	False
13406	13689	23558921:9:KLF4:DMP1	Based on further analysis of ChIP data, EMSA and dual luciferase activity assays, we confirmed that [TF] was able to specifically bind to the [TG] promoter and transactivate its expression.	Klf4	Dmp1	1	ACTIVATION	False
13407	13690	23625810:9:RUNX2:ACAN	[TG] mRNA levels and aggrecan promoter activity were enhanced in response to the over-expression of either [TF] and Runx3 in ATDC5 chondrogenic cell line, while sh-RNA knocked down of each Runx protein showed that only Runx3 knock down specifically suppressed aggrecan mRNA expression and promoter activity.	Runx2	Aggrecan	1	ACTIVATION	False
13408	13691	23625810:9:RUNX3:ACAN	[TG] mRNA levels and aggrecan promoter activity were enhanced in response to the over-expression of either Runx2 and [TF] in ATDC5 chondrogenic cell line, while sh-RNA knocked down of each Runx protein showed that only Runx3 knock down specifically suppressed aggrecan mRNA expression and promoter activity.	Runx3	Aggrecan	1	ACTIVATION	False
13409	13692	23846726:8:RUNX2:THBS1	In line with this, [TF] and Runx3 bound to the [TG] promoter and stimulated its activity.	Runx2	TSP-1	1	ACTIVATION	False
13410	13693	23846726:8:RUNX3:THBS1	In line with this, Runx2 and [TF] bound to the [TG] promoter and stimulated its activity.	Runx3	TSP-1	1	ACTIVATION	False
13411	13694	23884787:8:MEF2A:KLF4	Using [TG] reporter constructs, we verified that the elevated expression induced by EGCG was mediated by increasing levels of activated [TF], which bound to the promoter region of KLF4.	MEF2A	KLF4	1	ACTIVATION	False
13412	13695	24173808:5:PAX9:BMP4	We found that expression of the [TG], Fgf10, Msx1 and Osr2 genes is significantly downregulated in the developing palatal mesenchyme in [TF] mutant embryos.	Pax9	Bmp4	1	ACTIVATION	False
13413	13696	24173808:5:PAX9:FGF10	We found that expression of the Bmp4, [TG], Msx1 and Osr2 genes is significantly downregulated in the developing palatal mesenchyme in [TF] mutant embryos.	Pax9	Fgf10	1	ACTIVATION	False
13414	13697	24173808:5:PAX9:MSX1	We found that expression of the Bmp4, Fgf10, [TG] and Osr2 genes is significantly downregulated in the developing palatal mesenchyme in [TF] mutant embryos.	Pax9	Msx1	1	ACTIVATION	False
13415	13698	24244849:8:MEIS1:FOXN4	In addition, knockdown of [TF] expression diminishes the endogenous [TG] expression and affects cell lineage development.	Meis1	Foxn4	1	ACTIVATION	False
13416	13699	24802759:8:KDM5B:FOXA1	Mechanistically, [TF] was required for GATA3 recruitment to the [TG] promoter to activate Foxa1 expression.	JARID1B	Foxa1	1	ACTIVATION	False
13417	13700	24812666:5:KLF4:NPHS1	[TF] overexpression in cultured human podocytes increased expression of [TG] and other epithelial markers and reduced mesenchymal gene expression.	KLF4	nephrin	1	ACTIVATION	False
13418	13701	8760285:5:PAX2:WT1	In this report, we demonstrate that [TF] isoforms are capable of transactivating the [TG] promoter.	PAX2	wt1	1	ACTIVATION	False
13419	13702	8760285:8:PAX2:WT1	Finally, we demonstrate that [TF] can stimulate expression of the endogenous [TG] gene.	PAX2	wt1	1	ACTIVATION	False
13420	13703	9178767:6:PAX2:WT1	[TF] transactivated the [TG] promoter up to 35-fold in CHO-K1 cells, and from four- to sevenfold in 293 cells.	PAX2	WT1	1	ACTIVATION	False
13421	13704	9178767:7:PAX2:WT1	Two regions of the [TG] promoter were required in the same promoter construct for efficient transactivation by [TF] in CHO-K1 cells, and purified recombinant PAX2 protein was found to bind to two sites in the WT1 promoter, at -205/-230 and +377/+402.	PAX2	WT1	1	ACTIVATION	False
13422	13705	9732271:9:PAX9:BMP4	At this stage, [TF] is required for the mesenchymal expression of [TG], Msx1, and Lef1, suggesting a role for Pax9 in the establishment of the inductive capacity of the tooth mesenchyme.	Pax9	Bmp4	1	ACTIVATION	False
13423	13706	9862705:0:RUNX3:CD79A	CBF alpha3 ([TF]) is induced by TGF-beta1 to bind and activate the mouse germline [TG] promoter.	AML2	Ig alpha	1	ACTIVATION	False
13424	13707	21128246:0:RUNX3:TIMP1	[TF] suppresses gastric cancer metastasis through inactivation of MMP9 by upregulation of [TG].	Runx3	TIMP-1	1	ACTIVATION	False
13425	13708	14675715:8:KLF4:IAPP	The synergistic effect was lost with deletions of the T3 and [TF] response elements in the [TG] promoter and was completely or partially abolished in the case of mutant KLF4 expression vectors.	KLF4	IAP	0	UNDEFINED	True
13426	13709	17620326:9:KLF4:CLMP	Taken together, this differential interaction of the transcription factors, GATA-1, GATA-6, [TF], Sp1, and Sp3, in [TG] gene expression might provide a precise machinery in regulating Sertoli cell tight junction dynamics.	KLF4	CLMP	0	UNDEFINED	True
13427	13710	23159876:9:RUNX2:COL1A1	Our data show that overexpression of [TF] and Osterix leads to a cooperative effect on the expression of the [TG] endogenous gene and its promoter reporter construct.	Runx2	Col1a1	0	UNDEFINED	True
13428	13711	12756174:2:PAX2:MITF	[TF]; Pax6 compound mutants display a dose-dependent reduction in the expression of the melanocyte determinant [TG], accompanied by transdifferentiation of retinal pigmented epithelium (RPE) into neuroretina (NR) in Pax2(-/-); Pax6(+/-) embryos, which strongly resembles the phenotype of Mitf-null mutants.	Pax2	Mitf	1	ACTIVATION	False
13429	13712	16575901:9:LEF1:RUNX2	Co-transfection of lymphoid enhancer factor ([TF]) and beta-catenin in chicken upper sternal chondrocytes together with deletion constructs of the [TG] promoter shows that the proximal region spanning the first 128 base pairs of this promoter is responsible for the Wnt-mediated induction of Runx2.	Lef1	Runx2	1	ACTIVATION	False
13430	13713	23762395:10:NCOA3:SNAI1	Taken together, these results suggested that [TF] exerted its effect on EMT through its interaction with ER, which could directly bind to the ER-binding site on the [TG] promoter, allowing the AIB1-ER complex to promote the transcription of SNAI1 and eventually led to repression of E-cadherin expression, consistent with the loss of E-cadherin being a hallmark of EMT.	AIB1	SNAI1	1	ACTIVATION	False
13432	13715	11451945:3:RUNX2:AMBN	The objective of this study was to determine whether the transcription factor [TF], known to be essential for transcription of other mineralized tissue genes, is also required for [TG] transcription.	Cbfa1	ameloblastin	1	ACTIVATION	False
13433	13716	15564063:9:RUNX2:MMP13	Inhibitors of MEK/ERK signaling blocked up-regulation of the [TG] promoter by [TF] and FGF2, and also blocked the activation of RUNX2 by FGF2.	RUNX2	MMP-13	1	ACTIVATION	False
13434	13717	15728254:10:PITX2:LEF1	Deletion of a distal 800 bp segment of the [TG] promoter resulted in enhanced [TF] activation, and increased synergistic activation in the presence of LEF-1.	PITX2	LEF-1	1	ACTIVATION	False
13435	13718	18469187:4:KLF4:TKT	Transient cotransfections were used to test whether [TF] activates the aquaporin-3, Aldh3a1, and [TG] promoters.	Klf4	TKT	1	ACTIVATION	False
13436	13719	18814144:5:RUNX2:TNFSF11	Transient transfection studies with proximal [TG] 2kb promoter, [TF] knock-down in ST2, and forced expression of runx2 in RD-C6 all confirmed that runx2 set the steady-state expression of the RANKL gene at a low level, but exerted a positive effect on enhanced transcriptional activity in response to 1,25(OH)2D3.	runx2	RANKL	1	ACTIVATION	False
13437	13720	19121369:8:RUNX2:MMP13	These results suggest that [TF] signal input may lead to transactivation of [TG] gene without affecting OPN expression in astrocytes.	Runx2	MMP13	1	ACTIVATION	False
13438	13721	23042144:12:RUNX2:SMURF1	ERK activation by TNF- treatment or constitutively active MEK1 overexpression increased [TG] expression in a [TF]-dependent manner.	Runx2	Smurf1	1	ACTIVATION	False
13439	13722	23846700:0:KLF4:IL6	[TF] modulates expression of [TG] in dendritic cells via both promoter activation and epigenetic modification.	KLF4	IL-6	1	ACTIVATION	True
13440	13723	9545244:8:PAX5:LEF1	In contrast, the expression of the mb-1 and [TG] genes was already reconstituted by the paired domain polypeptide lacking any transactivation function, suggesting that the DNA-binding domain of [TF] is sufficient to recruit other transcription factors to the regulatory regions of these two genes.	BSAP	LEF-1	1	ACTIVATION	True
13441	13724	15457508:2:LEF1:MMP7	Expression of the T-cell factor, [TF], enhances transcriptional activation of the human [TG] promoter by beta-catenin, but represses activation of the mouse MMP-7 promoter, both activities through consensus Tcf binding sites.	Lef-1	MMP-7	1	ACTIVATION	True
13442	13725	16598781:6:RUNX2:TNFSF11	Here, we demonstrate that [TF] suppresses steady-state [TG] gene expression by condensing chromatin, while showing a slightly positive effect on RANKL basic promoter activity.	Runx2	RANKL	2	REPRESSION	True
13443	13726	15136142:14:RUNX2:FGF3	We conclude that [TF] mediates the functions of epithelial FGF signals regulating [TG] expression in the dental mesenchyme and that Fgf3 may be a direct target gene of Runx2.	Runx2	Fgf3	0	UNDEFINED	False
13445	13728	15728254:13:PITX2:LEF1	We show a new mechanism where [TG] expression is regulated through [TF], LEF-1 and beta-catenin direct physical interactions.	PITX2	LEF-1	0	UNDEFINED	False
13446	13729	15798204:5:RUNX2:CSN2	Chromatin immunoprecipitation, RNA interference, promoter mutagenesis, and transient expression analyses were used to demonstrate that the [TF]/Oct-1 complex contributes to the transcriptional regulation of the [TG] gene.	Runx2	beta-casein	0	UNDEFINED	False
13447	13730	16118513:0:PROX1:SOX2	Agonistic and antagonistic action of AP2, Msx2, Pax6, [TF] AND Six3 in the regulation of [TG] expression.	Prox1	Sox2	0	UNDEFINED	False
13448	13731	17141338:8:KLF4:LAMA1	These results indicate that transcription of the human [TG] gene is controlled by a combination of the actions of Sp1/Sp3 and Krppel-like factors, [TF] and KLF6.	KLF4	LAMA1	0	UNDEFINED	False
13449	13732	17620326:5:KLF4:CLMP	Using specific antibodies in EMSA analysis, a ternary protein complex GATA-1/GATA-6/[TF] was detected at all the three motifs, suggesting that a looping mechanism might involve in regulating [TG] gene transcription.	KLF4	CLMP	0	UNDEFINED	False
13450	13733	17719562:0:KLF4:IL10	[TF] regulates the expression of [TG] in RAW264.7 macrophages.	KLF4	interleukin-10	0	UNDEFINED	False
13451	13734	17719562:4:KLF4:IL10	The transcription and DNA binding activities of [TF] to the [TG] promoter were detected by the luciferase reporter and electrophoretic mobility shift assays.	KLF4	IL-10	0	UNDEFINED	False
13452	13735	17878366:8:KLF4:CCND2	We then demonstrated that [TF] directly bound to the promoter of [TG] and regulated its expression.	Klf4	cyclin D2	0	UNDEFINED	False
13453	13736	18379898:10:KLF4:HSPA8	Taken together, these findings suggest an important role for [TF] as a novel regulator of the constitutive expression of [TG].	KLF4	HSP73	0	UNDEFINED	False
13454	13737	18438928:6:RUNX2:LGALS3	In glioma cells, [TF] is directly involved in the regulation of [TG] expression, as shown by RNAi and transcription factor binding assays demonstrating that Runx2 interacts with a Runx2-binding motif present in the human galectin-3 promoter.	Runx2	galectin-3	0	UNDEFINED	False
13455	13738	19139168:5:RUNX3:IFNG	[TF] regulates Eomes expression as well as expression of three cardinal markers of the effector CTL program: [TG], perforin, and granzyme B.	Runx3	IFN-gamma	0	UNDEFINED	False
13456	13739	19147802:11:KLF4:SLC39A4	Reporter constructs with the [TG] promoter and mutation studies further demonstrated that Zip4 is regulated through a [TF] response element.	KLF4	Zip4	0	UNDEFINED	False
13457	13740	19669938:7:KLF4:HSP90AB1	Together, these findings support a role for [TF] as a novel regulator of the constitutive expression of [TG].	KLF4	HSP90	0	UNDEFINED	False
13458	13741	19799567:3:MEIS1:SOX3	In the present study we provide the first evidence that the TALE (three-amino-acid loop extension) transcription factors PBX1 (pre-B-cell leukaemia homeobox 1) and [TF] (myeloid ecotropic viral integration site 1 homologue) participate in regulating human [TG] gene expression in NT2/D1 cells by direct interaction with the consensus PBX/MEIS-binding site, which is conserved in all mammalian orthologue promoters analysed.	MEIS1	SOX3	0	UNDEFINED	False
13459	13742	19799567:3:PBX1:SOX3	In the present study we provide the first evidence that the TALE (three-amino-acid loop extension) transcription factors [TF] (pre-B-cell leukaemia homeobox 1) and MEIS1 (myeloid ecotropic viral integration site 1 homologue) participate in regulating human [TG] gene expression in NT2/D1 cells by direct interaction with the consensus PBX/MEIS-binding site, which is conserved in all mammalian orthologue promoters analysed.	PBX1	SOX3	0	UNDEFINED	False
13460	13743	21546760:1:PAX9:BMP4	For many years the molecular mechanisms governing bone morphogenetic protein 4 ([TG]) expression in tooth bud mesenchyme could be explained by an uncomplicated model involving the interaction of the homeobox gene Msx1 and the paired domain gene [TF] and a limited proximal promoter segment of Bmp4.	Pax9	Bmp4	0	UNDEFINED	False
13461	13744	22282354:3:KLF4:AGTR1	In the present study, we investigated the mechanisms of TGF--mediated [TF] regulation of [TG] expression.	KLF4	AT1R	0	UNDEFINED	False
13462	13745	22306741:9:KLF4:DLK2	These results indicate that [TF] mediates the transcriptional regulation of [TG] in response to IBMX during the early stages of adipogenesis.	KLF4	Dlk2	0	UNDEFINED	False
13463	13746	23451207:0:KLF4:MAPK8	[TF] is a transcriptional regulator of genes critical for EMT, including [TG] (Mapk8).	Klf4	Jnk1	0	UNDEFINED	False
13464	13747	24173808:4:PAX9:SHH	We found that tissue-specific deletion of [TF] in the palatal mesenchyme affected [TG] expression in palatal epithelial cells, indicating that Pax9 plays a crucial role in the mesenchyme-epithelium interactions during palate development.	Pax9	Shh	0	UNDEFINED	False
13465	13748	24447505:7:RUNX3:AXIN2	Moreover, the ChIP analyses revealed that TCF4, -catenin and [TF] bind the promoter region of the Wnt target genes, [TG] and c-Myc, and the occupancy of TCF4 and -catenin in these promoter regions is increased by the RUNX3 expression.	RUNX3	Axin2	0	UNDEFINED	False
13466	13749	8760285:6:PAX2:WT1	Deletion mutagenesis of the [TG] promoter identified an element responsible for mediating [TF] responsiveness, located between nucleotides -33 and -71 relative to the first wt1 transcription start site.	PAX2	wt1	0	UNDEFINED	False
13467	13750	15561714:5:KLF4:ITGAD	Differentiation of myeloid cells with phorbol ester led to activation of the [TG] promoter and reduced occupancy of the promoter by [TF]/GKLFa but an increased occupancy by TIEG1 in vivo.	GKLF	CD11d	0	UNDEFINED	False
13468	13751	15703179:7:NKX3-2:RUNX2	Our results demonstrate that [TG] is a direct transcriptional target of [TF], and that repression of Runx2 at the onset of chondrogenesis is a prerequisite for the activation of a chondrocyte-specific program of gene expression.	Nkx3.2	Runx2	0	UNDEFINED	False
13470	13753	15564063:1:RUNX2:MMP13	To understand the molecular mechanisms that lead to increased [TG] expression and cartilage degeneration during the progression of osteoarthritis (OA), we have investigated the expression of the transcription factor [TF] in OA cartilage and the regulation of MMP-13 expression by RUNX2 and FGF2 in articular chondrocytes.	RUNX2	MMP-13	1	ACTIVATION	True
13471	13754	17950631:12:RUNX2:DMP1	These results suggest that although MKP-1 increases DNA-binding activity of [TF], [TG] expression may require the collaboration of MKP-1 and additive factors to stimulate Runx2-mediated DMP1 expression in the post-transcriptional event of Dex-treated C26 cells.	Runx2	DMP1	0	UNDEFINED	False
13472	13755	17967138:8:RUNX2:TNFSF11	A reporter assay was used to determine whether BMP2-induced [TG] production is through transcriptional regulation of the RANKL promoter and whether it is mediated by [TF].	Runx2	RANKL	1	ACTIVATION	True
13473	13756	19020999:9:RUNX2:LGALS3	These results demonstrate a novel binding target for RUNX1 and [TF] proteins and suggest that [TG] is regulated by RUNX1 and RUNX2 in human pituitary tumor cells by direct binding to the promoter region of LGALS3 and thus may contribute to pituitary tumor progression.	RUNX2	Galectin-3	0	UNDEFINED	False
13475	13758	10660618:1:RUNX2:BGLAP	The bone-specific transcription factor, [TF], regulates expression of the osteocalcin ([TG]) gene and is essential for bone formation.	Cbfa1	OCN	0	UNDEFINED	False
13476	13759	10801838:4:RUNX2:CEBPD	This region of the [TG] promoter directed high reporter gene expression in osteoblasts, and specifically bound [TF] in osteoblast-derived nuclear extract.	Runx2	C/EBPdelta	0	UNDEFINED	True
13477	13760	10938089:8:PAX2:GCG	Our data indicate that [TF] is the third paired domain protein present in the endocrine pancreas and that one of its roles may be the regulation of [TG] gene expression.	Pax-2	glucagon	0	UNDEFINED	False
13478	13761	11451945:0:RUNX2:AMBN	Role of [TF] in [TG] gene transcription.	Cbfa1	ameloblastin	0	UNDEFINED	False
13479	13762	11691923:8:RUNX2:MMP13	In summary, our data suggest that the transcriptional [TG] response to IL-1 is controlled by the p38 pathway interacting at the MMP-13 promoter through the tissue-specific transcription factor [TF] and the ubiquitous AP-1 transcription factor.	Runx-2	MMP-13	0	UNDEFINED	False
13480	13763	12200151:5:PAX2:ROBO3	Furthermore, [TG] and [TF] mRNAs are coexpressed in the hindbrain and spinal cord of the E11.5 mouse embryo, suggesting that Pax-2 may regulate Rig-1 expression during the embryonic stage.	Pax-2	Rig-1	0	UNDEFINED	False
13481	13764	12200151:7:PAX2:ROBO3	In summary, the ubiquitous tumor suppressor RB and the neuron-enriched transcription factor [TF] may play a role in the regulation of [TG] expression during embryogenesis.	Pax-2	Rig-1	0	UNDEFINED	False
13482	13766	12489178:0:RUNX2:DSPP	Spatial expression of [TF]/Runx2 isoforms in teeth and characterization of binding sites in the [TG] gene.	Cbfa1	DSPP	0	UNDEFINED	False
13483	13767	12609849:0:MEIS1:PF4	Homeodomain proteins [TF] and PBXs regulate the lineage-specific transcription of the [TG] gene.	MEIS1	platelet factor 4	0	UNDEFINED	False
13485	13769	12732210:8:MEIS1:PF4	Additionally, these data imply functional similarities and differences between PREP1 and [TF] in the regulation of [TG] gene expression.	MEIS1	PF4	0	UNDEFINED	False
13486	13770	12773122:6:RUNX2:TNFSF11	As [TF]-binding site(s) have been located in the promoter of the receptor activator of nuclear factor-kappaB (RANK) ligand ([TG]) gene, we also examined RANKL expression.	Cbfa1	RANKL	0	UNDEFINED	False
13487	13771	12855590:6:RUNX3:ITGAL	RUNX3/[TF] binding to the [TG] promoter correlates with increased RUNX3/AML-2 protein levels and enhanced CD11a/CD18 cell surface expression.	AML-2	CD11a	1	ACTIVATION	True
13488	13772	14557073:0:KLF4:ITIH3	An interplay of Sp1, [TF] and CREB-2 controls human Pre-alpha-Inhibitor gene ([TG]) transcription.	GKLF	ITIH3	0	UNDEFINED	False
13489	13773	14627709:11:KLF4:CCNB1	Moreover, chromatin immunoprecipitation experiments demonstrated that both [TF] and HDAC were associated with the [TG] promoter in irradiated HCT116 cells.	KLF4	cyclin B1	0	UNDEFINED	False
13490	13774	14670968:4:KLF4:HDC	Among eight positives from the one-hybrid screen, we identified Kruppel-like factor 4 ([TF]) (previously known as gut-enriched Kruppel-like factor (GKLF)) as one factor that binds to the gastrin responsive elements in the [TG] promoter.	KLF4	HDC	0	UNDEFINED	False
13491	13775	14670968:7:KLF4:HDC	Regulation of [TG] transcription by [TF] was confirmed by changes in the endogenous HDC messenger RNA by KLF4 small interfering RNA and KLF4 overexpression.	KLF4	HDC	0	UNDEFINED	False
13492	13776	14706452:5:PAX5:CTNNB1	Subsequently, protein/DNA array analyses identified numerous other transcription factors through their high-affinity binding to the [TG] promoter, including E2F1, NFkappaB, MEF1, [TF], ISRE2, Smad3/4, GATA, and ZIC.	Pax5	Ctnnb1	0	UNDEFINED	False
13493	13778	15031118:7:LEF1:NEUROG1	Further, chromatin immunoprecipitation (ChIP) assays demonstrate that both beta-catenin and [TF] bind directly to the neurogenin promoter, and luciferase reporter assays demonstrate that beta-catenin is directly involved in the regulation of [TG] and possibly other proneural genes when neural stem cells are cultured in the presence of FGF2.	Lef1	neurogenin 1	0	UNDEFINED	False
13494	13779	15051730:0:RUNX2:TIMP1	Regulation of [TG] gene transcription by RUNX1 and [TF].	RUNX2	tissue inhibitor of metalloproteinase 1	0	UNDEFINED	False
13495	13780	15100293:8:LEF1:CD1D	The analysis of the [TG] promoter region indicates that IFN-gamma, NF-IL-6, and T cell factor 1/[TF] are most likely involved in the regulation of CD1d expression.	lymphoid enhancer-binding factor 1	CD1D	0	UNDEFINED	False
13496	13781	15457508:0:LEF1:MMP7	Tcf binding sequence and position determines beta-catenin and [TF] responsiveness of [TG] promoters.	Lef-1	MMP-7	0	UNDEFINED	True
13497	13782	15545629:3:LEF1:DLL1	[TF] was found to bind multiple sites in the [TG] promoter in vitro and in vivo.	LEF1	Dll1	0	UNDEFINED	False
13498	13783	15561714:2:KLF4:ITGAD	A yeast one-hybrid screen showed that a longer isoform of [TF] (GKLF) we term GKLFa interacts with the [TG] promoter.	gut-enriched Kruppel-like factor 4	CD11d	0	UNDEFINED	False
13500	13785	15632413:9:KLF4:BDKRB2	These results demonstrate that combinatorial interactions among the transcription factors, CREB, p53, and [TF], and the coactivator CBP, may be critical for the regulation of [TG] gene expression during terminal nephron differentiation.	KLF-4	B2R	0	UNDEFINED	False
13501	13786	15798204:7:RUNX2:CSN2	Oct-1 stimulates the recruitment of [TF] to the [TG] promoter by interacting with the C-terminal region of Runx2, suggesting that Oct-1 stimulates Runx2 recruitment by relieving the autoinhibition of Runx2 DNA binding.	Runx2	beta-casein	0	UNDEFINED	False
13502	13787	15829502:6:RUNX2:FGFR2	EMSA analysis of mutant osteoblast nuclear extracts showed reduced [TF] binding to a target OSE2 site in the [TG] promoter.	Runx2	Fgfr2	0	UNDEFINED	False
13503	13788	15829502:7:RUNX2:FGFR2	ChIP analyses showed that both Twist and [TF] in mutant osteoblast nuclear extracts bind to a specific region in the [TG] promoter.	Runx2	Fgfr2	0	UNDEFINED	False
13504	13789	15979100:8:LEF1:MYCBP	We suggest that the [TG] gene can be a direct target of beta-catenin/[TF] pathway through its LEF-1 binding site(s) in the MYCBP promoter, and that MYCBP up-regulation in colon carcinoma cell may play a co-activator role of c-MYC.	LEF-1	MYCBP	0	UNDEFINED	True
13505	13790	16034110:0:RUNX3:CD4	[TF] regulates integrin alpha E/CD103 and [TG] expression during development of CD4-/CD8+ T cells.	Runx3	CD4	0	UNDEFINED	False
13506	13791	16034110:0:RUNX3:ITGAE	[TF] regulates integrin alpha E/[TG] and CD4 expression during development of CD4-/CD8+ T cells.	Runx3	CD103	0	UNDEFINED	False
13507	13792	16164020:0:RUNX3:ITGA4	[TF] regulates the activity of the CD11a and [TG] integrin gene promoters.	RUNX3	CD49d	0	UNDEFINED	False
13508	13793	16164020:0:RUNX3:ITGAL	[TF] regulates the activity of the [TG] and CD49d integrin gene promoters.	RUNX3	CD11a	0	UNDEFINED	False
13509	13794	16283360:12:RUNX2:TNFSF11	Taken together with the fact that putative [TF] binding elements are located in the [TG] promoter, our data suggest that Runx2, an essential transcription factor for skeletal development, is also a key regulator of RANKL expression in chondrocytes in the GP.	Runx2	RANKL	0	UNDEFINED	False
13510	13795	16442859:0:RUNX2:GNAS	[TF] regulates the expression of [TG] on SaOs-2 cells.	Runx2	GNAS	0	UNDEFINED	False
13511	13796	16476583:3:RUNX2:PTGS2	We examined the role of [TF] in the fluid shear stress (FSS) induction of [TG] in MC3T3-E1 cells stably transfected with a COX-2 promoter-luciferase reporter.	Cbfa1	COX-2	1	ACTIVATION	True
13512	13797	16598781:5:RUNX2:TNFSF11	Osteoblastic/stromal cell lines derived from normal and [TF]-deficient mice were used to analyze endogenous [TG] gene expression by real-time reverse transcription (RT)-PCR, the acetylation status of the H3 and H4 histone proteins associated with the 5'-flanking region of the RANKL gene by chromatin immunoprecipitation, and the exogenously transfected RANKL gene promoter activity both in the steady-state and under PKA-activated conditions.	Runx2	RANKL	0	UNDEFINED	True
13513	13798	16631621:0:MEIS1:ZIC3	Pbx1 and [TF] regulate activity of the Xenopus laevis [TG] promoter through a highly conserved region.	Meis1	Zic3	0	UNDEFINED	False
13514	13799	16648484:10:MEIS1:FLT3	Chromatin immunoprecipitation confirmed co-occupancy of Hoxa9 and [TF] on the [TG] promoter.	Meis1	Flt3	0	UNDEFINED	False
13515	13800	16651263:7:PAX9:BMP4	This suggests that [TF] is critical for the regulation of [TG] expression through its paired domain rather than Msx1.	Pax9	Bmp4	0	UNDEFINED	False
13516	13801	16670084:13:RUNX2:SPP1	Ets-1 and [TF] are critical transcriptional regulators of [TG] expression in CT26 colorectal cancer cells.	Runx2	OPN	0	UNDEFINED	False
13517	13802	16914731:5:RUNX2:TNFSF11	Overexpression of [TF] potentiated cAMP responsiveness of the endogenous [TG] gene in a cell-type-specific manner.	Runx2	RANKL	1	ACTIVATION	True
13518	13803	17042739:10:RUNX2:NELL1	CHIP assays were used to study in vivo binding of [TF] to the [TG] promoter.	Runx2	Nell-1	0	UNDEFINED	False
13519	13804	17042739:18:RUNX2:NELL1	[TF] bound to [TG] promoter in vivo.	Runx2	NELL-1	0	UNDEFINED	False
13520	13805	17067785:11:PAX2:GBX2	Taken together, these findings suggest that [TG] expression during the somitogenesis stage in zebrafish is regulated by a complex mechanism involving [TF] as well as activators and suppressors in the regions flanking the gene.	Pax2	gbx2	0	UNDEFINED	False
13521	13806	17158875:9:RUNX2:FGF18	Significantly, [TF] formed a complex with Lef1 or TCF4 and this complex bound the composite binding site in the [TG] promoter.	Runx2	fgf18	0	UNDEFINED	False
13522	13807	17352650:10:RUNX2:TERT	The functional capacity of [TF] to bind to the h[TG] promoter was performed using a modified electrophoretic mobility shift assay (EMSA).	Cbfa1	TERT	0	UNDEFINED	False
13523	13808	17352650:17:RUNX2:TERT	ChIP analysis showed that [TF] interacted directly with the h[TG] promoter in vivo.	Cbfa1	TERT	0	UNDEFINED	False
13524	13809	17352650:6:RUNX2:TERT	This study examined whether [TF] was capable of regulating the promoter of the early stem cell-associated gene, [TG] (TERT).	Cbfa1	telomerase reverse transcriptase	0	UNDEFINED	False
13525	13810	17352693:11:RUNX3:SP7	These results demonstrate the transcriptional regulation of [TG] expression by [TF] during differentiation of dental pulp cells into odontoblasts during tooth development.	Runx3	Osterix	0	UNDEFINED	False
13526	13811	17397822:10:LEF1:DKK4	In addition, we demonstrate a direct physical interaction between [TF]/beta-catenin complex and the [TG] promoter using ChIP.	LEF1	Dkk4	0	UNDEFINED	False
13528	13813	17550981:7:RREB1:KLK3	[TF] bound to the prostate-specific antigen ([TG]) promoter as assessed by chromatin immunoprecipitation.	RREB-1	PSA	0	UNDEFINED	False
13529	13814	17719562:7:KLF4:IL10	These results indicate that [TF] plays an important role in regulating the expression of [TG].	KLF4	IL-10	0	UNDEFINED	False
13530	13815	17785445:2:PITX2:LEF1	Chromatin immunoprecipitation (ChIP) assays identified the [TG] promoter as a [TF] downstream target.	PITX2	Lef-1	0	UNDEFINED	False
13531	13816	18194215:8:LEF1:SNAP25	Several putative cis-acting elements including SP1, hypoxia inducible factor (HIF), cAMP-response element binding protein, T-cell factor/lymphocyte enhancer factor 1 (TCF/[TF]), AP1 and the signal transducer and activator of transcription-6 (STAT6) are found in the 5' flanking region of [TG] gene.	LEF1	SNAP-25	0	UNDEFINED	False
13532	13817	18197146:4:KLF4:HMGB1	Electrophoretic mobility shift assay was performed to detect the binding activity of [TF] to the [TG] promoter.	KLF4	HMGB1	0	UNDEFINED	False
13533	13818	18197146:7:KLF4:HMGB1	Electrophoretic mobility shift assay results showed the binding of [TF] to the oligonucleotides designed according to the [TG] promoter, and the binding activity was increased in response to LPS stimulation.	KLF4	HMGB1	0	UNDEFINED	False
13534	13819	18625716:8:RUNX2:GNA13	Target gene analysis by Affymetrix expression profiling shows that the C terminus of [TF] regulates genes involved in G protein-coupled receptor signaling (e.g. Rgs2, Rgs4, Rgs5, Rgs16, Gpr23, Gpr30, Gpr54, Gpr64, and [TG]).	Runx2	Gna13	0	UNDEFINED	False
13535	13820	18625716:8:RUNX2:GPER1	Target gene analysis by Affymetrix expression profiling shows that the C terminus of [TF] regulates genes involved in G protein-coupled receptor signaling (e.g. Rgs2, Rgs4, Rgs5, Rgs16, Gpr23, [TG], Gpr54, Gpr64, and Gna13).	Runx2	Gpr30	0	UNDEFINED	False
13536	13821	18625716:8:RUNX2:KISS1R	Target gene analysis by Affymetrix expression profiling shows that the C terminus of [TF] regulates genes involved in G protein-coupled receptor signaling (e.g. Rgs2, Rgs4, Rgs5, Rgs16, Gpr23, Gpr30, [TG], Gpr64, and Gna13).	Runx2	Gpr54	0	UNDEFINED	False
13537	13822	18625716:8:RUNX2:LPAR4	Target gene analysis by Affymetrix expression profiling shows that the C terminus of [TF] regulates genes involved in G protein-coupled receptor signaling (e.g. Rgs2, Rgs4, Rgs5, Rgs16, [TG], Gpr30, Gpr54, Gpr64, and Gna13).	Runx2	Gpr23	0	UNDEFINED	False
13538	13823	18804520:4:RUNX2:OSR1	Several [TF] and Ikzf1 binding sites were found in both mouse and human [TG] promoters.	Runx2	Osr1	0	UNDEFINED	False
13539	13824	18814144:2:RUNX2:TNFSF11	[TF], a master gene for osteoblastic differentiation, also modulates osteoclastogenesis by regulating the [TG] gene.	Runx2	RANKL	0	UNDEFINED	False
13540	13825	19005469:4:PAX2:ERBB2	We show that [TF] and the ER co-activator AIB-1/SRC-3 compete for binding and regulation of [TG] transcription, the outcome of which determines tamoxifen response in breast cancer cells.	PAX2	ERBB2	0	UNDEFINED	False
13541	13826	19048125:13:PAX2:WNT5A	This study underlines the importance of [TF] in the regulation of [TG].	PAX2	WNT5A	0	UNDEFINED	False
13542	13827	19116917:11:RUNX2:COL10A1	Our findings indicate that the HY box is the core element responsive to [TF] in human [TG] promoter.	RUNX-2	COL10A1	0	UNDEFINED	False
13543	13828	19147802:10:KLF4:SLC39A4	EMSAs with nuclear extracts of IECs showed [TF] binding to cis elements of the mouse [TG] promoter, with increased binding under zinc-limited conditions.	KLF4	Zip4	0	UNDEFINED	False
13544	13829	19342447:2:RUNX2:CYP51A1	We show here that the osteogenic transcription factor [TF] controls genes involved in sterol/steroid metabolism, including Cyp11a1, Cyp39a1, [TG], Lss, and Dhcr7 in murine osteoprogenitor cells.	Runx2	Cyp51	0	UNDEFINED	False
13545	13830	19342447:6:RUNX2:CYP11A1	Chromatin immunoprecipitation analyses and gel shift assays show that [TF] binds to the [TG] gene promoter in osteoblasts, indicating that Cyp11a1 is a direct target of Runx2.	Runx2	Cyp11a1	0	UNDEFINED	False
13546	13831	19403666:1:RUNX3:RUNX1	Cross-regulation of [TG] expression by [TF] plays a critical role in regulating proliferation of human B cells infected with Epstein-Barr virus (EBV).	RUNX3	RUNX1	0	UNDEFINED	False
13547	13832	19403666:5:RUNX3:RUNX1	Chromatin immunoprecipitation assays confirmed that [TF] binds to the [TG] promoter in a lymphoblastoid cell line and a Burkitt's lymphoma cell line.	RUNX3	RUNX1	0	UNDEFINED	False
13548	13833	19423655:6:RUNX2:MMP13	Upon PTH treatment, [TF], already bound to the runt domain site of the [TG] promoter, interacted with p300, which then acetylated histones H4 and H3.	Runx2	MMP-13	0	UNDEFINED	False
13549	13834	19423655:7:RUNX2:MMP13	The knockdown of either [TF] or p300 by RNA interference reduced PTH-induced acetylation of histones H3 and H4, association of p300 with the [TG] promoter, and resultant MMP-13 gene transcription.	Runx2	MMP-13	0	UNDEFINED	True
13550	13835	19522013:0:KLF4:NANOG	[TF] and PBX1 directly regulate [TG] expression in human embryonic stem cells.	KLF4	NANOG	0	UNDEFINED	False
13551	13836	19669938:2:KLF4:HSP90AB1	But little is known about the regulation of [TF] on the expression of HSP90 ([TG] and HSP86).	KLF4	HSP84	0	UNDEFINED	False
13552	13837	19808967:4:RUNX3:MDM2	[TF] directly binds [TG] through its Runt-related DNA-binding domain.	RUNX3	MDM2	0	UNDEFINED	True
13553	13838	19917773:3:RUNX3:FOXP3	This induction seems to be a prerequisite for the binding of RUNX1 and [TF] to three putative RUNX binding sites in the [TG] promoter.	RUNX3	FOXP3	0	UNDEFINED	False
13554	13839	20339004:9:RUNX2:HAPLN1	Chromatin immunoprecipitation assays verified the in vivo binding of RUNX1 and [TF] to the [TG] promoter in periovulatory granulosa cells.	RUNX2	Hapln1	0	UNDEFINED	False
13555	13840	20363964:5:LEF1:CD1D	We found that [TF] binds specifically to the [TG] promoter.	LEF-1	CD1D	0	UNDEFINED	False
13556	13841	20363964:9:LEF1:CD1D	Our finding links [TF] to [TG] and suggests a role of Wnt signaling in the regulation of the human CD1D gene.	LEF-1	CD1D	0	UNDEFINED	True
13557	13842	20371816:6:LEF1:CACNA1G	[TG] is the predominant T-type channel subunit in the thalamus, and we hypothesized that the Cacna1g gene encoding Cav3.1 is a target of the [TF]/beta-catenin complex.	LEF1	Cav3.1	0	UNDEFINED	False
13558	13843	20375011:7:KLF4:TGFBR1	Chromatin immunoprecipitation studies and oligonucleotide pull-down assays showed the direct binding of [TF] to the KLF4-binding sites 2 and 3 of the [TG] promoter and the recruitment of Smad2 to the Smad-responsive region.	KLF4	TbetaRI	0	UNDEFINED	False
13559	13844	20385121:9:KLF4:GDF15	This study shows that PPARgamma agonists up-regulate [TF] expression in receptor-dependent manner, and KLF4 was identified as a novel transcription factor that controls [TG] promoter activity in human and mouse colorectal cancers.	KLF4	NAG-1	0	UNDEFINED	False
13560	13845	20516218:0:MEIS1:GFI1	[TG] expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/Tal1, Gata2, PU.1, Erg, [TF], and Runx1 acting as upstream regulators in early hematopoietic cells.	Meis1	Gfi1	0	UNDEFINED	False
13561	13846	20718868:4:KLF4:SCARB1	The binding and transcriptional activities of [TF] to the [TG] promoter were detected by electrophoretic mobility shift assay, chromatin immunoprecipitation assay and luciferase reporter assay.	KLF4	SR-BI	0	UNDEFINED	False
13562	13847	21128246:8:RUNX3:TIMP1	Two [TF] binding sites were identified in the [TG] promoter and direct interaction of RUNX3 with the TIMP-1 promoter was confirmed in vitro and in vivo.	RUNX3	TIMP-1	0	UNDEFINED	False
13563	13848	21182892:7:KLF4:TRH	Thus, our data indicate that [TF] plays a key role in the maturation of [TG] expression in hypothalamic neurons.	Klf4	TRH	0	UNDEFINED	True
13564	13849	21454810:5:RUNX2:TNFSF11	Mechanistic studies using RNA interference, a luciferase reporter system, chromatin immunoprecipitation, and electrophoretic mobility shift assays indicated that [TF] regulated the expression of [TG] via a direct binding to the 5'-flanking region of the RANKL.	Runx2	RANKL	0	UNDEFINED	False
13565	13850	21461405:6:RUNX2:MMP13	We conclude that there was no synergy found between [TF] and AP-1 in the regulation of the [TG] expression and that these transcription factors may be independently regulated in these cells.	RUNX2	MMP13	0	UNDEFINED	False
13566	13852	21471200:7:RUNX2:BGLAP	Chromatin immunoprecipitation assay revealed that IGF1 increased [TF] interaction with a chromatin fragment of the proximal [TG] promoter in a PI3K/AKT-dependent manner.	Runx2	Bglap2	0	UNDEFINED	False
13567	13853	21531817:11:KLF4:IFITM3	These clinical and mechanistic findings indicate that [TG] is a direct transcriptional target of [TF] and that dysregulated KLF4 expression leads to aberrant IFITM3 expression, thus contributing to colon cancer progression and metastasis.	KLF4	IFITM3	0	UNDEFINED	True
13568	13854	21542013:5:RUNX2:LRP5	Here we test the functionality of this SNP and examine whether [TF] is indeed a regulator of [TG] expression.	RUNX2	LRP5	0	UNDEFINED	False
13569	13855	21793044:13:RUNX2:VEGFA	Chromatin immunoprecipitation also provided evidence for colocalization of [TF] and HIF-1 on the [TG] promoter.	Runx2	VEGF	0	UNDEFINED	False
13570	13856	21809344:3:RUNX2:PIP	Using BCa and PCa cells, we found that [TF], a pro-metastatic transcription factor, functionally interacts with the Androgen Receptor (AR) to regulate [TG] expression.	Runx2	PIP	0	UNDEFINED	False
13571	13857	21876729:0:PAX2:ADAM10	[TF] regulates [TG] expression and mediates anchorage-independent cell growth of melanoma cells.	PAX2	ADAM10	0	UNDEFINED	False
13572	13858	21876729:6:PAX2:ADAM10	In addition, with chromatin immunoprecipitation assay, [TF] overexpression and PAX2 siRNA we present compelling evidence that PAX2 can regulate [TG] expression, a metalloproteinase known to play important roles in melanoma metastasis.	PAX2	ADAM10	0	UNDEFINED	False
13573	13859	21880579:0:PAX2:ADAM10	The transcription factor [TF] regulates [TG] expression in renal cell carcinoma.	PAX2	ADAM10	0	UNDEFINED	False
13575	13861	22282354:7:KLF4:AGTR1	[TF] functions as a protein platform that is able to bind to the TCE of the [TG] promoter.	KLF4	AT1R	0	UNDEFINED	False
13576	13862	22293114:3:MEIS1:SOX3	Recently, we have established the first link between TALE (three-amino-acid loop extension) proteins, PBX1 (pre-B-cell leukemia homeobox 1) and [TF] (myeloid ecotropic viral integration site 1 homologue), and the expression of the human [TG] gene.	MEIS1	SOX3	0	UNDEFINED	False
13577	13863	22293114:3:PBX1:SOX3	Recently, we have established the first link between TALE (three-amino-acid loop extension) proteins, PBX1 ([TF]) and MEIS1 (myeloid ecotropic viral integration site 1 homologue), and the expression of the human [TG] gene.	pre-B-cell leukemia homeobox 1	SOX3	0	UNDEFINED	False
13579	13865	22513174:6:LEF1:COL10A1	Furthermore, we evaluated the effect of experimental activation of the Wnt/-catenin pathway with LiCl and [TF] silencing, in LiCl-treated chondrocytes, on matrix metalloproteinases (MMPs) 7, 9, 13, 14, ADAMTS-4, 5, and collagen X ([TG]) expression, as well as possible interactions between LEF-1 and MMPs and COL10A1 promoters by using a ChIP assay.	LEF-1	COL10A1	0	UNDEFINED	False
13580	13866	22653776:9:KLF4:IL10	In conclusion, [TF] is induced in a bacterial DNA-TLR9-Src-dependent manner and regulates [TG] expression, linking the detection of bacterial DNA by TLR9 to the control of an inflammatory response.	KLF4	IL-10	0	UNDEFINED	False
13581	13867	22677193:13:KLF4:VDR	[TF] binds to the promoter of [TG] to regulate its expression; levels of KLF4 are reduced and levels of VDR are increased in HCC cell lines and primary tumor samples.	KLF4	VDR	0	UNDEFINED	False
13582	13868	22686279:0:LEF1:MMP7	[TF] regulates proliferation and [TG] transcription in breast cancer cells.	LEF-1	MMP-7	0	UNDEFINED	False
13583	13869	22686279:8:LEF1:MMP7	Taken together, our results indicate a pivotal role of [TF] in the regulation of proliferation and [TG] transcription in breast cancer cells.	LEF-1	MMP-7	0	UNDEFINED	False
13584	13870	22713854:8:RUNX2:PTGS2	ChIP assays revealed the binding of [TF] in the Runx1 and [TG] promoters.	RUNX2	Ptgs2	0	UNDEFINED	False
13585	13871	22713854:8:RUNX2:RUNX1	ChIP assays revealed the binding of [TF] in the [TG] and Ptgs2 promoters.	RUNX2	Runx1	0	UNDEFINED	False
13586	13872	23272148:6:KLF4:MEG3	Furthermore, we show that the reprogramming factor [TF] binds to the promoter region of [TG].	Klf4	Gtl2	0	UNDEFINED	False
13587	13873	23451207:5:KLF4:CDH1	Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct [TF] target genes, including E-cadherin ([TG]), N-cadherin (Cdh2), vimentin (Vim), -catenin (Ctnnb1), VEGF-A (Vegfa), endothelin-1 (Edn1) and Jnk1 (Mapk8).	Klf4	Cdh1	0	UNDEFINED	False
13588	13874	23451207:5:KLF4:CDH2	Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct [TF] target genes, including E-cadherin (Cdh1), N-cadherin ([TG]), vimentin (Vim), -catenin (Ctnnb1), VEGF-A (Vegfa), endothelin-1 (Edn1) and Jnk1 (Mapk8).	Klf4	Cdh2	0	UNDEFINED	False
13589	13875	23451207:5:KLF4:CTNNB1	Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct [TF] target genes, including E-cadherin (Cdh1), N-cadherin (Cdh2), vimentin (Vim), -catenin ([TG]), VEGF-A (Vegfa), endothelin-1 (Edn1) and Jnk1 (Mapk8).	Klf4	Ctnnb1	0	UNDEFINED	False
13590	13876	23451207:5:KLF4:MAPK8	Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct [TF] target genes, including E-cadherin (Cdh1), N-cadherin (Cdh2), vimentin (Vim), -catenin (Ctnnb1), VEGF-A (Vegfa), endothelin-1 (Edn1) and [TG] (Mapk8).	Klf4	Jnk1	0	UNDEFINED	False
13591	13877	23451207:5:KLF4:VIM	Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct [TF] target genes, including E-cadherin (Cdh1), N-cadherin (Cdh2), vimentin ([TG]), -catenin (Ctnnb1), VEGF-A (Vegfa), endothelin-1 (Edn1) and Jnk1 (Mapk8).	Klf4	Vim	0	UNDEFINED	False
13592	13878	23625810:8:RUNX3:ACAN	The functional activities of [TF] during chondrocyte differentiation were assessed by examining its regulatory actions on [TG] gene expression.	Runx3	aggrecan	0	UNDEFINED	False
13593	13879	23733190:5:KLF4:CIITA	NO responsive recruitment of a bifunctional transcription factor, [TF], to the promoter of [TG] during M. bovis BCG infection of macrophages was essential to orchestrate the epigenetic modifications mediated by histone methyltransferase EZH2 or miR-150 and thus calibrate CIITA/MHC-II expression.	KLF4	CIITA	0	UNDEFINED	False
13594	13880	23846700:4:KLF4:IL6	We analyzed the role of [TF] in the production of [TG] by dendritic cells.	KLF4	IL-6	1	ACTIVATION	True
13595	13881	23846700:7:KLF4:IL6	[TF] also has a role in the chromatin remodeling of the [TG] promoter in that cells deficient in KLF4 exhibited a relative hypoacetylation.	KLF4	IL-6	0	UNDEFINED	False
13596	13882	23884787:4:KLF4:CDK4	We found that EGCG treatment results in increased expression of [TF] and alters expression of the KLF4 target genes p21, [TG], and cyclin D1.	KLF4	CDK4	0	UNDEFINED	False
13597	13883	24042352:7:RUNX3:CCND1	The inverse correlation between the expression levels of [TF] and Akt in H2O2-treated cells was also associated with nuclear translocation of -catenin and upregulation of [TG] expression, which induced cell proliferation.	RUNX3	cyclin D1	0	UNDEFINED	True
13598	13884	24440658:14:KLF5:SOX9	Furthermore, ChIP assays reveal a direct association of [TF] with both the [TG] and Reg1A promoters.	KLF5	Sox9	0	UNDEFINED	False
13599	13885	24812666:6:KLF4:NPHS1	DNA methylation profiling and bisulfite genomic sequencing revealed that [TF] expression reduced methylation at the [TG] promoter and the promoters of other epithelial markers; however, methylation was increased at the promoters of genes encoding mesenchymal markers, suggesting selective epigenetic regulation of podocyte gene expression.	KLF4	nephrin	0	UNDEFINED	False
13600	13886	8995235:6:RUNX2:NOBOX	However, we show that 1,25-(OH)2D3 treatment of primary osteoblasts abolishes the binding of [TF], an osteoblast-specific activator of transcription that binds to OSE2, a critical osteoblast-specific cis-acting element present in OG1 and [TG] promoters.	OSF2	OG2	0	UNDEFINED	True
13601	13887	9178767:10:PAX2:WT1	These findings suggest that [TF] is a tissue-specific modulator of [TG] expression, and is involved in cell growth control via WT1.	PAX2	WT1	0	UNDEFINED	False
13602	13888	9178767:5:PAX2:WT1	To investigate this possibility, the [TG] promoter and a series of WT1 promoter deletion fragments were cloned into a luciferase reporter vector, and used in co-transfection experiments with [TF] expression constructs.	PAX2	WT1	0	UNDEFINED	True
13603	13889	21765024:3:STAT3:ICOS	NPM-ALK induces [TG] expression via [TF], which triggers the transcriptional activity of the ICOS gene promoter.	STAT3	ICOS	1	ACTIVATION	False
13604	13890	21765024:8:STAT3:ICOS	These results demonstrate that NPM-ALK, acting through [TF] as the gene transcriptional activator, induces the expression of [TG], a cell growth promoting receptor.	STAT3	ICOS	1	ACTIVATION	False
13605	13891	16959849:11:STAT3:REN	[TF] overexpression significantly repressed transcription of the [TG] gene, whereas small interfering RNA-mediated knockdown of STAT3 increased renin at baseline and attenuated the IL-1beta response.	STAT3	renin	2	REPRESSION	False
13606	13892	21730069:8:STAT3:BAD	Moreover, we found that [TF] enhanced survival of activated T-cells by up-regulating OX-40 and Bcl-2 while down-regulating FasL and [TG] expression, suggesting that similar to role of FoxOs in regulating the lifespan of worms, STAT3 and FoxO pathways converge to regulate lifespan of T-lymphocytes.	STAT3	Bad	2	REPRESSION	False
13607	13893	24477565:5:SOX2:BMP4	We found that [TF]-silencing-mediated inhibition of cell growth was accompanied by upregulation of [TG] mRNA and its protein expression.	SOX2	BMP4	2	REPRESSION	False
13609	13895	15870198:0:STAT3:PTPN6	[TF]- and DNA methyltransferase 1-mediated epigenetic silencing of [TG] tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.	STAT3	SHP-1	2	REPRESSION	False
13610	13896	16148004:7:SOX6:INS	Furthermore, [TF] retroviral expression decreased acetylation of histones H3 and H4 in chromatin from the promoter for the [TG] gene, suggesting that SOX6 may decrease PDX1 stimulation through changes in chromatin structure at specific promoters.	SOX6	insulin II	2	REPRESSION	True
13611	13897	20435894:4:STAT3:MIR155HG	IL-10 inhibited miR-155 transcription from the [TG] gene in a [TF]-dependent manner.	STAT3	BIC	2	REPRESSION	False
13612	13898	23820254:12:STAT3:RECK	Delivery of pre-miR-92a reduces [TG] protein level whereas transfection of anti-miR-92a restores [TF]-induced downregulation of RECK.	STAT3	RECK	2	REPRESSION	False
13613	13899	14688368:5:STAT3:PTGS2	[TF] DN also blocked IL-10-mediated inhibition of MHC class II and [TG] expression.	STAT3	COX2	2	REPRESSION	False
13614	13900	16107692:7:STAT3:TP53	Furthermore, blocking [TF] in cancer cells up-regulates expression of [TG], leading to p53-mediated tumor cell apoptosis.	Stat3	p53	2	REPRESSION	False
13615	13901	10440232:6:STAT3:HSPA4	In contrast, [TF] and HSF-1 antagonize one another and reduce the activation of both the [TG] and Hsp90 promoters.	STAT-3	Hsp70	2	REPRESSION	False
13616	13902	11504872:9:SOX6:FGF3	Co-expression studies in NIH3T3 cells showed that [TF] and CtBP2 co-operate to repress activity from the [TG] promoter through the enhancer element PS4A.	SOX6	Fgf-3	2	REPRESSION	False
13617	13903	12057007:7:STAT3:NOS2	Overexpression of [TF] dramatically inhibited IL-1beta- or LPS+IFN-gamma-mediated induction of [TG] promoter-luciferase constructs that contained the wild-type iNOS promoter or ones harbouring mutated STAT-binding elements.	STAT3	iNOS	2	REPRESSION	False
13618	13904	12057007:9:STAT3:NOS2	Thus [TF], via direct interactions with NF-kappaB p65, serves as a dominant-negative inhibitor of NF-kappaB activity to suppress indirectly cytokine induction of the [TG] promoter in mesangial cells.	STAT3	iNOS	2	REPRESSION	False
13619	13905	14978160:2:STAT3:NOS2	The ability of [TF] to interact physically with NF-kappaB p65 in glomerular mesangial cells and thereby to inhibit NF-kappaB-mediated transactivation of the [TG] gene was demonstrated previously.	STAT3	iNOS	2	REPRESSION	False
13620	13906	15240880:5:STAT3:SREBF1	In obese animals, increased SOCS proteins enhance [TG] expression by antagonizing [TF]-mediated inhibition of SREBP-1c promoter activity.	STAT3	SREBP-1c	2	REPRESSION	False
13621	13907	15349837:7:SOX2:FGF4	Moreover, overexpression of [TF] in F9 EC cells decreases [TG] promoter activity.	Sox-2	FGF-4	2	REPRESSION	False
13624	13911	16148004:6:SOX6:INS	These effects can be explained by our mechanistic studies that show [TF] acts to suppress PDX1 stimulation of the [TG] promoter through a direct protein/protein interaction.	SOX6	insulin II	2	REPRESSION	False
13625	13912	17412698:0:SOX6:CCND1	[TF] suppresses [TG] promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation.	SOX6	cyclin D1	2	REPRESSION	False
13626	13913	17412698:5:SOX6:CCND1	Luciferase-reporter assay with beta-catenin showed that [TF] suppresses [TG] promoter activities.	SOX6	cyclin D1	2	REPRESSION	False
13627	13914	18085523:0:SOX5:SPARC	Transcription factor [TF] enhances nasopharyngeal carcinoma progression by down-regulating [TG] gene expression.	SOX-5	SPARC	2	REPRESSION	False
13628	13915	18085523:10:SOX5:SPARC	Our study suggests that [TF] transcriptionally down-regulates [TG] expression and plays an important role in the regulation of NPC progression.	SOX-5	SPARC	2	REPRESSION	False
13629	13916	18085523:6:SOX5:SPARC	RNA interference of [TF] by short hairpin RNA (shRNA) in NPC cells caused a dramatic increase in [TG] and chromosome immunoprecipitation assay showed that SOX-5 can bind directly to the SPARC promoter, suggesting that SOX-5 acts as a key transcriptional repressor of SPARC.	SOX-5	SPARC	2	REPRESSION	False
13630	13917	18160708:5:SIM2:SNAI2	[TF] protein was detectable on the [TG] promoter, and overexpression of SIM2s repressed expression from a SLUG-controlled reporter in a dose-dependent manner.	SIM2s	SLUG	2	REPRESSION	False
13631	13918	18160708:6:SIM2:SNAI2	To our knowledge, [TF] is the first protein shown to bind and repress the [TG] promoter, providing a plausible explanation for the development role and breast tumor-suppressive activity of SIM2s.	SIM2s	SLUG	2	REPRESSION	False
13632	13919	18485278:0:SNAI2:VDR	In vivo binding to and functional repression of the [TG] gene promoter by [TF] in human breast cells.	SLUG	VDR	2	REPRESSION	False
13633	13920	18485278:7:SNAI2:VDR	These data suggests that [TF] binds to the E2-box sequences of the [TG] gene promoter and recruits CtBP1 and HDAC1, which results in the inhibition of VDR gene expression by chromatin remodeling.	SLUG	VDR	2	REPRESSION	False
13634	13921	18519685:5:SOX9:CLDN7	In vitro, Tcf-4 was able to repress [TG] expression, and the high mobility group-box transcription factor [TF] was identified as an essential mediator of this effect.	Sox-9	claudin-7	2	REPRESSION	False
13635	13922	19185846:4:STAT3:IL12A	Furthermore, [TF] inhibits NF-kappaB/c-Rel-dependent [TG]/p35 gene expression in tumor-associated dendritic cells.	Stat3	IL-12	2	REPRESSION	False
13636	13923	19264844:3:STAT3:G6PC	Herein we demonstrate that phosphorylated [TF] is required for repression of [TG] expression by IL-6 in both HepG2 cells and mouse liver.	STAT3	G6Pase	2	REPRESSION	False
13637	13924	19306868:8:SOX9:COL10A1	Furthermore, while over-expression of [TF] decreased Runx2 and [TG] expressions, simultaneous transient knockdown of Bapx1 diminished that Sox9 over-expressing effect.	Sox9	Col10a1	2	REPRESSION	False
13638	13925	19306868:8:SOX9:RUNX2	Furthermore, while over-expression of [TF] decreased [TG] and Col10a1 expressions, simultaneous transient knockdown of Bapx1 diminished that Sox9 over-expressing effect.	Sox9	Runx2	2	REPRESSION	False
13640	13927	19729026:0:SOX9:SGCA	[TF] represses [TG] gene expression in early myogenic differentiation.	Sox9	alpha-sarcoglycan	2	REPRESSION	False
13641	13928	20400479:9:SOX4:BAX	More importantly, [TF] overexpression led to a significant repression of p53-induced [TG] expression and subsequent repression of p53-mediated apoptosis induced by gamma-irradiation.	SOX4	Bax	2	REPRESSION	False
13642	13929	20802155:7:SOX17:LEF1	Reporter assays revealed that ectopic expression of [TF] suppresses Wnt3A/-catenin activation of the [TG] promoter in cell lines.	Sox17	Lef-1	2	REPRESSION	False
13643	13930	20924113:0:STAT3:HIF1A	eIF2{alpha} Kinase PKR modulates the hypoxic response by [TF]-dependent transcriptional suppression of [TG].	Stat3	HIF-1{alpha}	2	REPRESSION	False
13644	13931	21730069:8:STAT3:FASLG	Moreover, we found that [TF] enhanced survival of activated T-cells by up-regulating OX-40 and Bcl-2 while down-regulating [TG] and Bad expression, suggesting that similar to role of FoxOs in regulating the lifespan of worms, STAT3 and FoxO pathways converge to regulate lifespan of T-lymphocytes.	STAT3	FasL	2	REPRESSION	False
13645	13932	21983268:8:SOX9:GCG	siRNA knockdown of [TF] significantly decreased islet-epithelial cell proliferation, NGN3, NKX6.1, PAX6 and INS mRNA levels and the number of NGN3(+) and insulin(+) cells (p<0.05) while increasing [TG] mRNA and glucagon(+) cells (p<0.05).	SOX9	GCG	2	REPRESSION	False
13646	13933	22046352:0:SOX9:SPP1	[TF] transcriptionally represses [TG] to prevent matrix mineralization in maturing heart valves and chondrocytes.	Sox9	Spp1	2	REPRESSION	False
13647	13934	22750444:0:STAT3:USP7	[TF] repressed [TG] expression is crucial for colon cancer development.	STAT3	USP7	2	REPRESSION	False
13648	13935	22750444:5:STAT3:USP7	Using luciferase reporter and ChIP assay, we found that [TF] bound to the promoter region of [TG] and inhibited its activity through recruiting HDAC1.	STAT3	USP7	2	REPRESSION	False
13649	13936	22768305:6:SOX9:PAX3	We found that Nkx3.2 and [TF] repress the activity of the [TG] promoter and that Nkx3.2 acts as a transcriptional repressor in this process.	Sox9	Pax3	2	REPRESSION	False
13652	13939	23686482:7:STAT3:MICA	On the contrary, inhibition of GSK3 correlated with a downregulation of [TF] activation, a negative regulator of [TG] transcription.	STAT3	MICA	2	REPRESSION	True
13653	13940	23686482:8:STAT3:MICA	Both Tyr(705) phosphorylation and binding of [TF] on [TG] promoter are reduced by GSK3 inhibitors; in addition, overexpression of a constitutively active form of STAT3 significantly inhibits MICA upregulation.	STAT3	MICA	0	UNDEFINED	True
13654	13941	23939942:10:STAT3:GADD45B	PPAR indirectly induces the [TG] gene in liver through promoting degradation of the repressor [TF] as a result of elevated oxidative stress.	STAT3	Gadd45b	2	REPRESSION	False
13655	13942	24191246:0:STAT3:PTPN13	[TF] inhibits [TG] expression in squamous cell lung carcinoma through recruitment of HDAC5.	Stat3	PTPN13	2	REPRESSION	False
13656	13943	24316986:4:SOX2:AHR	In ES cells, interactions between OCT3/4, NANOG, [TF] and Polycomb Group proteins at the [TG] promoter repress AHR expression, which can also be repressed by ectopic expression of reprogramming factors in hepatoma cells.	SOX2	Ahr	2	REPRESSION	False
13658	13945	24477565:9:SOX2:BMP4	Finally, chromatin immunoprecipitation analysis and luciferase reporter assay revealed that [TF] could negatively regulate [TG] promoter activity, possibly through binding to the promoter located in the first intron region of BMP4.	SOX2	BMP4	2	REPRESSION	False
13659	13946	24487391:10:SOX2:LEF1	Our findings provide the first evidence that [TF] acts as a repressor to directly modulate Wnt-responsive transcription of the [TG] gene promoter.	Sox2	Lef-1	2	REPRESSION	False
13660	13947	24487391:6:SOX2:LEF1	Thus we hypothesized that [TF] transcriptionally represses [TG] expression in the SAE and that suppression of Sox2 in SMG placodes activates Wnt/-catenin-dependent induction of Lef-1 during SMG morphogenesis.	Sox2	Lef-1	2	REPRESSION	False
13661	13948	24760274:5:STAT3:BECN1	Interleukin-6 (IL-6) treatment or transfection of a constitutively activated [TF] in AGS and NCI-H1650 cells inhibited [TG] expression.	Stat3	Beclin 1	2	REPRESSION	False
13662	13949	9812998:0:SMAD2:RUNX2	[TF] overexpression enhances Smad4 gene expression and suppresses [TG] gene expression in osteoblastic osteosarcoma ROS17/2.8 cells and primary rat calvaria cells.	Smad2	CBFA1	2	REPRESSION	False
13663	13950	22203039:8:SNAI2:KLF4	Furthermore, self-reinforcing regulatory loops for [TF]-KLF4 and SLUG-FOXA1 lead to SLUG-dependent binding of polycomb repressive complexes to the [TG] and Foxa1 promoters, silencing transcription and consolidating mesenchymal commitment.	SLUG	Klf4	2	REPRESSION	False
13664	13951	23438478:10:STAT3:DAPK1	Chromatin immunoprecipitation showed that [TF] restricted [TG] expression by promoter binding, thereby reinforcing its own activation by inducing IL-6.	STAT3	DAPK	2	REPRESSION	True
13665	13952	11504872:0:SOX6:FGF3	[TF] binds CtBP2 to repress transcription from the [TG] promoter.	SOX6	Fgf-3	2	REPRESSION	False
13666	13953	11504872:10:SOX6:FGF3	These results show that [TF] can recruit CtBP2 to repress transcription from the [TG] promoter.	SOX6	Fgf-3	2	REPRESSION	False
13667	13954	16959849:0:STAT3:REN	Interleukin-1beta attenuates [TG] gene expression via a mitogen-activated protein kinase kinase-extracellular signal-regulated kinase and [TF]-dependent mechanism in As4.1 cells.	signal transducer and activator of transcription 3	renin	2	REPRESSION	False
13668	13955	23335796:0:STAT3:SOCS3	[TG] promotor hypermethylation and [TF]-NF-B interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells.	STAT3	SOCS3	2	REPRESSION	False
13669	13956	23335796:4:STAT3:SOCS3	We propose that hypermethylation of CpG islands in the [TG] promoter is responsible for decrease in SOCS3 expression involving [TF] and NFkB-p65 interaction.	STAT3	SOCS3	2	REPRESSION	False
13670	13957	10023678:8:STAT3:CDKN1A	IL-6 dependent upregulation of p21WAF1/[TG] was associated with binding of both [TF] and STAT1 to the p21WAF1/CIP1 promoter.	STAT3	CIP1	1	ACTIVATION	False
13671	13958	10320524:6:SOX9:MIA	Overexpression of [TF] resulted in a dose-dependent increased activity of [TG] promoter-driven reporter gene in both chondrocytes and nonchondrogenic cells.	SOX9	CD-RAP	1	ACTIVATION	False
13672	13959	10359822:10:STAT3:SOCS3	Thus, LIF-stimulated [TG] gene expression is at least in part mediated by [TF] and STAT-1.	STAT-3	SOCS-3	1	ACTIVATION	False
13673	13960	10359822:5:STAT3:SOCS3	A STAT-1/[TF] binding element, located at nucleotides -72 to -64, was essential for LIF stimulation of [TG] promoter activity.	STAT-3	SOCS-3	1	ACTIVATION	False
13674	13961	10445852:5:STAT3:HP	Using a reporter gene construct containing a 190 bp promoter fragment of the acute phase protein [TG] we found that p38 is involved in transcriptional activation of the haptoglobin promoter by [TF] but not by NF-IL6.	STAT3	haptoglobin	1	ACTIVATION	False
13675	13962	10447736:4:STAT3:HSP90AB1	Recent studies have shown that the cytokine IL-6 activates [TG] gene expression via specific transcription factors that include STAT-3 ([TF]).	signal transducer and activator of transcription 3	hsp 90	1	ACTIVATION	False
13676	13963	10737606:5:STAT3:GFAP	This differentiation process is totally dependent on the gp130-mediated signal-transduction pathway involving activation of a latent cytoplasmic transcription factor, STAT3 (for [TF]), because (a) IL-11-induced astrocyte differentiation is not observed when neuroepithelial cells prepared from gp130-deficient mice were used, (b) stimulation of neuroepithelial cells by IL-11 rapidly induces tyrosine-phosphorylation of STAT3, and (c) transfection of neuroepithelial cells with a dominant-negative form of STAT3 inhibits IL-11-induced activation of the [TG] gene promoter.	signal transducer and activator of transcription 3	GFAP	1	ACTIVATION	False
13677	13964	10744750:0:STAT3:VEGFA	[TF] is required for glycoprotein 130-mediated induction of [TG] in cardiac myocytes.	Signal transducer and activator of transcription 3	vascular endothelial growth factor	1	ACTIVATION	False
13678	13965	10744750:6:STAT3:VEGFA	Adenovirus transfer of the dominant-negative form of [TF] to cultured cardiac myocytes inhibited induction of [TG] expression induced by LIF, but neither PD98059 nor wortmannin was affected.	STAT3	VEGF	1	ACTIVATION	False
13679	13966	10779764:5:STAT3:CDKN2D	IL-10 cannot induce [TG] expression or block proliferation when [TF] signaling is blocked by a dominant negative Stat3 or a mutant IL-10Ralpha which does not recruit Stat3 in J774 cells, whereas p21CIP1 induction is not affected.	Stat3	p19INK4D	1	ACTIVATION	False
13680	13967	10809230:6:STAT3:SOCS1	TSH increases [TF]-mediated promoter activity and also induces endogenous SOCS-1 ([TG]) gene expression, a known target gene of STAT3.	STAT3	suppressor of cytokine signaling-1	1	ACTIVATION	False
13681	13968	10809230:7:STAT3:SOCS1	The expression of a dominant negative form of [TF] completely inhibited TSH-mediated [TG] expression.	STAT3	SOCS-1	1	ACTIVATION	False
13682	13969	10825206:10:SOX9:COL2A1	Cotransfection of CRYBP1 with [TF] into BALB/c 3T3 cells inhibited activation of the [TG] enhancer by Sox9.	Sox9	Col2a1	1	ACTIVATION	False
13683	13970	10867011:5:STAT3:CEBPD	Overexpression of [TF] increases [TG] promoter activity during G(0) growth arrest of HC11 cells, whereas dominant negative Stat3 decreases C/EBPdelta promoter activity under the same conditions.	Stat3	C/EBPdelta	1	ACTIVATION	False
13684	13971	10867011:8:STAT3:CEBPD	These data indicate that [TF] activates [TG] transcription in G(0) growth-arrested mouse mammary epithelial cells and binds to the C/EBPdelta promoter during involution.	Stat3	C/EBPdelta	1	ACTIVATION	False
13685	13972	10880233:8:STAT3:CRP	[TF] appears to be necessary for both mouse SAP and [TG] gene transcription since overexpression of an inactive, deletion mutant of STAT3 inhibited transcription of both genes.	STAT3	CRP	1	ACTIVATION	False
13687	13974	10980415:2:SOX9:COL9A2	Our experiments have demonstrated that the HMG-box-containing transcription factor, [TF] which binds and activates this enhancer element, is required for chondrocyte differentiation and for expression of a series of chondrocyte-specific marker genes including Col2a1, [TG], Col11a2 and Aggrecan.	Sox9	Col9a2	1	ACTIVATION	False
13688	13975	10980415:5:SOX9:ACAN	Two other members of the Sox family, L-Sox5 and Sox6, also bind to the 48-bp Col2a1 enhancer and together with [TF] activate this enhancer as well as the endogenous Col2a1 and [TG] genes.	Sox9	aggrecan	1	ACTIVATION	False
13689	13976	10980415:5:SOX9:COL2A1	Two other members of the Sox family, L-Sox5 and Sox6, also bind to the 48-bp [TG] enhancer and together with [TF] activate this enhancer as well as the endogenous Col2a1 and aggrecan genes.	Sox9	Col2a1	1	ACTIVATION	False
13690	13977	11114718:4:STAT3:CDKN1A	Using reporter constructs in transient-transfection assays, the cyclin D1 and [TG] promoters were both found to be transcriptionaly induced by v-Src in a [TF]-dependent manner.	STAT3	p21	1	ACTIVATION	False
13691	13978	11134330:6:STAT3:IGFBP1	IL-6 acted through the [TF] pathway, as dominant negative STAT3 completely blocked IL-6-mediated stimulation of the [TG] promoter via the HNF-1 site.	STAT3	IGFBP-1	1	ACTIVATION	False
13692	13979	11160159:0:STAT3:MCL1	Inhibition of [TF] signaling leads to apoptosis of leukemic large granular lymphocytes and decreased [TG] expression.	STAT3	Mcl-1	1	ACTIVATION	False
13694	13981	11278729:0:STAT3:HGF	Co-operative effect of c-Src tyrosine kinase and [TF] in activation of [TG] expression in mammary carcinoma cells.	Stat3	hepatocyte growth factor	1	ACTIVATION	False
13695	13982	11278729:11:STAT3:HGF	Collectively, our data indicate a cooperative effect of c-Src kinase and [TF] in the activation of [TG] transcription and protein expression in breast carcinoma cells.	Stat3	HGF	1	ACTIVATION	False
13696	13983	11331273:0:STAT3:HP	Smad proteins suppress CCAAT/enhancer-binding protein (C/EBP) beta- and [TF]-mediated transcriptional activation of the [TG] promoter.	STAT3	haptoglobin	1	ACTIVATION	False
13697	13984	11431352:10:STAT3:BCL2	Additionally, piceatannol, an inhibitor of [TF] activation, down-regulates the expression of [TG].	STAT3	Bcl-2	1	ACTIVATION	False
13698	13985	11431352:6:STAT3:BCL2	We hypothesized that the down-regulation of IL-10 by Rituximab decreases activation of the [TF] (STAT3) protein, which in turn, is responsible for decreased levels of [TG].	signal transducer and activator of transcription 3	Bcl-2	1	ACTIVATION	False
13699	13987	11740937:3:STAT3:GFAP	A CpG dinucleotide within a [TF] binding element in the [TG] promoter is highly methylated in E11.5 neuroepithelial cells, but is demethylated in cells responsive to the STAT3 activation signal to express GFAP.	STAT3	GFAP	0	UNDEFINED	True
13700	13988	11744720:4:STAT3:VEGFA	Adenoviral gene transfer of ca[TF] induced an increase in the expression of [TG] in cultured cardiomyocytes.	STAT3	VEGF	1	ACTIVATION	False
13701	13989	11788590:5:STAT3:SFTPB	Interleukin 6 and interleukin 11, known to activate [TF] synergistically, stimulated the [TG] promoter activity with retinoic acid, which is at least partially mediated through interactions between STAT3 and retinoid nuclear receptor enhanceosome proteins in pulmonary epithelial cells.	STAT3	SP-B	1	ACTIVATION	True
13702	13990	11850821:7:STAT3:BCL2L1	NPM-ALK expression caused enhanced [TG] transcription, largely mediated by [TF].	Stat3	Bcl-x(L)	1	ACTIVATION	False
13703	13991	11960372:0:STAT3:VEGFA	Constitutive [TF] activity up-regulates [TG] expression and tumor angiogenesis.	Stat3	VEGF	1	ACTIVATION	False
13704	13992	11960372:4:STAT3:VEGFA	An activated [TF] mutant (Stat3C) up-regulates [TG] expression and stimulates tumor angiogenesis.	Stat3	VEGF	1	ACTIVATION	True
13705	13993	11960372:5:STAT3:VEGFA	[TF]C-induced [TG] up-regulation is abrogated when a Stat3-binding site in the VEGF promoter is mutated.	Stat3	VEGF	1	ACTIVATION	False
13706	13994	12203914:12:SOX9:SRY	We suggest that pig [TG] gene is responsive to a testicular environment and propose a model of feedback amplification of pig SRY transcription by [TF].	SOX9	SRY	1	ACTIVATION	False
13707	13996	12488456:5:SOX2:FGF4	[TF] and Oct-3 bind to the enhancer and are required for the activation of the [TG] gene.	Sox-2	FGF-4	1	ACTIVATION	False
13708	13997	12545153:6:STAT3:VEGFA	Furthermore, constitutively activated [TF] directly activated the [TG] promoter, whereas dominant-negative Stat3 inhibited the VEGF promoter.	Stat3	VEGF	1	ACTIVATION	False
13709	13998	12667216:3:STAT3:CRP	In previous studies of the proximal [TG] promoter, we found that [TF] (STAT3) and C/EBPbeta -mediated IL-6-induced transcription and that Rel p50 acted synergistically with C/EBPbeta, in the absence of p65, to enhance CRP transcription.	signal transducer and activator of transcription-3	CRP	1	ACTIVATION	False
13710	13999	12667216:8:STAT3:CRP	Co-overexpression of p50 or p65 with C/EBPbeta or [TF] synergistically enhanced [TG] expression.	STAT3	CRP	1	ACTIVATION	False
13711	14000	12732631:7:SOX9:COL2A1	Furthermore, the CBP/[TF] complex disrupter peptide suppresses [TG] gene expression and chondrogenesis from mesenchymal stem cells.	Sox9	Col2a1	1	ACTIVATION	False
13712	14001	12732652:7:SOX9:AMH	In vitro assays showed that SOX8 binds specifically to SOX binding sites within the [TG] minimal promoter and, like [TF], acts synergistically with SF1 through direct protein-protein interaction to enhance Amh expression, albeit at lower levels compared with SOX9.	SOX9	Amh	1	ACTIVATION	False
13713	14002	12817009:0:STAT3:IL10	IFN-alpha induces the human [TG] gene by recruiting both IFN regulatory factor 1 and [TF].	Stat3	IL-10	1	ACTIVATION	False
13714	14003	12847226:8:STAT3:CIITA	The cell line stably expressing the wild-type [TF] showed a higher [TG] induction in response to IFN-gamma and also exhibited TSH repression of the IFN-gamma-mediated induction of CIITA.	STAT3	CIITA	1	ACTIVATION	True
13715	14004	14647442:9:STAT3:HGF	Treatment with anti-LIF antibodies or interruption of [TF] signaling by dominant-negative Stat3 also reduced the [TG] promoter activity.	Stat3	HGF	1	ACTIVATION	False
13716	14005	14688368:4:STAT3:SOCS3	Overexpression of [TF] DN completely inhibited IL-10-induced [TG], tissue inhibitor of MMP-1, TNF receptor expression, and the recently identified IL-10-inducible genes, T cell protein tyrosine phosphatase and signaling lymphocyte activation molecule.	STAT3	suppressor of cytokine signaling 3	1	ACTIVATION	False
13717	14006	14712222:0:STAT3:VIM	[TF] enhances [TG] gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89.	Stat3	vimentin	1	ACTIVATION	False
13718	14007	14754894:4:STAT3:GFAP	Overexpression of the dominant-negative form of [TF] leads to the suppression of [TG] promoter activity, suggesting that STAT3 activity was essential for cAMP-induced GFAP promoter activation.	STAT3	GFAP	1	ACTIVATION	False
13719	14008	15082719:0:SOX7:FGF3	[TF] and GATA-4 are competitive activators of [TG] transcription.	SOX7	Fgf-3	1	ACTIVATION	False
13720	14009	15082719:12:SOX7:FGF3	These results show that [TF] is a potent activator of [TG] transcription.	SOX7	Fgf-3	1	ACTIVATION	False
13721	14010	15082719:6:SOX7:FGF3	However, only [TF] expression markedly activated the [TG] promoter in these cells.	Sox7	Fgf-3	1	ACTIVATION	False
13722	14011	15082719:8:SOX7:FGF3	More detailed analyses showed that [TF] competes with GATA-4 for PS4A occupancy and to activate the [TG] promoter.	SOX7	Fgf-3	1	ACTIVATION	False
13723	14012	15116091:5:STAT3:MMP2	Transfection of constitutively activated [TF] into poorly metastatic C23 tumor cells directly activated the [TG] promoter, whereas the expression of a dominant-negative Stat3 in highly metastatic C4 tumor cells inhibited the MMP-2 promoter.	Stat3	MMP-2	1	ACTIVATION	False
13724	14013	15116091:7:STAT3:MMP2	Blockade of activated [TF] through expression of a dominant-negative Stat3 significantly suppressed [TG] expression in the metastatic tumor cells.	Stat3	MMP-2	1	ACTIVATION	False
13725	14014	15116091:8:STAT3:MMP2	Therefore, overexpression of [TG] in the metastatic melanoma cells can be attributed to elevated [TF] activity, and Stat3 upregulates the transcription of MMP-2 through direct interaction with the MMP-2 promoter.	Stat3	MMP-2	1	ACTIVATION	False
13726	14015	15378007:0:STAT3:MAP2K5	[TF] upregulates [TG] expression in human breast cancer cells.	Stat3	MEK5	1	ACTIVATION	False
13727	14016	15378007:13:STAT3:MAP2K5	Taken together, our findings suggest that constitutively active [TF] upregulates [TG] in the breast epithelial cells.	Stat3	MEK5	1	ACTIVATION	False
13728	14017	15389878:7:STAT3:CEBPD	Transient transfection using [TG] promoter-luciferase constructs demonstrated that the APRE ([TF]) consensus binding site is essential for growth arrest or OSM induction of the C/EBPdelta promoter.	STAT3	C/EBPdelta	1	ACTIVATION	False
13729	14018	15486993:10:STAT3:CEBPD	Increased [TG] gene expression plays an important role in IL-6/[TF] mediated growth arrest of LNCaP prostate cancer cells.	STAT3	C/EBPdelta	1	ACTIVATION	False
13730	14019	15590666:4:SOX9:VNN1	SF-1 is able to activate the transcription of the [TG] promoter in in vitro reporter assays, and this activation is further augmented by [TF].	SOX9	Vanin-1	1	ACTIVATION	False
13731	14020	15606754:1:STAT3:FAAH	We have shown recently that in human T lymphocytes, leptin stimulates activity and expression of the endocannabinoid-degrading enzyme [TG] (FAAH), through STAT3 ([TF]) and its CRE (cAMP response element)-like transcriptional target in the FAAH promoter [Maccarrone, M., Di Rienzo, M., Finazzi-Agro, A., & Rossi, A. (2003) J. Biol. Chem. 278, 13318-13324].	signal transducer and activator of transcription 3	fatty acid amide hydrolase	1	ACTIVATION	False
13732	14021	15665043:11:STAT3:VEGFA	In summary, our data indicate OSM causes [TG] expression in HASM cells by a transcriptional mechanism involving [TF].	STAT3	VEGF	1	ACTIVATION	False
13733	14022	15688401:11:STAT3:VEGFA	The functional relevance of the [TF]/Sp1 association was corroborated by transient transfection experiments, which showed that overexpression of constitutively active STAT3 increased the minimal [TG] promoter activity.	STAT3	VEGF	1	ACTIVATION	False
13734	14023	15735682:6:STAT3:VEGFA	Inhibition of DNA binding by expression of either [TF] or HIF-1alpha dominant negative mutants significantly reduces [TG] expression.	STAT3	VEGF	1	ACTIVATION	False
13735	14024	15735682:7:STAT3:VEGFA	These data suggest that the binding of both [TF] and HIF-1alpha to the [TG] promoter is required for maximum transcription of VEGF mRNA following hypoxia.	STAT3	VEGF	1	ACTIVATION	False
13736	14025	15930175:5:STAT3:CEBPD	Moreover, the upregulation of [TG] correlated with binding to three sites in the C/EBPdelta promoter by LIF-activated protein complexes that contained STAT1 and not [TF].	STAT3	C/EBPdelta	1	ACTIVATION	False
13737	14026	16007214:7:STAT3:HIF1A	Targeting [TF] with a small-molecule inhibitor blocks [TG] and VEGF expression in vitro and inhibits tumor growth and angiogenesis in vivo.	Stat3	HIF-1	1	ACTIVATION	False
13738	14027	16007214:7:STAT3:VEGFA	Targeting [TF] with a small-molecule inhibitor blocks HIF-1 and [TG] expression in vitro and inhibits tumor growth and angiogenesis in vivo.	Stat3	VEGF	1	ACTIVATION	False
13739	14028	16014896:7:STAT3:CEBPB	Transfection of [TF] into THP-1 cells enhances [TG] promoter activity.	STAT-3	C/EBPbeta	1	ACTIVATION	False
13740	14029	16048438:10:STAT3:BCL2	Inhibition of [TF] by AG490 and DN-STAT3 decreased [TG] promoter activity.	STAT3	Bcl-2	1	ACTIVATION	False
13741	14030	16055112:9:SOX4:GCG	In addition, [TF]b knock-down leads to a drastic reduction in [TG] expression, while other pancreatic markers including insulin, somatostatin, and trypsin are not significantly affected.	sox4	glucagon	1	ACTIVATION	False
13742	14031	16116232:3:STAT3:CRP	In hepatoma Hep3B cells, IL-6 induces [TG] expression by activating transcription factors [TF] and C/EBPbeta.	STAT3	CRP	1	ACTIVATION	False
13743	14032	16174774:5:STAT3:AKT1	Knockdown of [TF] reduces [TG] expression induced by v-Src.	Stat3	AKT1	1	ACTIVATION	False
13744	14033	16236134:6:STAT3:SAA1	The formation of a complex with [TF], NF-kappaB p65, and p300 is thus essential for the synergistic induction of the [TG] gene by IL-1+6 stimulation.	STAT3	SAA	1	ACTIVATION	False
13745	14034	16300827:5:STAT3:SOCS3	Overexpression of [TF] increased the [TG] promoter activity, whereas expression of dominant-negative STAT3 reduced it.	STAT3	SOCS3	1	ACTIVATION	False
13746	14035	16407846:0:STAT3:HGF	A novel activating function of c-Src and [TF] on [TG] transcription in mammary carcinoma cells.	Stat3	HGF	1	ACTIVATION	False
13747	14036	16407846:4:STAT3:HGF	We previously demonstrated a cooperative effect between c-Src and [TF] in the activation of [TG] transcription in mammary carcinoma cells.	Stat3	HGF	1	ACTIVATION	False
13748	14037	16407846:5:STAT3:HGF	The present report defines a novel [TF] consensus site at nt -95 in the [TG] promoter that is highly conserved in human and mouse, and is required for c-Src and Stat3 to activate HGF transcription in breast epithelial cells.	Stat3	HGF	1	ACTIVATION	False
13749	14038	16606674:8:STAT3:IL10	The activated [TF] enhanced TGF-beta1 and [TG] expression in T cells, whereas the dominant-negative form of STAT3 suppressed these.	STAT3	IL-10	1	ACTIVATION	False
13750	14039	16714766:7:SOX2:ZFP42	Although Oct-3/4 and [TF] can both transactivate [TG] promoter, only Sox2 cooperates with Nanog in up-regulating Rex-1.	Sox2	Rex-1	1	ACTIVATION	False
13751	14040	16732314:0:STAT3:BCL3	[TG] is induced by IL-6 via [TF] binding to intronic enhancer HS4 and represses its own transcription.	Stat3	BCL3	1	ACTIVATION	True
13752	14041	16801560:4:STAT3:NANOG	Here, we show that [TG] expression is up-regulated in mouse ES cells by the binding of T (Brachyury) and [TF] to an enhancer element in the mouse Nanog gene.	STAT3	Nanog	1	ACTIVATION	False
13753	14042	16899623:8:STAT3:VEGFA	On the hand, the cyclin D1 inhibition plus [TF] inhibitor markedly decreased [TG] expression in HCT116, although VEGF did not change by the STAT3 inhibitor alone.	STAT3	VEGF	1	ACTIVATION	False
13754	14043	16912181:6:STAT3:BCL2L1	Overexpression of WT1 and [TF]CA in NIH 3T3 increases the expression level of STAT3 target genes, including cyclin D1 and [TG], which results in an advantage of cell proliferation.	STAT3	Bcl-xL	1	ACTIVATION	False
13755	14044	16931573:0:STAT3:TIMP1	Leptin increases [TG] (TIMP-1) gene expression by a specificity protein 1/[TF] mechanism.	signal transducer and activator of transcription 3	tissue inhibitor of metalloproteinase I	1	ACTIVATION	False
13756	14045	16954384:6:SOX2:LEFTY1	By functional screening of ES-specific transcription factors, we found that Krppel-like factor 4 (Klf4) cooperates with Oct3/4 and [TF] to activate [TG] expression, and that Klf4 acts as a mediating factor that specifically binds to the proximal element of the Lefty1 promoter.	Sox2	Lefty1	1	ACTIVATION	False
13757	14046	17066077:6:SIX3:SOX2	Using ChIP, electrophoretic mobility shift assay, and luciferase reporter assays, we determined that [TF] activates Pax6 and [TG] expression.	Six3	Sox2	1	ACTIVATION	False
13758	14047	17151127:6:STAT3:MUC1	Expression of LMP1 in EBV-negative nasopharyngeal cell lines induces expression of [TG] through activation of the MUC1 promoter via binding of STAT1 and [TF].	STAT3	MUC1	1	ACTIVATION	False
13759	14048	17157810:7:SP1:TWIST1	These results suggest critical implication of the CCT repeats in association with [TF] and Sp3 factors in sustaining expression of the [TG] gene in mesenchymal cells.	Sp1	TWIST1	1	ACTIVATION	False
13760	14049	17161614:3:STAT3:GFAP	NP stimulation leads to promoter activation of the gene for an astrocyte marker, glial fibrillary acidic protein ([TG]), which is clearly inhibited by either expression of a dominant-negative form of a transcription factor, [TF] (STAT3) or by a nucleotide-substitution in the STAT3-binding element within the gene promoter.	signal transducer and activator of transcription 3	GFAP	1	ACTIVATION	False
13761	14050	17169602:8:STAT3:VEGFA	These results strongly indicate that [TF] directly up-regulates [TG] transcription and thereby promotes angiogenesis in HNSCC.	Stat3	VEGF	1	ACTIVATION	False
13762	14051	17202361:2:STAT3:CXCL11	The present study explored the involvement of [TF] in the IFN-induced expression of the gene encoding the [TG] chemokine.	STAT3	CXCL11	1	ACTIVATION	False
13763	14052	17264118:0:SOX9:COL9A1	A [TG] element activated by two interdependent [TF] dimers.	SOX9	Col9a1 enhancer	1	ACTIVATION	False
13764	14053	17363300:4:STAT3:IL17A	Whereas [TF] appeared to be a key positive regulator of RORgammat and [TG] expression, absence of IL-2 or disruption of its signaling by deletion of the transcription factor STAT5 resulted in enhanced Th17 cell development.	STAT3	IL-17	1	ACTIVATION	False
13765	14054	17485346:10:SOX5:COMP	This study provides the first evidence that Sox9 directly associates with [TG] gene promoter and that mediation of COMP gene activation by Sox9 involves [TF], Sox6, CBP, and p300 coactivators.	Sox5	COMP	1	ACTIVATION	False
13766	14055	17485346:10:SOX6:COMP	This study provides the first evidence that Sox9 directly associates with [TG] gene promoter and that mediation of COMP gene activation by Sox9 involves Sox5, [TF], CBP, and p300 coactivators.	Sox6	COMP	1	ACTIVATION	False
13767	14056	17485346:10:SOX9:COMP	This study provides the first evidence that [TF] directly associates with [TG] gene promoter and that mediation of COMP gene activation by Sox9 involves Sox5, Sox6, CBP, and p300 coactivators.	Sox9	COMP	1	ACTIVATION	False
13768	14057	17485346:6:SOX9:COMP	[TF] activates [TG] gene expression and this activation is PRE-dependent.	Sox9	COMP	1	ACTIVATION	False
13769	14058	17485346:7:SOX9:COMP	[TF] is required for [TG] gene expression during chondrogenesis, since repression of Sox9 expression using the small interfering RNA approach inhibited COMP gene expression.	Sox9	COMP	1	ACTIVATION	False
13770	14059	17485346:8:SOX5:COMP	In addition, activation of [TG] gene expression by Sox9 requires the participation of transcription factors [TF] and Sox6 as well as the coactivators CBP and p300 histone acetylase.	Sox5	COMP	1	ACTIVATION	False
13771	14060	17485346:8:SOX6:COMP	In addition, activation of [TG] gene expression by Sox9 requires the participation of transcription factors Sox5 and [TF] as well as the coactivators CBP and p300 histone acetylase.	Sox6	COMP	1	ACTIVATION	False
13772	14061	17485346:8:SOX9:COMP	In addition, activation of [TG] gene expression by [TF] requires the participation of transcription factors Sox5 and Sox6 as well as the coactivators CBP and p300 histone acetylase.	Sox9	COMP	1	ACTIVATION	False
13773	14062	17485346:9:SOX9:COMP	It appears that there exists a balance between LRF repressor and [TF] activator in the control of [TG] gene, since transactivation of COMP gene by Sox9 was abolished by the coexpression of LRF, and excess Sox9 overcame the LRF-mediated inhibition.	Sox9	COMP	1	ACTIVATION	False
13774	14063	17525254:4:SOX9:COL4A2	[TF] strongly activated this enhancer when cotransfected with [TG] enhancer-promoter construct in mesangial cells and Swiss/3T3 cells.	SOX9	Col4a2	1	ACTIVATION	False
13776	14065	17525254:8:SOX9:COL4A2	These results indicate that [TF] is essential for [TG] expression in mesangial cells and might be involved in the accumulation of alpha2(IV) collagen in experimental nephritis.	SOX9	Col4a2	1	ACTIVATION	False
13777	14066	17557905:0:STAT3:VEGFA	Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking [TF]-mediated [TG] expression in human renal carcinoma cells.	STAT3	VEGF	1	ACTIVATION	False
13778	14067	17557905:5:STAT3:VEGFA	Consequently, sequential blockade of [TF] and HIF-1alpha resulted in the down-regulation of [TG] by inhibiting their recruitment to the VEGF promoter.	STAT3	VEGF	1	ACTIVATION	False
13779	14068	17572495:10:STAT3:MMP9	A juxtaposed [TF]/AP-1 element plays a crucial role in the manner of enhancersome in the activation of [TG] gene.	Stat3	MMP-9	1	ACTIVATION	False
13780	14069	17572495:11:STAT3:MMP9	The functional cooperation of the [TF] and AP-1 transcription factors is required for the transcription of [TG] gene.	Stat3	MMP-9	1	ACTIVATION	False
13781	14070	17572495:6:STAT3:MMP9	The reporter assay showed that [TG] promoter was activated remarkably by cotransfection with Fra-1 and [TF]C.	Stat3	MMP-9	1	ACTIVATION	False
13782	14071	17572495:9:STAT3:MMP9	Our study demonstrated that the activation of [TG] promoter is dependent upon interactions of Fra-1/c-Jun with [TF].	Stat3	MMP-9	1	ACTIVATION	False
13783	14072	17699108:10:STAT3:CD46	These results show that activated [TF] signaling induces the [TG] promoter and protects human cancer cells from complement-dependent cytotoxicity, suggesting a potential mechanism whereby oncogenic signaling contributes to tumor cell evasion of antibody-mediated immunity.	STAT3	CD46	1	ACTIVATION	False
13784	14073	17699108:7:STAT3:CD46	[TG] promoter activity is induced by activation of [TF] and blocked by a dominant-negative form of STAT3 in luciferase reporter assays.	STAT3	CD46	1	ACTIVATION	False
13785	14074	17699108:8:STAT3:CD46	[TG] mRNA expression is induced by interleukin-6 and by transient transfection of normal human epithelial cells with a persistently active mutant construct of [TF], STAT3C.	STAT3	CD46	1	ACTIVATION	True
13786	14075	17922140:0:STAT3:NNMT	[TF] up-regulates expression of [TG] in human cancer cells.	Stat3	nicotinamide N-methyltransferase	1	ACTIVATION	False
13787	14076	17967179:0:STAT3:HGF	A novel activating role of SRC and [TF] on [TG] transcription in human breast cancer cells.	STAT3	HGF	1	ACTIVATION	False
13788	14077	17967179:5:STAT3:HGF	The exception was the ErbB2 over-expressing cell line SK-BR-3 where [TF] alone could transactivate [TG] though Src augmented this effect.	Stat3	HGF	1	ACTIVATION	False
13789	14078	17967179:8:STAT3:HGF	Src/[TF] expression did activate [TG] transcription in OVCAR3 cells, but this effect was not mediated by the Stat3 site at nt-95.	Stat3	HGF	1	ACTIVATION	False
13790	14079	17971300:7:STAT3:MASP2	We conclude that [TF] binding is important for [TG] promoter activity.	Stat3	MASP2	1	ACTIVATION	False
13791	14080	18021292:0:STAT3:VEGFA	Ectopic decorin expression up-regulates [TG] expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and [TF].	Stat3	VEGF	1	ACTIVATION	False
13792	14081	18192274:6:STAT3:ECEL1	The injury-inducible transcription factors such as activating transcription factor 3 (ATF3), c-Jun, and [TF], which were located at the downstream of leukemia inhibitory factor and nerve growth factor withdrawal, seemed to be involved in the activation of the [TG] promoter.	STAT3	DINE	1	ACTIVATION	False
13793	14082	18237746:0:STAT3:SOCS3	Transcriptional activation of the [TG] (SOCS-3) gene via [TF] is increased in F9 REX1 (ZFP-42) knockout teratocarcinoma stem cells relative to wild-type cells.	STAT3	suppressor of cytokine signaling-3	1	ACTIVATION	False
13794	14083	18237746:4:STAT3:SOCS3	By promoter deletion, mutation, and transient transfection analyses, we have shown that this transcriptional increase is mediated by the [TF] DNA-binding elements located between -99 to -60 in the [TG] promoter.	STAT3	SOCS-3	1	ACTIVATION	False
13795	14084	18284609:6:STAT3:OPRM1	IGF-I activates the [TF] signaling pathway and this transcription factor, binding to the signal transducer and activator of transcription-1/3 DNA element located in the promoter, increases [TG] transcription.	signal transducer and activator of transcription-3	OPRM1	1	ACTIVATION	False
13796	14085	18331586:6:STAT3:PTPN6	Conversely, interferons-beta and IL-6 act through [TF] to induce [TG] promoter II transcripts.	STAT-3	SHP-1	1	ACTIVATION	False
13797	14086	18407919:7:SOX2:LHX3	Moreover, we show that [TF] is capable of binding to and activating transcription of the [TG] proximal promoter in vitro.	SOX2	LHX3	1	ACTIVATION	False
13798	14087	18537819:4:STAT3:NPPA	Interestingly, both specific silencing of signal transducers and activators of transcription 3 ([TF]) expression by lentivirus-mediated RNA interference and antagonism of gp130 signaling lead to significant inhibition of isoproterenol-stimulated [TG] expression.	STAT3	ANF	1	ACTIVATION	False
13799	14088	18544087:10:STAT3:BCL2L1	[TF] directly bound and activated the transcription of [TG] gene promoter, resulting in the induction of the expression of bcl-xL in myeloma cells.	STAT3	bcl-xL	1	ACTIVATION	False
13800	14089	18571793:8:STAT3:SOCS3	Using small interfering RNA against [TF], as well as a STAT-3 dominant-negative construct, we demonstrate that STAT-3 activation is critical for OSM induction of [TG] expression.	STAT-3	SOCS-3	1	ACTIVATION	False
13801	14090	18644974:0:STAT3:HIF1A	[TF] is required for [TG] RNA expression in both tumor cells and tumor-associated myeloid cells.	Signal transducer and activator of transcription 3	hypoxia-inducible factor-1alpha	1	ACTIVATION	False
13802	14091	18644974:9:STAT3:HIF1A	Consistent with a role of [TF] in regulating [TG] RNA transcription, elevated Stat3 activity increases HIF-1alpha promoter activity, and Stat3 protein binds to the HIF-1alpha promoter in both transformed cells and in growing tumors.	Stat3	HIF-1alpha	0	UNDEFINED	True
13803	14092	18677406:4:SOX9:COL2A1	We found that p54nrb physically interacted with [TF] and enhanced Sox9-dependent transcriptional activation of the [TG] promoter.	Sox9	Col2a1	1	ACTIVATION	False
13804	14093	18719084:9:SOX2:PAX6	The expression of [TG], which plays an important role in amacrine cell differentiation, was observed in the [TF]-expressing cells, and Sox2 activated the Pax6 promoter to drive luciferase expression in Y79 cells.	Sox2	Pax6	1	ACTIVATION	False
13806	14095	18769160:8:STAT3:SP1	Transient transfections of CDK4, Rad51, E2F-DP1, p21 and [TF] increased mRNA expression from the endogenous [TG] gene in HeLa cells whereas overexpression of NF kappaB, and p53 decreased Sp1 mRNA levels.	Stat3	Sp1	1	ACTIVATION	False
13807	14096	18818315:7:STAT3:APLN	A chromatin immunoprecipitation assay showed that IL-6 induced binding of phospho-[TF] to a putative Stat3 site in the [TG] promoter; mutation of this site abrogated the LPS-induced elevation in apelin promoter activity.	Stat3	apelin	1	ACTIVATION	False
13808	14097	18831784:5:SOX2:CTBP2	This network suggests that Oct4, [TF] and Klf4 indirectly repress lineage specific differentiation genes by activating transcriptional repressors of [TG], Rest and Mtf2.	Sox2	Ctbp2	1	ACTIVATION	False
13809	14098	18923447:0:SOX9:NES	[TF] and SOX10 but not BRN2 are required for [TG] expression in human melanoma cells.	SOX9	nestin	1	ACTIVATION	False
13810	14099	18923447:10:SOX9:NES	Downregulation of [TF] and of SOX10 markedly decreased [TG] levels in melanoma cells in a cooperative manner.	SOX9	nestin	1	ACTIVATION	False
13811	14100	18923447:11:SOX9:NES	Thus, [TF] and SOX10 but not BRN2 seem to be required for [TG] expression in human melanoma.	SOX9	nestin	1	ACTIVATION	False
13812	14101	18950534:12:SOX9:SOX10	Furthermore, we show that beta-catenin, Notch signalling and [TF] can induce ectopic [TG] expression in early embryos, consistent with regulatory roles predicted from our transgenic and computational results.	Sox9	sox10	1	ACTIVATION	False
13813	14102	19082717:0:STAT3:MMP2	[TF] is involved in angiotensin II-induced expression of [TG] in gastric cancer cells.	Stat3	MMP2	1	ACTIVATION	False
13815	14104	19147497:8:SOX2:NES	[TF] and SF1 may mediate basal [TG] expression in undifferentiated P19EC cells, whereas Sox2, Brn1, and Brn2 bind to the enhancer in P19 neural progenitor cells.	Sox2	nestin	1	ACTIVATION	False
13816	14105	19168719:13:SP1:KLF4	Taken together, the results suggest a novel role for [TF] in increasing the expression of [TG] in phenotypically modulated SMCs.	Sp1	KLF4	1	ACTIVATION	False
13817	14106	19168719:9:SP1:KLF4	In addition, overexpression of [TF] alone was sufficient to increase the activity of the [TG] promoter.	Sp1	KLF4	1	ACTIVATION	False
13818	14107	19185846:3:STAT3:IL23A	[TF] induces expression of [TG], which is mainly produced by tumor-associated macrophages, via direct transcriptional activation of the IL-23/p19 gene.	Stat3	IL-23	1	ACTIVATION	False
13819	14108	19211811:7:SOX9:CBLN4	In transgenic XY mouse embryos with reduced [TF] expression, [TG] expression also was reduced, whereas overexpression of Sox9 in XX mice caused an upregulation of Cbln4 expression.	Sox9	Cbln4	1	ACTIVATION	False
13820	14109	19211811:9:SOX9:CBLN4	Our findings suggest that both SRY and [TF] contribute to the male-specific upregulation of [TG] in the developing testis, and they identified a direct in vivo target gene of SRY.	SOX9	Cbln4	1	ACTIVATION	False
13821	14110	19265112:8:STAT3:CCL11	Overexpression of DN [TF] (STAT3beta) abolishes IL-17A-induced [TG] promoter activity.	STAT3	CCL11	1	ACTIVATION	False
13823	14112	19322650:0:SOX9:HES1	[TF] mediates the retinoic acid-induced [TG] gene expression in human breast cancer cells.	SOX9	HES-1	1	ACTIVATION	False
13824	14113	19322650:6:SOX9:HES1	In reporter assays, transfection of a [TF] expression plasmid increased the activity of the [TG] enhancer.	SOX9	HES-1	1	ACTIVATION	False
13825	14114	19329556:6:STAT3:CDKN1A	Using chromatin immunoprecipitation assays and expression of a dominant-negative [TF] mutant, we show that activation of Stat3 and its binding to the [TG] promoter are required for DEP-induced expression of p21, suggesting that Stat3 plays an essential role in the induction of p21 by DEP.	Stat3	p21	1	ACTIVATION	False
13826	14115	19332118:6:STAT3:SOCS3	The interaction between [TF] and C/EBPalpha was increased by oleic acid; these proteins subsequently enhanced the promoter activity of [TG] in the presence of oleic acid.	STAT3	SOCS3	1	ACTIVATION	False
13827	14116	19339266:7:STAT3:DNMT1	Taken together, LMP2A induces the phosphorylation of [TF], which activates [TG] transcription and causes PTEN expression loss through CpG island methylation of the PTEN promoter in EBV-associated GC.	STAT3	DNMT1	1	ACTIVATION	False
13828	14117	19372587:0:STAT3:CDKN1A	ErbB2-mediated Src and [TF] activation leads to transcriptional up-regulation of [TG] and chemoresistance in breast cancer cells.	signal transducer and activator of transcription 3	p21Cip1	1	ACTIVATION	False
13829	14118	19372587:5:STAT3:CDKN1A	Src activation further activated [TF] (STAT3) that recognizes a SIE binding site on the p21([TG] promoter required for ErbB2-mediated p21(Cip1) transcriptional up-regulation.	signal transducer and activator of transcription 3	Cip1)	1	ACTIVATION	False
13830	14119	19372587:7:STAT3:CDKN1A	Our data suggest that ErbB2 overexpression can activate [TF] through Src leading to transcriptional up-regulation of p21([TG] that confers Taxol resistance of breast cancer cells.	STAT3	Cip1)	1	ACTIVATION	False
13831	14120	19404962:10:STAT3:CCL2	STAT-1 and [TF] modulated the expression of c-Fos and directly transactivated the [TG] promoter.	STAT-3	CCL2	1	ACTIVATION	False
13832	14121	19404962:13:STAT3:CCL2	Reporter assay revealed synergistic attenuation of [TG] promoter activity by shRNA targeting of STAT-1, [TF], and c-Fos.	STAT-3	CCL2	1	ACTIVATION	False
13833	14122	19404962:9:STAT3:CCL2	In U2OS cells, STAT-1 and [TF] were involved in OSM-stimulated [TG] expression, and both the phosphatidylinositol 3-kinase/Akt and MEK/ERK pathways were implicated in the activation of these STATs.	STAT-3	CCL2	1	ACTIVATION	False
13834	14123	19416188:4:SOX9:RXFP2	The transcription factor [TF], a known male sex determination factor, upregulated the activity of the [TG] promoter.	SOX9	RXFP2	1	ACTIVATION	False
13835	14124	19476490:7:SOX9:TFAP2E	The inhibition of [TF] expression by small interfering RNA resulted in decreased [TG] expression.	Sox9	AP-2epsilon	1	ACTIVATION	False
13836	14125	19481139:10:SOX3:CYP19A1	The results, taken together, suggest that [TF] activates [TG] transcription by its direct binding to the binding site of the Cyp19 promoter region.	Sox3	Cyp19	1	ACTIVATION	False
13837	14126	19481139:8:SOX3:CYP19A1	[TF] lacking the HMG box had no ability to promote [TG] transcription.	Sox3	Cyp19	1	ACTIVATION	False
13838	14127	19522013:9:SOX2:NANOG	We also showed that specific members of the SP/KLF and PBX family are functionally redundant at the [TG] promoter and that KLF4 and PBX1 cooperated with OCT4 and [TF], and transactivated synergistically the NANOG promoter activity.	SOX2	NANOG	1	ACTIVATION	False
13839	14128	19578748:5:STAT3:MUC1	[TF] knockdown downregulated [TG] expression whereas constitutive STAT3 expression increased MUC1 expression at mRNA and protein levels.	STAT3	MUC1	1	ACTIVATION	False
13840	14129	19751774:0:STAT3:IL6	Visfatin through [TF] activation enhances [TG] expression that promotes endothelial angiogenesis.	STAT3	IL-6	1	ACTIVATION	False
13841	14130	19754877:0:STAT3:HSPA4	Hsp105beta upregulates [TG] gene expression through [TF].	signal transducer and activator of transcription-3	hsp70	1	ACTIVATION	False
13842	14131	19754877:8:STAT3:HSPA4	Downregulation of [TF] expression resulted in reduction of the activation of the [TG] promoter by Hsp105beta.	STAT3	hsp70	1	ACTIVATION	False
13843	14132	19801684:5:SP1:HIF1A	The up-regulation of [TG] transcription was abolished by mithramycin A, an [TF] inhibitor, but luciferase reporter and chromatin immunoprecipitation assays indicated that Sp1 was necessary but not sufficient for HIF-1alpha mRNA overexpression in A11 cells.	Sp1	HIF-1alpha	1	ACTIVATION	False
13845	14134	19882665:4:SOX2:EGFR	Knockdown of [TF] by RNA interference downregulates [TG] expression and attenuates colony formation of NPCs, whereas overexpression of Sox2 elevates Egfr expression and promotes NPC self-renewal.	Sox2	Egfr	1	ACTIVATION	False
13846	14135	19911006:5:STAT3:AKT1	We show that AATF is induced by ER stress through the PERK-eIF2alpha pathway and transcriptionally activates the v-akt murine thymoma viral oncogene homolog 1 (AKT1) gene through [TF] (Stat3), which sustains [TG] activation and promotes cell survival.	signal transducer and activator of transcription 3	Akt1	1	ACTIVATION	True
13847	14136	20011520:7:SOX2:AGR2	In vitro, [TF] activated promoter-luciferase reporter constructs for differentiation markers characteristic of Clara, ciliated, and goblet cells, Scgb1a1, FoxJ1, and [TG], respectively.	Sox2	Agr2	1	ACTIVATION	False
13849	14138	20049565:7:SOX4:NCAM1	Silencing of [TF] by shRNA transfection down-regulated [TG] expression and induced apoptosis to CD56(+) human myeloma cell line, AMO1.	SOX4	CD56	1	ACTIVATION	False
13850	14139	20064451:2:STAT3:PRDM1	We identified an IL-21 response element downstream of [TG] that binds the transcription factors [TF] and IRF4, which are required for optimal Prdm1 expression.	STAT3	Prdm1	1	ACTIVATION	False
13851	14140	20145033:8:STAT3:PTGS2	Increased expression of EGFR/EGFRvIII and activated [TF] leads to the synergistic activation of the [TG] promoter.	STAT3	COX-2	1	ACTIVATION	False
13852	14141	20169197:7:STAT3:CCL11	Disruption of [TF] activity with SH2 domain binding inhibitory peptide results in significant reduction of IL-9 mediated [TG] promoter activity.	STAT3	CCL11	1	ACTIVATION	False
13854	14143	20232316:11:STAT3:VEGFA	In summary, this report demonstrates, for the first time, that the [TG] expression in breast cancer cells is mediated by HIF-1 and [TF] in a miR-20b-dependent manner.	STAT3	VEGF	1	ACTIVATION	False
13855	14144	20384793:6:SOX2:CDX2	In contrast, using the Tet-on gene inducible system, [TF] over-expression in human ESCs induced trophectoderm differentiation accompanied by increased [TG] expression.	SOX2	CDX2	1	ACTIVATION	False
13856	14145	20460434:5:STAT3:GFAP	In cultured neurospheres, meteorin activates [TF], and in turn increases the transcriptional activity of [TG] by enhancing the binding of STAT3 to the promoter.	STAT3	GFAP	1	ACTIVATION	False
13857	14146	20530484:7:SOX9:BEST1	[TG] promoter activity was increased by [TF] overexpression and decreased by siRNA-mediated SOX9 knockdown.	SOX9	BEST1	1	ACTIVATION	False
13858	14147	20530484:8:SOX9:BEST1	Importantly, [TF] physically interacted with MITF and OTX2 and orchestrated synergistic activation of the [TG] promoter with the paired SOX site playing essential roles.	SOX9	BEST1	1	ACTIVATION	False
13859	14148	20603107:6:STAT3:DDAH1	Transfection of [TF] increased [TG] promoter activity, and ALA amplified it.	STAT3	DDAH II	1	ACTIVATION	False
13860	14149	20668334:6:SOX5:SPAG6	S-[TF] and FOXJ1 functioned cooperatively in stimulating [TG] promoter activity.	SOX5	SPAG6	1	ACTIVATION	False
13861	14150	20709526:0:STAT3:VEGFA	[TF] activation induced by Epstein-Barr virus latent membrane protein1 causes [TG] expression and cellular invasiveness via JAK3 And ERK signaling.	STAT3	vascular endothelial growth factor	1	ACTIVATION	False
13862	14151	20930550:5:STAT3:IL6	Activated [TF] directly bound to [TG] promoter and increased IL6 mRNA and protein secretion.	STAT3	IL6	1	ACTIVATION	False
13863	14152	20940257:6:SOX9:COL2A1	Znf219 markedly enhanced the transcriptional activity of [TF] on the [TG] gene promoter.	Sox9	Col2a1	1	ACTIVATION	True
13864	14153	20978825:4:STAT3:CRP	Phosphorylated [TF] then activates [TG] gene transcription.	STAT3	CRP	1	ACTIVATION	False
13865	14154	21187121:11:SOX9:AMH	[TF] up-regulates transcriptional activity through the am[TG] promoter region.	SOX9	AMH	1	ACTIVATION	False
13866	14155	21224490:0:STAT3:HP	Hypoxia-inducible factor-1alpha enhances [TG] gene expression by improving binding of [TF] to the promoter.	STAT3	haptoglobin	1	ACTIVATION	False
13867	14156	21262861:0:SOX5:ACAN	SHOX interacts with the chondrogenic transcription factors [TF] and SOX6 to activate the [TG] enhancer.	SOX5	aggrecan	1	ACTIVATION	False
13868	14157	21296860:3:STAT3:BATF	When treated with leukemia inhibitory factor, mouse M1 myeloid leukemia cells commit to a macrophage differentiation program that is dependent on [TF] and involves the induction of [TG] gene transcription via the binding of Stat3 to the Batf promoter.	Stat3	Batf	1	ACTIVATION	False
13869	14158	21385272:12:STAT3:IL10	[TF] silencing reduced [TG] expression significantly, while SOCS3 silencing induced, also significantly, the opposite effect.	STAT3	IL-10	1	ACTIVATION	False
13870	14159	21412441:6:SRY:SOX9	[TF] associates with transcriptionally active chromatin in NT2/D1 cells and over-expression increases endogenous [TG] expression.	SRY	SOX9	1	ACTIVATION	False
13871	14160	21508350:7:SOX9:NTF3	In a luciferase reporter assay system, both SRY and [TF] stimulated the [TG] promoter in vitro through an interaction with this SRY-binding motif.	SOX9	Ntf3	1	ACTIVATION	False
13872	14161	21531766:7:SOX2:ABCC6	Consequently, ID4-mediated [TF] induction enhanced ABCC3 and [TG] expression through direct transcriptional regulation, indicating that ID4 regulates the chemoresistance of iGSCs by promoting SOX2-mediated induction of ABC transporters.	SOX2	ABCC6	1	ACTIVATION	False
13873	14162	21611796:6:STAT3:NOS3	Overexpression of active [TF] significantly reversed the inhibitory effect of the 27-nt miRNA on [TG] expression and EC proliferation.	STAT3	eNOS	1	ACTIVATION	False
13874	14163	21677772:3:STAT3:ABCB1	Blockade of activation of [TF] by STAT3 decoy oligodeoxynucleotide (ODN) promoted the accumulation and increased their sensitivity to adriamycin by down-regulating transcription of [TG] and expression of P-gp, which were further confirmed by using STAT3-specific inhibitor JSI-124.	STAT3	mdr1	1	ACTIVATION	False
13875	14164	21677772:4:STAT3:ABCB1	Inhibition of [TF] could also decrease [TG] promoter mediated luciferase expression by using mdr1 promoter luciferase reporter construct.	STAT3	mdr1	1	ACTIVATION	False
13876	14165	21677772:5:STAT3:ABCB1	Otherwise, activation of [TF] by STAT3C improved [TG] transcription and P-gp expression.	STAT3	mdr1	1	ACTIVATION	False
13877	14166	21733558:5:STAT3:VEGFA	In addition, [TF]-short interfering RNA significantly reduced messenger RNA levels of [TG] in chronic lymphocytic leukemia cells, suggesting that signal transducer and activator of transcription 3 induces vascular endothelial growth factor expression in chronic lymphocytic leukemia.	signal transducer and activator of transcription 3	vascular endothelial growth factor	1	ACTIVATION	False
13878	14167	21757499:4:SOX9:CYP26B1	In the mouse gonadal somatic cell line TM3, transfection of constructs expressing [TF] and SF1 activated [TG] expression, independently of the positive regulator RA.	SOX9	Cyp26b1	1	ACTIVATION	False
13879	14168	21757499:5:SOX9:CYP26B1	In embryonic gonads deficient in [TF] or SF1, [TG] expression was decreased relative to wild-type (WT) controls, as measured by quantitative RT-PCR (qRT-PCR).	SOX9	Cyp26b1	1	ACTIVATION	False
13880	14169	21757499:6:SOX9:CYP26B1	Furthermore, qRT-PCR showed that [TG] up-regulation by [TF]/SF1 was attenuated by the ovarian transcription factor Forkhead box L2 (FOXL2) in TM3 cells, whereas in Foxl2-null mice, Cyp26b1 expression in XX gonads was increased 20-fold relative to WT controls.	SOX9	Cyp26b1	1	ACTIVATION	False
13881	14170	21757499:7:SOX9:CYP26B1	These data support the hypothesis that [TF] and SF1 ensure the male fate of germ cells by up-regulating [TG] and that FOXL2 acts to antagonize Cyp26b1 expression in ovaries.	SOX9	Cyp26b1	1	ACTIVATION	False
13882	14171	21796151:0:STAT3:KRT17	IL-17A upregulates [TG] expression in keratinocytes through STAT1- and [TF]-dependent mechanisms.	STAT3	keratin 17	1	ACTIVATION	False
13883	14172	21796151:10:STAT3:KRT17	We found that both the signal transducer and activator of transcription (STAT) 1 and [TF] pathways were involved in the upregulation of [TG] expression induced by IL-17A, and that such regulation could be partially suppressed by STAT1 or STAT3 small interfering RNA and inhibitor.	STAT3	K17	1	ACTIVATION	False
13884	14173	21796151:11:STAT3:KRT17	Our data suggest that IL-17A can upregulate [TG] expression in keratinocytes in a dose-dependent manner through STAT1- and [TF]-dependent mechanisms.	STAT3	K17	1	ACTIVATION	False
13885	14174	21829703:9:SOX9:PDX1	Our findings show [TF] plays an important role in endocrine development by maintaining Ngn3 and [TG] expression.	Sox9	Pdx1	1	ACTIVATION	False
13886	14175	21947321:0:SOX2:PROM1	Hypoxia induces [TG] expression in human lung cancer cells by up-regulation             of OCT3/4 and [TF].	SOX2	CD133	1	ACTIVATION	False
13887	14176	21953450:6:STAT3:CHI3L1	Knockdown of NFI-X3 and [TF] significantly reduced [TG] expression in astrocytes, whereas overexpression of NFI-X3 dramatically enhanced YKL-40 expression in glioma cells.	STAT3	YKL-40	1	ACTIVATION	False
13888	14177	21953450:7:STAT3:CHI3L1	Activation of [TF] by oncostatin M induced [TG] expression in astrocytes, whereas expression of a dominant-negative STAT3 had a suppressive effect.	STAT3	YKL-40	1	ACTIVATION	False
13889	14178	21953450:8:STAT3:CHI3L1	Mechanistically, NFI-X3 and [TF] form a complex that binds to weak regulatory elements in the [TG] promoter and activates transcription.	STAT3	YKL-40	1	ACTIVATION	False
13890	14179	21983268:10:SOX9:INS	In contrast, over-expression of [TF] significantly increased the number of islet cells proliferating, NGN3, NKX6.1, PAX6 and [TG] mRNA levels, the phospho-Akt/GSK3 cascade and the number of insulin(+) cells.	SOX9	INS	1	ACTIVATION	False
13891	14180	21983268:8:SOX9:INS	siRNA knockdown of [TF] significantly decreased islet-epithelial cell proliferation, NGN3, NKX6.1, PAX6 and [TG] mRNA levels and the number of NGN3(+) and insulin(+) cells (p<0.05) while increasing GCG mRNA and glucagon(+) cells (p<0.05).	SOX9	INS	1	ACTIVATION	False
13892	14181	21987575:4:SOX4:SOX2	We also show that, in glioma-initiating cells, Oct4 is associated with [TF] and that Oct4-Sox4 complexes cooperatively activate the enhancer activity of the [TG] gene.	Sox4	SOX2	1	ACTIVATION	False
13894	14183	22055460:4:STAT3:PTEN	We demonstrate that [TF] promotes the transcription of [TG] by directly binding on the PTEN promoter.	STAT3	PTEN	1	ACTIVATION	False
13895	14184	22069317:11:STAT3:HSPA4	Together, these data suggest that Elp2 and [TF] mediate, at least in part, the stimulation of [TG] expression by 4PBA.	STAT-3	Hsp70	1	ACTIVATION	False
13896	14185	22265740:13:SOX2:NTRK3	In addition, we found that [TF] drives expression of the [TG] gene by activating a luciferase reporter construct containing the TRKC regulatory region and the SOX binding motif.	SOX2	TRKC	1	ACTIVATION	False
13898	14187	22406269:4:STAT3:NT5E	[TF] supported whereas Gfi-1 repressed CD39 and [TG] expression by binding to their promoters.	Stat3	CD73	1	ACTIVATION	False
13899	14188	22542624:4:SOX2:ASXL1	Knockdown of [TF] in SOX2-rich NT2 cells resulted in the reduction of [TG] expression, whereas SOX2 overexpression in SOX2-deficient H1299 cells increased ASXL1 expression.	SOX2	ASXL1	1	ACTIVATION	False
13900	14189	22542624:5:SOX2:ASXL1	Using a cloned [TG]-luciferase reporter, we demonstrated that [TF] directly transactivates the ASXL1 promoter.	SOX2	ASXL1	1	ACTIVATION	False
13901	14190	22584896:12:STAT3:AKAP12	Phosphorylated [TF] increasingly binds to the chromatin and [TG] promoter and is necessary for maintaining the elevated levels of AKAP12 following HDAC7 knockdown.	STAT3	AKAP12	1	ACTIVATION	False
13902	14191	22674257:5:STAT3:NOS2	Endogenous [TF] occupies the endogenous [TG] promoter and stimulates iNOS transcription in EGFRvIII-expressing astrocytes.	STAT3	iNOS	1	ACTIVATION	False
13903	14192	22693070:0:STAT3:STAT1	[TG] gene expression is enhanced by nuclear EGFR and HER2 via cooperation with [TF].	STAT3	STAT1	1	ACTIVATION	False
13904	14193	22693070:5:STAT3:STAT1	The oncogenic transcription factor [TF] binds to the [TG] promoter and synergizes with nuclear EGFR to significantly enhance STAT1 gene expression.	STAT3	STAT1	1	ACTIVATION	False
13905	14194	22693070:9:STAT3:STAT1	Furthermore, we found that [TG] expression is transcriptionally upregulated by HER2 and heregulin stimulation in breast cancer cells, and the level is further augmented by activated [TF].	STAT3	STAT1	1	ACTIVATION	False
13906	14195	22855803:9:SOX2:CDKN1B	Finally, chromatin immunoprecipitation with [TF] antibodies and luciferase reporter assays with the [TG] promoter support that Sox2 directly activates p27(Kip1) transcription in postmitotic IPCs.	Sox2	p27(Kip1)	1	ACTIVATION	False
13907	14196	22937156:7:SOX2:PROM1	Furthermore, we show that elevating [TF] leads to a dramatic induction of [TG] expression in DAOY cells, yet inhibits the ability of both CD133(+) and CD133(-) cells to form neurospheres.	SOX2	CD133	1	ACTIVATION	False
13908	14197	22962574:0:STAT3:S100A9	Interleukin-6 induces [TG] expression in colonic epithelial cells through [TF] activation in experimental ulcerative colitis.	STAT3	S100A9	1	ACTIVATION	False
13909	14198	23024284:5:STAT3:CXCL2	Induction of [TG] was regulated directly by G-CSF-activated [TF] via interaction at a STAT consensus element in the Cxcl2 promoter.	STAT3	Cxcl2	1	ACTIVATION	False
13910	14199	23104276:7:STAT3:VEGFA	The enforced overexpression of SOCS3 abolished the hypoxia-induced [TF] activation and the STAT3-mediated transcriptional upregulation of the [TG] gene.	STAT3	VEGF	1	ACTIVATION	False
13911	14200	23178160:0:STAT3:CDKN1A	Progestin drives breast cancer growth by inducing p21([TG]) expression through the assembly of a transcriptional complex among [TF], progesterone receptor and ErbB-2.	Stat3	CIP1	1	ACTIVATION	False
13912	14201	23178160:6:STAT3:CDKN1A	Interestingly, we determined that progestin drives p21([TG]) transcriptional activation via a novel nonclassical transcriptional mechanism in which progesterone receptor is recruited along with [TF] and ErbB-2 to a Stat3 binding site at p21(CIP1) promoter.	Stat3	CIP1	1	ACTIVATION	False
13913	14202	23178160:7:STAT3:CDKN1A	Our findings revealed that ErbB-2 functions as a coactivator of [TF] in progestin induction of p21([TG]) transcriptional activation.	Stat3	CIP1	1	ACTIVATION	False
13914	14203	23284999:10:STAT3:DDAH1	Vaspin-induced increase in [TG] gene expression was through [TF]-mediated stimulation of DDAH II promoter activity.	STAT3	DDAH II	1	ACTIVATION	False
13915	14204	23318420:7:STAT3:LIN28A	[TF] promotes the transcription of [TG] by directly binding to the Lin-28 promoter, resulting in the repression of let-7 expression and concomitant upregulation of the let-7 target, high-mobility group A protein 2 (HMGA2).	Stat3	Lin-28	1	ACTIVATION	False
13916	14205	23361365:6:STAT3:CRP	Knockdown of [TF] (STAT3) and CCAAT box/Enhancer-Binding Protein  (C/EBP) by small interfering RNAs (siRNAs) significantly decreased IL-6-induced [TG] promoter activity.	Signal Transducer and Activator of Transcription 3	CRP	1	ACTIVATION	False
13917	14206	23391827:4:STAT3:SAA1	The present study defines a novel [TF] non-consensus TFBS at nt -75/-66 downstream of the NF-B RE in the [TG] promoter region that is required for NF-B p65 and STAT3 to activate SAA1 transcription in human HepG2 liver cells.	STAT3	SAA1	1	ACTIVATION	False
13918	14207	23439558:4:STAT3:SOCS3	We found that although the Gfap promoter was demethylated, [TF] failed to bind to its cognate element to induce Gfap transcription, whereas it induced transcription of a different target gene, [TG].	STAT3	Socs3	1	ACTIVATION	False
13919	14208	23583378:6:STAT3:NME1	Moreover, [TF] directly bound to the STAT3 binding site on the [TG] promoter and activated its expression.	STAT3	nm23-H1	1	ACTIVATION	False
13920	14209	23590833:4:STAT3:NOS2	[TF] directly binds the promoter of the [TG] gene and thereby stimulates its expression.	STAT3	iNOS	1	ACTIVATION	False
13922	14211	23727861:4:SOX9:H19	We show that ZBTB7A physically interacts with [TF] and functionally antagonizes its transcriptional activity on key target genes such as MIA, which is involved in tumor cell invasion, and [TG], a long noncoding RNA precursor for an RB-targeting microRNA.	SOX9	H19	1	ACTIVATION	False
13923	14212	23860260:0:SOX5:MATN1	Hmgb1 can facilitate activation of the [TG] gene promoter by Sox9 and [TF]/Sox6 in early steps of chondrogenesis.	L-Sox5	matrilin-1	1	ACTIVATION	False
13924	14213	23860260:0:SOX6:MATN1	Hmgb1 can facilitate activation of the [TG] gene promoter by Sox9 and L-Sox5/[TF] in early steps of chondrogenesis.	Sox6	matrilin-1	1	ACTIVATION	False
13925	14214	23860260:0:SOX9:MATN1	Hmgb1 can facilitate activation of the [TG] gene promoter by [TF] and L-Sox5/Sox6 in early steps of chondrogenesis.	Sox9	matrilin-1	1	ACTIVATION	False
13926	14215	23884650:2:SOX2:LIN28A	Using human embryonic stem cell-derived NPCs to model neurogenesis, we found that [TF] is required to maintain optimal levels of [TG], a well-characterized suppressor of let-7 microRNA biogenesis.	SOX2	LIN28	1	ACTIVATION	False
13927	14216	23923047:6:STAT3:ICOS	Gene reporter and ChIP experiments unambiguously demonstrated that upon IL-6 stimulation, [TF] induces the transcription of the [TG] gene through direct recruitment to the proximal promoter region indicating that STAT3 acts in part through the direct activation of the ICOS gene.	STAT3	ICOS	1	ACTIVATION	False
13928	14217	24036113:11:STAT3:TIMP1	Together, our results suggest a two-step mechanism, whereby LfcinB induces [TG] through an IL-11-dependent pathway involving transcription factor AP-1 and [TF].	STAT3	TIMP-1	1	ACTIVATION	False
13929	14218	24097101:5:STAT3:KDM6B	While knockdown of individual Stat had little effect on the expression of tested genes, knockdown of both Stat1 and [TF] inhibited the expression of [TG] and inflammatory genes.	Stat3	Jmjd3	1	ACTIVATION	False
13930	14219	24158981:7:STAT3:HAVCR1	Furthermore, [TF] bound to the [TG] promoter after ischemic and oxidant stress, and pharmacological or genetic induction of STAT3 in HPTECs increased KIM-1 mRNA and protein levels.	STAT3	KIM-1	1	ACTIVATION	False
13931	14220	24158981:8:STAT3:HAVCR1	Conversely, inhibition of [TF] using siRNAs or dominant negative mutants reduced [TG] expression in a kidney cancer cell line (769-P) that expresses high basal levels of KIM-1.	STAT3	KIM-1	1	ACTIVATION	False
13932	14221	24191246:7:STAT3:PTPN13	Using luciferase reporter and ChIP assays, we show that [TF] binds to the promoter region of [TG] and promotes its activity through recruiting HDAC5.	Stat3	PTPN13	1	ACTIVATION	False
13933	14222	24376686:9:STAT3:S100A11	Additionally, [TF] inhibitors can block [TG] expression and S100A11 promoter activity in HCC cells with stable overexpression of EGFRvIII.	STAT3	S100A11	1	ACTIVATION	False
13934	14223	24429361:5:STAT3:CCL2	We demonstrate that CEBP, PU.1, and [TF] interacted with each other physically to cooperatively bind to the promoter and activate [TG] expression.	STAT3	CCL2	1	ACTIVATION	False
13935	14224	25062971:3:STAT3:RC3H1	Luciferase reporter assays conducted using eight transcription factor plasmids (STAT1, [TF], STAT5, GATA2, c-Rel, IKZF1, IKZF2, and IKZF3) demonstrated that STAT1, STAT3, GATA2, and c-Rel increased [TG] promoter activity, whereas IKZF2 decreased activity.	STAT3	Rc3h1	1	ACTIVATION	False
13936	14225	25088258:6:STAT3:HSPA4	Luciferase reporter gene assay and Western blotting showed that Nmi enhanced both the Hsp105-induced phosphorylation of [TF] and the Hsp105-induced activation of the [TG] promoter in a manner that is dependent on the Stat3-binding site, which results in an increase in Hsp70 protein levels.	Stat3	hsp70	1	ACTIVATION	False
13937	14226	8621622:8:STAT3:CRP	Taken together, these findings indicate that [TF] participates in the transcriptional activation of [TG] in response to IL-6.	STAT3	CRP	1	ACTIVATION	False
13938	14227	8668165:8:STAT3:LBP	Gel retardation and supershift assays confirmed that upon cytokine stimulation APRF/[TF] binds to its recognition site, leading to strong activation of the [TG] gene.	STAT-3	LBP	1	ACTIVATION	False
13939	14228	8964411:10:STAT3:A2M	Increased [TG] transcription posthepatectomy is achieved by increased levels of interleukin 6 and consecutive binding of APRF/[TF] to the alpha 2-macroglobulin promoter.	Stat3	alpha 2-macroglobulin	1	ACTIVATION	False
13940	14229	8964411:7:STAT3:A2M	Increased levels of [TG] messenger RNA correlated with enhanced binding of acute-phase response factor/[TF] (APRF/Stat3) towards the cognate DNA sequence in the alpha 2-macroglobulin promoter and dramatically increased interleukin-6 levels in the liver vein.	signal transducer and activator of transcription 3	alpha 2-macroglobulin	1	ACTIVATION	False
13941	14230	9163525:0:STAT3:CEBPD	[TG] gene expression is mediated by APRF/[TF].	STAT3	CCAAT/enhancer-binding protein delta	1	ACTIVATION	False
13942	14231	9171829:7:SOX9:COL2A1	Furthermore, ectopic expression of [TF] trans-activates both a [TG]-driven reporter gene and the endogenous Col2a1 gene in transgenic mice.	Sox9	COL2A1	1	ACTIVATION	False
13943	14232	9264261:11:SOX9:COL2A1	Together with our previous results showing that the chondrocyte-specific enhancer element of the [TG] gene is a direct target for [TF], these results suggest that Sox9 plays a major role in expression of Col2a1.	Sox9	Col2a1	1	ACTIVATION	False
13944	14233	9528783:7:STAT3:CEBPD	Thus, [TF] and Sp1 function cooperatively to activate the [TG] promoter.	Stat3	C/EBPdelta	1	ACTIVATION	False
13945	14234	9694869:6:STAT3:CDKN1A	In addition, and in support of a mediating role of STATs in the activation of the [TG] promoter, overexpression of [TF] potentiated the cytokine effect on the p21 promoter; whereas a dominant negative Stat3, or a mutation of the STAT response element on the promoter, significantly reduced the cytokine effect.	Stat3	p21	1	ACTIVATION	False
13946	14235	17360815:7:SOX9:FURIN	Transient transfection of [TF] in nonchondrogenic cells resulted in a marked increase in [TG] mRNA and in the transactivation of the furin P1A promoter.	Sox9	furin	1	ACTIVATION	False
13947	14236	22120521:6:STAT3:NOX1	Cumulatively, these results suggest that TLR2 signaling enhances [TG] expression through the JAK1/3-[TF] pathway, and that RGS2, through its regulation by the PKC-/PLD2 pathway, represses STAT3's transcriptional activation of Nox1.	STAT3	Nox1	1	ACTIVATION	False
13948	14237	12545153:7:STAT3:VEGFA	A putative [TF]-responsive element on the [TG] promoter was identified using a protein-DNA binding assay and confirmed using a promoter mutagenesis assay.	Stat3	VEGF	0	UNDEFINED	True
13949	14238	12732652:4:SOX9:AMH	Expression of the [TG] gene during sex differentiation requires the interaction of several transcription factors, including SF1, [TF], GATA4, WT1, and DAX1.	SOX9	Amh	1	ACTIVATION	False
13950	14239	12847226:9:STAT3:CIITA	However, TSH repression of the IFN-gamma-induced [TG] expression was not observed in FRTL-5 thyroid cells, which stably expresses the dominant negative forms of [TF], STAT3-Y705F, and STAT3-S727A.	STAT3	CIITA	1	ACTIVATION	True
13951	14240	15694126:5:SOX9:COL11A2	The K398A mutation, which was introduced in a potential ubiquitin-binding site, increases the stability of [TF] protein and its transcriptional activity of Col2a1, [TG], and AMH promoter/enhancer constructs without affecting the subcellular localization and the DNA binding efficiency of Sox9.	Sox9	Col11a2	1	ACTIVATION	False
13952	14241	16077994:1:SOX2:FGF4	[TF] and POU5F1 (OCT3 or OCT4) transcription factors are implicated in [TG] expression in embryonic stem (ES) cells.	SOX2	FGF4	1	ACTIVATION	False
13953	14242	18209077:7:STAT3:IL21	Analysis of molecular mechanisms underlying [TG] induction reveals that IL-21 activates [TF] and enhances its recruitment to IL-21 gene promoter.	Stat3	IL-21	1	ACTIVATION	False
13955	14244	18403020:0:STAT3:IL10	Role of [TF] in glucocorticoid-induced expression of the human [TG] gene.	STAT3	IL-10	1	ACTIVATION	False
13956	14245	19124156:9:STAT3:IL10	These data demonstrate that IFNgamma down-regulates expression of the [TG] gene by a novel mechanism that involves displacement of transactiving [TF] by IFNgamma-induced Stat1.	Stat3	IL-10	1	ACTIVATION	True
13957	14246	19481139:0:SOX3:CYP19A1	[TF]: a transcription factor for [TG] expression in the frog Rana rugosa.	Sox3	Cyp19	1	ACTIVATION	False
13958	14247	21041726:6:STAT3:IL10	IL-27 leads directly to transcription of [TG] through the activation of two required transcription factors, STAT1 and [TF], which are recruited to the IL-10 promoter.	STAT3	IL-10	1	ACTIVATION	False
13960	14249	22665476:6:STAT3:IL17A	Loss of DNA methylation tended to occur at [TF] consensus elements, and we show that methylation of one of these elements in the [TG]a promoter directly inhibits STAT3 binding and transcriptional activity.	STAT3	il17	1	ACTIVATION	False
13961	14250	22855803:7:SOX2:CDKN1B	Interestingly, cell cycle control of IPCs by [TF]-mediated expression of [TG] gradually declined with age.	Sox2	p27(Kip1)	1	ACTIVATION	False
13962	14251	24525231:3:SOX2:HHAT	PKC-mediated [TF] phosphorylation is required for [TG] promoter occupancy, HHAT expression, and maintenance of a stem-like phenotype.	SOX2	HHAT	1	ACTIVATION	False
13963	14252	22547066:5:SOX9:MIR140	Recent findings suggest [TF] promotes [TG] expression, although the detailed mechanisms are not fully understood.	Sox9	miR-140	1	ACTIVATION	False
13964	14253	23548270:6:SOX9:ADAM17	miR-145 expression repressed TICs in HNC in a manner associated with [TF] interaction with the [TG] promoter, thereby activating ADAM17 expression.	SOX9	ADAM17	0	UNDEFINED	True
13965	14254	14688368:4:STAT3:MMP1	Overexpression of [TF] DN completely inhibited IL-10-induced suppressor of cytokine signaling 3, [TG], TNF receptor expression, and the recently identified IL-10-inducible genes, T cell protein tyrosine phosphatase and signaling lymphocyte activation molecule.	STAT3	tissue inhibitor of MMP-1	1	ACTIVATION	False
13967	14256	24607904:5:SOX5:FN1	We further demonstrated that knockdown of [TF] up-regulated epithelial phenotype cell biomarker (E-cadherin) and down-regulated mesenchymal phenotype cell biomarkers (N-cadherin, Vimentin, and [TG]), resulting in suppression of EMT.	Sox5	Fibronectin 1	1	ACTIVATION	False
13968	14257	10753864:6:SOX9:ACAN	[TF] enhancement of [TG] promoter activity was lost when we deleted a 4.5-kb fragment from the 3'-end of the 8-kb fragment corresponding to the region including the first intron.	SOX9	aggrecan	1	ACTIVATION	False
13969	14258	10880233:9:STAT3:SH2D1A	The results indicate that both [TF] and C/EBPbeta participate in mouse [TG] gene expression, whereas only STAT3 is involved in mouse CRP gene expression.	STAT3	SAP	1	ACTIVATION	False
13970	14259	11864780:8:STAT3:ECE1	Our data suggest that [TF] mediates hydrogen peroxide induction of [TG] expression.	STAT3	ECE-1	1	ACTIVATION	False
13971	14260	12438313:10:STAT3:CDKN1A	Together, these findings suggest that the phosphatidylinositol 3-kinase/Akt pathway inhibits the transcriptional activation of the p21([TG]) gene by [TF] proteins without altering the regulation of the myc promoter.	STAT3	waf1	1	ACTIVATION	False
13972	14261	15218058:10:STAT3:IL1RN	Together, these results demonstrate that endogenously produced IL-10 plays a significant role in LPS-induced s[TG] gene expression via the activation of [TF].	STAT3	IL-1Ra	1	ACTIVATION	False
13973	14262	16306356:7:STAT3:INS	These results suggest that SOCS3 represents a transcriptional inhibitor of prepro[TG] gene expression, which is induced by leptin through JAK-[TF]/5b signaling in pancreatic beta-cells.	STAT3	insulin	1	ACTIVATION	False
13974	14264	16718380:8:STAT3:SOCS3	Significantly, Delta 133[TF] stimulates expression of the endogenous [TG] gene in Stat3-/- MEFs upon IL-6 treatment with an activity similar to reconstituted STAT3, demonstrating that the N-domain is dispensable for Socs3 gene expression.	STAT3	Socs3	1	ACTIVATION	False
13975	14265	17202361:11:STAT3:CXCL11	Thus, [TF] also plays a role in the recruitment of the transcriptional activators p65 and IRF1, and the displacement of the transcriptional repressors p50 and IRF2 from the [TG] promoter also appears to regulate the induction of CXCL11 gene transcription.	STAT3	CXCL11	1	ACTIVATION	False
13976	14266	17557905:2:STAT3:VEGFA	Our previous study demonstrated that STAT3 ([TF]) up-regulates HIF-1alpha (hypoxia inducible factor-1alpha) protein stability and enhances HIF-1-mediated [TG] expression in hypoxic solid tumor cells, thus suggesting that the inhibition of STAT3 signaling may have clinical applications.	signal transducer and activator of transcription 3	VEGF	1	ACTIVATION	False
13977	14267	17572495:0:STAT3:MMP9	Fra-1 and [TF] synergistically regulate activation of human [TG] gene.	Stat3	MMP-9	1	ACTIVATION	False
13978	14268	17967179:11:STAT3:HGF	These results suggest that human breast cells are a uniquely permissive environment for [TG] transactivation by Src/[TF] which may allow for the inappropriate activation of HGF transcription during the early stages of breast transformation.	Stat3	HGF	1	ACTIVATION	False
13979	14269	18367518:0:STAT3:EGFR	Epstein-Barr virus latent membrane protein 1 induces expression of the [TG] through effects on Bcl-3 and [TF].	STAT3	epidermal growth factor receptor	1	ACTIVATION	False
13980	14270	18573283:0:STAT3:MUC4	IL-6 induces [TG] expression through gp130/[TF] pathway in gastric cancer cell lines.	STAT3	MUC4	1	ACTIVATION	False
13981	14271	18573283:8:STAT3:MUC4	In conclusion, IL-6 treatment induced [TG] expression through the gp130/[TF] pathway, indicating the direct role of IL-6 on the activation of the intestinal mucin gene MUC4 in gastric cancer cells.	STAT3	MUC4	1	ACTIVATION	False
13982	14272	18976543:10:STAT3:RGS7	Overall, our data suggest that the complete desensitization of 5-HT2A receptor-stimulated PLC activity by olanzapine, clozapine and MDL 100907 requires activation of the JAK-STAT pathway, which in turn increases [TG] expression probably by direct transcriptional activity of [TF].	STAT3	RGS7	1	ACTIVATION	False
13983	14274	20145033:11:STAT3:PTGS2	Together, these findings indicate the existence of the nuclear EGFR/EGFRvIII signaling pathway in GBM and its functional interaction with [TF] to activate [TG] gene expression, thus linking EGFR-STAT3 and EGFRvIII-STAT3 signaling axes to proinflammatory COX-2 mediated pathway.	STAT3	COX-2	1	ACTIVATION	False
13984	14275	20169197:0:STAT3:CCL11	IL-9 induces [TG] expression via [TF] signalling in human airway smooth muscle cells.	STAT3	CCL11	1	ACTIVATION	False
13985	14276	20510882:6:STAT3:NOS2	Furthermore, Rh1 inhibited the phosphorylation of JAK1, STAT1, [TF], and ERK, which are upstream signaling molecules for IFN-gamma-induced [TG] gene expression.	STAT3	iNOS	1	ACTIVATION	False
13986	14277	21184768:5:STAT3:BCL2L1	[TF] activity as a coactivator of PR was observed in both the classical and nonclassical ligand activated-PR transcriptional mechanisms, since the effects described were identified in the [TG] promoter which contains a progesterone responsive element and in the p21(CIP1) promoter which carries Sp1 binding sites where PR is recruited via the transcription factor Sp1.	Stat3	bcl-X	1	ACTIVATION	False
13987	14278	21262861:0:SOX6:ACAN	SHOX interacts with the chondrogenic transcription factors SOX5 and [TF] to activate the [TG] enhancer.	SOX6	aggrecan	1	ACTIVATION	False
13988	14279	21689417:17:STAT3:COPS5	These findings reveal a novel mechanism of [TG] gene regulation and provide functional and mechanistic links between the Src/[TF] and IL-6/Stat3 signaling axes that are involved in the activation of Jab1 transcription and regulation of this novel oncogenic protein.	Stat3	Jab1	1	ACTIVATION	False
13989	14280	22076197:0:STAT3:VEGFA	Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking [TF]-Mediated [TG] Expression.	STAT3	VEGF	1	ACTIVATION	False
13990	14281	22273698:7:STAT3:PIM1	Cucurbitacin I treatment alone increased pErk1/2 expression in wild-type and [TG]-overexpressing cell lines and resulted in exaggerated Pim-1 kinase protein levels in control and IL-6-stimulated cells, suggesting that up-regulation of Pim-1 may be partially [TF] independent.	STAT3	Pim-1	1	ACTIVATION	True
13991	14282	22406269:4:STAT3:ENTPD1	[TF] supported whereas Gfi-1 repressed [TG] and CD73 expression by binding to their promoters.	Stat3	CD39	1	ACTIVATION	True
13992	14283	23027374:2:STAT3:SOCS3	As a target gene of [TF] (STAT3) signaling, [TG] (SOCS3) can be quickly induced by interleukin-6 (IL-6) stimulation but it then strongly inhibits IL-6-mediated STAT3 activation, functioning as a negative feedback regulator of the IL-6/STAT3 pathway.	signal transducer and activator of transcription 3	suppressor of cytokine signaling 3	1	ACTIVATION	True
13993	14284	23056300:7:STAT3:GREB1	The effects of IL-6/JAK/[TF] cascade activation on estrogen-induced [TG] promoter activity were determined by luciferase assay and those on gene expression were measured by real time reverse transcription polymerase chain reaction (qRT-PCR).	STAT3	GREB1	1	ACTIVATION	False
13994	14285	23482931:11:SOX4:GCKR	Taken together, we have revealed an important oncogenic cascade involving FRA-2/JUND and [TF] in ATL, which leads to the expression of genes such as [TG], NAP1, and HDAC8.	SOX4	GCKR	1	ACTIVATION	False
13995	14286	23860260:3:SOX9:MATN1	We previously demonstrated that uniquely assembled proximal promoter elements restrict [TG] expression to specific growth plate cartilage zones by allowing varying doses of L-Sox5/Sox6 and Nfi proteins to fine-tune their [TF]-mediated transactivation.	Sox9	Matn1	1	ACTIVATION	False
13996	14287	25088258:8:STAT3:HSPA4	These results suggest that Nmi has a role as a positive regulator of Hsp105-mediated [TG] gene expression along the [TF] signaling pathway.	Stat3	hsp70	1	ACTIVATION	False
13997	14288	15082719:7:SOX2:FGF3	By contrast, [TF] was a poor activator of [TG] transcription, and when Sox2 was coexpressed with Gata4, it negatively modulated the strong activation mediated by GATA-4.	SOX2	Fgf-3	1	ACTIVATION	True
13998	14289	10497240:6:STAT3:JUNB	The [TF] and CRE-like binding sites of the [TG] promoter, identified as IL-6-responsive elements in HepG2 liver cells were found, however, to play no role in JunB inducibility by IL-6 in M1 myeloid cells.	STAT3	JunB	0	UNDEFINED	True
13999	14290	10903771:6:STAT3:IL10	Our results show that [TF], by binding to a single motif in the [TG] promoter, is controlling expression of the human IL-10 gene.	Stat3	IL-10	0	UNDEFINED	False
14000	14291	11259267:3:SOX9:AMH	Proper spatiotemporal expression of the [TG] gene requires the concerted action of several transcription factors that include [TF], SF-1, WT-1, GATA-4, and Dax-1.	Sox9	MIS	1	ACTIVATION	True
14001	14292	12514105:3:SOX2:FGF4	The transcription factor [TF] has also been implicated in the regulation of [TG] expression.	SOX2	Fgf4	0	UNDEFINED	False
14002	14293	15044588:0:STAT3:SFTPB	Synergy between [TF] and retinoic acid receptor-alpha in regulation of the [TG] gene in the lung.	signal transducer and activator of transcription 3	surfactant protein B	0	UNDEFINED	False
14003	14294	16407846:7:STAT3:HGF	Endogenous [TF] binding to this region of the [TG] promoter in carcinoma cells expressing HGF was demonstrated using a chromatin immunoprecipitation assay.	Stat3	HGF	0	UNDEFINED	False
14004	14295	16407846:9:STAT3:HGF	Our results delineate a novel c-Src/[TF]-dependent mechanism that regulates [TG] promoter activity, and is linked to transformation of mammary epithelial cells.	Stat3	HGF	0	UNDEFINED	False
14005	14296	17951530:7:STAT3:MCL1	These phenotypes are accompanied by decreased expression of several known [TF] target genes, including c-Myc, JunB, and [TG], and increased expression of the cell- cycle inhibitor p27.	STAT3	Mcl-1	0	UNDEFINED	False
14006	14297	17997399:5:STAT3:BCL2	Our conclusion is supported (i) by siRNA-mediated depletion of [TF] in Trps1-deficient chondrocytes, which normalized the expression of cyclin D1 and [TG], (ii) by overexpression of Trps1 in ATDC5 chondrocytes, which diminished Stat3 levels and increased proliferation and apoptosis, and (iii) by mutational analysis of the GATA-binding sites in the Stat3 gene, which revealed that their integrity is critical for the direct association with Trps1 and for Trps1-mediated repression of Stat3.	Stat3	Bcl2	0	UNDEFINED	True
14007	14298	18677406:2:SOX9:COL2A1	To identify genes that interact with [TF] in promoting chondrocyte differentiation, we screened a cDNA library generated from the murine chondrogenic ATDC5 cell line to identify activators of the collagen, type II, alpha 1 ([TG]) promoter.	Sox9	Col2a1	1	ACTIVATION	True
14009	14300	19578748:2:STAT3:MUC1	One putative downstream gene regulated by [TF] is [TG] which also has important roles in tumorigenesis.	Stat3	MUC1	0	UNDEFINED	False
14010	14301	19578748:8:STAT3:MUC1	These results demonstrate that constitutively activated [TF] regulates expression of [TG], which mediates lung cancer cell survival and metastasis in vitro and in vivo.	STAT3	MUC1	0	UNDEFINED	False
14011	14302	20032313:4:STAT3:IL1RN	However, in response to LPS plus IL-10, which were found to induce chromatin acetylation, recruitment of both NF-kappaBp65 and NF-kappaBp50 to the [TG] promoter efficiently occurs in a [TF]-dependent manner.	STAT3	IL-1ra	0	UNDEFINED	False
14012	14303	20032313:5:STAT3:IL1RN	Accordingly, in neutrophils from hyper-IgE syndrome patients, who carry a nonfunctional [TF], IL-10 failed to promote NF-kappaBp65 recruitment to the [TG] promoter and consequently to potentiate LPS-induced IL-1ra transcription.	STAT3	IL-1ra	0	UNDEFINED	True
14013	14304	20530484:0:SOX9:BEST1	[TF], through interaction with microphthalmia-associated transcription factor (MITF) and OTX2, regulates [TG] expression in the retinal pigment epithelium.	SOX9	BEST1	0	UNDEFINED	False
14014	14305	20654581:6:STAT3:CDKN1A	In agreement with these results, we additionally found that rGel/BLyS down-regulated levels of several [TF] targets (c-Myc, [TG], Mcl-1, and Bcl-x(L)) and p-SYK, a positive regulator of STAT3.	STAT3	p21	0	UNDEFINED	False
14015	14306	20654581:6:STAT3:MCL1	In agreement with these results, we additionally found that rGel/BLyS down-regulated levels of several [TF] targets (c-Myc, p21, [TG], and Bcl-x(L)) and p-SYK, a positive regulator of STAT3.	STAT3	Mcl-1	0	UNDEFINED	False
14016	14307	21157434:6:STAT3:IL10	TLR2 activation induced [TF] phosphorylation and increased phosphorylated histone 3 (H3) at the STAT3-binding site of the [TG] promoter.	STAT3	IL-10	0	UNDEFINED	False
14017	14308	21677772:6:STAT3:ABCB1	The ChIP results demonstrated that [TF] could bind to the potential promoter region of [TG], and STAT3 decoy depressed the binding.	STAT3	mdr1	0	UNDEFINED	False
14018	14309	21949021:4:STAT3:IL17A	Downregulation of [TG] by IL-4 is dependent on STAT6 and mediated by inhibition of [TF] binding at the Il17a promoter.	STAT3	IL-17	0	UNDEFINED	False
14019	14310	22015605:9:SOX2:DKK1	Our study shows that [TF] directly regulates [TG] expression and, as a consequence, determines the differentiation lineage of hMSCs.	SOX2	DKK1	0	UNDEFINED	False
14020	14311	23086340:7:STAT3:FGF2	The induced STAT1 activation also decreased VEGF-A-induced [TG] mRNA expression by competing with activated [TF] for a direct binding to the consensus STAT-binding site at positions -997 to -989 bp from transcription start site in the bFGF promoter.	STAT3	bFGF	1	ACTIVATION	True
14021	14312	23284999:11:STAT3:DDAH1	These results suggest that vaspin increases eNOS activity by reducing ADMA level through [TF]-mediated regulation of [TG] expression.	STAT3	DDAH II	0	UNDEFINED	False
14022	14313	23660500:7:SOX9:IGFBP4	Reporter assays and chromatin immunoprecipitation demonstrated direct binding of [TF] to the [TG] promoter.	SOX9	IGFBP-4	0	UNDEFINED	False
14023	14314	24046453:5:SOX4:CALD1	Promoter analysis of the caldesmon gene ([TG]) and gel mobility shift assays identified [TF] as a major trans-acting factor for the regulation of Cald1 expression during myoblast differentiation.	Sox4	Cald1	0	UNDEFINED	False
14024	14315	24097101:6:STAT3:KDM6B	Transcriptional regulation of [TG] by Stat1 and [TF] is a novel mechanism crucial for launching inflammatory responses in microglia.	Stat3	Jmjd3	0	UNDEFINED	False
14025	14316	24158981:9:STAT3:HAVCR1	These observations highlight Chk1 and [TF] as critical upstream regulators of [TG] expression after AKI and may suggest novel approaches for therapeutic intervention.	STAT3	KIM-1	0	UNDEFINED	False
14026	14317	24345215:13:STAT3:FTO	Our results reveal that [TG] expression in liver, but not in hypothalamus, is affected by the i.p. injection of LPS, which may be mediated through tissue-specific FTO transcriptional regulation by C/EBP beta and [TF] interaction.	STAT3	FTO	0	UNDEFINED	False
14027	14318	24661907:0:SOX9:TUBB3	[TF] and Hif-2 regulate [TG] gene expression and affect ovarian cancer aggressiveness.	Sox9	TUBB3	0	UNDEFINED	False
14028	14319	24661907:2:SOX9:TUBB3	This study investigated the role of [TF] in the expression of [TG] gene, a marker of aggressiveness in ovarian cancer (OC), encoding III-tubulin protein.	Sox9	TUBB3	0	UNDEFINED	False
14029	14320	24705138:9:SOX2:NR5A2	These results indicate that embryonic [TG] expression is regulated by both [TF] and Gabp.	Sox2	Lrh-1	0	UNDEFINED	False
14030	14321	7509445:2:STAT3:A2M	We report here that the rat [TG] promoter is activated by IFN-gamma in human hepatoma (HepG2) cells and that the IFN-gamma response element maps to the same site previously defined as the acute-phase response element (APRE), which binds the IL-6-activated transcription factor [TF] (acute-phase response factor).	APRF	alpha 2-macroglobulin	1	ACTIVATION	True
14031	14322	9343393:3:SOX2:FGF4	We have previously shown that [TG] (FGF-4) gene expression in embryonal carcinoma cells requires a synergistic interaction between Oct-3 and [TF] on the FGF-4 enhancer.	Sox2	fibroblast growth factor 4	1	ACTIVATION	True
14032	14323	9669521:6:SOX2:FGF4	In addition, we employed two experimental approaches to demonstrate that [TF] regulates the transcription of the [TG] gene in EC cells.	Sox-2	FGF-4	0	UNDEFINED	False
14033	14324	15251981:0:STAT3:IL12B	[TF] regulates NF-kappaB recruitment to the [TG]p40 promoter in dendritic cells.	STAT3	IL-12	0	UNDEFINED	False
14034	14325	23660500:9:SOX9:IGFBP4	These results suggest that [TF] regulates cell proliferation, at least in part via [TG].	SOX9	IGFBP-4	0	UNDEFINED	False
14035	14326	20802155:0:SOX17:LEF1	[TF] modulates Wnt3A/beta-catenin-mediated transcriptional activation of the [TG] promoter.	Sox17	Lef-1	0	UNDEFINED	False
14037	14328	16523502:3:SOX2:FGF4	Recently, it was suggested that a critical [TF]:Oct-3/4 target gene, [TG], is expressed at lower levels in P19 than in F9 embryonal carcinoma (EC) cells, due to lower levels of Sox2 in P19 than in F9 cells.	Sox2	FGF-4	0	UNDEFINED	False
14038	14329	17471507:0:STAT3:CEBPD	The mouse [TG] gene promoter is regulated by [TF] and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.	STAT3	C/EBPdelta	1	ACTIVATION	True
14039	14330	21345218:6:STAT3:MAD1L1	Moreover we have recently demonstrated that the [TG] promoter is controlled by the cytokine granulocyte colony-stimulating factor (G-CSF) through the activation of [TF], MAP kinases and C/EBP transcription factors.	STAT3	MAD1	0	UNDEFINED	False
14040	14331	22674257:6:STAT3:NOS2	[TF] does not appear to control [TG] transcription in astrocytes deficient in the major glioblastoma tumor suppressor protein phosphatase and tensin homolog (PTEN), suggesting that STAT3 regulates iNOS transcription specifically in EGFRvIII-expressing astrocytes.	STAT3	iNOS	0	UNDEFINED	False
14041	14332	23142594:5:STAT3:CXCR6	When [TF] activation was blocked by JAK2/STAT3 inhibitor AG490, RANKL failed to shut down [TG] expression during osteoclastogenesis.	STAT3	CXCR6	2	REPRESSION	True
14042	14333	10330124:7:SOX9:EPYC	There are 14 potential binding sites for [TF], a transcription factor present in cartilage, in the promoter, and in the first intron of [TG].	SOX9	DSPG3	0	UNDEFINED	False
14043	14334	10867011:7:STAT3:CEBPD	Band shift assays and antibody interference assays demonstrate specific binding of [TF] to the acute phase response element in the [TG] promoter in G(0) growth-arrested HC11 cell extracts and 24 h involuting mouse mammary gland extracts.	Stat3	C/EBPdelta	0	UNDEFINED	False
14044	14335	10903771:0:STAT3:IL10	Role of [TF] in lipopolysaccharide-induced [TG] gene expression.	Stat3	IL-10	1	ACTIVATION	True
14045	14336	11028563:4:STAT3:TNF	We identified binding sites for [TF] and STAT 5/6 within the promoter region of [TG] and hypothesize that alterations in these sites would affect TNFalpha expression.	STAT 3	TNFalpha	0	UNDEFINED	False
14046	14337	11514554:11:SOX9:MAPK3	These studies demonstrate that [TF] alters the rate of cell cycle progression of chondrocytes and their differentiation by enhancing or inhibiting the expression of selected genes, including p21(cip1) and [TG], and that N-cadherin is an additional direct target of this transcriptional regulator.	SOX9	ERK1	0	UNDEFINED	True
14047	14338	11682619:8:STAT3:SOCS3	Whereas [TF] binding to the [TG] promoter mediates LIF action, several SOCS-3 promoter regions containing cAMP-responsive elements are required for cAMP-PKA effect.	signal transducer and activator of transcription 3	SOCS-3	0	UNDEFINED	False
14048	14339	12545153:0:STAT3:VEGFA	[TF] activation regulates the expression of [TG] and human pancreatic cancer angiogenesis and metastasis.	Stat3	vascular endothelial growth factor	0	UNDEFINED	False
14049	14340	12681949:1:SOX9:ACAN	The [TF] transcription factor has emerged as an important determinant of chondrocyte differentiation, including the regulation of type II collagen (Col2) and [TG] gene expression.	Sox9	aggrecan	0	UNDEFINED	False
14050	14341	12732652:9:SOX9:AMH	Our data provide the first evidence that SOX8 may partially compensate for the reduced [TF] activity in campomelic dysplasia and substitute for Sox9 where Sox9 is either not expressed or expressed too late to be involved in sex determination or regulation of [TG] expression.	SOX9	Amh	0	UNDEFINED	False
14052	14343	12935820:10:SOX9:COL2A1	These results suggest that [TF] is not the key regulator of [TG] promoter activity in human adult articular chondrocytes.	SOX9	COL2A1	0	UNDEFINED	False
14053	14344	14647442:11:STAT3:HGF	These results suggest that cytokines, growth factors and oncogenes (v-Src, etc.) that activate [TF] are important regulators of [TG] expression.	Stat3	HGF	0	UNDEFINED	False
14054	14345	14659890:5:SOX2:FGF4	In this study, we identify a second essential HMG motif within the [TG] enhancer that binds the transcription factor [TF].	Sox-2	FGF-4	0	UNDEFINED	False
14055	14346	14688368:7:STAT3:TNF	However, real-time PCR analysis showed that [TF] DN expression did not affect immediate suppression of [TG] mRNA, but did reverse the suppression observed at later time points, suggesting a biphasic regulation of TNF-alpha mRNA levels by IL-10.	STAT3	TNF-alpha	1	ACTIVATION	True
14056	14347	14689607:6:SOX9:AMH	We have hypothesized that Sox8 may substitute for [TF] in species where Sox9 is expressed too late to be involved in sex determination or regulation of [TG] expression.	Sox9	Amh	0	UNDEFINED	False
14057	14349	14764629:4:STAT3:TRH	Here we show transfection data and in vivo evidence, suggesting that leptin can regulate trh gene expression via activation of intracellular [TF] (STAT3) proteins in [TG] neurons.	signal transducer and activator of transcription 3	TRH	0	UNDEFINED	False
14058	14350	14764630:8:STAT3:TRH	Taken together these experiments demonstrate that [TF] mediates transcriptional effects of leptin in vivo and that the [TG] promoter is a likely direct site of leptin action.	STAT3	TRH	0	UNDEFINED	False
14059	14351	14978160:1:STAT3:NOS2	[TF] (STAT3) and nuclear factor kappaB (NF-kappaB) are important transcription factors involved in glomerulonephritis and other inflammatory processes, including transcription of the inducible nitric oxide synthase ([TG]) gene.	Signal transducer and activator of transcription 3	iNOS	1	ACTIVATION	True
14060	14352	15063116:8:STAT3:CDKN1A	Introduction of NS5A in hepatoma cells modulated [TF] downstream molecules Bcl-xL and [TG] expression.	STAT3	p21	0	UNDEFINED	False
14061	14353	15116091:6:STAT3:MMP2	A high-affinity [TF]-binding element was identified in the [TG] promoter and Stat3 protein bound directly to the MMP-2 promoter.	Stat3	MMP-2	0	UNDEFINED	False
14062	14354	15178704:7:STAT3:IL21	The promoter analysis of [TG] gene revealed a putative IFN-gamma activation site element, which was found to bind signal transducer and activator of transcription 1 (STAT1), STAT2, [TF], and STAT4 proteins in IFN-alpha/beta-stimulated NK or T cell extracts.	STAT3	IL-21	0	UNDEFINED	False
14063	14355	15220343:10:SOX7:LAMA1	These results indicate that the transcription of the mouse [TG] gene during the differentiation of F9 cells is controlled by a combination of the actions of the ubiquitous factors, Sp1/Sp3 and NF-Y, and the parietal endoderm-specific factors, [TF] and SOX17.	SOX7	Lama1	0	UNDEFINED	False
14064	14356	15220343:5:SOX7:LAMA1	In the present study, we further showed that [TF] and SOX17 are involved in the regulation of parietal endoderm-specific enhancer activity of the mouse [TG] gene.	SOX7	Lama1	0	UNDEFINED	False
14065	14357	15251981:9:STAT3:IL12B	In conclusion, dysregulated LPS-induced [TG]p40 gene expression in IL-10(-/-) mice is due to enhanced NF-kappaB recruitment to the IL-12p40 promoter in the absence of activated [TF].	STAT3	IL-12	0	UNDEFINED	True
14066	14358	15542856:0:SOX7:GATA4	[TF] plays crucial roles in parietal endoderm differentiation in F9 embryonal carcinoma cells through regulating [TG] and Gata-6 expression.	Sox7	Gata-4	0	UNDEFINED	False
14067	14359	15542856:0:SOX7:GATA6	[TF] plays crucial roles in parietal endoderm differentiation in F9 embryonal carcinoma cells through regulating Gata-4 and [TG] expression.	Sox7	Gata-6	0	UNDEFINED	False
14069	14361	15590666:0:SOX9:VNN1	The transcription factors steroidogenic factor-1 and [TF] regulate expression of [TG] during mouse testis development.	SOX9	Vanin-1	0	UNDEFINED	False
14070	14362	15590666:5:SOX9:VNN1	We found that SF-1 is able to bind to two sites in the [TG] promoter, whereas [TF] can bind to a single interposed site defined by DNA footprinting.	SOX9	Vanin-1	0	UNDEFINED	False
14071	14363	15688401:0:STAT3:VEGFA	Interleukin-6 induces transcriptional activation of vascular endothelial growth factor ([TG]) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between [TF] and Sp1.	STAT3	VEGF	0	UNDEFINED	True
14072	14364	15735682:4:STAT3:VEGFA	[TF] and hypoxia-inducible factor (HIF)-1alpha bind simultaneously to the [TG] promoter, where they form a molecular complex with the transcription coactivators CBP/p300 and Ref-1/APE.	STAT3	VEGF	0	UNDEFINED	True
14073	14365	15816866:4:STAT3:GFAP	The CpG dinucleotide in the [TF] binding site in the [TG] gene promoter exhibited a high incidence of cytidine-methylation in undifferentiated pluripotent ES cells.	STAT3	GFAP	0	UNDEFINED	False
14074	14366	15860457:7:SOX2:NANOG	[TF] and Oct4 interaction with the [TG] promoter was confirmed through mutagenesis and in vitro binding assays.	Sox2	Nanog	0	UNDEFINED	False
14075	14367	15870198:2:STAT3:PTPN6	We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four [TF] SIE/GAS binding sites identified in the [TG] promoter.	STAT3	SHP-1	0	UNDEFINED	False
14076	14368	15870198:3:STAT3:PTPN6	[TF], DNMT1, and histone deacetylase 1 form complexes and bind to the [TG] promoter in vivo.	STAT3	SHP-1	0	UNDEFINED	False
14077	14369	15972681:6:STAT3:IL10	Inhibition of ERK activation prevented histone modifications, and decreased the binding of Sp1 and [TF] to the [TG] promoter.	STAT3	IL-10	0	UNDEFINED	False
14078	14370	16007214:0:STAT3:VEGFA	Targeting [TF] blocks both HIF-1 and [TG] expression induced by multiple oncogenic growth signaling pathways.	Stat3	VEGF	1	ACTIVATION	True
14079	14371	16077994:10:SOX9:SOX2	[TF], TCF/LEF, POU2F1 and COMP1 binding sites were conserved among human [TG] promoter, rat Sox2 promoter, and mouse Sox2 promoter.	SOX9	SOX2	0	UNDEFINED	False
14080	14372	16118513:0:SIX3:SOX2	Agonistic and antagonistic action of AP2, Msx2, Pax6, Prox1 AND [TF] in the regulation of [TG] expression.	Six3	Sox2	0	UNDEFINED	False
14081	14373	16293640:8:STAT3:PNP	[TF]-specific genes included the apoptosis regulators CCAAT enhancer binding protein-delta, phosphatidylinositol 3-kinase-regulatory subunits, [TG], and c-fos.	STAT3	purine nucleoside phosphorylase	0	UNDEFINED	False
14082	14374	16317687:8:STAT3:MCL1	Chromatin immunoprecipitation analysis demonstrated a direct binding of [TF] to the putative STAT3 binding sequences in the [TG] promoter.	STAT3	Mcl-1	0	UNDEFINED	False
14083	14375	16709597:4:STAT3:AGRP	We identify putative [TF] binding elements in the [TG] promoter that have been highly conserved during vertebrate evolution.	Stat3	Agrp	0	UNDEFINED	False
14084	14376	16718380:7:STAT3:SOCS3	[TF] binds predominantly to a single STAT consensus site in the [TG] promoter, despite the presence of an adjacent STAT motif.	STAT3	Socs3	0	UNDEFINED	False
14085	14377	16846370:6:SOX2:DPPA4	As an example, results from ChIP-on-chip studies show that OCT4, [TF], and NANOG co-occupy SOX2, OCT4, TDGF1, GJA1, SET, and [TG] genes.	SOX2	DPPA4	0	UNDEFINED	False
14086	14378	16887796:7:STAT3:NOS3	To explore the mechanism by which IL-6 affects [TG] expression, we examined activation of signal transducer and transactivator-3 ([TF]).	Stat3	eNOS	0	UNDEFINED	False
14087	14379	16954384:4:SOX2:LEFTY1	We identified an ES cell-specific enhancer upstream of the [TG] promoter that contains binding sites for Oct3/4 and [TF].	Sox2	Lefty1	0	UNDEFINED	False
14088	14380	17023536:3:STAT3:POMC	To determine the extent to which [TF] signaling in [TG] neurons was responsible for these effects, we constructed Pomc-specific Stat3 mutants using a Cre recombinase transgene driven by the Pomc promoter.	Stat3	Pomc	0	UNDEFINED	False
14089	14381	17202361:7:STAT3:CXCL11	Chromatin immunoprecipitation assays demonstrated that IFN treatment of Daudi and DRST3 cells induced [TF] binding to the [TG] promoter.	STAT3	CXCL11	0	UNDEFINED	False
14090	14382	17234760:0:SOX9:AR	[TF] is expressed in normal prostate basal cells and regulates [TG] expression in prostate cancer cells.	SOX9	androgen receptor	0	UNDEFINED	False
14091	14383	17267606:6:SOX9:HES1	Our finding that [TF] regulates the Notch-effector [TG] suggests a Notch-dependent mechanism and establishes a possible genetic link between SOX factors and Notch.	SOX9	HES1	0	UNDEFINED	False
14092	14384	17289023:0:SP1:SOX9	Regulation of the human [TG] promoter by [TF] and CREB.	Sp1	SOX9	0	UNDEFINED	False
14093	14385	17324931:8:STAT3:PHB	IL-6 also increases binding of nuclear proteins to the IL-6 response element in the [TG] promoter that are supershifted by a [TF] antibody.	STAT3	PHB	0	UNDEFINED	False
14094	14386	17485346:5:SOX9:COMP	In this study we demonstrated that [TF], an essential transcription factor of chondrogenesis, binds to the [TG] promoter at the PRE in which 13 nucleotides (TGTTTACCTTGTG) are required for the binding of Sox9.	Sox9	COMP	0	UNDEFINED	False
14095	14387	17487688:0:STAT3:A2M	[TF]/NFkappaB interplay in the regulation of [TG] gene expression during rat liver development and the acute phase response.	STAT3	alpha2-macroglobulin	0	UNDEFINED	False
14096	14388	17572495:7:STAT3:MMP9	DNA affinity precipitation assay confirmed the binding of [TF] and Fra-1 to the elements of [TG] promoter and also revealed c-Jun recruited to Stat3-Fra-1 complex.	Stat3	MMP-9	0	UNDEFINED	False
14097	14389	17611704:12:SOX2:HES3	Double NANOG-binding sites, CSL/RBPSUH-binding site and TATA-box in HES1 promoter, NANOG-, [TF]-, POU5F1/OCT3/OCT4-binding sites and TATA-box in [TG] promoter, double CSL-binding sites in HES5 promoter, SOX2-, POU-binding sites and TATA-box in HES6 promoter, and CSL-binding site in HEY1, HEY2 and HEYL promoters were evolutionarily conserved.	SOX2	HES3	0	UNDEFINED	True
14098	14390	17615260:3:STAT3:TERT	In determining the mechanism for enhanced telomerase activity, we observed that physiological concentrations of genistein activated signal transducers and activators of transcription 3 ([TF]) both in vitro and in vivo and increased STAT3 binding to the [TG] promoter in human prostate cancer cells.	STAT3	telomerase reverse transcriptase	0	UNDEFINED	False
14099	14391	17699108:5:STAT3:CD46	The [TG] promoter contains two binding sites for activated [TF] and mutations introduced into the major site abolished STAT3 binding.	STAT3	CD46	0	UNDEFINED	False
14100	14392	17699108:6:STAT3:CD46	Chromatin immunoprecipitation confirms binding of [TF] to the [TG] promoter.	STAT3	CD46	0	UNDEFINED	False
14101	14393	17922140:4:STAT3:NNMT	To examine the role of [TF], Hep-G2 hepatocellular carcinoma cells were transfected with [TG] promoter-luciferase reporter construct together with conditionally active Stat3 (Stat3ER) or dominant-negative Stat3 expression vector and NNMT promoter activity was determined.	Stat3	NNMT	0	UNDEFINED	False
14102	14394	17950682:9:SOX9:BAG1	To further investigate the regulation of [TG] gene expression by [TF], CHO cells were co-transfected with the human Bag-1 gene promoter-Luciferase reporter construct and the human pSox-9 expression vector.	SOX-9	Bag-1	0	UNDEFINED	False
14103	14395	17971300:0:STAT3:MASP2	[TF] is involved in control of [TG] gene expression.	Stat3	MASP2	0	UNDEFINED	False
14104	14396	18192274:9:STAT3:ECEL1	ATF3, c-Jun, and [TF] interacted with Sp1 and are associated with the GC box region of the [TG] gene in injured neurons.	STAT3	DINE	0	UNDEFINED	False
14105	14397	18341989:4:STAT3:BACE1	[TF] interacts with the [TG] promoter, and p25-overexpressing mice had elevated levels of pSTAT3 and BACE1, whereas cdk5-deficient mice had reduced levels.	STAT3	BACE1	0	UNDEFINED	True
14106	14398	18408167:6:STAT3:VEGFA	Transfac analysis of [TG] promoter revealed the presence of STAT-binding elements and 14,15-EET induced [TF] binding to this promoter in vivo, and this interaction was inhibited by suppression of Src-STAT-3 signaling.	STAT-3	VEGF	0	UNDEFINED	False
14107	14399	18454134:0:SRY:SOX9	Sex determination involves synergistic action of [TF] and SF1 on a specific [TG] enhancer.	SRY	Sox9	0	UNDEFINED	False
14108	14400	18472212:10:SP1:KLF16	The present observations suggest that [TG] auto-regulates its own promoter by competing with [TF] and that both AP1 and AP2 modulate expression of this gene.	Sp1	DRRF	0	UNDEFINED	False
14109	14401	18485278:3:SNAI2:VDR	To explore the possibility that [TF] regulates the [TG] gene promoter, we cloned a 628bp fragment (-613 to +15) of the human VDR gene promoter.	SLUG	VDR	0	UNDEFINED	False
14110	14402	18537119:2:SOX2:NANOG	Work with ES cells and embryonal carcinoma (EC) cells previously identified positive and negative cis-regulatory elements that influence the activity of the [TG] promoter, including adjacent cis-regulatory elements that bind [TF] and Oct-3/4.	Sox2	Nanog	0	UNDEFINED	False
14111	14403	18571793:10:STAT3:SOCS3	OSM stimulation led to a time-dependent recruitment of the transcription factors [TF], c-Fos, c-Jun, and Sp1 and the coactivators CREB-binding protein (CBP) and p300 to the endogenous [TG] promoter.	STAT-3	SOCS-3	0	UNDEFINED	False
14112	14404	18573283:7:STAT3:MUC4	We also demonstrated that p-[TF] binds to [TG] promoter and a three-fold increase in p-STAT3 binding was observed after treating GP220 cells with IL-6.	STAT3	MUC4	0	UNDEFINED	False
14113	14405	19064501:0:STAT3:SLC9A3	Cell confluency-induced [TF] activation regulates [TG] expression by recruiting Sp1 and Sp3 to the proximal NHE3 promoter region during epithelial dome formation.	Stat3	NHE3	0	UNDEFINED	False
14114	14406	19118090:10:STAT3:NOS3	In conclusion, shear decreases PKCdelta activity and, subsequently, reduces [TF] binding to the [TG] promoter.	STAT3	eNOS	0	UNDEFINED	False
14115	14407	19124156:6:STAT3:IL10	ChIP analysis for detection of transcription factor binding to chromatin in intact cells demonstrated [TF] binding to the proximal [TG] promoter when cells are stimulated with LPS only.	Stat3	IL-10	0	UNDEFINED	False
14116	14408	19147588:5:SOX4:EGFR	Direct transcriptional targets of [TF] include several key cellular regulators, such as [TG], HSP70, Tenascin C, Frizzled-5, Patched-1, and Delta-like 1.	SOX4	EGFR	0	UNDEFINED	False
14117	14409	19147588:5:SOX4:FZD5	Direct transcriptional targets of [TF] include several key cellular regulators, such as EGFR, HSP70, Tenascin C, [TG], Patched-1, and Delta-like 1.	SOX4	Frizzled-5	0	UNDEFINED	False
14118	14410	19147588:5:SOX4:PTCH1	Direct transcriptional targets of [TF] include several key cellular regulators, such as EGFR, HSP70, Tenascin C, Frizzled-5, [TG], and Delta-like 1.	SOX4	Patched-1	0	UNDEFINED	False
14119	14411	19151334:5:STAT3:SALL4	By chromatin immunoprecipitation, the segment of the [TG] promoter showing the highest affinity to [TF] was localized to -366 to -163, in which there was only one putative STAT3 binding site starting at -199.	STAT3	SALL4	0	UNDEFINED	False
14120	14412	19168719:12:SP1:KLF4	Finally, the results demonstrated enhanced [TF] binding to the [TG] promoter in SMCs treated with PDGF-BB in vitro and following vascular injury in vivo.	Sp1	KLF4	0	UNDEFINED	False
14121	14413	19168719:7:SP1:KLF4	The [TG] promoter contains three consensus [TF] binding sites.	Sp1	KLF4	0	UNDEFINED	False
14122	14414	19211811:0:SOX9:CBLN4	The [TG] gene is a direct target of SRY and [TF] in mice.	SOX9	cerebellin 4 precursor	0	UNDEFINED	False
14123	14415	19265112:7:STAT3:CCL11	However, [TF] but not STAT6 in vivo binding to the [TG] promoter was detected following IL-17A stimulation of ASM cells.	STAT3	CCL11	0	UNDEFINED	False
14124	14416	19322650:4:SOX9:HES1	We found an enhancer regulating [TG] expression: two [TF] binding sites upstream of the HES-1 gene that were capable of binding SOX9 in vitro.	SOX9	HES-1	0	UNDEFINED	False
14125	14417	19476490:8:SOX9:TFAP2E	In addition, direct interaction of [TF] with the [TG] promoter could be confirmed by chromatin immunoprecipitation and electromobility shift assays.	Sox9	AP-2epsilon	0	UNDEFINED	False
14126	14418	19531481:0:SOX2:FGF4	PARP1 poly(ADP-ribosyl)ates [TF] to control Sox2 protein levels and [TG] expression during embryonic stem cell differentiation.	Sox2	FGF4	0	UNDEFINED	False
14127	14419	19578748:3:STAT3:MUC1	We determined if [TF] regulates [TG] in lung cancer cell lines and what function MUC1 plays in lung cancer cell biology.	Stat3	MUC1	0	UNDEFINED	False
14128	14420	19684620:8:STAT3:CTTN	Chromatin immunoprecipitation assay showed direct binding of p-[TF] to the conservative STAT3-binding sequences in [TG] promoter.	STAT3	CTTN	0	UNDEFINED	False
14129	14421	19734891:0:SOX2:SHH	Hippocampal development and neural stem cell maintenance require [TF]-dependent regulation of [TG].	Sox2	Shh	0	UNDEFINED	False
14130	14422	19799567:2:SP1:SOX3	We have previously reported characterization of the [TG] promoter and demonstrated that the general transcription factors NF-Y (nuclear factor-Y), [TF] (specificity protein 1) and USF (upstream stimulatory factor) are involved in transcriptional regulation of SOX3 promoter activity.	Sp1	SOX3	0	UNDEFINED	False
14131	14423	20032196:7:STAT3:SOCS3	IL-6 induces both [TF] and APE1 to bind the [TG] and gamma-fibrionogen promoters in their native chromatin environment.	STAT3	suppressor of cytokine signaling-3	0	UNDEFINED	False
14132	14424	20032313:6:STAT3:IL1RN	Altogether our findings uncover a novel mechanism whereby IL-10-activated [TF] modulates [TG] transcription in LPS-treated phagocytes by making IL-1ra promoter accessible to readily available nuclear NF-kappaB.	STAT3	IL-1ra	0	UNDEFINED	False
14133	14425	20039267:10:STAT3:SLPI	These results indicate that [TF] may play an important role in regulating [TG] expression.	STAT3	ALP	0	UNDEFINED	False
14134	14426	20049565:0:SOX4:NCAM1	[TG] expression in human myeloma cells derived from the neurogenic gene expression: possible role of the SRY-HMG box gene, [TF].	SOX4	CD56	0	UNDEFINED	False
14135	14427	20049565:4:SOX4:NCAM1	ChIP analysis of the [TG] promoter region showed specific bindings of [TF] in the CD56(+) and SOX1 in the CD56(-) myeloma cell lines, respectively.	SOX4	CD56	0	UNDEFINED	False
14136	14428	20145033:7:STAT3:PTGS2	Nuclear EGFR and its transcriptional cofactor [TF] (STAT3) associate with the [TG] promoter.	signal transducer and activator of transcription 3	COX-2	0	UNDEFINED	False
14137	14429	20155810:0:STAT3:HP	Association of the glucocorticoid receptor with [TF], C/EBPbeta, and the hormone-responsive element within the rat [TG] gene promoter during the acute phase response.	STAT3	haptoglobin	0	UNDEFINED	False
14138	14430	20169197:6:STAT3:CCL11	[TF] binding to [TG] promoter was also observed in vivo upon IL-9 stimulation of ASM cells.	STAT3	CCL11	0	UNDEFINED	False
14139	14431	20236940:9:STAT3:VEGFA	Furthermore, chromatin immunoprecipitation assays showed that [TF] protein bound to the [TG] promoter in cells with the mutant.	Stat3	VEGF	0	UNDEFINED	False
14140	14432	20448145:8:SOX9:PDX1	Chromatin immunoprecipitation studies using the HIT-T15 beta-cell line demonstrated that GDNF can influence [TG] gene expression by enhancing the binding of [TF] and neuroD1/beta(2) to the Pdx1 promoter.	Sox9	Pdx1	0	UNDEFINED	False
14141	14433	20530484:11:SOX9:BEST1	These results define [TF] as a key regulator of [TG] expression and demonstrate for the first time its functional role in the RPE.	SOX9	BEST1	0	UNDEFINED	False
14142	14434	20530484:4:SOX9:BEST1	Here, we show that yeast one-hybrid screen with bait corresponding to [TG] -120 to -88 bp identified the SOX-E factors, SOX8, [TF], and SOX10.	SOX9	BEST1	0	UNDEFINED	False
14143	14435	20571031:0:SOX9:CTGF	Stage-specific control of connective tissue growth factor (CTGF/[TG]) expression in chondrocytes by [TF] and beta-catenin.	Sox9	CCN2	0	UNDEFINED	False
14144	14436	20802155:8:SOX17:LEF1	EMSA and ChIP analyses defined several [TF]- and TCF4-binding sites that collaborate in transcriptional control of the [TG] promoter.	Sox17	Lef-1	0	UNDEFINED	False
14145	14437	20802155:9:SOX17:LEF1	More specifically, [TF] bound to four sites in the [TG] promoter, either directly or indirectly through TCF complexes.	Sox17	Lef-1	0	UNDEFINED	False
14147	14439	21184768:4:STAT3:CDKN1A	We demonstrated that [TF] activation is required for MPA modulation of the endogenous genes bcl-X and p21([TG]) which are involved in MPA-induced cell cycle regulation.	Stat3	CIP1	0	UNDEFINED	False
14148	14440	21257710:11:STAT3:MICA	Together, our findings reveal a novel role for [TF] in NK cell immunosurveillance by modulating the [TG] expression in cancer cells.	STAT3	MICA	0	UNDEFINED	False
14149	14441	21263153:5:SOX6:SOCS3	Searching for direct [TF] targets, we found SOCS3 ([TG]), a known mediator of cytokine response.	Sox6	suppressor of cytokine signaling-3	0	UNDEFINED	False
14150	14442	21278793:12:STAT3:VEGFA	As [TF] binds to vascular endothelial growth factor ([TG]) promoter, we found that VEGF levels were elevated in ILK-overexpressing cells and declined upon transfection of IL-6 small interfering RNA, suggesting that ILK may regulate VEGF expression through IL-6 pathway by activating STAT3.	STAT3	VEGF	0	UNDEFINED	True
14151	14443	21385272:14:STAT3:IL10	CONCLUSION [TF] and SOCS3 are involved in regulation of NK cell cytotoxicity and [TG] expression.	STAT3	IL-10	0	UNDEFINED	False
14152	14444	21544581:8:SOX2:RLIM	In this manuscript, we report that [TG], a third X-linked gene critical for the regulation of X-inactivation, is under the control of Nanog, Oct4 and [TF], the three factors lying at the heart of the pluripotency network.	Sox2	Rnf12	0	UNDEFINED	False
14153	14445	21611796:2:STAT3:NOS3	This study was to investigate the role of [TF] (STAT3) in the regulation of [TG] expression and vascular EC proliferation by the intronic 27-nucleotide (nt) miRNA derived from the 27-base pair repeats in intron 4 of eNOS gene.	signal transducer and activator of transcription 3	eNOS	0	UNDEFINED	False
14154	14446	21677772:8:STAT3:ABCB1	Our data demonstrate a role of [TF] in regulation of [TG] gene expression in myeloid leukemia and suggest that STAT3 may be a promising therapeutic target for overcoming MDR resistance in myeloid leukemia.	STAT3	mdr1	0	UNDEFINED	False
14155	14447	21689417:0:STAT3:COPS5	[TF] and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate [TG]/CSN5 expression in mammary carcinoma cells.	Stat3	Jab1	0	UNDEFINED	False
14156	14448	21689417:12:STAT3:COPS5	EMSA and ChIP assays confirmed that C/EBP, GATA1 and [TF] bind to [TG] promoter in breast carcinoma cells.	Stat3	Jab1	0	UNDEFINED	False
14157	14449	21723864:2:STAT3:IRF1	Here we demonstrate that the increased gp130-mediated induction of the IFN--responsive [TG] gene observed in [TF](-/-) cells correlates with prolonged STAT1 binding to its promoter.	STAT3	interferon regulatory factor 1	2	REPRESSION	True
14158	14450	21731766:7:STAT3:VEGFA	Of note, chromatin immunoprecipitation (ChiP) assay revealed that BA inhibited binding of HIF-1 and [TF] to [TG] promoter.	STAT3	VEGF	0	UNDEFINED	False
14159	14451	21731766:9:STAT3:VEGFA	Taken together, our results suggest that BA has anti-angiogenic activity by disturbing the binding of HIF-1 and [TF] to the [TG] promoter in hypoxic PC-3 cells.	STAT3	VEGF	0	UNDEFINED	False
14160	14452	21733558:4:STAT3:VEGFA	Using chromatin immunoprecipitation, we found that anti-[TF] antibodies immunoprecipitated DNA of signal transducer and activator of transcription 3, [TG], and other signal transducer and activator of transcription 3-regulated genes.	signal transducer and activator of transcription 3	vascular endothelial growth factor	0	UNDEFINED	False
14161	14453	21853455:11:SOX9:COL2A1	Chromatin IP analyses revealed that CTS increased the association between [TF] and its DNA-binding site, included in the [TG] enhancer, on chromatin.	SOX9	COL2A1	0	UNDEFINED	False
14163	14455	22069317:9:STAT3:HSPA4	4PBA also caused transient activation of [TF], and increased abundance of nuclear proteins that bind to the STAT-3-responsive element of the [TG] promoter.	STAT-3	Hsp70	0	UNDEFINED	False
14164	14456	22076197:10:STAT3:VEGFA	The recruitment of [TF], ARNT and HIF-1 to the [TG] promoter was inhibited by eupatilin treatment.	STAT3	VEGF	0	UNDEFINED	False
14165	14457	22076197:6:STAT3:VEGFA	Using a chromatin immunoprecipitation assay, we tested whether eupatilin affects the recruitment of [TF] (STAT3), aryl hydrocarbon receptor nuclear translocator (ARNT) and hypoxia-inducible factor-1 (HIF-1) to the human [TG] promoter.	signal transducer and activator of transcription 3	VEGF	0	UNDEFINED	False
14166	14458	22265740:8:SOX2:NTRK3	Through RNA interference, we knocked down expression levels of [TF] in hES cells and examined the expression of [TG], as well as TRKB.	SOX2	TRKC	0	UNDEFINED	True
14167	14459	22319003:9:STAT3:CCL20	In addition, chromatin immunoprecipitation revealed that stimulation of primary astrocytes with IL-6 plus the sIL-6R induced [TF] binding to the [TG] promoter.	STAT3	CCL20	0	UNDEFINED	False
14168	14460	22328012:6:STAT3:CDKN1A	Our results demonstrate that [TF], but not STAT5, is involved in GC cell growth and cell cycle progression through regulation of gene expression, such as Bcl-2, p16(ink4a) and p21([TG]/cip1).	STAT3	waf1	0	UNDEFINED	False
14169	14461	22542624:3:SOX2:ASXL1	Concomitant downregulation of both [TF] and [TG] during the RA-induced differentiation of P19 cells prompted us to investigate the role of SOX2 in the regulation of ASXL1.	SOX2	ASXL1	0	UNDEFINED	False
14170	14462	22542624:6:SOX2:ASXL1	Serial deletion and mutation studies mapped the [TF] response element region in the [TG] promoter to -1600 to -1400 bp.	SOX2	ASXL1	0	UNDEFINED	False
14171	14463	22542624:7:SOX2:ASXL1	We showed by chromatin immunoprecipitation assay that [TF] directly binds to the [TG] promoter region.	SOX2	ASXL1	0	UNDEFINED	False
14172	14464	22984561:10:STAT3:BCL2	Silencing uPAR and MMP-9 inhibited DNA binding activity of [TF] and also reduced the recruitment of STAT3 protein at the promoter region of [TG] and survivin genes.	STAT3	Bcl-2	0	UNDEFINED	False
14173	14465	23042533:8:STAT3:PGF	Transfection of dominant negative Akt or application of PI3K inhibitorLY294002 significantly inhibited p-Tyr705-[TF], p-Ser727-STAT3, and [TG] expression, indicating that Akt is involved in JAK3/STAT3/PLGF signaling cascade.	STAT3	PLGF	1	ACTIVATION	True
14174	14466	23042533:9:STAT3:PGF	To further examine whether [TF] binds to the promoter region of [TG], Chip assay was used and it was found that OSM could bind with PLGF promoter, which was inhibited by JAK3 and PI3K inhibitors.	STAT3	PLGF	0	UNDEFINED	False
14175	14467	23104276:5:STAT3:VEGFA	Activated [TF] binds to the hypoxia-responsible element that is located -914 to -905 bp upstream of the transcription initiation site in the [TG] promoter and that transcriptionally regulates VEGF gene expression.	STAT3	VEGF	0	UNDEFINED	False
14176	14468	23178160:10:STAT3:CDKN1A	Moreover, we provided evidence that [TF] and nuclear ErbB-2 are key players in progestin-induced p21([TG]) regulation.	Stat3	CIP1	0	UNDEFINED	False
14177	14469	23303450:4:STAT3:SOCS3	The endogenous [TF] target gene, [TG], was upregulated in HSFs and showed increased STAT3 binding on its promoter relative to NFs in a chromatin immunoprecipitation assay.	STAT3	SOCS3	0	UNDEFINED	False
14178	14470	23424038:12:STAT3:EZH2	[TG] expression may be directly regulated by [TF], and STAT3 may play an important role in EZH2-mediated VDR down-regulation in CRC.	STAT3	EZH2	0	UNDEFINED	False
14179	14471	23424038:9:STAT3:EZH2	Moreover, we found that [TF] directly binds to the [TG] promoter and regulates VDR down-regulation in CRC cells.	STAT3	EZH2	2	REPRESSION	True
14180	14472	23454751:9:STAT3:ARG1	Analysis of the human [TG] promoter region showed multiple [TF]-binding elements, and ChIP demonstrated that phosphorylated STAT3 binds to multiple sites in the arginase-I promoter.	STAT3	arginase-I	0	UNDEFINED	False
14181	14473	23468913:2:SOX9:HAPLN1	Previous investigations into the transcriptional regulation of the [TG] gene have shown that [TF] regulates Crtl1 expression in both cartilage and the AV valves.	Sox9	Crtl1	0	UNDEFINED	False
14182	14474	23553930:6:SOX2:KIT	We also show that [TF] regulates [TG] expression in PGCs and binds to discrete transcriptional regulatory sequences of this gene, which is known to be important for PGCs survival and proliferation.	Sox2	Kit	0	UNDEFINED	False
14183	14475	23660500:0:SOX9:IGFBP4	[TF] directly regulates [TG] in the intestinal epithelium.	SOX9	IGFBP-4	0	UNDEFINED	False
14184	14476	23681230:4:STAT3:GADD45G	Next, ChIP assays revealed that SRT2183 reduces the DNA-binding activity of both NF-B and [TF] to the promoter of [TG], which is one of the most upregulated genes following SRT2183 treatment.	STAT3	GADD45G	0	UNDEFINED	False
14185	14477	23681230:9:STAT3:GADD45G	In addition, the binding of NF-B/[TF] complexes to the [TG] promoter is inhibited following panobinostat, SRT501 or resveratrol treatment.	STAT3	GADD45G	0	UNDEFINED	False
14186	14478	23686482:0:STAT3:MICA	Inhibition of glycogen synthase kinase-3 increases NKG2D ligand [TG] expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of [TF].	STAT3	MICA	1	ACTIVATION	True
14187	14479	23702480:6:STAT3:BST2	Furthermore, [TG] expression and promoter activity were regulated by activated [TF] (STAT3).	signal transducer and activator of transcription 3	BST-2	0	UNDEFINED	False
14188	14480	23716595:0:STAT3:BCL6	STAT5 outcompetes [TF] to regulate the expression of the oncogenic transcriptional modulator [TG].	STAT3	BCL6	0	UNDEFINED	False
14189	14481	23756865:12:STAT3:VEGFA	While hypoxia increases phospho-[TF], Hif1, and CBP/p300 recruitment as a transcriptional complex within the [TG] promoter, melatonin 1mM decreases their physical interaction.	STAT3	VEGF	0	UNDEFINED	False
14190	14482	23860260:8:SOX9:MATN1	The conserved [TG] control elements bind Hmgb1 and [TF] with opposite efficiency in vitro.	SOX9	Matn1	0	UNDEFINED	False
14191	14483	23884650:4:SOX2:LIN28A	We found that [TF] binds to a proximal site in the [TG] promoter region and regulates LIN28 promoter acetylation, likely through interactions with the histone acetyltransferase complex.	SOX2	LIN28	0	UNDEFINED	False
14192	14484	23911788:11:STAT3:ABCB1	Subsequently, JAB1 knockdown significantly decreased the expression levels of [TG], NANOG, and VEGF, which are [TF] target genes.	STAT3	MDR1	0	UNDEFINED	False
14193	14485	23911788:11:STAT3:VEGFA	Subsequently, JAB1 knockdown significantly decreased the expression levels of MDR1, NANOG, and [TG], which are [TF] target genes.	STAT3	VEGF	0	UNDEFINED	False
14194	14486	23954444:8:STAT3:HGF	Chromatin immunoprecipitation assay showed that [TF] is located at the active [TG] promoter in response to IL-6+Dx stimulation.	STAT3	HGF	0	UNDEFINED	False
14195	14487	24249112:5:SPI1:RUNX3	[TF] controls LC differentiation by regulating the expression of the critical TGF- responsive transcription factor [TG].	PU.1	RUNX3	0	UNDEFINED	False
14196	14488	24315995:4:STAT3:IL10	In-depth analysis revealed that histone acetyl transterase-1, in association with FoxP3, modified the [TG] promoter epigenetically, making a space for docking [TF]-FoxP3 complexes.	STAT3	IL10	0	UNDEFINED	False
14197	14489	24344131:6:SOX9:COL2A1	The expression of [TF] mRNA and nuclear protein was also repressed, resulting in decreased binding of SOX9 to the [TG] enhancer as shown by a ChIP assay.	Sox9	Col2a1	0	UNDEFINED	False
14198	14490	24429361:4:STAT3:CCL2	Computational analysis for DNA-bound transcription factors in the [TG] promoter identified adjacent binding sites for CCAAT/CEBP, spleen focus-forming virus, proviral integration oncogene (SPI1/PU.1), and [TF].	STAT3	CCL2	0	UNDEFINED	False
14199	14491	24462277:6:STAT3:NANOG	ChIP showed that phosphorylated [TF] directly binds to the [TG] promoter.	stat3	NANOG	0	UNDEFINED	False
14201	14493	24550541:5:STAT3:PRKCB	[TF] bound to previously undescribed negative regulatory elements within the promoter of [TG], which encodes PKCII.	STAT3	PRKCB	2	REPRESSION	True
14202	14494	24634209:5:SOX9:RGR	ChIP reveals that [TF] and OTX2 bind to the promoter regions of RPE65, RLBP1, and [TG] and that LHX2 binds to those of RPE65 and RGR in bovine RPE.	SOX9	RGR	0	UNDEFINED	False
14203	14495	24634209:5:SOX9:RLBP1	ChIP reveals that [TF] and OTX2 bind to the promoter regions of RPE65, [TG], and RGR and that LHX2 binds to those of RPE65 and RGR in bovine RPE.	SOX9	RLBP1	0	UNDEFINED	False
14204	14496	24634209:5:SOX9:RPE65	ChIP reveals that [TF] and OTX2 bind to the promoter regions of [TG], RLBP1, and RGR and that LHX2 binds to those of RPE65 and RGR in bovine RPE.	SOX9	RPE65	0	UNDEFINED	False
14205	14497	24634209:6:SOX9:RGR	ChIP with human fetal RPE cells shows that [TF] and OTX2 also bind to the human RPE65, RLBP1, and [TG] promoters.	SOX9	RGR	0	UNDEFINED	False
14206	14498	24634209:6:SOX9:RLBP1	ChIP with human fetal RPE cells shows that [TF] and OTX2 also bind to the human RPE65, [TG], and RGR promoters.	SOX9	RLBP1	0	UNDEFINED	False
14207	14499	24661907:4:SOX9:TUBB3	Using chromatin immunoprecipitation (ChIP) we found that [TF] engages [TG] promoter at minus 980 base pairs from the transcriptional start site with transcriptional enhancing effects.	Sox9	TUBB3	1	ACTIVATION	True
14208	14500	24865234:3:SOX5:CYP19A1	A number of cis-acting elements, such as the oestrogen receptor, steroidogenic factor 1 and [TF] recognition sites, were found in the promoter of the [TG] gene, which possesses a promoter function confirmed by a recombination green fluorescent protein checking system in vitro.	SOX-5	cyp19	0	UNDEFINED	False
14209	14501	24953186:4:STAT3:CDX2	ChIP assays determined that in IL-6-treated cells, c-JUN and p-[TF] bound to [TG] promoter in MKN45 cells whereas in NUGC-4 cells, p-STAT3 binds to and c-JUN releases from the CDX2 promoter.	STAT3	CDX2	0	UNDEFINED	False
14210	14502	7519723:6:STAT3:A2M	Bandshift experiments and oligonucleotide competition experiments showed that both factors, MGF and [TF], are able to bind to the IL-6 response element of the [TG] gene promoter and to the lactogenic hormone response element of the beta-casein gene promoter with very similar specificities.	APRF	alpha 2-M	0	UNDEFINED	False
14211	14503	7519723:6:STAT3:CSN2	Bandshift experiments and oligonucleotide competition experiments showed that both factors, MGF and [TF], are able to bind to the IL-6 response element of the alpha 2-M gene promoter and to the lactogenic hormone response element of the [TG] gene promoter with very similar specificities.	APRF	beta-casein	0	UNDEFINED	False
14212	14504	7592638:8:STAT3:A2M	These findings show for the first time that [TF] is involved in associating with the IL-6 responsive elements of fibrinogen gamma chain, a class II acute phase gene other than [TG].	Stat3	alpha 2-macroglobulin	0	UNDEFINED	False
14213	14505	7592638:8:STAT3:FGG	These findings show for the first time that [TF] is involved in associating with the IL-6 responsive elements of [TG], a class II acute phase gene other than alpha 2-macroglobulin.	Stat3	fibrinogen gamma chain	0	UNDEFINED	False
14214	14506	8647290:0:STAT3:FCGR1A	Granulocyte colony-stimulating factor induces the binding of STAT1 and [TF] to the IFNgamma response region within the promoter of the Fc(gamma)RI/[TG] gene in human neutrophils.	STAT3	CD64	0	UNDEFINED	False
14215	14507	8668165:6:STAT3:LBP	Furthermore, cloning of the [TG] promoter revealed the presence of regulatory elements, including the common APR promoter motif APRE/STAT-3 (acute-phase response element/[TF]).	signal transducer and activator of transcription 3	LBP	0	UNDEFINED	False
14216	14508	9121483:5:SOX9:COL2A1	Our experiments indicate that the minimal [TG] enhancer is a direct target for [TF].	Sox9	Col2a1	0	UNDEFINED	False
14217	14509	9669521:0:SOX2:FGF4	Role of the transcription factor [TF] in the expression of the [TG] gene in embryonal carcinoma cells.	Sox-2	FGF-4	0	UNDEFINED	False
14218	14510	9669521:10:SOX2:FGF4	Our studies also demonstrate that [TF] affects the expression of the [TG] gene in the multipotent EC cell line, P19.	Sox-2	FGF-4	0	UNDEFINED	False
14219	14511	9669521:11:SOX2:FGF4	Taken together, these studies argue strongly that [TF] plays an important role in the expression of the [TG] gene in vivo.	Sox-2	FGF-4	1	ACTIVATION	True
14221	14513	9812998:12:SMAD2:RUNX2	These data indicate that [TF] regulates Smad4 specifically and that [TG] gene is one of the downstream targets of Smad2.	Smad2	CBFA1	0	UNDEFINED	False
14222	14514	9880553:4:STAT3:HSPA4	The effect of IFN-gamma/STAT-1 was mediated via a short region of the [TG]/Hsp-90 promoters, which also mediates the effects of NF-IL6 and [TF] and can bind STAT-1.	STAT-3	Hsp-70	0	UNDEFINED	False
14223	14515	22761647:0:TEAD4:VEGFA	The related transcriptional enhancer factor-1 isoform, [TF](216), can repress [TG] expression in mammalian cells.	TEAD4	vascular endothelial growth factor	2	REPRESSION	False
14224	14516	22761647:4:TEAD4:VEGFA	In this study we describe a new [TF] isoform, TEAD4(216), which represses [TG] promoter activity.	TEAD4	VEGF	2	REPRESSION	False
14225	14517	19318582:8:TWIST1:YBX1	In summary, PDCD4 negatively regulates [TG] expression via its interaction with [TF] and is involved in cancer cell growth and chemoresistance.	Twist1	YB-1	2	REPRESSION	False
14226	14518	12161443:10:ZEB1:MUC1	[TF] could also repress E-cadherin and [TG] promoters but less strongly than Snail.	ZEB1	MUC1	2	REPRESSION	False
14227	14519	14969394:14:TFAP2A:SOX6	Expression profile analysis of key transcription factors involved in chondrogenesis showed that overexpression of [TF] maintained the expression of Sox9 but suppressed the expression of SoxS and [TG].	AP-2alpha	Sox6	2	REPRESSION	False
14228	14520	16804902:1:ZEB1:CDH1	[TF] and SNAIL repress [TG] and induce epithelial-mesenchymal transition (EMT).	ZEB1	CDH1	2	REPRESSION	False
14229	14521	17391671:0:ZEB1:PKP3	The transcription factor [TF] (deltaEF1) represses [TG] during human cancer progression.	ZEB1	Plakophilin 3	2	REPRESSION	False
14231	14523	18775765:0:TEAD1:PRL	[TF] inhibits [TG] gene expression in cultured human uterine decidual cells.	TEAD1	prolactin	2	REPRESSION	False
14232	14524	18775765:1:TEAD1:PRL	Forced overexpression of [TF] in human uterine fibroblast (HUF) and human endometrial stromal cells markedly inhibited [TG] promoter activity in both cell types in a dose-dependent manner, with maximal inhibition of greater than 90%.	TEAD1	prolactin	2	REPRESSION	False
14233	14525	19177200:0:ZEB1:SEMA3F	[TF], a repressor of the [TG] tumor suppressor gene in lung cancer cells.	ZEB-1	semaphorin 3F	2	REPRESSION	False
14234	14526	19177200:6:ZEB1:SEMA3F	In the present study, we demonstrated that [TF] also inhibits [TG] in lung cancer cells.	ZEB-1	SEMA3F	2	REPRESSION	False
14235	14527	19181930:6:ZEB1:IL2	Over-expression of [TF] can repress [TG] promoter activity, as well as endogenous IL-2 mRNA production in EL-4 T cells, and this repression is dependent on the ZEB-binding site at -100.	ZEB1	IL-2	2	REPRESSION	False
14236	14528	19181930:7:ZEB1:IL2	[TF] cooperates with the co-repressor C-terminal-binding protein (CtBP) 2 and with histone deacetylase 1 to repress the [TG] promoter and this cooperation depends on the ZEB-binding site in the promoter as well as the Pro-X-Asp-Leu-Ser protein-protein interaction domain in CtBP2.	ZEB1	IL-2	2	REPRESSION	False
14237	14529	19181930:8:ZEB1:IL2	Thus, [TF] may function to recruit a repressor complex to the [TG] promoter.	ZEB1	IL-2	2	REPRESSION	True
14238	14530	19424592:4:ZEB2:CDH1	[TF] represses transcription of [TG], CLDN4, CCND1, TERT, SFRP1, ALPL and miR-200b-200a-429 primary miRNA, and upregulates transcription of mesenchymal markers.	ZEB2	CDH1	2	REPRESSION	False
14239	14531	20807817:5:ZEB1:TP73	BRCA1-deficient ovarian carcinoma cells exhibit hypermethylation within a [TG] regulatory region, which includes the binding site for the p73 transcriptional repressor [TF], leading to the abrogation of ZEB1 binding and increased expression of transactivating p73 isoforms (TAp73).	ZEB1	p73	2	REPRESSION	False
14240	14532	21079000:6:ZEB1:OXTR	Excitingly, we observed that [TF] and ZEB2 inhibit expression of the contraction-associated genes, [TG] receptor and connexin-43, and block oxytocin-induced contractility in human myometrial cells.	ZEB1	oxytocin	2	REPRESSION	False
14241	14533	21079000:6:ZEB2:OXTR	Excitingly, we observed that ZEB1 and [TF] inhibit expression of the contraction-associated genes, [TG] receptor and connexin-43, and block oxytocin-induced contractility in human myometrial cells.	ZEB2	oxytocin	2	REPRESSION	False
14242	14534	21236582:7:ZEB2:COL1A2	Overexpression of [TF] in keloid and hypertrophic scar fibroblasts represses TGF-1-stimulated [TG] expression and induces MMP1 expression.	SIP1	COL1A2	2	REPRESSION	False
14243	14535	21236582:8:ZEB2:COL1A2	Alternatively, knockdown of [TF] in normal skin fibroblasts enhance TGF-1-induced [TG] levels.	SIP1	COL1A2	2	REPRESSION	False
14244	14536	21378168:5:WT1:PAX2	[TF] recruits PcG complex to the [TG] promoter and represses expression of Pax2 through PcG-dependent H3K27me3.	WT1	Pax2	2	REPRESSION	False
14245	14537	22293114:6:TGIF1:SOX3	[TF] overexpression downregulates [TG] promoter activity and decreases endogenous SOX3 protein expression in both uninduced and retinoic acid (RA)-induced NT2/D1 cells.	TGIF	SOX3	2	REPRESSION	False
14246	14538	22457607:4:TWIST1:ESR1	This association of [TF] efficiently recruited the nucleosome remodeling and deacetylase (NuRD) repressor complex to this region, which subsequently decreased histone H3K9 acetylation, increased histone H3K9 methylation and repressed [TG] expression in breast cancer cells.	TWIST	ESR1	2	REPRESSION	False
14247	14539	23133399:4:TRPS1:SOX9	We found that [TF] directly represses expression of the hair follicle stem cell regulator [TG] to control proliferation of the follicle epithelium.	Trps1	Sox9	2	REPRESSION	False
14248	14540	23667256:3:ZEB1:CDH1	Loss and gain of function analyses revealed that [TF] represses [TG] expression to fine-tune adhesiveness of migrating deep blastodermal cells.	Zeb1	cdh1	2	REPRESSION	False
14249	14541	23667256:5:ZEB1:EPCAM	We found a similar [TF]-dependent repression of [TG] expression in human pancreatic and breast cancer cell lines, mediated through direct binding of ZEB1 to the EPCAM promoter.	ZEB1	EPCAM	2	REPRESSION	False
14250	14542	23890107:0:ZEB1:CDH1	GLI2 cooperates with [TF] for transcriptional repression of [TG] expression in human melanoma cells.	ZEB1	CDH1	2	REPRESSION	False
14252	14544	23943797:9:ZEB1:GRHL2	The combination of TGF- and Wnt activation repressed [TG] expression by direct interaction of [TF] with the GRHL2 promoter, inducing EMT.	ZEB1	GRHL2	2	REPRESSION	False
14253	14545	24216980:4:ZEB1:EPCAM	In the present study, we show that in H358 non-small cell lung cancer cells, [TF] downregulates EpCAM (coding for an [TG]), ESRP1 (epithelial splicing regulatory protein), ST14 (a membrane associated serine protease involved in HGF processing) and RAB25 (a small G-protein) by direct binding to these genes.	ZEB1	epithelial cell adhesion molecule	2	REPRESSION	False
14254	14546	24216980:4:ZEB1:ESRP1	In the present study, we show that in H358 non-small cell lung cancer cells, [TF] downregulates EpCAM (coding for an epithelial cell adhesion molecule), [TG] (epithelial splicing regulatory protein), ST14 (a membrane associated serine protease involved in HGF processing) and RAB25 (a small G-protein) by direct binding to these genes.	ZEB1	ESRP1	2	REPRESSION	False
14255	14547	24216980:4:ZEB1:RAB25	In the present study, we show that in H358 non-small cell lung cancer cells, [TF] downregulates EpCAM (coding for an epithelial cell adhesion molecule), ESRP1 (epithelial splicing regulatory protein), ST14 (a membrane associated serine protease involved in HGF processing) and [TG] (a small G-protein) by direct binding to these genes.	ZEB1	RAB25	2	REPRESSION	False
14256	14548	24216980:4:ZEB1:ST14	In the present study, we show that in H358 non-small cell lung cancer cells, [TF] downregulates EpCAM (coding for an epithelial cell adhesion molecule), ESRP1 (epithelial splicing regulatory protein), [TG] (a membrane associated serine protease involved in HGF processing) and RAB25 (a small G-protein) by direct binding to these genes.	ZEB1	ST14	2	REPRESSION	False
14257	14549	9738017:8:WT1:PAX2	The [TF] tumor suppressor protein, which has previously been shown to repress murine Pax2 expression in vitro, was shown to also repress expression from the human [TG] promoter.	WT1	PAX2	2	REPRESSION	False
14258	14550	23667256:0:ZEB1:EPCAM	[TF] regulates E-cadherin and [TG] (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development.	Zeb1	Epcam	0	UNDEFINED	True
14259	14551	7720589:5:WT1:PAX2	A marked increase in [TF] protein levels coincided precisely with down-regulation of the [TG] gene in the individual precursor cells of the visceral glomerular epithelium, suggesting a direct effect of the WT1 repressor protein on Pax-2 regulatory elements.	WT1	Pax-2	2	REPRESSION	False
14261	14553	17644613:7:ZEB2:SFRP1	In cortical cells, [TF] protein was detected on the promoter of [TG] gene and both genes showed a mutually exclusive pattern of expression suggesting that Sfrp1 expression is negatively regulated by Sip1.	Sip1	Sfrp1	2	REPRESSION	False
14262	14554	19177200:10:ZEB1:SEMA3F	These results demonstrate that [TF] directly inhibits [TG] expression in lung cancer cells.	ZEB-1	SEMA3F	2	REPRESSION	False
14263	14555	22147512:10:ZEB1:CDH1	Moreover, knockdown of [TF] prevented HDAC from binding to the [TG] promoter, resulting in histone acetylation and expression of E-cadherin.	ZEB1	CDH1	2	REPRESSION	False
14264	14556	10446138:0:TEAD2:TP53	The adenovirus oncoprotein E1a stimulates binding of transcription factor [TF] to transcriptionally activate the [TG] gene.	ETF	p53	1	ACTIVATION	False
14265	14558	12642588:10:TEAD2:PCYT1A	These results suggest that Ets-1 is an important transcriptional activator of the [TG] gene and that Ets-1 activity is enhanced by [TF].	TEF-4	CTalpha	1	ACTIVATION	False
14266	14559	12642588:2:TEAD2:PCYT1A	Transcriptional enhancer factor-4 ([TF]) enhances the transcription of [TG] in COS-7 cells by interactions with the basal transcription machinery (Sugimoto, H., Bakovic, M., Yamashita, S., and Vance, D.E. (2001) J. Biol. Chem. 276,12338-12344).	TEF-4	CTalpha	1	ACTIVATION	False
14267	14560	12642588:9:TEAD2:PCYT1A	Co-transfection experiments with Ets-1 and [TF] showed enhanced expression of reporter constructs as well as [TG] mRNA.	TEF-4	CTalpha	1	ACTIVATION	False
14268	14561	15073166:0:TEAD4:VEGFA	[TF], a novel transcriptional stimulator of [TG] in hypoxic endothelial cells.	RTEF-1	vascular endothelial growth factor	1	ACTIVATION	False
14269	14562	15073166:11:TEAD4:VEGFA	These results indicate that [TF] acts as a transcriptional stimulator of [TG] by regulating VEGF promoter activity through binding to Sp1 site.	RTEF-1	VEGF	1	ACTIVATION	False
14270	14563	15073166:5:TEAD4:VEGFA	Overexpression of [TF] increases [TG] promoter activity and VEGF expression.	RTEF-1	VEGF	1	ACTIVATION	False
14271	14564	16118513:5:TFAP2A:SOX2	Taking our data together, [TF], Pax6 and PROX1 can activate the [TG] promoter.	AP2	Sox2	1	ACTIVATION	False
14272	14565	16162653:8:ZEB2:FOXE3	Using transfection assays, the [TG] promoter was activated by [TF] and this activation is further augmented by Smad8 in the manner dependent on the Smad-binding domain of Sip1.	Sip1	Foxe3	1	ACTIVATION	False
14273	14566	16391805:6:ZEB2:MMP2	Analysis of the [TG] promoter revealed that an Ets-1 binding site, located between position -1255 and -1248 relative to the transcriptional start site, was critical for the activation by Snail, [TF] and TGF-beta1 in SCC cells.	SIP1	MMP-2	1	ACTIVATION	False
14274	14567	16568083:6:ZEB2:VIM	Inversely, inhibition of [TF] expression by RNAi strategies in BT-549 cells and MCF10A cells decreased [TG] expression.	SIP1	vimentin	1	ACTIVATION	False
14275	14568	19236848:7:TEAD4:HIF1A	Conversely, [TF] appeared to regulate the expression of [TG]: HIF-1alpha promoter activity was increased (3.6-fold) by RTEF-1 overexpression in BAEC.	RTEF-1	HIF-1	1	ACTIVATION	False
14276	14569	19285023:4:TEAD4:FGFR1	[TF] stimulated [TG] promoter activity in a dose-dependent manner.	RTEF-1	FGFR-1	1	ACTIVATION	False
14277	14570	19285023:5:TEAD4:FGFR1	[TF] enhanced [TG] mRNA (4-fold) and protein expression (3.5-fold) whereas RTEF-1 siRNA decreased FGFR-1 protein expression (4-fold).	RTEF-1	FGFR-1	1	ACTIVATION	False
14278	14571	19285023:9:TEAD4:FGFR1	Our results indicate that [TF] acts as a transcriptional stimulator of [TG] in endothelial cells through its activation of the FGFR-1 promoter.	RTEF-1	FGFR-1	1	ACTIVATION	False
14279	14572	21169295:4:TEAD4:VEGFB	Additionally, [TG] was increased in endothelial cells from VE-Cad/[TF] mice, as well as in endothelial cells with forced RTEF-1 expression (HMEC-1/RTEF-1), and coincidentally decreased when RTEF-1 was deficient in HMEC-1.	RTEF-1	VEGF-B	1	ACTIVATION	False
14280	14573	21236582:7:ZEB2:MMP1	Overexpression of [TF] in keloid and hypertrophic scar fibroblasts represses TGF-1-stimulated COL1A2 expression and induces [TG] expression.	SIP1	MMP1	1	ACTIVATION	False
14281	14574	21540178:10:TEAD4:HIF1A	These results identify [TF] as a regulator of [TG] transcription, which results in up-regulation of HIF-1 and acceleration of recovery from ischemia.	RTEF-1	HIF-1	0	UNDEFINED	True
14282	14575	21677079:7:TWIST1:DSPP	For the first time, our results showed that [TF] overexpression in DPSCs enhanced the expression of [TG], a gene that marks odontoblast terminal differentiation.	Twist1	DSPP	1	ACTIVATION	False
14283	14576	21876555:10:TWIST1:AKT2	[TF] promotes EMT in part by directly repressing E-cadherin expression by recruiting the nucleosome remodeling and deacetylase complex for gene repression and by upregulating Bmi1, [TG], YB-1, etc.	Twist1	AKT2	1	ACTIVATION	False
14284	14577	21876555:10:TWIST1:BMI1	[TF] promotes EMT in part by directly repressing E-cadherin expression by recruiting the nucleosome remodeling and deacetylase complex for gene repression and by upregulating [TG], AKT2, YB-1, etc.	Twist1	Bmi1	1	ACTIVATION	False
14285	14578	21876555:10:TWIST1:YBX1	[TF] promotes EMT in part by directly repressing E-cadherin expression by recruiting the nucleosome remodeling and deacetylase complex for gene repression and by upregulating Bmi1, AKT2, [TG], etc.	Twist1	YB-1	1	ACTIVATION	False
14286	14579	22337869:7:YBX1:KLF4	Upon RAR agonist stimulation, RAR was recruited to the Klf4 promoter through its interaction with [TG], Sp1, and [TF] to form a transcriptional activation complex on the three GC boxes of the Klf4 promoter.	YB1	KLF4	1	ACTIVATION	True
14287	14580	22433836:4:TEAD4:FGFR1	We demonstrated that [TF] stimulated [TG] expression at the transcriptional level, specifically an area including Sp1 elements, as evidenced by promoter assays.	RTEF-1	FGFR1	1	ACTIVATION	False
14288	14581	22433836:5:TEAD4:FGFR1	Additionally, [TF] increased [TG] mRNA and protein expression in vitro and in VE-cadherin-promoted RTEF-1 (VE-Cad/RTEF-1) transgenic mice, whereas RTEF-1 siRNA blocked the upregulation of FGFR1 expression.	RTEF-1	FGFR1	1	ACTIVATION	False
14289	14582	22433836:7:TEAD4:FGFR1	Our results indicate that [TF] acts as a transcriptional stimulator of [TG] and is involved in FGF pathways by increasing microvessel dilatation via eNOS.	RTEF-1	FGFR1	1	ACTIVATION	False
14290	14583	22843786:9:TEAD4:IGFBP1	These results show that [TF]-stimulated [TG] expression may be central to the mechanism by which RTEF-1 attenuates blood glucose levels.	RTEF-1	IGFBP-1	1	ACTIVATION	False
14291	14584	23994529:0:TEAD1:NAIP	Interaction with the Yes-associated protein (YAP) allows [TF] to positively regulate [TG] expression.	TEAD1	NAIP	1	ACTIVATION	False
14292	14585	24130169:6:ZEB2:CDH11	We found that [TF] directly induced [TG] transcription in an Sp1-dependent, but Smad- and E-box-independent, manner and repressed E-cadherin expression in an Sp1- and Smad-independent manner, leading to cadherin switch.	ZEB2	cadherin-11	1	ACTIVATION	False
14293	14586	24224020:10:ZNF24:CTNNB1	The -Catenin ([TG]) luciferase assays showed that the [TF] mutants defective in nuclear localization could not promote CTNNB1 promoter activation as the wild-type ZNF24 did.	ZNF24	CTNNB1	1	ACTIVATION	False
14294	14587	24520353:5:TEAD4:S1PR1	[TF] could bind to [TG] promoter and subsequently induce its activity.	RTEF-1	Edg-1	1	ACTIVATION	False
14295	14588	25097756:5:ZEB1:SLC2A3	Furthermore, we identify that [TF] binds to the [TG] gene to activate transcription.	ZEB1	GLUT3	1	ACTIVATION	False
14296	14589	2768275:1:TEAD2:EGFR	Transcription factor [TF] stimulates the expression of the [TG] (EGFR) gene which does not have a TATA box in the promoter region.	ETF	epidermal growth factor receptor	1	ACTIVATION	False
14297	14590	3393529:2:TEAD2:EGFR	We found that a nuclear factor, termed [TG]-specific transcription factor ([TF]), specifically stimulated EGFR transcription by 5- to 10-fold.	ETF	EGFR	1	ACTIVATION	False
14298	14591	3393529:4:TEAD2:EGFR	"[TF] binds to the promoter region, as measured by DNase I ""footprinting"" and gel-mobility-shift assays, and specifically stimulates the transcription of the [TG] gene in a reconstituted in vitro transcription system."	ETF	EGFR	1	ACTIVATION	False
14299	14592	21355089:5:ZEB2:ANGPT1	Moreover, deletion of [TF] resulted in embryonic (Tie2-Cre) and perinatal (Vav-icre) lethality due to severe cephalic hemorrhaging and decreased levels of [TG] and, subsequently, improper pericyte coverage of the cephalic vasculature.	Zeb2	angiopoietin-1	1	ACTIVATION	False
14300	14593	12384280:5:TEAD1:ANKRD1	Previous reports suggested that the mouse [TG] promoter was dependent on the GATA4 transcription factor whereas the human CARP promoter was dependent on transcriptional enhancer factor-1 ([TF]).	TEF-1	CARP	1	ACTIVATION	False
14301	14594	21169295:5:TEAD4:VEGFB	Using chromatin immunoprecipitation and luciferase assays, we found that [TF] increased [TG] promoter activity through a direct interaction.	RTEF-1	VEGF-B	1	ACTIVATION	False
14302	14595	18275068:10:TP63:RUNX1	Consistent with this, endogenous [TG] levels are lower in the skin of [TF](+/-) animals as compared to wild type animals.	p63	Runx1	1	ACTIVATION	False
14303	14596	24371144:10:ZEB1:BMI1	Because miR-200 represses [TG], induction of [TF] leads to induction of Bmi1.	ZEB1	Bmi1	1	ACTIVATION	False
14304	14597	15073166:12:TEAD4:VEGFA	In addition, [TF]-induced [TG] promoter activity was enhanced in a hypoxic condition, indicating that RTEF-1 may play an important role in the regulation of VEGF under hypoxia.	RTEF-1	VEGF	1	ACTIVATION	False
14305	14598	15013809:0:YY1:PAX2	Expression of [TG] in the intermediate mesoderm is regulated by [TF].	YY1	Pax2	0	UNDEFINED	False
14306	14599	11169739:11:TWIST1:COL1A2	These results indicate that Egr-1 and [TF] are expressed in undifferentiated MC3T3-E1 osteoblast-like cells following treatment with FGF-2 and they may be potential transcriptional regulators of FGF-2s negative effects on [TG] gene expression.	TWIST	alpha2(I) collagen	2	REPRESSION	True
14307	14600	10076050:14:TEAD1:TGFA	The purification of [TF] furthers our understanding of how [TG] expression is regulated and may help us understand the upstream signaling events that lead to the elevated expression of this growth factor.	TEF1	TGF-alpha	0	UNDEFINED	False
14308	14601	10446138:6:TEAD2:TP53	One of these, [TF], binds to three upstream sites in the [TG] promoter and one downstream site, whereas E2F binds to one upstream site in the presence of E1a.	ETF	p53	0	UNDEFINED	False
14309	14602	12388300:9:TEAD4:S100B	Our results suggest that alpha(1)-adrenergic stimulation induces the [TG] gene after myocardial infarction through the PKC signaling pathway and that this induction is modulated by TEF-1 and [TF].	RTEF-1	S100B	1	ACTIVATION	True
14310	14603	14706452:5:ZIC1:CTNNB1	Subsequently, protein/DNA array analyses identified numerous other transcription factors through their high-affinity binding to the [TG] promoter, including E2F1, NFkappaB, MEF1, Pax5, ISRE2, Smad3/4, GATA, and [TF].	ZIC	Ctnnb1	0	UNDEFINED	False
14311	14604	15073166:9:TEAD4:VEGFA	Binding activity of [TF] to [TG] promoter is also confirmed by chromatin immunoprecipitation.	RTEF-1	VEGF	0	UNDEFINED	False
14312	14605	16568083:2:ZEB2:VIM	In the present study, we investigated the potential role of [TF] in the regulation of [TG] during the EMT associated with breast tumor cell migration and invasion.	SIP1	vimentin	0	UNDEFINED	False
14313	14606	16568083:7:ZEB2:VIM	We also showed that [TF] transfection did not activate the TOP-FLASH reporter system, suggesting that the beta-catenin/TCF pathway is not implicated in the regulation of [TG] by SIP1.	SIP1	vimentin	0	UNDEFINED	False
14314	14607	16568083:8:ZEB2:VIM	Our results therefore implicate [TF] in the regulation of [TG] observed in the EMT associated with breast tumor cell migration, a pathway that may contribute to the metastatic progression of breast cancer.	SIP1	vimentin	0	UNDEFINED	False
14315	14608	17997399:6:TRPS1:STAT3	Altogether our findings identify [TF] as a novel regulator of chondrocytes proliferation and survival through the control of [TG] expression.	Trps1	Stat3	0	UNDEFINED	False
14316	14609	18275068:12:TP63:RUNX1	Taken together our data demonstrate that [TF] directly regulates [TG] gene expression through a novel enhancer element and suggests a role for these two transcription factors in dictating skin keratinocyte and appendage development.	p63	Runx1	0	UNDEFINED	False
14317	14610	18275068:8:TP63:RUNX1	We demonstrate that DeltaN[TF] binds to a p63-response element located within a well-conserved enhancer of the [TG] gene.	p63	Runx1	0	UNDEFINED	False
14319	14612	19181930:5:ZEB1:IL2	We show here that [TF] is expressed in non-stimulated and stimulated T cells and using chromatin immunoprecipitation assays we show that ZEB1 binds to the [TG] promoter.	ZEB1	IL-2	0	UNDEFINED	False
14320	14613	19285023:10:TEAD4:FGFR1	[TF] thus plays an important role in the regulation of [TG] expression.	RTEF-1	FGFR-1	0	UNDEFINED	False
14321	14614	19285023:2:TEAD4:FGFR1	In this study, we report the regulation of [TG] expression by related transcriptional enhancer factor-1 ([TF]) in vitro (endothelial cells) and in vivo (RTEF-1 transgenic mice).	RTEF-1	FGFR-1	0	UNDEFINED	False
14322	14615	20175752:10:ZEB1:BCL6	CtBP is ubiquitously expressed and the results of the present study suggest that regulation of [TF] is required for control of [TG] expression.	ZEB1	BCL6	0	UNDEFINED	False
14323	14616	20826535:7:TWIST1:SHH	Previous studies have shown that [TF] functions by forming homodimers or heterodimers with other bHLH factors including HAND2, a key positive regulator of [TG] expression.	TWIST1	Shh	0	UNDEFINED	True
14324	14617	20972454:0:TP63:KLF4	Mutant p53 subverts [TF] control over [TG] expression in keratinocytes.	p63	KLF4	0	UNDEFINED	False
14325	14618	21378168:6:WT1:PAX2	Moreover, [TF] also interacts with DNA methyltransferase 1 (DNMT1), and recruits DNMT1 to the [TG] promoter, resulting in hypermethylation of CpG in the Pax2 promoter.	WT1	Pax2	0	UNDEFINED	False
14326	14619	21907184:4:XBP1:RUNX2	Analysis of a 1kb segment of the [TG] promoter revealed an [TF] binding site; electrophoretic mobility shift and chromatin immunoprecipitation assays demonstrated that XBP1 bound to the Runx2 promoter at this site in BMP-2-treated HCSMC.	XBP1	Runx2	0	UNDEFINED	False
14327	14620	22147512:13:ZEB1:CDH1	Recruitment of HDACs to the [TG] promoter is regulated by the transcription factor [TF], and inhibition of HDACs may be a promising antitumour therapy for pancreatic cancer.	ZEB1	CDH1	0	UNDEFINED	False
14328	14621	22147512:9:ZEB1:CDH1	Expression of [TF], a transcription factor known to recruit HDACs, was seen in E-cadherin-deficient cell lines in which ZEB1/HDAC complexes were found attached to the [TG] promoter.	ZEB1	CDH1	0	UNDEFINED	False
14329	14623	23220227:9:TEAD1:MRPL21	Together, our results suggested that [TF] may mediate muscle development through its target genes, [TG], Ndufa6 and Ccne1.	TEAD1	Mrpl21	0	UNDEFINED	False
14330	14624	23220227:9:TEAD1:NDUFA6	Together, our results suggested that [TF] may mediate muscle development through its target genes, Mrpl21, [TG] and Ccne1.	TEAD1	Ndufa6	0	UNDEFINED	False
14331	14625	23994529:4:TEAD1:NAIP	We finally identified an intronic region of the [TG] gene responding to [TF]/YAP activity, suggesting that regulation of NAIP by TEAD1/YAP is at the transcriptional level.	TEAD1	NAIP	0	UNDEFINED	False
14332	14626	2768275:5:TEAD2:EGFR	These inactive [TF]-binding sites became functional when placed upstream of the [TG] promoter whose own ETF-binding sites were removed.	ETF	EGFR	0	UNDEFINED	False
14333	14627	7742531:6:TEAD2:EGFR	This sequence is a motif for a trans-active transcription factor ([TF]) that regulates expression of the [TG] gene (EGFR), which also lacks TATA and CCAAT regulatory elements.	ETF	epidermal growth factor receptor	0	UNDEFINED	False
14334	14628	10978326:12:HNF1A:SRC	These results indicate that [TG] transcriptional regulation is much more complex than previously realized and implicates [TF] in both the tissue-specific regulation of the SRC gene in normal tissues and the overexpression of c-Src in certain human cancers.	HNF-1	SRC	0	UNDEFINED	False
14335	14629	12618758:5:FOSB:FASLG	Ectopic expression of transdominant negative Jun mutants strongly reduced [TG] promoter activity and activation-induced cell death (AICD), confirming the functional significance of [TF]/c-Jun binding.	FosB	CD95L	0	UNDEFINED	True
14336	14630	8584026:8:HNF1A:IGF1	Both [TF]-binding sites are evolutionary well conserved, emphasizing the importance of HNF-1 in the regulation of the [TG] gene expression.	HNF-1	IGF-I	0	UNDEFINED	False
14337	14631	9841917:10:TP53:FAS	In an attempt to understand how [TG] expression is regulated by [TF], we identified a p53-responsive element within the first intron of the CD95 gene, as well as three putative elements within the promoter.	p53	CD95	0	UNDEFINED	False
14338	14632	10330009:5:HNF1A:SERPINA1	Cotransfection studies showed that [TF] and HNF-4 had a synergistic effect on [TG] gene expression.	HNF-1alpha	alpha1-AT	0	UNDEFINED	True
14339	14633	15138269:6:TCF3:CDKN2A	The present study demonstrated not only the capacity of Id1 to regulate [TG] gene expression by [TF], but also the phenotypic consequence of the regulation on cellular senescence, moreover, raised the possibility of Id1-specific gene silencing for human cancer therapy.	E47	p16(INK4a)	0	UNDEFINED	False
14340	14634	18774944:2:SREBF1:FASN	In the present study, we showed that KLF5 acts as a key regulator controlling the expression of FASN ([TG]) through an interaction with [TF] (sterol-regulatory-element-binding protein-1) in the androgen-dependent LNCaP prostate cancer cell line.	SREBP-1	fatty acid synthase	0	UNDEFINED	False
14341	14635	19665600:9:FOSB:IL11	These observations are consistent with the notion that mechanical stress stimulates [TG] gene transcription via an enhanced [TF]/JunD binding to the IL-11 gene promoter, and that increased IL-11 enhances canonical Wnt signal at least in part via a reduction in Dkk2 expression to stimulate osteoblast differentiation.	DeltaFosB	IL-11	1	ACTIVATION	True
14342	14636	19710540:8:HDGF:FAS	Overexpression of IkappaBalpha by transient transfection or inhibition of NF-kappaB by BAY11-7082 suppressed [TF] knock-down effect on [TG] promoter activation, Fas up-regulation, apoptosis induction and growth suppression.	HDGF	fas	0	UNDEFINED	True
14343	14637	10092306:0:HNF1A:LCT	Transcriptional regulation of pig [TG]-phlorizin hydrolase: involvement of [TF] and FREACs.	HNF-1	lactase	0	UNDEFINED	False
14344	14638	10330009:4:HNF1A:SERPINA1	Footprint analysis and electrophoretic mobility shift assays showed that hepatocyte nuclear factor-1alpha ([TF]), HNF-1beta, and HNF-4 from nuclear extracts of Caco-2 cells specifically bound to two regions in the proximal promoter of the [TG] gene.	HNF-1alpha	alpha1-AT	0	UNDEFINED	False
14345	14639	10331424:6:HNF4A:HNF1A	The impaired synergy between COUP TFII and [TF] on the [TG] promoter results from an alteration of their interaction.	HNF-4	HNF-1	0	UNDEFINED	False
14346	14640	10491332:0:HNF1A:INS	Human [TG] gene is a target gene of hepatocyte nuclear factor-1alpha ([TF]) and HNF-1beta.	HNF-1alpha	insulin	0	UNDEFINED	False
14347	14641	10779377:13:HNF1A:UGT2B7	This interaction between [TF] and Oct-1 may fine-tune [TG] expression.	HNF1alpha	UGT2B7	0	UNDEFINED	False
14348	14642	10856241:7:JUNB:CDKN2A	These results demonstrate that [TG] is a direct transcriptional target gene of [TF] and identify JunB as a negative regulator of cell proliferation.	JunB	p16	0	UNDEFINED	False
14349	14643	11145965:9:HNF4A:HNF1A	Direct DNA binding action and cooperativity was demonstrated between FTF and HNF3beta on the Hnf3beta promoter and between FTF and [TF] on the [TG] promoter.	HNF4alpha	Hnf1alpha	0	UNDEFINED	False
14350	14644	11145965:9:NR5A2:HNF1A	Direct DNA binding action and cooperativity was demonstrated between [TF] and HNF3beta on the Hnf3beta promoter and between FTF and HNF4alpha on the [TG] promoter.	FTF	Hnf1alpha	0	UNDEFINED	False
14351	14645	11278466:0:HNF1A:PDX1	A pancreatic beta -cell-specific enhancer in the human [TG] gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta ), [TF], and SPs transcription factors.	HNF-1alpha	PDX-1	0	UNDEFINED	False
14352	14646	11284743:9:HNF1A:AKR1C4	These results indicate that HNF-4alpha, HNF-4gamma and [TF] regulate co-operatively the transcription of the [TG] gene in HepG2 cells.	HNF-1alpha	human DD4	0	UNDEFINED	False
14354	14648	11717395:4:HNF1A:HNF4A	This effect is tissue-specific and mediated through direct occupation by [TF] of an alternate promoter located 45.6 kb from the previously characterized [TG] promoter.	hnf1alpha	hnf4alpha	0	UNDEFINED	False
14355	14649	11733515:0:JUN:FAS	Regulation of [TG] expression by STAT3 and c-[TF] is mediated by phosphatidylinositol 3-kinase-AKT signaling.	Jun	Fas	0	UNDEFINED	False
14356	14650	11762195:4:HNF1A:PAH	These sequences respectively bind [TF] and CREB transcription factors present in rat nuclear extracts and may be significant in the tissue-specific and hormonal control of [TG] expression.	HNF1	PAH	0	UNDEFINED	False
14357	14651	11810258:0:FOXM1:HNF1A	A role for [TF] in the regulation of the [TG] gene of the Atlantic salmon.	HNF-3	HNF-1	0	UNDEFINED	False
14358	14652	11855808:1:SREBF1:FASN	Sterol response element binding protein 1c ([TF]c) is a transcription factor that has been implicated in the regulation of expression of key lipogenic genes in hepatocytes, including [TG] (FAS) and glucokinase.	SREBP-1	fatty acid synthase	0	UNDEFINED	False
14359	14653	12031966:12:HNF1A:IGF1	Our data suggest that [TF] is critical for modulating pancreatic beta-cell growth by regulating [TG] expression.	HNF-1alpha	IGF-1	0	UNDEFINED	False
14360	14654	12447615:3:TP53:FAS	Genetic alterations of [TG] and [TF], with consequent inactivation of gene protein products, may be involved in transcriptional downregulation of Fas.	p53	Fas	0	UNDEFINED	True
14361	14655	12565907:5:HNF1A:TYR	Specific binding of DCoH/[TF] complex to the human [TG] promoter was confirmed by gel shift analysis.	HNF-1	tyrosinase	0	UNDEFINED	False
14362	14656	12788915:2:TP53:FAS	We have evaluated the relative contribution of promoter and intronic [TF] consensus sites to the regulation of the human [TG] gene in breast tumor cells following doxorubicin treatment.	p53	CD95	0	UNDEFINED	False
14363	14657	12788915:7:TP53:FAS	Altogether, these results indicate the lack of involvement of [TF] consensus sites of the [TG] promoter region and the pivotal role of intronic p53-responsive element in the regulation of human CD95 gene expression in breast tumor cells.	p53	CD95	0	UNDEFINED	False
14365	14659	12944915:5:TP53:FAS	Furthermore, mutant [TF] protein binds the [TG] promoter in vitro, in a region distinct from the one implicated in tight interactions of the CD95 gene with wild-type p53.	p53	CD95	0	UNDEFINED	False
14367	14662	14521933:2:HNF1A:INS	Hepatocyte nuclear factor 1 (HNF1), which is encoded by the [TF] gene, has been shown to bind the [TG] promoter.	MODY3	insulin	0	UNDEFINED	False
14368	14663	14561216:4:HNF1A:ALB	We determined how [TF] and IL6DEX-NP regulate rGSTA2 and [TG] expression in rats during the acute phase response after LPS (lipopolysaccharide) treatment.	HNF1	albumin	0	UNDEFINED	False
14369	14664	14561216:4:HNF1A:GSTA2	We determined how [TF] and IL6DEX-NP regulate [TG] and albumin expression in rats during the acute phase response after LPS (lipopolysaccharide) treatment.	HNF1	rGSTA2	0	UNDEFINED	False
14370	14665	14561216:8:HNF1A:GSTA2	By 12 h, [TF] and IL6DEX-NP binding to the [TG] promoter reappeared and increased to above normal at 48 h.	HNF1	rGSTA2	0	UNDEFINED	False
14371	14666	14561216:9:HNF1A:ALB	The patterns of [TF] and IL6DEX-NP binding to the [TG] promoter were similar.	HNF1	albumin	0	UNDEFINED	False
14372	14667	14586772:0:HNF1A:NR1I2	Characterization of six base pair deletion in the putative [TF]-binding site of human [TG] promoter.	HNF1	PXR	0	UNDEFINED	False
14373	14668	14610283:8:ESRRA:NOS3	These results suggest that [TF] has a potential role in the regulation of [TG] expression and may stimulate NO production by endothelial cells, which may in turn result in a protective effect against atherosclerosis.	ERR alpha 1	eNOS	0	UNDEFINED	True
14374	14669	14633861:0:HNF1A:APOM	Regulation of [TG] gene expression by [TF] gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.	MODY3	apolipoprotein M	0	UNDEFINED	False
14375	14670	14699509:13:HNF1A:AFP	Two different mutations localized in either [TF] binding sites of the [TG] gene promoter may result in HPAFP.	HNF-1	AFP	0	UNDEFINED	False
14376	14671	14719118:9:TP53:FAS	These results suggest that [TF] regulates Fas/[TG] expression at the transcriptional level and through protein trafficking in mutant-p53 cell lines.	p53	CD95	0	UNDEFINED	False
14377	14672	14751836:14:EGR1:FAS	Finally, we identified a few genes such as cyclin D2, p19ink4d, and [TG] that are directly regulated by [TF] in prostate cancer cells and that control cell cycle and survival.	Egr-1	Fas	0	UNDEFINED	False
14378	14673	14984368:11:HNF1A:APOH	These results suggest that the atypical TATA box and HNF-1 cis-element are critical for [TG] transcription and [TF] may play an important role in cell-specific regulation of beta2-GPI gene expression.	HNF-1alpha	beta2-GPI	0	UNDEFINED	False
14379	14674	15138269:4:TCF3:CDKN2A	Furthermore, we found that [TF] protein could bind to the E-box-containing region in [TG] promoter in senescent cells by chromatin immunoprecipitation analyses, suggesting that E47 is indeed ultimately involved in the regulation of p16(INK4a) transcription in vivo.	E47	p16(INK4a)	0	UNDEFINED	False
14380	14675	15138269:6:ID1:CDKN2A	The present study demonstrated not only the capacity of [TF] to regulate [TG] gene expression by E47, but also the phenotypic consequence of the regulation on cellular senescence, moreover, raised the possibility of Id1-specific gene silencing for human cancer therapy.	Id1	p16(INK4a)	0	UNDEFINED	False
14381	14676	15191537:8:SP1:IVL	This cascade regulates activator protein one, [TF], and CCATT/enhancer-binding protein transcription factor DNA binding to two discrete [TG] promoter regions, the distal- and proximal-regulatory regions, to regulate involucrin gene expression.	Sp1	involucrin	0	UNDEFINED	False
14382	14677	15364550:6:HNF1A:UGT1A8	Cdx2 regulates the [TG] and 1A10 promoters in cooperation with hepatocyte nuclear factor 1alpha ([TF]).	HNF1alpha	UGT1A8	0	UNDEFINED	False
14383	14678	15580300:4:TP53:FAS	Furthermore, only IFNalpha upregulated [TF] as well as p53 target genes (Noxa, Mdm2 and [TG]).	p53	CD95	0	UNDEFINED	False
14384	14679	15598887:7:HNF1A:ALB	These results suggested that [TF], CBP and p300 were incorporated into a preinitiation complex of RNA polymerase II at the [TG] promoter.	HNF-1alpha	albumin	0	UNDEFINED	False
14385	14680	15601844:7:DMTF1:CDKN2A	A Ras(V12)-responsive element was mapped to the unique [TF]/Ets site on the [TG] promoter, where endogenous Dmp1 proteins bind upon oncogenic Raf activation.	Dmp1	Arf	0	UNDEFINED	False
14386	14681	15688012:6:FOSL1:CDKN2A	The [TG] promoter is regulated specifically by AP-1 heterodimers containing [TF].	Fra-1	ARF	0	UNDEFINED	False
14387	14682	15821111:0:ESRRG:ESRRA	[TF] and peroxisome proliferator-activated receptor-gamma coactivator-1alpha regulate [TG] gene expression via a conserved multi-hormone response element.	Estrogen-related receptor-gamma	estrogen-related receptor-alpha	0	UNDEFINED	False
14388	14683	15878968:0:ESRRA:SULT2A1	Transcriptional regulation of dehydroepiandrosterone sulfotransferase ([TG]) by [TF].	estrogen-related receptor alpha	SULT2A1	0	UNDEFINED	False
14389	14684	16061943:8:ESRRA:ACADM	Furthermore, binding of hepatic nuclear extracts to the [TF] response element found in the promoter region of [TG] was significantly decreased during the APR, suggesting the decreased transcription of the MCAD gene.	ERRalpha	MCAD	0	UNDEFINED	False
14390	14685	16242410:5:FOSB:CDK5	[TF], a cocaine-induced transcription factor, appears to mediate this regulation of the [TG] gene.	DeltaFosB	Cdk5	0	UNDEFINED	False
14391	14686	16274362:3:HNF1A:ACAT2	To investigate the molecular mechanism(s) responsible for the tissue-specific expression of [TG], we identified five cis-elements within the human ACAT2 promoter, four for the intestinal-specific transcription factor CDX2 (caudal type homeobox transcription factor 2), and one for the transcription factor [TF] (hepatocyte nuclear factor 1alpha).	HNF1alpha	ACAT2	0	UNDEFINED	True
14392	14687	16322229:8:TP53:FAS	Importantly, we show that HCV core protein inhibits PML-IV-induced apoptosis and interferes with the coactivator function of PML-IV for proapoptotic [TF] target genes including [TG] (Fas/APO-1).	p53	CD95	1	ACTIVATION	True
14393	14688	16557594:5:TP53:FAS	Main findings included an overexpression of [TF] target genes involved in cell cycle and apoptosis (CDKN1A/p21, TP53INP, [TG]/FAS and BBC3/PUMA), and significant repression of Myc.	p53	TNFRSF6	0	UNDEFINED	False
14394	14689	16603721:3:HNF1A:LIPC	Here, we report that the human hepatic lipase gene ([TG]) promoter is regulated by hepatocyte nuclear factor 4alpha (HNF4alpha), peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), apolipoprotein A-I regulatory protein-1 (ARP-1), and hepatocyte nuclear factor 1alpha ([TF]).	HNF1alpha	LIPC	0	UNDEFINED	False
14395	14690	16781669:2:HNF1A:DPP4	Hepatocyte nuclear factors (HNF)-1alpha and HNF-1beta, known as the causal genes of [TF] and MODY5, respectively, have been reported to be involved in regulation of [TG] gene expression.	MODY3	DPP-IV	0	UNDEFINED	False
14396	14691	16781669:3:HNF1A:DPP4	But, it is not completely clear (i) that they play roles in regulation of [TG] gene expression, and (ii) whether DPP-IV gene activity is changed by mutant [TF] and mutant HNF-1beta in MODY3 and MODY5.	HNF-1alpha	DPP-IV	0	UNDEFINED	False
14397	14692	16788384:13:HNF1A:UGT2B7	The demonstration that Cdx2 and [TF] are important regulators of [TG] expression will aid in defining pathways for coordinate control of drug metabolism in the gastrointestinal tract.	HNF1alpha	UGT2B7	0	UNDEFINED	False
14399	14694	16834571:7:SREBF1:FASN	Treatment of hepatocytes with insulin and/or T0901317 resulted in the recruitment of [TF] to the [TG] promoter as shown by chromatin immunoprecipitation, whereas SREBP-1c did not bind to the GCK promoter.	SREBP-1c	FASN	0	UNDEFINED	False
14400	14695	16840539:10:FOXL2:CGA	These data place [TF] in the hierarchy of pituitary developmental control and suggest a role in regulation of [TG] gene expression.	FOXL2	Cga	0	UNDEFINED	False
14401	14696	16840539:5:FOXL2:CGA	The coincident expression patterns of [TF] and alphaGSU suggested that the alphaGSU gene ([TG]) is a downstream target of FOXL2.	FOXL2	Cga	0	UNDEFINED	False
14402	14697	16951143:6:TP53:FAS	In this study, we used chromatin immunoprecipitation to determine that [TF] preferentially occupied the promoters of growth arrest genes p21 and GADD45 in senescent normal human diploid fibroblasts but not the promoters of other target genes that recruited p53 following doxorubicin-induced DNA damage, such as apoptosis regulators TNFRSF10b, [TG], and PUMA.	p53	TNFRSF6	0	UNDEFINED	False
14403	14698	17037983:7:HNF1A:MUC4	Studies at the mRNA, promoter and protein levels indicated that [TF] regulates endogenous [TG] expression by binding to two cognate cis-elements respectively located at -3332/-3327 and -3040/-3028 in the distal promoter.	HNF1alpha	MUC4	0	UNDEFINED	False
14404	14699	17050649:11:HNF1A:UGT1A3	This study suggests an important role for [TF] in the transcriptional regulation of the human [TG] and UGT1A4 genes.	HNF1alpha	UGT1A3	0	UNDEFINED	False
14405	14700	17050649:11:HNF1A:UGT1A4	This study suggests an important role for [TF] in the transcriptional regulation of the human UGT1A3 and [TG] genes.	HNF1alpha	UGT1A4	0	UNDEFINED	False
14406	14701	17061980:6:HNF1A:PROS1	We present evidence to show that the liver-specific factors hepatocyte nuclear factor 1 ([TF]) and HNF4 bind regions of the [TG] promoter, which lie within the identified protein binding sites V and VIII, respectively, and that HNF4 activates the protein S promoter.	HNF1	protein S	0	UNDEFINED	True
14411	14706	17210751:8:HNF1A:INS	Absence of the cooperation of HNF-1beta mutants with [TF] in the human [TG] gene promoter might be one cause of defective insulin secretion.	HNF-1alpha	insulin	0	UNDEFINED	False
14412	14707	17313375:0:SREBF1:FASN	Polyunsaturated fatty acid suppression of [TG] (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by [TF].	SREBP-1c	fatty acid synthase	0	UNDEFINED	False
14413	14708	17330131:0:PPARG:IVL	STAT5a/[TF] pathway regulates [TG] expression in keratinocyte differentiation.	PPARgamma	involucrin	0	UNDEFINED	False
14414	14709	17370299:2:JUNB:CDKN2A	Little is known about the mechanisms of [TG] regulation in normal and malignant cells apart from that many transcription factors such as Ets1, Ets2, SP1, SP3, [TF] and the polycomb protein Bmi1 have the potential to induce or repress p16 expression.	JunB	p16	0	UNDEFINED	False
14415	14710	17546045:8:DMTF1:CDKN2A	The amount of [TF] bound to the [TG] promoter decreased significantly upon anthracyclin treatment; this, in turn, downregulated the Arf levels.	Dmp1	Arf	1	ACTIVATION	True
14416	14711	17593031:4:HNF1A:CPB2	We identified additional transcription factors that bind within the proximal [TG] promoter, namely, nuclear factor-Y (NF-Y) and hepatocyte nuclear factor-1alpha ([TF]).	HNF-1alpha	CPB2	0	UNDEFINED	False
14417	14712	17848139:7:HNF1A:CFTR	Quantitative ChIP procedures indicate that [TF] (hepatic nuclear factor 1alpha) and Cdx2 (caudal homeobox protein 2) occupy and regulate through a novel intronic enhancer element of [TG] and that Tcf4 (T-cell factor 4) overlaps the same DNA element.	HNF1alpha	CFTR	0	UNDEFINED	False
14419	14714	17889508:1:SP1:CHGA	Our previous work revealed that gastrin regulates [TG] (CgA) transcription through enhanced binding of [TF], CREB and Egr-1 to a proximal gastrin-responsive promoter element (Gas-RE).	Sp1	chromogranin A	0	UNDEFINED	False
14420	14715	17932728:8:HNF1A:SLCO1B1	Our results suggest that [TF] is an essential regulator of [TG] mRNA expression and thus the level of HNF1alpha expression is one of the major determinants of interindividual variability in OATP1B1 mRNA expression.	HNF1alpha	OATP1B1	0	UNDEFINED	False
14421	14716	17956315:0:SREBF1:FASN	Retinoic acid-mediated transcription and maturation of [TF] regulates [TG] via cis-elements responsible for nutritional regulation.	SREBP-1c	fatty acid synthase	0	UNDEFINED	False
14422	14717	17960246:5:DNMT1:FAS	At least nine of these RESEs (Ras epigenetic silencing effectors), including the DNA methyltransferase [TF], are directly associated with specific regions of the [TG] promoter in K-ras-transformed NIH 3T3 cells but not in untransformed NIH 3T3 cells.	DNMT1	Fas	0	UNDEFINED	False
14423	14718	17960246:6:DNMT1:FAS	RNAi-mediated knockdown of any of the 28 RESEs results in failure to recruit [TF] to the [TG] promoter, loss of Fas promoter hypermethylation, and derepression of Fas expression.	DNMT1	Fas	0	UNDEFINED	True
14424	14719	17962340:11:HNF1A:SLC5A2	Our demonstration that [TF] binds DNA that encodes [TG] supports the hypothesis that HNF-1alpha, as a modulator of SGLT2 expression, may be involved in diabetic kidney disease.	HNF-1alpha	SGLT2	0	UNDEFINED	False
14426	14721	18234909:2:ESRRA:SPP1	There are conflicting published data on the transcriptional regulation by [TF] of the gene for osteopontin ([TG]), an extracellular matrix protein required in bone remodeling, and a potential direct target mediating ERRalpha effects in bone.	ERRalpha	OPN	0	UNDEFINED	False
14428	14723	18440731:0:HNF1A:FABP2	Transcriptional regulation of the fatty acid binding protein 2 ([TG]) gene by the hepatic nuclear factor 1 alpha ([TF]).	HNF-1alpha	FABP2	0	UNDEFINED	False
14429	14724	18440731:2:HNF1A:FABP2	Here we investigate transcriptional regulation of [TG] by the endodermal hepatic nuclear factor 1 alpha ([TF]).	HNF-1alpha	FABP2	0	UNDEFINED	False
14430	14725	18440731:6:HNF1A:FABP2	Thus, our data suggest a major role of [TF] in control of [TG] expression in intestine via a functional HNF-1alpha recognition element within FABP2 promoter region -185 to -165.	HNF-1alpha	FABP2	0	UNDEFINED	False
14431	14726	18537186:10:HNF1A:CYP2E1	Using the chromatin immunoprecipitation reimmunoprecipitation assay, time-dependent differences were demonstrated for CRY1 protein interaction with [TF] transcriptional complexes, including coactivator p300 on the HNF-1alpha binding site in the [TG] promoter.	HNF-1alpha	CYP2E1	0	UNDEFINED	False
14432	14727	18537186:9:HNF1A:CYP2E1	Chromatin immunoprecipitation assay in the [TG] promoter indicated that [TF] binding to the CYP2E1 promoter increased from the late light phase to the early dark phase.	HNF-1alpha	CYP2E1	0	UNDEFINED	False
14433	14728	18558095:5:YY1:CDKN2A	The chromatin immunoprecipitation (ChIP) assays verified that HDAC3 and HDAC4 were recruited to [TG] promoter by [TF].	YY1	p16(INK4a)	0	UNDEFINED	False
14434	14729	18682402:12:ZBTB7A:FASN	The molecular mechanism revealed provides insight into how proto-oncogene [TF] may attack the cellular regulatory mechanism of [TG] gene expression to provide more phospholipid membrane components needed for rapid cancer cell proliferation.	FBI-1	FASN	0	UNDEFINED	False
14435	14730	18774944:2:KLF5:FASN	In the present study, we showed that [TF] acts as a key regulator controlling the expression of FASN ([TG]) through an interaction with SREBP-1 (sterol-regulatory-element-binding protein-1) in the androgen-dependent LNCaP prostate cancer cell line.	KLF5	fatty acid synthase	0	UNDEFINED	False
14436	14731	19233846:5:JDP2:CDKN2A	Moreover, at the promoter of the gene for [TG] in [TF](-/-) MEF, the extent of methylation of lysine 27 of histone H3 (H3K27), which is important for gene silencing, increased.	Jdp2	p16(Ink4a)	1	ACTIVATION	True
14437	14732	19233846:8:JDP2:CDKN2A	Our results indicate that [TF] is involved in the signaling pathway for senescence via epigenetic regulation of the expression of the gene for [TG].	JDP2	p16(Ink4a)	0	UNDEFINED	False
14438	14733	19280766:7:HNF1A:CRP	Based on the recent genetic findings as well as delineation of the role of [TF] in regulating the expression of the [TG] gene, it appears that this transcription factor may play a key role in linking metabolic and inflammatory pathways underlying the pathogenesis of coronary heart disease.	HNF1-alpha	CRP	0	UNDEFINED	False
14439	14734	19381435:8:FOSB:CD9	We define 3 genes, INHBA, [TG], and ITGA2B as regulatory targets of [TF] and show that CD9, in particular, is a direct target of FosB.	FosB	CD9	0	UNDEFINED	False
14440	14735	19444006:1:LHX3:CGA	The aim of this study was to characterize the promoter activity of the porcine pituitary glycoprotein hormone common alpha gene ([TG]) promoter (-1059/+12) and the role of LIM homeodomain transcription factor [TF].	Lhx3	Cga	0	UNDEFINED	False
14441	14736	19444006:3:LHX3:CGA	A DNA binding and DNase I footprinting assay demonstrated that [TF] has seven binding sites in the -1059/+12 region of [TG], including a pituitary glycoprotein hormone basal element (PGBE) known as a LIM homeodomain factor-binding site.	Lhx3	Cga	0	UNDEFINED	False
14442	14737	19478207:2:HNF1A:ACAT2	Recently, we identified [TF] as an important regulator of the human [TG] promoter.	HNF1alpha	ACAT2	0	UNDEFINED	False
14443	14738	19478207:9:HNF1A:ACAT2	ChIP assays and protein-to-protein interaction studies showed that HNF4alpha, directly or indirectly (via [TF]), can bind to the [TG] promoter.	HNF1alpha	ACAT2	0	UNDEFINED	False
14444	14739	19536094:9:ESRRA:DAP3	ELK1 and [TF] may be considered as potential regulators of the [TG] gene expression.	ESRRA	DAP3	0	UNDEFINED	False
14445	14740	19583777:5:ZNF148:CDKN2A	Furthermore, chromatin immunoprecipitation assays verified that HDAC3 was recruited to the [TG] promoter by [TF] through an epigenetic mechanism involving histone acetylation modification.	ZBP-89	p16(INK4a)	0	UNDEFINED	False
14446	14741	19615968:3:TP53:FAS	In an attempt to understand how the [TG] gene is regulated by the [TF] family, we investigated the contributions of a p53-responsive element (RE) within the first intron of the CD95 gene as well as three elements within the promoter.	p53	CD95	0	UNDEFINED	False
14447	14742	19687008:5:HNF1A:PCSK9	In our investigations to define mechanisms underlying the transcriptional suppression of [TG] by BBR in HepG2 cells, we have identified a highly conserved hepatocyte nuclear factor 1 ([TF]) binding site residing 28 bp upstream from SRE as a critical sequence motif for PCSK9 transcription and its regulation by BBR.	HNF1	PCSK9	0	UNDEFINED	False
14448	14743	19782160:4:HNF1A:CFTR	Moreover, we demonstrated the likely involvement of [TF] in the regulation of [TG] expression in vivo.	HNF1	CFTR	0	UNDEFINED	False
14449	14744	19903962:7:NR1H3:FASN	These data define the [TG] gene as a direct target of [TF] and further expand the role of LXRalpha as a regulator of lipid metabolism in this species.	LXRalpha	chicken FASN	0	UNDEFINED	False
14450	14745	20106981:3:NKX6-1:HNF1A	We report that NK6 homeodomain 1 ([TF]) binds to a cis-regulatory element in the [TG] promoter and is a major regulator of this gene in beta cells.	NKX6.1	HNF1alpha	0	UNDEFINED	False
14451	14746	20106981:4:NKX6-1:HNF1A	We identified an [TF] recognition sequence in the distal region of the [TG] promoter and demonstrated specific binding of NKX6.1 in beta cells by electrophoretic mobility shift and chromatin immunoprecipitation assays.	NKX6.1	HNF1alpha	0	UNDEFINED	False
14452	14747	20133699:6:TCF4:MYC	We also demonstrate that one such enhancer element physically interacts with the [TG] promoter via transcription factor [TF] binding and acts in an allele specific manner to regulate Myc expression.	Tcf-4	Myc	0	UNDEFINED	False
14453	14748	20194619:6:TCF3:CDKN2A	Chromatin immunoprecipitation analysis demonstrated the association of Tal1 and [TF], one of its E protein DNA-binding partners, with an E box-GATA sequence element in intron 4 of the Gata2 gene and with three E boxes upstream of [TG].	E47	p16(Ink4a)	0	UNDEFINED	False
14454	14749	20215575:4:ESRRA:GCK	Electrophoretic mobility shift and chromatin immunoprecipitation assays revealed the interaction of [TF] with the [TG] promoter.	ERRalpha	glucokinase	0	UNDEFINED	False
14455	14750	20215575:6:ESRRA:GCK	Taken together, this research identifies [TG] as a novel target of PGC-1alpha/[TF] and underscores the regulatory function of ERRalpha in insulin-dependent enzyme regulation.	ERRalpha	glucokinase	0	UNDEFINED	False
14456	14751	20460578:0:HNF1A:NPC1L1	[TF] and SREBP2 are important regulators of [TG] in human liver.	HNF1alpha	NPC1L1	0	UNDEFINED	False
14457	14752	20460578:9:HNF1A:NPC1L1	ChIP assays confirmed that [TF] can bind to the [TG] promoter in vivo.	HNF1alpha	NPC1L1	0	UNDEFINED	False
14458	14753	20620135:8:DNMT1:CDKN2A	Moreover, HBx induces hypermethylation of [TG] promoter through [TF] and DNMT3A.	DNMT1	p16(INK4A)	0	UNDEFINED	True
14459	14754	20620135:9:DNMT1:CDKN2A	Regulation of [TF] and DNMT3A by HBx promoted hypermethylation of [TG] promoter region.	DNMT1	p16(INK4A)	0	UNDEFINED	False
14460	14755	20808772:9:ZNF277:CDKN2A	Our findings implicate [TF] in the transcriptional regulation of the [TG]/Arf locus and suggest that the interaction of Zfp277 with Bmi1 is essential for the recruitment of PRC1 to the Ink4a/Arf locus.	Zfp277	Ink4a	0	UNDEFINED	False
14461	14756	20810608:8:HNF1A:CLCN5	These data demonstrate that [TF] directly regulates the expression of [TG] in the renal proximal tubule and yield insights into the mechanisms governing epithelial differentiation and specialized transport activities in the kidney.	HNF1	ClC-5	0	UNDEFINED	False
14463	14759	21454713:5:HNF1A:APOM	We now show that the human [TG] promoter harbors a dual specificity regulatory element in the proximal region that binds hepatocyte nuclear factor 1 ([TF]) and members of the AP-1 family of pro-inflammatory transcription factors (c-Jun and JunB).	HNF-1	apoM	0	UNDEFINED	False
14464	14760	22005519:5:EGR1:TCF7L2	Luciferase reporter assays and EMSAs using the [TG] promoter fragments indicated that the binding site for the transcription factor [TF] (Egr-1), which is located in the -609 to -601 bp region relative to the start codon in the TCF7L2 promoter, was involved in DIF-1 activity.	early growth response-1	TCF7L2	0	UNDEFINED	True
14465	14761	22020338:7:POU1F1:CDKN2A	We have unveiled the relationship of [TF] with the [TG] gene.	Pit-1	p19Arf	0	UNDEFINED	False
14466	14762	22331133:0:SREBF1:FASN	Kr-pok increases [TG] expression by modulating the DNA binding of [TF]c and Sp1 at the proximal promoter.	SREBP-1	FASN	0	UNDEFINED	False
14467	14763	22383952:12:HNF1A:NAGS	The presented data strongly suggest that Sp1, CREB, [TF], and NF-Y, that are known to be responsive to hormones and diet, regulate [TG] transcription.	HNF-1	NAGS	0	UNDEFINED	False
14468	14764	24165022:7:YBX1:CDKN2A	Chromatin immunoprecipitation assays showed that [TF] directly associates with the [TG] promoter.	YB1	p16	0	UNDEFINED	False
14469	14765	24821727:5:ZBTB16:CDKN2A	[TF] may stimulate cell proliferation by controlling expression of the genes of the p53 pathway ([TG], TP53, and CDKN1A).	PLZF	ARF	0	UNDEFINED	False
14470	14766	2736625:3:HNF1A:ALB	[TF] appears to be heavily glycosylated since it is retained on a wheat germ agglutinin-agarose column and can be eluted from it with N-acetylglucosamine, a property not observed with other factors binding to the [TG] promoter.	HNF1	albumin	0	UNDEFINED	False
14471	14767	7692852:1:HNF1A:IGFBP1	In the liver, expression of [TG] (IGFBP-1) is regulated essentially at the transcriptional level, at least in part by [TF].	HNF1	insulin-like growth factor binding protein-1	0	UNDEFINED	False
14472	14768	7836361:4:HNF1A:IGF1	Since the sequence of the [TF] binding site is conserved in all mammalian, avian, and amphibian species from which the [TG] promoter sequences have been derived to date, we propose that HNF-1 may be an important regulator of IGF-I gene expression in all of these species.	HNF-1	IGF-I	0	UNDEFINED	False
14473	14769	8674436:0:HNF4A:HNF1A	Mesoderm and endoderm differentiation in animal cap explants: identification of the [TF]-binding site as an activin A responsive element in the Xenopus [TG] promoter.	HNF4	HNF1alpha	0	UNDEFINED	False
14474	14770	9639581:0:SP3:FAS	[TF] regulates [TG] expression in lung epithelial cells.	Sp3	fas	0	UNDEFINED	False
14475	14771	9639581:10:SP3:FAS	These results show that the [TF] protein is involved in regulating [TG] gene expression in lung epithelial cells.	Sp3	Fas	0	UNDEFINED	False
14476	14772	9685261:3:FOXA2:HNF1A	Regulation of HNF-4/[TG] expression by HNF-3alpha and [TF] was studied in embryoid bodies in which one or both HNF-3alpha or HNF-3beta alleles were inactivated.	HNF-3beta	HNF-1	0	UNDEFINED	False
14477	14773	9712664:5:FOSB:GRIN1	Activator protein-1 ([TF]) complexes composed of DeltaFosB were bound to a consensus AP-1 site in the 5'-promoter region of the [TG] gene.	AP-1	NMDAR1	0	UNDEFINED	False
14478	14774	16140218:14:NFKB:IVL	Our study demonstrated for the first time that [TG] expression of keratinocytes is suppressed by RXM through direct inhibition of AP-1 and indirect inhibition of [TF].	NF-kappaB	involucrin	1	ACTIVATION	True
14479	14775	10050749:0:HNF1A:IGF1	Growth hormone induces [TG] gene transcription by a synergistic action of STAT5 and [TF].	HNF-1alpha	insulin-like growth factor-I	1	ACTIVATION	False
14480	14776	10207097:2:TCF4:SSTR2	In an investigation of the molecular mechanisms controlling these patterns, we have recently shown that binding of the transcription factor [TF] to a novel initiator element in the [TG] promoter is essential for SSTR-2 gene expression.	SEF-2	SSTR-2	1	ACTIVATION	False
14481	14777	10330009:7:HNF1A:SERPINA1	Finally, overexpression of antisense ribozymes for [TF] in Caco-2 cells resulted in a selective decrease in endogenous [TG] gene expression.	HNF-1alpha	alpha1-AT	1	ACTIVATION	False
14482	14778	10330009:8:HNF1A:SERPINA1	Together, these results provide evidence that [TF] and HNF-4 play a role in the mechanism by which the [TG] gene is upregulated during enterocyte differentiation in the model Caco-2 cell system.	HNF-1alpha	alpha1-AT	1	ACTIVATION	False
14483	14779	10331424:5:HNF4A:HNF1A	On the other hand, in the presence of COUP TFII, the substitution impairs the enhancement of [TF]-mediated activation of [TG] promoter.	HNF-4	HNF-1	1	ACTIVATION	False
14484	14780	10585866:0:STAT1:IVL	Interferon-gamma-dependent stimulation of human [TG] gene expression: [TF] (signal transduction and activators of transcription 1) protein activates involucrin promoter activity.	STAT1	involucrin	1	ACTIVATION	False
14485	14781	10585866:11:STAT1:IVL	In contrast, transfection of a [TF] dominant-negative expression vector suppressed the IFN-gamma-dependent up-regulation of [TG] promoter activity.	STAT1	involucrin	1	ACTIVATION	False
14486	14782	10677375:4:HNF1A:LCT	In the present study, we examined whether Cdx2 and [TF] physically interact and co-operatively activate transcription from the [TG]-phlorizin hydrolase promoter.	HNF1alpha	lactase	1	ACTIVATION	False
14487	14783	10748140:7:HNF1A:SLC2A2	We identified that both [TF] and HNF3 function as transcriptional activators in [TG] gene expression.	HNF1	GLUT2	1	ACTIVATION	False
14488	14784	10748140:9:HNF1A:SLC2A2	These data suggest that [TF] and HNF3beta may be the most important players in the tissue-specific expression of the human [TG] gene.	HNF1alpha	GLUT2	1	ACTIVATION	True
14489	14785	10760574:11:HNF1A:GJB1	These data suggest that Sp1 is responsible for [TG] promoter basal activity, that [TF] determines the cell-specific expression of Cx32, and that dexamethasone increases Cx32 expression through other mechanisms.	HNF-1	Cx32	1	ACTIVATION	False
14490	14786	10766845:5:HNF1A:G6PC	However, in LLC-PK cells, but not in HepG2 cells, a hepatocyte nuclear factor-1 ([TF]) binding site was critical for the full induction of [TG]-CAT expression by PKA.	HNF-1	G6Pase	1	ACTIVATION	False
14491	14787	10779377:12:HNF1A:UGT2B7	These results strongly suggest that the liver-enriched factor [TF] binds to, and activates, the [TG] gene promoter and that the ubiquitous transcription factor, Oct-1, enhances this activation by directly interacting with HNF1alpha.	HNF1alpha	UGT2B7	1	ACTIVATION	False
14492	14788	10779377:7:HNF1A:UGT2B7	[TG] promoter activity with the HNF1/AT-rich element was stimulated by cotransfection with [TF].	HNF1alpha	UGT2B7	1	ACTIVATION	False
14493	14789	10856241:0:JUNB:CDKN2A	[TF] suppresses cell proliferation by transcriptional activation of [TG] expression.	JunB	p16(INK4a)	1	ACTIVATION	False
14494	14790	10856241:2:JUNB:CDKN2A	Increased [TF] expression induced high levels of the cyclin-dependent kinase inhibitor [TG], leading to premature senescence in primary cells and reduced proliferation in 3T3 cells, whereas lack of JunB expression results in decreased p16 levels.	JunB	p16(INK4a)	1	ACTIVATION	False
14495	14791	10856241:4:JUNB:CDKN2A	Moreover, three AP1-like binding sites were identified in the [TG] promoter through which [TF] directly activates p16 transcription.	JunB	p16	1	ACTIVATION	False
14496	14792	10908299:11:HNF1A:UGT1A7	These data provide evidence for an important stimulatory role of [TF] in promoting [TG] gene expression in rat liver.	HNF1	UGT1A7	1	ACTIVATION	False
14497	14793	10914734:2:E2F1:CDKN2A	Here we report that sequential transfer of the wild-type p53 and [TF] genes efficiently induces apoptosis in human esophageal cancer cells and that E2F-1 overexpression directly, activates expression of [TG], which inhibits MDM2-mediated p53 degradation, resulting in the stabilization of p53.	E2F-1	p14 (ARF)	1	ACTIVATION	False
14498	14794	10914734:3:E2F1:CDKN2A	Infection of human esophageal cancer cell lines T.Tn and TE8 with adenovirus vector-expressing [TF] (Ad-E2F-1) enhanced mRNA and protein expression of [TG] and decreased MDM2 protein expression.	E2F-1	ARF	1	ACTIVATION	False
14499	14795	11085951:3:HNF4A:HNF1A	A transcriptional hierarchy involving [TF]-mediated activation of the [TG] promoter has been proposed to be of crucial importance in maintaining the differentiated hepatocyte phenotype.	HNF4	HNF1	1	ACTIVATION	False
14500	14796	11085951:7:HNF4A:HNF1A	Transfection experiments in non-hepatic cells indicated that the salmon [TG] promoter was activated by both [TF] and COUP-TFs.	HNF4	HNF1	1	ACTIVATION	False
14501	14797	11103825:6:TP53:FAS	CD437 induced [TG] expression in three NSCLC cell lines with wild-type [TF] but not in six NSCLC cell lines containing mutant p53.	p53	Fas	1	ACTIVATION	False
14502	14798	11103825:8:TP53:FAS	These results implicate the involvement of wild-type [TF] in CD437-induced [TG] expression in human NSCLC cells.	p53	Fas	1	ACTIVATION	False
14503	14799	11110846:2:SREBF1:FASN	Because the nuclear transcription factor sterol regulatory element binding protein-1 ([TF]) is a strong enhancer of [TG] promoter activity, it was hypothesized that Cu deficiency induces fatty acid synthase gene transcription by increasing the nuclear localization of mature SREBP-1.	SREBP-1	fatty acid synthase	1	ACTIVATION	False
14505	14801	11191885:6:HNF1A:UGT2B17	In HepG2 cells, [TF] bound to this region and activated the [TG] promoter, as assessed by functional and gel shift assays.	HNF1alpha	UGT2B17	1	ACTIVATION	False
14506	14802	11278466:6:HNF1A:PDX1	Cotransfection experiments suggest that HNF-3beta, [TF], and SP1 are positive regulators of the herein-described human [TG] enhancer element.	HNF-1alpha	PDX-1	1	ACTIVATION	False
14507	14803	11287605:8:SREBF1:FASN	The activation of [TF]c by LXR is associated with a slight increase in nuclear SREBP-1c, resulting in activation of the gene for [TG], one of its downstream genes, as measured by the luciferase assay.	SREBP-1	fatty acid synthase	1	ACTIVATION	False
14508	14804	11314038:4:E2F1:CDKN2A	Among these is the transcription factor [TF], a final effector of the RB pathway, that induces [TG] expression.	E2F1	ARF	1	ACTIVATION	False
14509	14805	11316735:18:ID2:TF	Interestingly, an antisense to [TF] down-regulated [TG] promoter activity.	Id2	transferrin	1	ACTIVATION	False
14510	14807	11443121:2:SREBF1:FASN	[TF] introduced into primary hepatocytes with an adenovirus vector caused a total loss of PEPCK-C mRNA and a marked induction of [TG] mRNA that directly coincided with the appearance of SREBP-1c in the hepatocytes.	SREBP-1c	fatty acid synthase	1	ACTIVATION	False
14511	14808	11460882:0:HNF1A:GCK	[TF] and/or HNF3 may contribute to the tissue specific expression of [TG] gene.	HNF1	glucokinase	1	ACTIVATION	False
14512	14809	11483603:6:HNF1A:SLCO1B1	Coexpression of [TF] stimulated [TG] promoter activity 30-fold in HepG2 and 49-fold in HeLa cells.	HNF1 alpha	OATP-C	1	ACTIVATION	False
14513	14810	11585914:7:HNF1A:HNF4A	High levels of [TG] promoter activity were dependent on the synergism between either [TF] and HNF-6 or HNF-1beta and GATA-6, which implies that at least two alternative mechanisms may activate HNF-4alpha gene transcription.	HNF-1alpha	HNF-4alpha	1	ACTIVATION	False
14514	14811	11864989:5:HNF1A:G6PC	In HeLa cells, the [TG] promoter activity is induced by the co-expression of HNF4 alpha or [TF].	HNF1 alpha	glucose-6-phosphatase	1	ACTIVATION	False
14515	14812	11934881:4:HNF1A:CLDN2	[TF] augmented the Cdx2-induced but not Cdx1-induced transcriptional activation of the human [TG] promoter.	HNF-1alpha	claudin-2	1	ACTIVATION	False
14516	14813	11939905:9:HNF1A:ALB	We hypothesize that IL-6 along with DEX induced a novel protein that decreased transcription of rGSTA2 and possibly [TG] by interfering with the transactivating function of [TF].	HNF1	albumin	1	ACTIVATION	False
14517	14814	11978637:4:HNF1A:SLC2A2	[TF] enhanced human [TG] promoter activity sixfold.	HNF-1alpha	GLUT2	1	ACTIVATION	False
14518	14815	11978637:5:HNF1A:SLC2A2	Site-direct mutagenesis and footprint analyses showed that the [TF] binding site (+200 to +218) is critical in human [TG] gene expression.	HNF-1alpha	GLUT2	1	ACTIVATION	False
14519	14816	11978637:7:HNF1A:SLC2A2	These findings demonstrated that [TF] binds to the 5'-untranslated region of [TG] and that p300 acts as a transcriptional co-activator for HNF-1alpha.	HNF-1alpha	GLUT2	1	ACTIVATION	False
14520	14817	12055195:4:HNF1A:SLC10A2	The minimal construct that confers full promoter activity contains three functional hepatocyte nuclear factor 1alpha ([TF]) recognition sites, explaining the dependence of [TG] gene expression upon HNF1alpha.	HNF1alpha	ASBT	1	ACTIVATION	False
14521	14818	12065766:7:HNF1A:UGT2B17	This interaction of Pbx2-Prep1 and [TF] results in down-regulation of HNF1alpha-mediated activation of the [TG] promoter.	HNF1alpha	UGT2B17	1	ACTIVATION	True
14522	14819	12181319:7:ESRRA:ACADM	Furthermore, PGC-1alpha enhanced the transactivation of reporter plasmids containing an estrogen response element or the [TG] gene promoter by [TF] and the related isoform ERRgamma.	ERRalpha	MCAD	1	ACTIVATION	False
14523	14820	12367519:9:HNF1A:SLC17A1	Transient transfection experiments confirmed that [TF] directly transactivates the [TG] promoter and that the HSS3 region contributes to this activation.	HNF1alpha	Npt1	1	ACTIVATION	False
14524	14821	12413486:7:HNF1A:GJB1	These data indicate that [TF] is a positive regulator of [TG] expression in hepatic cells.	HNF-1alpha	Cx32	1	ACTIVATION	False
14525	14822	12456801:0:SP1:CHGA	Interaction of early growth response protein 1 (Egr-1), specificity protein 1 ([TF]), and cyclic adenosine 3'5'-monophosphate response element binding protein (CREB) at a proximal response element is critical for gastrin-dependent activation of the [TG] promoter.	Sp1	chromogranin A	1	ACTIVATION	False
14526	14823	12565907:0:HNF1A:TYR	In situ and in vitro evidence for DCoH/[TF] transcription of [TG] in human skin melanocytes.	HNF-1 alpha	tyrosinase	1	ACTIVATION	False
14527	14824	12601360:10:HNF4A:HNF1A	SHP directly inhibits [TF]-mediated transactivation of the [TG] promoter in cotransfection assays.	HNF4 alpha	HNF1 alpha	1	ACTIVATION	False
14529	14826	12601360:7:HNF4A:HNF1A	Characterization of the human [TG] gene promoter identified a consensus bile acid response element that binds and is activated by [TF].	HNF4 alpha	HNF1 alpha	1	ACTIVATION	False
14530	14827	12601360:9:HNF4A:HNF1A	The central mechanism by which bile acids repress [TG] is decreased activation by [TF].	HNF4 alpha	HNF1 alpha	1	ACTIVATION	False
14531	14828	12712243:6:HNF1A:INS	Transfection of wild-type [TF] increased the reporter activities of GLUT2 and [TG] promoters in NIH3T3 and SK-Hep1 cells, while R263L mutant was defective in transactivation of those promoters.	HNF-1alpha	insulin	1	ACTIVATION	False
14532	14829	12712243:6:HNF1A:SLC2A2	Transfection of wild-type [TF] increased the reporter activities of [TG] and insulin promoters in NIH3T3 and SK-Hep1 cells, while R263L mutant was defective in transactivation of those promoters.	HNF-1alpha	GLUT2	1	ACTIVATION	False
14533	14830	12788915:4:TP53:FAS	In contrast, a [TF] consensus site located within the first intron of [TG] gene is absolutely required for the inducible expression of CD95 upon genotoxic treatment in breast tumor cells.	p53	CD95	1	ACTIVATION	False
14534	14831	12837760:6:HNF1A:PAX4	Furthermore, exogenous expression of Neurogenin3 is sufficient to induce expression of the endogenous [TG] gene in the mouse pancreatic ductal cell line mPAC, which already expresses [TF], whereas expression of both Neurogenin3 and HNF1alpha are necessary to activate the pax4 gene in the fibroblast cell line NIH3T3.	HNF1alpha	pax4	1	ACTIVATION	True
14535	14832	12855703:8:HNF1A:B3GALT5	Four factors, Cdx1, Cdx2, [TF], and HNF1beta, could bind to GCE and transcriptionally activate the [TG] gene.	HNF1alpha	beta3Gal-T5	1	ACTIVATION	False
14536	14833	12944915:0:TP53:FAS	Mutant [TF] gain of function: repression of [TG](Fas/APO-1) gene expression by tumor-associated p53 mutants.	p53	CD95	1	ACTIVATION	False
14537	14834	12944915:2:TP53:FAS	We report that mutant [TF] suppresses the expression of the [TG] (Fas/APO-1) gene, encoding a death receptor implicated in a variety of apoptotic responses.	p53	CD95	1	ACTIVATION	False
14538	14835	12944915:4:TP53:FAS	Excess mutant [TF] represses the transcriptional activity of the [TG] promoter, with the extent of repression varying among different tumor-associated p53 mutants.	p53	CD95	1	ACTIVATION	True
14539	14836	12963547:6:TP53:FAS	Radiation-induced [TG] sensitization in prostate cancer cell was mediated through [TF]-dependent transactivation of the Fas gene, which can be blocked by androgen stimulation mainly through induction of c-jun.	p53	Fas	1	ACTIVATION	False
14540	14837	14534330:5:HNF1A:B3GALT5	We conclude that [TF] is at least partially responsible for the tissue-specific activation of the LTR promoter of [TG].	HNF-1	human beta 1,3-galactosyltransferase 5	1	ACTIVATION	False
14541	14838	14561216:2:HNF1A:ALB	The expression of [TG] and some GSTs are dependent on [TF] (hepatic nuclear factor 1).	HNF1	albumin	1	ACTIVATION	False
14542	14839	14575719:0:HNF1A:SLC4A2	[TF] upregulates the human AE2 anion exchanger gene ([TG]) from an alternate promoter.	HNF1alpha	SLC4A2	1	ACTIVATION	False
14543	14840	14585510:3:HNF1A:PCK1	Previously, we reported that in LLC-PK1 and derived kidney cell lines, mutation of the hepatic nuclear factor 1 ([TF]) binding site in [TG] gene promoter markedly reduced both the basal activity of the gene promoter and its response to acidic pH.	HNF-1	PEPCK-C	1	ACTIVATION	False
14544	14841	14602726:6:STAT1:FAS	In agreement with this lower p53 response to DNA damage in cells lacking [TF], the induction of p53 responsive genes, such as Bax, Noxa, and [TG], was reduced in STAT-1-deficient cells.	STAT-1	Fas	1	ACTIVATION	False
14545	14842	14610283:6:ESRRA:NOS3	Furthermore, through the use of truncated [TG] promoter luciferase constructs, we demonstrate that the activation of eNOS transcription by [TF] is mediated via three regions: base pairs -1001 to -743, base pairs -743 to -265, and downstream from base pair -265 on the eNOS promoter.	ERR alpha 1	eNOS	1	ACTIVATION	False
14546	14843	14610283:7:ESRRA:NOS3	In addition, [TF] up-regulates [TG] mRNA and protein expression and stimulates eNOS activity in bovine pulmonary artery endothelial cells.	ERR alpha 1	eNOS	1	ACTIVATION	False
14547	14844	14633861:12:HNF1A:APOM	This study demonstrates that [TF] is required for [TG] expression in vivo and that heterozygous HNF-1alpha mutations lead to an HNF-1alpha-dependent impairment of apoM expression.	HNF-1alpha	apoM	1	ACTIVATION	False
14548	14845	14633861:9:HNF1A:APOM	We show that [TF] is a potent activator of the [TG] promoter, that a specific mutation in the HNF-1 binding site abolished transcriptional activation of the apoM gene, and that Hnf-1alpha protein can bind to the Hnf-1 binding site of the apoM promoter in vitro.	Hnf-1alpha	apoM	1	ACTIVATION	False
14549	14846	14699509:14:HNF1A:AFP	This highlights the importance of [TF] in [TG] gene expression.	HNF-1	AFP	1	ACTIVATION	True
14550	14847	15025563:3:SP1:IVL	Binding sites for AP-1 (activator protein 1) and [TF] transcription factors were shown to be important for [TG] promoter activity and tissue-specific expression.	Sp1	involucrin	1	ACTIVATION	False
14552	14849	15155664:7:EGR1:FAS	Reporter-promoter transfection studies indicated that [TF] binding is required for the H. pylori-induced transcriptional promoter activity of the CD44, ICAM-1, and CD95L ([TG]/Fas) constructs.	Egr-1	APO-1	1	ACTIVATION	False
14553	14850	15155840:11:HNF1A:GSTA2	C2 similarly repressed the induction of [TG] promoter-luciferase by tert-butylhydroquinone via [TF] suppression, suggesting that constitutive HNF1 activation is required for GSTA2 induction.	HNF1	GSTA2	1	ACTIVATION	False
14554	14851	15389642:11:HNF1A:CLDN2	Cotransfection experiments showed that the [TG] promoter was activated by CDX2, [TF], and GATA-4 in a cooperative manner.	HNF-1alpha	claudin-2	1	ACTIVATION	False
14555	14852	15456881:8:ESRRA:PPARA	[TF] activated [TG] gene expression via direct binding of ERRalpha to the PPARalpha gene promoter.	ERRalpha	PPARalpha	1	ACTIVATION	False
14556	14853	1545795:12:HNF1A:APOB	Rather, [TF] and C/EBP act synergistically with protein II to enhance transcription of the [TG] gene.	HNF-1	apolipoprotein B	1	ACTIVATION	False
14557	14854	15488474:0:HNF1A:CYP2E1	The pig [TG] promoter is activated by COUP-TF1 and [TF] and is inhibited by androstenone.	HNF-1	CYP2E1	1	ACTIVATION	False
14558	14855	15566941:5:HNF1A:IAPP	Finally, utilising a series of deletion reporter gene constructs of the human [TG] gene promoter, we used overexpression studies to establish that HNF-3beta (FoxA2) negatively regulates the IAPP promoter, whilst the MODY3 transcription factor [TF] positively regulates promoter activity.	HNF-1alpha	IAPP	1	ACTIVATION	False
14559	14856	15598887:0:HNF1A:ALB	Transcriptional coactivators CBP and p300 cooperatively enhance [TF]-mediated expression of the [TG] gene in hepatocytes.	HNF-1alpha	albumin	1	ACTIVATION	False
14560	14857	15598887:8:HNF1A:ALB	Luciferase reporter assays showed that CBP and p300 cooperatively triggered [TF]-mediated transcription of the [TG] promoter.	HNF-1alpha	albumin	1	ACTIVATION	False
14561	14858	15670765:5:ESRRA:SP1	Indeed, human [TG] promoter-dependent luciferase activity is activated by [TF] transfection and a DNA-protein complex is observed by EMSA using oligonucleotides encompassing the putative ERRalpha1 binding site on the human Sp1 promoter (-1444/-1433: 5'-AGGACATGACCT-3').	ERRalpha1	Sp1	1	ACTIVATION	False
14562	14859	15716018:7:HNF1A:AFP	Additionally, overexpression of [TF] stimulated the activity of both the wild- and variant-type [TG] promoters in hepatoma cells.	HNF-1alpha	AFP	1	ACTIVATION	False
14563	14860	15716018:8:HNF1A:AFP	[TF] expression also activated both [TG] promoters even in nonhepatoma cells, and this activation was suppressed by nuclear factor (NF)-I overexpression.	HNF-1alpha	AFP	1	ACTIVATION	False
14564	14861	15716018:9:HNF1A:AFP	These results indicate that an [TF] binding site mutation leads to induction of the [TG] gene expression in adult liver, and suggest that competition between HNF-1 and NF-I in this region is involved in transcriptional regulation of the AFP gene during hepatic development.	HNF-1	AFP	1	ACTIVATION	True
14565	14862	15961790:5:HNF1A:ACAT2	We identified hepatic nuclear factor 1 ([TF]) as an important liver-specific trans-acting element for the human [TG] gene using the human hepatocellular carcinoma cell lines HuH7 and HepG2.	HNF1	ACAT2	0	UNDEFINED	True
14566	14863	15961790:6:HNF1A:ACAT2	Targeted deletion of the [TF] binding site in the DNA sequence abolished not only the basal promoter function in HepG2 and HuH7 cells but also the induction of the [TG] promoter by HNF1.	HNF1	ACAT2	1	ACTIVATION	False
14567	14864	16274362:4:HNF1A:ACAT2	Results of luciferase reporter and electrophoretic mobility shift assays show that CDX2 and [TF] exert a synergistic effect, enhancing the [TG] promoter activity through binding to these cis-elements.	HNF1alpha	ACAT2	1	ACTIVATION	False
14568	14865	16374477:12:SP1:IVL	These studies suggest that AP1, [TF], and C/EBP transcription factors are required for appropriate differentiation-dependent [TG] expression, and that the mechanism of regulation is similar in most surface epithelia.	Sp1	involucrin	1	ACTIVATION	False
14569	14866	16601238:4:SREBF1:FASN	Overexpression of a dominant-negative form of [TF] decreased lipogenesis and decreased the induction of [TG] and stearyl coenzyme A desaturase-1 by KGF.	SREBP-1	fatty acid synthase	1	ACTIVATION	False
14570	14867	16670373:8:HNF4A:HNF1A	A promoter-luciferase construct of the human [TG] gene was activated in an [TF]-dependent manner, and a mutant construct lacking the HNF4 binding site was not activated in HCV-positive cells.	HNF4	HNF1	1	ACTIVATION	False
14571	14868	16781669:0:HNF1A:DPP4	Mutant [TF] and mutant HNF-1beta identified in MODY3 and MODY5 downregulate [TG] gene expression in Caco-2 cells.	HNF-1alpha	DPP-IV	1	ACTIVATION	False
14572	14869	16781669:5:HNF1A:DPP4	Both wild [TF] and wild HNF-1beta significantly transactivated [TG] promoter, but mutant HNF-1alpha and mutant HNF-1beta exhibited low transactivation activity.	HNF-1alpha	DPP-IV	1	ACTIVATION	False
14573	14870	16781669:7:HNF1A:DPP4	We found that [TG] gene expression and enzyme activity were significantly increased in wild [TF] cells and wild HNF-1beta cells, whereas they decreased in HNF-1alphaT539fsdelC cells and HNF-1betaR177X cells, compared with DPP-IV gene expression and enzyme activity in Caco-2 cells.	HNF-1alpha	DPP-IV	1	ACTIVATION	False
14574	14871	16781669:8:HNF1A:DPP4	These results suggest that both wild [TF] and wild HNF-1beta have a stimulatory effect on [TG] gene expression, but that mutant HNF-1alpha and mutant HNF-1beta attenuate the stimulatory effect.	HNF-1alpha	DPP-IV	1	ACTIVATION	False
14575	14872	16788384:11:HNF1A:UGT2B7	In addition, Cdx2 was shown to cooperatively activate the [TG] promoter in conjunction with hepatocyte nuclear factor 1alpha ([TF]), a mechanism previously observed to regulate other intestine-specific genes.	HNF1alpha	UGT2B7	1	ACTIVATION	False
14576	14873	1685988:1:HNF1A:ALB	Hepatic nuclear factor 1 ([TF]) is a highly diverged homeoprotein that is crucial for transcription of many liver-specific genes including [TG].	HNF1	albumin	1	ACTIVATION	False
14577	14874	16899215:8:TCF7L2:SALL4	The [TG] promoter was strongly activated not only by LEF1 but also by [TF].	TCF4E	SALL4	1	ACTIVATION	False
14578	14875	16923809:5:ESRRA:NRIP1	Further analysis indicates that [TF] is capable of activating [TG] gene transcription by two mechanisms, directly by binding to an estrogen receptor element/ERR element at -650/-633 and indirectly through Sp1 binding sites in the proximal promoter.	ERRalpha	RIP140	1	ACTIVATION	False
14579	14876	17022998:11:ISL1:HNF1A	Moreover, [TF] could mediate the recruitment of the cofactor CLIM2 resulting in a further transcriptional enhancement of the [TG] promoter activity.	Isl1	HNF1alpha	1	ACTIVATION	False
14580	14877	17157980:7:ESRRG:ESRRA	Overexpression of [TF] in the HEC-1B cells robustly stimulated the multi-hormone response element (MHRE) of the [TG] gene promoter and this activity was repressed by increasing expression of ERRalpha.	ERRgamma	ERRalpha	1	ACTIVATION	False
14581	14878	1718972:1:HNF1A:AFP	The trans-acting factors of the mouse [TG] proximal promoter (-202 base pairs) are aligned as follows: regions Ia ([TF]), Ib (C/EBP), II (NF-1 or C/EBP), II' (NF-1 or HNF-1), III (NP-III), IV (NP-IV), Va (NP-Va), and Vb (C/EBP).	HNF-1	alpha-fetoprotein	1	ACTIVATION	True
14582	14879	17197698:0:SREBF1:FASN	Direct interaction between USF and [TF]c mediates synergistic activation of the [TG] promoter.	SREBP-1	fatty-acid synthase	1	ACTIVATION	False
14583	14880	17210751:9:HNF1A:IGF1	The H153N mutant-specific repression of [TF] and HNF-1beta transactivity in human [TG] and MRP2 promoters might explain the case-specific clinical features of growth retardation and cholestasis observed only in early infancy.	HNF-1alpha	IGF-I	1	ACTIVATION	False
14584	14881	1734282:4:HNF4A:HNF1A	[TF] was implicated as an essential positive regulator of [TG], as deletion of an HNF-4 binding site in the HNF-1 alpha promoter abolished promoter activity, and HNF-4 potently transactivated the HNF-1 alpha promoter in cotransfection assays.	HNF-4	HNF-1 alpha	1	ACTIVATION	False
14585	14882	17488974:6:HNF1A:GPR39	A functional analysis of the [TG] promoter region identified sites for the hepatocyte nuclear factors 1alpha and 4alpha ([TF]) and specificity protein 1 (SP1) transcription factors as being important for the expression of GPR39.	HNF-1alpha and -4alpha	GPR39	1	ACTIVATION	True
14586	14883	17531980:0:SREBF1:FASN	[TF]c mediates the retinoid-dependent increase in [TG] promoter activity in HepG2.	SREBP-1	fatty acid synthase	1	ACTIVATION	False
14587	14884	17593031:7:HNF1A:CPB2	Transient transfections of [TG] promoter-reporter constructs showed that [TF] binding is essential for the activity of this promoter in HepG2 cells, indicating that HNF-1alpha is involved in the liver-specific expression of CPB2.	HNF-1alpha	CPB2	1	ACTIVATION	False
14588	14885	17667940:11:LHX4:CGA	Using [TF] chromatin immunoprecipitation and [TG]-promoter assays, we found that endogenous LHX4 binds to the CGA promoter and that LHX4-mediated CGA activation is enhanced by the SS18-SSX protein, but not by the SSX protein.	LHX4	CGA	1	ACTIVATION	False
14589	14886	17855651:3:HNF1A:SLC22A12	Hepatocyte nuclear factor 1 alpha ([TF]) and HNF1beta positively regulate minimal promoter activity of the [TG] gene as shown by reporter gene assays.	HNF1alpha	URAT1	1	ACTIVATION	False
14591	14888	17878376:8:IRF8:FAS	Furthermore, it was found that constitutively expressed [TF] is associated with the [TG] promoter to activate Fas transcription.	IRF8	Fas	1	ACTIVATION	False
14592	14889	17889508:0:SP1:CHGA	Gastrin transactivates the [TG] gene through MEK-1/ERK- and PKC-dependent phosphorylation of [TF] and CREB.	Sp1	chromogranin A	1	ACTIVATION	False
14594	14891	18537186:5:HNF1A:CYP2E1	Luciferase reporter gene analysis revealed that [TF] activated [TG] promoter activity, which was restricted by CRY1, a member of the circadian organization of molecular clocks.	HNF-1alpha	CYP2E1	1	ACTIVATION	False
14595	14892	18682402:0:SREBF1:FASN	Proto-oncogene FBI-1 (Pokemon) and [TF] synergistically activate transcription of [TG] gene (FASN).	SREBP-1	fatty-acid synthase	1	ACTIVATION	False
14596	14893	18682402:7:SREBF1:FASN	FBI-1 and [TF] synergistically activate transcription of the [TG] gene by acting on the proximal GC-box and SRE/E-box.	SREBP-1	FASN	1	ACTIVATION	False
14597	14894	18682402:7:ZBTB7A:FASN	[TF] and SREBP-1 synergistically activate transcription of the [TG] gene by acting on the proximal GC-box and SRE/E-box.	FBI-1	FASN	1	ACTIVATION	False
14598	14895	18697814:4:ESRRA:KLK3	Furthermore, [TF] activates the expression of androgen response elements (ARE)-containing promoters, such as that of the prostate cancer marker [TG], in an ARE-dependent manner.	ERRalpha	PSA	1	ACTIVATION	False
14599	14896	18774944:0:KLF5:FASN	[TF] enhances SREBP-1 action in androgen-dependent induction of [TG] in prostate cancer cells.	KLF5	fatty acid synthase	1	ACTIVATION	False
14600	14897	18774944:0:SREBF1:FASN	KLF5 enhances [TF] action in androgen-dependent induction of [TG] in prostate cancer cells.	SREBP-1	fatty acid synthase	1	ACTIVATION	False
14601	14898	18774944:4:KLF5:FASN	Furthermore, [TF] bound to SREBP-1 and enhanced the SREBP-1-mediated increase in [TG] promoter activity.	KLF5	FASN	1	ACTIVATION	False
14602	14899	18774944:4:SREBF1:FASN	Furthermore, KLF5 bound to [TF] and enhanced the SREBP-1-mediated increase in [TG] promoter activity.	SREBP-1	FASN	1	ACTIVATION	False
14603	14900	18774944:5:KLF5:FASN	The results also demonstrated that the expression of [TF] in LNCaP prostate cancer cells enhanced [TG] expression, whereas silencing of KLF5 by small interfering RNA down-regulated FASN expression.	KLF5	FASN	1	ACTIVATION	False
14604	14901	18774944:8:SREBF1:FASN	Taken together, these results suggest that the [TG] gene is activated by the synergistic action of KLF5 and [TF], which was induced by androgen in androgen-dependent prostate cancer cells.	SREBP-1	FASN	1	ACTIVATION	False
14605	14902	18949455:5:HNF1A:INS	Previously we showed that suppression of [TF] function via expression of a dominant-negative mutant (DN-HNF1A) decreases [TG] gene transcription in insulinoma (INS-1) cells.	HNF1A	insulin	1	ACTIVATION	False
14606	14903	18974884:6:ESRRA:MFN2	Finally, we show that PGC-1beta increases [TG] promoter activity and transcription by coactivating the nuclear receptor Estrogen Related Receptor alpha ([TF]).	ERRalpha	Mfn2	1	ACTIVATION	False
14607	14904	1903195:8:FOSB:COL3A1	Transactivation by [TF] and v-fos of the c-jun and [TG] gene promoters and of a 3 x TRE-tk chimeric promoter could be shown in transient CAT assays.	FosB	alpha 1(III) collagen	1	ACTIVATION	False
14608	14905	19233846:4:JDP2:CDKN2A	Conversely, the overexpression of [TF] induced the expression of genes for [TG] and p19(Arf).	JDP2	p16(Ink4a)	1	ACTIVATION	False
14609	14906	19381435:5:FOSB:ITGA2B	Down-regulation of [TF] with specific shRNAs inhibited the induction of [TG], a specific cell surface marker of megakaryocytes.	FosB	CD41	1	ACTIVATION	False
14610	14907	1942067:0:HNF1A:ALB	NFY or a related CCAAT binding factor can be replaced by other transcriptional activators for co-operation with [TF] in driving the rat [TG] promoter in vivo.	HNF1	albumin	1	ACTIVATION	False
14612	14909	19541828:8:HNF1A:UGT1A1	In conclusion, the combined genotypes containing A(TA)(7)TAA and -3279G decrease [TG] transcription mediated by CAR, PXR, or GR but not by [TF] or HNF4 alpha.	HNF1 alpha	UGT1A	1	ACTIVATION	False
14613	14910	19615968:4:TP53:FAS	The intronic element conferred transcriptional activation by [TF], TAp63 and TAp73 and cooperated with the p53-REs in the promoter of the [TG] gene.	p53	CD95	1	ACTIVATION	False
14614	14911	19615968:4:TP73:FAS	The intronic element conferred transcriptional activation by p53, TAp63 and TA[TF] and cooperated with the p53-REs in the promoter of the [TG] gene.	p73	CD95	1	ACTIVATION	False
14615	14912	19615968:5:TP53:FAS	Cooperation between the [TF]-REs in the promoter and the intronic p53-binding site resulted in maximal transcriptional activation of the [TG] gene by the p53 family.	p53	CD95	1	ACTIVATION	False
14616	14913	19665600:3:FOSB:IL11	Mechanical stress to osteoblasts by fluid shear stress (FSS) in vitro rapidly and transiently enhances [TF] gene transcription, stimulates binding of DeltaFosB/JunD complex to activator protein (AP)-1 site of the [TG] gene promoter, and enhances IL-11 gene transcription.	fosB	IL-11	1	ACTIVATION	False
14617	14914	19665600:5:FOSB:IL11	Down-regulation of [TF]/JunD by small interfering RNA (siRNA) suppresses and overexpression of DeltaFosB/JunD enhances [TG] gene promoter activity.	DeltaFosB	IL-11	1	ACTIVATION	True
14618	14915	19687008:7:HNF1A:PCSK9	A battery of functional assays identified [TF] as the predominant trans-activator for [TG] gene working through this sequence motif.	HNF1alpha	PCSK9	1	ACTIVATION	False
14619	14916	19687008:9:HNF1A:PCSK9	Finally, we show that a coordinate modest reduction of [TF] and nuclear SREBP2 by BBR led to a strong suppression of [TG] transcription through these two critical regulatory sequences.	HNF1alpha	PCSK9	1	ACTIVATION	False
14620	14917	20106981:5:NKX6-1:HNF1A	Site-directed mutagenesis of the [TF] core-binding sequence eliminated NKX6.1-mediated activation and substantially decreased activity of the [TG] promoter in beta cells.	NKX6.1	HNF1alpha	1	ACTIVATION	False
14621	14918	20130133:2:SREBF1:FASN	We previously showed that, through sterol regulatory element binding protein-1 ([TF]), HCV-3a core protein upregulates the promoter activity of [TG], a major enzyme involved in de novo lipid synthesis.	SREBP-1	fatty acid synthase	1	ACTIVATION	False
14622	14919	20215575:0:ESRRA:GCK	PGC-1alpha coactivates [TF] to induce the expression of [TG].	estrogen-related receptor-alpha	glucokinase	1	ACTIVATION	False
14624	14921	20460578:8:HNF1A:NPC1L1	By contrast, [TF] increased the promoter activity and the gene expression, and an important HNF1 binding site was identified within the human [TG] promoter.	HNF1alpha	NPC1L1	1	ACTIVATION	False
14625	14922	20797428:6:TP53:FAS	Consistent with previous studies, RSVL induces the nuclear translocation of [TF] and the expression of p53-responsive genes such as Cdkn1a, Gadd45a, Gadd45, and [TG].	p53	Fas	1	ACTIVATION	False
14626	14923	20810608:6:HNF1A:CLCN5	The transactivation of the Clcn5/[TG] promoter by [TF] was verified in vitro, and the binding of HNF1 to the Clcn5 promoter in vivo was confirmed by chromatin immunoprecipitation in mouse kidney.	HNF1	CLCN5	1	ACTIVATION	False
14627	14924	20810608:7:HNF1A:CLCN5	The expression of [TG] was reduced in the proximal tubule segments of [TF]-null kidneys, and it was rescued upon transfection of HNF1-null cells with wild-type but not with mutant HNF1.	HNF1	Clcn5	1	ACTIVATION	False
14628	14925	20979532:5:HNF1A:AFM	Our data indicate that [TF] is a more potent activator of [TG] promoter than is HNF1.	HNF1	AFM	1	ACTIVATION	False
14629	14926	20979532:6:HNF1A:AFM	However, [TF] can act in a dominant manner to inhibit HNF1-dependent transactivation of the [TG] promoter when both proteins are expressed together.	HNF1	AFM	2	REPRESSION	True
14630	14927	21454713:6:HNF1A:APOM	Overexpression of c-Jun or JunB repressed both the basal and the [TF]-mediated transactivation of the human [TG] promoter.	HNF-1	apoM	1	ACTIVATION	False
14631	14928	22020338:0:POU1F1:CDKN2A	Direct promoter induction of [TG] by [TF] explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells.	Pit-1	p19Arf	1	ACTIVATION	False
14632	14929	22020338:11:POU1F1:CDKN2A	[TF] directly regulates the [TG] locus and binds to the p19Arft promoter inducing p19Arf gene expression.	Pit-1	CDKN2A	1	ACTIVATION	False
14633	14930	22084312:5:SP1:FAS	The -1377A variant destroys a binding site for the [TF] transcriptional regulator and is associated with lower transcriptional activity of the [TG] promoter.	SP1	CD95	1	ACTIVATION	False
14634	14931	22196858:11:HNF1A:ALB	Moreover, an increased interaction of [TF] with p300 and [TG] promoter seems to be responsible for overexpression of albumin in ischemic conditions.	HNF-1alpha	albumin	1	ACTIVATION	False
14635	14932	22357705:0:HNF1A:MTTP	NR2F1 disrupts synergistic activation of the [TG] gene transcription by HNF-4 and [TF].	HNF-1	MTTP	1	ACTIVATION	False
14636	14933	22461910:7:FOXM1:CDKN2A	Bisulfite modification and methylation-specific promoter analysis using absolute quantitative PCR (MS-qPCR) showed that upregulation of [TF] significantly induced [TG] promoter hypermethylation (10-fold, P<0.05) in primary NOK cells.	FOXM1	p16(INK4A)	1	ACTIVATION	False
14637	14934	22761926:3:ESRRA:SCT	In this report, we provide evidence that estrogen-related receptor  (ERR, [TF]), a transcription factor mainly involved in metabolism, acts as an upstream activator of the [TG] gene.	NR3B1	SCT	1	ACTIVATION	False
14638	14935	23300015:5:SREBF1:FASN	Furthermore, RBP4 treatment enhanced the levels of mature [TF] and its nuclear translocation, thereby increasing the expression of lipogenic genes, including [TG] (FAS), acetyl coenzyme A carboxylase-1 (ACC-1), and diacylglycerol O-acyltransferase 2 (DGAT-2).	SREBP-1	fatty acid synthase	1	ACTIVATION	False
14639	14936	23482931:11:FOSL2:GCKR	Taken together, we have revealed an important oncogenic cascade involving [TF]/JUND and SOX4 in ATL, which leads to the expression of genes such as [TG], NAP1, and HDAC8.	FRA-2	GCKR	1	ACTIVATION	False
14640	14937	23922447:7:HNF1A:POU2F1	Following [TF] overexpression in Huh7 cells, the intron 1 ECR increased SV40 promoter activity by 11-fold and [TG] promoter activity by 6-fold.	HNF1	OCT1	1	ACTIVATION	False
14641	14938	24382891:0:ZBTB48:CDKN2A	Human Kruppel-related 3 ([TF]) is a novel transcription activator of alternate reading frame ([TG]) gene.	HKR3	ARF	1	ACTIVATION	False
14642	14939	24382891:5:ZBTB48:CDKN2A	[TF] interacted with the co-activator p300 to activate [TG] transcription, which increased the acetylation of histones H3 and H4 within the proximal promoter.	HKR3	ARF	1	ACTIVATION	False
14643	14940	24382891:6:ZBTB48:CDKN2A	Oligonucleotide pull-down assays and ChIP assays revealed that [TF] interferes with the binding of the proto-oncogenic transcription repressor FBI-1 to proximal FREs, thus derepressing [TG] transcription.	HKR3	ARF	1	ACTIVATION	True
14644	14941	2736625:1:HNF1A:ALB	[TF] is a liver-specific transcription factor that plays the dominant role in determining the cell type-specific in vitro transcription of the [TG] gene.	HNF1	albumin	1	ACTIVATION	False
14645	14942	2736625:6:HNF1A:ALB	In addition to stimulating transcription directly by binding to its cognate site, [TF] may further enhance [TG] promoter activity by interacting cooperatively with other trans-acting factors.	HNF1	albumin	1	ACTIVATION	False
14646	14943	7518671:6:HNF1A:AFP	Interestingly, HNF-1 beta was found to be more potent than [TF] in activating the [TG] promoter.	HNF-1 alpha	AFP	1	ACTIVATION	False
14647	14944	7518671:9:HNF1A:AFP	Both [TF]s allowed expression of the [TG] promoter in cells of nonhepatic origin.	HNF-1	AFP	1	ACTIVATION	False
14648	14945	7539102:0:TP53:FAS	Wild-type human [TF] and a temperature-sensitive mutant induce Fas/[TG] expression.	p53	APO-1	1	ACTIVATION	False
14649	14946	7539102:9:TP53:FAS	Collectively, these observations argue that Fas/[TG] is a target gene for transcriptional activation by [TF].	p53	APO-1	1	ACTIVATION	False
14650	14947	7683517:1:HNF1A:IGFBP1	The liver-specificity of insulin-like growth factor binding protein-1 ([TG]) gene promoter activity has been studied by transient transfection in rat hepatoma cell lines, rat fibroblasts and human cervical carcinoma cells, and shown to be dependent on [TF].	HNF1	IGFBP-1	1	ACTIVATION	False
14651	14948	7684229:3:HNF1A:IGFBP1	To test whether [TF] activates [TG] transcription, HEP G2 cells and HeLa cells were cotransfected transiently with HNF1 expression vectors and with IGFBP-1 promoter/chloramphenicol acetyltransferase reporter gene constructs.	HNF1	IGFBP-1	1	ACTIVATION	False
14652	14949	7684229:4:HNF1A:IGFBP1	[TF] increased [TG] promoter activity in both HEP G2 and HeLa cells.	HNF1	IGFBP-1	1	ACTIVATION	False
14653	14950	7684229:5:HNF1A:IGFBP1	Gel mobility-shift assays and additional transfections in HeLa cells showed that expressed full-length and carboxy-terminal truncated forms of [TF] could each bind the HNF1 cis element of the [TG] promoter; however, significant trans-activation only occurred in the presence of the full-length HNF1 protein, similar to past experience with these two HNF1 forms and the albumin promoter.	HNF1	IGFBP-1	1	ACTIVATION	False
14654	14951	7692852:0:HNF1A:IGFBP1	Interplay of the liver-enriched trans-acting factors, DBP and [TF], in the transactivation of human [TG] promoter.	HNF1	IGFBP-1	1	ACTIVATION	False
14655	14952	7692852:4:HNF1A:IGFBP1	In addition, DBP and [TF] were capable of functional co-operation in activating the [TG] promoter.	HNF1	IGFBP-1	1	ACTIVATION	False
14656	14953	7710685:1:HNF1A:CYP2E1	The role of the trans-acting factor [TF] in activating [TG] gene expression was confirmed by transient co-transfection of an HNF-1 alpha expression plasmid and the CYP2E1 promoter fused to the chloramphenicol acetyl transferase (CAT) reporter gene.	HNF-1 alpha	CYP2E1	1	ACTIVATION	False
14657	14954	7881411:7:HNF1A:PROC	This analysis is therefore indicative of a vital role for [TF] in the expression of the [TG] gene in vivo.	HNF-1	PROC	1	ACTIVATION	True
14659	14956	8102976:6:HNF1A:ALB	Transfection of [TF] expression vector alone was able to activate an [TG] promoter (-1 kb, 5' flanking) promoted GPT construct in L cells, but not in HeLa cells, suggesting that different factors in L cells might interact with HNF1 to mediate activation.	HNF1	albumin	1	ACTIVATION	False
14661	14958	8443410:6:HNF1A:ALB	A transfected [TF] expression vector strongly trans-activates the [TG] promoter in HepG2 but only weakly in BW1J cells, and in hybrids (BW1J x Fao), inefficient HNF1 function is dominant.	HNF1	albumin	1	ACTIVATION	False
14662	14959	8443410:7:HNF1A:ALB	We conclude that hepatoma cells of the fetal phenotype are deficient in the use of [TF] to drive transcription of the [TG] gene and that they harbor a dominant modulator of HNF1 function.	HNF1	albumin	1	ACTIVATION	False
14663	14960	8550563:2:HNF4A:TF	Transcriptional suppression of liver [TG] by hypolipidemic peroxisome proliferators results from (a) displacement of hepatic nuclear factor (HNF)-4 from the transferrin promoter by nonproductive binding of the peroxisome proliferator-activated receptor-retinoic acid X receptor heterodimer to the (-76/-52) PRI promoter element of the human transferrin gene and (b) suppression of liver [TF] gene expression by hypolipidemic peroxisome proliferators with a concomitant decrease in its availability for binding to the transferrin PRI promoter element.	HNF-4	transferrin	1	ACTIVATION	True
14664	14961	8550563:3:HNF4A:TF	[TF] gene suppression and its displacement from the [TG] promoter result in eliminating HNF-4-enhanced transcription of transferrin.	HNF-4	transferrin	1	ACTIVATION	False
14665	14962	8550563:5:HNF4A:TF	Transcriptional suppression of [TF]-enhanced liver genes (e.g. apolipoprotein C-III, [TG]) may complement the pleiotropic biological effect exerted by hypolipidemic peroxisome proliferators.	HNF-4	transferrin	1	ACTIVATION	False
14666	14963	8622679:8:NR2F1:HNF1A	The v[TG] promoter is transactivated by COUP-TFI/[TF] and COUP-TFII/Arp1 and, unlike the HNF1 promoter, is virtually unaffected by HNF4.	Ear3	HNF1	1	ACTIVATION	False
14667	14964	8622679:8:NR2F2:HNF1A	The v[TG] promoter is transactivated by COUP-TFI/Ear3 and COUP-TFII/[TF] and, unlike the HNF1 promoter, is virtually unaffected by HNF4.	Arp1	HNF1	1	ACTIVATION	False
14668	14966	9053305:7:HNF4A:TF	Using [TF](-/-) ES cells we demonstrate that HNF-4 is a key regulator of tissue-specific gene expression in the VE, required for normal expression of secreted factors including alphafetoprotein, apolipoproteins, transthyretin, retinol binding protein, and [TG].	Hnf-4	transferrin	1	ACTIVATION	False
14670	14968	9271417:10:ESRRA:ACADM	In the absence of its putative ligand, [TF] does not activate the [TG] promoter in transient transfection studies; however, a VP16-ERR alpha chimera activates natural and synthetic promoters containing NRRE-1.	ERR alpha	MCAD	1	ACTIVATION	False
14671	14969	9710644:6:FOSB:CCND1	Although definitive evidence that c-Fos and [TF] directly induce [TG] transcription will require further analysis, these findings raise the possibility that c-Fos and FosB are either direct or indirect transcriptional regulators of the cyclin D1 gene and may function as a critical link between serum stimulation and cell cycle progression.	FosB	cyclin D1	1	ACTIVATION	False
14672	14970	9841917:0:TP53:FAS	[TF] activates the [TG] (APO-1/Fas) gene in response to DNA damage by anticancer drugs.	p53	CD95	1	ACTIVATION	False
14673	14971	9841917:11:TP53:FAS	The intronic element conferred transcriptional activation by [TF] and cooperated with p53-responsive elements in the promoter of the [TG] gene.	p53	CD95	1	ACTIVATION	False
14674	14972	9841917:12:TP53:FAS	wt [TF] bound to and transactivated the [TG] gene, whereas mt p53 failed to induce apoptosis via activation of the CD95 gene.	p53	CD95	1	ACTIVATION	False
14675	14973	10585866:10:STAT1:IVL	Gel-shift analyses revealed that [TF] (signal transduction and activators of transcription 1) protein bound to the G1 region and that [TG] promoter activity was augmented by transfection of a STAT1 expression vector in the presence of IFN-gamma.	STAT1	involucrin	1	ACTIVATION	False
14676	14974	16484337:3:ESRRA:MAOB	Additionally, [TF] (ERRalpha) up-regulates [TG] gene expression in breast cancer cells.	estrogen-related receptor alpha	MAO-B	1	ACTIVATION	False
14677	14975	16670373:5:HNF1A:ABCC2	Mutations within the putative [TF] binding site of the human [TG] promoter abrogated HCV-induced activation, implicating HNF1 in the induction of MRP2 by HCV.	HNF1	MRP2	1	ACTIVATION	False
14678	14976	20096102:3:HNF1A:UGT1A1	Interestingly, one of these CpG dinucleotides (CpG -4) is found close to a [TF] response element (HRE), known to be involved in activation of [TG] gene expression, and within an upstream stimulating factor (USF) binding site.	HNF1	UGT1A1	1	ACTIVATION	False
14679	14977	20576918:8:HNF1A:ABCC2	The net effects were upregulation of HNF6 target gene glucokinase and of Foxa2, [TF], and HNF4a target genes oatp1, ntcp, and [TG] over AdLacZ control in both cells, but with higher levels in AdH6-SV40SM over AdH6-SV40LG of glucokinase, oatp1, ntcp, and mrp2 (by 1.8-, 3.4-, 2.4-, and 2.5-fold, respectively).	HNF1a	mrp2	1	ACTIVATION	False
14680	14979	22761926:0:ESRRA:SCT	The [TF] upregulates [TG] expressions in response to hypertonicity and angiotensin II stimulation.	estrogen-related receptor alpha	secretin	1	ACTIVATION	False
14681	14980	24100303:6:HNF1A:ACE2	In the proximal part of the human [TG] promoter, we further identified three functional [TF], as they have binding affinity for HNF1 and HNF1 and are required for induction of promoter activity by HNF1 in insulinoma cells.	HNF1 binding sites	ACE2	1	ACTIVATION	False
14682	14981	2479822:6:HNF1A:AFP	Mutation of the [TF] recognition site at -120 resulted in a significant reduction in transcription in transfection assays, suggesting a biological role for HNF-1 in the regulation of [TG] expression.	HNF-1	AFP	1	ACTIVATION	False
14683	14982	7678342:8:HNF1A:IGFBP1	Our results indicate that [TF] is instrumental in human [TG] promoter activity in vivo and that v-HNF1 modulates this functional role.	HNF1	IGFBP-1	1	ACTIVATION	False
14684	14984	9553065:0:HNF1A:PROC	Type I [TG] deficiency caused by disruption of a hepatocyte nuclear factor (HNF)-6/[TF] binding site in the human protein C gene promoter.	HNF-1	protein C	1	ACTIVATION	True
14686	14986	16267049:6:ESRRA:CYC1	In agreement with the in vitro studies, animals that lack [TF] show increased expression of gluconeogenic genes, including PEPCK and glycerol kinase, but decreased expression of mitochondrial genes, such as ATP synthase subunit beta and [TG].	ERRalpha	cytochrome c-1	1	ACTIVATION	False
14687	14987	10542313:5:HNF1A:ALB	A single [TF] binding site located adjacent to the TATA box plays a major role in transcription directed by the [TG] promoter in transient transfection assays.	HNF-1	serum albumin	1	ACTIVATION	False
14688	14988	10677375:0:HNF1A:LCT	Interaction between the homeodomain proteins Cdx2 and [TF] mediates expression of the [TG]-phlorizin hydrolase gene.	HNF1alpha	lactase	1	ACTIVATION	False
14689	14989	11526499:6:E2F1:CDKN2A	We also show that together with the acquired expression of TA-p73, the 'retinoblastoma pathway' is inactivated, and [TF]-target genes including cyclin E and [TG] are activated in hepatocellular carcinoma.	E2F1	p14(ARF)	1	ACTIVATION	True
14690	14990	15155840:4:HNF1A:GSTA2	This study investigated the role of [TF] in [TG] gene transactivation, the ubiquitin proteasomal degradation of HNF1, and the inhibition of activating HNF1 by ceramide for GSTA2 repression.	HNF1	GSTA2	1	ACTIVATION	False
14691	14991	3263567:8:HNF1A:SERPINA1	We present evidence that [TF] and HNF-2 are positively acting, tissue-specific transcription factors that regulate hepatic expression of the human [TG] gene.	HNF-1	AAT	1	ACTIVATION	False
14692	14992	7710685:0:HNF1A:CYP2E1	Role of the liver-enriched transcription factor [TF] in expression of the [TG] gene.	HNF-1 alpha	CYP2E1	0	UNDEFINED	True
14693	14993	21901280:4:TCF7L2:G6PC	Silencing of [TF] induced a marked increase in basal HGP, which was accompanied by significant increases in the expression of the gluconeogenic genes Fbp1, Pck1 and [TG].	TCF7L2	G6pc	2	REPRESSION	False
14694	14994	18697801:6:HNF1A:MTTP	Enforced expression of [TF] was sufficient to reconstitute the negative insulin responsiveness of [TG] promoter in TM4SF1 myocytes that are HNF1A negative.	HNF1A	MTTP	2	REPRESSION	False
14695	14995	22805310:0:STAT1:FAS	Unphosphorylated [TF] promotes sarcoma development through repressing expression of [TG] and bad and conferring apoptotic resistance.	STAT1	Fas	2	REPRESSION	False
14696	14996	10903433:9:YBX1:FAS	Overexpression of [TF] and Puralpha in Jurkat cells was shown to reduce the level of cell surface Fas staining, providing further evidence that these proteins regulate the [TG] promoter.	YB-1	fas	0	UNDEFINED	True
14697	14997	11062467:0:TBX2:CDKN2A	Senescence bypass screen identifies [TF], which represses [TG] (p19(ARF)) and is amplified in a subset of human breast cancers.	TBX2	Cdkn2a	2	REPRESSION	False
14698	14998	11062467:2:TBX2:CDKN2A	We identified the T-box member [TF] as a potent immortalizing gene that acts by downregulating [TG] (p19(ARF)).	TBX2	Cdkn2a	2	REPRESSION	False
14699	14999	11234019:5:ID1:CDKN2A	In senescent cells, where the Ets2 levels and MEK signalling decline, the marked increase in [TG] expression is consistent with the reciprocal reduction of [TF] and accumulation of Ets1.	Id1	p16INK4a	2	REPRESSION	True
14700	15000	11316735:17:ID1:TF	Antisense to [TF] stimulated [TG] promoter activity in a transient transfection assay.	Id1	transferrin	2	REPRESSION	False
14701	15002	11427735:0:ID1:CDKN2A	[TF] regulation of cellular senescence through transcriptional repression of [TG].	Id1	p16/Ink4a	2	REPRESSION	False
14702	15003	11427735:6:ID1:CDKN2A	We also show that [TF] is able to directly inhibit [TG] but not p19/ARF promoter activity via its HLH domain, and that Id1 inhibits transcriptional activation at E-boxes within the p16/Ink4a promoter.	Id1	p16/Ink4a	2	REPRESSION	False
14703	15004	11427735:7:ID1:CDKN2A	Our data provide, to our knowledge, the first genetic evidence for a role for [TF] as an inhibitor of cellular senescence and suggest that Id1 functions to delay cellular senescence through repression of [TG].	Id1	p16/Ink4a	2	REPRESSION	False
14704	15005	11428722:7:HNF1A:INS	Transfection into MN6 cells with pINS-1998/luc in the absence of IPF1 resulted in constitutional transactivation of the [TG] gene, and this transactivation was abolished by the co-transfection with [TF].	HNF-1alpha	insulin	2	REPRESSION	False
14705	15006	11428722:8:HNF1A:INS	The present data indicate that IPF1 rather than [TF] predominantly transactivates the [TG] gene, and that HNF-1alpha inhibits IPF1-dependent insulin gene transactivation mediated through the 5' flanking sequence of the A3 element.	HNF-1alpha	insulin	0	UNDEFINED	True
14706	15007	11428722:9:HNF1A:INS	It is suggested that [TF] may be involved in [TG] gene expression as a negative regulator.	HNF-1alpha	insulin	2	REPRESSION	False
14707	15008	11435435:7:HOXA7:IVL	Antisense [TF] expression activated transglutaminase 1, [TG], and keratin 10 message and protein levels, demonstrating that endogenous HOXA7 down-regulates multiple differentiation-specific keratinocyte genes.	HOXA7	involucrin	2	REPRESSION	True
14708	15009	11507043:2:ID1:CDKN2A	Recently [TF] has been shown to repress Ets- and E-protein-mediated transactivation of p16/[TG].	Id1	Ink4a	2	REPRESSION	False
14709	15010	11733515:4:JUN:FAS	Conversely, inhibition of PI3K-AKT signaling via the specific pharmacological inhibitor LY294002 up-regulated [TF]/Jun- and STAT-dependent transcriptional activities, resulting in suppression of the [TG] promoter activities and decreased FasR surface expression.	AP1	FasR	2	REPRESSION	True
14710	15011	12556466:6:EGR1:FAS	One mechanism was illustrated by the ability of [TF] to inhibit [TG] (Fas/Apo) expression, leading to insensitivity to FasL.	Egr1	CD95	2	REPRESSION	False
14711	15012	12963547:6:JUN:FAS	Radiation-induced [TG] sensitization in prostate cancer cell was mediated through p53-dependent transactivation of the Fas gene, which can be blocked by androgen stimulation mainly through induction of [TF].	c-jun	Fas	2	REPRESSION	True
14712	15013	15138269:5:ID1:CDKN2A	Silencing [TF] expression in young cells by RNA interference induced an increased [TG] level and premature cellular senescence, whereas silencing E47 expression inhibited the expression of p16(INK4a) and delayed the onset of senescent phenotype.	Id1	p16(INK4a)	2	REPRESSION	False
14713	15014	15781639:4:TBX2:CDKN2A	Overexpression of [TF] and the related factor Tbx3, which is also overexpressed in breast cancer and melanomas, can suppress senescence in defined experimental systems through repression of [TG] expression.	Tbx2	ARF	2	REPRESSION	False
14714	15015	15781639:4:TBX3:CDKN2A	Overexpression of Tbx2 and the related factor [TF], which is also overexpressed in breast cancer and melanomas, can suppress senescence in defined experimental systems through repression of [TG] expression.	Tbx3	ARF	2	REPRESSION	False
14715	15016	16143308:10:YY1:FAS	The direct role of [TF] in the negative regulation of [TG] expression was demonstrated by transfection of cells with siRNA YY1.	YY1	Fas	2	REPRESSION	False
14716	15017	16267049:6:ESRRA:GK	In agreement with the in vitro studies, animals that lack [TF] show increased expression of gluconeogenic genes, including PEPCK and [TG], but decreased expression of mitochondrial genes, such as ATP synthase subunit beta and cytochrome c-1.	ERRalpha	glycerol kinase	2	REPRESSION	True
14717	15018	16314512:7:FOXM1:CDKN2A	Moreover, early-passage [TF](-)(/)(-) MEFs display premature senescence as evidenced by high expression of the senescence-associated beta-galactosidase, p19(ARF), and [TG] proteins.	Foxm1	p16(INK4A)	2	REPRESSION	True
14718	15019	16730707:2:TBX2:CDKN2A	[TF] is a transcriptional repressor implicated in several developmental processes and which has also been implicated in cancer through its ability to suppress senescence via repression of the [TG] and p21(Cip1) (CDKN1A) promoters.	Tbx2	p19(ARF)	2	REPRESSION	False
14719	15020	16784892:9:YY1:FAS	The direct role of [TF] expression in the regulation of PC-3 resistance to CH-11-induced apoptosis was shown in cells transfected with siRNA YY1 whereby such cells exhibited upregulation of [TG] expression and were sensitized to CH-11-induced apoptosis.	YY1	Fas	0	UNDEFINED	True
14720	15021	17630961:2:TBX2:CDKN2A	[TF] and Tbx3 have also been implicated in several cancers including melanoma, and can act as antisenescence factors through their ability to repress p19([TG]) and p21(CIP1) expression.	Tbx2	ARF	2	REPRESSION	False
14721	15022	17630961:2:TBX3:CDKN2A	Tbx2 and [TF] have also been implicated in several cancers including melanoma, and can act as antisenescence factors through their ability to repress p19([TG]) and p21(CIP1) expression.	Tbx3	ARF	2	REPRESSION	False
14722	15023	18025091:2:TBX3:CDKN2A	Importantly, the highly related T-box factors Tbx2 and [TF] can suppress senescence through repressing the cyclin-dependent kinase inhibitors p19([TG]) and p21(WAF1/CIP1/SDII).	Tbx3	ARF	2	REPRESSION	False
14723	15024	18038118:0:DNMT1:CDKN2A	[TF] as a mediator of mutant p53-determined [TG] down-regulation.	DNA (cytosine-5)-methyltransferase 1	p16(ink4A)	2	REPRESSION	False
14724	15025	18240291:6:ID1:CDKN2A	Here we show that constitutive expression of [TF] in primary human melanocytes leads to delayed cellular senescence and decreased expression of the familial melanoma gene, p16/[TG].	Id1	INK4a	2	REPRESSION	False
14725	15026	18245468:0:TBX3:CDKN2A	[TF] is overexpressed in breast cancer and represses [TG] by interacting with histone deacetylases.	TBX3	p14 ARF	2	REPRESSION	False
14726	15027	18356246:0:TBX3:CDKN2A	[TF] controls the fate of hepatic progenitor cells in liver development by suppressing [TG] expression.	Tbx3	p19ARF	2	REPRESSION	False
14727	15028	18356246:4:TBX3:CDKN2A	Deletion of [TF] resulted in the increased expression of the tumor suppressor p19(ARF) ([TG]), which in turn induced a growth arrest in hepatoblasts and activated a program of cholangiocyte differentiation.	Tbx3	Cdkn2a	2	REPRESSION	False
14728	15029	18558095:0:YY1:CDKN2A	[TF] restrained cell senescence through repressing the transcription of [TG].	YY1	p16	2	REPRESSION	False
14729	15030	18558095:3:YY1:CDKN2A	We also show that [TF] participated in the repression of [TG] expression in 293T cells through an epigenetic mechanism involving histone acetylation modification.	YY1	p16(INK4a)	2	REPRESSION	False
14730	15031	18558095:8:YY1:CDKN2A	Overall, data from this study suggest that [TF], HDAC3 and HDAC4 restrained cell senescence by repressing [TG] expression through an epigenetic modification of histones.	YY1	p16(INK4a)	2	REPRESSION	False
14731	15032	18571787:10:PROX1:CDKN2A	[TF] up-regulated expression of cyclins D2, E1, and E2, whereas it suppressed expression of [TG], the cdk inhibitor.	Prox1	p16(ink4a)	2	REPRESSION	False
14732	15033	18571787:11:PROX1:CDKN2A	In addition, overexpression of [TF] significantly inhibited the proximal promoter activity of [TG].	Prox1	p16(ink4a)	2	REPRESSION	False
14734	15035	18762810:3:TBX2:CDKN2A	[TF], a transcriptional repressor of [TG], can collaborate with c-Myc by suppressing apoptosis.	Tbx2	p19Arf	2	REPRESSION	False
14735	15036	19029143:0:TCF4:KDR	TAL1/SCL relieves the [TF]2-mediated repression of [TG] promoter activity.	E2-	VEGFR2	2	REPRESSION	False
14736	15037	19029143:3:TCF4:KDR	We recently demonstrated that E-box protein [TF]2 blocks endothelial cell activation via perturbation of [TG] promoter activity.	E2-	VEGFR2	2	REPRESSION	True
14737	15038	19216023:2:TBX2:CDKN2A	In carcinogenesis, [TF] regulates the cell cycle by suppressing the expression of cyclin-dependent kinase (CDK) inhibitors and destabilizes p53 by suppressing expression of [TG].	TBX2	ARF	2	REPRESSION	False
14738	15039	19244234:3:ZBTB7A:CDKN2A	Recently, [TF] was characterized as a critical oncogenic factor that specifically represses transcription of the tumor suppressor gene [TG], potentially leading indirectly to p53 inactivation.	FBI-1	ARF	2	REPRESSION	False
14739	15040	19583777:0:ZNF148:CDKN2A	The transcription factor [TF] suppresses [TG] expression through a histone modification mechanism to affect cell senescence.	ZBP-89	p16	2	REPRESSION	False
14740	15041	19710540:5:HDGF:FAS	Increases in Fas expression and [TG] promoter activity were detected upon [TF] knock-down by Western blot analysis and luciferase reporter assay.	HDGF	fas	2	REPRESSION	False
14741	15042	20348948:2:TBX2:CDKN2A	[TF] has previously been shown to repress growth control genes such as p14([TG]) and p21(WAF1/cip1).	TBX2	ARF	2	REPRESSION	False
14742	15044	22025288:10:YY1:CDKN2A	While transcription factors [TF] and Id1 suppress [TG] expression, transcription factors CTCF, Sp1 and Ets family members activate p16 transcription.	YY1	p16	2	REPRESSION	False
14743	15045	22039763:6:TBX3:CDKN2A	Previous studies have suggested that [TF] contributes to cancer development by its ability to bypass senescence by repressing the expression of [TG]-tumor suppressor.	TBX3	p14(ARF)	2	REPRESSION	False
14744	15046	22290439:3:TWIST1:CDKN2A	In the present study, we show that [TF] potently suppresses senescence and the [TG]/Arf locus with a dramatic decrease in the expression of p16 and to some extent a decrease in p14.	Twist-1	Ink4A	2	REPRESSION	False
14745	15047	24165022:0:YBX1:CDKN2A	[TF] binds to and represses the [TG] tumor suppressor gene.	YB1	p16	2	REPRESSION	False
14746	15048	24165022:4:YBX1:CDKN2A	Depletion of [TF] was associated with increased levels of [TG] in human and murine primary cells.	YB1	p16	2	REPRESSION	False
14747	15049	24165022:8:YBX1:CDKN2A	Taken together, all our findings indicate that [TF] directly binds to and represses [TG] transcription, subsequently resulting in the promotion of cell growth and prevention of cellular senescence.	YB1	p16	2	REPRESSION	False
14748	15050	9300687:9:EGR1:FAS	In B cells, [TF] therefore plays a critical role in integrating the short-lived signal delivered by triggering of the Ag receptor into phenotypic changes, including repression of [TG] and CD23 transcription.	Egr-1	CD95	2	REPRESSION	False
14749	15051	12850269:6:HNF1A:GJB1	The transcription factors [TF] and Sp1 have important functional roles in the transcriptional regulation of basal and cell-specific [TG] expression.	HNF-1	Cx32	0	UNDEFINED	True
14750	15052	16143308:2:YY1:FAS	Previous findings demonstrated that the transcription repressor Yin Yang 1 ([TF]), which is inhibited by NO, negatively regulates [TG] transcription [H.J. Garban, B. Bonavida, Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the upregulation of Fas gene expression in human tumor cells, J. Immunol. 167 (2001) 75-81].	YY1	Fas	2	REPRESSION	False
14751	15053	16784892:3:YY1:FAS	We have reported that [TG] expression and sensitivity to FasL is negatively regulated by the transcription repressor factor Yin Yang 1 ([TF]).	YY1	Fas	2	REPRESSION	False
14752	15054	17021248:2:HNF1A:GSTA1	We investigated the role of hepatic nuclear factor 1 ([TF]) in repression of human [TG] expression by interleukin (IL)-1beta in Caco-2 cells.	HNF-1	GSTA1	2	REPRESSION	False
14753	15055	18697801:2:HNF1A:MTTP	Here, we provide evidence that a hepatocyte nuclear factor 1 binding element ([TF] element) within the [TG] promoter serves as a novel negative insulin-responsive element.	HNF1A	MTTP	2	REPRESSION	True
14755	15057	14522900:8:HNF1A:AFP	Suppression of [TG] gene transcription by ING was strongly dependent on AT-motifs that bind to the hepatocyte nuclear factor 1 ([TF]) transcription factor.	HNF1	AFP	2	REPRESSION	False
14757	15059	23554223:5:POU5F1:CDKN2A	[TF] has been shown to induce Dnmt1 in mesenchymal stem cells, and we link Oct4 and Dnmt1 to silencing of cell cycle inhibitory cyclin dependent kinase inhibitors and [TG], and immortalization of the reprogrammed fibroblasts.	Oct4	Arf	2	REPRESSION	False
14758	15060	24382891:6:ZBTB7A:CDKN2A	Oligonucleotide pull-down assays and ChIP assays revealed that HKR3 interferes with the binding of the proto-oncogenic transcription repressor [TF] to proximal FREs, thus derepressing [TG] transcription.	FBI-1	ARF	2	REPRESSION	False
14759	15061	9317150:0:ATF2:SELE	TNF initiates [TG] transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/[TF] pathways.	ATF2	E-selectin	1	ACTIVATION	False
14760	15062	9317150:7:ATF2:SELE	These data suggest that TNF activates parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/[TF] pathways to initiate [TG] transcription.	ATF2	E-selectin	1	ACTIVATION	False
14761	15063	22138754:5:ATF3:EPO	At the molecular level, we show that the PDGF-BB-PDGFR-b signaling system activates the [TG] promoter, acting in part through transcriptional regulation by the transcription factor [TF], possibly through its association with two additional transcription factors, c-Jun and Sp1.	Atf3	EPO	1	ACTIVATION	False
14762	15064	1347906:4:MYB:CD4	We have determined that a [TF] transcription factor binds to the [TG] promoter and is critical for full promoter function.	Myb	CD4	1	ACTIVATION	False
14763	15065	7559553:7:EGR1:MYB	We showed that WT1, [TF], and Sp1 bound to this site, and that mutation of this site increased the activity of the [TG] promoter by 3.2-fold.	EGR-1	c-myb	2	REPRESSION	False
14764	15066	7559553:7:WT1:MYB	We showed that [TF], EGR-1, and Sp1 bound to this site, and that mutation of this site increased the activity of the [TG] promoter by 3.2-fold.	WT1	c-myb	2	REPRESSION	False
14765	15067	7640286:0:SP1:APOC3	Complex interactions between [TF] bound to multiple distal regulatory sites and HNF-4 bound to the proximal promoter lead to transcriptional activation of liver-specific [TG] gene.	SP1	human APOCIII	1	ACTIVATION	False
14766	15068	7649480:3:POU1F1:PRL	Synergistic activation of the [TG] gene by [TF] and the estrogen receptor requires a Pit-1 amino-terminal 25-amino-acid domain that is not required for analogous synergistic activation of the growth hormone promoter.	Pit-1	prolactin	1	ACTIVATION	False
14767	15069	7823919:10:RARA:POU5F1	Conversely, activation of [TG] promoter by [TF]:RXR heterodimers was completely abolished by EAR-3/COUP-TFI and by ARP-1/COUP-TFII.	RAR	Oct-3/4	1	ACTIVATION	False
14768	15070	7823919:10:NR2F1:POU5F1	Conversely, activation of [TG] promoter by RAR:RXR heterodimers was completely abolished by [TF]/COUP-TFI and by ARP-1/COUP-TFII.	EAR-3	Oct-3/4	2	REPRESSION	True
14769	15072	8055923:9:HNF4A:BGLAP	In cotransfection experiments, both the USF and [TF] transcription factors transactivate the [TG] gene promoter and compete for the same regulatory element.	HNF-4	BGP	1	ACTIVATION	False
14770	15073	8076602:3:MYC:ALB	Two differentiation-specific genes containing Inr, the C/EBP alpha and [TG] genes, are repressed through their basal promoters by [TF], but are activated by the related B-HLH-LZ factor, USF.	c-Myc	albumin	2	REPRESSION	False
14771	15074	8076602:3:MYC:CEBPA	Two differentiation-specific genes containing Inr, the [TG] and albumin genes, are repressed through their basal promoters by [TF], but are activated by the related B-HLH-LZ factor, USF.	c-Myc	C/EBP alpha	2	REPRESSION	False
14772	15076	8196642:8:MYC:CCND1	Expression of [TF] represses the [TG] promoter via core promoter elements and antagonizes USF-mediated transactivation.	MYC	cyclin D1	2	REPRESSION	False
14773	15077	8247540:0:ETV4:ETS1	[TF], Oct 1 and Oct 2 positively regulate the human [TG] promoter.	PEA3	ETS1	1	ACTIVATION	False
14774	15078	8289793:7:NR2F1:POU5F1	Cotransfected orphan receptors [TF], ARP-1, and EAR-2 were able to repress the activity of [TG] promoter-driven reporters in P19 EC cells, albeit with different efficiencies.	COUP-TF1	Oct4	2	REPRESSION	False
14775	15079	8289793:7:NR2F2:POU5F1	Cotransfected orphan receptors COUP-TF1, [TF], and EAR-2 were able to repress the activity of [TG] promoter-driven reporters in P19 EC cells, albeit with different efficiencies.	ARP-1	Oct4	2	REPRESSION	False
14776	15080	8349585:7:SP1:EGR1	Interestingly, EGR-1 is shown to down-regulate the transcription of its own gene expression, whereas [TF] activated [TG] gene expression.	Sp1	Egr-1	1	ACTIVATION	False
14777	15082	8417355:6:FOS:NPPA	In transient cotransfection assays, jun and [TF] were able to trans-repress the [TG] promoter in both quiescent and alpha 1-adrenergic stimulated myocytes.	fos	ANF	2	REPRESSION	False
14778	15083	8510925:0:ETS2:GATA1	Transactivation of [TG] promoter with ETS1, [TF] and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.	ETS2	GATA-1	1	ACTIVATION	False
14779	15084	8510925:10:ETS2:GATA1	Additionally, we show that the transcription of a reporter gene (CAT) either linked to the [TG] EBS palindrome or GATA-1 promoter can be activated by cotransfection with ETS1, alternatively-spliced ETS1, [TF] or ERGB/Hu-FLI-1 expression vectors.	ETS2	GATA-1	1	ACTIVATION	False
14780	15085	8649434:6:JUN:ITGAX	Co-transfection of c-fos and [TF] expression constructs with a [TG] promoter-CAT fusion into HL60 cells led to a 6.7-fold increase in CD11c promoter activity.	c-jun	CD11c	1	ACTIVATION	False
14781	15086	8877730:3:TP53:IL2	We investigated the possibility that wild-type (wt) [TF], a nuclear tumor suppressor protein, might serve to repress [TG] and IL-4 gene expression in murine E14 T lymphoma and in human Jurkat cells.	p53	IL-2	2	REPRESSION	False
14782	15087	8887646:9:POU2F2:CRISP3	Cotransfection experiments with expression vectors for Oct1 and [TF] together with a reporter driven by the [TG] promoter showed that transcriptional activation of this promoter can only be achieved with Oct2.	Oct2	crisp-3	1	ACTIVATION	False
14783	15088	8892753:5:TP53:GADD45A	This possibility was confirmed by the finding that disruption of [TF] function by transfection with dominant-negative vectors expressing HPV E6, mutant p53, or SV40 T Ag reduced the induction of [TG] and GADD153 as measured by increases in mRNA and protein levels in human lines with wild-type p53.	p53	GADD45	1	ACTIVATION	False
14784	15089	8892753:9:TP53:GADD45A	Interestingly, induction of reporter constructs driven by the [TG] or GADD153 promoters was substantially reduced in human cells transfected with mutant [TF] or E6 expression vectors or in cells lacking p53 following treatment with MMS, UV radiation, or starvation.	p53	GADD45	1	ACTIVATION	False
14785	15090	8934542:9:SPIB:BTK	In addition [TF] as well as PU.1 were able to transactivate [TG] expression.	Spi-B	Btk	1	ACTIVATION	False
14786	15091	9252399:2:FOXM1:SFTPB	We investigated the role of thyroid transcription factor-1 (TTF-1) and hepatocyte nuclear factor 3 ([TF]) in the down-regulation of [TG] gene expression by phorbol ester in pulmonary adenocarcinoma H441 cells.	HNF3	SP-B	2	REPRESSION	False
14788	15093	9325164:2:STAT3:IRF1	In the M1 myeloleukemic cell line, [TF] is a critical transcription factor causing repression of c-myc and c-myb genes, expression of junB and [TG], growth arrest at G1, and subsequent macrophage differentiation.	Stat3	IRF1	1	ACTIVATION	True
14789	15094	9325164:2:STAT3:JUNB	In the M1 myeloleukemic cell line, [TF] is a critical transcription factor causing repression of c-myc and c-myb genes, expression of [TG] and IRF1, growth arrest at G1, and subsequent macrophage differentiation.	Stat3	junB	1	ACTIVATION	False
14790	15095	9325164:2:STAT3:MYB	In the M1 myeloleukemic cell line, [TF] is a critical transcription factor causing repression of c-myc and [TG] genes, expression of junB and IRF1, growth arrest at G1, and subsequent macrophage differentiation.	Stat3	c-myb	2	REPRESSION	False
14791	15097	9389530:6:POU1F1:PRL	The pituitary-specific transcription factor GHF-1/[TF] activates both the GH and [TG] promoters.	Pit-1	PRL	1	ACTIVATION	False
14792	15098	9445037:6:CREB1:PDLIM7	Overexpression of ATF-1 and [TF] in the cells by expression vectors demonstrated that homodimeric as well as heterodimeric forms of the factors transactivate the [TG] promoter in an EBNA2-independent manner.	CREB-1	LMP1	1	ACTIVATION	False
14793	15099	9756940:5:EGR1:IL2	In Jurkat T cells, [TF] but not Sp1 acts as a potent coactivator for [TG] transcription, and in combination with NFATc, EGR-1 increases transcription of an IL-2 reporter construct 200-fold.	EGR-1	IL-2	1	ACTIVATION	False
14794	15100	9763470:11:CREB1:DBH	Collectively, this study emphasizes a critical role of Phox2a as well as its functional synergism with other transcription factors (e.g., [TF], AP2, and Sp1) in transcriptional activation of the [TG] gene.	CREB	DBH	1	ACTIVATION	False
14795	15101	9795195:9:EGR1:PNMT	While the mechanisms by which [TF] and the GR and Egr-1, AP-2 and the GR function cooperatively to stimulate [TG] promoter activity remain to be elucidated, this synergistic stimulation of the PNMT promoter by these factors may provide important in vivo and in vitro regulatory control of the PNMT gene.	Egr-1	PNMT	1	ACTIVATION	False
14796	15103	9872993:0:MXI1:MYC	[TF] is a repressor of the [TG] promoter and reverses activation by USF.	Mxi1	c-Myc	2	REPRESSION	False
14797	15104	9886825:4:CREBBP:MST1	However, the transcriptional coactivator, [TF] (CBP) coactivates expression of this gene through an indirect interaction with the HNF-4-binding site, and overexpression of CBP in HepG2 cells eliminates retinoic acid repression of reporter gene expression driven by the [TG] promoter.	CREB-binding protein	HGFL	1	ACTIVATION	False
14798	15105	9886825:6:CREBBP:MST1	These results suggest that [TG] gene expression requires [TF], and competition for limiting amounts of CBP by retinoic acid receptor may be a means of modifying the activity of HNF-4 at the HGFL gene promoter.	CBP	HGFL	1	ACTIVATION	False
14799	15106	9933606:0:PAX6:GCG	[TF] and Cdx-2/3 interact to activate [TG] gene expression on the G1 control element.	Pax-6	glucagon	1	ACTIVATION	False
14800	15107	10074148:7:USF1:PDLIM7	Moreover, the activity of the [TG] promoter in reporter constructs was upregulated by overexpression of [TF] and USF2a, and the transactivation was inhibited by the concurrent expression of Max and Mad1.	USF1	LMP1	1	ACTIVATION	False
14801	15108	10074148:7:MAX:PDLIM7	Moreover, the activity of the [TG] promoter in reporter constructs was upregulated by overexpression of USF1 and USF2a, and the transactivation was inhibited by the concurrent expression of [TF] and Mad1.	Max	LMP1	2	REPRESSION	False
14802	15109	10074148:7:MXD1:PDLIM7	Moreover, the activity of the [TG] promoter in reporter constructs was upregulated by overexpression of USF1 and USF2a, and the transactivation was inhibited by the concurrent expression of Max and [TF].	Mad1	LMP1	2	REPRESSION	False
14803	15110	10090829:1:NFKB:SELE	[TG] transcription requires binding of transcription factors, [TF], ATF-2, and HMG-I(Y).	NF-kappaB	E-selectin	1	ACTIVATION	False
14804	15111	10092624:6:SMAD4:SERPINE1	Both elements were required for TGFbeta-induced, Smad3- and [TF]-dependent activation of [TG] transcription.	Smad4	PAI-1	1	ACTIVATION	False
14805	15112	10218980:0:GABPA:OXTR	Identification of a [TF]/beta binding site involved in the induction of [TG] gene expression in human breast cells, potentiation by c-Fos/c-Jun.	GABP alpha	oxytocin receptor	1	ACTIVATION	False
14806	15113	10218980:0:GABPB1:OXTR	Identification of a [TF] binding site involved in the induction of [TG] gene expression in human breast cells, potentiation by c-Fos/c-Jun.	GABP alpha/beta	oxytocin receptor	1	ACTIVATION	False
14807	15114	10218980:10:GABPA:OXTR	We showed the requirement for [TF]/beta and c-Fos/c-Jun in endogenous [TG] gene expression, using oligonucleotide GABP and AP-1 binding decoys to inhibit serum-induced increases in 125I-labeled OT antagonist binding to Hs578T cells.	GABP alpha	OTR	1	ACTIVATION	False
14808	15115	10218980:10:GABPB1:OXTR	We showed the requirement for [TF] and c-Fos/c-Jun in endogenous [TG] gene expression, using oligonucleotide GABP and AP-1 binding decoys to inhibit serum-induced increases in 125I-labeled OT antagonist binding to Hs578T cells.	GABP alpha/beta	OTR	1	ACTIVATION	False
14809	15116	10229837:6:YY1:CXCR4	Mutation of the E box abolished USF/c-Myc-mediated up-regulation of [TG] promoter activity, and mutation of the [TF] binding site was associated with unresponsiveness to YY1-mediated inhibition.	YY1	CXCR4	2	REPRESSION	False
14810	15117	10318839:8:NKX2-5:ADORA1	These observations suggest that embryonic [TG] expression involves activation of the A1AR promoter by GATA-4 and [TF].	Nkx2.5	A1AR	1	ACTIVATION	False
14811	15118	10321740:8:TP53:CDKN1A	However, such deletion differentially affects [TF] induction of endogenous target genes, i.e., induction of [TG], MDM2, BTG2, p85, PIG3, PIG6 and PIG11 was reduced or abrogated but induction of BAX, KILLER/DR5, PIG2, PIG7 and PIG8 was not substantially affected.	p53	p21	1	ACTIVATION	False
14812	15119	10321740:8:TP53:MDM2	However, such deletion differentially affects [TF] induction of endogenous target genes, i.e., induction of p21, [TG], BTG2, p85, PIG3, PIG6 and PIG11 was reduced or abrogated but induction of BAX, KILLER/DR5, PIG2, PIG7 and PIG8 was not substantially affected.	p53	MDM2	1	ACTIVATION	False
14813	15120	10321740:8:TP53:TP53I11	However, such deletion differentially affects [TF] induction of endogenous target genes, i.e., induction of p21, MDM2, BTG2, p85, PIG3, PIG6 and [TG] was reduced or abrogated but induction of BAX, KILLER/DR5, PIG2, PIG7 and PIG8 was not substantially affected.	p53	PIG11	1	ACTIVATION	False
14814	15121	10321740:8:TP53:TP53I3	However, such deletion differentially affects [TF] induction of endogenous target genes, i.e., induction of p21, MDM2, BTG2, p85, [TG], PIG6 and PIG11 was reduced or abrogated but induction of BAX, KILLER/DR5, PIG2, PIG7 and PIG8 was not substantially affected.	p53	PIG3	1	ACTIVATION	False
14815	15122	10348347:6:NFKB1:TP53	The cooperative nature of transcriptional activation by these factors was documented by repression of c-fos or [TF] translation: Pretreatment of the cells with a c-fos or p50(NF-kappaB1) antisense oligonucleotide suppresses transcription from the human [TG] promoter completely.	NF-kappaB1	p53	1	ACTIVATION	False
14816	15123	10381566:8:MAX:NDRG1	The [TG] promoter activity was down-regulated by N-myc, and more strongly by the combination of N-myc and [TF] in the cotransfection assay.	Max	Ndr1	2	REPRESSION	True
14817	15124	10500157:7:ATF2:CCND1	Both c-Jun and [TF] transactivated the [TG] promoter in transient transfection experiments, and a clear additional increase was detected when ER was cotransfected with either c-Jun or with c-Jun and ATF-2 but not with ATF-2 alone.	ATF-2	cyclin D1	1	ACTIVATION	False
14818	15125	10500157:10:ATF2:CCND1	To interpret these results, we propose a mechanism in which [TF]/c-Jun heterodimers bind to the CRE-D1 element and mediate the activation of [TG] promoter by the ER.	ATF-2	cyclin D1	1	ACTIVATION	False
14819	15126	10506225:3:JUN:CDKN1A	In the present study we show that the Sp1-occupied promoter region mediates transactivation of the [TG] promoter by [TF] and the related proteins JunB, JunD, and ATF-2.	c-Jun	p21	1	ACTIVATION	False
14820	15127	10657993:6:JUN:CD44	In addition, cotransfection of the architectural transcription factor high mobility group (HMG)-I(Y) protein with c-Fos and [TF] markedly increased trans-activation of the [TG] promoter.	c-Jun	CD44	1	ACTIVATION	False
14821	15128	10671224:5:SP1:FASLG	We show that both elements bind to NF-kappaB and [TF] transcription factors and NF-kappaB is involved in transactivation of the [TG] promoter upon T cell activation.	SP-1	CD95L	1	ACTIVATION	False
14822	15129	10688648:5:E2F1:SERPINE1	Interestingly, an [TF] mutant lacking the pRB-binding region strongly repressed the uPA and [TG] promoters.	E2F1	PAI-1	1	ACTIVATION	False
14823	15130	10692469:10:RARA:POU5F1	Interestingly, SF1 and [TF] form a novel complex on the RAREoct sequence that synergistically activate the [TG] promoter.	RAR	Oct-3/4	1	ACTIVATION	False
14824	15131	10725705:7:IRF2:FASLG	Forced expression of either IRF-1 or [TF] leads to [TG] promoter activation in T cells and FasL expression in heterologous cells.	IRF-2	FasL	1	ACTIVATION	False
14825	15134	10787423:10:TP53:PTPRA	Thus, [TG] expression is negatively regulated by [TF] in normal conditions and in conditions where p53 is up-regulated, via an as yet unknown mechanism involving the negative control of YY1.	p53	PTPA	2	REPRESSION	False
14826	15136	10915780:5:ATF2:CCND1	ILK activation of the [TG] promoter was abolished by point mutation of a cAMP-responsive element-binding protein (CREB)/[TF] binding site at nucleotide -54 in the cyclin D1 promoter, and by overexpression of either glycogen synthase kinase-3beta (GSK-3beta) or dominant negative mutants of CREB or ATF-2.	ATF-2	cyclin D1	1	ACTIVATION	False
14827	15137	10921891:0:IRF1:PSMB9	How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and [TF] supports transcription of the [TG] gene.	IRF1	LMP2	1	ACTIVATION	False
14828	15138	11014230:17:CREB1:CGA	We conclude that differentiation-dependent transcription of the [TG] gene in villous trophoblasts is mainly governed by increasing expression of AP-2alpha and PKA-dependent phosphorylation of [TF] and ATF-1.	CREB-1	CGalpha	1	ACTIVATION	False
14829	15139	11014230:17:TFAP2A:CGA	We conclude that differentiation-dependent transcription of the [TG] gene in villous trophoblasts is mainly governed by increasing expression of [TF] and PKA-dependent phosphorylation of CREB-1 and ATF-1.	AP-2alpha	CGalpha	1	ACTIVATION	False
14831	15141	11035254:12:NFE2L1:NQO1	In addition to Nrf2 and c-Jun, other nuclear transcription factors including [TF], Jun-B, and Jun-D also bind to the ARE and regulate expression and induction of [TG] gene.	Nrf1	NQO1	1	ACTIVATION	True
14832	15142	11035254:12:NFE2L2:NQO1	In addition to [TF] and c-Jun, other nuclear transcription factors including Nrf1, Jun-B, and Jun-D also bind to the ARE and regulate expression and induction of [TG] gene.	Nrf2	NQO1	1	ACTIVATION	False
14833	15143	11035254:12:JUN:NQO1	In addition to Nrf2 and [TF], other nuclear transcription factors including Nrf1, Jun-B, and Jun-D also bind to the ARE and regulate expression and induction of [TG] gene.	c-Jun	NQO1	1	ACTIVATION	True
14835	15146	11158299:11:RBL2:DHFR	Upon withdrawal of cells into G(0), recruitment of [TF] to E2F-4-DP-1 complexes at the transcription start site results in a TSA-insensitive complex that cooperates with Sp1-HDAC-pRb complexes to stably repress [TG] promoter activity in quiescent cells.	p130	dhfr	2	REPRESSION	False
14836	15147	11230134:5:MTF1:MT1A	We report here that [TF] is absolutely essential for upregulation of [TG] gene expression in visceral endoderm cells and that optimal expression also involves interactions of the basic helix-loop-helix upstream stimulatory factor-1 (USF1) with an E-box1-containing sequence at -223 bp in the MT-I promoter.	MTF-1	MT-I	1	ACTIVATION	False
14837	15148	11254751:0:FOSL1:IVL	Cholesterol sulfate stimulates [TG] transcription in keratinocytes by increasing [TF], Fra-2, and Jun D.	Fra-1	involucrin	1	ACTIVATION	False
14838	15150	11279028:5:GATA4:NPPB	We show that YY1 cooperates with [TF] to synergistically activate [TG] transcription.	GATA-4	BNP	1	ACTIVATION	False
14839	15152	11410592:4:ATF2:CCND1	These results contrasted to a recent report showing that induction of [TG] by E2 in ER-positive MCF-7 and HeLa cells was due to up-regulation of c-jun and subsequent interaction of c-Jun-[TF] with the CRE.	ATF-2	cyclin D1	1	ACTIVATION	False
14840	15153	11423975:5:EWSR1:MYC	The inducible expression of [TF] led to a strong upregulation of [TG] and a considerable downregulation of p57KIP2.	EWS-FLI-1	c-Myc	1	ACTIVATION	False
14841	15154	11427482:10:SP1:MAT2A	Increased expression of c-Myb and [TF] and binding to the MAT2A promoter contribute to transcriptional up-regulation of MAT2A in HCC.-Yang, H., Huang, Z.-Z., Wang, J., Lu, S. C. The role of c-Myb and Sp1 in the up-regulation of [TG] gene expression in human hepatocellular carcinoma.	Sp1	methionine adenosyltransferase 2A	1	ACTIVATION	False
14842	15155	11435416:10:GATA4:EDN1	Consistent with this interaction, overexpression of [TF] and NFATc synergistically activated the [TG] promoter.	GATA4	ET-1	1	ACTIVATION	False
14843	15156	11509675:7:TCF3:CCND3	Consistent with these findings, [TF] null mice expressed decreased levels of cyclin D2 and [TG] transcripts.	E2A	cyclin D3	1	ACTIVATION	False
14844	15157	11518759:8:NR1H4:NR0B2	[TF] only moderately stimulated [TG] transcription, whereas FTF strongly inhibited SHP transcription in HepG2 cells.	FXR	SHP	1	ACTIVATION	False
14845	15158	11526505:6:CREB1:PTGS2	[TF] and ATF-1 were phosphorylated upon UVB treatment, and SB202190, a p38 MAPK inhibitor, decreased the phosphorylation of CREB/ATF-1 and suppressed [TG] promoter activity.	CREB	COX-2	1	ACTIVATION	False
14846	15159	11535594:10:HNF4A:CYP8B1	A negative nuclear receptor, small heterodimer partner markedly inhibited transactivation of [TG] by [TF].	HNF4alpha	CYP8B1	1	ACTIVATION	False
14847	15160	11550088:4:HIF1A:BNIP3	Overexpression of [TF], but not p53, induces the expression of [TG].	HIF1alpha	BNIP3	1	ACTIVATION	False
14848	15161	11593387:5:TP73:CDK1	In transient transfection assay, p63 and [TF] repress the [TG] promoter regardless of the presence of a dominant negative mutant form of p53.	p73	cdk1	2	REPRESSION	False
14849	15162	11689553:5:SMAD3:MYC	[TF] and E2F-4 directly bound to the element (TIE/E2F), and substitution of two nucleotides in TIE/E2F impaired binding of both Smad3 and E2F-4 as well as serum-induced activation and TGF-beta-induced suppression of the [TG] promoter activity.	Smad3	c-myc	2	REPRESSION	False
14850	15163	11736649:7:ATF2:JUN	A-Fos and A-[TF] also reduced MEKK1Delta-induced stimulation of the c-[TG] promoter.	ATF2	Jun	0	UNDEFINED	True
14851	15164	11773447:8:PAX6:GCG	However, HNF-3 via its transactivating domains specifically impaired [TF]-mediated transactivation of the [TG] promoter but had no effect on transactivation by Cdx2/3.	Pax6	glucagon	1	ACTIVATION	False
14852	15165	11773447:9:PAX6:GCG	We suggest that HNF-3 may play a dual role on [TG] gene transcription by 1) inhibiting the transactivation potential of [TF] on the G1 and G3 elements and 2) direct activation through G1 and G2.	Pax6	glucagon	1	ACTIVATION	False
14853	15166	11970950:0:SP1:FASLG	Ets-1 positively regulates [TG] transcription via cooperative interactions with [TF].	Sp1	Fas ligand	1	ACTIVATION	False
14854	15167	11970950:7:SP1:FASLG	The overexpression of Ets-1 together with [TF] produced cooperative activation of the [TG] promoter.	Sp1	FasL	1	ACTIVATION	False
14855	15168	12065766:0:PBX2:UGT2B17	The homeodomain [TF]-Prep1 complex modulates hepatocyte nuclear factor 1alpha-mediated activation of the [TG] gene.	Pbx2	UDP-glucuronosyltransferase 2B17	0	UNDEFINED	False
14856	15169	12080043:10:MAX:YBX1	Our data suggest that p73 stimulates the transcription of the [TG] promoter by enhancing recruitment of the c-Myc-[TF] complex to the E-box.	Max	YB-1	1	ACTIVATION	False
14857	15170	12080043:10:TP73:YBX1	Our data suggest that [TF] stimulates the transcription of the [TG] promoter by enhancing recruitment of the c-Myc-Max complex to the E-box.	p73	YB-1	1	ACTIVATION	False
14858	15171	12082616:5:ATF4:DDIT3	The transcriptional activity of the [TG] promoter as well as transcription from the C/EBP-activating transcription factor (ATF) composite motif in the GADD153 promoter was also stimulated by HRG-inducible [TF] and activated HER2 but not wild-type HER2.	ATF-4	GADD153	1	ACTIVATION	False
14859	15172	12203124:3:POU4F1:CDKN1A	In contrast, [TF] and p53 co-operative to induce maximal activation of another p53 target gene encoding the cyclin dependent kinase inhibitor, p21(CIP1/[TG]).	Brn-3a	Waf1	1	ACTIVATION	False
14860	15173	12223449:10:GATA2:EPO	Thus, both [TF] and NF-kappaB seem to be involved in the suppression of [TG] gene expression by IL-1beta and TNF-alpha in vitro and may be responsible for impaired Epo synthesis in inflammatory diseases in vivo.	GATA-2	Epo	2	REPRESSION	False
14861	15175	12235180:7:EGR1:LDLR	We show that overexpression of [TF] significantly increases [TG] promoter activity when cotransfected with CCAAT/enhancer binding protein beta (c/EBPbeta) or with cAMP-responsive element binding protein (CREB) expression vectors.	Egr1	LDLR	1	ACTIVATION	False
14862	15176	12355451:4:NFATC1:IL4	Using constitutively-active NFAT proteins with alanine substitutions instead of phosphorylated serine residues in the regulatory domain, we find that NFAT1 and [TF] are both positive regulators of [TG] gene transcription, intrinsically very similar in their ability to induce and sustain transcription of the IL-4 gene.	NFAT2	IL-4	1	ACTIVATION	False
14863	15177	12360408:4:NFKB:IER3	Interestingly, [TF]/rel-mediated activation of [TG] expression was synergized by p53, but strongly inhibited by c-Myc in a dose-dependent fashion.	NF-kappaB	IEX-1	1	ACTIVATION	False
14864	15178	12414801:10:NFKB:CCL20	Taken together, our findings demonstrate that co-ordinate activation and binding of ESE-1, Sp1, and [TF] to the [TG] promoter is required for maximal gene expression by cytokine-stimulated Caco-2 human intestinal epithelial cells.	NF-kappaB	MIP-3alpha	1	ACTIVATION	False
14865	15179	12433990:0:POU4F1:BAX	Distinct promoter elements mediate the co-operative effect of [TF] and p53 on the p21 promoter and their antagonism on the [TG] promoter.	Brn-3a	Bax	0	UNDEFINED	False
14866	15180	12433990:0:POU4F1:CDKN1A	Distinct promoter elements mediate the co-operative effect of [TF] and p53 on the [TG] promoter and their antagonism on the Bax promoter.	Brn-3a	p21	0	UNDEFINED	False
14867	15181	12433990:0:TP53:BAX	Distinct promoter elements mediate the co-operative effect of Brn-3a and [TF] on the p21 promoter and their antagonism on the [TG] promoter.	p53	Bax	0	UNDEFINED	False
14868	15182	12433990:1:TP53:BAX	Although the promoters of both the [TG] and p21 genes are activated by [TF], they differ in the effect on this activation of the POU family transcription factor Brn-3a.	p53	Bax	1	ACTIVATION	False
14869	15183	12433990:1:POU4F1:CDKN1A	Although the promoters of both the Bax and [TG] genes are activated by p53, they differ in the effect on this activation of the POU family transcription factor [TF].	Brn-3a	p21	0	UNDEFINED	True
14870	15184	12433990:2:POU4F1:CDKN1A	Thus, [TF] inhibits activation of the Bax promoter by p53 but enhances the ability of p53 to activate the [TG] promoter.	Brn-3a	p21	1	ACTIVATION	True
14871	15185	12433990:2:TP53:BAX	Thus, Brn-3a inhibits activation of the [TG] promoter by [TF] but enhances the ability of p53 to activate the p21 promoter.	p53	Bax	1	ACTIVATION	False
14872	15186	12433990:2:POU4F1:BAX	Thus, [TF] inhibits activation of the [TG] promoter by p53 but enhances the ability of p53 to activate the p21 promoter.	Brn-3a	Bax	2	REPRESSION	False
14873	15187	12493643:6:IRF1:CIITA	To further understand the mechanism of [TF] and IRF-2 cooperativity in the activation of [TG] type IV promoter, we characterized the binding of IRF-1 and IRF-2 to the CIITA IRF-E and mapped the domains of IRF-2 required for the cooperative transactivation.	IRF-1	CIITA	1	ACTIVATION	False
14874	15188	12560513:2:TP53:BAX	Active [TF] is able to stimulate the transcription of a variety of genes including the pro-apoptotic gene [TG], as well as p21, a cell cycle regulator.	p53	bax	1	ACTIVATION	False
14875	15191	12571228:6:NR0B2:DHFR	Overexpression of [TF] in intestinal epithelial crypt cells significantly inhibited [TG], c-myc, and cyclin D1 gene expression but did not interfere with c-fos gene expression.	SHP-1	dhfr	2	REPRESSION	False
14876	15192	12571228:6:NR0B2:MYC	Overexpression of [TF] in intestinal epithelial crypt cells significantly inhibited dhfr, [TG], and cyclin D1 gene expression but did not interfere with c-fos gene expression.	SHP-1	c-myc	2	REPRESSION	False
14877	15193	12644537:11:SP3:VEGFA	IFN-alpha confers its antitumor activity, at least in part, by its antiangiogenic activity, which results from Sp1- and/or [TF]-mediated inhibition of [TG] gene transcription.	Sp3	VEGF	2	REPRESSION	False
14878	15194	12682075:2:JUN:SPRR1B	Previously, we have shown that the transcriptional stimulation of [TG] expression by phorbol 12-myristate 13-acetate (PMA) is mainly mediated by a -150/-94 bp enhancer harboring two critical 12-O-tetradecanoylphorbol-13-acetate-responsive elements (TREs) and by [TF].Fra-1 dimers.	Jun	SPRR1B	1	ACTIVATION	False
14879	15195	12751796:7:ATF2:JUN	In transient transfection experiments, this constitutively active [TF] mutant stimulated [TG], tumor necrosis factor alpha, and Fas ligand promoter activities.	ATF2	c-jun	1	ACTIVATION	True
14881	15197	12806965:5:TP53:BAX	It is known that [TF] stimulates the promoter activities of p21/WAF1, gadd45 and [TG] genes to enhance their expression as a transcriptional factor, resulting in cell cycle arrest, DNA repair and apoptosis, respectively.	p53	bax	1	ACTIVATION	False
14882	15198	12808109:7:BCL3:CCND1	Importantly, p53-mediated suppression of the [TG] promoter was reversed by coexpression of [TF] and inhibition of p52 or deacetylase activity.	Bcl-3	cyclin D1	1	ACTIVATION	False
14883	15200	12808109:8:BCL3:CCND1	p53 therefore induces a transcriptional switch in which p52/[TF] activator complexes are replaced by p52/HDAC1 repressor complexes, resulting in active repression of [TG] transcription.	Bcl-3	cyclin D1	1	ACTIVATION	True
14884	15201	12808109:8:TP53:CCND1	[TF] therefore induces a transcriptional switch in which p52/Bcl-3 activator complexes are replaced by p52/HDAC1 repressor complexes, resulting in active repression of [TG] transcription.	p53	cyclin D1	2	REPRESSION	True
14885	15202	12832543:6:JUN:HSPB1	Immunoprecipitation analysis and promoter assay for [TG] expression suggest that both ATF3 and [TF] are necessary for transcriptional activation of Hsp27.	c-Jun	Hsp27	1	ACTIVATION	False
14886	15203	12832543:9:JUN:HSPB1	Our results suggest that ATF3- and [TF]-induced [TG] expression is a novel survival response in neurons under death stress such as nerve injury.	c-Jun	Hsp27	1	ACTIVATION	False
14887	15204	12835724:6:NFKB1:BCL2	As [TF] and p52 homodimers are devoid of any transactivating domains, we showed that they can transactivate the [TG] promoter through association with Bcl-3.	p50	bcl-2	1	ACTIVATION	False
14888	15205	12841847:7:POU4F1:BRCA1	Although another POU protein [TF] has been shown to be a repressor for [TG] (breast-cancer susceptibility gene 1), OCT3 does not repress human or mouse BRCA1/Brca-1 promoters.	Brn-3	BRCA1	2	REPRESSION	False
14889	15206	12842887:6:AP1:NR0B2	Mutation of the human [TG] promoter defined HNF-3, HNF-4, GATA, and [TF] sites as important for basal activity, whereas EE induction required two distinct elements located between -309 and -267.	AP-1	SHP	1	ACTIVATION	False
14890	15207	12855685:4:SP1:MAOB	Overexpression of Sp3 inhibited the induction of [TG] gene by [TF], and the expression of Sp3 was decreased during Caco-2 cell differentiation.	Sp1	MAO B	1	ACTIVATION	False
14891	15208	12888570:6:SP1:COL2A1	Because we demonstrated previously that [TF] was a strong activator of [TG] gene expression via the -63/+1 promoter region, whereas Sp3 overexpression blocked Sp1-induced promoter activity and inhibited COL2A1 gene transcription, we conclude that IL-1 beta down-regulation of that gene, as we found previously for transforming growth factor-beta 1, is mediated by an increase in the Sp3/Sp1 ratio.	Sp1	COL2A1	1	ACTIVATION	False
14892	15209	12888570:6:SP3:COL2A1	Because we demonstrated previously that Sp1 was a strong activator of [TG] gene expression via the -63/+1 promoter region, whereas [TF] overexpression blocked Sp1-induced promoter activity and inhibited COL2A1 gene transcription, we conclude that IL-1 beta down-regulation of that gene, as we found previously for transforming growth factor-beta 1, is mediated by an increase in the Sp3/Sp1 ratio.	Sp3	COL2A1	2	REPRESSION	False
14893	15210	12889596:7:TP53:CCNB2	We show that the expression of p21 was upregulated and expressions of cdc2, [TG] and protein regulator of cytokinesis 1 (PRC1) were suppressed by overexpression of the wt [TF] in MCF7-ptsp53 cells at the permissive temperature.	p53	cyclin B2	2	REPRESSION	True
14894	15211	12889596:7:TP53:CDK1	We show that the expression of p21 was upregulated and expressions of [TG], cyclin B2 and protein regulator of cytokinesis 1 (PRC1) were suppressed by overexpression of the wt [TF] in MCF7-ptsp53 cells at the permissive temperature.	p53	cdc2	2	REPRESSION	True
14895	15212	12889596:7:TP53:PRC1	We show that the expression of p21 was upregulated and expressions of cdc2, cyclin B2 and protein regulator of cytokinesis 1 ([TG]) were suppressed by overexpression of the wt [TF] in MCF7-ptsp53 cells at the permissive temperature.	p53	PRC1	2	REPRESSION	True
14896	15213	12914794:5:NFKB:CXCL2	We also provided evidence that [TF] and c-Jun contributes to the expression of [TG] gene in response to CpG-ODN, since ectopical expression of NF-kappaB and c-Jun in RAW 246.7 cells leads to dramatically increase the ability of CpG-ODN 1826(S) in MIP-2 promoter activity.	NF-kappaB	MIP-2	1	ACTIVATION	False
14897	15214	12944911:5:E2F2:FGFR2	The promoter activity of the mouse [TG] gene is also positively regulated by [TF]-2 and E2F-3, but not by E2F-4 and E2F-5.	E2F	FGFR-2	1	ACTIVATION	False
14898	15215	12944911:5:E2F3:FGFR2	The promoter activity of the mouse [TG] gene is also positively regulated by E2F-2 and [TF], but not by E2F-4 and E2F-5.	E2F-3	FGFR-2	1	ACTIVATION	False
14899	15217	12970370:2:PITX1:POMC	Tpit is also required, both in humans and mice, for cell-specific expression of the [TG] gene in cooperation with the homeoprotein [TF].	Pitx1	POMC	1	ACTIVATION	False
14900	15220	14560010:9:ZBTB17:CDKN1A	Expression of [TG], a target gene of [TF] is unaltered; in contrast, expression of p57Kip2, another target gene of Miz1 is absent in Miz1(-/-) embryos.	Miz1	p21Cip1	0	UNDEFINED	False
14901	15221	14623878:0:TP53:TNFRSF10C	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor [TG] is up-regulated by [TF] in breast tumor cells through a mechanism involving an intronic p53-binding site.	p53	TRAIL-R3	1	ACTIVATION	False
14902	15222	14627819:0:NR5A1:NR0B2	Synergistic activation of the human orphan nuclear receptor [TG] gene promoter by basic helix-loop-helix protein E2A and orphan nuclear receptor [TF].	SF-1	SHP	1	ACTIVATION	False
14903	15223	14627819:4:NEUROD1:NR0B2	In contrast, the tissue-specific E47 heterodimer partner [TF] repressed the E47- mediated transactivation of the human [TG] (hSHP) promoter.	BETA2	SHP	2	REPRESSION	False
14904	15224	14627819:7:NR5A1:NR0B2	Finally, we found that E47 and steroidogenic factor 1 ([TF]), a regulator of the [TG] promoter, synergistically activate the human but not the mouse SHP promoter.	SF-1	SHP	1	ACTIVATION	False
14905	15225	14627819:8:NR5A1:NR0B2	Our findings suggest that the E2A proteins differentially regulate the human and mouse [TG] promoters and cooperate with orphan nuclear receptor [TF] for transcriptional activation of the hSHP promoter.	SF-1	SHP	1	ACTIVATION	False
14906	15226	14672953:9:NR0B2:ANG	These results suggest that bile acids negatively regulate the human [TG] gene through the inhibitory effect of [TF] on HNF-4.	SHP	ANG	2	REPRESSION	False
14907	15227	14735146:10:IRF1:PSMB9	These results indicate that both STAT1 and [TF] are required for the IFN-gamma induction of Tap-1 and [TG] genes.	IRF-1	Lmp-2	1	ACTIVATION	False
14908	15228	14735146:10:IRF1:TAP1	These results indicate that both STAT1 and [TF] are required for the IFN-gamma induction of [TG] and Lmp-2 genes.	IRF-1	Tap-1	1	ACTIVATION	False
14909	15229	14744778:7:TFAP2A:VEGFA	Our evidence suggests that [TF] repressed transcriptionally the [TG] promoter by competing with the transcriptional activator Sp3.	AP-2	VEGF	2	REPRESSION	False
14910	15230	15013430:5:CDX2:PTGS2	Here we show that [TF] down-regulates [TG] promoter activity by interacting with NF-kappaB.	CDX2	COX-2	2	REPRESSION	False
14911	15231	15016801:5:TP53:CHEK1	Reporter and chromatin immunoprecipitation assays demonstrated that [TF] can suppress the promoter activities of three further studied candidate genes PLK, PTTG1, and [TG] but would only bind directly to PTTG1 and CHEK1 promoters, revealing that p53 can repress gene expression through both direct and indirect mechanisms.	p53	CHEK1	2	REPRESSION	False
14912	15232	15016801:5:TP53:PLK1	Reporter and chromatin immunoprecipitation assays demonstrated that [TF] can suppress the promoter activities of three further studied candidate genes [TG], PTTG1, and CHEK1 but would only bind directly to PTTG1 and CHEK1 promoters, revealing that p53 can repress gene expression through both direct and indirect mechanisms.	p53	PLK	2	REPRESSION	False
14913	15233	15021909:0:MYC:GADD45A	[TF] represses the proximal promoters of [TG] and GADD153 by a post-RNA polymerase II recruitment mechanism.	c-Myc	GADD45a	2	REPRESSION	False
14914	15234	15021909:4:MYC:GADD45A	We show that [TF] represses the expression of [TG] and GADD153 in response to thapsigargin, a nongenotoxic stress, as well as other endoplasmic reticulum (ER) stress agents.	c-Myc	GADD45a	2	REPRESSION	False
14915	15237	15188178:11:SMAD2:VEGFA	This study identifies activin A as a novel stimulus of [TG] gene expression in hepatocellular carcinoma and delineates physical and functional cooperation of Sp1 and [TF] as the underlying mechanism.	Smad2	vascular endothelial growth factor	1	ACTIVATION	False
14916	15238	15192123:4:TP53:TP53I3	Transient transfection of this mutant into a [TF] null cell line resulted in activation not only of the [TG] but also of the MDM2 gene compatible with the presence of constitutively expressed MDM2 transcripts initiated from the P2 promoter in the p53-C277Y hemizygous Ewing's sarcoma cell line.	p53	pig3	1	ACTIVATION	False
14917	15239	15195136:0:MYB:CEBPB	Identification of a [TF]-responsive enhancer of the chicken [TG] gene.	Myb	C/EBPbeta	0	UNDEFINED	True
14918	15240	15240568:0:SOX9:CDX2	[TF] is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the [TG] and MUC2 genes.	SOX9	CDX2	2	REPRESSION	False
14919	15241	15294971:5:CEBPA:TLR9	It appeared that suppression was mediated via c-Jun and NF-kappaB p65 and that cooperation among CREB1, Ets2, Elf1, Elk1, and [TF] culminated in maximal transcription of the [TG] gene.	C/EBPalpha	TLR9	1	ACTIVATION	False
14920	15242	15294971:5:CREB1:TLR9	It appeared that suppression was mediated via c-Jun and NF-kappaB p65 and that cooperation among [TF], Ets2, Elf1, Elk1, and C/EBPalpha culminated in maximal transcription of the [TG] gene.	CREB1	TLR9	1	ACTIVATION	False
14921	15243	15294971:5:ELF1:TLR9	It appeared that suppression was mediated via c-Jun and NF-kappaB p65 and that cooperation among CREB1, Ets2, [TF], Elk1, and C/EBPalpha culminated in maximal transcription of the [TG] gene.	Elf1	TLR9	1	ACTIVATION	False
14922	15244	15294971:5:ELK1:TLR9	It appeared that suppression was mediated via c-Jun and NF-kappaB p65 and that cooperation among CREB1, Ets2, Elf1, [TF], and C/EBPalpha culminated in maximal transcription of the [TG] gene.	Elk1	TLR9	1	ACTIVATION	False
14923	15245	15331348:12:NR1I2:CYP7A1	These results suggest that activation of [TF] by rifampicin promotes PXR interaction with HNF4 alpha and blocks PGC-1 alpha activation with HNF4 alpha and results in inhibition of [TG] gene transcription.	PXR	CYP7A1	2	REPRESSION	False
14924	15246	15345676:0:SP1:CDKN1A	Peroxisome proliferator-activated receptor gamma-dependent activation of [TG] in Panc-28 pancreatic cancer cells involves [TF] and Sp4 proteins.	Sp1	p21	1	ACTIVATION	False
14925	15247	15345676:0:SP4:CDKN1A	Peroxisome proliferator-activated receptor gamma-dependent activation of [TG] in Panc-28 pancreatic cancer cells involves Sp1 and [TF] proteins.	Sp4	p21	1	ACTIVATION	False
14926	15248	15385533:9:ATF3:ASNS	The data suggest that [TF]-FL and C/EBPbeta act as transcriptional suppressors for the [TG] gene to counterbalance the transcription rate activated by ATF4 following amino acid deprivation.	ATF3	ASNS	2	REPRESSION	False
14927	15249	15461591:8:ETV4:MUC4	We also demonstrate that [TF] acts in synergy with c-Jun and specificity protein 1 to transactivate the proximal region of the [TG] promoter and increase MUC4 mRNA levels in WD cells.	PEA3	MUC4	1	ACTIVATION	False
14928	15250	15466854:7:ETV4:BAX	We further demonstrate the ability of [TF] and USF-1 to cooperate for the transactivation of the [TG] promoter, mutation of the E boxes dramatically reducing the Pea3 transactivation potential.	Pea3	bax	1	ACTIVATION	False
14929	15251	15509806:4:BCL6:CCND2	Using reporter gene assays, we demonstrate that STI571, FoxO3a, and [TF] can repress [TG] transcription through a STAT5/BCL6 site located within the cyclin D2 promoter.	BCL6	cyclin D2	2	REPRESSION	False
14930	15252	15509808:2:IRF1:CDKN1A	Here we investigate the mechanism by which [TF] and p53 synergize at the [TG] promoter and show that stimulation of p21 transcription by IRF-1 does not require its DNA-binding activity but relies on the ability of IRF-1 to bind the coactivator p300 and to stimulate p53-dependent transcription by an allosteric mechanism.	IRF-1	p21	1	ACTIVATION	False
14931	15253	15509808:4:EP300:CDKN1A	Complementing this, small peptides derived from the IRF-1-[TF] interface can bind to p300, stabilize the binding of p300 to DNA-bound p53, stimulate p53 acetylation in trans, and up-regulate p53-dependent activity from the [TG] promoter.	p300	p21	1	ACTIVATION	False
14932	15254	15509808:4:IRF1:CDKN1A	Complementing this, small peptides derived from the [TF]-p300 interface can bind to p300, stabilize the binding of p300 to DNA-bound p53, stimulate p53 acetylation in trans, and up-regulate p53-dependent activity from the [TG] promoter.	IRF-1	p21	1	ACTIVATION	False
14933	15255	15509808:6:EP300:CDKN1A	These data expand the core [TF]-p53 protein LXXLL and PXXP interface by including an IRF-1-p300 interface as an allosteric modifier of DNA-dependent acetylation of p53 at the [TG] promoter.	p300	p21	0	UNDEFINED	False
14934	15256	15509808:6:IRF1:CDKN1A	These data expand the core p300-p53 protein LXXLL and PXXP interface by including an [TF]-p300 interface as an allosteric modifier of DNA-dependent acetylation of p53 at the [TG] promoter.	IRF-1	p21	0	UNDEFINED	False
14935	15257	15539944:0:BCCIP:CDKN1A	[TF] functions through p53 to regulate the expression of p21[TG]/Cip1.	BCCIP	Waf1	0	UNDEFINED	False
14936	15258	15539944:4:BCCIP:CDKN1A	We further show that the regulation of [TG] expression by [TF] is dependent on p53, and BCCIP regulates p53 transcription activity.	BCCIP	p21	0	UNDEFINED	False
14937	15259	15560761:6:IRF2:DST	Transient transfection studies with [TG] promoter-luciferase reporter gene plasmids and IRF1 and [TF] expression plasmids revealed that IRF1 and IRF2 directly down-regulated BPAG1 gene transcription in cultured normal human epidermal keratinocytes.	IRF2	BPAG1	2	REPRESSION	False
14938	15260	15566940:1:TP53:BAX	Active [TF] stimulates the transcription of a number of key genes, including the pro-apoptotic gene [TG], as well as p21, a cell cycle regulator.	p53	bax	1	ACTIVATION	False
14939	15261	15570219:13:KLF4:ODC1	[TF] transient overexpression in HCE cells down regulated both endoglin and [TG] mRNA levels.	KLF4	ODC	2	REPRESSION	False
14940	15262	15586248:0:YY1:IVL	[TF] and c-Jun transcription factors participate in the repression of the human [TG] promoter.	YY-1	involucrin	2	REPRESSION	False
14941	15263	15586248:4:YY1:IVL	Transient overexpression and site-directed mutagenesis experiments of the [TG] 5'-non-coding region (5'-NCR) confirmed that [TF] and c-Jun repress involucrin transcription.	YY1	involucrin	2	REPRESSION	False
14942	15264	15586248:6:YY1:IVL	The results with protein pull-down experiments are consistent with the hypothesis that interaction of [TF] with c-Jun is an important mechanism for [TG] repression.	YY1	involucrin	2	REPRESSION	False
14943	15265	15656994:11:NFYA:SOX3	Taken together, data presented in this paper suggest that transcription factors such as Sp1, USF and [TF] could function as key regulators for the basal activation of the human [TG] gene.	NF-Y	SOX3	1	ACTIVATION	False
14944	15266	15656994:11:SP1:SOX3	Taken together, data presented in this paper suggest that transcription factors such as [TF], USF and NF-Y could function as key regulators for the basal activation of the human [TG] gene.	Sp1	SOX3	1	ACTIVATION	False
14945	15267	15710329:4:MUC1:CDKN1A	Chromatin immunoprecipitation assays demonstrate that [TF] coprecipitates with p53 on the p53-responsive elements of the [TG] gene promoter and coactivates p21 gene transcription.	MUC1	p21	1	ACTIVATION	False
14946	15268	15767669:8:TBPL1:NF1	TBP affects the [TG] and c-fos promoters in a manner reciprocal to that of [TF], stimulating the c-fos promoter and inhibiting NF1 transcription.	TLF	NF1	0	UNDEFINED	True
14948	15270	15778351:8:IRF2:TAP1	Overall, our data indicate that TPO and IFN-gamma activate the expression of [TG] via a new mechanism that involves functional cooperation between STAT1 and [TF] on the TAP1 promoter.	IRF-2	TAP1	1	ACTIVATION	False
14949	15271	15792957:8:ETS1:REN	Finally, we show that the intracellular domain of Notch1, [TF], and HOXD10.PBX1b.PREP1 activate the rat [TG] promoter cooperatively in COS-7 cells.	Ets-1	renin	1	ACTIVATION	False
14950	15272	15811856:1:SP1:FGFR1	Developmentally controlled transcriptional regulation of myogenic cell proliferation and differentiation via expression of the [TG] (FGFR1) gene is positively regulated by [TF] and negatively regulated by E2F4-based transcriptional complexes.	Sp1	fibroblast growth factor receptor 1	1	ACTIVATION	False
14951	15273	15817812:7:NR1H4:ICAM1	Both [TG] and SHP expression were induced in a dose- and time-dependent manner by treatment with the [TF]-selective agonist GW4064.	FXR	ICAM-1	1	ACTIVATION	False
14952	15274	15843409:5:TBX20:NKX2-5	[TF] could activate promoters/enhancers of several genes in cultured cells, including the Mef2c AHF enhancer and the [TG] cardiac enhancer.	Tbx20	Nkx2-5	1	ACTIVATION	False
14953	15275	15843409:8:GATA4:NKX2-5	Tbx20 synergized with Isl1 and [TF] to activate both the Mef2c and [TG] enhancers, thus providing a unifying mechanism for gene activation by Tbx20 in the AHF.	Gata4	Nkx2-5	1	ACTIVATION	False
14954	15276	15843409:8:ISL1:MEF2C	Tbx20 synergized with [TF] and Gata4 to activate both the [TG] and Nkx2-5 enhancers, thus providing a unifying mechanism for gene activation by Tbx20 in the AHF.	Isl1	Mef2c	1	ACTIVATION	False
14955	15277	15843409:8:ISL1:NKX2-5	Tbx20 synergized with [TF] and Gata4 to activate both the Mef2c and [TG] enhancers, thus providing a unifying mechanism for gene activation by Tbx20 in the AHF.	Isl1	Nkx2-5	1	ACTIVATION	False
14956	15278	15864740:3:USF1:PIGR	We have previously shown in cultured tumor cell-lines that basal transcription of the [TG] gene is regulated by the transcription factors [TF], USF2 and AP2.	USF1	PIGR	1	ACTIVATION	True
14957	15279	15864740:3:USF2:PIGR	We have previously shown in cultured tumor cell-lines that basal transcription of the [TG] gene is regulated by the transcription factors USF1, [TF] and AP2.	USF2	PIGR	1	ACTIVATION	True
14958	15280	15870067:7:YY1:ERBB2	Notably, we showed that [TF] enhances AP-2alpha transcriptional activation of the [TG] promoter through an AP-2 site both in HepG2 and in HCT116 cells, whereas a carboxyl-terminal-truncated form of YY1 cannot.	YY1	ERBB2	1	ACTIVATION	False
14959	15281	15870300:1:TAF1:CCND1	A missense mutation within the histone acetyltransferase (HAT) domain of the TATA binding protein-associated factor [TF] induces ts13 cells to undergo a late G(1) arrest and decreases [TG] transcription.	TAF1	cyclin D1	1	ACTIVATION	False
14960	15282	15899840:10:SP1:CDKN1A	Together, these results identify TReP-132 as a basal cell cycle regulatory protein acting, at least in part, by interacting with [TF] to activate the [TG] and p27 gene promoters.	Sp1	p21	1	ACTIVATION	False
14961	15283	15936983:5:PPARA:FABP6	Using progressive 5' deletions of the h[TG] promoter and sequence analysis, we identified a putative [TF]-binding site located at the position -198 and -186 upstream of the transcription initiation site.	PPAR	I-BABP	0	UNDEFINED	False
14962	15284	15936983:7:PPARA:FABP6	The deletion of the PPRE within the h[TG] promoter abolished the [TF]-mediated transactivation in transient transfection assays.	PPAR	I-BABP	1	ACTIVATION	False
14963	15285	16102021:4:KLF5:EGR1	[TF] activates many genes inducible during cardiovascular remodeling, such as platelet-derived growth factor (PDGF)-A/B, [TG], plasminogen activator inhibitor-1 (PAI-1), inducible nitric oxide synthase (iNOS), and vascular endothelial growth factor (VEGF) receptors.	KLF5	Egr-1	1	ACTIVATION	False
14964	15286	16102021:4:KLF5:NOS2	[TF] activates many genes inducible during cardiovascular remodeling, such as platelet-derived growth factor (PDGF)-A/B, Egr-1, plasminogen activator inhibitor-1 (PAI-1), inducible nitric oxide synthase ([TG]), and vascular endothelial growth factor (VEGF) receptors.	KLF5	iNOS	1	ACTIVATION	False
14965	15287	16131836:6:DNMT3A:CDKN1A	In this report, we show that [TF] interacts with p53 directly and represses p53-mediated transactivation of the [TG] gene.	Dnmt3a	p21	2	REPRESSION	False
14966	15288	16164412:8:ATF5:ASNS	Overexpression of the C/EBP homologous transcription factor CHOP impaired transcriptional activation of the [TG] promoter following amino acid deprivation or over-expression of [TF] or CREB2/ATF4.	ATF5	asparagine synthetase	1	ACTIVATION	False
14967	15289	16164412:8:DDIT3:ASNS	Overexpression of the C/EBP homologous transcription factor [TF] impaired transcriptional activation of the [TG] promoter following amino acid deprivation or over-expression of ATF5 or CREB2/ATF4.	CHOP	asparagine synthetase	2	REPRESSION	False
14968	15290	16186125:0:GATA1:AHSP	[TF] and Oct-1 are required for expression of the human [TG]-stabilizing protein gene.	GATA-1	alpha-hemoglobin	1	ACTIVATION	True
14969	15291	16219765:6:NFATC4:CTSD	Overexpression of [TF] enhanced both ERalpha and ERbeta transcriptional activities in a ligand-independent manner and up-regulated downstream estrogen-responsive genes including pS2 and [TG].	NFAT3	cathepsin D	1	ACTIVATION	False
14970	15292	16219765:6:NFATC4:TFF1	Overexpression of [TF] enhanced both ERalpha and ERbeta transcriptional activities in a ligand-independent manner and up-regulated downstream estrogen-responsive genes including [TG] and cathepsin D.	NFAT3	pS2	1	ACTIVATION	False
14971	15293	16245312:9:ETS1:TNC	Overexpression of Sp1, [TF], or Ets2 activated the [TG] promoter and superinduced TN-C promoter activity stimulated by PDGF, whereas overexpression of Fli1 inhibited the effects of PDGF on TN-C expression.	Ets1	TN-C	1	ACTIVATION	False
14972	15294	16245312:9:ETS2:TNC	Overexpression of Sp1, Ets1, or [TF] activated the [TG] promoter and superinduced TN-C promoter activity stimulated by PDGF, whereas overexpression of Fli1 inhibited the effects of PDGF on TN-C expression.	Ets2	TN-C	1	ACTIVATION	False
14973	15295	16245312:9:SP1:TNC	Overexpression of [TF], Ets1, or Ets2 activated the [TG] promoter and superinduced TN-C promoter activity stimulated by PDGF, whereas overexpression of Fli1 inhibited the effects of PDGF on TN-C expression.	Sp1	TN-C	1	ACTIVATION	False
14974	15299	16294212:5:ETS1:GATA2	Overexpression of [TF] in erythroid cells blocks maturation at the polychromatophilic stage, increases [TG] and decreases both GATA-1 and erythropoietin receptor expression.	Ets-1	GATA-2	1	ACTIVATION	False
14975	15300	16294212:5:ETS1:EPOR	Overexpression of [TF] in erythroid cells blocks maturation at the polychromatophilic stage, increases GATA-2 and decreases both GATA-1 and [TG] expression.	Ets-1	erythropoietin receptor	2	REPRESSION	False
14976	15301	16554298:7:JUN:MMP9	Ectopic expression of p65, c-Fos, [TF], and Fra-1 induced [TG] promoter activity.	c-Jun	MMP9	1	ACTIVATION	False
14977	15302	16554298:7:RELA:MMP9	Ectopic expression of [TF], c-Fos, c-Jun, and Fra-1 induced [TG] promoter activity.	p65	MMP9	1	ACTIVATION	False
14978	15303	16557594:7:TP53:ID2	Furthermore, we establish a direct causal relationship between p21, ID1 and [TG] overexpression, increased acetylation of histones H3 and H4 and binding of [TF] to their promoters as a result of 5-FU treatment.	p53	ID2	1	ACTIVATION	True
14979	15307	16784892:4:YY1:FAS	Thus, we hypothesized that tumor-derived TNF-alpha induces the activation of NF-kappaB and the transcription repressor [TF], both of which negatively regulate [TG] expression and sensitivity to FasL-induced apoptosis.	YY1	Fas	2	REPRESSION	False
14980	15308	16784892:10:YY1:FAS	These findings demonstrate that the TNF-alpha autocrine-paracrine loop is involved in the constitutive activation of the transcription factors NF-kappaB and [TF] in the tumor cells and this loop leads to inhibition of [TG] expression and resistance to FasL-induced apoptosis.	YY1	Fas	2	REPRESSION	False
14981	15309	16785237:6:SMAD3:TERT	Expression of the [TF] antagonist, Smad7, also interrupts TGF-beta-mediated Smad3-induced repression of the [TG] gene.	Smad3	TERT	2	REPRESSION	False
14982	15310	16891625:4:SREBF1:FASN	Both ChREBP and [TF] were required for the induction of the [TG] (FAS) promoter by glucose, and chromatin immunoprecipitation (ChIP) assay revealed that glucose induced the binding of both ChREBP and SREBP-1c to the FAS promoter without affecting USF2 binding.	SREBP-1c	fatty acid synthase	1	ACTIVATION	False
14983	15311	16931621:5:TP53:BAX	JAZ functions to mediate G1 cell-cycle arrest followed by apoptosis in a [TF]-dependent mechanism that is associated with up-regulation of p21 and [TG], dephosphorylation of Rb, and repression of cyclin A.	p53	BAX	1	ACTIVATION	False
14984	15312	16965262:8:STAT5A:CSN2	In transient transfection experiments, Oct-1 collaboratively transactivated the [TG] gene promoter with [TF] and/or GR in the presence of Prl receptor in cells treated with the lactogenic hormones.	STAT5	beta-casein	1	ACTIVATION	False
14985	15313	16982744:3:DAXX:BIRC3	[TF] interacts with RelB and inhibits RelB-mediated transcriptional activation of the human [TG] gene promoter.	Daxx	cIAP2	2	REPRESSION	False
14986	15314	17001315:7:TP53:CDC25A	In contrast to [TF], neither p63 nor p73 can repress [TG] transcription.	p53	Cdc25A	2	REPRESSION	False
14987	15315	17030610:11:MBD2:POU5F1	Thus, recruitment of MBD3 and [TF] by GCNF links two events, gene-specific repression and DNA methylation, which occur differentially at the [TG] promoter.	MBD2	Oct4	2	REPRESSION	False
14988	15316	17030610:11:MBD3:POU5F1	Thus, recruitment of [TF] and MBD2 by GCNF links two events, gene-specific repression and DNA methylation, which occur differentially at the [TG] promoter.	MBD3	Oct4	2	REPRESSION	False
14989	15317	17043642:6:TP53:APAF1	Spalax and human-mutated [TF] lost induction of [TG] transcription, and increased induction of mdm2 transcription.	p53	apaf1	1	ACTIVATION	False
14990	15318	17050536:0:MYC:NDRG2	The repression of human differentiation-related gene [TG] expression by [TF] via Miz-1-dependent interaction with the NDRG2 core promoter.	Myc	NDRG2	2	REPRESSION	False
14991	15319	17079227:7:ESRRG:PDK4	Here we report that ERRalpha and [TF] stimulate the [TG] gene in hepatoma cells, suggesting a novel role for ERRs in controlling pyruvate metabolism.	ERRgamma	PDK4	1	ACTIVATION	False
14992	15320	17084713:4:PPARD:PPARGC1	Moreover, as the [TG] promoter contains a PPAR response element, the effect of [TF] on the formation and/or maintenance of slow muscle fibers can be ascribed, at least in part, to a stimulation of PGC1alpha expression at the transcriptional level.	PPARbeta	PGC1alpha	1	ACTIVATION	False
14993	15322	17132729:2:SMAD3:MYC	Smad4 mediates this inhibitory effect of TGF-beta by forming a complex with [TF], E2F4/5, and p107 at the TGF-beta inhibitory element (TIE) element on the [TG] promoter.	Smad3	c-myc	2	REPRESSION	False
14994	15323	17132729:2:SMAD4:MYC	[TF] mediates this inhibitory effect of TGF-beta by forming a complex with Smad3, E2F4/5, and p107 at the TGF-beta inhibitory element (TIE) element on the [TG] promoter.	Smad4	c-myc	2	REPRESSION	False
14995	15324	17189429:9:ATF2:SERPINB5	Thus, [TF] acts as a tumor susceptibility gene of mammary tumors, at least partly, by activating a group of target genes, including [TG] and Gadd45alpha.	ATF-2	Maspin	1	ACTIVATION	False
14996	15325	17204240:4:CLOCK:NR0B2	Liver receptor homologue-1 (LRH-1; NR5A2) stimulated the m[TG] promoter, and [TF]-BMAL1 synergistically enhanced the LRH-1-mediated transactivation.	CLOCK	SHP	1	ACTIVATION	False
14997	15326	17210690:7:TP53:E2F1	Northern and Western blot analyses revealed that the expression of MCM5 and its transcriptional regulator, [TG], is negatively regulated by [TF].	p53	E2F1	2	REPRESSION	False
14998	15327	17210690:7:E2F1:MCM5	Northern and Western blot analyses revealed that the expression of [TG] and its transcriptional regulator, [TF], is negatively regulated by p53.	E2F1	MCM5	0	UNDEFINED	False
14999	15328	17239350:8:TFAP4:CEBPA	These findings suggest that USF-1 and 2 play roles in [TG] expression, whereas the [TF] represses it.	AP-4	C/EBPalpha	2	REPRESSION	False
15000	15329	17275789:0:PPARD:PPARGC1A	[TF], but not PPARalpha, activates [TG] gene transcription in muscle.	PPARdelta	PGC-1alpha	1	ACTIVATION	False
15001	15330	17377499:9:TP53:CKS1B	In contrast to [TF], its homologues p63 and p73 do not significantly repress transcription from the [TG] promoter.	p53	Cks1	2	REPRESSION	False
15002	15331	17446175:8:REL:RELB	Cotransfection of Fra-2 with the Jun AP-1 subunits and p50/[TF] NF-kappaB led to synergistic activation of the [TG] promoter.	c-Rel	relB	1	ACTIVATION	False
15003	15332	17446175:8:NFKB1:RELB	Cotransfection of Fra-2 with the Jun AP-1 subunits and p50/c-Rel [TF] led to synergistic activation of the [TG] promoter.	NF-kappaB	relB	1	ACTIVATION	False
15004	15333	17468517:7:CDX2:CDKN2A	Moreover, transfected [TF] could inhibit beta-catenin/TCF4-mediated transcriptional activation of target genes, including [TG] and cyclin D1, probably through indirect mechanisms.	Cdx2	p14(ARF)	2	REPRESSION	False
15005	15334	17481938:10:JUN:CYP4A11	Overexpression of [TF] in rat liver-derived H4IIE cells increased [TG] mRNA to approximately 2-fold of control, but oct-1 overexpression was without significant effect.	c-Jun	CYP4A2	1	ACTIVATION	False
15006	15335	17516925:8:SOX10:TYR	The results suggest that [TF] directly, and Mitf, most likely indirectly, activate the [TG] enhancer, underlining the contribution of Sox10 to tyrosinase gene regulation in melanocytes.	Sox10	tyrosinase	1	ACTIVATION	False
15007	15336	17526725:6:FOXM1:SERPINA1	The deletion of [TF] and HNF-6 binding sites within the LCR reduced histone acetylation at both the LCR and the upstream regulatory region and decreased the transcription of the [TG], corticosteroid binding globulin, and protein Z-dependent protease inhibitor genes.	HNF-3	alpha1AT	1	ACTIVATION	False
15008	15337	17592024:7:PPARA:FST	Activation of [TF] and PPARgamma increased mRNA levels of [TG], but did not affect the expression of follistatin-related gene.	PPARalpha	follistatin	1	ACTIVATION	False
15009	15338	17700520:0:ATF2:SERPINB5	[TF] controls transcription of [TG] and GADD45 alpha genes independently from p53 to suppress mammary tumors.	ATF-2	Maspin	0	UNDEFINED	False
15010	15339	17700520:5:TP53:GADD45A	ATF-2 and [TF] independently activate the [TG] transcription.	p53	GADD45alpha	1	ACTIVATION	False
15011	15340	17761837:7:HNF4A:SLC26A3	Although hepatic nuclear factor [TF] is involved in the basal activity of [TG] promoter, sodium butyrate induces its activity in LS174T cells via the binding of Yin Yang 1 (YY1) and GATA transcription factors to their respective cis-elements in promoter region.	HNF-4	DRA	1	ACTIVATION	False
15012	15341	17851584:10:SP1:PADI1	These data indicate that MZF1 and [TF]/Sp3 binding to the promoter region drive the [TG] expression.	Sp1	PADI1	1	ACTIVATION	False
15013	15342	17851584:10:SP3:PADI1	These data indicate that MZF1 and Sp1/[TF] binding to the promoter region drive the [TG] expression.	Sp3	PADI1	1	ACTIVATION	False
15014	15344	17889508:1:EGR1:CHGA	Our previous work revealed that gastrin regulates [TG] (CgA) transcription through enhanced binding of Sp1, CREB and [TF] to a proximal gastrin-responsive promoter element (Gas-RE).	Egr-1	chromogranin A	0	UNDEFINED	False
15015	15345	17952119:4:ATF3:CAV1	Array analyses indicated that [TF] upregulates the expression of several genes in the tumor necrosis factor pathway in the MCF10A cells but upregulates the expression of several genes implicated in tumor metastasis, including TWIST1, fibronectin (FN)-1, plasminogen activator inhibitor-1, urokinase-type plasminogen activator, [TG] and Slug, in the MCF10CA1a cells.	ATF3	caveolin-1	1	ACTIVATION	False
15016	15346	17952119:4:ATF3:TWIST1	Array analyses indicated that [TF] upregulates the expression of several genes in the tumor necrosis factor pathway in the MCF10A cells but upregulates the expression of several genes implicated in tumor metastasis, including [TG], fibronectin (FN)-1, plasminogen activator inhibitor-1, urokinase-type plasminogen activator, caveolin-1 and Slug, in the MCF10CA1a cells.	ATF3	TWIST1	1	ACTIVATION	False
15017	15347	18000219:10:BRCA1:ESR1	The transcription factor Oct-1 recruited [TF] to the [TG] promoter, and both BRCA1 and Oct-1 were required for ER alpha expression.	BRCA1	ESR1	1	ACTIVATION	False
15018	15348	18056793:7:KLF13:CYP11A1	Transient transfection of KLF4, KLF9, and [TF] suppressed LDLR/luc, StAR/luc, and [TG]/luc by 80-90% (P < 0.001).	KLF13	CYP11A	2	REPRESSION	False
15019	15349	18056793:7:KLF13:LDLR	Transient transfection of KLF4, KLF9, and [TF] suppressed [TG]/luc, StAR/luc, and CYP11A/luc by 80-90% (P < 0.001).	KLF13	LDLR	2	REPRESSION	False
15020	15350	18056793:7:KLF4:CYP11A1	Transient transfection of [TF], KLF9, and KLF13 suppressed LDLR/luc, StAR/luc, and [TG]/luc by 80-90% (P < 0.001).	KLF4	CYP11A	2	REPRESSION	False
15021	15351	18056793:7:KLF4:LDLR	Transient transfection of [TF], KLF9, and KLF13 suppressed [TG]/luc, StAR/luc, and CYP11A/luc by 80-90% (P < 0.001).	KLF4	LDLR	2	REPRESSION	False
15022	15352	18056793:7:KLF9:CYP11A1	Transient transfection of KLF4, [TF], and KLF13 suppressed LDLR/luc, StAR/luc, and [TG]/luc by 80-90% (P < 0.001).	KLF9	CYP11A	2	REPRESSION	False
15023	15353	18068676:3:SP1:SREBF1	Intact [TF] are essential for promoter activity, whereas EGR-1 suppresses the transcription of the human [TG] promoter.	SP1-binding sites	SREBP-1a	1	ACTIVATION	False
15024	15354	18073142:2:TLX1:FHL1	Previous studies have shown that [TF] can regulate target genes including ALDH1A1 and [TG].	TLX1	FHL1	0	UNDEFINED	False
15025	15356	18213392:5:E2F1:DTL	By measuring the luciferase activity in A549 cells, the intergenic human sequence was shown to be able to drive the reporter gene expression in either direction and notably, among transcription factors E2F, [TF] approximately E2F4, but not E2F5 and E2F6, this sequence clearly up-regulated the reporter gene expression exclusively in the direction of the [TG] gene.	E2F1	CDT2	1	ACTIVATION	False
15026	15357	18218085:12:TFAP2A:ERBB2	Transfection of siRNAs targeting [TF] and AP-2gamma mRNAs in the BT-474 breast cancer cell line repressed the expression of the endogenous [TG] gene at both the mRNA and protein levels.	AP-2alpha	ERBB2	1	ACTIVATION	False
15027	15358	18319327:6:CREBBP:SETDB1	Our results suggest that [TF] is a transcriptional repressor of [TG] gene expression by limiting Ets-2 transcriptional activity, while CBP siRNA enhances basal and Ets-2-dependent ESET transcriptional activity.	CBP	ESET	2	REPRESSION	False
15028	15359	18358466:7:CITED2:CEBPA	[TF] and Tcfap2c were present on the [TG] promoter in E18.5 lungs to activate Cebpa transcription.	Cited2	Cebpa	1	ACTIVATION	False
15029	15360	18385139:6:NR0B2:NR5A2	We also show that transactivation of PGC-1alpha and [TG] is repressed by the small heterodimer partner ([TF]).	SHP	LRH-1	2	REPRESSION	False
15030	15361	18387357:6:GATA4:CEBPD	In [TF] expressing intestinal epithelial cells, GATA-4 led to decreased C/EBPbeta and [TG] protein levels, and decreased thiostatin expression in response to IL-1beta and dexamethasone.	GATA-4	C/EBPdelta	2	REPRESSION	False
15031	15362	18420801:1:SREBF1:FASN	Transcriptional factor sterol regulatory element-binding protein 1c ([TF]c) activates the transcription of lipogenic genes, including [TG] (FAS).	SREBP-1	fatty acid synthase	1	ACTIVATION	False
15032	15363	18424262:0:AP1:CASP14	Transcription of the [TG] gene in human epidermal keratinocytes requires [TF] and NFkappaB.	AP-1	caspase-14	1	ACTIVATION	False
15033	15364	18436815:8:EP300:ALDH3A1	Pax6, Oct1, and [TF] synergistically activate the [TG] promoter approximately 116-fold.	p300	Aldh3a1	1	ACTIVATION	False
15034	15365	18436815:8:PAX6:ALDH3A1	[TF], Oct1, and p300 synergistically activate the [TG] promoter approximately 116-fold.	Pax6	Aldh3a1	1	ACTIVATION	False
15035	15366	18455211:5:PPARA:GPT	The [TF] effect on [TG] expression was shown to act through a direct transcriptional mechanism involving at least one PPAR response element (PPRE) in the proximal ALT1 promoter, while no effect of fenofibrate and AZD4619 was observed on the ALT2 promoter.	PPAR	ALT1	0	UNDEFINED	False
15036	15367	18455888:7:MYC:NDRG1	The data revealed that both N-Myc and [TF] can repress human [TG] at the transcriptional level.	c-Myc	NDRG1	2	REPRESSION	False
15037	15368	18472212:3:SP1:KLF16	In the D2-dopamine receptor expressing NB41A3 cells, [TF] potently activates transcription from the [TG] promoter in pCAT-DRRF-1153/+17, while DRRF itself effectively inhibits it.	Sp1	DRRF	1	ACTIVATION	False
15038	15369	18483557:8:HOXA13:FOXF1	In vitro, [TF] binds sequences present in the Tie2 and [TG] promoters with high affinity (K(d) = 27-42 nM) and HOXA13 can use these bound promoter regions to direct gene expression.	HOXA13	Foxf1	1	ACTIVATION	False
15039	15370	18506085:6:MAFA:INS	Coexpression of Nkx6.1 and Ngn3 induced endogenous expression of the [TG] 2 gene, while coexpression of [TF] and Ngn3 induced both insulin 1 and 2 genes in AR42J-B13 cells.	Maf A	insulin	1	ACTIVATION	False
15040	15371	18506085:6:NKX6-1:INS	Coexpression of [TF] and Ngn3 induced endogenous expression of the [TG] 2 gene, while coexpression of Maf A and Ngn3 induced both insulin 1 and 2 genes in AR42J-B13 cells.	Nkx6.1	insulin	1	ACTIVATION	False
15041	15372	18552212:6:SPIB:XBP1	By chromatin immunoprecipitation and assays using an inducible [TF] construct BLIMP1 and [TG] were identified as direct target genes of Spi-B mediated repression.	Spi-B	XBP-1	2	REPRESSION	False
15042	15373	18591257:7:GATA4:CCND2	We show that [TF] is required for cyclin D2, cyclin A2, and Cdk4 expression in the right ventricle and that the [TG] and Cdk4 promoters are bound and activated by GATA4 via multiple consensus GATA binding sites in each gene's proximal promoter.	GATA4	Cyclin D2	1	ACTIVATION	False
15043	15374	18591257:7:GATA4:CDK4	We show that [TF] is required for cyclin D2, cyclin A2, and [TG] expression in the right ventricle and that the Cyclin D2 and Cdk4 promoters are bound and activated by GATA4 via multiple consensus GATA binding sites in each gene's proximal promoter.	GATA4	Cdk4	1	ACTIVATION	False
15044	15375	18617520:7:KLF5:MMP9	The [TF] overexpression caused gelatin degradation by stimulating promoter activity of [TG] without affecting chondrocyte differentiation or vascular endothelial growth factor expression in the culture of chondrogenic cells; however, in osteoclast precursors, it affected neither MMP9 expression nor osteoclastic differentiation.	KLF5	MMP9	1	ACTIVATION	False
15045	15376	18625721:0:CREB1:DUSP1	Retinoic acid utilizes [TF] and USF1 in a transcriptional feed-forward loop in order to stimulate [TG] expression in human immunodeficiency virus-infected podocytes.	CREB	MKP1	1	ACTIVATION	False
15046	15377	18765665:6:HNF4A:PEA15	[TF] represses PED/[TG] expression in HeLa cells, whereas COUP-TFII activates its expression.	HNF-4alpha	PEA-15	2	REPRESSION	False
15048	15379	18769160:8:TP53:SP1	Transient transfections of CDK4, Rad51, E2F-DP1, p21 and Stat3 increased mRNA expression from the endogenous [TG] gene in HeLa cells whereas overexpression of NF kappaB, and [TF] decreased Sp1 mRNA levels.	p53	Sp1	2	REPRESSION	False
15050	15383	18848838:8:PPARA:TXNIP	The interference of [TF]/retinoid X receptor alpha with the AP-1 transcription factor elements c-Jun/c-Fos resulted in the inhibition of AP-1 binding and down-regulation of the [TG] gene expression.	PPARalpha	VDUP-1	2	REPRESSION	True
15051	15384	18974883:8:GATA4:PPARGC1A	Overexpression of either [TF] or USF-1 alone increased the p851 [TG] promoter activity by 1.7- and 2.0-fold respectively, while co-expression of GATA-4 and USF-1 led to an additive increase in PGC-1alpha promoter activity.	GATA-4	PGC-1alpha	1	ACTIVATION	False
15052	15385	18981289:7:NR1H4:IL6	The results showed that [TF] deficiency resulted in increased colon cell proliferation, which was accompanied by an up-regulation in the expression of genes involved in cell cycle progression and inflammation, including cyclin D1 and [TG].	FXR	interleukin-6	2	REPRESSION	False
15053	15388	19131575:6:NR2C1:NANOG	Knocking down [TF] and TR4 mRNAs decreased the expression of Oct-3/4 and [TG] genes.	TR2	Nanog	1	ACTIVATION	False
15054	15389	19131575:6:NR2C2:NANOG	Knocking down TR2 and [TF] mRNAs decreased the expression of Oct-3/4 and [TG] genes.	TR4	Nanog	1	ACTIVATION	False
15055	15390	19137013:6:YAP1:BAX	Interaction of EGR-1 and Yes kinase-associated protein 1 ([TF]) through the WW domain of YAP-1 enhances the transcriptional activity of EGR-1 on the [TG] promoter as shown by chromatin immunoprecipitation and reporter assays.	YAP-1	Bax	1	ACTIVATION	False
15056	15391	19423764:8:ID2:FSHR	Overexpression of [TF] resulted in a dose-dependent decrease in USF-driven [TG] promoter activity in the MSC-1 Sertoli cell line, and ID2 inhibited USF binding to the Fshr E-box.	ID2	Fshr	2	REPRESSION	False
15057	15392	19423764:9:ID2:FSHR	Together, these studies suggest that stimulation of Sertoli cells with FSH transiently decreases expression of the USF1 activator and induces accumulation of the [TF] repressor, to block USF binding to the [TG] promoter and delay activation of Fshr transcription.	ID2	Fshr	2	REPRESSION	False
15058	15393	19437620:6:SP3:OCLN	The work identified a group of transcription factors including [TF] and YY1, which differentially interact with the [TG] promoter to induce expression of occludin in brain endothelium and repression in other endothelia.	Sp3	occludin	1	ACTIVATION	False
15059	15394	19479035:8:SOX17:CDKN2B	[TF] decreased the expression of transforming growth factor-beta (TGF-beta)-responsive cell cycle inhibitors in the adult mouse lung, including [TG], p21, and p57, and inhibited TGF-beta1-mediated transcriptional responses in vitro.	Sox17	p15	2	REPRESSION	False
15060	15395	19487462:6:BCL6:NFKB1	Rac1 signaling also regulated the expression of endogenous [TF]-regulated genes, including the p50 precursor [TG]/p105 and the cell adhesion molecule CD44.	BCL-6	NF-kappaB1	0	UNDEFINED	False
15061	15398	19564408:8:CEBPA:RETN	The data further show that repression of [TG] and angiotensinogen expression involves recruitment of CtBP1/2, directed by [TF], to the minimal promoter of the corresponding genes in response to the PPARgamma ligand.	C/EBPalpha	resistin	2	REPRESSION	False
15062	15399	19564408:8:PPARG:RETN	The data further show that repression of [TG] and angiotensinogen expression involves recruitment of CtBP1/2, directed by C/EBPalpha, to the minimal promoter of the corresponding genes in response to the [TF] ligand.	PPARgamma	resistin	2	REPRESSION	False
15066	15408	19723510:0:AP1:MYOD1	Estrogen receptor regulates [TG] gene expression by preventing [TF]-mediated repression.	AP-1	MyoD	2	REPRESSION	False
15067	15409	19808645:5:KLF6:TXNIP	[TF] overexpression increased [TG] expression and promoter activity, which was inhibited by concurrent exposure to PPAR-gamma agonists.	KLF6	Txnip	1	ACTIVATION	False
15068	15410	19846662:10:HIVEP1:PTGS2	Additionally, [TF] bound on cyclooxygenase 2 ([TG]) promoter and downregulated COX-2 expression.	MBP-1	COX-2	2	REPRESSION	False
15069	15411	19906305:10:TFAP2A:ERBB2	Ku siRNAs also inhibited the activity of this reporter vector in BT-474 and SKBR3 cell lines and the activity of the [TG] promoter was further reduced by combining Ku siRNAs with [TF] and AP-2gamma siRNAs.	AP-2alpha	ERBB2	1	ACTIVATION	False
15070	15412	19912882:0:JUN:TH	A 5'-flanking region of the [TG] gene is involved in cell-specific expression, activation of gene transcription by phorbol ester, and transactivation by c-Fos and [TF].	c-Jun	bovine tyrosine hydroxylase	1	ACTIVATION	False
15071	15413	20006311:11:CREB1:IFNG	ESAT-6 reduced [TG] mRNA levels by inhibiting the expression of the transcription factors, ATF-2, c-Jun and [TF], which upregulate IFN-gamma gene expression in T cells through binding to the IFN-gamma proximal promoter.	CREB	IFN-gamma	1	ACTIVATION	False
15072	15414	20125105:7:FOXO1:ADIPOR1	[TF] enhanced transcription from the [TG], but not the ADIPOR2 promoter in HepG2 cells.	FOXO1	ADIPOR1	1	ACTIVATION	False
15073	15415	20125105:9:FOXO1:ADIPOR1	[TF] may contribute to enhanced [TG], but not ADIPOR2 transcription in IR.	FOXO1	ADIPOR1	1	ACTIVATION	False
15074	15416	20136501:9:FOXO4:SERPINE1	Together, these findings provide the first evidence that oxidative stress and [TF] induce [TG] expression through an indirect mechanism involving modulation of HIF-1alpha and CREB protein levels and that enhanced CREB binding to the PAI-1 promoter is critical for the PAI-1 induction under oxidative stress.	FOXO4	PAI-1	1	ACTIVATION	False
15075	15417	20136501:9:HIF1A:SERPINE1	Together, these findings provide the first evidence that oxidative stress and FOXO4 induce [TG] expression through an indirect mechanism involving modulation of [TF] and CREB protein levels and that enhanced CREB binding to the PAI-1 promoter is critical for the PAI-1 induction under oxidative stress.	HIF-1alpha	PAI-1	0	UNDEFINED	True
15076	15418	20185827:5:BRCA1:NTHL1	The ability of [TF] to stimulate the expression of the three BER enzymes and to enhance [TG] promoter activity was dependent upon the octamer-binding transcription factor OCT1.	BRCA1	NTH1	1	ACTIVATION	False
15077	15419	20190815:6:ZBTB17:CDKN1A	Interestingly, Gfi-1 and c-Myc, through [TF], form a ternary complex on the [TG] promoter, and function in collaboration to repress CDKN1A.	Miz-1	CDKN1A	2	REPRESSION	False
15078	15420	20223820:5:NFYA:MAP2K3	In addition, we found that the studied p53 mutants regulate [TG] gene expression through the involvement of the transcriptional cofactors [TF] and NF-kappaB.	NF-Y	MAP2K3	0	UNDEFINED	False
15079	15421	20375098:6:SIRT1:CYP7A1	LRH1-mediated activation of [TG] and SHP gene transcription was significantly repressed by both SHP and [TF] whereas inhibition of SIRT1 activity by inhibitors or dominant negative SIRT1 or knockdown of SHP led to a significant release of this inhibitory effect.	SIRT1	CYP7A1	2	REPRESSION	False
15080	15422	20375098:6:SIRT1:NR0B2	LRH1-mediated activation of CYP7A1 and [TG] gene transcription was significantly repressed by both SHP and [TF] whereas inhibition of SIRT1 activity by inhibitors or dominant negative SIRT1 or knockdown of SHP led to a significant release of this inhibitory effect.	SIRT1	SHP	2	REPRESSION	False
15081	15425	20421209:5:NR0B1:CCND1	Moreover, AR-mediated repression of the [TG] involves the recruitment of the atypical orphan nuclear receptor [TF] as a component of a multiprotein repressor complex also embracing the participation of Histone Deacetylase 1.	DAX1	CCND1	2	REPRESSION	False
15082	15426	20519630:9:KLF4:CD86	In addition, we found that [TF] negatively regulates CXCL10, [TG], and MSC/ABF-1 genes.	KLF4	CD86	2	REPRESSION	False
15083	15427	20519630:9:KLF4:MSC	In addition, we found that [TF] negatively regulates CXCL10, CD86, and MSC/[TG] genes.	KLF4	ABF-1	2	REPRESSION	False
15084	15428	20566634:0:HSF1:HSPA4	p27 suppresses arsenite-induced Hsp27/[TG] expression through inhibiting JNK2/c-Jun- and [TF]-dependent pathways.	HSF-1	Hsp70	1	ACTIVATION	False
15085	15429	20568114:1:SP1:AKAP12	The SSeCKS/Gravin/[TG] gene, encoding a kinase scaffolding protein with metastasis-suppressing activity, is transcriptionally downregulated in Src-transformed cells through the recruitment of HDAC1 to a Src-responsive proximal promoter site charged with [TF], Sp3 and USF1.	Sp1	AKAP12	2	REPRESSION	True
15086	15430	20568114:1:SP3:AKAP12	The SSeCKS/Gravin/[TG] gene, encoding a kinase scaffolding protein with metastasis-suppressing activity, is transcriptionally downregulated in Src-transformed cells through the recruitment of HDAC1 to a Src-responsive proximal promoter site charged with Sp1, [TF] and USF1.	Sp3	AKAP12	2	REPRESSION	True
15087	15431	20600004:0:NFKB:ABCG2	Transcriptional suppression of breast cancer resistance protein ([TG]) by wild-type p53 through the [TF] pathway in MCF-7 cells.	NF-kappaB	BCRP	2	REPRESSION	False
15088	15432	20639906:4:E2F1:VEGFA	Here, we show that [TF] downregulates the activity of the [TG] promoter in tumour cells independently of p53, leading to a strong decrease in VEGF(xxx) mRNA levels.	E2F1	VEGF-A	2	REPRESSION	False
15090	15434	20697347:9:MUC1:CTGF	We found that [TF] reorganizes transcription factor occupancy of genomic regions upstream of the [TG] gene, directing -catenin and mutant p53 to CTGF gene regulatory elements to promote CTGF expression and destabilizing the interaction at these regions of the transcriptional repressor, c-Jun.	MUC1	CTGF	1	ACTIVATION	True
15091	15435	20736951:6:JUN:PLAUR	Luciferase/chromatin immunoprecipitation analysis showed that Enz transcriptionally controls urokinase-type plasminogen activator receptor ([TG]) expression by promoter inhibition through Sp1, Sp3, and c-Jun([TF]).	AP-1	u-PAR	2	REPRESSION	False
15092	15436	20736951:6:SP1:PLAUR	Luciferase/chromatin immunoprecipitation analysis showed that Enz transcriptionally controls urokinase-type plasminogen activator receptor ([TG]) expression by promoter inhibition through [TF], Sp3, and c-Jun(AP-1).	Sp1	u-PAR	2	REPRESSION	False
15093	15438	20816801:6:PITX2:LEF1	A new molecular mechanism has been identified where Tbx1 inhibits [TF] transcriptional activity and decreases the expression of Pitx2 target genes, p21, [TG] and Pitx2c.	Pitx2	Lef-1	1	ACTIVATION	False
15094	15439	20816801:9:PITX2:LEF1	Tbx1 physically interacts with the [TF] C-terminus and represses PITX2 transcriptional activation of the p21, [TG], and Pitx2c promoters.	PITX2	LEF-1	1	ACTIVATION	False
15095	15440	20826544:6:CITED2:MMP1	Competitive binding and transcription assays demonstrate that [TF] suppresses [TG] expression by competing with MMP transactivator, Ets-1 for its coactivator p300.	CITED2	MMP-1	2	REPRESSION	False
15096	15441	20947822:10:TP53:THBD	Conversely, overexpression of [TF] suppressed endothelial NO synthase and [TG] expression and stimulated plasminogen activator inhibitor 1 and endothelin-1 expression.	p53	thrombomodulin	2	REPRESSION	False
15097	15442	20971808:10:E2F1:PPARG	Furthermore, increased level of CEBPD attenuates [TF]-induced cancer cell proliferation and partially rescues RB/E2F1-mediated repression of [TG] and GADD153 transcription.	E2F1	PPARG2	2	REPRESSION	False
15098	15443	21081708:7:SIRT1:PDK4	After the gene is upregulated, Nr0b2 can feed back and repress FoxO1- and [TF]-activated G6pc and [TG] gene expression.	Sirt1	Pdk4	1	ACTIVATION	False
15099	15444	21084835:8:TFAP2C:CDKN1A	This pattern of promoter interaction by TFAP2A is distinct from that seen for the [TF] family member which represses [TG] expression.	TFAP2C	CDKN1A	2	REPRESSION	True
15100	15445	21126317:8:NKX2-1:MUC5B	By RT-PCR, co-transfection studies and gel-shift assays, we show that [TG] promoter activity is completely inhibited by [TF], whereas factors of the GATA family (GATA-4/GATA-5/GATA-6) are activators.	TTF-1	Muc5b	2	REPRESSION	False
15101	15446	21205742:5:KLF4:ATF3	Analysis of the [TG] promoter revealed the importance of early growth response-1 (Egr-1; located at -245 to -236) and Krppel-like factor 4 ([TF]; located at -178 to -174) putative binding sites in resveratrol-mediated ATF3 transactivation.	KLF4	ATF3	1	ACTIVATION	False
15102	15447	21212137:6:NFIL3:PGR	Overexpression of [TF] in granulosa cells inhibited the induction of prostaglandin-endoperoxide synthase 2 (Ptgs2), progesterone receptor ([TG]), epiregulin (Ereg), and amphiregulin (Areg) and down-regulated levels of prostaglandin E2.	NFIL3	Pgr	2	REPRESSION	False
15103	15448	21212137:6:NFIL3:PTGS2	Overexpression of [TF] in granulosa cells inhibited the induction of [TG] (Ptgs2), progesterone receptor (Pgr), epiregulin (Ereg), and amphiregulin (Areg) and down-regulated levels of prostaglandin E2.	NFIL3	prostaglandin-endoperoxide synthase 2	2	REPRESSION	False
15104	15449	21220691:4:IRF8:TLR3	In this study, we show that [TF] negatively controls [TG] gene expression by suppressing IRF-1- and/or polyinosinic-polycytidylic acid-stimulated TLR3 expression in primary human monocyte-derived DCs (MDDCs).	IRF-8	TLR3	2	REPRESSION	False
15105	15450	21238538:0:SP1:PRLR	Progesterone induces expression of the [TG] gene through cooperative action of [TF] and C/EBP.	Sp1	prolactin receptor	1	ACTIVATION	False
15106	15451	21244711:9:ETS1:MMP1	Chromatin immunoprecipitation (ChIP) experiments indicated that the transcription factors (TFs) [TF], ETS2 and GATA3, bind to the [TG] promoter in the region of this polymorphism and may contribute to the bimodal expression.	ETS1	MMP1	0	UNDEFINED	False
15107	15452	21244711:9:GATA3:MMP1	Chromatin immunoprecipitation (ChIP) experiments indicated that the transcription factors (TFs) ETS1, ETS2 and [TF], bind to the [TG] promoter in the region of this polymorphism and may contribute to the bimodal expression.	GATA3	MMP1	0	UNDEFINED	False
15108	15453	21295542:2:CREB1:MDM2	In this study, we have found that [TF] forms a complex with p53 and represses p53-mediated transactivation of [TG] but not of p21(WAF1).	CREB	MDM2	2	REPRESSION	False
15109	15454	21304988:9:ATF3:JUN	In vitro knockdown of [TF] expression results in significant decreases in expression of Wnt7b, Tcf7, Snai2 and [TG], suggesting that these genes may be direct transcriptional targets of ATF3 protein.	Atf3	Jun	1	ACTIVATION	False
15110	15455	21304988:9:ATF3:SNAI2	In vitro knockdown of [TF] expression results in significant decreases in expression of Wnt7b, Tcf7, [TG] and Jun, suggesting that these genes may be direct transcriptional targets of ATF3 protein.	Atf3	Snai2	1	ACTIVATION	False
15111	15457	21371435:5:REL:FOXP3	Under this condition, stimulation-dependent recruitment of JunB together with [TF] enhanced [TG] expression.	c-Rel	Foxp3	1	ACTIVATION	False
15112	15459	21454713:6:JUNB:APOM	Overexpression of c-Jun or [TF] repressed both the basal and the HNF-1-mediated transactivation of the human [TG] promoter.	JunB	apoM	2	REPRESSION	False
15113	15460	21566082:8:KLF5:E2F3	[TF] is essential for Pg to up-regulate the expression of cell cycle genes, including CyclinA, Cdt1, and [TG].	KLF5	E2F3	1	ACTIVATION	False
15114	15461	21608077:9:MBD3:POU5F1	Thus, recruitment of [TF], MBD2, and Dnmt3A by GCNF links two events: gene-specific repression and DNA methylation, which occur differentially at the [TG] promoter.	MBD3	Oct4	2	REPRESSION	False
15115	15462	21659477:4:FOS:FSHB	By mining a previous microarray data set, we found that mRNA for positive regulators of [TG] expression, such as [TF] and Jun, were up-regulated at slower pulse frequencies than a number of potential negative regulators, such as the corepressors Skil, Crem, and Tgif1.	Fos	Fshb	1	ACTIVATION	False
15116	15463	21659477:4:CREM:FSHB	By mining a previous microarray data set, we found that mRNA for positive regulators of [TG] expression, such as Fos and Jun, were up-regulated at slower pulse frequencies than a number of potential negative regulators, such as the corepressors Skil, [TF], and Tgif1.	Crem	Fshb	2	REPRESSION	False
15117	15464	21659477:4:SKIL:FSHB	By mining a previous microarray data set, we found that mRNA for positive regulators of [TG] expression, such as Fos and Jun, were up-regulated at slower pulse frequencies than a number of potential negative regulators, such as the corepressors [TF], Crem, and Tgif1.	Skil	Fshb	2	REPRESSION	False
15118	15465	21659477:4:TGIF1:FSHB	By mining a previous microarray data set, we found that mRNA for positive regulators of [TG] expression, such as Fos and Jun, were up-regulated at slower pulse frequencies than a number of potential negative regulators, such as the corepressors Skil, Crem, and [TF].	Tgif1	Fshb	2	REPRESSION	False
15120	15467	21791614:3:ATF5:EGR1	ARE-bound [TF]/p300 acetylates lysine-14 (K14) of nucleosomal histone H3 at both the ARE and serum response element (SRE) of the [TG] promoter, which facilitates binding of extracellular signal-regulated kinase (ERK)-phosphorylated Elk-1 to the SRE, activating the Egr-1 promoter.	ATF5	Egr-1	1	ACTIVATION	False
15121	15468	21825130:5:IRX3:GJA1	[TF] directly represses [TG] transcription and indirectly activates Cx40 transcription.	Irx3	Cx43	2	REPRESSION	False
15122	15469	21862591:3:TP53:SLC2A1	We showed that [TF] binds to the promoters of metabolic genes and represses their expression, including glucose transporters [TG]2 (GLUT12) and SLC2A1 (GLUT1).	p53	SLC2A1	2	REPRESSION	False
15123	15470	21957254:4:SOX17:AXIN2	[TF] knockdown also increases the levels of cyclin D1, [TG], and activated -catenin.	Sox17	Axin2	2	REPRESSION	False
15124	15471	21982894:5:BACH1:HMOX1	However, the regulation of [TG] by the antioxidant-response element is firmly established, with the transcription factor [TF] serving as a repressor and Nrf2 as an enhancer.	BACH1	HMOX1	2	REPRESSION	False
15125	15472	21983879:3:TBX21:IFNG	When IL-12 is produced by antigen-presenting cells, [TF] expression is induced, causing direct stimulation of [TG] gene transcription while simultaneously acting as a transcriptional repressor of the IL4 gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.	T-bet	ifng	1	ACTIVATION	False
15126	15473	21996423:5:ATF2:CASP3	Destroying c-Jun:[TF] heterodimers with dominant negative mutants of c-Jun and ATF2 or knockdown by small RNA interference reduced [TG] promoter activity and mRNA level.	ATF2	caspase-3	1	ACTIVATION	False
15127	15474	22083261:7:IRF3:IFNB1	[TG] is transcriptionally upregulated by interferon regulatory factor 3 ([TF]), NF-kB and activator protein-1 (AP-1), and the binding of IFN-beta to IFN-alpha/beta receptor (IFNAR) stimulates the transcription of IFN-alpha genes or other interferon stimulated genes (ISGs), which induces host antiviral activities, whereas host transcription suppression including IFN-beta gene by NSs prevents the gene upregulations of those ISGs in response to viral replication although IRF-3, NF-kB and activator protein-1 (AP-1) can be activated by RVFV7.	IRF-3	IFN-beta	1	ACTIVATION	False
15128	15475	22101269:7:MYB:SNAI2	Transfection with [TF] siRNAs blocked the increase of Slug ([TG]) and Bcl-2 expression and reversed the decrease in E-cadherin expression induced by TGF- treatment.	c-Myb	SNAI2	1	ACTIVATION	False
15129	15476	22138754:5:SP1:EPO	At the molecular level, we show that the PDGF-BB-PDGFR-b signaling system activates the [TG] promoter, acting in part through transcriptional regulation by the transcription factor Atf3, possibly through its association with two additional transcription factors, c-Jun and [TF].	Sp1	EPO	1	ACTIVATION	False
15130	15477	22159222:3:ZBTB17:RHOA	miR-34a was also found to repress [TG] expression by suppressing the c-Myc-Skp2-[TF] transcriptional complex that activates RhoA.	Miz1	RhoA	1	ACTIVATION	False
15132	15480	22209758:9:CUX1:IRF2BPL	TTF1 stimulates transcription from both DNA segments with equal potency, whereas YY1, [TF], and [TG] itself, behave as transcriptional repressors.	CUX1	EAP1	2	REPRESSION	True
15133	15482	22209758:11:CUX1:IRF2BPL	These observations suggest that [TG] gene expression is under dual transcriptional regulation imposed by a trans-activator (TTF1) and two repressors (YY1 and [TF]) previously postulated to be upstream components of a puberty-controlling gene network.	CUX1	EAP1	2	REPRESSION	False
15134	15484	22234186:3:ZBTB18:ID4	Here, we report that a transcriptional factor, [TF], negatively regulates all four Id genes (Id1-[TG]) in developing cerebral cortex.	RP58	Id4	2	REPRESSION	False
15135	15485	22235332:6:ZBTB17:RHOA	miR-34a was found to repress [TG], a regulator of cell migration and invasion, by suppressing c-Myc-Skp2-[TF] transcriptional complex that activates RhoA.	Miz1	RhoA	1	ACTIVATION	False
15136	15486	22278040:5:NR2F6:REN	Luciferase assays indicate that Nr2f2 negatively regulates the [TG] promoter more potently than [TF].	Nr2f6	renin	2	REPRESSION	False
15137	15487	22278040:6:NR2F6:REN	Gel-shift and chromatin immunoprecipitation (ChIP) indicate that Nr2f2 and [TF] can bind directly to the [TG] enhancer through the HRE.	Nr2f6	renin	0	UNDEFINED	False
15138	15488	22278040:9:NR2F6:REN	These data indicate that both [TF] and Nr2f2 can negatively regulate the [TG] promoter, under baseline conditions and in response to physiological queues, respectively.	Nr2f6	renin	2	REPRESSION	False
15139	15489	22278040:11:NR2F6:REN	We conclude that both Nr2f2 and [TF] negatively regulate [TG] promoter activity, but may do so by divergent mechanisms.	Nr2f6	renin	2	REPRESSION	False
15140	15490	22282354:8:SP1:AGTR1	On activation of TGF- signaling, KLF4 mediates [TF] dissociation from, and PPAR- association with, the [TG] promoter, leading to downregulation of AT1R expression in VSMCs.	Sp1	AT1R	1	ACTIVATION	True
15141	15492	22355284:7:ARX:ACKR3	We thus identified 14 [TF]-target genes enriched ([TG], Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Cxcr7	1	ACTIVATION	False
15142	15493	22355284:7:ARX:EGR1	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, [TG], Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Egr1	1	ACTIVATION	False
15143	15494	22355284:7:ARX:ETS2	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, [TG], Phlda1, Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Ets2	1	ACTIVATION	False
15144	15495	22355284:7:ARX:IGF1	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, [TG], Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Igf1	1	ACTIVATION	False
15145	15496	22355284:7:ARX:LMO3	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, Igf1, [TG], Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Lmo3	1	ACTIVATION	False
15146	15497	22355284:7:ARX:MEIS1	We thus identified 14 [TF]-target genes enriched (Cxcr7, [TG], Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Meis1	1	ACTIVATION	False
15147	15498	22355284:7:ARX:EBF3	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, [TG], Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Ebf3	2	REPRESSION	True
15148	15499	22355284:7:ARX:HMGN3	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated ([TG], Lmo1, Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Hmgn3	2	REPRESSION	False
15149	15500	22355284:7:ARX:LMO1	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, [TG], Ebf3, Rasgef1b, and Slit2) in cortical migrating neurons.	Arx	Lmo1	2	REPRESSION	True
15150	15501	22355284:7:ARX:SLIT2	We thus identified 14 [TF]-target genes enriched (Cxcr7, Meis1, Ppap2a, Slc 12a5, Ets2, Phlda1, Egr1, Igf1, Lmo3, Sema6, Lgi1, Alk, Tgfb3, and Napb) and 5 genes specifically down-regulated (Hmgn3, Lmo1, Ebf3, Rasgef1b, and [TG]) in cortical migrating neurons.	Arx	Slit2	2	REPRESSION	False
15151	15502	22446105:3:POU5F1:CGA	Here we show that [TF] represses activity of the [TG] promoter through its interactions with ETS2, a transcription factor required for both placental development and human chorionic gonadotropin subunit gene expression, by forming a complex that precludes ETS2 from interacting with the CGA promoter.	POU5F1	CGA	2	REPRESSION	False
15152	15504	22504641:4:SP1:CDKN2C	Moreover, we found that YY-1, E2F1, and [TF] can synergistically enhance the activity of the [TG] promoter.	Sp-1	p18	1	ACTIVATION	False
15153	15509	22511764:11:SP1:SREBF1	We conclude that FoxO1 inhibits [TG] transcription via combined actions on multiple transcription factors and that this effect is exerted at least in part through reduced transcriptional activity of [TF] and SREBP-1c and disrupted assembly of the transcriptional initiation complex on the SREBP-1c promoter.	Sp1	SREBP-1c	1	ACTIVATION	False
15154	15510	22547683:6:NEUROG2:CCND1	The use of [TF]VP16 and NEUROG2EnR, acting as the constitutive activator and repressor, respectively, indicates that NEUROG2 indirectly represses [TG] and CCNE2 but opens the possibility that CCNE2 is also repressed by a direct mechanism.	NEUROG2	CCND1	2	REPRESSION	False
15155	15511	22564737:7:TCF3:ID3	Silencing of [TF] in prostate cancer cells DU145 and PC3 led to a significant reduction in proliferation due to G1 arrest that was in part mediated by increased CDKN1A(p21) and decreased Id1, [TG] and c-myc.	E2A	Id3	1	ACTIVATION	False
15156	15512	22564737:7:TCF3:MYC	Silencing of [TF] in prostate cancer cells DU145 and PC3 led to a significant reduction in proliferation due to G1 arrest that was in part mediated by increased CDKN1A(p21) and decreased Id1, Id3 and [TG].	E2A	c-myc	1	ACTIVATION	False
15157	15513	22564737:7:TCF3:CDKN1A	Silencing of [TF] in prostate cancer cells DU145 and PC3 led to a significant reduction in proliferation due to G1 arrest that was in part mediated by increased [TG](p21) and decreased Id1, Id3 and c-myc.	E2A	CDKN1A	2	REPRESSION	False
15159	15515	22784578:9:GATA1:C1QA	[TF] was found to inhibit the activity of the [TG] promoter with the GATA-1 motifs and MafB motifs.	GATA-1	C1qa	2	REPRESSION	False
15160	15516	22827438:7:TP53:MAF	Third, exogenous [TF] induces dose-dependent expression of the luciferase report gene driven by both [TG] and Prox1 promoters, and p53 binds to both promoters in the ChIP assays.	p53	c-Maf	1	ACTIVATION	False
15161	15517	22865915:8:STAT3:ZFP36	Hence, by inducing [TG] expression, [TF] activates a negative regulatory loop that controls the IL-10/STAT3 anti-inflammatory response.	STAT3	TTP	1	ACTIVATION	False
15162	15518	22885335:8:FOXM1:SOX2	In co-transfection experiments, [TF] directly bound to and induced transcriptional activity of Scgb1a1 and [TG] promoters.	Foxm1	Sox2	1	ACTIVATION	False
15163	15519	22897851:4:TAL1:TRIB2	One of the critical downstream targets in this circuitry is the [TG] gene, which is oppositely regulated by [TF] and E2A/HEB and is essential for the survival of T-ALL cells.	TAL1	TRIB2	0	UNDEFINED	False
15164	15521	22956576:0:SPI1:BLNK	Regulation of [TG] transcription by [TF] and Spi-B in murine B cell acute lymphoblastic leukemia.	PU.1	B cell linker protein	0	UNDEFINED	False
15165	15522	22964636:9:SP1:PDGFA	Further, SMAD1/5 antagonize the activity of the transcription factor [TF], a well-known positive regulator of [TG], by inhibiting its occupancy at a key regulatory site on the proximal PDGFA promoter.	Sp1	PDGFA	1	ACTIVATION	False
15166	15523	22972545:4:TCF3:FGF10	We showed that Twist1 stimulated Fgfr2 and [TG] expression in a mesenchymal cell line and that it formed heterodimers with ubiquitously expressed E12 (together with E47 encoded by [TF] gene) and upregulated Fgfr2 and Fgf10 promoter activities in a dental mesenchyme-derived cell line.	E2A	Fgf10	1	ACTIVATION	False
15167	15524	22972545:4:TWIST1:FGF10	We showed that [TF] stimulated Fgfr2 and [TG] expression in a mesenchymal cell line and that it formed heterodimers with ubiquitously expressed E12 (together with E47 encoded by E2A gene) and upregulated Fgfr2 and Fgf10 promoter activities in a dental mesenchyme-derived cell line.	Twist1	Fgf10	1	ACTIVATION	False
15168	15525	22972545:4:TWIST1:FGFR2	We showed that [TF] stimulated [TG] and Fgf10 expression in a mesenchymal cell line and that it formed heterodimers with ubiquitously expressed E12 (together with E47 encoded by E2A gene) and upregulated Fgfr2 and Fgf10 promoter activities in a dental mesenchyme-derived cell line.	Twist1	Fgfr2	1	ACTIVATION	False
15169	15526	22972545:6:RUNX2:FGFR2	Although [TF] had no apparent effects on [TG] and Fgf10 promoter activities, it inhibited the stimulatory activity of Twist1 on Fgfr2 promoter.	Runx2	Fgfr2	2	REPRESSION	False
15171	15528	22990073:7:FOSL2:ITGAX	These results indicate that AP-1 composed with JunD and [TF] protein plays a primary role in enhancing the transcription level of the [TG] gene in DC.	Fra2	CD11c	1	ACTIVATION	False
15172	15529	23078099:6:E2F1:PCNA	Importantly, JUN may regulate activating transcription factor 3 expression to involve cell proliferation process; STAT1 and STAT3 can inhibit tissue inhibitor of metalloproteinases-3 expression to modulate the cell adhesion molecule pathway; NF-B and [TF] can downregulate cyclin D1, but upregulate [TG] expression to promote the cell cycle pathway.	E2F1	proliferating cell nuclear antigen	1	ACTIVATION	False
15173	15530	23160379:5:ZEB1:VIM	Overexpression of CLDN1 induced expression of the EMT-regulating transcription factors Slug and [TF], and thereby led to repression of E-cadherin, -catenin expression, enhanced expression of N-cadherin and [TG], a loss of cell adhesion, and increased cell motility in normal liver cells and HCC cells.	Zeb1	Vimentin	1	ACTIVATION	False
15174	15531	23255602:4:IRF1:CASP8	Smad7 was able to activate the [TG] promoter through recruitment of the interferon regulatory factor 1 ([TF]) transcription factor to the interferon-stimulated response element (ISRE) site.	IRF1	caspase 8	1	ACTIVATION	False
15175	15532	23255602:7:IRF1:CASP8	These results support that Smad7 recruits [TF] protein on the [TG] promoter and functions as a transcriptional coactivator.	IRF1	caspase 8	1	ACTIVATION	False
15176	15533	23288701:7:TFE3:CYP17A1	As validation of this approach to identify genuine ASPSCR1-[TF] target genes, two up-regulated genes bound by ASPSCR1-TFE3, [TG] and UPP1, were shown by multiple lines of evidence to be direct, endogenous targets of transactivation by ASPSCR1-TFE3.	TFE3	CYP17A1	1	ACTIVATION	False
15177	15534	23300083:0:RUNX2:AXIN2	[TF] protein represses [TG] expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice.	Runx2	Axin2	2	REPRESSION	False
15178	15535	23329847:0:ZBTB8A:CDKN1A	Regulation of the [TG] gene (CDKN1A) by the repressor [TF] through inhibition of p53 acetylation and transcription factor Sp1 binding.	BOZF1	cyclin-dependent kinase inhibitor 1A	0	UNDEFINED	False
15179	15536	23329847:4:ZBTB8A:CDKN1A	[TF] repressed the transcription of p21WAF/[TG] by acting on the proximal promoter concentrated with Sp1-binding GC boxes.	BOZF1	CDKN1A	2	REPRESSION	False
15180	15537	23334421:5:TP53:ME2	We show that [TF] represses the expression of the tricarboxylic-acid-cycle-associated malic enzymes ME1 and [TG] in human and mouse cells.	p53	ME2	2	REPRESSION	False
15181	15538	23340304:6:ZEB1:SERPINE1	[TF] regulates uPA and [TG] in opposite directions: induces uPA and inhibits PAI-1.	ZEB1	PAI-1	2	REPRESSION	True
15182	15539	23421821:3:HIVEP1:MYC	[TF] is a transcriptional repressor of the [TG] gene that acts by binding to the P2 promoter; only one other direct target of MBP-1, the COX2 gene, has been identified so far.	MBP-1	c-MYC	2	REPRESSION	False
15183	15540	23421821:3:HIVEP1:PTGS2	[TF] is a transcriptional repressor of the c-MYC gene that acts by binding to the P2 promoter; only one other direct target of MBP-1, the [TG] gene, has been identified so far.	MBP-1	COX2	0	UNDEFINED	False
15184	15541	23433354:0:POU5F1:BIRC5	[TF] increases [TG] and CCND1 expression and promotes cancer progression in hepatocellular carcinoma.	OCT4	BIRC5	1	ACTIVATION	False
15185	15542	23433354:8:POU5F1:BIRC5	[TF] can upregulate [TG] and CCND1 expression by increasing their promoter activity.	OCT4	BIRC5	1	ACTIVATION	False
15186	15543	23487742:5:RUNX1:CDKN1A	Conversely, we find that Runx1 ([TF]), which is known for promoting HFSC proliferation, represses [TG], p27, p57, and p15 transcription in HFSC in vivo.	runt related transcription factor 1	p21	2	REPRESSION	False
15187	15544	23487742:5:RUNX1:CDKN2B	Conversely, we find that Runx1 ([TF]), which is known for promoting HFSC proliferation, represses p21, p27, p57, and [TG] transcription in HFSC in vivo.	runt related transcription factor 1	p15	2	REPRESSION	False
15188	15545	23555309:5:SOX10:PHOX2B	Twist1 interacts with the pro-neural factor [TF] via its Twist-box domain and binds to the [TG] promoter to repress transcriptional activity.	Sox10	Phox2b	2	REPRESSION	False
15189	15546	23558680:11:SP3:FGF10	These data suggested that inhibition of [TG] by inflammatory signaling involves the NF-B-dependent interactions between RELA, [TF], and the Fgf-10 promoter.	SP3	FGF-10	2	REPRESSION	False
15190	15548	23598278:9:SP1:FOXM1	Also, [TF] mechanistically activated the [TG] promoter, whereas Krppel-like factor 4 (KLF4) repressed its activity.	Sp1	FOXM1	1	ACTIVATION	False
15191	15549	23610061:9:MITF:PAX6	Chromatin immunoprecipitation analysis shows that [TF] binds to Pax4 and [TG] regulatory regions, suggesting that Mitf represses their transcription in wild-type -cells.	Mitf	Pax6	2	REPRESSION	False
15192	15550	23637192:5:FOXA2:TH	Deletion of both Foxa1 and [TF] resulted in a significant reduction in the number of [TG] (TH)-positive mDA neurons.	Foxa2	tyrosine hydroxylase	1	ACTIVATION	True
15193	15551	23681230:0:SIRT1:GADD45G	[TF] activation enhances HDAC inhibition-mediated upregulation of [TG] by repressing the binding of NF-B/STAT3 complex to its promoter in malignant lymphoid cells.	SIRT1	GADD45G	1	ACTIVATION	False
15194	15552	23702880:9:KLF4:MYOCD	Promoter analyses and chromatin immunoprecipitation assays revealed that NF-B repressed [TG] by binding to the myocardin promoter region in concert with [TF].	Klf4	myocardin	2	REPRESSION	False
15195	15553	23752226:4:TFAP4:CD44	Besides many genes involved in the control of proliferation, the [TF] target genes included markers of stemness (LGR5 and [TG]) and epithelial-mesenchymal transition (EMT) such as SNAIL, E-cadherin/CDH1, OCLN, VIM, FN1, and the Claudins 1, 4, and 7.	AP4	CD44	0	UNDEFINED	False
15196	15554	23752226:4:TFAP4:CDH1	Besides many genes involved in the control of proliferation, the [TF] target genes included markers of stemness (LGR5 and CD44) and epithelial-mesenchymal transition (EMT) such as SNAIL, E-cadherin/[TG], OCLN, VIM, FN1, and the Claudins 1, 4, and 7.	AP4	CDH1	0	UNDEFINED	False
15197	15555	23752226:4:TFAP4:SNAI1	Besides many genes involved in the control of proliferation, the [TF] target genes included markers of stemness (LGR5 and CD44) and epithelial-mesenchymal transition (EMT) such as [TG], E-cadherin/CDH1, OCLN, VIM, FN1, and the Claudins 1, 4, and 7.	AP4	SNAIL	0	UNDEFINED	False
15198	15556	23752226:4:TFAP4:VIM	Besides many genes involved in the control of proliferation, the [TF] target genes included markers of stemness (LGR5 and CD44) and epithelial-mesenchymal transition (EMT) such as SNAIL, E-cadherin/CDH1, OCLN, [TG], FN1, and the Claudins 1, 4, and 7.	AP4	VIM	0	UNDEFINED	False
15199	15557	23818617:6:RBPJ:DLL4	Furthermore, triple knockdown of sox7, sox18 and [TF] also results in ablation of endogenous [TG] expression.	rbpj	dll4	1	ACTIVATION	False
15200	15558	23818617:6:SOX7:DLL4	Furthermore, triple knockdown of [TF], sox18 and rbpj also results in ablation of endogenous [TG] expression.	sox7	dll4	1	ACTIVATION	False
15201	15559	23861801:8:KLF4:CDKN1A	Moreover, the [TF] overexpression arrested the cell cycle progress at the G1/S phase transition by upregulating p21 ([TG]/CIP1) expression and downregulating cyclin D1 expression, KLF4 knockdown in HKC cells did the opposite.	KLF4	WAF1	1	ACTIVATION	False
15202	15560	23933487:8:NR4A2:THBS1	Bioinformatic and deletion studies identified a 5' region of the [TG] promoter repressed by [TF] and proangiogenic transcription factors, including NF-B and Ets1/2.	NR4A2	TSP-1	2	REPRESSION	False
15203	15561	23943797:5:LBX1:ZEB1	At least three homeodomain proteins, Six1, [TF], and HoxA5, transactivated the [TG] promoter, in the case of Six1, through direct protein-promoter interaction.	LBX1	ZEB1	1	ACTIVATION	False
15204	15562	23943797:5:SIX1:ZEB1	At least three homeodomain proteins, [TF], LBX1, and HoxA5, transactivated the [TG] promoter, in the case of Six1, through direct protein-promoter interaction.	Six1	ZEB1	1	ACTIVATION	False
15205	15563	24007921:7:NR1H4:GSTA2	[TF] also positively controls Fmo3 and [TG] expression through direct interaction with the response elements in these genes.	FXR	Gsta2	1	ACTIVATION	False
15206	15564	24117128:6:TP63:BAX	siRNA-mediated knockdown of [TF] resulted in partial protection from spontaneous apoptosis accompanied by reductions in PMAIP1 (NOXA), BBC3 (PUMA), and [TG] mRNA in CLL cells and increased proliferation of Raji lymphoma cells.	TP63	BAX	1	ACTIVATION	False
15207	15565	24117128:6:TP63:PMAIP1	siRNA-mediated knockdown of [TF] resulted in partial protection from spontaneous apoptosis accompanied by reductions in [TG] (NOXA), BBC3 (PUMA), and BAX mRNA in CLL cells and increased proliferation of Raji lymphoma cells.	TP63	PMAIP1	1	ACTIVATION	False
15208	15568	24155921:3:FOXP3:MMP9	[TF] downregulated LCK-induced [TG], SKP2, and VEGF-A expression.	FOXP3	MMP9	2	REPRESSION	False
15209	15569	24155921:3:FOXP3:SKP2	[TF] downregulated LCK-induced MMP9, [TG], and VEGF-A expression.	FOXP3	SKP2	2	REPRESSION	False
15210	15570	24217921:7:STAT3:DAPK1	[TF] and p52-NFkB transcription factors have been shown to down-regulate [TG] expression.	STAT3	DAPK	2	REPRESSION	False
15211	15571	24265317:8:CREBZF:ACACA	Furthermore, UDCA treatment repressed T7-induced SREBP-1c, FAS, and [TG] protein levels, whereas knockdown of endogenous [TF] gene expression by adenovirus SMILE shRNA (Ad-shSMILE) significantly reversed UDCA-mediated repression of SREBP-1c, FAS, and ACC protein levels.	SMILE	ACC	2	REPRESSION	False
15212	15572	24301678:8:CRX:RHO	NonO and its interactors can activate [TG] promoter in HEK293 cells and function synergistically with NRL and [TF].	CRX	rhodopsin	1	ACTIVATION	False
15213	15573	24301678:8:NONO:RHO	[TF] and its interactors can activate [TG] promoter in HEK293 cells and function synergistically with NRL and CRX.	NonO	rhodopsin	1	ACTIVATION	False
15214	15574	24556685:4:BRCA1:S100A2	Consequently, mutation of the Np63/p53 response element within the [TG] promoter completely abrogates the ability of [TF] to upregulate S100A2.	BRCA1	S100A2	1	ACTIVATION	False
15215	15575	24631292:6:RUNX2:SMURF1	Chromatin immunoprecipitation and [TG] promoter assays demonstrated that c-Jun and [TF] play roles in the EGF induction of Smurf1 transcription.	Runx2	Smurf1	1	ACTIVATION	False
15216	15576	24706823:5:NKX6-1:E2F1	Overexpression of [TF] and the Nr4a receptors results in increased expression of key cell cycle inducers [TG] and cyclin E1.	Nkx6.1	E2F transcription factor 1	1	ACTIVATION	False
15217	15577	24706823:5:NR4A1:CCNE1	Overexpression of Nkx6.1 and the [TF] results in increased expression of key cell cycle inducers E2F transcription factor 1 and [TG].	Nr4a receptors	cyclin E1	1	ACTIVATION	False
15218	15578	24706823:5:NR4A1:E2F1	Overexpression of Nkx6.1 and the [TF] results in increased expression of key cell cycle inducers [TG] and cyclin E1.	Nr4a receptors	E2F transcription factor 1	1	ACTIVATION	False
15219	15579	24739390:6:GLI1:BCL2	Activation of the TGF pathway induces [TF]-SMAD4 complex binding to the [TG] promoter whereas disruption of the complex through SMAD4 RNAi depletion impairs GLI1-mediated transcription of BCL2 and cellular survival.	GLI1	BCL2	1	ACTIVATION	False
15220	15581	25111898:6:KLF17:CD44	[TF] suppresses cell migration and invasion by decreasing [TG], PAI-1 and Cyclin-D1 expressions.	KLF17	CD44	2	REPRESSION	False
15221	15582	14570770:1:AR:SULT1A1	The purpose of the current study was to establish the role of the glucocorticoid receptor (GR) and [TF] (AR) transcription factors in the transactivation of rat aryl sulfotransferase ([TG]) gene transcription and to identify the functional hormone-responsive element(s) in the SULT1A1 gene.	androgen receptor	SULT1A1	1	ACTIVATION	False
15222	15583	16331276:6:BRCA1:CDKN1B	Cotransfection of [TF] and FOXA1 resulted in a synergistic activation of the [TG] promoter.	BRCA1	p27(Kip1)	1	ACTIVATION	False
15223	15584	16331276:13:BRCA1:CDKN1B	In summary, we identified a FOXA1 binding site within the [TF]-responsive element of the [TG] promoter and showed that FOXA1 activated the promoter alone and in conjunction with BRCA1.	BRCA1	p27(Kip1)	1	ACTIVATION	False
15224	15585	11934881:3:CDX1:CLDN2	Both [TF] and Cdx2 activated the [TG] promoter in the human intestinal epithelial cell line Caco-2.	Cdx1	claudin-2	1	ACTIVATION	False
15225	15586	18819935:0:CDX1:DSC2	Repression of the [TG] gene expression in human colon cancer cells is relieved by the homeodomain transcription factors [TF] and Cdx2.	Cdx1	desmocollin 2	1	ACTIVATION	True
15226	15587	18819935:15:CDX1:DSC2	We conclude that the homeodomain transcription factors [TF] and Cdx2 regulate [TG] gene expression in intestinal epithelia by reversing the actions of a transcriptional repressor.	Cdx1	DSC2	1	ACTIVATION	True
15227	15588	19900445:8:CDX1:SLC5A8	Consistently, [TG] expression was significantly reduced in colons of [TF](-/-) or Cdx2(+/-) mice compared with wild-type mice.	Cdx1	Slc5a8	1	ACTIVATION	False
15228	15589	19900445:10:CDX1:SLC5A8	[TF] and CDX2 bind the promoter region of [TG] and up-regulate its expression in cultured cells and in colonic epithelium.	CDX1	SLC5A8	1	ACTIVATION	False
15229	15591	15044625:7:CDX2:UGT1A8	In contrast, [TF] bound to and activated the [TG] and -1A10 promoters but could not activate the UGT1A9 promoter.	Cdx2	UGT1A8	1	ACTIVATION	False
15230	15592	22492284:9:CREB1:IBSP	The results of gel shift showed that 0.1 g/ml decreased while 0.01 g/ml A. actinomycetemcomitans LPS increased CRE-, FRE-, and HOX-binding protein complexes formation at 6 h, and revealed that 0.01 g/ml A. actinomycetemcomitans LPS induced [TG] transcription through [TF], JunD, Fra2, c-Fos, Runx2, Dlx5, and Smad1 targeting those response elements.	CREB1	BSP	1	ACTIVATION	False
15231	15593	21044953:4:DDIT3:TNFRSF10B	Both C/EBP homologous protein ([TF]) and Elk1 are required for celecoxib-induced [TG] expression based on promoter deletion and mutation analysis and siRNA-mediated gene silencing results.	CHOP	DR5	1	ACTIVATION	False
15232	15594	21044953:5:DDIT3:TNFRSF10B	Co-expression of both [TF] and Elk1 exhibited enhanced effects on increasing [TG] promoter activity and DR5 expression, indicating that CHOP and Elk1 co-operatively regulate DR5 expression.	CHOP	DR5	1	ACTIVATION	False
15233	15595	22065586:6:DDIT3:TNFRSF10B	Importantly, we have elucidated that Ras induces [TG] expression through co-activation of ERK/RSK and JNK signaling pathways and subsequent cooperative effects among the transcriptional factors [TF], Elk1, and c-Jun to enhance DR5 gene transcription.	CHOP	DR5	1	ACTIVATION	False
15234	15596	22243224:7:DLX3:KLK4	In contrast, [TG] mRNA was up-regulated by both [TF] and Runx2.	Dlx3	Klk4	1	ACTIVATION	False
15235	15597	23376077:7:DLX5:GJA1	Risedronate as well as the pro-osteogenic transcription factors, Runx2, Osterix or [TF], increased transcriptional activity of the [TG] promoter in a dose-dependent manner.	Dlx5	Cx43	1	ACTIVATION	False
15236	15598	22492284:9:DLX5:IBSP	The results of gel shift showed that 0.1 g/ml decreased while 0.01 g/ml A. actinomycetemcomitans LPS increased CRE-, FRE-, and HOX-binding protein complexes formation at 6 h, and revealed that 0.01 g/ml A. actinomycetemcomitans LPS induced [TG] transcription through CREB1, JunD, Fra2, c-Fos, Runx2, [TF], and Smad1 targeting those response elements.	Dlx5	BSP	1	ACTIVATION	False
15237	15599	9795195:0:EGR1:PNMT	[TG] gene expression: synergistic activation by [TF], AP-2 and the glucocorticoid receptor.	Egr-1	Phenylethanolamine N-methyltransferase	1	ACTIVATION	False
15238	15600	9795195:1:EGR1:PNMT	The gene encoding the epinephrine synthesizing enzyme, [TG] (PNMT), is transcriptionally activated by [TF], AP-2, and the glucocorticoid receptor (GR).	Egr-1	phenylethanolamine N-methyltransferase	1	ACTIVATION	False
15239	15601	9795195:3:EGR1:PNMT	The present studies show that the GR also cooperates with [TF] or the combination of Egr-1 and AP-2 to activate the [TG] promoter.	Egr-1	PNMT	1	ACTIVATION	False
15240	15602	9795195:4:EGR1:PNMT	Together [TF], AP-2, and the GR can induce [TG] promoter-mediated luciferase reporter gene expression beyond the sum of their independent contributions as well as synergistically activate the endogenous PNMT gene leading to marked increases in PNMT mRNA.	Egr-1	PNMT	1	ACTIVATION	False
15241	15605	21044953:4:ELK1:TNFRSF10B	Both C/EBP homologous protein (CHOP) and [TF] are required for celecoxib-induced [TG] expression based on promoter deletion and mutation analysis and siRNA-mediated gene silencing results.	Elk1	DR5	1	ACTIVATION	False
15242	15606	21044953:5:ELK1:TNFRSF10B	Co-expression of both CHOP and [TF] exhibited enhanced effects on increasing [TG] promoter activity and DR5 expression, indicating that CHOP and Elk1 co-operatively regulate DR5 expression.	Elk1	DR5	1	ACTIVATION	False
15243	15607	22065586:6:ELK1:TNFRSF10B	Importantly, we have elucidated that Ras induces [TG] expression through co-activation of ERK/RSK and JNK signaling pathways and subsequent cooperative effects among the transcriptional factors CHOP, [TF], and c-Jun to enhance DR5 gene transcription.	Elk1	DR5	1	ACTIVATION	False
15244	15608	21317430:8:ETS1:ZEB1	Besides this effect on Twist, Snail1 also induces the nuclear translocation of [TF], another factor required for [TG] expression.	Ets1	Zeb1	1	ACTIVATION	False
15245	15609	18096076:7:ETS2:NAB2	Analysis of the [TG] promoter showed that it is also activated by ETS proteins ([TF] and Etv1/ER81) and is bound by Ets2 in vivo.	Ets2	Nab2	1	ACTIVATION	False
15246	15610	22613723:5:ETV2:SOX9	Mutation of the [TF] binding site in the [TG] promoter suppressed ER71-dependent up-regulation of Sox9 transcription, and a dominant-negative ER71 molecule severely reduced Sox9 transcription in a Sertoli cell line.	ER71	Sox9	1	ACTIVATION	False
15247	15611	8895512:7:ETV4:VIM	Among members of the ETS transcription factor family only Erg showed ability to transactivate [TG] promoter besides [TF].	PEA3	vimentin	1	ACTIVATION	False
15248	15612	25109552:4:EWSR1:FGF10	Etv1 and [TF] stimulated transcription from the [TG] promoter in the sub-AER mesenchyme of mouse and chick limb buds in a conserved AGAAAR cluster-dependent manner.	Ewsr1	Fgf10	1	ACTIVATION	False
15249	15613	25109552:5:EWSR1:FGF10	We found that both Etv1 and [TF] were necessary for [TG] expression and elongation of the limb bud.	Ewsr1	Fgf10	1	ACTIVATION	False
15250	15614	25109552:6:EWSR1:FGF10	In addition, Etv1 and AER-FGF synergistically stimulated [TG] promoter activity in an [TF]-dependent manner.	Ewsr1	Fgf10	1	ACTIVATION	False
15251	15615	25109552:9:EWSR1:FGF10	Our results suggest that Etv1 and [TF] transactivate [TG] directly and cooperatively in response to AER-FGFs.	Ewsr1	Fgf10	1	ACTIVATION	False
15252	15616	1708774:2:FOS:AFP	[TG] promoter activity induced by c-jun/c-[TF] can be repressed by cotransfected glucocorticoid receptor.	fos	AFP	1	ACTIVATION	False
15253	15617	19607821:7:FOXA2:LMX1A	Our studies show that Foxa1 and [TF] positively regulate [TG] and Lmx1b expression and inhibit Nkx2.2 expression in mesodiencephalic dopaminergic progenitors.	Foxa2	Lmx1a	1	ACTIVATION	False
15254	15618	19607821:7:FOXA2:LMX1B	Our studies show that Foxa1 and [TF] positively regulate Lmx1a and [TG] expression and inhibit Nkx2.2 expression in mesodiencephalic dopaminergic progenitors.	Foxa2	Lmx1b	1	ACTIVATION	False
15255	15619	16678147:4:FOXC1:NOTCH1	Notably, consistent with this observation, overexpression of Foxc genes in vitro induces expression of arterial markers such as [TG] and its ligand Delta-like 4 (Dll4), and [TF] and Foxc2 directly activate the Dll4 promoter via a Foxc-binding site.	Foxc1	Notch1	1	ACTIVATION	False
15256	15620	18187037:4:FOXC2:CXCR4	Here we show that Foxc1 and [TF] directly induce [TG] expression by activating its promoter in endothelial cells.	Foxc2	CXCR4	1	ACTIVATION	False
15257	15621	16678147:4:FOXC2:DLL4	Notably, consistent with this observation, overexpression of Foxc genes in vitro induces expression of arterial markers such as Notch1 and its ligand Delta-like 4 ([TG]), and Foxc1 and [TF] directly activate the Dll4 promoter via a Foxc-binding site.	Foxc2	Dll4	1	ACTIVATION	False
15258	15622	18545664:6:FOXC2:HEY2	We found that Foxc1 and [TF] directly activate the [TG] promoter via Foxc binding elements.	Foxc2	Hey2	1	ACTIVATION	False
15259	15623	24005989:0:FOXQ1:ZEB2	[TF] promotes hepatocellular carcinoma metastasis by transactivating [TG] and VersicanV1 expression.	Forkhead box Q1	ZEB2	1	ACTIVATION	False
15260	15624	23310955:7:GATA3:CD4	Furthermore, whereas Runx3 represses [TG], we show that [TF] promotes Cd4 expression in Thpok-deficient thymocytes.	Gata3	Cd4	1	ACTIVATION	False
15261	15625	21536859:5:GATA3:ERG	We further demonstrate that [TG] expression in primary human T-ALL cells is mediated by the binding of other T-cell oncogenes SCL/TAL1, LMO2, and LYL1 in concert with ERG, FLI1, and [TF] to the ERG +85 enhancer.	GATA3	ERG	1	ACTIVATION	False
15262	15626	24802759:8:GATA3:FOXA1	Mechanistically, JARID1B was required for [TF] recruitment to the [TG] promoter to activate Foxa1 expression.	GATA3	Foxa1	1	ACTIVATION	False
15263	15627	15082719:0:GATA4:FGF3	SOX7 and [TF] are competitive activators of [TG] transcription.	GATA-4	Fgf-3	1	ACTIVATION	False
15264	15628	15082719:8:GATA4:FGF3	More detailed analyses showed that SOX7 competes with [TF] for PS4A occupancy and to activate the [TG] promoter.	GATA-4	Fgf-3	1	ACTIVATION	False
15265	15629	15520176:4:GLI2:BCL2	We show here that expression of the key antiapoptotic factor [TG] is predominantly activated by [TF] compared with GLI1.	GLI2	BCL2	1	ACTIVATION	False
15266	15630	18319260:7:GLI2:FST	Interestingly, activation of the [TG] promoter is highly [TF]-specific, because neither GLI1 nor GLI3 can significantly increase FST transcription.	GLI2	FST	1	ACTIVATION	False
15267	15631	23890107:2:GLI2:ZEB1	Herein, we provide evidence that [TF] represses E-cadherin gene (CDH1) expression in melanoma cells via distinct mechanisms, enhancing transcription of the EMT-activator [TG] and cooperative repression of CDH1 gene transcription via direct binding of both GLI2 and ZEB1 to two closely positioned Kruppel-like factor-binding sites within the CDH1 promoter.	GLI2	ZEB1	1	ACTIVATION	True
15268	15632	15087129:5:GLI3:PTCH1	We demonstrate that only one of two putative Gli-binding sites that were identified in the promoter region of [TG] is functional, and that the transactivating Gli proteins, GLI1, Gli2 and [TF], bind and enhance transcription through this site.	GLI3	PTCH1	1	ACTIVATION	False
15269	15633	20826535:7:HAND2:SHH	Previous studies have shown that TWIST1 functions by forming homodimers or heterodimers with other bHLH factors including [TF], a key positive regulator of [TG] expression.	HAND2	Shh	1	ACTIVATION	False
15270	15634	21259317:4:HEYL:NEUROG2	[TF] binds to and activates the promoter of the proneural gene [TG], which is inhibited by other Hes and Hey family members, and HeyL is a weak inhibitor of the Hes1 promoter.	HeyL	neurogenin2	1	ACTIVATION	False
15271	15635	22050843:5:HIF1A:GATA1	Enforced [TF] expression increased [TG] expression, while HIF1 knockdown by RNA interference decreased GATA1 expression.	HIF1	GATA1	1	ACTIVATION	False
15272	15636	14765989:7:ISL1:GCG	c-Maf protein stimulated [TG] promoter activity in a transient luciferase assay, and activation of the glucagon promoter by c-Maf was more efficient than by the other alpha-cell-enriched transcription factors, Cdx2, Pax6, and [TF].	Isl-1	glucagon	1	ACTIVATION	False
15273	15637	1708774:2:JUN:AFP	[TG] promoter activity induced by c-[TF]/c-fos can be repressed by cotransfected glucocorticoid receptor.	jun	AFP	1	ACTIVATION	False
15274	15638	22065586:6:JUN:TNFRSF10B	Importantly, we have elucidated that Ras induces [TG] expression through co-activation of ERK/RSK and JNK signaling pathways and subsequent cooperative effects among the transcriptional factors CHOP, Elk1, and [TF] to enhance DR5 gene transcription.	c-Jun	DR5	1	ACTIVATION	False
15275	15639	22492284:9:JUND:IBSP	The results of gel shift showed that 0.1 g/ml decreased while 0.01 g/ml A. actinomycetemcomitans LPS increased CRE-, FRE-, and HOX-binding protein complexes formation at 6 h, and revealed that 0.01 g/ml A. actinomycetemcomitans LPS induced [TG] transcription through CREB1, [TF], Fra2, c-Fos, Runx2, Dlx5, and Smad1 targeting those response elements.	JunD	BSP	1	ACTIVATION	False
15276	15640	21559363:4:KLF10:RUNX2	In this manuscript, data is presented demonstrating that over-expression of [TF] results in increased expression of [TG] while repression of TIEG1 results in suppression of Runx2.	TIEG1	Runx2	1	ACTIVATION	False
15277	15641	23558921:6:KLF4:ALPL	Overexpression of [TF] significantly up-regulated odontoblast-related genes, such as Dmp1, Dspp, and [TG], and promoted the accumulation of mineral nodules.	Klf4	Alp	1	ACTIVATION	False
15278	15642	21652709:0:KLF4:CDKN1A	Protein kinase C (PKC) delta suppresses keratinocyte proliferation by increasing p21([TG] level by a [TF] transcription factor-dependent mechanism.	KLF4	Cip1)	1	ACTIVATION	False
15279	15643	23558921:6:KLF4:DMP1	Overexpression of [TF] significantly up-regulated odontoblast-related genes, such as [TG], Dspp, and Alp, and promoted the accumulation of mineral nodules.	Klf4	Dmp1	1	ACTIVATION	False
15280	15644	23313509:7:KLF4:SLC46A1	These results suggest that the activity of [TG] promoter is basically induced by [TF] and the gradiented expression profile of PCFT may be at least in part accounted for by those of HNF4, CDX2 and C/EBP.	KLF4	PCFT	1	ACTIVATION	False
15281	15645	18511453:6:KLF4:TAGLN	We also show that overexpression of [TF] in VSMCs increased the expression of p53, [TG] and alpha-SMA, but decreased the expression of SMemb and VSMC proliferation and migration.	KLF4	SM22alpha	1	ACTIVATION	False
15282	15646	18511453:6:KLF4:TP53	We also show that overexpression of [TF] in VSMCs increased the expression of [TG], SM22alpha and alpha-SMA, but decreased the expression of SMemb and VSMC proliferation and migration.	KLF4	p53	1	ACTIVATION	False
15283	15647	18435741:4:KLF5:CD55	Overexpression of KLF4 and [TF] robustly induced transcriptional activity of the [TG] promoter.	KLF5	DAF	1	ACTIVATION	False
15284	15648	17141338:6:KLF6:LAMA1	Furthermore, we showed that Krppel-like factors KLF4 and [TF] also activate transcription of the human [TG] gene.	KLF6	LAMA1	1	ACTIVATION	False
15285	15649	21536859:5:LMO2:ERG	We further demonstrate that [TG] expression in primary human T-ALL cells is mediated by the binding of other T-cell oncogenes SCL/TAL1, [TF], and LYL1 in concert with ERG, FLI1, and GATA3 to the ERG +85 enhancer.	LMO2	ERG	1	ACTIVATION	False
15286	15650	17901057:2:MAF:GCG	Although it is known that multiple transcription factors such as Pax-6, Cdx-2/3, c-[TF], Maf-B, and Brain-4 can activate the [TG] gene promoter through G1, their relative importance in vivo is unknown.	Maf	glucagon	1	ACTIVATION	False
15287	15651	17263687:6:MAF:GCG	In BHK21 cells, Nkx6.1 inhibited by 93% Pax6-mediated activation of the [TG] promoter, whereas Cdx2/3 and [TF] stimulations were unaltered.	Maf	glucagon	1	ACTIVATION	False
15288	15652	14765989:7:MAF:GCG	c-[TF] protein stimulated [TG] promoter activity in a transient luciferase assay, and activation of the glucagon promoter by c-Maf was more efficient than by the other alpha-cell-enriched transcription factors, Cdx2, Pax6, and Isl-1.	Maf	glucagon	1	ACTIVATION	False
15289	15653	17901057:7:MAF:GCG	Although Pax-6, Cdx-2/3, [TF]-B, and c-Maf were all able to bind G1 by themselves, we showed that Pax-6 could interact with Maf-B, c-Maf, and Cdx-2/3 and activate transcription of the [TG] gene promoter.	Maf	glucagon	1	ACTIVATION	False
15290	15654	17901057:9:MAF:GCG	Finally, we show that specific inhibition of Pax-6 and c-[TF] but not Cdx-2/3 or Maf-B led to decreases in endogenous [TG] gene expression and that c-Maf binds the glucagon gene promoter in mouse islets.	Maf	glucagon	1	ACTIVATION	False
15291	15655	17901057:2:MAFB:GCG	Although it is known that multiple transcription factors such as Pax-6, Cdx-2/3, c-Maf, [TF], and Brain-4 can activate the [TG] gene promoter through G1, their relative importance in vivo is unknown.	Maf-B	glucagon	1	ACTIVATION	False
15292	15656	17901057:7:MAFB:GCG	Although Pax-6, Cdx-2/3, [TF], and c-Maf were all able to bind G1 by themselves, we showed that Pax-6 could interact with Maf-B, c-Maf, and Cdx-2/3 and activate transcription of the [TG] gene promoter.	Maf-B	glucagon	1	ACTIVATION	False
15293	15657	21746878:3:MEIS2:CDKN2A	[TF]d and Pbx1a activate expression of p15([TG] and E-cadherin, dependent on the Meis2d transcriptional activation domain.	Meis2	Ink4a)	1	ACTIVATION	False
15294	15658	20530484:8:MITF:BEST1	Importantly, SOX9 physically interacted with [TF] and OTX2 and orchestrated synergistic activation of the [TG] promoter with the paired SOX site playing essential roles.	MITF	BEST1	1	ACTIVATION	False
15295	15659	12753399:4:MITF:DCT	In addition, functional cooperation of [TF]-M with LEF-1 could lead to transcriptional activation of the M promoter and the dopachrome tautomerase ([TG]) gene, an early melanoblast marker.	MITF	DCT	1	ACTIVATION	False
15296	15663	21812759:7:NFE2L2:BACH1	We conclude that [TG] is a bona fide [TF] target gene and that induction of BACH1 by Nrf2 may serve as a feedback-inhibitory mechanism for ARE-mediated gene regulation.	Nrf2	BACH1	1	ACTIVATION	False
15297	15664	17942419:5:NFE2L2:HMOX1	BACH1 repression is dominant over [TF]-mediated [TG] transcription and inactivation of BACH1 is a prerequisite for HMOX1 induction.	NRF2	HMOX1	1	ACTIVATION	False
15298	15665	18003659:3:NKX2-1:SFTPB	Repression is mediated by SMAD3 through interactions with [TF] and FOXA1, two key transcription factors that are positive regulators of [TG] transcription.	NKX2.1	SpB	1	ACTIVATION	False
15299	15666	9006959:6:NKX2-1:SFTPB	We found that in addition to thyroid transcription factor 1 ([TF]) and hepatocyte nuclear factor 3alpha (HNF-3alpha) binding sites, two spatially separate DNA sequences that bind Sp1 and Sp3 factors are necessary for the maintenance of [TG] promoter activity.	TTF-1	SP-B	1	ACTIVATION	False
15300	15667	9006959:7:NKX2-1:SFTPB	Mutation of any one of the transcription factor binding sites caused a significant reduction in [TG] promoter activity suggesting that Sp1, Sp3, and [TF] and HNF-3alpha interact cooperatively with SP-B promoter to activate gene transcription.	TTF-1	SP-B	1	ACTIVATION	False
15301	15668	8994186:6:NR4A1:POMC	Finally, we provide evidence that the nurr1/[TF] response sequence is pivotal to both nurr1/nur77-dependent positive regulation and glucocorticoid receptor-dependent negative regulation of the [TG] gene.	nur77	POMC	0	UNDEFINED	True
15302	15669	20530484:8:OTX2:BEST1	Importantly, SOX9 physically interacted with MITF and [TF] and orchestrated synergistic activation of the [TG] promoter with the paired SOX site playing essential roles.	OTX2	BEST1	1	ACTIVATION	False
15303	15670	22858985:6:PAX5:BACH2	Analysis of these elements and transient transfection assays led to the identification of the [TF] transcription factor as a potent trans-activator of [TG], whose effect is predominantly mediated through occupation of a binding site on the BACH2 promoter, as demonstrated by both in vitro and in vivo experiments.	Pax5	BACH2	1	ACTIVATION	False
15304	15672	22807088:5:PAX5:SP7	Knockdown by small interfering RNA (siRNA) of endogenous [TF] led to significant inhibition of the expression of Osteocalcin, and [TG] through deterioration of gene transactivation, in addition to a1(I)Collagen expression and alkaline phosphatase (ALP) staining, without affecting runt-related transcription factor-2 (Runx2) expression and cell viability in osteoblastic MC3T3-E1 cells.	Pax5	Osterix	1	ACTIVATION	False
15305	15673	10506141:2:PAX6:GCG	The homeodomain transcription factors brain-4, [TF], and cdx-2 have been shown to bind to these sites and to transactivate [TG] gene expression.	pax-6	glucagon	1	ACTIVATION	False
15306	15674	17901057:2:PAX6:GCG	Although it is known that multiple transcription factors such as [TF], Cdx-2/3, c-Maf, Maf-B, and Brain-4 can activate the [TG] gene promoter through G1, their relative importance in vivo is unknown.	Pax-6	glucagon	1	ACTIVATION	False
15307	15675	10506141:4:PAX6:GCG	In transient transfection-expression experiments, we found that the transactivating effects of cdx-2 and [TF] on the [TG] gene were greatly enhanced by the additional expression of p300.	pax-6	glucagon	1	ACTIVATION	False
15308	15676	17263687:6:PAX6:GCG	In BHK21 cells, Nkx6.1 inhibited by 93% [TF]-mediated activation of the [TG] promoter, whereas Cdx2/3 and Maf stimulations were unaltered.	Pax6	glucagon	1	ACTIVATION	False
15309	15677	14765989:7:PAX6:GCG	c-Maf protein stimulated [TG] promoter activity in a transient luciferase assay, and activation of the glucagon promoter by c-Maf was more efficient than by the other alpha-cell-enriched transcription factors, Cdx2, [TF], and Isl-1.	Pax6	glucagon	1	ACTIVATION	False
15310	15678	17901057:7:PAX6:GCG	Although [TF], Cdx-2/3, Maf-B, and c-Maf were all able to bind G1 by themselves, we showed that Pax-6 could interact with Maf-B, c-Maf, and Cdx-2/3 and activate transcription of the [TG] gene promoter.	Pax-6	glucagon	1	ACTIVATION	False
15311	15679	17901057:9:PAX6:GCG	Finally, we show that specific inhibition of [TF] and c-Maf but not Cdx-2/3 or Maf-B led to decreases in endogenous [TG] gene expression and that c-Maf binds the glucagon gene promoter in mouse islets.	Pax-6	glucagon	1	ACTIVATION	False
15312	15680	21746878:3:PBX1:CDKN2A	Meis2d and [TF]a activate expression of p15([TG] and E-cadherin, dependent on the Meis2d transcriptional activation domain.	Pbx1	Ink4a)	1	ACTIVATION	False
15313	15681	15681849:6:PBX1:CYBB	We find HoxA9-mediated [TG]-transcription requires [TF] but is inhibited by Meis1.	Pbx1	CYBB	1	ACTIVATION	False
15314	15682	15187018:2:PBX1:PF4	We previously demonstrated that the homeodomain proteins (myeloid ecotropic integration site 1 [MEIS1], [TF] [PREP1], and pre-B-cell leukemia transcription factors [PBXs]) bind to the novel regulatory element tandem repeat of MEIS1 binding element [TME] and transactivate the rat [TG] promoter.	Pbx-regulating protein 1	PF4	1	ACTIVATION	False
15316	15684	15187018:2:PKNOX1:PF4	We previously demonstrated that the homeodomain proteins (myeloid ecotropic integration site 1 [MEIS1], Pbx-regulating protein 1 [[TF]], and pre-B-cell leukemia transcription factors [PBXs]) bind to the novel regulatory element tandem repeat of MEIS1 binding element [TME] and transactivate the rat [TG] promoter.	PREP1	PF4	1	ACTIVATION	False
15317	15685	17901057:2:POU3F4:GCG	Although it is known that multiple transcription factors such as Pax-6, Cdx-2/3, c-Maf, Maf-B, and [TF] can activate the [TG] gene promoter through G1, their relative importance in vivo is unknown.	Brain-4	glucagon	1	ACTIVATION	False
15318	15686	18201968:0:POU5F1:EED	STAT3 and [TF] control histone modification through induction of [TG] in embryonic stem cells.	Oct-3/4	Eed	1	ACTIVATION	False
15319	15687	18201968:5:POU5F1:EED	Artificial activation of STAT3 resulted in increased expression of [TG], whereas expression of a dominant negative mutant of STAT3 or suppression of [TF] expression led to down-regulation of Eed.	Oct-3/4	Eed	1	ACTIVATION	False
15320	15688	16954384:6:POU5F1:LEFTY1	By functional screening of ES-specific transcription factors, we found that Krppel-like factor 4 (Klf4) cooperates with [TF] and Sox2 to activate [TG] expression, and that Klf4 acts as a mediating factor that specifically binds to the proximal element of the Lefty1 promoter.	Oct3/4	Lefty1	1	ACTIVATION	False
15321	15689	19522013:9:POU5F1:NANOG	We also showed that specific members of the SP/KLF and PBX family are functionally redundant at the [TG] promoter and that KLF4 and PBX1 cooperated with [TF] and SOX2, and transactivated synergistically the NANOG promoter activity.	OCT4	NANOG	1	ACTIVATION	False
15322	15690	20385121:9:PPARG:KLF4	This study shows that [TF] agonists up-regulate [TG] expression in receptor-dependent manner, and KLF4 was identified as a novel transcription factor that controls NAG-1 promoter activity in human and mouse colorectal cancers.	PPARgamma	KLF4	1	ACTIVATION	False
15323	15691	19551868:12:PPARG:KLF4	This indicates that [TF] activation induces [TG] expression, which in turn increases GPA33 expression.	PPARgamma	KLF4	1	ACTIVATION	False
15324	15692	10077005:3:PGR:IRS2	Our analysis of the regulation of [TG] in HeLa cell models shows that synergistic induction of IRS-2 by cAMP and RU486 can be mediated by [TF] (PR) and glucocorticoid receptors (GR) and occurs through a relative slow mechanism that requires ongoing protein synthesis.	progesterone receptors	IRS-2	1	ACTIVATION	False
15325	15693	24348900:0:RREB1:CCK	Transcriptional activation of the [TG] gene by DJ-1 through interaction of DJ-1 with [TF] and the effect of DJ-1 on the cholecystokinin level in mice.	RREB1	cholecystokinin	1	ACTIVATION	False
15326	15694	22451420:8:RUNX1:CEBPA	Endogenous Runx1 binds the promoter and putative +37 kb enhancer as assessed by ChIP, and [TF]-ER rapidly induces [TG] mRNA in these cells, even in cycloheximide, consistent with direct gene regulation.	RUNX1	Cebpa	1	ACTIVATION	False
15327	15695	19020999:0:RUNX1:LGALS3	[TF] and RUNX2 upregulate [TG] expression in human pituitary tumors.	RUNX1	Galectin-3	1	ACTIVATION	False
15328	15696	19020999:6:RUNX1:LGALS3	[TG] promoter was further cloned into a luciferase reporter, and the experiments showed that both [TF] and RUNX2 upregulated LGALS3.	RUNX1	LGALS3	1	ACTIVATION	False
15329	15697	19020999:7:RUNX1:LGALS3	Knock-down of either [TF] or RUNX2 by siRNA resulted in a significant downregulation of [TG] expression and decreased cell proliferation in the HP 75 cell line.	RUNX1	Galectin-3	1	ACTIVATION	False
15330	15698	22102412:0:RUNX2:ATF6	BMP2 protein regulates osteocalcin expression via [TF]-mediated [TG] gene transcription.	Runx2	Atf6	1	ACTIVATION	False
15331	15702	22492284:9:RUNX2:IBSP	The results of gel shift showed that 0.1 g/ml decreased while 0.01 g/ml A. actinomycetemcomitans LPS increased CRE-, FRE-, and HOX-binding protein complexes formation at 6 h, and revealed that 0.01 g/ml A. actinomycetemcomitans LPS induced [TG] transcription through CREB1, JunD, Fra2, c-Fos, [TF], Dlx5, and Smad1 targeting those response elements.	Runx2	BSP	1	ACTIVATION	False
15332	15703	15107406:10:RUNX2:IHH	These findings demonstrate that [TF] and Runx3 are essential for chondrocyte maturation and that Runx2 regulates limb growth by organizing chondrocyte maturation and proliferation through the induction of [TG] expression.	Runx2	Ihh	1	ACTIVATION	False
15333	15704	22492284:9:SMAD1:IBSP	The results of gel shift showed that 0.1 g/ml decreased while 0.01 g/ml A. actinomycetemcomitans LPS increased CRE-, FRE-, and HOX-binding protein complexes formation at 6 h, and revealed that 0.01 g/ml A. actinomycetemcomitans LPS induced [TG] transcription through CREB1, JunD, Fra2, c-Fos, Runx2, Dlx5, and [TF] targeting those response elements.	Smad1	BSP	1	ACTIVATION	False
15334	15705	14551209:4:SMAD4:MSX2	Lef1 can synergize with [TF] and Smad1 to activate [TG] promoter, and this transcriptional complex is assembled on the endogenous promoter in response to BMP2.	Smad4	Msx2	1	ACTIVATION	False
15335	15706	17132729:8:SMAD4:MYC	Two tumor-derived mutant [TF] proteins that fail to mediate TGF-beta responses were still competent to cooperate with LEF1 to activate the [TG] promoter.	Smad4	c-myc	1	ACTIVATION	False
15336	15707	21044962:0:SNAI2:CCND1	[TF]-induced elevation of [TG] in breast cancer cells through the inhibition of its ubiquitination.	SLUG	D1 cyclin	1	ACTIVATION	False
15337	15708	18923447:0:SOX10:NES	SOX9 and [TF] but not BRN2 are required for [TG] expression in human melanoma cells.	SOX10	nestin	1	ACTIVATION	False
15338	15709	18923447:10:SOX10:NES	Downregulation of SOX9 and of [TF] markedly decreased [TG] levels in melanoma cells in a cooperative manner.	SOX10	nestin	1	ACTIVATION	False
15339	15710	18923447:11:SOX10:NES	Thus, SOX9 and [TF] but not BRN2 seem to be required for [TG] expression in human melanoma.	SOX10	nestin	1	ACTIVATION	False
15340	15711	21531766:7:SOX2:ABCC3	Consequently, ID4-mediated [TF] induction enhanced [TG] and ABCC6 expression through direct transcriptional regulation, indicating that ID4 regulates the chemoresistance of iGSCs by promoting SOX2-mediated induction of ABC transporters.	SOX2	ABCC3	1	ACTIVATION	False
15341	15712	22292066:3:SOX2:ATOH1	The results show that hair cells derive from [TF]-positive otic progenitors and that Sox2 directly activates [TG] through a transcriptional activator function that requires the integrity of Sox2 DNA binding domain.	Sox2	Atoh1	1	ACTIVATION	False
15343	15714	23860260:3:SOX5:MATN1	We previously demonstrated that uniquely assembled proximal promoter elements restrict [TG] expression to specific growth plate cartilage zones by allowing varying doses of [TF]/Sox6 and Nfi proteins to fine-tune their Sox9-mediated transactivation.	L-Sox5	Matn1	1	ACTIVATION	True
15344	15715	23860260:3:SOX6:MATN1	We previously demonstrated that uniquely assembled proximal promoter elements restrict [TG] expression to specific growth plate cartilage zones by allowing varying doses of L-Sox5/[TF] and Nfi proteins to fine-tune their Sox9-mediated transactivation.	Sox6	Matn1	1	ACTIVATION	False
15345	15716	12732652:7:SOX8:AMH	In vitro assays showed that [TF] binds specifically to SOX binding sites within the [TG] minimal promoter and, like SOX9, acts synergistically with SF1 through direct protein-protein interaction to enhance Amh expression, albeit at lower levels compared with SOX9.	SOX8	Amh	1	ACTIVATION	False
15346	15717	23727861:4:SOX9:MIA	We show that ZBTB7A physically interacts with [TF] and functionally antagonizes its transcriptional activity on key target genes such as [TG], which is involved in tumor cell invasion, and H19, a long noncoding RNA precursor for an RB-targeting microRNA.	SOX9	MIA	1	ACTIVATION	False
15347	15718	22675211:3:SOX9:NEUROG3	Notch signaling promotes the expression of [TF], which cell-autonomously activates the pro-endocrine gene [TG].	Sox9	Ngn3	1	ACTIVATION	False
15348	15719	21829703:9:SOX9:NEUROG3	Our findings show [TF] plays an important role in endocrine development by maintaining [TG] and Pdx1 expression.	Sox9	Ngn3	1	ACTIVATION	False
15349	15720	12034813:10:SP1:LAMC1	Thus, the [TF]-GKLF synergistic activation of the LAMC1 promoter may be one of the avenues for expression of [TG] chain when laminin is needed to regulate cell differentiation.	Sp1	laminin gamma1	1	ACTIVATION	False
15350	15721	9006959:6:SP1:SFTPB	We found that in addition to thyroid transcription factor 1 (TTF-1) and hepatocyte nuclear factor 3alpha (HNF-3alpha) binding sites, two spatially separate DNA sequences that bind [TF] and Sp3 factors are necessary for the maintenance of [TG] promoter activity.	Sp1	SP-B	1	ACTIVATION	False
15351	15722	9006959:7:SP1:SFTPB	Mutation of any one of the transcription factor binding sites caused a significant reduction in [TG] promoter activity suggesting that [TF], Sp3, and TTF-1 and HNF-3alpha interact cooperatively with SP-B promoter to activate gene transcription.	Sp1	SP-B	1	ACTIVATION	False
15352	15723	23068092:7:SP3:NEU2	PC-3 cells were characterized by high expression of Runx2 and [TF], and their silencing reduced [TG], suggesting regulatory roles.	Sp3	NEU2	1	ACTIVATION	False
15353	15724	9006959:6:SP3:SFTPB	We found that in addition to thyroid transcription factor 1 (TTF-1) and hepatocyte nuclear factor 3alpha (HNF-3alpha) binding sites, two spatially separate DNA sequences that bind Sp1 and [TF] factors are necessary for the maintenance of [TG] promoter activity.	Sp3	SP-B	1	ACTIVATION	False
15354	15725	9006959:7:SP3:SFTPB	Mutation of any one of the transcription factor binding sites caused a significant reduction in [TG] promoter activity suggesting that Sp1, [TF], and TTF-1 and HNF-3alpha interact cooperatively with SP-B promoter to activate gene transcription.	Sp3	SP-B	1	ACTIVATION	False
15355	15726	23430263:9:SP7:DSPP	First, KLF4 and [TF] bind to their motifs in [TG] and Dmp1 gene promoters and up-regulate their transcription thereby inducing odontoblast differentiation.	OSX	Dspp	1	ACTIVATION	False
15356	15727	23376077:7:SP7:GJA1	Risedronate as well as the pro-osteogenic transcription factors, Runx2, [TF] or Dlx5, increased transcriptional activity of the [TG] promoter in a dose-dependent manner.	Osterix	Cx43	1	ACTIVATION	False
15357	15728	11114718:4:STAT3:CCND1	Using reporter constructs in transient-transfection assays, the [TG] and p21 promoters were both found to be transcriptionaly induced by v-Src in a [TF]-dependent manner.	STAT3	cyclin D1	1	ACTIVATION	False
15358	15729	17344214:6:STAT3:CCND1	Using deletion constructs of [TG] promoter and chromatin immunoprecipitation assay, we show that leptin induced increase in CYCLIN D1 promoter activity is mediated through binding of activated [TF] at the Stat binding sites and changes in histone acetylation and methylation.	Stat3	CYCLIN D1	1	ACTIVATION	False
15359	15730	18201968:0:STAT3:EED	[TF] and Oct-3/4 control histone modification through induction of [TG] in embryonic stem cells.	STAT3	Eed	1	ACTIVATION	False
15360	15731	18201968:5:STAT3:EED	Artificial activation of [TF] resulted in increased expression of [TG], whereas expression of a dominant negative mutant of STAT3 or suppression of Oct-3/4 expression led to down-regulation of Eed.	STAT3	Eed	1	ACTIVATION	False
15361	15732	9252424:0:STAT5A:CSN2	Promoter-dependent synergy between glucocorticoid receptor and [TF] in the activation of [TG] gene transcription.	Stat5	beta-casein	1	ACTIVATION	False
15362	15733	16973758:2:STAT5A:CSN2	[TF] (Stat5) mediates PRL-dependent trans-activation, and glucocorticoid potentiation occurs through cross talk between glucocorticoid receptor (GR) and Stat5 at the [TG] promoter.	Signal transducer and activator of transcription 5	beta-casein	1	ACTIVATION	False
15363	15734	11287629:6:STAT5A:CSN2	Only at high expression levels did the GR exhibit the properties of a coactivator and enhanced [TF] activity in the absence of a functional DNA binding domain and of GR binding sites in the proximal region of the [TG] gene promoter.	STAT5	beta-casein	1	ACTIVATION	False
15364	15735	11287629:7:STAT5A:CSN2	Furthermore, at high GR expression levels RU486 was nearly as efficient as dexamethasone in activating transcription via the [TF] dependent [TG] gene promoter.	STAT5	beta-casein	1	ACTIVATION	False
15365	15736	21536859:5:TAL1:ERG	We further demonstrate that [TG] expression in primary human T-ALL cells is mediated by the binding of other T-cell oncogenes SCL/[TF], LMO2, and LYL1 in concert with ERG, FLI1, and GATA3 to the ERG +85 enhancer.	TAL1	ERG	1	ACTIVATION	False
15366	15739	9795195:0:TFAP2A:PNMT	[TG] gene expression: synergistic activation by Egr-1, [TF] and the glucocorticoid receptor.	AP-2	Phenylethanolamine N-methyltransferase	1	ACTIVATION	False
15367	15740	9795195:1:TFAP2A:PNMT	The gene encoding the epinephrine synthesizing enzyme, [TG] (PNMT), is transcriptionally activated by Egr-1, [TF], and the glucocorticoid receptor (GR).	AP-2	phenylethanolamine N-methyltransferase	1	ACTIVATION	False
15368	15741	9795195:3:TFAP2A:PNMT	The present studies show that the GR also cooperates with Egr-1 or the combination of Egr-1 and [TF] to activate the [TG] promoter.	AP-2	PNMT	1	ACTIVATION	False
15369	15742	9795195:4:TFAP2A:PNMT	Together Egr-1, [TF], and the GR can induce [TG] promoter-mediated luciferase reporter gene expression beyond the sum of their independent contributions as well as synergistically activate the endogenous PNMT gene leading to marked increases in PNMT mRNA.	AP-2	PNMT	1	ACTIVATION	False
15370	15743	14969394:14:TFAP2A:SOX9	Expression profile analysis of key transcription factors involved in chondrogenesis showed that overexpression of [TF] maintained the expression of [TG] but suppressed the expression of SoxS and Sox6.	AP-2alpha	Sox9	1	ACTIVATION	False
15371	15744	12270142:0:TWIST1:RUNX2	[TF] inactivation reduces [TG]/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts.	TWIST	CBFA1	1	ACTIVATION	False
15372	15745	20804746:4:TWIST1:TBX20	Persistent [TF] expression in the remodeling valves leads to increased valve cell proliferation, increased expression of [TG], and increased extracellular matrix (ECM) gene expression, characteristic of early valve progenitors.	Twist1	Tbx20	1	ACTIVATION	False
15373	15746	16804902:3:VDR:CDH1	For instance, [TF] (VDR), which activates [TG] expression upon ligand binding, is repressed by SNAIL but induced by ZEB1.	vitamin D receptor	CDH1	1	ACTIVATION	False
15374	15747	20713445:6:VDR:SPP1	The [TF] (VDR)- and Runx2-mediated expression of [TG], as well as Mediator recruitment to the Opn promoter, was specifically attenuated in the Med1(-/-) MEFs.	vitamin D receptor	OPN	1	ACTIVATION	False
15375	15748	10191264:7:YY1:SOD1	These results suggest that the transcription factors Elk1 and [TF], binding in the PRE and NRE respectively, co-ordinate the expression of the [TG] gene.	YY1	SOD1	1	ACTIVATION	False
15376	15749	16804902:3:ZEB1:VDR	For instance, [TG] (VDR), which activates CDH1 expression upon ligand binding, is repressed by SNAIL but induced by [TF].	ZEB1	vitamin D receptor	1	ACTIVATION	False
15377	15750	20940257:6:ZNF219:COL2A1	[TF] markedly enhanced the transcriptional activity of Sox9 on the [TG] gene promoter.	Znf219	Col2a1	1	ACTIVATION	False
15379	15752	14970218:6:RUNX1:BLK	The interaction between [TF] and NERF-2 led to cooperative transactivation of the [TG] promoter, whereas the interaction between AML1 and NERF-1a led to repression of AML1-mediated transactivation.	AML1	blk	1	ACTIVATION	True
15380	15753	16984628:11:ATF3:CCND1	Our data suggest that transcriptional induction of the [TF] gene in maturing chondrocytes results in down-regulation of [TG] and cyclin A expression as well as activation of RUNX2-dependent transcription.	Atf3	cyclin D1	2	REPRESSION	False
15381	15754	23852341:7:BCL6:TP53	Chromatin immunoprecipitation sequencing and gene expression analyses carried out by us revealed that BACH2 competes with [TF] for promoter binding and reverses BCL6-mediated repression of [TG] and other cell cycle checkpoint-control genes.	BCL6	p53	2	REPRESSION	False
15382	15755	22120723:6:BRCA1:FOXC1	This interaction requires fully functional [TF] as a mutant BRCA1 protein is unable to localize to the [TG] promoter or repress FOXC1 expression.	BRCA1	FOXC1	2	REPRESSION	False
15383	15756	22849325:3:CDX1:CDX2	Recently, we found that exogenous [TF] expression can suppress [TG] in a human colorectal tumour cell line, SW480, although the underlying molecular mechanisms were unclear.	Cdx1	Cdx2	2	REPRESSION	False
15384	15757	20937839:7:DACH1:KLF4	Genome-wide expression studies of mammary tumors demonstrated [TF] repressed a molecular signature associated with stem cells (SOX2, Nanog, and [TG]) and genome-wide ChIP-seq analysis identified DACH1 binding to the promoter of the Nanog, KLF4, and Lin28 genes.	DACH1	KLF4	2	REPRESSION	True
15385	15758	20937839:7:DACH1:NANOG	Genome-wide expression studies of mammary tumors demonstrated [TF] repressed a molecular signature associated with stem cells (SOX2, [TG], and KLF4) and genome-wide ChIP-seq analysis identified DACH1 binding to the promoter of the Nanog, KLF4, and Lin28 genes.	DACH1	Nanog	2	REPRESSION	True
15386	15759	23492369:8:DACH1:SOX2	Expression of the stem cell factor [TG] was repressed by [TF], and SOX2 expression was inversely correlated with DACH1 in NSCLC.	DACH1	SOX2	2	REPRESSION	False
15387	15760	11169739:11:EGR1:COL1A2	These results indicate that [TF] and TWIST are expressed in undifferentiated MC3T3-E1 osteoblast-like cells following treatment with FGF-2 and they may be potential transcriptional regulators of FGF-2s negative effects on [TG] gene expression.	Egr-1	alpha2(I) collagen	2	REPRESSION	True
15388	15762	7876544:8:ETS1:IL2	Taken together, these results suggest the possibility that [TF] may act as a negative regulator of [TG] gene transcription and provide a rational approach toward engineering the endogenous expression of IL-2 in T cells.	ETS1	IL-2	2	REPRESSION	False
15389	15763	23266329:7:FOXA1:ELF3	KLF5 directly inhibited activity of the FoxA1 promoter, and in turn [TF] inhibited [TG] gene expression in vitro, linking the observed loss of Elf3 with the persistent expression of FoxA1 observed in Klf5-deficient mice.	FOXA1	Elf3	2	REPRESSION	False
15390	15764	19607821:10:FOXA2:HELT	Foxa1 and [TF] also inhibit GABAergic neuron differentiation by repressing the [TG] gene in the ventral midbrain.	Foxa2	Helt	2	REPRESSION	False
15391	15765	19607821:7:FOXA2:NKX2-2	Our studies show that Foxa1 and [TF] positively regulate Lmx1a and Lmx1b expression and inhibit [TG] expression in mesodiencephalic dopaminergic progenitors.	Foxa2	Nkx2.2	2	REPRESSION	False
15392	15766	21757499:6:FOXL2:CYP26B1	Furthermore, qRT-PCR showed that [TG] up-regulation by SOX9/SF1 was attenuated by the ovarian transcription factor [TF] (FOXL2) in TM3 cells, whereas in Foxl2-null mice, Cyp26b1 expression in XX gonads was increased 20-fold relative to WT controls.	Forkhead box L2	Cyp26b1	2	REPRESSION	False
15394	15768	23803610:8:FOXO1:TXNIP	Together, these results demonstrate that [TF] inhibits beta cell [TG] transcription and suggest that FOXO1 confers this inhibition by interfering with ChREBP DNA binding at target gene promoters.	FOXO1	TXNIP	2	REPRESSION	False
15395	15769	21138866:8:FOXO3:TWIST1	[TF] negatively regulated [TG] and Y-box-binding protein 1 (YB-1), and positively regulated E-cadherin in KK47 and TCCsup cells that expressed Twist1, but not in T24 cells that did not express Twist1.	Foxo3a	Twist1	2	REPRESSION	False
15396	15770	21138866:8:FOXO3:YBX1	[TF] negatively regulated Twist1 and [TG] (YB-1), and positively regulated E-cadherin in KK47 and TCCsup cells that expressed Twist1, but not in T24 cells that did not express Twist1.	Foxo3a	Y-box-binding protein 1	2	REPRESSION	False
15397	15771	23310955:5:GATA3:RUNX3	Here we show that [TF], a transcription factor preferentially and transiently upregulated by CD4(+) T-cell precursors, represses [TG] and binds the Runx3 locus in vivo.	Gata3	Runx3	2	REPRESSION	False
15398	15772	22406269:4:GFI1:ENTPD1	Stat3 supported whereas [TF] repressed [TG] and CD73 expression by binding to their promoters.	Gfi-1	CD39	2	REPRESSION	False
15399	15773	22406269:4:GFI1:NT5E	Stat3 supported whereas [TF] repressed CD39 and [TG] expression by binding to their promoters.	Gfi-1	CD73	2	REPRESSION	False
15400	15774	18804520:5:IKZF1:OSR1	[TG] promoter activity was suppressed by cotransfection with Runx2- and [TF]-expressing vectors in a dose-dependent manner.	Ikzf1	Osr1	2	REPRESSION	False
15401	15775	12186428:8:KLF10:GSTP1	Moreover, transfection analyses revealed that BTEB2, EZF, and [TF] repressed the [TG] promoter activity.	TIEGI	GST-P	2	REPRESSION	False
15402	15776	12036432:7:KLF13:CYP1A1	Also, we show that both [TF] and BTEB4 repress the [TG] gene promoter via the BTE site in HepG2 and BxPC3 cells.	BTEB3	CYP1A1	2	REPRESSION	False
15403	15777	11005769:7:KLF4:CCND1	[TG] (CD1) protein level and CD1-associated kinase activity were decreased in HT-29 cell overexpressed [TF] cDNA, and CD1 promoter activity was profoundly suppressed by GKLF.	GKLF	Cyclin D1	2	REPRESSION	False
15404	15778	12186428:8:KLF5:GSTP1	Moreover, transfection analyses revealed that [TF], EZF, and TIEGI repressed the [TG] promoter activity.	BTEB2	GST-P	2	REPRESSION	False
15405	15779	24060351:9:KLF5:MYOCD	Moreover, ChIP analysis established that PDGF-BB-induced repression of [TG] gene expression is most likely regulated by enhanced binding of Klf4 and [TF] to a lesser extent, to the PRR of PrmM.	Klf5	Myocd	2	REPRESSION	False
15407	15781	15681849:6:MEIS1:CYBB	We find HoxA9-mediated [TG]-transcription requires Pbx1 but is inhibited by [TF].	Meis1	CYBB	2	REPRESSION	False
15408	15782	19833882:7:MLX:ARNT	We demonstrated that ChREBP and [TF] (MLX) bind on the ARNT/[TG] promoter on the proximal region that also confers the negative glucose responsiveness.	Max-like protein X	HIF-1beta	2	REPRESSION	True
15409	15783	21297014:4:MSX1:BMP4	We also found that [TF] by itself represses transcription from this proximal [TG] promoter, and that, in combination with Pax9, it acts as a potentiator of Pax9-induced Bmp4 transactivation.	Msx1	Bmp4	2	REPRESSION	False
15410	15784	21284881:11:MYC:DPP4	[TG] mRNA and protein levels increase in a confluence-dependent manner in colon carcinoma cell lines, with [TF] acting as a repressor and Cdx2 acting as an enhancer of CD26 expression.	c-Myc	CD26	2	REPRESSION	False
15411	15785	22768305:6:NKX3-2:PAX3	We found that [TF] and Sox9 repress the activity of the [TG] promoter and that Nkx3.2 acts as a transcriptional repressor in this process.	Nkx3.2	Pax3	2	REPRESSION	False
15412	15786	22858985:0:PAX5:BACH2	Transcriptional suppression of [TG] by the Bcr-Abl oncoprotein is mediated by [TF].	PAX5	BACH2	2	REPRESSION	False
15413	15787	14764597:4:PPARG:CCND1	Addition of [TF] ligand troglitazone (TZD) activated PPARgamma2 in proliferating hepatocytes and resulted in growth arrest accompanied by a down-regulation of proliferating cell nuclear antigen, [TG], and beta-catenin expression.	PPARgamma	cyclin D1	2	REPRESSION	False
15414	15788	14764597:8:PPARG:CCND1	Additionally pretreatment with okadaic acid antagonized [TF]2-mediated inhibition of [TG] transcription without any effect on beta-catenin expression.	PPARgamma	cyclin D1	2	REPRESSION	False
15415	15789	14764597:4:PPARG:PCNA	Addition of [TF] ligand troglitazone (TZD) activated PPARgamma2 in proliferating hepatocytes and resulted in growth arrest accompanied by a down-regulation of [TG], cyclin D1, and beta-catenin expression.	PPARgamma	proliferating cell nuclear antigen	2	REPRESSION	False
15416	15790	15034051:3:RUNX1:CD4	This effect arises from [TF]- or Runx3-mediated repression of [TG] expression, and is independent of positively selecting signals.	Runx1	CD4	2	REPRESSION	False
15417	15791	12796513:9:RUNX1:CD4	The results provide information on the role of Runx3 and [TF] in thymopoiesis and suggest that both act as transcriptional repressors of [TG] expression during T cell lineage decisions.	Runx1	CD4	2	REPRESSION	False
15418	15792	19229297:6:RUNX1:SLC22A17	We find that [TG] expression is regulated by Runx transcription factors, and that BCR-ABL induces a switch in binding from Runx3, an activator of 24p3R expression, to [TF], a repressor of 24p3R expression, through a Ras signalling pathway.	Runx1	24p3R	2	REPRESSION	False
15419	15793	19179305:6:RUNX2:CDKN1A	Sustained [TF] expression hinders myeloid progenitor differentiation capacity and represses expression of CBF targets Csf1R, Mpo, Cebpd, the cell cycle inhibitor [TG], and myeloid markers Cebpa and Gfi1.	Runx2	Cdkn1a	2	REPRESSION	False
15420	15794	19179305:6:RUNX2:CEBPA	Sustained [TF] expression hinders myeloid progenitor differentiation capacity and represses expression of CBF targets Csf1R, Mpo, Cebpd, the cell cycle inhibitor Cdkn1a, and myeloid markers [TG] and Gfi1.	Runx2	Cebpa	2	REPRESSION	False
15421	15795	19179305:6:RUNX2:GFI1	Sustained [TF] expression hinders myeloid progenitor differentiation capacity and represses expression of CBF targets Csf1R, Mpo, Cebpd, the cell cycle inhibitor Cdkn1a, and myeloid markers Cebpa and [TG].	Runx2	Gfi1	2	REPRESSION	False
15422	15796	17956871:9:RUNX2:IBSP	Our data demonstrate that [TF] and HDAC3 repress [TG] gene expression and that this repression is suspended upon osteoblastic cell differentiation.	Runx2	BSP	2	REPRESSION	False
15423	15797	17956871:10:RUNX2:IBSP	Both the nuclear disappearance of [TF] and the non-recruitment of HDAC3 represent new means to relieve Runx2-mediated suppression of [TG] expression, thus allowing the acquisition of a fully differentiated and mineralization-competent phenotype by osteoblast cells.	Runx2	BSP	2	REPRESSION	False
15424	15798	11283267:11:RUNX2:IBSP	However, removal of the C terminus of [TF] (amino acids 362 to 513) relieved suppression of the [TG] promoter.	Cbfa1	BSP	2	REPRESSION	False
15425	15799	19179305:6:RUNX2:MPO	Sustained [TF] expression hinders myeloid progenitor differentiation capacity and represses expression of CBF targets Csf1R, [TG], Cebpd, the cell cycle inhibitor Cdkn1a, and myeloid markers Cebpa and Gfi1.	Runx2	Mpo	2	REPRESSION	False
15426	15800	15756676:8:RUNX3:ABCB1	Semiquantitative RT-PCR and Western blot suggested that [TF] downregulated expression of Bcl-2, [TG] (P-gp) and MRP-1.	Runx3	MDR-1	2	REPRESSION	False
15427	15801	15756676:8:RUNX3:ABCC1	Semiquantitative RT-PCR and Western blot suggested that [TF] downregulated expression of Bcl-2, MDR-1 (P-gp) and [TG].	Runx3	MRP-1	2	REPRESSION	False
15428	15802	16034110:6:RUNX3:CD4	We demonstrate that [TF] is necessary not only to repress [TG], but also to induce CD103 expression during development of CD8 SP T cells.	Runx3	CD4	2	REPRESSION	False
15429	15803	23774402:7:RUNX3:SPP1	In contrast, knockdown of [TF] in GES-1, a normal gastric epithelial cell line, increased [TG] expression.	RUNX3	OPN	2	REPRESSION	False
15430	15804	23649632:8:SMAD2:CDX2	Additionally, induction of [TG] expression, as a result of decreased [TF] expression, leads to repression of Oct4 expression, which, together with the decreased Nanog expression, accelerates the loss of pluripotency.	Smad2	Cdx2	2	REPRESSION	True
15431	15805	16804902:3:SNAI1:VDR	For instance, [TG] (VDR), which activates CDH1 expression upon ligand binding, is repressed by [TF] but induced by ZEB1.	SNAIL	vitamin D receptor	2	REPRESSION	False
15432	15806	22902753:7:SOX2:CDX2	[TF] expression, but not Oct4, specifically increased the numbers of stem cells and repressed [TG], a master regulator of endodermal identity.	Sox2	Cdx2	2	REPRESSION	False
15433	15807	21931789:11:SP7:NELL1	These results suggest that [TF] is a direct transcriptional regulator with repressive effect on [TG] gene expression, contributing to a delicate balance of regulatory effects on NELL-1 transcription with Runx2, and may play a crucial role in osteoblast differentiation and mineralization.	Osterix	NELL-1	2	REPRESSION	False
15435	15809	18504427:6:TP53:YBX1	On the other hand, [TF] interacted with the N-terminal domain of Twist and repressed Twist-dependent [TG] promoter activity.	p53	YB-1	2	REPRESSION	False
15436	15810	17060462:4:VHL:ZEB2	Reintroduction of wild-type [TF] in CC-RCC (VHL(-/-)) cells markedly reduced the expression of E2 box-dependent E-cadherin-specific transcriptional repressors Snail and [TG] and concomitantly restored E-cadherin expression.	VHL	SIP1	2	REPRESSION	False
15437	15811	17485346:9:ZBTB7A:COMP	It appears that there exists a balance between [TF] repressor and Sox9 activator in the control of [TG] gene, since transactivation of COMP gene by Sox9 was abolished by the coexpression of LRF, and excess Sox9 overcame the LRF-mediated inhibition.	LRF	COMP	2	REPRESSION	False
15438	15812	23727861:4:ZBTB7A:H19	We show that [TF] physically interacts with SOX9 and functionally antagonizes its transcriptional activity on key target genes such as MIA, which is involved in tumor cell invasion, and [TG], a long noncoding RNA precursor for an RB-targeting microRNA.	ZBTB7A	H19	2	REPRESSION	False
15439	15813	23727861:4:ZBTB7A:MIA	We show that [TF] physically interacts with SOX9 and functionally antagonizes its transcriptional activity on key target genes such as [TG], which is involved in tumor cell invasion, and H19, a long noncoding RNA precursor for an RB-targeting microRNA.	ZBTB7A	MIA	2	REPRESSION	False
15440	15815	19424592:4:ZEB2:ALPL	[TF] represses transcription of CDH1, CLDN4, CCND1, TERT, SFRP1, [TG] and miR-200b-200a-429 primary miRNA, and upregulates transcription of mesenchymal markers.	ZEB2	ALPL	2	REPRESSION	False
15441	15816	19424592:4:ZEB2:CCND1	[TF] represses transcription of CDH1, CLDN4, [TG], TERT, SFRP1, ALPL and miR-200b-200a-429 primary miRNA, and upregulates transcription of mesenchymal markers.	ZEB2	CCND1	2	REPRESSION	False
15442	15817	19424592:4:ZEB2:CLDN4	[TF] represses transcription of CDH1, [TG], CCND1, TERT, SFRP1, ALPL and miR-200b-200a-429 primary miRNA, and upregulates transcription of mesenchymal markers.	ZEB2	CLDN4	2	REPRESSION	False
15443	15818	19424592:4:ZEB2:SFRP1	[TF] represses transcription of CDH1, CLDN4, CCND1, TERT, [TG], ALPL and miR-200b-200a-429 primary miRNA, and upregulates transcription of mesenchymal markers.	ZEB2	SFRP1	2	REPRESSION	False
15444	15819	19424592:4:ZEB2:TERT	[TF] represses transcription of CDH1, CLDN4, CCND1, [TG], SFRP1, ALPL and miR-200b-200a-429 primary miRNA, and upregulates transcription of mesenchymal markers.	ZEB2	TERT	2	REPRESSION	False
15445	15820	12135607:6:ZNF202:FSHR	Transfection studies indicated that [TF] repressed ovine [TG] promoter activity whereas RREB-1 was likely to function as an activator.	ZNF202	FSHR	2	REPRESSION	False
15446	15821	16331276:14:BRCA1:CDKN1B	Furthermore, we identified high expression of FOXA1 in breast cancer cell lines and tissues, discovered a role for [TF] in the regulation of [TG] transcription and a possible interaction with BRCA1.	BRCA1	p27(Kip1)	0	UNDEFINED	False
15447	15822	18819935:7:CDX1:DSC2	We now show that the [TG] gene is a transcriptional target for [TF] and Cdx2.	Cdx1	DSC2	0	UNDEFINED	False
15449	15828	19539715:6:EGR1:PNMT	The [TG] gene is highly regulated by key transcription factors including: [TF], Sp1, AP-2 and the glucocorticoid receptor.	Egr-1	PNMT	0	UNDEFINED	False
15450	15830	14670960:10:ELK1:PRKCI	We conclude that Bcr-Abl regulates [TG] expression through the MEK-dependent activation of an [TF] element within the proximal PKCiota promoter.	Elk1	PKCiota	0	UNDEFINED	False
15451	15833	14770179:4:ELK4:EGR1	T cell receptor-induced activation of [TF] target genes such as [TG] was substantially impaired in double-positive thymocytes, although Erk activation was normal.	SAP-1	Egr1	0	UNDEFINED	False
15452	15834	21245161:4:ERG:GATA2	We show that, from the fetal period, [TF] acts as a direct upstream regulator of [TG] and Runx1 gene activity.	ERG	Gata2	0	UNDEFINED	False
15453	15835	20516218:0:GATA2:GFI1	[TG] expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/Tal1, [TF], PU.1, Erg, Meis1, and Runx1 acting as upstream regulators in early hematopoietic cells.	Gata2	Gfi1	0	UNDEFINED	False
15454	15836	12435627:2:GLI3:GLI1	In contrast, Sonic hedgehog (Shh) signaling from the posterior zone of polarizing activity blocks [TF] processing and then induces the expression of Gli3 target genes, including [TG].	Gli3	Gli1	0	UNDEFINED	False
15455	15837	16648484:10:HOXA9:FLT3	Chromatin immunoprecipitation confirmed co-occupancy of [TF] and Meis1 on the [TG] promoter.	Hoxa9	Flt3	0	UNDEFINED	False
15456	15838	18804520:4:IKZF1:OSR1	Several Runx2 and [TF] binding sites were found in both mouse and human [TG] promoters.	Ikzf1	Osr1	0	UNDEFINED	False
15457	15839	14634001:7:KLF5:LAMA1	Interestingly, two Krppel-like factors KLF4 and [TF] exhibit opposing effects on the [TG] promoter activity that are decreased and increased, respectively, in the intestinal epithelial cells.	KLF5	Lama1	1	ACTIVATION	True
15458	15840	24440658:14:KLF5:REG1A	Furthermore, ChIP assays reveal a direct association of [TF] with both the Sox9 and [TG] promoters.	KLF5	Reg1A	0	UNDEFINED	False
15459	15841	17141338:8:KLF6:LAMA1	These results indicate that transcription of the human [TG] gene is controlled by a combination of the actions of Sp1/Sp3 and Krppel-like factors, KLF4 and [TF].	KLF6	LAMA1	0	UNDEFINED	False
15460	15842	17158875:9:LEF1:FGF18	Significantly, Runx2 formed a complex with [TF] or TCF4 and this complex bound the composite binding site in the [TG] promoter.	Lef1	fgf18	0	UNDEFINED	False
15461	15843	20128911:7:LEF1:SNAI2	We found that [TG] is positively correlated with RUNX2 expression and deposition of mineralized matrix, and is regulated by [TF] and beta-catenin.	Lef-1	SLUG	0	UNDEFINED	False
15464	15846	17901057:6:MAF:GCG	We then demonstrated the in vivo interactions of Pax-6, Cdx-2/3, [TF]-B, and c-Maf but not Brain-4 with the [TG] gene promoter in glucagon-producing cells.	Maf	glucagon	0	UNDEFINED	False
15465	15847	17901057:6:MAFB:GCG	We then demonstrated the in vivo interactions of Pax-6, Cdx-2/3, [TF], and c-Maf but not Brain-4 with the [TG] gene promoter in glucagon-producing cells.	Maf-B	glucagon	0	UNDEFINED	False
15466	15848	21059868:9:MTF2:CDKN2A	Taken together, we show that [TF] differentially regulates Polycomb-mediated repression of Hox and [TG] genes.	Pcl2	Cdkn2a	2	REPRESSION	True
15467	15850	17341548:0:MYC:PKLR	[TF] and ChREBP regulate glucose-mediated expression of the [TG] gene in INS-1-derived 832/13 cells.	c-Myc	L-type pyruvate kinase	0	UNDEFINED	False
15468	15851	20734354:4:NR5A2:POU5F1	Additional factors that promote pluripotency gene expression have been identified, including the direct regulation of [TG] by liver receptor homolog-1 ([TF]) and -catenin regulation of Nanog.	Lrh-1	Oct4	0	UNDEFINED	False
15469	15852	24634209:5:OTX2:RGR	ChIP reveals that SOX9 and [TF] bind to the promoter regions of RPE65, RLBP1, and [TG] and that LHX2 binds to those of RPE65 and RGR in bovine RPE.	OTX2	RGR	0	UNDEFINED	False
15470	15853	24634209:6:OTX2:RGR	ChIP with human fetal RPE cells shows that SOX9 and [TF] also bind to the human RPE65, RLBP1, and [TG] promoters.	OTX2	RGR	0	UNDEFINED	False
15471	15854	24634209:5:OTX2:RLBP1	ChIP reveals that SOX9 and [TF] bind to the promoter regions of RPE65, [TG], and RGR and that LHX2 binds to those of RPE65 and RGR in bovine RPE.	OTX2	RLBP1	0	UNDEFINED	False
15472	15855	24634209:6:OTX2:RLBP1	ChIP with human fetal RPE cells shows that SOX9 and [TF] also bind to the human RPE65, [TG], and RGR promoters.	OTX2	RLBP1	0	UNDEFINED	False
15473	15856	24634209:5:OTX2:RPE65	ChIP reveals that SOX9 and [TF] bind to the promoter regions of [TG], RLBP1, and RGR and that LHX2 binds to those of RPE65 and RGR in bovine RPE.	OTX2	RPE65	0	UNDEFINED	False
15474	15858	18307776:4:PAX6:ETV1	In this study, we investigated the transcriptional regulation of [TG] and provide evidence that Er81 is a direct target of [TF].	Pax6	Er81	0	UNDEFINED	False
15475	15859	17901057:6:PAX6:GCG	We then demonstrated the in vivo interactions of [TF], Cdx-2/3, Maf-B, and c-Maf but not Brain-4 with the [TG] gene promoter in glucagon-producing cells.	Pax-6	glucagon	0	UNDEFINED	False
15476	15860	16631621:0:PBX1:ZIC3	[TF] and Meis1 regulate activity of the Xenopus laevis [TG] promoter through a highly conserved region.	Pbx1	Zic3	0	UNDEFINED	False
15477	15861	16973758:4:PGR:CSN2	To investigate the mechanism of the inhibitory action of progesterone, experiments were performed with cell culture systems reconstituted to express [TF] (PR), the PRL receptor/Stat5 signaling pathway, and GR, enabling evaluation of PR, GR, and Stat5 interactions at the [TG] promoter.	progesterone receptor	beta-casein	0	UNDEFINED	False
15478	15862	12732210:0:PKNOX1:PF4	[TF], MEIS1 homolog protein, regulates [TG] gene expression.	PREP1	PF4	0	UNDEFINED	False
15479	15863	12732210:7:PKNOX1:PF4	These data demonstrate that [TF] is also an important transcription factor that regulates [TG] gene expression such as MEIS1.	PREP1	PF4	0	UNDEFINED	False
15480	15864	12732210:8:PKNOX1:PF4	Additionally, these data imply functional similarities and differences between [TF] and MEIS1 in the regulation of [TG] gene expression.	PREP1	PF4	0	UNDEFINED	False
15481	15865	19917773:3:RUNX1:FOXP3	This induction seems to be a prerequisite for the binding of [TF] and RUNX3 to three putative RUNX binding sites in the [TG] promoter.	RUNX1	FOXP3	0	UNDEFINED	False
15482	15866	20516218:0:RUNX1:GFI1	[TG] expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/Tal1, Gata2, PU.1, Erg, Meis1, and [TF] acting as upstream regulators in early hematopoietic cells.	Runx1	Gfi1	0	UNDEFINED	False
15483	15867	19020999:9:RUNX1:LGALS3	These results demonstrate a novel binding target for [TF] and RUNX2 proteins and suggest that [TG] is regulated by RUNX1 and RUNX2 in human pituitary tumor cells by direct binding to the promoter region of LGALS3 and thus may contribute to pituitary tumor progression.	RUNX1	Galectin-3	0	UNDEFINED	False
15484	15868	15051730:0:RUNX1:TIMP1	Regulation of [TG] gene transcription by [TF] and RUNX2.	RUNX1	tissue inhibitor of metalloproteinase 1	0	UNDEFINED	False
15485	15869	11106645:3:RUNX2:COL1A2	Here, we studied the role of [TF], an osteoblast-specific transcription factor, in the control of [TG] expression in osteoblasts.	Cbfa1	alpha1(I) and alpha2(I) collagen	0	UNDEFINED	False
15486	15871	17956871:3:RUNX2:IBSP	Therefore, we investigated the role of [TF] in the regulation of [TG] expression in Saos-2 cells.	Runx2	BSP	0	UNDEFINED	False
15487	15872	17956871:4:RUNX2:IBSP	Using a mobility shift assay, we demonstrated that [TF] binds to the [TG] promoter only in preconfluent cells.	Runx2	BSP	0	UNDEFINED	False
15488	15873	17956871:6:RUNX2:IBSP	Chromatin immunoprecipitation assays demonstrated that both [TF] and HDAC3 are detectable at the [TG] promoter in preconfluent Saos-2 cells but not when they are confluent and overexpress BSP.	Runx2	BSP	0	UNDEFINED	False
15489	15874	14667142:7:RUNX2:IBSP	Since it also regulates expression of at least two matrix metalloproteases implicated in tumor invasion and metastasis (collagenase 3, membrane type 1 matrix metalloproteinase), we propose that the relationship between [TG] expression and an invasive behavior in human epithelial cancer cells may be rooted in a common transcriptional control exerted by [TF].	Cbfa1	BSP	0	UNDEFINED	False
15490	15875	10027904:10:RUNX2:IBSP	These results suggest that [TF] binding to the [TG] promoter is not essential for its osteoblast-selective expression.	Osf2	BSP	1	ACTIVATION	True
15491	15876	19139168:5:RUNX3:EOMES	[TF] regulates [TG] expression as well as expression of three cardinal markers of the effector CTL program: IFN-gamma, perforin, and granzyme B.	Runx3	Eomes	0	UNDEFINED	False
15492	15877	19139168:5:RUNX3:GZMB	[TF] regulates Eomes expression as well as expression of three cardinal markers of the effector CTL program: IFN-gamma, perforin, and [TG].	Runx3	granzyme B	0	UNDEFINED	False
15493	15878	24447505:7:RUNX3:MYC	Moreover, the ChIP analyses revealed that TCF4, -catenin and [TF] bind the promoter region of the Wnt target genes, Axin2 and [TG], and the occupancy of TCF4 and -catenin in these promoter regions is increased by the RUNX3 expression.	RUNX3	c-Myc	0	UNDEFINED	False
15494	15879	20375011:7:SMAD2:TGFBR1	Chromatin immunoprecipitation studies and oligonucleotide pull-down assays showed the direct binding of KLF4 to the KLF4-binding sites 2 and 3 of the [TG] promoter and the recruitment of [TF] to the Smad-responsive region.	Smad2	TbetaRI	0	UNDEFINED	False
15495	15880	21124928:3:SOX11:TEAD2	Two genes under direct control of [TF] are the class- III -tubulin gene (TUBB3) in neural cells and the transcription factor [TG] (TEAD2) in neural and mesenchymal progenitor cells.	SOX11	TEA domain family member 2	0	UNDEFINED	False
15496	15881	14689607:6:SOX8:AMH	We have hypothesized that [TF] may substitute for Sox9 in species where Sox9 is expressed too late to be involved in sex determination or regulation of [TG] expression.	Sox8	Amh	0	UNDEFINED	False
15497	15882	12732652:9:SOX8:AMH	Our data provide the first evidence that [TF] may partially compensate for the reduced SOX9 activity in campomelic dysplasia and substitute for Sox9 where Sox9 is either not expressed or expressed too late to be involved in sex determination or regulation of [TG] expression.	SOX8	Amh	0	UNDEFINED	False
15498	15883	20530484:4:SOX8:BEST1	Here, we show that yeast one-hybrid screen with bait corresponding to [TG] -120 to -88 bp identified the SOX-E factors, [TF], SOX9, and SOX10.	SOX8	BEST1	0	UNDEFINED	False
15499	15884	17141338:8:SP1:LAMA1	These results indicate that transcription of the human [TG] gene is controlled by a combination of the actions of [TF]/Sp3 and Krppel-like factors, KLF4 and KLF6.	Sp1	LAMA1	0	UNDEFINED	False
15500	15885	19539715:6:SP1:PNMT	The [TG] gene is highly regulated by key transcription factors including: Egr-1, [TF], AP-2 and the glucocorticoid receptor.	Sp1	PNMT	0	UNDEFINED	False
15501	15886	17141338:8:SP3:LAMA1	These results indicate that transcription of the human [TG] gene is controlled by a combination of the actions of Sp1/[TF] and Krppel-like factors, KLF4 and KLF6.	Sp3	LAMA1	0	UNDEFINED	False
15502	15887	23159876:9:SP7:COL1A1	Our data show that overexpression of Runx2 and [TF] leads to a cooperative effect on the expression of the [TG] endogenous gene and its promoter reporter construct.	Osterix	Col1a1	0	UNDEFINED	False
15503	15888	20516218:0:SPI1:GFI1	[TG] expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/Tal1, Gata2, [TF], Erg, Meis1, and Runx1 acting as upstream regulators in early hematopoietic cells.	PU.1	Gfi1	0	UNDEFINED	False
15504	15889	21163886:11:STAT3:CCND1	These results indicate that [TF] plays an important role in BITC-mediated inhibition of leptin-induced [TG] transactivation.	Stat3	cyclin D1	2	REPRESSION	True
15505	15891	16973758:4:STAT5A:CSN2	To investigate the mechanism of the inhibitory action of progesterone, experiments were performed with cell culture systems reconstituted to express progesterone receptor (PR), the PRL receptor/[TF] signaling pathway, and GR, enabling evaluation of PR, GR, and Stat5 interactions at the [TG] promoter.	Stat5	beta-casein	0	UNDEFINED	False
15506	15892	12954634:9:STAT5A:CSN2	Moreover we observed that NCoA-1 is involved in the synergistic action of the glucocorticoid receptor and [TF] on the [TG] promoter.	STAT5a	beta-casein	0	UNDEFINED	False
15507	15893	9343435:10:STAT5A:CSN2	We find that the [TF] response element (Stat5RE) within the [TG] gene promoter is sufficient to elicit the cooperative action of Stat5 and the glucocorticoid receptor on transcription.	Stat5	beta-casein	0	UNDEFINED	False
15508	15894	20516218:0:TAL1:GFI1	[TG] expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl/[TF], Gata2, PU.1, Erg, Meis1, and Runx1 acting as upstream regulators in early hematopoietic cells.	Tal1	Gfi1	0	UNDEFINED	False
15509	15896	19539715:6:TFAP2A:PNMT	The [TG] gene is highly regulated by key transcription factors including: Egr-1, Sp1, [TF] and the glucocorticoid receptor.	AP-2	PNMT	0	UNDEFINED	False
15510	15897	17878336:4:ZBTB7B:CD4	We demonstrate that, although [TF] does not enhance [TG] expression on its own, it antagonizes the CD4 repression mediated by the transcription factor Runx3, which is normally up-regulated during CD8 differentiation and promotes CD4 silencing.	Zbtb7b	CD4	1	ACTIVATION	True
15511	15898	24447505:7:TCF4:AXIN2	Moreover, the ChIP analyses revealed that [TF], -catenin and RUNX3 bind the promoter region of the Wnt target genes, [TG] and c-Myc, and the occupancy of TCF4 and -catenin in these promoter regions is increased by the RUNX3 expression.	TCF4	Axin2	0	UNDEFINED	True
15512	15899	20711340:6:TCF4:PLD2	Wnt3a stimulated formation of the beta-catenin/TCF complexes to two functional [TF]-binding elements within the [TG] promoter as assessed by chromatin immunoprecipitation assay.	TCF-4	PLD2	0	UNDEFINED	True
15519	15906	10891470:6:NFE2:HBB	However, mice nullizygous for [TF] express nearly normal levels of [TG].	p45	beta-globin	0	UNDEFINED	True
15527	15914	7588318:15:NR1I2:CGA	Although the [TF] is important for the formation of a functional transcription complex at the TATA region, the DRR is important for the enhancement of [TG] gene expression in NE cells.	PRR	CgA	1	ACTIVATION	True
15528	15915	18643870:0:NEUROD6:SRGN	[TG] is regulated by the basic helix-loop-helix transcription factor [TF].	Math2	Prg1	0	UNDEFINED	True
15529	15916	21451047:7:ESR2:EZR	nuc-[TF]3 regulates the transcriptional activity of [TG] and HMGB1 promoters, whereas inhibition of nuc-ErbB3 expression results in reduced myelination and altered distribution of ezrin in the nodes of Ranvier.	ErbB	ezrin	0	UNDEFINED	True
15530	15917	15591588:3:NR0B2:SLC10A2	In DCA-fed rabbits, [TG] expression was repressed, associated with activated FXR, and evidenced by increased ileal short heterodimer partner ([TF]) mRNA.	SHP	ASBT	2	REPRESSION	True
15533	15920	17925401:8:NFE2L2:KEAP1	The antioxidant treatment of cells led to nuclear localization and stabilization of [TF] and induction of [TG] gene expression.	Nrf2	INrf2	1	ACTIVATION	True
15546	15933	12498690:7:TAF1:POLI	Cotransfection and in vitro transcription assays showed that [TF] stimulates [TG] transcription in a dosage-dependent manner.	TAF1	Pol I	1	ACTIVATION	True
15549	15936	21844352:4:POU5F1:NANOG	These NDRs are maintained by binding of [TF] and are required for OCT4 and [TG] expression.	OCT4	NANOG	1	ACTIVATION	True
15550	15937	10777217:5:TP53:MRPL41	The [TF]-homolog p73beta also activated the [TG] promoter, but in contrast to p53, the proline-rich domain of p73beta (residues 81-113) was dispensable to induce the PIG3 promoter.	p53	PIG3	1	ACTIVATION	True
15554	15942	18508077:10:AHR:LTBP1	In agreement, siRNA for HDAC2 increased [TG] expression and K8H4 acetylation in [TF]+/+ but not in AhR-/- MEF cells.	AhR	Ltbp-1	0	UNDEFINED	True
15558	15947	18420801:1:SREBF1:FAS	Transcriptional factor sterol regulatory element-binding protein 1c ([TF]c) activates the transcription of lipogenic genes, including fatty acid synthase ([TG]).	SREBP-1	FAS	1	ACTIVATION	True
15595	15984	10851069:7:CEBPZ:CDK4	Inhibition of [TF] activities by KRAB-AML1-ER or CBFbeta-SMMHC rapidly reduced endogenous [TG] mRNA levels, even in cells proliferating at or near control rates as a result of exogenous cdk4 expression.	CBF	cdk4	1	ACTIVATION	True
15597	15986	15131259:6:DLX3:HSD3B2	Although we identified specific binding sites for AP-2gamma and [TF] in the distal promoter of the human [TG] gene, HSD3B1, it was found that these transcription factors were not involved in determining placental-specific expression of human 3betaHSD I.	Dlx-3	3betaHSD I	0	UNDEFINED	True
15611	16002	16077994:10:HNF4A:SOX2	SOX9, [TF]/LEF, POU2F1 and COMP1 binding sites were conserved among human [TG] promoter, rat Sox2 promoter, and mouse Sox2 promoter.	TCF	SOX2	0	UNDEFINED	True
15617	16008	20553777:4:KLF6:LHB	In addition, increasing concentrations of PACAP stimulation augmented the promoter activities for both [TG] and FSHbeta in [TF] overexpressing cells.	PAC-1R	LHbeta	1	ACTIVATION	True
15620	16011	17182554:3:REL:CDKN2A	We report, in this study, that murine dendritic cells deficient in [TF], a member of the NF-kappaB family, are severely compromised in their ability to transcribe the [TG] gene, one of the two genes that encode the IL-23 protein.	c-Rel	p19	1	ACTIVATION	True
15652	16044	21546760:1:LBX1:BMP4	For many years the molecular mechanisms governing bone morphogenetic protein 4 ([TG]) expression in tooth bud mesenchyme could be explained by an uncomplicated model involving the interaction of the [TF] gene Msx1 and the paired domain gene Pax9 and a limited proximal promoter segment of Bmp4.	homeobox	Bmp4	0	UNDEFINED	True
15656	16048	20802155:8:TCF4:LEF1	EMSA and ChIP analyses defined several Sox17- and [TF]-binding sites that collaborate in transcriptional control of the [TG] promoter.	TCF4	Lef-1	0	UNDEFINED	True
15679	16071	19066456:5:E2F2:CDK1	A large set of [TF] target genes involved in DNA replication and cell cycle progression (such as Mcm's, cyclins and [TG]) that are silent in G(0) and typically transcribed late in G(1) phase are already actively expressed in quiescent T cells and MEFs lacking E2F2.	E2F	Cdc2a	0	UNDEFINED	True
15682	16074	19303024:8:IRF1:PARP1	We conclude that [TF] 1 represents an upstream control element that acts in conjunction with the mu[TG] promoter.	S/MAR	PARP-1	0	UNDEFINED	True
15694	16086	12584314:5:YY1:IFNA1	Overexpression of [TF] strongly repressed the transcriptional capacity of a stably integrated [TG]-beta promoter fused to a chloramphenicol acetyltransferase reporter gene as well as the endogenous IFN activity of murine L929 cells via an HDAC activity.	YY1	IFN	2	REPRESSION	True
15741	16133	18728219:2:ARNTL:CRYL1	CLOCK and [TF] are transcriptional activators that regulate Per and [TG] gene expression.	ARNTL	Cry	1	ACTIVATION	True
15769	16161	18728219:2:CLOCK:CRYL1	[TF] and ARNTL are transcriptional activators that regulate Per and [TG] gene expression.	CLOCK	Cry	1	ACTIVATION	True
15781	16173	19322193:4:CTCF:C9orf3	The depletion of either [TF] or RAD21 disrupts the chromatin loop structure, together with significant changes in the [TG] expression and the localization of transcription factor hepatocyte nuclear factor (HNF)-4alpha and transcriptionally active form of RNA polymerase II at the APO promoters.	CTCF	APO	0	UNDEFINED	True
15800	16192	12032776:6:GATA1:ZFPM1	PU.1:[TF] interaction and C/EBP suppression of [TG] transcription inhibits erythroid and megakaryocyte gene expression.	GATA-1	FOG	2	REPRESSION	True
15812	16204	21281489:10:HNF1A:LHX1	In an additional approach we could show that HNF1B induces several genes important in nephrogenesis and regulates [TG] expression by an [TF] site in the lhx1 promoter.	HNF1 binding	lhx1	0	UNDEFINED	True
15814	16206	20711340:6:HNF4A:PLD2	Wnt3a stimulated formation of the beta-catenin/[TF] complexes to two functional TCF-4-binding elements within the [TG] promoter as assessed by chromatin immunoprecipitation assay.	TCF	PLD2	0	UNDEFINED	True
15823	16215	20048147:8:IRF3:ZC3HAV1	Chromatin immunoprecipitation assays demonstrated that [TF] selectively binds the distal interferon-stimulated response elements in human [TG] promoter following viral infection.	IRF3	ZAP	0	UNDEFINED	True
15849	16241	20940401:4:MYC:LIG4	Chromatin immunoprecipitation studies showed that [TF] associates with several DSB repair gene promoters including Rad51, Rad51B, Rad51C, XRCC2, Rad50, BRCA1, BRCA2, DNA-PKcs, XRCC4, Ku70, and [TG].	MYC	DNA ligase IV	0	UNDEFINED	True
15850	16242	10606642:0:MYC:POLR3D	[TF] induces the nucleolin and [TG] genes: possible implications in ribosome biogenesis.	Myc	BN51	1	ACTIVATION	True
15879	16272	19303953:5:NFKB1:TLR5	In epithelial cells, both stimulation required the same promoter regions, especially the [TF] binding site but involved different NF-kappaB isoforms: p65/p50 and p52/RelB, for [TG] and LTbetaR-dependent activation, respectively.	NF-kappaB	TLR5	1	ACTIVATION	True
15881	16274	19303953:5:NFKB2:TLR5	In epithelial cells, both stimulation required the same promoter regions, especially the NF-kappaB binding site but involved different NF-kappaB isoforms: p65/p50 and [TF]/RelB, for [TG] and LTbetaR-dependent activation, respectively.	p52	TLR5	1	ACTIVATION	True
15906	16299	18025207:6:PRDM1:PSMB10	Repression of ERAP1, TAPASIN, [TG], and LMP7 by [TF] results in failure to up-regulate surface MHC class I in response to IFN-gamma in human cell lines.	PRDM1	MECL1	2	REPRESSION	True
15938	16331	22638570:6:SOX6:MYH14	We also provide the first evidence that Eos can regulate expression of additional [TG] genes (Myosin 1 and -Myosin) via the miR-499/[TF] pathway.	Sox6	myosin	0	UNDEFINED	True
15942	16335	21412441:8:SOX9:TES	[TF] also activates h[TG], augmented by SF1, suggesting a mechanism for maintenance of SOX9 expression by auto-regulation.	SOX9	TES	1	ACTIVATION	True
15943	16336	20060878:9:SP1:DUOX1	Gel shift experiments using extracts obtained from PCCl3 cells demonstrated the existence of at least one functional [TF] binding site within the [TG]-DUOXA1 promoter.	Sp1	THOX1	0	UNDEFINED	True
15947	16340	12062800:9:SP1:PORCN	Combined with the data from the supershift EMSAs, it appears that [TF] is the transcription factor binding to the GC region close to the intron to regulate transcription of the human [TG]/OFQ gene.	Sp1	ppN	0	UNDEFINED	True
15948	16341	7622044:8:SP1:PRPH	A 3-bp mutation abrogating the capacity of PER3 to bind [TF] in vitro completely abolished expression of the reporter gene construct containing only PER3 and PER1, while in a construct containing the first 256 bp of the [TG] promoter, it led to an 80% decrease with respect to the control wild-type construct.	Sp1	Prph	0	UNDEFINED	True
15954	16347	11861656:0:SPI1:AIF1	Macrophage-restricted and interferon gamma-inducible expression of the [TG] gene requires [TF].	Pu.1	allograft inflammatory factor-1	1	ACTIVATION	True
15955	16348	11861656:7:SPI1:AIF1	Cooperation between [TF] and proteins binding to the interferon regulatory factor element appears to be necessary for both macrophage-specific and interferon gamma-inducible expression of the [TG] gene.	Pu.1	aif-1	1	ACTIVATION	True
15968	16361	21706029:7:STAT5A:LGR5	TNC protects MSI1-dependent NOTCH signaling from inhibition by signal transducer and activator of transcription 5 ([TF]), and selectively enhances the expression of [TG] as a WNT target gene.	STAT5	LGR5	0	UNDEFINED	True
15989	16382	22451655:9:TP53:S100A14	Finally, RT-quantitative PCR analysis of human breast cancer specimens showed a significant correlation between [TG] mRNA expression and MMP2 mRNA expression in cases with wild-type [TF] but not in cases with mutant p53.	p53	S100A14	1	ACTIVATION	True
15991	16384	21267786:4:TP53:YPEL3	Colon cancer cell lines (Caco-2 and HCT116(-/-) [TF]) were used to assess [TG] gene expression after treatment with 5-azadeoxycytidine or trichostatin A.	p53	YPEL3	0	UNDEFINED	True
16008	16401	20346429:8:ZBED1:MAPK11	Our results suggest that the [TG] gene is regulated by the [TF] pathway and that DREF is involved in the regulation of proliferation and differentiation of Drosophila ISCs and progenitors.	DREF	D-p38b	0	UNDEFINED	True
16012	16405	24223164:7:ZBTB7A:BCAM	Moreover, luciferase reporter assays and chromatin immunoprecipitation analysis revealed that the 14-3-3-[TF]/Akirin2 complex bound to the [TG] promoter and repressed transcription.	FBI1	BCAM	2	REPRESSION	True
16026	16419	10103003:0:CEBPZ:FAS	FIRE3 in the promoter of the rat fatty acid synthase ([TG]) gene binds the ubiquitous transcription factors [TF] and USF but does not mediate an insulin response in a rat hepatoma cell line.	CBF	FAS	0	UNDEFINED	True
16027	16420	10103003:9:CEBPZ:FAS	The fact that the topology of the promoters of the [TG] genes in rat, human, goose and chicken is conserved regarding [TF]-binding sites and USF-binding sites implies an important role for these ubiquitously expressed transcription factors in the regulation of the FAS promoter.	CBF	FAS	0	UNDEFINED	True
16029	16422	10196169:6:TP53:PTGS2	Nuclear run-offs revealed decreased rates of [TG] transcription in cells expressing wt [TF].	p53	Cox-2	2	REPRESSION	True
16032	16425	10227974:6:NFKB:IFNG	These results are the first to show the actual significance of the [TF] pathway in the regulation of [TG] gene expression by IL-18.	NF-kappa B	IFN-gamma	0	UNDEFINED	True
16047	16440	10388555:5:FOS:TIMP1	Increased [TF] DNA binding activity in RAW264.7 cells was associated with raised levels of c-Fos expression and induction of mRNA for the AP-1 responsive tissue inhibitor of metalloproteinases-1 ([TG]) gene.	AP-1	TIMP-1	1	ACTIVATION	True
16054	16449	10435575:4:ETS1:GSTM1	In complementary analyses, expression of PU.1 in [TF]-containing 2017 pro-T cells or NIH 3T3 cells induced [TG] transcripts at the IgH locus and increased accessibility of the endogenous mu enhancer to restriction endonucleases.	Ets-1	sterile I mu	1	ACTIVATION	True
16069	16464	10531360:3:HIF1A:VEGFA	In this report, we show that EPAS1 increased [TG] gene expression through the [TF]-binding site.	HIF-1	VEGF	1	ACTIVATION	True
16079	16474	10551817:8:HIF1A:VEGFA	Finally, we found that in a [TG] promoter mutated at sites previously shown to be MAPK-sensitive (SP1/AP2-88-66 site), p42/p44 MAPK activation is sufficient to promote the transcriptional activity of [TF].	HIF-1	vascular endothelial growth factor	0	UNDEFINED	True
16098	16493	10640274:4:TP53:VEGFA	Loss of [TF] in tumor cells enhances HIF-1alpha levels and augments HIF-1-dependent transcriptional activation of the vascular endothelial growth factor ([TG]) gene in response to hypoxia.	p53	VEGF	2	REPRESSION	True
16100	16495	10656489:5:TP53:PAICS	Unmethylated and methylated pLS76 vectors were then UVC irradiated (lambda(max): 254 nm) and transfected into a yeast strain containing the [TG] gene regulated by a [TF]-responsive promoter.	p53	ADE2	0	UNDEFINED	True
16108	16504	10702805:2:TP53:CDKN1A	Here we show that activated V12-H-Ras can induce the [TG] promoter through the same region of the p21 promoter by a [TF]-independent mechanism in NIH3T3 cells.	p53	p21	1	ACTIVATION	True
16115	16511	10764778:0:STAT1:PSMB9	Adenovirus E1A down-regulates [TG] transcription by interfering with the binding of [TF] to IRF1.	stat1	LMP2	0	UNDEFINED	True
16130	16526	10982822:7:NFKB1:CDC25A	This resulted in marked rearrangement of the protein complexes that formed at the distal E2F site in the [TG] promoter, including the replacement of free E2F complexes with E2F4-[TF](Rb) complexes.	p105	cdc25A	0	UNDEFINED	True
16144	16540	11390395:9:STAT3:SCNN1A	Together, our results demonstrate that Ras/ERK-mediated induction of HMGI-C is required to effectively repress GR/Dex-stimulated transcription of [TG] gene and [TF]-mediated transactivation.	STAT3	alpha-ENaC	1	ACTIVATION	True
16151	16547	11526505:7:ATF1:PTGS2	In contrast, treatment with forskolin, an activator of adenylyl cyclase, led to phosphorylation of CREB and [TF] and activation of [TG] promoter.	ATF-1	COX-2	1	ACTIVATION	True
16161	16557	11723253:4:NFKB:PTGS2	Overexpression of wild-type [TF]-inducing kinase, IKKalpha, and IKKbeta led, respectively, to 3.5-, 2.6-, and 2.6-fold increases in [TG] promoter activity, and these effects were inhibited by both compounds.	NF-kappaB	COX-2	1	ACTIVATION	True
16175	16571	12177064:6:NFKB:PTGS2	To determine whether RON activation affects LPS-induced [TF] pathway, which is important for [TG] expression.	NF-kappa B	Cox-2	0	UNDEFINED	True
16187	16583	12374805:7:NFKB:NPM1	UV-induced activation of [TG]/B23 promoter could not be blocked by UV-inducible pathway inhibitors, such as those of growth factor tyrosine kinase, mitogen-activated protein kinase, AP-1, [TF], and DNA-dependent kinase.	NF-kappaB	NPM	2	REPRESSION	True
16195	16591	12488445:8:NFKB:HIF1A	Moreover, we provide evidence implicating a requirement for [TF] transcription in the [TG] induction mediated by MDAs.	NFkappaB	HIF-1	1	ACTIVATION	True
16210	16606	12736252:4:NFKB:IKBKE	Disruption of the [TF] pathway results in the blockade of the inducible up-regulation of C/EBPbeta, C/EBPdelta, and [TG] genes.	NF-kappaB	IKKi	1	ACTIVATION	True
16213	16609	12855710:10:NFKB:TRPC1	Thus, TNF-alpha induces [TG] expression through an [TF]-dependent pathway in endothelial cells, which can trigger augmented Ca2+ entry following Ca2+ store depletion.	NF-kappaB	TRPC1	1	ACTIVATION	True
16217	16615	12882972:7:NFKB:HSD11B1	Taking these results together, inhibition of [TF] increases apoA-I and [TG] cholesterol through activation of PPARalpha in vivo and in vitro.	NFkappaB	HDL	2	REPRESSION	True
16223	16621	12954221:0:STAT1:EIF2AK2	The [TG] kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with [TF] proteins.	ISGF-3	PKR	0	UNDEFINED	True
16224	16622	12954221:8:STAT1:EIF2AK2	Chromatin immunoprecipitation assays revealed that the binding of Sp3, similar to [TF] and STAT2, at the [TG] promoter in vivo was IFN-dependent, but that Sp1 binding was not dependent upon IFN treatment.	STAT1	PKR	0	UNDEFINED	True
16225	16623	10585876:5:SREBF1:FAS	Reciprocally, co-transfection of Id3 antisense and ADD1 expression vectors in preadipocytes potentiated the ADD1/[TF] effect on the [TG] promoter activity.	SREBP-1c	FAS	0	UNDEFINED	True
16226	16625	10924326:6:ZGLP1:INS	We hypothesize that [TF] may augment the effects of glucose on [TG] gene transcription.	GLP-1	insulin	0	UNDEFINED	True
16231	16630	11181533:8:ZGLP1:FOXM1	In conclusion, these results demonstrate a novel signaling mechanism whereby p38 MAPK represses [TG] promoter activity in response to [TF], suggesting the involvement of a robust regulatory control by p38 MAPK in insulin gene expression.	GLP-1	rINS1	1	ACTIVATION	True
16234	16634	11481488:7:TP53:CDKN1A	We demonstrated that DNA damage-induced up-regulation of [TF] transcriptional activity correlated with the expression of p53-dependent downstream genes, such as [TG], in U87 (wild-type p53), but not in SaOS-2 osteosarcoma (p53 -/-) cells.	p53	p21	0	UNDEFINED	True
16236	16636	11583420:11:USF1:FAS	These results suggest that a STRE may be located within the first 112 bp of the [TG] promoter and that [TF] does not directly mediate the effect of ST on transcription of the FAS gene in 3T3-F442A adipocytes.	USF1	FAS	0	UNDEFINED	True
16238	16638	11602259:0:NR2C2:JUNB	[TF] activation of the mouse [TG] promoter is mediated through a CCAAT box and NF-Y.	TAK1	JunB	1	ACTIVATION	True
16241	16641	11786925:5:FOXO1:SLPI	Reporter assays demonstrated that the overexpression of [TF] stimulated [TG] promoter activity through the forkhead response element in its promoter.	FKHR	ALP	1	ACTIVATION	True
16242	16642	11890931:0:TP53:CDKN1A	SN2 DNA-alkylating agent-induced phosphorylation of [TF] and activation of [TG] gene expression.	p53	p21	1	ACTIVATION	True
16250	16655	14520699:7:TP53:CDKN1A	Tax activated wild type (wt) [TG] promoter in [TF]-negative Jurkat and p53-positive A301cells, irrespective of endogenous p53 status, and activated a mutant p21 promoter containing a p53 responsive element (p53RE) deletion as strongly as wt promoter.	p53	p21	2	REPRESSION	True
16254	16661	14770182:5:TCF4:IHH	In turn, expression of [TG] is downregulated in polyps of individuals with FAP and expression of doxycycline-inducible dominant negative [TF] (dnTCF4) restores Ihh expression in APC mutant DLD-1 colon cancer cells.	TCF4	Ihh	1	ACTIVATION	True
16255	16662	14996738:4:HIF1A:VEGFA	Although [TF] was induced by hypoxia, [TG] reporter constructs with selectively mutated hypoxia-response elements remained responsive to hypoxia.	HIF-1alpha	VEGF	0	UNDEFINED	True
16260	16667	15383550:7:MSX2:SLPI	We also found that overexpression of [TF] suppressed the mRNA level and enzyme activity of [TG] that were induced by BMP-2 stimulation, and suppressed the Dlx5-stimulated ALP promoter activity by competing with Dlx5 for the cis-acting element in the ALP promoter.	Msx2	ALP	2	REPRESSION	True
16263	16670	15983196:7:STAT5A:FAS	Taken together, these data strongly suggest that PRL directly represses expression of [TG] in adipocytes through [TF] binding to the -908 to -893 site.	STAT5A	FAS	0	UNDEFINED	True
16264	16671	16007074:5:TCF4:JUN	Chromatin immunoprecipitation assays revealed JNK-dependent c-Jun-[TF] interaction on the [TG] promoter, and c-Jun and TCF4 cooperatively activated the c-jun promoter in reporter assays in a beta-catenin-dependent manner.	TCF4	c-jun	0	UNDEFINED	True
16266	16673	16199533:7:FOSL1:PTN	The effect of HP seems to be due to the binding of [TF], JunD, and phospho-c-Jun to the [TG] promoter.	Fra-1	HARP	0	UNDEFINED	True
16268	16675	16258268:5:TP63:CDKN1C	DeltaN[TF] can activate both the endogenous [TG] gene and a reporter vector containing a -2191 promoter fragment of the p57Kip2 gene.	p63	p57Kip2	1	ACTIVATION	True
16272	16682	16449968:4:TP63:S100A2	Transactivation assays reveal that p73beta and DeltaN[TF]alpha exert opposite transcriptional effects on [TG] gene.	p63	S100A2	0	UNDEFINED	True
16276	16688	16800817:6:HNF4A:FAS	[TF] transactivates reporter constructs containing the distal [TG] promoter in a DR-1-dependent manner, and this DR-1 is required for full glucose induction of the FAS promoter in primary hepatocytes.	HNF-4alpha	FAS	1	ACTIVATION	True
16278	16690	16957179:3:NR1H4:FAS	We show that [TF]/RXRalpha specifically binds to the [TG] IR-1 and that the FAS promoter is activated approximately 10-fold by the addition of a synthetic FXR agonist in transient transfection assays.	FXR	FAS	0	UNDEFINED	True
16280	16692	17042743:5:ATF3:TRPV6	Transfection experiments in control and mutant cells, and chromatin immunoprecipitations showed that ATF4 activates, whereas [TF] represses [TG] transcription, via an AARE (amino acid response element), TGATGAAAC, in the first exon of the cat-1 gene, which functions both in the endogenous and in a heterologous promoter.	ATF3	cat-1	2	REPRESSION	True
16281	16693	17042743:8:ATF3:TRPV6	These results suggest that the transient increase in [TG] transcription is due to transcriptional activation caused by ATF4 followed by transcriptional repression by [TF] via a feedback mechanism.	ATF3	cat-1	2	REPRESSION	True
16284	16697	17182554:6:REL:CDKN2A	Based on these observations, we conclude that [TF] controls IL-23 [TG] gene expression through two kappaB sites in the p19 promoter, and propose a c-Rel-dependent enhanceosome model for p19 gene activation.	c-Rel	p19	0	UNDEFINED	True
16285	16698	17213321:5:SMAD6:RUNX1	Moreover, [TF], an inhibitor of Bmp4 signaling, binds and inhibits [TG] activity, whereas Smad1, a positive mediator of Bmp4 signaling, transactivates the Runx1 promoter.	Smad6	Runx1	2	REPRESSION	True
16291	16704	17664270:0:JUN:TLR1	[TF] N-terminal kinase 1 is required for [TG] gene expression in macrophages.	c-Jun	Toll-like receptor 1	1	ACTIVATION	True
16294	16707	17889508:1:EGR1:CGA	Our previous work revealed that gastrin regulates chromogranin A ([TG]) transcription through enhanced binding of Sp1, CREB and [TF] to a proximal gastrin-responsive promoter element (Gas-RE).	Egr-1	CgA	1	ACTIVATION	True
16297	16712	18178618:6:PITX1:CCND1	Conversely, overexpression of ICA512-[TF] increases both [TG] and D2 levels and INS-1 cell proliferation.	CCF	cyclin D1	1	ACTIVATION	True
16298	16713	18180317:6:ZGLP1:SERPINE1	[TF] also inhibited the effect of TNF-alpha on a reporter gene construct harbouring the proximal [TG] promoter.	GLP-1	PAI-1	0	UNDEFINED	True
16300	16716	18281474:11:HIF1A:FAS	Taken together, our results indicate that [TG] gene is up-regulated by hypoxia via activation of the Akt and [TF] followed by the induction of the SREBP-1 gene, and that hypoxia-induced chemoresistance is partly due to the up-regulation of FAS.	HIF1	FAS	1	ACTIVATION	True
16304	16720	18765665:6:HNF4A:SLC2A1	[TF] represses [TG]/PEA-15 expression in HeLa cells, whereas COUP-TFII activates its expression.	HNF-4alpha	PED	2	REPRESSION	True
16307	16723	18798221:7:TCF4:EGR1	[TG] promoter activity was increased by serum but not 17beta-oestradiol, in contrast to the marked repression associated with [TF], p300, and Egr1 itself, indicating that the regulation involves several feedback loops.	TCF4	Egr1	2	REPRESSION	True
16311	16729	18948219:0:ATF1:TRPV6	[TF] transcription factor regulates the expression of ccg-1 and [TG] genes in response to fludioxonil under OS-2 MAP kinase in Neurospora crassa.	ATF-1	cat-1	0	UNDEFINED	True
16314	16734	19275551:3:NFKB:PPIG	We proposed three mechanisms by which [TF] can regulate [TG] expression and activity.	NF-kappaB	CYP	0	UNDEFINED	True
16315	16735	19279104:6:NFKB:PDLIM7	Our study established the importance of [TF] and several cis-acting elements in the regulation of the [TG] promoter in a latency III environment and highlighted a complex interplay between NF-kappaB and other transcription factors in this process.	NF-kappaB	LMP1	0	UNDEFINED	True
16320	16742	19553391:7:YY1:PSMD2	Furthermore, increasing concentrations of exogenous, purified recombinant [TF] repressed wild-type [TG] transcript levels by up to threefold, but did not influence the P97 promoter mutated in the 'initiator' YY1 site.	YY1	P97	2	REPRESSION	True
16321	16743	19605523:7:NR1H4:TRPV6	Promoter analyses suggest that [TG] is a likely target of [TF], and a functional FXR response element was found in the promoter region of CAT-1 gene.	FXR	CAT-1	0	UNDEFINED	True
16323	16753	19706789:6:SIX1:CDKN1A	[TF] treatment of CFK2R clones in culture inhibited their proliferation by restricting cells at the G(0)/G(1) phase of the cell cycle, coupled with decreased expression and activity of cyclin-dependent kinases Cdk2 and Cdk4, while [TG], an inhibitor of Cdks, was upregulated.	TIP39	p21	1	ACTIVATION	True
16325	16755	19843519:3:RELA:PDGFD	NF-kappaB [TF], induced by IL-1beta, interacts with a novel element in the [TG] promoter and inhibits PDGF-D transcription.	p65	PDGF-D	0	UNDEFINED	True
16326	16756	19843519:5:RELA:PDGFD	Immunoprecipitation and chromatin immunoprecipitation experiments showed that IL-1beta stimulates [TF] interaction with IRF-1 and the accumulation of both factors at the [TG] promoter.	p65	PDGF-D	0	UNDEFINED	True
16327	16757	19843519:9:RELA:PDGFD	Thus, HDAC-1 is enriched at the [TG] promoter in cells exposed to IL-1beta and forms a cytokine-inducible gene-silencing complex with [TF] and IRF-1.	p65	PDGF-D	2	REPRESSION	True
16330	16762	20459645:7:NFKB:ICAM1	We also observed that OPN-induced [TF] further controls AP-1 transactivation, suggesting that there is cross talk between NF-kappaB and AP-1 which is unidirectional towards AP-1 that in turn regulates [TG] expression in these cells.	NF-kappaB	ICAM-1	0	UNDEFINED	True
16334	16766	20805990:6:CREB1:CDKN1A	Upregulation of AP-2alpha expression following [TF] silencing increases endogenous p21([TG]) and decreases MCAM/MUC18, both known to be downstream target genes of AP-2alpha involved in melanoma progression.	CREB	Waf1	2	REPRESSION	True
16337	16769	21255844:5:NFKB1:TGFB1	Chromatin accessibility PCR and Chromatin immunoprecipitation reveal that the chromatin of the resting [TG] promoter is tightly packed and NF-B [TF] homodimer binding prevails.	p50	LAP	0	UNDEFINED	True
16338	16771	21447637:8:XBP1:FAS	Furthermore, the [TF]-mediated stimulation of the [TG] promoter was eliminated by knocking down the SREBP-1c gene (Srebf1).	XBP1	FAS	1	ACTIVATION	True
16342	16776	21966511:8:JUNB:TGM1	Chromatin immunoprecipitation confirmed that ANGPTL4 stimulated the activation and binding of [TF] and c-JUN to the promoter region of human involucrin and [TG] genes, respectively.	JUNB	transglutaminase type 1	0	UNDEFINED	True
16343	16777	22082586:10:TCF4:HPGD	[TG] regulation occurred at the protein, mRNA and promoter activity levels and chromatin immunoprecipitation indicated -catenin/[TF] binding to the 15-PGDH promoter.	TCF4	15-PGDH	0	UNDEFINED	True
16347	16788	22540002:8:TCF4:CYR61	We identified two [TF]-binding elements in the promoter region of human [TG] gene and demonstrated that -catenin/TCF4 complex specifically bound to the Cyr61 promoter in vivo and directly regulated its promoter activity.	TCF4	Cyr61	0	UNDEFINED	True
16349	16790	23086815:3:ARNT:VEGFA	Herein, we demonstrate that FHL1-3 decrease the promoter activity and expression of vascular endothelial growth factor ([TG]), the key regulator of angiogenesis in cancer growth and progression as well as an important target gene of the transcription factor hypoxia-inducible factor 1 ([TF]/HIF1).	HIF1	VEGF	0	UNDEFINED	True
16351	16792	23364326:6:OTX2:TGM2	Moreover, the predominant defects in the hindbrain ChP mediated by Gdf7-Cre deletion of [TF] revealed its key role in regulating early CSF composition, which was altered in protein content, including the levels of Wnt4 and the Wnt modulator [TG].	Otx2	Tgm2	0	UNDEFINED	True
16356	16798	23966000:8:NRG1:CXCR4	Neuregulin 1 (or [TF], hereafter referred to as heregulin) increased [TG] expression in breast cancer cells, and this coincided with increased LIP binding on the CXCR4 promoter.	NRG1	CXCR4	1	ACTIVATION	True
16361	16803	24511897:11:USF1:FAS	The overexpression of [TF] enhanced both adipogenesis and the expression of [TG] in VPA-treated cells.	USF1	FAS	1	ACTIVATION	True
16362	16804	24511897:8:USF1:FAS	The results of promoter-luciferase and chromatin immunoprecipitation assays demonstrated that [TF](upstream stimulating factor 1) bound to the E-box of the promoter region of the [TG] gene.	USF1	FAS	0	UNDEFINED	True
16363	16805	24556685:2:TP63:S100A2	Both BRCA1 and N[TF] proteins are required for [TG] expression.	p63	S100A2	1	ACTIVATION	True
16364	16806	24556685:3:TP63:S100A2	BRCA1 requires N[TF] proteins for recruitment to the [TG] proximal promoter region, while exogenous expression of individual Np63 proteins cannot activate S100A2 transcription in the absence of a functional BRCA1.	p63	S100A2	0	UNDEFINED	True
16365	16807	24556685:4:TP63:S100A2	Consequently, mutation of the N[TF]/p53 response element within the [TG] promoter completely abrogates the ability of BRCA1 to upregulate S100A2.	p63	S100A2	1	ACTIVATION	True
16367	16810	7537266:3:JUN:ALB	Overexpression of c-[TF] specifically repressed the rat AFP promoter but not the [TG] promoter.	Jun	albumin	2	REPRESSION	True
16369	16814	8444884:10:STAT1:IDO1	This inability to bind [TF] appears to be (at least in part) due to minor differences between the nucleotide sequence of the ISRE homolog present in the [TG] gene promoter and the ISRE consensus sequence found in IFN-alpha-inducible genes.	ISGF3	IDO	0	UNDEFINED	True
16370	16815	8567694:5:TFAP2A:FAS	Thus, the [TG] gene appears unusual in that the sequence element required for transcriptional regulation by cAMP is neither a cAMP response element (CRE) nor a binding site for AP-1, [TF], or C/EBP.	AP-2	FAS	0	UNDEFINED	True
16371	16816	8663317:5:ATF1:CREBBP	Both [TF] and CREB bound [TG] in a phosphorylation-dependent manner.	ATF1	CBP	0	UNDEFINED	True
16376	16821	9334210:3:USF1:FAS	We also reported that [TG] gene transcription was up-regulated by insulin through the proximal promoter region from -71 to -50 and that upstream stimulatory factors (USFs), including [TF] and USF2, interact with this region in vitro.	USF1	FAS	0	UNDEFINED	True
16377	16822	9334210:3:USF2:FAS	We also reported that [TG] gene transcription was up-regulated by insulin through the proximal promoter region from -71 to -50 and that upstream stimulatory factors (USFs), including USF1 and [TF], interact with this region in vitro.	USF2	FAS	1	ACTIVATION	True
16378	16823	9334210:8:USF1:FAS	Cotransfection of [TF] and USF2 expression vectors with the [TG] promoter-luciferase reporter constructs increased insulin-stimulated FAS promoter activity.	USF1	FAS	0	UNDEFINED	True
16379	16824	9334210:8:USF2:FAS	Cotransfection of USF1 and [TF] expression vectors with the [TG] promoter-luciferase reporter constructs increased insulin-stimulated FAS promoter activity.	USF2	FAS	0	UNDEFINED	True
16380	16825	9334210:9:USF1:FAS	Moreover, cotransfection of dominant negative [TF] and USF2 mutants lacking the DNA binding domain inhibited the insulin stimulation of the [TG] promoter activity.	USF1	FAS	1	ACTIVATION	True
16381	16826	9334210:9:USF2:FAS	Moreover, cotransfection of dominant negative USF1 and [TF] mutants lacking the DNA binding domain inhibited the insulin stimulation of the [TG] promoter activity.	USF2	FAS	1	ACTIVATION	True
16387	16833	21856745:0:ASCL1:YAP1	miR-375 is activated by [TF] and inhibits [TG] in a lineage-dependent manner in lung cancer.	ASH1	YAP1	2	REPRESSION	True
16395	16842	15713621:7:CEBPA:BCL2	TSA treatment increased the acetylation of the transcription factors Sp1 and [TF] and decreased their binding as well as the binding of CBP and HDAC2 to the [TG] promoters.	C/EBPalpha	bcl-2	0	UNDEFINED	True
16402	16849	10982390:5:CEBPA:CDKN1A	MAPK signaling increased the phosphorylation of the transcription factors Ets2, [TF], and C/EBPbeta, and rapidly increased transcription from the [TG] promoter via multiple Ets- and C/EBP-elements within the enhancer region.	C/EBPalpha	p21	1	ACTIVATION	True
16404	16851	12885907:5:CEBPA:CDKN1A	Cotransfection of RAP with [TF] cooperatively stimulated both the C/EBPalpha and [TG] promoters in luciferase reporter gene assays.	C/EBPalpha	p21	1	ACTIVATION	True
16406	16853	8846917:0:CEBPA:CDKN1A	[TF] (C/EBP alpha) inhibits cell proliferation through the p21 ([TG]/CIP-1/SDI-1) protein.	CCAAT/enhancer-binding protein alpha	WAF-1	0	UNDEFINED	True
16414	16861	11269666:12:CEBPA:CTSC	We also show that C/EBP delta was more efficient that [TF] and C/EBP beta to activate the [TG] promoter.	C/EBP alpha	m-HMS	1	ACTIVATION	True
16424	16871	20127863:9:CEBPA:IGFBP5	We conclude that curcumin activates p38, which, in turn, activates the [TF] transactivator by interacting with binding elements in the [TG] promoter.	C/EBPalpha	IGFBP-5	0	UNDEFINED	True
16435	16882	12477864:0:CEBPA:LRPAP1	Role of [TF] (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein ([TG]) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.	CCAAT/enhancer-binding protein alpha	RAP	1	ACTIVATION	True
16438	16885	12477864:3:CEBPA:LRPAP1	We recognized two potential consensus C/EBP binding sites in the [TG] promoter and performed electrophoretic mobility shift assay (EMSA) analysis with in vitro-translated [TF]; this analysis showed that one of these sites has a very high affinity for C/EBPalpha.	C/EBPalpha	RAP	0	UNDEFINED	True
16439	16886	12477864:4:CEBPA:LRPAP1	Luciferase (LUC) assays performed with a target [TG] promoter-LUC reporter gene confirmed that [TF] can transcriptionally activate the RAP promoter up to 50-fold.	C/EBPalpha	RAP	0	UNDEFINED	True
16440	16887	12477864:6:CEBPA:LRPAP1	Importantly, the introduction of exogenous Flag-tagged [TF] triggered [TG] expression in BCBL-1 cells latently infected with KSHV, as detected by both reverse transcription-PCR and double-label immunofluorescence assay analyses, suggesting the presence of a self-reinforcing loop with C/EBPalpha and RAP activating each other.	C/EBPalpha	RAP	1	ACTIVATION	True
16441	16888	12477864:8:CEBPA:LRPAP1	[TF] and RTA together cooperated to elevate [TG] promoter activity four- to sixfold more than either alone.	C/EBPalpha	RAP	1	ACTIVATION	True
16450	16897	12554749:8:CEBPA:PRL	This Pit-1 mutant functioned as a dominant inhibitor of [TG] gene transcription and, instead of recruiting [TF], was itself recruited by C/EBPalpha to centromeric heterochromatin.	C/EBPalpha	PRL	1	ACTIVATION	True
16455	16902	12915572:4:CEBPA:RBFOX2	Here we show that [TF] also activates the IE [TG] promoter in transient-cotransfection reporter gene assays and that addition of either RTA or RAP enhances the effect.	C/EBPalpha	RTA	1	ACTIVATION	True
16456	16903	12915572:5:CEBPA:RBFOX2	Electrophoretic mobility shift assay and deletion analysis revealed three C/EBP binding sites that mediate cooperative transactivation of the [TG] promoter by [TF] and RTA.	C/EBPalpha	RTA	1	ACTIVATION	True
16471	16918	10854425:12:CEBPB:CEBPA	Our data suggest that the dominant negative isoform of [TF], LIP, down-regulates the [TG] promoter in liver and in cultured hepatocytes.	C/EBPbeta	C/EBPalpha	1	ACTIVATION	True
16497	16944	15087126:10:CREB1:CDK11B	More importantly, Ets-1, [TF] and phosphorylated CREB were found binding to the endogenous [TG] promoter using chromatin immunoprecipitation (CHIP) assay.	CREB	Cdc2L2	0	UNDEFINED	True
16498	16945	15087126:9:CREB1:CDK11B	Electrophoretic mobility shift assay confirmed that transcription factors Ets-1 and [TF] bind to the [TG] promoter elements, indicating their potential role in the transcriptional regulation of Cdc2L2 gene.	CREB	Cdc2L2	0	UNDEFINED	True
16499	16946	14754893:5:CREB1:CELA2A	Here, we present evidence that the [TG]/METS gene is a transcriptional target of the cyclic AMP response element-binding protein-1 ([TF]).	CREB-1	PE-1	0	UNDEFINED	True
16500	16947	14754893:7:CREB1:CELA2A	Chromatin immunoprecipitation experiments demonstrate that [TF]/CREM-1 are recruited to the [TG]/METS promoter as well as to the promoters of other genes that are up-regulated during terminal macrophage differentiation.	CREB-1	PE-1	1	ACTIVATION	True
16501	16948	14754893:8:CREB1:CELA2A	Overexpression of [TF] stimulates the activities of the [TG]/METS, and macrosialin promoters, while expression of a dominant negative form of CREB-1 during macrophage differentiation inhibits expression of the PE-1/METS and macrosialin genes.	CREB-1	PE-1	1	ACTIVATION	True
16503	16950	10570944:5:CREB1:CGA	Furthermore, functional studies indicated that IFN-alpha exerts its effect on the [TG] promoter via interference with CRE binding protein ([TF])/CREB binding protein (CBP)-dependent transactivation of the CgA-CRE.	CREB	CgA	0	UNDEFINED	True
16504	16952	17889508:1:CREB1:CGA	Our previous work revealed that gastrin regulates chromogranin A ([TG]) transcription through enhanced binding of Sp1, [TF] and Egr-1 to a proximal gastrin-responsive promoter element (Gas-RE).	CREB	CgA	0	UNDEFINED	True
16505	16953	22449227:3:CREB1:CGA	The purpose of the present study is to define the molecular mechanisms of NCAM1, SYPT, and [TG] gene expressions, using cultivated lung cancer cells and focusing upon NeuroD1 (ND1), achaete-scute homolog-like 1 (ASCL1), and known transcription factors, repressor element 1 (RE1)-silencing transcription factor (REST) and c-AMP responsive element-binding protein ([TF]).	CREB	CGA	0	UNDEFINED	True
16540	16988	23595987:1:CREB1:CRTC2	cAMP-responsive element-binding protein ([TF])-regulated transcription coactivator 2 ([TG]) regulates transcription of gluconeogenic genes by specifying targets for the transcription factor CREB in response to glucagon.	CREB	CRTC2	0	UNDEFINED	True
16550	16998	22867433:0:CREB1:FMR1	Roles of [TF] in the regulation of [TG] by group I metabotropic glutamate receptors in cingulate cortex.	CREB	FMRP	0	UNDEFINED	True
16554	17002	10525051:0:CREB1:GH1	[TF]-independent regulation by CBP is a novel mechanism of human [TG] gene expression.	CREB	growth hormone	0	UNDEFINED	True
16572	17020	21398611:0:CREB1:IL10	Mal mediates TLR-induced activation of [TF] and expression of [TG].	CREB	IL-10	1	ACTIVATION	True
16573	17021	9171236:5:CREB1:IL2	Reduction of [TG] production is secondary to the inability to phosphorylate the cAMP response element binding protein, [TF], and induce expression of the immediate early genes such as Fos B that are required to transactivate the IL-2 promoter.	CREB	IL-2	1	ACTIVATION	True
16575	17023	10405202:5:CREB1:IL6	Elimination of individual transcription factor binding sites provided evidence for functional roles for four cis-acting elements, i.e., activator protein-1, cAMP response element-binding protein ([TF]), nuclear factor for [TG] expression (NF-IL6), and nuclear factor-kappaB (NF-kappaB).	CREB	IL-6	0	UNDEFINED	True
16580	17028	23608533:4:CREB1:ING3	Moreover, the RSK2[TF] signaling pathway provides antianoikis protection by regulating gene expression of protein effectors that are involved in cell death regulation, including the antiapoptotic factor protein tyrosine kinase 6 (PTK6) and the proapoptotic factor inhibitor-of-growth protein 3 ([TG]).	CREB	ING3	0	UNDEFINED	True
16582	17030	17337306:5:CREB1:INS	Co-transfection of INS-1 pancreatic beta-cells with promoter constructs containing the [TG] gene promoter placed upstream of the firefly luciferase reporter gene and expression plasmids for ATF-2 or [TF] showed that ATF-2 stimulated transcriptional activity while CREB-1 elicited an inhibitory effect.	CREB-1	human insulin	0	UNDEFINED	True
16588	17036	12391146:4:CREB1:LGALS4	In the breast cancer cell line MCF-7, overexpression of Oct-1 or its POU domain strongly increases transcriptional activation of cyclin D1 and [TG] reporter genes that is specifically dependent upon [TF] but independent of Oct-1 DNA binding.	CREB	GAL4	0	UNDEFINED	True
16609	17057	22761932:0:CREB1:MAPK8	Learning and nicotine interact to increase [TF] phosphorylation at the [TG] promoter in the hippocampus.	CREB	jnk1	0	UNDEFINED	True
16615	17063	23517531:5:CREB1:NT5E	Moreover, we observed that knockdown of [TF] significantly decreased luciferase activity of the [TG] gene promoter, while it had no effect on that of the CREB binding sites of mutated NTE gene promoter and truncated NTE gene promoter lacking the CREB binding site.	CREB	NTE	1	ACTIVATION	True
16616	17064	23517531:7:CREB1:NT5E	We found that the transcription factor [TF] can bind to the promoter sequence of [TG] by chromatin immunoprecipitation.	CREB	NTE	0	UNDEFINED	True
16617	17065	23517531:8:CREB1:NT5E	In conclusion, we provided evidence that [TF] is required for cAMP/PKA signals upregulating [TG] expression in HeLa cells.	CREB	NTE	1	ACTIVATION	True
16624	17072	8999965:11:CREB1:PKD1	In addition, it was shown that both [TF] and ATF-1 transactivate the human [TG] promoter in transient transfection experiments.	CREB-1	PC1	1	ACTIVATION	True
16629	17077	22827437:5:CREB1:PPP2R1A	Our previous work showed that the gene coding for [TG]-A is positively regulated by multiple transcription factors including Ets-1, [TF], and AP-2 but negatively regulated by SP-1/SP-3.	CREB	PP2A	0	UNDEFINED	True
16656	17104	9199295:0:CREB1:TGFB1	[TF] controls [TG]/C/EBP beta transcription.	CREB	LAP	0	UNDEFINED	True
16662	17110	8943074:11:CREM:BRD2	In addition, transfection studies show that [TF] powerfully represses [TG] transcription.	ICER	NAT	2	REPRESSION	True
16663	17111	9597751:20:CREM:BRD2	Analysis of the [TF]-null mice and of the promoter of the [TG] gene revealed that ICER controls the amplitude and rhythmicity of NAT, and thus the oscillation in the hormonal synthesis of melatonin.	CREM	NAT	0	UNDEFINED	True
16720	17168	12748276:7:E2F1:KHDRBS1	In contrast, neither [TF] nor E2F2 interacted with the [TG] promoter under these conditions.	E2F1	p68	0	UNDEFINED	True
16725	17173	12533675:3:E2F1:MCL1	Given the ability of cyclin/cyclin-dependent kinase 2 antagonists to kill transformed cells, we surmised that flavopiridol may stabilize [TF] and enhance apoptosis via repression of [TG].	E2F1	Mcl-1	2	REPRESSION	True
16729	17177	20805247:0:E2F1:MEFV	[TG]/ELF4 transactivation by [TF] is inhibited by p53.	E2F1	MEF	1	ACTIVATION	True
16730	17178	20805247:7:E2F1:MEFV	Subsequently, we determined that [TF] specifically binds to [TG] promoter and transactivates MEF.	E2F1	MEF	0	UNDEFINED	True
16731	17179	20805247:8:E2F1:MEFV	Nevertheless, [TF] DNA binding and transactivation of [TG] promoter was inhibited by p53 through the association between p53 and E2F1.	E2F1	MEF	1	ACTIVATION	True
16737	17185	24337320:3:E2F1:MYCN	The aims of this study were to explore the regulation of [TG] expression by miR202 in the LAN5 human neuroblastoma cell line and to confirm the presence of binding sites for [TF] in the miR202 promoter region.	E2F1	MYCN	0	UNDEFINED	True
16739	17187	23660594:7:E2F1:NCOA3	Using chromatin immunoprecipitation, we determined that FoxG1 is recruited to a region of the [TG] gene promoter previously characterized to be responsible for AIB1-induced, positive autoregulation of transcription through the recruitment of an activating, multiprotein complex, involving AIB1, [TF], and specificity protein 1.	E2F transcription factor 1	AIB1	0	UNDEFINED	True
16757	17205	20096375:5:E2F1:TCP1	We also investigated how [TF] influences the regulation of the [TG]-promoter during the S phase; we demonstrated that E2F1 is necessary, but not sufficient, to activate CCTalpha expression when this factor is over-expressed.	E2F1	CCTalpha	0	UNDEFINED	True
16768	17216	18424712:4:E2F1:TP53BP1	Moreover, overexpression of [TF] in mouse fibroblasts decreased expression of [TG].	E2F1	p202	2	REPRESSION	True
16776	17224	12748276:7:E2F2:KHDRBS1	In contrast, neither E2F1 nor [TF] interacted with the [TG] promoter under these conditions.	E2F2	p68	0	UNDEFINED	True
16794	17242	12077144:10:E2F4:UBE2I	Chromatin immunoprecipitation experiments demonstrated that E2F1 and [TF] associate with the [TG] promoter in unperturbed cells.	E2F4	p18	0	UNDEFINED	True
16796	17244	17096023:0:E2F6:BRCA1	[TF] negatively regulates ultraviolet-induced apoptosis via modulation of [TG].	E2F6	BRCA1	0	UNDEFINED	True
16821	17270	24019486:0:ETS1:IL2	[TF] facilitates nuclear entry of NFAT proteins and their recruitment to the [TG] promoter.	Ets-1	IL-2	0	UNDEFINED	True
16822	17271	24019486:3:ETS1:IL2	Although [TF] negatively regulates the expression of Blimp1, a known suppressor of [TG] expression, ablation of B lymphocyte-induced maturation protein 1 (Blimp1) does not rescue the expression of IL-2 by Ets-1-deficient Th cells.	Ets-1	IL-2	1	ACTIVATION	True
16824	17273	22267484:9:ETS1:LPA	Using promoter reporter assays, mutation analysis, gel shift, and chromatin immune-precipitation assays, an [TF] was identified at -1630/-1615bp region in the human [TG] promoter.	Ets-1 binding element	APOA	0	UNDEFINED	True
16833	17282	19411629:5:ETS1:MMP9	Analysis of [TF]/Ets2 target genes in isolated embryonic endothelial cells demonstrated down-regulation of [TG], Bcl-X(L), and cIAP2 in double mutants versus controls, and chromatin immunoprecipitation revealed that both Ets1 and Ets2 were loaded at target promoters.	Ets1	Mmp9	2	REPRESSION	True
16852	17301	8206588:5:ETV4:ATM	These results indicated that the [TG] enhanced by epidermal growth factor may be due to [TF] binding to the human AT1 promoter.	PEA3	human AT1 receptor	1	ACTIVATION	True
16855	17304	12855694:2:ETV4:DYM	Up-regulation of the Muc4/[TG] gene in the 13762 sublines of the rat mammary adenocarcinoma correlates with the overexpression of transcription factor [TF] and the receptor tyrosine kinase ErbB2.	PEA3	SMC	1	ACTIVATION	True
16856	17305	12855694:3:ETV4:DYM	Here we report that [TF] is capable of transactivating the Muc4/[TG] promoter in a dose-dependent manner via direct attachment to a PEA3 binding site.	PEA3	SMC	1	ACTIVATION	True
16857	17306	12855694:4:ETV4:DYM	ERM and ER81, the other two members of the [TF] subfamily of transcription factors, could not transactivate the Muc4/[TG] promoter.	PEA3	SMC	1	ACTIVATION	True
16858	17307	12855694:5:ETV4:DYM	Transcriptional activation of Muc4/[TG] by [TF] is potentiated by Ras and MEKK1 kinases.	PEA3	SMC	1	ACTIVATION	True
16871	17320	15756447:0:ETV4:MMP14	[TF] expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of [TG] gene promoters.	E1AF	MT1-MMP	1	ACTIVATION	True
16872	17321	12855694:4:ETV4:MUC4	ERM and ER81, the other two members of the [TF] subfamily of transcription factors, could not transactivate the [TG]/SMC promoter.	PEA3	Muc4	1	ACTIVATION	True
16874	17323	11519038:8:ETV4:PLAU	HGF further induced expression of the Ets-1 and [TG] (uPA) genes specifically in [TF]-transfected cells.	E1AF	urokinase-type plasminogen activator	1	ACTIVATION	True
16881	17330	12855694:4:ETV5:DYM	[TF] and ER81, the other two members of the PEA3 subfamily of transcription factors, could not transactivate the Muc4/[TG] promoter.	ERM	SMC	1	ACTIVATION	True
16891	17340	12739001:5:ETV6:ITGA2B	Overexpression of [TF] in K562 cells leads to inhibition of the endogenous expression of megakaryocyte-specific [TG] and GPIbalpha genes, and inhibition of cell growth.	TEL	GPIIb	2	REPRESSION	True
16935	17384	12130586:5:FOXO1:G6PC	Using a H4-hepatoma cell line stably overexpressing [TF], we found that both glucose starvation and treatment of cells with AICAR strongly repressed [TG] expression and led to an almost complete disappearance of the FKHR protein, whereas the levels of control proteins and FKHR mRNA were not affected.	FKHR	G6Pase	2	REPRESSION	True
16939	17388	10385407:0:FOXO1:INS	[TF] binds the [TG] response element in the insulin-like growth factor binding protein-1 promoter.	FKHR	insulin	0	UNDEFINED	True
16955	17404	23754802:0:FOXO1:LHCGR	[TG] expression in granulosa cells: roles for PKA-phosphorylated -catenin, TCF3, and [TF].	FOXO1	Lhcgr	0	UNDEFINED	True
16957	17406	17303659:7:FOXO1:MAPK1	In contrast, [TF]-ADA increases [TG] activity, and p38 is required for effects of Foxo1 on PKB, at least in part.	Foxo1	p38	1	ACTIVATION	True
16989	17438	18324310:3:FOXP3:IL2	However, no evidence could be found that [TF]+ cells actively suppress [TG] expression by FOXP3- cells.	FOXP3	IL2	2	REPRESSION	True
16993	17442	23275607:8:FOXP3:IL2	Conversely, forced expression of Helios in CD4(+)[TF](-) T cells results in a loss of their normal ability to produce [TG].	Foxp3	IL-2	1	ACTIVATION	True
17014	17463	22977658:4:FOXP3:IL6R	In our [TF] overexpression model, we found that IL-6/TGF- treatment upregulated [TG] expression but did not affect the stability of FOXP3 mRNA.	FOXP3	IL-6R	1	ACTIVATION	True
17032	17481	18832697:1:FOXP3:TNF	Although the transcription factor [TF] is implicated in regulating glucocorticoid-induced [TG] (GITR) expression in the T regulatory cell lineage, little is known about how GITR is transcriptionally regulated in conventional T cells.	Foxp3	TNF receptor	0	UNDEFINED	True
17042	17491	18849568:5:GATA1:CHST2	Results of our reporter assays, immunoprecipitation, and chromatin immunoprecipitation analyses indicated that GATA-3 and/or GATA-2, but not [TF], associates with NF-kappaB in a transcription factor complex on the 5'-regulatory region of the gene and acts synergistically with NF-kappaB in triggering [TG] transcription.	GATA-1	GlcNAc6ST-1	1	ACTIVATION	True
17055	17504	18299398:5:GATA1:GATA2	These lineage switches correlate with transcriptional down-regulation of [TG], an essential mast cell GATA factor, via switching of [TF] for GATA-2 at a key enhancer element upstream of the GATA-2 gene.	GATA-1	GATA-2	1	ACTIVATION	True
17062	17511	10926935:7:GATA1:ITGA2B	In 293 cells, FOG plus [TF] but not FOG alone only moderately stimulated [TG] transcription, and no direct interactions of FOG with the alpha IIb promoter were detectable.	GATA-1	alpha IIb	1	ACTIVATION	True
17063	17512	12356738:5:GATA1:ITGA2B	FOG-1 stimulates [TF]-dependent [TG] gene expression in a manner that requires their direct physical interaction.	GATA-1	alphaIIb	1	ACTIVATION	True
17064	17513	12356738:7:GATA1:ITGA2B	Chromatin immunoprecipitation experiments show that [TF], FOG-1 and Fli-1 co-occupy the [TG] promoter in vivo.	GATA-1	alphaIIb	0	UNDEFINED	True
17065	17514	8408012:9:GATA1:ITGA2B	These results indicate that the transcription factor [TF] plays an important role in the regulation of the transcription of the megakaryocyte specific [TG] gene.	GATA-1	GPIIb	0	UNDEFINED	True
17100	17550	23211524:4:GATA2:GNRHR	In this study, using a well-characterized transgenic mouse model, [TF] was found colocalized with [TG] promoter activity in the pituitary.	GATA2	Gnrhr	0	UNDEFINED	True
17104	17554	19168794:5:GATA2:MEFV	Gene expression analysis places [TF] upstream of the quiescence regulator [TG], but enforcing MEF expression does not prevent GATA-2-conferred quiescence, suggesting additional regulators are involved.	GATA-2	MEF	0	UNDEFINED	True
17111	17561	18442420:12:GATA2:RGN	Therefore, we suggest that SRY like protein may be acting as a strong repressor of [TG] gene along with CdxA and [TF].	GATA-2	SMP30	2	REPRESSION	True
17113	17563	19279013:8:GATA2:RNASE2	Taken together, our data suggest that [TF] functions directly via interactions with the [TG] promoter and also indirectly, via its ability to regulate the expression of GATA-1 in differentiating eosinophils and eosinophil cell lines.	GATA-2	EDN	0	UNDEFINED	True
17114	17564	19357811:6:GATA2:SERPINF2	Our results demonstrate that [TF] is involved in multiple promoter regions to activate the specific expression of the [TG] gene in placental tissue.	GATA-2	rPL-I	1	ACTIVATION	True
17134	17584	1922043:5:IKZF1:DNTT	Moreover, [TF] binds to the promoters for the lymphocyte-specific genes lambda 5, VpreB, and lck, all of which we speculate have additional features in common with the [TG] promoter.	LyF-1	TdT	0	UNDEFINED	True
17143	17593	17785777:8:IRF7:IFNA1	To conclude, the data suggest that the [TG]-lambda1 gene is regulated by virus-activated IRF3 and [TF], thus resembling that of the IFN-beta gene, whereas IFN-lambda2/3 gene expression is mainly controlled by IRF7, thus resembling those of IFN-alpha genes.	IRF7	IFN	0	UNDEFINED	True
17151	17601	21872224:5:IRF7:IL6	[TF] regulated [TG] gene expression by increasing IL-6 mRNA stability.	IRF7	IL-6	0	UNDEFINED	True
17153	17603	23916490:5:IRF7:IRF9	Luciferase assays confirmed that zebrafish [TG] promoter could be activated by zebrafish IFNs and zebrafish IFN2, as well as transcription factors IRF3, [TF], and combination of IRF9 and STAT2.	IRF7	IRF9	1	ACTIVATION	True
17162	17612	16140744:4:IRF7:PDLIM7	Transient expression of an [TF] dominant-negative mutant decreased [TG] levels.	IRF7	LMP1	1	ACTIVATION	True
17163	17613	16140744:6:IRF7:PDLIM7	Transient expression of IRF5 decreased activation of the [TG] promoter by [TF] in a dose-dependent manner.	IRF7	LMP1	1	ACTIVATION	True
17176	17627	10871633:0:JUN:SMAD3	[TF] inhibits transforming growth factor beta-mediated transcription by repressing [TG] transcriptional activity.	c-Jun	Smad3	2	REPRESSION	True
17194	17645	21262377:5:KLF10:TMBIM6	Eventually, the estrogen induced [TF] and then suppresses [TG] transcription.	Klf10	BI-1	2	REPRESSION	True
17200	17651	9209434:3:MAFB:ETS1	[TF] represses [TG] transactivation of synthetic promoters containing Ets binding sites in yeast as well as avian cells.	MafB	Ets-1	2	REPRESSION	True
17203	17655	16651263:6:MSX1:BMP4	In addition, synergistic transcriptional activation of the [TG] promoter was lost with coexpression of mutant Pax9 and wild-type [TF].	Msx1	Bmp4	2	REPRESSION	True
17204	17656	16651263:7:MSX1:BMP4	This suggests that Pax9 is critical for the regulation of [TG] expression through its paired domain rather than [TF].	Msx1	Bmp4	0	UNDEFINED	True
17211	17663	22078940:8:MSX1:ZHX2	Taken together, our results demonstrate multiple mechanisms decreasing expression of tumor suppressor gene [TG] in HL cell lines: loss of enhancing binding sites, reduced expression of activators [TF] and XBP1, and overexpression of MSX1-corepressor H1C.	MSX1	ZHX2	1	ACTIVATION	True
17219	17671	12782406:5:MSX2:CYP17A1	Coexpression of RIP140 and SF-1 in different cell types demonstrated that RIP140 acts as a potent corepressor of transcription from the SF-1 responsive cAMP regulatory sequence 2 ([TF]) element of the [TG] gene and a variety of SF-1 responsive promoter genes.	CRS2	CYP17	2	REPRESSION	True
17220	17672	12943735:4:MSX2:CYP17A1	Transfection studies showed that SF-1 activated and COUP-TFs repressed the transcription of bovine [TG] gene promoter from the [TF] element in a mutually exclusive manner in Y-1 cells.	CRS2	CYP17	0	UNDEFINED	True
17221	17673	7776979:1:MSX2:CYP17A1	ACTH-dependent transcriptional activation of the bovine [TG] gene (the gene encoding cytochrome P450 steroid 17 alpha-hydroxylase) involves two cAMP-responsive sequences (CRS1 and [TF]) located in the promoter region.	CRS2	CYP17	1	ACTIVATION	True
17228	17680	20089716:6:MSX2:IL6	Specific inhibition of MC2R and MC5R expression with short interfering Mc2r and Mc5r RNAs significantly attenuated the [TF]-induced increase of intracellular cAMP and both the level of [TG] mRNA and secretion of IL6 in 3T3-L1 adipocytes.	alpha-MSH	Il6	1	ACTIVATION	True
17233	17685	17371876:4:MSX2:MET	In the present report, we show that [TF] regulates [TG] expression in both human melanocytes and mouse melanoma cells through a transcriptional mechanism that requires MITF.	alphaMSH	MET	0	UNDEFINED	True
17234	17686	16766266:2:MSX2:MITF	We show that EWS-ATF1 occupies the [TG] promoter, mimicking melanocyte-stimulating hormone ([TF]) signaling to induce expression of MITF, the melanocytic master transcription factor and an amplified oncogene in melanoma.	MSH	MITF	0	UNDEFINED	True
17236	17688	10844594:10:MSX2:NOS2	These data indicate that [TF] inhibits the induction of C/EBPbeta DNA binding activity and that this effect is a major mechanism by which alpha-MSH inhibits the transcription of the [TG] gene.	alpha-MSH	NOS2	2	REPRESSION	True
17237	17689	10844594:3:MSX2:NOS2	To test the hypothesis that [TF] inhibits the expression of inducible trans-activating factors involved in [TG] regulation, we used RAW 264.7 macrophage cells to examine the effects of alpha-MSH on the activation of nuclear factor-kappaB (NF-kappaB) and CCAAT/enhancer binding protein-beta (C/EBPbeta), trans-acting factors known to be involved in LPS + interferon (IFN)-gamma induction of the NOS2 gene.	alpha-MSH	NOS2	2	REPRESSION	True
17238	17690	10844594:5:MSX2:NOS2	[TG] promoter assays were conducted to identify the effects of [TF] on LPS + IFN-gamma-mediated induction of NOS2 transcription.	alpha-MSH	NOS2	0	UNDEFINED	True
17261	17715	23280764:5:MYCN:RASSF1	However, using four model systems, we showed that long-term silencing of [TF] induces only a small loss of DNA methylation at the [TG] promoter in MYCN amplified neuroblastoma cell lines and over-expression of MYCN does not induce any DNA methylation, suggesting that MYCN is not critical for DNA hypermethylation in neuroblastoma.	MYCN	RASSF1A	0	UNDEFINED	True
17270	17724	7565760:0:MZF1:CD34	Overexpression of the zinc finger protein [TF] inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of [TG] and c-myb promoter activity.	MZF1	CD34	2	REPRESSION	True
17296	17750	20937355:0:NANOG:NR0B1	LRH-1 and [TF] regulate [TG] transcription in mouse embryonic stem cells.	Nanog	Dax1	0	UNDEFINED	True
17328	17782	10814830:7:NEUROG1:NEUROD2	Transient transfection experiments also showed that the same E box is required for the transactivation of the [TG] promoter activity by [TF].	neurogenin 1	NDRF	1	ACTIVATION	True
17335	17789	22174410:2:NFE2:GCM1	However, the [TG] promoter lacks a [TF]-binding site and hence the mechanisms linking Nfe2 and Gcm1 expression remained unknown.	Nfe2	Gcm1	0	UNDEFINED	True
17362	17816	21187389:6:NR1I2:ETS1	[TF] silencing did not affect [TG] or c-Jun expression; rather it resulted in increased expression of the chromatin remodeling complex CBP/p300, as well as decreased activity of the CBP/p300 inhibitor p38, resulting in increased binding of Ets-1 and c-Jun to the Maspin promoter and higher Maspin expression.	PAR-1	Ets-1	0	UNDEFINED	True
17367	17821	21880149:10:PAX4:ARX	Our analysis also suggests that one of the coupled functions of Nkx2.2 and [TF] is to counteract [TG] gene activity in early committed beta-cells.	Pax4	Arx	2	REPRESSION	True
17374	17828	23129807:5:PAX4:INS	Using pancreatic acinar AR42J cells, we demonstrated that RBM4 promoted [TG] gene expression by altering the isoform balance of the transcription factors Isl1 and [TF] via alternative splicing control.	Pax4	insulin	0	UNDEFINED	True
17421	17875	19804407:0:POU2F1:IL4	[TF] is responsible for the C-33T polymorphism effect in the [TG] promoter.	Oct-1	IL-4	0	UNDEFINED	True
17424	17878	16002244:4:POU2F1:PTBP2	The [TG] proximal promoter, although rich in G+C content and presenting putative binding sites for the transcription factors Sp1, NF-1, NF-kB and [TF], lacks a typical TATA box.	Oct-1	nPTB	0	UNDEFINED	True
17437	17891	18831784:5:POU5F1:CTBP2	This network suggests that [TF], Sox2 and Klf4 indirectly repress lineage specific differentiation genes by activating transcriptional repressors of [TG], Rest and Mtf2.	Oct4	Ctbp2	2	REPRESSION	True
17452	17906	18831784:5:POU5F1:MTF2	This network suggests that [TF], Sox2 and Klf4 indirectly repress lineage specific differentiation genes by activating transcriptional repressors of Ctbp2, Rest and [TG].	Oct4	Mtf2	2	REPRESSION	True
17481	17935	20107107:11:PPARA:CALR	Finally, specific binding of [TF]delta to a PPAR response element in the promoter region of the [TG] gene was identified by utilizing a specific chromatin immunoprecipitation assay.	PPAR	calreticulin	0	UNDEFINED	True
17492	17947	18455211:0:PPARA:GPT	[TF] regulates the hepatotoxic biomarker alanine aminotransferase ([TG]) gene expression in human hepatocytes.	PPARalpha	ALT1	0	UNDEFINED	True
17499	17954	12023905:6:PPARA:LPA	In contrast, co-transfection with [TF] increased the effect of the DHII enhancer on [TG] transcriptional activity by approx. 70% and could overcome the inhibitory effect of the oestrogen receptor on apo(a) transcription.	PPARalpha	apo(a)	0	UNDEFINED	True
17500	17955	11872694:4:PPARA:LPL	We determined the Pro12Ala polymorphism in the [TF]-gamma2 gene in 194 male CAD patients because this allele is associated with decreased PPAR activity and reduced [TG] promoter activity in vitro.	PPAR	LPL	1	ACTIVATION	True
17507	17962	14641110:4:PPARA:MUC1	To investigate whether [TF] is truly responsible for transcriptional regulation of the rat [TG] gene, transient reporter assay was performed in CV-1 cells.	PPARalpha	MCD	0	UNDEFINED	True
17517	17972	19275551:5:PPARA:PPIG	Second, NF-kappaB indirectly regulates the transcription of [TG] genes through mutual repression with some nuclear receptors that are involved in CYP regulation such as AhR, CAR, GR, PXR, RXR, [TF], FXR, and LXR.	PPAR	CYP	2	REPRESSION	True
17519	17974	15886523:4:PPARA:SLC2A2	Chromatin immunoprecipitation assay using ob/ob mice also showed that PPAR-gamma rather than [TF] binds to the -197/-184 region of [TG] promoter.	PPAR-alpha	GLUT2	0	UNDEFINED	True
17523	17978	12759335:9:PPARA:TNFRSF17	Thus [TF] is a key transcription factor for the transcriptional regulation of the [TG] gene, suggesting a broader function for PPARs in the regulation of carotenoid metabolism metabolism that is consistent with their established role in neutral lipid metabolism and transport.	PPAR	Bcm	0	UNDEFINED	True
17535	17990	11867749:5:PPARD:PPARA	Stable expression of [TF] inhibits the expression of endogenous [TG] target gene expression in 3T3-PPARalpha cells, whereas a PPARdelta mutant that does not interact with the corepressor SMRT loses its ability to repress the induction of PPARalpha target gene.	PPARdelta	PPARalpha	2	REPRESSION	True
17543	17998	11980898:5:PPARD:VEGFA	Its expression is increased by PPARalpha, beta, and gamma in RT4 cells and only by [TF] in T24 cells via a transcriptional activation of the [TG] promoter through an indirect mechanism.	PPARbeta	VEGF	1	ACTIVATION	True
17546	18001	16216869:6:PPARG:ADRA1D	In support of this notion, ectopic expression of [TF] suppresses hepatic stellate cells activation markers, most notably expression of [TG].	PPARgamma	alpha1(I) procollagen	2	REPRESSION	True
17549	18004	18501443:1:PPARG:APLN	By using pangenomic microarray, we identified [TG] as a unique adipokine up regulated by the transcriptional co-activator [TF] (PPARgamma) co-activator 1alpha (PGC-1alpha) in human white adipocytes.	peroxisome proliferator-activated receptor gamma	apelin	1	ACTIVATION	True
17561	18016	15041706:12:PPARG:CDKN1A	Finally, electrophoresis mobility shift experiments demonstrated that [TF] ligands increased the nuclear binding activities of Sp1 and NF-IL6 (C/EBP), two transcription factors with regulatory elements in the promoter region of the [TG] gene.	PPARgamma	p21	0	UNDEFINED	True
17568	18023	11269666:8:PPARG:CTSC	We found that C/EBP delta and [TF] activate the [TG] promoter in 3T3-L1 cells synergistically.	PPAR gamma	m-HMS	1	ACTIVATION	True
17582	18037	19797172:10:PPARG:HMOX1	Transfection of HAECs with mTOR (mammalian target of rapamycin) short hairpin RNA and with Akt2 small interfering RNA significantly inhibited RSG-mediated transcriptional upregulation of [TG], a [TF] target gene.	PPARgamma	heme oxygenase-1	1	ACTIVATION	True
17590	18045	19147542:6:PPARG:ILK	Western blot analysis and gel mobility shift assay showed that fish oil significantly induced AP-2alpha protein expression and AP-2 DNA-binding activity in the [TG] gene promoter and that this was dependent on [TF] activation.	PPARgamma	ILK	0	UNDEFINED	True
17622	18077	17317207:4:PPARG:SLC2A4	Based on our studies of the interplay between [TF], FOXO1 and free fatty acids, and inflammation in regulating [TG] transcription in sickness and in health, we suggest a novel paradigm to increase insulin sensitivity in bona fide insulin target cells.	PPAR-gamma	GLUT4	0	UNDEFINED	True
17635	18090	20564199:7:RARA:POU5F1	Furthermore, both [TF] over-expression and mutation of a proximal hormone response element (HRE) blocked the activation effect of VPA on [TG] promoter, implying that VPA may exert its activation effect through factors targeting this HRE.	RARalpha	Oct4	1	ACTIVATION	True
17654	18109	18284609:5:REST:OPRM1	IGF-I up-regulated [TG] transcription in: PC12 cells lacking [TF], in SH-SY5Y cells transfected with constructs deficient in the REST DNA binding element, or when REST was down-regulated in retinoic acid-differentiated cells.	REST	OPRM1	2	REPRESSION	True
17665	18120	23250796:8:REST:SYN1	Upon differentiation of neuroblastoma Neuro2a cells, we observe a decrease in endogenous [TF] and a higher stability of Sp1 on target GC boxes, resulting in an increase of [TG] transcription.	REST	SYN1	2	REPRESSION	True
17671	18126	21886838:0:RORC:AKT1S1	Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves [TF] through the regulation of [TG].	mTOR	PRAS40	0	UNDEFINED	True
17677	18132	24126911:3:RORC:DUSP1	We investigated the effect of [TF] inhibition through rapamycin and a dual mTOR inhibitor (AZD2014) on [TG] expression.	mTOR	MKP-1	0	UNDEFINED	True
17678	18133	24590896:0:RORC:DYRK1B	Mirk/[TG] kinase is upregulated following inhibition of [TF].	mTOR	dyrk1B	2	REPRESSION	True
17685	18140	15620355:6:RORC:HIPK3	[TF], via PKA, negatively regulates [TG] and maintains CRF1 in the cytoplasm.	TOR	YAK1	2	REPRESSION	True
17686	18141	22768106:4:RORC:HSP90B2P	As [TG] transcription is regulated by heat shock transcription factor 1 (HSF1), we examined whether m[TF] could directly phosphorylate this factor.	TOR	HSP	0	UNDEFINED	True
17687	18142	22768106:7:RORC:HSP90B2P	Null mutation of S326 to alanine led to loss of ability to activate an HSF1-regulated promoter-reporter construct, indicating a direct role for m[TF] and S326 in transcriptional regulation of [TG] genes during stress.	TOR	HSP	0	UNDEFINED	True
17688	18143	20459645:0:RORC:ICAM1	Osteopontin selectively regulates p70S6K/[TF] phosphorylation leading to NF-kappaB dependent AP-1-mediated [TG] expression in breast cancer cells.	mTOR	ICAM-1	1	ACTIVATION	True
17689	18144	20459645:8:RORC:ICAM1	We also delineated the role of [TF] and p70S6 kinase in OPN-induced [TG] expression.	mTOR	ICAM-1	1	ACTIVATION	True
17690	18145	20459645:9:RORC:ICAM1	The study suggests that inhibition of [TF] by rapamycin augments whereas overexpression of mTOR/p70S6 kinase inhibits OPN-induced [TG] expression.	mTOR	ICAM-1	2	REPRESSION	True
17693	18148	20370577:2:RORC:IGFBP2	The PI3K/AKT/[TF] pathway has recently been shown to be a predominant regulator of [TG] at the protein level in MCF-7 breast cancer cells.	mTOR	IGFBP-2	0	UNDEFINED	True
17700	18155	15716495:9:RORC:ISYNA1	However, analysis of rapamycin-treated cells suggests that Sit4 represses [TG] transcription through multiple mechanisms, only one of which may involve inhibition of [TF] signaling.	TOR	INO1	1	ACTIVATION	True
17702	18157	21304902:11:RORC:LEP	Akt knockdown, and inhibition of Akt signaling by LY294002 and [TF] inhibitor rapamycin reduced [TG] expression.	mTOR	leptin	1	ACTIVATION	True
17707	18162	17329361:10:RORC:MDM2	Our studies identify a novel mechanism for Met-triggered cell survival during embryogenesis, involving translational regulation of [TG] by [TF].	mTOR	Mdm2	0	UNDEFINED	True
17708	18163	23638184:5:RORC:MDM2	Inhibition of [TF] by rapamycin or expression of a dominant negative eukaryotic initiation factor 4E binding protein 1 (4EBP1) mutant protein, as well as ablation of eukaryotic initiation factor 4E (eIF4E), efficiently abolishes IGF-1-mediated up-regulation of [TG].	mTOR	MDM2	1	ACTIVATION	True
17709	18164	12592384:9:RORC:MMP2	The results demonstrate that IGF-IR controls tumor cell invasion by coordinately regulating [TG] expression and its MT1-MMP-mediated activation and identify PI 3-kinase/Akt/[TF] signaling as critical to this regulation.	mTOR	MMP-2	1	ACTIVATION	True
17711	18166	21208419:12:RORC:NOS2	In this experimental paradigm [TF] activation did not significantly affect astrocyte [TG] activity, but mTOR pathway was involved in the regulation of iNOS expression.	mTOR	iNOS	1	ACTIVATION	True
17713	18168	24334141:5:RORC:PDCD4	In conclusion, we described a novel molecular mechanism of [TG] suppression in cancer cells consisting from [TF] signaling-dependent transcriptional repression of Pdcd4.	mTOR	Pdcd4	2	REPRESSION	True
17717	18172	19654299:0:RORC:PPARD	Nicotine stimulates [TG] expression in human lung carcinoma cells through activation of PI3K/[TF] and suppression of AP-2alpha.	mTOR	PPARbeta/delta	1	ACTIVATION	True
17718	18173	19654299:8:RORC:PPARD	Collectively, our results show that nicotine increases [TG] gene expression through alpha7 nAChR-mediated activation of PI3K/[TF] signals that inhibit AP-2alpha protein expression and DNA binding activity to the PPARbeta/delta gene promoter.	mTOR	PPARbeta/delta	1	ACTIVATION	True
17721	18176	22184110:6:RORC:PTEN	We found that in TSC2(-/-) mouse embryonic fibroblasts expression of a kinase-dead mutant of [TF], which inhibits both TORC1 and TORC2, decreases the expression of [TG] via transcriptional mechanism.	mTOR	PTEN	1	ACTIVATION	True
17723	18178	12781866:4:RORC:RPS6KB1	Hamartin and tuberin control cell growth by negatively regulating [TG] (S6K1) and eukaryotic initiation factor 4E binding protein 1 (4E-BP1), potentially through their upstream modulator mammalian target of rapamycin ([TF]).	mTOR	S6 kinase 1	2	REPRESSION	True
17724	18179	14653992:1:RORC:RPS6KB1	The mammalian target of rapamycin ([TF]) regulates cell growth and proliferation via the downstream targets [TG] (S6K1) and eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1).	mTOR	ribosomal S6 kinase 1	0	UNDEFINED	True
17725	18180	20109524:4:RORC:SCD	We previously showed in hepatic cells that insulin acts through the PI3K and [TF] pathways to upregulate [TG] expression.	mTOR	SCD1	1	ACTIVATION	True
17726	18181	22104347:8:RORC:SLC2A3	In conclusion, we showed that the expression of [TG] in response to IGF-1 was dependent on PI-3-kinase and [TF] activity, and required the transcription factor HIF-1.	mTOR	GLUT3	1	ACTIVATION	True
17730	18185	23928058:12:RORC:SRRM4	Inhibition of the PI3K/Akt/[TF] pathway by LY294002 induced [TG] expression, whereas the specific MEK/ERK inhibitor U0126 inhibited nSR100 expression.	mTOR	nSR100	2	REPRESSION	True
17734	18189	18678646:6:RORC:TP73	Treatment of both primary cells and cancer cell lines with rapamycin, metformin, and pyrvinium resulted in an increase in [TG] levels, as did RNA interference-mediated knockdown of [TF].	mTOR	p73	2	REPRESSION	True
17741	18196	10965896:6:RXRB:PKD2	Electrophoretic mobility shift assays using purified TRal and [TF] protein as well as GH3 nuclear extracts showed that regions from +51 to +71 bp and from +118 to +137 bp of the h[TG] promoter bind to TRalpha1 as both a monomer and a homodimer and with TRalpha1/retinoid X receptor-beta as a heterodimer.	retinoid X receptor-beta	PC2	0	UNDEFINED	True
17742	18197	9140065:5:RXRB:RARB	P19 embryonal carcinoma cells stably expressing the truncated [TF] (termed delta C2) were deficient in activating the endogenous [TG] gene and an RA responsive reporter.	RXR beta	RAR beta	1	ACTIVATION	True
17746	18201	22385656:5:SALL4:SALL1	Plzf in turn antagonizes [TF] function by displacing Sall4 from cognate chromatin to induce [TG] expression.	Sall4	Sall1	2	REPRESSION	True
17749	18204	12783782:9:SIX1:SIX2	In [TF](-/-) kidney development, we have found that Pax2, [TG] and Sall1 expression was markedly reduced in the metanephric mesenchyme at E10.5, indicating that Six1 is required for the expression of these genes in the metanephric mesenchyme.	Six1	Six2	1	ACTIVATION	True
17759	18214	20852387:3:SMAD2:MET	In the present study, we found that mice with keratinocyte-specific deletion of the TGF- signaling mediator [TF] (referred to herein as K5.Smad2(-/-) mice), which have increased susceptibility to squamous cell carcinomas (SCCs), exhibited angiogenesis associated with epithelial overexpression of HGF and endothelial activation of the HGF receptor [TG].	Smad2	c-Met	2	REPRESSION	True
17791	18247	20595680:7:SMAD2:TGFB1	Moreover, deletion of [TF] increased autoinduction of [TG]1.	Smad2	TGF-beta	2	REPRESSION	True
17799	18255	12554780:14:SMAD3:FSHB	Furthermore, cotransfection of Pitx2c with [TF] in kidney-derived TSA cells resulted in activin-regulated [TG] response, suggesting its important role in tissue-restricted regulation of FSHbeta by activin.	Smad3	FSHbeta	0	UNDEFINED	True
17827	18283	15647271:7:SMAD4:BMP2	Overexpression of MAN1 results in inhibition of R-Smad phosphorylation, heterodimerization with [TF] and nuclear translocation, and repression of transcriptional activation of the TGFbeta, [TG], and activin-responsive promoters.	Smad4	BMP2	2	REPRESSION	True
17834	18290	9765209:5:SMAD4:ERF	TFE3 and Smad3 synergistically activate the [TG] promoter and phosphorylated Smad3 and [TF] bind to a sequence adjacent to the TFE3-binding site in this promoter.	Smad4	PE2	0	UNDEFINED	True
17838	18294	22945649:7:SMAD4:MUC1	It is proposed that loss of [TF] may convert TGF- from a tumor suppressor to a tumor promoter by causing the upregulation of AGR2, which then leads to increased [TG] expression, at which point both AGR2 and MUC1 facilitate mPanIN initiation and progression to PDAC.	Smad4	MUC1	2	REPRESSION	True
17841	18297	10636910:3:SMAD4:SERPINE1	TGFbeta responses, including growth arrest, induction of the endogenous [TG] gene, and other extracellular matrix components, were normal in [TF]-deficient fibroblasts.	Smad4	PAI-1	2	REPRESSION	True
17854	18310	20049565:4:SOX1:NCAM1	ChIP analysis of the [TG] promoter region showed specific bindings of SOX4 in the CD56(+) and [TF] in the CD56(-) myeloma cell lines, respectively.	SOX1	CD56	0	UNDEFINED	True
17880	18336	18245227:2:SREBF1:AR	Here, we show that [TF]c regulates [TG] (AR) transactivation through direct interaction with AR and represses androgen-dependent growth of prostatic cells.	SREBP-1	androgen receptor	1	ACTIVATION	True
17881	18337	15123720:12:SREBF1:AVP	We conclude that [TF] is a negative regulator of the [TG] gene and may work in concert with the CCAAT/enhancer-binding proteins to mediate ethanol induction of ADH in vivo.	SREBP-1	ADH	2	REPRESSION	True
17897	18354	16055439:9:SREBF1:INS	This cryptic [TF] action might play a compensatory role in [TG] expression in diabetes with beta cell lipotoxicity.	SREBP-1c	insulin	0	UNDEFINED	True
17934	18391	22279139:7:SREBF1:SCD	Subsequent chromatin immunoprecipitation analysis further demonstrated that the binding of p300/CBP-associated factor, a coactivator of [TF], and histone H3 lysine 14 acetylation at the FAS, [TG], and ACC1 promoters were significantly reduced in the livers of APOE2 mice and HepG2 cells treated with MOEO compared with their controls.	SREBP-1c	SCD1	0	UNDEFINED	True
17950	18407	15217807:11:SRF:DYM	Our data suggest that bFGF-induced MEK/extracellular signal-regulated kinase signaling plays an antagonistic role in TGFbeta1-induced [TG] gene expression through suppression of the [TF] function.	SRF	SMC	1	ACTIVATION	True
17951	18408	23110084:9:SRF:DYM	Chromatin- and co-immunoprecipitation studies demonstrated that regulation of [TG] genes by BAF60c is mediated via interaction with [TF] binding CArG box-containing promoter elements in SMC genes.	SRF	SMC	0	UNDEFINED	True
17975	18432	9529161:13:SRF:MYH11	In addition, we show that cotransfection with the [TF] dominant-negative mutant expression vector abolishes [TG] promoter activity, suggesting that SRF protein plays a critical role in SMHC gene regulation.	SRF	SMHC	1	ACTIVATION	True
17987	18444	16260603:7:SRF:MYOCD	Although overexpression of the [TF]-binding B-box domain of Elk-1 is sufficient to repress the [TG] activation of the telokin promoter, this repression is not as complete as that seen with an Elk-1 fragment that includes the DNA binding domain.	SRF	myocardin	2	REPRESSION	True
18013	18470	21525490:4:SRF:RIPK1	[TF] bound to the rat insulin promoter II ([TG]) serum response element, an element conserved in both rat I and murine I and II insulin promoters.	SRF	RIP II	0	UNDEFINED	True
18014	18471	21525490:5:SRF:RIPK1	[TF] activated [TG], and SRF binding to RIP II and the exon 5-encoded 64-aa subdomain of SRF was required for this activation.	SRF	RIP II	1	ACTIVATION	True
18016	18473	17303098:9:SRF:SMN1	The [TG] promoter is controlled largely by two major regulatory elements-CArG boxes activated by serum response factor ([TF]), and TGF-beta control elements (TCE).	SRF	SMA	1	ACTIVATION	True
18017	18474	19269978:7:SRF:SMN1	We also show that Barx2, MyoD, and [TF] simultaneously occupy the [TG] promoter in cells and that Barx2 interacts with MyoD.	serum response factor	SMA	0	UNDEFINED	True
18018	18475	19608972:6:SRF:SMN1	Chromatin immunoprecipitation assays suggest that S1P-induced recruitment of [TF] to the [TG] promoter and enhancer largely depends on S1P2R.	serum response factor	SMA	0	UNDEFINED	True
18019	18476	20016221:11:SRF:SMN1	Cdc42 is involved in the regulation of [TG] promoter activation through PAK, p38, MRTF and [TF].	SRF	SMA	0	UNDEFINED	True
18020	18477	20016221:3:SRF:SMN1	The Rho-Rho kinase-myosin light chain-myocardin-related transcription factor (MRTF)-serum response factor ([TF]) pathway and Rac1, p21-activated kinase (PAK) and p38 were described as important regulators of MRTF localization and [TG] expression.	SRF	SMA	0	UNDEFINED	True
18036	18493	11371641:6:TGIF1:SMAD2	Interestingly, c-Jun directly binds to the nuclear transcriptional corepressor [TF] and is required for TGIF-mediated repression of [TG] transcriptional activity.	TGIF	Smad2	2	REPRESSION	True
18044	18501	18004979:10:UBP1:GRHL1	We cotransfected [TF] and LBP-9 with the [TG]/MGR promoter and found that both stimulated LBP-32/MGR promoter activity.	LBP-1b	LBP-32	1	ACTIVATION	True
18098	18555	15464985:11:BACH1:NPRL3	These results indicated that heme plays an important role in the induction of alpha-globin gene expression through disrupting the interaction of [TF] and the NA site in [TG] enhancer in erythroid cells.	Bach1	HS-40	0	UNDEFINED	True
18113	18570	18819935:8:CDX2:DSC2	Colon cancer cell lines retaining [TF] expression typically express [TG].	Cdx2	DSC2	1	ACTIVATION	True
18117	18574	15215241:12:CDX2:HNF4A	We conclude that Cdx1 and [TF] inhibit colon cancer cell proliferation by blocking beta-catenin/[TG] transcriptional activity.	Cdx2	TCF	2	REPRESSION	True
18121	18578	16002547:1:CDX2:INS	Although the homeobox gene [TF] was initially isolated from the pancreatic beta cell line HIT-T15, no examination of its role in regulating endogenous [TG] gene expression has been reported.	Cdx-2	insulin	0	UNDEFINED	True
18152	18613	19133234:5:ELK1:EIF2AK1	Our results demonstrate the involvement of two transcription factors, [TF] and MZF-1 in regulating [TG] expression.	Elk-1	HRI	0	UNDEFINED	True
18153	18614	19133234:6:ELK1:EIF2AK1	Chromatin immunoprecipitation assays established further that [TF] is involved in upregulating [TG] expression during stress along with a co-activator p300, while MZF-1 along with HDAC-1 is instrumental in its downregulation during hemin treatment.	Elk-1	HRI	1	ACTIVATION	True
18157	18618	11441089:5:ELK1:IL2	These results identify a unique role for B7 costimulatory molecules and CD28 in the activation of JNK during Ag stimulation in Th1 cells, and suggest that JNK regulates [TF] transactivation at the c-fos gene to promote the formation of AP-1 complexes important to [TG] gene expression.	Elk-1	IL-2	1	ACTIVATION	True
18158	18619	8996240:4:ELK1:IL4	The transcription factors [TF], an immediate early gene regulator and the nuclear factor of activated T cells (NFAT), in the context of the [TG] gene, are identified as Ras targets in mast cells.	Elk-1	IL-4	0	UNDEFINED	True
18188	18650	14670960:10:ELK1:PRKCG	We conclude that Bcr-Abl regulates [TG]iota expression through the MEK-dependent activation of an [TF] element within the proximal PKCiota promoter.	Elk1	PKC	0	UNDEFINED	True
18210	18674	21628409:9:ERG:RAC1	Suppression of either [TF] or RhoJ during EC lumen formation was associated with a marked increase in RhoA activation and a decrease in [TG] and Cdc42 activation and their downstream effectors.	ERG	Rac1	1	ACTIVATION	True
18212	18676	23319146:5:ERG:TDRD1	Expression array analysis of the patient cohort from a different institute showed a large overlap in genes that were positively correlated with [TF] overexpression, including [TG].	ERG	TDRD1	1	ACTIVATION	True
18213	18677	10749119:6:ERG:TGFBR2	Cotransfection of these fusion genes and the [TG] promoter suppresses TGF-beta RII promoter activity and also FLI1-, [TF]-, or ETV1-induced promoter activity.	ERG	TGF-beta RII	1	ACTIVATION	True
18231	18695	18178153:0:FOXA1:AR	Hepatocyte nuclear factor-3 alpha ([TF]) negatively regulates [TG] transactivation in prostate cancer cells.	HNF-3alpha	androgen receptor	2	REPRESSION	True
18246	18710	22042697:5:GFI1:RUNX2	Trichostatin-A blocked the effects of [TF], suggesting that it induces epigenetic changes in the [TG] promoter.	Gfi1	Runx2	0	UNDEFINED	True
18258	18722	24165159:0:GLI1:MLH1	[TF] interferes with the DNA mismatch repair system in pancreatic cancer through BHLHE41-mediated suppression of [TG].	GLI1	MLH1	2	REPRESSION	True
18290	18754	20628571:11:HES1:RUNX2	[TF] increases the stability and transcriptional activity of [TG], a key molecule of osteoblast differentiation, which results in an enhanced osteoblast-specific gene expression.	Hes1	Runx2	1	ACTIVATION	True
18293	18757	14706452:4:HNF4A:CTNNB1	Several AP1 binding sites were confirmed in the promoters of all three species using mobility shift and reporter assays, and one putative [TF]/LEF site also was observed in the promoter of [TG].	TCF	CTNNB1	0	UNDEFINED	True
18297	18761	16575901:11:HNF4A:RUNX2	Additionally, gel-shift assay analyses determined the DNA/protein interaction of the [TF]/Lef binding sites on the [TG] promoter.	TCF	Runx2	0	UNDEFINED	True
18298	18762	16575901:8:HNF4A:RUNX2	We further investigated the effects of beta-catenin-[TF]/Lef on [TG] promoter.	TCF	Runx2	0	UNDEFINED	True
18308	18772	10908361:10:KLF4:CD1A	These results indicate that [TF] is a transcriptional repressor of the [TG] gene and that the inhibitory effect of GKLF is, in part, mediated by interaction with the Sp1 binding domain on its promoter.	GKLF	CD1	2	REPRESSION	True
18309	18773	10908361:5:KLF4:CD1A	The current study was undertaken to determine the mechanisms by which [TF] inhibited [TG] expression.	GKLF	CD1	2	REPRESSION	True
18310	18774	10908361:6:KLF4:CD1A	In a transient transfection system, [TF] suppressed [TG] promoter activity by 55%.	GKLF	CD1	2	REPRESSION	True
18311	18775	10908361:8:KLF4:CD1A	By electrophoretic mobility gel shift assay, recombinant [TF] and nuclear extracts from HT-29 cells were found to bind to the Sp1 motif on the [TG] promoter.	GKLF	CD1	0	UNDEFINED	True
18312	18776	10908361:9:KLF4:CD1A	The inhibitory effect of [TF] on the [TG] promoter activity was completely abolished by excessive amount of Sp1 DNA and GKLF significantly reduced the stimulatory function of Sp1 suggesting that GKLF and Sp1 may compete for the same binding site on the CD1 promoter.	GKLF	CD1	2	REPRESSION	True
18313	18777	11005769:10:KLF4:CD1A	Furthermore, [TF] appears to be a transcriptional repressor of the [TG] gene.	GKLF	CD1	2	REPRESSION	True
18314	18778	11005769:7:KLF4:CD1A	Cyclin D1 ([TG]) protein level and CD1-associated kinase activity were decreased in HT-29 cell overexpressed [TF] cDNA, and CD1 promoter activity was profoundly suppressed by GKLF.	GKLF	CD1	2	REPRESSION	True
18318	18782	12970361:7:KLF4:DYM	Finally, results of co-transfection studies showed that overexpression of IKLF/KLF5 reversed [TF]-dependent repression thus supporting a model of reciprocal activation-repression of [TG] gene expression by different members of the KLF gene family.	GKLF	SMC	2	REPRESSION	True
18330	18794	24599951:8:KLF4:NOTCH1	We also demonstrate that [TF] limits cleavage-mediated activation of [TG].	KLF4	Notch1	2	REPRESSION	True
18334	18798	20331458:6:KLF4:SCN2A	In K562 cells, induced [TF] expression with a Tet-off regulated cassette stimulated the expression of the endogenous [TG] genes.	KLF4	HBA	1	ACTIVATION	True
18335	18799	20331458:8:KLF4:SCN2A	All experiments combined support a regulatory role of [TF] in the control of [TG] gene expression.	KLF4	HBA	0	UNDEFINED	True
18354	18818	22234890:7:LEF1:OCA2	In darkly pigmented human melanocytes carrying the rs12913832 T-allele, we detected binding of the transcription factors HLTF, [TF], and MITF to the HERC2 rs12913832 enhancer, and a long-range chromatin loop between this enhancer and the [TG] promoter that leads to elevated OCA2 expression.	LEF1	OCA2	0	UNDEFINED	True
18359	18824	8035824:7:MEF2A:SOX9	Here we show that the [TG] promoter contains numerous E-box binding sites for CMD1 and the other myogenic factors, as well as a [TF] binding site.	MEF-2	CMD1	0	UNDEFINED	True
18370	18835	12732210:0:MEIS1:PF4	PREP1, [TF] homolog protein, regulates [TG] gene expression.	MEIS1	PF4	0	UNDEFINED	True
18376	18841	21746878:3:MEIS2:CDKN2B	[TF]d and Pbx1a activate expression of [TG](Ink4a) and E-cadherin, dependent on the Meis2d transcriptional activation domain.	Meis2	p15	1	ACTIVATION	True
18382	18847	17360662:8:MLXIP:ZEB2	TGF-beta treatment or transfection with [TF]-192 decreased endogenous [TG] expression as well as reporter activity of a SIP1 3' UTR-containing luciferase construct in MMC.	miR	SIP1	2	REPRESSION	True
18409	18874	24173808:0:PAX9:BMP4	[TF] regulates a molecular network involving [TG], Fgf10, Shh signaling and the Osr2 transcription factor to control palate morphogenesis.	Pax9	Bmp4	0	UNDEFINED	True
18426	18891	23185615:8:PRRX1:HIF1A	The results presented here show that [TF] stimulation increased NF-B interaction with the [TG] promoter, leading to enhanced promoter activity and increases in HIF-1 mRNA levels, as well as augmented HIF-1 activity that resulted in VEGF expression.	Prx1	HIF-1	0	UNDEFINED	True
18430	18895	23185615:8:PRRX1:VEGFA	The results presented here show that [TF] stimulation increased NF-B interaction with the HIF-1 promoter, leading to enhanced promoter activity and increases in HIF-1 mRNA levels, as well as augmented HIF-1 activity that resulted in [TG] expression.	Prx1	VEGF	1	ACTIVATION	True
18431	18896	12393646:9:RORC:HIF1A	Together, our data show that BCR/ABL induces VEGF- and [TG] gene expression through a pathway involving PI3-kinase and [TF].	mTOR	HIF-1alpha	1	ACTIVATION	True
18432	18897	19483472:5:RORC:HIF1A	Activation of PI3K/Akt/[TF] leads to increased [TG] expression in certain cancer cells, supporting the rationale of using mTOR inhibitors as anti-cancer agents.	mTOR	HIF-1alpha	1	ACTIVATION	True
18478	18944	20097749:3:RUNX2:MMP13	Here, we show that histone deacetylase 4 (HDAC4) interacts with [TF], binds the [TG] promoter, and suppresses MMP-13 gene transcription in the rat osteoblastic cell line, UMR 106-01.	Runx2	MMP-13	0	UNDEFINED	True
18481	18947	18974605:7:RUNX2:NES	Results showed Col1a1 expression was down-regulated, DSPP expression was lost, and [TG] expression was severely decreased in the odontoblasts of Tg(Col1a1-[TF]) mice.	Runx2	nestin	2	REPRESSION	True
18489	18955	21809344:0:RUNX2:PIP	[TF] controls a feed-forward loop between androgen and [TG] (PIP) in stimulating T47D cell proliferation.	Runx2	prolactin-induced protein	0	UNDEFINED	True
18503	18973	15383550:11:RUNX2:SLPI	Thus, Dlx5 transactivates [TG] expression, directly by binding to its cognate response element and/or indirectly by stimulating [TF] expression, and Msx2 counteracts the direct transactivation of Dlx5.	Runx2	ALP	1	ACTIVATION	True
18504	18974	15383550:5:RUNX2:SLPI	Dlx5 and the product of its target gene, [TF], stimulated [TG] promoter activity in an additive manner.	Runx2	ALP	1	ACTIVATION	True
18509	18979	23287548:10:RUNX2:SLPI	Our results showed for the first time that [TG] is a direct target gene of [TF] and illustrated that the recognition/binding and activation of the ALP by this transcription factor are dependent on its nuclear matrix-targeting.	Runx2	ALP	0	UNDEFINED	True
18512	18982	16195230:6:RUNX2:SPP1	In ROS 17/2.8 and MC3T3-E1 cells that contain endogenous [TF], AML-1/ETO, which acts as a repressor of Runx2, significantly inhibited 1,25(OH)(2)D(3) induction of [TG] transcription, OPN mRNA, and protein expression.	Runx2	OPN	0	UNDEFINED	True
18522	18992	23618908:11:RUNX2:TP53	Taken together, our present findings strongly suggest that [TF] inhibits DNA damage-induced transcriptional as well as pro-apoptotic activity of [TG] through the functional collaboration with HDAC6 and therefore might be an attractive therapeutic target for cancer treatment.	RUNX2	p53	2	REPRESSION	True
18545	19015	22025728:7:RUNX3:CD8A	Thus, our data suggest an E8(I)- and [TF]/CBF-dependent epigenetic programming of the [TG] locus during T-cell activation, leading to Runx/CBF complex-independent maintenance of CD8 expression in effector T cells.	Runx3	Cd8a	0	UNDEFINED	True
18573	19043	12783782:9:SIX1:PAX2	In [TF](-/-) kidney development, we have found that [TG], Six2 and Sall1 expression was markedly reduced in the metanephric mesenchyme at E10.5, indicating that Six1 is required for the expression of these genes in the metanephric mesenchyme.	Six1	Pax2	1	ACTIVATION	True
18574	19044	19706789:9:SIX1:SOX9	Moreover, [TG] promoter activity, as measured by luciferase reporter assay, was markedly diminished after [TF] treatment.	TIP39	Sox9	2	REPRESSION	True
18594	19064	24116102:6:SOX2:AKT1	We determined that increases of [TF] in i-OSKM-ESC lead to increases in activated [TG] and inactivation of FoxO1 (an activator of Sox2), as well as decreases in binding of FoxO1 to the 5'flanking region of Sox2.	Sox2	AKT	1	ACTIVATION	True
18621	19091	15557334:8:SOX2:FBXO15	These results indicate that Oct-3/4 is a member of the gene family regulated by Oct-3/4 and [TF], as reported before for the FGF-4, UTF1, Sox2, and [TG] genes.	Sox2	Fbx15	0	UNDEFINED	True
18623	19093	16846370:6:SOX2:GJA1	As an example, results from ChIP-on-chip studies show that OCT4, [TF], and NANOG co-occupy SOX2, OCT4, TDGF1, [TG], SET, and DPPA4 genes.	SOX2	GJA1	0	UNDEFINED	True
18634	19104	18831784:5:SOX2:MTF2	This network suggests that Oct4, [TF] and Klf4 indirectly repress lineage specific differentiation genes by activating transcriptional repressors of Ctbp2, Rest and [TG].	Sox2	Mtf2	2	REPRESSION	True
18642	19112	21304604:11:SOX2:PLAC1	siRNA- and miR-126-mediated [TF] knockdown experiments revealed that miR-126 positively regulated [TG] expression through suppression of SOX2 expression in gastric cancer cells.	SOX2	PLAC1	2	REPRESSION	True
18658	19128	19736317:5:SOX2:SOX17	This switch allows the cells to turn off the pluripotency Oct4-[TF] loop and to turn on the [TG] promoter.	Sox2	Sox17	2	REPRESSION	True
18670	19140	20400479:8:SOX4:BAX	We showed that the HMG box domain of [TF] interacted with p53, resulting in the inhibition of p53-mediated transcription by the [TG] promoter.	SOX4	Bax	2	REPRESSION	True
18678	19148	20400479:3:SOX4:TP53	In this study, we characterized the roles of [TF] in regulation of the [TG] transcription activity and evaluated the expression patterns and prognostic value of the transcription factor SOX4 in HCC.	SOX4	p53	0	UNDEFINED	True
18688	19158	18085523:5:SOX5:SPARC	In exploring the mechanism underlying the decreased transcription of [TG] in NPC cells, we found that the transcription factor [TF] (SOX-5) is up-regulated in NPC cells.	SRY (sex-determining region Y)-box 5	SPARC	2	REPRESSION	True
18691	19161	24607904:5:SOX5:VIM	We further demonstrated that knockdown of [TF] up-regulated epithelial phenotype cell biomarker (E-cadherin) and down-regulated mesenchymal phenotype cell biomarkers (N-cadherin, [TG], and Fibronectin 1), resulting in suppression of EMT.	Sox5	Vimentin	1	ACTIVATION	True
18710	19180	20571031:11:SOX9:CTGF	Hence, we propose that differential occupancy of the TCF x LEF x [TF] site by Sox9 versus beta-catenin restricts high levels of [TG] expression to hypertrophic chondrocytes.	Sox9	Ccn2	1	ACTIVATION	True
18713	19183	22580282:5:SOX9:DYM	qRT-PCR and luciferase assays show that over-expression of [TF] inhibits [TG] gene transcription and promoter activities induced by myocardin, the master regulator of smooth muscle differentiation.	SOX9	SMC	2	REPRESSION	True
18724	19194	8413304:8:SOX9:MLC1	These results show that [TF] and c-myogenin act on the [TG] gene by recognizing different upstream DNA sequences and that direct or indirect interactions between the regions outside the basic helix-loop-helix domain and flanking sequences of E boxes are involved in the target sequence specificity.	CMD1	MLC1	0	UNDEFINED	True
18749	19219	9576927:3:STAT3:AGT	Gel mobility-shift assay revealed that [TF] and STAT6 are selectively activated by AngII treatment of cardiomyocytes in culture and bind to a sequence motif (St-domain) in the [TG] promoter to activate its transcription in transient transfection assay.	STAT3	angiotensinogen	0	UNDEFINED	True
18757	19227	19304666:11:STAT3:AP3B1	Furthermore, we found that partial hepatectomy and IL-6 significantly induced promoter activity of [TG], depending on [TF] and HNF1 binding sites in the HPS promoter.	STAT3	HPS	1	ACTIVATION	True
18759	19229	21868636:8:STAT3:ATXN1	Thus the present study suggests that [TF], having been phosphorylated following MED ligation, was transferred to the nucleus, where it bound to the GAS element in the promoter of [TG] gene, resulting in promotion of Sca-1 gene expression.	STAT3	Sca-1	0	UNDEFINED	True
18760	19230	11431352:9:STAT3:BCL2	The decrease in [TF] activation by these treatments correlates with a decrease in [TG] expression.	STAT3	Bcl-2	1	ACTIVATION	True
18782	19252	17001312:6:STAT3:CISH	We provide direct evidence that [TF] pathways are constitutively activated in MCF-7 and HCC1937 cells and may drive the aberrant persistent activation of [TG] genes in breast-cancer cells.	STAT3	SOCS	1	ACTIVATION	True
18792	19262	23604529:0:STAT3:DIRAS3	[TF] acetylation-induced promoter methylation is associated with downregulation of the [TG] tumor-suppressor gene in ovarian cancer.	STAT3	ARHI	2	REPRESSION	True
18813	19283	17427945:4:STAT3:GAST	"The result of Stat1 in complex with [TF] and HSF1 that bound at the [TG] to lead a moderate heat shock induction was designated as an ""intrinsic"" induction of the hsp90alpha gene."	Stat3	GAS	0	UNDEFINED	True
18814	19284	19917672:9:STAT3:GAST	Moreover, electrophoretic mobility shift, supershift, and chromatin immunoprecipitation analyses revealed that both STAT1 and [TF] bind to the [TG] at the chromatin level in the IFN-gamma stimulated cells.	STAT3	GAS	0	UNDEFINED	True
18816	19286	9795374:11:STAT3:GAST	The synergism was studied on the two other IL-6 response elements, the junB promoter (JRE-IL-6) and the interferon regulatory factor-1 (IRF-1) promoter (IRF-[TG]) which could be activated by [TF].	STAT3	GAS	1	ACTIVATION	True
18821	19291	21470923:9:STAT3:GFAP	Importantly, exogenous recombinant rat IL-6 can also induce phosphorylation of [TF] concomitant with [TG] expression while JAK2 specific inhibitor AG490 could effectively block both cholera toxin- and IL-6-induced GFAP expression.	STAT3	GFAP	1	ACTIVATION	True
18825	19295	18268048:0:STAT3:GSK3B	[TF] sensitizes insulin signaling by negatively regulating [TG].	STAT3	glycogen synthase kinase-3 beta	2	REPRESSION	True
18890	19361	20930550:0:STAT3:IL6	[TF] transcriptional factor activated by reactive oxygen species induces [TG] in starvation-induced autophagy of cancer cells.	STAT3	IL6	1	ACTIVATION	True
18895	19366	23438478:10:STAT3:IL6	Chromatin immunoprecipitation showed that [TF] restricted DAPK expression by promoter binding, thereby reinforcing its own activation by inducing [TG].	STAT3	IL-6	1	ACTIVATION	True
18948	19419	8253797:5:TEAD1:PRKCG	These results are the first to suggest a role for [TF] in transcriptional regulation by [TG].	TEF-1	PKC	0	UNDEFINED	True
18964	19438	7776979:1:TWIST1:CYP17A1	ACTH-dependent transcriptional activation of the bovine [TG] gene (the gene encoding cytochrome P450 steroid 17 alpha-hydroxylase) involves two cAMP-responsive sequences ([TF] and CRS2) located in the promoter region.	CRS1	CYP17	1	ACTIVATION	True
18987	19461	21791114:10:ZEB1:CASR	These findings suggest that TGF- may inhibit [TG] expression by regulating factor(s) that cooperate with [TF] to repress the CAR promoter, rather than by regulating ZEB1 expression levels.	ZEB1	CAR	0	UNDEFINED	True
19001	19476	17442301:8:ZEB2:BMP4	These results suggest that [TF] acts in neural tissue formation through direct repression of [TG] but that BMP-independent mechanisms are involved as well.	Sip1	BMP4	2	REPRESSION	True
19002	19477	18633121:11:ZEB2:NIN	It is proposed that [TF] may be required for the expression of [TG] and involved in the initial communications between the rhizobia and the host root cells.	SIP1	NIN	1	ACTIVATION	True
19003	19478	18633121:7:ZEB2:NIN	[TF] recognizes two of the three AT-rich domains present in the [TG] gene promoter.	SIP1	NIN	0	UNDEFINED	True
19021	19496	15247247:8:SP1:PCYT1A	In cells that overexpress [TF], co-expression of cyclin A and CDK2 induces a high and constant level of [TG] expression, whereas reduction in the expression of cyclin A, cyclin E, and CDK2 eliminates the induction of CTalpha expression in S phase.	Sp1	CTalpha	0	UNDEFINED	True
19025	19500	15469934:10:ETS1:CHUK	These results suggest that the proximal 5'-flanking region of the [TG] gene contains a functional promoter reciprocally regulated by p53 and [TF].	ETS-1	IKKalpha	0	UNDEFINED	True
19038	19513	22714536:6:ID1:CDKN2A	From this interaction analysis, the residues of ETS-1 involved in interaction with the [TG] promoter were found to be targeted by [TF].	ID1	p16(INK4a)	0	UNDEFINED	True
19039	19514	12498690:3:UBTF:POLI	[TF] is an HMG box-containing factor that binds to the rDNA promoter and activates [TG] transcription through its acidic carboxy-terminal tail.	UBF	Pol I	1	ACTIVATION	True
19049	19524	24482232:6:KDM2A:NANOS1	HDAC3 knockdown significantly recovered the proliferation and invasiveness of [TF]-depleted NSCLC cells as well as the levels of CDK6 and [TG] expression in these cells.	KDM2A	NANOS1	0	UNDEFINED	True
19063	19538	11855808:5:SREBF1:FAS	Taken together, our data suggest that insulin does not stimulate [TG] gene expression through increasing [TF]c transcription in adipose cells.	SREBP-1	FAS	1	ACTIVATION	True
19065	19547	22761862:5:TCF4:AXIN1	Using HCC HepG2 cells we find that, on the one hand both protein and mRNA of KLF8 are up-regulated under Wnt3a stimulation, on the other hand overexpression of KLF8 increases the cytoplasm and nucleus accumulation of -catenin, recruits p300 to -catenin/T-cell factor 4 ([TF]) transcription complex, enhances TOP flash report gene transcription, and induces Wnt/-catenin signaling target genes c-Myc, cyclin D1 and [TG] expression.	TCF4	Axin1	1	ACTIVATION	True
19067	19549	23671559:7:TCF4:BCL2	Notably, an increased [TF] occupancy on [TG] gene was observed in prostatic tissues exhibiting high BMI1 levels.	TCF4	BCL2	0	UNDEFINED	True
19069	19551	23032104:6:TCF4:BMP2	Activation of Wnt signaling by Wnt3a or overexpression of -catenin/[TF] both stimulated [TG] transcription at promoter and mRNA levels.	TCF4	BMP2	1	ACTIVATION	True
19070	19552	23032104:7:TCF4:BMP2	In contrast, transcription of [TG] in osteogenic cells was decreased by either blocking the Wnt pathway with DKK1 and sFRP4, or inhibiting -catenin/[TF] activity with FWD1/-TrCP, ICAT, or TCF4.	TCF4	BMP2	1	ACTIVATION	True
19071	19556	17108104:7:TCF4:CCND1	Moreover, hARD1 knockdown reduced the binding of beta-catenin/[TF] transcription factor to [TG] promoter and repressed its transcriptional activity.	TCF4	cyclin D1	1	ACTIVATION	True
19072	19557	17468517:7:TCF4:CCND1	Moreover, transfected Cdx2 could inhibit beta-catenin/[TF]-mediated transcriptional activation of target genes, including p14(ARF) and [TG], probably through indirect mechanisms.	TCF4	cyclin D1	1	ACTIVATION	True
19075	19561	17468517:7:TCF4:CDKN2A	Moreover, transfected Cdx2 could inhibit beta-catenin/[TF]-mediated transcriptional activation of target genes, including [TG] and cyclin D1, probably through indirect mechanisms.	TCF4	p14(ARF)	1	ACTIVATION	True
19077	19563	17848139:8:TCF4:CFTR	RNAi (RNA interference) of [TF] and HNF1alpha decreased intestinal cell [TG] expression, identifying these as positive regulatory factors and CFTR as a target for Wnt signalling.	Tcf4	CFTR	1	ACTIVATION	True
19083	19572	24353279:5:TCF4:CYP51A1	Having previously identified that the [TF] (FoxO4) represses [TG] expression, we aimed to characterize its role at the CYP51 promoter.	forkhead transcription factor 4	CYP51	2	REPRESSION	True
19085	19574	17158875:9:TCF4:FGF18	Significantly, Runx2 formed a complex with Lef1 or [TF] and this complex bound the composite binding site in the [TG] promoter.	TCF4	fgf18	0	UNDEFINED	True
19086	19576	22805760:0:TCF4:GLCE	The [TF]/-catenin pathway and chromatin structure cooperate to regulate [TG] expression in breast cancer.	TCF4	D-glucuronyl C5-epimerase	0	UNDEFINED	True
19087	19577	22805760:5:TCF4:GLCE	Chromatin activation by Trichostatin A (TSA) or 5-aza-dC/TSA treatment increased [TG] expression by two to 3-fold due to an increased interaction between the GLCE promoter and the [TF]/-catenin transactivation complex, or H3K9ac and H3K4Me3 histone modifications.	TCF4	GLCE	1	ACTIVATION	True
19088	19578	22805760:6:TCF4:GLCE	However, ectopic expression of [TF]/-catenin was not sufficient to activate [TG] expression in MCF7 cells, suggesting that chromatin structure plays a key role in GLCE regulation.	TCF4	GLCE	1	ACTIVATION	True
19093	19583	22100912:6:TCF4:HECA	Here, we show that [TG] expression is negatively controlled by the Wnt-pathway and [TF], a Wnt related transcription factor, binds to the HECA promoter.	TCF4	HECA	2	REPRESSION	True
19096	19587	20802155:2:TCF4:LEF1	In this context, transcription of the [TG] gene is increased by Wnt-mediated [TF]/-catenin activation on the Lef-1 promoter through mechanisms that remain poorly defined.	TCF4	Lef-1	1	ACTIVATION	True
19098	19592	20818421:12:TCF4:MYC	Sequential ChIP analysis indicated -catenin and T-cell-specific 4 ([TF]) bound the endogenous [TG] promoter in the absence of Hic-5 expression.	TCF4	c-myc	0	UNDEFINED	True
19099	19593	20818421:13:TCF4:MYC	However, the formation of a [TF]/Hic-5 repressor complex inhibited [TG] promoter activity, by excluding -catenin binding with TCF4 on the promoter.	TCF4	c-myc	2	REPRESSION	True
19105	19601	19174556:9:TCF4:SKP2	Chromatin immunoprecipitation/real-time PCR analysis revealed that both WIF1 and dominant-negative LEF1 expression decreased the in vivo binding of [TF] and beta-catenin to the [TG] promoter.	TCF4	SKP2	0	UNDEFINED	True
19106	19602	23095742:3:TCF4:SMC2	In this work, we described the novel transcriptional regulation of [TG] protein by direct binding of the -catenin[TF] transcription factor to the SMC2 promoter.	TCF4	SMC2	0	UNDEFINED	True
19107	19603	12651860:4:TCF4:SMC3	The additional finding that the protein is significantly increased in the intestinal polyps of ApcMin/+ mice has led us to hypothesize that [TG] expression is linked to activation of the APC/beta-catenin/[TF] pathway.	TCF4	SMC3	1	ACTIVATION	True
19109	19605	16204248:4:TCF4:SPP1	Osteopontin ([TG]), a known beta-catenin/T cell factor-4 ([TF]) downstream target gene, is up-regulated in tumors and in cells with increased motility such as muscle cells.	Tcf-4	OPN	0	UNDEFINED	True
19110	19606	18952824:7:TCF4:SRSF3	In contrast, inhibition of endogenous beta-catenin signaling by a dominant-negative [TF] construct down-regulated both luciferase reporter and [TG] expression.	TCF4	SRp20	1	ACTIVATION	True
19111	19607	19602482:8:TCF4:SRSF3	Both splicing factors were found to be regulated by upstream signaling pathways: the inhibition of the phosphatidylinositol 3-kinase pathway increased protein levels of ASF/SF2 and promoted Rac1b, whereas activation of beta-catenin/[TF] increased expression of [TG] and inhibited that of Rac1b.	TCF4	SRp20	1	ACTIVATION	True
19112	19608	18602747:3:TCF4:STAT3	A functional TCF binding element was detected in [TG] promoter which specifically bound to [TF].	TCF4	STAT3	0	UNDEFINED	True
19116	19612	17050667:6:TCF4:UBE2B	Using electrophoresis mobility shift assay, Western blot analysis of electrophoresis mobility shift assay, UV cross-linking, and chromatin immunoprecipitation assay, we show that [TG] transcriptional repression in MCF10A cells is due to paucity of transcriptionally active beta-catenin assembled on the TCF binding sequence in the Rad6B promoter rather than to a deficit/decreased affinity of [TF] for the TCF binding element in Rad6B promoter.	TCF-4	Rad6B	0	UNDEFINED	True
19117	19613	18952601:9:TCF4:VEGFA	Chromatin immunoprecipitation assays showed in cell interactions of Smad2 and Smad3 with [TF] and beta-catenin at the [TG] promoter, whereas co-immunoprecipitation showed a direct physical interaction between Smad2 and beta-catenin in the nucleus of PASMCs.	TCF4	VEGF	0	UNDEFINED	True
19118	19615	22337891:6:TCF4:YAP1	Here we demonstrate that -catenin/[TF] complexes bind a DNA enhancer element within the first intron of the [TG] gene to drive YAP expression in CRC cells.	TCF4	YAP	0	UNDEFINED	True
19119	19616	22080605:7:TCF4:ZEB1	We found that -catenin/[TF] binds directly to the [TG] promoter and activates its transcription.	TCF4	ZEB1	1	ACTIVATION	True
19126	19623	18798221:0:EGR1:TCF4	Transcription factor [TF] acts as an upstream regulator of beta-catenin signalling through up-regulation of [TG] and p300 expression during trans-differentiation of endometrial carcinoma cells.	Egr1	TCF4	1	ACTIVATION	True
19127	19624	18798221:5:EGR1:TCF4	Transfection of [TF] led to transactivation of [TG] as well as p300 genes, through specific binding to a promoter region, and thus in turn resulted in nuclear accumulation of beta-catenin mediated by the up-regulating TCF4.	Egr1	TCF4	1	ACTIVATION	True
19129	19626	20417614:6:ESRRA:IBSP	Alterations in the expression of bone sialoprotein ([TG]) may at least partially explain the effects on mineralization as BSP expression was reduced in [TF] deficient MSCs and enhanced upon ERRalpha overexpression in MC3T3-E1 cells.	ERRalpha	BSP	1	ACTIVATION	True
19142	19639	19304666:11:HNF1A:AP3B1	Furthermore, we found that partial hepatectomy and IL-6 significantly induced promoter activity of [TG], depending on STAT3 and [TF] sites in the HPS promoter.	HNF1 binding	HPS	1	ACTIVATION	True
19144	19641	19304666:6:HNF1A:AP3B1	An electrophoretic mobility shift assay demonstrated that [TF] interacted with the [TG] gene promoter in vitro.	HNF1alpha	HPS	0	UNDEFINED	True
19145	19642	16675441:9:HNF1A:AVP	Taken together, our data indicate that [TF] binding, at approximately 51 kb upstream, plays a master role in controlling human class I [TG] gene expression and may govern alcohol metabolism in the liver.	HNF1	ADH	0	UNDEFINED	True
19147	19644	16339534:7:HNF1A:BCL2L1	In addition, [TF] as well as beta-catenin were able to stimulate transcriptional activity of the reporter driven by a [TG] promoter.	TCF-1	Bcl-xL	1	ACTIVATION	True
19150	19647	1827138:2:HNF1A:CD3E	We have recently identified and cloned a human transcription factor, [TF], that binds to a functional element in the T lymphocyte-specific enhancer of [TG].	TCF-1	CD3-epsilon	0	UNDEFINED	True
19165	19662	7935424:13:HNF1A:HNF4A	We also provide evidence for the existence of an autoregulatory loop in which [TF] regulates its own expression through activation of [TG].	HNF-1	HNF-4	1	ACTIVATION	True
19168	19665	19648923:6:HNF1A:IFNG	Thus, [TF] initiates T(H)2 differentiation of activated CD4(+) T cells by promoting GATA-3 expression and suppressing [TG] expression.	TCF-1	IFN-gamma	2	REPRESSION	True
19169	19667	21339363:5:HNF1A:IL17A	Instead, [TF] regulates IL-17 expression, in part, by binding to the regulatory regions of the [TG] gene.	TCF1	Il17	0	UNDEFINED	True
19174	19673	18029548:11:HNF1A:KCNK3	Direct binding of [TF]/HNF1alpha homodimer and HNF1alpha/HNF1beta heterodimer to the HNF1-motif found in the human [TG] promoter was demonstrated by electrophoretic mobility shift assays.	HNF1alpha	OAT1	0	UNDEFINED	True
19175	19674	18029548:6:HNF1A:KCNK3	However, in vitro evidence for the involvement of [TF] and further analyses are required to illustrate the transcriptional regulation of [TG] genes in more detail.	HNF1alpha	OAT1	0	UNDEFINED	True
19177	19676	23812425:7:HNF1A:MMP14	Promoter reporter assays and oligonucleotide and chromatin immunoprecipitations determined that KLF8 activates the human [TG] gene promoter by both directly acting on the promoter and indirectly via promoting the nuclear translocation of -catenin, the expression of T-cell factor-1 ([TF]) and subsequent activation of the promoter by the -catenin/TCF1 complex.	TCF1	MMP14	1	ACTIVATION	True
19187	19686	9582375:10:HNF1A:POMC	Both forms of HOXC11 potentiate transcriptional activation of the [TG] promoter by [TF].	HNF1alpha	LPH	1	ACTIVATION	True
19195	19694	11191885:10:HNF1A:UGT2B17	However, because these cells do not contain [TF], other transcription factors must regulate the [TG] promoter.	HNF1alpha	UGT2B17	0	UNDEFINED	True
19200	19699	16289024:4:HNF1A:WNT8A	Here, the modular cis-regulatory system of the [TG] gene of Strongylocentrotus purpuratus was characterized functionally, and shown to respond to blockade of both Blimp1/Krox and [TF]/beta-catenin inputs just as does the endogenous gene.	Tcf1	wnt8	0	UNDEFINED	True
19205	19704	8413240:2:HNF4A:HNF1A	By analyzing the promoter of the Xenopus [TG] gene, we identified potential autoregulation by LFB1 and regulation by [TF], a transcription factor with a tissue distribution similar to that of LFB1.	HNF4	LFB1	0	UNDEFINED	True
19206	19705	8622679:8:HNF4A:HNF1A	The v[TG] promoter is transactivated by COUP-TFI/Ear3 and COUP-TFII/Arp1 and, unlike the HNF1 promoter, is virtually unaffected by [TF].	HNF4	HNF1	0	UNDEFINED	True
19207	19706	14695187:10:HNF4A:TCF4	The ability of TIP49D302N to inhibit [TG] gene expression was linked to decreased acetylation of histones in the vicinity of the [TF]-binding sites in the ITF-2 promoter region.	TCF	ITF-2	1	ACTIVATION	True
19214	19713	18565323:4:LHX2:CGA	Using overexpression and knockdown approaches, we demonstrate that SSBP3 inhibits [TF] and Ldb1 turnover, stimulates assembly of this DNA-binding complex, promotes its recruitment to the [TG] promoter, and enhances Cga transcription.	Lhx2	Cga	0	UNDEFINED	True
19221	19720	7588318:13:NR1I2:CGA	Our studies demonstrate that both the [TF] and DRR are important for high level transcription of the [TG] gene in NE cells.	PRR	CgA	1	ACTIVATION	True
19229	19728	22449227:3:REST:CGA	The purpose of the present study is to define the molecular mechanisms of NCAM1, SYPT, and [TG] gene expressions, using cultivated lung cancer cells and focusing upon NeuroD1 (ND1), achaete-scute homolog-like 1 (ASCL1), and known transcription factors, repressor element 1 ([TF] (REST) and c-AMP responsive element-binding protein (CREB).	RE1)-silencing transcription factor	CGA	0	UNDEFINED	True
19230	19729	22231735:4:SOX4:TCF4	Of eight Sox factors investigated, [TF] could enhance -catenin/[TG] transcription, through upregulation of TCF4 at the transcription level, without any direct -catenin association.	Sox4	TCF4	1	ACTIVATION	True
19231	19731	11368006:4:SP1:FAS	Each of the GC boxes conferred [TF]-dependent transcription on the [TG]-Mini promoter and in the case of GC-I, Sp1, and Sp3 exert an additive effect on FAS promoter activity.	Sp1	FAS	1	ACTIVATION	True
19232	19732	12440974:2:SP1:FAS	The transcription factors, stimulatory proteins 1 and 3 ([TF] and Sp3), nuclear factor Y (NF-Y), upstream stimulatory factor (USF) and sterol regulatory element binding protein-1 (SREBP-1) have cognate binding sites on the promoter of the [TG] gene.	Sp1	FAS	0	UNDEFINED	True
19233	19733	19621387:7:SP1:FAS	Furthermore, mithramycin, which blocks [TF] binding sites, decreased proliferation, inhibited CDC25A and [TG] expression and reduced binding of Sp1 to the promoters of these genes as assessed by ChIP assays.	Sp1	FAS	1	ACTIVATION	True
19234	19734	7592729:4:SP1:FAS	It is also demonstrated that SREBP and [TF] synergistically activate the [TG] promoter in Drosophila tissue culture cells, which lack endogenous Sp1.	Sp1	FAS	1	ACTIVATION	True
19235	19735	9261184:11:SP1:FAS	The same relative positions of NF-Y and [TF] binding sites in the promoters of [TG] genes of goose, rat, chicken, and man emphasize the involvement of these transcription factors in the diet and hormonal regulation of FAS.	Sp1	FAS	0	UNDEFINED	True
19236	19736	12440974:2:SP3:FAS	The transcription factors, stimulatory proteins 1 and 3 (Sp1 and [TF]), nuclear factor Y (NF-Y), upstream stimulatory factor (USF) and sterol regulatory element binding protein-1 (SREBP-1) have cognate binding sites on the promoter of the [TG] gene.	Sp3	FAS	0	UNDEFINED	True
19237	19737	11790787:5:SREBF1:FAS	We demonstrate here that LXRs regulate [TG] expression through direct interaction with the FAS promoter as well as through activation of [TF]c expression.	SREBP-1	FAS	0	UNDEFINED	True
19239	19739	17197698:4:SREBF1:FAS	Furthermore, cotransfection of USF and [TF]c with an [TG] promoter-luciferase reporter construct in Drosophila SL2 cells results in highly synergistic activation of the FAS promoter.	SREBP-1	FAS	0	UNDEFINED	True
19240	19740	21447637:8:SREBF1:FAS	Furthermore, the XBP1-mediated stimulation of the [TG] promoter was eliminated by knocking down the [TF]c gene (Srebf1).	SREBP-1	FAS	1	ACTIVATION	True
19241	19741	12440974:2:SREBF1:FAS	The transcription factors, stimulatory proteins 1 and 3 (Sp1 and Sp3), nuclear factor Y (NF-Y), upstream stimulatory factor (USF) and sterol regulatory element binding protein-1 ([TF]) have cognate binding sites on the promoter of the [TG] gene.	SREBP-1	FAS	0	UNDEFINED	True
19242	19742	15220339:6:SREBF1:FAS	Chromatin immunoprecipitation also shows that [TF] is recruited efficiently to Red and [TG] promoters but not to SQS.	SREBP-1a	FAS	0	UNDEFINED	True
19243	19743	18281474:7:SREBF1:FAS	Moreover, our results of reporter assay and chromatin immunoprecipitation analysis indicate that [TF] strongly bound to the SREBP binding site/E-box sequence on the [TG] promoter under hypoxia.	SREBP-1	FAS	0	UNDEFINED	True
19245	19745	11855808:1:SREBF1:FAS	Sterol response element binding protein 1c ([TF]c) is a transcription factor that has been implicated in the regulation of expression of key lipogenic genes in hepatocytes, including fatty acid synthase ([TG]) and glucokinase.	SREBP-1	FAS	0	UNDEFINED	True
19248	19748	15627654:0:SREBF1:FAS	Regulation of [TF] expression and transcriptional action on HKII and [TG] genes during fasting and refeeding in rat tissues.	SREBP-1	FAS	0	UNDEFINED	True
19250	19750	17456898:5:SREBF1:FAS	Supportively, transcriptional activity of the mature form of [TF]c for the [TG] promoter was negligible when measured by reporter analysis.	SREBP-1	FAS	1	ACTIVATION	True
19252	19752	18420801:7:SREBF1:FAS	We also showed that [TG] upregulation by HCV NS2 was [TF]-dependent since deleting the SRE sequence in a FAS promoter and expressing a dominant-negative SREBP-1 abrogated FAS promoter upregulation by HCV NS2.	SREBP-1	FAS	1	ACTIVATION	True
19253	19753	20173757:6:SREBF1:FAS	Because [TG] was a target gene of [TF], we further showed that HBxDelta127 was able to strongly activate the promoter activity of FAS and upregulated the mRNA expression level of FAS as well, by luciferase reporter gene assay and RT-PCR.	SREBP-1c	FAS	0	UNDEFINED	True
19254	19754	22279139:6:SREBF1:FAS	This reduction was due to the decreased expression of [TF] and its responsive genes in fatty acid synthesis, including [TG], SCD1, and ACC1.	SREBP-1c	FAS	0	UNDEFINED	True
19255	19755	22768070:11:SREBF1:FAS	In terms of regulating [TG] expression, treatment of palmitoleate increased the transcription activity of [TF] and enhanced the binding of SREBP1c to FAS promoter.	SREBP1c	FAS	1	ACTIVATION	True
19256	19756	23065756:4:SREBF1:FAS	Furthermore, we found that a blockade of Akt/[TF] signaling through mollugin treatment significantly reduced [TG] expression and subsequently suppressed cell proliferation and induced apoptosis in HER2-overexpressing cancer cells.	SREBP-1c	FAS	1	ACTIVATION	True
19257	19757	23065756:7:SREBF1:FAS	These data provide evidence that mollugin inhibits proliferation and induces apoptosis in HER2-overexpressing cancer cells by blocking expression of the [TG] gene through modulation of a HER2/Akt/[TF] signaling pathway.	SREBP-1c	FAS	2	REPRESSION	True
19258	19758	23300015:5:SREBF1:FAS	Furthermore, RBP4 treatment enhanced the levels of mature [TF] and its nuclear translocation, thereby increasing the expression of lipogenic genes, including fatty acid synthase ([TG]), acetyl coenzyme A carboxylase-1 (ACC-1), and diacylglycerol O-acyltransferase 2 (DGAT-2).	SREBP-1	FAS	1	ACTIVATION	True
19261	19761	9421459:5:SREBF1:FAS	We also show that the promoters for both leptin and [TG] are transactivated by ADD1/[TF].	SREBP1	FAS	1	ACTIVATION	True
19269	19769	19262492:6:STAT1:FAS	As subjects with the -670AA genotype had a [TF] (STAT1)-binding site in the [TG] promoter region, STAT-1 activation by interferon-gamma may upregulate Fas expression in human vascular smooth muscle cells (VSMCs) of -670AA genotype subjects as described earlier.	signal transducer and activator of transcription 1	Fas	0	UNDEFINED	True
19275	19775	10987283:4:TCF4:ABCB1	Luciferase reporter and gel retardation assays revealed the [TF]/beta-catenin responsive elements in the promoter of the human [TG] gene.	TCF4	MDR1	0	UNDEFINED	True
19279	19786	17848139:7:TCF7L2:CFTR	Quantitative ChIP procedures indicate that HNF1alpha (hepatic nuclear factor 1alpha) and Cdx2 (caudal homeobox protein 2) occupy and regulate through a novel intronic enhancer element of [TG] and that [TF] (T-cell factor 4) overlaps the same DNA element.	Tcf4	CFTR	0	UNDEFINED	True
19284	19791	14990988:7:TP53:TCF4	Expression of a luciferase reporter controlled by the [TG] promoter is repressed by wild-type [TF], but not by a p53 mutant deficient in DNA binding.	p53	Tcf-4	2	REPRESSION	True
19286	19793	22290439:5:TWIST1:CDKN2A	Furthermore, [TF] inhibits the expression of the bHLH transcription factor E47, which is normally expressed in senescent MSCs and induces transcription of the [TG] promoter.	Twist-1	p16	2	REPRESSION	True
19287	19794	19924301:7:VDR:TCF7L2	In silico analysis of the human and mouse [TG] promoters identified several putative [TF] binding elements.	VDR	TCF7L2	0	UNDEFINED	True
19296	19803	9746364:7:FOSB:CYP11B1	Furthermore, when components of [TF] factors were overexpressed by transfecting Y1 cells with their expression vectors, a paired expression of AP-1 components such as c-Jun and c-Fos, which were inducible by corticotropin, transactivated the [TG] promoter more strongly in the absence of corticotropin than other combinations such as JunD and Fra-2 expressed constitutively.	AP-1	CYP11B1	1	ACTIVATION	True
19297	19804	10908602:6:FOSB:DBH	The induction of Fra2 and increased [TF]-like binding activity was reflected in sustained transcriptional activation of tyrosine hydroxylase and [TG] genes after repeated episodes of stress.	AP1	dopamine beta-hydroxylase	1	ACTIVATION	True
19316	19829	14521933:3:HNF1A:GCK	Since the promoters of three pancreas-specific genes involved in glucose homeostasis-insulin, [TG], and amylin bind similar transcription factors, we were interested in whether [TF] could also regulate amylin expression.	HNF1	glucokinase	0	UNDEFINED	True
19318	19831	1737937:8:FOSB:IL2	Northern analysis indicates that mRNAs for at least six members of the Fos/Jun family (c-fos, fosB, fra-1, c-jun, junB, and junD) are expressed in activated Ar-5 cells; thus the [TF] sites of the [TG] promoter may bind different dimeric Fos/Jun complexes at different times after T cell activation, perhaps mediating both positive and negative regulation of the IL-2 promoter.	AP-1	IL-2	0	UNDEFINED	True
19323	19836	17085443:9:TCF4:BEST1	Taken together, we suggest that [TG] is regulated by the MITF-TFE family through two E-boxes, with E-box 1 required for a direct interaction of MITF-TFE factors and [TF] for binding of the as yet unidentified factor(s).	E-box 2	VMD2	0	UNDEFINED	True
19325	19838	12408868:4:TCF4:CDKN1A	The [TF] target gene c-MYC plays a central role in this switch by direct repression of the p21(CIP1/[TG]) promoter.	TCF-4	WAF1	1	ACTIVATION	True
19339	19854	24265317:3:CREBZF:FAS	We found that [TF] inhibited T0901317 (T7)-induced transcriptional activity of LXR, which functions as a major regulator of lipid metabolism by inducing SREBP-1c, fatty acid synthase ([TG]), and acetyl-CoA carboxylase (ACC) gene expression.	SMILE	FAS	2	REPRESSION	True
19354	19869	22187159:8:RUNX2:FASN	Indeed, using SDS-PAGE, mass spectrometry and western analyses, we show that [TF] enhances secretion of several proteins, including [TG] and metastasis-associated laminins.	Runx2	fatty acid synthase	1	ACTIVATION	True
19378	19893	24265317:3:CREBZF:FASN	We found that [TF] inhibited T0901317 (T7)-induced transcriptional activity of LXR, which functions as a major regulator of lipid metabolism by inducing SREBP-1c, [TG] (FAS), and acetyl-CoA carboxylase (ACC) gene expression.	SMILE	fatty acid synthase	0	UNDEFINED	True
19387	19902	15816857:5:SP3:SCT	The human [TG] gene in SH-SY5Y cells is controlled by the (Sp1 + Sp4)/[TF] ratio and the RA-induced activation is a partial result of a decrease in Sp3 levels.	Sp3	secretin	0	UNDEFINED	True
19399	19914	21115105:10:VDR:CYP24A1	In conclusion, VPA enhances transcriptional activity of [TF] and increases expression of [TG] mRNA in the presence of VD3 in physiological concentrations.	VDR	CYP24	1	ACTIVATION	True
19405	19920	22115574:11:TBPL1:WEE1	Since KLF3-repressed [TG] promoter function was further inhibited by [TF] overexpression regardless of the inhibition degree of KLF3, we propose that TLP and KLF3 repress wee1 promoter independently.	TLP	wee1	2	REPRESSION	True
19407	19922	24733393:10:SP1:MMP14	Taken together, these results strongly suggest that CD81 stimulates melanoma cell motility by inducing [TG] expression through the Akt-dependent [TF] activation signaling pathway, leading to increased melanoma invasion and metastasis.	Sp1	MT1-MMP	1	ACTIVATION	True
19413	19928	10744738:6:MYC:CDKN1A	These results suggest that [TF] activates DNA replication via inactivation of [TG] and that p21, vice versa, represses the transcriptional activity of c-Myc.	c-Myc	p21	2	REPRESSION	True
19414	19929	10788799:0:TP53:CDKN1A	IL-1 induces expression of p21([TG]) independently of [TF] in high-passage human embryonic fibroblasts WI38.	p53	WAF1	1	ACTIVATION	True
19436	19953	11097743:2:TP53:CDKN1A	TNF-alpha induced expression of p21([TG])at protein and mRNA levels in a dose-dependent fashion with an association with G(1)-arrest in human colon cancer cells WiDr that carry mutated [TF] at codon 273 (His(273)).	p53	WAF1	2	REPRESSION	True
19437	19954	11097743:5:TP53:CDKN1A	Co-transfection of the [TF] His(273)expression construct with a luciferase gene controlled by the p21([TG])promoter showed that the p53 His(273)was inactive, although TNF-alpha increased the transcriptional rate of p21(WAF1)in these cells.	p53	WAF1	0	UNDEFINED	True
19438	19955	11126357:0:TP53:CDKN1A	Activation of the p21WAF1/[TG] promoter independent of [TF] by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.	p53	CIP1	1	ACTIVATION	True
19439	19956	11126357:7:SP3:CDKN1A	However, SAHA did not alter their DNA binding activities, suggesting that SAHA mediates [TG] promoter activity by a mechanism other than altering the DNA binding activities of Sp1 and [TF].	Sp3	p21	1	ACTIVATION	True
19440	19957	11136975:6:TP53:CDKN1A	This function of c-Jun is exerted through negative regulation of [TF] association with the [TG] promoter.	p53	p21	0	UNDEFINED	True
19441	19958	11145742:0:CEBPB:AKR1B10	SF-1 (steroidogenic factor-1), [TF] (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene ([TG]) expression in adrenocortical cells.	C/EBPbeta	AKR1B7	0	UNDEFINED	True
19448	19965	11313801:5:TP53:NTSR1	In p53 null cells (Hep3B), Ad.[TF] directed the same level of [TG] expression as Ad.p53NR which lacks the tkGC3-lacI cassette.	p53R	NTR	0	UNDEFINED	True
19454	19971	11348466:6:SP1:COL7A1	Transfection of human dermal fibroblasts with several extracellular matrix gene (COL1A1, COL1A2, COL3A1, COL5A2, [TG], TIMP-1, and decorin) promoter/reporter constructs demonstrated that anti-sense [TF]-induced reduction of extracellular matrix gene mRNA steady-state levels results from transcriptional repression, consistent with the role of Sp1 as a transcription factor.	Sp1	COL7A1	1	ACTIVATION	True
19462	19979	11429705:5:TP53:PAICS	We have determined the transactivation ability of 77 [TF] mutants using reporter yeast strains containing a p53-regulated [TG] gene whose promoter is regulated by p53 responsive elements derived from the regulatory region of the p21, Bax and PIG3 genes.	p53	ADE2	0	UNDEFINED	True
19468	19985	11477103:7:ZEB2:SLPI	We demonstrate that [TF] can repress LBK-[TG] promoter activity induced by constitutively active Alk2-Smad1/Smad5 and that this repression depends on the binding of SIP1 to the CACCT/CACCTG cluster present in this promoter.	SIP1	ALP	2	REPRESSION	True
19496	20014	12055601:2:NR1I2:SLCO1B3	We investigated whether [TG] gene expression is regulated by the nuclear receptors farnesoid X receptor/bile acid receptor (FXR/BAR; NR1H4), pregnane X receptor ([TF]), or liver X receptor (LXR).	PXR	OATP8	0	UNDEFINED	True
19500	20018	12149270:6:NR1H4:LDLR	Although it seems possible that [TF] might be involved in genetic regulation, both reporter assays with a reporter gene containing the [TG] promoter as well as Northern blot analysis reveal that FXR is not involved in the process.	FXR	LDL receptor	0	UNDEFINED	True
19507	20025	12243350:5:NR2C2:CCL5	Second, the expression of dominant negative mutants of TGF-beta-activated kinasel ([TF]) and NF-kappaB-inducing kinase (NIK), blocked the LPS-induced transcriptional activation of [TG] promoter.	TAK1	RANTES	1	ACTIVATION	True
19508	20026	12243350:6:NR2C2:CCL5	Moreover, the overexpression of [TF] along with TAK1-binding protein 1 (TAB1), or NIK stimulated the transcriptional activation of [TG] in the absence of external stimuli.	TAK1	RANTES	1	ACTIVATION	True
19529	20047	12631065:11:NR1I3:EDN1	In cells that express [TF], [TG] promoter was activated in a dose-dependent manner by extracellular calcium over the range of 0.5 to 3.0 mmol/L.	CaR	ET-1	1	ACTIVATION	True
19530	20048	12631065:8:NR1I3:EDN1	[TF] and [TG] promoter luciferase constructs were co-expressed in COS-7 cells and the ET-1 promoter activity following the addition of extracellular calcium was measured by the luciferase assay.	CaR	ET-1	0	UNDEFINED	True
19531	20049	12642900:9:MYRF:ACACB	In transient transfection in NIH3T3 fibroblast, the activation of [TG] promoter by MyoD, main [TF] in myoblast, was significantly suppressed by RARalpha and to a less extent by RXRalpha while the RXRalpha drastically augmented the activation by MRF4, major MRF in myotube.	MRF	ACCbeta	1	ACTIVATION	True
19537	20056	12713735:10:PRRX2:SERPINE2	It was demonstrated that [TF] directly regulates [TG] because (1) Prx2 binds to a cis element in the PN-1 promoter in vitro, and (2) Prx2 regulates the PN-1 promoter in transient transfection assays.	Prx2	PN-1	0	UNDEFINED	True
19538	20057	12748190:12:TP53:CDKN1A	Overexpressed c-Myc reduced the transcription of p21/[TG] and impaired [TF]-mediated repression but did not abolish repression by ectopic p21.	p53	CDKN1A	2	REPRESSION	True
19547	20066	12823590:4:TP53:CDKN1A	To explain the [TF]-independent regulation of [TG] by Core, we identified a Core-responsive element between positions -74 and -83 of the p21 promoter, exactly overlapped with a tumour growth factor beta (TGF-beta)/butyrate responsive element.	p53	p21	0	UNDEFINED	True
19560	20079	1431100:5:CEBPG:CCND1	We also show by antibody-depletion that [TF] activates the [TG] promoter in vitro.	Ig/EBP-1	BCL1	1	ACTIVATION	True
19561	20080	14507857:15:NFKB:VEGFA	[TG] expression appears to be regulated through dual interdependent mechanisms involving HIF-1 directly and indirectly through [TF]-mediated COX-2 expression and PGE(2) production.	NF-kappaB	VEGF	0	UNDEFINED	True
19565	20084	14530270:8:NFKB:CCND1	Together, these findings suggest a model wherein Pak1 regulation of [TG] expression might involve an [TF]-dependent pathway and that hyperplasia in the mammary glands of Pak1-TG mice may be associated, at least in part, with the up-regulation of cyclin D1, and that Pak1 is up-regulated in human breast tumors.	NF-kappaB	cyclin D1	0	UNDEFINED	True
19571	20090	14581561:10:TP53:CDKN1A	Furthermore, we showed that activation of p21([TG]) expression was repressed in cyclosporine-treated BDV-infected cells, as well as [TF]-transduced NCI-H1299 cells.	p53	waf1	2	REPRESSION	True
19578	20097	14653992:1:RORC:EIF4EBP1	The mammalian target of rapamycin ([TF]) regulates cell growth and proliferation via the downstream targets ribosomal S6 kinase 1 (S6K1) and [TG] (4E-BP1).	mTOR	eukaryotic translation initiation factor 4E binding protein 1	0	UNDEFINED	True
19582	20101	14673169:5:TP53:CDKN1A	BRG1 can associate with the [TG] promoter in a [TF]-independent manner, suggesting that the induction of p21 by BRG1 may be direct.	p53	p21	1	ACTIVATION	True
19585	20104	14695215:3:ZKSCAN7:VEGFA	We create potent transcriptional repressors by fusing a designed [TF] targeted to the [TG] promoter with either the ligand-binding domain of thyroid hormone receptor alpha or its viral relative, vErbA.	ZFP	VEGF-A	0	UNDEFINED	True
19588	20107	14729605:6:EPAS1:NR4A1	We show that HIF-1alpha, but not [TF], binds to a putative HIF responsive element in the [TG] promoter, activating the expression of Nur77.	HIF-2alpha	Nur77	0	UNDEFINED	True
19595	20114	15016316:8:NFKB:PTGS2	The present study was undertaken to determine the involvement of [TF] pathway and IkappaB (an inhibitor of NF-kappaB) in the regulation of [TG] expression and to determine more precisely the downstream targets of Akt involved in this process.	NF-kappaB	COX-2	0	UNDEFINED	True
19598	20117	15050414:12:RORC:VEGFA	Our results also indicated that the [TF]/FRAP inhibitor, rapamycin, inhibited 4-OHE2-induced HIF-1alpha and [TG] expression.	mTOR	VEGF-A	1	ACTIVATION	True
19605	20124	15150122:7:TP53:CDKN1A	Moreover, UCN-01 promoted the accumulation of [TG] at the mRNA level in the [TF]-deficient HaCaT cells without increase in the p21 mRNA half-life, suggesting that UCN-01 induced p21 at the transcriptional level.	p53	p21	2	REPRESSION	True
19618	20137	15269344:7:CUX1:CDKN3	The endogenous level of p21(waf1/[TG]) expression is repressed through [TF]/cut and mediated by HKMT activity of G9a.	CDP	cdi1	2	REPRESSION	True
19623	20142	15345217:0:NFKB:MYC	The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/[TF]-dependent [TG] expression.	NF-kappaB	c-myc	0	UNDEFINED	True
19628	20147	15383550:11:DLX5:SLPI	Thus, [TF] transactivates [TG] expression, directly by binding to its cognate response element and/or indirectly by stimulating Runx2 expression, and Msx2 counteracts the direct transactivation of Dlx5.	Dlx5	ALP	1	ACTIVATION	True
19629	20148	15383550:5:DLX5:SLPI	[TF] and the product of its target gene, Runx2, stimulated [TG] promoter activity in an additive manner.	Dlx5	ALP	1	ACTIVATION	True
19636	20156	15528212:4:TP53:CDKN1A	Because K562 cells are deficient for p15INK4b, p16INK4a, p14ARF, and [TF], this would be the main mechanism whereby Ras up-regulates [TG] expression in these cells.	p53	p21	2	REPRESSION	True
19637	20157	15545628:3:HNF4A:DLL1	LEF/[TF] factors cooperate with TBX6 to activate transcription from the [TG] promoter in vitro.	TCF	Dll1	1	ACTIVATION	True
19643	20163	15652748:5:NFKB:CCND1	Mechanistically, the effects of Vav1 require its GEF activity and the activation of Rac1, PAK1, and [TF] and involve [TG] upregulation.	NF-kappaB	cyclin D1	1	ACTIVATION	True
19648	20168	15716483:9:PPARA:EGR1	In conclusion, PAHs activate [TF] and PPAR beta/delta, and up-regulate [TG] expression in vitro as well as in vivo.	PPAR alpha	EGR-1	1	ACTIVATION	True
19657	20177	15843409:5:TBX20:F8	[TF] could activate promoters/enhancers of several genes in cultured cells, including the Mef2c [TG] and the Nkx2-5 cardiac enhancer.	Tbx20	AHF enhancer	1	ACTIVATION	True
19672	20192	16007255:3:NR1H3:REN	In the present study, we investigated the role of liver X receptor alpha ([TF])) and LXR(beta) in the regulation of [TG].	LXR(alpha	renin	0	UNDEFINED	True
19675	20195	16026328:9:ATF4:ASNS	Immediately following amino acid removal, the kinetics of binding for [TF], ATF3, and C/EBPbeta itself to the 93 bp regulatory region were similar to those observed for the amino-acid-responsive [TG] gene.	ATF4	asparagine synthetase	0	UNDEFINED	True
19679	20199	16150866:6:CEBPA:NAPSA	Using several genetically deficient mouse models and different pharmacologic and hormonal treatments, we determined that thyroid and GH modulate [TF] levels that, in turn, control [TG] expression in PCT cells in a developmentally dependent manner.	CCAAT/enhancer binding protein alpha and beta	KAP	0	UNDEFINED	True
19686	20206	16243295:5:HNF4A:CCND1	Eliminating the [TF]/LEF consensus site from the [TG] promoter diminished the effect of DIF-1.	TCF	cyclin D1	0	UNDEFINED	True
19697	20217	16440308:0:JUN:VEGFA	[TF] kinase mediates expression of [TG] induced at transcriptional level by Rac1 and Cdc42Hs but not by RhoA.	c-Jun	VEGF	1	ACTIVATION	True
19698	20218	16440308:7:JUN:VEGFA	Interestingly, we found that [TF] kinase chemical inhibition as well as transient transactivation assays using dominant negative c-Jun kinase mutant abolished the [TG] promoter transcriptional induction by Rac1 and Cdc42 but not by RhoA.	c-Jun	VEGF	1	ACTIVATION	True
19702	20222	16452189:6:HNF4A:FGF9	Evidence that beta-catenin and [TF]s regulate [TG] expression in several epithelial cell lines was obtained.	TCF	FGF9	0	UNDEFINED	True
19707	20227	16508963:7:NFKB:PTGS2	Association of phosphorylated H3, [TF] (NF-kappaB), and RNA polymerase II to the [TG] gene promoter was evaluated by chromatin immunoprecipitation (ChIP).	RelA	COX-2	0	UNDEFINED	True
19710	20231	16565071:3:NFIC:ACTG1	Here we identify a new regulatory element, located within the -13-kb enhancer of the [TG] gene, that binds nuclear factor-1 ([TF]) and is indispensable for the full basal transcriptional activity of the ACT gene.	NFI	ACT	1	ACTIVATION	True
19711	20232	16572115:5:NFKB:PTGS2	To determine whether TGFbeta1 activates elements of the [TG] promoter, we performed gel shift analyses to examine activation of activator protein-1 (AP-1) and nuclear factor kappaB ([TF]).	NF-kappaB	COX-2	0	UNDEFINED	True
19715	20236	16618748:8:RORC:VEGFA	The BDNF-stimulated increases in HIF-1alpha and [TG] expression required TrkB tyrosine kinase activity and were completely blocked by inhibitors of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin ([TF]) pathways.	mTOR	VEGF	1	ACTIVATION	True
19718	20239	16652147:8:RUNX1:SUV39H1	The association between [TF], histone deacetylases and [TG] provides a molecular mechanism for repression and possibly gene silencing mediated by RUNX1.	RUNX1	SUV39H1	0	UNDEFINED	True
19719	20240	16682453:8:RORC:VEGFA	IGF-1-stimulated [TG] promoter activity was phosphatidylinositol 3-kinase (PI3K)/Akt/[TF] (mammalian target of rapamycin)-dependent, whereas VEGF secretion was only partially reduced by inhibition of PI3K/Akt/mTOR and HIF-1 activities.	mTOR	VEGF	1	ACTIVATION	True
19728	20249	16757381:8:CEBPZ:PDK4	The p300/CBP may enhance acetylation of histones bound to the h[TG] promoter and cooperate with Sp1 and [TF] to stimulate transcription of the hPDK4 gene in response to RA and TSA.	CBF	PDK4	1	ACTIVATION	True
19729	20250	16757577:10:ATF6:DDIT3	C/EBPbeta is selective and binding to the [TG] promoter precedes that of XBP-1, [TF] and CHOP.	ATF6	CHOP	0	UNDEFINED	True
19732	20253	16772530:7:RELA:PTGS2	Using chromatin immunoprecipitation, we observed that IL-1beta stimulated recruitment of NF-kappaB [TF] to both proximal and distal NF-kappaB elements of the [TG] promoter; these effects were diminished by coincubation with progesterone.	p65	COX-2	0	UNDEFINED	True
19740	20261	16835303:4:TP53:VEGFA	Under hypoxic conditions, E2F1 down-regulates the expression of [TG] promoter activity by associating with [TF] and specifically down-regulating expression of VEGF but not other hypoxia-inducible genes, suggesting a promoter structure context-dependent regulation mechanism.	p53	VEGF	2	REPRESSION	True
19744	20265	16865543:5:NFKB:VEGFA	The role of [TF] and Hypoxia Inducible Factor-1alpha (HIF-1alpha) in the transcriptional regulation of Vascular Endothelial Growth Factor ([TG]) in macrophages was investigated using CMV-promoter-driven expression of either wild type or dominant negative proteins involved in these pathways.	NF-kappaB	VEGF	0	UNDEFINED	True
19748	20269	16912181:6:WT1:CCND1	Overexpression of [TF] and STAT3CA in NIH 3T3 increases the expression level of STAT3 target genes, including [TG] and Bcl-xL, which results in an advantage of cell proliferation.	WT1	cyclin D1	1	ACTIVATION	True
19756	20277	16990795:3:CUX1:CCND1	However, stimulation of [TG] expression alone cannot account for all the cell cycle effects of p52/[TF] and we also find that p52 represses expression of the Cyclin-dependent kinase inhibitor p21(WAF/CIP1).	p100	Cyclin D1	1	ACTIVATION	True
19761	20282	17056252:9:SP1:SLC7A1	Surprisingly, RIP140 positively regulates [TG] transactivation when the receptors are recruited to target promoters through interaction with the [TF] transcription factor and this effect could involve titration of histone deacetylases.	Sp1	ERR	1	ACTIVATION	True
19787	20308	17158882:7:CREB1:PCNA	Using chromatin immunoprecipitation, we provide evidence that HBx physically occupied the [TF]-binding domain of CREB-responsive promoters of endogenous cellular genes such as interleukin 8 and [TG].	CREB	proliferating cell nuclear antigen	0	UNDEFINED	True
19795	20316	17259176:6:LBX1:NRP2	Both [TF] repress [TG] expression in vitro, confirming the functional significance of DLX binding.	homeobox proteins	Nrp-2	2	REPRESSION	True
19796	20317	17287278:5:AP1:ANG	Mechanistically, KSHV activated the [TG] promoter via [TF] and Ets1 transcriptional factors, which were mediated by ERK, JNK, and p38 mitogen-activated protein kinase (MAPK) pathways.	AP-1	Ang-2	1	ACTIVATION	True
19809	20330	17363560:10:NFKB:PTGS2	Results identify both [TG] and Opn as transcriptional targets of TAM67 with CRE, but not [TF] sites important in the Cox-2 promoter and an AP-1 site important in the Opn promoter.	NFkappaB	Cox-2	0	UNDEFINED	True
19811	20332	17384033:2:NFKB:PTGS2	Here we investigated the role of Nuclear Factor kappaB ([TF]) in the regulation of [TG] expression in synovial fibroblasts from human TMJ induced by tumor necrosis factor-alpha (TNF-alpha).	NF-kappaB	COX-2	0	UNDEFINED	True
19812	20333	17384033:4:NFKB:PTGS2	Electrophoretic mobility shift assay (EMSA) revealed that transient [TF] activation in the [TG] promoter was triggered by TNF-alpha.	NF-kappaB	COX-2	0	UNDEFINED	True
19815	20336	17412694:5:GATAD2B:CCND1	The phosphorylated [TF] (referred to as phospho-p68) promotes cell proliferation by activating the transcription of [TG] and c-Myc genes.	p68	cyclin D1	1	ACTIVATION	True
19816	20337	17412694:6:GATAD2B:CCND1	We show that the ATPase/helicase activities of [TF] are required for the activation of [TG] transcription.	p68	cyclin D1	1	ACTIVATION	True
19817	20338	17412694:7:GATAD2B:MYC	The phospho-[TF] participates in the complex assembled at the cyclin D1 and [TG] promoters, which strongly suggests a direct role in transcriptional regulation.	p68	c-Myc	0	UNDEFINED	True
19819	20340	17426454:6:NFKB:CCND1	We conclude that, in MEFs, Rac-mediated induction of [TG] mRNA requires activation of a parallel [TF] pathway whereas ERK induces cyclin D1 transcription independent of NFkappaB.	NFkappaB	cyclin D1	1	ACTIVATION	True
19821	20342	17464208:2:CREB1:VEGFA	In the present study we investigated the possible role of [TF] in the expression of vascular endothelial growth factor ([TG]) by mouse macrophages.	CREB	VEGF	0	UNDEFINED	True
19839	20360	17632087:7:NFKB:PTGS2	The activation of key signaling molecules, ERK, p38 MAPK, CREB and [TF], involved in the [TG] transcription was further studied at the phosphorylation step.	NF-kappaB	COX-2	0	UNDEFINED	True
19840	20361	17632087:9:NFKB:PTGS2	The role of CREB and [TF] in I-BOP-induced [TG] expression was further explored at the promoter level.	NF-kappaB	COX-2	1	ACTIVATION	True
19844	20365	17668048:7:IRF1:CCND1	In a recent report we have shown that S[TF]1 represses [TG] transcription through recruitment of HDAC1 dependent repressor complex at the MAR site of Cyclin D1 promoter.	MAR	Cyclin D1	2	REPRESSION	True
19847	20368	17873065:7:NR2E1:CDKN1A	Recruitment of HDACs led to transcriptional repression of [TF] target genes, the cyclin-dependent kinase inhibitor, p21(CIP1/[TG])(p21), and the tumor suppressor gene, pten.	TLX	WAF1	0	UNDEFINED	True
19857	20378	17986608:4:PAX3:EGR1	This defect is caused by reduced levels of the [TG] transcriptional activator resulting from a direct, destabilizing interaction with [TF]-FOXO1.	PAX3	EGR1	0	UNDEFINED	True
19858	20379	17993259:4:RORC:MYC	The PKB-dependent mechanism of insulin-stimulated [TG] expression in HT29 cells was shown to involve the activation of [TF] in c-Myc translation.	mTOR	c-Myc	1	ACTIVATION	True
19859	20380	17997399:4:TRPS1:CCND1	Our analyses revealed that [TF] is a repressor of Stat3 expression, which in turn controls chondrocyte proliferation and survival by regulating the expression of [TG] and Bcl2.	Trps1	cyclin D1	0	UNDEFINED	True
19860	20381	17997399:5:TRPS1:CCND1	Our conclusion is supported (i) by siRNA-mediated depletion of Stat3 in [TF]-deficient chondrocytes, which normalized the expression of [TG] and Bcl2, (ii) by overexpression of Trps1 in ATDC5 chondrocytes, which diminished Stat3 levels and increased proliferation and apoptosis, and (iii) by mutational analysis of the GATA-binding sites in the Stat3 gene, which revealed that their integrity is critical for the direct association with Trps1 and for Trps1-mediated repression of Stat3.	Trps1	cyclin D1	0	UNDEFINED	True
19876	20397	18287524:2:ID3:SLPI	In this study, we established that inhibitor of differentiation (Id) proteins, including Id1, Id2, and [TF], associate with core binding factor alpha-1 (Cbfa1) to cause diminished transcription of the alkaline phosphatase ([TG]) and osteocalcin (OCL) gene, leading to less ALP activity and osteocalcin (OCL) production.	Id3	ALP	2	REPRESSION	True
19886	20407	18353896:4:HNF4A:CCND1	beta-Catenin promotes cell proliferation by activation of a family of T-cell factor ([TF]) transcription factors, which drive the transcription of genes implicated in cell cycle progression including [TG].	TCF	cyclin D1	1	ACTIVATION	True
19920	20441	18799618:2:HNF4A:TGFB3	Here, we show that Snail and Slug promote formation of beta-catenin-T-cell factor ([TF])-4 transcription complexes that bind to the promoter of the [TG] gene to increase its transcription.	TCF	TGF-beta3	1	ACTIVATION	True
19923	20444	18845538:0:JUN:KIF11	Parkin regulates [TG] expression by Hsp70 ubiquitination-dependent inactivation of [TF] NH2-terminal kinase.	c-Jun	Eg5	2	REPRESSION	True
19927	20448	18940792:0:ATF4:ASNS	C/EBP homology protein (CHOP) interacts with [TF] (ATF4) and negatively regulates the stress-dependent induction of the [TG] gene.	activating transcription factor 4	asparagine synthetase	2	REPRESSION	True
19929	20450	18952601:6:HNF4A:VEGFA	[TG] promoter reporter constructs identified a region of the VEGF promoter containing two T cell factor ([TF])-binding sites as necessary for TGFbeta(1)-induced VEGF transcription.	TCF	VEGF	0	UNDEFINED	True
19931	20452	18981260:1:NR1I2:CYP24A1	We have studied the molecular mechanism by which the nuclear xenobiotic receptors pregnane X receptor ([TF]) and constitutive active/androstane receptor (CAR) regulate transcription of the vitamin D(3) 24-hydroxylase ([TG]) gene.	PXR	CYP24A1	0	UNDEFINED	True
19932	20453	18981260:1:NR1I3:CYP24A1	We have studied the molecular mechanism by which the nuclear xenobiotic receptors pregnane X receptor (PXR) and constitutive active/androstane receptor ([TF]) regulate transcription of the vitamin D(3) 24-hydroxylase ([TG]) gene.	CAR	CYP24A1	0	UNDEFINED	True
19934	20455	18987887:8:MYOG:MUC2	In addition, chromatin immunoprecipitation (ChIP) and re-ChIP showed that [TF] and MEF2C were associated with the activated [TG] promoter.	myogenin	MLP	1	ACTIVATION	True
19935	20456	1900040:3:AP1:FOS	delta [TF] retains the dimerization and DNA-binding activities of FosB but has lost the ability in transfection assays to activate a promoter with an [TG] and to repress the c-fos promoter.	FosB	AP-1 site	1	ACTIVATION	True
19945	20466	19088796:7:NFKB:SERPINE1	In addition, we also found that the inhibition of [TG] synthesis by antisense oligonucleotide to PAI-1 mRNA results in markedly increased u-PAR expression and that [TF] and AP-1 are involved in this regulation.	NF-kappaB	PAI-1	0	UNDEFINED	True
19955	20476	19129222:5:NR1I2:CYP4F12	The role of [TF] in the basal and inductive response of [TG] was confirmed in hepatocytes in which PXR was silenced.	PXR	CYP4F12	1	ACTIVATION	True
19966	20487	19220857:5:JUN:AGT	Likewise, angiotensin II resulted in similar enhancements of the DNA-binding activity of STAT5B and [TF] in angiotensin II-induced [TG] expression.	c-Jun	angiotensinogen	0	UNDEFINED	True
19970	20491	19269978:6:MYOD1:SMN1	We found that Barx2 binds to the HBS element and potentiates up-regulation of [TG] promoter activity by [TF].	MyoD	SMA	1	ACTIVATION	True
19971	20492	19269978:7:MYOD1:SMN1	We also show that Barx2, [TF], and serum response factor simultaneously occupy the [TG] promoter in cells and that Barx2 interacts with MyoD.	MyoD	SMA	0	UNDEFINED	True
19976	20497	19413886:8:HNF4A:CCND1	Moreover, suppression of endogenous URG11 expression results in decreased activation of beta-catenin/[TF] and its downstream effector genes, [TG] and membrane type 1 matrix metallopeptidase (MT1-MMP), which are known to be involved in cell proliferation and invasion, respectively.	TCF	cyclinD1	0	UNDEFINED	True
19996	20517	19710540:8:NFKB:FAS	Overexpression of IkappaBalpha by transient transfection or inhibition of [TF] by BAY11-7082 suppressed HDGF knock-down effect on [TG] promoter activation, Fas up-regulation, apoptosis induction and growth suppression.	NF-kappaB	fas	2	REPRESSION	True
20007	20528	19783677:4:NFKB:PTGS2	IL-1beta stimulation induced gene looping in [TG] and MMP13 genomic loci, which is mediated by the physical interaction of Lef1 with its binding partners, including beta-catenin, AP-1, and [TF].	NF-kappaB	COX2	0	UNDEFINED	True
20008	20529	19800042:0:NFKB:CCND1	An inhibitory role of p53 via [TF] element on the [TG] gene under heat shock.	NF-kappaB	cyclin D1	2	REPRESSION	True
20030	20551	20053791:0:CREB1:CTGF	[TF] trans-activation of disruptor of telomeric silencing-1 mediates forskolin inhibition of [TG] transcription in mesangial cells.	CREB	CTGF	2	REPRESSION	True
20031	20552	20053791:12:CREB1:CTGF	We conclude that forskolin stimulates [TF]-mediated trans-activation of the Dot1 gene, which leads to hypermethylation of histone H3K79 at the [TG] promoter, and inhibition of CTGF transcription.	CREB	CTGF	0	UNDEFINED	True
20035	20556	20118482:4:NR1H3:REN	In this study we test the hypothesis that [TF] plays an important role not only in [TG] expression but also in renin-containing cell differentiation, specifically from the mesenchymal stem cell (MSC), which may be the origin of the JG cell.	LXRalpha	renin	0	UNDEFINED	True
20040	20561	20154722:11:GATA3:CCND1	Chromatin immune precipitation confirmed binding of [TF] to the [TG] promoter.	GATA3	Cyclin D1	0	UNDEFINED	True
20041	20562	20160059:10:CREB1:CCND1	Our study suggest that ZIP4 overexpression causes increased IL-6 transcription through [TF], which in turn activates STAT3 and leads to increased [TG] expression, resulting in increased cell proliferation and tumor progression in pancreatic cancer.	CREB	cyclin D1	1	ACTIVATION	True
20042	20563	20164184:7:NR2C2:CXCL10	Furthermore, we show that HBx induces activation of NF-kappaB through the TRAF2/[TF] signaling pathway, leading to up-regulation of [TG] expression.	TAK1	IP-10	1	ACTIVATION	True
20058	20579	20432243:8:NFKB:VEGFA	Dimethyl bisphenol A, the HIF-1alpha inhibitor, decreased [TG] mRNA expression, whereas blocking [TF], AP-1, and NFATc1 had no effect.	NF-kappaB	Vegfa	2	REPRESSION	True
20059	20580	20439707:2:CEBPD:CCNB1	Here, we report that [TF] induces expression of the Cdc27 (APC3) subunit of the anaphase promoting complex/cyclosome (APC/C), which results in the polyubiquitination and degradation of the prooncogenic cell cycle regulator cyclin D1, and also down-regulates [TG], Skp2, and Plk-1.	C/EBPdelta	cyclin B1	2	REPRESSION	True
20062	20583	20479568:8:KLF4:CCND1	These results suggest that PR agonists induce [TF] expression and then inhibit [TG] expression, and consequently inhibit cell proliferation in human endometrial epithelial cells.	KLF4	cyclin D1	0	UNDEFINED	True
20065	20586	20571031:11:HNF4A:CTGF	Hence, we propose that differential occupancy of the [TF] x LEF x Sox9 site by Sox9 versus beta-catenin restricts high levels of [TG] expression to hypertrophic chondrocytes.	TCF	Ccn2	0	UNDEFINED	True
20066	20587	20571031:8:HNF4A:CTGF	Luciferase, electrophoretic mobility shift assay (EMSA), and ChIP analysis revealed that Sox9 represses [TG] expression by binding to the consensus [TF] x LEF x Sox9 site.	TCF	Ccn2	0	UNDEFINED	True
20067	20588	20571031:9:HNF4A:CTGF	On the other hand, the same assays showed that in hypertrophic chondrocytes, [TF] x LEF x beta-catenin complexes occupy the consensus TCF x LEF x Sox9 site and activate [TG] expression.	TCF	Ccn2	1	ACTIVATION	True
20068	20589	20574527:6:RORC:VEGFA	In addition, activation of phosphatidylinositol 3-kinase (PI3K)-dependent integrin linked kinase (ILK)-AKT-mammalian target of rapamycin ([TF]) pathway is required for ET(B)R-mediated PHD2 inhibition, HIF-1alpha, HIF-2alpha, and [TG] expression.	mTOR	VEGF	1	ACTIVATION	True
20077	20598	20665674:3:RORC:DUSP6	We first confirm the key role of MEK/ERK in maintaining the levels of [TG] mRNA, while PI3K/[TF], p38 MAPK, and JNK signaling pathways had no significant effects.	mTOR	dusp6	1	ACTIVATION	True
20079	20600	20723226:12:NR1I2:TNC	Over expression of NF-kappaB, EGFR, and [TG], are among the effects of [TF] activation and TN-C induces EGFR activation in an autocrine manner.	PAR1	TN-C	1	ACTIVATION	True
20086	20608	20861226:0:PPARG:REN	[TF]-dependent regulation of adenylate cyclase 6 amplifies the stimulatory effect of cAMP on [TG] gene expression.	PPARgamma	renin	1	ACTIVATION	True
20093	20615	20940401:4:MYC:BRCA2	Chromatin immunoprecipitation studies showed that [TF] associates with several DSB repair gene promoters including Rad51, Rad51B, Rad51C, XRCC2, Rad50, BRCA1, [TG], DNA-PKcs, XRCC4, Ku70, and DNA ligase IV.	MYC	BRCA2	0	UNDEFINED	True
20117	20641	21344481:6:CREB1:EPHA2	Similarly, activation of [TF] by the adenylate cyclase agonist forskolin failed to induce [TG] promoter activation.	CREB	EphA2	1	ACTIVATION	True
20119	20643	21394106:0:NR1I2:VEGFA	Cathepsin B and [TF] knockdown inhibits tumor-induced angiogenesis by modulating [TG] expression in glioma.	uPAR	VEGF	0	UNDEFINED	True
20120	20644	21394106:4:NR1I2:VEGFA	In the present study, we observed that knockdown of [TF] and cathepsin B using puPAR (pU), pCathepsin B (pC), and a bicistronic construct of uPAR and cathepsin B (pCU) caused significant inhibition of angiogenesis by disrupting the janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway-dependent expression of vascular endothelial growth factor ([TG]).	uPAR	VEGF	1	ACTIVATION	True
20121	20645	21394106:5:NR1I2:CCND1	Further, transcriptional suppression of [TF] and cathepsin B inhibited tumor-induced migration, proliferation of endothelial cells and decreased tumor-promoted expression of VEGF receptor-2, Rac1, gp91phox, [TG], cyclin dependent kinase 4 and p-Rb in human dermal microvascular endothelial cell.	uPAR	cyclin D1	1	ACTIVATION	True
20136	20661	21628529:4:CTCF:DIO3	Here we report that cohesins colocalize with [TF] at two additional imprinted loci, the Dlk1-[TG] and the Kcnq1/Kcnq1ot1 loci.	CTCF	Dio3	0	UNDEFINED	True
20151	20676	21711161:2:POU1F1:AKR1B10	[TF] binding to [TG] is required for efficient pituitary expression.	Pit-1	HS I/II	1	ACTIVATION	True
20161	20686	21886838:0:RORC:VEGFA	Calcineurin inhibitor-induced and Ras-mediated overexpression of [TG] in renal cancer cells involves [TF] through the regulation of PRAS40.	mTOR	VEGF	1	ACTIVATION	True
20165	20690	21927026:6:TP53:POU5F1	Here, using [TF]-/- mice expressing green fluorescent protein and the puromycin resistance gene under the control of the [TG] promoter, we show that OCT-4 is expressed in 5% onwards of the undifferentiated tumour cell populations derived from different organs.	p53	Oct-4	0	UNDEFINED	True
20166	20691	21955753:10:ID1:CCND1	The increase in cell migration following [TG] silencing in MDA-MB-231 cells was abolished by [TF] siRNA treatment and we observed cyclin D1 occupancy of the Id1 promoter region.	Id1	cyclin D1	2	REPRESSION	True
20179	20704	22093699:4:NR1I3:ABCG2	Reporter assays suggested the existence of an h[TF]-responsive element between -8000 and -7485 of h[TG] promoter.	CAR	ABCG2	0	UNDEFINED	True
20181	20706	22120493:8:HNF4A:POU5F1	Through promoter mapping and chromatin immuno-precipitation assays, we found that [TG] is a direct target of -catenin/[TF]-mediated transcription and the binding site at -875/-881 of Oct4 promoter is critical for b-catenin/TCF-dependent expression regulation.	TCF	Oct4	0	UNDEFINED	True
20190	20716	22278040:4:PITX2:REN	Here, we determined whether another nuclear receptor, Nr2f2 (Coup-TFII, [TF]), identified in a screen of proteins that bind the HRE, also regulates [TG] expression.	Arp-1	renin	0	UNDEFINED	True
20191	20717	22278040:7:NR2F2:REN	Surprisingly, baseline expression of endogenous [TG] was not effected when [TF] was knocked down in As4.1 cells, whereas knockdown of Nr2f6 increased renin expression twofold.	Nr2f2	renin	0	UNDEFINED	True
20192	20718	22292946:14:SREBF1:EGR1	Importantly, [TG] upregulation paralleled the expression and transcriptional activity of [TF].	SREBP1c	EGR1	1	ACTIVATION	True
20209	20735	22362755:0:NR0B2:DNMT1	Zinc-induced [TG] expression involves antagonism between MTF-1 and nuclear receptor [TF].	SHP	Dnmt1	0	UNDEFINED	True
20212	20738	22362755:5:NR0B2:DNMT1	[TF] in turn represses MTF-1 expression and abolishes zinc-mediated changes in the chromatin configuration of the [TG] promoter.	SHP	Dnmt1	0	UNDEFINED	True
20213	20739	22381696:8:NANOG:CCNE1	Interestingly, we found that the expression levels of [TG] and c-myc were markedly down-regulated and the cell cycle were blocked at the G0/G1 phases after the knockdown of [TF], while the expression of cyclinE and signal transducers and activators of transcription3 (STAT3) remained unaffected.	NANOG	cyclinD1	1	ACTIVATION	True
20221	20747	22431734:3:LEF1:H2AFX	-catenin and its DNA-binding partner [TF] indirectly increase levels of [TG] by suppressing the promoter of the RNF8 ubiquitin ligase, which decreases levels of H2AX protein under conditions of low intercellular contact.	LEF-1	H2AX	1	ACTIVATION	True
20223	20749	22474292:7:ID1:SMN1	Inhibitor of differentiation 1 ([TF]) was further induced by extended treatment with AGE, thereby dislodging Scx from the [TG] promoter.	Id1	SMA	0	UNDEFINED	True
20236	20762	22711822:7:YBX3:CDKN1A	Up-regulation is mediated by [TF] binding to specific sites in the 3'-untranslated region of the [TG] mRNA, resulting in mRNA stabilization and enhanced translation.	ZONAB	p21	1	ACTIVATION	True
20237	20763	22711822:8:YBX3:CDKN1A	Binding of [TF] to mRNA is activated by GEF-H1 via Rho stimulation and also mediates Ras-induced [TG] expression.	ZONAB	p21	1	ACTIVATION	True
20243	20769	22803374:5:NFKB:PTGS2	[TF] in the vicinity of [TG] promoter-262 was an important cis-acting element of brucine for inhibiting the activity of COX-2 promoter.	NF-kappaB	COX-2	0	UNDEFINED	True
20250	20776	22879953:8:SATB1:TTR	We show that [TF] (SATB1), specifically expressed in T-cells, binds to the early domain immediately adjacent to [TG] and delays the replication timing of the TTR.	Special AT-rich sequence Binding protein 1	TTR	0	UNDEFINED	True
20252	20778	22890831:10:IRF1:MKI67	It suggests that the inhibitory effect on [TG] gene expression mediated by decreasing level of Sp1 protein might be a novel function of the anti-tumor activity of [TF].	IRF1	Ki-67	0	UNDEFINED	True
20253	20779	22890831:9:IRF1:MKI67	Our findings establish a casual series of events that connect anti-proliferative effects of [TF] with the [TG] gene, which encodes a key regulator of the G1/S phase transition.	IRF1	Ki-67	0	UNDEFINED	True
20255	20781	22897851:3:RUNX1:MYB	We show that TAL1 forms a positive interconnected autoregulatory loop with GATA3 and [TF] and that the TAL1 complex directly activates the [TG] oncogene, forming a positive feed-forward regulatory loop that reinforces and stabilizes the TAL1-regulated oncogenic program.	RUNX1	MYB	0	UNDEFINED	True
20290	20817	23438076:4:NPAS4:TGFB3	In the present study, we found that mouse [TF]3, specifically expressed in principal cells in segment II of the caput epididymis, as well as Sertoli cells in the mouse testis, was required to mediate TGF- (transforming growth factor )-induced down-regulation of [TG]/TGF-3 mRNA expression and protein secretion in Sertoli cells.	NXF	Tgfb3	2	REPRESSION	True
20293	20820	23538752:6:RORC:FANCD2	Consistent with these genetic findings, inactivation of [TF] in human lymphoblast cells by pp242 or Torin 1, mTOR kinase inhibitors, suppresses [TG] expression and causes a defective DDR that can be rescued by reconstitution of exogenous FANCD2.	mTOR	FANCD2	1	ACTIVATION	True
20295	20822	23596302:4:IRF3:RSAD2	RSV infection induces ISG54, ISG56, and [TG] gene expression in an [TF]-dependent manner demonstrated by IRF3 small interfering RNA (siRNA) silencing in both A549 epithelial cells and IRF3(-/-) MEFs.	IRF3	CIG5	1	ACTIVATION	True
20296	20823	23630076:4:ZGPAT:TNFSF10	We discovered that the [TF] transcriptional repressor NFIL3 (nuclear factor interleukin 3-regulated) hindered FOXO transcription factor access to chromatin at the [TG] promoter by binding to nearby DNA and recruiting histone deacetylase-2 (HDAC2) to reduce histone acetylation.	bZIP	TRAIL	0	UNDEFINED	True
20297	20824	23650552:0:TP53:KIF23	[TF] and cell cycle dependent transcription of [TG] (KIF23) is controlled via a CHR promoter element bound by DREAM and MMB complexes.	p53	kinesin family member 23	1	ACTIVATION	True
20307	20834	23733932:4:ATF3:DHFR	Although the [TF] target genes, including [TG] (DHFR), were unable to recover RNA synthesis in CSB-deficient cells, transcription was restored rapidly in normal cells.	ATF3	dihydrofolate reductase	0	UNDEFINED	True
20310	20837	23769673:3:HNF4A:TRIB2	Here, we identify tribbles homolog 2 ([TG]) as a direct target of Wnt/[TF] in liver cancer and demonstrate that transcription of Wnt target genes, including TRIB2, is coordinated by the TCF and FoxA transcription factors in liver cancer cells.	TCF	TRIB2	0	UNDEFINED	True
20317	20844	23907762:8:ZBED1:E2F1	From these results and previous reports, we conclude that regulation of [TG] and PCNA by [TF] in vivo is complex and the regulation mechanism may differ with the tissue and/or positions in the tissue.	DREF	e2f1	0	UNDEFINED	True
20338	20866	24163369:0:TP53:NEK2	Local depletion of DNA methylation identifies a repressive [TF] regulatory region in the [TG] promoter.	p53	NEK2	2	REPRESSION	True
20342	20870	24276245:6:E2F1:ABCG2	We show that [TF] causes chemotherapeutic drug efflux both in vitro and in vivo via [TG].	E2F1	ABCG2	0	UNDEFINED	True
20348	20876	24366007:11:TP53:HMOX1	Collectively, these results suggest that nutlin-3 induces [TG] expression via the activation of both JNK which is dependent on ROS generated by [TF] translocated to the mitochondria and p38 MAPK which appears to be stimulated by a ROS-independent mechanism, and this HO-1 induction may inhibit nutlin-3-induced apoptosis, constituting a negative feedback loop of p53-induced apoptosis.	p53	HO-1	1	ACTIVATION	True
20358	20886	24633887:6:SUZ12:ROBO1	Furthermore, we found that [TF] silencing significantly reduced the expression levels of transcription factor transcription factor E2F1 (E2F1) as well as potential metastasis promoters Rho-associated, coiled-coil-containing protein kinase 1 (ROCK1) and roundabout homolog 1 ([TG]) through Western blot analysis.	SUZ12	ROBO1	1	ACTIVATION	True
20363	20891	25005473:6:MYRF:CDKN1C	Finally, we identify a muscle-specific regulatory element of [TG] directly activated by [TF]s in myoblasts but repressed by the Notch targets Hes1/Hey1 in progenitor cells.	MRF	p57(kip2)	1	ACTIVATION	True
20364	20892	25005473:7:MYRF:CDKN1C	We propose a molecular mechanism whereby information provided by Hes/Hey downstream of Notch as well as [TF] activities are integrated at the level of the [TG] enhancer to regulate the decision between progenitor cell maintenance and muscle differentiation.	MRF	p57(kip2)	0	UNDEFINED	True
20370	20898	7565760:0:MZF1:MYB	Overexpression of the zinc finger protein [TF] inhibits hematopoietic development from embryonic stem cells: correlation with negative regulation of CD34 and [TG] promoter activity.	MZF1	c-myb	2	REPRESSION	True
20377	20906	8093222:5:NFKB1:PCNA	The data suggest that E1A activates transcription of the [TG] gene by multiple mechanisms and that, of the known 243R-associated proteins, p300 and p107-cyclin A can mediate the response while [TF]-RB does not appear to participate.	p105	PCNA	1	ACTIVATION	True
20380	20909	8268720:5:EGR1:SERPINE2	The rat GDN/[TG] promoter contains five SP1 consensus sites, four consensus sites for the MyoD1 transcription factor, and one binding site for the transcription factors [TF], NGFI-C, Krox-20, and Wilms tumor factor.	NGFI-A	PN-1	0	UNDEFINED	True
20391	20921	9000129:4:USF1:PLAU	Here we present a characterization of the COM sequence: our results show that COM and COM-binding proteins ([TF], Urokinase Enhancer Factors) may play a structural role in the induction of the [TG] enhancer by phorbol-myristate-acetate (TPA).	UEF	uPA	1	ACTIVATION	True
20404	20934	9420275:10:CEBPZ:PSMB9	In addition, the affinities of [TF] for binding to the LMP-1, [TG], and CD23 promoters were also measured.	CBF2	LMP-2	0	UNDEFINED	True
20406	20936	9440807:5:NFKB1:ME1	Thus, iodide decreases the formation of Mod-1, an enhancer A complex involving the p50 subunit of [TF] and a c-fos family member, fra-2, which was previously shown to be important in the suppression of [TG] levels by hydrocortisone.	NF-kappa B	class I	2	REPRESSION	True
20407	20937	9502427:6:MYOG:MGP	However, cotransfection of the [TG] promoter with myogenic regulatory factors, including MyoD and [TF], produced less than 2-fold activation compared with 20-fold activation of the desmin promoter.	myogenin	MGP	1	ACTIVATION	True
20408	20938	9571207:0:TCF3:DBP	Regulation of the [TG] promoter by PAR proteins and in leukemic cells bearing an [TF]/HLF translocation.	E2A	DBP	0	UNDEFINED	True
20409	20939	9571207:6:TCF3:DBP	The [TG] promoter is active in the UOC-B1 cell line, which bears a 17:19 translocation resulting in the creation of an [TF]:HLF fusion protein.	E2A	DBP	1	ACTIVATION	True
20410	20940	9576927:3:STAT6:AGT	Gel mobility-shift assay revealed that STAT3 and [TF] are selectively activated by AngII treatment of cardiomyocytes in culture and bind to a sequence motif (St-domain) in the [TG] promoter to activate its transcription in transient transfection assay.	STAT6	angiotensinogen	0	UNDEFINED	True
20433	20963	18663147:7:CEBPZ:RUNX3	In in vitro studies, ectopically expressed RUNX1-ETO and [TF]-MYH11 also inhibited endogenous [TG] expression.	CBFbeta	RUNX3	2	REPRESSION	True
20436	20967	11340077:11:ELK1:PRL	Expression of [TF] converts CHO cells into a phenotype in which [TG] gene expression is increased by insulin treatment.	Elk-1	prolactin	1	ACTIVATION	True
20444	20975	21128246:0:RUNX3:MMP9	[TF] suppresses gastric cancer metastasis through inactivation of [TG] by upregulation of TIMP-1.	Runx3	MMP9	2	REPRESSION	True
20446	20977	20032313:0:STAT3:IL1RN	Uncovering an IL-10-dependent NF-kappaB recruitment to the [TG] promoter that is impaired in [TF] functionally defective patients.	STAT3	IL-1ra	0	UNDEFINED	True
20450	20981	17855430:7:SOX3:NODAL	This work shows that Tcf, [TF]B1 and Univin play essential roles in the regulation of [TG] expression in the sea urchin and suggests that some of the regulatory interactions controlling nodal expression predate the chordates.	Sox	nodal	0	UNDEFINED	True
20451	20982	20232316:0:STAT3:VEGFA	miR-20b modulates [TG] expression by targeting HIF-1 alpha and [TF] in MCF-7 breast cancer cells.	STAT3	VEGF	0	UNDEFINED	True
20452	20983	20232316:6:STAT3:VEGFA	Next, we investigated the molecular mechanism by which pre-miR-20b can affect [TG] transcription, focusing on hypoxia inducible factor 1 (HIF-1) and [TF] (STAT3), transcriptional inducers of VEGF and putative targets of miR-20b.	signal transducer and activator of transcription 3	VEGF	0	UNDEFINED	True
20455	20986	12488456:6:SOX2:FGF4	Previously, we implicated the co-activator p300 as a mediator of [TF]/Oct-3 synergistic activation of a heterologous promoter, suggesting that p300 may play a role in mediating enhancer activation of the [TG] gene.	Sox-2	FGF-4	1	ACTIVATION	True
20470	21001	12586756:12:AP1:MAPK1	ANP lead to activation of the transcription factor [TF], and subsequently of JNK, as well as of [TG].	AP-1	ERK	1	ACTIVATION	True
20478	21009	15684396:8:AP1:NOTCH4	Vascular angiogenic factors activated [TF] and reprogrammed the endogenous [TG] gene in HeLa cells from a repressed to a transcriptionally active state.	AP-1	NOTCH4	1	ACTIVATION	True
20533	21065	9573531:3:AP1:TREH	[TF] binding to the [TG] promoter is regulated by the quantity, composition and post-translational modifications of proteins in the AP-1 complex.	AP-1	TRE	0	UNDEFINED	True
20541	21073	16418168:8:ATF2:PTEN	We further found that p38 target transcriptional factor [TF] (ATF-2) bound to ATF sites in the [TG] promoter.	activating transcription factor-2	PTEN	0	UNDEFINED	True
20543	21075	17166845:6:ATF2:IL13	Cotransfection of an [TG] reporter construct with expression vectors for wild type or mutant CREB and [TF] showed that CREB, but not ATF-2, regulates CNS-1 enhancer activity.	ATF-2	IL13	0	UNDEFINED	True
20546	21078	17700520:6:ATF2:GADD45A	[TF] does not directly bind to the [TG] promoter; instead, it is recruited via Oct-1 and NF-I.	ATF-2	GADD45alpha	0	UNDEFINED	True
20550	21082	22628303:4:ATF2:REN	N-terminal phosphorylation of [TF], which controls its transactivation, is associated with downregulation of [TG] gene expression by the cytokine tumor necrosis factor- (TNF).	ATF2	renin	2	REPRESSION	True
20556	21089	7523851:8:ATF2:SELE	The organization of the TNF-alpha-inducible element of the [TG] promoter is remarkably similar to that of the virus-inducible promoter of the human beta interferon gene in that both promoters require NF-kappa B, [TF], and HMG I(Y).	ATF-2	E-selectin	0	UNDEFINED	True
20557	21090	7542214:4:ATF2:SELE	The organization of the cytokine-inducible element in the [TG] promoter is remarkably similar to that of the virus-inducible promoter of the human interferon-beta gene in that both promoters require NF-kappa B, [TF] (ATF-2), and high mobility group protein I(Y) for induction.	activating transcription factor-2	E-selectin	1	ACTIVATION	True
20560	21093	9317150:1:ATF2:SELE	TNF acts on the [TG] gene promoter at three kappa B elements and at a variant cAMP-responsive element that binds [TF]/c-Jun.	ATF2	E-selectin	0	UNDEFINED	True
20563	21096	16079301:0:ATF3:EGR1	Transcriptional regulation of [TF] involves the [TG] gene.	activating transcription factor 3	early growth response-1	0	UNDEFINED	True
20565	21098	18057093:2:ATF3:IRS2	We tested the hypothesis that [TF] (ATF3), a stress-inducible proapoptotic gene, downregulates the expression of [TG] in beta-cells.	activating transcription factor 3	IRS2	2	REPRESSION	True
20566	21099	18057093:4:ATF3:IRS2	We also analyzed the binding of [TF] to the [TG] promoter by chromatin immunoprecipitation assay and the transcription of the IRS2 gene by polymerase II occupancy assay.	ATF3	IRS2	0	UNDEFINED	True
20575	21108	24098051:7:ATF3:EGR1	Although [TF] induced by ribosomal inactivation regulated Nod2-induced [TG] expression epigenetically through the recruitment of histone deacetylase 1, NF-B regulation was associated with posttranscriptional regulation by ATF3 rather than epigenetic modification.	ATF3	EGR-1	0	UNDEFINED	True
20576	21109	21244365:6:ATF4:PTGS2	The reduction in intracellular ATP levels by HBx induced the unfolded protein response and [TG] expression through the eIF2 (eukaryotic initiation factor 2)/ATF4 ([TF]) pathway.	activating transcription factor 4	COX2	1	ACTIVATION	True
20577	21110	14592829:2:BHLHE23:SERPINE1	We have found that [TF] upregulates the expression of plasminogen activator inhibitor 1 ([TG]) in endothelial cells measured both at the level of mRNA and protein synthesis.	T beta 4	PAI-1	1	ACTIVATION	True
20578	21111	14592829:4:BHLHE23:SERPINE1	[TF] significantly activated the [TG] promoter in EA.hy 926 cells transiently transfected either with plasmid p800LUC containing PAI-1 promoter fragment (-800 to +71) or the PAI-1 promoter linked with green fluorescent protein.	T beta 4	PAI-1	1	ACTIVATION	True
20579	21112	14592829:5:BHLHE23:SERPINE1	[TF] mediated up-regulation of [TG] involved activation of the mitogen-activated protein kinase cascade.	T beta 4	PAI-1	1	ACTIVATION	True
20580	21113	14592829:8:BHLHE23:SERPINE1	Taken together, these data indicate that, in response to [TF] stimulation, AP-1 activity increases to enhance [TG] transcription through its unique AP-1-like element at -59 to -52 in the PAI-1 promoter.	T beta 4	PAI-1	1	ACTIVATION	True
20582	21115	18838394:8:BHLHE40:SREBF1	Our findings imply that [TF] and DEC2 are the mediators to repress [TG] gene in response to hypoxia.	Stra13	SREBP-1c	2	REPRESSION	True
20585	21118	21036460:10:CDX2:MUC5AC	[TF] increased the transcriptional activity of the Sox2 gene, and Sox2 increased the transcriptional activity of the [TG] gene, which was reduced by cotransfecion of Cdx2 together with Sox2 in the human gastric carcinoma cell line AGS.	Cdx2	Muc5Ac	1	ACTIVATION	True
20592	21125	16397300:4:CEBPG:PTGS2	NF-IL6beta could directly bind to [TF] (C/EBP) and cyclic AMP-response element (CRE) sites of the [TG] promoter by in vitro-DNA binding assay.	CCAAT/enhancer-binding protein	cox-2	0	UNDEFINED	True
20596	21129	19703903:2:CREB1:MCAM	Here, we demonstrate a novel signaling mechanism whereby protease-activated receptor 1 (PAR1) mediates expression of melanoma cell adhesion molecule MCAM/[TG] (MUC18), a critical marker of melanoma metastasis, via activation of platelet-activating factor receptor (PAFR) and cAMP-responsive element-binding protein ([TF]).	CREB	MUC18	1	ACTIVATION	True
20602	21135	21608077:6:DNMT3A:POU5F1	Upon differentiation, endogenous GCNF binds to the [TG] proximal promoter and differentially recruits MBD3 and MBD2 as well as [TF].	Dnmt3A	Oct4	0	UNDEFINED	True
20605	21138	12077144:10:E2F1:UBE2I	Chromatin immunoprecipitation experiments demonstrated that [TF] and E2F4 associate with the [TG] promoter in unperturbed cells.	E2F1	p18	0	UNDEFINED	True
20606	21139	12077144:6:E2F1:UBE2I	Mutational inactivation of these elements revealed that the Sp1 sites were important for the basal activity of the promoter but could also mediate the effects of [TF] on the [TG] promoter.	E2F1	p18	0	UNDEFINED	True
20607	21140	12077144:7:E2F1:UBE2I	Moreover, we found that [TF] and Sp1 can synergistically enhance the activity of the proximal [TG] promoter.	E2F1	p18	1	ACTIVATION	True
20616	21149	18408756:4:E2F1:MAP1LC3A	[TF]-mediated induction of [TG], ATG1 and DRAM is direct and indeed, endogenous E2F1 can be found bound to regions encompassing the promoters of these genes.	E2F1	LC3	1	ACTIVATION	True
20617	21150	21085677:8:E2F1:NFKB1	[TF] increases the levels of endogenous [TG] mRNA in breast carcinoma and other transformed cell lines.	E2F1	EBP1	1	ACTIVATION	True
20622	21156	24014887:0:E2F1:PDGFB	[TF] promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of [TG].	E2F1	PDGF-B	1	ACTIVATION	True
20670	21204	19307576:7:EGR1:IL10	In summary, our results showed that [TG] expression may be regulated by miR-106a, which is in turn transcriptionally regulated by [TF] and Sp1.	Egr1	IL-10	0	UNDEFINED	True
20695	21229	9242190:7:EGR1:FGF1	[TF] bound to the [TG] response element in the proximal PDGF-A promoter in a specific and time-dependent manner.	Egr-1	FGF-1	0	UNDEFINED	True
20698	21232	16622840:4:ERF:SERPINE1	[TG] repression (in G0) was associated with upstream stimulatory factor-1 (USF-1) occupancy of two consensus E box motifs (5'-CACGTG-3') at the PE1 and [TF] domains in the PF1 region (nucleotides -794 to -532) of the PAI-1 promoter.	PE2	PAI-1	2	REPRESSION	True
20704	21238	12032832:7:ESR2:ELF3	These results indicate that the [TG] promoter represents a transcriptional target of [TF]2, and ESX expression may represent a downstream mediator of ErbB2 signaling and ErbB2-induced gene expression.	ErbB	ESX	0	UNDEFINED	True
20752	21289	7609077:11:FOS:CNTN2	Finally, we have used anti-TFIIA antibody ([TF]) to ask if [TG] transactivation required TFIIA activity.	p55	Tax1	0	UNDEFINED	True
20760	21298	14521963:5:FOXA1:AFP	Besides known [TF]-regulated genes such as albumin and [TG] genes, the genes newly identified as the HNF-3alpha-regulated ones include three encoding CDP-diacylglycerol-inositol 3-phosphatidyltransferase, phosphatidylserine decarboxylase, and phospholipase A2, which are located en suite in the lipid metabolic pathway in liver.	HNF-3alpha	alpha-fetoprotein	0	UNDEFINED	True
20764	21302	22203039:8:FOXA1:KLF4	Furthermore, self-reinforcing regulatory loops for SLUG-KLF4 and SLUG-[TF] lead to SLUG-dependent binding of polycomb repressive complexes to the [TG] and Foxa1 promoters, silencing transcription and consolidating mesenchymal commitment.	FOXA1	Klf4	2	REPRESSION	True
20772	21310	11572852:2:FOXM1:AFP	We have shown that p53 represses hepatic-specific [TG] (AFP) gene expression by direct interaction with a composite [TF]/p53 DNA binding element.	HNF-3	alpha-fetoprotein	2	REPRESSION	True
20787	21325	23804320:10:FOXM1:CDKN1A	Nuclear translocation enhanced [TF] transcriptional activity and promoted its downstream target gene c-Myc expression that could inhibit [TG] expression.	FOXM1	p21	2	REPRESSION	True
20815	21355	20862322:7:FOXO3:PTEN	[TF] promotes increased transcription of Egr-1, which can further stimulate the transcription of [TG], thereby reinforcing the pathway that leads to FOXO3a transcriptional activation.	FOXO3a	PTEN	1	ACTIVATION	True
20819	21359	23624922:4:FOXO3:SPRY2	We found binding of -catenin to the [TG] promoter at [TF] response elements.	FOXO3a	SPRY2	0	UNDEFINED	True
20839	21379	15531578:3:HNF4A:SRF	The binding of the [TF] Elk-1 to the [TG] promoter and subsequent regulation of SRF expression occurs in a ternary complex-dependent manner.	TCF	SRF	0	UNDEFINED	True
20842	21382	19417216:1:HNF4A:EGR1	Transcript elongation by polymerase II paused at the [TG] promoter is activated by mitogen-activated protein kinase phosphorylation of the ternary complex factor ([TF]) ELK1 bound at multiple upstream sites and subsequent phospho-ELK1 interaction with mediator through the MED23 subunit.	TCF	Egr1	1	ACTIVATION	True
20843	21383	20019092:4:HNF4A:DKK1	We present evidence demonstrating that the Wnt inhibitor and beta-catenin/T-cell factor ([TF])-responsive gene DICKKOPF-1 ([TG]) is a transcriptional target of EWS/FLI1, which can inhibit both basal and beta-catenin-induced transactivation of the DKK-1 promoter.	TCF	DKK-1	0	UNDEFINED	True
20845	21385	23059951:4:HNF4A:EGR1	Expression of a dominant-negative mutant of the ternary complex factor ([TF]) Elk-1, a key transcriptional regulator of serum response element (SRE)-driven gene transcription, prevented [TG] expression.	TCF	Egr-1	1	ACTIVATION	True
20847	21387	11313255:5:HOXB6:SERPINE1	Luciferase (Luc) gene constructs driven by 766 and 276 base pairs of the 5'-flanking region of the [TG] gene were transfected into primary hepatocytes together with expression vectors encoding wild-type USF-2a and a USF-2a mutant lacking DNA binding and dimerization activity ([TF]).	DeltaHU2a	PAI-1	0	UNDEFINED	True
20862	21402	7678054:5:IRF8:ISG15	Similarly, [TF] repressed expression of chloramphenicol acetyltransferase reporters driven by the ISREs of the 2'-5' oligoadenylate synthetase, guanylate-binding protein, and [TG] genes in IFN-treated cells.	ICSBP	ISG-15	2	REPRESSION	True
20887	21434	18374905:3:JUN:PSEN1	We tested the role of [TF]-NH2-terminal kinase (JNK) on [TG] gene expression using a JNK specific inhibitor, SP600125.	c-jun	PS1	0	UNDEFINED	True
20888	21435	18604200:4:JUN:NOTCH1	The underlying mechanism for negative control of the [TG] gene in human cells, as well as in a mouse model of EGFR-dependent skin carcinogenesis, involves transcriptional suppression of p53 by the EGFR effector [TF].	c-Jun	Notch1	2	REPRESSION	True
20903	21453	24606718:0:JUN:BCL2	Hyaluronan-CD44 interaction promotes [TF] signaling and miRNA21 expression leading to [TG] expression and chemoresistance in breast cancer cells.	c-Jun	Bcl-2	1	ACTIVATION	True
20905	21455	7862133:8:JUN:LGALS4	Repression of [TG]:E2A was mediated by the basic leucine zipper regions of [TF], which are also the essential regions of this protein necessary for controlling ICE activator-stimulated expression in vivo.	c-Jun	GAL4	2	REPRESSION	True
20930	21482	12848620:2:KLF13:TAGLN	We show that recombinant [TF] binds to three TGGG motifs in the minimal [TG] promoter.	BTEB3	SM22alpha	0	UNDEFINED	True
20931	21483	12848620:4:KLF13:TAGLN	Transient transfection experiments show that [TF] also activates reporter gene expression from the [TG] promoter in VSMCs (vascular smooth muscle cells).	BTEB3	SM22alpha	1	ACTIVATION	True
20933	21485	10954723:6:KLF4:TAGLN	However, cotransfection studies in cultured cells showed that [TF] repressed the TGF-beta-dependent increases in [TG] alpha-smooth muscle actin promoter activities.	GKLF	SM22alpha and	2	REPRESSION	True
20941	21493	16823799:6:KLF8:CCND1	FAK also plays an important role in regulating cell cycle progression through transcriptional control of the [TG] promoter by the Ets B and Kruppel-like factor 8 ([TF]) transcription factors.	KLF8	cyclin D1	0	UNDEFINED	True
20955	21507	22384171:10:MAX:MYC	In agreement with these phenotypic changes, we show by q-RT-PCR that the treatment of HeLa cells with [TF] leads to the activation of the transcription [TG] repressed genes as well as the repression of the expression of c-Myc activated genes.	Max*	c-Myc	1	ACTIVATION	True
20967	21519	21242962:6:MLXIP:PLAU	[TG] is the target gene for [TF]-23b as the miR repressed uPA expression and interacted with the 3'-untranslated region of uPA mRNA.	miR	uPA	0	UNDEFINED	True
21041	21593	1986238:0:MYCN:MYC	Mechanism of endogenous [TG] gene down-regulation in E mu-[TF] tumors.	N-myc	myc	2	REPRESSION	True
21043	21595	21321994:0:MYOD1:FOXO1	Pax7-[TG] transcriptional activity is enhanced by transcriptionally repressed [TF].	MyoD	FKHR	2	REPRESSION	True
21047	21599	14565864:7:NFE2:TBXAS1	Ecotopic expression of [TF] related factors showed that Nrf2, but not Nrf1, Nrf3, or Bach1, activated [TG] promoter in a dose-dependent manner.	NF-E2	TXAS	1	ACTIVATION	True
21054	21607	14563845:0:NFKB:REN	Tumor necrosis factor-alpha activates [TF] to inhibit [TG] transcription by targeting cAMP-responsive element.	NFkappaB	renin	2	REPRESSION	True
21055	21608	14563845:4:NFKB:REN	Constitutive activation of [TF] suppressed [TG] gene transcription, but NFkappaB appeared not to target the NFkappaB binding sites in the renin promoter.	NFkappaB	renin	2	REPRESSION	True
21056	21609	14563845:5:NFKB:REN	Thus, [TF], but not the canonical NFkappaB binding sequences in the [TG] promoter, seemed to be involved in the suppression of renin transcription by TNFalpha.	NFkappaB	renin	2	REPRESSION	True
21062	21615	15024051:8:NFKB:NR4A1	The [TF] inhibition of [TG] transactivation was likely due to the competition of p65 for Nur77 binding with coactivators.	NF-kappaB	Nur77	2	REPRESSION	True
21063	21616	15081317:12:NFKB:HSPA1A	[TF] activation is necessary for the increase in [TG], suggesting that estrogen treatment activates NF kappa B, with subsequent HSF1 activation.	NF kappa B	HSP72	1	ACTIVATION	True
21071	21624	15381721:7:NFKB:CTSK	We therefore conclude that IL-1alpha up-regulates [TG] gene expression at the transcription level, and this regulation may be via the tyrosine-kinase-[TF] pathway.	NF-kappaB	cathepsin K	1	ACTIVATION	True
21085	21638	15857826:3:NFKB:REN	Here we aimed to further clarify the role of [TF] and the canonical CRE-binding proteins of the CRE-binding protein/activating transcription factor (CREB/ATF) family in the inhibition of [TG] gene expression by TNFalpha in the juxtaglomerular cell line As4.1.	NFkappaB	renin	2	REPRESSION	True
21086	21639	15857826:6:NFKB:REN	Our results suggest that TNFalpha inhibits [TG] gene expression by decreasing the transactivating capacity of [TF]-p65 and partially by attenuating CREB1 binding to CRE.	NFkappaB	renin	1	ACTIVATION	True
21087	21640	15894614:7:NFKB:CDX1	These effects were primarily mediated by [TF] signaling but only occurred when the [TG] promoter was unmethylated or partially methylated.	NF-kappaB	CDX1	0	UNDEFINED	True
21088	21641	15901641:7:NFKB:MIF	Taken together, these findings clearly show that IL1B up-regulates the expression of [TG] in endometrial stromal cells in vitro and acts via [TF].	NFkappaB	MIF	1	ACTIVATION	True
21090	21643	15983725:8:NFKB:GADD45B	Hair cell death occurred through an apoptotic pathway through activation of caspase-3 and may involve transcriptional down-regulation of the [TG] gene, an anti-apoptotic [TF] target.	NF-kappaB	gadd45beta	0	UNDEFINED	True
21108	21661	17289052:10:NFKB:TRPC1	An electrophoretic mobility shift assay showed that Ang II increased the [TG] promoter's [TF] binding activity.	NF-kappaB	TRPC1	0	UNDEFINED	True
21109	21662	17296613:11:NFKB:CREB3	Chemotaxis analysis showed that [TG] expression because of the [TF] subfamily is specifically involved in Lkn-1-induced chemotaxis.	NF-kappaB	LZIP	0	UNDEFINED	True
21121	21674	17540846:6:NFKB:PTPN6	Chromatin immunoprecipitation studies demonstrated that [TF] dissociates from the [TG] P2 promoter following the binding of Tax and HDAC1.	NF-kappaB	SHP-1	0	UNDEFINED	True
21142	21695	18508759:10:NFKB:DUSP1	Together, these results suggest that [TG] is a [TF]-mediated prosurvival effector in attenuating JNK-mediated pro-apoptotic response; NF-kappaB/MKP-1-mediated negative JNK regulation represents a potential therapeutic target for adjusting cell radiosensitivity.	NF-kappaB	MKP-1	0	UNDEFINED	True
21143	21696	18511806:5:NFKB:CCR5	Using in vitro assays, we determined that neither IRF-1 nor [TF] is involved in the activation of the [TG] promoter.	NF-kappaB	CCR5	1	ACTIVATION	True
21146	21699	18652825:7:NFKB:STC1	A cotreatment of HT29 cells with a [TF] inhibitor (parthenolide) significantly inhibited the TSA-induced cellular levels of acetyl NFkappaB p65 and abolished the stimulation of [TG] gene expression.	NFkappaB	STC1	1	ACTIVATION	True
21148	21701	18752316:2:NFKB:NQO1	In the current study, we examined the role of redox-sensitive transcription factors, [TF] and AP-1 signaling pathways in the modulation of [TG] by heavy metals.	NF-kappaB	Nqo1	0	UNDEFINED	True
21149	21702	18764868:7:NFKB:OLFM4	Inhibition of the ERK pathway remarkably decreased [TG] expression and this inhibition required [TF] transcription factor.	NF-kappaB	OLFM4	2	REPRESSION	True
21155	21708	18948549:4:NFKB:PTPN6	We have shown previously that human T cell lymphotropic virus type-1 (HTLV-1) Tax-induced promoter silencing (TIPS) is an early event causing down-regulation of [TG] expression, which is dependent on [TF].	NF-kappaB	SHP-1	2	REPRESSION	True
21160	21713	19275551:5:NFKB:PPIG	Second, [TF] indirectly regulates the transcription of [TG] genes through mutual repression with some nuclear receptors that are involved in CYP regulation such as AhR, CAR, GR, PXR, RXR, PPAR, FXR, and LXR.	NF-kappaB	CYP	0	UNDEFINED	True
21161	21714	19275551:9:NFKB:PPIG	Therefore, we propose that [TF] could be one of the links between inflammation, oxidative stress, and [TG] regulation in these diseases.	NF-kappaB	CYP	0	UNDEFINED	True
21164	21717	19433777:10:NFKB:REN	Our data further suggest that tumor necrosis factor-alpha decreases [TG] expression through both [TF]-dependent and NFkappaB-independent mechanisms, the latter involving the production of reactive oxygen species.	NFkappaB	renin	2	REPRESSION	True
21172	21725	19945465:11:NFKB:HSPD1	TNFalpha treatment was used to test the role of [TF] activation in [TG] expression in a cardiac cell line.	NFkappaB	HSP60	0	UNDEFINED	True
21175	21728	20006706:8:NFKB:RHOA	The findings also suggest that STAT6 and [TF] are important for the upregulation of [TG] in human BSM induced by IL-13 and TNF-alpha, both of which are major cytokines in the pathogenesis of allergic bronchial asthma.	NF-kappaB	RhoA	1	ACTIVATION	True
21181	21734	20357818:6:NFKB:CD44	In gel shift assays, the initial binding of p100/p52 [TF], C/EBP-beta, and Egr-1 to the [TG] promoter experienced reshuffling toward increased affinity of C/EBP-beta after HGF stimulation.	NF-kappaB	CD44	0	UNDEFINED	True
21186	21739	20814569:10:NFKB:NOTCH1	We propose that in dystrophic muscles, elevated levels of TNFalpha and [TF] inhibit the regenerative potential of satellite cells via epigenetic silencing of the [TG] gene.	NF-kappaB	Notch-1	2	REPRESSION	True
21189	21742	21850191:8:NFKB:CASP3	WB experiments and luciferase reporter assays showed that NF-B-inducible BCL2-associated X protein (Bax) and a pro-apoptotic factor, activated [TG] were expressed in the retina of [TF]-deficient mice as well as NMDA-treated RGC-5 cells.	p50	caspase 3	0	UNDEFINED	True
21191	21744	23660387:9:NFKB:EDN1	This treatment favoured the [TG] repressional control, taking place at the level of mRNA stability due to the 3'-untranslated region in the ET-1 gene, and also decreased transcription via [TF].	NF-kB	ET-1	1	ACTIVATION	True
21193	21746	23939288:5:NFKB:NBPF1	The activities of NF-B in HeLa, HepG2 and ECa109 cells were then manipulated with NF-B activator (TNF) and inhibitors (BAY11-7082 or [TF] siRNA), and the expressions of [TG] genes in these cells were checked.	p65	NBPF	0	UNDEFINED	True
21202	21755	8754826:7:NFKB:ORM1	Furthermore, extracellular stimuli that are known to be [TF] inducers can selectively activate the [TG] gene by cooperating with one of the two activator forms of AGP/EBP.	NF-kappaB	agp	1	ACTIVATION	True
21209	21762	9456329:0:NFKB:ITGA2	A three-dimensional collagen lattice activates [TF] in human fibroblasts: role in [TG] gene expression and tissue remodeling.	NF-kappaB	integrin alpha2	0	UNDEFINED	True
21210	21763	9456329:7:NFKB:ITGA2	Therefore, an indirect regulatory mechanism by [TF] in [TG] gene expression induced by three-dimensional collagen lattice is suggested.	NF-kappaB	integrin alpha2	0	UNDEFINED	True
21225	21779	16990795:3:NFKB2:CCND1	However, stimulation of [TG] expression alone cannot account for all the cell cycle effects of [TF]/p100 and we also find that p52 represses expression of the Cyclin-dependent kinase inhibitor p21(WAF/CIP1).	p52	Cyclin D1	1	ACTIVATION	True
21227	21781	19219072:3:NFKB2:MMP9	We show here that [TG] gene expression is induced through the alternative NF-kappaB-activating pathway in fibroblasts and also on Hut-78 or [TF] overexpression in fibroblasts as well as in lymphoma cells.	p52	MMP9	1	ACTIVATION	True
21230	21785	16436500:11:NR0B2:POU2F1	In addition, bile acid-inducible transcriptional repressor, small heterodimer partner ([TF]), inhibited activation of the reporter-linked h[TG] promoter and of the endogenous hOCT1 gene by HNF-4alpha.	SHP	OCT1	2	REPRESSION	True
21251	21806	20599696:11:NRF1:USF1	[TF] also suppressed endogenous [TG] transcriptional activity by 55+/-6.2% (p<0.001 vs. control).	NRF-1	USF1	2	REPRESSION	True
21252	21807	9927187:7:NRG1:PTGS2	Activation of the HER2/HER3 pathway by [TF] induced the activation of [TG] promoter, expression of COX-2 mRNA, COX-2 protein and accumulation of prostaglandin E2 in the culture medium.	NDF	COX-2	1	ACTIVATION	True
21262	21817	12391146:4:POU2F1:LGALS4	In the breast cancer cell line MCF-7, overexpression of [TF] or its POU domain strongly increases transcriptional activation of cyclin D1 and [TG] reporter genes that is specifically dependent upon CREB but independent of Oct-1 DNA binding.	Oct-1	GAL4	1	ACTIVATION	True
21265	21820	18390905:5:POU2F1:PPIG	Oxidative stress resulted in activation of [TF], a transcriptional repressor of various vascular cytochrome P450 ([TG]) monooxygenases.	Oct-1	CYP	2	REPRESSION	True
21266	21821	18390905:9:POU2F1:PPIG	Small interference RNA-mediated functional knockdown of [TF] prevented oxLDL-mediated silencing of [TG] expression.	Oct-1	CYP	2	REPRESSION	True
21287	21842	21311674:8:REL:NOS2	Collectively, the results of the series of experiments indicate that magnolol inhibits [TG] gene expression by blocking NF-B/[TF] and p38 kinase signaling.	Rel	iNOS	1	ACTIVATION	True
21288	21843	9679644:0:REL:NOS2	Inhibition of NF-kappa B/[TF] nuclear translocation by dexamethasone: mechanism for the inhibition of [TG] gene expression.	Rel	iNOS	1	ACTIVATION	True
21289	21844	9679644:6:REL:NOS2	These results suggest that DEX may inhibit [TG] gene expression by a mechanism involving the blockade of LPS-induced nuclear translocation of NF-kappa B/[TF].	Rel	iNOS	1	ACTIVATION	True
21290	21845	15024051:8:RELA:NR4A1	The NF-kappaB inhibition of [TG] transactivation was likely due to the competition of [TF] for Nur77 binding with coactivators.	p65	Nur77	2	REPRESSION	True
21300	21856	18652825:7:RELA:STC1	A cotreatment of HT29 cells with a NFkappaB inhibitor (parthenolide) significantly inhibited the TSA-induced cellular levels of acetyl NFkappaB [TF] and abolished the stimulation of [TG] gene expression.	p65	STC1	1	ACTIVATION	True
21333	21894	20595680:4:SMAD2:TIMP1	In vitro, [TF] knockdown in tubular epithelial cells increased expression of collagen I, collagen III, and [TG] and decreased expression of the matrix-degrading enzyme MMP-2 in response to TGF-beta1 compared with similarly treated wild-type cells.	Smad2	TIMP-1	2	REPRESSION	True
21336	21897	12718878:2:SMAD3:ID1	Opposite responses of [TG] to TGFbeta and the related factor BMP are dictated by the specific ability of the TGFbeta mediator, [TF], to activate expression of stress response factor ATF3 and then recruit this factor to the Id1 promoter.	Smad3	Id1	0	UNDEFINED	True
21399	21961	23255602:11:SMAD7:CASP8	In conclusion, we suggest a novel role for [TF] as a transcriptional coactivator for [TG] through the interaction with IRF1 in regulation of the cell death pathway.	Smad7	caspase 8	1	ACTIVATION	True
21407	21969	2216458:4:SP1:ETS2	This region includes half of the lengthy polypyrimidine (CT) tract of the [TG] promoter, one [TF] and the GC element proximal to the initiation site.	Sp1 binding site	ETS-2	0	UNDEFINED	True
21420	21982	15055356:0:STAT1:IGF1R	[TF] (STAT1), but not STAT5b, regulates [TG] gene expression in an osteosarcoma cell line.	Signal transducer and activator of transcription-1	IGF-I receptor	0	UNDEFINED	True
21422	21984	16380218:6:STAT1:TRIP6	[TF] specific inhibitor, fludarabine (50 muM) abolished IFN-gamma stimulated [TG] gene promoter activity.	Stat-1	OIP-1	1	ACTIVATION	True
21425	21987	19124747:4:STAT1:FOXP3	In the present study, the effect of Th1 cytokines on human T regulatory cell differentiation was analyzed at epigenetic and gene expression levels and reveals a mechanism by which the [TF]-activating cytokines IL-27 and IFN-gamma amplify TGF-beta-induced [TG] expression.	STAT1	FOXP3	1	ACTIVATION	True
21434	21996	24285265:5:STAT1:SLPI	The role of [TF] in regulating [TG] expression was further elucidated using WT and stat1(-/-) mice.	STAT1	SLPI	0	UNDEFINED	True
21435	21997	24907345:8:STAT1:HTRA1	Mechanistically, IFN- negatively controls [TG] expression through activation of p38 MAPK/[TF] pathway.	STAT1	HTRA1	2	REPRESSION	True
21475	22038	23820254:0:STAT3:RECK	[TF] upregulates miR-92a to inhibit [TG] expression and to promote invasiveness of lung cancer cells.	STAT3	RECK	2	REPRESSION	True
21476	22039	23820254:10:STAT3:RECK	We demonstrate that [TF] upregulates miR-92a to repress [TG] via post-transcriptional inhibition.	STAT3	RECK	2	REPRESSION	True
21488	22051	22711989:6:TBP:CCND1	Release of TAF7 from [TF] by TAF1 phosphorylation of TAF7 increased TAF1 HAT activity and elevated histone H3 acetylation levels at the [TG] and cyclin A promoters.	TFIID	cyclin D1	0	UNDEFINED	True
21513	22076	20647772:5:TP53:BRD7	We further found low [TG] expression specifically in a subgroup of human breast tumors harboring wild-type, but not mutant, [TF] and showed that one of the responsible mechanisms is deletion of the BRD7 gene locus.	p53	BRD7	1	ACTIVATION	True
21521	22084	17496887:8:TP73:JUN	Furthermore, c-Jun-dependent [TG] transcriptional activity was augmented by [TF] and, consistently, induction of endogenous AP-1 target genes was compromised in the absence of p73.	p73	AP-1	1	ACTIVATION	True
21525	22088	12063293:2:USF1:MYH6	An E-box hemodynamic response element (HME) located at position -47 within the [TG] promoter is both necessary and sufficient to confer contractile responsiveness to the gene and has been shown to bind upstream stimulatory factor-1 ([TF]).	USF1	alpha-MHC	0	UNDEFINED	True
21526	22089	12063293:3:USF1:MYH6	When studied in spontaneously contracting cardiac myocytes, there is enhanced binding of [TF] to the HME compared with quiescent cells, which correlates with a threefold increase in [TG] promoter activity.	USF1	alpha-MHC	1	ACTIVATION	True
21548	22111	19402223:8:YY1:NOS2	Lipopolysaccharide, an inflammatory stimulating factor, could induce [TF] to augment DNA-binding affinity; it could also be involved in the inhibited transcriptional activity of the [TG] promoter with allele C.	YY1	iNOS	2	REPRESSION	True
21550	22113	21406062:5:YY1:MAT2A	IGF-1 induced [TG] promoter activity and increased nuclear protein binding to USF (upstream stimulatory factor)/c-Myb, [TF] (Yin and Yang 1), E2F, AP-1 (activator protein 1) and NF-B (nuclear factor B) consensus elements.	YY1	MAT2A	0	UNDEFINED	True
21555	22118	22937159:7:YY1:GSTM1	Transfection experiments with a reporter gene under the control of the [TG] promoter revealed that [TF] binding to BM1 and BM4 independently repressed the promoter.	YY1	muPARP-1	2	REPRESSION	True
21563	22126	19244234:7:ZBTB7A:TP53	[TF] acted as a competitive transcriptional repressor of [TG] and Sp1 and was shown to bind the proximal Sp1-3 GC-box and the distal p53-responsive elements of p21.	FBI-1	p53	2	REPRESSION	True
